PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Khan, D; Sharathchandra, A; Ponnuswamy, A; Grover, R; Das, S				Khan, D.; Sharathchandra, A.; Ponnuswamy, A.; Grover, R.; Das, S.			Effect of a natural mutation in the 5 ' untranslated region on the translational control of p53 mRNA	ONCOGENE			English	Article						p53 mRNA; translational control; SNP; IRES; PTB; internal initiation	CELL-CYCLE; ENTRY SITE; POLYMORPHISM; MECHANISM; BINDING; TP53; PTB	Tumor-suppressor protein p53, the 'guardian of the genome', is critical in maintaining cellular homeostasis and genomic stability. Earlier, we have reported the discovery of internal ribosome entry sites (IRESs) within the p53 mRNA that regulate the translation of the full length and its N-terminal-truncated isoform, Delta N-p53. Polypyrimidine tract-binding protein (PTB) is an IRES trans-acting factor that positively regulates the IRES activities of both p53 isoforms by relocating from nucleus to the cytoplasm during stress conditions. Here we have demonstrated the putative contact points of PTB on the p53 IRES RNA. Studies on mutations that occur naturally in the 5' untranslated region (5' UTR) in p53 mRNA were lacking. We have investigated a naturally occurring C-to-T single-nucleotide polymorphism (SNP) first reported in human melanoma tumors. This SNP is at position 119 in the 5' UTR of p53 mRNA and we demonstrate that it has consequences on the translational control of p53. Introduction of this SNP has led to decrease in cap-independent translation from p53 5' UTR in bicistronic reporter assay. Further, the effects of this SNP on cap-independent translation have been studied in the context of p53 cDNA as well. Interestingly, the 5' UTR with this SNP has shown reduced binding to PTB that can be corroborated to its weaker IRES activity. Previously, it has been shown that G2-M checkpoint, DNA-damaging stress and oncogenic insult favor IRES-mediated translation. Under similar conditions, we demonstrate that this SNP interferes with the enhancement of the IRES activity of the 5' UTR. Taken together, the results demonstrate for the first time that SNP in the 5' UTR of the p53 mRNA might have a role in translational control of this critical tumor-suppressor gene.	[Khan, D.; Sharathchandra, A.; Ponnuswamy, A.; Grover, R.; Das, S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Das, S (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	sdas@mcbl.iisc.ernet.in		Khan, Debjit/0000-0001-5568-3361; Arandkar, Sharathchandra/0000-0001-6160-6338	CSIR, India; IFCPAR	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); IFCPAR	We are grateful to Professor Robin Fahraeus (INSERM, France) for sharing the pcDNA3-GFP-hp-p53-5' UTR-cDNA construct with us. Professor Julian Downward (London Research Institute, UK) and Professor Annapoorni Rangarajan (Department of Molecular Reproduction and Developmental Genetics, IISc) are duly acknowledged for sharing the pBabe-H-Ras<SUP>V12</SUP> construct and anti-Ras antibody. We thank Professor K Somasundaram for sharing the WWP-Luciferase construct and Professor KN Balaji for providing anti-caspase-3 antibody. We also thank the FACS facility (Division of Biological Sciences, IISc) headed by Dr Omana Joy for the acquisition of the flow-cytometric data. We thank the present and past SD Lab members for critical discussion of the work and Ranjitha Tatineni for her help with the phylogenetic analysis. DK and SA are supported by pre-doctoral fellowships from CSIR, India. This work was partly supported by an Indo-French grant from IFCPAR to SD.	ARA S, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bhattacharyya Sankar, 2006, RNA Biol, V3, P60; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Li XX, 2005, J BIOL CHEM, V280, P24245, DOI 10.1074/jbc.M414637200; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; Pudi R, 2004, J BIOL CHEM, V279, P29879, DOI 10.1074/jbc.M403417200; Ray AJ, 2002, INFECT CONT HOSP EP, V23, P474, DOI 10.1086/502090; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Soto JL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-36; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483	28	28	29	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4148	4159		10.1038/onc.2012.422	http://dx.doi.org/10.1038/onc.2012.422			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23027126				2022-12-25	WOS:000323748500010
J	Ehira, S; Ohmori, M				Ehira, Shigeki; Ohmori, Masayuki			The Redox-sensing Transcriptional Regulator RexT Controls Expression of Thioredoxin A2 in the Cyanobacterium Anabaena sp Strain PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HETEROCYST DEVELOPMENT; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; SIGMA-FACTOR; SP PCC-7120; NITROGEN; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; REPRESSOR; GROWTH	Thioredoxins are ubiquitous proteins that catalyze thiol-disulfide redox reactions. They have a crucial role in the oxidative stress response as well as the redox regulation of metabolic enzymes. In cyanobacteria, little is known about the regulation of trx gene expression despite the importance of thioredoxins in cellular functions. In the present study, transcriptional regulation of the trx genes under oxidative stress conditions was investigated in the heterocystous cyanobacterium Anabaena sp. strain PCC 7120. When cells were exposed to H2O2, only the trxA2 gene (all1866) of seven trx genes was induced. Disruption of the rexT gene (alr1867), encoding a transcriptional regulator of the ArsR family, resulted in increased expression of trxA2. RexT bound to the region downstream of the transcription initiation site of trxA2. The DNA binding activity of RexT was impaired by H2O2 through the formation of an intramolecular disulfide bond, which induced expression of the trxA2 gene. The inactivated DNA binding activity of RexT was restored by reduced TrxA2. Hence, RexT is considered as a redox-sensing transcriptional repressor of trxA2. These results support the idea that the RexT-TrxA2 regulatory system is important for the oxidative stress response in this cyanobacterium.	[Ehira, Shigeki; Ohmori, Masayuki] Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, Tokyo 1128551, Japan; [Ehira, Shigeki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan	Chuo University; Japan Science & Technology Agency (JST)	Ohmori, M (corresponding author), Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	ohmori@bio.chuo-u.ac.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367	PRESTO of the Japan Science and Technology Agency; Japan Society for the Promotion of Science [23603005]	PRESTO of the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by PRESTO of the Japan Science and Technology Agency (to S. E.) and Grant-in-aid for Scientific Research (C) 23603005 from the Japan Society for the Promotion of Science (to S. E.).	BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; COSSAR JD, 1984, J GEN MICROBIOL, V130, P991; DAI HP, 1992, J PHOTOCH PHOTOBIO B, V16, P285; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ehira S, 2011, J BIOL CHEM, V286, P38109, DOI 10.1074/jbc.M111.289124; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Florencio FJ, 2006, PHOTOSYNTH RES, V89, P157, DOI 10.1007/s11120-006-9093-5; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Guimaraes BG, 2011, J BIOL CHEM, V286, P26148, DOI 10.1074/jbc.M111.234039; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lechno-Yossef S, 2011, J BACTERIOL, V193, P3482, DOI 10.1128/JB.05010-11; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Tichy M, 1999, J BACTERIOL, V181, P1875, DOI 10.1128/JB.181.6.1875-1882.1999; UDVARDY J, 1984, J BACTERIOL, V157, P681, DOI 10.1128/JB.157.2.681-683.1984; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0; Zhao WX, 2007, MOL MICROBIOL, V66, P1219, DOI 10.1111/j.1365-2958.2007.05994.x; Zhao WX, 2007, PLANT CELL PHYSIOL, V48, P563, DOI 10.1093/pcp/pcm025	39	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40433	40440		10.1074/jbc.M112.384206	http://dx.doi.org/10.1074/jbc.M112.384206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027868	Green Published, hybrid			2022-12-25	WOS:000311448800034
J	Veverka, V; Baker, T; Redpath, NT; Carrington, B; Muskett, FW; Taylor, RJ; Lawson, ADG; Henry, AJ; Carr, MD				Veverka, Vaclav; Baker, Terry; Redpath, Nicholas T.; Carrington, Bruce; Muskett, Frederick W.; Taylor, Richard J.; Lawson, Alastair D. G.; Henry, Alistair J.; Carr, Mark D.			Conservation of Functional Sites on Interleukin-6 and Implications for Evolution of Signaling Complex Assembly and Therapeutic Intervention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; CYTOKINE RECEPTOR; NMR ASSIGNMENT; GP130; DYNAMICS; DOMAIN; IL-6; SEQUENCE; MTOR; ACID	A number of secreted cytokines, such as interleukin-6 (IL-6), are attractive targets for the treatment of inflammatory diseases. We have determined the solution structure of mouse IL-6 to assess the functional significance of apparent differences in the receptor interaction sites (IL-6R alpha and gp130) suggested by the fairly low degree of sequence similarity with human IL-6. Structure-based sequence alignment of mouse IL-6 and human IL-6 revealed surprising differences in the conservation of the two distinct gp130 binding sites (IIa and IIIa), which suggests a primacy for site III-mediated interactions in driving initial assembly of the IL-6/IL-6R alpha/gp130 ternary complex. This is further supported by a series of direct binding experiments, which clearly demonstrate a high affinity IL-6/IL-6R alpha-gp130 interaction via site III but only weak binding via site II. Collectively, our findings suggest a pathway for the evolution of the hexameric, IL-6/IL-6R alpha/gp130 signaling complex and strategies for therapeutic targeting. We propose that the signaling complex originally involved specific interactions between IL-6 and IL-6R alpha (site I) and between the D1 domain of gp130 and IL-6/IL-6R alpha (site III), with the later inclusion of interactions between the D2 and D3 domains of gp130 and IL-6/IL-6R alpha (site II) through serendipity. It seems likely that IL-6 signaling benefited from the evolution of a multipurpose, nonspecific protein interaction surface on gp130, now known as the cytokine binding homology region (site II contact surface), which fortuitously contributes to stabilization of the IL-6/IL-6R alpha/gp130 signaling complex.	[Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Baker, Terry; Redpath, Nicholas T.; Carrington, Bruce; Taylor, Richard J.; Lawson, Alastair D. G.; Henry, Alistair J.] UCB Pharma, Slough SL1 4EN, Berks, England; [Veverka, Vaclav] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic	University of Leicester; UCB Pharma SA; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996				Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doreleijers J. F., 2012, J BIOMOL NM IN PRESS; Finckh A, 2008, CURR OPIN RHEUMATOL, V20, P269, DOI 10.1097/BOR.0b013e3282fa13b4; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Moritz RL, 1999, GROWTH FACTORS, V16, P265, DOI 10.3109/08977199909069145; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SIMPSON RJ, 1988, EUR J BIOCHEM, V176, P187, DOI 10.1111/j.1432-1033.1988.tb14267.x; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TANABE O, 1988, J IMMUNOL, V141, P3875; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Xu GY, 1997, J MOL BIOL, V268, P468, DOI 10.1006/jmbi.1997.0933	32	14	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405597	http://dx.doi.org/10.1074/jbc.M112.405597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027872	hybrid, Green Published			2022-12-25	WOS:000311233800071
J	Burrows, AC; Prokop, J; Summers, MK				Burrows, Amy C.; Prokop, John; Summers, Matthew K.			Skp1-Cul1-F-box Ubiquitin Ligase (SCF beta TrCP)-mediated Destruction of the Ubiquitin-specific Protease USP37 during G(2)-phase Promotes Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF-BETA-TRCP; S-PHASE ENTRY; CELL-CYCLE; DNA-DAMAGE; ANAPHASE; DEGRADATION; CHECKPOINT; COMPLEX; PROGRESSION; BOX	Ubiquitin-mediated proteolysis is a key regulatory process in cell cycle progression. The Skp1-Cul1-F-box (SCF) and anaphase-promoting complex (APC) ubiquitin ligases target numerous components of the cell cycle machinery for destruction. Throughout the cell cycle, these ligases cooperate to maintain precise levels of key regulatory proteins, and indirectly, each other. Recently, we have identified the deubiquitinase USP37 as a regulator of the cell cycle. USP37 expression is cell cycle-regulated, being expressed in late G(1) and ubiquitinated by APC(Cdh1) in early G(1). Here we report that in addition to destruction at G(1), a major fraction of USP37 is degraded at the G(2)/M transition, prior to APC substrates and similar to SCF beta TrCP substrates. Consistent with this hypothesis, USP37 interacts with components of the SCF in a beta TrCP-dependent manner. Interaction with beta TrCP and subsequent degradation is phosphorylation-dependent and is mediated by the Polo-like kinase (Plk1). USP37 is stabilized in G(2) by depletion of beta TrCP as well as chemical or genetic manipulation of Plk1. Similarly, mutation of the phospho-sites abolishes beta TrCP binding and renders USP37 resistant to Plk1 activity. Expression of this mutant hinders the G(2)/M transition. Our data demonstrate that tight regulation of USP37 levels is required for proper cell cycle progression.	[Burrows, Amy C.; Prokop, John; Summers, Matthew K.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Summers, MK (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	summerm@ccf.org			Lerner Research Institute; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Lerner Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by seed funds provided by the Lerner Research Institute (to M.K.S.).	Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g	44	31	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39021	39029		10.1074/jbc.M112.390328	http://dx.doi.org/10.1074/jbc.M112.390328			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027877	Green Published, hybrid			2022-12-25	WOS:000310982800058
J	Canzoneri, E; Magosso, E; Serino, A				Canzoneri, Elisa; Magosso, Elisa; Serino, Andrea			Dynamic Sounds Capture the Boundaries of Peripersonal Space Representation in Humans	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SOMATOSENSORY MULTISENSORY INTERACTIONS; ENDOGENOUS SPATIAL ATTENTION; VISUAL RECEPTIVE-FIELDS; COMPLEX MOVEMENTS; PARIETAL CORTEX; REAR SPACE; AUDIOTACTILE INTERACTIONS; POSTERIOR PARIETAL; CROSSMODAL LINKS	Background: We physically interact with external stimuli when they occur within a limited space immediately surrounding the body, i.e., Peripersonal Space (PPS). In the primate brain, specific fronto-parietal areas are responsible for the multisensory representation of PPS, by integrating tactile, visual and auditory information occurring on and near the body. Dynamic stimuli are particularly relevant for PPS representation, as they might refer to potential harms approaching the body. However, behavioural tasks for studying PPS representation with moving stimuli are lacking. Here we propose a new dynamic audio-tactile interaction task in order to assess the extension of PPS in a more functionally and ecologically valid condition. Methodology/Principal Findings: Participants vocally responded to a tactile stimulus administered at the hand at different delays from the onset of task-irrelevant dynamic sounds which gave the impression of a sound source either approaching or receding from the subject's hand. Results showed that a moving auditory stimulus speeded up the processing of a tactile stimulus at the hand as long as it was perceived at a limited distance from the hand, that is within the boundaries of PPS representation. The audio-tactile interaction effect was stronger when sounds were approaching compared to when sounds were receding. Conclusion/Significance: This study provides a new method to dynamically assess PPS representation: The function describing the relationship between tactile processing and the position of sounds in space can be used to estimate the location of PPS boundaries, along a spatial continuum between far and near space, in a valuable and ecologically significant way.	[Canzoneri, Elisa; Serino, Andrea] ALMA MATER STUDIORUM Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Canzoneri, Elisa; Serino, Andrea] Ctr Studi Ric & Neurosci Cognit, Cesena, Italy; [Magosso, Elisa] ALMA MATER STUDIORUM Univ Bologna, Dipartimento Elettron Informat & Sistemist, Bologna, Italy	University of Bologna; University of Bologna	Serino, A (corresponding author), ALMA MATER STUDIORUM Univ Bologna, Dipartimento Psicol, Bologna, Italy.	andrea.serino@unibo.it		Magosso, Elisa/0000-0002-4673-2974	Volkswagen Stiftung grant [85 639]	Volkswagen Stiftung grant(Volkswagen)	This work was supported by a Volkswagen Stiftung grant (the_unboundbody_project, ref. 85 639; www.unboundbody.eu) to AS. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspell JE, 2010, EUR J NEUROSCI, V31, P1868, DOI 10.1111/j.1460-9568.2010.07210.x; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Bruns P, 2010, EXP PSYCHOL, V57, P267, DOI 10.1027/1618-3169/a000032; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Farne A, 2002, J COGNITIVE NEUROSCI, V14, P1030, DOI 10.1162/089892902320474481; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gillmeister H, 2007, BRAIN RES, V1160, P58, DOI 10.1016/j.brainres.2007.03.041; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1993, EXP BRAIN RES, V97, P96; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hall DA, 2003, CURR BIOL, V13, pR91, DOI 10.1016/S0960-9822(03)00034-4; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Jacobs S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00089; Kitagawa N, 2005, EXP BRAIN RES, V166, P528, DOI 10.1007/s00221-005-2393-8; Ladavas E, 1998, BRAIN, V121, P2317, DOI 10.1093/brain/121.12.2317; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Lloyd DM, 2003, PERCEPT PSYCHOPHYS, V65, P901, DOI 10.3758/BF03194823; Longo MR, BEHAV BRAIN IN PRESS; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Makin TR, 2009, J NEUROSCI, V29, P11841, DOI 10.1523/JNEUROSCI.2955-09.2009; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Occelli V, 2011, NEUROSCI BIOBEHAV R, V35, P589, DOI 10.1016/j.neubiorev.2010.07.004; Occelli V, 2010, EXP BRAIN RES, V203, P517, DOI 10.1007/s00221-010-2255-x; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Ro T, 2009, EXP BRAIN RES, V195, P135, DOI 10.1007/s00221-009-1759-8; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sambo CF, 2009, J COGNITIVE NEUROSCI, V21, P1550, DOI 10.1162/jocn.2009.21109; Schiff W, 1965, PSYCHOL MONOGR, V79, P11; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006582; Soto-Faraco S, 2009, BEHAV BRAIN RES, V196, P145, DOI 10.1016/j.bbr.2008.09.018; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Stein BE., 1993, MERGING SENSES; Stepniewska I, 2005, P NATL ACAD SCI USA, V102, P4878, DOI 10.1073/pnas.0501048102; Tajadura-Jimenez A, 2009, NEUROPSYCHOLOGIA, V47, P195, DOI 10.1016/j.neuropsychologia.2008.07.025; Yau JM, 2009, CURR BIOL, V19, P561, DOI 10.1016/j.cub.2009.02.013; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017; Zampini M, 2007, NEUROPSYCHOLOGIA, V45, P1869, DOI 10.1016/j.neuropsychologia.2006.12.004	65	144	144	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44306	10.1371/journal.pone.0044306	http://dx.doi.org/10.1371/journal.pone.0044306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23028516	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900008
J	Harvey, AJ; Mao, SH; Lalancette, C; Krawetz, SA; Brenner, CA				Harvey, Alexandra J.; Mao, Shihong; Lalancette, Claudia; Krawetz, Stephen A.; Brenner, Carol A.			Transcriptional Differences between Rhesus Embryonic Stem Cells Generated from In Vitro and In Vivo Derived Embryos	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PREIMPLANTATION BOVINE EMBRYOS; LARGE OFFSPRING SYNDROME; GENE-EXPRESSION; SELF-RENEWAL; OXYGEN-TENSION; MONKEY OOCYTES; MOUSE EMBRYOS; ES CELLS; MOLECULAR SIGNATURE	Numerous studies have focused on the transcriptional signatures that underlie the maintenance of embryonic stem cell (ESC) pluripotency. However, it remains unclear whether ESC retain transcriptional aberrations seen in in vitro cultured embryos. Here we report the first global transcriptional profile comparison between ESC generated from either in vitro cultured or in vivo derived primate embryos by microarray analysis. Genes involved in pluripotency, oxygen regulation and the cell cycle were downregulated in rhesus ESC generated from in vitro cultured embryos (in vitro ESC). Significantly, several gene differences are similarly downregulated in preimplantation embryos cultured in vitro, which have been associated with long term developmental consequences and disease predisposition. This data indicates that prior to derivation, embryo quality may influence the molecular signature of ESC lines, and may differentially impact the physiology of cells prior to or following differentiation.	[Harvey, Alexandra J.; Brenner, Carol A.] Wayne State Univ, Dept Physiol, Detroit, MI USA; [Mao, Shihong; Lalancette, Claudia; Krawetz, Stephen A.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Lalancette, Claudia] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Krawetz, Stephen A.; Brenner, Carol A.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Krawetz, Stephen A.] Wayne State Univ, Inst Comp Sci, Detroit, MI USA	Wayne State University; Wayne State University; McGill University; Wayne State University; Wayne State University	Harvey, AJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	ajharvey@unimelb.edu.au	krawetz, stephen/GQQ-3308-2022; Lalancette, Claudia/K-2502-2013	HARVEY, ALEXANDRA/0000-0001-6696-0950	National Institutes of Health [HD045966, RR015395, RR021881, HD046553]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD046553, R01HD045966] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021881, R24RR015395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the National Institutes of Health grants HD045966, RR015395, RR021881 and HD046553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Abe H, 1999, ANAT EMBRYOL, V199, P519, DOI 10.1007/s004290050249; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bertolini M, 2002, THERIOGENOLOGY, V58, P973, DOI 10.1016/S0093-691X(02)00935-4; Bertolini M, 2002, MOL REPROD DEV, V63, P318, DOI 10.1002/mrd.90015; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Brink TC, 2008, CELLS TISSUES ORGANS, V188, P9, DOI 10.1159/000112843; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2009, REPRODUCTION, V137, P271, DOI 10.1530/REP-08-0265; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Frost JM, 2010, EPIGENETICS, P6; Fujimoto A, 2006, STEM CELLS, V24, P595, DOI 10.1634/stemcells.2005-0301; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; Harvey AJ, 2004, BIOL REPROD, V71, P1108, DOI 10.1095/biolreprod.104.028639; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Horii T, 2010, CELL REPROGRAM, V12, P551, DOI 10.1089/cell.2009.0104; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Huntriss John, 2008, Hum Fertil (Camb), V11, P85, DOI 10.1080/14647270802116250; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim CG, 2006, MOL CELLS, V21, P343; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kind KL, 2005, MOL REPROD DEV, V70, P37, DOI 10.1002/mrd.20183; Lawrence LT, 2008, SEMIN REPROD MED, V26, P143, DOI 10.1055/s-2008-1042953; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li XP, 2006, CLONING STEM CELLS, V8, P214, DOI 10.1089/clo.2006.8.214; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; MASTROIANNI L, 1965, J REPROD FERTIL, V9, P99; Mitalipov S, 2007, STEM CELLS, V25, P581, DOI 10.1634/stemcells.2006-0120; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mtango NR, 2008, REPROD FERT DEVELOP, V20, P846, DOI 10.1071/RD08078; Mtango NR, 2008, BIOL REPROD, V78, P254, DOI 10.1095/biolreprod.107.064931; Mtango NR, 2011, GENE EXPR PATTERNS, V11, P285, DOI 10.1016/j.gep.2011.02.001; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nowak-Imialek M, 2008, MOL REPROD DEV, V75, P731, DOI 10.1002/mrd.20816; Pannetier M, 2007, TRENDS BIOTECHNOL, V25, P556, DOI 10.1016/j.tibtech.2007.09.003; Park SB, 2009, GROWTH FACTORS, V27, P425, DOI 10.3109/08977190903289875; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Player A, 2006, STEM CELLS DEV, V15, P315, DOI 10.1089/scd.2006.15.315; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; Rinaudo PF, 2006, FERTIL STERIL, V86, P1252, DOI 10.1016/j.fertnstert.2006.05.017; Rizos D, 2002, MOL REPROD DEV, V62, P320, DOI 10.1002/mrd.10138; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sinclair KD, 2000, HUM REPROD, V15, P68, DOI 10.1093/humrep/15.suppl_5.68; Sinclair KD, 2007, THERIOGENOLOGY, V67, P43, DOI 10.1016/j.theriogenology.2006.09.017; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Skottman H, 2006, STEM CELLS; Skottman H, 2006, REPRODUCTION, V132, P691, DOI 10.1530/rep.1.01079; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Turan N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001033; Vassena R, 2005, MOL REPROD DEV, V72, P430, DOI 10.1002/mrd.20375; Wale PL, 2010, REPROD BIOMED ONLINE, V21, P402, DOI 10.1016/j.rbmo.2010.04.028; Watkins AJ, 2008, SEMIN REPROD MED, V26, P175, DOI 10.1055/s-2008-1042956; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2004, ANIM REPROD SCI, V82-3, P593, DOI 10.1016/j.anireprosci.2004.05.009; Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yaseen MA, 2001, REPRODUCTION, V122, P601, DOI 10.1530/rep.0.1220601; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zheng P, 2007, MOL HUM REPROD, V13, P361, DOI 10.1093/molehr/gam014; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417	87	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43239	10.1371/journal.pone.0043239	http://dx.doi.org/10.1371/journal.pone.0043239			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028448	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900005
J	Kapusi, E; Kempe, K; Rubtsova, M; Kumlehn, J; Gils, M				Kapusi, Eszter; Kempe, Katja; Rubtsova, Myroslava; Kumlehn, Jochen; Gils, Mario			phiC31 Integrase-Mediated Site-Specific Recombination in Barley	PLOS ONE			English	Article							TRANSGENIC WHEAT; PHAGE PHI-C31-INTEGRASE; GENE INTEGRATION; LOX SITES; CRE; DNA; TRANSFORMATION; EXPRESSION; SYSTEM; ARABIDOPSIS	The Streptomyces phage phiC31 integrase was tested for its feasibility in excising transgenes from the barley genome through site-specific recombination. We produced transgenic barley plants expressing an active phiC31 integrase and crossed them with transgenic barley plants carrying a target locus for recombination. The target sequence involves a reporter gene encoding green fluorescent protein (GFP), which is flanked by the attB and attP recognition sites for the phiC31 integrase. This sequence disruptively separates a gusA coding sequence from an upstream rice actin promoter. We succeeded in producing site-specific recombination events in the hybrid progeny of 11 independent barley plants carrying the above target sequence after crossing with plants carrying a phiC31 expression cassette. Some of the hybrids displayed fully executed recombination. Excision of the GFP gene fostered activation of the gusA gene, as visualized in tissue of hybrid plants by histochemical staining. The recombinant loci were detected in progeny of selfed F-1, even in individuals lacking the phiC31 transgene, which provides evidence of stability and generative transmission of the recombination events. In several plants that displayed incomplete recombination, extrachromosomal excision circles were identified. Besides the technical advance achieved in this study, the generated phiC31 integrase-expressing barley plants provide foundational stock material for use in future approaches to barley genetic improvement, such as the production of marker-free transgenic plants or switching transgene activity.	[Kapusi, Eszter; Kempe, Katja; Rubtsova, Myroslava; Kumlehn, Jochen; Gils, Mario] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Kapusi, E (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	gils@ipk-gatersleben.de	Kumlehn, Jochen/AAF-8241-2020	Kumlehn, Jochen/0000-0001-7080-7983; Rubtsova, Myroslava/0000-0002-5950-5914	Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE) [0315043A]; GABI- FUTURE grant [0315043*B*]	Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE)(Federal Ministry of Education & Research (BMBF)); GABI- FUTURE grant	Financed with funding from the Bundesministerium fur Bildung und Forschung (BMBF, GABI-FUTURE grant 0315043A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nordsaat received its own funding for a separate part of the project (GABI- FUTURE grant 0315043*B*) which is not part of the research described in the submitted manuscript. The involvement of Nordsaat as a project partner does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmad K, 1996, GENETICS, V144, P657; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chawla R, 2006, PLANT BIOTECHNOL J, V4, P209, DOI 10.1111/j.1467-7652.2005.00173.x; Coppoolse ER, 2005, PLANT MOL BIOL, V58, P687, DOI 10.1007/s11103-005-7705-7; Coppoolse ER, 2003, PLANT MOL BIOL, V51, P263, DOI 10.1023/A:1021174726070; De Buck S, 2007, PLANT PHYSIOL, V145, P1171, DOI 10.1104/pp.107.104067; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Druka A., 2011, BARLEY PRODUCTION IM, P1; Dunwell Jim M., 2009, V478, P333, DOI 10.1007/978-1-59745-379-0_20; Gils M, 2008, PLANT BIOTECHNOL J, V6, P226, DOI 10.1111/j.1467-7652.2007.00318.x; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Goedeke S, 2007, TRANSGENIC PLANT J, V1, P104; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gronlund JT, 2007, PLANT MOL BIOL, V63, P545, DOI 10.1007/s11103-006-9108-9; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hensel Goetz, 2009, Int J Plant Genomics, V2009, P835608, DOI 10.1155/2009/835608; Hoa TTC, 2002, THEOR APPL GENET, V104, P518, DOI 10.1007/s001220100748; Hohn B, 2001, CURR OPIN BIOTECH, V12, P139, DOI 10.1016/S0958-1669(00)00188-9; Hu Q, 2008, PLANT BIOTECHNOL J, V6, P176, DOI 10.1111/j.1467-7652.2007.00310.x; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Karow M, 2011, EXPERT OPIN BIOL TH, V11, P1287, DOI 10.1517/14712598.2011.601293; Kempe K, 2010, PLANT MOL BIOL, V72, P673, DOI 10.1007/s11103-010-9606-7; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; Kittiwongwattana C, 2007, PLANT MOL BIOL, V64, P137, DOI 10.1007/s11103-007-9140-4; Kopertekh L, 2012, TRANSGENIC PLANTS AD; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Leonhard WN, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-18; Luo H, 2000, PLANT J, V23, P423, DOI 10.1046/j.1365-313x.2000.00782.x; Lutz KA, 2004, PLANT J, V37, P906, DOI 10.1111/j.1365-313X.2004.02015.x; Lyznik LA, 2003, PLANT CELL REP, V21, P925, DOI 10.1007/s00299-003-0616-7; Lyznik LA, 2007, TRANSGENIC PLANT J, V1, P1; MAESER S, 1991, MOL GEN GENET, V230, P170, DOI 10.1007/BF00290665; Mengiste T, 1999, EMBO J, V18, P4505, DOI 10.1093/emboj/18.16.4505; Mlynarova L, 2003, TRANSGENIC RES, V12, P45, DOI 10.1023/A:1022112221427; Moon HS, 2011, PLANT MOL BIOL, V75, P621, DOI 10.1007/s11103-011-9756-2; Ow DW, 2007, CURR OPIN BIOTECH, V18, P115, DOI 10.1016/j.copbio.2007.02.004; Ow DW, 2011, J INTEGR PLANT BIOL, V53, P512, DOI 10.1111/j.1744-7909.2011.01061.x; Ow DW, 2005, IN VITRO CELL DEV-PL, V41, P213, DOI 10.1079/IVP2004610; OW DW, 1995, CRIT REV PLANT SCI, V14, P239, DOI 10.1080/713608117; Ow DW, 2002, PLANT MOL BIOL, V48, P183, DOI 10.1023/A:1013718106742; Que QD, 1998, PLANT J, V13, P401, DOI 10.1046/j.1365-313X.1998.00038.x; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rubtsova M, 2008, PLANT CELL REP, V27, P1821, DOI 10.1007/s00299-008-0604-z; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Smith MCA, 2004, NUCLEIC ACIDS RES, V32, P2607, DOI 10.1093/nar/gkh538; Southern E M, 1992, Biotechnology, V24, P122; Sreenivasulu N., 2008, INT J PLANT GENOMICS, DOI DOI 10.1155/2008/486258; Srivastava V, 2004, PLANT BIOTECHNOL J, V2, P169, DOI 10.1111/j.1467-7652.2003.00061.x; Srivastava V, 2003, PLANT MOL BIOL, V52, P661, DOI 10.1023/A:1024839617490; Srivastava V, 1999, P NATL ACAD SCI USA, V96, P11117, DOI 10.1073/pnas.96.20.11117; Srivastava V, 2001, PLANT MOL BIOL, V46, P561, DOI 10.1023/A:1010646100261; Thomas WTB, 2011, BARLEY PRODUCTION IM, P122; Thomason LC, 2001, MOL GENET GENOMICS, V265, P1031, DOI 10.1007/s004380100498; Thomson JG, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-9; Thomson JG, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-17; Thorpe HM, 2000, MOL MICROBIOL, V38, P232, DOI 10.1046/j.1365-2958.2000.02142.x; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tungsuchat T, 2006, PLANT MOL BIOL, V61, P711, DOI 10.1007/s11103-006-0044-5; Tungsuchat-Huang T, 2012, PLANT J, V70, P717, DOI 10.1111/j.1365-313X.2012.04918.x; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; von Wettstein D, 2007, ANNU REV PLANT BIOL, V58, P1, DOI 10.1146/annurev.arplant.58.032806.104003; Wang YJ, 2011, PLANT CELL REP, V30, P267, DOI 10.1007/s00299-010-0938-1; Yang MZ, 2009, PLANT MOL BIOL, V70, P669, DOI 10.1007/s11103-009-9499-5; Yau YY, 2011, METHODS MOL BIOL, V701, P147, DOI 10.1007/978-1-61737-957-4_8	71	23	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45353	10.1371/journal.pone.0045353	http://dx.doi.org/10.1371/journal.pone.0045353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024817	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100075
J	Shi, BS; Ren, GX; Hu, YW; Wang, S; Zhang, ZQ; Yuan, ZH				Shi, Bisheng; Ren, Guangxu; Hu, Yunwen; Wang, Sen; Zhang, Zhanqing; Yuan, Zhenghong			HBsAg Inhibits IFN-alpha Production in Plasmacytoid Dendritic Cells through TNF-alpha and IL-10 Induction in Monocytes	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; VIRUS INFECTION; T-CELLS; I INTERFERON; PROTEIN; ACTIVATION; ANTIGEN; BLOOD	Type I Interferon (IFN) is one of the first lines of defense against viral infection. Plasmacytoid dendritic cells (pDCs) are professional IFN-alpha-producing cells that play an important role in the antiviral immune response. Previous studies have reported that IFN-alpha production is impaired in chronic hepatitis B (CHB) patients. However, the mechanisms underlying the impairment in IFN-alpha production are not fully understood. Here, we report that plasma-derived hepatitis B surface antigen (HBsAg) and HBsAg expressed in CHO cells can significantly inhibit toll like receptor (TLR) 9-mediated Interferon-alpha (IFN-alpha) production in peripheral blood mononuclear cells (PBMCs) from healthy donors. Further analysis indicated that monocytes participate in the inhibitory effect of HBsAg on pDCs through the secretion of TNF-alpha and IL-10. Furthermore, TLR9 expression on pDCs was down-regulated by TNF-alpha, IL-10 and HBsAg treatment. This down-regulation may partially explain the inhibition of IFN-alpha production in pDCs. In conclusion, we determined that HBsAg inhibited the production of IFN-alpha by pDCs through the induction of monocytes that secreted TNF-alpha and IL-10 and through the down-regulation of TLR9 expression on pDCs. These data may aid in the development of effective antiviral treatments and lead to the immune control of the viral infections.	[Shi, Bisheng; Ren, Guangxu; Hu, Yunwen; Wang, Sen; Zhang, Zhanqing; Yuan, Zhenghong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Ren, Guangxu; Yuan, Zhenghong] Fudan Univ, Mol Virol Lab, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shi, BS (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org		Ren, Guangxu/0000-0003-2378-260X; zhang, zhanqing/0000-0001-7709-9027	National Program on Key Basic Research Project [2012CB519005]; Shanghai Clinical New Frontier Project [SHDC12010106]; National Natural Science Foundation of China [81101242]; Shanghai Science and Technology Commission [09ZR1426500]	National Program on Key Basic Research Project(National Basic Research Program of China); Shanghai Clinical New Frontier Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Program on Key Basic Research Project (2012CB519005), Shanghai Clinical New Frontier Project (SHDC12010106), National Natural Science Foundation of China (81101242) and grants from Shanghai Science and Technology Commission (09ZR1426500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborsangaya KB, 2007, HEPATOLOGY, V45, P623, DOI 10.1002/hep.21511; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; den Brouw MLO, 2008, J VIRAL HEPATITIS, V15, P675, DOI 10.1111/j.1365-2893.2008.00993.x; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Schroeder JT, 2008, J ALLERGY CLIN IMMUN, V121, P486, DOI 10.1016/j.jaci.2007.09.049; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Untergasser A, 2006, HEPATOLOGY, V43, P539, DOI 10.1002/hep.21048; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Vanlandschoot P, 2002, J GEN VIROL, V83, P2279, DOI 10.1099/0022-1317-83-9-2279; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Xie Q, 2009, MICROBES INFECT, V11, P515, DOI 10.1016/j.micinf.2009.02.008; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107	30	69	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44900	10.1371/journal.pone.0044900	http://dx.doi.org/10.1371/journal.pone.0044900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024774	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100032
J	Wyse, MM; Lei, J; Nestor-Kalinoski, AL; Eisenmann, KM				Wyse, Meghan M.; Lei, Jun; Nestor-Kalinoski, Andrea L.; Eisenmann, Kathryn M.			Dia-Interacting Protein (DIP) Imposes Migratory Plasticity in mDia2-Dependent Tumor Cells in Three-Dimensional Matrices	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; ARP2/3 COMPLEX; CHEMOKINE RECEPTORS; ACTIN; FORMIN; INVASION; ACTIVATION; MOTILITY; SRC; PROMOTES	Tumor cells rely upon membrane pliancy to escape primary lesions and invade secondary metastatic sites. This process relies upon localized assembly and disassembly cycles of F-actin that support and underlie the plasma membrane. Dynamic actin generates both spear-like and bleb structures respectively characterizing mesenchymal and amoeboid motility programs utilized by metastatic cells in three-dimensional matrices. The molecular mechanism and physiological trigger(s) driving membrane plasticity are poorly understood. mDia formins are F-actin assembly factors directing membrane pliancy in motile cells. mDia2 is functionally coupled with its binding partner DIP, regulating cortical actin and inducing membrane blebbing in amoeboid cells. Here we show that mDia2 and DIP co-tether to nascent blebs and this linkage is required for bleb formation. DIP controls mesenchymal/amoeboid cell interconvertability, while CXCL12 induces assembly of mDia2: DIP complexes to bleb cortices in 3D matrices. These results demonstrate how DIP-directed mDia2-dependent F-actin dynamics regulate morphological plasticity in motile cancer cells.	[Wyse, Meghan M.; Lei, Jun; Eisenmann, Kathryn M.] Univ Toledo, Dept Biochem, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea L.] Univ Toledo, Dept Surg, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Wyse, MM (corresponding author), Univ Toledo, Dept Biochem, Hlth Sci Campus, Toledo, OH 43606 USA.	kathryn.eisenmann@utoledo.edu		Eisenmann, Kathryn/0000-0002-5337-5928	University of Toledo Foundation; Department of Defense Breast Cancer Concept Award [BC062565]; National Cancer Institute [R01CA151632]; NATIONAL CANCER INSTITUTE [R01CA151632] Funding Source: NIH RePORTER	University of Toledo Foundation; Department of Defense Breast Cancer Concept Award(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Toledo Foundation (KME, ALNK), the Department of Defense Breast Cancer Concept Award (KME, BC062565), and the National Cancer Institute (KME, ALNK, R01CA151632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Aspenstrom P, 2010, BBA-MOL CELL RES, V1803, P174, DOI 10.1016/j.bbamcr.2009.06.002; Asrar S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-39; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Basu R, 2011, CURR BIOL, V21, P905, DOI 10.1016/j.cub.2011.04.047; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demou ZN, 2005, CANCER RES, V65, P5674, DOI 10.1158/0008-5472.CAN-04-1682; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fukumi-Tominaga T, 2009, GENES CELLS, V14, P1197, DOI 10.1111/j.1365-2443.2009.01345.x; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Hager MH, 2012, EMBO MOL MED; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; KAGEYAMA T, 1977, DEV GROWTH DIFFER, V19, P103; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Liang ZX, 2005, CANCER RES, V65, P967; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Teodorof C, 2009, EXP CELL RES, V315, P2410, DOI 10.1016/j.yexcr.2009.05.010; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	64	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45085	10.1371/journal.pone.0045085	http://dx.doi.org/10.1371/journal.pone.0045085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024796	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100054
J	Sciacqua, A; Maio, R; Miceli, S; Pascale, A; Carullo, G; Grillo, N; Arturi, F; Sesti, G; Perticone, F				Sciacqua, Angela; Maio, Raffaele; Miceli, Sofia; Pascale, Alessandra; Carullo, Giuseppe; Grillo, Nadia; Arturi, Franco; Sesti, Giorgio; Perticone, Francesco			Association between One- Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension	PLOS ONE			English	Article							ARTERIAL STIFFNESS; ENDOTHELIAL DYSFUNCTION; INSULIN SENSITIVITY; STROKE; RISK; DISTENSIBILITY; THICKNESS; TOLERANCE; INCREASES; WOMEN	Objectives: Pulse wave velocity (PWV) is a surrogate end-point for cardiovascular morbidity and mortality. A plasma glucose value >= 155 mg/dl for the 1-hour post-load plasma glucose during an oral glucose tolerance test (OGTT) is able to identify subjects with normal glucose tolerance (NGT) at high-risk for type-2 diabetes (T2D) and for subclinical organ damage. Thus, we addressed the question if 1-hour post-load plasma glucose levels, affects PWV and its central hemodynamic correlates, as augmentation pressure (AP) and augmentation index (AI). Methods: We enrolled 584 newly diagnosed hypertensives. All patients underwent OGTT and measurements of PWV, AP and AI. Insulin sensitivity was assessed by Matsuda-index. Results: Among participants, 424 were NGT and 160 had impaired glucose tolerance (IGT). Of 424 NGT, 278 had 1-h post-load plasma glucose <155 mg/dl (NGT < 155) and 146 had 1-h post-load plasma glucose >= 155 mg/dl (NGT > 155). NGT >= 155 had a worse insulin sensitivity and higher hs-CRP than NGT < 155, similar to IGT subjects. In addition, NGT >= 155 in comparison with NGT, 155 had higher central systolic blood pressure (134 +/- 12 vs 131 +/- 10 mmHg), as well as PWV (8.4 +/- 3.7 vs 6.7 +/- 1.7 m/s), AP (12.5 +/- 7.1 vs 9.8 +/- 5.7 mmHg) and AI (29.4 +/- 11.9 vs 25.1 +/- 12.4%), and similar to IGT. At multiple regression analysis, 1-h post-load plasma glucose resulted the major determinant of all indices of vascular stiffness. Conclusion: Hypertensive NGT >= 155 subjects, compared with NGT< 155, have higher PWV and its hemodynamic correlates that increase their cardiovascular risk profile.	[Sciacqua, Angela; Maio, Raffaele; Miceli, Sofia; Pascale, Alessandra; Carullo, Giuseppe; Grillo, Nadia; Arturi, Franco; Sesti, Giorgio; Perticone, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Sciacqua, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	perticone@unicz.it	Sesti, Giorgio/B-1509-2012; Perticone, Francesco/I-4260-2017; Maio, Raffaele/A-2846-2015	Maio, Raffaele/0000-0002-7290-9470; ARTURI, Franco/0000-0002-1660-1228; Sesti, Giorgio/0000-0002-1618-7688				Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Arcaro G, 2002, CIRCULATION, V105, P576, DOI 10.1161/hc0502.103333; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Chen CH, 1996, HYPERTENSION, V27, P168, DOI 10.1161/01.HYP.27.2.168; Giltay EJ, 1999, DIABETOLOGIA, V42, P214, DOI 10.1007/s001250051141; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Ilercil A, 2001, AM HEART J, V141, P992, DOI 10.1067/mhj.2001.115302; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kimoto E, 2003, DIABETES, V52, P448, DOI 10.2337/diabetes.52.2.448; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Lee IK, 2002, INT J CLIN PRACT, P59; Matsuda M, 1999, DIABETES CARE; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Perticone F, 2001, EUR J CLIN INVEST, V31, P1013, DOI 10.1046/j.1365-2362.2001.00909.x; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Sciacqua A, 2011, DIABETES CARE, V34, P2291, DOI 10.2337/dc11-0879; Sciacqua A, 2011, DIABETES CARE, V34, P1406, DOI 10.2337/dc11-0155; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Sengstock DM, 2005, J CLIN ENDOCR METAB, V90, P2823, DOI 10.1210/jc.2004-1686; Stacey RB, 2010, HYPERTENSION, V55, P26, DOI 10.1161/HYPERTENSIONAHA.109.134031; Succurro E, 2009, ATHEROSCLER IN PRESS; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; van Dijk RAJM, 2003, EUR J CLIN INVEST, V33, P307, DOI 10.1046/j.1365-2362.2003.01137.x; Wautier J L, 1998, Vasc Med, V3, P131, DOI 10.1191/135886398672565440; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970	30	52	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44470	10.1371/journal.pone.0044470	http://dx.doi.org/10.1371/journal.pone.0044470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028545	gold, Green Submitted, Green Published			2022-12-25	WOS:000308788700021
J	Mishra, J; Karanki, SS; Kumar, N				Mishra, Jayshree; Karanki, Satya Sridhar; Kumar, Narendra			Identification of Molecular Switch Regulating Interactions of Janus Kinase 3 with Cytoskeletal Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; JAK3; DOMAIN; VILLIN; EXPRESSION; MUTATIONS	Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Although mutations that abrogate Jak3 functions cause different immunological disorders, its constitutive activation leads to various types of cancer. Previously, we demonstrated that Jak3 interacted with actin-binding protein villin, thereby facilitating cytoskeletal remodeling and wound repair. In this study, we characterize the structural determinants that regulate the interactions between Jak3 and cytoskeletal proteins of the villin/gelsolin family. Functional reconstitution of kinase activity by recombinant full-length (wt) Jak3 using Jak3-wt or villin/gelsolin-wt as substrate showed that Jak3 autophosphorylation was the rate-limiting step during interactions between Jak3 and cytoskeletal proteins. Determination of kinetic parameters showed that phosphorylated (P) Jak3-wt binds to P-villin-wt with a dissociation constant (K-d) of 23 nM and a Hill's coefficient of 3.7. Pairwise binding between Jak3 mutants and P-villin-wt showed that the FERM domain of Jak3 was sufficient for binding to P-villin-wt with a K-d of 40.0 nM. However, the SH2 domain of Jak3 prevented P-villin-wt from binding to the FERM domain of nonphosphorylated protein. We demonstrate that the intramolecular interaction between the FERM and SH2 domains of nonphosphorylated Jak3 prevented Jak3 from binding to villin and that tyrosine autophosphorylation of Jak3 at the SH2 domain decreased these intramolecular interactions and facilitated binding of the FERM domain to villin. Thus we demonstrate the molecular mechanism of interactions between Jak3 and cytoskeletal proteins where tyrosine phosphorylation of the SH2 domain acted as an intramolecular switch for the interactions between Jak3 and cytoskeletal proteins.	[Mishra, Jayshree; Karanki, Satya Sridhar; Kumar, Narendra] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kumar, N (corresponding author), Texas A&M HSC, ILR Coll Pharm, 1010 West Ave B,MSC 131, Kingsville, TX 78363 USA.	nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	National Institutes of Health [DK081661]; Crohn's & Colitis Foundation of America [1351, 2188]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081661 to N. K.). This work was also supported by grants from the Crohn's & Colitis Foundation of America (CCFA Reference Numbers 1351 and 2188).	Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; FRIEDERICH E, 1990, BIOESSAYS, V12, P403, DOI 10.1002/bies.950120902; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kampa D, 2000, BIOCHEM BIOPH RES CO, V278, P175, DOI 10.1006/bbrc.2000.3757; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Safford MG, 1997, EXP HEMATOL, V25, P374; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	16	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41386	41391		10.1074/jbc.C112.363507	http://dx.doi.org/10.1074/jbc.C112.363507			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23012362	Green Published, hybrid			2022-12-25	WOS:000311887600051
J	Schneider, EH; Weaver, JD; Gaur, SS; Tripathi, BK; Jesaitis, AJ; Zelenka, PS; Gao, JL; Murphy, PM				Schneider, Erich H.; Weaver, Joseph D.; Gaur, Sonia S.; Tripathi, Brajendra K.; Jesaitis, Algirdas J.; Zelenka, Peggy S.; Gao, Ji-Liang; Murphy, Philip M.			The Leukocyte Chemotactic Receptor FPR1 Is Functionally Expressed on Human Lens Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL PEPTIDE RECEPTOR; N-FORMYLPEPTIDE RECEPTOR; MESENCHYMAL STEM-CELLS; CHEMOATTRACTANT RECEPTORS; HUMAN NEUTROPHIL; G-PROTEIN; BINDING; LIGAND; ACTIVATION; FAMILY	Formyl peptide receptor 1 (FPR1) is a G protein-coupled chemoattractant receptor expressed mainly on leukocytes. Surprisingly, aging Fpr1(-/-) mice develop spontaneous lens degeneration without inflammation or infection (J.-L. Gao et al., manuscript in preparation). Therefore, we hypothesized that FPR1 is functionally expressed directly on lens epithelial cells, the only cell type in the lens. Consistent with this, the human fetal lens epithelial cell line FHL 124 expressed FPR1 FPR1 mRNA and was strongly FPR1 protein-positive by Western blot and FACS. Competition binding using FPR1 ligands N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys (Nle = Norleucine), formylmethionylleucylphenylalanine, and peptide W revealed the same profile for FHL 124 cells, neutrophils, and FPR1-transfected HEK 293 cells. Saturation binding with fluorescein-labeled N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys revealed similar to 2500 specific binding sites on FHL-124 cells (K-D similar to 0.5 nM) versus similar to 40,000 sites on neutrophils (K-D = 3.2 nM). Moreover, formylmethionylleucylphenylalanine induced pertussis toxin-sensitive Ca2+ flux in FHL 124 cells, consistent with classic G(i)-mediated FPR1 signaling. FHL 124 cell FPR1 was atypical in that it resisted agonist-induced internalization. Expression of FPR1 was additionally supported by detection of the intact full-length open reading frame in sequenced cDNA from FHL 124 cells. Thus, FHL-124 cells express functional FPR1, which is consistent with a direct functional role for FPR1 in the lens, as suggested by the phenotype of Fpr1 knock-out mice.	[Schneider, Erich H.; Weaver, Joseph D.; Gaur, Sonia S.; Gao, Ji-Liang; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Tripathi, Brajendra K.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Zelenka, Peggy S.] NEI, Sect Cellular Differentiat, Lab Mol & Dev Biol, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Rm 11N113,10 Ctr Dr, Bethesda, MD 20892 USA.	pmm@nih.gov	Schneider, Erich H/B-9051-2016; Gao, Ji-Liang/Y-4397-2019	Schneider, Erich H/0000-0002-7905-4276; Gaur, Sonia/0000-0001-9497-5412; Jesaitis, Algirdas/0000-0001-9001-5617	Division of Intramural Research of the NIAID, National Institutes of Health; German Research Foundation Grant [SCHN 1192/1-1]; Public Health Service Grant [R01 AI22735]; Helmsley Senior Investigator Award from the Crohn and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022735, ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation Grant; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Helmsley Senior Investigator Award from the Crohn and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research of the NIAID, National Institutes of Health. This work was also supported by German Research Foundation Grant SCHN 1192/1-1 (to E. H. S.).; Supported by Public Health Service Grant R01 AI22735 and a Helmsley Senior Investigator Award from the Crohn and Colitis Foundation.	Augusteyn RC, 2007, MOL VIS, V13, P252; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; CROWELL RE, 1989, AM J PHYSIOL, V257, pH107, DOI 10.1152/ajpheart.1989.257.1.H107; de Paulis A, 2009, J IMMUNOL, V183, P3761, DOI 10.4049/jimmunol.0900863; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; Hartt JK, 2000, BIOCHEM BIOPH RES CO, V272, P699, DOI 10.1006/bbrc.2000.2846; Harvath L, 1999, Methods Mol Biol, V115, P299; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Huang J, 2008, CANCER LETT, V267, P254, DOI 10.1016/j.canlet.2008.03.014; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; JESAITIS AJ, 1993, J IMMUNOL, V151, P5653; Keitoku M, 1997, J MOL CELL CARDIOL, V29, P881, DOI 10.1006/jmcc.1996.0291; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; MALECH HL, 1985, J BIOL CHEM, V260, P2509; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; McDermott DH, 2010, BLOOD, V116, P2793, DOI 10.1182/blood-2010-01-265942; Miettinen HM, 1997, J IMMUNOL, V159, P4045; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; PEREZ HD, 1991, J CLIN INVEST, V87, P971, DOI 10.1172/JCI115105; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Rane MJ, 1997, J IMMUNOL, V159, P5070; Reddan JR, 1999, INVEST OPHTH VIS SCI, V40, pS970; REMES JJ, 1991, BIOCHEM J, V277, P67, DOI 10.1042/bj2770067; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1985, MOL PHARMACOL, V28, P323; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Wenzel-Seifert K, 2003, N-S ARCH PHARMACOL, V367, P509, DOI 10.1007/s00210-003-0714-7; Wenzel-Seifert K, 2003, BIOCHEM BIOPH RES CO, V301, P693, DOI 10.1016/S0006-291X(03)00023-8; Yang H, 2010, J GENET GENOMICS, V37, P771, DOI 10.1016/S1673-8527(09)60094-1; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang XG, 2011, INVEST OPHTH VIS SCI, V52, P3160, DOI 10.1167/iovs.10-5156	44	11	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40779	40792		10.1074/jbc.M112.411181	http://dx.doi.org/10.1074/jbc.M112.411181			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012360	hybrid, Green Published			2022-12-25	WOS:000311448800066
J	Maxwell, JT; Natesan, S; Mignery, GA				Maxwell, Joshua T.; Natesan, Sankar; Mignery, Gregory A.			Modulation of Inositol 1,4,5-Trisphosphate Receptor Type 2 Channel Activity by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; HISTONE DEACETYLASE-4; ATRIAL MYOCYTES; INSP3 RECEPTOR; CA2+ RELEASE; CALCIUM; BINDING; SIGNALS; CAMKII; LIGAND	InsP(3)-mediated calcium release through the type 2 inositol 1,4,5-trisphosphate receptor (InsP(3)R2) in cardiac myocytes results in the activation of associated CaMKII, thus enabling the kinase to act on downstream targets, such as histone deacetylases 4 and 5 (HDAC4 and HDAC5). The CaMKII activity also feedback modulates InsP(3)R2 function by direct phosphorylation and results in a dramatic decrease in the receptor-channel open probability (P-0). We have identified S150 in the InsP(3)R2 core suppressor domain (amino acids 1-225) as the specific residue that is phosphorylated by CaMKII. Site-directed mutagenesis reveals that S150 is the CaMKII phosphorylation site responsible for modulation of channel activity. Nonphosphorylatable (S150A) and phosphomimetic (S150E) mutations were studied in planar lipid bilayers. The InsP(3)R2 S150A channel showed no decrease in activity when treated with CaMKII. Conversely, the phosphomimetic (S150E) channel displayed a very low P-0 under normal recording conditions in the absence of CaMKII (2 mu M InsP(3) and 250 nM [Ca2+](FREE)) and mimicked a WT channel that has been phosphorylated by CaMKII. Phopho-specific antibodies demonstrate that InsP(3)R2 Ser-150 is phosphorylated in vivo by CaMKII delta. The results of this study show that serine 150 of the InsP(3)R2 is phosphorylated by CaMKII and results in a decrease in the channel open probability.	[Maxwell, Joshua T.; Natesan, Sankar; Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Mignery, GA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	gmigner@lumc.edu	Natesan, Sankar/C-9866-2015		National Institutes of Health [P01HL080101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported, in whole or in part, by National Institutes of Health Grant P01HL080101 (to G. A. M.).	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Kaznacheyeva E, 1998, J GEN PHYSIOL, V111, P847, DOI 10.1085/jgp.111.6.847; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Matifat F, 2001, PFLUG ARCH EUR J PHY, V441, P796, DOI 10.1007/s004240000479; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu DM, 1996, BIOCHEMISTRY-US, V35, P7214, DOI 10.1021/bi952471h; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	31	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.374058	http://dx.doi.org/10.1074/jbc.M112.374058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019322	Green Published, hybrid			2022-12-25	WOS:000311233800014
J	Murphy, RA; Marconi, VC; Gandhi, RT; Kuritzkes, DR; Sunpath, H				Murphy, Richard A.; Marconi, Vincent C.; Gandhi, Rajesh T.; Kuritzkes, Daniel R.; Sunpath, Henry			Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa	PLOS ONE			English	Article							CLINICAL-EXPERIENCE; PHARMACOKINETICS; RITONAVIR	Background: In HIV-infected patients receiving rifampicin-based treatment for tuberculosis (TB), the dosage of lopinavir/ritonavir (LPV/r) is adjusted to prevent sub-therapeutic lopinavir concentrations. In this setting, South African clinicians were advised to administer super-boosted LPV/r (400 mg/400 mg) twice daily, instead of standard dosed LPV/r (400 mg/100 mg) twice daily. We sought to determine - in routine practice - the tolerability and HIV treatment outcomes associated with super-boosted LPV/r compared to unadjusted LPV/r in combination with rifampicin-based TB treatment. Methodology/Principle Findings: We conducted a retrospective review of HIV-infected patients who receiving second-line ART with a LPV/r-containing regimen who required concomitant TB treatment. We identified 29 patients; the median age was 36 years (IQR 29-40), 22 (76%) were female, the median CD4 cell count and viral load at first-line ART failure was 86 cells/mm(3) (IQR 21-159) and 39,457 copies/mL (IQR 6,025-157,500), respectively. According to physician preference, 15 (52%) of 29 patients received super-boosted LPV/r (400 mg/400 mg) every 12 hours during TB treatment and 14 (48%) of 29 patients received standard dose LPV/r (400 mg/100 mg) twice daily during TB treatment. Among patients who received super-boosted LPV/r there was a trend towards a higher rate of symptomatic transaminitis (27% vs. 7%; p = 0.3), gastrointestinal toxicity (20% vs. 0%; p = 0.2) and a significantly increased need for treatment discontinuation (47% vs. 7%; p = 0.035. The durability of coadministered treatment was significantly shorter in patients who received super-boosted lopinavir/ritonavir with TB treatment compared to patients who received standard lopinavir/ritonavir dosing (log rank, P = 0.036). The rate of virologic failure was not higher in patients with unadjusted LPV/r dosing. Conclusions/Significance: We observed a high rate of toxicity and need for treatment discontinuation among patients on standard rifampicin-based TB treatment who received super-boosted LPV/r.	[Murphy, Richard A.] Medecins Sans Frontieres Doctors Borders, Med Unit, New York, NY USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Infect Dis Unit, Boston, MA 02114 USA; [Kuritzkes, Daniel R.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Sunpath, Henry] Nelson Mandela Sch Med, Infect Dis Unit, Durban, South Africa; [Sunpath, Henry] McCord Hosp, Dept Med, Durban, South Africa	Emory University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Kwazulu Natal	Murphy, RA (corresponding author), Medecins Sans Frontieres Doctors Borders, Med Unit, New York, NY USA.	ramurphy@gmail.com	Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Murphy, Richard/0000-0003-2249-7452	IDSA Medical Scholars Program; Arnold P. Gold Foundation Medical Student Scholarship; Partners AIDS Research Center; McCord Hospital; National Institutes of Health [K24-RR016482, P30 AI060354]; Abbott; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead; Merck; Roche; ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	IDSA Medical Scholars Program; Arnold P. Gold Foundation Medical Student Scholarship; Partners AIDS Research Center; McCord Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck(Merck & Company); Roche(Roche Holding); ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the IDSA Medical Scholars Program, the Arnold P. Gold Foundation Medical Student Scholarship, Partners AIDS Research Center, McCord Hospital, and by National Institutes of Health grants K24-RR016482 and P30 AI060354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.R.K. is a consultant to, or has received research funding from, Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Merck, Roche and ViiV. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	[Anonymous], 2011, MANAGING DRUG INTERA; [Anonymous], 2004, S AFR NAT ANT TREATM; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Burger DM, 2006, ANTIMICROB AGENTS CH, V50, P3336, DOI 10.1128/AAC.00461-06; Burman WJ, 1999, CLIN INFECT DIS, V28, P419, DOI 10.1086/515174; Decloedt EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032173; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Matteelli A, 2012, J ANTIMICROB CHEMOTH; Mena A, 2011, J ANTIMICROB CHEMOTH, V66, P951, DOI 10.1093/jac/dkq540; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nijland HMJ, 2008, AIDS, V22, P931, DOI 10.1097/QAD.0b013e3282faa71e; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; World Health Organization, 2010, UN ACC SCAL PRIOR HI	16	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44793	10.1371/journal.pone.0044793	http://dx.doi.org/10.1371/journal.pone.0044793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028623	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900017
J	Bosak, S; Pletikapic, G; Hozic, A; Svetlicic, V; Sarno, D; Vilicic, D				Bosak, Suncica; Pletikapic, Galja; Hozic, Amela; Svetlicic, Vesna; Sarno, Diana; Vilicic, Damir			A Novel Type of Colony Formation in Marine Planktonic Diatoms Revealed by Atomic Force Microscopy	PLOS ONE			English	Article							RELEASE; CHAETOCEROTACEAE; PHYTOPLANKTON; PARTICLES; GULF	Diatoms have evolved a variety of colonial life forms in which cells are connected by organic threads, mucilage pads or silicate structures. In this study, we provide the first description of a novel strategy of colony formation among marine planktonic diatoms. Bacteriastrum jadranum forms loose but regular chains with distinct heterovalvate terminal cells. The colonial cells and their siliceous projections, the setae, are not in direct contact; instead, they are enclosed within the optically transparent organic matrix. This cell jacket structure was detected by staining procedure with Alcian Blue, which showed that the polysaccharides are predominant matrix constituents and revealed that the jacket reaches the span of the setae. The scanning electron microscopy (SEM) observations showed distinguishable fibrillar network firmly associated with cells. Using atomic force microscopy (AFM), we were able to visualise and characterise the cell jacket structure at molecular resolution. At nanoscale resolution, the cell jacket appears as a cross-linked fibrillar network organised into a recognisable structure. The circular patches of self-repeating pattern (hexagonal pores with openings of 8-100 nm) are connected through thicker surrounding fibrils and reinforced by branching fibrils. The pore-forming fibrils within the patches are only 0.6-1.6 nm high, the surrounding fibrils connecting patches are 2.0-2.8 nm high, and the branching fibrils are considerably wider but not higher than 4.0 nm. The discovered polysaccharide fibrillar network is highly organised and delicately structured with a monomolecular fibril height of 0.6 nm. We conclude that the Bacteriastrum polysaccharide jacket represents an essential part of the cell, as the conjunction of the polymer network with the frustule appears to be extremely tight and such specific and unique patterns have never been found in self-assembled polysaccharide gel networks, which are usually encountered in the marine environment.	[Bosak, Suncica; Vilicic, Damir] Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia; [Pletikapic, Galja; Hozic, Amela; Svetlicic, Vesna] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia; [Sarno, Diana] Stn Zool Anton Dohrn, Naples, Italy	University of Zagreb; Rudjer Boskovic Institute; Stazione Zoologica Anton Dohrn di Napoli	Bosak, S (corresponding author), Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia.	sbosak@biol.pmf.hr	Hozic, Amela/R-6086-2018; Bosak, Suncica/L-7149-2015; Svetličić, Vesna/C-6932-2011	Bosak, Suncica/0000-0002-4604-2324; Svetličić, Vesna/0000-0002-5127-5472; SARNO, DIANA/0000-0001-9697-5301	Ministry of Science, Education and Sport of the Republic of Croatia [0982934-2744, 119-1191189-1228]; European Community [227799]	Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); European Community(European Commission)	The research was funded by the Ministry of Science, Education and Sport of the Republic of Croatia (Project Nos. 0982934-2744, 119-1191189-1228). S.B. was partially supported by the European Community - Research Infrastructure Action under the FP7 "Capacities" Specific Programme (Ref. ASSEMBLE grant agreement no. 227799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Elbrachter M., 1978, UPWELLING ECOSYSTEMS, P24; Freire-Nordi CS, 2006, BRAZ J PHYS, V36, P75; Freire-Nordi CS, 1998, J PHYCOL, V34, P631, DOI 10.1046/j.1529-8817.1998.340631.x; Freire-Nordi CS, 2005, MICROSC MICROANAL, V11, P40; FRYXELL GA, 1984, BRIT PHYCOL J, V19, P141, DOI 10.1080/00071618400650151; Godrijan J, 2012, BOT MAR, V55, P415, DOI 10.1515/bot-2011-0021; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, P136; Higgins MJ, 2011, LIFE AT THE NANOSCALE: ATOMIC FORCE MICROSCOPY OF LIVE CELLS, P405; Jensen K.G., 1998, OPERA BOT, V133, P5, DOI [10.1111/j.1756-1051.1998.tb01103.x, DOI 10.1111/J.1756-1051.1998.TB01103.X]; Kooistra WHCF, 2010, PHYCOLOGIA, V49, P471, DOI 10.2216/09-59.1; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Misic Radic T, 2011, J MOL RECOGNIT, V24, P397, DOI 10.1002/jmr.1072; MYKLESTAD S, 1989, J PLANKTON RES, V11, P763, DOI 10.1093/plankt/11.4.763; MYKLESTAD S, 1972, Journal of Experimental Marine Biology and Ecology, V9, P137, DOI 10.1016/0022-0981(72)90042-1; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; PAULSEN BS, 1994, J PHYCOL, V30, P638, DOI 10.1111/j.0022-3646.1994.00638.x; Pletikapic G, 2011, J MOL RECOGNIT, V24, P436, DOI 10.1002/jmr.1114; PRASAD AKSK, 1990, PHYCOLOGIA, V29, P418, DOI 10.2216/i0031-8884-29-4-418.1; RAMUS J, 1977, J PHYCOL, V13, P345, DOI 10.1111/j.1529-8817.1977.tb02939.x; Sarno D, 1997, PHYCOLOGIA, V36, P257, DOI 10.2216/i0031-8884-36-4-257.1; Supraha L, 2011, ACTA ADRIAT, V52, P29; Svetlicic V, 2011, MAR DRUGS, V9, P666, DOI 10.3390/md9040666; Troedsson C, 2007, LIMNOL OCEANOGR, V52, P416, DOI 10.4319/lo.2007.52.1.0416	30	18	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44851	10.1371/journal.pone.0044851	http://dx.doi.org/10.1371/journal.pone.0044851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028646	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388900014
J	Yan, HF; Zhang, CY; Wang, FY; Hu, CM; Ge, XJ; Hao, G				Yan, Hai-Fei; Zhang, Cai-Yun; Wang, Feng-Ying; Hu, Chi-Ming; Ge, Xue-Jun; Hao, Gang			Population Expanding with the Phalanx Model and Lineages Split by Environmental Heterogeneity: A Case Study of Primula obconica in Subtropical China	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; TEMPERATE PLANTS; COMPARATIVE PHYLOGEOGRAPHY; HISTORICAL DEMOGRAPHY; HENGDUAN MOUNTAINS; EAST-ASIA; DNA; CHLOROPLAST; PLEISTOCENE; MITOCHONDRIAL	Background: Current and historical events have both affected the current distribution patterns and intraspecific divergence of plants. While numerous studies have focused on the Qinghai-Tibetan Plateau (QTP), the impacts of such events on the flora of subtropical China remain poorly understood. Subtropical China is famous for its highly complex topography and the limited impact from glaciation during the Pleistocene; this may have resulted in a different genetic legacy for species in this region compared to fully glaciated areas. Methodology/Principal Findings: We used plastid and nuclear DNA sequence data and distribution modeling to analyze the divergence patterns and demographic history of Primula obconica Hance, a widespread herbaceous montane species in subtropical China. The phylogenetic analysis revealed two major lineages (lineage A and lineage B), representing a west-east split into the Yunnan and Eastern groups, and the Sichuan and Central groups, respectively. The Eastern and Central groups comprised relatively new derived haplotypes. Nested Clade Analysis and Bayesian Skyline Plot analyses both indicated that P. obconica mainly experienced a gradual expansion of populations. In addition, the simulated distribution of P. obconica during the Last Glacial Maximum was slightly larger than its present-day distribution. Conclusion/Significance: Our results are the first to identify a west-east migration of P. obconica. The gradual expansion pattern and a larger potential distribution range in cold periods detected for P. obconica indicate that the population expansion of this species is consistent with the phalanx model. In addition, the current patterns of genetic differentiation have persisted as a result of the extensive environmental heterogeneity that exists in subtropical China.	[Hao, Gang] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Feng-Ying] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Zhang, Cai-Yun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yan, Hai-Fei; Zhang, Cai-Yun; Hu, Chi-Ming; Ge, Xue-Jun] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Hao, G (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475	National Natural Science Foundation of China [31170205, 30900160]; Special Research Program of Shanghai Chenshan Botanical Garden [G102401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Program of Shanghai Chenshan Botanical Garden	This study was financially supported by the National Natural Science Foundation of China (Grant Nos. 31170205 and 30900160) and a Special Research Program of Shanghai Chenshan Botanical Garden (G102401). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang YC, 2004, MOL PHYLOGENET EVOL, V31, P929, DOI 10.1016/j.ympev.2003.09.017; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; *COMM CHIN AC SCI, 1985, PHYS GEOGR CHIN PAND; CRANDALL KA, 1993, GENETICS, V134, P959; Cui ZJ, 2005, QUATERARY GLACIATION; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; DOWRICK V. PAMELA J., 1956, HEREDITY, V10, P219; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; Guggisberg A, 2006, NEW PHYTOL, V171, P617, DOI 10.1111/j.1469-8137.2006.01722.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasumi H., 2004, 1 U TOK CTR CLIM SYS; [何国生 He Guosheng], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P551; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu CM, 1996, PRIMULACEAE; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, PRIMULACEAE; KELSO S, 1992, ARCTIC ALPINE RES, V24, P82, DOI 10.2307/1551324; Li BY., 1989, J MOUNTAIN RES, V7, P13; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mast AR, 2006, NEW PHYTOL, V171, P605, DOI [10.1111/j.1469-8137.2006.01700.x, 10.1111/j.1469-8137.2006.01833.x]; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Porter J.E., 1994, QUATERNARY SCI, V1, P24; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2002, AM J BOT, V89, P1818, DOI 10.3732/ajb.89.11.1818; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A, 2005, TRACER V1 5; Richards J, 2003, PRIMULA; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SARKAR A K, 1988, Feddes Repertorium, V99, P113; Schneider S, 1999, GENETICS, V152, P1079; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Sun XJ, 2000, ACTA BOT SIN, V42, P1201; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1993, GENETICS, V134, P659; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Geert A, 2008, CONSERV GENET, V9, P845, DOI 10.1007/s10592-007-9409-9; Wang FY, 2008, J SYST EVOL, V46, P13, DOI 10.3724/SP.J.1002.2008.07049; Wang JF, 2011, J SYST EVOL, V49, P108, DOI 10.1111/j.1759-6831.2011.00117.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang L., 2011, PLOS ONE, V6; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu ZY, 1980, CHINAS VEGETATION; Wu ZY, 2011, FLORISICS SEED PLANT; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Ying T.-S., 1993, ENDEMIC GENERA SEED; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Zhang DC, 2009, NORD J BOT, V27, P405, DOI 10.1111/j.1756-1051.2008.00235.x; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; Zhang R., 1997, PHYS GEOGRAPHY HENGD; Zheng BX, 2005, QUATERARY GLACIATION	94	32	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e41315	10.1371/journal.pone.0041315	http://dx.doi.org/10.1371/journal.pone.0041315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028425	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388400002
J	Duncan, JR; Dick, ALW; Egan, G; Kolbe, S; Gavrilescu, M; Wright, D; Lubman, DI; Lawrence, AJ				Duncan, Jhodie Rubina; Dick, Alec Lindsay Ward; Egan, Gary; Kolbe, Scott; Gavrilescu, Maria; Wright, David; Lubman, Dan Ian; Lawrence, Andrew John			Adolescent Toluene Inhalation in Rats Affects White Matter Maturation with the Potential for Recovery Following Abstinence	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CONDITIONED PLACE PREFERENCE; EARLY POSTNATAL-DEVELOPMENT; MEDIAL PREFRONTAL CORTEX; CHRONIC SOLVENT ABUSE; LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS; CORPUS-CALLOSUM; ADULT RATS; COGNITIVE RECOVERY	Inhalant misuse is common during adolescence, with ongoing chronic misuse associated with neurobiological and cognitive abnormalities. While human imaging studies consistently report white matter abnormalities among long-term inhalant users, longitudinal studies have been lacking with limited data available regarding the progressive nature of such abnormalities, including the potential for recovery following periods of sustained abstinence. We exposed adolescent male Wistar rats (postnatal day 27) to chronic intermittent inhaled toluene (3,000 ppm) for 1 hour/day, 3 times/week for 8 weeks to model abuse patterns observed in adolescent and young adult human users. This dosing regimen resulted in a significant retardation in weight gain during the exposure period (p<0.05). In parallel, we performed longitudinal magnetic resonance imaging (T-2-weighted) and diffusion tensor imaging prior to exposure, and after 4 and 8 weeks, to examine the integrity of white matter tracts, including the anterior commissure and corpus callosum. We also conducted imaging after 8 weeks of abstinence to assess for potential recovery. Chronic intermittent toluene exposure during adolescence and early adulthood resulted in white matter abnormalities, including a decrease in axial(p<0.05) and radial (p<0.05) diffusivity. These abnormalities appeared region-specific, occurring in the anterior commissure but not the corpus callosum and were not present until after at least 4 weeks of exposure. Toluene-induced effects on both body weight and white matter parameters recovered following abstinence. Behaviourally, we observed a progressive decrease in rearing activity following toluene exposure but no difference in motor function, suggesting cognitive function may be more sensitive to the effects of toluene. Furthermore, deficits in rearing were present by 4 weeks suggesting that toluene may affect behaviour prior to detectable white matter abnormalities. Consequently, exposure to inhalants that contain toluene during adolescence and early adulthood appear to differentially affect white matter maturation and behavioural outcomes, although recovery can occur following abstinence.	[Duncan, Jhodie Rubina; Dick, Alec Lindsay Ward; Egan, Gary; Kolbe, Scott; Gavrilescu, Maria; Wright, David; Lawrence, Andrew John] Univ Melbourne, Florey Neurosci Inst, Div Behav Neurosci, Melbourne, Vic, Australia; [Duncan, Jhodie Rubina] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Dick, Alec Lindsay Ward; Lawrence, Andrew John] Univ Melbourne, Ctr Neurosci Res, Melbourne, Vic, Australia; [Lubman, Dan Ian] Eastern Hlth & Monash Univ, Turning Point Alcohol & Drug Ctr, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; Turning Point Alcohol & Drug Centre - Australia	Duncan, JR (corresponding author), Univ Melbourne, Florey Neurosci Inst, Div Behav Neurosci, Melbourne, Vic, Australia.	Jhodie.duncan@florey.edu.au	Egan, Gary F./A-1381-2013; Maria, Gavrilescu/F-9265-2014	Maria, Gavrilescu/0000-0002-0663-0316; Dick, Alec/0000-0002-2303-9720; Kolbe, Scott/0000-0003-4685-1380; Egan, Gary/0000-0002-3186-4026; Lubman, Dan/0000-0002-6747-1937; Wright, David/0000-0002-7535-8651	National Health and Medical Research Council of Australia [1020737]; Australian Research Council [DP 110100379, 100100235]; Lew Carty Foundation; Alcohol and Health Research Grant Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Lew Carty Foundation; Alcohol and Health Research Grant Scheme	This research was supported by The National Health and Medical Research Council of Australia of which AJL is a Principal Fellow (1020737), the Australian Research Council (DP 110100379) of which JRD is a Future Fellow (100100235), The Lew Carty Foundation and the Alcohol and Health Research Grant Scheme. The authors also acknowledge the Victorian Government's Operational Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez EO, 2001, BEHAV BRAIN RES, V123, P143, DOI 10.1016/S0166-4328(01)00190-5; Abin-Carriquiry JA, 2010, EUR J PHARMACOL, V634, P89, DOI 10.1016/j.ejphar.2010.02.030; Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Aydin K, 2002, AM J NEURORADIOL, V23, P1173; Aydin K, 2003, MAGN RESON IMAGING, V21, P777, DOI 10.1016/S0730-725X(03)00175-9; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Batis JC, 2010, PHARMACOL BIOCHEM BE, V96, P438, DOI 10.1016/j.pbb.2010.07.003; Beckley JT, 2011, NEUROPSYCHOPHARMACOL, V36, P1531, DOI 10.1038/npp.2011.38; Beckstead MJ, 2000, MOL PHARMACOL, V57, P1199; Berenguer P, 2003, PHARMACOL BIOCHEM BE, V74, P997, DOI 10.1016/S0091-3057(03)00027-3; Berenguer P, 2004, PHYSIOL BEHAV, V81, P527, DOI 10.1016/j.physbeh.2004.02.017; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Bowen SE, 2007, NEUROTOXICOL TERATOL, V29, P599, DOI 10.1016/j.ntt.2007.08.001; Bowen SE, 2006, NEUROTOXICOL TERATOL, V28, P636, DOI 10.1016/j.ntt.2006.09.005; Bowen SE, 2005, NEUROTOXICOL TERATOL, V27, P105, DOI 10.1016/j.ntt.2004.09.007; Burns LH, 1996, BEHAV NEUROSCI, V110, P60, DOI 10.1037/0735-7044.110.1.60; Cairney S, 2005, NEUROPSYCHOPHARMACOL, V30, P1019, DOI 10.1038/sj.npp.1300682; Cairney S, 2004, DRUG ALCOHOL DEPEN, V73, P183, DOI 10.1016/j.drugalcdep.2003.10.010; CALDEMEYER KS, 1993, AM J ROENTGENOL, V161, P1259, DOI 10.2214/ajr.161.6.8249738; Chan KC, 2009, INT J DEV NEUROSCI, V27, P607, DOI 10.1016/j.ijdevneu.2009.05.012; Choi H, 2011, SCHIZOPHR RES, V130, P78, DOI 10.1016/j.schres.2011.04.016; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Deleu D, 2000, J NEUROL NEUROSUR PS, V68, P118, DOI 10.1136/jnnp.68.1.118; Dingwall KM, 2011, DRUG ALCOHOL DEPEN, V118, P180, DOI 10.1016/j.drugalcdep.2011.03.017; Filley CM, 2004, J NEUROPATH EXP NEUR, V63, P1; FINK JS, 1980, BRAIN RES, V199, P359; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Funada M, 2002, BRAIN RES PROTOC, V10, P47; Gerasimov MR, 2003, EUR J PHARMACOL, V477, P45, DOI 10.1016/j.ejphar.2003.08.022; HILLEFORSBERGLUND M, 1995, TOXICOLOGY, V100, P185, DOI 10.1016/0300-483X(95)03084-S; HINMAN DJ, 1987, PHARMACOL BIOCHEM BE, V26, P65, DOI 10.1016/0091-3057(87)90535-1; Jarosz PA, 2008, PHYSIOL BEHAV, V93, P984, DOI 10.1016/j.physbeh.2007.12.016; Jito J, 2008, J MAGN RESON IMAGING, V28, P847, DOI 10.1002/jmri.21496; Johnson EO, 1995, DRUG ALCOHOL DEPEN, V40, P159, DOI 10.1016/0376-8716(95)01201-X; Laviola G, 2001, PHARMACOL BIOCHEM BE, V68, P115, DOI 10.1016/S0091-3057(00)00430-5; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Lubman DI, 2008, BRIT J PHARMACOL, V154, P316, DOI 10.1038/bjp.2008.76; Lubman DI, 2006, MED J AUSTRALIA, V185, P327, DOI 10.5694/j.1326-5377.2006.tb00588.x; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; McGarvey EL, 1999, AM J DRUG ALCOHOL AB, V25, P731, DOI 10.1081/ADA-100101889; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; O'Leary-Moore SK, 2009, NEUROTOXICOL TERATOL, V31, P382, DOI 10.1016/j.ntt.2009.07.005; Pawlak CR, 2002, PHARMACOL BIOCHEM BE, V73, P679, DOI 10.1016/S0091-3057(02)00852-3; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perit KE, 2012, NEUROTOXICOL TERATOL, V34, P37, DOI 10.1016/j.ntt.2011.10.007; Perron BE, 2009, ADDICTION, V104, P1185, DOI 10.1111/j.1360-0443.2009.02557.x; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Qureshi SU, 2009, CAN J NEUROL SCI, V36, P388, DOI 10.1017/S0317167100007204; Riegel AC, 2003, NEUROPSYCHOPHARMACOL, V28, P1440, DOI 10.1038/sj.npp.1300193; Riegel AC, 2007, NEUROPSYCHOPHARMACOL, V32, P1558, DOI 10.1038/sj.npp.1301273; ROSENBERG NL, 1988, NEUROTOXICOL TERATOL, V10, P489, DOI 10.1016/0892-0362(88)90014-1; ROSENBERG NL, 1988, ANN NEUROL, V23, P611, DOI 10.1002/ana.410230614; Rosenberg NL, 2002, J TOXICOL-CLIN TOXIC, V40, P21, DOI 10.1081/CLT-120002883; Ryu YH, 1998, J NUCL MED, V39, P632; Shereen A, 2011, J CEREBR BLOOD F MET, V31, P1155, DOI 10.1038/jcbfm.2010.212; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; STINUS L, 1978, J COMP PHYSIOL PSYCH, V92, P289, DOI 10.1037/h0077467; Thiel CM, 1999, NEUROSCIENCE, V93, P243, DOI 10.1016/S0306-4522(99)00158-X; von Euler M, 2000, EXP NEUROL, V163, P1, DOI 10.1006/exnr.1999.7288; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; WEISS B, 1979, ENVIRON HEALTH PERSP, V30, P39, DOI 10.2307/3429100; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; YAMANOUCHI N, 1995, AM J NEURORADIOL, V16, P1643; Yucel M, 2008, NEUROSCI BIOBEHAV R, V32, P910, DOI 10.1016/j.neubiorev.2008.01.006; Yucel M, 2010, J PSYCHIATR NEUROSCI, V35, P409, DOI 10.1503/jpn.090177; Zhou WX, 2005, NEUROPSYCHOPHARMACOL, V30, P880, DOI 10.1038/sj.npp.1300635	72	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44790	10.1371/journal.pone.0044790	http://dx.doi.org/10.1371/journal.pone.0044790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028622	gold, Green Published			2022-12-25	WOS:000311313900041
J	Kong, DJ; Ahmad, A; Bao, B; Li, YW; Banerjee, S; Sarkar, FH				Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.			Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; PLURIPOTENT STEM-CELLS; ANDROGEN-DEPRIVATION; METASTASIS; GROWTH; INVASION; ANGIOGENESIS; CARCINOMA; EMT; 3,3'-DIINDOLYLMETHANE	Clinical experience of histone deacetylase inhibitors (HDACIs) in patients with solid tumors has been disappointing; however, the molecular mechanism of treatment failure is not known. Therefore, we sought to investigate the molecular mechanism of treatment failure of HDACIs in the present study. We found that HDACIs Trichostatin A (TSA) and Suberoylanilide hydroxamic acid (SAHA) could induce epithelial-to-mesenchymal transition (EMT) phenotype in prostate cancer (PCa) cells, which was associated with changes in cellular morphology consistent with increased expression of transcription factors ZEB1, ZEB2 and Slug, and mesenchymal markers such as vimentin, N-cadherin and Fibronectin. CHIP assay showed acetylation of histone 3 on proximal promoters of selected genes, which was in part responsible for increased expression of EMT markers. Moreover, TSA treatment led to further increase in the expression of Sox2 and Nanog in PCa cells with EMT phenotype, which was associated with cancer stem-like cell (CSLC) characteristics consistent with increased cell motility. Our results suggest that HDACIs alone would lead to tumor aggressiveness, and thus strategies for reverting EMT-phenotype to mesenchymal-to-epithelial transition (MET) phenotype or the reversal of CSLC characteristics prior to the use of HDACIs would be beneficial to realize the value of HDACIs for the treatment of solid tumors especially PCa.	[Kong, Dejuan; Ahmad, Aamir; Bao, Bin; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kong, DJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723	National Cancer Institute, National Institutes of Health [5R01CA108535-06, 5R01CA083695-09]; NATIONAL CANCER INSTITUTE [R01CA083695, R01CA108535] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (5R01CA108535-06 and 5R01CA083695-09) awarded to FHS (http://projectreporter.nih.gov/reporter_searchresults.cfm?&new = 1&icde = 4342569&loc = 2&CFID = 28929570&CFTOKEN = 80568291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Barriere G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-114; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Chin SP, 2011, CLIN EPIGENETICS, V2, P151, DOI 10.1007/s13148-011-0041-7; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Kanwal R, 2012, CLIN GENET, V81, P303, DOI 10.1111/j.1399-0004.2011.01809.x; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Pasha Z, 2012, STEM CELLS DEV; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Uchida H, 2012, J BIOL CHEM, V287, P4441, DOI 10.1074/jbc.M111.286138; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544	50	31	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45045	10.1371/journal.pone.0045045	http://dx.doi.org/10.1371/journal.pone.0045045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024790	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100048
J	Lopez-Arenas, E; Mackay-Sim, A; Bacigalupo, J; Sulz, L				Lopez-Arenas, Estefania; Mackay-Sim, Alan; Bacigalupo, Juan; Sulz, Lorena			Leukaemia Inhibitory Factor Stimulates Proliferation of Olfactory Neuronal Progenitors via Inducible Nitric Oxide Synthase	PLOS ONE			English	Article							GLOBOSE BASAL-CELLS; NEURAL STEM-CELLS; MOUSE SUBVENTRICULAR ZONE; MESSENGER-RNA EXPRESSION; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; DENTATE GYRUS; INDUCED NEUROGENESIS; FUNCTIONAL DEFICITS	Neurogenesis continues in the adult brain and in the adult olfactory epithelium. The cytokine, leukaemia inhibitory factor and nitric oxide are both known to stimulate neuronal progenitor cell proliferation in the olfactory epithelium after injury. Our aim here was to determine whether these observations are independent, specifically, whether leukaemia inhibitory factor triggers neural precursor proliferation via the inducible nitric oxide synthase pathway. We evaluated the effects of leukaemia inhibitory factor on inducible form of nitric oxide synthase (iNOS) expression, and cell proliferation in olfactory epithelial cell cultures and olfactory neurosphere-derived cells. Leukaemia inhibitory factor induced expression of iNOS and increased cell proliferation. An iNOS inhibitor and an anti-leukaemia inhibitory factor receptor blocking antibody inhibited leukaemia inhibitory factor-induced cell proliferation, an effect that was reversed by a NO donor. Altogether, the results strongly suggest that leukaemia inhibitory factor induces iNOS expression, increasing nitric oxide levels, to stimulate proliferation of olfactory neural precursor cells. This finding sheds light on neuronal regeneration occurring after injury of the olfactory epithelium.	[Lopez-Arenas, Estefania; Bacigalupo, Juan] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Lopez-Arenas, Estefania; Bacigalupo, Juan] Univ Chile, Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile; [Mackay-Sim, Alan] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Sulz, Lorena] Univ Santiago Chile, Lab Embryol, Sch Med, Fac Med Sci, Usach Santiago, Chile	Universidad de Chile; Universidad de Chile; Griffith University	Lopez-Arenas, E (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	bacigalu@uchile.cl; lorena.sulz@usach.cl	Mackay-Sim, Alan/C-3431-2008	Mackay-Sim, Alan/0000-0003-4446-5371	DICYT (Direccion de Investigacion en Ciencia y Tecnologia) [021091SE]; MIDEPLAN (Ministerio de Planificacion y Desarrollo) [ICM-P05-001-F]; DICYT [021091SE]; MIDEPLAN [ICM-P05-001-F]; Fondecyt [1100682]; Australian Department of Health and Ageing	DICYT (Direccion de Investigacion en Ciencia y Tecnologia); MIDEPLAN (Ministerio de Planificacion y Desarrollo); DICYT; MIDEPLAN; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	Funded by national grants DICYT (Direccion de Investigacion en Ciencia y Tecnologia) 021091SE and MIDEPLAN (Ministerio de Planificacion y Desarrollo) ICM-P05-001-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jimena Sierralta (Laboratory of Cellular and Molecular Neurobiology, Faculty of Medicine, University of Chile) and Dr. Luis Michea (Laboratory of Integrative Physiology Faculty of Medicine, University of Chile) for their assistance in the qPCRs experiments and to Dr. Maria Rosa Bono (Laboratory of Immunology, Faculty of Science, Universidad de Chile) for her assistance in the flow cytometer protocols. Funded by DICYT 021091SE to LS, MIDEPLAN ICM-P05-001-F and Fondecyt 1100682 to JB and Australian Department of Health and Ageing to AMS.	BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; Bauer S, 2003, J NEUROSCI, V23, P1792; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Corsani L, 2008, EXP NEUROL, V211, P433, DOI 10.1016/j.expneurol.2008.02.008; Dell'Albani P, 2001, J NEUROSCI RES, V65, P417, DOI 10.1002/jnr.1169; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; Getchell TV, 2002, J NEUROSCI RES, V67, P246, DOI 10.1002/jnr.10090; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; Hambartsoumian E, 2001, AM J REPROD IMMUNOL, V45, P78, DOI 10.1111/j.8755-8920.2001.450203.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUARD JMT, 1995, DEV DYNAM, V203, P17, DOI 10.1002/aja.1002030103; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Kim EJ, 2005, NEUROREPORT, V16, P25, DOI 10.1097/00001756-200501190-00007; Kim SJ, 2000, BIOCHEM BIOPH RES CO, V278, P712, DOI 10.1006/bbrc.2000.3862; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Leung CT, 2006, HORIZONTAL BASEL CEL, P115; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; Minami M, 2002, MOL BRAIN RES, V107, P39, DOI 10.1016/S0169-328X(02)00443-6; Moon C, 2002, P NATL ACAD SCI USA, V99, P9015, DOI 10.1073/pnas.132131699; Moran CS, 1997, J VASC RES, V34, P378, DOI 10.1159/000159246; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moreno-Lopez B, 2000, BRAIN RES, V869, P244, DOI 10.1016/S0006-8993(00)02474-4; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; MOULTON DG, 1974, ANN NY ACAD SCI, V237, P52, DOI 10.1111/j.1749-6632.1974.tb49843.x; Murphy M, 1997, PROG NEUROBIOL, V52, P355, DOI 10.1016/S0301-0082(97)00020-8; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Nan B, 2001, J COMP NEUROL, V435, P60, DOI 10.1002/cne.1193; Newman MP, 2000, NEUROSCIENCE, V99, P343, DOI 10.1016/S0306-4522(00)00194-9; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Park C, 2001, NEUROSCI LETT, V309, P9, DOI 10.1016/S0304-3940(01)02003-1; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Pitman M, 2004, MOL CELL NEUROSCI, V27, P255, DOI 10.1016/j.mcn.2004.07.004; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rolfe BE, 2003, CARDIOVASC RES, V58, P222, DOI 10.1016/S0008-6363(02)00832-5; ROSKAMS AJ, 1994, NEURON, V13, P289; Satoh M, 1997, NEUROSCI LETT, V225, P165, DOI 10.1016/S0304-3940(97)00216-4; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Sulz L, 2009, NITRIC OXIDE-BIOL CH, V20, P238, DOI 10.1016/j.niox.2009.01.004; Sugiyama T, 2003, J ENDOTOXIN RES, V9, P108, DOI 10.1179/096805103125001496; Sun YJ, 2005, J CEREBR BLOOD F MET, V25, P485, DOI 10.1038/sj.jcbfm.9600049; Suzuki S, 2000, J CEREBR BLOOD F MET, V20, P661, DOI 10.1097/00004647-200004000-00003; Wetzig A, 2011, CELL TRANSP IN PRESS; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhu DY, 2003, J NEUROSCI, V23, P223	56	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45018	10.1371/journal.pone.0045018	http://dx.doi.org/10.1371/journal.pone.0045018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024784	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100042
J	Poudel, A; Elsasser, TH; Rahman, KS; Chowdhury, EU; Kaltenboeck, B				Poudel, Anil; Elsasser, Theodore H.; Rahman, Kh. Shamsur; Chowdhury, Erfan U.; Kaltenboeck, Bernhard			Asymptomatic Endemic Chlamydia pecorum Infections Reduce Growth Rates in Calves by up to 48 Percent	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACUTE-PHASE PROTEINS; CHLAMYDOPHILA-ABORTUS; BINDING-PROTEINS; HIGH PREVALENCE; FACTOR-I; PSITTACI; CATTLE; FEED; IMMUNOGLOBULINS	Intracellular Chlamydia (C.) bacteria cause in cattle some acute but rare diseases such as abortion, sporadic bovine encephalomyelitis, kerato-conjunctivitis, pneumonia, enteritis and polyarthritis. More frequent, essentially ubiquitous worldwide, are low-level, asymptomatic chlamydial infections in cattle. We investigated the impact of these naturally acquired infections in a cohort of 51 female Holstein and Jersey calves from birth to 15 weeks of age. In biweekly sampling, we measured blood/plasma markers of health and infection and analyzed their association with clinical appearance and growth in dependence of chlamydial infection intensity as determined by mucosal chlamydial burden or contemporaneous anti-chlamydial plasma IgM. Chlamydia 23S rRNA gene PCR and ompA genotyping identified only C. pecorum (strains 1710S, Maeda, and novel strain Smith3v8) in conjunctival and vaginal swabs. All calves acquired the infection but remained clinically asymptomatic. High chlamydial infection associated with reduction of body weight gains by up to 48% and increased conjunctival reddening (P<10(-4)). Simultaneously decreased plasma albumin and increased globulin (P<10(-4)) suggested liver injury by inflammatory mediators as mechanisms for the growth inhibition. This was confirmed by the reduction of plasma insulin like growth factor-1 at high chlamydial infection intensity (P<10(-4)). High anti-C. pecorum IgM associated eight weeks later with 66% increased growth (P = 0.027), indicating a potential for immune protection from C. pecorum-mediated growth depression. The worldwide prevalence of chlamydiae in livestock and their high susceptibility to common feed-additive antibiotics suggests the possibility that suppression of chlamydial infections may be a major contributor to the growth promoting effect of feed-additive antibiotics.	[Poudel, Anil; Rahman, Kh. Shamsur; Chowdhury, Erfan U.; Kaltenboeck, Bernhard] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Elsasser, Theodore H.] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Auburn University System; Auburn University; United States Department of Agriculture (USDA)	Poudel, A (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	kaltebe@auburn.edu	Rahman, Kh Shamsur/M-2419-2019	Rahman, Kh Shamsur/0000-0001-7243-8501	United States Department of Agriculture Hatch Grant of the Alabama Agricultural Experiment Station [ALA051-1-10012]	United States Department of Agriculture Hatch Grant of the Alabama Agricultural Experiment Station	This study was supported by United States Department of Agriculture Hatch Grant ALA051-1-10012 of the Alabama Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2003, VET J, V166, P86, DOI 10.1016/S1090-0233(02)00251-4; Biesenkamp-Uhe C, 2007, INFECT IMMUN, V75, P870, DOI 10.1128/IAI.00691-06; Brun-Hansen HC, 2006, VET CLIN PATH, V35, P182, DOI 10.1111/j.1939-165X.2006.tb00111.x; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Cray C, 2009, COMPARATIVE MED, V59, P517; DeGraves FJ, 2004, INFECT IMMUN, V72, P2538, DOI 10.1128/IAI.72.5.2538-2545.2004; DeGraves FJ, 2003, J CLIN MICROBIOL, V41, P1726, DOI 10.1128/JCM.41.4.1726-1729.2003; DeGraves FJ, 2003, BIOTECHNIQUES, V34, P106, DOI 10.2144/03341rr01; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Elsasser T. H., 2008, J ANIM SCI, V86, pE105, DOI [10.2527/jas.2007-0634, DOI 10.2527/JAS.2007-0634]; ELSASSER TH, 1988, J ENDOCRINOL, V116, P191, DOI 10.1677/joe.0.1160191; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GALLO GF, 1995, CAN VET J, V36, P223; Godin AC, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-39; Horn M, 2011, BERGEYS MANUAL SYSTE, V4, P843; HUSBAND AJ, 1972, AUST J EXP BIOL MED, V50, P491, DOI 10.1038/icb.1972.41; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Kaltenbock B, 1997, J CLIN MICROBIOL, V35, P1835; Kaltenboeck B, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0832-4; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Kaltenboeck B, 2009, VET MICROBIOL, V135, P175, DOI 10.1016/j.vetmic.2008.09.036; Kaltenboeck B, 1997, J CLIN MICROBIOL, V35, P2293, DOI 10.1128/JCM.35.9.2293-2298.1997; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kemmerling K, 2009, J DAIRY SCI, V92, P4347, DOI 10.3168/jds.2009-2051; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Knowles TG, 2000, VET REC, V147, P593, DOI 10.1136/vr.147.21.593; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; Lang CH, 2002, CURR OPIN CLIN NUTR, V5, P271, DOI 10.1097/00075197-200205000-00006; Li D, 2005, J MICROBIOL METH, V61, P17, DOI 10.1016/j.mimet.2004.10.020; Livingstone M, 2006, VET J, V172, P3, DOI 10.1016/j.tvjl.2005.05.001; McNUTT S. H., 1940, CORNELL VET, V30, P437; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Mohri M, 2007, RES VET SCI, V83, P30, DOI 10.1016/j.rvsc.2006.10.017; Otter P, 2003, VET REC, V152, P787; PEREZMARTINEZ JA, 1986, AM J VET RES, V47, P1501; Petit T, 2008, VET MICROBIOL, V127, P325, DOI 10.1016/j.vetmic.2007.08.022; PORTER P, 1972, IMMUNOLOGY, V23, P225; Reggiardo C, 1989, J Vet Diagn Invest, V1, P305; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; RONSHOLT L, 1981, ACTA VET SCAND, V22, P9; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; SHEWEN PE, 1980, CAN VET J, V21, P2; SHUSTER DE, 1995, P SOC EXP BIOL MED, V210, P140; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; SMITH WD, 1976, CLIN EXP IMMUNOL, V23, P544; STORZ J., 1960, JOUR AMER VET MED ASSOC, V137, P509; STORZ J, 1966, AM J VET RES, V27, P633; STORZ J, 1971, ANN NY ACAD SCI, V176, P162, DOI 10.1111/j.1749-6632.1971.tb35002.x; Wang CM, 2009, J INFECT DIS, V200, P279, DOI 10.1086/599796; Wang FI, 2001, J VET MED SCI, V63, P1215, DOI 10.1292/jvms.63.1215; Wehrend A, 2005, THERIOGENOLOGY, V63, P923, DOI 10.1016/j.theriogenology.2004.05.009; WILSON MR, 1968, RES VET SCI, V9, P467; WITTENBRINK MM, 1988, J VET MED B, V35, P237, DOI 10.1111/j.1439-0450.1988.tb00493.x	61	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44961	10.1371/journal.pone.0044961	http://dx.doi.org/10.1371/journal.pone.0044961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024776	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100034
J	Cai, YJ; Wang, WS; Liang, HY; Sun, LH; Teitelbaum, DH; Yang, H				Cai, Yujiao; Wang, Wensheng; Liang, Hongying; Sun, Lihua; Teitelbaum, Daniel H.; Yang, Hua			Keratinocyte Growth Factor Improves Epithelial Structure and Function in a Mouse Model of Intestinal Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTION PROTEINS; DELTA T-CELLS; BARRIER FUNCTION; MICE; MECHANISMS; APOPTOSIS; REPAIR; RATS	Background: Intestinal ischemia/reperfusion (I/R) induces the desquamation of the intestinal epithelium, increases the intestinal permeability, and in patients often causes fatal conditions including sepsis and multiple organ failure. Keratinocyte growth factor (KGF) increases intestinal growth, although little is known about KGF activity on intestinal function after intestinal I/R. We hypothesized that KGF administration would improve the intestinal function in a mouse model of intestinal I/R. Methods: Adult C57BL/6J mice were randomized to three groups: Sham, I/R group and I/R+KGF group. Mice were killed on day 5, and the small bowel was harvested for histology, wet weight, RNA and protein content analysis. Epithelial cell (EC) proliferation was detected by immunohistochemistry for PCNA, and apoptosis was determined by TUNEL staining. The expressions of Claudin-1 and ZO-1 were detected by immunohistochemistry. Epithelial barrier function was assessed with transepithelial resistance (TER). Results: KGF significantly increased the intestinal wet weight, contents of intestinal protein and RNA, villus height, crypt depth and crypt cell proliferation, while KGF resulted in the decrease of epithelial apoptosis. KGF also stimulated the recovery of mucosal structures and attenuated the disrupted distribution of TJ proteins. Moreover, KGF attenuated the intestinal I/R-induced decrease in TER and maintained the intestinal barrier function. Conclusion: KGF administration improves the epithelial structure and barrier function in a mouse model of intestinal I/R. This suggests that KGF may have clinical applicability.	[Cai, Yujiao; Wang, Wensheng; Liang, Hongying; Sun, Lihua; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Teitelbaum, Daniel H.; Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Cai, YJ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	hyang@umich.edu			National Natural Science Foundation of China [30973113, 81020108023, 81000830]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30973113; No. 81020108023; No. 81000830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Aranow JS, 1996, BRIT J ANAESTH, V77, P71, DOI 10.1093/bja/77.1.71; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Byrne FR, 2002, AM J PHYSIOL-GASTR L, V282, pG690, DOI 10.1152/ajpgi.00314.2001; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Drucker DJ, 1997, AM J PHYSIOL-GASTR L, V273, pG3, DOI 10.1152/ajpgi.1997.273.1.G3; Egger B, 1999, DIGEST DIS SCI, V44, P836, DOI 10.1023/A:1026642715764; Farrell CL, 1998, CANCER RES, V58, P933; Finch PW, 1996, GASTROENTEROLOGY, V110, P441, DOI 10.1053/gast.1996.v110.pm8566591; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Daniel RAF, 2011, ACTA CIR BRAS, V26, P463, DOI 10.1590/S0102-86502011000600010; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Higuchi S, 2008, INT J CLIN EXP PATHO, V1, P409; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Hung WT, 2004, J PEDIATR SURG, V39, P1077, DOI 10.1016/j.jpedsurg.2004.03.047; Johnson WF, 2000, VET SURG, V29, P17, DOI 10.1111/j.1532-950X.2000.00017.x; Kocogullari CU, 2008, SURG TODAY, V38, P237, DOI 10.1007/s00595-007-3614-5; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matthijsen RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007045; Moeser AJ, 2008, AM J PHYSIOL-GASTR L, V295, pG791, DOI 10.1152/ajpgi.00538.2007; Montalto M, 2004, DIGESTION, V69, P225, DOI 10.1159/000079152; Munro H.N., 1969, MAMMALIAN PROTEIN ME, P465; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Smith P L, 1996, Pharm Biotechnol, V8, P13; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Yang H, 2002, JPEN-PARENTER ENTER, V26, P333, DOI 10.1177/0148607102026006333; Yang H, 2003, JPEN-PARENTER ENTER, V27, P198, DOI 10.1177/0148607103027003198; Yucel AF, 2011, J MOL HISTOL, V42, P579, DOI 10.1007/s10735-011-9364-0; Zeeh JM, 1996, GASTROENTEROLOGY, V110, P1077, DOI 10.1053/gast.1996.v110.pm8612996; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	39	24	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44772	10.1371/journal.pone.0044772	http://dx.doi.org/10.1371/journal.pone.0044772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028616	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700038
J	Li, YF; Qian, H; Wang, Y; Cucinotta, FA				Li, Yongfeng; Qian, Hong; Wang, Ya; Cucinotta, Francis A.			A Stochastic Model of DNA Fragments Rejoining	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; INDUCE CHROMOSOME BREAKAGE; GAMMA-H2AX FOCI; DSB-REPAIR; END; KU; RADIATION; DAMAGE; KINETICS; COMPLEX	When cells are exposed to ionizing radiation, DNA damages in the form of single strand breaks (SSBs), double strand breaks (DSBs), base damage or their combinations are frequent events. It is known that the complexity and severity of DNA damage depends on the quality of radiation, and the microscopic dose deposited in small segments of DNA, which is often related to the linear transfer energy (LET) of the radiation. Experimental studies have suggested that under the same dose, high LET radiation induces more small DNA fragments than low-LET radiation, which affects Ku efficiently binding with DNA end and might be a main reason for high-LET radiation induced RBE [1] since DNA DSB is a major cause for radiationinduced cell death. In this work, we proposed a mathematical model of DNA fragments rejoining according to nonhomologous end joining (NHEJ) mechanism. By conducting Gillespie's stochastic simulation, we found several factors that impact the efficiency of DNA fragments rejoining. Our results demonstrated that aberrant DNA damage repair can result predominantly from the occurrence of a spatial distribution of DSBs leading to short DNA fragments. Because of the low efficiency that short DNA fragments recruit repair protein and release the protein residue after fragments rejoining, Kudependent NHEJ is significantly interfered with short fragments. Overall, our work suggests that inhibiting the Kudependent NHEJ may significantly contribute to the increased efficiency for cell death and mutation observed for high LET radiation.	[Li, Yongfeng] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Wang, Ya] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Universities Space Research Association (USRA); University of Washington; University of Washington Seattle; Emory University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Li, YF (corresponding author), Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA.	francis.a.cucinotta@nasa.gov	Cucinotta, Francis/AAZ-5941-2020		NASA Space Radiation Program	NASA Space Radiation Program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Space Radiation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; Asaithamby A, 2011, NUCLEIC ACIDS RES, V39, P5474, DOI 10.1093/nar/gkr149; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; *BEIR 7, 2006, HLTH RISKS EXP LOW L; BEIR VI, 1999, HLTH EFF EXP RAND BE; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; de Almodovar JMR, 2002, RADIOTHER ONCOL, V62, P327, DOI 10.1016/S0167-8140(01)00490-X; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Georgakilas AG, 2004, NUCLEIC ACIDS RES, V32, P5609, DOI 10.1093/nar/gkh871; George KA, 2009, RADIAT RES, V171, P752, DOI 10.1667/RR1680.1; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Gulston M, 2002, NUCLEIC ACIDS RES, V30, P3464, DOI 10.1093/nar/gkf467; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lobrich M, 1996, INT J RADIAT BIOL, V70, P493, DOI 10.1080/095530096144680; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Pinto M, 2004, RADIAT RES, V162, P453, DOI 10.1667/RR3241; Ponomarev AL, 2006, INT J RADIAT BIOL, V82, P293, DOI 10.1080/09553000600637716; Postow L, 2011, FEBS LETT, V585, P2876, DOI 10.1016/j.febslet.2011.05.046; PRIDAL I, 1984, J THEOR BIOL, V111, P81, DOI 10.1016/S0022-5193(84)80197-6; Richard M, 2012, J THEOR BIOL, V292, P39, DOI 10.1016/j.jtbi.2011.08.024; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Schulz-Ertner D, 2007, J CLIN ONCOL, V25; Schwartz JL, 1996, BRIT J CANCER, V74, P37, DOI 10.1038/bjc.1996.312; Smith J, 2001, NUCLEIC ACIDS RES, V29, P4783, DOI 10.1093/nar/29.23.4783; THOMPSON B, 1987, MATH BIOSCI, V84, P139, DOI 10.1016/0025-5564(87)90088-5; TSENG SJ, 1990, MATH BIOSCI, V100, P21, DOI 10.1016/0025-5564(90)90045-Z; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Wang HY, 2010, NUCLEIC ACIDS RES, V38, P3245, DOI 10.1093/nar/gkq069; Wang HY, 2009, INT J RADIAT ONCOL, V74, P1236, DOI 10.1016/j.ijrobp.2008.12.089; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	44	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44293	10.1371/journal.pone.0044293	http://dx.doi.org/10.1371/journal.pone.0044293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028515	gold, Green Published, Green Submitted			2022-12-25	WOS:000308788700018
J	Patrawalla, P; Kazeros, A; Rogers, L; Shao, YZ; Liu, ML; Fernandez-Beros, ME; Shang, SL; Reibman, J				Patrawalla, Paru; Kazeros, Angeliki; Rogers, Linda; Shao, Yongzhao; Liu, Mengling; Fernandez-Beros, Maria-Elena; Shang, Shulian; Reibman, Joan			Application of the Asthma Phenotype Algorithm from the Severe Asthma Research Program to an Urban Population	PLOS ONE			English	Article							CLUSTER-ANALYSIS; SENSITIZATION; ASSOCIATION	Rationale: Identification and characterization of asthma phenotypes are challenging due to disease complexity and heterogeneity. The Severe Asthma Research Program (SARP) used unsupervised cluster analysis to define 5 phenotypically distinct asthma clusters that they replicated using 3 variables in a simplified algorithm. We evaluated whether this simplified SARP algorithm could be used in a separate and diverse urban asthma population to recreate these 5 phenotypic clusters. Methods: The SARP simplified algorithm was applied to adults with asthma recruited to the New York University/Bellevue Asthma Registry (NYUBAR) to classify patients into five groups. The clinical phenotypes were summarized and compared. Results: Asthma subjects in NYUBAR (n = 471) were predominantly women (70%) and Hispanic (57%), which were demographically different from the SARP population. The clinical phenotypes of the five groups generated by the simplified SARP algorithm were distinct across groups and distributed similarly to those described for the SARP population. Groups 1 and 2 (6 and 63%, respectively) had predominantly childhood onset atopic asthma. Groups 4 and 5 (20%) were older, with the longest duration of asthma, increased symptoms and exacerbations. Group 4 subjects were the most atopic and had the highest peripheral eosinophils. Group 3 (10%) had the least atopy, but included older obese women with adult-onset asthma, and increased exacerbations. Conclusions: Application of the simplified SARP algorithm to the NYUBAR yielded groups that were phenotypically distinct and useful to characterize disease heterogeneity. Differences across NYUBAR groups support phenotypic variation and support the use of the simplified SARP algorithm for classification of asthma phenotypes in future prospective studies to investigate treatment and outcome differences between these distinct groups.	[Patrawalla, Paru; Kazeros, Angeliki; Rogers, Linda; Fernandez-Beros, Maria-Elena; Reibman, Joan] NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY 10003 USA	New York University	Patrawalla, P (corresponding author), NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY 10003 USA.	joan.reibman@nyumc.org	Shang, Shulian/A-2173-2013	Reibman, Joan/0000-0001-7878-1511; Liu, Mengling/0000-0001-9758-8522	Colton Family Foundation; National Institutes of Health [T32 ES007267, M01RR00096]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	Colton Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Colton Family Foundation, and the National Institutes of Health (Grants T32 ES007267, M01RR00096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Cassino C, 2000, AM J RESP CRIT CARE, V162, P1423, DOI 10.1164/ajrccm.162.4.9912140; Centers for Disease Control and Prevention Asthma Prevalence Health care use and Mortality, 2003, HLTH CAR US MORT US; Enright PL, 1999, CHEST, V116, P603, DOI 10.1378/chest.116.3.603; Global Initiative for Asthma, 2002, GLOB IN ASTHM PUBL; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; National Heart Lung and Blood Institute, 2007, NIH PUBL; National Heart Lung and Blood Institute., 2009, MORB MORT CHART BOOK; Pleis John R, 2009, Vital Health Stat 10, P1; Ravault C, 2001, INT J TUBERC LUNG D, V5, P191; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Rogers L, 2002, CHEST, V122, P1580, DOI 10.1378/chest.122.5.1580; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wisnivesky JP, 2007, J ALLERGY CLIN IMMUN, V120, P113, DOI 10.1016/j.jaci.2007.03.044	22	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44540	10.1371/journal.pone.0044540	http://dx.doi.org/10.1371/journal.pone.0044540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028556	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700023
J	Hneino, M; Blirando, K; Buard, V; Tarlet, G; Benderitter, M; Hoodless, P; Francois, A; Milliat, F				Hneino, Mohammad; Blirando, Karl; Buard, Valerie; Tarlet, Georges; Benderitter, Marc; Hoodless, Pamela; Francois, Agnes; Milliat, Fabien			The TG-interacting Factor TGIF1 Regulates Stress-induced Proinflammatory Phenotype of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD TRANSCRIPTIONAL COREPRESSOR; RADIATION ENTEROPATHY; IONIZING-RADIATION; KAPPA-B; MICE; INFLAMMATION; ACTIVATION; PATHWAY; INJURY; DAMAGE	The endothelium contributes to the control of the tissue inflammatory response following stress and in particular after exposure to ionizing radiation. We previously showed that the TG-interacting factor 1 (TGIF1) plays a role in radiation-induced normal tissue injury. In this study we hypothesized that this protein could play a role in inflammation. The role of TGIF1 in the stress-induced proinflammatory phenotype was investigated in human endothelial cells. In HUVECs ionizing radiation induces TGIF1 expression as well as a proinflammatory phenotype associated with up-regulation of IL-6, IL-8, CXCL1, MIP-2, and MCP-1. TGIF1 overexpression enhances the radiation-induced proinflammatory phenotype whereas TGIF1 silencing limits both the TNF-alpha- and radiation-induced overexpression of proinflammatory cytokines. Interestingly, in vivo, in radiation-induced intestinal inflammation in mice, TGIF1 genetic deficiency is associated with a reduced radiation-induced overexpression of proinflammatory molecules. In HUVECs, TNF-alpha and radiation-induced NF-kappa B pathway activation is not influenced by TGIF1 expression, whereas TGIF1 knockdown inhibits both TNF-alpha- and radiation-induced p38 MAPK pathway activation. This study demonstrates that TGIF1 plays a role in TNF-alpha- and radiation-induced inflammation and suggests that it could be a target in limiting this event in the vascular compartment.	[Hneino, Mohammad; Blirando, Karl; Buard, Valerie; Tarlet, Georges; Benderitter, Marc; Francois, Agnes; Milliat, Fabien] Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, F-92262 Fontenay Aux Roses, France; [Hoodless, Pamela] Univ British Columbia, British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia	Milliat, F (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt Therapeut, BP17, F-92262 Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		Hoodless, Pamela/0000-0003-1371-0725; Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127	Institute for Radiological Protection and Nuclear Safety	Institute for Radiological Protection and Nuclear Safety	This work was supported by the Institute for Radiological Protection and Nuclear Safety.	Abderrahmani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035740; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Blirando K, 2011, AM J PATHOL, V178, P640, DOI 10.1016/j.ajpath.2010.10.003; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Flanders KC, 2008, AM J PATHOL, V173, P68, DOI 10.2353/ajpath.2008.070937; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Halle M, 2010, J AM COLL CARDIOL, V55, P1227, DOI 10.1016/j.jacc.2009.10.047; Hneino M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035672; Holler V, 2009, J INVEST DERMATOL, V129, P1280, DOI 10.1038/jid.2008.360; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kruse JJCM, 2009, RADIAT RES, V171, P188, DOI 10.1667/RR1526.1; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Molla M, 2007, WORLD J GASTROENTERO, V13, P3043, DOI 10.3748/wjg.v13.i22.3043; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38913	38921		10.1074/jbc.M112.388389	http://dx.doi.org/10.1074/jbc.M112.388389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995913	Green Published, hybrid			2022-12-25	WOS:000310982800047
J	Koul, S; Khandrika, L; Meacham, RB; Koul, HK				Koul, Sweaty; Khandrika, Lakshmipathi; Meacham, Randall B.; Koul, Hari K.			Genome Wide Analysis of Differentially Expressed Genes in HK-2 Cells, a Line of Human Kidney Epithelial Cells in Response to Oxalate	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CALCIUM-OXALATE; LLC-PK1 CELLS; DNA-SYNTHESIS; CRYSTAL RETENTION; MICROARRAY DATA; TRANSPORT; PATHWAYS; EXPOSURE; PROLIFERATION	Nephrolithiasis is a multi-factorial disease which, in the majority of cases, involves the renal deposition of calcium oxalate. Oxalate is a metabolic end product excreted primarily by the kidney. Previous studies have shown that elevated levels of oxalate are detrimental to the renal epithelial cells; however, oxalate renal epithelial cell interactions are not completely understood. In this study, we utilized an unbiased approach of gene expression profiling using Affymetrix HG_U133_plus2 gene chips to understand the global gene expression changes in human renal epithelial cells [HK-2] after exposure to oxalate. We analyzed the expression of 47,000 transcripts and variants, including 38,500 well characterized human genes, in the HK2 cells after 4 hours and 24 hours of oxalate exposure. Gene expression was compared among replicates as per the Affymetrix statistical program. Gene expression among various groups was compared using various analytical tools, and differentially expressed genes were classified according to the Gene Ontology Functional Category. The results from this study show that oxalate exposure induces significant expression changes in many genes. We show for the first time that oxalate exposure induces as well as shuts off genes differentially. We found 750 up-regulated and 2276 down-regulated genes which have not been reported before. Our results also show that renal cells exposed to oxalate results in the regulation of genes that are associated with specific molecular function, biological processes, and other cellular components. In addition we have identified a set of 20 genes that is differentially regulated by oxalate irrespective of duration of exposure and may be useful in monitoring oxalate nephrotoxicity. Taken together our studies profile global gene expression changes and provide a unique insight into oxalate renal cell interactions and oxalate nephrotoxicity.	[Koul, Sweaty; Khandrika, Lakshmipathi; Meacham, Randall B.; Koul, Hari K.] Univ Colorado, Signal Transduct & Mol Urol Lab, Sch Med, Div Urol,Dept Surg,Program Urosci, Aurora, CO USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Sch Med, Aurora, CO USA; [Koul, Hari K.] Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Koul, HK (corresponding author), Univ Colorado, Signal Transduct & Mol Urol Lab, Sch Med, Div Urol,Dept Surg,Program Urosci, Aurora, CO USA.	hari.koul@uchsc.edu		Khandrika, Lakshmipathi/0000-0003-4438-9073	National Institutes of Health (NIH) [NIH-DK-RO1-54084]; Department of Surgery Academic Enrichment Funds; VA Merit Award [01BX001258]; NIH/National Cancer Institute [R01CA161880]; NATIONAL CANCER INSTITUTE [R01CA161880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery Academic Enrichment Funds; VA Merit Award(US Department of Veterans Affairs); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a research grant to Hari K. Koul from the National Institutes of Health (NIH) (NIH-DK-RO1-54084) and Department of Surgery Academic Enrichment Funds (HKK). HKK is also supported in part by VA Merit Award-01BX001258 and NIH/National Cancer Institute R01CA161880 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari A, 2002, J UROLOGY, V168, P253, DOI 10.1016/S0022-5347(05)64903-8; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chaturvedi LS, 2002, J BIOL CHEM, V277, P13321, DOI 10.1074/jbc.M108203200; Habibzadegah-Tari P, 2005, UROL RES, V33, P440, DOI 10.1007/s00240-005-0505-3; HACKETT RL, 1988, SCANNING MICROSCOPY, V2, P241; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Iida S, 1999, J UROLOGY, V162, P1480, DOI 10.1016/S0022-5347(05)68344-9; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; KNIGHT TF, 1979, KIDNEY INT, V16, P572, DOI 10.1038/ki.1979.167; KOUL H, 1994, AM J PHYSIOL, V266, pF266, DOI 10.1152/ajprenal.1994.266.2.F266; KOUL H, 1994, BIOCHEM BIOPH RES CO, V205, P1632, DOI 10.1006/bbrc.1994.2854; Koul H, 1996, ITAL J MINER ELECT M, V10, P67; Koul HK, 2008, AIP CONF PROC, V1049, P120, DOI 10.1063/1.2998006; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul HK, 1999, J AM SOC NEPHROL, V10, pS417; Koul S, 2006, J UROLOGY, V175, P499, DOI 10.1016/S0022-5347(18)33751-0; Koul S, 2003, ANN NY ACAD SCI, V1010, P292, DOI 10.1196/annals.1299.050; Koul S, 2002, KIDNEY INT, V61, P525, DOI 10.1046/j.1523-1755.2002.00163.x; Koul S, 2008, UROL RES, V36, P1, DOI 10.1007/s00240-007-0130-4; Kuo SM, 1996, J BIOL CHEM, V271, P15491, DOI 10.1074/jbc.271.26.15491; Lieske JC, 1997, KIDNEY INT, V51, P679, DOI 10.1038/ki.1997.98; LIESKE JC, 1992, J UROLOGY, V148, P1517, DOI 10.1016/S0022-5347(17)36954-9; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Ono K, 1987, ASAIO Trans, V33, P245; RADI MJ, 1989, ARCH PATHOL LAB MED, V113, P1367; Robertson WG, 1979, OXALATE HUMAN BIOCH, P173; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; TRUONG LD, 1992, MODERN PATHOL, V5, P146; Verkoelen CF, 1998, AM J PHYSIOL-RENAL, V274, pF958, DOI 10.1152/ajprenal.1998.274.5.F958; WHARTON R, 1990, CLIN NEPHROL, V34, P116; Wiessner JH, 2001, KIDNEY INT, V59, P637, DOI 10.1046/j.1523-1755.2001.059002637.x	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43886	10.1371/journal.pone.0043886	http://dx.doi.org/10.1371/journal.pone.0043886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028475	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400013
J	Gobin, YP; Dunkel, IJ; Marr, BP; Francis, JH; Brodie, SE; Abramson, DH				Gobin, Y. Pierre; Dunkel, Ira J.; Marr, Brian P.; Francis, Jasmine H.; Brodie, Scott E.; Abramson, David H.			Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma	PLOS ONE			English	Article							OPHTHALMIC ARTERY CHEMOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; LIFE; CARBOPLATIN; MELPHALAN; THERAPY; TUMORS; AGE	Background: Intra-arterial (IA) chemotherapy has more risks of procedural complications in neonates and young infants. For these reasons, we have developed a strategy of bridge intravenous single agent chemotherapy to postpone IA chemotherapy in these children Procedure: Neonates and young infants with retinoblastoma who required chemotherapy were treated with systemic carboplatin chemotherapy (18.7 mg/kg IV every 3-4 weeks) until they reached the age of 3 months and a weight of 6 Kg. If necessary, IA chemotherapy was subsequently performed at 4 weeks intervals. Efficacy was judged by tumor regression on ophthalmological examination. Retinal toxicity was judged by electroretinography. Results: Eleven children (19 eyes) were treated. All patients are alive and no patient has developed metastatic disease or second malignancies (mean follow-up 27 months, range 9-46 months). Intravenous carboplatin (median 2 cycles, range 15) combined with cryotherapy and laser was given to all children. This was effective for five eyes, which did not require IA chemotherapy. IA chemotherapy was administered to 14 eyes (median 3.5 cycles per eye, range 1 to 6). No radiation therapy was required. The Kaplan Meier estimate of ocular radiation-free survival was 94.7% at one year (95% confidence interval 68.1-99.2%). One eye was enucleated due to tumor progression. ERG showed no deterioration of retinal function. Conclusion: Bridge IV-IA chemotherapy was feasible and safe, and is a promising strategy to treat retinoblastoma in neonates and young infants.	[Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Neurol Neurosurg, New York, NY 10032 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Radiol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Marr, Brian P.; Francis, Jasmine H.; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Marr, Brian P.; Francis, Jasmine H.; Abramson, David H.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Icahn School of Medicine at Mount Sinai	Gobin, YP (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Serv Intervent Neuroradiol, Dept Neurol Neurosurg, New York, NY 10032 USA.	yvg2001@med.cornell.edu		Dunkel, Ira/0000-0001-8091-6067; Brodie, Scott/0000-0002-3303-4552; Francis, Jasmine/0000-0002-7637-3108				Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1992, OPHTHALMIC PAED GEN, V13, P191, DOI 10.3109/13816819209105167; Abramson DH, 2002, ARCH OPHTHALMOL-CHIC, V120, P738; ABRAMSON DH, 1983, ARCH OPHTHALMOL-CHIC, V101, P1362; Antoneli CBG, 2006, J PEDIAT HEMATOL ONC, V28, P342, DOI 10.1097/00043426-200606000-00004; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Cohen VML, 2009, BRIT J OPHTHALMOL, V93, P887, DOI 10.1136/bjo.2008.142679; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Gombos DS, 2002, BRIT J OPHTHALMOL, V86, P80, DOI 10.1136/bjo.86.1.80; Graeber CP, 2011, OPEN OPHTHALMOL J, V5, P1, DOI 10.2174/1874364101105010001; Lambert MP, 2008, PEDIATR BLOOD CANCER, V50, P223, DOI 10.1002/pbc.21155; Marees T, 2009, EUR J CANCER, V45, P3245, DOI 10.1016/j.ejca.2009.05.011; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Peterson EC, 2011, J NEUROSURG, V114, P1603, DOI 10.3171/2011.1.JNS10466; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1399, DOI 10.1001/archophthalmol.2011.150; Venturi C, 2013, ACTA OPHTHALMOL, V91, P335, DOI 10.1111/j.1755-3768.2011.02296.x; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6	26	44	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44322	10.1371/journal.pone.0044322	http://dx.doi.org/10.1371/journal.pone.0044322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028521	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900018
J	Wang, K; Li, M; Gao, F; Li, SQ; Zhu, YG; Yang, PF				Wang, Kun; Li, Ming; Gao, Feng; Li, Shaoqing; Zhu, Yingguo; Yang, Pingfang			Identification of Conserved and Novel microRNAs from Liriodendron chinense Floral Tissues	PLOS ONE			English	Article							SMALL RNAS; EXPRESSION; GENES; TIME; QUANTIFICATION; BIOGENESIS; EVOLUTION; RESOURCE; GENOMICS; REVEALS	Background: Liriodendron chinense (L. chinense) is an endangered basal angiosperm plant in China because of its low reproductive efficiency. Recently, miRNAs have obtained great attention because they can play important roles. Through high throughput sequencing technique, large amount of miRNAs were identified from different plant species. But there were few studies about the miRNAs in the basal angiosperms especially in the sexual reproduction process. Results: Deep sequencing technology was applied to discover miRNAs in L. chinense flowers at different stages. After bioinformatic analysis, 496 putative conserved miRNAs representing 97 families and 2 novel miRNAs were found. Among them, one is previously regarded as gymnosperm specific. Their expressions were further validated by Real-time PCR for 13 selected miRNAs. Putative targeting genes were predicted and categorized with gene ontology (GO) analysis. About ten percents of the targets are involved in the reproduction process. Further expressional analysis showed that many of these miRNAs were highly related to the reproductive growth. Conclusions: This is the first comprehensive identification of conserved and novel miRNAs in L. chinense. The data presented here might not only help to fill the gap of miRNA registered about basal angiosperm plants but also contribute to understanding the evolution of miRNAs. The differential expression of some of the miRNAs and the prediction of their target genes are also helpful in understanding the regulation of L. chinense sexual reproduction.	[Wang, Kun; Li, Ming; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Wang, Kun; Gao, Feng; Li, Shaoqing; Zhu, Yingguo] Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Wang, Kun; Gao, Feng; Li, Shaoqing; Zhu, Yingguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Wuhan University; Wuhan University	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	yangpf@wbgcas.cn		Li, Ming/0000-0002-2679-6137	Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the 100 talents program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barakat A, 2007, PLANT J, V51, P991, DOI 10.1111/j.1365-313X.2007.03197.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brady BS, 2010, GENE, V462, P18, DOI 10.1016/j.gene.2010.04.007; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen ZX, 2001, PLANT PHYSIOL, V126, P473, DOI 10.1104/pp.126.2.473; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai X, 2011, NUCL ACIDS RES; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Huang SQ, 2002, BOT J LINN SOC, V140, P31, DOI 10.1046/j.1095-8339.2002.00080.x; Ivanov R, 2009, PLANT CELL, V21, P2107, DOI 10.1105/tpc.108.063479; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung JH, 2007, PLANTA, V225, P1327, DOI 10.1007/s00425-006-0439-1; KAMBOJ RK, 1987, PLANT PHYSIOL, V84, P688, DOI 10.1104/pp.84.3.688; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; KOLLOFFEL C, 1982, PLANT PHYSIOL, V69, P143, DOI 10.1104/pp.69.1.143; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li BS, 2009, BIOCHEM BIOPH RES CO, V388, P272, DOI 10.1016/j.bbrc.2009.07.161; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mosher Rebecca A, 2010, Silence, V1, P13, DOI 10.1186/1758-907X-1-13; Ohtake Y, 2000, PLANT CELL PHYSIOL, V41, P1038, DOI 10.1093/pcp/pcd028; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puzey JR, 2009, GENE, V448, P46, DOI 10.1016/j.gene.2009.08.005; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	59	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44696	10.1371/journal.pone.0044696	http://dx.doi.org/10.1371/journal.pone.0044696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028583	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900035
J	Zhu, X; Srivastava, DS; Smith, JNM; Martin, K				Zhu, Xiang; Srivastava, Diane S.; Smith, James N. M.; Martin, Kathy			Habitat Selection and Reproductive Success of Lewis's Woodpecker (Melanerpes lewis) at Its Northern Limit	PLOS ONE			English	Article							NEST-SITE SELECTION; LOGISTIC-REGRESSION; CAVITY AVAILABILITY; ACORN WOODPECKER; ECOLOGICAL TRAPS; SOUTH-DAKOTA; BLACK-HILLS; SURVIVAL; BIRDS; FORESTS	Lewis's Woodpecker (Melanerpes lewis) has experienced population declines in both Canada and the United States and in 2010 was assigned a national listing of threatened in Canada. We conducted a two-year study (2004-2005) of this species at its northern range limit, the South Okanagan Valley in British Columbia, Canada. Our main objective was to determine whether the habitat features that influenced nest-site selection also predicted nest success, or whether other factors (e. g. cavity dimensions, clutch initiation date or time of season) were more important. Nest tree decay class, density of suitable cavities and total basal area of large trees were the best predictors of nest-site selection, but these factors were unrelated to nesting success. Estimates of demographic parameters (mean 6 SE) included daily nest survival rate (0.988 +/- 0.003, years combined), nest success (0.52 +/- 0.08), clutch size (5.00 +/- 0.14 eggs), female fledglings per successful nest (1.31 +/- 0.11), and annual productivity (0.68 +/- 0.12 female fledglings per nest per year). Although higher nest survival was associated with both early and late initiated clutches, early-initiated clutches allowed birds to gain the highest annual productivity as early clutches were larger. Nests in deep cavities with small entrances experienced lower predation risk especially during the peak period of nest predation. We concluded that nest-site selection can be predicted by a number of easily measured habitat variables, whereas nest success depended on complicated ecological interactions among nest predators, breeding behaviors, and cavity features. Thus, habitat-based conservation strategies should also consider ecological factors that may not be well predicted by habitat.	[Zhu, Xiang; Srivastava, Diane S.; Smith, James N. M.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Martin, Kathy] Univ British Columbia, Ctr Appl Conservat Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Srivastava, DS (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	srivast@zoology.ubc.ca			Natural Sciences and Engineering Research Council of Canada; Endangered Species Recovery Fund of the World Wildlife Fund (Canada); Southern Interior Bluebird Trail Society	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Endangered Species Recovery Fund of the World Wildlife Fund (Canada); Southern Interior Bluebird Trail Society	Funding was provided by the Natural Sciences and Engineering Research Council of Canada, the Endangered Species Recovery Fund of the World Wildlife Fund (Canada) to J.N.M. Smith and by the Southern Interior Bluebird Trail Society to X. Zhu. The authors thank the Nature Conservancy Canada, the Nature Trust of British Columbia and British Columbia Parks for allowing us to conduct field research on their lands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2004, CAN J FOREST RES, V34, P2099, DOI [10.1139/x04-086, 10.1139/X04-086]; Block WM, 1987, W BIRDS, P209; Bock C.E., 1970, ZOOLOGY, V92, P1; Bonnot TW, 2008, CONDOR, V110, P450, DOI 10.1525/cond.2008.8460; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell RW, 1990, BIRDS BRIT COLUMBIA, V2, P1; CAMPBELL RW, 1990, BIRDS BRIT COLUMBIA, V0002; Cannings R. A., 1987, BIRDS OKANAGAN VALLE; Chase MK, 2002, CONDOR, V104, P103, DOI 10.1650/0010-5422(2002)104[0103:NSSANS]2.0.CO;2; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Cockle K, 2011, BIOTROPICA, V43, P228, DOI 10.1111/j.1744-7429.2010.00661.x; Cooper JM, 1998, STATUS LEWISS WOODPE; COSEWIC, 2010, WILDL SPEC ASS DET V; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; FOLLMANN DA, 1989, J AM STAT ASSOC, V84, P295, DOI 10.2307/2289877; Gentry DJ, 2007, CONDOR, V109, P122, DOI 10.1650/0010-5422(2007)109[122:OBASHF]2.0.CO;2; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Hazler KR, 2004, AUK, V121, P707, DOI 10.1642/0004-8038(2004)121[0707:MLRAPA]2.0.CO;2; Hoekstra JM, 2002, ECOL APPL, V12, P701, DOI 10.1890/1051-0761(2002)012[0701:ACRFCH]2.0.CO;2; Holt RF, 1997, AUK, V114, P443; Hooge PN, 1999, AUK, V116, P45, DOI 10.2307/4089452; *IUCN, 2004, RED LIST THREAT SPEC; Janos Mark, 1991, C.F.O. Journal, V25, P43; Koenig WD, 2001, BEHAV ECOL SOCIOBIOL, V49, P357, DOI 10.1007/s002650000316; Kozma JM, 2010, CONDOR, V112, P87, DOI 10.1525/cond.2010.090153; Kristan WB, 2003, OIKOS, V103, P457; LEONARD ML, 1987, AUK, V104, P491, DOI 10.2307/4087548; LI PJ, 1991, AUK, V108, P405; Linder KA, 1998, J FIELD ORNITHOL, V69, P109; Mahon CL, 2006, J WILDLIFE MANAGE, V70, P1257, DOI 10.2193/0022-541X(2006)70[1257:NSOCIM]2.0.CO;2; Mahon CL, 2008, FOREST ECOL MANAG, V256, P2145, DOI 10.1016/j.foreco.2008.08.005; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; Misenhelter MD, 2000, ECOLOGY, V81, P2892, DOI 10.2307/177349; Mood AM, 1974, INTRO THEORY STAT, V3rd; Newlon KR, 2011, CONDOR, V113, P183, DOI 10.1525/cond.2011.100056; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nguyen LP, 2003, WILSON BULL, V115, P285, DOI 10.1676/03-044; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Nordby JC, 2009, BIOL INVASIONS, V11, P565, DOI 10.1007/s10530-008-9271-9; Nur N, 2004, CONDOR, V106, P457, DOI 10.1650/7336; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Pribil S, 1998, CAN J ZOOL, V76, P2227, DOI 10.1139/cjz-76-12-2227; Rangel-Salazar JL, 2008, AUK, V125, P358, DOI 10.1525/auk.2008.06233; RAPHAEL MG, 1984, WILDLIFE MONOGR, P1; Remes V, 2003, CONSERV BIOL, V17, P1127, DOI 10.1046/j.1523-1739.2003.01611.x; RENDELL WB, 1989, CONDOR, V91, P875, DOI 10.2307/1368072; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; Russell RE, 2007, J WILDLIFE MANAGE, V71, P2600, DOI 10.2193/2007-034; Saab VA, 2004, CONDOR, V106, P20, DOI 10.1650/7485; Saab VA, 2001, CONDOR, V103, P491, DOI 10.1650/0010-5422(2001)103[0491:RSOLSW]2.0.CO;2; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saab VA, 2009, FOREST ECOL MANAG, V257, P151, DOI 10.1016/j.foreco.2008.08.028; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sousa PJ, 1982, FWSOBS82103214 SERV; StataCorp, 2007, STAT STAT SOFTW REL; Thomas J.W., 1979, WILDLIFE HABITATS MA, P512; Tobalske B. W., 1997, BIRDS N AM; Tobalske Bret W., 1997, Birds of North America, V284, P1; Vierling KT, 1997, WILSON BULL, V109, P121; Wiebe KL, 2003, OIKOS, V100, P291, DOI 10.1034/j.1600-0706.2003.12046.x; Wildlife Tree Committee of British Columbia, 2001, WILDL DANG TREE ASS; Wilson S, 2007, CONDOR, V109, P377, DOI 10.1650/0010-5422(2007)109[377:NSPIWP]2.0.CO;2; Zhu X, 2006, HABITAT SELECTION RE	68	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44346	10.1371/journal.pone.0044346	http://dx.doi.org/10.1371/journal.pone.0044346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028525	Green Submitted, gold, Green Published			2022-12-25	WOS:000311313900020
J	Ribas-Maynou, J; Garcia-Peiro, A; Fernandez-Encinas, A; Amengual, MJ; Prada, E; Cortes, P; Navarro, J; Benet, J				Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Jose Amengual, Maria; Prada, Elena; Cortes, Pilar; Navarro, Joaquima; Benet, Jordi			Double Stranded Sperm DNA Breaks, Measured by Comet Assay, Are Associated with Unexplained Recurrent Miscarriage in Couples without a Female Factor	PLOS ONE			English	Article							OXIDATIVE STRESS; MALE-INFERTILITY; CHROMATIN STRUCTURE; HUMAN SPERMATOZOA; DAMAGE; FRAGMENTATION; MOUSE; CELLS; FERTILIZATION; HAMSTER	It is known that sperm samples from recurrent pregnancy loss (RPL) couples have an increase in their sperm DNA fragmentation (SDF), but no studies have been performed in order to identify differences between single stranded SDF (ssSDF) and double stranded SDF (dsSDF) in these patients. This could be relevant because the type of DNA damage could have different effects. Semen samples were classified attending their clinical status: 25 fertile donors and 20 RPL patients with at least two unexplained first trimester miscarriages. SDF was analysed using alkaline and neutral Comet assay, SCD test and pulsed-field gel electrophoresis (PFGE), and ROC analysis including data from 105 more infertile patients (n = 150) was performed to establish predictive threshold values. SDF for alkaline and neutral Comet, and the SCD test was analysed in these categories of individuals. Data revealed the presence of two subgroups within fertile donors. The values obtained were 21.10 +/- 9.13, 23.35 +/- 10.45 and 12.31 +/- 4.31, respectively, for fertile donors with low values for both ssSDF and dsSDF; 27.86 +/- 12.64, 80.69 +/- 12.67 and 12.43 +/- 5.22, for fertile donors with low ssSDF and high dsSDF; and 33.61 +/- 15.50, 84.64 +/- 11.28 and 19.28 +/- 6.05, for unexplained RPL patients, also showing a low ssSDF and high dsSDF profile. This latter profile was seen in 85% of unexplained RPL and 33% of fertile donors, suggesting that it may be associated to a male risk factor for undergoing RPL. ROC analysis regarding recurrent miscarriage set the cut-off value at 77.50% of dsDNA SDF. PFGE for low ssSDF and high dsSDF profile samples and positive controls treated with DNase, to induce dsDNA breaks, showed a more intense band of about 48 kb, which fits the toroid model of DNA compaction in sperm, pointing out that some nuclease activity may be affecting their sperm DNA in RPL patients. This work identifies a very specific SDF profile related to the paternal risk of having RPL.	[Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Navarro, Joaquima; Benet, Jordi] Univ Autonoma Barcelona, Catedra Recerca Eugin UAB, Bellaterra, Spain; [Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Navarro, Joaquima; Benet, Jordi] Univ Autonoma Barcelona, Dept Biol Cel lular Fisiol & Immunol, Bellaterra, Spain; [Jose Amengual, Maria] UAB, Inst Univ Parc Tauli, Corp Sanitaria Parc Tauli, Ctr Diag,UDIAT, Sabadell, Spain; [Prada, Elena] Hosp Univ Mutua de Terrassa, Serv Ginecol, Terrassa, Spain; [Cortes, Pilar] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Mutua Terrassa; Autonomous University of Barcelona	Benet, J (corresponding author), Univ Autonoma Barcelona, Catedra Recerca Eugin UAB, Bellaterra, Spain.	jordi.benet@uab.cat	Cortés, Pilar/E-4390-2010; Benet, Jordi/I-1690-2017; Amengual, Maria/AAQ-5543-2021; Ribas-Maynou, Jordi/AAU-3642-2020	Cortés, Pilar/0000-0002-5924-0653; Benet, Jordi/0000-0001-6185-2555; Ribas-Maynou, Jordi/0000-0002-9101-2044; Navarro, Joaquima/0000-0002-9245-2260; Amengual, Maria Jose/0000-0002-5385-3061; FERNANDEZ ENCINAS, ALBA/0000-0003-2701-4739	Fondo de Investigacion Sanitaria [PI080623, PI11/00630]; Generalitat de Catalunya [2009 SGR 1107]; Catedra de Recerca Eugin-UAB; Generalitat de Catalunya	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); Catedra de Recerca Eugin-UAB; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by Fondo de Investigacion Sanitaria (PI080623, PI11/00630), Generalitat de Catalunya (2009 SGR 1107) and Catedra de Recerca Eugin-UAB. J. Ribas-Maynou has a FI grant from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalan F, 2012, J ASSIST REPROD GEN, V29, P11, DOI 10.1007/s10815-011-9647-0; Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Aitken RJ, 2010, MOL HUM REPROD, V16, P3, DOI 10.1093/molehr/gap059; Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Al-Hassan S, 2005, ARCH ANDROLOGY, V51, P69, DOI 10.1080/014850190518062; American Society for Reproductive Medicine (ASRM), 2008, REC PREGN LOSS PAT F; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Bellver J, 2010, HUM REPROD, V25, P1713, DOI 10.1093/humrep/deq098; Bernardini LM, 2004, REPROD BIOMED ONLINE, V9, P312, DOI 10.1016/S1472-6483(10)62147-5; Brahem S, 2011, UROLOGY, V78, P792, DOI 10.1016/j.urology.2011.05.049; Carrell DT, 2003, ARCH ANDROLOGY, V49, P49, DOI 10.1080/01485010290099390; Collodel G, 2011, UROLOGY, V78, P796; Collodel G, 2011, UROLOGY, V41, P352; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; de la Calle JFV, 2008, FERTIL STERIL, V90, P1792, DOI 10.1016/j.fertnstert.2007.09.021; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dewan S, 2006, FERTIL STERIL, V85, P441, DOI 10.1016/j.fertnstert.2005.08.035; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Enciso M, 2009, REPROD BIOMED ONLINE, V18, P609, DOI 10.1016/S1472-6483(10)60003-X; Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023; EVENSON DP, 1980, CHROMOSOMA, V78, P225, DOI 10.1007/BF00328394; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fernandez JL, 2005, FERTIL STERIL, V84, P833, DOI 10.1016/j.fertnstert.2004.11.089; Garcia-Peiro A, 2011, INT J ANDROL, V34, pE546, DOI 10.1111/j.1365-2605.2011.01153.x; Gil-Villa AM, 2010, FERTIL STERIL, V94, P1465, DOI 10.1016/j.fertnstert.2009.05.042; GORCZYCA W, 1993, CANCER RES, V53, P1945; Karaer A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.013; Kovalevsky G, 2004, ARCH INTERN MED, V164, P558, DOI 10.1001/archinte.164.5.558; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; Lewis SEM, 2010, HUM FERTIL, V13, P201, DOI 10.3109/14647273.2010.528823; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Maione B, 1997, DNA CELL BIOL, V16, P1087, DOI 10.1089/dna.1997.16.1087; Makker K, 2009, INDIAN J MED RES, V129, P357; Meseguer M, 2008, FERTIL STERIL, V89, P1191, DOI 10.1016/j.fertnstert.2007.05.005; Mitchell LA, 2011, INT J ANDROL, V34, P2, DOI 10.1111/j.1365-2605.2009.01042.x; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; Porter TF, 2005, BEST PRACT RES CL OB, V19, P85, DOI 10.1016/j.bpobgyn.2004.11.005; Ribas-Maynou J, 2012, HUM REPROD, V27, P652, DOI 10.1093/humrep/der461; Sailer BL, 1997, J ANDROL, V18, P294; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; Sharma RK, 2010, UROLOGY, V76, P1380, DOI 10.1016/j.urology.2010.04.036; Simon L, 2011, SYST BIOL REPROD MED, V57, P133, DOI 10.3109/19396368.2011.553984; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Sotolongo B, 2005, J ANDROL, V26, P272; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Wold ASD, 2006, SEMIN REPROD MED, V24, P25; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zini A, 2011, SYST BIOL REPROD MED, V57, P78, DOI 10.3109/19396368.2010.515704	54	74	77	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44679	10.1371/journal.pone.0044679	http://dx.doi.org/10.1371/journal.pone.0044679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028579	Green Submitted, Green Published, gold			2022-12-25	WOS:000309742800014
J	Jang, KY; Noh, SJ; Lehwald, N; Tao, GZ; Bellovin, DI; Park, HS; Moon, WS; Felsher, DW; Sylvester, KG				Jang, Kyu Yun; Noh, Sang Jae; Lehwald, Nadja; Tao, Guo-Zhong; Bellovin, David I.; Park, Ho Sung; Moon, Woo Sung; Felsher, Dean W.; Sylvester, Karl G.			SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas	PLOS ONE			English	Article							BETA-CATENIN; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; TISSUE MICROARRAY; FEEDBACK LOOP; EXPRESSION; GROWTH; DEACETYLASE; APOPTOSIS; PROTEIN	The increased expression of SIRT1 has recently been identified in numerous human tumors and a possible correlation with c-Myc oncogene has been proposed. However, it remains unclear whether SIRT1 functions as an oncogene or tumor suppressor. We sought to elucidate the role of SIRT1 in liver cancer under the influence of c-Myc and to determine the prognostic significance of SIRT1 and c-Myc expression in human hepatocellular carcinoma. The effect of either overexpression or knock down of SIRT1 on cell proliferation and survival was evaluated in both mouse and human liver cancer cells. Nicotinamide, an inhibitor of SIRT1, was also evaluated for its effects on liver tumorigenesis. The prognostic significance of the immunohistochemical detection of SIRT1 and c-Myc was evaluated in 154 hepatocellular carcinoma patients. SIRT1 and c-Myc regulate each other via a positive feedback loop and act synergistically to promote hepatocellular proliferation in both mice and human liver tumor cells. Tumor growth was significantly inhibited by nicotinamide in vivo and in vitro. In human hepatocellular carcinoma, SIRT1 expression positively correlated with c-Myc, Ki67 and p53 expression, as well as high a-fetoprotein level. Moreover, the expression of SIRT1, c-Myc and p53 were independent prognostic indicators of hepatocellular carcinoma. In conclusion, this study demonstrates that SIRT1 expression supports liver tumorigenesis and is closely correlated with oncogenic c-MYC expression. In addition, both SIRT1 and c-Myc may be useful prognostic indicators of hepatocellular carcinoma and SIRT1 targeted therapy may be beneficial in the treatment of hepatocellular carcinoma.	[Jang, Kyu Yun; Noh, Sang Jae; Park, Ho Sung; Moon, Woo Sung] Chonbuk Natl Univ, Dept Pathol, Sch Med, Jeonju, South Korea; [Jang, Kyu Yun; Noh, Sang Jae; Park, Ho Sung; Moon, Woo Sung] Res Inst Clin Med, Jeonju, South Korea; [Jang, Kyu Yun; Lehwald, Nadja; Tao, Guo-Zhong; Sylvester, Karl G.] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA; [Lehwald, Nadja] Univ Dusseldorf, Sch Med, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA; [Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA	Jeonbuk National University; Stanford University; Heinrich Heine University Dusseldorf; Stanford University; Stanford University	Jang, KY (corresponding author), Chonbuk Natl Univ, Dept Pathol, Sch Med, Jeonju, South Korea.	sylvester@stanford.edu	NOH, SANG JAE/R-4395-2019	NOH, SANG JAE/0000-0002-7005-056X; Sylvester, Karl G./0000-0002-8559-0155	Chonbuk National University; National Research Foundation of Korea; Korean Government [2011-0028223]; American Pediatric Surgical Association; Oak Foundation; Packard Foundation; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (Digestive Disease Center at Stanford) [DK56339]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Chonbuk National University; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); American Pediatric Surgical Association; Oak Foundation; Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (Digestive Disease Center at Stanford); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research funds of Chonbuk National University in 2009, the National Research Foundation of Korea grant funded by the Korean Government (2011-0028223) and grants from the American Pediatric Surgical Association, Oak Foundation, Packard Foundation, and the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (pilot grant DK56339: Digestive Disease Center at Stanford). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Bosman FT, 2010, WHO CALSSIFICATION T; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Boyle P, 2008, WORLD CANC REPORT 20; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen H. T., 2011, ANN SURG ONCOL; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dang CV, 1999, MOL CELL BIOL, V19, P1; Edge S, 2010, AJCC CANC STAGING HD; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kim KM, 2011, INT J CANC; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zucnan-Rossi J, 2007, PHARMACOGENOMICS, V8, P997, DOI 10.2217/14622416.8.8.997	44	82	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45119	10.1371/journal.pone.0045119	http://dx.doi.org/10.1371/journal.pone.0045119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024800	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100058
J	Yeo, RWY; Yang, KY; Li, GD; Lim, SK				Yeo, Ronne Wee Yeh; Yang, Kaiyuan; Li, GuoDong; Lim, Sai Kiang			High Glucose Predisposes Gene Expression and ERK Phosphorylation to Apoptosis and Impaired Glucose-Stimulated Insulin Secretion via the Cytoskeleton	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GAP-JUNCTION; INTERCELLULAR COMMUNICATION; CONNEXIN-43 EXPRESSION; ACTIN CYTOSKELETON; FILAMENTOUS ACTIN; ELEVATED GLUCOSE; CHRONIC EXPOSURE; PROTEIN-KINASE; MAP KINASE	Chronic high glucose (HG) inflicts glucotoxicity on vulnerable cell types such as pancreatic beta cells and contributes to insulin resistance and impaired insulin secretion in diabetic patients. To identify HG-induced cellular aberrations that are candidate mediators of glucotoxicity in pancreatic b cells, we analyzed gene expression in ERoSHK6, a mouse insulin-secreting cell line after chronic HG exposure (six-day exposure to 33.3 mM glucose). Chronic HG exposure which reduced glucose-stimulated insulin secretion (GSIS) increased transcript levels of 185 genes that clustered primarily in 5 processes namely cellular growth and proliferation; cell death; cellular assembly and organization; cell morphology; and cell-to-cell signaling and interaction. The former two were validated by increased apoptosis of ERoSHK6 cells after chronic HG exposure and reaffirmed the vulnerability of b cells to glucotoxicity. The three remaining processes were partially substantiated by changes in cellular morphology and structure, and instigated an investigation of the cytoskeleton and cell-cell adhesion. These studies revealed a depolymerized actin cytoskeleton that lacked actin stress fibers anchored at vinculin-containing focal adhesion sites as well as loss of E-cadherin-mediated cell-cell adherence after exposure to chronic HG, and were concomitant with constitutive ERK1/2 phosphorylation that was refractory to serum and glucose deprivation. Although inhibition of ERK phosphorylation by PD98059 promoted actin polymerization, it increased apoptosis and GSIS impairment. These findings suggest that ERK phosphorylation is a proximate regulator of cellular processes targeted by chronic HG-induced gene expression and that dynamic actin polymerization and depolymerization is important in b cell survival and function. Therefore, chronic HG alters gene expression and signal transduction to predispose the cytoskeleton towards apoptosis and GSIS impairment.	[Yeo, Ronne Wee Yeh; Lim, Sai Kiang] ASTAR, Inst Med Biol, Singapore, Singapore; [Yeo, Ronne Wee Yeh] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Yang, Kaiyuan] Raffles Inst, Singapore, Singapore; [Li, GuoDong] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; [Lim, Sai Kiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore General Hospital; National University of Singapore	Yeo, RWY (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	saikiang.lim@imb.a-star.edu.sg	Yang, Kaiyuan/T-7575-2017; Lim, Sai Kiang/AEN-0252-2022	Yang, Kaiyuan/0000-0003-0591-2079; Lim, Sai Kiang/0000-0002-5752-3297	Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC); National Medical Research Council of Singapore [NMRC1218/2009, NMRC/EDG/0056/2009]	Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was funded by the Agency for Science, Technology and Research - Biomedical Research Council (A*STAR BMRC) and partially supported by grants from the National Medical Research Council of Singapore (NMRC1218/2009; NMRC/EDG/0056/2009 to G.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Buchanan Thomas A., 2003, Clinical Therapeutics, V25, pB32, DOI 10.1016/S0149-2918(03)80241-2; BURGOYNE RD, 1990, ANNU REV PHYSIOL, V52, P647; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CARVER TD, 1995, PEDIATR RES, V38, P754, DOI 10.1203/00006450-199511000-00020; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; Chen JG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1906, DOI 10.1152/ajpendo.00356.2006; Chen TS, 2010, ENDOCRINOLOGY, V151, P3600, DOI 10.1210/en.2009-1418; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Dahl U, 1996, DEVELOPMENT, V122, P2895; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fei HQ, 2008, MOL CELL BIOCHEM, V315, P75, DOI 10.1007/s11010-008-9791-8; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Hayden MR, 2008, EXP BIOL MED, V233, P1109, DOI 10.3181/0709-RM-251; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; Hayden Melvin R, 2008, J Cardiometab Syndr, V3, P234, DOI 10.1111/j.1559-4572.2008.00024.x; Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; HOWELL SL, 1979, BIOCHEM J, V178, P367, DOI 10.1042/bj1780367; INOGUCHI T, 1995, BIOCHEM BIOPH RES CO, V208, P492, DOI 10.1006/bbrc.1995.1365; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kuroki T, 1998, DIABETES, V47, P931, DOI 10.2337/diabetes.47.6.931; Leahy JL, 2004, DIABETES MELLITUS FU, pxviii; Li AF, 2003, INVEST OPHTH VIS SCI, V44, P5376, DOI 10.1167/iovs.03-0360; Li GD, 2009, STEM CELL RES, V2, P41, DOI 10.1016/j.scr.2008.07.006; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MALAISSE WJ, 1971, DIABETES, V20, P257, DOI 10.2337/diab.20.5.257; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Maris M, 2010, J PROTEOME RES, V9, P6274, DOI 10.1021/pr100557w; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nyblom HK, 2006, PROTEOMICS, V6, P5193, DOI 10.1002/pmic.200600137; Oku H, 2001, INVEST OPHTH VIS SCI, V42, P1915; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Pratley Richard E, 2002, Curr Diab Rep, V2, P242, DOI 10.1007/s11892-002-0090-6; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rose SD, 2001, J BIOL CHEM, V276, P36757, DOI 10.1074/jbc.M006518200; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; Sato T, 2002, DIABETES, V51, P1565, DOI 10.2337/diabetes.51.5.1565; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Skyler J.S., 2004, CLIN DIABETES, V22, P162, DOI [10.2337/diaclin.22.4.162, DOI 10.2337/DIACLIN.22.4.162]; SNABES MC, 1982, BIOCHEM BIOPH RES CO, V104, P207, DOI 10.1016/0006-291X(82)91960-X; Stalmans P, 1997, INVEST OPHTH VIS SCI, V38, P1598; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; SWANSTONFLATT SK, 1980, FEBS LETT, V117, P299, DOI 10.1016/0014-5793(80)80966-5; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; WANG JL, 1990, BIOCHEM BIOPH RES CO, V171, P424, DOI 10.1016/0006-291X(90)91410-T; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wilson JR, 2001, FEBS LETT, V492, P101, DOI 10.1016/S0014-5793(01)02241-4	92	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44988	10.1371/journal.pone.0044988	http://dx.doi.org/10.1371/journal.pone.0044988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024780	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100038
J	Iyer, A; Zurolo, E; Prabowo, A; Fluiter, K; Spliet, WGM; van Rijen, PC; Gorter, JA; Aronica, E				Iyer, Anand; Zurolo, Emanuele; Prabowo, Avanita; Fluiter, Kees; Spliet, Wim G. M.; van Rijen, Peter C.; Gorter, Jan A.; Aronica, Eleonora			MicroRNA-146a: A Key Regulator of Astrocyte-Mediated Inflammatory Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; CORTICAL DYSPLASIA; RAT MODEL; EXPRESSION; INTERLEUKIN-1; EPILEPSY; MALFORMATIONS; ACTIVATION; DISEASE	Increasing evidence supports the involvement of microRNAs (miRNA) in the regulation of inflammation in human neurological disorders. In the present study we investigated the role of miR-146a, a key regulator of the innate immune response, in the modulation of astrocyte-mediated inflammation. Using Taqman PCR and in situ hybridization, we studied the expression of miR-146a in epilepsy-associated glioneuronal lesions which are characterized by prominent activation of the innate immune response. In addition, cultured human astrocytes were used to study the regulation of miR-146a expression in response to proinflammatory cytokines. qPCR and western blot were used to evaluate the effects of overexpression or knockdown of miR-146a on IL-1 beta signaling. Downstream signaling in the IL-1 beta pathway, as well as the expression of IL-6 and COX-2 were evaluated by western blot and ELISA. Release several cytokines was evaluated using a human magnetic multiplex cytokine assay on a LuminexH (R) 100 (TM)/200 (TM) platform. Increased expression of miR-146a was observed in glioneuronal lesions by Taqman PCR. MiR-146a expression in human glial cell cultures was strongly induced by IL-1 beta and blocked by IL-1 beta receptor antagonist. Modulation of miR-146a expression by transfection of astrocytes with anti miR146a or mimic, regulated the mRNA expression levels of downstream targets of miR-146a (IRAK-1, IRAK-2 and TRAF-6) and the expression of IRAK-1 protein. In addition, the expression of IL-6 and COX-2 upon IL-1 beta stimulation was suppressed by increased levels of miR-146a and increased by the reduction of miR-146a. Modulation of miR-146a expression affected also the release of several cytokines such as IL-6 and TNF-alpha. Our observations indicate that in response to inflammatory cues, miR-146a was induced as a negative-feedback regulator of the astrocyte-mediated inflammatory response. This supports an important role of miR-146a in human neurological disorders associated with chronic inflammation and suggests that this miR may represent a novel target for therapeutic strategies.	[Iyer, Anand; Zurolo, Emanuele; Prabowo, Avanita; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, NL-1105 AZ Amsterdam, Netherlands; [Fluiter, Kees] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Rijen, Peter C.] Univ Med Ctr Utrecht, Dept Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Gorter, Jan A.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Gorter, Jan A.; Aronica, Eleonora] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam	Iyer, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.aronica@amc.uva.nl	Fluiter, Kees/H-2828-2015	Fluiter, Kees/0000-0003-0898-7260; Aronica, Eleonora/0000-0002-3542-3770; Iyer, Anand/0000-0001-6821-1048	National Epilepsy Fund - "Power of the Small"; Hersenstichting Nederland [NEF 09-05, NEF13-01]; EU [202167, 278486]; KIKA (Stichting Kinderen Kankervrij)	National Epilepsy Fund - "Power of the Small"; Hersenstichting Nederland; EU(European Commission); KIKA (Stichting Kinderen Kankervrij)	This work was supported by the National Epilepsy Fund - "Power of the Small'', the Hersenstichting Nederland (NEF 09-05; NEF13-01); EU FP7 project NeuroGlia (Grant Agreement No 202167) and EU FP7 project DEVELAGE (Grant Agreement No 278486) EA; KIKA (Stichting Kinderen Kankervrij; AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; Aronica E, 2008, NEUROSCIENCE, V151, P272, DOI 10.1016/j.neuroscience.2007.10.036; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Aronica E, 2005, EPILEPSIA, V46, P849, DOI 10.1111/j.1528-1167.2005.66604.x; Aronica E, 2005, J NEUROIMMUNOL, V160, P188, DOI 10.1016/j.jneuroim.2004.11.015; Aronica E, 2005, NEUROSCIENCE, V130, P927, DOI 10.1016/j.neuroscience.2004.10.024; Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Aronica E, GLIA IN PRESS; Aronica E, 2007, NEUROSCIENTIST, V13, P100, DOI 10.1177/1073858406295832; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Blumcke I, 2011, LANCET NEUROL, V10, P26, DOI 10.1016/S1474-4422(10)70225-8; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Boer K, 2006, J NEUROIMMUNOL, V173, P188, DOI 10.1016/j.jneuroim.2006.01.002; Boer K, 2010, BRAIN PATHOL, V20, P704, DOI 10.1111/j.1750-3639.2009.00341.x; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Iyer A, 2010, EPILEPSIA, V51, P1763, DOI 10.1111/j.1528-1167.2010.02547.x; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Li X, 2011, GENE, V480, P34, DOI 10.1016/j.gene.2011.03.003; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2005, EPILEPSIA, V46, P274; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song YJ, 2011, BRAIN RES; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; The WHO, 2020, CLASSIFICATION TUMOU; Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Heteren JT, 2008, GLIA, V56, P568, DOI 10.1002/glia.20639; van Thiel PPAM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000428; Vezzani A, 2011, BRAIN BEHAV IMMUN; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Whichard ZL, 2011, J BIOL CHEM, V286, P4742, DOI 10.1074/jbc.M110.166348; Yasin SA, 2010, ACTA NEUROPATHOL, V120, P85, DOI 10.1007/s00401-010-0677-y; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	56	241	258	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44789	10.1371/journal.pone.0044789	http://dx.doi.org/10.1371/journal.pone.0044789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028621	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700040
J	Moncada-Pazos, A; Obaya, AJ; Llamazares, M; Heljasvaara, R; Suarez, MF; Colado, E; Noel, A; Cal, S; Lopez-Otin, C				Moncada-Pazos, Angela; Obaya, Alvaro J.; Llamazares, Maria; Heljasvaara, Ritva; Suarez, Maria F.; Colado, Enrique; Noel, Agnes; Cal, Santiago; Lopez-Otin, Carlos			ADAMTS-12 Metalloprotease Is Necessary for Normal Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL APOPTOSIS; SIGNALING PATHWAY; BOWEL-DISEASE; EXPRESSION; CANCER; CELLS; GENE; IDENTIFICATION; INTERLEUKIN-6; DISINTEGRIN	ADAMTSs (a disintegrin and metalloprotease with thrombospondin domains) are a family of enzymes with both proteolytic and protein interaction functions, which have been implicated in distinct pathologies. In this work, we have investigated the putative role of ADAMTS-12 in inflammation by using a mouse model deficient in this metalloprotease. Control and mutant mice were subjected to different experimental conditions to induce colitis, endotoxic sepsis, and pancreatitis. We have observed that Adamts12-deficient mice exhibit more severe inflammation and a delayed recovery from these challenges compared with their wild-type littermates. These changes are accompanied by an increase in inflammatory markers including several cytokines, as assessed by microarray expression analysis and proteomic-based approaches. Interestingly, the clinical symptoms observed in Adamts12-deficient mice are also concomitant with an elevation in the number of neutrophils in affected tissues. Finally, isolation and in vitro culture of human neutrophils demonstrate that the presence of ADAMTS-12 induces neutrophil apoptosis. On the basis of these results, we propose that ADAMTS-12 is implicated in the inflammatory response by modulating normal neutrophil apoptosis.	[Moncada-Pazos, Angela; Llamazares, Maria; Heljasvaara, Ritva; Suarez, Maria F.; Cal, Santiago; Lopez-Otin, Carlos] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Obaya, Alvaro J.] Univ Oviedo, Inst Univ Oncol IUOPA, E-33006 Oviedo, Spain; [Heljasvaara, Ritva] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90570 Oulu, Finland; [Heljasvaara, Ritva] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90570 Oulu, Finland; [Colado, Enrique] Hosp Univ Cent Asturias, Serv Hematol, Oviedo 33006, Spain; [Noel, Agnes] Univ Liege, Grp Interdisciplinaire Genoprote Appl Canc GIGA C, B-4000 Liege, Belgium	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oulu; University of Oulu; Central University Hospital Asturias; University of Liege	Moncada-Pazos, A (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	amoncada@degradome.uniovi.es	Suárez, María Fernanda Valencia/F-8200-2019; López-Otín, Carlos/AAB-2106-2020; Obaya, Alvaro J./AAQ-6115-2021; Colado, Enrique/Z-6326-2019; Llamazares-Prada, Maria/ABX-0849-2022; Colado, Enrique/GXF-7705-2022	Suárez, María Fernanda Valencia/0000-0001-8987-8431; López-Otín, Carlos/0000-0001-6964-1904; Obaya, Alvaro J./0000-0002-4163-2173; Colado, Enrique/0000-0001-8675-8207; Heljasvaara, Ritva/0000-0003-4763-3844; Llamazares Prada, Maria/0000-0001-6559-9374; Noel, Agnes/0000-0002-7670-6179; MONCADA PAZOS, ANGELA/0000-0002-3871-2965	Ministerio de Economia y Competitividad-Spain; European Union; Fundacion M. Botin; Obra Social Cajastur; Accion Transversal del Cancer-RTICC; Finnish Cultural Foundation; Maud Kuistila Memorial Foundation	Ministerio de Economia y Competitividad-Spain; European Union(European Commission); Fundacion M. Botin; Obra Social Cajastur; Accion Transversal del Cancer-RTICC; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Maud Kuistila Memorial Foundation	This work was supported by grants from Ministerio de Economia y Competitividad-Spain, Fundacion M. Botin and European Union (FP7-Micro-EnviMet). The Instituto Universitario de Oncologia is supported by Obra Social Cajastur and Accion Transversal del Cancer-RTICC.; Supported by grants from Finnish Cultural Foundation and Maud Kuistila Memorial Foundation.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Arruda MA, 2004, J IMMUNOL, V173, P2023, DOI 10.4049/jimmunol.173.3.2023; Bespalova IN, 2012, NEUROMOL MED, V14, P53, DOI 10.1007/s12017-012-8169-y; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Chauhan AK, 2008, J EXP MED, V205, P2065, DOI 10.1084/jem.20080130; Davis AK, 2009, TRANSFUSION, V49, P206, DOI 10.1111/j.1537-2995.2008.01978.x; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Lawrence DW, 2009, EARLY HUM DEV, V85, P659, DOI 10.1016/j.earlhumdev.2009.09.005; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Maianski NA, 2004, J IMMUNOL, V172, P7024, DOI 10.4049/jimmunol.172.11.7024; Majumdar MK, 2007, ARTHRITIS RHEUM, V56, P3670, DOI 10.1002/art.23027; Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x; MITSUYAMA K, 1991, DIGESTION, V50, P104, DOI 10.1159/000200747; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Nah SS, 2012, MOL MED REP, V6, P227, DOI 10.3892/mmr.2012.867; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Sen AI, 2010, EXP LUNG RES, V36, P615, DOI 10.3109/01902148.2010.497201; Wang D, 2011, DIGEST DIS SCI, V56, P3281, DOI 10.1007/s10620-011-1723-x; Wang K, 2010, WORLD J GASTROENTERO, V16, P2252, DOI 10.3748/wjg.v16.i18.2252; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003	37	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.408625	http://dx.doi.org/10.1074/jbc.M112.408625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019333	hybrid, Green Published			2022-12-25	WOS:000311233800026
J	Bobbs, AS; Saarela, AV; Yatskievych, TA; Antin, PB				Bobbs, Alexander S.; Saarela, Aleksi V.; Yatskievych, Tatiana A.; Antin, Parker B.			Fibroblast Growth Factor (FGF) Signaling during Gastrulation Negatively Modulates the Abundance of MicroRNAs That Regulate Proteins Required for Cell Migration and Embryo Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; CHICK-EMBRYO; SELF-RENEWAL; LET-7; EXPRESSION; LIN-28; DETERMINANTS; BIOGENESIS; MOVEMENT; COMPLEX	FGF signaling plays a pivotal role in regulating cell movements and lineage induction during gastrulation. Here we identify 44 microRNAs that are expressed in the primitive streak region of gastrula stage chicken embryos. We show that the primary effect of FGF signaling on microRNA abundance is to negatively regulate the levels of miR-let-7b, -9, -19b, -107, -130b, and -218. LIN28B inhibits microRNA processing and is positively regulated by FGF signaling. Gain- and loss-of-function experiments show that LIN28B negatively regulates the expression of miR-19b, -130b, and let-7b, whereas negative modulation of miR-9, -107, and -218 appears to be independent of LIN28B function. Predicted mRNA targets of the FGF-regulated microRNAs are over-represented in serine/threonine and tyrosine kinase receptors, including ACVR1, ACVR2B, PDGFRA, TGFBR1, and TGFBR3. Luciferase assays show that these and other candidates are targeted by FGF-regulated microRNAs. PDGFRA, a receptor whose activity is required for cell migration through the primitive streak, is a target of miR-130b and -218 in vivo. These results identify a novel mechanism by which FGF signaling regulates gene expression by negatively modulating microRNA abundance through both LIN28B-dependent and LIN28B-independent pathways.	[Yatskievych, Tatiana A.; Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Bobbs, Alexander S.; Saarela, Aleksi V.; Antin, Parker B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Antin, PB (corresponding author), Univ Arizona, Dept Cellular & Mol Med, POB 245217,1656 E Mabel St, Tucson, AZ 85724 USA.	pba@email.arizona.edu		Antin, Parker/0000-0001-9066-7412	National Institutes of Health Grant [1 P41 HD064559]; American Heart Association grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 P41 HD064559 (to P. B. A.). This work was also supported by an American Heart Association grant (to P. B. A.).	Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Antin P. B., 2012, GEISHA GALLUS EXPRES; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Hardy KM, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-20; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nakaya Y, 2009, CELL ADHES MIGR, V3, P160, DOI 10.4161/cam.3.2.7373; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; STERN CD, 2004, GASTRULATION CELLS E, P219; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	21	22	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38505	38514		10.1074/jbc.M112.400598	http://dx.doi.org/10.1074/jbc.M112.400598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995917	Green Published, hybrid			2022-12-25	WOS:000310982800010
J	Byun, EH; Kim, WS; Kim, JS; Won, CJ; Choi, HG; Kim, HJ; Cho, SN; Lee, K; Zhang, T; Hur, GM; Shin, SJ				Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Choi, Han-Gyu; Kim, Hwa-Jung; Cho, Sang-Nae; Lee, Keehoon; Zhang, Tiejun; Hur, Gang Min; Shin, Sung Jae			Mycobacterium paratuberculosis CobT Activates Dendritic Cells via Engagement of Toll-like Receptor 4 Resulting in Th1 Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIUM SUBSP PARATUBERCULOSIS; FIBRONECTIN ATTACHMENT PROTEIN; IMMUNE-RESPONSES; CROHNS-DISEASE; IN-VITRO; ADAPTIVE IMMUNITY; CULTURE FILTRATE; LINKING INNATE; T-CELLS; TUBERCULOSIS	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of Johne disease in animals and MAP involvement in human Crohn disease has been recently emphasized. Evidence from M. tuberculosis studies suggests mycobacterial proteins activate dendritic cells (DCs) via Toll-like receptor (TLR) 4, eventually determining the fate of immune responses. Here, we investigated whether MAP CobT contributes to the development of T cell immunity through the activation of DCs. MAP CobT recognizes TLR4, and induces DC maturation and activation via the MyD88 and TRIF signaling cascades, which are followed by MAP kinases and NF-kappa B. We further found that MAP CobT-treated DCs activated naive T cells, effectively polarized CD4(+) and CD8(+) T cells to secrete IFN-gamma and IL-2, but not IL-4 and IL-10, and induced T cell proliferation. These data indicate that MAP CobT contributes to T helper (Th) 1 polarization of the immune response. MAP CobT-treated DCs specifically induced the expansion of CD4(+)/CD8(+)CD44(high)CD62L(low) memory T cells in the mesenteric lymph node of MAP-infected mice in a TLR4-dependent manner. Our results indicate that MAP CobT is a novel DC maturation-inducing antigen that drives Th1 polarized-naive/memory T cell expansion in a TLR4-dependent cascade, suggesting that MAP CobT potentially links innate and adaptive immunity against MAP.	[Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Cho, Sang-Nae; Lee, Keehoon; Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Cho, Sang-Nae; Lee, Keehoon; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Choi, Han-Gyu; Kim, Hwa-Jung] Chungnam Natl Univ, Dept Microbiol, Taejon, South Korea; [Choi, Han-Gyu; Kim, Hwa-Jung] Chungnam Natl Univ, Res Inst Med Sci, Taejon, South Korea; [Zhang, Tiejun; Hur, Gang Min] Chungnam Natl Univ, Dept Phamacol, Coll Med, Taejon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Chungnam National University; Chungnam National University	Shin, SJ (corresponding author), 50 Yonsei Ro, Seoul 120752, South Korea.	sjshin@yuhs.ac	Hur, Gang-min/ABF-9263-2021; Lee, Keehoon/GSO-0002-2022	Hur, Gang-min/0000-0003-4870-6574; Kim, Hwa-Jung/0000-0002-1127-0909; Shin, Sung Jae/0000-0003-0854-4582	National Research Foundation of Korea grant; Korea government (MEST) Grant [2012-0004927]	National Research Foundation of Korea grant(National Research Foundation of Korea); Korea government (MEST) Grant	This work was supported by a National Research Foundation of Korea grant funded by Korea government (MEST) Grant 2012-0004927.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baksh FK, 2004, MODERN PATHOL, V17, P1289, DOI 10.1038/modpathol.3800184; Barton GM, 2002, CURR OPIN IMMUNOL, V14, P380, DOI 10.1016/S0952-7915(02)00343-6; Basagoudanavar SH, 2006, VET RES COMMUN, V30, P357, DOI 10.1007/s11259-006-3253-0; Batoni G, 2002, SCAND J IMMUNOL, V56, P43, DOI 10.1046/j.1365-3083.2002.01104.x; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Byun EH, 2012, J MOL MED, V90, P285, DOI 10.1007/s00109-011-0819-2; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; Claas KR, 2010, J BACTERIOL, V192, P145, DOI 10.1128/JB.01159-09; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Druszczynska M, 2011, POSTEP HIG MED DOSW, V65, P28, DOI 10.5604/17322693.931545; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Gerberick GF, 1997, TOXICOL APPL PHARM, V146, P1, DOI 10.1006/taap.1997.8218; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Guan HB, 2009, J IMMUNOL, V183, P172, DOI 10.4049/jimmunol.0802325; Hermon-Taylor J, 2000, WORLD J GASTROENTERO, V6, P630; Hoek A, 2010, VACCINE, V28, P5910, DOI 10.1016/j.vaccine.2010.06.042; Hogevold HE, 1997, PERFUSION-UK, V12, P9, DOI 10.1177/026765919701200103; Huntley JFJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-3; Jeon J, 2011, J ETHNOPHARMACOL, V137, P626, DOI 10.1016/j.jep.2011.06.022; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Kathaperumal K, 2008, VACCINE, V26, P1652, DOI 10.1016/j.vaccine.2008.01.015; Lee JS, 2009, INFECT IMMUN, V77, P2979, DOI 10.1128/IAI.01411-08; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Moll H, 2003, IMMUNOL LETT, V85, P153, DOI 10.1016/S0165-2478(02)00222-5; Noh KT, 2012, EXP MOL MED, V44, P340, DOI 10.3858/emm.2012.44.5.038; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Roupie V, 2008, VACCINE, V26, P4783, DOI 10.1016/j.vaccine.2008.07.009; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Santema W, 2011, VACCINE, V29, P1364, DOI 10.1016/j.vaccine.2010.12.071; Santos F, 2008, MICROBIOL-SGM, V154, P81, DOI 10.1099/mic.0.2007/011569-0; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shin AR, 2010, FEMS IMMUNOL MED MIC, V58, P128, DOI 10.1111/j.1574-695X.2009.00617.x; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	52	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38609	38624		10.1074/jbc.M112.391060	http://dx.doi.org/10.1074/jbc.M112.391060			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019321	Green Published, hybrid			2022-12-25	WOS:000310982800021
J	Mathieu, Y; Prosper, P; Buee, M; Dumarcay, S; Favier, F; Gelhaye, E; Gerardin, P; Harvengt, L; Jacquot, JP; Lamant, T; Meux, E; Mathiot, S; Didierjean, C; Morel, M				Mathieu, Yann; Prosper, Pascalita; Buee, Marc; Dumarcay, Stephane; Favier, Frederique; Gelhaye, Eric; Gerardin, Philippe; Harvengt, Luc; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Mathiot, Sandrine; Didierjean, Claude; Morel, Melanie			Characterization of a Phanerochaete chrysosporium Glutathione Transferase Reveals a Novel Structural and Functional Class with Ligandin Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; CRYSTAL-STRUCTURE; X-RAY; BINDING; PROTEIN; SITE; GLUTAREDOXIN; IDENTIFICATION; PURIFICATION; EXPRESSION	Glutathione S-transferases (GSTs) form a superfamily of multifunctional proteins with essential roles in cellular detoxification processes. Anew fungal specific class of GST has been highlighted by genomic approaches. The biochemical and structural characterization of one isoform of this class in Phanerochaete chrysosporium revealed original properties. The three-dimensional structure showed a new dimerization mode and specific features by comparison with the canonical GST structure. An additional beta-hairpin motif in the N-terminal domain prevents the formation of the regular GST dimer and acts as a lid, which closes upon glutathione binding. Moreover, this isoform is the first described GST that contains all secondary structural elements, including helix alpha 4' in the C-terminal domain, of the pre-sumed common ancestor of cytosolic GSTs (i.e. glutaredoxin 2). A sulfate binding site has been identified close to the glutathione binding site and allows the binding of 8-anilino-1-naphtalene sulfonic acid. Competition experiments between 8-anilino-1-naphtalene sulfonic acid, which has fluorescent properties, and various molecules showed that this GST binds glutathionylated and sulfated compounds but also wood extractive molecules, such as vanillin, chloronitrobenzoic acid, hydroxyacetophenone, catechins, and aldehydes, in the glutathione pocket. This enzyme could thus function as a classical GST through the addition of glutathione mainly to phenethyl isothiocyanate, but alternatively and in a competitive way, it could also act as a ligandin of wood extractive compounds. These new structural and functional properties lead us to propose that this GST belongs to a new class that we name GSTFuA, for fungal specific GST class A.	[Didierjean, Claude] Univ Lorraine, UMR 7036, CRM2, Inst Jean Barriol,Fac Sci & Technol, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Gelhaye, Eric; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Morel, Melanie] Univ Lorraine, UMR 1136, Inst Federatif Rech EFABA 110, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Buee, Marc; Gelhaye, Eric; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Morel, Melanie] INRA, UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Prosper, Pascalita; Favier, Frederique; Mathiot, Sandrine; Didierjean, Claude] CNRS, CRM2, UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Dumarcay, Stephane; Gerardin, Philippe] Univ Lorraine, Lab Etud & Rech Mat Bois, EA 1093, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Harvengt, Luc] Inst Technol Foret Cellulose Bois Construct Ameub, Biotechnol Lab, F-33610 Cestas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CHU de Nancy; Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine	Didierjean, C (corresponding author), Univ Lorraine, UMR 7036, CRM2, Inst Jean Barriol,Fac Sci & Technol, BP 70239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@crm2.uhp-nancy.fr; mmorel@scbiol.uhp-nancy.fr	gelhaye, eric/K-7390-2013; DIDIERJEAN, Claude/L-1493-2013; Harvengt, Luc/G-4569-2011; Favier, Frederique/B-3090-2013; Jacquot, Jean-Pierre/A-1571-2012	gelhaye, eric/0000-0002-0699-9113; DIDIERJEAN, Claude/0000-0002-3176-8974; Harvengt, Luc/0000-0003-1524-5273; Favier, Frederique/0000-0003-3249-997X; Buee, Marc/0000-0001-8614-3886; Morel-Rouhier, Melanie/0000-0001-5149-0474; Jacquot, Jean-Pierre/0000-0003-4975-8587; MATHIEU, Yann/0000-0001-6698-1911	Convention industrielle de formation par la recherche (CIFRE); Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0012]; Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; Institut National de la Recherche Agronomique (INRA); CNRS	Convention industrielle de formation par la recherche (CIFRE); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; Institut National de la Recherche Agronomique (INRA); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Convention industrielle de formation par la recherche (CIFRE) and Agence Nationale de la Recherche (ANR) Research Grant ANR-09-BLAN-0012; the Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; the Institut National de la Recherche Agronomique (INRA); and CNRS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agianian B, 2003, J MOL BIOL, V326, P151, DOI 10.1016/S0022-2836(02)01327-X; Allocati N, 1999, FEBS LETT, V445, P347, DOI 10.1016/S0014-5793(99)00147-7; BILANG J, 1993, PLANT PHYSIOL, V102, P29, DOI 10.1104/pp.102.1.29; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Burns C, 2005, FUNGAL GENET BIOL, V42, P319, DOI 10.1016/j.fgb.2005.01.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; D'Ambrosio K, 2003, ACTA CRYSTALLOGR D, V59, P1043, DOI 10.1107/S0907444903006814; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gille C, 2006, PROTEIN SCI, V15, P208, DOI 10.1110/ps.051882006; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DE, 2005, PROTEIN EXPRES PURIF, V39, P107, DOI 10.1016/j.pep.2004.09.007; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lederer B, 2003, BBA-GEN SUBJECTS, V1621, P226, DOI 10.1016/S0304-4165(03)00073-4; Lee CY, 2009, BIOORG MED CHEM LETT, V19, P6326, DOI 10.1016/j.bmcl.2009.09.088; Lee S, 2012, BMB REP, V45, P265, DOI 10.5483/BMBRep.2012.45.5.265; Lian HY, 2006, BBA-PROTEINS PROTEOM, V1764, P535, DOI 10.1016/j.bbapap.2005.11.016; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1993, FEBS LETT, V323, P135, DOI 10.1016/0014-5793(93)81465-C; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Menchise V., 2000, Biopolymers, V56, P1, DOI 10.1002/1097-0282(2000)56:1<1::AID-BIP1036>3.0.CO;2-5; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Nakamura T, 2012, BIODEGRADATION, V23, P343, DOI 10.1007/s10532-011-9521-x; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Polekhina G, 2001, BIOCHEMISTRY-US, V40, P1567, DOI 10.1021/bi002249z; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shimizu M, 2005, PROTEOMICS, V5, P3919, DOI 10.1002/pmic.200401251; Shimizu M, 2005, APPL MICROBIOL BIOT, V68, P673, DOI 10.1007/s00253-005-1933-2; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Skopelitou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034263; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thuillier A., 2011, INT J EVOL BIOL, V2011; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia B, 2001, J MOL BIOL, V310, P907, DOI 10.1006/jmbi.2001.4721; Zhang J, 2011, J AM CHEM SOC, V133, P14109, DOI 10.1021/ja205500y; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047	60	28	28	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39001	39011		10.1074/jbc.M112.402776	http://dx.doi.org/10.1074/jbc.M112.402776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007392	Green Published, hybrid			2022-12-25	WOS:000310982800056
J	Wang, XS; Han, ZZ; He, Y; Liu, L; Bi, YC				Wang, Xiaosha; Han, Zaizhu; He, Yong; Liu, Li; Bi, Yanchao			Resting-State Functional Connectivity Patterns Predict Chinese Word Reading Competency	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; HUMAN BRAIN; SEX-DIFFERENCES; MENTAL ROTATION; WORKING-MEMORY; VISUAL-CORTEX; FORM AREA; NETWORKS; LANGUAGE; MRI	Resting-state functional connectivity (RSFC) offers a novel approach to reveal the temporal synchronization of functionally related brain regions. Recent studies have identified several RSFCs whose strength was associated with reading competence in alphabetic languages. In the present study, we examined the role of intrinsic functional relations for reading a nonalphabetic language - Chinese - by correlating RSFC maps of nine Chinese reading-related seed regions and reaction time in the single-character reading task. We found that Chinese reading efficiency was positively correlated with the connection between left inferior occipital gyrus and left superior parietal lobule, between right posterior fusiform gyrus and right superior parietal lobule, and between left inferior temporal gyrus and left inferior parietal lobule. These results could not be attributed to inter-individual differences arising from the peripheral processes of the reading task such as visual input detection and articulation. The observed RSFC-reading correlation relationships are discussed in the framework of Chinese character reading, including visuospatial analyses and semantic/phonological processes.	[Wang, Xiaosha; Han, Zaizhu; He, Yong; Liu, Li; Bi, Yanchao] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Bi, YC (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	ybi@bnu.edu.cn	He, Yong/C-2161-2009; He, Yong/Q-5756-2018	He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81030028, 30870667, 31000500]; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (Grant Nos. 81030028, 30870667, 31000500) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Bi YC, 2007, NEUROPSYCHOLOGIA, V45, P2660, DOI 10.1016/j.neuropsychologia.2007.02.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burman DD, 2008, NEUROPSYCHOLOGIA, V46, P1349, DOI 10.1016/j.neuropsychologia.2007.12.021; Cao F, 2010, CEREB CORTEX, V20, P1223, DOI 10.1093/cercor/bhp186; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Chou TL, 2009, EXP BRAIN RES, V198, P465, DOI 10.1007/s00221-009-1942-y; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Crosson B, 1999, BRAIN COGNITION, V40, P414, DOI 10.1006/brcg.1999.1088; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey S, 2004, NEUROIMAGE, V22, P1384, DOI 10.1016/j.neuroimage.2004.03.018; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Kuo WJ, 2001, NEUROREPORT, V12, P3997, DOI 10.1097/00001756-200112210-00029; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu L, 2009, J COGNITIVE NEUROSCI, V21, P1473, DOI 10.1162/jocn.2009.21141; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Peng DL, 2003, HUM BRAIN MAPP, V18, P215, DOI 10.1002/hbm.10096; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Siok WT, 2009, CURR BIOL, V19, pR890, DOI 10.1016/j.cub.2009.08.014; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Song X, 2011, PLOS ONE IN PRESS; Sun Y, 2011, BRAIN LANG IN PRESS; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond; Wechsler D., 1997, WECHSLER ADULT INTEL; Wirth M, 2007, CEREB CORTEX, V17, P1987, DOI 10.1093/cercor/bhl121; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yin W, 1992, DEEP SURFACE DYSLEXI, P349; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	68	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44848	10.1371/journal.pone.0044848	http://dx.doi.org/10.1371/journal.pone.0044848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028644	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700018
J	Brommer, JE; Lehikoinen, A; Valkama, J				Brommer, Jon E.; Lehikoinen, Aleksi; Valkama, Jari			The Breeding Ranges of Central European and Arctic Bird Species Move Poleward	PLOS ONE			English	Article							BOREAL PROTECTED AREAS; CLIMATE-CHANGE; NORTHERN BIRDS; SHIFTS; VARIABILITY; BOUNDARIES; RESPONSES	Background: Climatic warming predicts that species move their entire distribution poleward. Poleward movement of the 'cold' side of the distribution of species is empirically supported, but evidence of poleward movement at the 'warm' distributional side is relatively scarce. Methodology/Principal Finding: Finland has, as the first country in the world, completed three national atlas surveys of breeding birds, which we here use to calculate the sizes and weighted mean latitudes of the national range of 114 southern and 34 northern bird species during three periods (1974-1979; 1986-1989; 2006-2010), each denoting species presence in approximately 3 800 10610 km(2) squares. We find strong evidence that southern species (breeding predominantly in central Europe) showed a latitudinal shift of 1.1-1.3 km/year poleward during all three pairwise comparisons between these atlases (covering 11, 20.5 and 31.5 years respectively). We find evidence of a latitudinal shift of 0.7-0.8 km/year poleward of northern boreal and Arctic species, but this shift was not found in all study periods and may have been influenced by increased effort put into the more recent surveys. Species showed no significant correlation in changes in range size and weighted mean latitude between the first (11 year) and second (20.5 year) period covered by consecutive atlases, suggesting weak phylogenetic signal and little scope of species characteristics in explaining latitudinal avian range changes. Conclusions: Extinction-driven avian range changes (at the 'warm' side) of a species' distribution occur at approximately half the rate of colonisation-driven range changes (at the 'cold' side), and its quantification therefore requires long-term monitoring data, possibly explaining why evidence for such changes is currently rare. A clear latitudinal shift in an assemblage of species may still harbour considerable temporal inconsistency in latitudinal movement on the species level. Understanding this inconsistency is important for predictive modelling of species composition in a changing world.	[Brommer, Jon E.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Brommer, Jon E.] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Brommer, Jon E.] Abo Akad Univ, Ekenas, Finland; [Lehikoinen, Aleksi; Valkama, Jari] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Helsinki; Novia University of Applied Sciences; Abo Akademi University; University of Helsinki	Brommer, JE (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	jon.brommer@helsinki.fi	Brommer, Jon E/C-3613-2008; Lehikoinen, Aleksi/O-5444-2016	Brommer, Jon E/0000-0002-2435-2612; Valkama, Jari/0000-0002-0393-7320; Lehikoinen, Aleksi/0000-0002-1989-277X	Academy of Finland	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (JEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brommer JE, 2010, CLIMATE CHANGE BIRDS; Brommer JE, 2008, ORNIS FENNICA, V85, P109; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Cormont A, 2011, CLIM RES, V49, P59, DOI 10.3354/cr01007; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Holm S., 1979, SCAND J STAT, V6, P56; Hyytia K, 1983, SUOMEN LINTUATLAS; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kellomaki S, 2005, FINNISH ENV I MIMEOG, V334, P1; MacArthur R.H., 1972, pvii; Metsantutkimuslaitos, 2010, METS VUOS 2010; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Setchell WA, 1920, SCIENCE, V52, P187, DOI 10.1126/science.52.1339.187; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tietavainen H, 2009, ACTA GEOSCI SIN, V30, P2247; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Valkama J., 2011, 3 FINNISH BREEDING B; Virkkala R, 2011, BOREAL ENVIRON RES, V16, P2; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	28	64	72	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43648	10.1371/journal.pone.0043648	http://dx.doi.org/10.1371/journal.pone.0043648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028465	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900004
J	Gross, S; Catez, F; Masumoto, H; Lomonte, P				Gross, Sylvain; Catez, Frederic; Masumoto, Hiroshi; Lomonte, Patrick			Centromere Architecture Breakdown Induced by the Viral E3 Ubiquitin Ligase ICP0 Protein of Herpes Simplex Virus Type 1	PLOS ONE			English	Article							ALPHA-SATELLITE DNA; PROTEASOME-DEPENDENT DEGRADATION; CENP-A NUCLEOSOMES; OUTER KINETOCHORE; BINDING PROTEIN; HISTONE H3; CELL-FATE; CHROMATIN; COMPLEX; DOMAIN	The viral E3 ubiquitin ligase ICP0 protein has the unique property to temporarily localize at interphase and mitotic centromeres early after infection of cells by the herpes simplex virus type 1 (HSV-1). As a consequence ICP0 induces the proteasomal degradation of several centromeric proteins (CENPs), namely CENP-A, the centromeric histone H3 variant, CENP-B and CENP-C. Following ICP0-induced centromere modification cells trigger a specific response to centromeres called interphase Centromere Damage Response (iCDR). The biological significance of the iCDR is unknown; so is the degree of centromere structural damage induced by ICP0. Interphase centromeres are complex structures made of proximal and distal protein layers closely associated to CENP-A-containing centromeric chromatin. Using several cell lines constitutively expressing GFP-tagged CENPs, we investigated the extent of the centromere destabilization induced by ICP0. We show that ICP0 provokes the disappearance from centromeres, and the proteasomal degradation of several CENPs from the NAC (CENP-A nucleosome associated) and CAD (CENP-A Distal) complexes. We then investigated the nucleosomal occupancy of the centromeric chromatin in ICP0-expressing cells by micrococcal nuclease (MNase) digestion analysis. ICP0 expression either following infection or in cell lines constitutively expressing ICP0 provokes significant modifications of the centromeric chromatin structure resulting in higher MNase accessibility. Finally, using human artificial chromosomes (HACs), we established that ICP0-induced iCDR could also target exogenous centromeres. These results demonstrate that, in addition to the protein complexes, ICP0 also destabilizes the centromeric chromatin resulting in the complete breakdown of the centromere architecture, which consequently induces iCDR.	[Gross, Sylvain; Catez, Frederic; Lomonte, Patrick] CNRS, Ctr Genet & Physiol Mol & Cellulaire, UMR5534, Virus & Centromere Team, Villeurbanne, France; [Gross, Sylvain; Catez, Frederic; Lomonte, Patrick] Univ Lyon 1, F-69365 Lyon, France; [Gross, Sylvain; Lomonte, Patrick] Labex DEVweCAN, Lab Excellence, Lyon, France; [Masumoto, Hiroshi] Kazusa DNA Res Inst, Lab Cell Engn, Chiba, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Kazusa DNA Research Institute	Lomonte, P (corresponding author), CNRS, Ctr Genet & Physiol Mol & Cellulaire, UMR5534, Virus & Centromere Team, Villeurbanne, France.	patrick.lomonte@univ-lyon1.fr	CATEZ, Frédéric/GQP-7328-2022; CATEZ, Frédéric/AAM-4854-2020	CATEZ, Frédéric/0000-0001-8255-9091; LOMONTE, PATRICK/0000-0001-9248-648X	Association pour la Recherche contre le Cancer [ARC-7979, ARC-4910]; ANR [ANR-05-MIIM-008-01]; FINOVI Foundation; LabEX DEVweCAN [ANR-10-LABX-61]; Ligue Nationale Contre le Cancer (LNCC); French Ministry for Education and Research; Fondation pour la Recherche Medicale (FRM)	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); FINOVI Foundation; LabEX DEVweCAN; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); French Ministry for Education and Research; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was funded by the Association pour la Recherche contre le Cancer (grants ARC-7979 and ARC-4910), ANR (grant ANR-05-MIIM-008-01, CENTROLAT), FINOVI Foundation, the LabEX DEVweCAN (ANR-10-LABX-61), and the Ligue Nationale Contre le Cancer (LNCC). SG was supported by the French Ministry for Education and Research and the Fondation pour la Recherche Medicale (FRM). FC and PL are CNRS researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002245; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Catez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002852; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Conn KL, 2008, J VIROL, V82, P8629, DOI 10.1128/JVI.00616-08; Conn KL, 2011, J VIROL, V85, P13234, DOI 10.1128/JVI.06038-11; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Guasconi V, 2010, EPIGENETICS-US, V5, P704, DOI 10.4161/epi.5.8.13025; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hagglund R, 2004, J VIROL, V78, P2169, DOI 10.1128/JVI.78.5.2169-2178.2004; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McAinsh AD, 2011, SEMIN CELL DEV BIOL, V22, P946, DOI 10.1016/j.semcdb.2011.09.016; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Morency E, 2005, ARCH VIROL, V150, P2387, DOI 10.1007/s00705-005-0546-5; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pluta AF, 1998, J CELL SCI, V111, P2029; Politi V, 2002, J CELL SCI, V115, P2317; Preston CM, 2000, J GEN VIROL, V81, P1; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schang LM, 2000, J VIROL, V74, P2107, DOI 10.1128/JVI.74.5.2107-2120.2000; Schubeler D, 2000, GENE DEV, V14, P940; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Sekulic N, 2009, NAT CELL BIOL, V11, P793, DOI 10.1038/ncb0709-793; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; STOW ND, 1986, J GEN VIROL, V67, P2571, DOI 10.1099/0022-1317-67-12-2571; Sugata N, 2000, HUM MOL GENET, V9, P2919, DOI 10.1093/hmg/9.19.2919; SUGIMOTO K, 1994, J BIOCHEM-TOKYO, V116, P877, DOI 10.1093/oxfordjournals.jbchem.a124610; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Thompson RL, 2006, J VIROL, V80, P10919, DOI 10.1128/JVI.01253-06; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; Trazzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005832; Wagner EK, 1997, CLIN MICROBIOL REV, V10, P419, DOI 10.1128/CMR.10.3.419; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	94	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44227	10.1371/journal.pone.0044227	http://dx.doi.org/10.1371/journal.pone.0044227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028505	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388900006
J	Khunjar, WO; Sahin, A; West, AC; Chandran, K; Banta, S				Khunjar, Wendell O.; Sahin, Asli; West, Alan C.; Chandran, Kartik; Banta, Scott			Biomass Production from Electricity Using Ammonia as an Electron Carrier in a Reverse Microbial Fuel Cell	PLOS ONE			English	Article							NITRITE OXIDATION; GLASSY-CARBON; NITROSOMONAS-EUROPAEA; AUTOTROPHIC AMMONIA; CONVERSION; REDUCTION; PATHWAYS; NITRATE	The storage of renewable electrical energy within chemical bonds of biofuels and other chemicals is a route to decreasing petroleum usage. A critical challenge is the efficient transfer of electrons into a biological host that can covert this energy into high energy organic compounds. In this paper, we describe an approach whereby biomass is grown using energy obtained from a soluble mediator that is regenerated electrochemically. The net result is a separate-stage reverse microbial fuel cell (rMFC) that fixes CO2 into biomass using electrical energy. We selected ammonia as a low cost, abundant, safe, and soluble redox mediator that facilitated energy transfer to biomass. Nitrosomonas europaea, a chemolithoautotroph, was used as the biocatalyst due to its inherent capability to utilize ammonia as its sole energy source for growth. An electrochemical reactor was designed for the regeneration of ammonia from nitrite, and current efficiencies of 100% were achieved. Calculations indicated that overall bioproduction efficiency could approach 2.7 +/- 0.2% under optimal electrolysis conditions. The application of chemolithoautotrophy for industrial bioproduction has been largely unexplored, and results suggest that this and related rMFC platforms may enable biofuel and related biochemical production.	[Khunjar, Wendell O.; West, Alan C.; Chandran, Kartik] Columbia Univ, Dept Chem Engn, Dept Earth & Environm Engn, New York, NY 10027 USA	Columbia University	West, AC (corresponding author), Columbia Univ, Dept Chem Engn, Dept Earth & Environm Engn, New York, NY 10027 USA.	acw17@columbia.edu; kc2288@columbia.edu; sbanta@columbia.edu	Chandran, Kartik/O-1202-2013	Chandran, Kartik/0000-0002-7526-3724	Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program [DE-AR000060]	Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program	This work was funded by the Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program (http://arpa-e.energy.gov/ProgramsProjects/Electrofuels.aspx) under grant number DE-AR000060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, BIOTECHNOL BIOENG, V100, P1078, DOI 10.1002/bit.21863; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; AWWA APHA WPCF, 1992, STANDARD METHODS EXA; BEADLE CL, 1985, BIOMASS, V8, P119, DOI 10.1016/0144-4565(85)90022-8; Bouzek K, 2001, J APPL ELECTROCHEM, V31, P1185, DOI 10.1023/A:1012755222981; Boyle NR, 2011, METAB ENG, V13, P150, DOI 10.1016/j.ymben.2011.01.005; Cann AF, 2008, APPL MICROBIOL BIOT, V81, P89, DOI 10.1007/s00253-008-1631-y; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chandran K, 2005, WATER RES, V39, P4969, DOI 10.1016/j.watres.2005.10.001; Chandran K, 2001, WATER RES, V35, P3153, DOI 10.1016/S0043-1354(01)00022-7; Chandran K, 2008, APPL ENVIRON MICROB, V74, P2447, DOI 10.1128/AEM.01940-07; Connor MR, 2009, CURR OPIN BIOTECH, V20, P307, DOI 10.1016/j.copbio.2009.04.002; Cussler E.L., 1997, DIFFUSION MASS TRANS; Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1; Dooley J.J., 2008, LONG TERM AVERAGE CO; Durivault L, 2007, J ALLOY COMPD, V432, P323, DOI 10.1016/j.jallcom.2006.06.023; Gallaway J, 2008, BIOSENS BIOELECTRON, V23, P1229, DOI 10.1016/j.bios.2007.11.004; Gratzel M, 2007, PHILOS T R SOC A, V365, P993, DOI 10.1098/rsta.2006.1963; Guven D, 2009, PROCESS BIOCHEM, V44, P516, DOI 10.1016/j.procbio.2009.01.005; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Henze MG, 1987, FINAL REPORT ACTIVAT; Hoffman T, 1952, BIOCHEM J, V54, P579; HUCKE EE, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070318; Jang Y.S., 2011, BIOTECHNOL ADV; Kelly T. D., 2010, HIST STAT MINERAL MA; Khunjar WO, 2011, ENV MICROBIOLO UNPUB; Larkum AWD, 2010, CURR OPIN BIOTECH, V21, P271, DOI 10.1016/j.copbio.2010.03.004; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Maalouf R, 2006, MAT SCI ENG C-BIO S, V26, P564, DOI 10.1016/j.msec.2005.10.005; Munz G, 2011, CHEMOSPHERE, V83, P720, DOI 10.1016/j.chemosphere.2011.01.058; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Pandit AV, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-76; POLLOCK JTA, 1987, J MATER SCI LETT, V6, P1023, DOI 10.1007/BF01729119; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; Rittmann B.E., 2001, ENV BIOTECHNOLOGY PR, DOI [10.1016/S0958-1669(96)80047-4, DOI 10.1016/S0958-1669(96)80047-4]; Sahin A, 2012, J ELECTROCHEMI UNPUB; Schmachtel S, 2009, J APPL ELECTROCHEM, V39, P1835, DOI 10.1007/s10800-009-9887-1; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Walker DA, 2009, J APPL PHYCOL, V21, P509, DOI 10.1007/s10811-009-9446-5; Yu R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-70; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhu Z-G, 2008, CURRENT OPINION BIOT, V19, P152	46	34	38	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44846	10.1371/journal.pone.0044846	http://dx.doi.org/10.1371/journal.pone.0044846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028643	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388400043
J	Astrup, E; Lekva, T; Davi, G; Otterdal, K; Santilli, F; Oie, E; Halvorsen, B; Damas, JK; Raoult, D; Vitale, G; Olano, JP; Ueland, T; Aukrust, P				Astrup, Elisabeth; Lekva, Tove; Davi, Giovanni; Otterdal, Kari; Santilli, Francesca; Oie, Erik; Halvorsen, Bente; Damas, Jan Kristian; Raoult, Didier; Vitale, Giustina; Olano, Juan P.; Ueland, Thor; Aukrust, Pal			A Complex Interaction between Rickettsia conorii and Dickkopf-1-Potential Role in Immune Evasion Mechanisms in Endothelial Cells	PLOS ONE			English	Article							MEDITERRANEAN SPOTTED-FEVER; TICK BITE FEVER; ACTIVATION; EXPRESSION; MODULATORS; PLATELETS; APOPTOSIS; RESPONSES; ADHESION; PATHWAY	The pathophysiological hallmark of spotted fever group rickettsioses comprises vascular inflammation. Based on the emerging importance of the wingless (Wnt) pathways in inflammation and vascular biology, we hypothesized that Dickkopf-1 (DKK-1), as a major modulator of Wnt signaling, could be involved in the pathogenesis in rickettsial infections. Our major findings were: (i) While baseline concentration of DKK-1 in patients with R. conorii infection (n = 32) were not different from levels in controls (n = 24), DKK-1 rose significantly from presentation to first follow-up sample (median 7 days after baseline). (ii) In vitro experiments in human umbilical vein endothelial cells (HUVECs) showed that while heat-inactivated R. conorii enhanced the release of interleukin-6 (IL-6) and IL-8, it down-regulated the release of endothelial-derived DKK-1 in a time-and dose-dependent manner. (iii) Silencing of DKK-1 attenuated the release of IL-6, IL-8 and growth-related oncogene (GRO)alpha in R. conorii-exposed HUVECs, suggesting inflammatory effects of DKK-1. (iv) Silencing of DKK-1 attenuated the expression of tissue factor and enhanced the expression of thrombomodulin in R. conorii-exposed HUVECs suggesting pro-thrombotic effects of DKK-1. The capacity of R. conorii to down-regulate endothelial-derived DKK-1 and the ability of silencing DKK-1 to attenuate R. conorii-induced inflammation in endothelial cells could potentially reflect a novel mechanism by which R. conorii escapes the immune response at the site of infection.	[Astrup, Elisabeth] Akershus Univ Hosp, Inst Clin Med, Lorenskog, Norway; [Astrup, Elisabeth; Lekva, Tove; Otterdal, Kari; Oie, Erik; Halvorsen, Bente; Ueland, Thor; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Lekva, Tove] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Specialized Endocrinol, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Astrup, Elisabeth; Ueland, Thor; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Damas, Jan Kristian] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Damas, Jan Kristian] St Olavs Hosp, Dept Infect Dis, Trondheim, Norway; [Davi, Giovanni; Santilli, Francesca] Univ G dAnnunzio, Ctr Excellence Aging, Palermo, Italy; [Vitale, Giustina] Sch Med, Dept Med, Palermo, Italy; [Raoult, Didier] Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France; [Olano, Juan P.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); G d'Annunzio University of Chieti-Pescara; University of Palermo; UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Medical Branch Galveston	Astrup, E (corresponding author), Akershus Univ Hosp, Inst Clin Med, Lorenskog, Norway.	Elisabeth.Astrup.Strand@rr-research.no	Santilli, Francesca/ABC-6243-2021; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; RAOULT, Didier/A-8434-2008; Davi, Giovanni/K-7659-2016	Santilli, Francesca/0000-0002-4593-905X; RAOULT, Didier/0000-0002-0633-5974; Davi, Giovanni/0000-0002-3044-0870; Lekva, Tove/0000-0002-7962-4726	Norwegian Research Council; University of Oslo; Helse Sor-Ost	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo; Helse Sor-Ost	Sources of financial support are Norwegian Research Council, www.forskningsradet.no University of Oslo,uio.no, Helse Sor-Ost, www.helse-sorost.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Damas JK, 2006, J IMMUNOL, V177, P2699, DOI 10.4049/jimmunol.177.4.2699; Damas JK, 2009, J INFECTION, V58, P68, DOI 10.1016/j.jinf.2008.11.008; DAVI G, 1995, THROMB HAEMOSTASIS, V74, P631; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kessler M, 2012, AM J PATHOL, V180, P186, DOI 10.1016/j.ajpath.2011.09.015; Ko JY, 2010, BONE, V46, P584, DOI 10.1016/j.bone.2009.10.030; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee DK, 2006, BIOCHEM BIOPH RES CO, V347, P109, DOI 10.1016/j.bbrc.2006.06.082; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; RAOULT D, 1987, J INFECT DIS, V155, P1059, DOI 10.1093/infdis/155.5.1059; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Vitale G, 2001, J INFECTION, V42, P33, DOI 10.1053/jinf.2000.0758; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Walker DH, 2003, ANN NY ACAD SCI, V990, P1, DOI 10.1111/j.1749-6632.2003.tb07331.x; Weng LH, 2010, ARTHRITIS RHEUM-US, V62, P1393, DOI 10.1002/art.27357; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	28	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43638	10.1371/journal.pone.0043638	http://dx.doi.org/10.1371/journal.pone.0043638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028464	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900008
J	Recio-Spinoso, A				Recio-Spinoso, Alberto			Enhancement and Distortion in the Temporal Representation of Sounds in the Ventral Cochlear Nucleus of Chinchillas and Cats	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; SPHERICAL BUSHY CELLS; DISCHARGE PATTERNS; NEURAL SYNCHRONIZATION; LATERAL LEMNISCUS; RESPONSE PATTERNS; TONAL STIMULI; NEURONS; TONES; MECHANISMS	A subset of neurons in the cochlear nucleus (CN) of the auditory brainstem has the ability to enhance the auditory nerve's temporal representation of stimulating sounds. These neurons reside in the ventral region of the CN (VCN) and are usually known as highly synchronized, or high-sync, neurons. Most published reports about the existence and properties of high-sync neurons are based on recordings performed on a VCN output tract-not the VCN itself-of cats. In other species, comprehensive studies detailing the properties of high-sync neurons, or even acknowledging their existence, are missing. Examination of the responses of a population of VCN neurons in chinchillas revealed that a subset of those neurons have temporal properties similar to high-sync neurons in the cat. Phase locking and entrainment-the ability of a neuron to fire action potentials at a certain stimulus phase and at almost every stimulus period, respectively-have similar maximum values in cats and chinchillas. Ranges of characteristic frequencies for high-sync neurons in chinchillas and cats extend up to 600 and 1000 Hz, respectively. Enhancement of temporal processing relative to auditory nerve fibers (ANFs), which has been shown previously in cats using tonal and white-noise stimuli, is also demonstrated here in the responses of VCN neurons to synthetic and spoken vowel sounds. Along with the large amount of phase locking displayed by some VCN neurons there occurs a deterioration in the spectral representation of the stimuli (tones or vowels). High-sync neurons exhibit a greater distortion in their responses to tones or vowels than do other types of VCN neurons and auditory nerve fibers. Standard deviations of first-spike latency measured in responses of high-sync neurons are lower than similar values measured in ANFs' responses. This might indicate a role of high-sync neurons in other tasks beyond sound localization.	Univ Castilla La Mancha, IDINE, Lab Auditory Neuroengn, Albacete, Spain	Universidad de Castilla-La Mancha	Recio-Spinoso, A (corresponding author), Univ Castilla La Mancha, IDINE, Lab Auditory Neuroengn, Albacete, Spain.	alberto.recio@uclm.es	Recio-Spinoso, Alberto/F-7744-2013	Recio-Spinoso, Alberto/0000-0003-1909-832X	National Institute on Deafness and Other Communication Disorders [NS-17590]; Regional Operational Programme European Social Fund within the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017590] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Regional Operational Programme European Social Fund within the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported by National Institute on Deafness and Other Communication Disorders grant NS-17590 (http://www.nidcd.nih.gov) and by the Regional Operational Programme European Social Fund 2007/2013 within the frame of the Spain Instituto de Recursos Humanos para la Ciencia y la Tecnologia program of the Fundacion Parque Cientifico y Tecnologico de Albacete (http://www.pcyta.com). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKBURN CC, 1990, J NEUROPHYSIOL, V63, P1191, DOI 10.1152/jn.1990.63.5.1191; BLACKBURN CC, 1989, J NEUROPHYSIOL, V62, P1303, DOI 10.1152/jn.1989.62.6.1303; BOURK TR, 1976, THESIS MIT CAMBRIDGE; CARNEY LH, 1990, J NEUROPHYSIOL, V64, P437, DOI 10.1152/jn.1990.64.2.437; COVEY E, 1991, J NEUROSCI, V11, P3456; Dehmel S, 2010, HEARING RES, V268, P234, DOI 10.1016/j.heares.2010.06.005; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Gai Y, 2008, J NEUROPHYSIOL, V99, P1077, DOI 10.1152/jn.00708.2007; Galambos R, 1943, J NEUROPHYSIOL, V6, P39, DOI 10.1152/jn.1943.6.1.39; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Joris PX, 2008, NEUROSCIENCE, V154, P65, DOI 10.1016/j.neuroscience.2008.03.002; Joris PX, 2006, HEARING RES, V216, P19, DOI 10.1016/j.heares.2006.03.010; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Kiang NYS, 1965, DISCHARGE PATTERNS S; KNOX CK, 1970, KYBERNETIK, V7, P167, DOI 10.1007/BF00289403; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; Kuenzel T, 2011, J NEUROSCI, V31, P4260, DOI 10.1523/JNEUROSCI.5433-10.2011; LAVINE RA, 1971, J NEUROPHYSIOL, V34, P467, DOI 10.1152/jn.1971.34.3.467; Louage DHG, 2005, J NEUROSCI, V25, P1560, DOI 10.1523/JNEUROSCI.4742-04.2005; Mardia K. V., 2000, DIRECTIONAL STAT; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; MOREST DK, 1990, J COMP NEUROL, V300, P230, DOI 10.1002/cne.903000207; Oertel D, 2002, SPR HDB AUD, V15, P207; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; Recio A, 2000, HEARING RES, V146, P167, DOI 10.1016/S0378-5955(00)00111-8; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; Rhode WS, 1999, J NEUROPHYSIOL, V82, P1019, DOI 10.1152/jn.1999.82.2.1019; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; RHODE WS, 1986, J NEUROPHYSIOL, V56, P287, DOI 10.1152/jn.1986.56.2.287; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Rhode WS, 1998, HEARING RES, V117, P39, DOI 10.1016/S0378-5955(98)00002-1; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Shofner WP, 1999, J NEUROPHYSIOL, V81, P2662, DOI 10.1152/jn.1999.81.6.2662; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; SINEX DG, 1983, J ACOUST SOC AM, V73, P602, DOI 10.1121/1.389007; Smith PH, 2005, J COMP NEUROL, V482, P349, DOI 10.1002/cne.20407; Stein R.B, 1970, NEUROSCIENCES, P597; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Temchin AN, 2005, J NEUROPHYSIOL, V93, P3635, DOI 10.1152/jn.00885.2004; Temchin AN, 2010, JARO-J ASSOC RES OTO, V11, P297, DOI 10.1007/s10162-009-0197-4; THOMAS IB, 1969, J ACOUST SOC AM, V46, P468, DOI 10.1121/1.1911712; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4; Yin TCT, 2002, SPR HDB AUD, V15, P99; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44286	10.1371/journal.pone.0044286	http://dx.doi.org/10.1371/journal.pone.0044286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028514	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900017
J	Bragg, JN; Wu, JJ; Gordon, SP; Guttman, ME; Thilmony, R; Lazo, GR; Gu, YQ; Vogel, JP				Bragg, Jennifer N.; Wu, Jiajie; Gordon, Sean P.; Guttman, Mara E.; Thilmony, Roger; Lazo, Gerard R.; Gu, Yong Q.; Vogel, John P.			Generation and Characterization of the Western Regional Research Center Brachypodium T-DNA Insertional Mutant Collection	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENETIC-LINKAGE MAP; TAGGING LINES; FUNCTIONAL GENOMICS; MODEL SYSTEM; DISTACHYON; MUTAGENESIS; EXPRESSION; DATABASE; VECTOR	The model grass Brachypodium distachyon (Brachypodium) is an excellent system for studying the basic biology underlying traits relevant to the use of grasses as food, forage and energy crops. To add to the growing collection of Brachypodium resources available to plant scientists, we further optimized our Agrobacterium tumefaciens-mediated high-efficiency transformation method and generated 8,491 Brachypodium T-DNA lines. We used inverse PCR to sequence the DNA flanking the insertion sites in the mutants. Using these flanking sequence tags (FSTs) we were able to assign 7,389 FSTs from 4,402 T-DNA mutants to 5,285 specific insertion sites (ISs) in the Brachypodium genome. More than 29% of the assigned ISs are supported by multiple FSTs. T-DNA insertions span the entire genome with an average of 19.3 insertions/Mb. The distribution of T-DNA insertions is non-uniform with a larger number of insertions at the distal ends compared to the centromeric regions of the chromosomes. Insertions are correlated with genic regions, but are biased toward UTRs and non-coding regions within 1 kb of genes over exons and intron regions. More than 1,300 unique genes have been tagged in this population. Information about the Western Regional Research Center Brachypodium insertional mutant population is available on a searchable website (http://brachypodium.pw.usda.gov) designed to provide researchers with a means to order T-DNA lines with mutations in genes of interest.	[Bragg, Jennifer N.; Wu, Jiajie; Gordon, Sean P.; Guttman, Mara E.; Thilmony, Roger; Lazo, Gerard R.; Gu, Yong Q.; Vogel, John P.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Bragg, Jennifer N.; Wu, Jiajie] Univ Calif Davis, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis	Vogel, JP (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	john.vogel@ars.usda.gov	Lazo, Gerard/A-8900-2009	Lazo, Gerard/0000-0002-9160-2052; Vogel, John/0000-0003-1786-2689	Office of Science (BER), US Department of Energy, Interagency Agreement [DE-AI02-07ER64452]; USDA CRIS project [5325-21000-013-00]	Office of Science (BER), US Department of Energy, Interagency Agreement(United States Department of Energy (DOE)); USDA CRIS project	This work was supported by the Office of Science (BER), US Department of Energy, Interagency Agreement No. DE-AI02-07ER64452 and by USDA CRIS project 5325-21000-013-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; An SY, 2003, PLANT PHYSIOL, V133, P2040, DOI 10.1104/pp.103.030478; BABLAK P, 1995, PLANT CELL TISS ORG, V42, P97, DOI 10.1007/BF00037687; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Bouteille M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032319; Bragg J, 2010, HDB BIOENERGY CROP P; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brown AN, 2011, G3-GENES GENOM GENET, V1, P437, DOI 10.1534/g3.111.000703; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Catalan P, 2012, ANN BOT; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christensen U, 2010, PHYTOCHEMISTRY, V71, P62, DOI 10.1016/j.phytochem.2009.09.019; Christiansen P, 2005, PLANT CELL REP, V23, P751, DOI 10.1007/s00299-004-0889-5; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Faricelli ME, 2010, FUNCT INTEGR GENOMIC, V10, P293, DOI 10.1007/s10142-009-0146-7; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/g09-062, 10.1139/G09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Guillon F, 2012, J EXP BOT, V63, P739, DOI 10.1093/jxb/err298; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kumar CS, 2005, PLANT J, V44, P879, DOI 10.1111/j.1365-313X.2005.02570.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Liu LZ, 2012, THEOR APPL GENET, V124, P1573, DOI 10.1007/s00122-012-1811-0; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Mochida K, 2011, DNA RES, V18, P321, DOI 10.1093/dnares/dsr019; Mori M, 2007, PLANT MOL BIOL, V63, P847, DOI 10.1007/s11103-006-9130-y; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; Podevin N, 2006, TRANSGENIC RES, V15, P557, DOI 10.1007/s11248-006-9003-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Ryu CH, 2004, PLANT MOL BIOL, V54, P489, DOI 10.1023/B:PLAN.0000038257.93381.05; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Thole V, 2007, PLANT PHYSIOL, V145, P1211, DOI 10.1104/pp.107.108563; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Trijatmiko KR, 2005, COMP ANAL DROUGHT RE; US-DOE, 2006, BREAK BIOL BARR CELL; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wan SY, 2009, PLANT MOL BIOL, V69, P69, DOI 10.1007/s11103-008-9406-5; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yordem BK, 2011, ANN BOT-LONDON, V108, P821, DOI 10.1093/aob/mcr200; Yu SM, 2007, PLANT MOL BIOL, V65, P417, DOI 10.1007/s11103-007-9232-1; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x	61	82	83	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e41916	10.1371/journal.pone.0041916	http://dx.doi.org/10.1371/journal.pone.0041916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028431	gold, Green Submitted, Green Published			2022-12-25	WOS:000309742800002
J	Chen, SM; Lu, C; Gu, HB; Mehta, A; Li, JW; Romano, PB; Horn, D; Hooper, DC; Bazemore-Walker, CR; Block, T				Chen, Songming; Lu, Chen; Gu, Hongbo; Mehta, Anand; Li, Jianwei; Romano, Patrick B.; Horn, David; Hooper, D. Craig; Bazemore-Walker, Carthene R.; Block, Timothy			Aleuria Aurantia Lectin (AAL)-Reactive Immunoglobulin G Rapidly Appears in Sera of Animals following Antigen Exposure	PLOS ONE			English	Article							IGG GLYCOSYLATION; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; IMPACT; SPECIFICITIES; GLYCANS	We have discovered an Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G (IgG) that naturally occurs in the circulation of rabbits and mice, following immune responses induced by various foreign antigens. AAL can specifically bind to fucose moieties on glycoproteins. However, most serum IgGs are poorly bound by AAL unless they are denatured or treated with glycosidase. In this study, using an immunogen-independent AAL-antibody microarray assay that we developed, we detected AAL-reactive IgG in the sera of all animals that had been immunized 1-2 weeks previously with various immunogens with and without adjuvants and developed immunogen-specific responses. All of these animals subsequently developed immunogen-specific immune responses. The kinetics of the production of AAL-reactive IgG in mice and rabbits were distinct from those of the immunogen-specific IgGs elicited in the same animals: they rose and fell within one to two weeks, and peaked between four to seven days after exposure, while immunogen-specific IgGs continued to rise during the same period. Mass spectrometric profiling of the Fc glycoforms of purified AAL-reactive IgGs indicates that these are mainly comprised of IgGs with core-fucosylated and either mono- or non-galactosylated Fc N-glycan structures. Our results suggest that AAL-reactive IgG could be a previously unrecognized IgG subset that is selectively produced at the onset of a humoral response.	[Chen, Songming; Lu, Chen; Horn, David; Block, Timothy] Inst Hepatitis & Virus Res, Doylestown, PA USA; [Gu, Hongbo; Bazemore-Walker, Carthene R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Mehta, Anand; Romano, Patrick B.; Block, Timothy] Drexel Univ, Coll Med, Doylestown, PA USA; [Li, Jianwei; Hooper, D. Craig] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Li, Jianwei; Hooper, D. Craig] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA	Brown University; Drexel University; Jefferson University; Jefferson University	Chen, SM (corresponding author), Inst Hepatitis & Virus Res, Doylestown, PA USA.	songming.chen@ihvr.org; Timothy.Block@DrexelMed.edu	Bazemore-Walker, Carthene/I-1879-2013	Hooper, Douglas/0000-0002-8578-5104; Bazemore-Walker, Carthene/0000-0001-5157-4440	Department of Defense [HDTRA1-07-RDINO-BAA]; NATIONAL CANCER INSTITUTE [U01CA168856, R01CA120206] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense (HDTRA1-07-RDINO-BAA) to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2007, CELLUAR MOL IMMUNOLO; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anthony RM, 2010, CURRENT OPINION ORGA; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Prados MB, 2011, IMMUNOL LETT, V137, P28, DOI 10.1016/j.imlet.2011.01.017; Bergsma D, 2010, MOL CELL PROTEOMICS, V9, P446, DOI 10.1074/mcp.M900418-MCP200; Chen Lu JLW, 2011, J VISUALIZE IN PRESS; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Chen Songming, 2009, V520, P39, DOI 10.1007/978-1-60327-811-9_4; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Guo NX, 2005, CLIN BIOCHEM, V38, P149, DOI 10.1016/j.clinbiochem.2004.10.002; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Huhn C, 2009, PROTEOMICS, V9, P882, DOI 10.1002/pmic.200800715; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Jung JH, 2010, ANGEW CHEM INT EDIT, V49, P5708, DOI 10.1002/anie.201001428; Kim WD, 2010, APPL MICROBIOL BIOT, V85, P535, DOI 10.1007/s00253-009-2152-z; Lastra GC, 1998, AUTOIMMUNITY, V28, P25, DOI 10.3109/08916939808993842; Lee BE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-277; Lin S, 2010, LANCET, V375, P178, DOI 10.1016/S0140-6736(09)61791-8; Lu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3791; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; MATSUDA H, 1990, MOL IMMUNOL, V27, P571, DOI 10.1016/0161-5890(90)90076-C; Mehta AS, 2008, J VIROL, V82, P1259, DOI 10.1128/JVI.01600-07; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Perdivara I, 2011, J PROTEOME RES, V10, P2969, DOI 10.1021/pr200397h; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Renaudineau Y, 1998, REV RHUM, V65, P429; Romano PR, 2011, BIOCHEM BIOPH RES CO, V414, P84, DOI 10.1016/j.bbrc.2011.09.027; Scherer HU, 2009, PROTEOM CLIN APPL, V3, P106, DOI 10.1002/prca.200800098; Selman MHJ, 2011, J PROTEOME RES, V10, P143, DOI 10.1021/pr1004373; Shao CX, 2009, PROTEOM CLIN APPL, V3, P923, DOI 10.1002/prca.200800245; Siberil S, 2006, CLIN IMMUNOL, V118, P170, DOI 10.1016/j.clim.2005.10.008; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang J, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010017-1, 10.1074/mcp.M110.004655, 10.1074/mcp.M111.010017]; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Wuhrer M, 2009, J PROTEOME RES, V8, P450, DOI 10.1021/pr800651j	43	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44422	10.1371/journal.pone.0044422	http://dx.doi.org/10.1371/journal.pone.0044422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024749	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100007
J	Li, DD; Sun, T; Wu, XQ; Chen, SP; Deng, R; Jiang, S; Feng, GK; Pan, JX; Zhang, XS; Zeng, YX; Zhu, XF				Li, Dan-Dan; Sun, Ting; Wu, Xiao-Qi; Chen, Shu-Peng; Deng, Rong; Jiang, Shan; Feng, Gong-Kan; Pan, Jing-Xuan; Zhang, Xiao-Shi; Zeng, Yi-Xin; Zhu, Xiao-Feng			The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEATH; MECHANISM; APOPTOSIS; SESTRIN2; DISEASE; STRESS; PHOSPHORYLATION; UPSTREAM; PATHWAYS	Background: Topotecan produces DNA damage that induces autophagy in cancer cells. In this study, sensitising topotecan to colon cancer cells with different P53 status via modulation of autophagy was examined. Methodology/Principal Findings: The DNA damage induced by topotecan treatment resulted in cytoprotective autophagy in colon cancer cells with wild-type p53. However, in cells with mutant p53 or p53 knockout, treatment with topotecan induced autophagy-associated cell death. In wild-type p53 colon cancer cells, topotecan treatment activated p53, upregulated the expression of sestrin 2, induced the phosphorylation of the AMPKa subunit at Thr172, and inhibited the mTORC1 pathway. Furthermore, the inhibition of autophagy enhanced the anti-tumour effect of topotecan treatment in wild-type p53 colon cancer cells but alleviated the anti-tumour effect of topotecan treatment in p53 knockout cells in vivo. Conclusions/Significance: These results imply that the wild-type p53-dependent induction of cytoprotective autophagy is one of the cellular responses that determines the cellular sensitivity to the DNA-damaging drug topotecan. Therefore, our study provides a potential therapeutic strategy that utilises a combination of DNA-damaging agents and autophagy inhibitors for the treatment of colon cancer with wild-type p53.	[Li, Dan-Dan; Sun, Ting; Wu, Xiao-Qi; Chen, Shu-Peng; Deng, Rong; Jiang, Shan; Feng, Gong-Kan; Zhang, Xiao-Shi; Zeng, Yi-Xin; Zhu, Xiao-Feng] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Jing-Xuan] Sun Yat Sen Univ, Dept Pathophysiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, DD (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn			National Natural Science Foundation of China [30873085, 30972882, 81101670]; Major Science and Technology Project of the National Basic Research Program (973 Program) of China [2011CB504300]; Natural Science Foundation of Guangdong in China [S2011020002759]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project of the National Basic Research Program (973 Program) of China(National Basic Research Program of China); Natural Science Foundation of Guangdong in China	This work was supported by grants from the National Natural Science Foundation of China (30873085, 30972882, 81101670) (http://www.nsfc.gov.cn/Portal0/default106.htm), the Major Science and Technology Project of the National Basic Research Program (973 Program) of China (2011CB504300) and the Natural Science Foundation of Guangdong in China (S2011020002759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; D'Amelio M, 2009, CELL CYCLE, V8, P1467; Facompre M, 2002, MOL PHARMACOL, V62, P1215, DOI 10.1124/mol.62.5.1215; Florey O, 2011, NAT CELL BIOL; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grander D, 2010, FUTURE MED CHEM, V2, P285, DOI [10.4155/fmc.09.155, 10.4155/FMC.09.155]; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kim HS, 2008, J BIOL CHEM, V283, P3731, DOI 10.1074/jbc.M704432200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012176; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu B, 2010, ACTA PHARMACOL SIN, V31, P1154, DOI 10.1038/aps.2010.118; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mujumdar N, 2010, AUTOPHAGY, V6, P997, DOI 10.4161/auto.6.7.13334; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sanchez AM, 2011, J CELL BIOCH; Scherz-Shouval R, P NATL ACAD SCI US, V107, P18511; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Szigeti A, 2010, J BIOL CHEM, V285, P2140, DOI 10.1074/jbc.M109.015222; Tang Y, 2012, MOL PHARM; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; White EJ, 2011, AM J CANCER RES, V1, P362; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou WJ, 2009, MOL CANCER THER, V8, P3203, DOI 10.1158/1535-7163.MCT-09-0244	50	52	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45058	10.1371/journal.pone.0045058	http://dx.doi.org/10.1371/journal.pone.0045058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024792	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100050
J	Moore, SM; Monaghan, A; Griffith, KS; Apangu, T; Mead, PS; Eisen, RJ				Moore, Sean M.; Monaghan, Andrew; Griffith, Kevin S.; Apangu, Titus; Mead, Paul S.; Eisen, Rebecca J.			Improvement of Disease Prediction and Modeling through the Use of Meteorological Ensembles: Human Plague in Uganda	PLOS ONE			English	Article							WEST NILE REGION; GLOBAL PRECIPITATION; USAMBARA MOUNTAINS; CLIMATE-CHANGE; RAINFALL; PATTERNS; OUTBREAKS; DYNAMICS; RODENTS; EPIDEMIOLOGY	Climate and weather influence the occurrence, distribution, and incidence of infectious diseases, particularly those caused by vector-borne or zoonotic pathogens. Thus, models based on meteorological data have helped predict when and where human cases are most likely to occur. Such knowledge aids in targeting limited prevention and control resources and may ultimately reduce the burden of diseases. Paradoxically, localities where such models could yield the greatest benefits, such as tropical regions where morbidity and mortality caused by vector-borne diseases is greatest, often lack high-quality in situ local meteorological data. Satellite- and model-based gridded climate datasets can be used to approximate local meteorological conditions in data-sparse regions, however their accuracy varies. Here we investigate how the selection of a particular dataset can influence the outcomes of disease forecasting models. Our model system focuses on plague (Yersinia pestis infection) in the West Nile region of Uganda. The majority of recent human cases have been reported from East Africa and Madagascar, where meteorological observations are sparse and topography yields complex weather patterns. Using an ensemble of meteorological datasets and model-averaging techniques we find that the number of suspected cases in the West Nile region was negatively associated with dry season rainfall (December-February) and positively with rainfall prior to the plague season. We demonstrate that ensembles of available meteorological datasets can be used to quantify climatic uncertainty and minimize its impacts on infectious disease models. These methods are particularly valuable in regions with sparse observational networks and high morbidity and mortality from vector-borne diseases.	[Moore, Sean M.; Monaghan, Andrew] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Moore, Sean M.; Griffith, Kevin S.; Mead, Paul S.; Eisen, Rebecca J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Apangu, Titus] Uganda Virus Res Inst, Arua, Uganda	National Center Atmospheric Research (NCAR) - USA; Centers for Disease Control & Prevention - USA	Moore, SM (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	smoore@ucar.edu		Monaghan, Andrew/0000-0002-8170-2359	Centers for Disease Control and Prevention; United States Agency for International Development through an Interagency Agreement; National Science Foundation; National Center for Atmospheric Research (NCAR); U.S. National Science Foundation; Div Atmospheric & Geospace Sciences [0964768] Funding Source: National Science Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development through an Interagency Agreement(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF)); National Center for Atmospheric Research (NCAR)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); U.S. National Science Foundation(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the Centers for Disease Control and Prevention (www.cdc.gov) and the United States Agency for International Development (www.usaid.gov) through an Interagency Agreement with the National Science Foundation (www.nsf.gov). National Center for Atmospheric Research (NCAR) is funded by the U.S. National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatre G, 2009, AM J TROP MED HYG, V81, P718, DOI 10.4269/ajtmh.2009.09-0104; [Anonymous], 1999, WALKERS MAMMALS WORL; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Asadullah A, 2008, HYDROLOG SCI J, V53, P1137, DOI 10.1623/hysj.53.6.1137; Ben Ari T, 2008, BIOL LETTERS, V4, P737, DOI 10.1098/rsbl.2008.0363; Brown HE, 2010, AM J TROP MED HYG, V82, P95, DOI 10.4269/ajtmh.2010.09-0247; CAVANAUGH D C, 1972, Journal of Wildlife Diseases, V8, P85; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; CROOK LD, 1992, ARCH INTERN MED, V152, P1253, DOI 10.1001/archinte.152.6.1253; Davis D. H. S., 1953, Bulletin of the World Health Organization, V9, P665; DAVIS DHS, 1968, T ROY SOC TROP MED H, V62, P838, DOI 10.1016/0035-9203(68)90013-8; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dennis D. T., 2003, INFECT DIS, V2, P1641; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255; Gratz N., 1999, PLAGUE MANUAL EPIDEM, V6, P63; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; HEISCH RB, 1953, T ROY SOC TROP MED H, V47, P503, DOI 10.1016/S0035-9203(53)80004-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Hughes DA, 2006, J HYDROL, V327, P399, DOI 10.1016/j.jhydrol.2005.11.041; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; KILONZO BS, 1992, ACTA TROP, V50, P323, DOI 10.1016/0001-706X(92)90067-8; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Love TB, 2004, 20 YEAR DAILY AFRICA; MacMillan K, 2012, AM J TROP MED HYG, V86, P514, DOI 10.4269/ajtmh.2012.11-0569; MacMillan K, 2011, AM J TROP MED HYG, V84, P435, DOI 10.4269/ajtmh.2011.10-0571; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; Monaghan AJ, 2012, J APPL METEOROL CLIM, V51, P1201, DOI 10.1175/JAMC-D-11-0195.1; Msangi A.S., 1975, University Sci J Dar-es-Salaam, V1, P8; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Neerinckx S, 2010, T ROY SOC TROP MED H, V104, P97, DOI 10.1016/j.trstmh.2009.07.028; Nicholson SE, 1997, INT J CLIMATOL, V17, P345, DOI 10.1002/(SICI)1097-0088(19970330)17:4<345::AID-JOC127>3.0.CO;2-3; NJUNWA KJ, 1989, MED VET ENTOMOL, V3, P17, DOI 10.1111/j.1365-2915.1989.tb00469.x; OLSON WP, 1969, AM J TROP MED HYG, V18, P621, DOI 10.4269/ajtmh.1969.18.621; Orochi-Orach, 2002, PLAGUE OUTBREAKS GEN; Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pham HV, 2009, INT J EPIDEMIOL, V38, P1634, DOI 10.1093/ije/dyp244; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sachs J.D., 2001, TROPICAL UNDERDEVELO; Salkeld DJ, 2010, P NATL ACAD SCI USA, V107, P14247, DOI 10.1073/pnas.1002826107; Samia NI, 2011, P NATL ACAD SCI USA, V108, P14527, DOI 10.1073/pnas.1015946108; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stapp P, 2004, FRONT ECOL ENVIRON, V2, P235, DOI 10.2307/3868263; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; VELIMIROVIC B, 1969, Z TROPENMED PARASIT, V20, P373; WHO (World Health Organization), 2005, WKLY EPIDEMIOL REC, V80, P433; Winters AM, 2009, AM J TROP MED HYG, V80, P1014, DOI 10.4269/ajtmh.2009.80.1014; World Health Organization, 2010, Weekly Epidemiological Record, V85, P37; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108	75	37	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44431	10.1371/journal.pone.0044431	http://dx.doi.org/10.1371/journal.pone.0044431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024750	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100008
J	Waller, BM; Peirce, K; Mitchell, H; Micheletta, J				Waller, Bridget M.; Peirce, Kate; Mitchell, Heidi; Micheletta, Jerome			Evidence of Public Engagement with Science: Visitor Learning at a Zoo-Housed Primate Research Centre	PLOS ONE			English	Article							BEHAVIOR	Primate behavioural and cognitive research is increasingly conducted on direct public view in zoo settings. The potential of such facilities for public engagement with science is often heralded, but evidence of tangible, positive effects on public understanding is rare. Here, the effect of a new zoo-based primate research centre on visitor behaviour, learning and attitudes was assessed using a quasi-experimental design. Zoo visitors approached the primate research centre more often when a scientist was present and working with the primates, and reported greater awareness of primates (including conservation) compared to when the scientist was not present. Visitors also reported greater perceived learning when the scientist was present. Installation of information signage had no main effect on visitor attitudes or learning. Visitors who interacted with the signage, however, demonstrated increased knowledge and understanding when asked about the specific information present on the signs (which was related to the ongoing facial expression research at the research centre). The findings show that primate behaviour research centres on public view can have a demonstrable and beneficial effect on public understanding of science.	[Waller, Bridget M.; Peirce, Kate; Micheletta, Jerome] Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England; [Waller, Bridget M.; Mitchell, Heidi; Micheletta, Jerome] Marwell Wildlife, Winchester, Hants, England	University of Portsmouth	Waller, BM (corresponding author), Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England.	bridget.waller@port.ac.uk	Micheletta, Jérôme/E-4699-2014	Micheletta, Jérôme/0000-0002-4480-6781; Waller, Bridget/0000-0001-6303-7458				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson US, 2003, ENVIRON BEHAV, V35, P826, DOI 10.1177/0013916503254746; Borun M., 1996, CURATOR, V39, P123, DOI [DOI 10.1111/J.2151-6952.1996.TB01084.X, 10.1111/j.2151-6952.1996.tb01084.x]; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; HADIDIAN J, 1980, BEHAVIOUR, V75, P133, DOI 10.1163/156853980X00375; Hasserd J, 2002, ACCELERATING ACHIEVE; HEINRICH CJ, 1992, ANTHROZOOS, V5, P113, DOI 10.2752/089279392787011557; Micheletta J, 2012, ANIM BEHAV, V83, P459, DOI 10.1016/j.anbehav.2011.11.018; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2005, VISITOR STUDIES TODA, V8, P4; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Ross SR, 2009, ZOO BIOL, V28, P462, DOI 10.1002/zoo.20220; Visscher NC, 2009, ZOO BIOL, V28, P488, DOI 10.1002/zoo.20174; Waller BM, EMOTION REV IN PRESS	15	16	17	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44680	10.1371/journal.pone.0044680	http://dx.doi.org/10.1371/journal.pone.0044680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028580	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000308788700029
J	Louie, E; Chen, XF; Coomes, A; Ji, K; Tsirka, S; Chen, E				Louie, E.; Chen, X. F.; Coomes, A.; Ji, K.; Tsirka, S.; Chen, El			Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis	ONCOGENE			English	Article						breast cancer; brain metastasis; neurotrophin-3; protein signature; HER2 positive; HER2 signaling	CENTRAL-NERVOUS-SYSTEM; OF-THE-LITERATURE; CARCINOMA-CELLS; E-CADHERIN; FACTOR RECEPTOR-2; EXPRESSION; MODEL; TRANSITION; LUNG; OVEREXPRESSION	Metastasis, which remains incompletely characterized at the molecular and biochemical levels, is a highly specific process. Despite the ability of disseminated cancer cells to intravasate into distant tissues, it has been long recognized that only a limited subset of target organs develop clinically overt metastases. Therefore, subsequent adaptation of disseminated cancer cells to foreign tissue microenvironment determines the metastatic latency and tissue tropism of these cells. As a result, studying interactions between the disseminated cancer cells and the adjacent stromal cells will provide a better understanding of what constitutes a favorable or unfavorable microenvironment for disseminated cancer cells in a tissue-specific manner. Previously, we reported a protein signature of brain metastasis showing increased ability of brain metastatic breast cancer cells to counteract oxidative stress. In this study, we showed that another protein from the brain metastatic protein signature, neurotrophin-3 (NT-3), has a dual function of regulating the metastatic growth of metastatic breast cancer cells and reducing the activation of immune response in the brain. More importantly, increased NT-3 secretion in metastatic breast cancer cells results in a reversion of mesenchymal-like (EMT) state to epithelial-like (MET) state and vice versa. Ectopic expression of NT-3 in EMT-like breast cancer cells reduces their migratory ability and increases the expression of HER2 (human epidermal growth factor receptor 2) and E-cadherin at the cell-cell junction. In addition, both endogenous and ectopic expression of NT-3 reduced the number of fully activated cytotoxic microglia. In summary, NT-3 appears to promote growth of metastatic breast cancer cells in the brain by facilitating the re-epithelialization of metastatic breast cancer cells and downmodulating the cytotoxic response of microglia. Most importantly, our results provide new insights into the latency and development of central nervous system macrometastases in patients with HER2-positive breast tumors and provide mechanistic rationale to target HER2 signaling for HER2-positive breast cancer brain metastasis.	[Louie, E.; Chen, X. F.; Coomes, A.; Ji, K.; Tsirka, S.; Chen, El] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Louie, E (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST 8-125, Stony Brook, NY 11794 USA.	emily@pharm.stonybrook.edu	Tsirka, Stella/AAD-4018-2019		Susan Komen Foundation; Mary Anita Conroy Memorial Breast Cancer Fund from the Manhasset Women's Coalition Against Breast Cancer;  [R01NS42168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Mary Anita Conroy Memorial Breast Cancer Fund from the Manhasset Women's Coalition Against Breast Cancer; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to EIC from the Susan Komen Foundation and the Mary Anita Conroy Memorial Breast Cancer Fund from the Manhasset Women's Coalition Against Breast Cancer. S Tsirka and K Ji were supported by R01NS42168.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chaffer CL, 2005, CLIN EXP METASTAS, V22, P115, DOI 10.1007/s10585-005-5141-3; Chang EL, 2003, ONCOLOGIST, V8, P398, DOI 10.1634/theoncologist.8-5-398; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Choi YH, 2009, ANN ONCOL, V20, P1337, DOI 10.1093/annonc/mdp003; Descamps S, 2001, CANCER RES, V61, P4337; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; He BP, 2006, MOL MED, V12, P161, DOI 10.2119/2006-00033.He; Hondermarck H, 2008, AM J PATHOL, V172, P865, DOI 10.2353/ajpath.2008.080008; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jung S, 2002, J CANCER RES CLIN, V128, P469, DOI 10.1007/s00432-002-0366-x; Kim JW, 2004, CANCER LETT, V213, P203, DOI 10.1016/j.canlet.2004.03.042; Kirsch David G, 2005, Clin Breast Cancer, V6, P115, DOI 10.3816/CBC.2005.n.013; Klos KJ, 2004, NEUROLOGIST, V10, P31, DOI 10.1097/01.nrl.0000106922.83090.71; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kwon HC, ONKOLOGIE, V33, P146; Lin NU, 2008, J CLIN ONCOL, V26, P1993, DOI 10.1200/JCO.2007.12.3588; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; MacDonald IC, 2002, BIOESSAYS, V24, P885, DOI 10.1002/bies.10156; Matsumura H, 2000, BIOCHEM BIOPH RES CO, V269, P513, DOI 10.1006/bbrc.2000.2332; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Menon MB, 2009, CELL MOTIL CYTOSKEL, V66, P1041, DOI 10.1002/cm.20418; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; Ohno Shinji, 2004, Breast Cancer, V11, P27, DOI 10.1007/BF02967997; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Oltean S, 2006, P NATL ACAD SCI USA, V103, P14116, DOI 10.1073/pnas.0603090103; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Piccirilli M, 2007, TUMORI, V93, P150; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Puduvalli V K, 2001, Curr Oncol Rep, V3, P467, DOI 10.1007/s11912-001-0067-7; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; Tomasevic Z, 2009, J BUON, V14, P225; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Tzeng SF, 2005, J NEUROSCI RES, V81, P666, DOI 10.1002/jnr.20586; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Vincan E, 2005, DIFFERENTIATION, V73, P142, DOI 10.1111/j.1432-0436.2005.00015.x; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Welch DR, 2000, BREAST CANCER RES, V2, P408, DOI 10.1186/bcr87; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yonemori K, 2010, CANCER-AM CANCER SOC, V116, P302, DOI 10.1002/cncr.24735	54	70	70	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 29	2013	32	35					4064	4077		10.1038/onc.2012.417	http://dx.doi.org/10.1038/onc.2012.417			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23001042	Green Accepted			2022-12-25	WOS:000323748500002
J	Huin-Schohn, C; Gueguinou, N; Schenten, V; Bascove, M; Koch, GG; Baatout, S; Tschirhart, E; Frippiat, JP				Huin-Schohn, Cecile; Gueguinou, Nathan; Schenten, Veronique; Bascove, Matthieu; Koch, Guillemette Gauquelin; Baatout, Sarah; Tschirhart, Eric; Frippiat, Jean-Pol			Gravity changes during animal development affect IgM heavy-chain transcription and probably lymphopoiesis	FASEB JOURNAL			English	Article						humoral immune system; antibody; B lymphocyte	NF-KAPPA-B; GENE-EXPRESSION; SHOCK PROTEINS; SPACEFLIGHT; MICROGRAVITY; PATHWAYS; STRESS	Our previous research demonstrated that spaceflight conditions affect antibody production in response to an antigenic stimulation in adult amphibians. Here, we investigated whether antibody synthesis is affected when animal development occurs onboard a space station. To answer this question, embryos of the Iberian ribbed newt, Pleurodeles waltl, were sent to the International Space Station (ISS) before the initiation of immunoglobulin heavy-chain expression. Thus, antibody synthesis began in space. On landing, we determined the effects of spaceflight on P. waltl development and IgM heavy-chain transcription. Results were compared with those obtained using embryos that developed on Earth. We find that IgM heavy-chain transcription is doubled at landing and that spaceflight does not affect P. waltl development and does not induce inflammation. We also recreated the environmental modifications encountered by the embryos during their development onboard the ISS. This strategy allowed us to demonstrate that gravity change is the factor responsible for antibody heavy-chain transcription modifications that are associated with NF-kappa B mRNA level variations. Taken together, and given that the larvae were not immunized, these data suggest a modification of lymphopoiesis when gravity changes occur during ontogeny.-Huin-Schohn, C., Gueguinou, N., Schenten, V., Bascove, M., Koch, G. G., Baatout, S., Tschirhart, E., Frippiat, J.-P. Gravity changes during animal development affect IgM heavy-chain transcription and probably lymphopoiesis. FASEB J. 27, 333-341 (2013). www.fasebj.org	[Frippiat, Jean-Pol] Lorraine Univ, Fac Med Dev & Immunogenet, Dept Dev & Immunogenet, F-54500 Vandoeuvre Les Nancy, France; [Huin-Schohn, Cecile; Gueguinou, Nathan; Tschirhart, Eric] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Koch, Guillemette Gauquelin] French Natl Space Agcy CNES, Paris, France; [Baatout, Sarah] Belgian Nucl Res Ctr SCK CEN, Mol, Belgium; [Baatout, Sarah] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium	Universite de Lorraine; University of Luxembourg; Belgian Nuclear Research Centre (SCK-CEN); Ghent University	Frippiat, JP (corresponding author), Lorraine Univ, Fac Med Dev & Immunogenet, Dept Dev & Immunogenet, JE 2537,9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr		Baatout, Sarah/0000-0001-8110-751X; Frippiat, Jean-Pol/0000-0002-4027-6269	CNES; French Ministry of Higher Education and Research; Lorraine area, Lorraine University; ESA/Belspo/PRODEX program; Fonds National de la Recherche of Luxembourg; University of Rochester, Rochester, NY, USA; SCK . CEN; European Space Agency (ESA)	CNES(Centre National D'etudes Spatiales); French Ministry of Higher Education and Research; Lorraine area, Lorraine University; ESA/Belspo/PRODEX program; Fonds National de la Recherche of Luxembourg(Luxembourg National Research Fund); University of Rochester, Rochester, NY, USA; SCK . CEN; European Space Agency (ESA)(European Space Agency)	The authors thank D. Chaput (CNES) for his support during the space mission, J. Robert (University of Rochester, Rochester, NY, USA), for providing the 10A9 hydridoma, M. Beck and F. Mastroleo (SCK . CEN) for their support during the irradiations and RPM experiments, the European Space Agency (ESA) for the spaceflight opportunity, the CNES, the French Ministry of Higher Education and Research, the Lorraine area, Lorraine University, and the ESA/Belspo/PRODEX program for their financial support. C.H.-S. and N.G. were supported by postdoctoral and Ph.D. fellowships from the Fonds National de la Recherche of Luxembourg, V.S. by a CNES postdoctoral fellowship, and M.B. by a Ph.D. fellowship of the French Ministry of Higher Education and Research.	Aimar C, 2000, BIOL REPROD, V63, P551, DOI 10.1095/biolreprod63.2.551; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boudarra N, 2002, DEV COMP IMMUNOL, V26, P659, DOI 10.1016/S0145-305X(02)00014-9; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Cernysiov V, 2010, INT IMMUNOL, V22, P25, DOI 10.1093/intimm/dxp109; Chouker A, 2002, J APPL PHYSIOL, V92, P1619, DOI 10.1152/japplphysiol.00732.2001; Committee on the Planetary Science Decadal Survey, 2011, VIS VOYAG PLAN SCI D; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Courtade M, 2001, INT J RADIAT BIOL, V77, P587, DOI 10.1080/09553000110034621; Cui MA, 2010, FISH SHELLFISH IMMUN, V29, P1060, DOI 10.1016/j.fsi.2010.08.018; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dominguez M, 2004, AQUACULTURE, V241, P491, DOI 10.1016/j.aquaculture.2004.06.027; Dournon C, 2003, ADV SPACE B, V9, P101, DOI 10.1016/S1569-2574(03)09005-1; Frippiat C, 2001, IMMUNOGENETICS, V52, P264; Gabriel Martin, 2012, J Exp Zool A Ecol Genet Physiol, V317, P333, DOI 10.1002/jez.1727; GALLIEN L., 1957, BULL BIOL FRANCE ET BELGIQUE, V91, P97; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gualandris-Parisot Lydie, 2002, Biol Sci Space, V16, P3, DOI 10.2187/bss.16.3; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Ishihara A, 2008, J PHYSIOL SCI, V58, P413, DOI 10.2170/physiolsci.RP000808; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Kumei Yasuhiro, 2002, J Gravit Physiol, V9, pP263; Mussmann R, 1998, EUR J IMMUNOL, V28, P2947, DOI 10.1002/(SICI)1521-4141(199809)28:09<2947::AID-IMMU2947>3.0.CO;2-A; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Patterson JS, 2007, EVOL DEV, V9, P525, DOI 10.1111/j.1525-142X.2007.00193.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Rupik W, 2011, COMP BIOCHEM PHYS A, V159, P349, DOI 10.1016/j.cbpa.2011.04.002; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rykova MP, 2008, ACTA ASTRONAUT, V63, P697, DOI 10.1016/j.actaastro.2008.03.016; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Shimada N, 2006, DEV DYNAM, V235, P2686, DOI 10.1002/dvdy.20901; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanhavere F, 2001, RADIAT PROT DOSIM, V96, P105, DOI 10.1093/oxfordjournals.rpd.a006563; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106	46	29	30	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					333	341		10.1096/fj.12-217547	http://dx.doi.org/10.1096/fj.12-217547			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22993194				2022-12-25	WOS:000313103200031
J	Uehara, H; Cho, Y; Simonis, J; Cahoon, J; Archer, B; Luo, L; Das, SK; Singh, N; Ambati, J; Ambati, BK				Uehara, Hironori; Cho, YangKyung; Simonis, Jackie; Cahoon, Judd; Archer, Bonnie; Luo, Ling; Das, Subrata K.; Singh, Nirbhai; Ambati, Jayakrishna; Ambati, Balamurali K.			Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR)	FASEB JOURNAL			English	Article						alternative polyadenylation; corneal graft rejection	MESSENGER-RNA POLYADENYLATION; EXTRACELLULAR-MATRIX; ANGIOGENESIS; MECHANISMS; MOUSE; VEGF; MICE; TRANSPLANTATION; METASTASIS; SEQUENCE	The KDR gene, which participates in angiogenesis and lymphangiogenesis, produces two functionally distinct protein products, membrane-bound KDR (mbKDR) and its isoform, soluble KDR (sKDR). Since sKDR does not have a tyrosine kinase domain and does not dimerize, it is principally an antagonist of lymphangiogenesis by sequestering VEGF-C. Alternative polyadenylation of exon 30 or intron 13 leads to the production of mbKDR or sKDR, respectively, yet the regulatory mechanisms are unknown. Here we show that an antisense morpholino oligomer directed against the exon 13-intron 13 junction increases sKDR (suppressing lymphangiogenesis) and decreases mbKDR (inhibiting hemangiogenesis). The latent polyadenylation site in intron 13 of KDR is activated by blocking the upstream 5' splicing site with an antisense morpholino oligomer. Intravitreal morpholino injection suppressed laser choroidal neovascularization while increasing sKDR. In the mouse cornea, subconjunctival injection of the morpholino-inhibited corneal angiogenesis and lymphangiogenesis, and suppressed graft rejection after transplantation. Thus, this morpholino can be used for concurrent suppression of hemangiogenesis and lymphangiogenesis. This study offers new insight into the mechanisms and potential therapeutic modulation of alternative polyadenylation.-Uehara, H., Cho, YK., Simonis, J., Cahoon, J., Archer, B., Luo, L., Das, S. K., Singh, N., Ambati, J., Ambati, B. K. Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J. 27, 76-85 (2013). www.fasebj.org	[Uehara, Hironori; Cho, YangKyung; Simonis, Jackie; Cahoon, Judd; Archer, Bonnie; Luo, Ling; Das, Subrata K.; Singh, Nirbhai; Ambati, Balamurali K.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Cho, YangKyung] Catholic Univ Korea, St Vincent Hosp, Suwon, South Korea; [Ambati, Jayakrishna] Univ Kentucky, Coll Med, Dept Ophthalmol & Visual Sci, Lexington, KY USA	Utah System of Higher Education; University of Utah; Catholic University of Korea; University of Kentucky	Ambati, BK (corresponding author), Univ Utah, Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	bala.ambati@utah.edu		DAS, SUBRATA/0000-0001-8608-3270	Research to Prevent Blindness Physician Scientist Award; U.S. Department of Veterans Affairs Merit Award; U.S. National Eye Institute [R01EY017950]; NATIONAL EYE INSTITUTE [P30EY014800, R01EY020672, R01EY017950, R01EY022238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER	Research to Prevent Blindness Physician Scientist Award(Research to Prevent Blindness (RPB)); U.S. Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Research to Prevent Blindness Physician Scientist Award, a U.S. Department of Veterans Affairs Merit Award, and U.S. National Eye Institute grant R01EY017950.	Abad X, 2008, NUCLEIC ACIDS RES, V36, P2338, DOI 10.1093/nar/gkn068; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Fukumura K, 2009, RNA BIOL, V6, P395, DOI 10.4161/rna.6.4.9318; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hayashi T, 2008, CORNEA, V27, P699, DOI 10.1097/QAI.0b013e31815e722b; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Jain K, 2010, INT J PHARMACEUT, V394, P122, DOI 10.1016/j.ijpharm.2010.04.027; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Uehara H, 2010, VISION RES, V50, P674, DOI 10.1016/j.visres.2009.12.003; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	35	22	23	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2013	27	1					76	85		10.1096/fj.12-213835	http://dx.doi.org/10.1096/fj.12-213835			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22997228	Green Published, Bronze			2022-12-25	WOS:000313103200009
J	Luck, M; Mathes, T; Bruun, S; Fudim, R; Hagedorn, R; Tra, MTN; Kateriya, S; Kennis, JTM; Hildebrandt, P; Hegemann, P				Luck, Meike; Mathes, Tilo; Bruun, Sara; Fudim, Roman; Hagedorn, Rolf; Tra My Tran Nguyen; Kateriya, Suneel; Kennis, John T. M.; Hildebrandt, Peter; Hegemann, Peter			A Photochromic Histidine Kinase Rhodopsin (HKR1) That Is Bimodally Switched by Ultraviolet and Blue Light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; SENSORY RHODOPSIN; CHLAMYDOMONAS-REINHARDTII; VISUAL PIGMENTS; SCHIFF-BASE; CHROMOPHORE STRUCTURE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CHANNELRHODOPSIN-2	Rhodopsins are light-activated chromoproteins that mediate signaling processes via transducer proteins or promote active or passive ion transport as ion pumps or directly light-activated channels. Here, we provide spectroscopic characterization of a rhodopsin from the Chlamydomonas eyespot. It belongs to a recently discovered but so far uncharacterized family of histidine kinase rhodopsins (HKRs). These are modular proteins consisting of rhodopsin, a histidine kinase, a response regulator, and in some cases an effector domain such as an adenylyl or guanylyl cyclase, all encoded in a single protein as a two-component system. The recombinant rhodopsin fragment, Rh, of HKR1 is a UVA receptor (lambda(max) = 380 nm) that is photoconverted by UV light into a stable blue light-absorbing meta state Rh-Bl (lambda(max) = 490 nm). Rh-Bl is converted back to Rh-UV by blue light. Raman spectroscopy revealed that the Rh-UV chromophore is in an unusual 13-cis, 15-anti configuration, which explains why the chromophore is deprotonated. The excited state lifetime of Rh-UV is exceptionally stable, probably caused by a relatively unpolar retinal binding pocket, converting into the photoproduct within about 100 ps, whereas the blue form reacts 100 times faster. We propose that the photochromic HKR1 plays a role in the adaptation of behavioral responses in the presence of UVA light.	[Luck, Meike; Mathes, Tilo; Bruun, Sara; Fudim, Roman; Hagedorn, Rolf; Tra My Tran Nguyen; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Mathes, Tilo; Kennis, John T. M.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, NL-1081 HV Amsterdam, Netherlands; [Bruun, Sara; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Kateriya, Suneel] Univ Delhi, Dept Biochem, New Delhi 110021, India	Humboldt University of Berlin; Vrije Universiteit Amsterdam; Technical University of Berlin; University of Delhi	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol, D-10115 Berlin, Germany.	hegemann@rz.hu-berlin.de	Hildebrandt, Peter/J-5658-2014; Mathes, Tilo/C-5715-2011	Hildebrandt, Peter/0000-0003-1030-5900; Mathes, Tilo/0000-0002-9694-748X; Kateriya, Suneel/0000-0001-5428-4297	Deutsche Forschungsgemeinschaft [FOR1261, HE3824/19-1]; Cluster of Excellence Grant UniCat/BIG-NSE; LaserLab Europe access program [LCVU001753]; Chemical Sciences Council of The Netherlands Organization for Scientific Research through ECHO grant; NWO-DFG Bilateral program; Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Grant UniCat/BIG-NSE; LaserLab Europe access program; Chemical Sciences Council of The Netherlands Organization for Scientific Research through ECHO grant; NWO-DFG Bilateral program; Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR1261 (to P. Hegemann), HE3824/19-1 (to S. B. and P. Hildebrandt), and Cluster of Excellence Grant UniCat/BIG-NSE.; Supported by the LaserLab Europe access program LCVU001753.; Supported by the Chemical Sciences Council of The Netherlands Organization for Scientific Research through an ECHO grant (to J. T. M. K.). Supported by NWO-DFG Bilateral program.; Supported by a Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant. Supported by NWO-DFG Bilateral program.	Bachilo SM, 1999, J PHYS CHEM A, V103, P2481, DOI 10.1021/jp983646a; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Curry B., 1985, ADV INFRARED RAMAN S, V12, P115; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P7988, DOI 10.1021/bi050219w; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gerscher S, 1997, BIOCHEMISTRY-US, V36, P11012, DOI 10.1021/bi970722b; Imai H, 1999, PHOTOCHEM PHOTOBIOL, V70, P111, DOI 10.1111/j.1751-1097.1999.tb01956.x; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; KLEINSCHMIDT J, 1992, P NATL ACAD SCI USA, V89, P9181, DOI 10.1073/pnas.89.19.9181; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kusnetzow AK, 2004, P NATL ACAD SCI USA, V101, P941, DOI 10.1073/pnas.0305206101; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Lutz I, 2001, P NATL ACAD SCI USA, V98, P962, DOI 10.1073/pnas.021560298; Ly HK, 2011, J ELECTROANAL CHEM, V660, P367, DOI 10.1016/j.jelechem.2010.12.020; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Naumann H, 2006, J RAMAN SPECTROSC, V37, P436, DOI 10.1002/jrs.1459; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; SAITO T, 1993, J CELL BIOL, V122, P137, DOI 10.1083/jcb.122.1.137; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Troein C, 2011, PLANT J, V66, P375, DOI 10.1111/j.1365-313X.2011.04489.x; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	39	88	88	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.401604	http://dx.doi.org/10.1074/jbc.M112.401604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027869	Green Published, hybrid			2022-12-25	WOS:000311233800075
J	Bond, LM; Arden, SD; Kendrick-Jones, J; Buss, F; Sellers, JR				Bond, Lisa M.; Arden, Susan D.; Kendrick-Jones, John; Buss, Folma; Sellers, James R.			Dynamic Exchange of Myosin VI on Endocytic Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SNELLS-WALTZER MICE; LARGE STEP-SIZE; CELLULAR FUNCTIONS; ACTIN-FILAMENTS; MOTOR; DEAFNESS; BINDING; DOMAIN; MYO6	The actin-based molecular motor myosin VI functions in the endocytic uptake pathway, both during the early stages of clathrin-mediated uptake and in later transport to/from early endosomes. This study uses fluorescence recovery after photobleaching (FRAP) to examine the turnover rate of myosin VI during endocytosis. The results demonstrate that myosin VI turns over dynamically on endocytic structures with a characteristic half-life common to both the large insert isoform of myosin VI on clathrin-coated structures and the no-insert isoform on early endosomes. This half-life is shared by the myosin VI-binding partner Dab2 and is identical for full-length myosin VI and the cargo-binding tail region. The 4-fold slower half-life of an artificially dimerized construct of myosin VI on clathrin-coated structures suggests that wild type myosin VI does not function as a stable dimer, but either as a monomer or in a monomer/dimer equilibrium. Taken together, these FRAP results offer insight into both the basic turnover dynamics and the monomer/dimer nature of myosin VI.	[Bond, Lisa M.; Arden, Susan D.; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Bond, Lisa M.; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Kendrick-Jones, John] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MRC Laboratory Molecular Biology	Buss, F (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	fb1@mole.bio.cam.ac.uk; sellersj@nhlbi.nih.gov		Buss, Folma/0000-0003-4457-3479	NHLBI, National Institutes of Health, Intramural Program; Wellcome Trust; Winston Churchill Foundation of the United States; National Institutes of Health-Oxford-Cambridge Ph.D. studentship; Medical Research Council; Medical Research Council [MC_U105184323] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, ZICHL006019] Funding Source: NIH RePORTER; MRC [MC_U105184323] Funding Source: UKRI	NHLBI, National Institutes of Health, Intramural Program; Wellcome Trust(Wellcome Trust); Winston Churchill Foundation of the United States; National Institutes of Health-Oxford-Cambridge Ph.D. studentship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by the NHLBI, National Institutes of Health, Intramural Program (to J. R. S.). This work was also supported by the Wellcome Trust (to F. B.), a scholarship from the Winston Churchill Foundation of the United States (to L. M. B.), a National Institutes of Health-Oxford-Cambridge Ph.D. studentship (to L. M. B.), and the Medical Research Council (to J. K-J.). The Cambridge Institute for Medical Research received a strategic award from the Wellcome Trust.	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Biemesderfer D, 2002, AM J PHYSIOL-RENAL, V282, pF785, DOI 10.1152/ajprenal.00287.2001; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Chibalina MV, 2010, TRAFFIC, V11, P1290, DOI 10.1111/j.1600-0854.2010.01101.x; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Knudsen B, 2006, AM J PATHOL, V169, P1523, DOI 10.2353/ajpath.2006.060712; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mohiddin SA, 2004, J MED GENET, V41, P309, DOI 10.1136/jmg.2003.011973; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	48	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38637	38646		10.1074/jbc.M112.373969	http://dx.doi.org/10.1074/jbc.M112.373969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992744	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000310982800023
J	Devaiah, BN; Singer, DS				Devaiah, Ballachanda N.; Singer, Dinah S.			Cross-talk Among RNA Polymerase II Kinases Modulates C-terminal Domain Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; ELONGATION-FACTOR-B; P-TEFB; CTD KINASE; TRANSCRIPTION; CHROMATIN; TAF7; COMPONENT; RELEASE; TFIIH	The RNA polymerase II (Pol II) C-terminal domain (CTD) serves as a docking site for numerous proteins, bridging various nuclear processes to transcription. The recruitment of these proteins is mediated by CTD phospho-epitopes generated during transcription. The mechanisms regulating the kinases that establish these phosphorylation patterns on the CTD are not known. We report that three CTD kinases, CDK7, CDK9, and BRD4, engage in cross-talk, modulating their subsequent CTD phosphorylation. BRD4 phosphorylates PTEFb/CDK9 at either Thr-29 or Thr-186, depending on its relative abundance, which represses or activates CDK9 CTD kinase activity, respectively. Conversely, CDK9 phosphorylates BRD4 enhancing its CTD kinase activity. The CTD Ser-5 kinase CDK7 also interacts with and phosphorylates BRD4, potently inhibiting BRD4 kinase activity. Additionally, the three kinases regulate each other indirectly through the general transcription factor TAF7. An inhibitor of CDK9 and CDK7 CTD kinase activities, TAF7 also binds to BRD4 and inhibits its kinase activity. Each of these kinases phosphorylates TAF7, affecting its subsequent ability to inhibit the other two. Thus, a complex regulatory network governs Pol II CTD kinases.	[Devaiah, Ballachanda N.; Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, DS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	dinah.singer@nih.gov			NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011381] Funding Source: NIH RePORTER	NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Devaiah BN, 2010, J BIOL CHEM, V285, P38772, DOI 10.1074/jbc.M110.173864; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zhou MS, 2001, J BIOL CHEM, V276, P44633, DOI 10.1074/jbc.M107466200	27	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38755	38766		10.1074/jbc.M112.412015	http://dx.doi.org/10.1074/jbc.M112.412015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027873	Green Published, hybrid			2022-12-25	WOS:000310982800033
J	Haque, I; De, A; Majumder, M; Mehta, S; McGregor, D; Banerjee, SK; Van Veldhuizen, P; Banerjee, S				Haque, Inamul; De, Archana; Majumder, Monami; Mehta, Smita; McGregor, Douglas; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha			The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; SMOOTH-MUSCLE-CELLS; CANCER CELLS; SIDE POPULATION; BREAST-CANCER; GROWTH-FACTOR; CCN PROTEINS; E-CADHERIN; PATHWAY; CYR61	CCN1 is a matricellular protein and a member of the CCN family of growth factors. CCN1 is associated with the development of various cancers including pancreatic ductal adenocarcinoma (PDAC). Our recent studies found that CCN1 plays a critical role in pancreatic carcinogenesis through the induction of EMT and stemness. CCN1 mRNA and protein were detected in the early precursor lesions, and their expression intensified with disease progression. However, biochemical activity and the molecular targets of CCN1 in pancreatic cancer cells are unknown. Here we show that CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression and poor prognosis. SHh regulation by CCN1 in pancreatic cancer cells is mediated through the active Notch-1. Notably, active Notch-1is recruited by CCN1 in these cells via the inhibition of proteasomal degradation results in stabilization of the receptor. We find that CCN1-induced activation of SHh signaling might be necessary for CCN1-dependent in vitro pancreatic cancer cell migration and tumorigenicity of the side population of pancreatic cancer cells (cancer stem cells) in a xenograft in nude mice. Moreover, the functional role of CCN1 could be mediated through the interaction with the alpha v beta 3 integrin receptor. These extensive studies propose that targeting CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1) associated with the development of the disease as well as drug resistance.	[Haque, Inamul; De, Archana; Majumder, Monami; Mehta, Smita; McGregor, Douglas; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha] Kansas City Vet Affairs Med Ctr, Canc Res Unit, Kansas City, MO 64128 USA; [Haque, Inamul; Majumder, Monami; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha] Univ Kansas, Med Ctr, Div Hematol & Oncol, Kansas City, KS 66206 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66206 USA; [McGregor, Douglas; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66206 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Banerjee, S (corresponding author), VA Med Ctr, Canc Res Unit, Div Res, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee@kumc.edu	Haque, Inamul/I-2482-2019	Haque, Inamul/0000-0002-1307-9446	Dept. of Veterans Affairs	Dept. of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit review grant from the Dept. of Veterans Affairs (to S. B. and S. K. B.).	Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Banerjee SK, 2012, J CELL COMMUN SIGNAL, V6, P63, DOI 10.1007/s12079-012-0158-2; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dimou A, 2011, J PANCREAS, V12, P1; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Feldmann G, 2009, EXPERT OPIN DRUG DIS, V4, P429, DOI 10.1517/17460440902821657; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Hidalgo M, 2009, NEW ENGL J MED, V361, P2094, DOI 10.1056/NEJMcibr0905857; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hruban RH, 2001, CANCER J, V7, P251; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kambhampati S, 2010, MOL CANCER THER, V9, P523, DOI 10.1158/1535-7163.MCT-09-0845; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Kim MY, 2012, J BIOL CHEM, V287, P4690, DOI 10.1074/jbc.M111.289637; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; McCarthy DM, 2001, HUM PATHOL, V32, P638, DOI 10.1053/hupa.2001.24991; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Morton JP, 2007, CELL CYCLE, V6, P1553, DOI 10.4161/cc.6.13.4467; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Ray G, 2005, ONCOL REP, V13, P445; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Sengupta K, 2004, MOL CANCER RES, V2, P150; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wilentz R. E., 2001, EXOCRINE PANCREAS PA; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yao J, 2011, SWISS MED WEEKLY, V31, P141; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925	55	42	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38569	38579		10.1074/jbc.M112.389064	http://dx.doi.org/10.1074/jbc.M112.389064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027863	Green Published, hybrid			2022-12-25	WOS:000310982800017
J	Langlais, P; Dillon, JL; Mengos, A; Baluch, DP; Ardebili, R; Miranda, DN; Xie, XT; Heckmann, BL; Liu, J; Mandarino, LJ				Langlais, Paul; Dillon, James L.; Mengos, April; Baluch, Debra P.; Ardebili, Ranna; Miranda, Danielle N.; Xie, Xitao; Heckmann, Bradlee L.; Liu, Jun; Mandarino, Lawrence J.			Identification of a Role for CLASP2 in Insulin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN KINASE-B; GLUT4 TRANSLOCATION; MICROTUBULE DYNAMICS; EXOCYST COMPLEX; PLASMA-MEMBRANE; CELL CORTEX; PHOSPHORYLATION; ADIPOCYTES; TRAFFICKING; TRANSPORT	Insulin stimulates the mobilization of glucose transporter 4 (GLUT4) storage vesicles to the plasma membrane, resulting in an influx of glucose into target tissues such as muscle and fat. We present evidence that CLIP-associating protein 2 (CLASP2), a protein previously unassociated with insulin action, is responsive to insulin stimulation. Using mass spectrometry-based protein identification combined with phosphoantibody immuno-precipitation in L6 myotubes, we detected a 4.8-fold increase of CLASP2 in the anti-phosphoserine immunoprecipitates upon insulin stimulation. Western blotting of CLASP2 immunoprecipitates with the phosphoantibody confirmed the finding that CLASP2 undergoes insulin-stimulated phosphorylation, and a number of novel phosphorylation sites were identified. Confocal imaging of L6 myotubes revealed that CLASP2 colocalizes with GLUT4 at the plasma membrane within areas of insulin-mediated cortical actin remodeling. CLASP2 is responsible for directing the distal end of microtubules to the cell cortex, and it has been shown that GLUT4 travels along microtubule tracks. In support of the concept that CLASP2 plays a role in the trafficking of GLUT4 at the cell periphery, CLASP2 knockdown by siRNA in L6 myotubes interfered with insulin-stimulated GLUT4 localization to the plasma membrane. Furthermore, siRNA mediated knockdown of CLASP2 in 3T3-L1 adipocytes inhibited insulin-stimulated glucose transport. We therefore propose a new model for CLASP2 in insulin action, where CLASP2 directs the delivery of GLUT4 to cell cortex landing zones important for insulin action.	[Mandarino, Lawrence J.] Arizona State Univ, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Langlais, Paul; Mengos, April; Miranda, Danielle N.; Xie, Xitao; Heckmann, Bradlee L.; Liu, Jun; Mandarino, Lawrence J.] Mayo Clin Arizona, Scottsdale, AZ 85259 USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix	Mandarino, LJ (corresponding author), Mayo Clin, Coll Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	mandarino.lawrence@mayo.edu	Baluch, Debra/AAO-1972-2021	Heckmann, Bradlee/0000-0002-3271-7183; Baluch, Debra/0000-0003-4043-5394	National Institutes of Health Grant [R01DK047936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047936, R01DK089178] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK047936 (to L. J. M.).	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Eyster CA, 2006, J BIOL CHEM, V281, P39719, DOI 10.1074/jbc.M607101200; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Khayat ZA, 2000, J CELL SCI, V113, P279; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Takabayashi T, 2010, J BIOL CHEM, V285, P16155, DOI 10.1074/jbc.M109.081901; Xu YK, 2007, BIOCHEM BIOPH RES CO, V359, P121, DOI 10.1016/j.bbrc.2007.05.075; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zhou QOL, 2010, J BIOL CHEM, V285, P27581, DOI 10.1074/jbc.M110.146886; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	33	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39245	39253		10.1074/jbc.M112.394148	http://dx.doi.org/10.1074/jbc.M112.394148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992739	Green Published, hybrid			2022-12-25	WOS:000310982800079
J	Riek, AE; Oh, J; Sprague, JE; Timpson, A; de las Fuentes, L; Bernal-Mizrachi, L; Schechtman, KB; Bernal-Mizrachi, C				Riek, Amy E.; Oh, Jisu; Sprague, Jennifer E.; Timpson, Alexandra; de las Fuentes, Lisa; Bernal-Mizrachi, Leon; Schechtman, Kenneth B.; Bernal-Mizrachi, Carlos			Vitamin D Suppression of Endoplasmic Reticulum Stress Promotes an Antiatherogenic Monocyte/Macrophage Phenotype in Type 2 Diabetic Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED ATHEROSCLEROTIC LESIONS; UNFOLDED PROTEIN RESPONSE; MONOCYTE-DERIVED CELLS; MACROPHAGE DIFFERENTIATION; SUBCLINICAL ATHEROSCLEROSIS; PROINFLAMMATORY CYTOKINE; ALTERNATIVE ACTIVATION; CD14+CD16+ MONOCYTES; ADHESION MOLECULES; INSULIN-RESISTANCE	Cardiovascular disease is the leading cause of morbidity/mortality in patients with type 2 diabetes mellitus (T2DM), but there is a lack of knowledge about the mechanism(s) of increased atherosclerosis in these patients. In patients with T2DM, the prevalence of 25-hydroxy vitamin D (25(OH) D) deficiency is almost twice that for nondiabetics and doubles the relative risk of developing cardiovascular disease compared with diabetic patients with normal 25(OH) D. We tested the hypothesis that monocytes from vitamin D-deficient subjects will have a proatherogenic phenotype compared with vitamin D-sufficient subjects in 43 patients with T2DM. Serum 25(OH) D level inversely correlated with monocyte adhesion to endothelial cells even after adjustment for demographic and comorbidity characteristics. Vitamin D-sufficient patients (>= 30 ng/ml 25(OH) D) had lower monocyte endoplasmic reticulum (ER) stress, a predominance of M1 over M2 macrophage membrane receptors, and decreased mRNA expression of monocyte adhesion molecules PSGL-1, beta(1)-integrin, and beta(2)-integrin compared with patients with 25(OH) D levels of <30 ng/ml. In vitamin D-deficient macrophages, activation of ER stress increased adhesion and adhesion molecule expression and induced an M2-predominant phenotype. Moreover, adding 1,25(OH)(2)D-3 to vitamin D-deficient macrophages shifted their phenotype toward an M1-predominant phenotype with suppressed adhesion. Conversely, deletion of the vitamin D receptor in macrophages from diabetic patients activated ER stress, accelerated adhesion, and increased adhesion molecule expression. The absence of ER stress protein CCAAT enhancer-binding protein homologous protein suppressed monocyte adhesion, adhesion molecule expression, and the M2-predominant phenotype induced by vitamin D deficiency. Thus, vitamin D is a natural ER stress reliever that induced an antiatherogenic monocyte/macrophage phenotype.	[Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med, St Louis, MO 63110 USA; [Sprague, Jennifer E.] Washington Univ, Div Pediat Endocrinol & Diabet, St Louis, MO 63110 USA; [de las Fuentes, Lisa] Washington Univ, Div Cardiovasc Dis, St Louis, MO 63110 USA; [Schechtman, Kenneth B.] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bernal-Mizrachi, Leon] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University	Bernal-Mizrachi, C (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	cbernal@dom.wustl.edu		Jackson, Alexandra Malia/0000-0003-4423-1292; Bernal-Mizrachi, Carlos/0000-0002-8991-7522; de las Fuentes, Lisa/0000-0002-4689-325X	National Institutes of Health [R01HL094818-0, P30DK079333]; American Diabetes Association Grant [1-12-CT-08]; Endocrine Society; Endocrine Fellows Foundation, National Institutes of Health [UL1RR024992, KL2RR024994]; National Institutes of Health National Center for Research Resources, National Institutes of Health [UL1TR000448, KL2TR000450]; National Center for Advancing Translational Sciences; National Institutes of Health Roadmap for Medical Research; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NICHD [2 T32 HD043010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); Endocrine Society; Endocrine Fellows Foundation, National Institutes of Health; National Institutes of Health National Center for Research Resources, National Institutes of Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094818-0 and P30DK079333. This work was also supported by American Diabetes Association Grant 1-12-CT-08.; Supported by the Endocrine Society, the Endocrine Fellows Foundation, National Institutes of Health UL1RR024992/Sub-Award KL2RR024994 from the National Institutes of Health National Center for Research Resources, National Institutes of Health UL1TR000448/Sub-Award KL2TR000450 from the National Center for Advancing Translational Sciences, and the National Institutes of Health Roadmap for Medical Research.; Supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 2 T32 HD043010 from the NICHD.g	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bories G, 2012, DIABETES VASC DIS RE, V9, P189, DOI 10.1177/1479164111430242; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen NG, 1999, J CLIN ENDOCR METAB, V84, P3485, DOI 10.1210/jc.84.10.3485; Chen NG, 1999, CIRCULATION, V100, P940, DOI 10.1161/01.CIR.100.9.940; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Du T, 2009, DIABETES RES CLIN PR, V83, P208, DOI 10.1016/j.diabres.2008.09.046; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fasching P, 1996, DIABETOLOGIA, V39, P1242, DOI 10.1007/BF02658518; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Grey A, 2010, ARCH INTERN MED, V170, P1099, DOI 10.1001/archinternmed.2010.174; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; HEWISON M, 1994, J IMMUNOL, V153, P5709; Hotamisligil G.S, 2000, DIABETES MELLITUS, P651; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; Jilma B, 1996, THROMB HAEMOSTASIS, V76, P328; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; Kostidou E, 2009, CLIN BIOCHEM, V42, P634, DOI 10.1016/j.clinbiochem.2008.12.007; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mita T, 2010, BIOCHEM BIOPH RES CO, V395, P477, DOI 10.1016/j.bbrc.2010.04.031; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nemere I, 1998, BIOCHEM BIOPH RES CO, V248, P443, DOI 10.1006/bbrc.1998.8492; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; POLLA BS, 1986, J CLIN INVEST, V77, P1332, DOI 10.1172/JCI112438; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	61	78	83	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38482	38494		10.1074/jbc.M112.386912	http://dx.doi.org/10.1074/jbc.M112.386912			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012375	Green Published, hybrid			2022-12-25	WOS:000310982800008
J	Unterer, B; Becker, CM; Villmann, C				Unterer, Bea; Becker, Cord-Michael; Villmann, Carmen			The Importance of TM3-4 Loop Subdomains for Functional Reconstitution of Glycine Receptors by Independent Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; SUBUNIT; DETERMINES; GEPHYRIN; GLRA1(SPD-OT); AGGREGATION; MODULATION; TOPOLOGY; MUTATION	Truncated glycine receptors that have been found in human patients suffering from the neuromotor disorder hyperekplexia or in spontaneous mouse models resulted in non-functional ion channels. Rescue of function experiments with the lacking protein portion expressed as a separate independent domain demonstrated restoration of glycine receptor functionality in vitro. This construct harbored most of the TM3-4 loop, TM4, and the C terminus and was required for concomitant transport of the truncated alpha 1 and the complementation domain from the endoplasmic reticulum toward the cell surface, thereby enabling complex formation of functional glycine receptors. Here, the complementation domain was stepwise truncated from its N terminus in the TM3-4 loop. Truncation of more than 49 amino acids led again to loss of functionality in the receptor complex expressed from two independent domain constructs. We identified residues 357-418 in the intracellular TM3-4 loop as being required for reconstitution of functional glycine-gated channels. All complementation constructs showed cell surface protein expression and correct orientation according to glycine receptor topology. Moreover, we demonstrated that the truncations did not result in a decreased protein-protein interaction between both glycine receptor domains. Rather, deletions of more than 49 amino acids abolished conformational changes necessary for ion channel opening. When the TM3-4 loop subdomain harboring residues 357-418 was expressed as a third independent construct together with the truncated N-terminal and C-terminal glycine receptor domains, functionality of the glycine receptor was again restored. Thus, residues 357-418 represent an important determinant in the process of conformational rearrangements following ligand binding resulting in channel opening.	[Unterer, Bea; Becker, Cord-Michael; Villmann, Carmen] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Villmann, C (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Versbacherstr 5, D-97078 Wurzburg, Germany.	Villmann_C@klinik.uni-wuerzburg.de		Unterer, Bea/0000-0001-8610-6882	Deutsche Forschungsgemeinschaft [VI586]; EU Neurocypres; Johannes und Frieda Marohn Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU Neurocypres; Johannes und Frieda Marohn Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grant VI586, EU Neurocypres, and the Johannes und Frieda Marohn Stiftung.	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Becker Kristina, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9455; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Dutertre S, 2012, J NEUROCHEM, V122, P38, DOI 10.1111/j.1471-4159.2012.07755.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Peters TW, 2007, PRION, V1, P144, DOI 10.4161/pri.1.2.4630; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Tsai CH, 2004, NEUROLOGY, V63, P893, DOI 10.1212/01.WNL.0000138566.65519.67; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Villmann C., 2009, ION CHANNELS STRUCTU, P251; Villmann C, 2008, J NEUROCHEM, V107, P453, DOI 10.1111/j.1471-4159.2008.05623.x; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	37	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39205	39215		10.1074/jbc.M112.376053	http://dx.doi.org/10.1074/jbc.M112.376053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995908	Green Published, hybrid			2022-12-25	WOS:000310982800075
J	Casteel, DE; Turner, S; Schwappacher, R; Rangaswami, H; Su-Yuo, J; Zhuang, SH; Boss, GR; Pilz, RB				Casteel, Darren E.; Turner, Stephanie; Schwappacher, Raphaela; Rangaswami, Hema; Su-Yuo, Jacqueline; Zhuang, Shunhui; Boss, Gerry R.; Pilz, Renate B.			Rho Isoform-specific Interaction with IQGAP1 Promotes Breast Cancer Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; BINDING-PROTEIN; FAMILY GTPASES; INVASION; KINASE; CDC42; METASTASIS; EXPRESSION; EFFECTOR; ADHESION	We performed a proteomics screen for Rho isoform-specific binding proteins to clarify the tumor-promoting effects of RhoA and C that contrast with the tumor-suppressive effects of RhoB. We found that the IQ-motif-containing GTPase-activating protein IQGAP1 interacts directly with GTP-bound, prenylated RhoA and RhoC, but not with RhoB. Co-immunoprecipitation of IQGAP1 with endogenous RhoA/C was enhanced when RhoA/C were activated by epidermal growth factor (EGF) or transfection of a constitutively active guanine nucleotide exchange factor (GEF). Overexpression of IQGAP1 increased GTP-loading of RhoA/C, while siRNA-mediated depletion of IQGAP1 prevented endogenous RhoA/C activation by growth factors. IQGAP1 knockdown also reduced the amount of GTP bound to GTPase-deficient RhoA/C mutants, suggesting that IQGAP enhances Rho activation by GEF(s) or stabilizes Rho-GTP. IQGAP1 depletion in MDA-MB-231 breast cancer cells blocked EGF- and RhoA-induced stimulation of DNA synthesis. Infecting cells with adenovirus encoding constitutively active RhoA(L63) and measuring absolute amounts of RhoA-GTP in infected cells demonstrated that the lack of RhoA(L63)-induced DNA synthesis in IQGAP1-depleted cells was not due to reduced GTP-bound RhoA. These data suggested that IQGAP1 functions downstream of RhoA. Overexpression of IQGAP1 in MDA-MB-231 cells increased DNA synthesis irrespective of siRNA-mediated RhoA knockdown. Breast cancer cell motility was increased by expressing a constitutively-active RhoC(V14) mutant or overexpressing IQGAP1. EGF- or RhoC-induced migration required IQGAP1, but IQGAP1-stimulated migration independently of RhoC, placing IQGAP1 downstream of RhoC. We conclude that IQGAP1 acts both upstream of RhoA/C, regulating their activation state, and downstream of RhoA/C, mediating their effects on breast cancer cell proliferation and migration, respectively.	[Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [K22-CA124517, R01-AR051300]; Deutsche Forschungsgemeinschaft;  [T32-HL007261]; NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22-CA124517 (to D. C.) and R01-AR051300 (to R. B. P.).; Supported by T32-HL007261.; Supported by a research fellowship grant from the Deutsche Forschungsgemeinschaft.	Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hu S., 2009, CANCER RES, V69, P794; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Liberto M, 2002, ONCOGENE, V21, P1590, DOI 10.1038/sj.onc.1205242; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; van Golen KL, 2000, CANCER RES, V60, P5832; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu M, 2004, BREAST CANCER RES TR, V84, P3, DOI 10.1023/B:BREA.0000018426.76893.21; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200	48	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377499	http://dx.doi.org/10.1074/jbc.M112.377499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992742	Green Published, hybrid			2022-12-25	WOS:000310642200069
J	Grachev, P; Li, XF; Lin, YS; Hu, MH; Elsamani, L; Paterson, SJ; Millar, RP; Lightman, SL; O'Byrne, KT				Grachev, Pasha; Li, Xiao Feng; Lin, Yuan Shao; Hu, Ming Han; Elsamani, Leena; Paterson, Stewart J.; Millar, Robert P.; Lightman, Stafford L.; O'Byrne, Kevin T.			GPR54-Dependent Stimulation of Luteinizing Hormone Secretion by Neurokinin B in Prepubertal Rats	PLOS ONE			English	Article							GNRH PULSE-GENERATOR; STRESS-INDUCED SUPPRESSION; MONKEY MACACA-MULATTA; ARCUATE NUCLEUS; GONADOTROPIN-SECRETION; FEMALE RAT; HYPOGONADOTROPIC HYPOGONADISM; MORPHOLOGIC EVIDENCE; KISSPEPTIN NEURONS; SEXUAL-MATURATION	Kisspeptin, neurokinin B (NKB) and dynorphin A (Dyn) are coexpressed within KNDy neurons that project from the hypothalamic arcuate nucleus (ARC) to GnRH neurons and numerous other hypothalamic targets. Each of the KNDy neuropeptides has been implicated in regulating pulsatile GnRH/LH secretion. In isolation, kisspeptin is generally known to stimulate, and Dyn to inhibit LH secretion. However, the NKB analog, senktide, has variously been reported to inhibit, stimulate or have no effect on LH secretion. In prepubertal mice, rats and monkeys, senktide stimulates LH secretion. Furthermore, in the monkey this effect is dependent on kisspeptin signaling through its receptor, GPR54. The present study tested the hypotheses that the stimulatory effects of NKB on LH secretion in intact rats are mediated by kisspeptin/GPR54 signaling and are independent of a Dyn tone. To test this, ovarian-intact prepubertal rats were subjected to frequent automated blood sampling before and after intracerebroventricular injections of KNDy neuropeptide analogs. Senktide robustly induced single LH pulses, while neither the GPR54 antagonist, Kp-234, nor the Dyn agonist and antagonist (U50488 and nor-BNI, respectively) had an effect on basal LH levels. However, Kp-234 potently blocked the senktide-induced LH pulses. Modulation of the Dyn tone by U50488 or nor-BNI did not affect the senktide-induced LH pulses. These data demonstrate that the stimulatory effect of NKB on LH secretion in intact female rats is dependent upon kisspeptin/GPR54 signaling, but not on Dyn signaling.	[Grachev, Pasha; Li, Xiao Feng; Lin, Yuan Shao; Hu, Ming Han; Elsamani, Leena; O'Byrne, Kevin T.] Kings Coll London, Sch Med, Div Womens Hlth, London WC2R 2LS, England; [Paterson, Stewart J.] Kings Coll London, Sch Biomed Sci, Dept Pharmacol & Therapeut, London WC2R 2LS, England; [Millar, Robert P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Millar, Robert P.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Cape Town, Res Grp Receptor Biol, MRC, Div Med Biochem,Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of London; King's College London; University of London; King's College London; University of Edinburgh; University of Pretoria; University of Cape Town; University of Bristol	O'Byrne, KT (corresponding author), Kings Coll London, Sch Med, Div Womens Hlth, London WC2R 2LS, England.	kevin.o'byrne@kcl.ac.uk	Grachev, Pasha/I-4460-2019; Grachev, Pasha/A-1193-2012; Hu, Minghan/L-3085-2019	Grachev, Pasha/0000-0002-6611-6423; Grachev, Pasha/0000-0002-6611-6423; Millar, Robert P/0000-0003-3606-2708; Lightman, Stafford/0000-0002-8546-9646	Biotechnology and Biological Sciences Research Council (BBSRC) UK; Medical Research Council (MRC) UK; BBSRC [BB/J002232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002232/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) UK. PG is a recipient of a Medical Research Council (MRC) UK PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARB CR, 1988, BIOL REPROD, V39, P603, DOI 10.1095/biolreprod39.3.603; BHANOT R, 1983, ENDOCRINOLOGY, V113, P596, DOI 10.1210/endo-113-2-596; Bowe JE, 2005, J PHYSIOL-LONDON, V566, P921, DOI 10.1113/jphysiol.2005.085662; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Cates PS, 1999, J NEUROENDOCRINOL, V11, P677; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Chan YM, 2011, J CLIN ENDOCR METAB, V96, pE1771, DOI 10.1210/jc.2011-0518; Ciofi P, 2007, NEUROSCIENCE, V146, P630, DOI 10.1016/j.neuroscience.2007.02.028; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; EBLING FJP, 1989, ENDOCRINOLOGY, V125, P369, DOI 10.1210/endo-125-1-369; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Grachev P, 2012, ENDOCRINOLOGY, DOI [10.1210/en.2012-1574, DOI 10.1210/EN.20121574]; KALRA SP, 1983, ENDOCR REV, V4, P311, DOI 10.1210/edrv-4-4-311; Kauffman AS, 2009, AM J PHYSIOL-ENDOC M, V297, pE1212, DOI 10.1152/ajpendo.00461.2009; KIMURA F, 1982, NEUROENDOCRINOLOGY, V35, P128, DOI 10.1159/000123367; KINOSHITA F, 1982, LIFE SCI, V30, P1915, DOI 10.1016/0024-3205(82)90472-6; Kinsey-Jones JS, 2012, ENDOCRINOLOGY, V153, P307, DOI 10.1210/en.2011-1641; KNOBIL E, 1990, AM J OBSTET GYNECOL, V163, P1721, DOI 10.1016/0002-9378(90)91435-F; Krajewski SJ, 2010, NEUROSCIENCE, V166, P680, DOI 10.1016/j.neuroscience.2009.12.053; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; Li XF, 2003, J NEUROENDOCRINOL, V15, P468, DOI 10.1046/j.1365-2826.2003.01014.x; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; MAURAS N, 1987, J ANDROL, V8, P203; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; MEDHAMURTHY R, 1990, ENDOCRINOLOGY, V126, P1036, DOI 10.1210/endo-126-2-1036; MONROE SE, 1968, ENDOCRINOLOGY, V83, P1004, DOI 10.1210/endo-83-5-1004; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2012, J NEUROSCI, V32, P2388, DOI 10.1523/JNEUROSCI.4288-11.2012; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro Victor M, 2011, Front Biosci (Schol Ed), V3, P267, DOI 10.2741/s150; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Neal-Perry G, 2009, ENDOCRINOLOGY, V150, P3699, DOI 10.1210/en.2008-1667; OHKURA S, 1991, J NEUROENDOCRINOL, V3, P503, DOI 10.1111/j.1365-2826.1991.tb00310.x; Ojeda Sergio R., 1994, P363; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Ramaswamy S, 2011, NEUROENDOCRINOLOGY, V94, P237, DOI 10.1159/000329045; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; RECABARREN SE, 1989, J VET MED A, V36, P467, DOI 10.1111/j.1439-0442.1989.tb00754.x; SAUDER SE, 1984, PEDIATR RES, V18, P322, DOI 10.1203/00006450-198404000-00004; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Takase K, 2009, J NEUROENDOCRINOL, V21, P527, DOI 10.1111/j.1365-2826.2009.01868.x; Takumi K, 2011, J MOL NEUROSCI, V43, P138, DOI 10.1007/s12031-010-9430-1; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; True C, 2011, J NEUROENDOCRINOL, V23, P52, DOI 10.1111/j.1365-2826.2010.02076.x; ULLOAAGUIRRE A, 1988, CLIN ENDOCRINOL, V29, P17, DOI 10.1111/j.1365-2265.1988.tb00245.x; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; YOUNGLAI EV, 1988, CAN J PHYSIOL PHARM, V66, P38, DOI 10.1139/y88-007	52	49	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44344	10.1371/journal.pone.0044344	http://dx.doi.org/10.1371/journal.pone.0044344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028524	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900009
J	Jansen, BD; Jenks, JA				Jansen, Brian D.; Jenks, Jonathan A.			Birth Timing for Mountain Lions (Puma concolor); Testing the Prey Availability Hypothesis	PLOS ONE			English	Article							SURVIVAL; COUGARS; CONSERVATION; POPULATION; DISPERSAL; PATTERNS	We investigated potential advantages in birth timing for mountain lion (Puma concolor) cubs. We examined cub body mass, survival, and age of natal dispersal in relation to specific timing of birth. We also investigated the role of maternal age relative to timing of births. We captured mountain lion cubs while in the natal den to determine birth date, which allowed for precise estimates of the population birth pulse and age of natal dispersal. A birth pulse occurred during June-August. Body mass of cubs was related to litter size and timing of birth; heaviest cubs occurred in litters of 2, and those born after 1 July. Cubs born within pulse months exhibited similar survival to those born out of the pulse. We found that cubs born April-June dispersed at younger ages than those born after 1 July. There was less variation in birth timing for 1st litters of females than older females. We hypothesize that cubs born after the peak in births of neonate prey are advantaged by the abundance of vulnerable prey and those cubs and mothers realize an evolutionary advantage.	[Jansen, Brian D.; Jenks, Jonathan A.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	South Dakota State University	Jansen, BD (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	bighorns101@yahoo.com	Jenks, Jonathan A/B-7321-2009		Federal Aid in Fish and Wildlife Restoration [7587]	Federal Aid in Fish and Wildlife Restoration	This study was funded by Federal Aid in Fish and Wildlife Restoration administered through South Dakota Game, Fish and Parks (Study Number 7587). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that members of the funding agency participated in capture of study animals.	Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Bauer JW, 2005, SW NATURALIST, V50, P446, DOI [10.1894/0038-4909(2005)050[0466:SBIP]2.0.CO;2, DOI 10.1894/0038-4909(2005)050C[0466:SBIP]2.0.CO;2]; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bleich VC, 1996, GREAT BASIN NAT, V56, P276; Currier M.J.P, 1983, MAMMALIAN SPECIES, V200, P1, DOI [10.2307/3503951, DOI 10.2307/3503951]; Fisher DO, 2002, EVOLUTION, V56, P167; Froiland S. G., 1990, NATURAL HIST BLACK H; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Halls L.K., 1978, P43; Hemker T.P., 1986, P327; HEMKER TP, 1984, J WILDLIFE MANAGE, V48, P1275, DOI 10.2307/3801788; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; Jansen B.D., 2005, THESIS U ARIZONA TUC; Johnson JR, 1999, PLANTS BLACK HILLS B; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; Laundre JW, 2007, J MAMMAL, V88, P1300, DOI 10.1644/06-MAMM-A-296R.1; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; LINDZEY F. G., 2000, GUIDE ESTIMATING MOU; Logan KA, 1999, WILDLIFE SOC B, V27, P201; Logan KA, 2001, DESERT PUMA EVOLUTIO, P1; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Robbins C. T, 2001, WILDLIFE FEEDING NUT; ROBINETTE W. LESLIE, 1961, JOUR MAMMAL, V42, P204, DOI 10.2307/1376830; ROSS PI, 1992, J WILDLIFE MANAGE, V56, P417, DOI 10.2307/3808853; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Samuel M. D., 1996, RES MANAGEMENT TECHN, P370; Schmitz LE, 2006, THESIS S DAKOTA STAT; Schmitz LE, 2010, 201005 S DAK GAM FIS, P1; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson D. J., 2009, THESIS S DAKOTA STAT; Wallace MC, 1996, BIOL DEER, P69; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whittaker DG, 1999, WILDLIFE SOC B, V27, P256; [No title captured]	36	19	19	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44625	10.1371/journal.pone.0044625	http://dx.doi.org/10.1371/journal.pone.0044625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028569	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700014
J	Watson, CT; Disanto, G; Sandve, GK; Breden, F; Giovannoni, G; Ramagopalan, SV				Watson, Corey T.; Disanto, Giulio; Sandve, Geir Kjetil; Breden, Felix; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Age-Associated Hyper-Methylated Regions in the Human Brain Overlap with Bivalent Chromatin Domains	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LARGE GENE LISTS; DNA METHYLATION; EPIGENETIC DIFFERENCES; ALZHEIMERS-DISEASE; MONOZYGOTIC TWINS; HYPERMETHYLATION; PLURIPOTENT; SIGNATURES	Recent associations between age-related differentially methylated sites and bivalently marked chromatin domains have implicated a role for these genomic regions in aging and age-related diseases. However, the overlap between such epigenetic modifications has so far only been identified with respect to age-associated hyper-methylated sites in blood. In this study, we observed that age-associated differentially methylated sites characterized in the human brain were also highly enriched in bivalent domains. Analysis of hyper-vs. hypo-methylated sites partitioned by age (fetal, child, and adult) revealed that enrichment was significant for hyper-methylated sites identified in children and adults (child, fold difference = 2.28, P = 0.0016; adult, fold difference = 4.73, P = 4.00 x 10(-5)); this trend was markedly more pronounced in adults when only the top 100 most significantly hypo-and hyper-methylated sites were considered (adult, fold difference = 10.7, P = 2.00 x 10(-5)). Interestingly, we found that bivalently marked genes overlapped by age-associated hyper-methylation in the adult brain had strong involvement in biological functions related to developmental processes, including neuronal differentiation. Our findings provide evidence that the accumulation of methylation in bivalent gene regions with age is likely to be a common process that occurs across tissue types. Furthermore, particularly with respect to the aging brain, this accumulation might be targeted to loci with important roles in cell differentiation and development, and the closing off of these developmental pathways. Further study of these genes is warranted to assess their potential impact upon the development of age-related neurological disorders.	[Giovannoni, Gavin; Ramagopalan, Sreeram V.] Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Watson, Corey T.; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Disanto, Giulio] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Disanto, Giulio] Univ Oxford, Dept Clin Neurol, John Radcliffe Hosp, Oxford, England; [Sandve, Geir Kjetil] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Ramagopalan, Sreeram V.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England	University of London; Queen Mary University London; Simon Fraser University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oslo; University of Oxford	Ramagopalan, SV (corresponding author), Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England.	s.ramagopalan@qmul.ac.uk		Watson, Corey/0000-0001-7248-8787; Sandve, Geir Kjetil/0000-0002-4959-1409; McKeating, Jane/0000-0002-7229-5886; Breden, Felix/0000-0001-9762-6314	FISM-Fondazione Italiana Sclerosi Multipla [2010/B/5]; EMBIO at the University of Oslo; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Northern Ireland; Medical Research Council [G0801976]; Wellcome Trust [075491/Z/04]; Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma; Biogen Idec; Merck Serono; Novartis; UCB; Merz Pharmaceuticals, LLC; Teva Pharmaceutical Industries Ltd.-sanofiaventis; GW Pharma; Ironwood; MRC [G0801976] Funding Source: UKRI	FISM-Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EMBIO at the University of Oslo; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Multiple Sclerosis Society of Great Britain; Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); UCB(UCB Pharma SA); Merz Pharmaceuticals, LLC; Teva Pharmaceutical Industries Ltd.-sanofiaventis(Sanofi-Aventis); GW Pharma; Ironwood; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Disanto is funded by research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. Dr. Kjetil is supported by EMBIO at the University of Oslo. Dr. Breden is supported by the Natural Sciences and Engineering Research Council of Canada. Dr. Ramagopalan receives research support from the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of Great Britain and Northern Ireland. This work was supported by the Medical Research Council (G0801976), the Wellcome Trust (075491/Z/04), and by a research fellowship FISM Fondazione Italiana Sclerosi Multipla-Cod.: 2010/B/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr. Giovannoni serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; has served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofiaventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofiaventis, GW Pharma, and Ironwood. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	21	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e43840	10.1371/journal.pone.0043840	http://dx.doi.org/10.1371/journal.pone.0043840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028473	Green Published, gold			2022-12-25	WOS:000309554700004
J	Yan, YB; Qi, W; Wu, ZX; Qiu, TX; Teo, EC; Lei, W				Yan, Ya-Bo; Qi, Wei; Wu, Zi-Xiang; Qiu, Tian-Xia; Teo, Ee-Chon; Lei, Wei			Finite Element Study of the Mechanical Response in Spinal Cord during the Thoracolumbar Burst Fracture	PLOS ONE			English	Article							QUANTITATIVE 3-DIMENSIONAL ANATOMY; CANAL STENOSIS; NEUROLOGICAL DEFICIT; LUMBAR VERTEBRAE; WHITE-MATTER; GRAY-MATTER; PIA MATER; INJURY; MODEL	Background: The mechanical response of the spinal cord during burst fracture was seldom quantitatively addressed and only few studies look into the internal strain of the white and grey matters within the spinal cord during thoracolumbar burst fracture (TLBF). The aim of the study is to investigate the mechanical response of the spinal cord during TLBF and correlate the percent canal compromise (PCC) with the strain in the spinal cord. Methodology/Principal Findings: A three-dimensional (3D) finite element (FE) model of human T12-L1 spinal cord with visco-elastic property was generated based on the transverse sections images of spinal cord, and the model was validated against published literatures under static uniaxial tension and compression. With the validated model, a TLBF simulation was performed to compute the mechanical strain in the spinal cord with the PCC. Linear regressions between PCC and strain in the spinal cord show that at the initial stage, with the PCC at 20%, and 45%, the corresponding mechanical strains in ventral grey, dorsal grey, ventral white, dorsal white matters were 0.06, 0.04, 0.12, 0.06, and increased to 0.14, 0.12, 0.23, and 0.13, respectively. At the recoiled stage, when the PCC was decreased from 45% to 20%, the corresponding strains were reduced to 0.03, 0.02, 0.04 and 0.03. The strain was correlated well with PCC. Conclusions/Significance: The simulation shows that the strain in the spinal cord correlated well with the PCC, and the mechanical strains in the ventral regions are higher than those in the dorsal regions of spinal cord tissue during burst fracture, suggesting that the ventral regions of the spinal cord may susceptible to injury than the dorsal regions.	[Yan, Ya-Bo; Qi, Wei; Wu, Zi-Xiang; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Yan, Ya-Bo; Qiu, Tian-Xia; Teo, Ee-Chon] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore; [Qi, Wei] PLA, Hosp 520, Dept Surg, Mianyang, Peoples R China	Air Force Military Medical University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	leiwei@fmmu.edu.cn	Teo, Ee Chon/F-7308-2010	Lei, Wei/0000-0002-7346-6915				Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bilston LE, 1996, ANN BIOMED ENG, V24, P67, DOI 10.1007/BF02770996; Boerger TO, 2000, J BONE JOINT SURG BR, V82B, P629, DOI 10.1302/0301-620X.82B5.11321; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Clarke EC, 2009, J BIOMECH, V42, P1397, DOI 10.1016/j.jbiomech.2009.04.008; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Dai LY, 2008, EUR J RADIOL, V67, P526, DOI 10.1016/j.ejrad.2007.08.020; Drake R. L., 2010, GRAYS ANATOMY STUDEN; FONTIJNE WPJ, 1992, J BONE JOINT SURG BR, V74, P683, DOI 10.1302/0301-620X.74B5.1527112; Greaves CY, 2008, ANN BIOMED ENG, V36, P396, DOI 10.1007/s10439-008-9440-0; HASHIMOTO T, 1988, SPINE, V13, P1268, DOI 10.1097/00007632-198811000-00011; HUNG TK, 1982, SURG NEUROL, V17, P213, DOI 10.1016/0090-3019(82)90284-1; HUNG TK, 1979, SURG NEUROL, V11, P470; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; Li XF, 2009, SPINE, V34, P1140, DOI 10.1097/BRS.0b013e31819e2af1; LIMB D, 1995, J BONE JOINT SURG BR, V77, P774, DOI 10.1302/0301-620X.77B5.7559709; Meves R, 2006, SPINE, V31, P2137, DOI 10.1097/01.brs.0000231730.34754.9e; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424, DOI 10.5435/00124635-200411000-00007; Mohanty S P, 2008, J Orthop Surg (Hong Kong), V16, P20; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; PANJABI MM, 1994, SPINE, V19, P578, DOI 10.1097/00007632-199403000-00014; PANJABI MM, 1992, SPINE, V17, P299, DOI 10.1097/00007632-199203000-00010; Qiu TX, 2006, MED ENG PHYS, V28, P656, DOI 10.1016/j.medengphy.2005.10.011; RASMUSSEN PA, 1994, J NEUROTRAUM, V11, P711, DOI 10.1089/neu.1994.11.711; Schoenen J., 2004, HUMAN NERVOUS SYSTEM; Shirado O, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P644; SHUMAN WP, 1985, AM J ROENTGENOL, V145, P337, DOI 10.2214/ajr.145.2.337; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Tan SH, 2002, EUR SPINE J, V11, P152, DOI 10.1007/s00586-001-0365-7; TENCER AF, 1985, SPINE, V10, P741, DOI 10.1097/00007632-198510000-00009; Wilcox RK, 2004, EUR SPINE J, V13, P481, DOI 10.1007/s00586-003-0625-9; Wilcox RK, 2003, J BONE JOINT SURG AM, V85A, P2184, DOI 10.2106/00004623-200311000-00020; Wilcox Ruth K, 2003, J Orthop Sci, V8, P432, DOI 10.1007/s10776-003-0644-9; Wood K, 2003, J BONE JOINT SURG AM, V85A, P773, DOI 10.2106/00004623-200305000-00001; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao X, 2010, MED HYPOTHESES, V75, P550, DOI 10.1016/j.mehy.2010.07.026	38	12	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e41397	10.1371/journal.pone.0041397	http://dx.doi.org/10.1371/journal.pone.0041397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028426	gold, Green Published			2022-12-25	WOS:000309554700002
J	Bernhardt, SA; Simmons, MP; Olson, KE; Beaty, BJ; Blair, CD; Black, WC				Bernhardt, Scott A.; Simmons, Mark P.; Olson, Ken E.; Beaty, Barry J.; Blair, Carol D.; Black, William C.			Rapid Intraspecific Evolution of miRNA and siRNA Genes in the Mosquito Aedes aegypti	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; RNA INTERFERENCE RESPONSE; INDUCED SILENCING COMPLEX; ANTIVIRAL IMMUNITY; VECTOR COMPETENCE; ORAL INFECTION; DROSOPHILA-MELANOGASTER; MAXIMUM-LIKELIHOOD; NODAMURA VIRUS; DNA-SEQUENCES	RNA silencing, or RNA interference (RNAi) in metazoans mediates development, reduces viral infection and limits transposon mobility. RNA silencing involves 21-30 nucleotide RNAs classified into microRNA (miRNA), exogenous and endogenous small interfering RNAs (siRNA), and Piwi-interacting RNA (piRNA). Knock-out, silencing and mutagenesis of genes in the exogenous siRNA (exo-siRNA) regulatory network demonstrate the importance of this RNAi pathway in antiviral immunity in Drosophila and mosquitoes. In Drosophila, genes encoding components for processing exo-siRNAs are among the fastest evolving 3% of all genes, suggesting that infection with pathogenic RNA viruses may drive diversifying selection in their host. In contrast, paralogous miRNA pathway genes do not evolve more rapidly than the genome average. Silencing of exo-siRNA pathway genes in mosquitoes orally infected with arboviruses leads to increased viral replication, but little is known about the comparative patterns of molecular evolution among the exo-siRNA and miRNA pathways genes in mosquitoes. We generated nearly complete sequences of all exons of major miRNA and siRNA pathway genes dicer-1 and dicer-2, argonaute-1 and argonaute-2, and r3d1 and r2d2 in 104 Aedes aegypti mosquitoes collected from six distinct geographic populations and analyzed their genetic diversity. The ratio of replacement to silent amino acid substitutions was 1.4 fold higher in dicer-2 than in dicer-1, 27.4 fold higher in argonaute-2 than in argonaute-1 and similar in r2d2 and r3d1. Positive selection was supported in 32% of non-synonymous sites in dicer-1, in 47% of sites in dicer-2, in 30% of sites in argonaute-1, in all sites in argonaute-2, in 22% of sites in r3d1 and in 55% of sites in r2d2. Unlike Drosophila, in Ae. aegypti, both exo-siRNA and miRNA pathway genes appear to be undergoing rapid, positive, diversifying selection. Furthermore, refractoriness of mosquitoes to infection with dengue virus was significantly positively correlated for nucleotide diversity indices in dicer-2.	[Bernhardt, Scott A.; Olson, Ken E.; Beaty, Barry J.; Blair, Carol D.; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Simmons, Mark P.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	wcb4@lamar.colostate.edu	Simmons, Mark Pitkin/F-7157-2013	Simmons, Mark Pitkin/0000-0003-3896-4633	UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR) [A50363]; NIH/NIAID [N01-AI 25489, R01 AI034014, AI083368]; FTP Training Grant from the Centers for Disease Control and Prevention [CCT 822307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034014, R01AI083368, N01AI025489] Funding Source: NIH RePORTER	UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FTP Training Grant from the Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from the UNICEF/UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Disease (TDR): A50363. This work was also supported by NIH/NIAID contract N01-AI 25489 and R01 AI034014 to CDB and AI083368 to WCB4. SAB was supported by the FTP Training Grant CCT 822307 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Attarzadeh-Yazdi G, 2009, J VIROL, V83, P5735, DOI 10.1128/JVI.02440-08; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Black W. C. IV, 1997, The molecular biology of insect disease vectors: a methods manual., P361; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; Chung YK, 2002, TROP MED INT HEALTH, V7, P322, DOI 10.1046/j.1365-3156.2002.00873.x; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lim DH, 2008, BIOCHEM BIOPH RES CO, V371, P525, DOI 10.1016/j.bbrc.2008.04.118; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690; Lozano-Fuentes S., 2009, PLoS Neglected Tropical Diseases, V3, pe468; MADDISON DR, 2001, MACCLADE ANAL PHYLOG, P13102; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Nei M., 1987, MOL EVOLUTIONARY GEN; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Obbard DJ, 2011, MOL BIOL EVOL, V28, P1043, DOI 10.1093/molbev/msq280; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; SCHERER WF, 1967, AM J EPIDEMIOL, V86, P271, DOI 10.1093/oxfordjournals.aje.a120737; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408; TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219; TAJIMA F, 1983, GENETICS, V105, P437; TESH RB, 1980, J GEN VIROL, V48, P177, DOI 10.1099/0022-1317-48-1-177; Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225, DOI 10.4269/ajtmh.1985.34.1225; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a	75	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44198	10.1371/journal.pone.0044198	http://dx.doi.org/10.1371/journal.pone.0044198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028502	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800004
J	White, LJ; Newton, PN; Maude, RJ; Pan-ngum, W; Fried, JR; Mayxay, M; Maude, RR; Day, NPJ				White, Lisa J.; Newton, Paul N.; Maude, Richard J.; Pan-ngum, Wirichada; Fried, Jessica R.; Mayxay, Mayfong; Maude, Rapeephan R.; Day, Nicholas P. J.			Defining Disease Heterogeneity to Guide the Empirical Treatment of Febrile Illness in Resource Poor Settings	PLOS ONE			English	Article							FEVER; VIENTIANE; MALARIA	Background: Malaria incidence is in decline in many parts of SE Asia leading to a decreasing proportion of febrile illness that is attributable to malaria. However in the absence of rapid, affordable and accurate diagnostic tests, the non-malaria causes of these illnesses cannot be reliably identified. Studies on the aetiology of febrile illness have indicated that the causes are likely to vary by geographical location within countries (i.e. be spatially heterogeneous) and that national empirical treatment policies based on the aetiology measured in a single location could lead to inappropriate treatment. Methods: Using data from Vientiane as a reference for the incidence of major febrile illnesses in the Lao People's Democratic Republic (Laos) and estimated incidences, plausible incidence in other Lao provinces were generated using a mathematical model for a range of national and local scale variations. For a range of treatment protocols, the mean number of appropriate treatments was predicted and the potential impact of a spatially explicit national empirical treatment protocol assessed. Findings: The model predicted a negative correlation between number of appropriate treatments and the level of spatial heterogeneity. A spatially explicit national treatment protocol was predicted to increase the number of appropriate treatments by 50% for intermediate levels of spatial heterogeneity. Conclusions: The results suggest that given even only moderate spatial variation, a spatially explicit treatment algorithm will result in a significant improvement in the outcome of undifferentiated fevers in Laos and other similar resource poor settings.	[White, Lisa J.; Newton, Paul N.; Maude, Richard J.; Fried, Jessica R.; Mayxay, Mayfong; Day, Nicholas P. J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [White, Lisa J.; Maude, Richard J.; Pan-ngum, Wirichada; Fried, Jessica R.; Maude, Rapeephan R.; Day, Nicholas P. J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Newton, Paul N.; Mayxay, Mayfong] Mahosot Hosp, Wellcome Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Microbiol Lab, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos	University of Oxford; Mahidol University	White, LJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England.	lisa@tropmedres.ac	Maude, Richard James/AAV-3567-2020; Maude, Rapeephan/AHB-3558-2022; White, Lisa/AAC-9396-2020	Maude, Richard James/0000-0002-5355-0562; White, Lisa/0000-0002-6523-185X; pan-ngum, wirichada/0000-0002-9839-5359; Newton, Paul/0000-0002-4608-6431; Maude, Rapeephan/0000-0002-3383-3629	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant); Li Ka Shing Foundation - University of Oxford Global Health Programme	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant)(Wellcome Trust); Li Ka Shing Foundation - University of Oxford Global Health Programme	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant) and was funded by the Li Ka Shing Foundation - University of Oxford Global Health Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE IN PRESS; Anglaret X, 2002, AIDS, V16, P909, DOI 10.1097/00002030-200204120-00011; Clark TW, 2010, J INFECTION, V60, P91, DOI 10.1016/j.jinf.2009.11.009; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Laurichesse H, 1998, EUR RESPIR J, V11, P73, DOI 10.1183/09031936.98.11010073; Machado BM, 2009, J PEDIAT-BRAZIL, V85, P426, DOI [10.2223/JPED.1928, 10.1590/S0021-75572009000500010]; Mayxay M, 2012, CAUSES NONMALA UNPUB; Mayxay M, 2010, AM J TROP MED HYG, V83, P1221, DOI 10.4269/ajtmh.2010.10-0276; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Societe de Pathologie Infectieuse de Langue Francaise, 1991, MED MAL INFECT S, V21, P1; Stoesser N, 2012, J ANTIMICROB CHEMOTH, V67, P240, DOI 10.1093/jac/dkr434; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	14	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44545	10.1371/journal.pone.0044545	http://dx.doi.org/10.1371/journal.pone.0044545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028559	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800011
J	Loiseau, C; Harrigan, RJ; Cornel, AJ; Guers, SL; Dodge, M; Marzec, T; Carlson, JS; Seppi, B; Sehgal, RNM				Loiseau, Claire; Harrigan, Ryan J.; Cornel, Anthony J.; Guers, Sue L.; Dodge, Molly; Marzec, Timothy; Carlson, Jenny S.; Seppi, Bruce; Sehgal, Ravinder N. M.			First Evidence and Predictions of Plasmodium Transmission in Alaskan Bird Populations	PLOS ONE			English	Article							CLIMATE-CHANGE; BLOOD PARASITES; AVIAN MALARIA; TEMPERATURE; HOST; RISK; VARIABILITY; INFECTIONS; PREVALENCE; ABUNDANCE	The unprecedented rate of change in the Arctic climate is expected to have major impacts on the emergence of infectious diseases and host susceptibility to these diseases. It is predicted that malaria parasites will spread to both higher altitudes and latitudes with global warming. Here we show for the first time that avian Plasmodium transmission occurs in the North American Arctic. Over a latitudinal gradient in Alaska, from 61 degrees N to 67 degrees N, we collected blood samples of resident and migratory bird species. We found both residents and hatch year birds infected with Plasmodium as far north as 64 degrees N, providing clear evidence that malaria transmission occurs in these climates. Based on our empirical data, we make the first projections of the habitat suitability for Plasmodium under a future-warming scenario in Alaska. These findings raise new concerns about the spread of malaria to naive host populations.	[Loiseau, Claire; Dodge, Molly; Marzec, Timothy; Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Harrigan, Ryan J.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Ctr Trop Res, Los Angeles, CA USA; [Cornel, Anthony J.; Carlson, Jenny S.] Univ Calif Davis, Dept Entomol, Mosquito Control & Res Lab, Parlier, CA USA; [Guers, Sue L.] Alaska Bird Observ, Fairbanks, AK USA; [Seppi, Bruce] Anchorage Field Off, Bur Land Management, Anchorage, AK USA	California State University System; San Francisco State University; University of California System; University of California Los Angeles; University of California System; University of California Davis	Loiseau, C (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	clair.loiseau@gmail.com	B, A N/E-9182-2011	SEHGAL, Ravinder/0000-0002-5255-4641; Loiseau, Claire/0000-0002-0407-2904	AXA Research Fund; The National Geographic Committee for Research and Exploration grant [9072-12he]	AXA Research Fund(AXA Research Fund); The National Geographic Committee for Research and Exploration grant	AXA Research Fund and The National Geographic Committee for Research and Exploration grant 9072-12he supported this work by funding equipment and field expenses as well as the salary of one post doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; Ball MC, 2001, CAN J ZOOL, V79, P1265, DOI 10.1139/cjz-79-7-1265; Barnard WH, 2010, CONDOR, V112, P849, DOI 10.1525/cond.2010.100143; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Davidson R, 2011, TRENDS PARASITOL, V27, P238, DOI 10.1016/j.pt.2011.02.001; Deviche P, 2001, J WILDLIFE DIS, V37, P28, DOI 10.7589/0090-3558-37.1.28; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Gardner AM, 2012, J MED ENTOMOL, V49, P270, DOI 10.1603/ME11073; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gjullin CM, 1961, AGR HDB, V182; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hellgren O, 2005, J ORNITHOL, V146, P55, DOI 10.1007/s10336-004-0055-4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Krams I, 2010, ANN ZOOL FENN, V47, P335, DOI 10.5735/086.047.0504; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Laaksonen S, 2010, ECOHEALTH, V7, P7, DOI 10.1007/s10393-010-0308-z; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; MacDonald GM, 2010, J EXP BIOL, V213, P855, DOI 10.1242/jeb.039511; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Matthews KR, 2011, SCIENCE, V332, P421; MEYER CL, 1976, CAN J ZOOL, V54, P133, DOI 10.1139/z76-014; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Pyle P., 1997, IDENTIFICATION GUI 1; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Ramirez J, 2008, HIGH RESOLUTION STAT; Sainz-Elipe S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-221; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Yohannes E, 2009, J ORNITHOL, V150, P287, DOI 10.1007/s10336-008-0349-z	41	78	80	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44729	10.1371/journal.pone.0044729	http://dx.doi.org/10.1371/journal.pone.0044729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028595	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400036
J	Xu, GYG; Slebodnick, C; Etzkorn, FA				Xu, Guoyan G.; Slebodnick, Carla; Etzkorn, Felicia A.			Cyclohexyl Ketone Inhibitors of Pin1 Dock in a Trans-Diaxial Cyclohexane Conformation	PLOS ONE			English	Article							ALZHEIMERS GAMMA-SECRETASE; CIS/TRANS ISOMERASE PIN1; SUBSTRATE RECOGNITION; PROLINE ISOMERIZATION; PROLYL; CYCLOPHILIN; MECHANISM; CATALYSIS; INACTIVATION; CALCINEURIN	Cyclohexyl ketone substrate analogue inhibitors (Ac-pSer-Psi[C = OCH]-Pip-tryptamine) of Pin1, the cell cycle regulatory peptidyl-prolyl isomerase (PPIase), were designed and synthesized as potential electrophilic acceptors for the Pin1 active site Cys113 nucleophile to test a proposed nucleophilic addition-isomerization mechanism. Because they were weak inhibitors, models of all three stereoisomers were docked into the active site of Pin1. Each isomer consistently minimized to a trans-diaxial cyclohexane conformation. From this, we hypothesize that Pin1 stretches substrates into a trans-pyrrolidine conformation to lower the barrier to isomerization. Our reduced amide inhibitor of Pin1 adopted a similar trans-pyrrolidine conformation in the crystal structure. The molecular model of 1, which mimics the L-Ser-L-Pro stereochemistry, in the Pin1 active site showed a distance of 4.4 angstrom, and an angle of 31 degrees between Cys113-S and the ketone carbon. The computational models suggest that the mechanism of Pin1 PPIase is not likely to proceed through nucleophilic addition.	[Xu, Guoyan G.; Slebodnick, Carla; Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Etzkorn, FA (corresponding author), Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA.	fetzkorn@vt.edu		Etzkorn, Felicia A./0000-0001-5850-3661; Slebodnick, Carla/0000-0003-4188-7595	National Institutes of Health (NIH) [R01 CA110940, S10 RR16658]; NATIONAL CANCER INSTITUTE [R01CA110940] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016658] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank National Institutes of Health (NIH) (http://www.nih.gov/) grant R01 CA110940, and NIH grant S10 RR16658 for the LC-MSMS, and Oxford Instruments for the use of the diffractometer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton D. H. R., 1997, ORG SYNTH, V74, P101; Braukmuller S, 2006, EUR J ORG CHEM, V2006, P2110, DOI 10.1002/ejoc.200500961; Chatterjee S, 1997, J MED CHEM, V40, P3820, DOI 10.1021/jm970197e; Dai Y, 2000, BIOCHEMISTRY-US, V39, P6498, DOI 10.1021/bi0002378; Daum S, 2006, ANGEW CHEM INT EDIT, V45, P7454, DOI 10.1002/anie.200601569; DEBONT HBA, 1989, INT J PEPT PROT RES, V33, P115; DELANO WL, 2006, MACPYMOL; ETZKORN FA, 1993, CURR OPIN STRUC BIOL, V3, P929, DOI 10.1016/0959-440X(93)90158-H; FISCHER S, 1993, BIOCHEMISTRY-US, V32, P13830, DOI 10.1021/bi00213a011; Frisch MJ, 2009, GAUSSIAN; HARRISON RK, 1990, J AM CHEM SOC, V112, P7063, DOI 10.1021/ja00175a052; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hur S, 2002, J AM CHEM SOC, V124, P7303, DOI 10.1021/ja020222s; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Moore CL, 2000, J MED CHEM, V43, P3434, DOI 10.1021/jm000100f; Namanja AT, 2007, STRUCTURE, V15, P313, DOI 10.1016/j.str.2007.01.014; *OXF DIFFR, 2004, CRYSALIS V1 171; PARK ST, 1992, J BIOL CHEM, V267, P3316; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Schroeder OE, 2006, J PHYS CHEM A, V110, P6522, DOI 10.1021/jp060642u; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; *TRIP INT, 2008, SYBYL; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wang XDJ, 2004, J AM CHEM SOC, V126, P15533, DOI 10.1021/ja046396m; Wang XDJ, 2003, J ORG CHEM, V68, P2343, DOI 10.1021/jo026663b; Wiederrecht Greg, 1994, Perspectives in Drug Discovery and Design, V2, P57, DOI 10.1007/BF02171737; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; WILLIAMS DR, 1989, J AM CHEM SOC, V111, P1923, DOI 10.1021/ja00187a081; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Xie J, 2005, CARBOHYD RES, V340, P481, DOI 10.1016/j.carres.2004.12.001; Xu GYG, 2011, BIOCHEMISTRY-US, V50, P9545, DOI 10.1021/bi201055c; Xu GYG, 2010, ORG LETT, V12, P696, DOI 10.1021/ol9027013; Xu GYG, 2009, DRUG NEWS PERSPECT, V22, P399, DOI [10.1358/dnp.2009.22.7.1381751, 10.1358/dnp.2009.22.7.1414594]; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang MM, 2012, ACS CHEM BIOL, V7, P1462, DOI 10.1021/cb3000887; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhang YX, 2002, BIOCHEMISTRY-US, V41, P11868, DOI 10.1021/bi0262395; Zhao S, 2007, BIOORG MED CHEM LETT, V17, P6615, DOI 10.1016/j.bmcl.2007.09.073; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	44	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44226	10.1371/journal.pone.0044226	http://dx.doi.org/10.1371/journal.pone.0044226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028504	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400022
J	Yan, F; Liu, HH; Hao, JJ; Liu, ZR				Yan, Fang; Liu, Haihong; Hao, Junjun; Liu, Zengrong			Dynamical Behaviors of Rb-E2F Pathway Including Negative Feedback Loops Involving miR449	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CELL-PROLIFERATION; MICRORNAS; NETWORK; DIFFERENTIATION; MODEL; E2F1; TARGETS; SWITCH; LIFE	MiRNAs, which are a family of small non-coding RNAs, regulate a broad array of physiological and developmental processes. However, their regulatory roles have remained largely mysterious. E2F is a positive regulator of cell cycle progression and also a potent inducer of apoptosis. Positive feedback loops in the regulation of Rb-E2F pathway are predicted and shown experimentally. Recently, it has been discovered that E2F induce a cluster of miRNAs called miR449. In turn, E2F is inhibited by miR449 through regulating different transcripts, thus forming negative feedback loops in the interaction network. Here, based on the integration of experimental evidence and quantitative data, we studied Rb-E2F pathway coupling the positive feedback loops and negative feedback loops mediated by miR449. Therefore, a mathematical model is constructed based in part on the model proposed in Yao-Lee et al. (2008) and nonlinear dynamical behaviors including the stability and bifurcations of the model are discussed. A comparison is given to reveal the implication of the fundamental differences of Rb-E2F pathway between regulation and deregulation of miR449. Coherent with the experiments it predicts that miR449 plays a critical role in regulating the cell cycle progression and provides a twofold safety mechanism to avoid excessive E2F-induced proliferation by cell cycle arrest and apoptosis. Moreover, numerical simulation and bifurcation analysis shows that the mechanisms of the negative regulation of miR449 to three different transcripts are quite distinctive which needs to be verified experimentally. This study may help us to analyze the whole cell cycle process mediated by other miRNAs more easily. A better knowledge of the dynamical behaviors of miRNAs mediated networks is also of interest for bio-engineering and artificial control.	[Yan, Fang; Liu, Zengrong] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Yan, Fang; Hao, Junjun; Liu, Zengrong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Haihong] Yunnan Normal Univ, Dept Math, Kunming, Peoples R China	Shanghai University; Shanghai University; Yunnan Normal University	Liu, ZR (corresponding author), Shanghai Univ, Dept Math, Shanghai, Peoples R China.	zrongliu@126.com		Yan, Fang/0000-0001-6624-9720	National Natural Science Foundation of China (NSFC) [10832006, 11172158]; Yunnan NSFC [2011FZ086]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunnan NSFC	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant No. 10832006 and 11172158) and Yunnan NSFC (Grant No. 2011FZ086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin K, 2010, MOL DIVERS, V14, P719, DOI 10.1007/s11030-009-9216-y; Liu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017029; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Obeyesekere MN, 1999, B MATH BIOL, V61, P917, DOI 10.1006/bulm.1999.0118; Petri A, 2009, CANCER RES, V69, P393, DOI 10.1158/0008-5472.CAN-08-2749; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Stiefel KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003947; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650	48	24	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43908	10.1371/journal.pone.0043908	http://dx.doi.org/10.1371/journal.pone.0043908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028477	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900011
J	Wang, YJ; Tang, X; Yu, B; Gu, Y; Yuan, Y; Yao, DB; Ding, F; Gu, XS				Wang, Yongjun; Tang, Xin; Yu, Bin; Gu, Yun; Yuan, Ying; Yao, Dengbing; Ding, Fei; Gu, Xiaosong			Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SCHWANN-CELL DEATH; FACTOR-ALPHA; TNF-ALPHA; INFLAMMATORY MEDIATORS; IN-VITRO; ACTIVATION; MECHANISMS; EXPRESSION; DEGENERATION	Crush injury or axotomy of peripheral nerves results in the rapid production of the inflammatory cytokines, which were confirmed in various models, to some extent, to be noxious to the myelin sheath or Schwann cells (SCs). TNF-alpha is one of the primary initiators of the inflammatory cascade and exerts pleiotropic functions in the physiological conditions by binding to its receptors, type I (TNFRI) and type II (TNFRII). The pathway molecules TNFRI, Birc2 and Birc3 play key roles during the activation of the signaling. Injured peripheral nerves, preventing them from TNF-alpha-mediated destruction and proceeding to successful regeneration, might initiate an anti-apoptotic mechanism. To identity the exact functions of TNFRI, Birc2 and Birc3, as well as its involved pathways in the cellular events, we inferred a dynamic gene regulatory network from short time-series measurements of the proximal nerve segment cDNA microarray following rat sciatic nerve transection. TNFRI family member Tnfrsf1a, Birc2 and Birc3 were mined out integrating as master regulators to mediate inflammatory responses. Experiments revealed that Tnfrsf1a, Birc2 and Birc3 proteins colocalized with S100 in the rat peripheral nerve tissues, and the expression levels increased with the time extension. Knockdown of the proteins induced the apoptotic formation of primary cultured SCs by upregulation of caspase 3 and caspase 6. Our systematic analysis indicated that Tnfrsf1a, Birc2 and Birc3 of SCs, not originally regarded as XIAP, were mainly responsible for the inflammation-mediated anti-apoptosis of peripheral nerves. Birc2 and Birc3 might be the most potential targets for anti-apoptotic protection mediated by inflammatory cytokines.	[Wang, Yongjun; Tang, Xin; Yu, Bin; Gu, Yun; Yuan, Ying; Yao, Dengbing; Ding, Fei; Gu, Xiaosong] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China	Nantong University	Gu, XS (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn			National Natural Science Foundation of China [81130080, 81171180, 81000678]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation [BK2008010]; Jiangsu Education Department [08KJA310002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Education Department	This study was supported by the National Natural Science Foundation of China (Grant No. 81130080, No. 81171180 and No. 81000678), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Jiangsu Provincial Natural Science Foundation (Grant No. BK2008010), and the Basic Research Program of Jiangsu Education Department (Grant No. 08KJA310002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Bonetti B, 2000, J NEUROPATH EXP NEUR, V59, P74, DOI 10.1093/jnen/59.1.74; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Deretzi G, 1999, IMMUNOLOGY, V97, P582; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Dhadialla PS, 2009, P NATL ACAD SCI USA, V106, P12494, DOI 10.1073/pnas.0902237106; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; HARTUNG HP, 1992, J NEUROIMMUNOL, V40, P197, DOI 10.1016/0165-5728(92)90134-7; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jensen LE, 2003, CELL SIGNAL, V15, P793, DOI 10.1016/S0898-6568(03)00039-1; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; OPPENHEIM JJ, 2001, CYTOKINE REFERENCE, P3; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; Petratos S, 2003, J NEUROPATH EXP NEUR, V62, P398, DOI 10.1093/jnen/62.4.398; Popko B, 2010, NAT NEUROSCI, V13, P275, DOI 10.1038/nn0310-275; Qin YW, 2008, NEUROCHEM RES, V33, P1077, DOI 10.1007/s11064-007-9552-1; REDFORD EJ, 1995, BRAIN, V118, P869, DOI 10.1093/brain/118.4.869; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Stuebgen JP, 2008, MUSCLE NERVE, V37, P281, DOI 10.1002/mus.20924; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; Tao T, 2009, J NEUROCHEM, V111, P647, DOI 10.1111/j.1471-4159.2009.06346.x; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200	43	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43436	10.1371/journal.pone.0043436	http://dx.doi.org/10.1371/journal.pone.0043436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028454	gold, Green Published, Green Submitted			2022-12-25	WOS:000309742800004
J	Bagnall, RD; Tsoutsman, T; Shephard, RE; Ritchie, W; Semsarian, C				Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Ritchie, William; Semsarian, Christopher			Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; EXPRESSION; MUTATIONS; COMPOUND; DISEASE; GENES; IDENTIFICATION; PROLIFERATION; CARDIOGENESIS; DYSREGULATION	MicroRNAs (miRNAs) regulate post-transcriptional gene expression during development and disease. We have determined the miRNA expression levels of early- and end-stage hypertrophic cardiomyopathy (HCM) in a severe, transgenic mouse model of the disease. Five miRNAs were differentially expressed at an early stage of HCM development. Time-course analysis revealed that decreased expression of miR-1 and miR-133a commences at a pre-disease stage, and precedes upregulation of target genes causal of cardiac hypertrophy and extracellular matrix remodelling, suggesting a role for miR-1 and miR-133a in early disease development. At end-stage HCM, 16 miRNA are dysregulated to form an expression profile resembling that of other forms of cardiac hypertrophy, suggesting common responses. Analysis of the mRNA transcriptome revealed that miRNAs potentially target 15.7% upregulated and 4.8% downregulated mRNAs at end-stage HCM, and regulate mRNAs associated with cardiac hypertrophy and electrophysiology, calcium signalling, fibrosis, and the TGF-beta signalling pathway. Collectively, these results define the miRNA expression signatures during development and progression of severe HCM and highlight critical miRNA regulated gene networks that are involved in disease pathogenesis.	[Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia; [Bagnall, Richard D.; Tsoutsman, Tatiana; Shephard, Rhian E.; Semsarian, Christopher] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ritchie, William] Royal Prince Alfred Hosp, Centenary Inst, Dept Bioinformat, Sydney, NSW, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Bagnall, RD (corresponding author), Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia.	c.semsarian@centenary.org.au			Rotary Australia PhD scholarship; National Health and Medical Research Council (NHMRC) of Australia fellowship [517756]; NHMRC Practitioner fellowship [571084]; NHMRC [635576]	Rotary Australia PhD scholarship; National Health and Medical Research Council (NHMRC) of Australia fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	RS is the recipient of a Rotary Australia PhD scholarship (www.rotaryaustralia.org.au). WR is a recipient of a National Health and Medical Research Council (NHMRC) of Australia fellowship (No. 517756; www.nhmrc.gov.au). CS is the recipient of an NHMRC Practitioner fellowship (No. 571084). This work was supported by a research project grant from NHMRC (No. 635576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lind Joanne M, 2006, Expert Rev Cardiovasc Ther, V4, P927, DOI 10.1586/14779072.4.6.927; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Maron BJ, 2012, HEART RHYTHM, V9, P57, DOI 10.1016/j.hrthm.2011.08.009; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schellings MWM, 2009, J CELL COMMUN SIGNAL, V3, P201, DOI 10.1007/s12079-009-0070-6; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shephard R, 2009, J CARDIOVASC TRANSL, V2, P471, DOI 10.1007/s12265-009-9120-y; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	41	61	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44744	10.1371/journal.pone.0044744	http://dx.doi.org/10.1371/journal.pone.0044744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024758	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100016
J	Lim, TS; Goh, JKH; Mortellaro, A; Lim, CT; Hammerling, GJ; Ricciardi-Castagnoli, P				Lim, Tong Seng; Goh, James Kang Hao; Mortellaro, Alessandra; Lim, Chwee Teck; Haemmerling, Guenter J.; Ricciardi-Castagnoli, Paola			CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-Cells	PLOS ONE			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTERS; ATOMIC-FORCE MICROSCOPY; KINASE-C-THETA; IMMUNOLOGICAL SYNAPSE; MOLECULAR-CLONING; LYMPH-NODES; LIPID RAFTS; CD28; RECEPTOR; CTLA-4	Functional T-cell responses are initiated by physical interactions between T-cells and antigen-presenting cells (APCs), including dendritic cells (DCs) and B-cells. T-cells are activated more effectively by DCs than by B-cells, but little is known about the key molecular mechanisms that underpin the particular potency of DC in triggering T-cell responses. To better understand the influence of physical intercellular interactions on APC efficacy in activating T-cells, we used single cell force spectroscopy to characterize and compare the mechanical forces of interactions between DC:T-cells and B:T-cells. Following antigen stimulation, intercellular interactions of DC:T-cell conjugates were stronger than B:T-cell interactions. DCs induced higher levels of T-cell calcium mobilization and production of IL-2 and IFN gamma than were elicited by B-cells, thus suggesting that tight intercellular contacts are important in providing mechanically stable environment to initiate T-cell activation. Blocking antibodies targeting surface co-stimulatory molecules CD80 or CD86 weakened intercellular interactions and dampen T-cell activation, highlighting the amplificatory roles of CD80/86 in regulating APC:T-cell interactions and T-cell functional activation. The variable strength of mechanical forces between DC:T-cells and B:T-cell interactions were not solely dependent on differential APC expression of CD80/86, since DCs were superior to B-cells in promoting strong interactions with T-cells even when CD80 and CD86 were inhibited. These data provide mechanical insights into the effects of costimulatory molecules in regulating APC:T-cell interactions.	[Lim, Tong Seng; Goh, James Kang Hao; Mortellaro, Alessandra; Ricciardi-Castagnoli, Paola] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Haemmerling, Guenter J.] German Canc Res Ctr, Div Mol Immunol, Heidelberg, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; National University of Singapore; Helmholtz Association; German Cancer Research Center (DKFZ)	Lim, TS (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	lim_tong_seng@immunol.a-star.edu.sg; paola_castagnoli@immunol.a-star.edu.sg	Lim, chwee Teck/B-3307-2011; Mortellaro, Alessandra/AAN-4678-2020	Lim, chwee Teck/0000-0003-4019-9782; Mortellaro, Alessandra/0000-0003-1744-2430	Biomedical Research Council (BMRC); Joint Council Office Grant (JCO) from the Agency for Science, Technology and Research (A*STAR) [10/03/FG/05/03]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Joint Council Office Grant (JCO) from the Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council (BMRC) and Joint Council Office Grant (JCO Grant No: 10/03/FG/05/03) from the Agency for Science, Technology and Research (A*STAR) are acknowledged for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Andres PG, 2004, J IMMUNOL, V172, P5880, DOI 10.4049/jimmunol.172.10.5880; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bhatia S, J IMMUNOL, V184, P1821; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; GROSS JA, 1990, J IMMUNOL, V144, P3201; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaga S, 1998, J IMMUNOL, V160, P24; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kovacs B, 2005, J IMMUNOL, V175, P7848, DOI 10.4049/jimmunol.175.12.7848; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lim TS, 2011, J IMMUNOL, V187, P258, DOI 10.4049/jimmunol.1100267; Lim TS, J IMMUNOL, V187, P258; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Masten BJ, 1999, J IMMUNOL, V162, P1310; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; Sadra A, 2004, P NATL ACAD SCI USA, V101, P11422, DOI 10.1073/pnas.0403792101; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Tomas EM, 2002, IMMUNOL LETT, V83, P143, DOI 10.1016/S0165-2478(02)00075-5; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Wetzel SA, 2002, J IMMUNOL, V169, P6092, DOI 10.4049/jimmunol.169.11.6092; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wojcikiewicz EP, 2006, BIOMACROMOLECULES, V7, P3188, DOI 10.1021/bm060559c; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	61	78	83	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45185	10.1371/journal.pone.0045185	http://dx.doi.org/10.1371/journal.pone.0045185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024807	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100065
J	Duan, CH; Zhu, LC; Xu, Y; Lau, GW				Duan, Chaohui; Zhu, Luchang; Xu, Ying; Lau, Gee W.			Saturated Alanine Scanning Mutagenesis of the Pneumococcus Competence Stimulating Peptide Identifies Analogs That Inhibit Genetic Transformation	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE VIRULENCE; GENUS STREPTOCOCCUS; HORIZONTAL TRANSFER; REGULATORY SYSTEM; PHEROMONE; RESISTANCE; COLONIZATION; SPECIFICITY; MECHANISMS; INDUCTION	Antibiotic resistance is a major challenge to modern medicine. Intraspecies and interspecies dissemination of antibiotic resistance genes among bacteria can occur through horizontal gene transfer. Competence-mediated gene transfer has been reported to contribute to the spread of antibiotic resistance genes in Streptococcus pneumoniae. Induction of the competence regulon is mediated by a 17-amino acid peptide pheromone called the competence stimulating peptide (CSP). Thus, synthetic analogs that competitively inhibit CSPs may reduce horizontal gene transfer. We performed saturated alanine scanning mutagenesis and other amino acid substitutions on CSP1 to screen for analogs that disable genetic transformation in S. pneumoniae. Substitution of the glutamate residue at the first position created analogs that could competitively inhibit CSP1-mediated competence development in a concentration-dependent manner. Additional substitutions of the negatively-charged glutamate residue with amino acids of different charge, acidity and hydrophobicity, as well as enantiomeric D-glutamate, generated analogs that efficiently outcompeted CSP1, suggesting the importance of negative charge and enantiomericity of the first glutamate residue for the function of CSP1. Collectively, these results indicate that glutamate residue at the first position is important for the ability of CSP1 to induce ComD, but is dispensable for the peptide to bind the receptor. Furthermore, these results demonstrate the potential applicability of competitive CSP analogs to control horizontal transfer of antibiotic resistance genes in S. pneumoniae.	[Duan, Chaohui; Zhu, Luchang; Xu, Ying; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Duan, Chaohui; Xu, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Immunol Lab, Guangzhou 510275, Guangdong, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Sun Yat Sen University	Duan, CH (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL USA.	geelau@illinois.edu	Zhu, Luchang/C-9784-2017; Lau, Gee W/H-4073-2018	Zhu, Luchang/0000-0002-4064-5781; 	National Institutes of Health [HL090699]; University of Illinois Research Board; Research Facilities Improvement Program from National Center for Research Resources, National Institutes of Health [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Research Board; Research Facilities Improvement Program from National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by the National Institutes of Health (HL090699) and a University of Illinois Research Board Arnold O. Beckman research award to G.W. Lau. This investigation was conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY OT, 1979, J EXP MED, V149, P297, DOI 10.1084/jem.149.2.297; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; COOMARASWAMY G, 1996, THESIS U ILLINOIS CH; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Iannelli F, 2005, FEMS MICROBIOL LETT, V252, P321, DOI 10.1016/j.femsle.2005.09.008; Jacobs MR, 2008, EXPERT REV ANTI-INFE, V6, P619, DOI 10.1586/14787210.6.5.619; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Jones RN, 2010, INT J ANTIMICROB AG, V36, P197, DOI 10.1016/j.ijantimicag.2010.04.013; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; MORRISON DA, 1979, NATURE, V282, P215, DOI 10.1038/282215a0; Morrison DA, 2000, RES MICROBIOL, V151, P445, DOI 10.1016/S0923-2508(00)00171-6; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Pozzi Gianni, 2004, Current Drug Targets - Infectious Disorders, V4, P203, DOI 10.2174/1568005043340641; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Shen XZ, 2008, MICROB DRUG RESIST, V14, P155, DOI 10.1089/mdr.2008.0773; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Widdowson CA, 1998, MICROB DRUG RESIST, V4, P79, DOI 10.1089/mdr.1998.4.79; Zhu LC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002241	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44710	10.1371/journal.pone.0044710	http://dx.doi.org/10.1371/journal.pone.0044710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028586	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700030
J	Shafat, I; Agbaria, A; Boaz, M; Schwartz, D; Baruch, R; Nakash, R; Ilan, N; Vlodavsky, I; Weinstein, T				Shafat, Itay; Agbaria, Amir; Boaz, Mona; Schwartz, Doron; Baruch, Ronny; Nakash, Richard; Ilan, Neta; Vlodavsky, Israel; Weinstein, Talia			Elevated Urine Heparanase Levels Are Associated with Proteinuria and Decreased Renal Allograft Function	PLOS ONE			English	Article							OVERT DIABETIC-NEPHROPATHY; TISSUE FACTOR; MAMMALIAN HEPARANASE; INCREASED EXPRESSION; GLOMERULAR-DISEASES; REDUCES PROTEINURIA; NEPHROTIC SYNDROME; BASEMENT-MEMBRANE; HEYMANN NEPHRITIS; SULFATE	Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate side chains, leading to structural modifications that loosen the extracellular matrix barrier and associated with tumor metastasis, inflammation and angiogenesis. In addition, the highly sulfated heparan sulfate proteoglycans are important constituents of the glomerular basement membrane and its permselective properties. Recent studies suggest a role for heparanase in several experimental and human glomerular diseases associated with proteinuria such as diabetes, minimal change disease, and membranous nephropathy. Here, we quantified blood and urine heparanase levels in renal transplant recipients and patients with chronic kidney disease (CKD), and assessed whether alterations in heparanase levels correlate with proteinuria and renal function. We report that in transplanted patients, urinary heparanase was markedly elevated, inversely associated with estimated glomerular filtration rate (eGFR), suggesting a relationship between heparanase and graft function. In CKD patients, urinary heparanase was markedly elevated and associated with proteinuria, but not with eGFR. In addition, urinary heparanase correlated significantly with plasma heparanase in transplanted patients. Such a systemic spread of heparanase may lead to damage of cells and tissues alongside the kidney. The newly described association between heparanase, proteinuria and decreased renal function is expected to pave the way for new therapeutic options aimed at attenuating chronic renal allograft nephropathy, leading to improved graft survival and patient outcome.	[Shafat, Itay; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Agbaria, Amir; Schwartz, Doron; Baruch, Ronny; Weinstein, Talia] Tel Aviv Med Ctr & Sch Med, Dept Nephrol, Tel Aviv, Israel; [Boaz, Mona] E Wolfson Med Ctr, Epidemiol Unit, Holon, Israel; [Nakash, Richard] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Med Ctr, Transplant Clin, IL-69978 Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Shafat, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	vlodavsk@cc.huji.ac.il; tweinste@post.tau.ac.il	Boaz, Mona/O-6940-2014	Boaz, Mona/0000-0002-3920-7549	Israel Science Foundation [549/06]; Israel Ministry of Health, National Cancer Institute, National Institutes of Health [RO1-CA106456]; Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation [JDRF 1-2006-695, 38-2009-635]; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health, National Cancer Institute, National Institutes of Health; Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (549/06); Israel Ministry of Health, National Cancer Institute, National Institutes of Health (RO1-CA106456); the Israel Cancer Research Fund (ICRF); and the Juvenile Diabetes Research Foundation (JDRF 1-2006-695 and 38-2009-635). IV is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2009, J AM SOC NEPHROL, V20, P2490, DOI 10.1681/ASN.2008091005; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Holt RCL, 2005, KIDNEY INT, V67, P122, DOI 10.1111/j.1523-1755.2005.00062.x; Kanwar YS, 2007, AM J PATHOL, V171, P9, DOI 10.2353/ajpath.2007.070356; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; Kramer A, 2006, J AM SOC NEPHROL, V17, P2513, DOI 10.1681/ASN.2006020184; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levidiotis V, 2005, NEPHROLOGY, V10, P167, DOI 10.1111/j.1440-1797.2005.00388.x; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P2882, DOI 10.1097/01.ASN.0000142426.55612.6D; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levidiotis V, 2001, KIDNEY INT, V60, P1287, DOI 10.1046/j.1523-1755.2001.00934.x; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Lewis KD, 2008, INVEST NEW DRUG, V26, P89, DOI 10.1007/s10637-007-9080-5; Massy ZA, 1996, KIDNEY INT, V49, P518, DOI 10.1038/ki.1996.74; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Myler HA, 2006, J BIOCHEM, V139, P339, DOI 10.1093/jb/mvj061; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Nadir Y, 2008, THROMB HAEMOSTASIS, V99, P133, DOI 10.1055/s-0037-1608919; Nadir Y, 2010, HAEMATOL-HEMATOL J, V95, P1927, DOI 10.3324/haematol.2010.023713; Najafian B, 2008, CURR OPIN NEPHROL HY, V17, P149, DOI 10.1097/MNH.0b013e3282f4e514; Raats CJI, 1999, J AM SOC NEPHROL, V10, P1689; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Shafat I, 2007, NEOPLASIA, V9, P909, DOI 10.1593/neo.07673; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2008, NEOPLASIA, V10, P125, DOI 10.1593/neo.07875; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wijnhoven TJM, 2008, DIABETOLOGIA, V51, P372, DOI 10.1007/s00125-007-0879-6; Wijnhoven TJM, 2007, CURR OPIN MOL THER, V9, P364; Yilmaz MI, 2011, NEPHROL DIA IN PRESS	45	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44076	10.1371/journal.pone.0044076	http://dx.doi.org/10.1371/journal.pone.0044076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028487	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700014
J	Yang, S; Li, Y; Gao, J; Zhang, T; Li, S; Luo, A; Chen, H; Ding, F; Wang, X; Liu, Z				Yang, S.; Li, Y.; Gao, J.; Zhang, T.; Li, S.; Luo, A.; Chen, H.; Ding, F.; Wang, X.; Liu, Z.			MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1	ONCOGENE			English	Article						miR-34a; miR-34c; breast cancer; metastasis	NEGATIVE FEEDBACK LOOP; C-MET EXPRESSION; MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; DOWN-REGULATION; INHIBITS MIGRATION; MIR-34A; FAMILY; METHYLATION	MicroRNAs have key roles in tumor metastasis. Here, we describe the regulation and function of miR-34a and miR-34c (miR-34a/c) in breast cancer metastasis. Expression analysis verified that miR-34a/c expression is significantly decreased in metastatic breast cancer cells and human primary breast tumors with lymph node metastases. Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo. Further studies revealed that Fos-related antigen 1 (Fra-1 or Fosl1) is a downstream target of miR-34a/c as miR-34a/c bound directly to the 3'untranslated region of Fra-1, subsequently reducing both the mRNA and protein levels of Fra-1. Silencing of Fra-1 recapitulated the effects of miR-34a/c overexpression, whereas enforced expression of Fra-1 reverses the suppressive effects of miR-34a/c. Moreover, significant downregulation of miR-34a in metastatic breast cancer tissues was found to be inversely correlated with Fra-1 expression. Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer.	[Yang, S.; Li, Y.; Zhang, T.; Li, S.; Luo, A.; Chen, H.; Ding, F.; Liu, Z.] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Yang, S.; Li, Y.; Gao, J.; Zhang, T.; Li, S.; Luo, A.; Chen, H.; Ding, F.; Wang, X.; Liu, Z.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gao, J.; Wang, X.] Chinese Acad Med Sci, Dept Abdominal Surg, Canc Inst & Hosp, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Wang, X (corresponding author), Chinese Acad Med Sci, Dept Abdominal Surg, Canc Inst & Hosp, Beijing 100021, Peoples R China.	xiangw@vip.sina.com; liuzh@cicams.ac.cn	Yang, Shouhui/M-5374-2017	Wang, Xiang/0000-0002-1522-9532; Li, Sheng/0000-0001-8080-9712	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [91019009, 81021061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Ziqiang Zhang, Yongquan Wang and Zhiyuan Wu for providing technical support. This work was supported by the National Basic Research Program of China (2011CB504205) and National Natural Science Foundation of China (91019009, 81021061).	Bamberger AM, 1999, INT J CANCER, V84, P533, DOI 10.1002/(SICI)1097-0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bieche I, 1999, GENE CHROMOSOME CANC, V24, P255, DOI 10.1002/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO;2-2; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen L, 2009, CANCER RES, V69, P8853, DOI 10.1158/0008-5472.CAN-09-1636; Chiappetta G, 2000, CLIN CANCER RES, V6, P4300; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Debinski W, 2005, MOL CANCER RES, V3, P237; Ellsworth RE, 2008, BREAST CANCER RES TR, V107, P259, DOI 10.1007/s10549-007-9547-2; Ellsworth RE, 2003, CANCER EPIDEM BIOMAR, V12, P915; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Lv Xiao-Bin, 2011, Chin J Cancer, V30, P821, DOI 10.5732/cjc.011.10289; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mackiewicz M, 2011, BREAST CANCER RES TR, V130, P663, DOI 10.1007/s10549-011-1690-0; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; NAGAI H, 1995, CANCER RES, V55, P1752; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Osborne RJ, 2000, CANCER RES, V60, P3706; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sayan AE, 2011, ONCOGENE, V25, P8; Serewko MM, 2002, CANCER RES, V62, P3759; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tkach V, 2003, ONCOGENE, V22, P5045, DOI 10.1038/sj.onc.1206570; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; WINQVIST R, 1995, CANCER RES, V55, P2660; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Yu FY, 2012, J BIOL CHEM, V287, P465, DOI 10.1074/jbc.M111.280768; Zajchowski DA, 2001, CANCER RES, V61, P5168	67	176	181	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4294	4303		10.1038/onc.2012.432	http://dx.doi.org/10.1038/onc.2012.432			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23001043				2022-12-25	WOS:000324168000011
J	Ghosh, A; Corbett, GT; Gonzalez, FJ; Pahan, K				Ghosh, Arunava; Corbett, Grant T.; Gonzalez, Frank J.; Pahan, Kalipada			Gemfibrozil and Fenofibrate, Food and Drug Administration-approved Lipid-lowering Drugs, Up-regulate Tripeptidyl-peptidase 1 in Brain Cells via Peroxisome Proliferator-activated Receptor alpha IMPLICATIONS FOR LATE INFANTILE BATTEN DISEASE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; RETINOID-X-RECEPTOR; DENSITY-LIPOPROTEIN-CHOLESTEROL; LYSOSOMAL STORAGE DISORDERS; KAPPA-B; MOUSE MODEL; ADOPTIVE TRANSFER; HUMAN ASTROCYTES; GENE-EXPRESSION; MESSENGER-RNAS	The classical late infantile neuronal ceroid lipofuscinosis (LINCLs) is an autosomal recessive disease, where the defective gene is Cln2, encoding tripeptidyl-peptidase I (TPP1). At the molecular level, LINCL is caused by accumulation of autofluorescent storage materials in neurons and other cell types. Currently, there is no established treatment for this fatal disease. This study reveals a novel use of gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, in up-regulating TPP1 in brain cells. Both gemfibrozil and fenofibrate up-regulated mRNA, protein, and enzymatic activity of TPP1 in primary mouse neurons and astrocytes as well as human astrocytes and neuronal cells. Because gemfibrozil and fenofibrate are known to activate peroxisome proliferator-activated receptor-alpha (PPAR alpha), the role of PPAR alpha in gemfibrozil-and fenofibrate-mediated up-regulation of TPP1 was investigated revealing that both drugs up-regulated TPP1 mRNA, protein, and enzymatic activity both in vitro and in vivo in wild type (WT) and PPAR alpha(-/-), but not PPAR alpha(-/-), mice. In an attempt to delineate the mechanism of TPP1 up-regulation, it was found that the effects of the fibrate drugs were abrogated in the absence of retinoid X receptor-alpha (RXR alpha), a molecule known to form a heterodimer with PPAR alpha. Accordingly, all-trans-retinoic acid, alone or together with gemfibrozil, up-regulated TPP1. Co-immuno-precipitation and ChIP studies revealed the formation of a PPAR alpha/RXR alpha heterodimer and binding of the heterodimer to an RXR-binding site on the Cln2 promoter. Together, this study demonstrates a unique mechanism for the up-regulation of TPP1 by fibrate drugs via PPAR alpha /RXR alpha pathway.	[Ghosh, Arunava; Corbett, Grant T.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161; Corbett, Grant/0000-0003-3606-9686	National Institutes of Health [AT6681, NS64564, NS71479]; Noah's Hope Foundation; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Noah's Hope Foundation; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479. This work was also supported by a generous donation from Noah's Hope Foundation.	Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602; Hachiya Y, 2006, ACTA NEUROPATHOL, V111, P168, DOI 10.1007/s00401-005-0024-x; Hemsley KM, 2010, J INHERIT METAB DIS, V33, P363, DOI 10.1007/s10545-010-9078-6; Jackson TC, 2007, TRANSPL INT, V20, P277, DOI 10.1111/j.1432-2277.2006.00431.x; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Lane SC, 1996, J NEUROCHEM, V67, P677; Marcus Sandra L., 1995, Gene Expression, V4, P227; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nishizawa H, 2003, J REPROD DEVELOP, V49, P539, DOI 10.1262/jrd.49.539; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Viglio S, 2001, ELECTROPHORESIS, V22, P2343, DOI 10.1002/1522-2683(20017)22:11<2343::AID-ELPS2343>3.0.CO;2-2; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Vuillemenot BR, 2011, MOL GENET METAB, V104, P325, DOI 10.1016/j.ymgme.2011.06.018; Walus M, 2010, HUM MUTAT, V31, P710, DOI 10.1002/humu.21251; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130	48	37	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38922	38935		10.1074/jbc.M112.365148	http://dx.doi.org/10.1074/jbc.M112.365148			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989886	Green Published, hybrid			2022-12-25	WOS:000310982800048
J	Brugarolas, P; Movahedzadeh, F; Wang, YH; Zhang, N; Bartek, IL; Gao, YHN; Voskuil, MI; Franzblau, SG; He, C				Brugarolas, Pedro; Movahedzadeh, Farahnaz; Wang, Yuehong; Zhang, Nan; Bartek, Iona L.; Gao, Yihe N.; Voskuil, Martin I.; Franzblau, Scott G.; He, Chuan			The Oxidation-sensing Regulator (MosR) Is a New Redox-dependent Transcription Factor in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL REGULATOR; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURES; REACTIVE OXYGEN; NITRIC-OXIDE; GENE; SURVIVAL; VIRULENCE; MECHANISM; DEFENSE	Mycobacterium tuberculosis thrives in oxidative environments such as the macrophage. To survive, the bacterium must sense and adapt to the oxidative conditions. Several antioxidant defenses including a thick cell wall, millimolar concentrations of small molecule thiols, and protective enzymes are known to help the bacterium withstand the oxidative stress. However, oxidation-sensing regulators that control these defenses have remained elusive. In this study, we report a new oxidation-sensing regulator, Rv1049 or MosR (M. tuberculosis oxidation-sensing regulator). MosR is a transcriptional repressor of the MarR family, which, similarly to Bacillus subtilis OhrR and Staphylococcus aureus MgrA, dissociates from DNA in the presence of oxidants, enabling transcription. MosR senses oxidation through a pair of cysteines near the N terminus (Cys-10 and Cys-12) that upon oxidation forms a disulfide bond. Disulfide formation rearranges a network of hydrogen bonds, which leads to a large conformational change of the protein and dissociation from DNA. MosR has been shown previously to play an important role in survival of the bacterium in the macrophage. In this study, we show that the main role of MosR is to up-regulate expression of rv1050 (a putative exported oxidoreductase that has not yet been characterized) in response to oxidants and propose that it is through this role that MosR contributes to the bacterium survival in the macrophage.	[Brugarolas, Pedro; Gao, Yihe N.; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Brugarolas, Pedro; Gao, Yihe N.; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Movahedzadeh, Farahnaz; Wang, Yuehong; Zhang, Nan; Franzblau, Scott G.] Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 60612 USA; [Bartek, Iona L.; Voskuil, Martin I.] Univ Colorado Denver, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	He, C (corresponding author), Univ Chicago, Dept Chem, GCIS 319B,929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Brugarolas, Pedro/0000-0002-7455-2743; Franzblau, Scott/0000-0002-8698-0243	National Institutes of Health from the NIAID [AI074658]; Chicago Biomedical Consortium; Chicago Community Trust; National Institutes of Health [R01 AI061505]; Fundacion Caja Madrid; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658, R01AI061505] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chicago Biomedical Consortium; Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Caja Madrid; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 (to C. H.) from the NIAID. This work was also supported by the Chicago Biomedical Consortium with support from The Searle Funds at the Chicago Community Trust (to C. H. and S. G. F.), a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.), National Institutes of Health Grant R01 AI061505 (to M. I. V.), and a Graduate Fellowship from Fundacion Caja Madrid (to P. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x; Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Ha UW, 1999, INFECT IMMUN, V67, P5324, DOI 10.1128/IAI.67.10.5324-5331.1999; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Leblanc B, 1994, Methods Mol Biol, V30, P1; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; McCann JR, 2011, J BACTERIOL, V193, P854, DOI 10.1128/JB.01271-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Petrova T, 2010, ACTA CRYSTALLOGR D, V66, P1075, DOI 10.1107/S0907444910033986; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson M, 2001, Methods Mol Med, V54, P335, DOI 10.1385/1-59259-147-7:335; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x	55	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388611	http://dx.doi.org/10.1074/jbc.M112.388611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992749	hybrid, Green Published			2022-12-25	WOS:000310642200010
J	Ramasamy, A; Kuokkanen, M; Vedantam, S; Gajdos, ZK; Alves, AC; Lyon, HN; Ferreira, MAR; Strachan, DP; Zhao, JH; Abramson, MJ; Brown, MA; Coin, L; Dharmage, SC; Duffy, DL; Haahtela, T; Heath, AC; Janson, C; Kahonen, M; Khaw, KT; Laitinen, J; Le Souef, P; Lehtimaki, T; Madden, PAF; Marks, GB; Martin, NG; Matheson, MC; Palmer, CD; Palotie, A; Pouta, A; Robertson, CF; Viikari, J; Widen, E; Wjst, M; Jarvis, DL; Montgomery, GW; Thompson, PJ; Wareham, N; Eriksson, J; Jousilahti, P; Laitinen, T; Pekkanen, J; Raitakari, OT; O'Connor, GT; Salomaa, V; Jarvelin, MR; Hirschhorn, JN				Ramasamy, Adaikalavan; Kuokkanen, Mikko; Vedantam, Sailaja; Gajdos, Zofia K.; Alves, Alexessander Couto; Lyon, Helen N.; Ferreira, Manuel A. R.; Strachan, David P.; Zhao, Jing Hua; Abramson, Michael J.; Brown, Matthew A.; Coin, Lachlan; Dharmage, Shyamali C.; Duffy, David L.; Haahtela, Tari; Heath, Andrew C.; Janson, Christer; Kahonen, Mika; Khaw, Kay-Tee; Laitinen, Jaana; Le Souef, Peter; Lehtimaki, Terho; Madden, Pamela A. F.; Marks, Guy B.; Martin, Nicholas G.; Matheson, Melanie C.; Palmer, Cameron D.; Palotie, Aarno; Pouta, Anneli; Robertson, Colin F.; Viikari, Jorma; Widen, Elisabeth; Wjst, Matthias; Jarvis, Deborah L.; Montgomery, Grant W.; Thompson, Philip J.; Wareham, Nick; Eriksson, Johan; Jousilahti, Pekka; Laitinen, Tarja; Pekkanen, Juha; Raitakari, Olli T.; O'Connor, George T.; Salomaa, Veikko; Jarvelin, Marjo-Riitta; Hirschhorn, Joel N.		Australian Asthma Genetics	Genome-Wide Association Studies of Asthma in Population-Based Cohorts Confirm Known and Suggested Loci and Identify an Additional Association near HLA	PLOS ONE			English	Article							CARDIOVASCULAR RISK; ROR-ALPHA; VARIANTS; GENETICS; LUNG; SUSCEPTIBILITY; METAANALYSIS; ALLERGY; HEALTH; HEART	Rationale: Asthma has substantial morbidity and mortality and a strong genetic component, but identification of genetic risk factors is limited by availability of suitable studies. Objectives: To test if population-based cohorts with self-reported physician-diagnosed asthma and genome-wide association (GWA) data could be used to validate known associations with asthma and identify novel associations. Methods: The APCAT (Analysis in Population-based Cohorts of Asthma Traits) consortium consists of 1,716 individuals with asthma and 16,888 healthy controls from six European-descent population-based cohorts. We examined associations in APCAT of thirteen variants previously reported as genome-wide significant (P < 5x10(-8)) and three variants reported as suggestive (P < 5 x 10(-7)). We also searched for novel associations in APCAT (Stage 1) and followed-up the most promising variants in 4,035 asthmatics and 11,251 healthy controls (Stage 2). Finally, we conducted the first genome-wide screen for interactions with smoking or hay fever. Main Results: We observed association in the same direction for all thirteen previously reported variants and nominally replicated ten of them. One variant that was previously suggestive, rs11071559 in RORA, now reaches genome-wide significance when combined with our data (P = 2.4x10(-9)). We also identified two genome-wide significant associations: rs13408661 near IL1RL1/IL18R1 (PStage1+Stage2 = 1.1x10(-9)), which is correlated with a variant recently shown to be associated with asthma (rs3771180), and rs9268516 in the HLA region (PStage1+Stage2 = 1.1x10(-8)), which appears to be independent of previously reported associations in this locus. Finally, we found no strong evidence for gene-environment interactions with smoking or hay fever status. Conclusions: Population-based cohorts with simple asthma phenotypes represent a valuable and largely untapped resource for genetic studies of asthma.	[Kuokkanen, Mikko; Jousilahti, Pekka; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ramasamy, Adaikalavan; Alves, Alexessander Couto; Coin, Lachlan; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Gajdos, Zofia K.; Lyon, Helen N.; Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Ferreira, Manuel A. R.; Duffy, David L.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Zhao, Jing Hua; Wareham, Nick] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Abramson, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Dharmage, Shyamali C.; Matheson, Melanie C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, St Louis, MO USA; [Haahtela, Tari] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Khaw, Kay-Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge, England; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Le Souef, Peter] Princess Margaret Hosp Children, Sch Paediat & Child Hlth, Perth, WA, Australia; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Palotie, Aarno] Wellcome Trust Sanger Inst, Hinxton, England; [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA USA; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Helsinki, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Wjst, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Munich, Germany; [Jarvis, Deborah L.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Laitinen, Tarja] Turku Univ Hosp, Dept Pulm Dis & Clin Allergol, FIN-20520 Turku, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Pekkanen, Juha] Natl Inst Hlth & Welf THL, Dept Environm Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Finland National Institute for Health & Welfare; Imperial College London; University of London; King's College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; QIMR Berghofer Medical Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Monash University; University of Queensland; University of Melbourne; Washington University (WUSTL); University of Helsinki; Helsinki University Central Hospital; Uppsala University; Tampere University; Tampere University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Finnish Institute of Occupational Health; University of Western Australia; Tampere University; University of Sydney; Woolcock Institute of Medical Research; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; Murdoch Children's Research Institute; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; University of Western Australia; University of Western Australia; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; Folkhalsan Research Center; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Turku; University of Turku; Boston University; University of Oulu; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Oulu; Harvard University; Harvard Medical School	Salomaa, V (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	veikko.salomaa@thl.fi; m.jarvelin@imperial.ac.uk; joelh@broadinstitute.org	Martin, Nicholas/R-9235-2019; Ramasamy, Adaikalavan/G-2632-2010; Abramson, Michael/AAQ-2671-2020; Kuokkanen, Mikko/M-8247-2016; Marks, Guy B./F-5058-2013; Lehtimäki, Terho/AAD-1094-2022; Coin, Lachlan JM/A-9001-2014; Matheson, Melanie C/O-4721-2015; Le Souef, Peter N/H-5256-2014; Jarvis, Deborah/E-6494-2011; Brown, Matthew A/E-5749-2010; Raitakari, Olli/AAQ-7389-2021; Duffy, David L/B-7392-2013; Khaw, Kay-Tee/AAZ-3209-2021; Montgomery, Grant W/B-7148-2008; Coin, Lachlan/O-4976-2019; Ferreira, Manuel A R/D-3609-2013	Martin, Nicholas/0000-0003-4069-8020; Ramasamy, Adaikalavan/0000-0002-7598-2892; Abramson, Michael/0000-0002-9954-0538; Kuokkanen, Mikko/0000-0003-4375-9327; Marks, Guy B./0000-0002-8976-8053; Lehtimäki, Terho/0000-0002-2555-4427; Coin, Lachlan JM/0000-0002-4300-455X; Matheson, Melanie C/0000-0002-5822-3499; Brown, Matthew A/0000-0003-0538-8211; Duffy, David L/0000-0001-7227-632X; Montgomery, Grant W/0000-0002-4140-8139; Coin, Lachlan/0000-0002-4300-455X; Ferreira, Manuel A R/0000-0001-9059-1825; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Jarvis, Deborah/0000-0002-1753-3896; Dharmage, Shyamali/0000-0001-6063-1937; Kahonen, Mika/0000-0002-4510-7341; O'Connor, George/0000-0002-6476-3926; Couto Alves, Alex/0000-0001-8519-7356; Le Souef, Peter/0000-0003-0930-1654; Eriksson, Johan/0000-0002-2516-2060; Palotie, Aarno/0000-0002-2527-5874	European Commission [018996, LSH-2004-1.2.5-1, 223367]; Department of Health, UK; National Health and Medical Research Council, Australia (NHMRC) [613627, 455836]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Wellcome Trust [089062]; European Community; ENGAGE Consortium [201413]; Academy of Finland [129287, 134839, 129494, 139635]; Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Foundation of the Finnish Anti-Tuberculosis Association; Foundation of the Allergy Association; Biocenter Oulu, University of Oulu; National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health [5R01HL087679-02, 1RL1MH083268-01]; American Asthma Foundation; MRC [G0901214] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0901214, G1000143, G0801056B, G0401527] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Health, UK; National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); ENGAGE Consortium; Academy of Finland(Academy of Finland); Samfundet Folkhalsan; Finnish Diabetes Research Foundation; Finska Lakaresallskapet; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; Foundation Liv och Halsa; Foundation of the Finnish Anti-Tuberculosis Association; Foundation of the Allergy Association; Biocenter Oulu, University of Oulu; National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Asthma Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Please see Supplementary Methods S1 for the details of the many charities, governmental bodies and scientific funding organisations that supported the study recruitment, phenotyping, DNA collection and genotyping for the studies involved in the discovery stage (Stage1) and replication stage (Stage2). The personal research funding supports are listed as follows: AR was supported through the European Commission (through project GABRIEL - contract #018996 under the Integrated Program LSH-2004-1.2.5-1) and the Department of Health, UK. ACA was funded by the European Commission, Framework 7 (grant #223367). The National Health and Medical Research Council, Australia (NHMRC) supported MARF through a project grant (#613627), MAB via a Principal Research Fellowship (#455836) and SCD, DLD, NGM, MCM and GWM via a fellowship scheme. AP acknowledges funding from The Academy of Finland Center of Excellence in Complex Disease Genetics (#213506 and 129680), the Wellcome Trust (#089062), the European Community's Framework 7 Programme and the ENGAGE Consortium (#201413). The Academy of Finland supported EW (#129287, #134839) and VS (#129494, #139635). JE was supported through Academy of Finland, Samfundet Folkhalsan, Finnish Diabetes Research Foundation, Finska Lakaresallskapet, Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation and Foundation Liv och Halsa. TL was supported by Foundation of the Finnish Anti-Tuberculosis and Allergy Associations. M-RJ has received financial support from the Academy of Finland, Biocenter Oulu, University of Oulu and National Heart Lung and Blood Institute (NHLBI) - National Institutes of Health (#5R01HL087679-02 through the STAMPEED program 1RL1MH083268-01). JNH was supported by a grant from the American Asthma Foundation for analysis of Framingham SHARe data for association with asthma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; AROMAA A, 2004, BASELINE RESULTS HLT; Barnes KC, 2010, CURR OPIN ALLERGY CL, V10, P427, DOI 10.1097/ACI.0b013e32833de6ee; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Borish L, 2008, ANN ALLERG ASTHMA IM, V101, P1, DOI 10.1016/S1081-1206(10)60826-5; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Burney P, 1997, AM J RESP CRIT CARE, V156, P1773; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Ferreira MAR, 2011, LANCET IN PRESS; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Meyers DA, 2010, J ALLERGY CLIN IMMUN, V126, P439, DOI 10.1016/j.jaci.2010.07.012; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; NIEMINEN MM, 1991, CHEST, V100, P70, DOI 10.1378/chest.100.1.70; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Rantakallio P, 1969, ACTA PAEDIAT SC S193, V193, P191; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Torgerson DG, 2011, NAT GENET; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wan YI, 2012, THORAX; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208	46	83	85	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44008	10.1371/journal.pone.0044008	http://dx.doi.org/10.1371/journal.pone.0044008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028483	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309973900004
J	Xiong, J; Zhou, T				Xiong, Jie; Zhou, Tong			Gene Regulatory Network Inference from Multifactorial Perturbation Data Using both Regression and Correlation Analyses	PLOS ONE			English	Article							EXPRESSION DATA; BIOLOGY; SYSTEMS; SIMULATION	An important problem in systems biology is to reconstruct gene regulatory networks (GRNs) from experimental data and other a priori information. The DREAM project offers some types of experimental data, such as knockout data, knockdown data, time series data, etc. Among them, multifactorial perturbation data are easier and less expensive to obtain than other types of experimental data and are thus more common in practice. In this article, a new algorithm is presented for the inference of GRNs using the DREAM4 multifactorial perturbation data. The GRN inference problem among p genes is decomposed into p x (p-1) different regression problems. In each of the regression problems, the expression level of a target gene is predicted solely from the expression level of a potential regulation gene. For different potential regulation genes, different weights for a specific target gene are constructed by using the sum of squared residuals and the Pearson correlation coefficient. Then these weights are normalized to reflect effort differences of regulating distinct genes. By appropriately choosing the parameters of the power law, we constructe a 0-1 integer programming problem. By solving this problem, direct regulation genes for an arbitrary gene can be estimated. And, the normalized weight of a gene is modified, on the basis of the estimation results about the existence of direct regulations to it. These normalized and modified weights are used in queuing the possibility of the existence of a corresponding direct regulation. Computation results with the DREAM4 In Silico Size 100 Multifactorial subchallenge show that estimation performances of the suggested algorithm can even outperform the best team. Using the real data provided by the DREAM5 Network Inference Challenge, estimation performances can be ranked third. Furthermore, the high precision of the obtained most reliable predictions shows the suggested algorithm may be helpful in guiding biological experiment designs.	[Xiong, Jie; Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xiong, J (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	xiongj08@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602 and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003, and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andrecut M, 2008, INT J MOD PHYS C, V19, P283, DOI 10.1142/S0129183108012091; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009901; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Menendez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014147; Nemhauser GL., 1988, INTEGER COMBINATORIA, DOI [10.1002/9781118627372, DOI 10.1002/9781118627372]; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Wang YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031194; Weisberg S, 1981, APPL LINEAR REGRESSI; Wolsey L.A., 1988, INTEGER PROGRAMMING; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	21	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43819	10.1371/journal.pone.0043819	http://dx.doi.org/10.1371/journal.pone.0043819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028471	Green Published, gold			2022-12-25	WOS:000309392800003
J	Chae, YK; Neagu, S; Kim, J; Smyrlis, A; Gooptu, M; Tester, W				Chae, Young Kwang; Neagu, Stefan; Kim, Jongoh; Smyrlis, Athanasios; Gooptu, Mahasweta; Tester, William			Association between Common Allergic Symptoms and Cancer in the NHANES III Female Cohort	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PRIMARY LUNG-CANCER; UNITED-STATES; COMMUNITY INCOME; IMMUNE-SYSTEM; BREAST-CANCER; RISK; ASTHMA; ATOPY; DISEASE	Background: Previous epidemiological studies have investigated the association between allergic symptoms and cancer occurrence. However, the role of allergy in cancer has been elusive, especially for the female population. Methods: We examined the relationship between cancer prevalence and common allergic symptoms of rhinoconjunctivitis (RC) and wheezing (WZ) among NHANES III female participants. Results: Among 4600 people, 36.3% (n = 1669) did not have any allergic symptoms (NO), while 47.6% (n = 2188) reported RC, and 16.2% (n = 743), WZ. The proportion of cancer among NO groups was 5.43% (91/1669), among RC group, 7.63% (167/2188), and among WZ group, 11.23% (83/743) (RC group- OR 1.44 with 95% CI 1.00-2.08; p = 0.05 while for WZ group- OR 2.20 with 95% CI 1.27-3.80; p = 0.01). After adjusting for all the possible confounding variables including age, smoking, or COPD, having symptoms of RC (AOR 1.49 with 95% CI 1.12-2.36; p = 0.01) or WC (AOR 2.08 with 95% CI 1.11-3.89; p = 0.02) demonstrated consistent strong association with cancer. Among nonsmokers (n = 2505, 54.5%) only symptoms of RC showed association with cancer (AOR 1.51 with 95% CI 1.00-2.28; p = 0.05). Among former or current smokers (n = 2094, 45.5%), only symptoms of WZ demonstrated association with cancer (AOR 2.38 with 95% CI 1.16-4.87; p = 0.02). Among different types of cancers, odds of having breast cancer among participants with symptoms of RC or WZ were approximately twice the odds of having breast cancer among participants without any of these symptoms. AOR for RC group was 1.89 with 95% CI 1.04-3.42 and p = 0.04 while AOR for WC group was 2.08 with 95% CI 0.90-4.78 and p = 0.08. Conclusions: In summary, we found associations between common allergic symptoms like rhinitis/conjunctivitis and wheezing and prevalence of cancer, specifically between rhinitis/conjunctivitis and breast cancer that were not found in previous studies. Larger prospective studies are required to validate our findings.	[Neagu, Stefan] Christiana Care Hlth Syst, Dept Med, Newark, DE 19718 USA; [Chae, Young Kwang] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Kim, Jongoh] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Smyrlis, Athanasios; Gooptu, Mahasweta; Tester, William] Albert Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA	Christiana Care Health System; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Yeshiva University	Neagu, S (corresponding author), Christiana Care Hlth Syst, Dept Med, Newark, DE 19718 USA.	neagustefan@yahoo.com						ALDERSON M, 1974, LANCET, V2, P1475; ALLEGRA J, 1976, CANCER RES, V36, P3225; AMLOT PL, 1983, BRIT J CANCER, V48, P209, DOI 10.1038/bjc.1983.176; Bergmann RL, 2000, CLIN EXP ALLERGY, V30, P1740, DOI 10.1046/j.1365-2222.2000.00927.x; BILEK O, 1975, NEOPLASMA, V22, P441; Boffetta P, 2002, EUR RESPIR J, V19, P127, DOI 10.1183/09031936.02.00245802; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; BRANDES LJ, 1994, J NATL CANCER I, V86, P770, DOI 10.1093/jnci/86.10.770; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Castaing M, 2005, AM J EPIDEMIOL, V162, P542, DOI 10.1093/aje/kwi241; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; COCKCROFT DW, 1979, ANN ALLERGY, V43, P345; ERIKSSON NE, 1995, ALLERGY, V50, P718, DOI 10.1111/j.1398-9995.1995.tb01212.x; FISHERMAN EW, 1960, J ALLERGY, V31, P74, DOI 10.1016/0021-8707(60)90026-5; FORD RM, 1978, ANN ALLERGY, V40, P240; Gabriel R, 1972, Br J Clin Pract, V26, P202; GALLAGHER RP, 1983, BRIT J CANCER, V48, P853, DOI 10.1038/bjc.1983.277; Hedderson MM, 2003, CANCER CAUSE CONTROL, V14, P619, DOI 10.1023/A:1025686913626; Holly EA, 2003, AM J EPIDEMIOL, V158, P432, DOI 10.1093/aje/kwg174; HUGHES WF, 1979, ANN ALLERGY, V43, P163; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; JOHNSON KJ, 1966, J LANCET, V86, P5; KALLEN B, 1993, EUR RESPIR J, V6, P694; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Lewis SA, 2001, J ALLERGY CLIN IMMUN, V107, P615, DOI 10.1067/mai.2001.113523; Lindelof B, 2005, ALLERGY, V60, P1116, DOI 10.1111/j.1398-9995.2005.00808.x; LOGAN J, 1953, N Z Med J, V52, P210; MACKAY WD, 1966, BRIT J CANCER, V20, P434, DOI 10.1038/bjc.1966.52; Mackillop WJ, 2000, CANCER-AM CANCER SOC, V89, P901, DOI 10.1002/1097-0142(20000815)89:4<901::AID-CNCR25>3.0.CO;2-I; MCDUFFIE HH, 1991, CHEST, V99, P404, DOI 10.1378/chest.99.2.404; MCDUFFIE HH, 1988, CHEST, V93, P241, DOI 10.1378/chest.93.2.241; MCWHORTER WP, 1988, CANCER-AM CANCER SOC, V62, P451, DOI 10.1002/1097-0142(19880715)62:2<451::AID-CNCR2820620234>3.0.CO;2-D; MEERS PD, 1973, LANCET, V1, P884; MILLS PK, 1992, AM J EPIDEMIOL, V136, P287, DOI 10.1093/oxfordjournals.aje.a116494; Ming ME, 2004, J AM ACAD DERMATOL, V50, P357, DOI 10.1016/j.jaad.2003.09.024; Nadalin V, 2003, INT J CANCER, V106, P566, DOI 10.1002/ijc.11240; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Parimon T, 2007, AM J RESP CRIT CARE, V175, P712, DOI 10.1164/rccm.200608-1125OC; PETROIANU A, 1995, J INT MED RES, V23, P358, DOI 10.1177/030006059502300505; PRATTER MR, 1983, CHEST, V84, P42, DOI 10.1378/chest.84.1.42; ROBINETTE CD, 1978, J CHRON DIS, V31, P619, DOI 10.1016/0021-9681(78)90022-X; SANCHEZBORGES M, 1986, CLIN IMMUNOL IMMUNOP, V41, P314, DOI 10.1016/0090-1229(86)90002-4; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Schuz J, 1999, BRIT J CANCER, V80, P585, DOI 10.1038/sj.bjc.6690395; Schuz J, 2003, INT J CANCER, V105, P255, DOI 10.1002/ijc.11054; Schwartzbaum J, 2003, INT J CANCER, V106, P423, DOI 10.1002/ijc.11230; SEVERSON RK, 1989, J CLIN EPIDEMIOL, V42, P995, DOI 10.1016/0895-4356(89)90165-0; SHAPIRO S, 1973, LANCET, V1, P1055; Sigurgeirsson B, 1991, AM J CONTACT DERMATI, V2, P235; Talbot-Smith A, 2003, AM J EPIDEMIOL, V157, P606, DOI 10.1093/aje/kwg020; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Turner MC, 2005, AM J EPIDEMIOL, V162, P212, DOI 10.1093/aje/kwi193; Turner MC, 2006, INT J CANCER, V118, P3124, DOI 10.1002/ijc.21752; URE D M J, 1969, Scottish Medical Journal, V14, P51; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; VESTERINEN E, 1993, INT J EPIDEMIOL, V22, P976, DOI 10.1093/ije/22.6.976; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wen WQ, 2000, CANCER CAUSE CONTROL, V11, P303, DOI 10.1023/A:1008958724739; Wigertz A, 2007, AM J EPIDEMIOL, V166, P941, DOI 10.1093/aje/kwm203	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e42896	10.1371/journal.pone.0042896	http://dx.doi.org/10.1371/journal.pone.0042896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028435	Green Submitted, gold, Green Published			2022-12-25	WOS:000311313900003
J	Bourguignon, T; Sobotnik, J; Sillam-Dusses, D; Jiros, P; Hanus, R; Roisin, Y; Miura, T				Bourguignon, Thomas; Sobotnik, Jan; Sillam-Dusses, David; Jiros, Pavel; Hanus, Robert; Roisin, Yves; Miura, Toru			Developmental Pathways of Psammotermes hybostoma (Isoptera: Rhinotermitidae): Old Pseudergates Make up a New Sterile Caste	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; JUVENILE-HORMONE TITERS; WORKER CASTE; EVOLUTION; DIFFERENTIATION; REPRODUCTIVES; MORPHOLOGY; PHYLOGENY; SOLDIERS; SYSTEM	Background: Ergonomic efficiency is in termites maximized by task partitioning among specialized castes. The isopteran caste systems can be classified as either (i) linear, when tasks are performed by pluripotent immatures (pseudergates), retaining the ability to develop into winged imagoes or (ii) bifurcated, with the presence of a true worker caste, which diverges early and permanently from the sexual (nymph/alate) line. Principal Findings: Here, we report on the ontogenetic potentialities of the highly polymorphic sand termite Psammotermes hybostoma. Beside numerous pluripotent pseudergates, constituting the main work force, some larger non-feeding apterous immatures, also occur. These individuals are unable to proceed to the winged imago stage, but store large amounts of fat and also give rise to large soldiers. Soldiers therefore originate from a wide range of apterous instars, consequently being highly polymorphic. Conclusions: The caste system of P. hybostoma is essentially linear, as in other basal Rhinotermitidae, but is distinguished by the late bifurcation leading to large apterous immatures. Because these large worker-like individuals deviate late and do not perform worker tasks, they cannot be considered homologous to the true workers of Termitidae and advanced Rhinotermitidae, but they provide a novel example of the evolution of sterile immatures in termites.	[Sobotnik, Jan; Sillam-Dusses, David; Jiros, Pavel; Hanus, Robert] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Bourguignon, Thomas; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Bourguignon, Thomas; Hanus, Robert; Roisin, Yves] Univ Libre Bruxelles, Brussels, Belgium; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Sillam-Dusses, David] Univ Paris 06, Lab Ecol & Evolut, Paris, France; [Sillam-Dusses, David] IBIOS, BIOEMCO, UMR 211, IRD, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Lab Ethol Expt & Comparee, Villetaneuse, France	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Hokkaido University; Universite Libre de Bruxelles; Czech University of Life Sciences Prague; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris 13	Sobotnik, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	sobotnik@uochb.cas.cz	Hanus, Robert/D-4765-2013; Miura, Toru/P-2456-2019; Sillam-Dussès, David/AAI-5942-2021	Hanus, Robert/0000-0002-7054-1975; Miura, Toru/0000-0002-7456-4402; Sillam-Dusses, David/0000-0001-5027-8703; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977	Czech Science Foundation [P506/10/1570]; Institute of Organic Chemistry and Biochemistry [Z40550506]; Japan Society for Promotion of Science [22-00393]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; Grants-in-Aid for Scientific Research [21677001] Funding Source: KAKEN	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was received from the Czech Science Foundation (project P506/10/1570; http://www.gacr.cz/); the Institute of Organic Chemistry and Biochemistry (project Z40550506; http://www.uochb.cz); Japan Society for Promotion of Science (postdoctoral fellowship to TB, 22-00393; www.jsps.go.jp/english/); Grants-in-Aid for Young Scientists, the Ministry of Education, Culture, Sports, Science and Technology of Japan(project 21677001; www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bourguignon T, 2009, EVOL DEV, V11, P659, DOI 10.1111/j.1525-142X.2009.00373.x; BUCHLJ HARRO H. R., 1958, ANN SCI NAT ZOOL, V20, P263; CLEMENT GERMAINE, 1952, ANN SCI NAT ZOOL LLE SER, V14, P95; COATON W G H, 1973, Cimbebasia Series A, V3, P19; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; GRASSE PP, 1947, CR HEBD ACAD SCI, V224, P219; Heath H, 1927, J MORPHOL PHYSIOL, V43, P387, DOI 10.1002/jmor.1050430206; HIGASHI M, 1991, P ROY SOC B-BIOL SCI, V246, P25, DOI 10.1098/rspb.1991.0120; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Korb J, 2012, J INSECT PHYSIOL, V58, P376, DOI 10.1016/j.jinsphys.2011.12.016; Krasulova J, 2012, J CHEM ECOL, V38, P557, DOI 10.1007/s10886-012-0123-9; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Leniaud L, 2011, EVOL DEV, V13, P138, DOI 10.1111/j.1525-142X.2011.00464.x; Liu YX, 2005, ENVIRON ENTOMOL, V34, P557, DOI 10.1603/0046-225X-34.3.557; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Luamba J.L.N., 1980, Biologie et Ecologie Mediterraneenne, V7, P169; Mao LX, 2005, ANN ENTOMOL SOC AM, V98, P340, DOI 10.1603/0013-8746(2005)098[0340:FSTIRS]2.0.CO;2; Miller EM, 1942, B U MIAMI, V15, P3; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Noirot C., 1985, Current Themes in Tropical Science, V3, P41; Noirot C., 1985, Current Themes in Tropical Science, V3, P75; NOIROT C, 1987, EXPERIENTIA, V43, P851, DOI 10.1007/BF01951642; NOIROT C, 1988, SOCIOBIOLOGY, V14, P15; Noirot Ch., 1969, P311; NOIROT CHARLES, 1955, ANN SCI NAT ZOOL, V17, P399; Parmentier D, 2003, J MORPHOL, V255, P69, DOI 10.1002/jmor.10047; RENOUX J, 1976, INSECT SOC, V23, P287; ROISIN Y, 1991, ETHOL ECOL EVOL, V3, P327, DOI 10.1080/08927014.1991.9525361; ROISIN Y, 1988, ZOOMORPHOLOGY, V107, P339, DOI 10.1007/BF00312217; Roisin Y, 1999, INSECT SOC, V46, P273, DOI 10.1007/s000400050146; ROISIN Y, 1994, AM NAT, V143, P751, DOI 10.1086/285631; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Roisin Y, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P133, DOI 10.1007/978-90-481-3977-4_6; Roonwal ML, 1988, INDIAN J ENTOMOL, V47, P455; Rupf T, 2008, NATURWISSENSCHAFTEN, V95, P811, DOI 10.1007/s00114-008-0387-7; Sillam-Dusses D, 2011, J CHEM ECOL, V37, P179, DOI 10.1007/s10886-011-9910-y; Stys Pavel, 1999, Acta Societatis Zoologicae Bohemicae, V63, P483; Thompson GJ, 2000, J EVOLUTION BIOL, V13, P869, DOI 10.1046/j.1420-9101.2000.00237.x; Watson J.A.L., 1981, Sociobiology, V6, P101; WATSON JAL, 1977, AUST J ZOOL, V25, P25, DOI 10.1071/ZO9770025	46	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44527	10.1371/journal.pone.0044527	http://dx.doi.org/10.1371/journal.pone.0044527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028554	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800011
J	Choi, K; Yu, C				Choi, Kyungwho; Yu, Choongho			Highly Doped Carbon Nanotubes with Gold Nanoparticles and Their Influence on Electrical Conductivity and Thermopower of Nanocomposites	PLOS ONE			English	Article							WORK FUNCTION; THERMOELECTRIC PROPERTIES; POLYMER COMPOSITES; FILMS; TRANSPARENT; PERFORMANCE; NETWORKS; ENHANCEMENT; ELECTRONICS; TRANSPORT	Carbon nanotubes (CNTs) are often used as conductive fillers in composite materials, but electrical conductivity is limited by the maximum filler concentration that is necessary to maintain composite structures. This paper presents further improvement in electrical conductivity by precipitating gold nanoparticles onto CNTs. In our composites, the concentrations of CNTs and poly (vinyl acetate) were respectively 60 and 10 vol%. Four different gold concentrations, 0, 10, 15, or 20 vol% were used to compare the influence of the gold precipitation on electrical conductivity and thermopower of the composites. The remaining portion was occupied by poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate), which debundled and stabilized CNTs in water during synthesis processes. The concentrations of gold nanoparticles are below the percolation threshold of similar composites. However, with 15-vol% gold, the electrical conductivity of our composites was as high as similar to 6x10(5) S/m, which is at least similar to 500% higher than those of similar composites as well as orders of magnitude higher than those of other polymer composites containing CNTs and gold particles. According to our analysis with a variable range hopping model, the high conductivity can be attributed to gold doping on CNT networks. Additionally, the electrical properties of composites made of different types of CNTs were also compared.	[Choi, Kyungwho; Yu, Choongho] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Choi, K (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.	chyu@tamu.edu		Choi, Kyungwho/0000-0002-4011-0402	US Air Force Office of Scientific Research under the auspices of Dr. Charles Lee, II-VI Foundation [FA9550-09-1-0609]; Pioneer Research Center Program through the National Research Foundation of Korea [2011-0001645]; Ministry of Education, Science and Technology	US Air Force Office of Scientific Research under the auspices of Dr. Charles Lee, II-VI Foundation; Pioneer Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors gratefully acknowledge financial support from the US Air Force Office of Scientific Research (FA9550-09-1-0609) under the auspices of Dr. Charles Lee, II-VI Foundation, and the Pioneer Research Center Program through the National Research Foundation of Korea (2011-0001645) and funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 1999, J PHYS CHEM B, V103, P8116, DOI 10.1021/jp991659y; Carroll DL, 2005, SYNTHETIC MET, V155, P694, DOI 10.1016/j.synthmet.2005.08.031; Choi HC, 2002, J AM CHEM SOC, V124, P9058, DOI 10.1021/ja026824t; Collins PG, 2000, SCI AM, V283, P62, DOI 10.1038/scientificamerican1200-62; Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Devadoss A, 2011, ANAL CHEM, V83, P2383, DOI 10.1021/ac102697c; Forster RJ, 2003, J ELECTROANAL CHEM, V554, P345, DOI 10.1016/S0022-0728(03)00258-4; Geng HZ, 2007, NANO, V2, P157, DOI 10.1142/S1793292007000532; Hecht DS, 2011, NANOTECHNOLOGY, V22; Hellstrom SL, 2009, ACS NANO, V3, P1423, DOI 10.1021/nn9002456; Hu XJ, 2004, ITHERM 2004, VOL 1, P63, DOI 10.1109/ITHERM.2004.1319155; Kim D, 2010, ACS NANO, V4, P513, DOI 10.1021/nn9013577; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Kong BS, 2007, J PHYS CHEM C, V111, P8377, DOI 10.1021/jp071297r; Kong BS, 2009, CHEM COMMUN, P2174, DOI 10.1039/b821920f; Kongkanand A, 2007, NANO LETT, V7, P676, DOI 10.1021/nl0627238; Kymakis E, 2003, J APPL PHYS, V93, P1764, DOI 10.1063/1.1535231; Kymakis E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2189931; Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7; Li J, 1999, APPL PHYS LETT, V75, P367, DOI 10.1063/1.124377; Liu XM, 2008, NANO LETT, V8, P2613, DOI 10.1021/nl0729734; Meng CZ, 2010, ADV MATER, V22, P535, DOI 10.1002/adma.200902221; Park W, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005201; Podhajecka K, 2008, MACROMOL SYMP, V268, P72, DOI 10.1002/masy.200850815; Reyes-Reyes M, 2010, J PHYS CHEM C, V114, P20220, DOI 10.1021/jp107386x; RIVIERE JC, 1966, APPL PHYS LETT, V8, P172, DOI 10.1063/1.1754539; Rowe D. M., 1995, CRC HDB THERMOELECTR; Ryu Y, 2012, J MATER CHEM, V22, P6959, DOI [10.1039/c2jm16000e, 10.1039/c2jm16000c]; Ryu Y, 2011, SOLID STATE COMMUN, V151, P1932, DOI 10.1016/j.ssc.2011.09.022; Ryu YT, 2011, CARBON, V49, P4745, DOI 10.1016/j.carbon.2011.06.082; SACHTLER WM, 1966, SURF SCI, V5, P221, DOI 10.1016/0039-6028(66)90083-5; Shiraishi M, 2001, CARBON, V39, P1913, DOI 10.1016/S0008-6223(00)00322-5; Sun JP, 2002, APPL PHYS A-MATER, V75, P479, DOI [10.1007/s003390201403, 10.1007/S003390201403]; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Yang SB, 2010, J PHYS CHEM C, V114, P9296, DOI 10.1021/jp102066k; Yao Q, 2010, ACS NANO, V4, P2445, DOI 10.1021/nn1002562; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Yu CH, 2011, ACS NANO, V5, P1297, DOI 10.1021/nn102999h; Yu C, 2008, NANO LETT, V8, P4428, DOI 10.1021/nl802345s; Zhang B, 2010, ACS APPL MATER INTER, V2, P3170, DOI 10.1021/am100654p	41	29	29	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44977	10.1371/journal.pone.0044977	http://dx.doi.org/10.1371/journal.pone.0044977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024778	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100036
J	Filgueiras, LR; Martins, JO; Serezani, CH; Capelozzi, VL; Montes, MBA; Jancar, S				Filgueiras, Luciano R., Jr.; Martins, Joilson O.; Serezani, Carlos H.; Capelozzi, Vera L.; Montes, Marlise B. A.; Jancar, Sonia			Sepsis-Induced Acute Lung Injury (ALI) Is Milder in Diabetic Rats and Correlates with Impaired NFkB Activation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MELLITUS; PHAGOCYTOSIS; DYSFUNCTION; PULMONARY; INSULIN	Acute lung injury (ALI) develops in response to a direct insult to the lung or secondarily to a systemic inflammatory response, such as sepsis. There is clinical evidence that the incidence and severity of ALI induced by direct insult are lower in diabetics. In the present study we investigated whether the same occurs in ALI secondarily to sepsis and the molecular mechanisms involved. Diabetes was induced in male Wistar rats by alloxan and sepsis by caecal ligation and puncture surgery (CLP). Six hours later, the lungs were examined for oedema and cell infiltration in bronchoalveolar lavage. Alveolar macrophages (AMs) were cultured in vitro for analysis of I kappa B and p65 subunit of NF kappa B phosphorylation and MyD88 and SOCS-1 mRNA. Diabetic rats were more susceptible to sepsis than non-diabetics. In non-diabetic rats, the lung presented oedema, leukocyte infiltration and increased COX2 expression. In diabetic rats these inflammatory events were significantly less intense. To understand why diabetic rats despite being more susceptible to sepsis develop milder ALI, we examined the NF kappa B activation in AMs of animals with sepsis. Whereas in non-diabetic rats the phosphorylation of I kappa B and p65 subunit occurred after 6 h of sepsis induction, this did not occur in diabetics. Moreover, in AMs from diabetic rats the expression of MyD88 mRNA was lower and that of SOCS-1 mRNA was increased compared with AMs from non-diabetic rats. These results show that ALI secondary to sepsis is milder in diabetic rats and this correlates with impaired activation of NF kappa B, increased SOCS-1 and decreased MyD88 mRNA.	[Filgueiras, Luciano R., Jr.; Montes, Marlise B. A.; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Martins, Joilson O.] Univ Sao Paulo, Dept Clin & Toxicol Analyses, Fac Pharmaceut Sci, Sao Paulo, Brazil; [Serezani, Carlos H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA; [Capelozzi, Vera L.] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Indiana University System; Indiana University Bloomington; Universidade de Sao Paulo	Filgueiras, LR (corresponding author), Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	sojancar@icb.usp.br	Capelozzi, Vera Luiza/C-6363-2013; Jancar, Sonia/C-5153-2012; Martins, Joilson O./G-4367-2011; , Capelozzi/N-1737-2019; serezani, C. Henrique/H-1675-2013	Jancar, Sonia/0000-0001-7983-3459; Martins, Joilson O./0000-0003-2630-7038; , Capelozzi/0000-0001-9732-5853; delmonte, samuel/0000-0002-3289-4577; serezani, C. Henrique/0000-0002-5363-415X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Institutes of Health [NIH R00HL103777-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and National Institutes of Health (NIH R00HL103777-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Ferracini M, 2010, MOL IMMUNOL, V47, P1974, DOI 10.1016/j.molimm.2010.04.018; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P255; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4; Hizume DC, 2007, SHOCK, V27, P584, DOI 10.1097/01.shk.0000248594.79012.d6; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Martins JO, 2010, SHOCK, V33, P76, DOI 10.1097/SHK.0b013e3181a85ec4; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Noursadeghi M, 2000, J ROY COLL PHYS LOND, V34, P432; Rocco PRM, 2008, CURR OPIN CRIT CARE, V14, P50, DOI 10.1097/MCC.0b013e3282f2405b; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Santiago VR, 2010, CRIT CARE MED, V38, P2207, DOI 10.1097/CCM.0b013e3181f3e076; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Szkudelski T, 2001, PHYSIOL RES, V50, P537	23	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44987	10.1371/journal.pone.0044987	http://dx.doi.org/10.1371/journal.pone.0044987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024779	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100037
J	Garmyn, D; Augagneur, Y; Gal, L; Vivant, AL; Piveteau, P				Garmyn, Dominique; Augagneur, Yoann; Gal, Laurent; Vivant, Anne-Laure; Piveteau, Pascal			Listeria monocytogenes Differential Transcriptome Analysis Reveals Temperature-Dependent Agr Regulation and Suggests Overlaps with Other Regulons	PLOS ONE			English	Article							VIRULENCE GENES; SIGMA-B; BACILLUS-SUBTILIS; BIOFILM FORMATION; EXPRESSION; PRFA; IDENTIFICATION; GROWTH; ACID; DIFFUSION	Listeria monocytogenes is a ubiquitous, opportunistic pathogenic organism. Environmental adaptation requires constant regulation of gene expression. Among transcriptional regulators, AgrA is part of an auto-induction system. Temperature is an environmental cue critical for in vivo adaptation. In order to investigate how temperature may affect AgrA-dependent transcription, we compared the transcriptomes of the parental strain L. monocytogenes EGD-e and its Delta agrA mutant at the saprophytic temperature of 25 degrees C and in vivo temperature of 37 degrees C. Variations of transcriptome were higher at 37 degrees C than at 25 degrees C. Results suggested that AgrA may be involved in the regulation of nitrogen transport, amino acids, purine and pyrimidine biosynthetic pathways and phage-related functions. Deregulations resulted in a growth advantage at 37 degrees C, but affected salt tolerance. Finally, our results suggest overlaps with PrfA, sigma B, sigma H and CodY regulons. These overlaps may suggest that through AgrA, Listeria monocytogenes integrates information on its biotic environment.	[Garmyn, Dominique; Augagneur, Yoann; Vivant, Anne-Laure; Piveteau, Pascal] Univ Bourgogne, UMR1347, Dijon, France; [Garmyn, Dominique; Augagneur, Yoann; Gal, Laurent; Vivant, Anne-Laure; Piveteau, Pascal] INRA, UMR 1347, F-21034 Dijon, France; [Gal, Laurent] AgroSup Dijon, UMR1347, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Garmyn, D (corresponding author), Univ Bourgogne, UMR1347, Dijon, France.	piveteau@u-bourgognre.fr	gal, laurent/A-2824-2011; augagneur, yoann/L-2000-2015	gal, laurent/0000-0001-6598-7262; augagneur, yoann/0000-0002-6816-5931; Garmyn, Dominique/0000-0003-4693-6026	local authorities grant support (Conseil Regional de Bourgogne Grant) [PARI Agrale 11]	local authorities grant support (Conseil Regional de Bourgogne Grant)(Region Bourgogne-Franche-Comte)	This work was funded by local authorities grant support (Conseil Regional de Bourgogne Grant number PARI Agrale 11 [http://region-bourgogne.fr/Leplan-d-actions-regional-pour-l-innovation-PARI,40,4438]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Begley M, 2002, APPL ENVIRON MICROB, V68, P6005, DOI 10.1128/AEM.68.12.6005-6012.2002; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Cossart P, 2012, P NAT AC SC US, V108, P19484; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Garcia E, 1996, J FOOD PROTECT, V59, P950, DOI 10.4315/0362-028X-59.9.950; Garmyn Dominique, 2009, Commun Integr Biol, V2, P371; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Ivy RA, 2012, APPL ENVIRON MICROB, V78, P3824, DOI 10.1128/AEM.00051-12; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lyautey E, 2007, CAN J MICROBIOL, V53, P1158, DOI 10.1139/W07-084; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Olier M, 2003, INFECT IMMUN, V71, P1217, DOI 10.1128/IAI.71.3.1217-1224.2003; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rieu A, 2007, APPL ENVIRON MICROB, V73, P6125, DOI 10.1128/AEM.00608-07; Schwab U, 2005, FEMS MICROBIOL LETT, V245, P329, DOI 10.1016/j.femsle.2005.03.025; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stritzker J, 2004, INFECT IMMUN, V72, P5622, DOI 10.1128/IAI.72.10.5622-5629.2004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van der Veen S, 2007, MICROBIOL-SGM, V153, P3593, DOI 10.1099/mic.0.2007/006361-0; van Teeffelen S, 2011, EMBO J, V30, P4856, DOI 10.1038/emboj.2011.430; Wels M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-330; WELSHIME.HJ, 1968, J BACTERIOL, V95, P300, DOI 10.1128/JB.95.2.300-303.1968; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x	54	33	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e43154	10.1371/journal.pone.0043154	http://dx.doi.org/10.1371/journal.pone.0043154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024744	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100002
J	Hasim, A; Abudula, M; Aimiduo, R; Ma, JQ; Jiao, Z; Akula, G; Wang, T; Abudula, A				Hasim, Ayshamgul; Abudula, Mangnishahan; Aimiduo, Reshalaiti; Ma, Jun-Qi; Jiao, Zhen; Akula, Gulzareye; Wang, Ting; Abudula, Abulizi			Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HUMAN-PAPILLOMAVIRUS; MOLECULAR-MECHANISMS; DOWN-REGULATION; EXPRESSION; METHYLATION; GENES; ASSOCIATION; CARCINOMAS; ACTIVATION	Normal function of human leukocyte antigen class I (HLA-I) and antigen processing machinery (APM) proteins is required for T cell-mediated anti-tumor or antiviral immunity, whereas the tumor survival indicates a failure of the host in immune surveillance associated with the dysfunction in antigen presentation, mainly due to the deregulation in HLA-I and APM expression or function. The posttranscriptional regulation of HLA-I and APM expression may associate with epigenetic modifications in cancer development which was not described so far. Here we showed that the development of cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (CSCC) in Uighur women was accompanied with the partial or total loss of protein expression of HLA-I, beta 2-m and APM components, including the transporter associated with antigen processing (TAP1/2), low molecular mass protein (LMP2, LMP7), endoplasmic reticulum aminopeptidase 1(ERAP1), chaperone molecules include calreticulin (CLR), calnexin (CNX) and ERp57, and this was proved again by analysis of transcription of the same genes in addition to three genes HLA-A, B and C coding for HLA-I. By bisulfite sequencing approach, we identified target CpG islands methylated at the gene promoter region of TAP1, TAP2, LMP7, tapasin and ERp57 in cervical carcinoma cells. Further analysis of CpG site specific methylation of these genes in cases of CSCC and CIN demonstrated an inverse correlation of altered CpG island methylation of TAP1, LMP7, and ERp57 with changes in protein expression. Moreover, promoter methylation of these genes was significantly higher in cases positive for human papillomavirus 16 (HPV 16) than negative ones. Our results suggested that epigenetic modifications are responsible for the aberrant expression of certain HLA-I and APM genes, and may help to understand unrevealed mechanisms of tumor escape from immune surveillance in cervical carcinogenesis.	[Hasim, Ayshamgul; Aimiduo, Reshalaiti; Wang, Ting] Med Univ Xinjiang, Dept Pathol, Coll Basic Med, Urumqi, Peoples R China; [Abudula, Mangnishahan] Med Univ Xinjiang, Ctr Oncol, Affiliated Hosp 1, Urumqi, Peoples R China; [Ma, Jun-Qi] Med Univ Xinjiang, Dept Gynecol, Affiliated Hosp 1, Urumqi, Peoples R China; [Jiao, Zhen] Hosp Xinjiang Uighur Autonomous Reg, Dept Gynecol, Urumqi, Peoples R China; [Akula, Gulzareye; Abudula, Abulizi] Med Univ Xinjiang, Key Labs Mol Biol & Endem Dis Xinjiang Uighur Aut, Urumqi, Peoples R China		Hasim, A (corresponding author), Med Univ Xinjiang, Dept Pathol, Coll Basic Med, Urumqi, Peoples R China.	abulizi_de@126.com			Xinjiang Uighur Autonomous Region Fund [2009211B14]; National Natural Science Foundation of China [81060164]	Xinjiang Uighur Autonomous Region Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported with funding from the Xinjiang Uighur Autonomous Region Fund (2009211B14) and National Natural Science Foundation of China (81060164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhya D, 2010, J BIOSCIENCES, V35, P647, DOI 10.1007/s12038-010-0072-9; Ayshamgul H, 2010, JCLIN EXP PATHOL, V26, P684; Ayshamgul Hasim, 2010, Chinese Journal of Pathology, V39, P703, DOI 10.3760/cma.j.issn.0529-5807.2010.10.014; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Cathro HP, 2010, CANCER IMMUNOL IMMUN, V59, P465, DOI 10.1007/s00262-009-0765-9; Corneanu LM, 2011, ROM J MORPHOL EMBRYO, V52, P89; Hasim A, 2011, CHINESE MED J-PEKING, V124, P341, DOI 10.3760/cma.j.issn.0366-6999.2011.03.004; [阿仙姑·哈斯木 HASIMU Axiangu], 2011, [肿瘤, Tumor], V31, P432; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; IARC. International Agency on Research on Cancer, 1995, MON CANC HUM PAP, V64; Khan ANH, 2008, CANCER IMMUNOL IMMUN, V57, P647, DOI 10.1007/s00262-007-0402-4; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Kuzmin I, 2003, CANCER RES, V63, P1888; Lee HW, 2011, J GASTROINTEST SURG, V15, P1336, DOI 10.1007/s11605-011-1545-3; Liu Q, 2009, SCAND J GASTROENTERO, V44, P960, DOI 10.1080/00365520902998679; Lou Y, 2008, CLIN CANCER RES, V14, P1494, DOI 10.1158/1078-0432.CCR-07-1066; Ma Qi, 2010, Chinese Journal of Pathology, V39, P255, DOI 10.3760/cma.j.issn.0529-5807.2010.04.010; Manning J, 2008, IMMUNOLOGY, V123, P218, DOI 10.1111/j.1365-2567.2007.02689.x; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Moretta L, 2005, IMMUNOL LETT, V100, P7, DOI 10.1016/j.imlet.2005.07.004; Nie Xiao-rui, 2009, Zhonghua Yufang Yixue Zazhi, V43, P571, DOI 10.3760/cma.j.issn.0253-9624.2009.07.009; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Olk-Batz C, 2011, BLOOD, V117, P4871, DOI 10.1182/blood-2010-08-298968; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Sanchez CJ, 2011, CANCER IMMUNOL IMMUN, V60, P1, DOI 10.1007/s00262-010-0898-x; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Sigalotti L, 2004, CANCER RES, V64, P9167, DOI 10.1158/0008-5472.CAN-04-1442; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Suzuk Lalai, 2006, J XINJIANG MED U, V29, P569; Tanaka K, 2011, INT J ONCOL, V1274; Tomasi TB, 2006, CANCER IMMUNOL IMMUN, V55, P1159, DOI 10.1007/s00262-006-0164-4; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719	37	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44952	10.1371/journal.pone.0044952	http://dx.doi.org/10.1371/journal.pone.0044952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024775	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100033
J	Majeed, W; Zhang, Y; Xue, Y; Ranade, S; Blue, RN; Wang, Q; He, QF				Majeed, Waqar; Zhang, Yan; Xue, Yong; Ranade, Saurabh; Blue, Ryan Nastashia; Wang, Qiang; He, Qingfang			RpaA Regulates the Accumulation of Monomeric Photosystem I and PsbA under High Light Conditions in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP STRAIN PCC-6803; CYCLIC ADP-RIBOSE; PHYSIOLOGICAL SIGNIFICANCE; INDUCIBLE POLYPEPTIDES; STATE TRANSITIONS; GENE-EXPRESSION; STOICHIOMETRY; CYANOBACTERIA; PHOTOPROTECTION; PHOTOINHIBITION	The response regulator RpaA was examined by targeted mutagenesis under high light conditions in Synechocystis sp. PCC 6803. A significant reduction in chlorophyll fluorescence from photosystem I at 77 K was observed in the RpaA mutant cells under high light conditions. Interestingly, the chlorophyll fluorescence emission from the photosystem I trimers at 77 K are similar to that of the wild type, while the chlorophyll fluorescence from the photosystem I monomers was at a much lower level in the mutant than in the wild type under high light conditions. The RpaA inactivation resulted in a dramatic reduction in the monomeric photosystem I and the D1 protein but not the CP47 content. However, there is no significant difference in the transcript levels of psaA or psbA or other genes examined, most of which are involved in photosynthesis, pigment biosynthesis, or stress responses. Under high light conditions, the growth of the mutant was affected, and both the chlorophyll content and the whole-chain oxygen evolution capability of the mutant were found to be significantly lower than those of the wild type, respectively. We propose that RpaA regulates the accumulation of the monomeric photosystem I and the D1 protein under high light conditions. This is the first report demonstrating that inactivation of a stress response regulator has specifically reduced the monomeric photosystem I. It suggests that PS I monomers and PS I trimers can be regulated independently for acclimation of cells to high light stress.	[Majeed, Waqar; Xue, Yong; Ranade, Saurabh; Blue, Ryan Nastashia; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA; [Zhang, Yan; He, Qingfang] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Shandong, Peoples R China; [Wang, Qiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Shandong Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Majeed, W (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu	Wang, Qiang/P-7806-2016; He, Qingfang/I-4181-2013; Majeed, Waqar/K-9802-2016	Wang, Qiang/0000-0002-7388-4703; Xue, Yong/0000-0002-9091-3772	National Science Foundation [MCB 1120153]; Program on Key Basic Research Project [2011CB200902]	National Science Foundation(National Science Foundation (NSF)); Program on Key Basic Research Project	This work was supported by National Science Foundation grant MCB 1120153 (http://www.nsf.gov/) and by Program on Key Basic Research Project (2011CB200902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARO EM, 1993, PLANT PHYSIOL, V103, P835, DOI 10.1104/pp.103.3.835; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; Ashby MK, 2002, FEMS MICROBIOL LETT, V214, P25; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Bailey S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1410, DOI 10.1111/j.1751-1097.2008.00453.x; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Cunningham FX, 2010, J BACTERIOL, V192, P1700, DOI 10.1128/JB.01434-09; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Fujimori T, 2005, PLANT PHYSIOL, V139, P408, DOI 10.1104/pp.105.064782; Fujimori T, 2005, J BIOL CHEM, V280, P22191, DOI 10.1074/jbc.M500369200; Gill RT, 2002, J BACTERIOL, V184, P3671, DOI 10.1128/JB.184.13.3671-3681.2002; Halliwell B., 1999, FREE RADICAL BIO MED, P1, DOI DOI 10.1093/ACPROF:OSO/9780198717478.001.0001; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Herranen M, 2005, PLANT CELL PHYSIOL, V46, P1484, DOI 10.1093/pcp/pci160; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hihara Y, 1998, PLANT PHYSIOL, V117, P1205, DOI 10.1104/pp.117.4.1205; Hsiao HY, 2004, J BACTERIOL, V186, P3882, DOI 10.1128/JB.186.12.3882-3888.2004; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Jantaro S, 2006, J BIOL CHEM, V281, P30865, DOI 10.1074/jbc.M606252200; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Mulo P, 1998, PLANT PHYSIOL, V117, P483, DOI 10.1104/pp.117.2.483; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P392, DOI 10.1093/oxfordjournals.pcp.a029181; Muramatsu M, 2009, MICROBIOL-SGM, V155, P989, DOI 10.1099/mic.0.024018-0; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; PETER GF, 1991, J BIOL CHEM, V266, P16745; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sonoike K, 2001, PLANT CELL PHYSIOL, V42, P379, DOI 10.1093/pcp/pce046; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; TSIOTIS G, 1995, EUR J BIOCHEM, V231, P823, DOI 10.1111/j.1432-1033.1995.tb20767.x; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; van Thor JJ, 1998, BOT ACTA, V111, P430, DOI 10.1111/j.1438-8677.1998.tb00731.x; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126	47	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45139	10.1371/journal.pone.0045139	http://dx.doi.org/10.1371/journal.pone.0045139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024802	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100060
J	Tucci, S; Herebian, D; Sturm, M; Seibt, A; Spiekerkoetter, U				Tucci, Sara; Herebian, Diran; Sturm, Marga; Seibt, Annette; Spiekerkoetter, Ute			Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD(-/-)) Mouse to Compensate a Defective Fatty Acid beta-Oxidation	PLOS ONE			English	Article							MUSCLE-FIBER TYPES; SKELETAL-MUSCLE; LYSINE ACETYLATION; MYOSIN ISOFORMS; COENZYME-A; MICE; EXPRESSION; CARNITINE; HEART; MITOCHONDRIA	Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatty acid oxidation disorder presenting with heterogeneous phenotypes. Similar to many patients with VLCADD, VLCAD-deficient mice (VLCAD(-/-)) remain asymptomatic over a long period of time. In order to identify the involved compensatory mechanisms, wild-type and VLCAD(-/-) mice were fed one year either with a normal diet or with a diet in which medium-chain triglycerides (MCT) replaced long-chain triglycerides, as approved intervention in VLCADD. The expression of the mitochondrial long-chain acyl-CoA dehydrogenase (LCAD) and medium-chain acyl-CoA dehydrogenase (MCAD) was quantified at mRNA and protein level in heart, liver and skeletal muscle. The oxidation capacity of the different tissues was measured by LC-MS/MS using acyl-CoA substrates with a chain length of 8 to 20 carbons. Moreover, in white skeletal muscle the role of glycolysis and concomitant muscle fibre adaptation was investigated. In one year old VLCAD(-/-) mice MCAD and LCAD play an important role in order to compensate deficiency of VLCAD especially in the heart and in the liver. However, the white gastrocnemius muscle develops alternative compensatory mechanism based on a different substrate selection and increased glucose oxidation. Finally, the application of an MCT diet over one year has no effects on LCAD or MCAD expression. MCT results in the VLCAD(-/-) mice only in a very modest improvement of medium-chain acyl-CoA oxidation capacity restricted to cardiac tissue. In conclusion, VLCAD(-/-) mice develop tissue-specific strategies to compensate deficiency of VLCAD either by induction of other mitochondrial acyl-CoA dehydrogenases or by enhancement of glucose oxidation. In the muscle, there is evidence of a muscle fibre type adaptation with a predominance of glycolytic muscle fibres. Dietary modification as represented by an MCT-diet does not improve these strategies long-term.	[Tucci, Sara; Herebian, Diran; Sturm, Marga; Seibt, Annette; Spiekerkoetter, Ute] Univ Childrens Hosp, Dept Gen Pediat & Neonatol, Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Tucci, S (corresponding author), Univ Childrens Hosp, Dept Gen Pediat & Neonatol, Dusseldorf, Germany.	sara.tucci@med.uni-duesseldorf.de	Herebian, Diran/A-1440-2017	Dr. Herebian, Diran/0000-0002-8528-0122; Spiekerkoetter, Ute/0000-0002-5385-6705	Deutsche Forschungsgemeinschaft (DFG) [SFB 575, SFB 612]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was financially supported by grants from the Deutsche Forschungsgemeinschaft (DFG: SFB 575 and SFB 612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Gelinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010; GLATZ JFC, 1984, BIOCHIM BIOPHYS ACTA, V794, P454, DOI 10.1016/0005-2760(84)90012-2; Goetzman ES, 2005, MOL GENET METAB, V84, P39, DOI 10.1016/j.ymgme.2004.09.010; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Primassin S, 2008, PEDIATR RES, V63, P632, DOI 10.1203/PDR.0b013e31816ff6f0; Primassin S, 2010, J INHERIT METAB DIS, V33, P237, DOI 10.1007/s10545-010-9105-7; Quiroz-Rothe E, 2004, MICROSC RES TECHNIQ, V65, P43, DOI 10.1002/jemt.20090; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; Spiekerkoetter U, 2005, PEDIATR RES, V57, P760, DOI 10.1203/01.PDR.0000157915.26049.47; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Tucci S, 2011, AM J CLIN NUTR, V94, P439, DOI 10.3945/ajcn.111.012948; Tucci S, 2010, FEBS J, V277, P4699, DOI 10.1111/j.1742-4658.2010.07876.x; Tucci S, 2010, MOL GENET METAB, V101, P40, DOI 10.1016/j.ymgme.2010.05.005; Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553; Werdich AA, 2007, AM J PHYSIOL-HEART C, V292, pH2202, DOI 10.1152/ajpheart.00382.2006; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	47	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45429	10.1371/journal.pone.0045429	http://dx.doi.org/10.1371/journal.pone.0045429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024820	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100078
J	Holman, EC; Campbell, LJ; Hines, J; Crews, CM				Holman, Edna C.; Campbell, Leah J.; Hines, John; Crews, Craig M.			Microarray Analysis of microRNA Expression during Axolotl Limb Regeneration	PLOS ONE			English	Article							HAIR CELL REGENERATION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; ADULT NEWT; RETINA REGENERATION; NOTCH LIGAND; URODELE LIMB; SMALL RNAS; INNER-EAR; DIFFERENTIATION	Among vertebrates, salamanders stand out for their remarkable capacity to quickly regrow a myriad of tissues and organs after injury or amputation. The limb regeneration process in axolotls (Ambystoma mexicanum) has been well studied for decades at the cell-tissue level. While several developmental genes are known to be reactivated during this epimorphic process, less is known about the role of microRNAs in urodele amphibian limb regeneration. Given the compelling evidence that many microRNAs tightly regulate cell fate and morphogenetic processes through development and adulthood by modulating the expression (or re-expression) of developmental genes, we investigated the possibility that microRNA levels change during limb regeneration. Using two different microarray platforms to compare the axolotl microRNA expression between mid-bud limb regenerating blastemas and non-regenerating stump tissues, we found that miR-21 was overexpressed in mid-bud blastemas compared to stump tissue. Mature A. mexicanum ("Amex") miR-21 was detected in axolotl RNA by Northern blot and differential expression of Amex-miR-21 in blastema versus stump was confirmed by quantitative RT-PCR. We identified the Amex Jagged1 as a putative target gene for miR-21 during salamander limb regeneration. We cloned the full length 3'UTR of Amex-Jag1, and our in vitro assays demonstrated that its single miR-21 target recognition site is functional and essential for the response of the Jagged1 gene to miR-21 levels. Our findings pave the road for advanced in vivo functional assays aimed to clarify how microRNAs such as miR-21, often linked to pathogenic cell growth, might be modulating the redeployment of developmental genes such as Jagged1 during regenerative processes.	[Holman, Edna C.; Campbell, Leah J.; Hines, John; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT USA; [Crews, Craig M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Holman, EC (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	craig.crews@yale.edu	Holman, Edna/D-1536-2011; Crews, Craig M./ABH-9346-2020	Holman, Edna/0000-0001-6949-5003; Crews, Craig M./0000-0002-8456-2005; Campbell, Leah/0000-0002-1666-2143	National Institutes of Health [GM094944]; Army Research Office (Army US) [W911NF-07-1-0252]; National Science Foundation, Division of Biological Infrastructure [NSF-DBI-0443496]; National Institutes of Health, National Center for Research Resources [NIH-NCRR-R24RR16344]; NIH [GM094944]; Ellison Medical Foundation; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office (Army US); National Science Foundation, Division of Biological Infrastructure(National Science Foundation (NSF)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (GM094944) and the Army Research Office (Army US #W911NF-07-1-0252). The Ambystoma Genetic Stock Center is supported by the National Science Foundation, Division of Biological Infrastructure (NSF-DBI-0443496). The Sal-Site is supported by the National Institutes of Health, National Center for Research Resources (NIH-NCRR-R24RR16344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mohamed Bouzaffour (Yale University) for his expertise and assistance in the implementation of the reporter assays. We thank the NIH (GM094944) and the Ellison Medical Foundation for their support and Exiqon Life Sciences for their assistance in microRNA microarray profiling/qPCR validation for miR-21 expression. We acknowledge the services of the NSF-funded Ambystoma Genetic Stock Center and the resources available at the Sal-Site.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Brown D, 2005, PRECURSOR MIRNAS SUC; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 1995, NAT REV CANCER, V6, P259; Garcia-Arraras J.E., 1993, HDB ENDOCRINE RES TR, P207; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gardiner DM, 1999, SEMIN CELL DEV BIOL, V10, P385, DOI 10.1006/scdb.1999.0325; Gardiner DM, 1998, AM ZOOL, V38, P659; GHOSH S, 1994, INT J DEV BIOL, V38, P479; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Imokawa Y, 1997, P NATL ACAD SCI USA, V94, P9159, DOI 10.1073/pnas.94.17.9159; Katoh M, 2006, INT J MOL MED, V17, P681; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Levesque M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001227; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makarev E, 2006, MOL VIS, V12, P1386; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mitashov VI, 1996, INT J DEV BIOL, V40, P833; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012058; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; O'STEEN W. KEITH, 1958, JOUR MORPHOL, V103, P435, DOI 10.1002/jmor.1051030303; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pearson H, 2001, NATURE, V414, P388, DOI 10.1038/35106653; Rarnkissoon SH, 2006, MOL CELL PROBE, V20, P1, DOI 10.1016/j.mcp.2005.07.004; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Smith JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-181; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; TANK PW, 1976, J MORPHOL, V150, P117, DOI 10.1002/jmor.1051500106; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Thatcher EJ, 2010, RNA BIOL, V7, P333, DOI 10.4161/rna.7.3.12085; Thomson JM, 2007, METHOD ENZYMOL, V427, P107, DOI 10.1016/S0076-6879(07)27006-5; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Torok MA, 1999, J EXP ZOOL, V284, P197, DOI 10.1002/(SICI)1097-010X(19990701)284:2<197::AID-JEZ9>3.0.CO;2-F; Torok MA, 1998, DEV BIOL, V200, P225, DOI 10.1006/dbio.1998.8956; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vecchione A, 2010, ENDOCR-RELAT CANCER, V17, pF37, DOI 10.1677/ERC-09-0163; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	60	27	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41804	10.1371/journal.pone.0041804	http://dx.doi.org/10.1371/journal.pone.0041804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028429	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700003
J	Morrow, KM; Ritson-Williams, R; Ross, C; Liles, MR; Paul, VJ				Morrow, Kathleen M.; Ritson-Williams, Raphael; Ross, Cliff; Liles, Mark R.; Paul, Valerie J.			Macroalgal Extracts Induce Bacterial Assemblage Shifts and Sublethal Tissue Stress in Caribbean Corals	PLOS ONE			English	Article							ANTIFUNGAL CHEMICAL DEFENSE; LONG-TERM DYNAMICS; HARD CORAL; ANTIMICROBIAL ACTIVITIES; MICROBIAL-POPULATIONS; CELLULAR DIAGNOSTICS; MARINE PATHOGENS; BROWN ALGA; REEFS; COMPETITION	Benthic macroalgae can be abundant on present-day coral reefs, especially where rates of herbivory are low and/or dissolved nutrients are high. This study investigated the impact of macroalgal extracts on both coral-associated bacterial assemblages and sublethal stress response of corals. Crude extracts and live algal thalli from common Caribbean macroalgae were applied onto the surface of Montastraea faveolata and Porites astreoides corals on reefs in both Florida and Belize. Denaturing gradient gel electrophoresis (DGGE) of 16S rRNA gene amplicons was used to examine changes in the surface mucus layer (SML) bacteria in both coral species. Some of the extracts and live algae induced detectable shifts in coral-associated bacterial assemblages. However, one aqueous extract caused the bacterial assemblages to shift to an entirely new state (Lobophora variegata), whereas other organic extracts had little to no impact (e.g. Dictyota sp.). Macroalgal extracts more frequently induced sublethal stress responses in M. faveolata than in P. astreoides corals, suggesting that cellular integrity can be negatively impacted in selected corals when comparing co-occurring species. As modern reefs experience phase-shifts to a higher abundance of macroalgae with potent chemical defenses, these macroalgae are likely impacting the composition of microbial assemblages associated with corals and affecting overall reef health in unpredicted and unprecedented ways.	[Morrow, Kathleen M.; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Inst, Smithsonian Marine Stn, Ft Pierce, FL USA; [Ross, Cliff] Univ N Florida, Dept Biol, Jacksonville, FL USA	Auburn University System; Auburn University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University System of Florida; University of North Florida	Morrow, KM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	morrow.kathleen@gmail.com	Ross, Cliff/B-8291-2011	Liles, Mark/0000-0002-9313-8150	National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship [NA08NOS4290448]; Mote Protect our Reefs grant [POR-2009-16]	National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship; Mote Protect our Reefs grant	Daily stipend and tuition support to KMM from National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship #NA08NOS4290448. http://fosterscholars.noaa.gov/aboutscholarship.html. Mote Protect our Reefs grant #POR-2009-16; supported travel to field sites and stress enzyme analysis. http://www.mote.org/index.php? src = gendocs&link = Reefplategrantapp&category = Main. The Hunterdon Oceanographic Research Fund and the Smithsonian Caribbean Coral Reef Ecosystems Program supported field work at Carrie Bow Cay Field Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Dinsdale EA, 2008, NAT BIOTECHNOL, V26, P997, DOI 10.1038/nbt0908-997; Dobretsov S, 2011, BIOFOULING, V27, P869, DOI 10.1080/08927014.2011.607233; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2006, ENVIRON TOXICOL CHEM, V25, P3171, DOI 10.1897/05-509R1.1; Downs CA, 2012, ECOTOXICOLOGY, V21, P768, DOI 10.1007/s10646-011-0837-4; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Engel S, 2006, MAR BIOL, V149, P991, DOI 10.1007/s00227-006-0264-x; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jiang RW, 2008, J NAT PROD, V71, P1616, DOI 10.1021/np800307h; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lane A. L., 2008, P229, DOI 10.1007/978-3-540-74181-7_11; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Leaver MJ, 1998, MAR ENVIRON RES, V46, P71, DOI 10.1016/S0141-1136(97)00071-8; Littler D, 2003, S PACIFIC REEF PLANT, P172; Maximilien R, 1998, AQUAT MICROB ECOL, V15, P233, DOI 10.3354/ame015233; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCune B., 2002, ANAL ECOLOGICAL COMM, P125; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Morgan MB, 2001, ENVIRON TOXICOL CHEM, V20, P537, DOI 10.1002/etc.5620200312; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Morrow KM, APPL ENV MI IN PRESS; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2008, CORAL REEFS, V27, P389, DOI 10.1007/s00338-007-0346-3; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Puglisi MP, 2007, MAR BIOL, V150, P531, DOI 10.1007/s00227-006-0376-3; Puglisi MP, 2004, TETRAHEDRON, V60, P7035, DOI 10.1016/j.tet.2003.10.131; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher Douglas B., 2010, Communicative & Integrative Biology, V3, P564, DOI 10.4161/cib.3.6.12978; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rasmussen TB, 2000, MICROBIOL-UK, V146, P3237, DOI 10.1099/00221287-146-12-3237; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rougee L, 2006, ENVIRON TOXICOL CHEM, V25, P3181, DOI 10.1897/05-510R2.1; SCHMITT TM, 1995, ECOLOGY, V76, P107, DOI 10.2307/1940635; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steinberg PD, 2002, J CHEM ECOL, V28, P1935, DOI 10.1023/A:1020789625989; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Targett NM, 1998, J PHYCOL, V34, P195, DOI 10.1046/j.1529-8817.1998.340195.x; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; Wu GH, 1999, PLANT PHYSIOL, V120, P513, DOI 10.1104/pp.120.2.513	72	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44859	10.1371/journal.pone.0044859	http://dx.doi.org/10.1371/journal.pone.0044859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028648	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700046
J	Tritt, A; Eisen, JA; Facciotti, MT; Darling, AE				Tritt, Andrew; Eisen, Jonathan A.; Facciotti, Marc T.; Darling, Aaron E.			An Integrated Pipeline for de Novo Assembly of Microbial Genomes	PLOS ONE			English	Article							SEQUENCING DATA; ALGORITHM; REARRANGEMENTS; CONSTRUCTION; ALIGNMENT; MAUVE; TOOL	Remarkable advances in DNA sequencing technology have created a need for de novo genome assembly methods tailored to work with the new sequencing data types. Many such methods have been published in recent years, but assembling raw sequence data to obtain a draft genome has remained a complex, multi-step process, involving several stages of sequence data cleaning, error correction, assembly, and quality control. Successful application of these steps usually requires intimate knowledge of a diverse set of algorithms and software. We present an assembly pipeline called A5 (Andrew And Aaron's Awesome Assembly pipeline) that simplifies the entire genome assembly process by automating these stages, by integrating several previously published algorithms with new algorithms for quality control and automated assembly parameter selection. We demonstrate that A5 can produce assemblies of quality comparable to a leading assembly algorithm, SOAPdenovo, without any prior knowledge of the particular genome being assembled and without the extensive parameter tuning required by the other assembly algorithm. In particular, the assemblies produced by A5 exhibit 50% or more reduction in broken protein coding sequences relative to SOAPdenovo assemblies. The A5 pipeline can also assemble Illumina sequence data from libraries constructed by the Nextera (transposon-catalyzed) protocol, which have markedly different characteristics to mechanically sheared libraries. Finally, A5 has modest compute requirements, and can assemble a typical bacterial genome on current desktop or laptop computer hardware in under two hours, depending on depth of coverage.	[Tritt, Andrew; Eisen, Jonathan A.; Facciotti, Marc T.; Darling, Aaron E.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tritt, A (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	aarondarling@ucdavis.edu	Facciotti, Marc/AAF-9227-2020; Eisen, Jonathan A./H-2706-2019; Darling, Aaron/G-8119-2017	Facciotti, Marc/0000-0003-4453-3274; Eisen, Jonathan A./0000-0002-0159-2197; Darling, Aaron/0000-0003-2397-7925	National Science Foundation award [ER 0949453]	National Science Foundation award(National Science Foundation (NSF))	This work was supported by National Science Foundation award ER 0949453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Calabrese PP, 2003, BIOINFORMATICS, V19, pi74, DOI 10.1093/bioinformatics/btg1008; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Deng M, 2009, SPIE, V7492; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Ester M, 1996, IEEE COMPUTER    NOV, V96; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gupta MR, 2010, FOUND TRENDS SIGNAL, V4, P223, DOI 10.1561/2000000034; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Imelfort M, 2011, SASSY UNPUB; Kao WC, 2011, GENOME RES, V21, P1181, DOI 10.1101/gr.111351.110; Kao WC, 2009, GENOME RES, V19, P1884, DOI 10.1101/gr.095299.109; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Koren S, 2011, BIOINFOMATICS; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Seemann T, 2011, VELVETOPTIMISE UNPUB; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; [No title captured]	35	348	355	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42304	10.1371/journal.pone.0042304	http://dx.doi.org/10.1371/journal.pone.0042304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028432	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700005
J	Vial, D; McKeown-Longo, PJ				Vial, Daniel; McKeown-Longo, Paula J.			Epidermal Growth Factor (EGF) Regulates alpha 5 beta 1 Integrin Activation State in Human Cancer Cell Lines through the p90RSK-dependent Phosphorylation of Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; TUMOR-CELLS; AUTO-INHIBITION; BINDING; ADHESION; RESISTANCE; INVASION; TAIL	Cell adhesion, motility, and invasion are regulated by the ligand-binding activity of integrin receptors, transmembrane proteins that bind to the extracellular matrix. Integrins whose conformation allows for ligand binding and appropriate functional activity are said to be in an active state. Integrin activation and subsequent ligand binding are dynamically regulated by the association of cytoplasmic proteins with integrin intracellular domains. In this study, we evaluated the role of EGF in the regulation of the activation state of the alpha 5 beta 1 integrin receptor for fibronectin. The addition of EGF to either A431 squamous carcinoma cells or DiFi colon cancer cells resulted in loss of alpha 5 beta 1-dependent adhesion to fibronectin but no loss of integrin from the cell surface. EGF activated the EGF receptor/ERK/p90RSK and Rho/Rho kinase signaling pathways. Blocking either pathway inhibited EGF-mediated loss of adhesion, suggesting that they work in parallel to regulate integrin function. EGF treatment also resulted in phosphorylation of filamin A (FLNa), which binds and inactivates beta 1 integrins. EGF-mediated FLNa phosphorylation was completely blocked by an inhibitor of p90RSK and partially attenuated by an inhibitor of Rho kinase, suggesting that both pathways converge on FLNa to regulate integrin function. A431 clonal cell lines expressing non-phosphorylated dominant-negative FLNa were resistant to the inhibitory effects of EGF on integrin function, whereas clonal cell lines overexpressing wild-type FLNa were more sensitive to the inhibitory effect of EGF. These data suggest that EGF-dependent inactivation of alpha 5 beta 1 integrin is regulated through FLNa phosphorylation and cellular contractility.	[Vial, Daniel; McKeown-Longo, Paula J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	McKeown-Longo, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	mckeowp@mail.amc.edu			National Institutes of Health [R01 CA58626]; NATIONAL CANCER INSTITUTE [R01CA058626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA58626.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Carter CA, 2012, CURR OPIN ONCOL, V24, P123, DOI 10.1097/CCO.0b013e32834ec6a7; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Genersch E, 1996, J MOL MED-JMM, V74, P609, DOI 10.1007/s001090050064; Genersch E, 1998, INT J CANCER, V75, P205, DOI 10.1002/(SICI)1097-0215(19980119)75:2<205::AID-IJC7>3.0.CO;2-Y; GROSS ME, 1991, CANCER RES, V51, P1452; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lau MT, 2012, CANCER LETT, V320, P198, DOI 10.1016/j.canlet.2012.02.028; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mehra R, 2011, DRUG RESIST UPDATE, V14, P260, DOI 10.1016/j.drup.2011.08.002; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	33	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40371	40380		10.1074/jbc.M112.389577	http://dx.doi.org/10.1074/jbc.M112.389577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23007402	hybrid, Green Published			2022-12-25	WOS:000311448800028
J	Hansen, HG; Schmidt, JD; Soltoft, CL; Ramming, T; Geertz-Hansen, HM; Christensen, B; Sorensen, ES; Juncker, AS; Appenzeller-Herzog, C; Ellgaard, L				Hansen, Henning Gram; Schmidt, Jonas Damgard; Soltoft, Cecilie Lutzen; Ramming, Thomas; Geertz-Hansen, Henrik Marcus; Christensen, Brian; Sorensen, Esben Skipper; Juncker, Agnieszka Sierakowska; Appenzeller-Herzog, Christian; Ellgaard, Lars			Hyperactivity of the Ero1 alpha Oxidase Elicits Endoplasmic Reticulum Stress but No Broad Antioxidant Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND FORMATION; UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; REDOX STATE; GLUTATHIONE; GENE; ACTIVATION; ISOMERASE; PATHWAY	Oxidizing equivalents for the process of oxidative protein folding in the endoplasmic reticulum (ER) of mammalian cells are mainly provided by the Ero1 alpha oxidase. The molecular mechanisms that regulate Ero1 alpha activity in order to harness its oxidative power are quite well understood. However, the overall cellular response to oxidative stress generated by Ero1 alpha in the lumen of the mammalian ER is poorly characterized. Here we investigate the effects of overexpressing a hyperactive mutant (C104A/C131A) of Ero1 alpha. We show that Ero1 alpha hyperactivity leads to hyperoxidation of the ER oxidoreductase ERp57 and induces expression of two established unfolded protein response (UPR) targets, BiP (immunoglobulin-binding protein) and HERP (homocysteine-induced ER protein). These effects could be reverted or aggravated by N-acetylcysteine and buthionine sulfoximine, respectively. Because both agents manipulate the cellular glutathione redox buffer, we conclude that the observed effects of Ero1 alpha-C104A/C131A overexpression are likely caused by an oxidative perturbation of the ER glutathione redox buffer. In accordance, we show that Ero1 alpha hyperactivity affects cell viability when cellular glutathione levels are compromised. Using microarray analysis, we demonstrate that the cell reacts to the oxidative challenge caused by Ero1 alpha hyperactivity by turning on the UPR. Moreover, this analysis allowed the identification of two new targets of the mammalian UPR, CRELD1 and c18orf45. Interestingly, a broad antioxidant response was not induced. Our findings suggest that the hyperoxidation generated by Ero1 alpha-C104A/C131A is addressed in the ER lumen and is unlikely to exert oxidative injury throughout the cell.	[Hansen, Henning Gram; Schmidt, Jonas Damgard; Soltoft, Cecilie Lutzen; Appenzeller-Herzog, Christian; Ellgaard, Lars] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Ramming, Thomas; Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland; [Geertz-Hansen, Henrik Marcus; Juncker, Agnieszka Sierakowska] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Geertz-Hansen, Henrik Marcus; Juncker, Agnieszka Sierakowska] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Geertz-Hansen, Henrik Marcus] Novozymes AS, DK-2800 Bagsvaerd, Denmark; [Christensen, Brian; Sorensen, Esben Skipper] Aarhus Univ, Dept Mol Biol & Genet, Prot Chem Lab, DK-8000 Aarhus, Denmark	University of Copenhagen; University of Basel; Technical University of Denmark; Technical University of Denmark; Novozymes; Aarhus University	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	lellgaard@bio.ku.dk	Ellgaard, Lars/I-9034-2014; Appenzeller-Herzog, Christian/A-2894-2014; Søltoft, Cecilie L/B-4901-2015	Ellgaard, Lars/0000-0002-7018-0137; Appenzeller-Herzog, Christian/0000-0001-7430-294X; Søltoft, Cecilie L/0000-0002-3194-0287; Hansen, Henning Gram/0000-0002-2832-730X; Geertz-Hansen, Henrik Marcus/0000-0003-0425-7551; Sorensen, Esben Skipper/0000-0002-7050-3354	Lundbeckfonden; Faculty of Science at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education; Boehringer Ingelheim Fonds; Swiss National Science Foundation; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Lundbeckfonden(Lundbeckfonden); Faculty of Science at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by a shared Ph.D. scholarship from Lundbeckfonden and the Faculty of Science at the University of Copenhagen and a recipient of an EliteForsk Travel Stipend from the Danish Ministry of Science, Innovation, and Higher Education.; Recipient of a Ph.D. fellowship from the Boehringer Ingelheim Fonds.; Recipient of an Ambizione grant from the Swiss National Science Foundation.; Supported by the Danish Council for Independent Research (Natural Sciences), Novo Nordisk Fonden, and by Lundbeckfonden. To whom correspondence should be addressed: Dept. of Biology, University of Copenhagen, Ole Maaloes Vej 5, 2200 Copenhagen N., Denmark. Tel.: 45-35321725; Fax: 45-35322128; E-mail: lellgaard@bio.ku.dk.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Kolossov VL, 2012, EXP BIOL MED, V237, P652, DOI 10.1258/ebm.2012.011436; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Margittai E, 2012, ANTIOXID REDOX SIGN, V16, P1088, DOI 10.1089/ars.2011.4221; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	62	47	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405050	http://dx.doi.org/10.1074/jbc.M112.405050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027870	Green Published, hybrid			2022-12-25	WOS:000311233800023
J	Imai, S; Osawa, M; Mita, K; Toyonaga, S; Machiyama, A; Ueda, T; Takeuchi, K; Oiki, S; Shimada, I				Imai, Shunsuke; Osawa, Masanori; Mita, Kenichiro; Toyonaga, Shou; Machiyama, Asako; Ueda, Takumi; Takeuchi, Koh; Oiki, Shigetoshi; Shimada, Ichio			Functional Equilibrium of the KcsA Structure Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; QUANTITATIVE DESCRIPTION; INACTIVATION; SELECTIVITY; STABILITY; NANODISCS; MECHANISM; PROTEINS; LIPIDS	KcsA is a tetrameric K+ channel that is activated by acidic pH. Under open conditions of the helix bundle crossing, the selectivity filter undergoes an equilibrium between permeable and impermeable conformations. Here we report that the population of the permeable conformation (p(perm)) positively correlates with the tetrameric stability and that the population in reconstituted high density lipoprotein, where KcsA is surrounded by the lipid bilayer, is lower than that in detergent micelles, indicating that dynamic properties of KcsA are different in these two media. Perturbation of the membrane environment by the addition of 1-3% 2,2,2-trifluoroethanol increases p(perm) and the open probability, revealed by NMR and single-channel recording analyses. These results demonstrate that KcsA inactivation is determined not only by the protein itself but also by the surrounding membrane environments.	[Imai, Shunsuke; Osawa, Masanori; Toyonaga, Shou; Machiyama, Asako; Ueda, Takumi; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Mita, Kenichiro; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 9101193, Japan; [Takeuchi, Koh; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; University of Fukui; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Takeuchi, Koh/B-4971-2010; Osawa, Masanori/GRS-5726-2022	Takeuchi, Koh/0000-0002-6227-4627; Mita, Kenichiro/0000-0001-7177-110X; Imai, Shunsuke/0000-0001-9346-2359; Oiki, Shigetoshi/0000-0002-8438-6750; Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23790064] Funding Source: KAKEN	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from the Takeda Science Foundation (to M. O.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fedida D, 2001, PROG BIOPHYS MOL BIO, V75, P165, DOI 10.1016/S0079-6107(01)00006-2; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Irie K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1797; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; McCoy JG, 2012, BBA-BIOMEMBRANES, V1818, P272, DOI 10.1016/j.bbamem.2011.09.007; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	28	42	42	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.401265	http://dx.doi.org/10.1074/jbc.M112.401265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024361	Green Published, hybrid			2022-12-25	WOS:000311233800033
J	Wu, YC; Liu, CY; Chen, YH; Chen, RF; Huang, CJ; Wang, IJ				Wu, Yu-Ching; Liu, Chia-Yang; Chen, Yau-Hung; Chen, Ruei-Feng; Huang, Chang-Jen; Wang, I-Jong			Blood Vessel Epicardial Substance (Bves) Regulates Epidermal Tight Junction Integrity through Atypical Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE JAM; CELL POLARITY; SKELETAL-MUSCLE; PHOSPHORYLATION; EPITHELIA; BARRIER; COMPLEX; PAR-3	Bves is widely observed in the cell junction of the skin, epicardium, intestine, and cornea of both developmental embryos and mature adults. However, it is not clear how Bves confers its role in intercellular adhesion. Here, we identified the zebrafish bves (zBves) and found that the epidermal barrier function could be disrupted after knockdown of Bves, and these zBves morphants were sensitive to osmotic stress. A loss of zBves would affect the partitioning defective protein (PAR) junctional complex identified by the rescue experiment with tjp-2/ZO-2 or the PAR complex (par-3, par-6, and prkci/atypical (a)PKC) mRNAs, in which the survival rate of embryos increased 11, 24, 25, and 28%, respectively, after injection with junctional components; the tjp-2 and aPKC mRNA-rescued embryos also had 24 and 45% decreases in the defective rate. Immunofluorescent studies demonstrated that the aggregation of aPKC around the cell junctions had disintegrated in zBves morphants. However, the expression and assembly of zBves were not influenced by aPKC-MO. These results indicate that a loss of zBves affects the proteins involved in the pathway of the PAR junctional complex, especially aPKC, and both aPKC and Bves are indispensable to claudin expression.	[Wu, Yu-Ching; Chen, Ruei-Feng] Natl Taiwan Univ, Inst Zool, Coll Life Sci, Taipei 10673, Taiwan; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol, Grad Program Neurosci, Cincinnati, OH 45267 USA; [Chen, Yau-Hung] Tamkang Univ, Grad Inst Life Sci, Tamsui 25137, Taiwan; [Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University; University System of Ohio; University of Cincinnati; Tamkang University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Chug Shan S Rd, Taipei 100, Taiwan.	ijong@ms8.hinet.net		CHEN, RUEI-FENG/0000-0002-7505-5415; Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614	National Science Council [983112B002040, 993112B002029, 992314B002039MY3]; National Taiwan University Hospital [98S-1105]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported in part by National Science Council Grants 983112B002040, 993112B002029, and 992314B002039MY3 and by National Taiwan University Hospital Grant 98S-1105.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; Denning MF, 2007, J INVEST DERMATOL, V127, P742, DOI 10.1038/sj.jid.5700694; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Reese DE, 1999, DEV BIOL, V209, P159, DOI 10.1006/dbio.1999.9246; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1995, ZEBRAFISH BOOK, P2; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	19	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.372078	http://dx.doi.org/10.1074/jbc.M112.372078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019331	hybrid, Green Published			2022-12-25	WOS:000311233800057
J	Hougland, JL; Gangopadhyay, SA; Fierke, CA				Hougland, James L.; Gangopadhyay, Soumyashree A.; Fierke, Carol A.			Expansion of Protein Farnesyltransferase Specificity Using "Tunable" Active Site Interactions DEVELOPMENT OF BIOENGINEERED PRENYLATION PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL DETERMINANTS; SUBSTRATE-SPECIFICITY; K-RAS; PEPTIDE; FARNESYL; GERANYLGERANYLTRANSFERASE; PRENYLTRANSFERASES; ISOPRENYLATION; TRANSFERASE; ENZYMOLOGY	Post-translational modifications play essential roles in regulating protein structure and function. Protein farnesyltransferase (FTase) catalyzes the biologically relevant lipidation of up to several hundred cellular proteins. Site-directed mutagenesis of FTase coupled with peptide selectivity measurements demonstrates that molecular recognition is determined by a combination of multiple interactions. Targeted randomization of these interactions yields FTase variants with altered and, in some cases, bio-orthogonal selectivity. We demonstrate that FTase specificity can be "tuned" using a small number of active site contacts that play essential roles in discriminating against non-substrates in the wild-type enzyme. This tunable selectivity extends in vivo, with FTase variants enabling the creation of bioengineered parallel prenylation pathways with altered substrate selectivity within a cell. Engineered FTase variants provide a novel avenue for probing both the selectivity of prenylation pathway enzymes and the effects of prenylation pathway modifications on the cellular function of a protein.	[Hougland, James L.] Syracuse Univ, Dept Chem, Ctr Sci & Technol 1 014, Syracuse, NY 13244 USA; [Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Syracuse University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hougland, JL (corresponding author), Syracuse Univ, Dept Chem, Ctr Sci & Technol 1 014, Syracuse, NY 13244 USA.	hougland@syr.edu; fierke@umich.edu	Gangopadhyay, Soumyashree/J-1172-2019	Gangopadhyay, Soumyashree/0000-0002-8764-1788; Hougland, James/0000-0003-0444-1017	National Institutes of Health Grant [GM040602]; National Institutes of Health Postdoctoral Fellowship [GM078894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040602, R01GM040602, F32GM078894] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040602 (to C. A. F.) and National Institutes of Health Postdoctoral Fellowship GM078894 (to J. L. H.).	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Benetka W, 2006, MONATSH CHEM, V137, P1241, DOI 10.1007/s00706-006-0534-9; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CASSIDY PB, 1995, METHOD ENZYMOL, V250, P30; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Crowell DN, 2000, PROG LIPID RES, V39, P393, DOI 10.1016/S0163-7827(00)00010-2; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; FERSHT A, 1999, STRUCTURE MECH PROTE, P110; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hicks KA, 2005, BIOCHEMISTRY-US, V44, P15325, DOI 10.1021/bi050951v; Hightower KE, 2001, BIOCHEMISTRY-US, V40, P1002, DOI 10.1021/bi002237d; Hightower KE, 1998, BIOCHEMISTRY-US, V37, P15555, DOI 10.1021/bi981525v; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Hougland JL, 2009, BIOCHEMISTRY-US, V48, P1691, DOI 10.1021/bi801710g; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Krzysiak AJ, 2007, BIOORG MED CHEM LETT, V17, P5548, DOI 10.1016/j.bmcl.2007.08.024; Krzysiak AJ, 2010, BIOORG MED CHEM LETT, V20, P767, DOI 10.1016/j.bmcl.2009.11.011; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; OMER CA, 1993, BIOCHEMISTRY-US, V32, P5167, DOI 10.1021/bi00070a028; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reigard SA, 2005, BIOCHEMISTRY-US, V44, P11214, DOI 10.1021/bi050725l; REISS Y, 1991, J BIOL CHEM, V266, P10672; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zimmerman KK, 1998, PROTEIN EXPRES PURIF, V14, P395, DOI 10.1006/prep.1998.0979	50	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404954	http://dx.doi.org/10.1074/jbc.M112.404954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992747	hybrid, Green Published			2022-12-25	WOS:000310642200043
J	Spelat, R; Ferro, F; Curcio, F				Spelat, Renza; Ferro, Federico; Curcio, Francesco			Serine 111 Phosphorylation Regulates OCT4A Protein Subcellular Distribution and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; DNA-BINDING; STEM-CELLS; PLURIPOTENCY; OCT-4; EXPRESSION; UBIQUITIN; SOX2; DIFFERENTIATION	Embryonic stem cell self-renewal properties are attributed to critical amounts of OCT4A, but little is known about its post-translational regulation. Sequence analysis revealed that OCT4A contains five putative ERK1/2 phosphorylation sites. Consistent with the hypothesis that OCT4A is a putative ERK1/2 substrate, we demonstrate that OCT4A interacts with ERK1/2 by using both in vitro GST pulldown and in vivo co-immunoprecipitation assays. MS analysis identified phosphorylation of OCT4A at Ser-111. To investigate the possibility that ERK1/2 activation can enhance OCT4A degradation, we analyzed endogenous ubiquitination in cells transfected with FLAG-OCT4A alone or with constitutively active MEK1 (MEK1(CA)), and we observed that the extent of OCT4 ubiquitination was clearly increased when MEK1(CA) was coexpressed and that this increase was more evident after MG132 treatment. These results suggest an increase in OCT4A ubiquitination downstream of MEK1 activation, and this could account for the protein loss observed after FGF2 treatment and MEK1(CA) transfection. Understanding and controlling the mechanism by which stem cells balance self-renewal would substantially advance our knowledge of stem cells.	[Spelat, Renza; Ferro, Federico; Curcio, Francesco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Spelat, R (corresponding author), Univ Udine, Dept Med & Biol Sci, Ple M Kolbe 4, I-33100 Udine, Italy.	renzaspelat@yahoo.it	Spelat, Renza/AAZ-2980-2021; Ferro, Federico/GPK-8383-2022; Curcio, Francesco/K-4669-2014	Spelat, Renza/0000-0001-5794-8976; Ferro, Federico/0000-0002-6023-8227; CURCIO, Francesco/0000-0002-9070-4807				Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Hansis C, 2000, MOL HUM REPROD, V6, P999, DOI 10.1093/molehr/6.11.999; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mayer RJ, 2000, NAT REV MOL CELL BIO, V1, P145; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	36	29	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386755	http://dx.doi.org/10.1074/jbc.M112.386755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	23024368	Green Published, hybrid			2022-12-25	WOS:000310642200060
J	Martin, SL; Husband, BC				Martin, Sara L.; Husband, Brian C.			Whole Genome Duplication Affects Evolvability of Flowering Time in an Autotetraploid Plant	PLOS ONE			English	Article							EPILOBIUM-ANGUSTIFOLIUM; EVOLUTIONARY CONSEQUENCES; POLYPLOIDY; CONSTRAINTS; SELECTION; AUTOPOLYPLOIDY; REARRANGEMENTS; ANGIOSPERMS; BRASSICA; FIREWEED	Whole genome duplications have occurred recurrently throughout the evolutionary history of eukaryotes. The resulting genetic and phenotypic changes can influence physiological and ecological responses to the environment; however, the impact of genome copy number on evolvability has rarely been examined experimentally. Here, we evaluate the effect of genome duplication on the ability to respond to selection for early flowering time in lines drawn from naturally occurring diploid and autotetraploid populations of the plant Chamerion angustifolium (fireweed). We contrast this with the result of four generations of selection on synthesized neoautotetraploids, whose genic variability is similar to diploids but genome copy number is similar to autotetraploids. In addition, we examine correlated responses to selection in all three groups. Diploid and both extant tetraploid and neoautotetraploid lines responded to selection with significant reductions in time to flowering. Evolvability, measured as realized heritability, was significantly lower in extant tetraploids ((b) over cap (T) = 0.31) than diploids ((b) over cap (T) = 0.40). Neotetraploids exhibited the highest evolutionary response ((b) over cap (T) = 0.55). The rapid shift in flowering time in neotetraploids was associated with an increase in phenotypic variability across generations, but not with change in genome size or phenotypic correlations among traits. Our results suggest that whole genome duplications, without hybridization, may initially alter evolutionary rate, and that the dynamic nature of neoautopolyploids may contribute to the prevalence of polyploidy throughout eukaryotes.	[Martin, Sara L.; Husband, Brian C.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Martin, SL (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	slwmartin@gmail.com			Ontario Graduate Scholarship; Natural Science and Engineering Research Council of Canada; Premier's Research Excellence Award; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Award; Canadian Foundation for Innovation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Premier's Research Excellence Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The authors gratefully acknowledge financial support from Ontario Graduate Scholarship and Natural Science and Engineering Research Council of Canada to SLM, and from Premier's Research Excellence Award, Natural Sciences and Engineering Research Council of Canada, Canada Research Chair Award and Canadian Foundation for Innovation to BCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Anderson JB, 2003, GENETICS, V163, P1287; [Anonymous], 1907, SCIENCE, V26, P151; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Burgess KS, 2007, HEREDITY, V99, P641, DOI 10.1038/sj.hdy.6801043; Caruso CM, 2005, EVOLUTION, V59, P826; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Dart S, 2004, CAN J BOT, V82, P185, DOI [10.1139/B03-134, 10.1139/b03-134]; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Eilam T, 2009, GENOME, V52, P275, DOI 10.1139/G09-004; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; FOWLER NL, 1984, AM NAT, V124, P703, DOI 10.1086/284307; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Husband BC, 1998, AM J BOT, V85, P1688, DOI 10.2307/2446502; HUSBAND BC, 1995, HEREDITY, V75, P206, DOI 10.1038/hdy.1995.125; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; Husband BC, 1997, EVOLUTION, V51, P737, DOI [10.2307/2411150, 10.1111/j.1558-5646.1997.tb03657.x]; Kashkush K, 2002, GENETICS, V160, P1651; Kelley K, 2011, MBESS; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; Levin D. A, 2002, OX ECOL EV; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Lynch M, 2008, EVOLUTION SELECTION, P209; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Martelotto LG, 2007, PLANT SCI, V172, P970, DOI 10.1016/j.plantsci.2007.02.001; Martin SL, 2008, SIGNIFICANCE POLYPLO; MOSQUIN T, 1967, EVOLUTION, V21, P713, DOI 10.1111/j.1558-5646.1967.tb03428.x; Muntzing A, 1935, HEREDITAS, V21, P263; ONeil P, 1997, EVOLUTION, V51, P267, DOI [10.1111/j.1558-5646.1997.tb02408.x, 10.2307/2410980]; ORR HA, 1994, GENETICS, V136, P1475; Oswald BP, 2010, EVOLUTION, P1667; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Otto SP, 2002, ADV GENET, V46, P451; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; R Development Core Team, 2011, R LANG DAT AN GRAPH; RAINA SN, 1994, GENOME, V37, P560, DOI 10.1139/g94-080; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Roy Y, 2008, EVOLUTIONARY HIST PO; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Schranz ME, 2000, J HERED, V91, P242, DOI 10.1093/jhered/91.3.242; SOLBRECK C, 1987, CAN J BOT, V65, P2177, DOI 10.1139/b87-299; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; Stebbins GL, 1940, AM NAT, V74, P54, DOI 10.1086/280872; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Vamosi JC, 2006, INT J PLANT SCI, V167, P349, DOI 10.1086/499251; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	68	30	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44784	10.1371/journal.pone.0044784	http://dx.doi.org/10.1371/journal.pone.0044784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028620	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400039
J	Miao, CY; Duan, QY; Yang, L; Borthwick, AGL				Miao, Chiyuan; Duan, Qingyun; Yang, Lin; Borthwick, Alistair G. L.			On the Applicability of Temperature and Precipitation Data from CMIP3 for China	PLOS ONE			English	Article							CLIMATE-CHANGE; SUMMER MONSOON; IMPACTS; MODELS; SIMULATION; ERA	Global Circulation Models (GCMs) contributed to the Intergovernmental Panel on Climate Change (IPCC) Fourth Assessment Report (AR4) and are widely used in global change research. This paper assesses the performance of the AR4 GCMs in simulating precipitation and temperature in China from 1960 to 1999 by comparison with observed data, using system bias (B), root-mean-square error (RMSE), Pearson correlation coefficient (R) and Nash-Sutcliffe model efficiency (E) metrics. Probability density functions (PDFs) are also fitted to the outputs of each model. It is shown that the performance of each GCM varies to different degrees across China. Based on the skill score derived from the four metrics, it is suggested that GCM 15 (ipsl_cm4) and GCM 3 (cccma_cgcm_t63) provide the best representations of temperature and precipitation, respectively, in terms of spatial distribution and trend over 10 years. The results also indicate that users should apply carefully the results of annual precipitation and annual temperature generated by AR4 GCMs in China due to poor performance. At a finer scale, the four metrics are also used to obtain best fit scores for ten river basins covering mainland China. Further research is proposed to improve the simulation accuracy of the AR4 GCMs regarding China.	[Miao, Chiyuan; Duan, Qingyun] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yang, Lin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Borthwick, Alistair G. L.] Univ Coll Cork, Dept Civil & Environm Engn, Cork, Ireland	Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University College Cork	Miao, CY (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	miaocy@vip.sina.com	Yang, Lin/ABG-5551-2021; Duan, Qingyun/C-7652-2011; Miao, Chiyuan/E-6036-2011	Duan, Qingyun/0000-0001-9955-1512; Miao, Chiyuan/0000-0001-6413-7020; Yang, Lin/0000-0002-7576-4481	National Natural Science Foundation of China [41001153]; National Key Basic Special Foundation Project of China [2010CB951604, 2010CB428402]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Special Foundation Project of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Natural Science Foundation of China (no. 41001153), the National Key Basic Special Foundation Project of China (no. 2010CB951604 and no. 2010CB428402), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfeld DP, 2006, P 16 INT C COMP METH; Beaulieu C, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007501; Black R, 2011, NATURE, V478, P447, DOI 10.1038/478477a; Brunsell NA, 2011, ACTA GEOSCI SIN, V30, P1178; Coquard J, 2004, CLIM DYNAM, V23, P455, DOI 10.1007/s00382-004-0437-6; Delire C, 2008, GLOBAL PLANET CHANGE, V64, P3, DOI 10.1016/j.gloplacha.2008.01.008; Duan QY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013654; Ducre-Robitaille JF, 2003, INT J CLIMATOL, V23, P1087, DOI 10.1002/joc.924; Dutton JA, 2002, B AM METEOROL SOC, V83, P1303, DOI 10.1175/1520-0477-83.9.1303; Errasti I, 2011, THEOR APPL CLIMATOL, V103, P61, DOI 10.1007/s00704-010-0282-y; Frame DJ, 2009, PHILOS T R SOC A, V367, P855, DOI 10.1098/rsta.2008.0240; Gao X, 2008, METEOROL ATMOS PHYS, V100, P73, DOI 10.1007/s00703-008-0296-5; Giorgi F, 2002, J CLIMATE, V15, P1141, DOI 10.1175/1520-0442(2002)015<1141:COAURA>2.0.CO;2; Im ES, 2007, CLIM DYNAM, V28, P759, DOI [10.1007/s00382-006-0203-z, 10.1007/s00382-006-0203-Z]; Kiktev D, 2003, J CLIMATE, V16, P3560, DOI 10.1175/1520-0442(2003)016<3560:COMAOT>2.0.CO;2; Lambert SJ, 2001, CLIM DYNAM, V17, P83, DOI 10.1007/PL00013736; Li HM, 2011, ADV ATMOS SCI, V28, P448, DOI 10.1007/s00376-010-0052-x; Li HM, 2011, ADV ATMOS SCI, V28, P433, DOI 10.1007/s00376-010-0013-4; Li LJ, 2007, CHINESE SCI BULL, V52, P3148, DOI 10.1007/s11434-007-0463-y; Li P, 2011, ENG SCI, V04, P29; Lofgren BM, 2004, 18 C HYDR 8 ANN M AM, P3; Masson D, 2011, J CLIMATE, V24, P2680, DOI 10.1175/2011JCLI3513.1; Maxino CC, 2008, INT J CLIMATOL, V28, P1097, DOI 10.1002/joc.1612; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Nieto S, 2006, J CLIMATE, V19, P4254, DOI 10.1175/JCLI3859.1; Phillips TJ, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004313; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Ren G, 2005, CLIMATIC ENV RES, V10, P711; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Warner GS, 1997, T ASAE, V40, P585, DOI 10.13031/2013.21317; Watterson IG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014502; Yu RC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021270; Yu RC, 2007, J CLIMATE, V20, P5344, DOI 10.1175/2007JCLI1559.1; Zhao T, 2008, J CLIMATE, V21, P1440, DOI 10.1175/2007JCLI1463.1; Zhou TJ, 2006, J CLIMATE, V19, P5843, DOI 10.1175/JCLI3952.1; Zhou TJ, 2009, METEOROL Z, V18, P455, DOI 10.1127/0941-2948/2009/0396	40	26	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44659	10.1371/journal.pone.0044659	http://dx.doi.org/10.1371/journal.pone.0044659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028575	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400031
J	Gao, SG; Roberts, HK; Wang, XJ				Gao, Shouguo; Roberts, Herbert Keith; Wang, Xujing			Cross Tissue Trait-Pathway Network Reveals the Importance of Oxidative Stress and Inflammation Pathways in Obesity-Induced Diabetes in Mouse	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLISM; CENTRALITY; GLUCOSE; HUMANS	Complex disorders often involve dysfunctions in multiple tissue organs. Elucidating the communication among them is important to understanding disease pathophysiology. In this study we integrate multiple tissue gene expression and quantitative trait measurements of an obesity-induced diabetes mouse model, with databases of molecular interaction networks, to construct a cross tissue trait-pathway network. The animals belong to two strains of mice (BTBR or B6), of two obesity status (obese or lean), and at two different ages (4 weeks and 10 weeks). Only 10 week obese BTBR animals are diabetic. The expression data was first utilized to determine the state of every pathway in each tissue, which is subsequently utilized to construct a pathway co-expression network and to define trait-relevant and trait-linking pathways. Among the six tissues profiled, the adipose contains the largest number of trait-linking pathways. Among the eight traits measured, the body weight and plasma insulin level possess the most number of relevant and linking pathways. Topological analysis of the trait-pathway network revealed that the glycolysis/gluconeogenesis pathway in liver and the insulin signaling pathway in muscle are of top importance to the information flow in the network, with the highest degrees and betweenness centralities. Interestingly, pathways related to metabolism and oxidative stress actively interact with many other pathways in all animals, whereas, among the 10 week animals, the inflammation pathways were preferentially interactive in the diabetic ones only. In summary, our method offers a systems approach to delineate disease trait relevant intra-and cross tissue pathway interactions, and provides insights to the molecular basis of the obesity-induced diabetes.	[Gao, Shouguo; Roberts, Herbert Keith; Wang, Xujing] Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; [Gao, Shouguo; Wang, Xujing] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, XJ (corresponding author), Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA.	xujingw@uab.edu			United States National Institutes of Health (NIH) [NIH-DK080100]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080100] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by United States National Institutes of Health (NIH) NIH-DK080100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batagelj V, 2004, MATH VIS, P77; Bordonaro M, 2009, VITAM HORM, V80, P563, DOI 10.1016/S0083-6729(08)00619-5; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Gao S, 2009, ONLINE J BIOINFORMAT, V10, P191; Gao S, 2012, OMICS IN PRESS; Gao S, 2011, BIOINF BIOM WORKSH B; Gao SG, 2007, BIOINFORMATICS, V23, P3100, DOI 10.1093/bioinformatics/btm460; Gao Shouguo, 2009, J Comput Sci Syst Biol, V2, P133; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hu Haiyan, 2008, Pac Symp Biocomput, P255; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Koshiyama H, 2006, MED HYPOTHESES, V67, P307, DOI 10.1016/j.mehy.2006.02.033; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Maliackal Poulo Joy AB, 2005, J BIOMEDICINE BIOTEC; Mirela D, 2009, PROTEIN TYROSINE PHO; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ogawa Wataru, 2006, Nihon Rinsho, V64, P1381; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995; Palumbo PJ, 2004, CLEV CLIN J MED, V71, P385, DOI 10.3949/ccjm.71.5.385; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUHAIL M, 1989, ACTA DIABETOL LAT, V26, P315, DOI 10.1007/BF02624643; TODESCO T, 1991, AM J CLIN NUTR, V54, P860, DOI 10.1093/ajcn/54.5.860; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; Webber J, 1998, ABNORMALITIES GLUCOS, P191; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44544	10.1371/journal.pone.0044544	http://dx.doi.org/10.1371/journal.pone.0044544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028558	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800013
J	Piret, SE; Esapa, CT; Gorvin, CM; Head, R; Loh, NY; Devuyst, O; Thomas, G; Brown, SDM; Brown, M; Croucher, P; Cox, R; Thakker, RV				Piret, Sian E.; Esapa, Christopher T.; Gorvin, Caroline M.; Head, Rosie; Loh, Nellie Y.; Devuyst, Olivier; Thomas, Gethin; Brown, Steve D. M.; Brown, Matthew; Croucher, Peter; Cox, Roger; Thakker, Rajesh V.			A Mouse Model of Early-Onset Renal Failure Due to a Xanthine Dehydrogenase Nonsense Mutation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TUBULOINTERSTITIAL FIBROSIS; CLASSICAL XANTHINURIA; DEFICIENT MICE; I XANTHINURIA; GENE-FUNCTION; GENOME-WIDE; DRIVEN; IDENTIFICATION; DYSPLASIA	Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal failure, and studies have supported a strong genetic influence on the risk of developing CKD. However, investigations of the underlying molecular mechanisms are hampered by the lack of suitable hereditary models in animals. We therefore sought to establish hereditary mouse models for CKD and renal fibrosis by investigating mice treated with the chemical mutagen N-ethyl-N-nitrosourea, and identified a mouse with autosomal recessive renal failure, designated RENF. Three-week old RENF mice were smaller than their littermates, whereas at birth they had been of similar size. RENF mice, at 4-weeks of age, had elevated concentrations of plasma urea and creatinine, indicating renal failure, which was associated with small and irregularly shaped kidneys. Genetic studies using DNA from 10 affected mice and 91 single nucleotide polymorphisms mapped the Renf locus to a 5.8Mbp region on chromosome 17E1.3. DNA sequencing of the xanthine dehydrogenase (Xdh) gene revealed a nonsense mutation at codon 26 that co-segregated with affected RENF mice. The Xdh mutation resulted in loss of hepatic XDH and renal Cyclooxygenase-2 (COX-2) expression. XDH mutations in man cause xanthinuria with undetectable plasma uric acid levels and three RENF mice had plasma uric acid levels below the limit of detection. Histological analysis of RENF kidney sections revealed abnormal arrangement of glomeruli, intratubular casts, cellular infiltration in the interstitial space, and interstitial fibrosis. TUNEL analysis of RENF kidney sections showed extensive apoptosis predominantly affecting the tubules. Thus, we have established a mouse model for autosomal recessive early-onset renal failure due to a nonsense mutation in Xdh that is a model for xanthinuria in man. This mouse model could help to increase our understanding of the molecular mechanisms associated with renal fibrosis and the specific roles of XDH and uric acid.	[Piret, Sian E.; Esapa, Christopher T.; Gorvin, Caroline M.; Head, Rosie; Loh, Nellie Y.; Brown, Matthew; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Thomas, Gethin; Brown, Matthew] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Woolloongabba, Qld, Australia; [Croucher, Peter] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Queensland; Garvan Institute of Medical Research	Piret, SE (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010; Thomas, Gethin P/A-3624-2011; Gorvin, Caroline/T-2406-2019	Brown, Matthew A/0000-0003-0538-8211; Gorvin, Caroline/0000-0002-1361-9174; Piret, Sian/0000-0002-3586-7654; Croucher, Peter/0000-0002-7102-2413; Devuyst, Olivier/0000-0003-3744-4767; Thomas, Gethin/0000-0001-9081-3686; Thakker, Rajesh/0000-0002-1438-3220; Cox, Roger/0000-0001-7170-5014	Medical Research Council UK [G0600702/1, G9825289, G1000467]; European Union program grants, EuReGene (FP6) [05085]; TREAT-OA (FP7) [200800]; NCCR Kidney; CH (Swiss National Science Foundation); ZIHP (Zurich Center for 298 Integrative Human Physiology); Medical Research Council [G1000467, G9825289, MC_U142684172, MC_U142661184] Funding Source: researchfish; MRC [G9825289, MC_U142661184, MC_U142684172, G1000467] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union program grants, EuReGene (FP6); TREAT-OA (FP7); NCCR Kidney; CH (Swiss National Science Foundation); ZIHP (Zurich Center for 298 Integrative Human Physiology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (G0600702/1, G9825289 and G1000467), and the European Union program grants, EuReGene (FP6) (05085) and TREAT-OA (FP7) (200800). OD is supported by the NCCR Kidney, CH (Swiss National Science Foundation) and the ZIHP (Zurich Center for 298 Integrative Human Physiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Barbaric I, 2007, J AM ASSOC LAB ANIM, V46, P44; Bosman EA, 2009, DEV BIOL, V328, P285, DOI 10.1016/j.ydbio.2009.01.030; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Gavett SH, 1999, J CLIN INVEST, V104, P721, DOI 10.1172/JCI6890; Gok F, 2003, NEPHROL DIAL TRANSPL, V18, P2278, DOI 10.1093/ndt/gfg385; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; He C, 2012, MOL BIOSYST, V8, P1585, DOI 10.1039/c2mb05503a; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Ichida K, 1997, J CLIN INVEST, V99, P2391, DOI 10.1172/JCI119421; Jurecka A, 2010, J INHERIT METAB DIS, V33, pS21, DOI 10.1007/s10545-009-9011-z; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Levartovsky D, 2000, KIDNEY INT, V57, P2215, DOI 10.1046/j.1523-1755.2000.00082.x; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Piret SE, 2011, J ENDOCRINOL, V211, P211, DOI 10.1530/JOE-11-0193; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Sakamoto N, 2001, HUM GENET, V108, P279, DOI 10.1007/s004390100477; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	33	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45217	10.1371/journal.pone.0045217	http://dx.doi.org/10.1371/journal.pone.0045217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024809	Green Published, gold, Green Accepted			2022-12-25	WOS:000308860100067
J	Potvin, J; Goldbogen, JA; Shadwick, RE				Potvin, Jean; Goldbogen, Jeremy A.; Shadwick, Robert E.			Metabolic Expenditures of Lunge Feeding Rorquals Across Scale: Implications for the Evolution of Filter Feeding and the Limits to Maximum Body Size	PLOS ONE			English	Article							FIN WHALES; BALAENOPTERA-PHYSALUS; ENERGY-EXPENDITURE; AQUATIC LOCOMOTION; HUMPBACK WHALES; PLASMA LACTATE; BOWHEAD WHALE; MINKE WHALES; PERFORMANCE; BEHAVIOR	Bulk-filter feeding is an energetically efficient strategy for resource acquisition and assimilation, and facilitates the maintenance of extreme body size as exemplified by baleen whales (Mysticeti) and multiple lineages of bony and cartilaginous fishes. Among mysticetes, rorqual whales (Balaenopteridae) exhibit an intermittent ram filter feeding mode, lunge feeding, which requires the abandonment of body-streamlining in favor of a high-drag, mouth-open configuration aimed at engulfing a very large amount of prey-laden water. Particularly while lunge feeding on krill (the most widespread prey preference among rorquals), the effort required during engulfment involve short bouts of high-intensity muscle activity that demand high metabolic output. We used computational modeling together with morphological and kinematic data on humpback (Megaptera noveaangliae), fin (Balaenoptera physalus), blue (Balaenoptera musculus) and minke (Balaenoptera acutorostrata) whales to estimate engulfment power output in comparison with standard metrics of metabolic rate. The simulations reveal that engulfment metabolism increases across the full body size of the larger rorqual species to nearly 50 times the basal metabolic rate of terrestrial mammals of the same body mass. Moreover, they suggest that the metabolism of the largest body sizes runs with significant oxygen deficits during mouth opening, namely, 20% over maximum (V) over dot O(2)at the size of the largest blue whales, thus requiring significant contributions from anaerobic catabolism during a lunge and significant recovery after a lunge. Our analyses show that engulfment metabolism is also significantly lower for smaller adults, typically one-tenth to one-half (V) over dot O-2 vertical bar max. These results not only point to a physiological limit on maximum body size in this lineage, but also have major implications for the ontogeny of extant rorquals as well as the evolutionary pathways used by ancestral toothed whales to transition from hunting individual prey items to filter feeding on prey aggregations.	[Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA; [Goldbogen, Jeremy A.] Cascadia Res Collect, Olympia, WA USA; [Shadwick, Robert E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Saint Louis University; University of British Columbia	Potvin, J (corresponding author), St Louis Univ, Dept Phys, St Louis, MO 63103 USA.	potvinj@slu.edu	Goldbogen, Jeremy A./H-4287-2019	Goldbogen, Jeremy A./0000-0002-4170-7294	United States Navy; Office of Naval Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	United States Navy(United States Department of Defense); Office of Naval Research(Office of Naval Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	J. Goldbogen was supported by funding from the United States Navy and Office of Naval Research awarded to J. Calambokidis and Cascadia Research Collective. R. Shadwick was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn B. K., 2004, ZOOLOGICAL PHYS; Ahlborn BK, 2009, CAN J ZOOL, V87, P124, DOI 10.1139/Z08-144; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Alexander RM., 2003, PRINCIPLES ANIMAL LO; [Anonymous], 1981, MECH WAVE FORCES OFF, DOI 10.1115/1.3162189; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Arnold PW, 2005, MEM QUEENSL MUS; Ash C. E., 1953, Norsk Hvalfangsttidende Sandefjord, V42, P387; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BLIX AS, 1995, ACTA PHYSIOL SCAND, V153, P61, DOI 10.1111/j.1748-1716.1995.tb09834.x; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; Boyd IL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P247; Brodie Paul F., 2001, P345; BRODIE PF, 1993, CAN J ZOOL, V71, P2546, DOI 10.1139/z93-348; Cochran BC, 1991, EXPT INVESTIGATION A, P171; Costa Daniel P., 1999, P176; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; DANIEL TL, 1984, AM ZOOL, V24, P121; DANIEL TL, 1985, J EXP BIOL, V119, P149; DANIEL TL, 1989, J EXP BIOL, V143, P245; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2011, INTEGR COMP BIOL, V51, pE193; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Goldbogen JA, 2010, P R SOC B, V277, P861, DOI 10.1098/rspb.2009.1680; Higham TE, 2007, INTEGR COMP BIOL, V47, P82, DOI 10.1093/icb/icm021; Hill RW, 2008, ANIMAL PHYSL; Kanatous SB, 2002, J EXP BIOL, V205, P3601; KERMACK KA, 1948, J EXP BIOL, V25, P237; KLEIBER M, 1961, Annu Rev Physiol, V23, P5; Kleiber M., 1975, FIRE LIFE INTRO ANIM; LAMBERTSEN R, 1995, J MAMMAL, V76, P877, DOI 10.2307/1382758; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; LAMBERTSEN RH, 1983, J MAMMAL, V64, P76, DOI 10.2307/1380752; LOCKYER C, 1986, MAR MAMMAL SCI, V2, P169, DOI 10.1111/j.1748-7692.1986.tb00039.x; Lockyer C, 1981, GEN PAPERS LARGE CET, V3, P379; Lockyer C., 1976, ICES J MAR SCI, V36, P259, DOI DOI 10.1093/ICESJMS/36.3.259; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Macha JM, 1993, SIMPLE APPROXIMATE M, V1993; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mackintosh N. A., 1942, Discovery Reports Cambridge, V22, P197; Matthews L. H, 1937, DISCOVERY REP, V22, P197; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Munk MM, 1924, SOME TABLES FACTOR A, P197; Nemoto T., 1970, P241; Nishiwaki M., 1951, Scientific Reports of the Whales Research Institute Tokyo, VNo. 5, P91; Nowacek D.P., 2011, PLOS ONE, V6; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Pennycuick C. J., 1992, NEWTON RULES BIOL; Perrine D, 2009, NATL GEOGR, V216, P65; PERRINE D, 2009, NATL GEOGR, V216, P70; PIVORUNAS A, 1977, J MORPHOL, V151, P299, DOI 10.1002/jmor.1051510207; Potvin J, 2010, J THEOR BIOL, V267, P437, DOI 10.1016/j.jtbi.2010.08.026; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Quiring Daniel P., 1943, JOUR MAMMAL, V24, P39, DOI 10.2307/1374778; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schulte H. W., 1916, MEMOIRS AM MUSEUM NA, V1, P389; Shaffer SA, 1997, J EXP BIOL, V200, P3091; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; Simon M, 2009, P ROYAL SOC B; Sousa-Lima RS, 2010, MAR MAMMAL SCI, V26, P977, DOI 10.1111/j.1748-7692.2010.00373.x; STRICKLAND JH, 1990, J AIRCRAFT, V27, P501, DOI 10.2514/3.25311; Tuckerman, 1925, INERTIA FACTORS ELLI; Van Wassenbergh S, 2009, J R SOC INTERFACE, V6, P149, DOI 10.1098/rsif.2008.0311; Vikingsson G., 1988, REP INT WHAL COMMN, V38, P323; Vogel S, 2008, INTEGR COMP BIOL, V48, P702, DOI 10.1093/icb/icn014; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Watanabe YY, 2011, J ANIM ECOL, V80, P57, DOI 10.1111/j.1365-2656.2010.01760.x; Watkins WA, 1996, MAR MAMMAL SCI, V12, P564; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Wiedenmann J, 2011, ECOL MODEL, V222, P3366, DOI 10.1016/j.ecolmodel.2011.07.013; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Williams TM, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P191; WILLIAMS TM, 1989, J COMP PHYSIOL A, V164, P815, DOI 10.1007/BF00616753; Williams TM, 2004, INT CONGR SER, V1275, P351, DOI 10.1016/j.ics.2004.08.069; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; Wilson JF., 2003, DYNAMICS OFFSHORE ST; Woodward BL, 2006, J MORPHOL, V267, P1284, DOI 10.1002/jmor.10474	99	64	64	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44854	10.1371/journal.pone.0044854	http://dx.doi.org/10.1371/journal.pone.0044854			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024769	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100027
J	Rudnicki, M; Perco, P; Neuwirt, H; Noppert, SJ; Leierer, J; Sunzenauer, J; Eder, S; Zoja, C; Eller, K; Rosenkranz, AR; Muller, GA; Mayer, B; Mayer, G				Rudnicki, Michael; Perco, Paul; Neuwirt, Hannes; Noppert, Susie-Jane; Leierer, Johannes; Sunzenauer, Judith; Eder, Susanne; Zoja, Carlamaria; Eller, Kathrin; Rosenkranz, Alexander R.; Mueller, Gerhard A.; Mayer, Bernd; Mayer, Gert			Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease	PLOS ONE			English	Article							MEMBRANOUS NEPHROPATHY; CELL-PROLIFERATION; PROSTATE-CANCER; P-SELECTIN; BINDING; GROWTH; GLOMERULONEPHRITIS; PROTEOGLYCAN; ACCUMULATION; PROTEINURIA	Novel prognostic markers for progression of kidney disease are needed to distinguish patients who might benefit from a more aggressive nephroprotective therapy. Expression of the proteoglycan versican was evaluated in renal transcriptomics profiles and in an independent set of 74 renal biopsies. Versican levels were correlated to histologic damage scores and to renal outcome, and versican expression and regulation was evaluated in vitro. In transcriptomics profiles of renal tissue versican was positively correlated with (i) histological parameters in kidney biopsies, (ii) progressive decline of renal function in proteinuric kidney diseases, and (iii) impaired renal function and histology scores in diabetic nephropathy. In an independent cohort of 74 biopsies of glomerular diseases renal RNA levels of versican isoforms V0 and V1, but not V2 and V3 correlated significantly with creatinine after a mean follow up time of 53 months. Versican isoforms V0 and V1 together with serum creatinine at time of biopsy and the degree of glomerulosclerosis predicted 20% and 24% of the variability of creatinine at follow up, which was significantly more than serum creatinine and histological parameters alone (16%). However, when patients with acute kidney failure at time of biopsy (n = 5) were excluded, the additive predictive value of versican V1 was only marginally higher (35%) than creatinine and glomerulosclerosis alone (34%). Versican isoforms V0 and V1 were primarily expressed in vitro in proximal tubule cells and in fibroblasts. The results in humans were confirmed in three rodent models of kidney disease, in which renal versican expression was significantly upregulated as compared to corresponding controls. These data show for the first time an association of renal versican isoform V0 and V1 expression with progressive renal disease.	[Rudnicki, Michael; Neuwirt, Hannes; Noppert, Susie-Jane; Leierer, Johannes; Sunzenauer, Judith; Eder, Susanne; Eller, Kathrin; Rosenkranz, Alexander R.; Mayer, Gert] Med Univ Innsbruck, Deptartment Internal Med Nephrol & Hypertens 5, Innsbruck, Austria; [Perco, Paul; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria; [Zoja, Carlamaria] Ctr Anna Maria Astori, Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Eller, Kathrin; Rosenkranz, Alexander R.] Med Univ Graz, Deptartment Internal Med, Clin Div Nephrol & Hemodialysis, Graz, Austria; [Mueller, Gerhard A.] Univ Gottingen, Dept Med Nephrol & Rheumatol, Gottingen, Germany	Medical University of Innsbruck; Emergentec Biodevelopment GmbH; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Medical University of Graz; University of Gottingen	Rudnicki, M (corresponding author), Med Univ Innsbruck, Deptartment Internal Med Nephrol & Hypertens 5, Innsbruck, Austria.	michael.rudnicki@i-med.ac.at	Perco, Paul/U-2489-2019; Neuwirt, Hannes/AAF-1090-2019; zoja, carlamaria/ABF-5896-2020; Rudnicki, Michael/D-5288-2013	Perco, Paul/0000-0003-2087-5691; zoja, carlamaria/0000-0003-2507-8894; Neuwirt, Hannes/0000-0003-1064-0098; Leierer, Johannes/0000-0002-7884-9827; Mayer, Gert/0000-0002-5039-543X; Eller, Kathrin/0000-0002-6214-5008	European Community's Seventh Framework Programme (FP7) [241544]	European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement 241544 (SysKid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza I, 2006, AM J PATHOL, V169, P2199, DOI 10.2353/ajpath.2006.060171; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; KLOCKER H, 1992, AM J HUM GENET, V50, P1318; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Massoner P, 2008, PROSTATE, V68, P1165, DOI 10.1002/pros.20785; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Meyer TW, 2003, KIDNEY INT, V63, P774, DOI 10.1046/j.1523-1755.2003.00795.x; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Perco P, 2009, TRANSPLANTATION, V87, P290, DOI 10.1097/TP.0b013e318191b4c0; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; REMUZZI G, 1985, KIDNEY INT, V28, P21, DOI 10.1038/ki.1985.113; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Sakko AJ, 2001, CANCER RES, V61, P926; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schuttert JB, 2003, PFLUG ARCH EUR J PHY, V446, P387, DOI 10.1007/s00424-003-1026-y; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Theocharis AD, 2008, CONNECT TISSUE RES, V49, P230, DOI 10.1080/03008200802147571; True LD, 2009, PROSTATE, V69, P149, DOI 10.1002/pros.20861; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC; Zoja C, 2010, AM J PHYSIOL-RENAL, V299, pF1203, DOI 10.1152/ajprenal.00045.2010	37	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44891	10.1371/journal.pone.0044891	http://dx.doi.org/10.1371/journal.pone.0044891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024773	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100031
J	Singh, NP; Singh, UP; Guan, HB; Nagarkatti, P; Nagarkatti, M				Singh, Narendra P.; Singh, Udai P.; Guan, Hongbing; Nagarkatti, Prakash; Nagarkatti, Mitzi			Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NF-KAPPA-B; 24-WEEK-OLD SNF1 MICE; T-CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; AH RECEPTOR; DOWN-REGULATION; CANCER-CELLS; FAS LIGAND; ESTROGEN-RECEPTOR	Background: MicroRNAs (miRs) are a class of small RNAs that regulate gene expression. There are over 700 miRs encoded in the mouse genome and modulate most of the cellular pathways and functions by controlling gene expression. However, there is not much known about the pathophysiological role of miRs. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin), an environmental contaminant is well known to induce severe toxicity (acute and chronic) with long-term effects. Also, in utero exposure of fetus to TCDD has been shown to cause thymic atrophy and alterations in T cell differentiation. It is also relevant to understand "the fetal basis of adult disease'' hypothesis, which proposes that prenatal exposure to certain forms of nutritional and environmental stress can cause increased susceptibility to clinical disorders later in life. In the current study, therefore, we investigated the effects of prenatal exposure to TCDD on miR profile in fetal thymocytes and searched for their possible role in causing thymic atrophy and alterations in the expression of apoptotic genes. Methodology/Principal Findings: miR arrays of fetal thymocytes post exposure to TCDD and vehicle were performed. Of the 608 mouse miRs screened, 78 miRs were altered more than 1.5 fold and 28 miRs were changed more than 2 fold in fetal thymocytes post-TCDD exposure when compared to vehicle controls. We validated the expression of several of the miRs using RT-PCR. Furthermore, several of the miRs that were downregulated contained highly complementary sequence to the 3'-UTR region of AhR, CYP1A1, Fas and FasL. Also, the Ingenuity Pathway Analysis software and database was used to analyze the 78 miRs that exhibited significant expression changes and revealed that as many as 15 pathways may be affected. Conclusions/Significance: These studies revealed that TCDD-mediated alterations in miR expression may be involved in the regulation of its toxicity including cancer, hepatic injury, apoptosis, and cellular development.	[Singh, Narendra P.; Singh, Udai P.; Guan, Hongbing; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Singh, NP (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	NIH grants [R01 ES09098, P01AT003961, R01AT006888, R01ES019313, R01MH094755]; VA Merit Award [1I01BX001357]; National Center for Complementary & Integrative Health [P01AT003961, R01AT006888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313, R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported in part by NIH grants R01 ES09098, P01AT003961, R01AT006888, R01ES019313, R01MH094755 and VA Merit Award 1I01BX001357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpiainen S, 2005, MOL PHARMACOL, V67, P1325, DOI 10.1124/mol.104.008078; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BERTAZZI P A, 1989, Medicina del Lavoro, V80, P316; BIHRER V, 2011, AM J GASTROENTEROL; BLAYLOCK BL, 1992, TOXICOL APPL PHARM, V112, P207, DOI 10.1016/0041-008X(92)90189-Y; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Boverhof DR, 2004, MOL PHARMACOL, V66, P1662, DOI 10.1124/mol.104.002915; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90; Camacho IA, 2004, ARCH TOXICOL, V78, P290, DOI 10.1007/s00204-003-0538-8; Camacho IA, 2004, TOXICOL SCI, V78, P96, DOI 10.1093/toxsci/kfh048; Camacho IA, 2002, ARCH TOXICOL, V76, P570, DOI 10.1007/s00204-002-0390-2; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dearstyne EA, 2002, TOXICOLOGY, V170, P139, DOI 10.1016/S0300-483X(01)00542-X; Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dietert RR, 2008, HUM EXP TOXICOL, V27, P129, DOI 10.1177/0960327108090753; Dong W, 2001, NEUROSCI LETT, V303, P169, DOI 10.1016/S0304-3940(01)01743-8; DURRIN LK, 1987, J CELL BIOCHEM, V35, P153, DOI 10.1002/jcb.240350208; ESSER C, 1994, INT ARCH ALLERGY IMM, V104, P126, DOI 10.1159/000236719; Faith R E, 1979, Ann N Y Acad Sci, V320, P564, DOI 10.1111/j.1749-6632.1979.tb13177.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fisher MT, 2005, MOL PHARMACOL, V67, P327, DOI 10.1124/mol.104.005868; FRAZIER DE, 1994, BIOCHEM PHARMACOL, V47, P2039, DOI 10.1016/0006-2952(94)90079-5; Fukushima Tamio, 2007, Journal of Toxicological Sciences, V32, P401, DOI 10.2131/jts.32.401; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu WY, 2011, ARCH VIROL, V156, P1161, DOI 10.1007/s00705-011-0974-3; Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011; HOLSAPPLE MP, 1991, ANNU REV PHARMACOL, V31, P73; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Jenkins S, 2007, REPROD TOXICOL, V23, P391, DOI 10.1016/j.reprotox.2006.10.004; Kamath AB, 1999, TOXICOL APPL PHARM, V160, P141, DOI 10.1006/taap.1999.8753; Kamath AB, 1998, TOXICOL APPL PHARM, V150, P117, DOI 10.1006/taap.1998.8390; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kiyohara C, 1998, PHARMACOGENETICS, V8, P315, DOI 10.1097/00008571-199808000-00005; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Krutovskikh VA, 2010, BIOESSAYS, V32, P894, DOI 10.1002/bies.201000040; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ma Li ping, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P129; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Malik AI, 2012, ENV MOL MUTAGEN; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Moffat ID, 2007, TOXICOL SCI, V99, P470, DOI 10.1093/toxsci/kfm189; Mustafa A, 2009, TOXICOL SCI, V112, P133, DOI 10.1093/toxsci/kfp177; Mustafa A, 2009, BIRTH DEFECTS RES A, V85, P828, DOI 10.1002/bdra.20603; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; OLNES MJ, 1994, EXP CLIN IMMUNOGENET, V11, P102; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Phillips DIW, 2006, LUPUS, V15, P794, DOI 10.1177/0961203306069354; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Singh NP, 2008, MOL PHARMACOL, V73, P1722, DOI 10.1124/mol.107.043406; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Singh NP, 2011, MOL NUTR FOOD RES, V55, P209, DOI 10.1002/mnfr.201000206; Sulentic CEW, 1998, MOL PHARMACOL, V53, P623, DOI 10.1124/mol.53.4.623; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takemoto K, 2004, ARCH TOXICOL, V78, P309, DOI 10.1007/s00204-004-0550-7; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; Viluksela M, 2000, CANCER RES, V60, P6911; Wyde ME, 2004, TOXICOL SCI, V82, P34, DOI 10.1093/toxsci/kfh233; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Yoshioka W, 2011, TOXICOL SCI; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	100	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45054	10.1371/journal.pone.0045054	http://dx.doi.org/10.1371/journal.pone.0045054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024791	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100049
J	Nowak, I; Magott-Procelewska, M; Kowal, A; Miazga, M; Wagner, M; Niepieklo-Miniewska, W; Kaminska, M; Wisniewski, A; Majorczyk, E; Klinger, M; Luszczek, W; Pawlik, A; Ploski, R; Barcz, E; Senitzer, D; Kusnierczyk, P				Nowak, Izabela; Magott-Procelewska, Maria; Kowal, Agnieszka; Miazga, Maciej; Wagner, Marta; Niepieklo-Miniewska, Wanda; Kaminska, Malgorzata; Wisniewski, Andrzej; Majorczyk, Edyta; Klinger, Marian; Luszczek, Wioleta; Pawlik, Andrzej; Ploski, Rafal; Barcz, Ewa; Senitzer, David; Kusnierczyk, Piotr			Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation	PLOS ONE			English	Article							PCR-SSP METHOD; LIGAND INCOMPATIBILITY; HAPLOTYPE FREQUENCIES; GRAFT-REJECTION; T-CELLS; GENE; DISEASE; SUSCEPTIBILITY; ACTIVATION; BIOPSIES	Background: Recipient NK cells may detect the lack of recipient's (i.e., self) HLA antigens on donor renal tissue by means of their killer cell immunoglobulin-like receptors (KIRs). KIR genes are differently distributed in individuals, possibly contributing to differences in response to allogeneic graft. Methodology/Principal Findings: We compared frequencies of 10 KIR genes by PCR-SSP in 93 kidney graft recipients rejecting allogeneic renal transplants with those in 190 recipients accepting grafts and 690 healthy control individuals. HLA matching results were drawn from medical records. We observed associations of both a full-length KIR2DS4 gene and its variant with 22-bp deletion with kidney graft rejection. This effect was modulated by the HLA-B,-DR matching, particularly in recipients who did not have glomerulonephritis but had both forms of KIR2DS4 gene. In contrast, in recipients with glomerulonephritis, HLA compatibility seemed to be much less important for graft rejection than the presence of KIR2DS4 gene. Simultaneous presence of both KIR2DS4 variants strongly increased the probability of rejection. Interestingly, KIR2DS5 seemed to protect the graft in the presence of KIR2DS4fl but in the absence of KIR2DS4del. Conclusions/Significance: Our results suggest a protective role of KIR2DS5 in graft rejection and an association of KIR2DS4 with kidney rejection, particularly in recipients with glomerulonephritis.	[Nowak, Izabela; Kowal, Agnieszka; Miazga, Maciej; Wagner, Marta; Niepieklo-Miniewska, Wanda; Wisniewski, Andrzej; Majorczyk, Edyta; Luszczek, Wioleta; Kusnierczyk, Piotr] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Med Univ Wroclaw, Dept & Clin Nephrol & Transplant Med, Fac Med, Wroclaw, Poland; [Kaminska, Malgorzata] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Hlth Care Ctr, Wroclaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Pharmacokinet & Therapeut Drug Monitoring, Szczecin, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair & Clin Obstet & Gynecol 1, Warsaw, Poland; [Senitzer, David] City Hope Comprehens Canc Ctr, Duarte, CA USA	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Pomeranian Medical University; Medical University of Warsaw; Medical University of Warsaw; City of Hope	Nowak, I (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland.	pkusnier@iitd.pan.wroc.pl	Majorczyk, Edyta/P-3066-2019; Pawlik, Andrzej/A-9052-2015; Barcz, Ewa/AAS-7533-2020; Kusnierczyk, Piotr/ABB-6734-2020	Majorczyk, Edyta/0000-0001-7248-9544; Pawlik, Andrzej/0000-0001-6557-1208; Wagner, Marta/0000-0002-2710-2301; Kusnierczyk, Piotr/0000-0002-9224-8921; Wisniewski, Andrzej/0000-0002-1919-2298; Niepieklo-Miniewska, Wanda/0000-0002-3326-4059; Ploski, Rafal/0000-0001-6286-5526; Nowak, Izabela/0000-0002-9127-1089	Ministry of Science and High Education grant [N401077 31/1819]; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant [14/2011]	Ministry of Science and High Education grant; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant	This work was supported by the Ministry of Science and High Education grant No. N401077 31/1819 and by the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant no. 14/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JM, 2003, GENET SEL EVOL, V35, P513, DOI [10.1186/1297-9686-35-6-513, 10.1051/gse:2003037]; ANDERSEN CB, 1994, APMIS, V102, P23, DOI 10.1111/j.1699-0463.1994.tb04841.x; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Bhasi K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl520; Cirocco RE, 2007, TISSUE ANTIGENS, V69, P123, DOI 10.1111/j.1399-0039.2006.76211.x; COOKSEY G, 1984, BRIT J SURG, V71, P874, DOI 10.1002/bjs.1800711124; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; HANCOCK WW, 1985, TRANSPLANTATION, V39, P430, DOI 10.1097/00007890-198504000-00018; Hanvesakul R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023631; Kreijveld E, 2007, TRANSPLANTATION, V84, P1045, DOI 10.1097/01.tp.0000286097.11173.70; Kunert K, 2007, TRANSPLANTATION, V84, P1527, DOI 10.1097/01.tp.0000290681.41859.41; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; Lopez-Alvarez MR, 2011, HUM IMMUNOL, V72, P229, DOI 10.1016/j.humimm.2010.12.015; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; Middleton D, 2008, TISSUE ANTIGENS, V71, P105, DOI 10.1111/j.1399-0039.2007.00973.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Nowak I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012381; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pegram HJ, 2011, LEUKEMIA RES, V35, P14, DOI 10.1016/j.leukres.2010.07.030; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rajalingam R, 2011, AM J TRANSPLANT, V11, P1771, DOI 10.1111/j.1600-6143.2011.03619.x; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Snyder MR, 2004, J IMMUNOL, V173, P3725, DOI 10.4049/jimmunol.173.6.3725; Sun JY, 2004, TISSUE ANTIGENS, V64, P462, DOI 10.1111/j.1399-0039.2004.00303.x; Thewissen M, 2007, J IMMUNOL, V179, P6514, DOI 10.4049/jimmunol.179.10.6514; TOTTERMAN TH, 1989, TRANSPLANTATION, V47, P817, DOI 10.1097/00007890-198905000-00014; Tran TH, 2005, TRANSPLANTATION, V80, P1121, DOI 10.1097/01.tp.0000179110.15304.90; Vampa ML, 2003, TRANSPLANTATION, V76, P1220, DOI 10.1097/01.TP.0000083896.91215.C7; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; van der Meer A, 2008, MOL IMMUNOL, V45, P3631, DOI 10.1016/j.molimm.2008.04.016; Velardi A, 2009, CURR OPIN IMMUNOL, V21, P525, DOI 10.1016/j.coi.2009.07.015; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Yadav AK, 2011, NEPHROL DIAL TRANSPL, V26, P1689, DOI 10.1093/ndt/gfr010; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	43	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44718	10.1371/journal.pone.0044718	http://dx.doi.org/10.1371/journal.pone.0044718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028591	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700031
J	Choi, SY; Kim, JY; Kim, HW; Cho, B; Cho, HM; Oppenheim, RW; Kim, H; Rhyu, IJ; Sun, W				Choi, So Yoen; Kim, Joo Yeon; Kim, Hyun-Wook; Cho, Bongki; Cho, Hyo Min; Oppenheim, Ronald W.; Kim, Hyun; Rhyu, Im Joo; Sun, Woong			Drp1-mediated mitochondrial dynamics and survival of developing chick motoneurons during the period of normal programmed cell death	FASEB JOURNAL			English	Article						mitochondria; chick embryo; apoptosis	GROWTH-FACTOR; FISSION; DRP1; MEMBRANE; PHOSPHORYLATION; PROTEIN-1; INCREASES; TRANSPORT; AXONS; MORPHOGENESIS	Mitochondrial morphology is dynamically remodeled by fusion and fission in neurons, and this process is implicated in nervous system development and pathology. However, the mechanism by which mitochondrial dynamics influence neuronal development is less clear. In this study, we found that the length of mitochondria is progressively reduced during normal development of chick embryo motoneurons (MNs), a process partly controlled by a fission-promoting protein, dynamin-related protein 1 (Drp1). Suppression of Drp1 activity by gene electroporation of dominant-negative mutant Drp1 in a subset of developing MNs increased mitochondrial length in vivo, and a greater proportion of Drp1-suppressed MNs underwent programmed cell death (PCD). By contrast, the survival of nontransfected MNs in proximity to the transfected MNs was significantly increased, suggesting that the suppression of Drp1 confers disadvantage during the competition for limited survival signals. Because we also monitored perturbation of neurite outgrowth and mitochondrial membrane depolarization following Drp1 suppression, we suggest that impairments of ATP production and axonal growth may be downstream factors that influence the competition of MNs for survival. Collectively, these results indicate that mitochondrial dynamics are required for normal axonal development and competition-dependent MN PCD.-Choi, S. Y., Kim, J. Y., Kim, H.-W., Cho, B., Cho, H. M., Oppenheim, R. W., Kim, H., Rhyu, I. J., Sun, W. Drp1-mediated mitochondrial dynamics and survival of developing chick motoneurons during the period of normal programmed cell death. FASEB J. 27, 51-62 (2013). www.fasebj.org	[Choi, So Yoen; Kim, Joo Yeon; Kim, Hyun-Wook; Cho, Bongki; Cho, Hyo Min; Kim, Hyun; Rhyu, Im Joo; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Oppenheim, Ronald W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Oppenheim, Ronald W.] Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA	Korea University; Korea University Medicine (KU Medicine); Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Choi, SY (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Cho, Bongki/ABG-8744-2021; Choi, So Yoen/AAV-1947-2020	Cho, Bongki/0000-0001-5832-2705; Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894; Rhyu, Im Joo/0000-0002-5558-6278	Korean Ministry of Education, Science, and Technology [2010000143, 20100020237, 2010K000803]; U.S. National Institutes of Health (NIH) [NS-069212]; Robert Packard Center for ALS Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069212] Funding Source: NIH RePORTER	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Korean Ministry of Education, Science, and Technology (2010000143, 20100020237, and 2010K000803; to W. S.), by U.S. National Institutes of Health (NIH) grant NS-069212, and by the Robert Packard Center for ALS Research. The authors thank Dr. Richard J. Youle (NIH, Bethesda, MD, USA) for the mutant Drp1 clone.	Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Caldero J, 1998, J NEUROSCI, V18, P356; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Choi SY, 2006, BIOCHEM BIOPH RES CO, V346, P872, DOI 10.1016/j.bbrc.2006.05.207; D'Costa AP, 1998, J NEUROBIOL, V36, P379; de Graaf AO, 2004, EXP CELL RES, V299, P533, DOI 10.1016/j.yexcr.2004.06.024; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; He MD, 2011, TOXICOL APPL PHARM, V253, P38, DOI 10.1016/j.taap.2011.03.008; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MCKAY SE, 1991, J NEUROBIOL, V22, P721, DOI 10.1002/neu.480220707; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; MORRIS RL, 1993, J CELL SCI, V104, P917; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; PILAR G, 1980, J NEUROPHYSIOL, V43, P233, DOI 10.1152/jn.1980.43.1.233; PITTMAN RH, 1978, NATURE, V271, P364, DOI 10.1038/271364a0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tada-Oikawa S, 2003, LIFE SCI, V73, P3277, DOI 10.1016/j.lfs.2003.06.013; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	51	21	22	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					51	62		10.1096/fj.12-211920	http://dx.doi.org/10.1096/fj.12-211920			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22997225	Green Published			2022-12-25	WOS:000313103200007
J	Hu, HM; Chen, YC; Liu, L; Zhang, CG; Wang, W; Gong, K; Huang, Z; Guo, MX; Li, WX; Li, WH				Hu, Hai-Ming; Chen, Yicheng; Liu, Lu; Zhang, Chuan-Geng; Wang, Wei; Gong, Ke; Huang, Zan; Guo, Ming-Xiong; Li, Wen-Xin; Li, Wenhua			C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis	FASEB JOURNAL			English	Article						liver cancer; progression	COMPARATIVE GENOMIC HYBRIDIZATION; HEPATITIS-B-VIRUS; GENE-EXPRESSION; AMPLIFICATION; IMBALANCES; COMPLEX; GROWTH; PROLIFERATION; INHIBITION; INVASION	The genomic amplification of chromosome 1q long arm, the chromosomal region containing C1orf61, is a common event in human cancers. However, the expression pattern of chromosome 1 open reading frame 61 (C1orf61) in hepatocellular carcinoma (HCC) and its effects on HCC progression remain unclear. We have previously reported that C1orf61 is highly up-regulated during human embryogenesis. In this study, we report that C1orf61 expression is associated with the progression of liver disease. We found that C1orf61 is up-regulated in hepatic cirrhosis tissues and is further up-regulated in primary HCC tumors. Moreover, hepatitis B virus (HBV)-positive patients exhibited significantly higher levels of C1orf61 expression than HBV-negative patients. The evaluation of highly malignant HCC cell lines revealed high protein expression levels of C1orf61. Furthermore, the C1orf61 protein was found to be predominantly distributed within the cytoplasm. The ectopic expression of C1orf61 in the nonmalignant L02 cell line promoted cellular proliferation and colony formation in vitro, as well as cell cycle progression via the regulation of the expression of specific cell cycle-related proteins. In addition, the overexpression of C1orf61 in L02 cells facilitated cellular invasion and metastasis. The down-regulation of epithelial markers (E-cadherin and occludin) and the up-regulation of mesenchymal markers (N-cadherin, vimentin, and snail) suggested that the overexpression of C1orf61 induced the epithelial-mesenchymal transition (EMT) that is linked to metastasis. Taken together, our findings demonstrate, for the first time, the roles of C1orf61 in HCC tumorigenesis and metastasis.-Hu, H-M., Chen, Y., Liu, L., Zhang, C-C., Wang, W., Gong, K., Huang, Z., Guo, M-X., Li, W-X., Li, W. C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis. FASEB J. 27, 163-173 (2013). www.fasebj.org	[Hu, Hai-Ming; Chen, Yicheng; Liu, Lu; Zhang, Chuan-Geng; Wang, Wei; Gong, Ke; Huang, Zan; Guo, Ming-Xiong; Li, Wen-Xin; Li, Wenhua] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; whli@whu.edu.cn		Liu, Lu/0000-0001-7984-6671; Huang, Zan/0000-0001-5623-6950; Wang, Wei/0000-0001-7429-1013	National Basic Research Program of China [2010CB529800]; National Nature Science Foundation of China [81072151, 31271511]; Chinese 111 project [B06018]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200804861004]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project(Ministry of Education, China - 111 Project); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (2010CB529800), the National Nature Science Foundation of China (81072151, 31271511), the Chinese 111 project (B06018), and Specialized Research Fund for the Doctoral Program of Higher Education of China grant 200804861004.	Awuah Prince K, 2012, Hepatology, V55, P970, DOI 10.1002/hep.24774; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Chen LL, 2010, ACTA PHARMACOL SIN, V31, P1165, DOI 10.1038/aps.2010.94; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chi F, 2010, BIOCHEM J, V427, P79, DOI 10.1042/BJ20091097; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Guo H, 2011, CARCINOGENESIS, V32, P1897, DOI 10.1093/carcin/bgr220; Hirsch D, 2012, GENE CHROMOSOME CANC, V51, P490, DOI 10.1002/gcc.21937; Jeannot E, 2012, INT J CANCER, V130, P1347, DOI 10.1002/ijc.26140; Jeffrey PL, 2000, MOL CELL NEUROSCI, V16, P185, DOI 10.1006/mcne.2000.0866; Kaemmerer D, 2011, EUR J NUCL MED MOL I, V38, P1659, DOI 10.1007/s00259-011-1846-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karna P, 2012, CARCINOGENESIS, V33, P1769, DOI 10.1093/carcin/bgs200; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kolupaeva V, 2012, CELL CYCLE, V11, P2557, DOI 10.4161/cc.20944; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Liu L, 2011, INT J CANCER, V128, P1692, DOI 10.1002/ijc.25488; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Lou CY, 2004, WORLD J GASTROENTERO, V10, P1462; Lu YJ, 2002, LANCET, V360, P385, DOI 10.1016/S0140-6736(02)09596-X; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Moore MD, 2005, J GENE MED, V7, P918, DOI 10.1002/jgm.739; Luna LEM, 2009, NAT REV GASTRO HEPAT, V6, P679, DOI 10.1038/nrgastro.2009.165; Niketeghad F, 2001, BRIT J CANCER, V85, P697, DOI 10.1054/bjoc.2001.1963; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Reppe S, 2010, BONE, V46, P604, DOI 10.1016/j.bone.2009.11.007; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Serrano I, 2012, ONCOGENE, V31, P1, DOI DOI 10.1038/0NC.2012.30; Shaughnessy J, 2005, HEMATOLOGY, V10, P117, DOI 10.1080/10245330512331390140; Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Su YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019412; Tanaka S, 2012, INT J CANCER, V131, P2537, DOI 10.1002/ijc.27575; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036818; Wang SH, 2011, HEPATOLOGY, V53, P1932, DOI 10.1002/hep.24291; Wong N, 2003, J HEPATOL, V38, P298, DOI 10.1016/S0168-8278(02)00412-9; Yi H, 2010, FASEB J, V24, P3341, DOI 10.1096/fj.10-158782; Zhang SG, 2010, MOL BIOL REP, V37, P381, DOI 10.1007/s11033-009-9817-7; Zudaire I, 2002, HISTOPATHOLOGY, V40, P547, DOI 10.1046/j.1365-2559.2002.01413.x	54	15	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					163	173		10.1096/fj.12-216622	http://dx.doi.org/10.1096/fj.12-216622			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23012322				2022-12-25	WOS:000313103200016
J	Xu, Y; Ishizuka, T; Yang, J; Ito, K; Katada, H; Komiyama, M; Hayashi, T				Xu, Yan; Ishizuka, Takumi; Yang, Jie; Ito, Kenichiro; Katada, Hitoshi; Komiyama, Makoto; Hayashi, Tetsuya			Oligonucleotide Models of Telomeric DNA and RNA Form a Hybrid G-quadruplex Structure as a Potential Component of Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT-CONTAINING RNA; NEWLY SYNTHESIZED PROTEINS; K+ SOLUTION; MAMMALIAN TELOMERES; BINDING-PROTEIN; SEQUENCE FORMS; IN-VITRO; CELLS; TERRA; SENESCENCE	Telomeric repeat-containing RNA, a non-coding RNA molecule, has recently been found in mammalian cells. The detailed structural features and functions of the telomeric RNA at human chromosome ends remain unclear, although this RNA molecule may be a key component of the telomere machinery. In this study, using model human telomeric DNA and RNA sequences, we demonstrated that human telomeric RNA and DNA oligonucleotides form a DNA-RNA G-quadruplex. We next employed chemistry-based oligonucleotide probes to mimic the naturally formed telomeric DNA-RNA G-quadruplexes in living cells, suggesting that the process of DNA-RNA G-quadruplex formation with oligonucleotide models of telomeric DNA and RNA could occur in cells. Furthermore, we investigated the possible roles of this DNA-RNA G-quadruplex. The formation of the DNA-RNA G-quadruplex causes a significant increase in the clonogenic capacity of cells and has an effect on inhibition of cellular senescence. Here, we have used a model system to provide evidence about the formation of G-quadruplex structures involving telomeric DNA and RNA sequences that have the potential to provide a protective capping structure for telomere ends.	[Xu, Yan; Yang, Jie; Hayashi, Tetsuya] Miyazaki Univ, Div Chem, Dept Med Sci, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Ishizuka, Takumi; Ito, Kenichiro; Katada, Hitoshi; Komiyama, Makoto] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	University of Miyazaki; University of Tokyo	Xu, Y (corresponding author), Miyazaki Univ, Div Chem, Dept Med Sci, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	xuyan@fc.miyazaki-u.ac.jp	Ishizuka, Takumi/E-9491-2012; Hayashi, Tetsuya/ABA-1074-2020	Ishizuka, Takumi/0000-0003-0956-784X; Ito, Kenichiro/0000-0001-7231-6838; Xu, Yan/0000-0003-0379-8866	Ministry of Education, Science, Sports, Culture, and Technology, Japan [22350071]; Grants-in-Aid for Scientific Research [22350071] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Ministry of Education, Science, Sports, Culture, and Technology, Japan Grant-in-aid for Scientific Research (B) 22350071. This work was also supported by grants from the Takeda Science Foundation, the Naito Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Beatty KE, 2005, J AM CHEM SOC, V127, P14150, DOI 10.1021/ja054643W; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; Collie GW, 2010, NUCLEIC ACIDS RES, V38, P5569, DOI 10.1093/nar/gkq259; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El-Sagheer AH, 2010, CHEM SOC REV, V39, P1388, DOI 10.1039/b901971p; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hayashi N, 2002, MOL GENET GENOMICS, V267, P806, DOI 10.1007/s00438-002-0712-3; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P5944, DOI 10.1021/ja031508f; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li GZ, 2004, EXP CELL RES, V301, P189, DOI 10.1016/j.yexcr.2004.08.019; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Martadinata H, 2009, J AM CHEM SOC, V131, P2570, DOI 10.1021/ja806592z; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Randall A, 2009, J BIOL CHEM, V284, P13980, DOI 10.1074/jbc.M900631200; Rueda M, 2006, J AM CHEM SOC, V128, P3608, DOI 10.1021/ja055936s; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sivakumar K, 2004, ORG LETT, V6, P4603, DOI 10.1021/ol047955x; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2008, J AM CHEM SOC, V130, P11179, DOI 10.1021/ja8031532; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; Xu Y, 2012, METHODS, V57, P100, DOI 10.1016/j.ymeth.2012.02.015; Xu Y, 2011, CHEM SOC REV, V40, P2719, DOI 10.1039/c0cs00134a; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14579, DOI 10.1073/pnas.1001177107; Xu Y, 2010, J AM CHEM SOC, V132, P7231, DOI 10.1021/ja909708a; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P3281, DOI 10.1002/anie.200806306; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhou Z, 2004, J AM CHEM SOC, V126, P8862, DOI 10.1021/ja049684r	49	43	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41787	41796		10.1074/jbc.M112.342030	http://dx.doi.org/10.1074/jbc.M112.342030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23012368	hybrid, Green Published			2022-12-25	WOS:000312103000020
J	Miyamoto, L; Ebihara, K; Kusakabe, T; Aotani, D; Yamamoto-Kataoka, S; Sakai, T; Aizawa-Abe, M; Yamamoto, Y; Fujikura, J; Hayashi, T; Hosoda, K; Nakao, K				Miyamoto, Licht; Ebihara, Ken; Kusakabe, Toru; Aotani, Daisuke; Yamamoto-Kataoka, Sachiko; Sakai, Takeru; Aizawa-Abe, Megumi; Yamamoto, Yuji; Fujikura, Junji; Hayashi, Tatsuya; Hosoda, Kiminori; Nakao, Kazuwa			Leptin Activates Hepatic 5 '-AMP-activated Protein Kinase through Sympathetic Nervous System and alpha 1-Adrenergic Receptor A POTENTIAL MECHANISM FOR IMPROVEMENT OF FATTY LIVER IN LIPODYSTROPHY BY LEPTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSES INSULIN-RESISTANCE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; REPLACEMENT THERAPY; DIABETES-MELLITUS; RATS; MICE; METABOLISM; MOUSE	Leptin is an adipocyte-derived hormone that regulates energy homeostasis. Leptin treatment strikingly ameliorates metabolic disorders of lipodystrophy, which exhibits ectopic fat accumulation and severe insulin-resistant diabetes due to a paucity of adipose tissue. Although leptin is shown to activate 5'-AMP-activated protein kinase (AMPK) in the skeletal muscle, the effect of leptin in the liver is still unclear. We investigated the effect of leptin on hepatic AMPK and its pathophysiological relevance in A-ZIP/F-1 mice, a model of generalized lipodystrophy. Here, we demonstrated that leptin activates hepatic AMPK through the central nervous system and alpha-adrenergic sympathetic nerves. AMPK activities were decreased in the fatty liver of A-ZIP/F-1 mice, and leptin administration increased AMPK activities in the liver as well as in skeletal muscle with significant reduction in triglyceride content. Activation of hepatic AMPK with A769662 also led to a decrease in hepatic triglyceride content and blood glucose levels in A-ZIP/F-1 mice. These results indicate that the down-regulation of hepatic AMPK activities plays a pathophysiological role in the metabolic disturbances of lipodystrophy, and the hepatic AMPK activation is involved in the therapeutic effects of leptin.	[Miyamoto, Licht; Ebihara, Ken; Kusakabe, Toru; Aotani, Daisuke; Yamamoto-Kataoka, Sachiko; Sakai, Takeru; Aizawa-Abe, Megumi; Yamamoto, Yuji; Fujikura, Junji; Hosoda, Kiminori; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan; [Ebihara, Ken; Aizawa-Abe, Megumi; Hosoda, Kiminori; Nakao, Kazuwa] Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Hosoda, Kiminori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ebihara, K (corresponding author), 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kebihara@kuhp.kyoto-u.ac.jp	Fujikura, Junji/AAR-2684-2020; Miyamoto, Licht/K-8947-2012	hayashi, Tatsuya/0000-0001-7600-4735	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Takeda Medical Research Foundation; Japan Foundation of Applied Enzymology; Eli Lilly and Co.; Nakatomi Foundation; Grants-in-Aid for Scientific Research [21229013, 22126012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Medical Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Eli Lilly and Co.(Eli Lilly); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labor and Welfare of Japan, The Takeda Medical Research Foundation, The Japan Foundation of Applied Enzymology, Eli Lilly and Co., and The Nakatomi Foundation.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Barnes BR, 2002, DIABETES, V51, P2703, DOI 10.2337/diabetes.51.9.2703; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Ebihara K, 2007, J CLIN ENDOCR METAB, V92, P532, DOI 10.1210/jc.2006-1546; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Miyanaga F, 2003, DIABETOLOGIA, V46, P1329, DOI 10.1007/s00125-003-1193-6; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Uyama N, 2004, ANAT REC PART A, V280A, P808, DOI 10.1002/ar.a.20086; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Xu Ming, 2007, Shengli Xuebao, V59, P175; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	38	58	59	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40441	40447		10.1074/jbc.M112.384545	http://dx.doi.org/10.1074/jbc.M112.384545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23024365	Green Published, hybrid			2022-12-25	WOS:000311448800035
J	Clausen, JD; Vandecaetsbeek, I; Wuytack, F; Vangheluwe, P; Andersen, JP				Clausen, Johannes D.; Vandecaetsbeek, Ilse; Wuytack, Frank; Vangheluwe, Peter; Andersen, Jens Peter			Distinct Roles of the C-terminal 11th Transmembrane Helix and Luminal Extension in the Partial Reactions Determining the High Ca2+ Affinity of Sarco(endo) plasmic Reticulum Ca2+-ATPase Isoform 2b (SERCA2b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; FUNCTIONAL CONSEQUENCES; CRYSTAL-STRUCTURE; STEADY-STATE; PHOSPHORYLATION; CA-2+-ATPASE; DEPHOSPHORYLATION; LOCALIZATION; DISSECTION; EFFICIENCY	The molecular mechanism underlying the characteristic high apparent Ca2+ affinity of SERCA2b relative to SERCA1a and SERCA2a isoforms was studied. The C-terminal tail of SERCA2b consists of an 11th transmembrane helix (TM11) with an associated 11-amino acid luminal extension (LE). The effects of each of these parts and their interactions with the SERCA environment were examined by transient kinetic analysis of the partial reaction steps in the Ca2+ transport cycle in mutant and chimeric Ca2+-ATPase constructs. Manipulations to the LE of SERCA2b markedly increased the rate of Ca2+ dissociation from Ca(2)E1. Addition of the SERCA2b tail to SERCA1a slowed Ca2+ dissociation, but only when the luminal L7/8 loop of SERCA1 was simultaneously replaced with that of SERCA2, thus suggesting that the LE interacts with L7/8 in Ca(2)E1. The interaction of LE with L7/8 is also important for the low rate of the Ca(2)E1P -> E2P conformational transition. These findings can be rationalized in terms of stabilization of the Ca(2)E1 and Ca(2)E1P forms by docking of the LE near L7/8. By contrast, low rates of E2P dephosphorylation and E2 -> E1 transition in SERCA2b depend critically on TM11, particularly in a SERCA2 environment, but do not at all depend on the LE or L7/8. This indicates that interaction of TM11 with SERCA2-specific sequence element(s) elsewhere in the structure is critical in the Ca2+-free E2/E2P states. Collectively these properties ensure a higher Ca2+ affinity of SERCA2b relative to other SERCA isoforms, not only on the cytosolic side, but also on the luminal side.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Biomed,Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark; [Clausen, Johannes D.] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol & Genet,Ctr Membrane Pumps Cells &, DK-8000 Aarhus C, Denmark; [Vandecaetsbeek, Ilse; Wuytack, Frank; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, B-3000 Louvain, Belgium	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond; KU Leuven	Andersen, JP (corresponding author), Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Andersen, Jens Peter/0000-0003-0654-4300	Lundbeck Foundation; Danish Medical Research Council; Novo Nordisk Foundation; Danish National Research Foundation (PUMPKIN Centre); Research Program of the Flanders Research Foundation (FWO-Vlaanderen) [G.0646.08, G.0442.12]; Interuniversity Attraction Poles Program of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs [P6/28]	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Research Program of the Flanders Research Foundation (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Program of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs	This work was supported in part by grants from the Lundbeck Foundation (to J. D. C.), the Danish Medical Research Council (to J. P. A.), the Novo Nordisk Foundation (to J. P. A.), the Danish National Research Foundation (PUMPKIN Centre), Research Program of the Flanders Research Foundation (FWO-Vlaanderen) Grants G.0646.08 and G.0442.12, and the Interuniversity Attraction Poles Program P6/28 of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs.	Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; BAYLE D, 1995, J BIOL CHEM, V270, P25678, DOI 10.1074/jbc.270.43.25678; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; Bobe R, 2004, J BIOL CHEM, V279, P24297, DOI 10.1074/jbc.M314286200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; FORGE V, 1993, J BIOL CHEM, V268, P10961; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LYTTON J, 1988, J BIOL CHEM, V263, P15024; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; VILSEN B, 1989, J BIOL CHEM, V264, P21024	28	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397331	http://dx.doi.org/10.1074/jbc.M112.397331			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024360	Green Published, hybrid			2022-12-25	WOS:000311233800018
J	Dai, RY; Li, JJ; Fu, J; Chen, Y; Wang, RY; Zhao, XF; Luo, T; Zhu, JJ; Ren, YB; Cao, J; Qian, YW; Li, N; Wang, HY				Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Wang, Ruoyu; Zhao, Xiaofang; Luo, Tao; Zhu, Junjie; Ren, Yibin; Cao, Jie; Qian, Youwen; Li, Ning; Wang, Hongyang			The Tyrosine Kinase c-Met Contributes to the Pro-tumorigenic Function of the p38 Kinase in Human Bile Duct Cholangiocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR-RECEPTOR; THERAPEUTIC INHIBITION; SIGNALING PATHWAYS; PHOSPHATASE DEP-1; GENE-EXPRESSION; STEM-CELLS; CYCLIN D1	Pro-tumorigenic function of the p38 kinase plays a critical role in human cholangiocarcinogenesis. However, the underlying mechanism remains incompletely understood. Here, we report that c-Met, the tyrosine kinase receptor for hepatocyte growth factor (HGF), contributes to the pro-tumorigenic ability of p38 in human cholangiocarcinoma cells. Both p38 and c-Met promote the proliferation and invasion of human cholangiocarcinoma cells. Importantly, inhibition or knockdown of p38 decreased the basal activation of c-Met. Tyrosine phosphatase inhibitor studies revealed that p38 promotes the activity of c-Met, at least in part, by inhibiting dephosphorylation of the receptor. Moreover, density enhanced phosphatase-1 (DEP-1) is involved in p38-mediated inhibiting dephosphorylation of c-Met. Furthermore, p38 inhibits the degradation of c-Met. Taken together, these data provide a potential mechanism to explain how p38 promotes human cholangiocarcinoma cell proliferation and invasion. We propose that the link between p38 and c-Met is implicated in the progression of human cholangiocarcinoma.	[Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Wang, Ruoyu; Zhao, Xiaofang; Luo, Tao; Zhu, Junjie; Ren, Yibin; Cao, Jie; Qian, Youwen; Li, Ning; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Dai, Rongyang] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China; [Dai, Rongyang; Li, Ning; Wang, Hongyang] Shanghai Jiao Tong Univ, Renji Hosp, Inst Canc, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China	Naval Medical University; Southwest Medical University; Shanghai Jiao Tong University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com			National Natural Science Foundation of China [81000886, 81170377, 81101714, 30921006, 91029732]; State Key Project for Infectious Diseases Grant [2012ZX10002-009, 2012ZX10002-010, 2012ZX10002-011]; New Century Excellent Talents in University Grant [NCET-11-1058]; State Key Laboratory of Oncogenes and Related Genes [91-10-02, 90-10-03, 10JC1418500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project for Infectious Diseases Grant; New Century Excellent Talents in University Grant(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Oncogenes and Related Genes	This work was supported by National Natural Science Foundation of China Grants 81000886, 81170377, 81101714, 30921006, and 91029732, State Key Project for Infectious Diseases Grant 2012ZX10002-009 and -011, New Century Excellent Talents in University Grant NCET-11-1058, and State Key Laboratory of Oncogenes and Related Genes Grants 91-10-02, 90-10-03, and 10JC1418500.	Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Dai RY, 2012, J BIOL CHEM, V287, P14586, DOI 10.1074/jbc.M111.333435; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Farazi PA, 2006, CANCER RES, V66, P6622, DOI 10.1158/0008-5472.CAN-05-4609; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Figueras J, 2000, NEW ENGL J MED, V342, P663; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gay B, 1999, J BIOL CHEM, V274, P23311, DOI 10.1074/jbc.274.33.23311; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Han C, 2005, J BIOL CHEM, V280, P24053, DOI 10.1074/jbc.M500562200; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kogai T, 2012, J BIOL CHEM, V287, P3292, DOI 10.1074/jbc.M111.315523; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Leelawat K, 2006, J SURG RES, V136, P78, DOI 10.1016/j.jss.2006.05.031; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Park J, 1999, HEPATOLOGY, V30, P1128, DOI 10.1002/hep.510300522; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Terada T, 1998, HUM PATHOL, V29, P175, DOI 10.1016/S0046-8177(98)90229-5; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZQ, 2010, J CELL PHYSIOL, V224, P559, DOI 10.1002/jcp.22160; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Xu LH, 2006, J BIOL CHEM, V281, P33982, DOI 10.1074/jbc.M600135200; Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100	53	13	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406520	http://dx.doi.org/10.1074/jbc.M112.406520			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024367	Green Published, hybrid			2022-12-25	WOS:000311233800049
J	Prantner, D; Perkins, DJ; Lai, W; Williams, MS; Sharma, S; Fitzgerald, KA; Vogel, SN				Prantner, Daniel; Perkins, Darren J.; Lai, Wendy; Williams, Mark S.; Sharma, Shruti; Fitzgerald, Katherine A.; Vogel, Stefanie N.			5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CHRONIC GRANULOMATOUS-DISEASE; TYROSINE-PHOSPHATASE 1B; DOUBLE-STRANDED-RNA; IFN-BETA; RIG-I; ADAPTER PROTEIN; AGENT DMXAA; TETRAZOLIUM REDUCTION; FACTOR-3 ACTIVATION	The chemotherapeutic agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a potent inducer of type I IFNs and other cytokines. This ability is essential for its chemotherapeutic benefit in a mouse cancer model and suggests that it might also be useful as an antiviral agent. However, the mechanism underlying DMXAA-induced type I IFNs, including the host proteins involved, remains unclear. Recently, it was reported that the antioxidant N-acetylcysteine (NAC) decreased DMXAA-induced TNF-alpha and IL-6, suggesting that oxidative stress may play a role. The goal of this study was to identify host proteins involved in DMXAA-dependent signaling and determine how antioxidants modulate this response. We found that expression of IFN-beta in response to DMXAA in mouse macrophages requires the mitochondrial and endoplasmic reticulum resident protein STING. Addition of the antioxidant diphenylene iodonium (DPI) diminished DMXAA-induced IFN-beta, but this decrease was independent of both the NADPH oxidase, Nox2, and de novo generation of reactive oxygen species. Additionally, IFN-beta up-regulation by DMXAA was inhibited by agents that target the mitochondrial electron transport chain and, conversely, loss of mitochondrial membrane potential correlated with diminished innate immune signaling in response to DMXAA. Up-regulation of Ifnb1 gene expression mediated by cyclic dinucleotides was also impaired by DPI, whereas up-regulation of Ifnb1 mRNA due to cytosolic double-stranded DNA was not. Although both stimuli signal through STING, cyclic dinucleotides interact directly with STING, suggesting that recognition of DMXAA by STING may also be mediated by direct interaction.	[Prantner, Daniel; Perkins, Darren J.; Lai, Wendy; Williams, Mark S.; Vogel, Stefanie N.] Univ Maryland, Sch Med UMB, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Williams, Mark S.] Univ Maryland, Sch Med UMB, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Sharma, Shruti; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester	Vogel, SN (corresponding author), 685 W Baltimore St,Rm 380, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI-18797, AI-070823, AI-067497]; Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823, R01AI067497, R37AI018797, R56AI018797, R56AI067497, R01AI018797, R37AI067497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-18797 (to S. N. V.), AI-070823 (to M. S. W.), and AI-067497 (to K. A. F.) and a Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows (to D. P.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BAGINSKY ML, 1969, J BIOL CHEM, V244, P5313; Baguley BC, 2003, LANCET ONCOL, V4, P141, DOI 10.1016/S1470-2045(03)01018-0; Brauer R, 2010, NEOPLASIA, V12, P755, DOI 10.1593/neo.10636; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; CHAPPELL JB, 1965, BIOCHEM J, V95, P707, DOI 10.1042/bj0950707; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; de Souza WR, 2011, J BIOENERG BIOMEMBR, V43, P237, DOI 10.1007/s10863-011-9357-4; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; GUTMAN M, 1970, P NATL ACAD SCI USA, V65, P763, DOI 10.1073/pnas.65.3.763; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOLLAND PC, 1972, BIOCHEM J, V129, P39, DOI 10.1042/bj1290039; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson DS, 2007, CELL SIGNAL, V19, P1610, DOI 10.1016/j.cellsig.2007.02.006; Indukuri H, 2006, VIROLOGY, V353, P155, DOI 10.1016/j.virol.2006.05.022; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KESSLER RJ, 1976, P NATL ACAD SCI USA, V73, P3141, DOI 10.1073/pnas.73.9.3141; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Lohrke B, 2010, CYTOM PART A, V77A, P310, DOI 10.1002/cyto.a.20873; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; McKeage MJ, 2009, LUNG CANCER, V65, P192, DOI 10.1016/j.lungcan.2009.03.027; MCPHAIL LC, 1976, J CLIN INVEST, V58, P774, DOI 10.1172/JCI108528; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NATHAN DG, 1969, J CLIN INVEST, V48, P1895, DOI 10.1172/JCI106156; PERERA PY, 1994, J IMMUNOL, V153, P4684; PICK E, 1981, J RETICULOENDOTH SOC, V30, P581; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PORTER CD, 1993, BLOOD, V82, P2196; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prantner D, 2009, INFECT IMMUN, V77, P76, DOI 10.1128/IAI.00963-08; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; RAGAN CI, 1978, BIOCHEM J, V174, P783, DOI 10.1042/bj1740783; Roberts ZJ, 2008, J INTERF CYTOK RES, V28, P133, DOI 10.1089/jir.2007.0992; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	83	129	141	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382986	http://dx.doi.org/10.1074/jbc.M112.382986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027866	Green Published, hybrid			2022-12-25	WOS:000311233800046
J	Chen, CL; Calhoun, JD; Zhang, YQ; Lopez-Santiago, L; Zhou, N; Davis, TH; Salzer, JL; Isom, LL				Chen, Chunling; Calhoun, Jeffrey D.; Zhang, Yanqing; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Salzer, James L.; Isom, Lori L.			Identification of the Cysteine Residue Responsible for Disulfide Linkage of Na+ Channel alpha and beta 2 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; HOMOPHILIC CELL-ADHESION; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; NODES; SEGMENTS; SEIZURES; MUTATION; ANKYRIN	Voltage-gated Na+ channels in the brain are composed of a single pore-forming alpha subunit, one non-covalently linked beta subunit (beta 1 or beta 3), and one disulfide-linked beta subunit (beta 2 or beta 4). The final step in Na+ channel biosynthesis in central neurons is concomitant alpha-beta 2 disulfide linkage and insertion into the plasma membrane. Consistent with this, Scn2b (encoding beta 2) null mice have reduced Na+ channel cell surface expression in neurons, and action potential conduction is compromised. Here we generated a series of mutant beta 2 cDNA constructs to investigate the cysteine residue(s) responsible for alpha-beta 2 subunit covalent linkage. We demonstrate that a single cysteine-to-alanine substitution at extracellular residue Cys-26, located within the immunoglobulin (Ig) domain, abolishes the covalent linkage between alpha and beta 2 subunits. Loss of alpha-beta 2 covalent complex formation disrupts the targeting of beta 2 to nodes of Ranvier in a myelinating co-culture system and to the axon initial segment in primary hippocampal neurons, suggesting that linkage with alpha is required for normal beta 2 subcellular localization in vivo. WT beta 2 subunits are resistant to live cell Triton X-100 detergent extraction from the hippocampal axon initial segment, whereas mutant beta 2 subunits, which cannot form disulfide bonds with alpha, are removed by detergent. Taken together, our results demonstrate that alpha-beta 2 covalent association via a single, extracellular disulfide bond is required for beta 2 targeting to specialized neuronal subcellular domains and for beta 2 association with the neuronal cytoskeleton within those domains.	[Chen, Chunling; Calhoun, Jeffrey D.; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Isom, Lori L.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chen, Chunling; Calhoun, Jeffrey D.; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Isom, Lori L.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; New York University; New York University	Isom, LL (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, SPC 5632,1301 Catherine St, Ann Arbor, MI 48109 USA.	lisom@umich.edu		Zhang, Yanqing/0000-0003-3413-6726; Salzer, James/0000-0001-9126-7197; Calhoun, Jeffrey/0000-0003-0554-2231; Isom, Lori/0000-0002-9479-6729	National Institutes of Health [NS076752, NS 064245, NS043474]; National Multiple Sclerosis Society [RG 4748A13, RG 3771A4/3]; American Epilepsy Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064245, R37NS076752, R01NS043474, R01NS076752, R56NS076752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Epilepsy Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS076752 and NS 064245 (to L. L. I.) and NS043474 (to J. L. S.). This work was also supported by National Multiple Sclerosis Society Grants RG 4748A13 (to J. L. S.) and RG 3771A4/3 (to L. L. I.).; Supported by a fellowship from the American Epilepsy Society.	Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Liu ZG, 2012, PROTEINS, V80, P307, DOI 10.1002/prot.23164; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2001, CIRCULATION, V103, P1303; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; McEwen DP, 2009, NEUROSCI LETT, V462, P272, DOI 10.1016/j.neulet.2009.07.020; Meadows LS, 2002, J NEUROSCI, V22, P10699; O'Malley HA, 2009, MOL CELL NEUROSCI, V40, P143, DOI 10.1016/j.mcn.2008.10.001; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhang YQ, 2012, NEURON, V73, P92, DOI 10.1016/j.neuron.2011.10.016	30	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39061	39069		10.1074/jbc.M112.397646	http://dx.doi.org/10.1074/jbc.M112.397646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992729	Green Published, hybrid			2022-12-25	WOS:000310982800062
J	Friedrich, MG; Lam, J; Truscott, RJW				Friedrich, Michael G.; Lam, Jackson; Truscott, Roger J. W.			Degradation of an Old Human Protein AGE-DEPENDENT CLEAVAGE OF gamma S-CRYSTALLIN GENERATES A PEPTIDE THAT BINDS TO CELL MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LENS CRYSTALLINS; AGING HUMAN LENS; ALPHA-B-CRYSTALLIN; DE-NOVO PEPTIDE; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; PENETRATING-PEPTIDES; STRUCTURE PREDICTION; LIFELONG PROTEINS; BASIC RESIDUES	Long-lived proteins exist in a number of tissues in the human body; however, little is known about the reactions involved in their degradation over time. Lens proteins, which do not turn over, provide a useful system to examine such processes. Using a combination of Western blotting and proteomic methodology, age-related changes to a major protein, gamma S-crystallin, were studied. By teenage years, insoluble intact gamma S-crystallin was detected, indicative of protein denaturation. This was not the only change, however, because blots revealed evidence of significant cross-linking as well as cleavage of gamma S-crystallin in all adult lenses. Cleavage at a serine residue near the C terminus was a major reaction that caused the release of a 12-residue peptide, SPAVQSFRRIVE, which bound tightly to lens cell membranes. Several other crystallin-derived peptides with double basic residues also lodged in the cell membrane fraction. Model studies showed that once cleaved from gamma S-crystallin, SPAVQSFRRIVE adopts a markedly different shape from that in the intact protein. Further, the acquired helical conformation may explain why the peptide seems to affect water permeability. This observation may help explain the changes to cell membranes known to be associated with aging in human lenses. Age-related cleavage of long-lived proteins may therefore yield peptides with untoward biological activity.	[Friedrich, Michael G.; Truscott, Roger J. W.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2500, Australia; [Friedrich, Michael G.; Lam, Jackson; Truscott, Roger J. W.] Save Sight Inst, Sydney, NSW 2001, Australia	University of Wollongong; University of Sydney	Truscott, RJW (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2500, Australia.	rjwt@uow.edu.au	Friedrich, Michael/C-8669-2016	Friedrich, Michael/0000-0002-8274-1552	National Health and Medical Research Council [512334]; Claffy Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Claffy Foundation	This work was supported by National Health and Medical Research Council Grant 512334 and the Claffy Foundation.	Asomugha CO, 2011, MOL VIS, V17, P2407; Asomugha CO, 2010, MOL VIS, V16, P476; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; CLARKE ND, 1994, P NATL ACAD SCI USA, V91, P11084, DOI 10.1073/pnas.91.23.11084; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DOVRAT A, 1984, MECH AGEING DEV, V28, P187, DOI 10.1016/0047-6374(84)90019-8; Friedrich MG, 2009, INVEST OPHTH VIS SCI, V50, P4786, DOI 10.1167/iovs.09-3588; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Harrington V, 2004, MOL VIS, V10, P476; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hooi MYS, 2011, AGE, V33, P131, DOI 10.1007/s11357-010-9171-7; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; Korlimbinis A, 2009, EXP EYE RES, V88, P966, DOI 10.1016/j.exer.2008.12.008; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lapko VN, 2005, PROTEIN SCI, V14, P45, DOI 10.1110/ps.04738505; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; Lyons B, 2011, INT J PEPT RES THER, V17, P131, DOI 10.1007/s10989-011-9250-3; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MCFALLNGAI MJ, 1985, EXP EYE RES, V41, P745, DOI 10.1016/0014-4835(85)90183-6; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Mortazavi SM, 2007, J BIOTECHNOL, V129, P604, DOI 10.1016/j.jbiotec.2007.02.005; Nowakowski RS, 2006, P NATL ACAD SCI USA, V103, P12219, DOI 10.1073/pnas.0605605103; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; ROY D, 1976, P NATL ACAD SCI USA, V73, P3484, DOI 10.1073/pnas.73.10.3484; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Scheglmann D, 2002, PROTEIN ENG, V15, P521, DOI 10.1093/protein/15.6.521; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; Shestopalov VI, 2000, J CELL SCI, V113, P1913; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1998, BIOCHEM BIOPH RES CO, V253, P288, DOI 10.1006/bbrc.1998.9728; Su SP, 2012, AGING CELL, V11, P1125, DOI 10.1111/j.1474-9726.2012.00860.x; Su SP, 2011, BBA-PROTEINS PROTEOM, V1814, P647, DOI 10.1016/j.bbapap.2011.03.014; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; THOMSON JA, 1985, EXP EYE RES, V40, P393, DOI 10.1016/0014-4835(85)90152-6; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; Truscott RJW, 2010, REJUV RES, V13, P83, DOI 10.1089/rej.2009.0938; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Yamaguchi T, 2007, J GERONTOL A-BIOL, V62, P481, DOI 10.1093/gerona/62.5.481; YOSHIDA H, 1984, BIOCHIM BIOPHYS ACTA, V798, P252, DOI 10.1016/0304-4165(84)90313-1; Zhu XJ, 2010, REJUV RES, V13, P553, DOI 10.1089/rej.2009.1009; Zhu XJ, 2010, INVEST OPHTH VIS SCI, V51, P5162, DOI 10.1167/iovs.09-4947	61	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39012	39020		10.1074/jbc.M112.391565	http://dx.doi.org/10.1074/jbc.M112.391565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995907	Green Published, hybrid			2022-12-25	WOS:000310982800057
J	Xiong, YB; Song, C; Snyder, GA; Sundberg, EJ; Medvedev, AE				Xiong, Yanbao; Song, Chang; Snyder, Greg A.; Sundberg, Eric J.; Medvedev, Andrei E.			R753Q Polymorphism Inhibits Toll-like Receptor (TLR) 2 Tyrosine Phosphorylation, Dimerization with TLR6, and Recruitment of Myeloid Differentiation Primary Response Protein 88	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; SIGNAL-TRANSDUCTION; CUTTING EDGE; MYCOBACTERIUM-TUBERCULOSIS; LIVER-TRANSPLANTATION; BACTERIAL-INFECTIONS; ENDOTOXIN TOLERANCE; PATTERN-RECOGNITION; LEPROMATOUS LEPROSY	The R753Q polymorphism in the Toll-IL-1 receptor domain of Toll-like receptor 2 (TLR2) has been linked to increased incidence of tuberculosis and other infectious diseases, but the mechanisms by which it affects TLR2 functions are unclear. Here, we studied the impact of the R753Q polymorphism on TLR2 expression, hetero-dimerization with TLR6, tyrosine phosphorylation, and recruitment of myeloid differentiation primary response protein (MyD) 88 and MyD88 adapter-like (Mal). Complementation of HEK293 cells with transfected WT or R753Q TLR2 revealed their comparable total levels and only minimal changes in cell surface expression of the mutant species. Notably, even a 100-fold increase in amounts of transfected R753Q TLR2 versus WT variant did not overcome the compromised ability of the mutant TLR2 to activate nuclear factor kappa B (NF-kappa B), indicating that a minimal decrease in cell surface levels of the R753Q TLR2 cannot account for the signaling deficiency. Molecular modeling studies suggested that the R753Q mutation changes the electrostatic potential of the DD loop and results in a discrete movement of the residues critical for protein-protein interactions. Confirming these predictions, biochemical assays demonstrated that R753Q TLR2 exhibits deficient agonist-induced tyrosine phosphorylation, hetero-dimerization with TLR6, and recruitment of Mal and MyD88. These proximal signaling deficiencies correlated with impaired capacities of the R753Q TLR2 to mediate p38 phosphorylation, NF-kappa B activation, and induction of IL-8 mRNA in transfected HEK293 cells challenged with inactivated Mycobacterium tuberculosis or mycobacterial components. Thus, the R753Q polymorphism renders TLR2 signaling-incompetent by impairing its tyrosine phosphorylation, dimerization with TLR6, and recruitment of Mal and MyD88.	[Xiong, Yanbao; Song, Chang; Sundberg, Eric J.; Medvedev, Andrei E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Snyder, Greg A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Snyder, Greg A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Medvedev, AE (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF I Bldg,Rm 380, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [R21 AI067468, RO1 AI059524]; University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067468, R01AI059524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI067468 and RO1 AI059524 and the University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant (to A. E. M.).	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Chockalingam A, 2012, J IMMUNOL, V188, P527, DOI 10.4049/jimmunol.1102713; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Ferwerda B, 2007, AIDS, V21, P1375, DOI 10.1097/QAD.0b013e32814e6b2d; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Guggemoos S, 2008, J IMMUNOL, V180, P438, DOI 10.4049/jimmunol.180.1.438; Hayes MW, 2012, J VIROL, V86, P7216, DOI 10.1128/JVI.06508-11; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kajava AV, 2010, J BIOL CHEM, V285, P6227, DOI 10.1074/jbc.M109.063669; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kang TJ, 2002, CYTOKINE, V20, P56, DOI 10.1006/cyto.2002.1982; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Means TK, 1999, J IMMUNOL, V163, P3920; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mrabet-Dahbi S, 2008, J ALLERGY CLIN IMMUN, V121, P1013, DOI 10.1016/j.jaci.2007.11.029; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Salpietro C, 2011, INT J IMMUNOPATH PH, V24, P33, DOI 10.1177/03946320110240S408; Sarkar SN, 2007, J BIOL CHEM, V282, P3423, DOI 10.1074/jbc.C600226200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Soylu A, 2011, INFLAMMATION, V34, P379, DOI 10.1007/s10753-010-9245-9; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	78	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375493	http://dx.doi.org/10.1074/jbc.M112.375493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992740	Green Published, hybrid			2022-12-25	WOS:000310642200065
J	Engreitz, JM; Agarwala, V; Mirny, LA				Engreitz, Jesse M.; Agarwala, Vineeta; Mirny, Leonid A.			Three-Dimensional Genome Architecture Influences Partner Selection for Chromosomal Translocations in Human Disease	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; SPATIAL-ORGANIZATION; SEQUENCING REVEALS; MULTIPLE-MYELOMA; GENE; REARRANGEMENTS; PROXIMITY; BCR; ABL; EXPRESSION	Chromosomal translocations are frequent features of cancer genomes that contribute to disease progression. These rearrangements result from formation and illegitimate repair of DNA double-strand breaks (DSBs), a process that requires spatial colocalization of chromosomal breakpoints. The "contact first" hypothesis suggests that translocation partners colocalize in the nuclei of normal cells, prior to rearrangement. It is unclear, however, the extent to which spatial interactions based on three-dimensional genome architecture contribute to chromosomal rearrangements in human disease. Here we intersect Hi-C maps of three-dimensional chromosome conformation with collections of 1,533 chromosomal translocations from cancer and germline genomes. We show that many translocation-prone pairs of regions genome-wide, including the cancer translocation partners BCR-ABL and MYC-IGH, display elevated Hi-C contact frequencies in normal human cells. Considering tissue specificity, we find that translocation breakpoints reported in human hematologic malignancies have higher Hi-C contact frequencies in lymphoid cells than those reported in sarcomas and epithelial tumors. However, translocations from multiple tissue types show significant correlation with Hi-C contact frequencies, suggesting that both tissue-specific and universal features of chromatin structure contribute to chromosomal alterations. Our results demonstrate that three-dimensional genome architecture shapes the landscape of rearrangements directly observed in human disease and establish Hi-C as a key method for dissecting these effects.	[Engreitz, Jesse M.; Agarwala, Vineeta; Mirny, Leonid A.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Engreitz, Jesse M.; Agarwala, Vineeta] Broad Inst, Cambridge, MA USA; [Agarwala, Vineeta] Harvard Univ, Biophys Program, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leonid@mit.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410	National Human Genome Research Institute [T32 HG002295]; National Defense Science and Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation; Medical Scientist Training Program; National Institute of General Medical Sciences [5T32 GM008313]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Defense Science and Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JE was supported by the National Human Genome Research Institute (grant T32 HG002295), the National Defense Science and Engineering Graduate Fellowship Program, and the Fannie and John Hertz Foundation. VA was supported by the Medical Scientist Training Program and the National Institute of General Medical Sciences (grant 5T32 GM008313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Khalidi HS, 1999, CANCER GENET CYTOGEN, V109, P58, DOI 10.1016/S0165-4608(98)00153-8; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; KOEFFLER HP, 1981, NEW ENGL J MED, V304, P1201, DOI 10.1056/NEJM198105143042004; Kozubek S, 1999, CHROMOSOMA, V108, P426, DOI 10.1007/s004120050394; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Malgeri U, 2000, CANCER RES, V60, P4058; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mitelman F., MITELMAN DATABASE CH; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; NOWELL PC, 1960, SCIENCE, V132, P1497; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; ROWLEY JD, 1980, ANNU REV GENET, V14, P17, DOI 10.1146/annurev.ge.14.120180.000313; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	39	85	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44196	10.1371/journal.pone.0044196	http://dx.doi.org/10.1371/journal.pone.0044196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028501	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900005
J	Schuler, PK; Haegeli, LM; Saguner, AM; Wolber, T; Tanner, FC; Jenni, R; Corti, N; Luscher, TF; Brunckhorst, C; Duru, F				Schuler, Pia K.; Haegeli, Laurent M.; Saguner, Ardan M.; Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Corti, Natascia; Luescher, Thomas F.; Brunckhorst, Corinna; Duru, Firat			Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center	PLOS ONE			English	Article							CARDIOVERTER-DEFIBRILLATOR THERAPY; SUDDEN CARDIAC DEATH; IMPLANTABLE DEFIBRILLATOR; YOUNG-PEOPLE; DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; DIAGNOSIS; REGISTRY; PREVENTION; HEART	Introduction: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetically transmitted disease prone to ventricular arrhythmias. We therefore investigated the clinical, echocardiographical and electrophysiological predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in patients with ARVC. Methods: A retrospective analysis was performed in 26 patients (median age of 40 years at diagnosis, 21 males and 5 females) with ARVC who underwent ICD implantation. Results: Over a median (range) follow-up period of 10 (2.7, 37) years, appropriate ICD therapy for ventricular arrhythmias was documented in 12 (46%) out of 26 patients. In all patients with appropriate ICD therapy the ICD was originally inserted for secondary prevention. Median time from ICD implantation to ICD therapy was 9 months (range 3.6, 54 months). History of heart failure was a significant predictor of appropriate ICD therapy (p = 0.033). Left ventricular disease involvement (p = 0.059) and age at implantation (p = 0.063) were borderline significant predictors. Patients with syncope at time of diagnosis were significantly less likely to receive ICD therapy (p = 0.02). Invasive electrophysiological testing was not significantly associated with appropriate ICD therapy. Conclusion: In our cohort of patients with ARVC, history of heart failure was a significant predictor of appropriate ICD therapy, whereas left ventricular involvement and age at time of ICD implantation were of borderline significance. These predictors should be tested in larger prospective cohorts to optimize ICD therapy in this rare cardiomyopathy.	[Schuler, Pia K.; Haegeli, Laurent M.; Saguner, Ardan M.; Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Luescher, Thomas F.; Brunckhorst, Corinna; Duru, Firat] Univ Zurich Hosp, Clin Cardiol, Cardiovas Ctr, CH-8091 Zurich, Switzerland; [Schuler, Pia K.] Univ Hosp Muenster, Dept Cardiol & Angiol, Adult Congenital & Valvular Heart Dis Ctr, Munster, Germany; [Wolber, Thomas; Tanner, Felix C.; Jenni, Rolf; Luescher, Thomas F.; Duru, Firat] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Corti, Natascia] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Munster; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Haegeli, LM (corresponding author), Univ Zurich Hosp, Clin Cardiol, Cardiovas Ctr, CH-8091 Zurich, Switzerland.	laurent.haegeli@usz.ch	Saguner, Ardan M./AAV-3624-2020; rolf jenni, MSEE/B-2334-2015	Duru, Firat/0000-0002-4748-0158; Jenni, Rolf/0000-0002-2609-6915	Schwyzer Foundation; Medtronic; Biotronik; St. Jude; Boston Scientific	Schwyzer Foundation; Medtronic(Medtronic); Biotronik; St. Jude(St. Jude Medical); Boston Scientific(Boston Scientific)	This study was supported by a donation by the Schwyzer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; There are no conflicts of interest involved other than research grants to the institution from Medtronic, Biotronik, St. Jude and Boston Scientific not directly related to this project. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berul CI, 2008, J AM COLL CARDIOL, V51, P1685, DOI 10.1016/j.jacc.2008.01.033; Bhonsale A, 2011, J AM COLL CARDIOL, V58, P1485, DOI 10.1016/j.jacc.2011.06.043; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Hodgkinson KA, 2005, J AM COLL CARDIOL, V45, P400, DOI 10.1016/j.jacc.2004.08.068; JENNI R, 1981, EUR HEART J, V2, P217, DOI 10.1093/oxfordjournals.eurheartj.a061197; Komura M, 2010, INT HEART J, V51, P34, DOI 10.1536/ihj.51.34; KULLO IJ, 1995, MAYO CLIN PROC, V70, P541, DOI 10.4065/70.6.541; Lemola K, 2005, HEART, V91, P1167, DOI 10.1136/hrt.2004.038620; Link M S, 1997, J Interv Card Electrophysiol, V1, P41, DOI 10.1023/A:1009714718034; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Marcus F, 2010, AM J CARDIOL, V105, P1036, DOI 10.1016/j.amjcard.2009.11.033; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Marcus FI, 2009, HEART RHYTHM, V6, P984, DOI 10.1016/j.hrthm.2009.03.013; Marcus GM, 2009, J AM COLL CARDIOL, V54, P609, DOI 10.1016/j.jacc.2009.04.052; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nicolosi GL, 2008, TRATTATO ECOCARDIOGR; Piccini JP, 2005, HEART RHYTHM, V2, P1188, DOI 10.1016/j.hrthm.2005.08.022; PINAMONTI B, 1995, AM HEART J, V129, P412, DOI 10.1016/0002-8703(95)90029-2; Pinamonti B, 2011, EUR HEART J, V32, P1105, DOI 10.1093/eurheartj/ehr040; Roguin A, 2004, J AM COLL CARDIOL, V43, P1843, DOI 10.1016/j.jacc.2004.01.030; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; Tabib A, 1999, EUR HEART J, V20, P900, DOI 10.1053/euhj.1998.1403; Tandri H, 2008, AM HEART J, V155, P147, DOI 10.1016/j.ahj.2007.08.011; Tavernier R, 2001, HEART, V85, P53, DOI 10.1136/heart.85.1.53; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Wichter T, 2004, CIRCULATION, V109, P1503, DOI 10.1161/01.CIR.0000121738.88273.43; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	35	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e39584	10.1371/journal.pone.0039584	http://dx.doi.org/10.1371/journal.pone.0039584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028419	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500002
J	Castillo, AB; Blundo, JT; Chen, JC; Lee, KL; Yereddi, NR; Jang, E; Kumar, S; Tang, WJ; Zarrin, S; Kim, JB; Jacobs, CR				Castillo, Alesha B.; Blundo, Jennifer T.; Chen, Julia C.; Lee, Kristen L.; Yereddi, Nikitha Reddy; Jang, Eugene; Kumar, Shefali; Tang, W. Joyce; Zarrin, Sarah; Kim, Jae-Beom; Jacobs, Christopher R.			Focal Adhesion Kinase Plays a Role in Osteoblast Mechanotransduction In Vitro but Does Not Affect Load-Induced Bone Formation In Vivo	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION PATHWAYS; CELL-MIGRATION; MECHANICAL STIMULATION; FAK; INTEGRIN; REGENERATION; EXPRESSION; MICE; FLOW	A healthy skeleton relies on bone's ability to respond to external mechanical forces. The molecular mechanisms by which bone cells sense and convert mechanical stimuli into biochemical signals, a process known as mechanotransduction, are unclear. Focal adhesions play a critical role in cell survival, migration and sensing physical force. Focal adhesion kinase (FAK) is a non-receptor protein tyrosine kinase that controls focal adhesion dynamics and can mediate reparative bone formation in vivo and osteoblast mechanotransduction in vitro. Based on these data, we hypothesized that FAK plays a role in load-induced bone formation. To test this hypothesis, we performed in vitro fluid flow experiments and in vivo bone loading studies in FAK-/- clonal lines and conditional FAK knockout mice, respectively. FAK-/- osteoblasts showed an ablated prostaglandin E-2 (PGE(2)) response to fluid flow shear. This effect was reversed with the re-expression of wild-type FAK. Re-expression of FAK containing site-specific mutations at Tyr-397 and Tyr-925 phosphorylation sites did not rescue the phenotype, suggesting that these sites are important in osteoblast mechanotransduction. Interestingly, mice in which FAK was conditionally deleted in osteoblasts and osteocytes did not exhibit altered load-induced periosteal bone formation. Together these data suggest that although FAK is important in mechanically-induced signaling in osteoblasts in vitro, it is not required for an adaptive response in vivo, possibly due to a compensatory mechanism that does not exist in the cell culture system.	[Castillo, Alesha B.; Tang, W. Joyce; Zarrin, Sarah; Jacobs, Christopher R.] Vet Affairs Palo Alto Hlth Care Syst, Dept Rehabil Res & Dev, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA; [Castillo, Alesha B.; Kim, Jae-Beom] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Castillo, Alesha B.; Blundo, Jennifer T.; Jacobs, Christopher R.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Blundo, Jennifer T.; Chen, Julia C.; Lee, Kristen L.; Yereddi, Nikitha Reddy; Jang, Eugene; Kumar, Shefali; Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Columbia University	Castillo, AB (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Dept Rehabil Res & Dev, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA.	alesha.castillo@stanford.edu	Castillo, Alesha B./AAC-9961-2019; Castillo, Alesha B/A-8728-2014	Castillo, Alesha B./0000-0002-1371-7567; Castillo, Alesha B/0000-0002-1371-7567; Jang, Eugene/0000-0002-9808-2678	Stanford Center on Longevity Postdoctoral Fellowship; National Institutes of Health (NIH) [AR45989, AR54156]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045989] Funding Source: NIH RePORTER	Stanford Center on Longevity Postdoctoral Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Stanford Center on Longevity Postdoctoral Fellowship (ABC) and National Institutes of Health (NIH) grants AR45989 (CRJ) and AR54156 (CRJ). The Stanford Center on Longevity Postdoctoral Fellowship provided salary support for Dr. Alesha Castillo. NIH grants AR45989 and AR54156 provided support for consumables, reagents, cell culture work and animal husbandry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Castillo AB, 2006, BONE, V39, P1087, DOI 10.1016/j.bone.2006.04.026; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; CHOW JWM, 1994, AM J PHYSIOL, V267, pE287, DOI 10.1152/ajpendo.1994.267.2.E287; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Lee DY, 2009, J BIOL CHEM; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Litzenberger JB, 2009, CELLULAR MOL BIOENGI; Ma A, 2001, MOL BIOL CELL, V12, P1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Monfoulet L, 2009, CALCIF TISSUE INT; Nguyen KT, 2009, KNOCKOUT PYK2 IMPROV; Orr AW, 2004, FRONT BIOSCI-LANDMRK, V9, P1254, DOI 10.2741/1239; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petzold T, 2009, AM J PHYSL CELL PHYS; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Santos A, 2009, BIOCH BIOPHYS RES CO; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wen HA, 2009, INT WOUND J, V6, P149, DOI 10.1111/j.1742-481X.2009.00591.x; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43291	10.1371/journal.pone.0043291	http://dx.doi.org/10.1371/journal.pone.0043291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028449	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800001
J	Lugar, PL; Love, C; Grammer, AC; Dave, SS; Lipsky, PE				Lugar, Patricia L.; Love, Cassandra; Grammer, Amrie C.; Dave, Sandeep S.; Lipsky, Peter E.			Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; PERIPHERAL-BLOOD CELLS; LYMPHOCYTE EGRESS; BONE-MARROW; DISEASE-ACTIVITY; B-LYMPHOCYTES; EXPRESSION; DIFFERENTIATION; MAINTENANCE; BLIMP-1	Systemic lupus erythematosus (SLE) is a generalized autoimmune disease characterized by abnormal B cell activation and the occurrence of increased frequencies of circulating plasma cells (PC). The molecular characteristics and nature of circulating PC and B cells in SLE have not been completely characterized. Microarray analysis of gene expression was used to characterize circulating PC in subjects with active SLE. Flow cytometry was used to sort PC and comparator B cell populations from active SLE blood, normal blood and normal tonsil. The gene expression profiles of the sorted B cell populations were then compared. SLE PC exhibited a similar gene expression signature as tonsil PC. The differences in gene expression between SLE PC and normal tonsil PC and tonsil plasmablasts (PB) suggest a mature Ig secreting cell phenotype in the former population. Despite this, SLE PC differed in expression of about half the genes from previously published gene expression profiles of normal bone marrow PC, indicating that these cells had not achieved a fully mature status. Abnormal expression of several genes, including CXCR4 and S1P(1), suggests a mechanism for the persistence of SLE PC in the circulation. All SLE B cell populations revealed an interferon (IFN) gene signature previously only reported in unseparated SLE peripheral blood mononuclear cells. These data indicate that SLE PC are a unique population of Ig secreting cells with a gene expression profile indicative of a mature, but not fully differentiated phenotype.	[Lugar, Patricia L.; Grammer, Amrie C.; Lipsky, Peter E.] NIH, Autoimmun Branch, Bethesda, MD 20892 USA; [Love, Cassandra; Dave, Sandeep S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	National Institutes of Health (NIH) - USA; Duke University	Lugar, PL (corresponding author), Duke Univ, Div Pulm Allergy & Crit Care, Durham, NC 27706 USA.	patricia.lugar@duke.edu		Grammer, Amrie/0000-0001-7142-2284	intramural NIH funding	intramural NIH funding	The research work was performed at the National Institutes of Health (NIH) and NIH Clinical Center and funded through intramural NIH funding. The NIH had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; De Vos J, 2006, IMMUNOL REV, V210, P86, DOI 10.1111/j.0105-2896.2006.00362.x; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Gerl V, 2010, ANN RHEUM DIS; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2004, ARTHRITIS RES THER, V6, P28, DOI 10.1186/ar1155; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kuhn A, 2009, ARCH DERMATOL RES, V301, P71, DOI 10.1007/s00403-008-0891-9; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Moser K, 2006, IMMUNOL LETT, V103, P83, DOI 10.1016/j.imlet.2005.09.009; Nakayama Y, 2006, J CELL BIOCHEM, V99, P1308, DOI 10.1002/jcb.20952; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham TH, 2010, J EXP MED, V207, pS11; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; ROMAN C, 1990, PROG CLIN BIOL RES, V352, P241; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang HJ, 2005, CELL IMMUNOL, V235, P117, DOI 10.1016/j.cellimm.2005.08.031; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44362	10.1371/journal.pone.0044362	http://dx.doi.org/10.1371/journal.pone.0044362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028528	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800007
J	Scala, A; Auconi, P; Scazzocchio, M; Caldarelli, G; McNamara, JA; Franchi, L				Scala, Antonio; Auconi, Pietro; Scazzocchio, Marco; Caldarelli, Guido; McNamara, James A.; Franchi, Lorenzo			Using Networks To Understand Medical Data: The Case of Class III Malocclusions	PLOS ONE			English	Article							BIOLOGY	A system of elements that interact or regulate each other can be represented by a mathematical object called a network. While network analysis has been successfully applied to high-throughput biological systems, less has been done regarding their application in more applied fields of medicine; here we show an application based on standard medical diagnostic data. We apply network analysis to Class III malocclusion, one of the most difficult to understand and treat orofacial anomaly. We hypothesize that different interactions of the skeletal components can contribute to pathological disequilibrium; in order to test this hypothesis, we apply network analysis to 532 Class III young female patients. The topology of the Class III malocclusion obtained by network analysis shows a strong co-occurrence of abnormal skeletal features. The pattern of these occurrences influences the vertical and horizontal balance of disharmony in skeletal form and position. Patients with more unbalanced orthodontic phenotypes show preponderance of the pathological skeletal nodes and minor relevance of adaptive dentoalveolar equilibrating nodes. Furthermore, by applying Power Graphs analysis we identify some functional modules among orthodontic nodes. These modules correspond to groups of tightly inter-related features and presumably constitute the key regulators of plasticity and the sites of unbalance of the growing dentofacial Class III system. The data of the present study show that, in their most basic abstraction level, the orofacial characteristics can be represented as graphs using nodes to represent orthodontic characteristics, and edges to represent their various types of interactions. The applications of this mathematical model could improve the interpretation of the quantitative, patient-specific information, and help to better targeting therapy. Last but not least, the methodology we have applied in analyzing orthodontic features can be applied easily to other fields of the medical science.	[Scala, Antonio; Auconi, Pietro; Scazzocchio, Marco; Caldarelli, Guido] Ist Sistemi Complessi Udr La Sapienza, Rome, Italy; [Scala, Antonio; Caldarelli, Guido] London Inst Math Sci, London, England; [Caldarelli, Guido] IMT Lucca Inst Adv Studies, NATWORKS Unit Study Nat Networks, Lucca, Italy; [McNamara, James A.; Franchi, Lorenzo] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [McNamara, James A.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [McNamara, James A.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Franchi, Lorenzo] Univ Florence, Dept Orthodont, Florence, Italy	IMT School for Advanced Studies Lucca; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Florence	Scala, A (corresponding author), Ist Sistemi Complessi Udr La Sapienza, Rome, Italy.	antonio.scala@phys.uniroma1.it	Scala, Antonio/H-9153-2019; Franchi, Lorenzo/B-2730-2009; Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010	Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Auconi, Pietro/0000-0001-8380-2698; Caldarelli, Guido/0000-0001-9377-3616; FRANCHI, LORENZO/0000-0002-2072-460X				Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Auconi P, 2011, ORTHOD CRANIOFAC RES, V14, P189, DOI 10.1111/j.1601-6343.2011.01523.x; Baccetti T, 2005, ANGLE ORTHOD, V75, P510; Baccetti T, 2007, AM J ORTHOD DENTOFAC, V132, P171, DOI 10.1016/j.ajodo.2005.07.031; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; BATTAGEL JM, 1994, EUR J ORTHODONT, V16, P71, DOI 10.1093/ejo/16.1.71; Berthold MR, 2007, STUDIES CLASSIFICATI; Betzenberger D, 1999, ANGLE ORTHOD, V69, P27; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Buchanan M, 2010, PHYS WORLD, V23, P22; Bui C, 2006, ANGLE ORTHOD, V76, P564; Caldarelli G., 2007, SCALE FREE NETWORKS; Franchi L, 1998, ANGLE ORTHOD, V68, P497; FREER TJ, 1973, AM J ORTHOD DENTOFAC, V64, P155, DOI 10.1016/S0002-9416(73)90307-2; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Reyes BC, 2006, ANGLE ORTHOD, V76, P577; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Sanborn RT, 1955, ANGLE ORTHOD, V24, P208; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Solow B, 1980, Br J Orthod, V7, P145; Staley RN, 1995, TXB ORTHODONTICS, P98; Steilzig-Eisenhauer A, 2002, AM J ORTHOD DENTOFAC, V122, P27, DOI 10.1067/mod.2002.123632; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44521	10.1371/journal.pone.0044521	http://dx.doi.org/10.1371/journal.pone.0044521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028552	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000309392800010
J	Eskat, A; Deng, W; Hofmeister, A; Rudolphi, S; Emmerth, S; Hellwig, D; Ulbricht, T; Doring, V; Bancroft, JM; McAinsh, AD; Cardoso, MC; Meraldi, P; Hoischen, C; Leonhardt, H; Diekmann, S				Eskat, Anja; Deng, Wen; Hofmeister, Antje; Rudolphi, Sven; Emmerth, Stephan; Hellwig, Daniela; Ulbricht, Tobias; Doering, Volker; Bancroft, James M.; McAinsh, Andrew D.; Cardoso, M. Cristina; Meraldi, Patrick; Hoischen, Christian; Leonhardt, Heinrich; Diekmann, Stephan			Step-Wise Assembly, Maturation and Dynamic Behavior of the Human CENP-P/O/R/Q/U Kinetochore SubComplex	PLOS ONE			English	Article							CONSTITUTIVE CENTROMERE COMPONENT; LIVING HUMAN-CELLS; OUTER KINETOCHORE; IN-VIVO; A NUCLEOSOMES; MLF1-INTERACTING PROTEIN; MICROTUBULE INTERACTIONS; VERTEBRATE KINETOCHORES; MOLECULAR ARCHITECTURE; CHROMOSOME SEGREGATION	Kinetochores are multi-protein megadalton assemblies that are required for attachment of microtubules to centromeres and, in turn, the segregation of chromosomes in mitosis. Kinetochore assembly is a cell cycle regulated multi-step process. The initial step occurs during interphase and involves loading of the 15-subunit constitutive centromere associated complex (CCAN), which contains a 5-subunit (CENP-P/O/R/Q/U) sub-complex. Here we show using a fluorescent three-hybrid (F3H) assay and fluorescence resonance energy transfer (FRET) in living mammalian cells that CENP-P/O/R/Q/U subunits exist in a tightly packed arrangement that involves multifold protein-protein interactions. This sub-complex is, however, not pre-assembled in the cytoplasm, but rather assembled on kinetochores through the step-wise recruitment of CENP-O/P heterodimers and the CENP-P, -O, -R, -Q and -U single protein units. SNAP-tag experiments and immuno-staining indicate that these loading events occur during S-phase in a manner similar to the nucleosome binding components of the CCAN, CENP-T/W/N. Furthermore, CENP-P/O/R/Q/U binding to the CCAN is largely mediated through interactions with the CENP-N binding protein CENP-L as well as CENP-K. Once assembled, CENP-P/O/R/Q/U exchanges slowly with the free nucleoplasmic pool indicating a low off-rate for individual CENP-P/O/R/Q/U subunits. Surprisingly, we then find that during late S-phase, following the kinetochore-binding step, both CENP-Q and -U but not -R undergo oligomerization. We propose that CENP-P/O/R/Q/U self-assembles on kinetochores with varying stoichiometry and undergoes a pre-mitotic maturation step that could be important for kinetochores switching into the correct conformation necessary for microtubule-attachment.	[Eskat, Anja; Hofmeister, Antje; Rudolphi, Sven; Hellwig, Daniela; Ulbricht, Tobias; Doering, Volker; Hoischen, Christian; Diekmann, Stephan] FLI, Jena, Germany; [Deng, Wen; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, Dept Biol 2, Munich, Germany; [Emmerth, Stephan; Meraldi, Patrick] ETH, Inst Biochem, Zurich, Switzerland; [Bancroft, James M.; McAinsh, Andrew D.] Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England; [Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Warwick; Technical University of Darmstadt	Diekmann, S (corresponding author), FLI, Jena, Germany.	diekmann@fli-leibniz.de	Deng, Wen/GQH-3160-2022; Meraldi, Patrick/D-6190-2013; McAinsh, Andrew/C-6438-2012; Leonhardt, Heinrich/B-2791-2014	Deng, Wen/0000-0003-3062-7843; Meraldi, Patrick/0000-0001-9742-8756; McAinsh, Andrew/0000-0001-6808-0711	Deutsche Forschungsgemeinschaft [DFG DI 258/17-1, SPP1128, SPP1395]; Thuringer Aufbaubank [2007 FE 9011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thuringer Aufbaubank	This work was supported by Deutsche Forschungsgemeinschaft (DFG DI 258/17-1, SPP1128, SPP1395), and Thuringer Aufbaubank (2007 FE 9011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NATURE PROTOCOLS; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dong Y, 2010, NAT CELL BIOL, V9, P516; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; Hellwig D, 2009, EUR BIOPHYS J BIOPHY, V38, P781, DOI 10.1007/s00249-009-0498-x; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Johnston K, 2010, J CELL BIOL, V189, P937, DOI 10.1083/jcb.200912022; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Orthaus S, 2009, NUCLEIC ACIDS RES, V37, P3391, DOI 10.1093/nar/gkp199; Orthaus S, 2008, CHEMBIOCHEM, V9, P77, DOI 10.1002/cbic.200700358; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Qiu SL, 2009, SCI CHINA SER C, V52, P352, DOI 10.1007/s11427-009-0050-3; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schmitzberger F, 2012, EMBO REP, V13, P216, DOI 10.1038/embor.2012.1; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Suzuki H, 2007, ANTICANCER RES, V27, P1423; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Takeuchi K, 2012, EXP CELL RES, V318, P1367, DOI 10.1016/j.yexcr.2012.02.016; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	70	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44717	10.1371/journal.pone.0044717	http://dx.doi.org/10.1371/journal.pone.0044717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028590	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900039
J	Pereda, J; Perez, S; Escobar, J; Arduini, A; Asensi, M; Serviddio, G; Sabater, L; Aparisi, L; Sastre, J				Pereda, Javier; Perez, Salvador; Escobar, Javier; Arduini, Alessandro; Asensi, Miguel; Serviddio, Gaetano; Sabater, Luis; Aparisi, Luis; Sastre, Juan			Obese Rats Exhibit High Levels of Fat Necrosis and Isoprostanes in Taurocholate-Induced Acute Pancreatitis	PLOS ONE			English	Article							OXIDATIVE STRESS; ASCITIC FLUID; ACINAR-CELLS; INFLAMMATORY RESPONSE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; THROMBOXANE RECEPTORS; BILIARY PANCREATITIS; PERITONEAL-LAVAGE; DEFICIENT MICE	Background: Obesity is a prognostic factor for severity in acute pancreatitis in humans. Our aim was to assess the role of oxidative stress and abdominal fat in the increased severity of acute pancreatitis in obese rats. Methodology: Taurocholate-induced acute pancreatitis was performed in lean and obese Zucker rats. Levels of reduced glutathione, oxidized glutathione, L-cysteine, cystine, and S-adenosylmethionine were measured in pancreas as well as the activities of serine/threonine protein phosphatases PP1 and PP2A and tyrosin phosphatases. Isoprostane, malondialdehyde, triglyceride, and free fatty acid levels and lipase activity were measured in plasma and ascites. Lipase activity was measured in white adipose tissue with and without necrosis and confirmed by western blotting. Findings: Under basal conditions obese rats exhibited lower reduced glutathione levels in pancreas and higher triglyceride and free fatty acid levels in plasma than lean rats. S-adenosyl methionine levels were markedly increased in pancreas of obese rats. Acute pancreatitis in obese rats led to glutathione oxidation and lower reduced glutathione levels in pancreas together with decreased activities of redox-sensitive phosphatases PP1, and PP2A. S-adenosyl methionine levels decreased but cystine levels increased markedly in pancreas upon pancreatitis. Acute pancreatitis triggered an increase in isoprostane levels in plasma and ascites in obese rats. Free fatty acid levels were extremely high in pancreatitis-associated ascitic fluid from obese rats and lipase was bound with great affinity to white adipose tissue, especially to areas of necrosis. Conclusions: Our results show that oxidative stress occurs locally and systemically in obese rats with pancreatitis favouring inactivation of protein phosphatases in pancreas, which would promote up-regulation of pro-inflammatory cytokines, and the increase of isoprostanes which might cause powerful pulmonary and renal vasoconstriction. Future studies are needed to confirm the translational relevance of the present findings obtained in a rat model of taurocholate-induced pancreatic damage and necrosis.	[Pereda, Javier; Perez, Salvador; Escobar, Javier; Arduini, Alessandro; Asensi, Miguel; Sastre, Juan] Univ Valencia, Sch Pharm, Dept Physiol, Valencia, Spain; [Escobar, Javier] Univ Hosp Materno Infantil La Fe, Div Neonatol, Valencia, Spain; [Serviddio, Gaetano] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Sabater, Luis] Univ Valencia, Univ Clin Hosp, Dept Surg, Valencia, Spain; [Aparisi, Luis] Univ Clin Hosp, Lab Pancreat Funct, Valencia, Spain	University of Valencia; University of Foggia; University of Valencia	Sastre, J (corresponding author), Univ Valencia, Sch Pharm, Dept Physiol, Valencia, Spain.	juan.sastre@uv.es	serviddio, gaetano/C-7629-2011; Pérez, Salvador/N-5943-2014; Miralles, Miguel A Asensi/I-2756-2015; Pereda, Javier/N-2424-2014	serviddio, gaetano/0000-0002-6424-7841; Pérez, Salvador/0000-0003-0766-1744; Miralles, Miguel A Asensi/0000-0003-1922-7777; Pereda, Javier/0000-0002-8690-8938; Arduini, Alessandro/0000-0002-0038-8741; Escobar, Javier/0000-0002-5044-991X	Spanish Ministry of Science and Innovation [SAF2009-09500, SAF2006-06963, CSD-2007-00020]; FEDER; University of Valencia [UV-INV-AE11-42462]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); University of Valencia	This work was supported by grants (SAF2009-09500, SAF2006-06963, and CSD-2007-00020) from the Spanish Ministry of Science and Innovation together with FEDER funds to JS and grant UV-INV-AE11-42462 from the University of Valencia to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsfasser G, 2002, DIGEST DIS SCI, V47, P1793, DOI 10.1023/A:1016496612906; Araki H, 2008, GUT, V57, P1431, DOI 10.1136/gut.2007.135665; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; BANERJEE M, 1992, AM J PHYSIOL, V263, pH660, DOI 10.1152/ajpheart.1992.263.3.H660; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; CLEARY MP, 1980, AM J PHYSIOL, V238, pE284, DOI 10.1152/ajpendo.1980.238.3.E284; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Crosswhite P, 2010, J HYPERTENS, V28, P201, DOI 10.1097/HJH.0b013e328332bcdb; Davies SS, 2011, FREE RADICAL BIO MED, V50, P559, DOI 10.1016/j.freeradbiomed.2010.11.023; de Dios I, 2006, J PATHOL, V210, P234, DOI 10.1002/path.2037; De Waele B, 2006, PANCREAS, V32, P343, DOI 10.1097/01.mpa.0000220857.55378.7b; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; deVries JE, 1997, J LIPID RES, V38, P1384; Ellis MP, 2009, BRIT J SURG, V96, P74, DOI 10.1002/bjs.6414; Escobar J, 2009, CURR PHARM DESIGN, V15, P3027, DOI 10.2174/138161209789058075; Folch E, 1999, ANN SURG, V230, P792, DOI 10.1097/00000658-199912000-00008; Folch E, 2000, FREE RADICAL BIO MED, V28, P1286, DOI 10.1016/S0891-5849(00)00245-8; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Fujita M, 2001, PANCREAS, V22, P409, DOI 10.1097/00006676-200105000-00012; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gutierrez PT, 2008, GUT, V57, P642, DOI 10.1136/gut.2007.127472; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; LEE PC, 1979, SURG GYNECOL OBSTET, V148, P39; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lu KK, 2003, FASEB J, V17, pA56, DOI 10.1096/fj.01-0752fje; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinez J, 2006, PANCREATOLOGY, V6, P206, DOI 10.1159/000092104; Martinez J, 1999, PANCREAS, V19, P15, DOI 10.1097/00006676-199907000-00002; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Mohler ER, 1996, BIOCHEM BIOPH RES CO, V225, P915, DOI 10.1006/bbrc.1996.1272; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Mueed I, 2008, J THORAC CARDIOV SUR, V135, P131, DOI 10.1016/j.jtcvs.2007.06.023; Murr MM, 2002, J SURG RES, V106, P308, DOI 10.1006/jsre.2002.6474; NEUSCHWANDERTETRI BA, 1992, J CLIN INVEST, V89, P109, DOI 10.1172/JCI115550; NIEDERAU C, 1988, GASTROENTEROLOGY, V95, P1648, DOI 10.1016/S0016-5085(88)80091-X; Niederau C, 1996, FREE RADICAL BIO MED, V20, P877, DOI 10.1016/0891-5849(95)02153-1; Odinokova IV, 2009, GUT, V58, P431, DOI 10.1136/gut.2007.147207; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Papachristou GI, 2006, PANCREATOLOGY, V6, P279, DOI 10.1159/000092689; PAPPAS TN, 1981, CLIN CHEM, V27, P358; Pereda J, 2008, FREE RADICAL BIO MED, V44, P1599, DOI 10.1016/j.freeradbiomed.2008.01.018; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pfister SL, 2011, AM J PHYSIOL-HEART C, V300, pH2064, DOI 10.1152/ajpheart.01135.2010; Platell C, 2001, J GASTROEN HEPATOL, V16, P689, DOI 10.1046/j.1440-1746.2001.02497.x; PORTER KA, 1991, INT J PANCREATOL, V10, P247; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ramudo L, 2005, CRIT CARE MED, V33, P143, DOI 10.1097/01.CCM.0000150654.13653.5B; Satoh A, 1999, PANCREAS, V19, P268, DOI 10.1097/00006676-199910000-00007; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; SCHOENBERG MH, 1992, FREE RADICAL BIO MED, V12, P515, DOI 10.1016/0891-5849(92)90104-O; Segersvaerd R, 2008, OBESITY, V16, P23, DOI 10.1038/oby.2007.27; Segersvard R, 2001, SCAND J GASTROENTERO, V36, P658, DOI 10.1080/003655201750163213; Sempere L, 2008, PANCREATOLOGY, V8, P257, DOI 10.1159/000134273; Sennello JA, 2008, P NATL ACAD SCI USA, V105, P8085, DOI 10.1073/pnas.0804091105; Takacs P, 2001, FASEB J, V15, P279; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; TOSKES PP, 1990, GASTROENTEROL CLIN N, V19, P783; TRAYHURN P, 1984, CLIN ENDOCRINOL META, V13, P451, DOI 10.1016/S0300-595X(84)80033-X; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Wang Y, 2009, GUT, V58, P422, DOI 10.1136/gut.2007.146258; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; WONG SHY, 1987, CLIN CHEM, V33, P214; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Zhang XP, 2008, DIGEST DIS SCI, V53, P297, DOI 10.1007/s10620-007-9866-5	69	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44383	10.1371/journal.pone.0044383	http://dx.doi.org/10.1371/journal.pone.0044383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028532	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900024
J	Lahtz, C; Bates, SE; Jiang, Y; Li, AX; Wu, XW; Hahn, MA; Pfeifer, GP				Lahtz, Christoph; Bates, Steven E.; Jiang, Yong; Li, Arthur X.; Wu, Xiwei; Hahn, Maria A.; Pfeifer, Gerd P.			Gamma Irradiation Does Not Induce Detectable Changes in DNA Methylation Directly following Exposure of Human Cells	PLOS ONE			English	Article							BIOLOGICAL HALF-LIFE; IONIZING-RADIATION; INDUCED MUTATIONS; CANCER INCIDENCE; GENE-EXPRESSION; HYPERMETHYLATION; RADIOTHERAPY; CARCINOMA; CS-137; ASSAY	Environmental chemicals and radiation have often been implicated in producing alterations of the epigenome thus potentially contributing to cancer and other diseases. Ionizing radiation, released during accidents at nuclear power plants or after atomic bomb explosions, is a potentially serious health threat for the exposed human population. This type of high-energy radiation causes DNA damage including single- and double-strand breaks and induces chromosomal rearrangements and mutations, but it is not known if ionizing radiation directly induces changes in the epigenome of irradiated cells. We treated normal human fibroblasts and normal human bronchial epithelial cells with different doses of gamma-radiation emitted from a cesium 137 (Cs-137) radiation source. After a seven-day recovery period, we analyzed global DNA methylation patterns in the irradiated and control cells using the methylated-CpG island recovery assay (MIRA) in combination with high-resolution microarrays. Bioinformatics analysis revealed only a small number of potential methylation changes with low fold-difference ratios in the irradiated cells. These minor methylation differences seen on the microarrays could not be verified by COBRA (combined bisulfite restriction analysis) or bisulfite sequencing of selected target loci. Our study shows that acute gamma-radiation treatment of two types of human cells had no appreciable direct effect on DNA cytosine methylation patterns in exposed cells.	[Lahtz, Christoph; Bates, Steven E.; Jiang, Yong; Hahn, Maria A.; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA USA; [Li, Arthur X.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA; [Wu, Xiwei] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope	Lahtz, C (corresponding author), City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA USA.	gpfeifer@coh.org		Lahtz, Christoph/0000-0002-0432-9773; Jiang, Yong/0000-0002-1198-1807	U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA [W911QY-10-C-0176]	U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA	This material is based upon work supported by the U.S. Army RDECOM Acquisition Center, Natick Contracting Division, Natick, MA under Contract No. W911QY-10-C-0176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Charles M, 2001, J Radiol Prot, V21, P83, DOI 10.1088/0952-4746/21/1/609; Cologne JE, 1999, RADIAT RES, V152, P364, DOI 10.2307/3580221; CRYER MA, 1972, HEALTH PHYS, V23, P394; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; FELDBERG RS, 1981, INT J RADIAT BIOL, V40, P11, DOI 10.1080/713858228; Fornace AJ, 1999, GENE EXPRESSION, V7, P387; Gilbert ES, 2000, RADIAT RES, V154, P246, DOI 10.1667/0033-7587(2000)154[0246:LCIMW]2.0.CO;2; Goans RE, 2005, HEALTH PHYS, V89, P505, DOI 10.1097/01.HP.0000172144.94491.84; HASANEN E, 1971, ANN CLIN RES, V3, P236; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KLEINERMAN RA, 1995, CANCER, V76, P442, DOI 10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L; Kodama Y., 2012, INT J RAD BIOL; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; MARKOWITZ EH, 1970, GENETICS, V64, P313; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Rauch TA, 2010, METHODS, V52, P213, DOI 10.1016/j.ymeth.2010.03.004; Rauch Tibor A., 2009, V507, P65, DOI 10.1007/978-1-59745-522-0_6; Ron E, 1998, RADIAT RES, V150, pS30, DOI 10.2307/3579806; Ron E, 1999, INT J CANCER, V82, P795, DOI 10.1002/(SICI)1097-0215(19990909)82:6<795::AID-IJC4>3.3.CO;2-B; Sont WN, 2001, AM J EPIDEMIOL, V153, P309, DOI 10.1093/aje/153.4.309; Spotheim-Maurizot M, 2010, MUTAT RES, V711, P41; Stohl A., 2011, ATMOS CHEM PHYS DISC, V11, P28319, DOI DOI 10.5194/ACPD-11-28319-2011; Vizir IY, 1999, J HERED, V90, P412, DOI 10.1093/jhered/90.3.412; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yap J, 2002, INT J RADIAT ONCOL, V52, P1231, DOI 10.1016/S0360-3016(01)02799-7; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yeh HC, 2001, AM J EPIDEMIOL, V153, P749, DOI 10.1093/aje/153.8.749	37	27	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44858	10.1371/journal.pone.0044858	http://dx.doi.org/10.1371/journal.pone.0044858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024770	Green Submitted, gold, Green Published			2022-12-25	WOS:000308860100028
J	Ruhwald, M; Andersen, ES; Christensen, PB; Moessner, BK; Weis, N				Ruhwald, Morten; Andersen, Ellen Sloth; Christensen, Peer Brehm; Moessner, Belinda Klemmensen; Weis, Nina			IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection	PLOS ONE			English	Article							PREDICTIVE-VALUE; LIVER FIBROSIS; BLOOD SPOTS; VIRUS-RNA; HCV; INFLAMMATION; CHEMOKINES; CORRELATE	The chemokine IP-10 (CXCL10) is a candidate marker for hepatitis C virus (HCV) fibrosis monitoring. The aim of this proof-ofconcept study is to assess if IP-10 measurements from dried plasma spots (DPS) are accurate in HCV-infected patients with either minimal or significant fibrosis. We measured IP-10 levels in plasma and DPS of 21 HCV-infected patients with cirrhosis and 19 patients with no/little fibrosis (determined with FibroScan). Cirrhotic patients had significantly higher levels of IP-10 compared to patients with minimal fibrosis. DPS and plasma measurements of IP-10 are comparable and the correlation was excellent (r(2) = 0.97, p<0.0001). The DPS based method for IP-10 detection performs well in HCV-infected patients with either minimal or significant fibrosis.	[Ruhwald, Morten] Copenhagen Univ Hosp, Clin Res Ctr, Copenhagen, Denmark; [Andersen, Ellen Sloth; Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Andersen, Ellen Sloth] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Christensen, Peer Brehm; Moessner, Belinda Klemmensen] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Ruhwald, M (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Copenhagen, Denmark.	mruhwald@gmail.com	Ruhwald, Morten/E-5757-2012; Weis, Nina/GLT-4232-2022; Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X; Weis, Nina/0000-0002-3133-2724	Danish National Advanced Technology Foundation	Danish National Advanced Technology Foundation	The work was supported by the Danish National Advanced Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Lai M, 2011, AM J GASTROENTEROL, V106, P2121, DOI 10.1038/ajg.2011.343; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Reiberger T, 2008, ANTIVIR THER, V13, P969; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	22	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45181	10.1371/journal.pone.0045181	http://dx.doi.org/10.1371/journal.pone.0045181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024806	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100064
J	Li, J; Ang, M; Cheung, CMG; Vania, M; Chan, ASY; Waduthantri, S; Yang, H; Chee, SP				Li, Jing; Ang, Marcus; Cheung, Chui Ming Gemmy; Vania, Maya; Chan, Anita Sook Yee; Waduthantri, Samanthila; Yang, Henry; Chee, Soon Phaik			Aqueous Cytokine Changes Associated with Posner-Schlossman Syndrome with and without Human Cytomegalovirus	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTERIOR UVEITIS; IMMUNOCOMPETENT PATIENTS; INFECTION; HUMOR; PROFILES; IL-10; REACTIVATION; EXPRESSION; LATENCY	Aim: To study the differences in aqueous cytokines in Posner-Schlossman Syndrome (PSS) patients with and without human cytomegalovirus (CMV) DNA in the aqueous humor. Methods: This is a prospective study. Fifty-three uveitis patients with clinical signs of PSS were enrolled and aqueous humor samples were collected. Fourteen PSS patients were positive of CMV DNA in the aqueous by polymerase chain reaction (PCR) analysis. These eyes were negative of common ocular pathogens such as herpes simplex virus, varicella-zoster virus, rubella virus and toxoplasma. Twenty-five otherwise healthy cataract patients were enrolled as controls. Cytokine concentration was measured by a magnetic color-bead-based multiplex assay and analyzed using statistical and classification approaches. Results: The average age of 53 PSS patients was 48.74 +/- 13.43 years (yrs) (mean 6 standard deviation) and 66.3 +/- 15.0 yrs for the controls. The median CMV viral DNA copy number was 26000/mL aqueous (range 1400 to 85000 copies/mL) in 14 CMV positive patients as determined by quantitative PCR. PSS aqueous had significantly higher Interleukin (IL)-8 (CXCL8), monocyte chemotactic protein-1 (CCL2), macrophage inhibitory protein 1-beta (CCL4), granulocyte colony-stimulating factor (GCSF) and transforming growth factor-beta (TGF-beta) levels than controls after adjusted by age and gender. IL-2, IL-12, tumor necrosis factor-alpha (TNF-alpha) and interferon-alpha (IFN-alpha) levels were significantly lower in PSS aqueous than controls. No difference between CMV positive PSS and CMV negative PSS aqueous was observed. Over 97% of PSS samples were distinguished from controls by elevated CXCL10 (> 500 ng/mL), CXCL8 (> 30 ng/mL) and CCL2 (> 60 ng/mL) levels. Conclusion: PSS eyes were characterized by elevated aqueous chemokine concentration. The presence of CMV viral DNA was not associated with significant change of the type of cytokine expression in PSS patients.	[Li, Jing; Ang, Marcus; Vania, Maya; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Li, Jing] Singapore Eye Res Inst, Ocular Inflammat Grp, Singapore, Singapore; [Ang, Marcus; Cheung, Chui Ming Gemmy; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Singapore Natl Eye Ctr, Ocular Inflammat Serv, Singapore, Singapore; [Ang, Marcus; Cheung, Chui Ming Gemmy; Chan, Anita Sook Yee; Waduthantri, Samanthila; Chee, Soon Phaik] Singapore Natl Eye Ctr, Serv Immunol, Singapore, Singapore; [Yang, Henry] Canc Sci Inst Singapore, Singapore, Singapore; [Chee, Soon Phaik] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Chan, Anita Sook Yee] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore	Shanghai Jiao Tong University; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Singapore General Hospital	Li, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China.	chee.soon.phaik@snec.com.sg		Cheung, Chui Ming Gemmy/0000-0003-3358-3516	Singapore Biomedical Research Council [SigN 09-026]; Singapore National Medical Research Council [NMRC/EDG/0050/2009, NMRC/CG/SERI/2010]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council(National Medical Research Council, Singapore)	This study was supported by grants from Singapore Biomedical Research Council (SigN 09-026), Singapore National Medical Research Council (NMRC/EDG/0050/2009) and centre grant (NMRC/CG/SERI/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2006, AM J OPHTHALMOL, V142, P429, DOI 10.1016/j.ajo.2006.04.016; Anshu A, 2009, OPHTHALMOLOGY, V116, P624, DOI 10.1016/j.ophtha.2008.10.031; Calder VL, 1999, INVEST OPHTH VIS SCI, V40, P2019; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chee SP, 2010, BRIT J OPHTHALMOL, V94, P1648, DOI 10.1136/bjo.2009.167767; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Chee SP, 2007, OPHTHALMOLOGY, V114, P798, DOI 10.1016/j.ophtha.2006.07.057; Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001; Chee SP, 2011, GRAEFES ARCH CLIN EX; Cheung CMG, 2012, MOL VIS, V18, P830; Chua J, 2012, MOL VIS, V18, P431; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; El-Asrar AM, 2011, CLIN IMMUNOL; Hwang YS, 2011, GRAEF ARCH CLIN EXP, V249, P103, DOI 10.1007/s00417-010-1510-y; Hwang YS, 2010, GRAEF ARCH CLIN EXP, V248, P263, DOI 10.1007/s00417-009-1195-2; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kongyai N, 2012, EYE LOND; Kuchtey J, 2010, INVEST OPHTH VIS SCI, V51, P6441, DOI 10.1167/iovs.10-5216; Lacomba MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P768, DOI 10.1001/archopht.118.6.768; Lahmar I, 2009, J INFECT DIS, V199, P1239, DOI 10.1086/597478; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Miyanaga M, 2010, BRIT J OPHTHALMOL, V94, P336, DOI 10.1136/bjo.2008.156422; Muhaya M, 1998, CLIN EXP IMMUNOL, V111, P123; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Toro AI, 1996, RES VIROLOGY, V147, P233, DOI 10.1016/0923-2516(96)89654-3; van Boxtel LAA, 2007, OPHTHALMOLOGY, V114, P1358, DOI 10.1016/j.ophtha.2006.09.035; Verdonk RC, 2010, AM J PATHOL, V176, P3098, DOI 10.2353/ajpath.2010.100101; von Muller L, 2008, MED MICROBIOL IMMUN, V197, P75, DOI 10.1007/s00430-008-0087-0; Yamauchi Y, 2007, OCUL IMMUNOL INFLAMM, V15, P399, DOI 10.1080/09273940701486795; Zamir E, 2011, CLIN EXP OPHTHALMOL, V39, P913, DOI 10.1111/j.1442-9071.2011.02577.x	38	41	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44453	10.1371/journal.pone.0044453	http://dx.doi.org/10.1371/journal.pone.0044453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028541	gold, Green Published, Green Submitted			2022-12-25	WOS:000308788700020
J	Okano, J; Levy, C; Lichti, U; Sun, HW; Yuspa, SH; Sakai, Y; Morasso, MI				Okano, Junko; Levy, Clara; Lichti, Ulrike; Sun, Hong-Wei; Yuspa, Stuart H.; Sakai, Yasuo; Morasso, Maria I.			Cutaneous Retinoic Acid Levels Determine Hair Follicle Development and Downgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN ACTIVITY; DERMAL PAPILLA CELLS; GENE-EXPRESSION; SEBACEOUS GLAND; THYROID-HORMONE; SONIC HEDGEHOG; KERATIN GENE; RNA-SEQ; DIFFERENTIATION; GROWTH	Retinoic acid (RA) is essential during embryogenesis and for tissue homeostasis, whereas excess RA is well known as a teratogen. In humans, excess RA is associated with hair loss. In the present study, we demonstrate that specific levels of RA, regulated by Cyp26b1, one of the RA-degrading enzymes, are required for hair follicle (hf) morphogenesis. Mice with embryonic ablation of Cyp26b1 (Cyp26b1(-/-)) have excessive endogenous RA, resulting in arrest of hf growth at the hair germ stage. The altered hf development is rescued by grafting the mutant skin on immunodeficient mice. Our results show that normalization of RA levels is associated with reinitiation of hf development. Conditional deficiency of Cyp26b1 in the dermis (En1Cre; Cyp26b1f/-) results in decreased hair follicle density and specific effect on hair type, indicating that RA levels also influence regulators of hair bending. Our results support the model of RA-dependent dermal signals regulating hf downgrowth and bending. To elucidate target gene pathways of RA, we performed microarray and RNA-Seq profiling of genes differentially expressed in Cyp26b1(-/-) skin and En1Cre; Cyp26b1f/- tissues. We show specific effects on the Wnt-catenin pathway and on members of the Runx, Fox, and Sox transcription factor families, indicating that RA modulates pathways and factors implicated in hf downgrowth and bending. Our results establish that proper RA distribution is essential for morphogenesis, development, and differentiation of hfs.	[Okano, Junko; Levy, Clara; Morasso, Maria I.] NIAMS, Dev Skin Biol Sect, NIH, Bethesda, MD 20892 USA; [Lichti, Ulrike; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Sakai, Yasuo] Osaka Univ, Dept Plast Surg, Sch Med, Suita, Osaka 5650871, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Osaka University	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Sect, NIH, 50 South Dr,Rm 1523, Bethesda, MD 20892 USA.	morassom@mail.nih.gov		Meaders, Clara/0000-0002-4620-141X	National Institutes of Health grant from the Intramural Research Program of the NIAMS; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZICAR041186, ZIAAR041171] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program of the NIAMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a National Institutes of Health grant from the Intramural Research Program of the NIAMS.	Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Brancaccio A, 2004, HUM MOL GENET, V13, P2595, DOI 10.1093/hmg/ddh292; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010009; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Duverger O, 2009, BIRTH DEFECTS RES C, V87, P263, DOI 10.1002/bdrc.20158; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Everts HB, 2012, BBA-MOL CELL BIOL L, V1821, P222, DOI 10.1016/j.bbalip.2011.08.017; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hembree JR, 1996, J CELL PHYSIOL, V167, P556, DOI 10.1002/(SICI)1097-4652(199606)167:3<556::AID-JCP19>3.0.CO;2-1; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morasso MI, 2010, METHODS MOL BIOL, V585, P253, DOI 10.1007/978-1-60761-380-0_17; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Ohtsuki Mamitaro, 1992, Journal of Dermatology (Tokyo), V19, P774; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Schlake T, 2006, MECH DEVELOP, V123, P641, DOI 10.1016/j.mod.2006.06.001; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; TOMICCANIC M, 1992, J INVEST DERMATOL, V99, P842, DOI 10.1111/1523-1747.ep12614806; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Widelitz Randall B, 2008, Organogenesis, V4, P123; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005	54	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397273	http://dx.doi.org/10.1074/jbc.M112.397273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007396	Green Published, hybrid			2022-12-25	WOS:000311233800003
J	Plenge, P; Shi, L; Beuming, T; Te, J; Newman, AH; Weinstein, H; Gether, U; Loland, CJ				Plenge, Per; Shi, Lei; Beuming, Thijs; Te, Jerez; Newman, Amy Hauck; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.			Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER-SODIUM SYMPORTER; HIGH-AFFINITY; R-CITALOPRAM; DOPAMINE TRANSPORTER; H-3 IMIPRAMINE; BACTERIAL HOMOLOG; 5-HT TRANSPORTER; IN-VITRO; SITE; SUBSTRATE	The serotonin transporter (SERT) controls synaptic serotonin levels and is the primary target for antidepressants, including selective serotonin reuptake inhibitors (e.g. (S)-citalopram) and tricyclic antidepressants (e.g. clomipramine). In addition to a high affinity binding site, SERT possesses a low affinity allosteric site for antidepressants. Binding to the allosteric site impedes dissociation of antidepressants from the high affinity site, which may enhance antidepressant efficacy. Here we employ an induced fit docking/molecular dynamics protocol to identify the residues that may be involved in the allosteric binding in the extracellular vestibule located above the central substrate binding (S1) site. Indeed, mutagenesis of selected residues in the vestibule reduces the allosteric potency of (S)-citalopram and clomipramine. The identified site is further supported by the inhibitory effects of Zn2+ binding in an engineered site and the covalent attachment of benzocaine-methanethiosulfonate to a cysteine introduced in the extracellular vestibule. The data provide a mechanistic explanation for the allosteric action of antidepressants at SERT and suggest that the role of the vestibule is evolutionarily conserved among neurotransmitter: sodium symporter proteins as a binding pocket for small molecule ligands.	[Shi, Lei; Te, Jerez; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Plenge, Per; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab, DK-2200 Copenhagen, Denmark; [Beuming, Thijs] Schrodinger Inc, New York, NY 10036 USA; [Newman, Amy Hauck] NIDA, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program,Dept Hlth & Human Serv,NIH, Baltimore, MD 21224 USA	Cornell University; Cornell University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shi, L (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	les2007@med.cornell.edu; cllo@sund.ku.dk	Shi, Lei/AAV-1321-2020; Loland, Claus/E-5975-2014; WEINSTEIN, HAREL/O-8245-2019	Shi, Lei/0000-0002-4137-096X; Loland, Claus/0000-0002-1773-1446; WEINSTEIN, HAREL/0000-0003-3473-9818; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [DA12408, DA023694]; National Institutes of Health, NIDA, Intramural Research Program; Danish Independent Research Council-Sapere Aude; Danish Health Science Research Council; Lundbeck Foundation; Novo Nordic Foundation; Maersk Foundation; BioSCART center of excellence program; Lundbeck A/S; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDA, Intramural Research Program; Danish Independent Research Council-Sapere Aude; Danish Health Science Research Council; Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Maersk Foundation; BioSCART center of excellence program; Lundbeck A/S; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA12408 (to U. G. and H. W.) and DA023694 (to L. S.) and the National Institutes of Health, NIDA, Intramural Research Program (to A. H. N.). This work was also supported in part by the Danish Independent Research Council-Sapere Aude (to C. J. L.), the Danish Health Science Research Council (to C. J. L. and U. G.), the Lundbeck Foundation (to C. J. L. and U. G.), the Novo Nordic Foundation (to C. J. L. and U. G.), the Maersk Foundation (to C. J. L.), the BioSCART center of excellence program (to C. J. L. and U. G.), and Lundbeck A/S (to P. P.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Bowers K.J., 2006, SCALABLE ALGORITHMS; Chen FH, 2005, EUR NEUROPSYCHOPHARM, V15, P193, DOI 10.1016/j.euroneuro.2004.08.008; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; El Mansari M, 2007, INT J NEUROPSYCHOPH, V10, P31, DOI 10.1017/S1461145705006462; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mnie-Filali O, 2007, NEUROREPORT, V18, P1553, DOI 10.1097/WNR.0b013e3282f04047; Mork A, 2003, NEUROPHARMACOLOGY, V45, P167, DOI 10.1016/S0028-3908(03)00138-2; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; PLENGE P, 1991, EUR J PHARM-MOLEC PH, V206, P243, DOI 10.1016/S0922-4106(05)80025-2; PLENGE P, 1985, EUR J PHARMACOL, V119, P1, DOI 10.1016/0014-2999(85)90314-0; Plenge P, 1997, PHARMACOL TOXICOL, V80, P197, DOI 10.1111/j.1600-0773.1997.tb00396.x; Plenge P, 2007, EUR J PHARMACOL, V567, P1, DOI 10.1016/j.ejphar.2007.03.055; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Roth B L, 1994, Ann Clin Psychiatry, V6, P67, DOI 10.3109/10401239409148985; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sanchez C, 2004, PSYCHOPHARMACOLOGY, V174, P163, DOI 10.1007/s00213-004-1865-z; Sanchez C, 2006, BASIC CLIN PHARMACOL, V99, P91, DOI 10.1111/j.1742-7843.2006.pto_295.x; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Sheline YI, 1997, J CLIN PSYCHOPHARM, V17, P11, DOI 10.1097/00004714-199702000-00003; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Storustovu SI, 2004, BRIT J PHARMACOL, V142, P172, DOI 10.1038/sj.bjp.0705738; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; WENNOGLE LP, 1982, EUR J PHARMACOL, V86, P303, DOI 10.1016/0014-2999(82)90333-8; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhong HL, 2009, NEUROSCI LETT, V462, P207, DOI 10.1016/j.neulet.2009.07.030; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	53	71	73	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.371765	http://dx.doi.org/10.1074/jbc.M112.371765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007398	Green Published, hybrid			2022-12-25	WOS:000311233800004
J	Kim, IH; Carlson, BR; Heindel, CC; Kim, H; Soderling, SH				Kim, Il Hwan; Carlson, Benjamin R.; Heindel, Clifford C.; Kim, Hyun; Soderling, Scott H.			Disruption of Wave-associated Rac GTPase-activating Protein (Wrp) Leads to Abnormal Adult Neural Progenitor Migration Associated with Hydrocephalus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CHOROID-PLEXUS FUNCTION; F-BAR DOMAIN; STEM-CELLS; NEURONAL MIGRATION; FACTOR RECEPTOR; BRAIN; EXPRESSION; DAMAGE; MICE	Hydrocephalus is the most common developmental disability and leading cause of brain surgery for children. Current treatments are limited to surgical intervention, as the factors that contribute to the initiation of hydrocephalus are poorly understood. Here, we describe the development of obstructive hydrocephalus in mice that are null for Wrp (Srgap3). Wrp is highly expressed in the ventricular stem cell niche, and it is a gene required for cytoskeletal organization and is associated with syndromic and psychiatric disorders in humans. During the postnatal period of progenitor cell expansion and ventricular wall remodeling, loss of Wrp results in the abnormal migration of lineage-tagged cells from the ventricular region into the corpus callosum. Within this region, mutant progenitors appear to give rise to abnormal astroglial cells and induce periventricular lesions and hemorrhage that leads to cerebral aqueductal occlusion. These results indicate that periventricular abnormalities arising from abnormal migration from the ventricular niche can be an initiating cause of noncommunicating hydrocephalus.	[Kim, Il Hwan; Carlson, Benjamin R.; Heindel, Clifford C.; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Duke University; Korea University; Korea University Medicine (KU Medicine)	Soderling, SH (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	s.soderling@cellbio.duke.edu		Kim, Hyun/0000-0002-7210-5798; Carlson, Benjamin/0000-0002-9797-3196	National Institutes of Health [R01 NS059957]; March of Dimes [6-FY10-289]; Duke Neonatal-Perinatal Research Institute award; Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Duke Neonatal-Perinatal Research Institute award; Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS059957. This work was also supported by March of Dimes Grant 6-FY10-289, a Duke Neonatal-Perinatal Research Institute award (to S. H. S.), and by a Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award (to I. K.).	Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Beni-Adani L, 2006, CHILD NERV SYST, V22, P1543, DOI 10.1007/s00381-006-0193-5; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Craig CG, 1996, J NEUROSCI, V16, P2649; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hatano M, 2005, NEOPLASIA, V7, P717, DOI 10.1593/neo.05277; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Kanno S, 2011, J NEUROL, V258, P1949, DOI 10.1007/s00415-011-6038-5; Kariya S, 2000, INT J PEDIATR OTORHI, V56, P71, DOI 10.1016/S0165-5876(00)00409-2; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; Mendoza-Torreblanca JG, 2008, NEUROSCI RES, V60, P289, DOI 10.1016/j.neures.2007.11.013; Ohmiya M, 2001, J NEUROSCI RES, V65, P228, DOI 10.1002/jnr.1146; Rolf B, 2001, BRAIN RES, V891, P247, DOI 10.1016/S0006-8993(00)03219-4; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; WELLER RO, 1975, ARCH DIS CHILD, V50, P763, DOI 10.1136/adc.50.10.763; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	50	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39263	39274		10.1074/jbc.M112.398834	http://dx.doi.org/10.1074/jbc.M112.398834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007397	Green Published, hybrid			2022-12-25	WOS:000310982800081
J	Lin, TY; Werther, T; Jeoung, JH; Dobbek, H				Lin, Tzong-Yuan; Werther, Tobias; Jeoung, Jae-Hun; Dobbek, Holger			Suppression of Electron Transfer to Dioxygen by Charge Transfer and Electron Transfer Complexes in the FAD-dependent Reductase Component of Toluene Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; PSEUDOMONAS-PUTIDA; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; BINDING-SITE; PURIFICATION; MECHANISM; ENZYME; ELECTROSTATICS; FERREDOXINTOL	The three-component toluene dioxygenase system consists of an FAD-containing reductase, a Rieske-type [2Fe-2S] ferredoxin, and a Rieske-type dioxygenase. The task of the FAD-containing reductase is to shuttle electrons from NADH to the ferredoxin, a reaction the enzyme has to catalyze in the presence of dioxygen. We investigated the kinetics of the reductase in the reductive and oxidative half-reaction and detected a stable charge transfer complex between the reduced reductase and NAD(+) at the end of the reductive half-reaction, which is substantially less reactive toward dioxygen than the reduced reductase in the absence of NAD(+). A plausible reason for the low reactivity toward dioxygen is revealed by the crystal structure of the complex between NAD(+) and reduced reductase, which shows that the nicotinamide ring and the protein matrix shield the reactive C4a position of the isoalloxazine ring and force the tricycle into an atypical planar conformation, both factors disfavoring the reaction of the reduced flavin with dioxygen. A rapid electron transfer from the charge transfer complex to electron acceptors further reduces the risk of unwanted side reactions, and the crystal structure of a complex between the reductase and its cognate ferredoxin shows a short distance between the electron-donating and -accepting cofactors. Attraction between the two proteins is likely mediated by opposite charges at one large patch of the complex interface. The stability, specificity, and reactivity of the observed charge transfer and electron transfer complexes are thought to prevent the reaction of reductase(TOL) with dioxygen and thus present a solution toward conflicting requirements.	[Lin, Tzong-Yuan; Werther, Tobias; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Dobbek, H (corresponding author), Humboldt Univ, Inst Biol, Unter Linden 6, D-10115 Berlin, Germany.	Holger.Dobbek@biologie.hu-berlin.de		Lin, Tzong-Yuan/0000-0002-0708-8127	Deutsche Forschungsgemeinschaft [DO 785/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DO 785/2-2 (to H. D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Crowley PB, 2003, ACCOUNTS CHEM RES, V36, P723, DOI 10.1021/ar0200955; Crowley PB, 2004, PROTEINS, V55, P603, DOI 10.1002/prot.20043; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friemann R, 2009, ACTA CRYSTALLOGR D, V65, P24, DOI 10.1107/S0907444908036524; Frisch MJ, 2003, GAUSSIAN03; GIBSON DT, 1968, BIOCHEMISTRY-US, V7, P2653, DOI 10.1021/bi00847a031; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KARPLUS PA, 1989, EUR J BIOCHEM, V178, P693, DOI 10.1111/j.1432-1033.1989.tb14500.x; Lee K, 2005, ACTA CRYSTALLOGR F, V61, P669, DOI 10.1107/S1744309105017549; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Sambrook J, 2001, MOL CLONING LAB MANU; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Senda T, 2009, ANTIOXID REDOX SIGN, V11, P1741, DOI 10.1089/ARS.2008.2348; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2009, J MOL BIOL, V390, P924, DOI 10.1016/j.jmb.2009.05.013; STRICKLAND S, 1973, J BIOL CHEM, V248, P2953; SUBRAMANIAN V, 1981, J BIOL CHEM, V256, P2723; SUBRAMANIAN V, 1985, J BIOL CHEM, V260, P2355; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898	35	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.374918	http://dx.doi.org/10.1074/jbc.M112.374918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992736	Green Published, hybrid			2022-12-25	WOS:000310642200066
J	Fujiwara, T; Yokoyama, H; Okitsu, Y; Kamata, M; Fukuhara, N; Onishi, Y; Fujimaki, S; Takahashi, S; Ishizawa, K; Bresnick, EH; Harigae, H				Fujiwara, Tohru; Yokoyama, Hisayuki; Okitsu, Yoko; Kamata, Mayumi; Fukuhara, Noriko; Onishi, Yasushi; Fujimaki, Shinichi; Takahashi, Shinichiro; Ishizawa, Kenichi; Bresnick, Emery H.; Harigae, Hideo			Gene Expression Profiling Identifies HOXB4 as a Direct Downstream Target of GATA-2 in Human CD34+Hematopoietic Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-2; SEVERE APLASTIC-ANEMIA; NF-Y; STIMULATING FACTOR; DIFFERENTIATION; PROLIFERATION; EXPANSION; PROMOTER; GROWTH	Aplastic anemia is characterized by a reduced hematopoietic stem cell number. Although GATA-2 expression was reported to be decreased in CD34-positive cells in aplastic anemia, many questions remain regarding the intrinsic characteristics of hematopoietic stem cells in this disease. In this study, we identified HOXB4 as a downstream target of GATA-2 based on expression profiling with human cord blood-derived CD34-positive cells infected with control or GATA-2 lentiviral shRNA. To confirm the functional link between GATA-2 and HOXB4, we conducted GATA-2 gain-of-function and loss-of-function experiments, and HOXB4 promoter analysis, including luciferase assay, in vitro DNA binding analysis and quantitative ChIP analysis, using K562 and CD34-positive cells. The analyses suggested that GATA-2 directly regulates HOXB4 expression through the GATA sequence in the promoter region. Furthermore, we assessed GATA-2 and HOXB4 expression in CD34-positive cells from patients with aplastic anemia (n = 10) and idiopathic thrombocytopenic purpura (n = 13), and demonstrated that the expression levels of HOXB4 and GATA-2 were correlated in these populations (r = 0.6573, p<0.01). Our results suggested that GATA-2 directly regulates HOXB4 expression in hematopoietic stem cells, which may play an important role in the development and/or progression of aplastic anemia.	[Fujiwara, Tohru; Yokoyama, Hisayuki; Okitsu, Yoko; Kamata, Mayumi; Fukuhara, Noriko; Onishi, Yasushi; Fujimaki, Shinichi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Yokoyama, Hisayuki] Sendai Med Ctr, Dept Hematol, Sendai, Miyagi, Japan; [Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Sagamihara, Kanagawa 228, Japan; [Bresnick, Emery H.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Inst Med Res, Dept Cell & Regenerat Biol, Madison, WI USA	Tohoku University; Kitasato University; University of Wisconsin System; University of Wisconsin Madison	Harigae, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	harigae@med.tohoku.ac.jp	Fujiwara, Tohru/GOG-9775-2022; 寿行, 横山/AAF-7015-2019; Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065; Yokoyama, Hisayuki/0000-0001-7658-0687				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; CAMITTA BM, 1976, BLOOD, V48, P63; Cassel DL, 2000, BLOOD CELL MOL DIS, V26, P587, DOI 10.1006/bcmd.2000.0337; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fan R, 2012, BLOOD IN PRESS; Fang XD, 2004, J BIOL CHEM, V279, P5444, DOI 10.1074/jbc.M306241200; Fujimaki S, 2001, BRIT J HAEMATOL, V113, P52, DOI 10.1046/j.1365-2141.2001.02736.x; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2006, BRIT J HAEMATOL, V135, P583, DOI 10.1111/j.1365-2141.2006.06340.x; Giannola DM, 2000, J EXP MED, V192, P1479, DOI 10.1084/jem.192.10.1479; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Harigae H, 2006, INT J HEMATOL, V84, P38, DOI 10.1532/IJH97.06020; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jiang J, 2010, BLOOD, V116, P711, DOI 10.1182/blood-2009-07-235341; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kirito K, 2003, BLOOD, V102, P3172, DOI 10.1182/blood-2003-03-0944; Klump H, 2005, ANN NY ACAD SCI, V1044, P6, DOI 10.1196/annals.1349.002; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Lee HM, 2010, BLOOD, V116, P720, DOI 10.1182/blood-2009-11-253872; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Mitsuma A, 2005, BBA-GENE STRUCT EXPR, V1727, P125, DOI 10.1016/j.bbaexp.2004.12.007; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Oshima M, 2011, BLOOD, V117, pE142, DOI 10.1182/blood-2010-12-323212; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; Tang Y, 2009, BRIT J HAEMATOL, V144, P603, DOI 10.1111/j.1365-2141.2008.07509.x; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Xu YY, 2009, EXP HEMATOL, V37, P1393, DOI 10.1016/j.exphem.2009.09.005; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 2010, BIOL BLOOD MARROW TR, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e40959	10.1371/journal.pone.0040959	http://dx.doi.org/10.1371/journal.pone.0040959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028422	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700001
J	Larena, M; Regner, M; Lobigs, M				Larena, Maximilian; Regner, Matthias; Lobigs, Mario			The Chemokine Receptor CCR5, a Therapeutic Target for HIV/AIDS Antagonists, Is Critical for Recovery in a Mouse Model of Japanese Encephalitis	PLOS ONE			English	Article							WEST-NILE-VIRUS; CD8(+) T-CELLS; MHC CLASS-I; GLYCOSAMINOGLYCAN-BINDING VARIANTS; ADAPTIVE IMMUNE-RESPONSES; CCR5-DEFICIENT MICE; UP-REGULATION; FLAVIVIRUS; INFECTION; DEFICIENCY	Japanese encephalitis is a severe central nervous system (CNS) inflammatory disease caused by the mosquito-borne flavivirus, Japanese encephalitis virus (JEV). In the current study we have investigated the immune responses against JEV in mice lacking expression of the chemokine receptor CCR5, which functions in activation and chemotaxis of leukocytes during infection. We show that CCR5 serves as a host antiviral factor against Japanese encephalitis, with CCR5 deficiency markedly increasing mortality, and viral burden in the CNS. Humoral immune responses, which are essential in recovery from JEV infection, were of similar magnitude in CCR5 sufficient and deficient mice. However, absence of CCR5 resulted in a multifaceted deficiency of cellular immune responses characterized by reduced natural killer and CD8(+) T cell activity, low splenic cellularity, and impaired trafficking of leukocytes to the brain. Interestingly, adoptive transfer of immune spleen cells, depleted of B lymphocytes, increased resistance of CCR5-deficient recipient mice against JEV regardless of whether the cells were obtained from CCR5-deficient or wild-type donor mice, and only when transferred at one but not at three days post-challenge. This result is consistent with a mechanism by which CCR5 expression enhances lymphocyte activation and thereby promotes host survival in Japanese encephalitis.	[Larena, Maximilian; Regner, Matthias; Lobigs, Mario] Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia; [Lobigs, Mario] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	Australian National University; John Curtin School of Medical Research; University of Queensland	Lobigs, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia.	Mario.Lobigs@anu.edu.au	lobigs, mario/ABC-5711-2020	larena, maximilian/0000-0003-2327-3063; larena, maximilian/0000-0002-8799-7645				Algood HMS, 2004, J IMMUNOL, V173, P3287; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ank N, 2005, J VIROL, V79, P9831, DOI 10.1128/JVI.79.15.9831-9841.2005; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2003, J VIROL, V77, P191, DOI 10.1128/JVI.77.1.191-198.2003; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Hardison JL, 2006, INFECT IMMUN, V74, P135, DOI 10.1128/IAI.74.1.135-143.2006; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603; KESSON AM, 1987, J GEN VIROL, V68, P2001, DOI 10.1099/0022-1317-68-7-2001; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709; KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535; Klein RS, 2008, J INFECT DIS, V197, P183, DOI 10.1086/524692; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Komatsu K, 2008, CURR EYE RES, V33, P736, DOI 10.1080/02713680802344716; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Larena M, 2011, IMMUNOBIOLOGY JAPANE; Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lim JK, 2006, TRENDS IMMUNOL, V27, P308, DOI 10.1016/j.it.2006.05.007; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Lobigs M, 1996, IMMUNOL REV, V152, P5, DOI 10.1111/j.1600-065X.1996.tb00908.x; Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x; Lobigs M, 2010, J GEN VIROL, V91, P1407, DOI 10.1099/vir.0.019190-0; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; Nansen A, 2002, BLOOD, V99, P1237, DOI 10.1182/blood.V99.4.1237; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Peterson KE, 2004, J VIROL, V78, P6449, DOI 10.1128/JVI.78.12.6449-6458.2004; Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sato N, 1999, J IMMUNOL, V163, P5519; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Souza ALS, 2011, INFECT IMMUN, V79, P1741, DOI 10.1128/IAI.00502-10; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Weiss ID, 2011, CYTOKINE, V54, P249, DOI 10.1016/j.cyto.2011.01.011; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	61	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44834	10.1371/journal.pone.0044834	http://dx.doi.org/10.1371/journal.pone.0044834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028638	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800019
J	Harkonen, T; Harding, KC; Wilson, S; Baimukanov, M; Dmitrieva, L; Svensson, CJ; Goodman, SJ				Harkonen, Tero; Harding, Karin C.; Wilson, Susan; Baimukanov, Mirgaliy; Dmitrieva, Lilia; Svensson, Carl Johan; Goodman, Simon J.			Collapse of a Marine Mammal Species Driven by Human Impacts	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; SOUTHERN CASPIAN SEA; PHOCA-CASPICA; RINGED SEAL; BALTIC SEA; MONK SEAL; MNEMIOPSIS-LEIDYI; TROPHIC CASCADES; POPULATION; CONSEQUENCES	Understanding historical roles of species in ecosystems can be crucial for assessing long term human impacts on environments, providing context for management or restoration objectives, and making conservation evaluations of species status. In most cases limited historical abundance data impedes quantitative investigations, but harvested species may have long-term data accessible from hunting records. Here we make use of annual hunting records for Caspian seals (Pusa caspica) dating back to the mid-19th century, and current census data from aerial surveys, to reconstruct historical abundance using a hind-casting model. We estimate the minimum numbers of seals in 1867 to have been 1-1.6 million, but the population declined by at least 90% to around 100,000 individuals by 2005, primarily due to unsustainable hunting throughout the 20th century. This collapse is part of a broader picture of catastrophic ecological change in the Caspian over the 20th Century. Our results combined with fisheries data show that the current biomass of top predators in the Caspian is much reduced compared to historical conditions. The potential for the Caspian and other similar perturbed ecosystems to sustain natural resources of much greater biological and economic value than at present depends on the extent to which a number of anthropogenic impacts can be harnessed.	[Harkonen, Tero] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Harding, Karin C.; Svensson, Carl Johan] Gothenburg Univ, Dept Marine Ecol, Gothenburg, Sweden; [Wilson, Susan] Tara Seal Res Ctr, Killyleagh, County Down, North Ireland; [Baimukanov, Mirgaliy] Inst Hydrobiol & Ecol, Alma Ata, Kazakhstan; [Dmitrieva, Lilia; Goodman, Simon J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	Swedish Museum of Natural History; University of Gothenburg; Institute of Hydrobiology & Ecology; University of Leeds	Harkonen, T (corresponding author), Swedish Museum Nat Hist, S-10405 Stockholm, Sweden.	tero.harkonen@nrm.se	Harding, Karin/F-9957-2013	Harding, Karin/0000-0003-1527-0903; Goodman, Simon/0000-0003-4118-8575; Svensson, Carl Johan/0000-0002-8265-9313	United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme [162-15-24]; Centre of Theoretical Biology at the University of Gothenburg, Sweden; United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme [162-15-24]; Centre of Theoretical Biology at the University of Gothenburg, Sweden	United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme; Centre of Theoretical Biology at the University of Gothenburg, Sweden; United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme; Centre of Theoretical Biology at the University of Gothenburg, Sweden	This study was supported by a grant from the United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) Darwin Initiative scheme (grant 162-15-24). KCH was financed by the Centre of Theoretical Biology at the University of Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PUSA CASPICA VERS 20; [Anonymous], RUSS FED FISH AG REP; Badamshin BI, 1961, P M ICHTH COMM AC SC, V12, P170; Bredhult C, 2008, REPROD TOXICOL, V25, P247, DOI 10.1016/j.reprotox.2007.11.008; Caspian Environment Programme, 2007, CASP SEAL CONS ACT P; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; COOPER CF, 1983, SCIENCE, V219, P969, DOI 10.1126/science.219.4587.969; Daskalov GM, 2007, ICES J MAR SCI, V64, P503, DOI 10.1093/icesjms/fsl047; Dorofeev SV, 1928, PUBLICATIONS FISHERI, V3, P5; DUMONT H, 1995, NATURE, V377, P673, DOI 10.1038/377673a0; Eybatov T, 1997, P 1 BION WORKSH BORD, P95; Eybatov T, 2002, CASPIAN PHOCA CASPIC; Forsyth MA, 1998, VET REC, V143, P662; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Gucu AC, 2004, BIOL CONSERV, V116, P417, DOI 10.1016/S0006-3207(03)00234-9; Harding Karin C., 2007, NAMMCO Scientific Publications, V6, P33; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harding KC, 1999, AMBIO, V28, P619; Harding KC, 2005, AM NAT, V166, P722, DOI 10.1086/497580; Harding KC, 1995, CAN J FISH AQUAT SCI, V52, P2347, DOI 10.1139/f95-827; HARKONEN T, 1991, OPHELIA, V34, P191; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harkonen Tero, 2007, NAMMCO Scientific Publications, V6, P57; HEIDEJORGENSEN MP, 1988, MAR MAMMAL SCI, V4, P231, DOI 10.1111/j.1748-7692.1988.tb00204.x; HELLE E, 1980, ANN ZOOL FENN, V17, P147; IUCN, 2001, 2001 IUCN RED LIST C; Ivanov Vladimir P., 2000, Biological Invasions, V2, P255, DOI 10.1023/A:1010098624728; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kajiwara N, 2002, ENVIRON POLLUT, V117, P391, DOI 10.1016/S0269-7491(01)00200-7; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; KJELLQWIST SA, 1995, ICES J MAR SCI, V52, P197, DOI 10.1016/1054-3139(95)80035-2; Kokko H, 1999, ANN ZOOL FENN, V36, P65; Kouraev AV, 2004, J MARINE SYST, V47, P89, DOI 10.1016/j.jmarsys.2003.12.011; Kouraev AV, 2003, POLAR RES, V22, P43, DOI 10.1111/j.1751-8369.2003.tb00094.x; Kovacs KM, 2011, MAR MAMMAL SCI, V28, P428; Krylov V.I., 1990, Finnish Game Research, V47, P32; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Lander RH, 1980, NMFFSTNWC3 NOAA US D, V1; LAWS R. M., 1957, PROC ZOOL SOC LONDON, V129, P315; Lunneryd S-G, 2004, 20048 FINF SWED BOAR, P8; Mamedov EV, 2006, ICES J MAR SCI, V63, P1665, DOI 10.1016/j.icesjms.2006.07.005; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Meier HEM, 2004, AMBIO, V33, P249, DOI 10.1639/0044-7447(2004)033[0249:SDOBSI]2.0.CO;2; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Ohashi K, 2001, VET MICROBIOL, V82, P203, DOI 10.1016/S0378-1135(01)00371-6; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Peasnall B, 2002, ENCY PREHISTORY, V8, P198; Piletskii AM, 1990, SOME REMARKS BIOL EC, P58; Popov L., 1979, FAO FISHERIES SERIES, VII, P74; Reeves R.R., 1998, NAMMCO SCI PUBL, V1, P9, DOI [10.7557/3.2979, DOI 10.7557/3.2979]; REIJNDERS PJH, 1985, BIOL CONSERV, V31, P75, DOI 10.1016/0006-3207(85)90035-7; REIJNDERS PJH, 1978, NETH J SEA RES, V12, P164, DOI 10.1016/0077-7579(78)90003-0; Roohi A, 2010, BIOL INVASIONS, V12, P2343, DOI 10.1007/s10530-009-9648-4; Sklabinskij N, 1891, SVEDENIJA TIULENIEJ; Smith T., 1987, CANADIAN B FISHERIES, V216, P1; Strukova E, 2010, STUDY EC BIORESOURCE; Sundqvist L, AMBIO IN PRESS; Tonder M, 2004, FISHERIES MANAG ECOL, V11, P283, DOI 10.1111/j.1365-2400.2004.00389.x; Wilson SC, IMPLICATIONS C UNPUB; Yablonskaya E.A., 1994, CASPIAN SEA; Yousefian M, 2003, FISH PHYSIOL BIOCHEM, V29, P127, DOI 10.1023/B:FISH.0000035921.70639.fb	64	20	21	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43130	10.1371/journal.pone.0043130	http://dx.doi.org/10.1371/journal.pone.0043130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028446	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400006
J	Lam, WWT; Ye, M; Fielding, R				Lam, Wendy W. T.; Ye, Michelle; Fielding, Richard			Trajectories of Quality of Life among Chinese Patients Diagnosed with Nasopharynegeal Cancer	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL-ASSESSMENT; PSYCHOLOGICAL DISTRESS; EUROPEAN-ORGANIZATION; CARCINOMA PATIENTS; 1ST YEAR; SATISFACTION; VALIDATION; OPTIMISM; WOMEN	Objective: This secondary longitudinal analysis describes distinct quality of life trajectories during eight months of radiation therapy (RT) among patients with nasopharyngeal cancer (NPC) and examines factors differentiating these trajectories. Methods: 253 Chinese patients with NPC scheduled for RT were assessed at pre-treatment, and 4 months and 8 months later on QoL (Chinese version of the FACT-G), optimism, pain, eating function, and patient satisfaction. Latent growth mixture modelling identified different trajectories within each of four QoL domains: Physical, Emotional, Social/family, and Functional well-being. Multinomial logistic regression compared optimism, pain, eating function, and patient satisfaction by trajectories adjusted for demographic and medical characteristics. Results: We identified three distinct trajectories for physical and emotional QoL domains, four trajectories for social/family, and two trajectories for functional domains. Within each domain most patients (physical (77%), emotional (85%), social/family (55%) and functional (63%)) experienced relatively stable high levels of well-being over the 8-month period. Different Physical trajectory patterns were predicted by pain and optimism, whereas for Emotion-domain trajectories pain, optimism, eating enjoyment, patient satisfaction with information, and gender were predictive. Age, appetite, optimism, martial status, and household income predicted Social/family trajectories; household income, eating enjoyment, optimism, and patient satisfaction with information predicted Functional trajectories. Conclusion: Most patients with NPC showed high stable QoL during radiotherapy. Optimism predicted good QoL. Symptom impacts varied by QoL domain. Information satisfaction was protective in emotional and functional well-being, reflecting the importance in helping patients to establish a realistic expectation of treatment impacts.	[Lam, Wendy W. T.; Ye, Michelle; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Teaching, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Fielding, R (corresponding author), Univ Hong Kong, Sch Publ Hlth, Ctr Psychooncol Res & Teaching, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	Lam, Wendy Wing Tak/C-4319-2009	Lam, Wendy Wing Tak/0000-0003-2383-0149	Hong Kong Government Health Services Research Committee (HSRC) [821005]	Hong Kong Government Health Services Research Committee (HSRC)	This project was supported by grants from the Hong Kong Government Health Services Research Committee (HSRC#821005) and a donation from Mr. C.S. Suen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bjordal K, 1999, J CLIN ONCOL, V17, P1008, DOI 10.1200/JCO.1999.17.3.1008; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Brucker PS, 2005, EVAL HEALTH PROF, V28, P192, DOI 10.1177/0163278705275341; Burkett V Shannon, 2007, J Cancer Surviv, V1, P167, DOI 10.1007/s11764-007-0017-y; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang VT, 2000, CANCER-AM CANCER SOC, V88, P1175, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1175::AID-CNCR30>3.0.CO;2-N; DEMBER WN, 1989, CURR PSYCHOL RES REV, V8, P102, DOI 10.1007/BF02686675; Dunn LB, 2012, EUR J ONCOL NURS, V16, P1, DOI 10.1016/j.ejon.2011.01.003; Enders CK, 2001, EDUC PSYCHOL MEAS, V61, P713, DOI 10.1177/0013164401615001; Epping-Jordan JE, 1999, HEALTH PSYCHOL, V18, P315, DOI 10.1037/0278-6133.18.4.315; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hair J.F., 2006, MULTIVARIATE DATA AN, V6th ed.; He GP, 2005, CANCER NURS, V28, P179; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Henselmans I, 2010, HEALTH PSYCHOL, V29, P160, DOI 10.1037/a0017806; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; Holzner B, 2004, ACTA ONCOL, V43, P153, DOI 10.1080/02841860310023453; Huber GF, 2007, LARYNGOSCOPE, V117, P559, DOI 10.1097/MLG.0b013e31802ca4c2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Karnell LH, 2000, HEAD NECK-J SCI SPEC, V22, P6, DOI 10.1002/(SICI)1097-0347(200001)22:1<6::AID-HED2>3.3.CO;2-G; Lam WWT, 2012, HEALTH EDUC RES, V27, P767, DOI 10.1093/her/cys087; Lam WWT, 2007, PSYCHO-ONCOL, V16, P904, DOI 10.1002/pon.1147; Lam WWT, 2012, BREAST CANCER RES TR, V131, P957, DOI 10.1007/s10549-011-1798-2; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lam WWT, 2009, PSYCHO-ONCOLOGY, V18, P1189, DOI 10.1002/pon.1403; Lam WWT, 2005, QUAL LIFE RES, V14, P1187, DOI 10.1007/s11136-004-2391-5; Lam WWT, 2003, PSYCHO-ONCOL, V12, P127, DOI 10.1002/pon.621; Law CC, 2008, J PAIN SYMPTOM MANAG, V35, P203, DOI 10.1016/j.jpainsymman.2007.03.013; Lee AWM, 1999, INT J CANCER, V84, P179, DOI 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6; Lee PWH, 2007, CANCER-AM CANCER SOC, V109, P1344, DOI 10.1002/cncr.22539; Lovell SJ, 2005, HEAD NECK-J SCI SPEC, V27, P864, DOI 10.1002/hed.20250; Miller DL, 1996, J CLIN PSYCHOL MED S, V3, P115, DOI 10.1007/BF01996132; Muthen LK, 2007, MPLUS USERS GUIDE, P197; Mystakidou K, 2008, DEPRESS ANXIETY, V25, P730, DOI 10.1002/da.20319; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Rose JH, 2009, CANCER, V115, P4298, DOI 10.1002/cncr.24584; Thienthong Somboon, 2006, Journal of the Medical Association of Thailand, V89, P1120; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; Wolf M H, 1978, J Behav Med, V1, P391, DOI 10.1007/BF00846695; Wong WS, 2008, PSYCHO-ONCOL, V17, P292, DOI 10.1002/pon.1247; Wong WS, 2008, ACTA ONCOL, V47, P71, DOI 10.1080/02841860701441814; Wong WS, 2007, QUAL LIFE RES, V16, P53, DOI 10.1007/s11136-006-9106-z; Wong WS, 2009, MED CARE, V47, P875, DOI 10.1097/MLR.0b013e3181a393cf; Wu Y, 2007, QUAL LIFE RES, V16, P65, DOI 10.1007/s11136-006-9113-0; Yu CLM, 2000, CANCER, V88, P1715, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1715::AID-CNCR28>3.3.CO;2-B; Yu CLM, 2001, CANCER, V92, P2126, DOI 10.1002/cncr.1554; Yu CLM, 2000, THESIS U HONG KONG H; Yu LMC, 2003, QUAL LIFE RES, V12, P41	53	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44022	10.1371/journal.pone.0044022	http://dx.doi.org/10.1371/journal.pone.0044022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028484	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900012
J	Nadjar, Y; Gordon, P; Corcia, P; Bensimon, G; Pieroni, L; Meininger, V; Salachas, F				Nadjar, Yann; Gordon, Paul; Corcia, Philippe; Bensimon, Gilbert; Pieroni, Laurence; Meininger, Vincent; Salachas, Francois			Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							IRON HOMEOSTASIS; ALS; HFE; CONSEQUENCES	Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by the loss of motor neurons. Its etiology remains unknown, but several hypothesis have been raised to explain motor neuron death, including oxidative stress. Dysregulation of cellular iron metabolism can lead to increased oxidative stress, and existing data argue for a role of iron metabolism in ALS pathophysiology. Methods: We performed a retrospective analysis of iron metabolism (IM) variables (serum levels of iron, transferrin, ferritin, and TSC for Transferrin Saturation Coefficient) in a cohort of 694 ALS patients and 297 healthy controls. Results: Serum ferritin levels and TSC were higher, whereas serum transferrin levels were lower in ALS patients than controls. In addition, patients with a high level serum ferritin had a shorter survival time compared to those with low level serum ferritin (618 days versus 921 days for men subgroup; p = .007). Site of onset and ALS-FRS score were not associated with IM variables. Conclusion: This study suggests that ALS patients may have increased iron storage, as measured by increased serum ferritin and TSC. Elevated serum ferritin may also have a deleterious impact on survival in ALS.	[Nadjar, Yann; Gordon, Paul; Meininger, Vincent; Salachas, Francois] Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Rares SLA, Paris, France; [Corcia, Philippe] Univ Tours, Ctr SLA, CHU Tours, Tours, France; [Bensimon, Gilbert] Hop La Pitie Salpetriere, Dept Clin Pharmacol, Paris, France; [Bensimon, Gilbert] UPMC Pharmacol, UMR 7211, Paris 6, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Nadjar, Y (corresponding author), Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Rares SLA, Paris, France.	ynadjar@gmail.com	Pieroni, Laurence/AAA-4583-2019	Gordon, Paul/0000-0001-5714-9875				Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; de Aguilar JLG, 2007, J NEUROCHEM, V101, P1153, DOI 10.1111/j.1471-4159.2006.04408.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Goodall EF, 2005, NEUROLOGY, V65, P934, DOI 10.1212/01.wnl.0000176032.94434.d4; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; INCE PG, 1994, NEUROSCI LETT, V182, P87, DOI 10.1016/0304-3940(94)90213-5; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kuhle J, 2009, EUR J NEUROL; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Mizuno Y, 2006, ACTA NEUROPATHOL, V112, P597, DOI 10.1007/s00401-006-0122-4; Nappi AJ, 2000, CELL MOL BIOL, V46, P637; Qureshi Muddasir, 2008, Open Neurol J, V2, P51, DOI 10.2174/1874205X00802010051; Restagno G, 2007, J NEUROL NEUROSUR PS, V78, P327, DOI 10.1136/jnnp.2006.092338; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Wang XS, 2004, J NEUROL SCI, V227, P27, DOI 10.1016/j.jns.2004.08.003	20	62	64	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45034	10.1371/journal.pone.0045034	http://dx.doi.org/10.1371/journal.pone.0045034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024788	Green Submitted, gold, Green Published			2022-12-25	WOS:000308860100046
J	Thomas, LW; Lam, C; Clark, RE; White, MRH; Spiller, DG; Moots, RJ; Edwards, SW				Thomas, Luke W.; Lam, Connie; Clark, Richard E.; White, Michael R. H.; Spiller, David G.; Moots, Robert J.; Edwards, Steven W.			Serine 162, an Essential Residue for the Mitochondrial Localization, Stability and Anti-Apoptotic Function of Mcl-1	PLOS ONE			English	Article							NEUTROPHIL APOPTOSIS; CELL LEUKEMIA-1; EXPRESSION; INHIBITION; SURVIVAL; CANCER; CHEMOSENSITIZATION; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION	Mcl-1 is an anti-apoptotic member of the Bcl-2 family that plays a key role in normal development, but also in pathologies such as cancer. It has some unusual properties compared to other anti-apoptotic members of the Bcl-2 family, and its expression and function are dynamically regulated by a variety of post-transcriptional and post-translational processes. Of note, Mcl-1 protein has a very short half life, and its stability and function may be regulated by reversible phosphorylation. There is also evidence to suggest that it may be localized to different subcellular compartments. The aim of this work was to determine whether residues within the PEST region of Mcl-1 that may undergo reversible phosphorylation, also regulate its subcellular distribution. We show that EGFP: Mcl-1 localizes mainly to the mitochondria of HeLa cells, with some additional cytoplasmic and nuclear localization. The mutations, S64A, S64E, S121A, S159A, T163A and T163E did not significantly affect the localization of Mcl-1. However, mutation of Ser162 to the phospho-null residue, Alanine resulted in an essentially nuclear localization, with some cytoplasmic but no mitochondrial localization. This mutant Mcl-1 protein, S162A, showed significantly decreased stability and it decreased the ability to protect against Bak-induced apoptosis. These data identify a new molecular determinant of Mcl-1 function, localization and stability that may be important for understanding the role of this protein in disease.	[Thomas, Luke W.; Lam, Connie; White, Michael R. H.; Spiller, David G.; Edwards, Steven W.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Clark, Richard E.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Moots, Robert J.] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Thomas, LW (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	w.edwards@liv.ac.uk	Moots, Robert/AAM-8091-2020; Spiller, David G/I-3645-2012	Spiller, David Geoffrey/0000-0003-2502-6787; White, Michael/0000-0002-3617-3232; Edwards, Steven/0000-0002-7074-0552	Arthritis Research UK; Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council [BB/E012965/1] Funding Source: researchfish; BBSRC [BB/E012965/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Leukaemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Arthritis Research UK and Leukaemia and Lymphoma Research for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; Fleischer B, 2006, INT J ONCOL, V28, P25; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Jamil S, 2010, CELL CYCLE, V9, P2843, DOI 10.4161/cc.9.14.12354; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sano M, 2001, EXP CELL RES, V266, P114, DOI 10.1006/excr.2001.5203; Subramaniam D, 2008, AM J PHYSIOL-GASTR L, V294, pG1025, DOI 10.1152/ajpgi.00602.2007; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Ulrich-Pur H, 2005, WIEN KLIN WOCHENSCHR, V117, P136, DOI 10.1007/s00508-004-0278-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Xue LY, 2005, ONCOGENE, V24, P6987, DOI 10.1038/sj.onc.1208837; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yoon JH, 2002, CANCER RES, V62, P6500; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	39	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45088	10.1371/journal.pone.0045088	http://dx.doi.org/10.1371/journal.pone.0045088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024798	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100056
J	Bitoun, JP; Liao, SM; Yao, X; Xie, GG; Wen, ZZT				Bitoun, Jacob P.; Liao, Sumei; Yao, Xin; Xie, Gary G.; Wen, Zezhang T.			The Redox-Sensing Regulator Rex Modulates Central Carbon Metabolism, Stress Tolerance Response and Biofilm Formation by Streptococcus mutans	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR REX; STRICTLY ANAEROBIC CONDITIONS; ORAL STREPTOCOCCI; OXIDATIVE STRESS; GENE-EXPRESSION; BACILLUS-SUBTILIS; PHOSPHOTRANSFERASE SYSTEM; LACTATE-DEHYDROGENASE; SUGAR METABOLISM; NADH OXIDASES	The Rex repressor has been implicated in regulation of central carbon and energy metabolism in Gram-positive bacteria. We have previously shown that Streptococcus mutans, the primary causative agent of dental caries, alters its transcriptome upon Rex-deficiency and renders S. mutans to have increased susceptibility to oxidative stress, aberrations in glucan production, and poor biofilm formation. In this study, we showed that rex in S. mutans is co-transcribed as an operon with downstream guaA, encoding a putative glutamine amidotransferase. Electrophoretic mobility shift assays showed that recombinant Rex bound promoters of target genes avidly and specifically, including those down-regulated in response to Rex-deficiency, and that the ability of recombinant Rex to bind to selected promoters was modulated by NADH and NAD(+). Results suggest that Rex in S. mutans can function as an activator in response to intracellular NADH/NAD(+) level, although the exact binding site for activator Rex remains unclear. Consistent with a role in oxidative stress tolerance, hydrogen peroxide challenge assays showed that the Rex-deficient mutant, TW239, and the Rex/GuaA double mutant, JB314, were more susceptible to hydrogen peroxide killing than the wildtype, UA159. Relative to UA159, JB314 displayed major defects in biofilm formation, with a decrease of more than 50-fold in biomass after 48-hours. Collectively, these results further suggest that Rex in S. mutans regulates fermentation pathways, oxidative stress tolerance, and biofilm formation in response to intracellular NADH/NAD(+) level. Current effort is being directed to further investigation of the role of GuaA in S. mutans cellular physiology.	[Bitoun, Jacob P.; Liao, Sumei; Yao, Xin; Wen, Zezhang T.] Louisiana State Univ, Sch Dent, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA; [Xie, Gary G.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Wen, Zezhang T.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; United States Department of Energy (DOE); Los Alamos National Laboratory; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bitoun, JP (corresponding author), Louisiana State Univ, Sch Dent, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA.	zwen@lsuhsc.edu	Liao, Sumei/E-6589-2015	xie, gary/0000-0002-9176-924X	National Institute for Dental and Craniofacial Research, United States of America [R01 DE19452]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019452] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research, United States of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grant R01 DE19452 from the National Institute for Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBE K, 1982, J BACTERIOL, V152, P175; Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Burne RA, 1998, J DENT RES, V77, P445, DOI 10.1177/00220345980770030301; Burne RA, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P185; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Faustoferri RC, 2005, J BACTERIOL, V187, P2705, DOI 10.1128/JB.187.8.2705-2714.2005; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Higuchi M, 2000, J BIOSCI BIOENG, V90, P484, DOI 10.1016/S1389-1723(01)80028-1; IWAMI Y, 1985, INFECT IMMUN, V50, P378, DOI 10.1128/IAI.50.2.378-381.1985; Iwami Y, 2000, ORAL MICROBIOL IMMUN, V15, P325, DOI 10.1034/j.1399-302x.2000.150510.x; KENNEY EB, 1969, J PERIODONTOL, V40, P630, DOI 10.1902/jop.1969.40.11.630; KRUGER N, 1994, J BACTERIOL, V176, P3614; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Larsson JT, 2005, MICROBIOL-SGM, V151, P3323, DOI 10.1099/mic.0.28124-0; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LeBanc D., 1991, GENETICS MOL BIOL ST, P235; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Mehmeti I, 2011, APPL ENVIRON MICROB, V77, P2406, DOI 10.1128/AEM.02485-10; Nguyen PTM, 2002, CURR MICROBIOL, V44, P262, DOI 10.1007/s00284-001-0001-0; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Ravcheev DA, 2011, J BACTERIOL; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Sheng JY, 2006, FEMS MICROBIOL LETT, V262, P93, DOI 10.1111/j.1574-6968.2006.00374.x; Sheng JY, 2010, CAN J MICROBIOL, V56, P539, DOI [10.1139/W10-039, 10.1139/w10-039]; Smith EG, 2011, J DENT RES; TAKAHASHI N, 1991, ORAL MICROBIOL IMMUN, V6, P299, DOI 10.1111/j.1399-302X.1991.tb00497.x; Tanzer JM, 2006, J DENT RES, V85, P369, DOI 10.1177/154405910608500417; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Wen ZZT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-111; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; YAMADA T, 1985, INFECT IMMUN, V47, P129, DOI 10.1128/IAI.47.1.129-134.1985; YAMADA T, 1975, J BACTERIOL, V124, P55, DOI 10.1128/JB.124.1.55-61.1975; YAMADA T, 1980, CARIES RES, V14, P239, DOI 10.1159/000260460; Yamamoto Y, 2000, INFECT IMMUN, V68, P4773, DOI 10.1128/IAI.68.8.4773-4777.2000; Yamamoto Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1056, DOI 10.1271/bbb.63.1056; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x	55	43	49	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44766	10.1371/journal.pone.0044766	http://dx.doi.org/10.1371/journal.pone.0044766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028612	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700036
J	Boyce, T; Holmes, A				Boyce, Tammy; Holmes, Alison			Addressing Health Inequalities in the Delivery of the Human Papillomavirus Vaccination Programme: Examining the Role of the School Nurse	PLOS ONE			English	Article							HPV VACCINATION; QUALITATIVE RESEARCH; SYSTEMATIC REVIEWS; PARENTAL ATTITUDES; PUBLIC-HEALTH; URBAN AREA; IMMUNIZATION; MANCHESTER; CHALLENGES; BREAST	Background: HPV immunisation of adolescent girls is expected to have a significant impact in the reduction of cervical cancer. UK The HPV immunisation programme is primarily delivered by school nurses. We examine the role of school nurses in delivering the HPV immunisation programme and their impact on minimising health inequalities in vaccine uptake. Methods and Findings: A rapid evidence assessment (REA) and semi-structured interviews with health professionals were conducted and analysed using thematic analysis. 80 health professionals from across the UK are interviewed, primarily school nurses and HPV immunisation programme coordinators. The REA identified 2,795 articles and after analysis and hand searches, 34 relevant articles were identified and analysed. Interviews revealed that health inequalities in HPV vaccination uptake were mainly related to income and other social factors in contrast to published research which emphasises potential inequalities related to ethnicity and/or religion. Most school nurses interviewed understood local health inequalities and made particular efforts to target girls who did not attend or missed doses. Interviews also revealed maintaining accurate and consistent records influenced both school nurses' understanding and efforts to target inequalities in HPV vaccination uptake. Conclusions: Despite high uptake in the UK, some girls remain at risk of not being vaccinated with all three doses. School nurses played a key role in reducing health inequalities in the delivery of the HPV programme. Other studies identified religious beliefs and ethnicity as potentially influencing HPV vaccination uptake but interviews for this research found this appeared not to have occurred. Instead school nurses stated girls who were more likely to be missed were those not in education. Improving understanding of the delivery processes of immunisation programmes and this impact on health inequalities can help to inform solutions to increase uptake and address health inequalities in childhood and adolescent vaccination programmes.	[Boyce, Tammy; Holmes, Alison] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Natl Ctr Infect Prevent & Management, London, England	Imperial College London	Boyce, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Natl Ctr Infect Prevent & Management, London, England.	tboyce@imperial.ac.uk			Sanofi Pasteur MSD; National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; UK Clinical Research Collaboration; NIHR; MRC [G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	Sanofi Pasteur MSD; National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; UK Clinical Research Collaboration; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TB received funding from Sanofi Pasteur MSD to carry out the research; TB was one of the authors of The Marmot Review's Fair Society Healthy Lives report. TB has no financial relationships with any organisations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work. AH is funded by grants from the National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College and the National Centre for Infection Prevention and Management, which is funded by the UK Clinical Research Collaboration. AH is also affiliated with the Imperial Centre for Patient Safety and Service Quality, which is funded by the NIHR. The funders had no role in the design, conduct or publication of the research. Sanofi Pasteur MSD granted the authors freedom to make public and publish all study results. The authors retain full control of all the data and the content of the article.	Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; [Anonymous], 2011, ANN HPV VACC COV ENG; Ashmore J., 2007, EURO SURVEILL, V12; Asthana S, 2006, MILBANK Q, V84, P577, DOI 10.1111/j.1468-0009.2006.00459.x; Baker D, 2011, J EPIDEMIOL COMMUN H, V65, P346, DOI 10.1136/jech.2008.085142; Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Birmingham City Council, 2010, IND MULT DEPR 2010; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brabin L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-20; Brabin L, 2011, VACCINE, V29, P3192, DOI 10.1016/j.vaccine.2011.02.038; Cabinet Office, 2010, INCL HLTH IMPR WAY W; Chase E., 2010, PROMOTING HLTH CHILD; Coombes R, 2000, NURS TIMES, V96, P13; Cunningham PJ, 2011, MED CARE RES REV, V68, P34, DOI 10.1177/1077558710385468; Department of Health, 2011, CERV CANC JAB UPT IN; Department of Health and Health Protection Agency, 2012, ANN HPV VACC COV ENG; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Egger M, 2003, Health Technol Assess, V7, P1; End Child Poverty, 2011, CHILD POV MAP UK 1; Fagot JP, 2011, VACCINE, V29, P3610, DOI 10.1016/j.vaccine.2011.02.064; FEDER GS, 1993, BRIT J GEN PRACT, V43, P281; Field P., 1995, QUALITATIVE RES METH; Gottvall M, 2011, VACCINE, V29, P4576, DOI 10.1016/j.vaccine.2011.04.054; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Harden A., 2005, INT J SOC RES METHOD, V8, P257, DOI DOI 10.1080/13645570500155078; Harris V, 1998, CANC REGISTRATION ST, P182; Hawker JI, 2007, VACCINE, V25, P7516, DOI 10.1016/j.vaccine.2007.08.043; Hilton S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-226; Jenkins M, 2004, NO TRAVELLERS REPORT; Kelly MP, 2005, EC APPRAISAL PUBLIC; Kumar VM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-172; Lawrence Helen, 2007, Emerg Nurse, V15, P12; Limia A, 2011, EURO SURVEILL, V16; London Health Observatory and Health Protection Agency 92008, LOND SEX HLTH IND; Marlow LAV, 2009, J EPIDEMIOL COMMUN H, V63, P1010, DOI 10.1136/jech.2008.085886; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Marlow LAV, 2009, VACCINE, V27, P2483, DOI 10.1016/j.vaccine.2009.02.057; Marlow LAV, 2009, HUM VACCINES, V5, P105, DOI 10.4161/hv.5.2.7368; Maxwell Joseph, 2005, QUALITATIVE RES SOCI; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Mixer RE, 2007, J EPIDEMIOL COMMUN H, V61, P797, DOI 10.1136/jech.2005.045633; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Muscat M, 2011, J INFECT DIS, V204, P1293, DOI 10.1093/infdis/jir519; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Paul-Ebhohimhen Virginia, 2010, Community Pract, V83, P30; Pollack AE, 2007, B WORLD HEALTH ORGAN, V85, P57, DOI 10.2471/BLT.06.034397; Quinn M, 2005, CANC ATLAS UK IRELAN; Roberts C, 2006, TIMES ED SUPPLEMENT; Roberts SA, 2011, EPIDEMIOL INFECT, V139, P400, DOI 10.1017/S095026881000066X; Royal College of Nursing, 2005, SCH NURS RES CENS SU; Scottish Executive, 2001, FAIR ALL IMPR HLTH E; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; Srinivasan R, 2006, THORAX, V61, P247, DOI 10.1136/thx.2004.036269; Stiennon R, 2012, RIGHT STRATEGY TACTI; Stretch R, 2008, BRIT J CANCER, V99, P1908, DOI 10.1038/sj.bjc.6604766; Stronegger WJ, 2010, EUR J PUBLIC HEALTH, V20, P354, DOI 10.1093/eurpub/ckp188; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Teutsch SM, 2011, HEALTH AFFAIR, V30, P349, DOI 10.1377/hlthaff.2010.0593; The Information Centre Workforce and Facilities Team, 2010, NHS WORKF SUMM STAFF; Vandermeulen C, 2008, PEDIATRICS, V121, pE428, DOI 10.1542/peds.2007-1415; Wainwright P, 2000, J ADV NURS, V32, P1083, DOI 10.1046/j.1365-2648.2000.01579.x; Wallace A, 2004, POLICY POLIT, V32, P455, DOI 10.1332/0305573042009444; Wallace LA, 2004, ARCH DIS CHILD, V89, P1041, DOI 10.1136/adc.2003.043687; Walsh CD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-368; Warren CAB, 2001, HDB INTERVIEW RES, P91; Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185; WEISS ROBERT S., 1994, LEARNING STRANGERS A, P55; Weller DP, 2009, BRIT J CANCER, V101, pS55, DOI 10.1038/sj.bjc.6605391; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194	71	43	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43416	10.1371/journal.pone.0043416	http://dx.doi.org/10.1371/journal.pone.0043416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028452	Green Published, gold			2022-12-25	WOS:000308788700010
J	Hwang, SG; Park, J; Park, JY; Park, CH; Lee, KH; Cho, JW; Hwang, JI; Seong, JY				Hwang, Sun Gwan; Park, Jinah; Park, Joo Young; Park, Cheol Hyoung; Lee, Ki-Ho; Cho, Jeong Woo; Hwang, Jong-Ik; Seong, Jae Young			Anti-Cancer Activity of a Novel Small Molecule Compound That Simultaneously Activates p53 and Inhibits NF-kappa B Signaling	PLOS ONE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; TRANSCRIPTION FACTOR; INDUCED PHOSPHORYLATION; SESQUITERPENE LACTONE; CELL-GROWTH; CANCER; APOPTOSIS; RAS; REQUIREMENT; SUPPRESSION	The p53 and NF-kappa B pathways play important roles in diverse cellular functions, including cell growth, apoptosis, and tumorigenesis. Mutations that inactivate the p53 gene and constitutive NF-kappa B pathway activation are common occurrences in human cancers. Although many drugs are being developed that selectively activate p53 or inhibit NF-kappa B, there are few drug candidates that can do both. Simultaneous activation of p53 and inhibition of the NF-kappa B pathway is therefore a prime target for new cancer drug development. This study is the first report of a high-throughput approach with mass compounds that concurrently target both pathways. Using a cell-based screening assay and a library of 200,000 synthetic compounds, we identified 9 small molecules that simultaneously inhibit NF-kappa B and activate p53. One of these compounds, N-2, increased the expression of p53 target genes, including p21 and GADD45a. In addition, N-2 inhibited the transcriptional activity of NF-kappa B, concomitantly repressing interleukin-6 and monocyte chemotactic protein-1 (MCP-1) expression. When cell lines derived from a diverse range of cancers were treated in vitro with N-2, we observed increased cell death. N-2 also significantly inhibited allograft growth in murine models of melanoma and lung carcinoma. Our findings suggest that N-2 may act as a bivalent anti-cancer agent through simultaneous modulation of NF-kappa B and p53 activities.	[Hwang, Sun Gwan; Park, Joo Young; Park, Cheol Hyoung; Lee, Ki-Ho; Cho, Jeong Woo] SK Biopharmaceut Co Ltd, Drug Dev Ctr, Taejon, South Korea; [Hwang, Sun Gwan; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Lab Prot Coupled Receptors G, Seoul, South Korea; [Park, Jinah] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea	SK Group; Korea University; Korea University Medicine (KU Medicine); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hwang, SG (corresponding author), SK Biopharmaceut Co Ltd, Drug Dev Ctr, Taejon, South Korea.	jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	SK Biopharmaceuticals Co., Ltd.; Brain Research Center of the 21st Century Frontier Research Program [2011K00277]	SK Biopharmaceuticals Co., Ltd.; Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by SK Biopharmaceuticals Co., Ltd., and grants (2011K00277) from the Brain Research Center of the 21st Century Frontier Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chenette EJ, 2009, NAT REV DRUG DISCOV, V8, DOI 10.1038/nrd3060; COLBURN NH, 1978, CANCER RES, V38, P624; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Dey A, 2008, CELL DEATH DIFFER, V15, P263, DOI 10.1038/sj.cdd.4402257; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gu HY, 2008, MOL CANCER THER, V7, P3298, DOI 10.1158/1535-7163.MCT-08-0212; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hwang SG, 2002, J BIOL CHEM, V277, P2923, DOI 10.1074/jbc.M109113200; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang YX, 2001, ONCOGENE, V20, P2254, DOI 10.1038/sj.onc.1204293; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; McCarthy N, 2011, NAT REV CANCER, V11, P4, DOI 10.1038/nrc2987; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rong JJ, 2010, CANCER LETT, V296, P55, DOI 10.1016/j.canlet.2010.03.016; Saha MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030215; Saha MN, 2010, MOL CANCER THER, V9, P3041, DOI 10.1158/1535-7163.MCT-10-0471; Sakamoto K, 2010, EXPERT OPIN THER TAR, V14, P593, DOI 10.1517/14728221003769903; Sharma HW, 1996, ANTICANCER RES, V16, P589; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sohn TA, 2002, CARCINOGENESIS, V23, P949, DOI 10.1093/carcin/23.6.949; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Xia Y, 2012, NAT CELL BIOL; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	57	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44259	10.1371/journal.pone.0044259	http://dx.doi.org/10.1371/journal.pone.0044259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028510	gold, Green Published, Green Submitted			2022-12-25	WOS:000308788700017
J	Reikie, BA; Adams, RCM; Ruck, CE; Ho, K; Leligdowicz, A; Pillay, S; Naidoo, S; Fortuno, ES; de Beer, C; Preiser, W; Cotton, MF; Speert, DP; Esser, M; Kollmann, TR				Reikie, Brian A.; Adams, Rozanne C. M.; Ruck, Candice E.; Ho, Kevin; Leligdowicz, Aleksandra; Pillay, Santoshan; Naidoo, Shalena; Fortuno, Edgardo S., III; de Beer, Corena; Preiser, Wolfgang; Cotton, Mark F.; Speert, David P.; Esser, Monika; Kollmann, Tobias R.			Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of South African Infants throughout the First Year of Life	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HUMAN NEWBORNS; B-CELLS; INDUCTION; MIFLOWCYT; CHILDREN; DISTINCT	The first year of life represents a time of marked susceptibility to infections; this is particularly true for regions in sub-Saharan Africa. As innate immunity directs the adaptive immune response, the observed increased risk for infection as well as a suboptimal response to vaccination in early life may be due to less effective innate immune function. In this study, we followed a longitudinal cohort of infants born and raised in South Africa over the first year of life, employing the most comprehensive analysis of innate immune response to stimulation published to date. Our findings reveal rapid changes in innate immune development over the first year of life. This is the first report depicting dramatic differences in innate immune ontogeny between different populations in the world, with important implications for global vaccination strategies.	[Reikie, Brian A.; Ruck, Candice E.; Ho, Kevin; Leligdowicz, Aleksandra; Fortuno, Edgardo S., III; Speert, David P.; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Ctr Understanding & Preventing Infect Children, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Adams, Rozanne C. M.; Pillay, Santoshan; Naidoo, Shalena; de Beer, Corena; Preiser, Wolfgang; Cotton, Mark F.; Esser, Monika] Univ Stellenbosch, Cape Town, South Africa; [Adams, Rozanne C. M.; Pillay, Santoshan; Naidoo, Shalena; Esser, Monika] NHLS, Dept Pathol, Div Med Microbiol, Immunol Unit, Cape Town, South Africa; [de Beer, Corena; Preiser, Wolfgang] NHLS, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Cotton, Mark F.] Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Reikie, Brian A.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	University of British Columbia; Stellenbosch University; University of Cape Town; University of Cape Town; University of Calgary	Reikie, BA (corresponding author), Univ British Columbia, Dept Pediat, Ctr Understanding & Preventing Infect Children, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollm@mac.com	Leligdowicz, Aleksandra/GLS-9028-2022; Cotton, Mark/AAQ-9936-2020; Leligdowicz, Aleksandra/Q-2494-2016; Preiser, Wolfgang/J-4875-2016	Leligdowicz, Aleksandra/0000-0001-6055-4644; Cotton, Mark/0000-0003-2559-6034; Leligdowicz, Aleksandra/0000-0001-6055-4644; Preiser, Wolfgang/0000-0002-0254-7910; Kollmann, Tobias/0000-0003-2403-9762; Fortuno, Edgardo/0000-0001-5294-1679	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [N01 AI50023]; British Columbia Children's Hospital Foundation; Martha Piper Fund; Peter Wall Institute for Advanced Studies; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program; SickKids Foundation; Child & Family Research Institute (BC); Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; Michael Smith Foundation for Health Research [ST-SGS-02657(09-1)CLIN]; CIHR Canada-HOPE Scholarship; National Health Laboratory Service Research Trust [TY94171]; National Health Laboratory Service, K Fund [KNC97, KNC103]; Poliomyelitis Research Foundation [10/02, 10/31, 11/37]; Harry Crossley Foundation [5415, 5762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050023] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); British Columbia Children's Hospital Foundation; Martha Piper Fund; Peter Wall Institute for Advanced Studies; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program(Canadian Institutes of Health Research (CIHR)); SickKids Foundation; Child & Family Research Institute (BC); Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Canada-HOPE Scholarship(Canadian Institutes of Health Research (CIHR)); National Health Laboratory Service Research Trust; National Health Laboratory Service, K Fund; Poliomyelitis Research Foundation; Harry Crossley Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Grant number: N01 AI50023, British Columbia Children's Hospital Foundation, The Martha Piper Fund, and the Peter Wall Institute for Advanced Studies. TRK is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and by a Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program, in partnership with SickKids Foundation, Child & Family Research Institute (BC), Women & Children's Health Research Institute (Alberta), Manitoba Institute of Child Health. BAR is supported in full by the Michael Smith Foundation for Health Research (ST-SGS-02657(09-1)CLIN). ALS is supported by a CIHR Canada-HOPE Scholarship. DPS in the Sauder Family Professor of Pediatric Infectious Diseases. Laboratory analyses in South Africa were funded through National Health Laboratory Service Research Trust, Grant number TY94171; National Health Laboratory Service, K Fund numbers KNC97 and KNC103; Poliomyelitis Research Foundation, Short Term Research Grant number 10/02; and Harry Crossley Foundation, numbers 5415 and 5762. Student bursaries were awarded by Poliomyelitis Research Foundation, numbers 10/31 and 11/37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; AIDS-denying mother sentenced, 2010, AUSTR IND; Arama C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018319; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Blimkie D, 2010, CYTOM PART A, V77A, P546, DOI 10.1002/cyto.a.20862; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dauby N, 2012, LANCET INFECT DIS; Figueiredo CA, 2009, ENVIRON HEALTH PERSP, V117, P845, DOI 10.1289/ehp.0800366; Flanagan KL, 2010, EXPERT REV VACCINES, V9, P665, DOI 10.1586/ERV.10.41; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klein J.O., 2006, CURRENT CONCEPTS INF; Kohler C, 2008, PEDIATR RES, V64, P631, DOI 10.1203/PDR.0b013e31818718ba; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Lewis D, 2006, DEV IMMUNOLOGY ROLE; Lewis D. B., 2006, INFECT DIS FETUS NEW, P25; Lisciandro JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036793; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; MCELHANEY JE, 2012, VACCINE; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Shey MS, 2011, J IMMUNOL METHODS; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Teran R, 2011, CLIN IMMUNOL, V138, P299, DOI 10.1016/j.clim.2010.12.011; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493	42	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44763	10.1371/journal.pone.0044763	http://dx.doi.org/10.1371/journal.pone.0044763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028609	gold, Green Published			2022-12-25	WOS:000308788700034
J	Schmidt, SK; Siepmann, S; Kuhlmann, K; Meyer, HE; Metzger, S; Pudelko, S; Leineweber, M; Daubener, W				Schmidt, Silvia K.; Siepmann, Stephan; Kuhlmann, Katja; Meyer, Helmut E.; Metzger, Sabine; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter			Influence of Tryptophan Contained in 1-Methyl-Tryptophan on Antimicrobial and Immunoregulatory Functions of Indoleamine 2,3-Dioxygenase	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELL; DEXTRO-1-METHYL TRYPTOPHAN; INHIBITION; INTERFERON; GROWTH; IDO; PROLIFERATION; CATABOLITES; TOLERANCE	Indoleamine 2,3-dioxygenase (IDO) has been identified as an important antimicrobial and immunoregulatory effector molecule essential for the establishment of tolerance by regulating local tryptophan (Trp) concentrations. On the other hand, the immunosuppressive capacity of IDO can have detrimental effects for the host as it can lead to deleterious alterations of the immune response by promoting tolerance to some types of tumors. To suppress this disadvantageous IDO effect, the competitive inhibitor 1-Methyl-Tryptophan (1-MT) is being tested in clinical trials. However, it remains inconclusive which stereoisomer of 1-MT is the more effective inhibitor of IDO-mediated immunosuppression. While IDO enzyme activity is more efficiently inhibited by 1-L-MT in cell-free or in vitro settings, 1-D-MT is superior to 1-L-MT in the enhancement of anti-tumor responses in vivo. Here, we present new data showing that commercially available 1-L-MT lots contain tryptophan in amounts sufficient to compensate for the IDO-mediated tryptophan depletion in vitro. The addition of 1-L-MT abrogated IDO-mediated antimicrobial effects and permitted the growth of the tryptophan-auxotroph microorganisms Staphylococcus aureus and Toxoplasma gondii. Consistent with this, the tryptophan within 1-L-MT lots was sufficient to antagonize IDO-mediated inhibition of T cell responses. Mass spectrometry (MS) analysis revealed not only tryptophan within 1-L-MT, but also the incorporation of this tryptophan in bacterial and human proteins that were generated in the presence of 1-L-MT in otherwise tryptophan-free conditions. In summary, these data reveal that tryptophan within 1-L-MT can affect the results of in vitro studies in an L-stereospecific and IDO-independent way.	[Schmidt, Silvia K.; Siepmann, Stephan; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Schmidt, Silvia K.; Siepmann, Stephan; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Kuhlmann, Katja; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteome Ctr, Bochum, Germany; [Metzger, Sabine] Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Schmidt, SK (corresponding author), Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany.	silvia.schmidt@uni-duesseldorf.de			German Federal Ministry of Education and Research (BMBF) [01GN0951, 01KI1002E]; German Research Concil (DFG) grant [RU 729]; Manchot Graduate School [TP 11]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Concil (DFG) grant(German Research Foundation (DFG)); Manchot Graduate School	This study was supported by German Federal Ministry of Education and Research (BMBF) grants no. 01GN0951 (WD) and no. 01KI1002E (WD), German Research Concil (DFG) grant no. RU 729 (WD) and Manchot Graduate School TP 11 (WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Capece L, 2010, PROTEINS, V78, P2961, DOI 10.1002/prot.22819; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Curti A, 2010, HAEMATOL-HEMATOL J, V95, P2022, DOI 10.3324/haematol.2010.025924; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Heseler K, 2008, FEMS IMMUNOL MED MIC, V52, P273, DOI 10.1111/j.1574-695X.2007.00374.x; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hucke C, 2004, INFECT IMMUN, V72, P2723, DOI 10.1128/IAI.72.5.2723-2730.2004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; Liu XD, 2009, STUD FUZZ SOFT COMP, V244, P3; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; MacKenzie CR, 1999, J MED MICROBIOL, V48, P935, DOI 10.1099/00222615-48-10-935; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Okamoto T, 2007, CYTOTECHNOLOGY, V54, P107, DOI 10.1007/s10616-007-9081-4; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Qian F, 2009, CANCER RES, V69, P5498, DOI 10.1158/0008-5472.CAN-08-2106; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Schroten H, 2001, NEUROPEDIATRICS, V32, P206, DOI 10.1055/s-2001-17375; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Terness P, 2006, TRENDS IMMUNOL, V27, P68, DOI 10.1016/j.it.2005.12.006; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Yuasa HJ, 2010, COMP BIOCHEM PHYS B, V157, P10, DOI 10.1016/j.cbpb.2010.04.006	32	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44797	10.1371/journal.pone.0044797	http://dx.doi.org/10.1371/journal.pone.0044797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028625	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700041
J	Belmonte, L; Youmba, SB; Bertiaux-Vandaele, N; Antonietti, M; Lecleire, S; Zalar, A; Gourcerol, G; Leroi, AM; Dechelotte, P; Coeffier, M; Ducrotte, P				Belmonte, Liliana; Youmba, Stephanie Beutheu; Bertiaux-Vandaele, Nathalie; Antonietti, Michel; Lecleire, Stephane; Zalar, Alberto; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe			Role of Toll Like Receptors in Irritable Bowel Syndrome: Differential Mucosal Immune Activation According to the Disease Subtype	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; EXPRESSION; TLR4; GUT; RECOGNITION; ASSOCIATION; GLUTAMINE; GAMMA	Background: The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose pathogenesis is not completely understood. Its high prevalence and the considerable effects on quality of life make IBS a disease with high social cost. Recent studies suggest that low grade mucosal immune activation, increased intestinal permeability and the altered host-microbiota interactions that modulate innate immune response, contribute to the pathophysiology of IBS. However, the understanding of the precise molecular pathophysiology remains largely unknown. Methodology and Findings: In this study our objective was to evaluate the TLR expression as a key player in the innate immune response, in the colonic mucosa of IBS patients classified into the three main subtypes (with constipation, with diarrhea or mixed). TLR2 and TLR4 mRNA expression was assessed by real time RT-PCR while TLRs protein expression in intestinal epithelial cells was specifically assessed by flow cytometry and immunofluorescence. Mucosal inflammatory cytokine production was investigated by the multiplex technology. Here we report that the IBS-Mixed subgroup displayed a significant up-regulation of TLR2 and TLR4 in the colonic mucosa. Furthermore, these expressions were localized in the epithelial cells, opening new perspectives for a potential role of epithelial cells in host-immune interactions in IBS. In addition, the increased TLR expression in IBS-M patients elicited intracellular signaling pathways resulting in increased expression of the mucosal proinflammatory cytokines IL-8 and IL1 beta. Conclusions: Our results provide the first evidence of differential expression of TLR in IBS patients according to the disease subtype. These results offer further support that microflora plays a central role in the complex pathophysiology of IBS providing novel pharmacological targets for this chronic gastrointestinal disorder according to bowel habits.	[Belmonte, Liliana; Youmba, Stephanie Beutheu; Lecleire, Stephane; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe] Univ Rouen, INSERM, U1073, Rouen, France; [Belmonte, Liliana; Youmba, Stephanie Beutheu; Lecleire, Stephane; Gourcerol, Guillaume; Leroi, Anne-Marie; Dechelotte, Pierre; Coeffier, Moise; Ducrotte, Philippe] Univ Rouen, Inst Res & Innovat Biomed, Rouen, France; [Belmonte, Liliana] Natl Acad Med Buenos Aires, Consejo Nacl Invest Cient & Tecn, Immunol Lab, IIHema, Buenos Aires, DF, Argentina; [Bertiaux-Vandaele, Nathalie; Antonietti, Michel; Lecleire, Stephane; Zalar, Alberto; Ducrotte, Philippe] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Gourcerol, Guillaume; Leroi, Anne-Marie] Rouen Univ Hosp, Dept Physiol, Rouen, France; [Dechelotte, Pierre; Coeffier, Moise] Rouen Univ Hosp, Nutr Unit, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CHU de Rouen; CHU de Rouen; CHU de Rouen	Belmonte, L (corresponding author), Univ Rouen, INSERM, U1073, Rouen, France.	liliana.belmonte-zalar@inv.univ-rouen.fr		Gourcerol, Guillaume/0000-0001-8220-9155; Coeffier, Moise/0000-0002-7469-2682	Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France; Ministry of Sciences and Technology of Buenos Aires, Argentina	Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France; Ministry of Sciences and Technology of Buenos Aires, Argentina	The study was supported by the Institut National de la Sante et de la Recherche Medicale Unit U1073, University of Rouen, France and Ministry of Sciences and Technology of Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2002, GUT, V51, pI41, DOI 10.1136/gut.51.suppl_1.i41; Brint EK, 2011, AM J GASTROENTEROL, V106, P329, DOI 10.1038/ajg.2010.438; Camilleri M, 2007, NEUROGASTROENT MOTIL, V19, P545, DOI 10.1111/j.1365-2982.2007.00925.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Coeffier M, 2003, AM J PHYSIOL-GASTR L, V285, pG266, DOI 10.1152/ajpgi.00385.2002; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Drossman DA, 2005, GASTROENTEROLOGY, V128, P580, DOI 10.1053/j.gastro.2004.12.006; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lecleire S, 2008, J NUTR, V138, P2481, DOI 10.3945/jn.108.099127; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ohman L, 2009, AM J GASTROENTEROL, V104, P1205, DOI 10.1038/ajg.2009.116; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; SRIKANTH CV, 2008, INTERDISCIP PERSPECT; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Szebeni B, 2007, J PEDIATR GASTR NUTR, V45, P187, DOI 10.1097/MPG.0b013e318064514a; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thompson WG, 1999, GUT, V45, P43; Zalar A, 2010, ANTIVIR RES, V87, P269, DOI 10.1016/j.antiviral.2010.05.005	32	95	105	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2012	7	8							e42777	10.1371/journal.pone.0042777	http://dx.doi.org/10.1371/journal.pone.0042777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996DG	23028414	gold, Green Published, Green Submitted			2022-12-25	WOS:000308063700022
J	Aoki, I; Higuchi, M; Gotoh, Y				Aoki, I.; Higuchi, M.; Gotoh, Y.			NEDDylation controls the target specificity of E2F1 and apoptosis induction	ONCOGENE			English	Article						apoptosis; cell cycle; E2F transcription factor; post-translational modification; NEDD8	DNA-DAMAGE; FAMILY-MEMBERS; CELL-CYCLE; TRANSCRIPTION; P73; NEDD8; DEGRADATION; ACTIVATION; PROTEINS; CHECKPOINT	The transcription factor E2F1 has pivotal roles in both cell proliferation and cell death, and is an important molecular target in cancer. Under proliferative conditions E2F1 induces the expression of genes that promote cell cycle progression, such as E2F2, whereas under proapoptotic conditions E2F1 induces expression of genes such as p73 that lead to apoptosis. The mechanism by which the apoptotic function of E2F1 is activated remains unclear, however. We now show that members of the E2F family are covalently conjugated with the ubiquitin-like modifier NEDD8. Overexpression of SENP8, a NEDD8-specific cysteine protease, resulted in deNEDDylation of E2F1 and promoted its transactivation activity at the p73 gene but not at the E2F2 gene. Knockdown of SENP8, on the other hand, attenuated p73 expression and apoptosis induced by E2F1 or by DNA damage. SENP8 also promoted the interaction between E2F1 and its cofactor Microcephalin 1, which is required for p73 induction. These results suggest that NEDDylation is a molecular trigger that modifies the target specificity of E2F1, and could have important implications for E2F1 regulation of apoptosis.	[Aoki, I.; Higuchi, M.; Gotoh, Y.] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	University of Tokyo	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ygotoh@iam.u-tokyo.ac.jp	Aoki, Ichiro/J-6578-2012	Aoki, Ichiro/0000-0001-5756-2723	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; CREST from the Japan Science and Technology Agency; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan; Grants-in-Aid for Scientific Research [22123003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Elizabeth Nigh and colleagues for critical reading of the manuscript. This work was supported by Grants-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by CREST from the Japan Science and Technology Agency. This work was also supported in part by the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; DeGregori J, 2006, CURR MOL MED, V6, P739; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Engels IH, 2009, ANAL BIOCHEM, V390, P85, DOI 10.1016/j.ab.2009.03.035; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hughes TA, 2005, BIOCHEM BIOPH RES CO, V329, P1267, DOI 10.1016/j.bbrc.2005.02.102; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Lin WC, 2001, GENE DEV, V15, P1833; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Watson IR, 2010, ONCOGENE, V29, P297, DOI 10.1038/onc.2009.314; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128	49	31	34	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3954	3964		10.1038/onc.2012.428	http://dx.doi.org/10.1038/onc.2012.428			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	23001041				2022-12-25	WOS:000323748100004
J	Coelho, C; Mahro, M; Trincao, J; Carvalho, ATP; Ramos, MJ; Terao, M; Garattini, E; Leimkuhler, S; Romao, MJ				Coelho, Catarina; Mahro, Martin; Trincao, Jose; Carvalho, Alexandra T. P.; Ramos, Maria Joao; Terao, Mineko; Garattini, Enrico; Leimkuehler, Silke; Romao, Maria Joao			The First Mammalian Aldehyde Oxidase Crystal Structure INSIGHTS INTO SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; XANTHINE-OXIDASE; MOLYBDO-FLAVOENZYMES; GENE-CLUSTER; ACTIVE-SITE; OXIDOREDUCTASE; DEHYDROGENASE; MECHANISM; PURIFICATION; INHIBITION	Aldehyde oxidases (AOXs) are homodimeric proteins belonging to the xanthine oxidase family of molybdenum-containing enzymes. Each 150-kDa monomer contains a FAD redox cofactor, two spectroscopically distinct [2Fe-2S] clusters, and a molybdenum cofactor located within the protein active site. AOXs are characterized by broad range substrate specificity, oxidizing different aldehydes and aromatic N-heterocycles. Despite increasing recognition of its role in the metabolism of drugs and xenobiotics, the physiological function of the protein is still largely unknown. We have crystallized and solved the crystal structure of mouse liver aldehyde oxidase 3 to 2.9 angstrom. This is the first mammalian AOX whose structure has been solved. The structure provides important insights into the protein active center and further evidence on the catalytic differences characterizing AOX and xanthine oxidoreductase. The mouse liver aldehyde oxidase 3 three-dimensional structure combined with kinetic, mutagenesis data, molecular docking, and molecular dynamics studies make a decisive contribution to understand the molecular basis of its rather broad substrate specificity.	[Coelho, Catarina; Trincao, Jose; Romao, Maria Joao] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte, P-2829516 Caparica, Portugal; [Mahro, Martin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Carvalho, Alexandra T. P.; Ramos, Maria Joao] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE, P-4169007 Oporto, Portugal; [Terao, Mineko; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, Dept Biochem & Mol Pharmacol, I-20156 Milan, Italy	Universidade Nova de Lisboa; University of Potsdam; Universidade do Porto; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Romao, MJ (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte, P-2829516 Caparica, Portugal.	maria.romao@fct.unl.pt	terao, mineko/AAU-8089-2020; Romao, Maria J/A-4115-2013; Garattini, Enrico/AAI-1998-2019; Carvalho, Alexandra T. P./J-1192-2018; UCIBIO, U Cienc Biom Apl/F-7948-2017; Coelho, Catarina M C/D-2073-2013; Terao, Mineko/AAA-6415-2020; Ramos, Maria J/D-6183-2013	Romao, Maria J/0000-0002-3004-0543; Carvalho, Alexandra T. P./0000-0003-2827-5527; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Coelho, Catarina M C/0000-0003-1852-5406; Terao, Mineko/0000-0002-9976-9869; Ramos, Maria J/0000-0002-7554-8324; Leimkuhler, Silke/0000-0003-3238-2122; Garattini, Enrico/0000-0001-8983-886X	Portuguese Science and Technology Foundation (FCT-MCTES) [PTDC/BIA-PRO/118377/2010, SFRH/BD/37948/2007]; Deutsche Forschungsgemeinschaft; DAAD-GRICES; Associazione Italiana per la Ricerca controil Cancro(AIRC); Fondazione Italo Monzino; Negri-Weizmann Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-PRO/118377/2010] Funding Source: FCT	Portuguese Science and Technology Foundation (FCT-MCTES)(Portuguese Foundation for Science and Technology); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD-GRICES(Deutscher Akademischer Austausch Dienst (DAAD)); Associazione Italiana per la Ricerca controil Cancro(AIRC)(Fondazione AIRC per la ricerca sul cancroEuropean Commission); Fondazione Italo Monzino; Negri-Weizmann Foundation; Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Science and Technology Foundation (FCT-MCTES) through Project PTDC/BIA-PRO/118377/2010 and Grant SFRH/BD/37948/2007(to C. C.) and by the Cluster of Excellence "Unifying Concepts in Catalysis" (to S. L. and M. M.) coordinated by the Technische Universitat Berlin and funded by the Deutsche Forschungsgemeinschaft. The exchange of researchers among laboratories was funded by the DAAD-GRICES program (to M. J. R. and S. L.). The work was also supported by grants from the Associazione Italiana per la Ricerca controil Cancro(AIRC), the Fondazione Italo Monzino, and the Negri-Weizmann Foundation (to E. G.).	Afonine P., 2005, CCP4 NEWSLETTER, V42; Alfaro JF, 2008, J ORG CHEM, V73, P9469, DOI 10.1021/jo801053u; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr JT, 2011, DRUG METAB DISPOS, V39, P2381, DOI 10.1124/dmd.111.041806; Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Garattini E, 2011, DRUG METAB REV, V43, P374, DOI 10.3109/03602532.2011.560606; Garattini Enrico, 2009, Human Genomics, V4, P119; GURTOO HL, 1971, J BIOL CHEM, V246, P286; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Kurosaki M, 2004, J BIOL CHEM, V279, P50482, DOI 10.1074/jbc.M408734200; Kuwabara Y, 2003, P NATL ACAD SCI USA, V100, P8170, DOI 10.1073/pnas.1431485100; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mahro M, 2011, DRUG METAB DISPOS, V39, P1939, DOI 10.1124/dmd.111.040873; McManaman JL, 1996, ARCH BIOCHEM BIOPHYS, V332, P135, DOI 10.1006/abbi.1996.0325; MORIWAKI Y, 1993, BIOCHEM PHARMACOL, V46, P975, DOI 10.1016/0006-2952(93)90661-F; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Obach RS, 2004, DRUG METAB DISPOS, V32, P89, DOI 10.1124/dmd.32.1.89; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Okamoto K, 2008, NUCLEOS NUCLEOT NUCL, V27, P888, DOI 10.1080/15257770802146577; Okamoto K, 2010, J AM CHEM SOC, V132, P17080, DOI 10.1021/ja1077574; Okamoto Ken, 2008, Journal of Nippon Medical School, V75, P2, DOI 10.1272/jnms.75.2; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; Schumann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005348; Team R.D.C, 2010, R LANG ENV STAT COMP; Terao M, 2000, J BIOL CHEM, V275, P30690, DOI 10.1074/jbc.M005355200; Terao M, 1998, BIOCHEM J, V332, P383, DOI 10.1042/bj3320383; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; Terao M, 2006, J BIOL CHEM, V281, P19748, DOI 10.1074/jbc.M600850200; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	52	80	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40690	40702		10.1074/jbc.M112.390419	http://dx.doi.org/10.1074/jbc.M112.390419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23019336	Green Published, hybrid			2022-12-25	WOS:000311448800058
J	Aleshin, AE; Drag, M; Gombosuren, N; Wei, G; Mikolajczyk, J; Satterthwait, AC; Strongin, AY; Liddington, RC; Salvesen, GS				Aleshin, Alexander E.; Drag, Marcin; Gombosuren, Naran; Wei, Ge; Mikolajczyk, Jowita; Satterthwait, Arnold C.; Strongin, Alex Y.; Liddington, Robert C.; Salvesen, Guy S.			Activity, Specificity, and Probe Design for the Smallpox Virus Protease K7L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADENOVIRUS PROTEINASE; UNEXPECTED SPECIFICITY; CRYSTAL-STRUCTURE; CLEAVAGE; UBIQUITIN; DNA; MORPHOGENESIS; POLYPEPTIDE; PROTEOLYSIS; PEPTIDASE	The K7L gene product of the smallpox virus is a protease implicated in the maturation of viral proteins. K7L belongs to protease Clan CE, which includes distantly related cysteine proteases from eukaryotes, pathogenic bacteria, and viruses. Here, we describe its recombinant high level expression, biochemical mechanism, substrate preference, and regulation. Earlier studies inferred that the orthologous I7L vaccinia protease cleaves at an AG-X motif in six viral proteins. Our data for K7L suggest that the AG-X motif is necessary but not sufficient for optimal cleavage activity. Thus, K7L requires peptides extended into the P7 and P8 positions for efficient substrate cleavage. Catalytic activity of K7L is substantially enhanced by homodimerization, by the substrate protein P25K as well as by glycerol. RNA and DNA also enhance cleavage of the P25K protein but not of synthetic peptides, suggesting that nucleic acids augment the interaction of K7L with its protein substrate. Library-based peptide preference analyses enabled us to design an activity-based probe that covalently and selectively labels K7L in lysates of transfected and infected cells. Our study thus provides proof-of-concept for the design of inhibitors and probes that may contribute both to a better understanding of the role of K7L in the virus life cycle and the design of novel anti-virals.	[Liddington, Robert C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; Sanford Burnham Med Res Inst, Program Infect Dis, La Jolla, CA 92037 USA; Sanford Burnham Med Res Inst, Program Tumor Microenvironm, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org; salvesen@sansfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [AI061139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI061139 (to R. C. L., G. S. S., and A. Y. S.).	Aleshin AE, 2009, STRUCTURE, V17, P1465, DOI 10.1016/j.str.2009.09.009; ANDERSON CW, 1990, VIROLOGY, V177, P259, DOI 10.1016/0042-6822(90)90479-B; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6855, DOI 10.1128/JVI.78.13.6855-6863.2004; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bayliss CD, 1997, NUCLEIC ACIDS RES, V25, P3984, DOI 10.1093/nar/25.20.3984; Brown MT, 2002, J BIOL CHEM, V277, P46298, DOI 10.1074/jbc.M202988200; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Byrd CA, 2003, J VIROL, V77, P11279, DOI 10.1128/JVI.77.20.11279-11283.2003; Byrd CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-63; Byrd CM, 2006, REV MED VIROL, V16, P187, DOI 10.1002/rmv.499; Byrd CM, 2004, J VIROL, V78, P12147, DOI 10.1128/JVI.78.22.12147-12156.2004; Byrd CM, 2002, J VIROL, V76, P8973, DOI 10.1128/JVI.76.17.8973-8976.2002; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; CHEN PH, 1993, J VIROL, V67, P3507, DOI 10.1128/JVI.67.6.3507-3514.1993; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Golicnik M, 2011, BIOCHEM ENG J, V53, P234, DOI 10.1016/j.bej.2010.10.012; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hedengren-Olcott M, 2004, J VIROL, V78, P9947, DOI 10.1128/JVI.78.18.9947-9953.2004; Isaacs S. N., 2004, VACCINIA VIRUS POXVI, P101; KANE EM, 1993, J VIROL, V67, P2689, DOI 10.1128/JVI.67.5.2689-2698.1993; Katritch V, 2007, J COMPUT AID MOL DES, V21, P549, DOI 10.1007/s10822-007-9138-7; KATZ E, 1970, P NATL ACAD SCI USA, V66, P677, DOI 10.1073/pnas.66.3.677; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; LEE PY, 1995, VIROLOGY, V207, P229, DOI 10.1006/viro.1995.1069; LEE PY, 1993, J VIROL, V67, P4252, DOI 10.1128/JVI.67.7.4252-4263.1993; LEE PY, 1994, J BIOL CHEM, V269, P8616; LOPEZOTIN C, 1989, J BIOL CHEM, V264, P9107; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; Moss B, 2001, FIELDS VIROLOGY, P2849; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Vedrenne E, 2005, SYNLETT, P670, DOI 10.1055/s-2005-862375; WHITEHEAD SS, 1994, J VIROL, V68, P7603, DOI 10.1128/JVI.68.11.7603-7608.1994; Yang SJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-73	47	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.388678	http://dx.doi.org/10.1074/jbc.M112.388678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012361	hybrid, Green Published			2022-12-25	WOS:000311233800019
J	Faure, E; Starek, G; McGuire, H; Berneche, S; Blunck, R				Faure, Elise; Starek, Greg; McGuire, Hugo; Berneche, Simon; Blunck, Rikard			A Limited 4 angstrom Radial Displacement of the S4-S5 Linker Is Sufficient for Internal Gate Closing in Kv Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SHAKER POTASSIUM CHANNEL; VOLTAGE-SENSING RESIDUES; DEPENDENT K+ CHANNEL; GATING CHARGE; STRUCTURAL BASIS; LIPID-MEMBRANE; RESTING STATE; CLOSED-STATE; SENSOR	Voltage-gated ion channels are responsible for the generation of action potentials in our nervous system. Conformational rearrangements in their voltage sensor domains in response to changes of the membrane potential control pore opening and thus ion conduction. Crystal structures of the open channel in combination with a wealth of biophysical data and molecular dynamics simulations led to a consensus on the voltage sensor movement. However, the coupling between voltage sensor movement and pore opening, the electromechanical coupling, occurs at the cytosolic face of the channel, from where no structural information is available yet. In particular, the question how far the cytosolic pore gate has to close to prevent ion conduction remains controversial. In cells, spectroscopic methods are hindered because labeling of internal sites remains difficult, whereas liposomes or detergent solutions containing purified ion channels lack voltage control. Here, to overcome these problems, we controlled the state of the channel by varying the lipid environment. This way, we directly measured the position of the S4-S5 linker in both the open and the closed state of a prokaryotic Kv channel (KvAP) in a lipid environment using Lanthanide-based resonance energy transfer. We were able to reconstruct the movement of the covalent link between the voltage sensor and the pore domain and used this information as restraints for molecular dynamics simulations of the closed state structure. We found that a small decrease of the pore radius of about 3-4 angstrom is sufficient to prevent ion permeation through the pore.	[McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Faure, Elise; McGuire, Hugo; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ H3C 3J7, Canada; [Faure, Elise; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Starek, Greg; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [Starek, Greg; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Starek, Greg] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Swiss Institute of Bioinformatics; University of Basel; University of Basel; University of California System; University of California Irvine	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Bernèche, Simon/L-6389-2013; Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Bernèche, Simon/0000-0002-6274-4094; Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research Grant [MOP-102689]; Canadian Foundation for Innovation; Swiss National Science Foundation [118928]; Fonds de recherche du Quebec - Nature et technologies (FRQNT); Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes for Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds de recherche du Quebec - Nature et technologies (FRQNT); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was funded by the Canadian Institutes for Health Research Grant MOP-102689 (to R. B.), the Canadian Foundation for Innovation (to R. B.), and the Swiss National Science Foundation (SNF-Professorship Number 118928) (to S. B).; Recipients of student fellowships of Fonds de recherche du Quebec - Nature et technologies (FRQNT).; We thank Mireille Marsolais and Michel Brunette for technical assistance and Drs. William Skene and Matthieu Starck for help in synthesizing terbium chelate. The molecular dynamics simulations were performed at the Swiss National Super-computing Center (CSCS). GEPROM is a research group funded by the Fonds de la recherche en sante du Quebec (FRSQ).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ashcroft F., 1999, ION CHANNELS DIS, P97; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chapman ML, 2005, J GEN PHYSIOL, V126, P87, DOI 10.1085/jgp.200509253; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Ge PH, 2003, BIOCONJUGATE CHEM, V14, P870, DOI 10.1021/bc034029e; Haddad GA, 2011, J GEN PHYSIOL, V137, P455, DOI 10.1085/jgp.201010573; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Lin MCA, 2010, J GEN PHYSIOL, V135, P415, DOI 10.1085/jgp.200910320; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramu Y, 2007, P NATL ACAD SCI USA, V104, P6448, DOI 10.1073/pnas.0701354104; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Xu XP, 2008, EPILEPSY RES, V80, P57, DOI 10.1016/j.eplepsyres.2008.03.013; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	53	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.415497	http://dx.doi.org/10.1074/jbc.M112.415497			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019337	Green Published, hybrid			2022-12-25	WOS:000311233800076
J	Grinter, R; Roszak, AW; Cogdell, RJ; Milner, JJ; Walker, D				Grinter, Rhys; Roszak, Aleksander W.; Cogdell, Richard J.; Milner, Joel J.; Walker, Daniel			The Crystal Structure of the Lipid II-degrading Bacteriocin Syringacin M Suggests Unexpected Evolutionary Relationships between Colicin M-like Bacteriocins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; IMMUNITY PROTEIN; PEPTIDOGLYCAN PRECURSORS; DOMAIN; MAGNESIUM; BINDING; ENZYME; SUPERFAMILY; SELECTION	Colicin-like bacteriocins show potential as next generation antibiotics with clinical and agricultural applications. Key to these potential applications is their high potency and species specificity that enables a single pathogenic species to be targeted with minimal disturbance of the wider microbial community. Here we present the structure and function of the colicin M-like bacteriocin, syringacin M from Pseudomonas syringae pv. tomato DC3000. Syringacin M kills susceptible cells through a highly specific phosphatase activity that targets lipid II, ultimately inhibiting peptidoglycan synthesis. Comparison of the structures of syringacin M and colicin M reveals that, in addition to the expected similarity between the homologous C-terminal catalytic domains, the receptor binding domains of these proteins, which share no discernible sequence homology, share a striking structural similarity. This indicates that the generation of the novel receptor binding and species specificities of these bacteriocins has been driven by diversifying selection rather than diversifying recombination as suggested previously. Additionally, the structure of syringacin M reveals the presence of an active site calcium ion that is coordinated by a conserved aspartic acid side chain and is essential for catalytic activity. We show that mutation of this residue to alanine inactivates syringacin M and that the metal ion is absent from the structure of the mutant protein. Consistent with the presence of Ca2+ in the active site, we show that syringacin M activity is supported by Ca2+, along with Mg2+ and Mn2+, and the protein is catalytically inactive in the absence of these ions.	[Grinter, Rhys; Walker, Daniel] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Cogdell, Richard J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8TA, Lanark, Scotland; [Milner, Joel J.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Roszak, Aleksander W.] Univ Glasgow, Coll Sci & Engn, Sch Chem, WestCHEM, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Walker, D (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.	Daniel.Walker@glasgow.ac.uk		Walker, Daniel/0000-0002-4206-2942; Grinter, Rhys/0000-0002-8195-5348				Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; BAJAJ M, 1984, ANNU REV BIOPHYS BIO, V13, P453; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHANG CF, 1986, J BACTERIOL, V167, P935, DOI 10.1128/jb.167.3.935-939.1986; Chuang DY, 2007, J BACTERIOL, V189, P620, DOI 10.1128/JB.01090-06; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldgarden M, 1998, EVOLUTION, V52, P1270, DOI 10.1111/j.1558-5646.1998.tb02008.x; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; GRAHAM AC, 1977, J BACTERIOL, V130, P1214, DOI 10.1128/JB.130.3.1214-1223.1977; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P140; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Roh E, 2010, APPL ENVIRON MICROB, V76, P7541, DOI 10.1128/AEM.03103-09; SANO Y, 1993, J BACTERIOL, V175, P6179, DOI 10.1128/JB.175.19.6179-6185.1993; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Tummler B, 2005, J BACTERIOL, V187, P3289, DOI 10.1128/JB.187.10.3289-3292.2005; Uson I, 2012, J STRUCT BIOL, V178, P45, DOI 10.1016/j.jsb.2012.02.004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker D, 2003, BIOCHEMISTRY-US, V42, P4161, DOI 10.1021/bi0273720; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojdyla JA, 2012, J MOL BIOL, V417, P79, DOI 10.1016/j.jmb.2012.01.019; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200; Zhang XYZ, 2010, J BIOL CHEM, V285, P38053, DOI 10.1074/jbc.M110.144071; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	59	26	26	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38876	38888		10.1074/jbc.M112.400150	http://dx.doi.org/10.1074/jbc.M112.400150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995910	hybrid, Green Published			2022-12-25	WOS:000310982800044
J	Ma, Y; Li, CL; Gu, JJ; Tang, F; Li, C; Li, P; Ping, P; Yang, S; Li, Z; Jin, Y				Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Li, Peng; Ping, Ping; Yang, Shi; Li, Zheng; Jin, Ying			Aberrant Gene Expression Profiles in Pluripotent Stem Cells Induced from Fibroblasts of a Klinefelter Syndrome Patient	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME INACTIVATION; DIFFERENTIATION; DERIVATION; PROTEINS; DISEASE; LINES	Klinefelter syndrome (KS) is the most common male chromosome aneuploidy. Its pathophysiology is largely unexplained due to the lack of adequate models. Here, we report the derivation of induced pluripotent stem cell (iPSCs) lines from a KS patient with a karyotype of 47, XXY. Derived KS-iPSCs meet all criteria of normal iPSCs with the potential for germ cell differentiation. Although X chromosome inactivation occurs in all KS-iPSCs, genome-wide transcriptome analysis identifies aberrantly expressed genes associated with the clinical features of KS. Our KS-iPSCs can serve as a cellular model for KS research. Identified genes may become biomarkers for early diagnosis or potential therapeutic targets for KS and significantly accelerate the understanding, diagnosis, and treatment of Klinefelter syndrome.	[Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China; [Li, Peng; Ping, Ping; Yang, Shi; Li, Zheng] Shanghai Jiao Tong Univ, Dept Urol,Sperm Dev & Genet Lab, Shanghai Human Sperm Bank,Shanghai Inst Androl, Renji Hosp,Sch Med, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, Z (corresponding author), 145 Shandong Zhong Rd, Shanghai 200001, Peoples R China.	doc.zheng.li@gmail.com; yjin@sibs.ac.cn	, chunliang.li@stjude.org/P-4373-2018	, chunliang.li@stjude.org/0000-0002-5938-5510; , jin ying/0000-0003-0070-2048	National High Technology Research and Development Program of China [2010CB945200, 2011DFB300100, 2011CB965101, 2009CB941103]; National Natural Science Foundation [91019023]; Chinese Academy of Science [XDA01010102]; Shanghai Leading Academic Discipline Project [S30201]; Shanghai Municipal Education Commission [10ZZ70]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by National High Technology Research and Development Program of China Grants 2010CB945200, 2011DFB300100, 2011CB965101, and 2009CB941103, National Natural Science Foundation Grant 91019023, Chinese Academy of Science Grant XDA01010102, Shanghai Leading Academic Discipline Project Grant S30201, and Key Project of Shanghai Municipal Education Commission Grant 10ZZ70.	Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bojesen A, 2011, OSTEOPOROSIS INT, V22, P1441, DOI 10.1007/s00198-010-1354-7; Brinton LA, 2011, ACTA PAEDIATR, V100, P814, DOI 10.1111/j.1651-2227.2010.02131.x; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Forti G, 2010, SEX DEV, V4, P249, DOI 10.1159/000316604; Giltay JC, 2010, EXPERT REV MOL DIAGN, V10, P765, DOI [10.1586/erm.10.63, 10.1586/ERM.10.63]; Gravholt CH, 2011, ACTA PAEDIATR, V100, P871, DOI 10.1111/j.1651-2227.2011.02233.x; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Iitsuka Y, 2001, AM J MED GENET, V98, P25, DOI 10.1002/1096-8628(20010101)98:1<25::AID-AJMG1015>3.3.CO;2-O; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Li CL, 2010, IN VITRO CELL DEV-AN, V46, P186, DOI 10.1007/s11626-010-9304-4; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006724; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Poplinski A, 2010, EUR J ENDOCRINOL, V162, P169, DOI 10.1530/EJE-09-0768; Ross JL, 2008, AM J MED GENET A, V146A, P708, DOI 10.1002/ajmg.a.32232; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Scofield RH, 2008, ARTHRITIS RHEUM-US, V58, P2511, DOI 10.1002/art.23701; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tuttelmann F, 2010, MOL HUM REPROD, V16, P386, DOI 10.1093/molehr/gaq019; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454	34	24	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38970	38979		10.1074/jbc.M112.380204	http://dx.doi.org/10.1074/jbc.M112.380204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019320	Green Published, hybrid			2022-12-25	WOS:000310982800053
J	Manzo, C; Torreno-Pina, JA; Joosten, B; Reinieren-Beeren, I; Gualda, EJ; Loza-Alvarez, P; Figdor, CG; Garcia-Parajo, MF; Cambi, A				Manzo, Carlo; Torreno-Pina, Juan A.; Joosten, Ben; Reinieren-Beeren, Inge; Gualda, Emilio J.; Loza-Alvarez, Pablo; Figdor, Carl G.; Garcia-Parajo, Maria F.; Cambi, Alessandra			The Neck Region of the C-type Lectin DC-SIGN Regulates Its Surface Spatiotemporal Organization and Virus-binding Capacity on Antigen-presenting Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC-CELL; IN-VIVO; IMMUNODEFICIENCY-VIRUS; LATERAL MOBILITY; RECEPTOR; INFECTION; MICRODOMAINS; MICROSCOPY; MECHANISM; ADHESION	The C-type lectin DC-SIGN expressed on dendritic cells (DCs) facilitates capture and internalization of a plethora of different pathogens. Although it is known that DC-SIGN organizes in nanoclusters at the surface of DCs, the molecular mechanisms responsible for this well defined nanopatterning and role in viral binding remain enigmatic. By combining biochemical and advanced biophysical techniques, including optical super-resolution and single particle tracking, we demonstrate that DC-SIGN intrinsic nanoclustering strictly depends on its molecular structure. DC-SIGN nanoclusters exhibited free, Brownian diffusion on the cell membrane. Truncation of the extracellular neck region, known to abrogate tetramerization, significantly reduced nanoclustering and concomitantly increased lateral diffusion. Importantly, DC-SIGN nanocluster dissolution exclusively compromised binding to nanoscale size pathogens. Monte Carlo simulations revealed that heterogeneity on nanocluster density and spatial distribution confers broader binding capabilities to DC-SIGN. As such, our results underscore a direct relationship between spatial nanopatterning, driven by intermolecular interactions between the neck regions, and receptor diffusion to provide DC-SIGN with the exquisite ability to dock pathogens at the virus length scale. Insight into how virus receptors are organized prior to virus binding and how they assemble into functional platforms for virus docking is helpful to develop novel strategies to prevent virus entry and infection.	[Manzo, Carlo; Torreno-Pina, Juan A.; Gualda, Emilio J.; Loza-Alvarez, Pablo; Garcia-Parajo, Maria F.] Inst Ciencies Fotoniques, Castelldefels 08860, Barcelona, Spain; [Joosten, Ben; Reinieren-Beeren, Inge; Figdor, Carl G.; Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Garcia-Parajo, Maria F.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Cambi, Alessandra] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Nanobiophys Grp, NL-7500 AE Enschede, Netherlands	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Radboud University Nijmegen; ICREA; University of Twente	Garcia-Parajo, MF (corresponding author), Inst Ciencies Fotoniques, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain.	maria.garcia-parajo@icfo.es; a.cambi@ncmls.ru.nl	Joosten, Ben HGM/Q-5527-2016; Figdor, Carl G/A-4232-2010; Loza-Alvarez, Pablo/AAA-9118-2020; Garcia-Parajo, Maria F./I-4610-2015; Gualda, Emilio J/C-8935-2014; Loza Alvarez, Pablo/M-2564-2014; Torreno-Pina, Juan Andres/P-3010-2014; Manzo, Carlo/B-9745-2012; Cambi, Alessandra/L-4242-2015	Figdor, Carl G/0000-0002-2366-9212; Loza-Alvarez, Pablo/0000-0002-3129-1213; Garcia-Parajo, Maria F./0000-0001-6618-3944; Gualda, Emilio J/0000-0001-5948-5493; Loza Alvarez, Pablo/0000-0002-3129-1213; Manzo, Carlo/0000-0002-8625-0996; Cambi, Alessandra/0000-0003-1597-1582	Spanish Ministry of Science and Technology [MAT2010-19898]; Generalitat de Catalunya [2009 SGR 597]; Netherlands Organization for Scientific Research (NWO) [916.66.028]; Human Frontier Science Program Young Investigator grant; NWO TOP; ICREA Funding Source: Custom	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Human Frontier Science Program Young Investigator grant(Human Frontier Science Program); NWO TOP(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Technology Grant MAT2010-19898 and Generalitat de Catalunya Grant 2009 SGR 597 (to M. F. G.-P.), Netherlands Organization for Scientific Research (NWO) Veni Grant 916.66.028 and a Human Frontier Science Program Young Investigator grant (to A. C.), and partially by an NWO TOP grant (to C. G. F.).	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Cambi A, 2009, EUR J IMMUNOL, V39, P1923, DOI 10.1002/eji.200939351; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gaborski TR, 2008, BIOPHYS J, V95, P4934, DOI 10.1529/biophysj.108.132886; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Itano MS, 2012, BIOPHYS J, V102, P1534, DOI 10.1016/j.bpj.2012.02.022; Itano MS, 2011, BIOPHYS J, V100, P2662, DOI 10.1016/j.bpj.2011.04.044; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Liu P, 2012, TRAFFIC, V13, P715, DOI 10.1111/j.1600-0854.2012.01337.x; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Ludwig IS, 2004, J VIROL, V78, P8322, DOI 10.1128/jvi.78.15.8322-8332.2004; Menon S, 2009, P NATL ACAD SCI USA, V106, P11524, DOI 10.1073/pnas.0901783106; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Regan AD, 2008, J VIROL, V82, P11992, DOI 10.1128/JVI.01094-08; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Sierra-Filardi E, 2010, MOL IMMUNOL, V47, P840, DOI 10.1016/j.molimm.2009.09.036; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tacken PJ, 2011, BLOOD, V118, P4111, DOI 10.1182/blood-2011-04-346957; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Yu QD, 2009, J MOL BIOL, V387, P1075, DOI 10.1016/j.jmb.2009.02.046; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	50	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38946	38955		10.1074/jbc.M112.380121	http://dx.doi.org/10.1074/jbc.M112.380121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019323	hybrid, Green Published			2022-12-25	WOS:000310982800050
J	Serventi, F; Youard, ZA; Murset, V; Huwiler, S; Buhler, D; Richter, M; Luchsinger, R; Fischer, HM; Brogioli, R; Niederer, M; Hennecke, H				Serventi, Fabio; Youard, Zeb Andrew; Murset, Valerie; Huwiler, Simona; Buehler, Doris; Richter, Miriam; Luchsinger, Ronny; Fischer, Hans-Martin; Brogioli, Robert; Niederer, Martina; Hennecke, Hauke			Copper Starvation-inducible Protein for Cytochrome Oxidase Biogenesis in Bradyrhizobium japonicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; RHIZOBIUM-JAPONICUM; AEROBIC RESPIRATION; NITROGEN-FIXATION; GENES; INSIGHTS; BINDING; IDENTIFICATION; SUPERFAMILY; ACQUISITION	Microarray analysis of Bradyrhizobium japonicum grown under copper limitation uncovered five genes named pcuABCDE, which are co-transcribed and co-regulated as an operon. The predicted gene products are periplasmic proteins (PcuA, PcuC, and PcuD), a TonB-dependent outer membrane receptor (PcuB), and a cytoplasmic membrane-integral protein (PcuE). Homologs of PcuC and PcuE had been discovered in other bacteria, namely PCuAC and YcnJ, where they play a role in cytochrome oxidase biogenesis and copper transport, respectively. Deletion of the pcuABCDE operon led to a pleiotropic phenotype, including defects in the aa(3)-type cytochrome oxidase, symbiotic nitrogen fixation, and anoxic nitrate respiration. Complementation analyses revealed that, under our assay conditions, the tested functions depended only on the pcuC gene and not on pcuA, pcuB, pcuD, or pcuE. The B. japonicum genome harbors a second pcuC-like gene (blr7088), which, however, did not functionally replace the mutated pcuC. The PcuC protein was overexpressed in Escherichia coli, purified to homogeneity, and shown to bind Cu(I) with high affinity in a 1: 1 stoichiometry. The replacement of His(79), Met(90), His(113), and Met(115) by alanine perturbed copper binding. This corroborates the previously purported role of this protein as a periplasmic copper chaperone for the formation of the Cu-A center on the aa(3)-type cytochrome oxidase. In addition, we provide evidence that PcuC and the copper chaperone ScoI are important for the symbiotically essential, Cu-A-free cbb(3)-type cytochrome oxidase specifically in endosymbiotic bacteroids of soybean root nodules, which could explain the symbiosis-defective phenotype of the pcuC and scoI mutants.	[Serventi, Fabio; Youard, Zeb Andrew; Murset, Valerie; Huwiler, Simona; Buehler, Doris; Richter, Miriam; Luchsinger, Ronny; Fischer, Hans-Martin; Hennecke, Hauke] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Brogioli, Robert] Swiss Fed Inst Technol, Inorgan Chem Lab, CH-8093 Zurich, Switzerland; [Niederer, Martina] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hennecke, H (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hennecke@micro.biol.ethz.ch	Huwiler, Simona G./AAK-1322-2020	Huwiler, Simona G./0000-0002-4876-9308	Swiss National Foundation for Scientific Research; ETH Zurich	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by grants from the Swiss National Foundation for Scientific Research and the ETH Zurich.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Arunothayanan H, 2010, PLANT CELL PHYSIOL, V51, P1242, DOI 10.1093/pcp/pcq079; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Beck C, 1997, J BACTERIOL, V179, P364, DOI 10.1128/jb.179.2.364-369.1997; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BENDER CL, 1986, J BACTERIOL, V165, P534, DOI 10.1128/jb.165.2.534-541.1986; BISHOP PE, 1976, PLANT PHYSIOL, V57, P542, DOI 10.1104/pp.57.4.542; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhler D, 2010, J BIOL CHEM, V285, P15704, DOI 10.1074/jbc.M109.085217; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Cawthorn TR, 2009, BIOCHEMISTRY-US, V48, P4448, DOI 10.1021/bi802288m; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANIEL RM, 1972, BIOCHIM BIOPHYS ACTA, V275, P347, DOI 10.1016/0005-2728(72)90215-0; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2680, DOI 10.1073/pnas.87.7.2680; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; HAHN M, 1984, MOL GEN GENET, V193, P46, DOI 10.1007/BF00327412; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Miller J. H., 1972, EXPT MOL GENETICS, P433; NICHOLAS DJD, 1957, METHOD ENZYMOL, V3, P981; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; SMITH GF, 1953, ANAL CHEM, V25, P510, DOI 10.1021/ac60075a037; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; Thompson AK, 2010, BIOCHEMISTRY-US, V49, P5651, DOI 10.1021/bi1003876; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1991, J BIOENERG BIOMEMBR, V23, P257, DOI 10.1007/BF00762221; Velasco L, 2001, BBA-GENE STRUCT EXPR, V1521, P130, DOI 10.1016/S0167-4781(01)00279-2; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; ZAK B, 1958, CLIN CHIM ACTA, V3, P328, DOI 10.1016/0009-8981(58)90021-4; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467	63	30	30	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38812	38823		10.1074/jbc.M112.406173	http://dx.doi.org/10.1074/jbc.M112.406173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012364	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000310982800038
J	Lee, RJ; Foskett, JK				Lee, Robert J.; Foskett, J. Kevin			Why Mouse Airway Submucosal Gland Serous Cells Do Not Secrete Fluid in Response to cAMP Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYSTIC-FIBROSIS; MUCUS SECRETION; ACINAR-CELLS; CL-SECRETION; CFTR GENE; ACTIVATION; MODEL; MODULATION; PORCINE	Airway submucosal glands are important sites of cystic fibrosis transmembrane conductance regulator (CFTR) chloride (Cl-) channel expression and fluid secretion in the airway. Whereas both mouse and human submucosal glands and their serous acinar cells express CFTR, human glands and serous cells secrete much more robustly than mouse cells/glands in response to cAMP-generating agonists such as forskolin and vasoactive intestinal peptide. In this study, we examined mouse and human serous acinar cells to explain this difference and reveal further insights into the mechanisms of serous cell secretion. We found that mouse serous cells possess a robust cAMP-activated CFTR-dependent Cl- permeability, but they lack cAMP-activated calcium (Ca2+) signaling observed in human cells. Similar to human cells, basal K+ conductance is extremely small in mouse acinar cells. Lack of cAMP-activated Ca2+ signaling in mouse cells results in the absence of K+ conductances required for secretion. However, cAMP activates CFTR-dependent fluid secretion during low-level cholinergic stimulation that fails to activate secretion on its own. Robust CFTR-dependent fluid secretion was also observed when cAMP stimulation was combined with direct pharmacological activation of epithelial K+ channels with 1-ethyl-2-benzimidazolinone (EBIO). Our data suggest that mouse serous cells lack cAMP-mediated Ca2+ signaling to activate basolateral membrane K+ conductance, resulting in weak cAMP-driven serous cell fluid secretion, providing the likely explanation for reduced cAMP-driven secretion observed in mouse compared with human glands.	[Lee, Robert J.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, 726 Clin Res Bldg, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Foskett, J. Kevin/0000-0002-8854-0268	Cystic Fibrosis Foundation [LEE09F0, FOSKET11G0]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a Cystic Fibrosis Foundation postdoctoral fellowship (to R. J. L.) (LEE09F0) and a research grant (to J. K. F.) (FOSKET11G0).	Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Boucher R C, 2001, Trans Am Clin Climatol Assoc, V112, P99; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Cuthbert AW, 1999, AM J PHYSIOL-CELL PH, V277, pC111, DOI 10.1152/ajpcell.1999.277.1.C111; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; DHO S, 1993, BIOCHIM BIOPHYS ACTA, V1152, P83, DOI 10.1016/0005-2736(93)90234-Q; FOSKETT JK, 1988, AM J PHYSIOL, V255, pC566, DOI 10.1152/ajpcell.1988.255.4.C566; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; FOSKETT JK, 1989, P NATL ACAD SCI USA, V86, P167, DOI 10.1073/pnas.86.1.167; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Hougaard C, 2009, J PHARMACOL EXP THER, V328, P28, DOI 10.1124/jpet.108.143123; Ianowski JP, 2007, J PHYSIOL-LONDON, V580, P301, DOI 10.1113/jphysiol.2006.123653; Ianowski JP, 2008, PFLUG ARCH EUR J PHY, V457, P529, DOI 10.1007/s00424-008-0527-0; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; MacVinish LJ, 2001, PFLUG ARCH EUR J PHY, V443, pS127; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	43	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412817	http://dx.doi.org/10.1074/jbc.M112.412817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989883	Green Published, hybrid			2022-12-25	WOS:000310642200064
J	Vandersteen, A; Masman, MF; De Baets, G; Jonckheere, W; van der Werf, K; Marrink, SJ; Rozenski, J; Benilova, I; De Strooper, B; Subramaniam, V; Schymkowitz, J; Rousseau, F; Broersen, K				Vandersteen, Annelies; Masman, Marcelo F.; De Baets, Greet; Jonckheere, Wim; van der Werf, Kees; Marrink, Siewert J.; Rozenski, Jef; Benilova, Iryna; De Strooper, Bart; Subramaniam, Vinod; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa			Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-beta Peptide Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN A-BETA; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; IN-SILICO; MECHANISM; A-BETA-42	Current therapeutic approaches under development for Alzheimer disease, including gamma-secretase modulating therapy, aim at increasing the production of A beta(1-38) and A beta(1-40) at the cost of longer A beta peptides. Here, we consider the aggregation of A beta(1-38) and A beta(1-43) in addition to A beta(1-40) and A beta(1-42), in particular their behavior in mixtures representing the complex in vivo A beta pool. We demonstrate that A beta(1-38) and A beta(1-43) aggregate similar to A beta(1-40) and A beta(1-42), respectively, but display a variation in the kinetics of assembly and toxicity due to differences in short timescale conformational plasticity. In biologically relevant mixtures of A beta, A beta(1-38) and A beta(1-43) significantly affect the behaviors of A beta(1-40) and A beta(1-42). The short timescale conformational flexibility of A beta(1-38) is suggested to be responsible for enhancing toxicity of A beta(1-40) while exerting a cyto-protective effect on A beta(1-42). Our results indicate that the complex in vivo A beta peptide array and variations thereof is critical in Alzheimer disease, which can influence the selection of current and new therapeutic strategies.	[Broersen, Kerensa] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, Nanobiophys Grp, NL-7500 AE Enschede, Netherlands; [Vandersteen, Annelies; van der Werf, Kees; Subramaniam, Vinod; Broersen, Kerensa] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Schymkowitz, Joost; Rousseau, Frederic] VIB, SWITCH Lab, B-3000 Louvain, Belgium; [Vandersteen, Annelies; De Baets, Greet; Schymkowitz, Joost; Rousseau, Frederic] Katholieke Univ Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Broersen, Kerensa] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Broersen, Kerensa] VIB, B-1050 Brussels, Belgium; [Masman, Marcelo F.] Univ Groningen, Dept Mol Neurobiol, NL-9747 AG Groningen, Netherlands; [Masman, Marcelo F.; Marrink, Siewert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Masman, Marcelo F.; Marrink, Siewert J.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Rozenski, Jef] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] Katholieke Univ Leuven VIB, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	University of Twente; University of Twente; Flanders Institute for Biotechnology (VIB); KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Groningen; University of Groningen; University of Groningen; KU Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Broersen, K (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, Nanobiophys Grp, POB 217, NL-7500 AE Enschede, Netherlands.	k.broersen@utwente.nl	Institute, Zernike/W-7033-2019; Subramaniam, Vinod/B-4197-2010; Marrink, Siewert J/G-3706-2014; Rousseau, Frederic/J-9044-2016; De Strooper, Bart/F-6507-2012; Benilova, Iryna/H-6533-2019; Schymkowitz, Joost/AAV-3680-2021; de+Strooper, Bart/Z-1638-2019; De Baets, Greet/J-1881-2014; Schymkowitz, Joost/K-7764-2016	Subramaniam, Vinod/0000-0001-6712-7266; Marrink, Siewert J/0000-0001-8423-5277; Rousseau, Frederic/0000-0002-9189-7399; De Strooper, Bart/0000-0001-5455-5819; De Baets, Greet/0000-0001-8844-800X; Schymkowitz, Joost/0000-0003-2020-0168; Masman, Marcelo Fabricio/0000-0002-9849-3901; Rozenski, Jef/0000-0001-9624-5536	Agency for Innovation by Science and Technology in Flanders (IWT); "Stichting voor Alzheimer Onderzoek" (SAO); Odysseus grant from the National Funds for Scientific Research Flanders (FWO); Alzheimer Research UK (ARUK) grant; European Molecular Biology Organization Short-term Fellowship	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); "Stichting voor Alzheimer Onderzoek" (SAO); Odysseus grant from the National Funds for Scientific Research Flanders (FWO)(FWO); Alzheimer Research UK (ARUK) grant(Alzheimer's Research UK (ARUK)); European Molecular Biology Organization Short-term Fellowship	This work was supported by the Agency for Innovation by Science and Technology in Flanders (IWT), a project grant from the "Stichting voor Alzheimer Onderzoek" (SAO), an Odysseus grant from the National Funds for Scientific Research Flanders (FWO), an Alzheimer Research UK (ARUK) grant, and a European Molecular Biology Organization Short-term Fellowship.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bibl M, 2007, J NEURAL TRANSM, V114, P621, DOI 10.1007/s00702-006-0618-z; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borreguero JM, 2005, P NATL ACAD SCI USA, V102, P6015, DOI 10.1073/pnas.0502006102; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Golde TE, 2012, EMBO J, V31, P2237, DOI 10.1038/emboj.2012.111; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Laino C, 2009, NEUROL TODAY, V9, P21; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lewczuk P, 2003, RAPID COMMUN MASS SP, V17, P1291, DOI 10.1002/rcm.1048; Maddalena AS, 2004, NEURODEGENER DIS, V1, P231, DOI 10.1159/000080991; Mann DMA, 1996, AM J PATHOL, V148, P1257; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rohrig UF, 2006, BIOPHYS J, V91, P3217, DOI 10.1529/biophysj.106.088542; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wisniewski T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S5; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	63	34	35	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36732	36743		10.1074/jbc.M112.394635	http://dx.doi.org/10.1074/jbc.M112.394635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22992745	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000310588500011
J	Andersen, JM; Barrangou, R; Abou Hachem, M; Lahtinen, SJ; Goh, YJ; Svensson, B; Klaenhammer, TR				Andersen, Joakim Mark; Barrangou, Rodolphe; Abou Hachem, Maher; Lahtinen, Sampo J.; Goh, Yong-Jun; Svensson, Birte; Klaenhammer, Todd R.			Transcriptional Analysis of Prebiotic Uptake and Catabolism by Lactobacillus acidophilus NCFM	PLOS ONE			English	Article							FRUCTOOLIGOSACCHARIDE UTILIZATION; GALACTO-OLIGOSACCHARIDES; COMPARATIVE GENOMICS; FUNCTIONAL-ANALYSIS; DOUBLE-BLIND; SYSTEM; METABOLISM; PROBIOTICS; OPERON; INTEGRATION	The human gastrointestinal tract can be positively modulated by dietary supplementation of probiotic bacteria in combination with prebiotic carbohydrates. Here differential transcriptomics and functional genomics were used to identify genes in Lactobacillus acidophilus NCFM involved in the uptake and catabolism of 11 potential prebiotic compounds consisting of alpha- and beta-linked galactosides and glucosides. These oligosaccharides induced genes encoding phosphoenolpyruvate-dependent sugar phosphotransferase systems (PTS), galactoside pentose hexuronide (GPH) permease, and ATP-binding cassette (ABC) transporters. PTS systems were upregulated primarily by di- and tri-saccharides such as cellobiose, isomaltose, isomaltulose, panose and gentiobiose, while ABC transporters were upregulated by raffinose, Polydextrose, and stachyose. A single GPH transporter was induced by lactitol and galactooligosaccharides (GOS). The various transporters were associated with a number of glycoside hydrolases from families 1, 2, 4, 13, 32, 36, 42, and 65, involved in the catabolism of various alpha- and beta-linked glucosides and galactosides. Further subfamily specialization was also observed for different PTS-associated GH1 6-phospho-beta-glucosidases implicated in the catabolism of gentiobiose and cellobiose. These findings highlight the broad oligosaccharide metabolic repertoire of L. acidophilus NCFM and establish a platform for selection and screening of both probiotic bacteria and prebiotic compounds that may positively influence the gastrointestinal microbiota.	[Andersen, Joakim Mark; Goh, Yong-Jun; Klaenhammer, Todd R.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Andersen, Joakim Mark; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Barrangou, Rodolphe] DuPont Nutr & Hlth, Madison, WI USA; [Lahtinen, Sampo J.] DuPont Nutr & Hlth, Kantvik, Finland	University of North Carolina; North Carolina State University; Technical University of Denmark; DuPont	Klaenhammer, TR (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	klaenhammer@ncsu.edu	Abou Hachem, Maher/M-4772-2019; Barrangou, Rodolphe/I-2878-2014	Abou Hachem, Maher/0000-0001-8250-1842; Barrangou, Rodolphe/0000-0002-0648-3504; Andersen, Joakim/0000-0001-8902-8162; Goh, Yong Jun/0000-0001-7998-8469; Svensson, Birte/0000-0002-2993-8196	Danisco United States of America; North Carolina Dairy Foundation; Danish Strategic Research Council; Danisco A/S; FoSu grant; Technical University of Denmark; Dupont Nutrition and Health	Danisco United States of America; North Carolina Dairy Foundation; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danisco A/S; FoSu grant; Technical University of Denmark; Dupont Nutrition and Health	This research was funded by Danisco United States of America, North Carolina Dairy Foundation and the FoSu grant from the Danish Strategic Research Council to the project "Gene discovery and molecular interactions in prebiotics/probiotics systems. Focus on carbohydrate prebiotics". J.M.A. is funded by a joint Ph.D. stipend from Danisco A/S, the FoSu grant, and the Technical University of Denmark. R. B. and S. L. are employed by DuPont Nutrition and Health, a commercial manufacturer of Lactobacillus acidophilus NCFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dupont Nutrition and Health funded portions of the project and two primary contributing authors, R. B. and S. L. are research scientists employed by DuPont Nutrition and Health. This association had no impact on the scientific integrity of the experiments, objectivity of the data generated or validity of the scientific conclusions made from this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JM, 2011, P NATL ACAD SCI USA, V108, P17785, DOI 10.1073/pnas.1114152108; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DANIELS L, 1975, APPL MICROBIOL, V29, P710, DOI 10.1128/AEM.29.5.710-711.1975; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Francl AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-77; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goh YJ, 2007, APPL ENVIRON MICROB, V73, P5716, DOI 10.1128/AEM.00805-07; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Grimoud J, 2010, INT J FOOD MICROBIOL, V144, P42, DOI 10.1016/j.ijfoodmicro.2010.09.007; Hedin C, 2007, P NUTR SOC, V66, P307, DOI 10.1017/S0029665107005563; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kimmel SA, 1998, INT J FOOD MICROBIOL, V40, P87, DOI 10.1016/S0168-1605(98)00023-3; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Makelainen HS, 2007, J FOOD SCI, V72, pM153, DOI 10.1111/j.1750-3841.2007.00350.x; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Nakai H, 2009, FEBS J, V276, P7353, DOI 10.1111/j.1742-4658.2009.07445.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Petersen A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-245; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeiler EA, 2007, J BACTERIOL, V189, P4624, DOI 10.1128/JB.00337-07; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Rycroft CE, 2001, LETT APPL MICROBIOL, V32, P156, DOI 10.1046/j.1472-765x.2001.00875.x; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Scarpellini E, 2010, INTERN EMERG MED, V5, pS53, DOI 10.1007/s11739-010-0450-1; Schouler C, 2009, J BACTERIOL, V191, P388, DOI 10.1128/JB.01052-08; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; WALKER DC, 1994, J BACTERIOL, V176, P5330, DOI 10.1128/JB.176.17.5330-5340.1994; Wiesmann C, 1997, J MOL BIOL, V269, P851, DOI 10.1006/jmbi.1997.1084; Zhong J, 2000, AM J CLIN NUTR, V72, P1503	55	60	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44409	10.1371/journal.pone.0044409	http://dx.doi.org/10.1371/journal.pone.0044409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028535	gold, Green Published			2022-12-25	WOS:000309388400024
J	Pierce, MB; Silverwood, RJ; Nitsch, D; Adams, JE; Stephen, AM; Nip, W; Macfarlane, P; Wong, A; Richards, M; Hardy, R; Kuh, D				Pierce, Mary B.; Silverwood, Richard J.; Nitsch, Dorothea; Adams, Judith E.; Stephen, Alison M.; Nip, Wing; Macfarlane, Peter; Wong, Andrew; Richards, Marcus; Hardy, Rebecca; Kuh, Diana		NSHD Sci & Data Collection Teams	Clinical Disorders in a Post War British Cohort Reaching Retirement: Evidence from the First National Birth Cohort Study	PLOS ONE			English	Article							DISEASE; HEALTH; QUESTIONNAIRE; COMMUNITY	Background: The medical needs of older people are growing because the proportion of the older population is increasing and disease boundaries are widening. This study describes the distribution and clustering of 15 common clinical disorders requiring medical treatment or supervision in a representative British cohort approaching retirement, and how health tracked across adulthood. Methods and Findings: The data come from a cohort of 2661 men and women, 84% of the target sample, followed since birth in England, Scotland and Wales in 1946, and assessed at 60-64 years for: cardio and cerebro-vascular disease, hypertension, raised cholesterol, renal impairment, diabetes, obesity, hypothyroidism, hyperthyroidism, anaemia, respiratory disease, liver disease, psychiatric problems, cancers, atrial fibrillation on ECG and osteoporosis. We calculated the proportions disorder-free, with one or more disorders, and the level of undiagnosed disorders; and how these disorders cluster into latent classes and relate to health assessed at 36 years. Participants had, on average, two disorders (range 0-9); only 15% were disorder-free. The commonest disorders were hypertension (54.3%, 95% CI 51.8%-56.7%), obesity (31.1%, 28.8%-33.5%), raised cholesterol (25.6%, 23.1-28.26%), and diabetes or impaired fasting glucose (25.0%, 22.6-27.5%). A cluster of one in five individuals had a high probability of cardio-metabolic disorders and were twice as likely than others to have been in the poorest health at 36 years. The main limitations are that the native born sample is entirely white, and a combination of clinical assessments and self reports were used. Conclusions: Most British people reaching retirement already have clinical disorders requiring medical supervision. Widening disease definitions and the move from a disease-based to a risk-based medical model will increase pressure on health services. The promotion of healthy ageing should start earlier in life and consider the individual's ability to adapt to and self manage changes in health.	[Pierce, Mary B.; Wong, Andrew; Richards, Marcus; Hardy, Rebecca; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London, England; [Silverwood, Richard J.; Nitsch, Dorothea] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Adams, Judith E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Stephen, Alison M.; Nip, Wing] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Macfarlane, Peter] Univ Glasgow, Royal Infirm, Electrocardiol Sect, Glasgow, Lanark, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Royal Infirmary of Edinburgh; University of Glasgow	Pierce, MB (corresponding author), MRC Unit Lifelong Hlth & Ageing, London, England.	m.pierce@nshd.mrc.ac.uk	Wong, Andrew/M-8899-2016; Wong, Andrew/AAE-6995-2019; Silverwood, Richard/A-1249-2014; Hardy, Rebecca/AFR-1989-2022; Kuh, Diana/L-6019-2014	Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Silverwood, Richard/0000-0002-2744-1194; Kuh, Diana/0000-0001-7386-2857; Nitsch, Dorothea/0000-0001-5767-248X	Medical Research Council [U1200632239, U123092720]; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_U123092720, MC_U105960384] Funding Source: UKRI; Economic and Social Research Council [ES/G00773X/1] Funding Source: researchfish; Kidney Research UK [RP34/2009] Funding Source: researchfish; Medical Research Council [MC_U105960384, MC_U123092720] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant numbers U1200632239 and U123092720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; [Anonymous], 2008, WORLDW PREV AN 1993; Centres for Disease Control and prevention, 2012, NAT HLTH NUTR SURV; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Deeg D, GLOBAL AGEING 21 CEN; Department of Health, 2008, PUTT PREV 1 VASC CHE; Ebrahim S, 2001, BMJ-BRIT MED J, V324, P861; Ferrucci L, 2012, HARRISONS PRINCIPLES, P570; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; Gielen E, 2011, BEST PRACT RES CL EN, V25, P321, DOI 10.1016/j.beem.2010.08.012; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hippsley-Cox J, 2009, TRENDS CONSULTATION; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Illich Ivan., 1975, MED NEMESIS EXPROPRI; Insighteast, 2001, CENS TABL S101 SEX A; Joint Committee of the Royal College of Obstetricians and Gynaecologists and the Population Investigation Committee, 1948, MAT GREAT BRIT; Kaplan GA, 2007, INT J EPIDEMIOL, V36, P542, DOI 10.1093/ije/dym008; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P845, DOI 10.1093/ije/dyr114; Klungel OH, 1999, NETH J MED, V55, P177, DOI 10.1016/S0300-2977(99)00045-5; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; KUH DJL, 1993, SOC SCI MED, V37, P905, DOI 10.1016/0277-9536(93)90145-T; Lafortune G, 2007, OECD HLTH WORKING PA; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Little R.J.A., 2002, STAT ANAL MISSING DA; Martyn C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2800; McManus S, 2007, ADULT PSYCHIAT MORBI; Moynihan R, 2011, BMJ-BRIT MED J, V342, P1054; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Muthen & Muthen, 2010, MPLUS STAT SOFTW REL; [NHS National Institute for Clinical Excellence], 2008, EARL ID MAN REN DIS; NHS Information Centre, 2007, HLTH SURV ENGL 2007, V1; NHS Information centre, 2012, HLTH SURV ENGL; NHS Information Centre, 2009, HLTH SURV ENGL 2009; NHS Information Centre, 2005, HLTH SURV ENGL 2005; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; OECD, 2011, HLTH GLANC 2011 OECD, DOI [10.1787/health_glance-2011-29-en, DOI 10.1787/HEALTH_GLANCE-2011-29-EN]; Office for National Statistics, 2009, NAT POP PROJ 2008 BA; Pastorino S, 2011, DIABETIC MED, V28, P32; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Royal College of Physicians, 1999, OST GUID PREV TREATM, P63; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; The Scottish Government, 2012, SCOTT HLTH SURV; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilson S, 2006, J CLIN ENDOCR METAB, V91, P4809, DOI 10.1210/jc.2006-1557; World Health Organisation, 1994, ASS FRACT RISK ITS A; World Health Organization, 2004, OB PREV MAN GLOB EP; World Health Organization, 2006, DEF DIAGN DIAB MELL	59	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44857	10.1371/journal.pone.0044857	http://dx.doi.org/10.1371/journal.pone.0044857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028647	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309388400044
J	Takemura, Y; Imai, S; Kojima, H; Katagi, M; Yamakawa, I; Kasahara, T; Urabe, H; Terashima, T; Yasuda, H; Chan, L; Kimura, H; Matsusue, Y				Takemura, Yoshinori; Imai, Shinji; Kojima, Hideto; Katagi, Miwako; Yamakawa, Isamu; Kasahara, Toshiyuki; Urabe, Hiroshi; Terashima, Tomoya; Yasuda, Hitoshi; Chan, Lawrence; Kimura, Hiroshi; Matsusue, Yoshitaka			Brain-Derived Neurotrophic Factor from Bone Marrow-Derived Cells Promotes Post-Injury Repair of Peripheral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; STEM-CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; NEUROPATHIC PAIN; IN-VIVO; BDNF; RECEPTOR; NEURONS; MOUSE	Brain-derived neurotrophic factor (BDNF) stimulates peripheral nerve regeneration. However, the origin of BNDF and its precise effect on nerve repair have not been clarified. In this study, we examined the role of BDNF from bone marrow-derived cells (BMDCs) in post-injury nerve repair. Control and heterozygote BDNF knockout mice (BDNF+/-) received a left sciatic nerve crush using a cerebral blood clip. Especially, for the evaluation of BDNF from BMDCs, studies with bone marrow transplantation (BMT) were performed before the injury. We evaluated nerve function using a rotarod test, sciatic function index (SFI), and motor nerve conduction velocity (MNCV) simultaneously with histological nerve analyses by immunohistochemistry before and after the nerve injury until 8 weeks. BDNF production was examined by immunohistochemistry and mRNA analyses. After the nerve crush, the controls showed severe nerve dysfunction evaluated at 1 week. However, nerve function was gradually restored and reached normal levels by 8 weeks. By immunohistochemistry, BDNF expression was very faint before injury, but was dramatically increased after injury at 1 week in the distal segment from the crush site. BDNF expression was mainly co-localized with CD45 in BMDCs, which was further confirmed by the appearance of GFP-positive cells in the BMT study. Variant analysis of BDNF mRNA also confirmed this finding. BDNF+/- mice showed a loss of function with delayed histological recovery and BDNF+/+ -> RBDNF+/- BMT mice showed complete recovery both functionally and histologically. These results suggested that the attenuated recovery of the BDNF+/- mice was rescued by the transplantation of BMCs and that BDNF from BMDCs has an essential role in nerve repair.	[Takemura, Yoshinori; Kojima, Hideto; Katagi, Miwako; Kimura, Hiroshi] Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan; [Takemura, Yoshinori; Imai, Shinji; Kasahara, Toshiyuki; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 52021, Japan; [Yamakawa, Isamu; Urabe, Hiroshi; Terashima, Tomoya] Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 52021, Japan; [Yasuda, Hitoshi] Shiga Univ Med Sci, Dept Community Life Nursing, Otsu, Shiga 52021, Japan; [Chan, Lawrence] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Baylor College of Medicine	Kojima, H (corresponding author), Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan.	kojima@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [18390100]; Shiga University of Medical Science [1515503L]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shiga University of Medical Science(Shiga University of Medical Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Grant-in-Aid (#18390100 to H. Kojima) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the President's Discretionary Fund from Shiga University of Medical Science (#1515503L to H. Kojima), and by a grant (HL-51586) from the US National Institutes of Health (to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fu KY, 2011, ARTIF ORGANS, V35, P363, DOI 10.1111/j.1525-1594.2010.01105.x; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Garcia N, 2010, J PERIPHER NERV SYST, V15, P40, DOI 10.1111/j.1529-8027.2010.00250.x; Geremia NM, 2009, EXP NEUROL; Gorski JA, 2003, J NEUROSCI, V23, P6856; Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020; Harris VK, 2012, J NEUROL SCI; Kasahara T, 2010, BONE, V47, P617, DOI 10.1016/j.bone.2010.06.014; Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760; Poblete-Naredo I, 2011, NEUROCHEM INT, V59, P1133, DOI 10.1016/j.neuint.2011.10.002; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Seddon HJ, 1942, BRIT MED J, V1942, P237, DOI 10.1136/bmj.2.4260.237; Tan AM, 2008, J NEUROSCI, V28, P13173, DOI 10.1523/JNEUROSCI.3142-08.2008; Uchida K, 1998, J NEUROL, V245, P781, DOI 10.1007/s004150050287; Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F	31	24	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44592	10.1371/journal.pone.0044592	http://dx.doi.org/10.1371/journal.pone.0044592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028564	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400028
J	Delprato, A				Delprato, Anna			Topological and Functional Properties of the Small GTPases Protein Interaction Network	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHAGOCYTE NADPH OXIDASE; RHO-GTPASES; BINDING-PROTEINS; STRUCTURAL BASIS; FAMILY PROTEINS; TYROSINE KINASE; RAN GTPASE; ROLES; ACTIVATION	Small GTP binding proteins of the Ras superfamily (Ras, Rho, Rab, Arf, and Ran) regulate key cellular processes such as signal transduction, cell proliferation, cell motility, and vesicle transport. A great deal of experimental evidence supports the existence of signaling cascades and feedback loops within and among the small GTPase subfamilies suggesting that these proteins function in a coordinated and cooperative manner. The interplay occurs largely through association with bi-partite regulatory and effector proteins but can also occur through the active form of the small GTPases themselves. In order to understand the connectivity of the small GTPases signaling routes, a systems-level approach that analyzes data describing direct and indirect interactions was used to construct the small GTPases protein interaction network. The data were curated from the Search Tool for the Retrieval of Interacting Genes (STRING) database and include only experimentally validated interactions. The network method enables the conceptualization of the overall structure as well as the underlying organization of the protein-protein interactions. The interaction network described here is comprised of 778 nodes and 1943 edges and has a scale-free topology. Rac1, Cdc42, RhoA, and HRas are identified as the hubs. Ten sub-network motifs are also identified in this study with themes in apoptosis, cell growth/proliferation, vesicle traffic, cell adhesion/junction dynamics, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase response, transcription regulation, receptor-mediated endocytosis, gene silencing, and growth factor signaling. Bottleneck proteins that bridge signaling paths and proteins that overlap in multiple small GTPase networks are described along with the functional annotation of all proteins in the network.	BioSci Project, Wakefield, MA USA		Delprato, A (corresponding author), BioSci Project, Wakefield, MA USA.	delprato@bioscienceproject.org		Delprato, Anna/0000-0002-6134-2560				AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Badolato R, 2007, J ALLERGY CLIN IMMUN, V120, P735, DOI 10.1016/j.jaci.2007.08.039; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen Y, 2004, MOL CELL BIOL, V24, P3048, DOI 10.1128/MCB.24.7.3048-3056.2004; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Cox Adrienne D, 2010, Small GTPases, V1, P2; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de la Vega Michelle, 2011, Small GTPases, V2, P192; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Foster DV, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031912; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Ghibelli L, 2010, MITOCHONDRION, V10, P604, DOI 10.1016/j.mito.2010.08.003; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Hughes AL, 2005, J MOL EVOL, V61, P758, DOI 10.1007/s00239-005-0037-z; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kobayashi H, 2011, J BIOL CHEM, V286, P39259, DOI 10.1074/jbc.M111.255489; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; Kumar S, 2005, CELL CYCLE, V4, P1667, DOI 10.4161/cc.4.11.2169; Lau ASN, 2003, ENDOCRINOLOGY, V144, P1549, DOI 10.1210/en.2002-220893; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lebowitz PF, 1997, CANCER RES, V57, P708; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lin CY, 2002, J CELL SCI, V115, P4433, DOI 10.1242/jcs.00123; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McDonel P, 2011, DEV BIOL; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Nimnual AS, 2011, SMALL GTPASES, V1, P89; Ohno S., 1970, P1; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Pylayeva-Gupta Y, NAT REV CANC, V11, P761; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rousseau M, 2011, BIOCHEM BIOPH RES CO, V414, P750, DOI 10.1016/j.bbrc.2011.09.150; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sanchez-Miranda E, 2010, BIOCHEM BIOPH RES CO, V391, P1714, DOI 10.1016/j.bbrc.2009.12.139; Schulze Waltraud X, 2005, Mol Syst Biol, V1; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Seyed-allaei H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046113; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Street CA, 2011, ANTICANCER RES, V31, P3645; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Xu K, 2011, PROTEOMICS, V11, P1857, DOI 10.1002/pmic.201000684; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	135	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44882	10.1371/journal.pone.0044882	http://dx.doi.org/10.1371/journal.pone.0044882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028658	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700048
J	Glazko, GV; Zybailov, BL; Rogozin, IB				Glazko, Galina V.; Zybailov, Boris L.; Rogozin, Igor B.			Computational Prediction of Polycomb-Associated Long Non-Coding RNAs	PLOS ONE			English	Article							DARK-MATTER; CHROMATIN; GENOME; IDENTIFICATION; TRANSCRIPTOME; BIOINFORMATICS; COMPLEXES; SEQUENCE; ELEMENTS; REVEALS	Among thousands of long non-coding RNAs (lncRNAs) only a small subset is functionally characterized and the functional annotation of lncRNAs on the genomic scale remains inadequate. In this study we computationally characterized two functionally different parts of human lncRNAs transcriptome based on their ability to bind the polycomb repressive complex, PRC2. This classification is enabled by the fact that while all lncRNAs constitute a diverse set of sequences, the classes of PRC2-binding and PRC2 non-binding lncRNAs possess characteristic combinations of sequence-structure patterns and, therefore, can be separated within the feature space. Based on the specific combination of features, we built several machine-learning classifiers and identified the SVM-based classifier as the best performing. We further showed that the SVM-based classifier is able to generalize on the independent data sets. We observed that this classifier, trained on the human lncRNAs, can predict up to 59.4% of PRC2-binding lncRNAs in mice. This suggests that, despite the low degree of sequence conservation, many lncRNAs play functionally conserved biological roles.	[Glazko, Galina V.] Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA; [Zybailov, Boris L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Glazko, GV (corresponding author), Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA.	gvglazko@uams.edu; blzybaylov@uams.edu		Zybailov, Boris/0000-0003-2432-9145; Rogozin, Igor/0000-0003-0802-4851	Arkansas Translational Research Institute; academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant [UL1RR029884]; UAMS Biochemistry Department Chair special fund; Intramural Research Program of the National Library of Medicine at the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	Arkansas Translational Research Institute; academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant; UAMS Biochemistry Department Chair special fund; Intramural Research Program of the National Library of Medicine at the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication in part was supported by the Arkansas Translational Research Institute, with an academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant UL1RR029884; and by the UAMS Biochemistry Department Chair special fund to Dr. Kevin Raney. IBR was supported by the Intramural Research Program of the National Library of Medicine at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Da Sacco L, 2012, INT J MOL SCI, V13, P97, DOI 10.3390/ijms13010097; Duszczyk MM, 2008, NUCLEIC ACIDS RES, V36, P7068, DOI 10.1093/nar/gkn776; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glazko GV, 2001, BBA-GENE STRUCT EXPR, V1517, P351, DOI 10.1016/S0167-4781(00)00297-9; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jelizarow M, 2010, BIOINFORMATICS, V26, P1990, DOI 10.1093/bioinformatics/btq323; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li M., 2008, INTRO KOLMOGOROV COM; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-214; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Moran VA, 2012, NUCL ACIDS RES; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Noble W.S, 2004, SUPPORT VECTOR MACHI, DOI [10.7551/mitpress/4057.003.0005, DOI 10.7551/MITPRESS/4057.003.0005]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robinson Richard, 2010, PLoS Biol, V8, pe1000370, DOI 10.1371/journal.pbio.1000370; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Spizzo R, 2012, ONCOGENE; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XQD, 2011, CURR GENOMICS, V12, P307, DOI 10.2174/138920211796429772; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	56	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44878	10.1371/journal.pone.0044878	http://dx.doi.org/10.1371/journal.pone.0044878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028655	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700047
J	Tong, C; Morrison, A; Mattison, S; Qian, S; Bryniarski, M; Rankin, B; Wang, J; Thomas, DP; Li, J				Tong, Chao; Morrison, Alex; Mattison, Samantha; Qian, Su; Bryniarski, Mark; Rankin, Bethany; Wang, Jun; Thomas, D. Paul; Li, Ji			Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress	FASEB JOURNAL			English	Article						Sirtuin 1; sumoylation; myocardial infarction	ACTIVATED PROTEIN-KINASE; SMALL-MOLECULE ACTIVATORS; CARDIAC DYSFUNCTION; CALORIE RESTRICTION; MUTANT MICE; SUMOYLATION; DEACETYLASE; COMPLEX; AMPK; RESVERATROL	A longevity gene, sirtuin 1 (SIRT1), can attenuate age-dependent induction of left ventricular dysfunction. This study aimed to characterize the role of SIRT1 in the tolerance of aged heart to ischemic insults. Male C57BL/6 young (4-6 mo) and aged (24-26 mo) mice were used to determine the role of SIRT1 in myocardial ischemia/reperfusion (I/R) tolerance. SIRT1 localization was assessed by confocal microscopy. Immunoblotting was used to evaluate SIRT1 expression and translocation. The results demonstrated that SIRT1 is expressed predominantly as a sumoylated form in cardiomyocyte nuclei. Moreover, cardiac overexpression of desumoylase, sentrin-specific protease 2 (SENP2), significantly reduces nuclear sumoylated SIRT1 levels (P<0.05). Interestingly, I/R stress leads to desumoylation and translocation of nuclear SIRT1 into the cytoplasm in aged but not in young hearts. SIRT1 activity in ischemic young hearts was 3.2-fold higher than that seen in ischemic aged hearts, which suggests that aging causes impaired nucleocytoplasmic shuttling and activation of SIRT1 during ischemic stress. The infarct size in aged and Sirt1(+/-) knockout hearts was higher than that observed in young and Sirt1(+/+) WT littermate hearts, respectively (all P<0.05). SIRT1 agonist, SRT1720, reduced myocardial infarction in both aged and Sirt1(+/-) hearts. Therefore, impaired cardiac SIRT1 activity plays a critical role in the observed increase in susceptibility of the aged heart to I/R injury. SIRT1 agonist can restore this aging-related loss of cardioprotection.Tong, C., Morrison, A., Mattison, S., Qian, S., Bryniarski, M., Rankin, B., Wang, J., Thomas, D.P., Li, J. Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress.	[Tong, Chao; Morrison, Alex; Mattison, Samantha; Bryniarski, Mark; Rankin, Bethany; Li, Ji] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Qian, Su] SUNY Buffalo, Dept Biostat, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14214 USA; [Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Thomas, D. Paul] Univ Wyoming, Div Kinesiol & Hlth, Laramie, WY 82071 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Texas Heart Institute; University of Wyoming	Li, J (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, 615 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA.	jli23@buffalo.edu	Tong, Chao/AAM-2225-2020	Tong, Chao/0000-0003-0828-2674	National Institute on Aging of the U.S. National Institutes of Health [AG 028163]; American Heart Association [SDG0835169N, 12GRNT11620029]; American Diabetes Association [11-BS-92]; NATIONAL INSTITUTE ON AGING [R03AG028163] Funding Source: NIH RePORTER	National Institute on Aging of the U.S. National Institutes of Health; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants awarded by the National Institute on Aging of the U.S. National Institutes of Health (AG 028163; J.L.), the American Heart Association (SDG0835169N and 12GRNT11620029; J.L.), and the American Diabetes Association (Basic Science grant 11-BS-92; J.L.).	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Azhar G, 1999, EXP GERONTOL, V34, P699, DOI 10.1016/S0531-5565(99)00031-5; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EY, 2012, J MOL CELL CARDIOL, V52, P638, DOI 10.1016/j.yjmcc.2011.11.011; Li F, 2008, MECH AGEING DEV, V129, P515, DOI 10.1016/j.mad.2008.04.007; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tong C, 2010, J DIABETES, V2, P267, DOI 10.1111/j.1753-0407.2010.00088.x; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xie ZL, 2000, JPN J PHYSIOL, V50, P159, DOI 10.2170/jjphysiol.50.159; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung ED, 2012, PROSTATE, V72, P165, DOI 10.1002/pros.21417; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	48	96	99	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4332	4342		10.1096/fj.12-216473	http://dx.doi.org/10.1096/fj.12-216473			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23024374	Green Published			2022-12-25	WOS:000329937500002
J	Zheng, Y; Gierut, J; Wang, Z; Miao, J; Asara, JM; Tyner, AL				Zheng, Y.; Gierut, J.; Wang, Z.; Miao, J.; Asara, J. M.; Tyner, A. L.			Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT	ONCOGENE			English	Article						BRK; Sik; PTK6; FAK; AKT; anoikis	BREAST-TUMOR KINASE; BRK; SURVIVAL; EXPRESSION; MIGRATION; GROWTH; PROLIFERATION; BRK/SIK; BINDING; FAK	Protein tyrosine kinase 6 (PTK6) is a non-receptor tyrosine kinase expressed in epithelial cancers. Disruption of Ptk6 decreases azoxymethane-induced colon tumorigenesis in mice by preventing signal transducer and activator of transcription 3 activation. Relocalization of PTK6 in prostate cancers contributes to increased growth. Although not expressed in normal breast or ovary, PTK6 promotes anchorage-independent survival of breast and ovarian tumor cells. We identified several potential PTK6 substrates in the human SW620 colon cancer cell line using mass spectrometry, including FAK (focal adhesion kinase). We show that FAK is a direct substrate of PTK6 in vitro and in vivo. Expression of membrane-targeted active PTK6 (Palm-PTK6-YF) induces constitutive activation of FAK and cell morphology changes, which are independent of SRC family kinases in Src-/-, Yes-/-, Fyn-/- (SYF) mouse embryonic fibroblasts (MEFs). Palm-PTK6-YF expressing SYF cells are transformed and overcome contact inhibition, form colonies in transformation assays, proliferate in suspension and form tumors in a xenograft model. Expression of FAK and Palm-PTK6-YF in Fak-/- MEFs synergistically activates AKT and protects cells against anoikis. However, expression of Palm-PTK6-YF in Akt1/2-/- MEFs fails to protect cells from anoikis, indicating AKT is critical in PTK6 and FAK-mediated survival signaling. In a conditional Pten knockout murine prostate cancer model, we identify prostate epithelial cells with enhanced activation of endogenous PTK6 and FAK at the plasma membrane. Knockdown of PTK6 in the PC3 human prostate cancer cell line disrupts FAK and AKT activation and promotes anoikis, which can be rescued by exogenous expression of FAK. Our data reveal important roles for a PTK6-FAK-AKT signaling axis in promoting anchorage-independent cell survival.	[Zheng, Y.; Gierut, J.; Wang, Z.; Miao, J.; Tyner, A. L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Asara, J. M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Asara, J. M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, M-C 669,900 South Ashland Ave, Chicago, IL 60607 USA.	atyner@uic.edu		Tyner, Angela/0000-0001-7448-8625	NIH [5R01DK044525, 5P01CA120964]; NIH DF/HCC Cancer Center Support Grant [5P30CA006516]; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH DF/HCC Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants 5R01DK044525 (ALT), 5P01CA120964 (JMA) and NIH DF/HCC Cancer Center Support Grant 5P30CA006516 (JMA). We thank Wenjun Bie and Min Yuan for technical assistance, Dr Nissim Hay (University of Illinois at Chicago, Chicago, IL, USA) for his gifts of Akt1/2-/- MEFs and PTEN<SUP>fl/fl</SUP>, Probasin-Cre and control mouse tissues, and Dr David D Schlaepfer (University of California, San Diego, CA, USA) for providing FAK expression constructs.	Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gierut J, 2011, GASTROENTEROLOGY, V141, P1371, DOI 10.1053/j.gastro.2011.06.071; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lofgren KA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2946; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rasband W.S., 1997, IMAGE J; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zheng Y, 2012, J BIOL CHEM, V287, P148, DOI 10.1074/jbc.M111.298117; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	50	39	41	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4304	4312		10.1038/onc.2012.427	http://dx.doi.org/10.1038/onc.2012.427			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23027128	Green Submitted, Green Accepted			2022-12-25	WOS:000324168000012
J	Matilla, MA; Stockmann, H; Leeper, FJ; Salmond, GPC				Matilla, Miguel A.; Stoeckmann, Henning; Leeper, Finian J.; Salmond, George P. C.			Bacterial Biosynthetic Gene Clusters Encoding the Anti-cancer Haterumalide Class of Molecules BIOGENESIS OF THE BROAD SPECTRUM ANTIFUNGAL AND ANTI-OOMYCETE COMPOUND, OOCYDIN A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAPENEM ANTIBIOTIC PRODUCTION; POLYKETIDE SYNTHASE; PEPTIDE SYNTHETASE; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURE; IN-VIVO; IDENTIFICATION; PRODIGIOSIN; PATHWAY; CLONING	Haterumalides are halogenated macrolides with strong antitumor properties, making them attractive targets for chemical synthesis. Unfortunately, current synthetic routes to these molecules are inefficient. The potent haterumalide, oocydin A, was previously identified from two plant-associated bacteria through its high bioactivity against plant pathogenic fungi and oomycetes. In this study, we describe oocydin A (ooc) biosynthetic gene clusters identified by genome sequencing, comparative genomics, and chemical analysis in four plant-associated enterobacteria of the Serratia and Dickeya genera. Disruption of the ooc gene cluster abolished oocydin A production and bioactivity against fungi and oomycetes. The ooc gene clusters span between 77 and 80 kb and encode five multimodular polyketide synthase (PKS) proteins, a hydroxymethylglutaryl-CoA synthase cassette and three flavin-dependent tailoring enzymes. The presence of two free-standing acyltransferase proteins classifies the oocydin A gene cluster within the growing family of trans-AT PKSs. The amino acid sequences and organization of the PKS domains are consistent with the chemical predictions and functional peculiarities associated with trans-acyltransferase PKS. Based on extensive in silico analysis of the gene cluster, we propose a biosynthetic model for the production of oocydin A and, by extension, for other members of the haterumalide family of halogenated macrolides exhibiting anti-cancer, antifungal, and other interesting biological properties.	[Matilla, Miguel A.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Stoeckmann, Henning; Leeper, Finian J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Salmond, GPC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	gpcs2@cam.ac.uk	Matilla, Miguel A./G-8839-2015; Stockmann, Henning/A-1891-2012	Matilla, Miguel A./0000-0002-8468-9604; Leeper, Finian James/0000-0003-3408-5199; Stockmann, Henning/0000-0002-2409-5476	Spanish Government Postdoctoral Research [BVA-2009-0200]; Cancer Research UK [6934] Funding Source: researchfish	Spanish Government Postdoctoral Research; Cancer Research UK(Cancer Research UK)	Supported by a Spanish Government Postdoctoral Research Contract BVA-2009-0200.	Anderson JLR, 2006, MOL BIOSYST, V2, P350, DOI 10.1039/b607813c; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berg G, 2002, APPL ENVIRON MICROB, V68, P3328, DOI 10.1128/AEM.68.7.3328-3338.2002; Bumpus SB, 2008, J AM CHEM SOC, V130, P11614, DOI 10.1021/ja8040042; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; Coulthurst SJ, 2004, MICROBIOL-SGM, V150, P1901, DOI 10.1099/mic.0.26946-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Dickschat JS, 2011, CHEMBIOCHEM, V12, P2408, DOI 10.1002/cbic.201100474; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; GRINTER NJ, 1983, GENE, V21, P133, DOI 10.1016/0378-1119(83)90155-5; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Gurney R, 2011, APPL MICROBIOL BIOT, V90, P11, DOI 10.1007/s00253-011-3128-3; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hokeberg M, 1997, EUR J PLANT PATHOL, V103, P25, DOI 10.1023/A:1008681608400; Hoye TR, 2005, J AM CHEM SOC, V127, P6950, DOI 10.1021/ja051749i; Irschik H, 2010, CHEMBIOCHEM, V11, P1840, DOI 10.1002/cbic.201000313; Jensen K, 2012, CHEM BIOL, V19, P329, DOI 10.1016/j.chembiol.2012.01.005; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kigoshi H, 2003, ORG LETT, V5, P957, DOI 10.1021/ol0341804; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lopanik NB, 2008, CHEM BIOL, V15, P1175, DOI 10.1016/j.chembiol.2008.09.013; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Menche D, 2008, J AM CHEM SOC, V130, P14234, DOI 10.1021/ja804194c; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Pistorius D, 2012, CHEMBIOCHEM, V13, P416, DOI 10.1002/cbic.201100575; Podzelinska K, 2010, J MOL BIOL, V397, P316, DOI 10.1016/j.jmb.2010.01.020; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramsay JP, 2011, P NATL ACAD SCI USA, V108, P14932, DOI 10.1073/pnas.1109169108; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Roberts K.J., 2010, THESIS U CAMBRIDGE C; Sambrook J., 1989, MOL CLONING LAB MANU; Sato B, 2005, J ANTIBIOT, V58, P634, DOI 10.1038/ja.2005.87; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Strobel G, 1999, MICROBIOL-UK, V145, P3557, DOI 10.1099/00221287-145-12-3557; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Sun YH, 2008, CHEMBIOCHEM, V9, P150, DOI 10.1002/cbic.200700492; Takada N, 1999, TETRAHEDRON LETT, V40, P6309, DOI 10.1016/S0040-4039(99)01291-5; Tang GL, 2006, J NAT PROD, V69, P387, DOI 10.1021/np050467t; Teruya T, 2005, TETRAHEDRON, V61, P6561, DOI 10.1016/j.tet.2005.04.052; Teruya T, 2004, CHEM LETT, V33, P1184, DOI 10.1246/cl.2004.1184; Teta R, 2010, CHEMBIOCHEM, V11, P2506, DOI 10.1002/cbic.201000542; Thaning C, 2001, SOIL BIOL BIOCHEM, V33, P1817, DOI 10.1016/S0038-0717(01)00109-2; Ueda M, 2009, J ORG CHEM, V74, P3370, DOI 10.1021/jo802806z; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Weber T, 2008, CHEM BIOL, V15, P175, DOI 10.1016/j.chembiol.2007.12.009; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Xiao Y, 2011, J AM CHEM SOC, V133, P1092, DOI 10.1021/ja109445q; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092	84	56	57	2	38	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39125	39138		10.1074/jbc.M112.401026	http://dx.doi.org/10.1074/jbc.M112.401026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012376	hybrid, Green Published			2022-12-25	WOS:000310982800068
J	Gu, DS; Fan, QP; Zhang, XL; Xie, JW				Gu, Dongsheng; Fan, Qipeng; Zhang, Xiaoli; Xie, Jingwu			A Role for Transcription Factor STAT3 Signaling in Oncogene Smoothened-driven Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMAS; INTERLEUKIN-11 RECEPTOR; HEDGEHOG PATHWAY; SONIC HEDGEHOG; MOUSE MODEL; STEM-CELLS; EPITHELIAL CARCINOGENESIS; FAS EXPRESSION; HAIR FOLLICLE; HUMAN HOMOLOG	Activation of the Hedgehog (Hh) pathway is known to drive development of basal cell carcinoma and medulloblastomas and to associate with many other types of cancer, but the exact molecular mechanisms underlying the carcinogenesis process remain elusive. We discovered that skin tumors derived from epidermal expression of oncogenic Smo, SmoM2, have elevated levels of IL-11, IL-11R alpha, and STAT3 phosphorylation at Tyr(705). The relevance of our data to human conditions was reflected by the fact that all human basal cell carcinomas examined have detectable STAT3 phosphorylation, mostly in keratinocytes. The functional relevance of STAT3 in Smo-mediated carcinogenesis was revealed by epidermal specific knockout of STAT3. We showed that removal of STAT3 from mouse epidermis dramatically reduced SmoM2-mediated cell proliferation, leading to a significant decrease in epidermal thickness and tumor development. We also observed a significant reduction of epidermal stem/progenitor cell population and cyclin D1 expression in mice with epidermis-specific knockout of STAT3. Our evidence indicates that STAT3 signaling activation may be mediated by the IL-11/IL-11R alpha signaling axis. We showed that tumor development was reduced after induced expression of SmoM2 in IL-11R alpha null mice. Similarly, neutralizing antibodies for IL-11 reduced the tumor size. In two Hh-responsive cell lines, ES14 and C3H10T1/2, we found that addition of Smo agonist purmorphamine is sufficient to induce STAT3 phosphorylation at Tyr705, but this effect was abolished after IL-11R alpha down-regulation by shRNAs. Taken together, our results support an important role of the IL-11R alpha/STAT3 signaling axis for Hh signaling-mediated signaling and carcinogenesis.	Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46074 USA; Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Biochem Mol Biol, Indianapolis, IN 46074 USA; Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Pharmacol Toxicol, Indianapolis, IN 46074 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Xie, JW (corresponding author), Well Ctr Pediat Res, 1044 W Walnut St, Indianapolis, IN 46202 USA.	jinxie@iupui.edu			National Cancer Institute [R01CA155086, R01CA94160]; Wells Center for Pediatric Research; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [R01CA155086, R01CA094160] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wells Center for Pediatric Research; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants R01CA155086 and R01CA94160, by the Wells Center for Pediatric Research, and by the Indiana University Simon Cancer Center.	Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hatanaka H, 2010, CANCER SCI, V101, P60, DOI 10.1111/j.1349-7006.2009.01355.x; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Li CX, 2004, ONCOGENE, V23, P1608, DOI 10.1038/sj.onc.1207273; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakayama T, 2007, INT J ONCOL, V30, P825; Nandurkar HH, 1997, BLOOD, V90, P2148; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Park HL, 2000, DEVELOPMENT, V127, P1593; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Reifenberger J, 1998, CANCER RES, V58, P1798; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	59	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377382	http://dx.doi.org/10.1074/jbc.M112.377382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992748	hybrid, Green Published			2022-12-25	WOS:000310642200068
J	Barth, T; Schmidt, D; Botteron, C; Nguyen, TTT; Ritter, U; Mannel, DN; Lechner, A				Barth, Thomas; Schmidt, Dominic; Botteron, Catherine; Nguyen, Trang T. T.; Ritter, Uwe; Maennel, Daniela N.; Lechner, Anja			An Early Reduction in Treg Cells Correlates with Enhanced Local Inflammation in Cutaneous Leishmaniasis in CCR6-Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; TH17 CELLS; C57BL/6 MICE; BETA-2-MICROGLOBULIN-DEFICIENT MICE; MUCOSAL LEISHMANIASIS; SUSCEPTIBLE MICE; IMMUNITY; RECEPTOR; CCR6; CHEMOKINE	Resistance to Leishmania major infection is dependent on the development of a cell-mediated Th1 immune response in resistant C57BL/6 mice whereas Th2-prone BALB/c mice develop non-healing lesions after infection. The chemokine receptor CCR6 is shared by anti-inflammatory regulatory T cells and pro-inflammatory Th17 cells. In a recent study we showed that C57BL/6 mice deficient in CCR6 exhibited enhanced footpad swelling and impaired T helper cell migration indicated by reduced recruitment of total T helper cells into the skin after infection and a reduced delayed type hypersensitivity reaction. Based on these findings we tested whether the lack of CCR6 alters Treg or Th17 cell responses during the course of Leishmania major infection. When we analyzed T cell subsets in the lymph nodes of CCR6-deficient mice, Th17 cell numbers were not different. However, reduced numbers of Treg cells paralleled with a stronger IFN gamma response. Furthermore, the early increase in IFN gamma-producing cells correlated with increased local tissue inflammation at later time points. Our data indicate an important role of CCR6 for Treg cells and a redundant role for Th17 cells in a Th1 cell-driven anti-parasitic immune response against Leishmania major parasites in resistant C57BL/6 mice.	[Barth, Thomas; Schmidt, Dominic; Botteron, Catherine; Nguyen, Trang T. T.; Ritter, Uwe; Maennel, Daniela N.; Lechner, Anja] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Botteron, Catherine] Univ Regensburg, Inst Pediat, Regensburg, Germany	University of Regensburg; University of Regensburg	Lechner, A (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	anja.lechner@klinik.uni-regensburg.de			Deutsche Forschungsgemeinschaft [LE 2435/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the project grant LE 2435/1-1 of the Deutsche Forschungsgemeinschaft (www.dfg.de) awarded to A. Lechner. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Brewig N, 2009, J IMMUNOL, V182, P774, DOI 10.4049/jimmunol.182.2.774; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; Cahalan MD, 2006, NAT IMMUNOL, V7, P329, DOI 10.1038/ni0406-329; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Ebert LM, 2002, J IMMUNOL, V168, P65, DOI 10.4049/jimmunol.168.1.65; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gu XG, 2008, EXP HEMATOL, V36, P1417, DOI 10.1016/j.exphem.2008.06.003; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Herath S, 2003, PARASITE IMMUNOL, V25, P559, DOI 10.1111/j.0141-9838.2004.00668.x; Huber M, 1998, INFECT IMMUN, V66, P3968, DOI 10.1128/IAI.66.8.3968-3970.1998; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lechner A, 2007, MICROBES INFECT, V9, P291, DOI 10.1016/j.micinf.2006.12.002; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Machado P, 2002, EUR J DERMATOL, V12, P449; Mizgerd JP, 2001, J IMMUNOL, V166, P4042, DOI 10.4049/jimmunol.166.6.4042; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; OVERATH P, 1993, IMMUNOL LETT, V37, P13, DOI 10.1016/0165-2478(93)90126-M; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Potzl J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002951; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Scott P, 1996, EXP PARASITOL, V84, P178, DOI 10.1006/expr.1996.0103; SOLBACH W, 1986, J IMMUNOL, V137, P702; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; WANG ZE, 1993, J IMMUNOL, V151, P2077; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Wu WH, 2010, EUR J IMMUNOL, V40, P2517, DOI 10.1002/eji.201040484; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	51	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44499	10.1371/journal.pone.0044499	http://dx.doi.org/10.1371/journal.pone.0044499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028548	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900011
J	Bilbija, D; Haugen, F; Sagave, J; Baysa, A; Bastani, N; Levy, FO; Sirsjo, A; Blomhoff, R; Valen, G				Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Bastani, Nasser; Levy, Finn Olav; Sirsjo, Allan; Blomhoff, Rune; Valen, Guro			Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; THERAPY; MEDIATE; GROWTH	Background: All-trans retinoic acid (atRA), an active derivative of vitamin A, regulates cell differentiation, proliferation and cardiac morphogenesis via transcriptional activation of retinoic acid receptors (RARs) acting on retinoic acid response elements (RARE). We hypothesized that the retinoic acid (RA) signalling pathway is activated in myocardial ischemia and postischemic remodelling. Methods and Findings: Myocardial infarction was induced through ligating the left coronary artery in mice. In vivo cardiac activation of the RARs was measured by imaging RARE-luciferase reporter mice, and analysing expression of RAR target genes and proteins by real time RT-PCR and western blot. Endogenous retinoids in postinfarcted hearts were analysed by triple-stage liquid chromatography/tandem mass spectrometry. Cardiomyocytes (CM) and cardiofibroblasts (CF) were isolated from infarcted and sham operated RARE luciferase reporter hearts and monitored for RAR activity and expression of target genes. The effect of atRA on CF proliferation was evaluated by EdU incorporation. Myocardial infarction increased thoracic RAR activity in vivo (p<0.001), which was ascribed to the heart through ex vivo imaging (p = 0.002) with the largest signal 1 week postinfarct. This was accompanied by increased cardiac gene and protein expression of the RAR target genes retinol binding protein 1 (p = 0.01 for RNA, p = 0,006 for protein) and aldehyde dehydrogenase 1A2 (p = 0.04 for RNA, p = 0,014 for protein), while gene expression of cytochrome P450 26B1 was downregulated (p = 0.007). Concomitantly, retinol accumulated in the infarcted zone (p = 0.02). CM and CF isolated from infarcted hearts had higher luminescence than those from sham operated hearts (p = 0.02 and p = 0.008). AtRA inhibited CF proliferation in vitro (p = 0.02). Conclusion: The RA signalling pathway is activated in postischemic hearts and may play a role in regulation of damage and repair during remodelling.	[Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Valen, Guro] Univ Oslo, Dept Physiol, Oslo, Norway; [Bastani, Nasser; Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Levy, Finn Olav] Univ Oslo, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Levy, Finn Olav; Valen, Guro] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Sirsjo, Allan] Univ Orebro, Dept Clin Med, Div Biomed, Orebro, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Orebro University	Bilbija, D (corresponding author), Univ Oslo, Dept Physiol, Oslo, Norway.	dusan.bilbija@medisin.uio.no	Haugen, Fred/AAK-6703-2021; Haugen, Fred/I-6341-2018	Haugen, Fred/0000-0001-7201-7344	Norwegian Health Association; Throne Holst Foundation; Novo Nordisk Foundation; Freia Chocolate Factory's Medical Fund; Center for Heart Failure Research; University of Oslo	Norwegian Health Association; Throne Holst Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Freia Chocolate Factory's Medical Fund; Center for Heart Failure Research; University of Oslo	The study was supported by grants from the Norwegian Health Association, Throne Holst Foundation, The Novo Nordisk Foundation, Freia Chocolate Factory's Medical Fund, the Center for Heart Failure Research, and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo PS, 2010, CELL PHYSIOL BIOCHEM, V26, P395, DOI 10.1159/000320563; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Colbert MC, 1997, J CLIN INVEST, V100, P1958, DOI 10.1172/JCI119727; Czibik G, 2011, LIFE SCI, V88, P543, DOI 10.1016/j.lfs.2011.01.006; Fenaux P, 2000, LEUKEMIA, V14, P1371, DOI 10.1038/sj.leu.2401859; Gudas LJ, 2011, BIOCH BIOPHYSICA ACT; Gundersen TE, 2007, RAPID COMMUN MASS SP, V21, P1176, DOI 10.1002/rcm.2946; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Lee K, 2011, ARCH PHARM RES, V34, P1583, DOI 10.1007/s12272-011-1021-3; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oliveira LC, 2011, ACTA CARDIOL, V66, P3, DOI 10.1080/AC.66.1.2064960; Paiva SAR, 2005, J NUTR, V135, P2326, DOI 10.1093/jn/135.10.2326; Palm-Leis A, 2004, J BIOL CHEM, V279, P54905, DOI 10.1074/jbc.M407383200; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Tanaka R, 2003, GYNECOL ONCOL, V90, P297, DOI 10.1016/S0090-8258(03)00335-4; Tavani A, 2006, FREE RADICAL RES, V40, P659, DOI 10.1080/10715760600615649; Wang HJ, 2002, J APPL PHYSIOL, V92, P2162, DOI 10.1152/japplphysiol.01192.2001; Wolf G, 2008, NUTR REV, V66, P55, DOI 10.1111/j.1753-4887.2007.00006.x; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582	25	40	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44740	10.1371/journal.pone.0044740	http://dx.doi.org/10.1371/journal.pone.0044740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028599	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900014
J	Mi, YY; Zhang, LF; Feng, NH; Wu, S; You, XM; Shao, HB; Dai, F; Peng, T; Qin, F; Zou, JG; Zhu, LJ				Mi, Yuanyuan; Zhang, Lifeng; Feng, Ninghan; Wu, Sheng; You, Xiaoming; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng; Zou, Jiangang; Zhu, Lijie			Impact of Two Common Xeroderma Pigmentosum Group D (XPD) Gene Polymorphisms on Risk of Prostate Cancer	PLOS ONE			English	Article							DNA-REPAIR GENES; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; XRCC1; VARIANTS; ERCC2	Background: DNA repair genes (eg: xeroderma pigmentosum group D, XPD) may affect the capacity of encoded DNA repair enzymes to effectively remove DNA adducts or lesions, which may result in enhanced cancer risk. The association between XPD gene polymorphisms and the susceptibility of prostate cancer (PCa) was inconsistent in previous studies. Methodology/Principal Findings: A meta-analysis based on 9 independent case-control studies involving 3165 PCa patients and 3539 healthy controls for XPD Gln751Lys SNP (single nucleotide polymorphism) and 2555 cases and 3182 controls for Asn312Asp SNP was performed to address this association. Meanwhile, odds ratio (OR) and 95% confidence intervals (CIs) were used to evaluate this relationship. Statistical analysis was performed with STATA10.0. No significant association was found between XPD Gln751Lys SNP and PCa risk. On the other hand, in subgroup analysis based on ethnicity, associations were observed in Asian (eg. Asn vs. Asp: OR = 1.34, 95% CI = 1.16-1.55; Asn/Asn+Asn/Asp vs. Asp/Asp: OR = 1.23, 95% CI = 1.07-1.42) and African (eg. Asn vs. Asp: OR = 1.31, 95% CI = 1.01-1.70; Asn/Asn vs. Asp/Asp: OR = 1.71, 95% CI = 1.03-7.10) populations for Asn312Asp SNP. Moreover, similar associations were detected in hospital-based controls studies; the frequency of Asn/Asn genotype in early stage of PCa men was poorly higher than those in advanced stage of PCa men (OR = 1.45, 95% CI = 1.00-2.11). Conclusion/Significance: Our investigations demonstrate that XPD Asn312Asp SNP not the Gln751Lys SNP, might poorly increase PCa risk in Asians and Africans, moreover, this SNPs may associate with the tumor stage of PCa. Further studies based on larger sample size and gene-environment interactions should be conducted to determine the role of XPD gene polymorphisms in PCa risk.	[Zhang, Lifeng; Zou, Jiangang] Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China; [Mi, Yuanyuan; Wu, Sheng; You, Xiaoming; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng; Zhu, Lijie] Nantong Univ, Affiliated Hosp 3, Dept Urol, Wuxi, Jiangsu, Peoples R China; [Feng, Ninghan] Nanjing Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nantong University; Nanjing University	Zou, JG (corresponding author), Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China.	zoujiangangmeta@hotmail.com; zhulijiemeta@hotmail.com	Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021		Nature Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader program [RC201178]	Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader program	This study was supported by the Nature Science Foundation of Jiangsu Province (NO. BK2010577) and Jiangsu Province's Outstanding Medical Academic Leader program (RC201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Bau DT, 2007, ANTICANCER RES, V27, P2893; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bray F, 2010, EUR J CANCER, V46, P3040, DOI 10.1016/j.ejca.2010.09.013; Camps C, 2007, CLIN LUNG CANCER, V8, P369, DOI 10.3816/CLC.2007.n.017; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon VS, 2011, UROL ONCOL-SEMIN ORI, V29, P641, DOI 10.1016/j.urolonc.2009.08.013; Ding DP, 2012, MOL BIOL REP, V39, P2533, DOI 10.1007/s11033-011-1005-x; Dunn Mary Weinstein, 2011, Semin Oncol Nurs, V27, P241, DOI 10.1016/j.soncn.2011.07.002; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Feng Z, 2012, MOL BIOL REP, V39, P57, DOI 10.1007/s11033-011-0710-9; Gao R, 2010, CANCER BIOL THER, V10, P13, DOI 10.4161/cbt.10.1.12172; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Inoue R, 2000, PHARMACOGENETICS, V10, P59, DOI 10.1097/00008571-200002000-00008; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Lavender NA, 2010, PROSTATE, V70, P113, DOI 10.1002/pros.21048; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Mandal RK, 2010, DNA CELL BIOL, V29, P183, DOI 10.1089/dna.2009.0956; MANTEL N, 1959, J NATL CANCER I, V22, P719; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Powell Isaac J., 2011, Archivos Espanoles de Urologia, V64, P711; Ritchey JD, 2005, CANCER EPIDEM BIOMAR, V14, P1703, DOI 10.1158/1055-9965.EPI-04-0809; Rybicki BA, 2004, CANCER EPIDEM BIOMAR, V13, P23, DOI 10.1158/1055-9965.EPI-03-0053; SANCAR A, 1993, PHOTOCHEM PHOTOBIOL, V57, P905, DOI 10.1111/j.1751-1097.1993.tb09233.x; Shen MR, 1998, CANCER RES, V58, P604; Sobti RC, 2012, MOL CELL BIOCHEM, V362, P263, DOI 10.1007/s11010-011-1152-3; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yuan H, 2011, GENET MOL RES, V10, P3356, DOI 10.4238/2011.November.22.6	39	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44756	10.1371/journal.pone.0044756	http://dx.doi.org/10.1371/journal.pone.0044756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028604	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800016
J	Verdoodt, B; Vogt, M; Schmitz, I; Liffers, ST; Tannapfel, A; Mirmohammadsadegh, A				Verdoodt, Berlinda; Vogt, Markus; Schmitz, Inge; Liffers, Sven-Thorsten; Tannapfel, Andrea; Mirmohammadsadegh, Alireza			Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species	PLOS ONE			English	Article							DEATH; APOPTOSIS; KINASE; RESISTANCE; ROLES; ROS; METASTASIS; ACTIVATION; EXPRESSION; CROSSTALK	Background: Salinomycin is a polyether ionophore antibiotic that has recently been shown to induce cell death in human cancer cells displaying multiple mechanisms of drug resistance. The underlying mechanisms leading to cell death after salinomycin treatment have not been well characterized. We therefore investigated the role of salinomycin in caspase dependent and independent cell death in colon cancer (SW480, SW620, RKO) and breast cancer cell lines (MCF-7, T47D, MDA-MB-453). Methodology/Principal Findings: We detected features of apoptosis in all cell lines tested, but the executor caspases 3 and 7 were only strongly activated in RKO and MDA-MB-453 cells. MCF-7 and SW620 cells instead presented features of autophagy such as cytoplasmic vacuolization and LC3 processing. Caspase proficient cell lines activated autophagy at lower salinomycin concentrations and before the onset of caspase activation. Salinomycin also led to the formation of reactive oxygen species (ROS) eliciting JNK activation and induction of the transcription factor JUN. Salinomycin mediated cell death could be partially inhibited by the free radical scavenger N-acetyl-cysteine, implicating ROS formation in the mechanism of salinomycin toxicity. Conclusions: Our data indicate that, in addition to its previously reported induction of caspase dependent apoptosis, the initiation of autophagy is an important and early effect of salinomycin in tumor cells.	[Verdoodt, Berlinda; Vogt, Markus; Schmitz, Inge; Liffers, Sven-Thorsten; Tannapfel, Andrea; Mirmohammadsadegh, Alireza] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Ruhr University Bochum	Mirmohammadsadegh, A (corresponding author), Ruhr Univ Bochum, Inst Pathol, Univ Str 150, Bochum, Germany.	alireza.mirmohammadsadegh@rub.de			Ministry for Innovation, Science and Research of Nordrhein-Westfalen; Protein Research Unit Ruhr within Europe, PURE	Ministry for Innovation, Science and Research of Nordrhein-Westfalen; Protein Research Unit Ruhr within Europe, PURE	This work was funded by the Ministry for Innovation, Science and Research of Nordrhein-Westfalen, and by the Protein Research Unit Ruhr within Europe, PURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DALTON AJ, 1955, ANAT REC, V121, P281; DANFORTH HD, 1977, POULTRY SCI, V56, P926, DOI 10.3382/ps.0560926; Daugschies A, 1998, VET PARASITOL, V76, P163, DOI 10.1016/S0304-4017(97)00203-3; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Ferguson HA, 2003, J BIOL CHEM, V278, P45793, DOI 10.1074/jbc.M307979200; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Ghosh D, 2011, J PROTEOME RES, V10, P4373, DOI 10.1021/pr2005617; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koneri K, 2007, ANTICANCER RES, V27, P1453; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Moretti L, 2007, AUTOPHAGY, V3, P142, DOI 10.4161/auto.3607; Munafo DB, 2001, J CELL SCI, V114, P3619; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Oak PS, 2012, INT J CANCER, V131, P2808, DOI 10.1002/ijc.27595; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sun T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-161; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	45	71	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44132	10.1371/journal.pone.0044132	http://dx.doi.org/10.1371/journal.pone.0044132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028492	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400019
J	Strier, KB; Ives, AR				Strier, Karen B.; Ives, Anthony R.			Unexpected Demography in the Recovery of an Endangered Primate Population	PLOS ONE			English	Article							MURIQUIS BRACHYTELES-HYPOXANTHUS; VIABILITY ANALYSIS; NATIONAL-PARK; VITAL-RATES; CONSERVATION; DYNAMICS; GROWTH; VARIABILITY; COMPONENTS; RESOURCE	Assessments of the status of endangered species have focused on population sizes, often without knowledge of demographic and behavioral processes underlying population recovery. We analyzed demographic data from a 28-year study of a critically endangered primate, the northern muriqui, to investigate possible changes in demographic rates as this population recovered from near extirpation. As the population increased from 60 to nearly 300 individuals, its growth rate declined due to increased mortality and male-biased birth sex ratios; the increased mortality was not uniform across ages and sexes, and there has been a recent increase in mortality of prime-aged males. If not for a concurrent increase in fertility rates, the population would have stabilized at 200 individuals instead of continuing to grow. The unexpected increase in fertility rates and in adult male mortality can be attributed to the muriquis' expansion of their habitat by spending more time on the ground. The demographic consequences of this behavioral shift must be incorporated into management tactics for this population and emphasize the importance of understanding demographic rates in the recovery of endangered species.	[Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Strier, KB (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.	kbstrier@wisc.edu	Ives, Anthony/A-5698-2008; Strier, Karen B./AAJ-3482-2020	Ives, Anthony/0000-0001-9375-9523; Strier, Karen/0000-0003-2520-9110	National Science Foundation [BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013, DEB-0816613]; National Geographic Society; Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund [213]; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo Neotropic Fund; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Division Of Behavioral and Cognitive Sci [0921013] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo Neotropic Fund; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Financial support for the study was from the National Science Foundation (BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013, DEB-0816613), National Geographic Society, Liz Claiborne and Art Ortenberg Foundation, Fulbright Foundation, Sigma Xi Grants-in-Aid, Grant #213 from the Joseph Henry Fund of the National Academy of Sciences, World Wildlife Fund, L.S.B. Leakey Foundation, Chicago Zoological Society, Lincoln Park Zoo Neotropic Fund, Margot Marsh Biodiversity Foundation, Conservation International, the Graduate School of the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boubli JP, 2011, ECOTROPICA, V17, P53; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Caswell H, 1989, MATRIX POPULATION MO; Chapman CA, 2009, CAM S BIO EVOL ANTHR, V57, P463; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chirakkal H, 2010, ECOL APPL, V20, P783, DOI 10.1890/09-0560.1; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Cowlishaw G., 2000, PRIMATE CONSERVATION; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Erhart EM, 2008, AM J PHYS ANTHROPOL, V136, P183, DOI 10.1002/ajpa.20793; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Gelman A., 2007, DATA ANAL USING REGR; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Mendes Sergio L., 2005, Neotropical Primates, V13, P7; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; Morris WF, 2011, AM NAT, V177, pE14, DOI 10.1086/657443; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; Nunn CL, 2006, INFECT DIS PRIMATES; package R, 2008, LME4 LIN MIX EFF MOD; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; *R DEV COR TEAM, 2008, R FDN STAT COMP VIEN; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Robbins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019788; Rudran R, 2003, INT J PRIMATOL, V24, P925, DOI 10.1023/A:1026241625910; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sibly RM, 2002, PHILOS T ROY SOC B, V357, P1149, DOI 10.1098/rstb.2002.1130; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Strier Karen B., 2006, Primate Conservation, V20, P53, DOI 10.1896/0898-6207.20.1.53; Strier KB, 2006, AM J PHYS ANTHROPOL, V130, P227, DOI 10.1002/ajpa.20366; Strier Karen B., 2012, P125; Strier KB, 2010, METHODS ECOL EVOL, V1, P199, DOI 10.1111/j.2041-210X.2010.00023.x; Strier KB, 2000, ANIM BEHAV, V59, P849, DOI 10.1006/anbe.1999.1387; Struhsaker TT, 2008, INT J PRIMATOL, V29, P19, DOI 10.1007/s10764-007-9146-4; Tabacow FP, 2009, AM ANTHROPOL, V111, P238, DOI 10.1111/j.1548-1433.2009.01116.x; Tabacow Fernando P., 2009, Neotropical Primates, V16, P67; VALLE CMC, 1984, PRIMATOLOGIA BRASIL, P271	44	18	18	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44407	10.1371/journal.pone.0044407	http://dx.doi.org/10.1371/journal.pone.0044407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028534	Green Submitted, Green Published, gold			2022-12-25	WOS:000309742800010
J	Negroni, J; Meunier, N; Monnerie, R; Salesse, R; Baly, C; Caillol, M; Congar, P				Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice			Neuropeptide Y Enhances Olfactory Mucosa Responses to Odorant in Hungry Rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INCREASES FOOD-INTAKE; YY1 RECEPTOR; PEPTIDE-YY; IMMUNOHISTOCHEMICAL LOCALIZATION; NUTRITIONAL-STATUS; SENSORY NEURONS; PRECURSOR CELLS; XENOPUS-LAEVIS; SWEET TASTE	Neuropeptide Y (NPY) plays an important role in regulating appetite and hunger in vertebrates. In the hypothalamus, NPY stimulates food intake under the control of the nutritional status. Previous studies have shown the presence of NPY and receptors in rodent olfactory system, and suggested a neuroproliferative role. Interestingly, NPY was also shown to directly modulate olfactory responses evoked by a food-related odorant in hungry axolotls. We have recently demonstrated that another nutritional cue, insulin, modulates the odorant responses of the rat olfactory mucosa (OM). Therefore, the aim of the present study was to investigate the potential effect of NPY on rat OM responses to odorants, in relation to the animal's nutritional state. We measured the potential NPY modulation of OM responses to odorant, using electro-olfactogram (EOG) recordings, in fed and fasted adult rats. NPY application significantly and transiently increased EOG amplitudes in fasted but not in fed rats. The effects of specific NPY-receptor agonists were similarly quantified, showing that NPY operated mainly through Y1 receptors. These receptors appeared as heterogeneously expressed by olfactory neurons in the OM, and western blot analysis showed that they were overexpressed in fasted rats. These data provide the first evidence that NPY modulates the initial events of odorant detection in the rat OM. Because this modulation depends on the nutritional status of the animal, and is ascribed to NPY, the most potent orexigenic peptide in the central nervous system, it evidences a strong supplementary physiological link between olfaction and nutritional processes.	[Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice] INRA, Neurobiol Olfact & Modelisat & Imagerie UR1197, Jouy En Josas, France; [Negroni, Julia; Meunier, Nicolas; Monnerie, Regine; Salesse, Roland; Baly, Christine; Caillol, Monique; Congar, Patrice] NeuroSud Paris, IFR144, Gif Sur Yvette, France; [Meunier, Nicolas] Univ Versailles, F-78000 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Negroni, J (corresponding author), INRA, Neurobiol Olfact & Modelisat & Imagerie UR1197, Jouy En Josas, France.	patrice.congar@jouy.inra.fr		Baly, Christine/0000-0002-8966-9522	Institut National de la Recherche Agronomique (INRA); INRA	Institut National de la Recherche Agronomique (INRA); INRA	This work was funded by the Institut National de la Recherche Agronomique (INRA). JN was supported by a post-doctoral grant from the INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Apelbaum AF, 2005, REGUL PEPTIDES, V129, P49, DOI 10.1016/j.regpep.2005.01.003; Apelbaum AF, 2003, CHEM SENSES, V28, P389, DOI 10.1093/chemse/28.5.389; Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Cabrele C, 2000, J BIOL CHEM, V275, P36043, DOI 10.1074/jbc.M000626200; Caillol M, 2003, BRAIN RES, V960, P48, DOI 10.1016/S0006-8993(02)03755-1; CHAPUT M, 1976, CHEM SENS FLAV, V2, P189, DOI 10.1093/chemse/2.2.189; Chen H, 2009, OBESITY, V17, P1356, DOI 10.1038/oby.2009.56; Crespi EJ, 2004, J NEUROENDOCRINOL, V16, P279, DOI 10.1111/j.0953-8194.2004.01168.x; Czesnik D, 2007, P NATL ACAD SCI US; DANGER JM, 1990, FUNDAM CLIN PHARM, V4, P307, DOI 10.1111/j.1472-8206.1990.tb00497.x; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Doyle KL, 2012, J NEUROSCI RES, V90, P1126, DOI 10.1002/jnr.23008; DUCLAUX R, 1973, PHYSIOL BEHAV, V10, P1029, DOI 10.1016/0031-9384(73)90184-4; Eckard CP, 2001, MOLECULES, V6, P448, DOI 10.3390/60500448; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Eva C, 2006, FRONT NEUROENDOCRIN, V27, P308, DOI 10.1016/j.yfrne.2006.07.002; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; Getchell TV, 2006, PSYSL BEHAV; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Grove KL, 2003, MOL BRAIN RES, V113, P133, DOI 10.1016/S0169-328X(03)00093-7; Hansel DE, 2001, J NEUROSCI RES, V66, P1, DOI 10.1002/jnr.1191; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hardy AB, 2005, ENDOCRINOLOGY, V146, P4042, DOI 10.1210/en.2005-0020; Holliday ND, 2005, MOL PHARMACOL, V67, P655, DOI 10.1124/mol.104.006114; Holliday ND, 2003, BRIT J PHARMACOL, V139, P501, DOI 10.1038/sj.bjp.0705276; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; INUI A, 1991, AM J PHYSIOL, V261, pR588, DOI 10.1152/ajpregu.1991.261.3.R588; Jia CH, 2012, MOL CELL NEUROSCI, V49, P158, DOI 10.1016/j.mcn.2011.11.004; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Julliard AK, 2007, BEHAV BRAIN RES, V183, P123, DOI 10.1016/j.bbr.2007.05.033; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kanekar S, 2009, J NEUROSCI RES, V87, P1424, DOI 10.1002/jnr.21954; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Lacroix MC, 2008, J NEUROENDOCRINOL, V20, P1176, DOI 10.1111/j.1365-2826.2008.01777.x; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Mao YK, 1996, AM J PHYSIOL-GASTR L, V271, pG36, DOI 10.1152/ajpgi.1996.271.1.G36; MCDONALD JK, 1988, CRIT REV NEUROBIOL, V4, P97; Michel MC, 1998, PHARMACOL REV, V50, P143; Migita K, 2001, BRAIN RES, V889, P23, DOI 10.1016/S0006-8993(00)03092-4; Montani G, 2006, EUR J NEUROSCI, V24, P20, DOI 10.1111/j.1460-9568.2006.04878.x; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; MORLEY JE, 1987, AM J PHYSIOL, V252, pR599, DOI 10.1152/ajpregu.1987.252.3.R599; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Niki M, 2010, RESULTS PROBL CELL D, V52, P101, DOI 10.1007/978-3-642-14426-4_9; PAGER J, 1972, PHYSIOL BEHAV, V9, P573, DOI 10.1016/0031-9384(72)90014-5; POLAK JM, 1984, PEPTIDES, V5, P79, DOI 10.1016/0196-9781(84)90267-5; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Reuter D, 1998, J NEUROSCI, V18, P6623; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Scott JW, 1999, CHEM SENSES, V24, P679, DOI 10.1093/chemse/24.6.679; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; SHEIKH SP, 1990, J BIOL CHEM, V265, P8304; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Soll RM, 2001, EUR J BIOCHEM, V268, P2828, DOI 10.1046/j.1432-1327.2001.02161.x; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Xu B, 1998, REGUL PEPTIDES, V75-6, P391, DOI 10.1016/S0167-0115(98)00093-7	72	29	29	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45266	10.1371/journal.pone.0045266	http://dx.doi.org/10.1371/journal.pone.0045266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024812	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100070
J	Visschedyk, D; Rochon, A; Tempel, W; Dimov, S; Park, HW; Merrill, AR				Visschedyk, Danielle; Rochon, Amanda; Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won; Merrill, A. Rod			Certhrax Toxin, an Anthrax-related ADP-ribosyltransferase from Bacillus cereus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; CRYSTAL-STRUCTURE; LETHAL FACTOR; CLOSTRIDIUM-BOTULINUM; EXFOLIATIVE TOXIN; CATALYTIC DOMAIN; MECHANISM; EXOTOXIN; BINDING; PROTEIN	We identified Certhrax, the first anthrax-like mART toxin from the pathogenic G9241 strain of Bacillus cereus. Certhrax shares 31% sequence identity with anthrax lethal factor from Bacillus anthracis; however, we have shown that the toxicity of Certhrax resides in the mART domain, whereas anthrax uses a metalloprotease mechanism. Like anthrax lethal factor, Certhrax was found to require protective antigen for host cell entry. This two-domain enzyme was shown to be 60-fold more toxic to mammalian cells than anthrax lethal factor. Certhrax localizes to distinct regions within mouse RAW264.7 cells by 10 min postinfection and is extranuclear in its cellular location. Substitution of catalytic residues shows that the mART function is responsible for the toxicity, and it binds NAD(+) with high affinity (K-D = 52.3 +/- 12.2 mu M). We report the 2.2 angstrom Certhrax structure, highlighting its structural similarities and differences with anthrax lethal factor. We also determined the crystal structures of two good inhibitors (P6 (K-D = 1.7 +/- 0.2 mu M, K-i = 1.8 +/- 0.4 mu M) and PJ34 (K-D = 5.8 +/- 2.6 mu M, K-i = 9.6 +/- 0.3 mu M)) in complex with Certhrax. As with other toxins in this family, the phosphate-nicotinamide loop moves toward the NAD(+) binding site with bound inhibitor. These results indicate that Certhrax may be important in the pathogenesis of B. cereus.	[Visschedyk, Danielle; Rochon, Amanda; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada	University of Guelph; University of Toronto; Structural Genomics Consortium; University of Toronto	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Canadian Institutes of Health Research; Cystic Fibrosis Canada; Human Frontier Science Program; National Sciences and Engineering Research Council; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Human Frontier Science Program(Human Frontier Science Program); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This study was funded by the Canadian Institutes of Health Research (to A. R. M. and H. W. P.), Cystic Fibrosis Canada (to A. R. M.), the Human Frontier Science Program (to A. R. M.), and a National Sciences and Engineering Research Council graduate fellowship (to D. V.). The Structural Genomics Consortium is a registered charity (Number 1097737) and receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; We thank Dawn White for excellent technical assistance. We acknowledge Xinyu (Johnny) Guan for the crystallization of the N-domain of Certhrax<SUP>4</SUP> and thank Limin Shen for providing multiple clones for Certhrax. We are grateful to Bum-Soo Hong for early work on the crystallography and to Kyung-Phil Kim for help with DNA sequencing. We thank Zachari Turgeon for initial work on Certhrax cytotoxicity and inhibitor development and testing. We also thank Dr. Robert Fieldhouse for bioinformatics analysis of Certhrax and for insightful discussions. Research described here was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Burns D., 2003, BACTERIAL PROTEIN TO; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Gupta P, 2001, BIOCHEM BIOPH RES CO, V280, P158, DOI 10.1006/bbrc.2000.4099; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; JUST I, 1992, J BIOL CHEM, V267, P10274; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; Oh SY, 2011, MOL MICROBIOL, V80, P455, DOI 10.1111/j.1365-2958.2011.07582.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Papazisi L, 2011, GENOMICS, V98, P26, DOI 10.1016/j.ygeno.2011.03.008; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; QUINN CP, 1991, J BIOL CHEM, V266, P20124; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Salter SJ, 2011, NAT REV MICROBIOL, V9, P83, DOI 10.1038/nrmicro2506; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Yamaguchi T, 2001, INFECT IMMUN, V69, P7760, DOI 10.1128/IAI.69.12.7760-7771.2001; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Zornetta I, 2010, CELL MICROBIOL, V12, P1435, DOI 10.1111/j.1462-5822.2010.01480.x	64	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41089	41102		10.1074/jbc.M112.412809	http://dx.doi.org/10.1074/jbc.M112.412809			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	22992735	Green Published, hybrid			2022-12-25	WOS:000311887600026
J	Ali, MF; Chachadi, VB; Petrosyan, A; Cheng, PW				Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan			Golgi Phosphoprotein 3 Determines Cell Binding Properties under Dynamic Flow by Controlling Golgi Localization of Core 2 N-Acetylglucosaminyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH SYNDROME; INTERCELLULAR-ADHESION MOLECULE-1; FRONTAL AFFINITY-CHROMATOGRAPHY; O-LINKED OLIGOSACCHARIDES; P-SELECTIN; MEMBRANE-GLYCOPROTEINS; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; TUMOR-METASTASIS; CYTOPLASMIC TAIL	Core 2 N-acetylglucosaminyltransferase 1 (C2GnT1) is a key enzyme participating in the synthesis of core 2-associated sialyl Lewis x (C2-O-sLe(x)), a ligand involved in selectin-mediated leukocyte trafficking and cancer metastasis. To accomplish that, C2GnT1 needs to be localized to the Golgi and this step requires interaction of its cytoplasmic tail (CT) with a protein that has not been identified. Employing C2GnT1 CT as the bait to perform a yeast two-hybrid screen, we have identified Golgi phosphoprotein 3 (GOLPH3) as a principal candidate protein that interacts with C2GnT1 and demonstrated that C2GnT1 binds to GOLPH3 via the LLRRR9 sequence in the CT. Confocal fluorescence microscopic analysis shows substantial Golgi co-localization of C2GnT1 and GOLPH3. Upon GOLPH3 knockdown, C2GnT1 is found mainly in the endoplasmic reticulum and decorated with complex-typeN-glycans, indicating that the enzyme has been transported to the Golgi but is not retained. Also, we have found that a recombinant protein consisting of C2GnT1 CT1-16-Leu(17-32)-Gly(33-42)-GFP is localized to the Golgi although the same construct with mutated CT (AAAAA(9)) is not. The data demonstrate that the C2GnT1 CT is necessary and sufficient for Golgi localization of C2GnT1. Furthermore, GOLPH3 knockdown results in reduced synthesis of C2-O-sLe(x) associated with P-selectin glycoprotein ligand-1, reduced cell tethering to and rolling on immobilized P- or E-selectin, and compromised E-selectin-induced activation of spleen tyrosine kinase and cell adhesion to intercellular adhesion molecule-1 under dynamic flow. Our results reveal that GOLPH3 can regulate cell-cell interaction by controlling Golgi retention of C2GnT1.	[Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	pcheng@unmc.edu	Chachadi, Vishwanath/ABG-8002-2021; Petrosyan, Armen/T-7071-2018	Chachadi, Vishwanath/0000-0002-4488-419X; Petrosyan, Armen/0000-0003-3895-3993	National Institutes of Health [1R21HL097238, 2RO1HL48282]; Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs [VA 1I1BX000985]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238, R01HL048282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs; State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R21HL097238 and 2RO1HL48282, the Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs Grant VA 1I1BX000985, and State of Nebraska Grant LB506 (to P.W.C.).	Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Beum PV, 2001, ADV EXP MED BIOL, V491, P279; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Chen SH, 2006, METHOD ENZYMOL, V416, P371, DOI 10.1016/S0076-6879(06)16024-3; Cheng PW, 2011, ADV EXP MED BIOL, V705, P465, DOI 10.1007/978-1-4419-7877-6_25; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FEIZI T, 1980, REV FR TRANSFUS IMMU, V23, P563, DOI 10.1016/S0338-4535(80)80160-7; GONATAS JO, 1989, J BIOL CHEM, V264, P4264; Gopalan PK, 1997, J IMMUNOL, V158, P367; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Jacobson DA, 2006, AM J PHYSIOL-ENDOC M, V291, pE587, DOI 10.1152/ajpendo.00612.2005; Kikuchi J, 2005, LEUKEMIA, V19, P1934, DOI 10.1038/sj.leu.2403951; Krull M, 1999, J IMMUNOL, V162, P4834; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MEGA T, 1992, J BIOCHEM-TOKYO, V111, P396, DOI 10.1093/oxfordjournals.jbchem.a123768; Moll T, 1999, METH MOL B, V96, P77; Nakamura M, 1998, J BIOL CHEM, V273, P26779, DOI 10.1074/jbc.273.41.26779; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; OCHS HD, 1986, CLIN IMMUNOL IMMUNOP, V40, P94, DOI 10.1016/0090-1229(86)90072-3; OHYAMA Y, 1985, J BIOL CHEM, V260, P6882; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; PARK JK, 1991, NATURE, V350, P706, DOI 10.1038/350706a0; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Radhakrishnan P, 2011, BIOCHEM BIOPH RES CO, V409, P436, DOI 10.1016/j.bbrc.2011.05.019; Ross JM, 1998, THROMB HAEMOSTASIS, V79, P155; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Sours-Brothers S, 2009, FRONT BIOSCI-LANDMRK, V14, P1851, DOI 10.2741/3346; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sriramarao P, 1996, J IMMUNOL, V157, P4672; St Hill CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016281; Tarr JM, 2012, CELL SIGNAL, V24, P873, DOI 10.1016/j.cellsig.2011.12.003; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; van den Berg TK, 2001, IMMUNOL REV, V184, P45, DOI 10.1034/j.1600-065x.2001.1840105.x; Varki A., 2009, ESSENTIALS GLYCOBIOL; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; Wang XM, 2004, BIOMED ENVIRON SCI, V17, P341; Wassler MJ, 2001, J CELL SCI, V114, P2291; Wiese Georg, 2009, J Vis Exp, DOI 10.3791/1009; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15	70	52	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.346528	http://dx.doi.org/10.1074/jbc.M112.346528			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027862	hybrid, Green Published			2022-12-25	WOS:000311233800027
J	Baumann, T; Affentranger, S; Niggli, V				Baumann, Tommy; Affentranger, Sarah; Niggli, Verena			Evidence for Chemokine-mediated Coalescence of Preformed Flotillin Hetero-oligomers in Human T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGGIE/FLOTILLIN PROTEINS; MEMBRANE MICRODOMAINS; FLUORESCENT PROTEIN; REGGIE-1/FLOTILLIN-2; OLIGOMERIZATION; ASSOCIATION; CHEMOTAXIS; MIGRATION; INTERACT; UROPOD	We have shown previously that endogenous flotillin-1 and -2, closely related proteins implicated in scaffolding of membrane microdomains, are rapidly recruited to the uropods of chemoattractant-stimulated human neutrophils and T-cells and are involved in cell polarization. Coexpressed flotillin-1 and -2, but not singly expressed proteins, are also targeted to the uropod of T-cells and neutrophils. Biochemical studies suggest formation of flotillin homo- and hetero-oligomers in other cell types, but so far knowledge is lacking on in situ flotillin organization in leukocytes. We have now analyzed flotillin organization in human T-cells using fluorescence resonance energy transfer (FRET). Coexpressed C-terminally tagged flotillin-1-mCherry and flotillin-2-enhanced green fluorescent protein (EGFP) show significant FRET when analyzed in intact human T-cells in the absence and presence of chemokine. In contrast, little FRET was observed between coexpressed flotillin-1-mCherry and flotillin-1-EGFP before or after chemokine addition, indicating predominant formation of heterodimers and/or -oligomers. Interestingly coexpression of untagged flotillin-2 strongly enhanced FRET between differently tagged flotillin-1 molecules in resting and chemokine-stimulated cells, indicating that close contacts of flotillin-1 molecules only occur in flotillin-2-containing hetero-oligomers. Comparable results were obtained for tagged flotillin-2. We further show that disruption of the actin network, depletion of intracellular calcium, and inhibition of phospholipase C all result in suppression of chemokine-induced polarization and flotillin cap formation, but do not abolish FRET between tagged flotillin-1 and -2. Our results support predominant formation of flotillin-1 and -2 hetero-oligomers in resting and chemokine-stimulated human T-cells which may importantly contribute to structuring of the uropod.	[Baumann, Tommy; Affentranger, Sarah; Niggli, Verena] Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland	University of Bern	Niggli, V (corresponding author), Univ Bern, Inst Pathol, Murtenstr 31, CH-3010 Bern, Switzerland.	verena.niggli@pathology.unibe.ch		Baumann, Tommy/0000-0002-5950-4137	Swiss National Science Foundation Grant [3100A_129655/1]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 3100A_129655/1 (to V. N.).	Affentranger S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-28; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Frick M., CURR BIOL, V17, P1151; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	18	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412742	http://dx.doi.org/10.1074/jbc.M112.412742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012365	Green Published, hybrid			2022-12-25	WOS:000311233800036
J	Lee, KH; Biswas, A; Liu, YJ; Kobayashi, KS				Lee, Kyoung-Hee; Biswas, Amlan; Liu, Yuen-Joyce; Kobayashi, Koichi S.			Proteasomal Degradation of Nod2 Protein Mediates Tolerance to Bacterial Cell Wall Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRED ANTIGEN PRESENTATION; INNATE IMMUNE-RESPONSES; MONOPHOSPHORYL-LIPID-A; NF-KAPPA-B; ENDOTOXIN TOLERANCE; HUMAN MONOCYTES; MURAMYL-DIPEPTIDE; BLAU-SYNDROME; SEPTIC SHOCK; MOLECULAR-MECHANISMS	The innate immune system serves as the first line of defense by detecting microbes and initiating inflammatory responses. Although both Toll-like receptor (TLR) and nucleotide binding domain and leucine-rich repeat (NLR) proteins are important for this process, their excessive activation is hazardous to hosts; thus, tight regulation is required. Endotoxin tolerance is refractory to repeated lipopolysaccharide (LPS) stimulation and serves as a host defense mechanism against septic shock caused by an excessive TLR4 response during Gram-negative bacterial infection. Gram-positive bacteria as well as their cell wall components also induce shock. However, the mechanism underlying tolerance is not understood. Here, we show that activation of Nod2 by its ligand, muramyl dipeptide (MDP) in the bacterial cell wall, induces rapid degradation of Nod2, which confers MDP tolerance in vitro and in vivo. Nod2 is constitutively associated with a chaperone protein, Hsp90, which is required for Nod2 stability and protects Nod2 from degradation. Upon MDP stimulation, Hsp90 rapidly dissociates from Nod2, which subsequently undergoes ubiquitination and proteasomal degradation. The SOCS-3 protein induced by Nod2 activation further facilitates this degradation process. Therefore, Nod2 protein stability is a key factor in determining responsiveness to MDP stimulation. This indicates that TLRs and NLRs induce a tolerant state through distinct molecular mechanisms that protect the host from septic shock.	[Kobayashi, Koichi S.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Liu, Yuen-Joyce; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kobayashi, KS (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, 415A Reynolds Med Bldg, College Stn, TX 77843 USA.	kobayashi@medicine.tamhsc.edu		Kobayashi, Koichi/0000-0003-2930-0114; Liu, Yuen-Joyce/0000-0003-1772-0082	National Institutes of Health [R01DK074738]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK074738 (to K. S. K.). This work was also supported by a grant from the Crohn's and Colitis Foundation of America (to K. S. K.).; Recipient of Crohn's and Colits Foundation of America research fellowship.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Ferreira MES, 2001, AM J PHYSIOL-REG I, V281, pR162, DOI 10.1152/ajpregu.2001.281.1.R162; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; FRANKENBERGER M, 1995, J INFLAMM, V45, P56; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; GALLIS HA, 1976, INFECT IMMUN, V13, P1459, DOI 10.1128/IAI.13.5.1459-1466.1976; Gustafson G L, 1995, Prog Clin Biol Res, V392, P567; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; Mages J, 2007, IMMUNOBIOLOGY, V212, P723, DOI 10.1016/j.imbio.2007.09.015; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meshcheryakova E, 2001, INT IMMUNOPHARMACOL, V1, P1857, DOI 10.1016/S1567-5769(01)00111-4; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Monneret G, 2004, IMMUNOL LETT, V95, P193, DOI 10.1016/j.imlet.2004.07.009; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogawa Chikako, 2011, Curr Bioact Compd, V7, P180; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rose CD, 2005, J RHEUMATOL, V32, P373; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shimauchi H, 1999, INFECT IMMUN, V67, P2153, DOI 10.1128/IAI.67.5.2153-2159.1999; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TAKADA H, 1987, INFECT IMMUN, V55, P409, DOI 10.1128/IAI.55.2.409-413.1987; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223	68	61	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.410027	http://dx.doi.org/10.1074/jbc.M112.410027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019338	hybrid, Green Published			2022-12-25	WOS:000311233800048
J	Tran, NQ; Lee, SJ; Akabayov, B; Johnson, DE; Richardson, CC				Tran, Ngoc Q.; Lee, Seung-Joo; Akabayov, Barak; Johnson, Donald E.; Richardson, Charles C.			Thioredoxin, the Processivity Factor, Sequesters an Exposed Cysteine in the Thumb Domain of Bacteriophage T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; RAY SOLUTION SCATTERING; DEOXYRIBONUCLEIC-ACID; CONFERS PROCESSIVITY; SULFHYDRYL-GROUPS; HELICASE-PRIMASE; BINDING-PROTEIN; III HOLOENZYME; REPLICATION; CLAMP	Gene 5 protein (gp5) of bacteriophage T7 is a non-processive DNA polymerase. It achieves processivity by binding to Escherichia coli thioredoxin (trx). gp5/trx complex binds tightly to a primer-DNA template enabling the polymerization of hundreds of nucleotides per binding event. gp5 contains 10 cysteines. Under non-reducing condition, exposed cysteines form intermolecular disulfide linkages resulting in the loss of polymerase activity. No disulfide linkage is detected when Cys-275 and Cys-313 are replaced with serines. Cys-275 and Cys-313 are located on loop A and loop B of the thioredoxin binding domain, respectively. Replacement of either cysteine with serine (gp5-C275S, gp5-C313S) drastically decreases polymerase activity of gp5 on dA(350)/dT(25). On this primer-template gp5/trx in which Cys-313 or Cys-275 is replaced with serine have 50 and 90%, respectively, of the polymerase activity observed with wild-type gp5/trx. With single-stranded M13 DNA as a template gp5-C275S/trx retains 60% of the polymerase activity of wild-type gp5/trx. In contrast, gp5-C313S/trx has only one-tenth of the polymerase activity of wild-type gp5/trx on M13 DNA. Both wild-type gp5/trx and gp5-C275S/trx catalyze the synthesis of the entire complementary strand of M13 DNA, whereas gp5-C313S/trx has difficulty in synthesizing DNA through sites of secondary structure. gp5-C313S fails to form a functional complex with trx as measured by the apparent binding affinity as well as by the lack of a physical interaction with thioredoxin during hydroxyapatite-phosphate chromatography. Small angle x-ray scattering reveals an elongated conformation of gp5-C313S in comparison to a compact and spherical conformation of wild-type gp5.	[Tran, Ngoc Q.; Lee, Seung-Joo; Akabayov, Barak; Johnson, Donald E.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742	National Institutes of Health [GM54397]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397.; Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	ADLER S, 1983, J BIOL CHEM, V258, P6956; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Camacho A, 2010, FEMS MICROBIOL REV, V34, P828, DOI 10.1111/j.1574-6976.2010.00219.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Etson CM, 2010, P NATL ACAD SCI USA, V107, P1900, DOI 10.1073/pnas.0912664107; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUBBARD J, 1993, NACCESS COMPUTER PRO; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson DE, 2003, J BIOL CHEM, V278, P23762, DOI 10.1074/jbc.M301366200; JOVIN TM, 1969, J BIOL CHEM, V244, P3009; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; MODRICH P, 1975, J BIOL CHEM, V250, P5508; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; MYERS TW, 1988, J BIOL CHEM, V263, P17006; OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun D., 1992, J APPL CRYSTALLOGR, V25, P8; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang XM, 1997, J BIOL CHEM, V272, P6599, DOI 10.1074/jbc.272.10.6599; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440	39	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.409235	http://dx.doi.org/10.1074/jbc.M112.409235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012374	Green Published, hybrid			2022-12-25	WOS:000311233800042
J	Zhang, L; Chen, B; Zhao, Y; Dubielecka, PM; Wei, L; Qin, GJ; Chin, YE; Wang, YG; Zhao, TC				Zhang, Ling; Chen, Bing; Zhao, Yu; Dubielecka, Patrycja M.; Wei, Lei; Qin, Gang J.; Chin, Y. Eugene; Wang, Yigang; Zhao, Ting C.			Inhibition of Histone Deacetylase-induced Myocardial Repair Is Mediated by c-kit in Infarcted Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CARDIAC-HYPERTROPHY; BONE-MARROW; REGENERATION; DIFFERENTIATION; SURVIVAL; INJURY; CARDIOPROTECTION; PERFORMANCE; PROGENITOR	Histone deacetylases (HDACs) play a critical role in the regulation of gene transcription, cardiac development, and diseases. The aim of this study was to test whether inhibition of HDACs induces myocardial repair and cardiac function restoration through c-kit signaling in mouse myocardial infarction models. Myocardial infarction in wild type Kit(+/+) and Kit(W)/Kit(W-v) mice was created following thoracotomy by applying permanent ligation to the left anterior descending artery. The HDAC inhibitor, trichostatin A (TSA, 0.1 mg/kg), was intraperitoneally injected daily for a consecutive 8 weeks after myocardial infarction. 5-Bromo-2-deoxyuridine (BrdU, 50 mg/kg) was intraperitoneally delivered every other day to pulse-chase label in vivo endogenous cardiac replication. Eight weeks later, inhibition of HDACs in vivo resulted in an improvement in ventricular functional recovery and the prevention of myocardial remodeling in Kit(+/+) mice, which was eliminated in Kit(W)/Kit(W-v) mice. HDAC inhibition promoted cardiac repairs and neovascularization in the infarcted myocardium, which were absent in Kit(W)/Kit(W-v) mice. Re-introduction of TSA-treated wild type c-kit(+) CSCs into Kit(W)/Kit(W-v) myocardial infarction heart restored myocardial functional improvement and cardiac repair. To further validate that HDAC inhibition stimulates c-kit(+) cardiac stem cells (CSCs) to facilitate myocardial repair, GFP(+) c-kit(+) CSCs were preconditioned with TSA (50 nmol/liter) for 24 h and re-introduced into infarcted hearts for 2 weeks. Preconditioning of c-kit(+) CSCs via HDAC inhibition with trichostatin A significantly increased c-kit(+) CSC-derived myocytes and microvessels and enhanced functional recovery in myocardial infarction hearts in vivo. Our results provide evidence that HDAC inhibition promotes myocardial repair and prevents cardiac remodeling, which is dependent upon c-kit signaling.	[Zhao, Ting C.] Boston Univ, Sch Med, Cardiovasc Labs, Dept Surg,Roger Williams Med Ctr, Providence, RI 02908 USA; [Zhang, Ling; Chin, Y. Eugene] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Med, Providence, RI 02905 USA; [Wei, Lei] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02905 USA; [Qin, Gang J.] Northwestern Univ, Feinberg Sch Med, Cardiovasc Inst, Chicago, IL 60611 USA; [Wang, Yigang] Univ Cincinnati, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45267 USA	Boston University; Roger Williams Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati	Zhao, TC (corresponding author), Boston Univ, Sch Med, Cardiovasc Labs, Dept Surg,Roger Williams Med Ctr, 50 Maude St, Providence, RI 02908 USA.	tzhao@bu.edu	Dubielecka, Patrycja/AAF-8128-2019		National Institutes of Health from NHLBI [R01 HL089405]; American Heart Association-National Center [0735458N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089405] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association-National Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089405 from NHLBI. This work was also supported by American Heart Association-National Center, Grant 0735458N (to T. C. Z.).	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Zhang LX, 2010, AM J PHYSIOL-HEART C, V298, pH2154, DOI 10.1152/ajpheart.01015.2009; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010; Zhao TC, 2010, BBA-MOL CELL RES, V1803, P872, DOI 10.1016/j.bbamcr.2010.04.007	31	56	64	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.379115	http://dx.doi.org/10.1074/jbc.M112.379115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024362	Green Published, hybrid			2022-12-25	WOS:000311233800006
J	Gonzalez-Flores, JN; Gupta, N; DeMong, LW; Copeland, PR				Gonzalez-Flores, Jonathan N.; Gupta, Nirupama; DeMong, Louise W.; Copeland, Paul R.			The Selenocysteine-specific Elongation Factor Contains a Novel and Multi-functional Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN MESSENGER-RNAS; EUKARYOTIC SECIS ELEMENTS; TRANSLATION FACTOR SELB; GTP HYDROLYSIS; MAMMALIAN SELENOPROTEIN; INCORPORATION MACHINERY; DECODING APPARATUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING PROTEIN	The selenocysteine (Sec)-specific eukaryotic elongation factor (eEFSec) delivers the aminoacylated selenocysteine-tRNA (Sec-tRNA(Sec)) to the ribosome and suppresses UGA codons that are upstream of Sec insertion sequence (SECIS) elements bound by SECIS-binding protein 2 (SBP2). Multiple studies have highlighted the importance of SBP2 forming a complex with the SECIS element, but it is not clear how this regulates eEFSec during Sec incorporation. Compared with the canonical elongation factor eEF1A, eEFSec has a unique C-terminal extension called Domain IV. To understand the role of Domain IV in Sec incorporation, we examined a series of mutant proteins for all of the known molecular functions for eEFSec: GTP hydrolysis, Sec-tRNA(Sec) binding, and SBP2/SECIS binding. In addition, wildtype and mutant versions of eEFSec were analyzed for Sec incorporation activity in a novel eEFSec-dependent translation extract. We have found that Domain IV is essential for both tRNA and SBP2 binding as well as regulating GTPase activity. We propose a model where the SBP2/SECIS complex activates eEFSec by directing functional interactions between Domain IV and the ribosome to promote Sec-tRNA(Sec) binding and accommodation into the ribosomal A-site.	[Gonzalez-Flores, Jonathan N.; Gupta, Nirupama; DeMong, Louise W.; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health [2T32GM008339-21]; Public Health Service [GM077073]; National Science Foundation Directorate of Graduate Education [0333196]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM077073] Funding Source: NIH RePORTER	Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation Directorate of Graduate Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health 2T32GM008339-21, Public Health Service Grant GM077073, and the graduate fellowship programs of Integrative Graduate Education and Research Traineeship Biointerfaces National Science Foundation Directorate of Graduate Education 0333196.	BARON C, 1993, P NATL ACAD SCI USA, V90, P4181, DOI 10.1073/pnas.90.9.4181; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Burakovskii D E, 2007, Mol Biol (Mosk), V41, P1031; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Caban K, 2012, J BIOL CHEM, V287, P10664, DOI 10.1074/jbc.M111.320929; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Donovan J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-229; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fletcher JE, 2001, RNA, V7, P1442; Fourmy D, 2002, J MOL BIOL, V324, P137, DOI 10.1016/S0022-2836(02)01030-6; Hauryliuk V, 2006, BIOCHIMIE, V88, P747, DOI 10.1016/j.biochi.2006.06.001; Huttenhofer A, 1998, BIOCHEMISTRY-US, V37, P885, DOI 10.1021/bi972298k; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kohrer C, 2008, METHODS, V44, P129, DOI 10.1016/j.ymeth.2007.10.006; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kromayer M, 1996, J MOL BIOL, V262, P413, DOI 10.1006/jmbi.1996.0525; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Ose T, 2007, STRUCTURE, V15, P577, DOI 10.1016/j.str.2007.03.007; Paleskava A, 2012, J BIOL CHEM, V287, P27906, DOI 10.1074/jbc.M112.366120; Paleskava A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081380; Rebsch CM, 2006, CELL RES, V16, P940, DOI 10.1038/sj.cr.7310117; Selmer M, 2002, EMBO J, V21, P4145, DOI 10.1093/emboj/cdf408; Sergiev PV, 2005, FEBS LETT, V579, P5439, DOI 10.1016/j.febslet.2005.09.010; Soler N, 2007, J MOL BIOL, V370, P728, DOI 10.1016/j.jmb.2007.05.001; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Walczak R, 1996, RNA, V2, P367; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	43	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38936	38945		10.1074/jbc.M112.415463	http://dx.doi.org/10.1074/jbc.M112.415463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992746	Green Published, hybrid			2022-12-25	WOS:000310982800049
J	Kroh, HK; Bock, PE				Kroh, Heather K.; Bock, Paul E.			Effect of Zymogen Domains and Active Site Occupation on Activation of Prothrombin by von Willebrand Factor-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; REGULATORY EXOSITE-I; SUBSTRATE RECOGNITION; FLUORESCENCE PROBES; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; STRUCTURAL BASIS; KINETIC-DATA; FACTOR-VIIA	Prothrombin is conformationally activated by von Willebrand factor-binding protein (vWbp) from Staphylococcus aureus through insertion of the NH2-terminal residues of vWbp into the prothrombin catalytic domain. The rate of prothrombin activation by vWbp(1-263) is controlled by a hysteretic kinetic mechanism initiated by substrate binding. The present study evaluates activation of prothrombin by full-length vWbp(1-474) through activity progress curve analysis. Additional interactions from the COOH-terminal half of vWbp(1-474) strengthened the initial binding of vWbp to prothrombin, resulting in higher activity and an similar to 100-fold enhancement in affinity. The affinities of vWbp(1-263) or vWbp(1-474) were compared by equilibrium binding to the prothrombin derivatives prethrombin 1, prethrombin 2, thrombin, meizothrombin, and meizothrombin(des-fragment 1) and their corresponding active site-blocked analogs. Loss of fragment 1 in prethrombin 1 enhanced affinity for both vWbp(1-263) and vWbp(1-474), with a 30-45% increase in Gibbs free energy, implicating a regulatory role for fragment 1 in the activation mechanism. Active site labeling of all prothrombin derivatives with D-Phe-Pro-Arg-chloromethyl ketone, analogous to irreversible binding of a substrate, decreased their K-D values for vWbp into the subnanomolar range, reflecting the dependence of the activating conformational change on substrate binding. The results suggest a role for prothrombin domains in the pathophysiological activation of prothrombin by vWbp, and may reveal a function for autocatalysis of the vWbp.prothrombin complexes during initiation of blood coagulation.	[Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, C-3321A Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [R37 HL071544]; National Institutes of Health [T32 HL007751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL071544, T32HL007751] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 HL071544 from the NHLBI (to P. E. B.).; Supported in part by National Institutes of Health Grant T32 HL007751.	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; CHURCH FC, 1985, ARCH BIOCHEM BIOPHYS, V240, P607, DOI 10.1016/0003-9861(85)90067-0; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Eigenbrot C, 2002, TRENDS CARDIOVAS MED, V12, P19, DOI 10.1016/S1050-1738(01)00139-6; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Khan AR, 1998, PROTEIN SCI, V7, P815; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Mac Sweeney A, 2000, ACTA CRYSTALLOGR D, V56, P280, DOI 10.1107/S0907444999016583; Monteiro RQ, 2001, PROTEIN SCI, V10, P1897, DOI 10.1110/ps.09001; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; Newell-Caito JL, 2011, J BIOL CHEM, V286, P38286, DOI 10.1074/jbc.M111.247122; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; SORIANOGARCIA M, 1989, BIOCHEMISTRY-US, V28, P6805, DOI 10.1021/bi00443a004; Stevens WK, 1996, J BIOL CHEM, V271, P8062, DOI 10.1074/jbc.271.14.8062; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; YE J, 1992, J BIOL CHEM, V267, P11023	46	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39149	39157		10.1074/jbc.M112.415562	http://dx.doi.org/10.1074/jbc.M112.415562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012355	Green Published, hybrid			2022-12-25	WOS:000310982800070
J	Shim, JY; Bertalovitz, AC; Kendall, DA				Shim, Joong-Youn; Bertalovitz, Alexander C.; Kendall, Debra A.			Probing the Interaction of SR141716A with the CB1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CANNABINOID RECEPTOR; MOLECULAR-DYNAMICS; TRANSMEMBRANE HELICES; CONFORMATIONAL-ANALYSIS; CRYSTAL-STRUCTURE; FORCE-FIELD; ACTIVATION; RHODOPSIN; CHOLESTEROL	SR141716A binds selectively to the brain cannabinoid (CB1) receptor and exhibits a potent inverse agonist/antagonist activity. Although SR141716A, also known as rimonabant, has been withdrawn from the market due to severe side effects, there remains interest in some of its many potential medical applications. Consequently, it is imperative to understand the mechanism by which SR141716A exerts its inverse agonist activity. As a result of using an approach combining mutagenesis and molecular dynamics simulations, we determined the binding mode of SR141716A. We found from the simulation of the CB1-SR141716A complex that SR141716A projects toward TM5 to interact tightly with the major binding pocket, replacing the coordinated water molecules, and secures the Trp-356(6.48) rotameric switch in the inactive state to promote the formation of an extensive water-mediated H-bonding network to the highly conserved SLAXAD and NPXXY motifs in TM2/TM7. We identify for the first time the involvement of the minor binding pocket formed by TM2/TM3/TM7 for SR141716A binding, which complements the major binding pocket formed by TM3/TM5/TM6. Simulation of the F174(2.61)A mutant CB1-SR141716A complex demonstrates the perturbation of TM2 that attenuates SR141716A binding indirectly. These results suggest SR141716A exerts inverse agonist activity through the stabilization of both TM2 and TM5, securing the Trp-356(6.48) rotameric switch and restraining it from activation.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Bertalovitz, Alexander C.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [DA020663, DA020763]; National Science Foundation [ACI-0338618l, OCI-0451237, OCI-0535258, OCI-0504075, OCI-1053575]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA020663, R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020663 (to J.-Y.S.) and Grant DA020763 (to D.A.K.). This work was also supported by National Science Foundation Grants ACI-0338618l, OCI-0451237, OCI-0535258, and OCI-0504075.; J.-Y.S. acknowledges the Texas Advanced Computing Center at University of Texas at Austin for providing HPC resources that have contributed to the research results. This work used the Extreme Science and Engineering Discovery Environment, which is supported by National Science Foundation Grant OCI-1053575.	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Francisco MEY, 2002, J MED CHEM, V45, P2708, DOI 10.1021/jm010498v; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Lin LS, 2008, J MED CHEM, V51, P2108, DOI 10.1021/jm7014974; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makriyannis A, 2001, PCT int. Appl, Patent No. 2001029007; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Salo OMH, 2004, J MED CHEM, V47, P3048, DOI 10.1021/jm031052c; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shim JY, 2002, J MED CHEM, V45, P1447, DOI 10.1021/jm010267o; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Shire D, 1999, LIFE SCI, V65, P627, DOI 10.1016/S0024-3205(99)00285-4; Silvestri R, 2008, J MED CHEM, V51, P1560, DOI 10.1021/jm070566z; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiley JL, 2001, J PHARMACOL EXP THER, V296, P1013	52	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38741	38754		10.1074/jbc.M112.390955	http://dx.doi.org/10.1074/jbc.M112.390955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995906	hybrid, Green Published			2022-12-25	WOS:000310982800032
J	Bouchecareilh, M; Hutt, DM; Szajner, P; Flotte, TR; Balch, WE				Bouchecareilh, Marion; Hutt, Darren M.; Szajner, Patricia; Flotte, Terence R.; Balch, William E.			Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of alpha 1-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MEDIATE INCREASED SECRETION; ENDOPLASMIC-RETICULUM; MUTANT ALPHA-1-ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN DEFICIENCY; OXIDATIVE STRESS; QUALITY-CONTROL; MOLECULAR-MECHANISMS; THERAPEUTIC PARADIGM; LIVER-DISEASE	alpha 1-Antitrypsin (alpha 1AT) deficiency (alpha 1ATD) is a consequence of defective folding, trafficking, and secretion of alpha 1AT in response to a defect in its interaction with the endoplasmic reticulum proteostasis machineries. The most common and severe form of alpha 1ATD is caused by the Z-variant and is characterized by the accumulation of alpha 1AT polymers in the endoplasmic reticulum of the liver leading to a severe reduction (>85%) of alpha 1AT in the serum and its anti-protease activity in the lung. In this organ alpha 1AT is critical for ensuring tissue integrity by inhibiting neutrophil elastase, a protease that degrades elastin. Given the limited therapeutic options in alpha 1ATD, a more detailed understanding of the folding and trafficking biology governing alpha 1AT biogenesis and its response to small molecule regulators is required. Herein we report the correction of Z-alpha 1AT secretion in response to treatment with the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA), acting in part through HDAC7 silencing and involving a calnexin-sensitive mechanism. SAHA-mediated correction restores Z-alpha 1AT secretion and serpin activity to a level 50% that observed for wild-type alpha 1AT. These data suggest that HDAC activity can influence Z-alpha 1AT protein traffic and that SAHA may represent a potential therapeutic approach for alpha 1ATD and other protein misfolding diseases.	[Bouchecareilh, Marion; Hutt, Darren M.; Szajner, Patricia; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Flotte, Terence R.] UMass Med Sch, Dept Pediat, Worcester, MA 01655 USA; [Flotte, Terence R.] UMass Med Sch, Gene Therapy Ctr, Worcester, MA 01655 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu			National Institutes of Health [GM33301, GM42336, HL15674]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33301, GM42336, and HL15674 (to W. E. B.).	Aka Juliette Adjo, 2011, Handb Exp Pharmacol, V206, P1, DOI 10.1007/978-3-642-21631-2_1; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alam S, 2012, J HEPATOL, V57, P116, DOI 10.1016/j.jhep.2012.02.025; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouchecareilh M, 2012, CURR MOL MED, V12, P815, DOI 10.2174/156652412801318782; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Buckland Jenny, 2011, Nat Rev Rheumatol, V7, P682, DOI 10.1038/nrrheum.2011.162; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Cook C., 2012, J ALZHEIMER IN PRESS; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Ekeowa UI, 2011, EXPERT REV CLIN IMMU, V7, P243, DOI [10.1586/eci.10.95, 10.1586/ECI.10.95]; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Flotte TR, 2011, HUM MOL GENET, V20, pR87, DOI 10.1093/hmg/ddr156; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; Hidvegi T, 2011, METHOD ENZYMOL, V499, P33, DOI [10.1016/B978-0-12-386471-0.00003-1, 10.1016/13978-0-12-386471-0.00003-1]; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hutt D. M., 2012, COLD SPRING IN PRESS; Hutt D, 2010, SCIENCE, V329, P766, DOI 10.1126/science.1194160; Hutt DM, 2011, ACS MED CHEM LETT, V2, P703, DOI 10.1021/ml200136e; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Isajevs S, 2011, RESPIRATION, V81, P362, DOI 10.1159/000322560; Jagannath S, 2010, LEUKEMIA RES, V34, P1111, DOI 10.1016/j.leukres.2010.04.001; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kelly E, 2010, RESP MED, V104, P763, DOI 10.1016/j.rmed.2010.01.016; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Leggatt GR, 2012, IMMUNOL CELL BIOL, V90, P33, DOI 10.1038/icb.2011.94; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2010, NEW ENGL J MED, V363, P1863, DOI 10.1056/NEJMcibr1008007; Marcus NY, 2000, J BIOL CHEM, V275, P1987, DOI 10.1074/jbc.275.3.1987; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; PERLMUTTER DH, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A005801; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sifers Richard N, 2010, Proc Am Thorac Soc, V7, P376, DOI 10.1513/pats.201001-011AW; Sifers RN, 2010, SCIENCE, V329, P154, DOI 10.1126/science.1192681; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; To M, 2012, CHEST, V141, P1233, DOI 10.1378/chest.11-1536; Topic A, 2011, FETAL PEDIATR PATHOL, V30, P312, DOI 10.3109/15513815.2011.572961; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zeng L, 2009, GERIATR GERONTOL INT, V9, P7, DOI 10.1111/j.1447-0594.2008.00504.x; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	111	53	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404707	http://dx.doi.org/10.1074/jbc.M112.404707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22995909	hybrid, Green Published			2022-12-25	WOS:000310642200059
J	Sigala, PA; Crowley, JR; Hsieh, S; Henderson, JP; Goldberg, DE				Sigala, Paul A.; Crowley, Jan R.; Hsieh, Samantha; Henderson, Jeffrey P.; Goldberg, Daniel E.			Direct Tests of Enzymatic Heme Degradation by the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME CHROMOPHORE; BILIVERDIN REDUCTASE; FOOD VACUOLE; OXYGENASE; BIOSYNTHESIS; EXPRESSION; PROTEIN; METABOLISM; IRON; TRAFFICKING	Malaria parasites generate vast quantities of heme during blood stage infection via hemoglobin digestion and limited de novo biosynthesis, but it remains unclear if parasites metabolize heme for utilization or disposal. Recent in vitro experiments with a heme oxygenase (HO)-like protein from Plasmodium falciparum suggested that parasites may enzymatically degrade some heme to the canonical HO product, biliverdin (BV), or its downstream metabolite, bilirubin (BR). To directly test for BV and BR production by P. falciparum parasites, we DMSO-extracted equal numbers of infected and uninfected erythrocytes and developed a sensitive LC-MS/MS assay to quantify these tetrapyrroles. We found comparable low levels of BV and BR in both samples, suggesting the absence of HO activity in parasites. We further tested live parasites by targeted expression of a fluorescent BV-binding protein within the parasite cytosol, mitochondrion, and plant-like plastid. This probe could detect exogenously added BV but gave no signal indicative of endogenous BV production within parasites. Finally, we recombinantly expressed and tested the proposed heme degrading activity of the HO-like protein, PfHO. Although PfHO bound heme and protoporphyrin IX with modest affinity, it did not catalyze heme degradation in vivo within bacteria or in vitro in UV absorbance and HPLC assays. These observations are consistent with PfHO's lack of a heme-coordinating His residue and suggest an alternative function within parasites. We conclude that P. falciparum parasites lack a canonical HO pathway for heme degradation and thus rely fully on alternative mechanisms for heme detoxification and iron acquisition during blood stage infection.	[Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; [Crowley, Jan R.; Henderson, Jeffrey P.; Goldberg, Daniel E.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	goldberg@borcim.wustl.edu	Henderson, Jeffrey P/D-3337-2015	Hsieh, Samantha/0000-0002-1846-2583; Sigala, Paul/0000-0002-3464-3042	National Institutes of Health [HD001459, HL101263, DK064540, P41-RR00954, P60-DK20579, P30-DK56341]; Helen Hay Whitney Foundation; Washington University; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P50DK064540, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Washington University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants HD001459, HL101263, and DK064540 (to J. P. H.).; Supported in part by a postdoctoral fellowship from the Helen Hay Whitney Foundation.; Supported in part by National Institutes of Health Grants P41-RR00954, P60-DK20579, and P30-DK56341.; Supported in part by a summer undergraduate research fellowship from Washington University.; Recipient of a career award for medical scientists from the Burroughs Wellcome Fund.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; BRODERSEN R, 1979, J BIOL CHEM, V254, P2364; CAMMACK R, 1977, BIOCHEM J, V168, P205, DOI 10.1042/bj1680205; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; DELANO WL, 2007, MACPYMOL PYMOL BASED; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; ECKMAN JR, 1977, J LAB CLIN MED, V90, P767; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Ehlgen F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038781; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gisk B, 2010, BIOCHEM J, V425, P425, DOI 10.1042/BJ20090775; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kimata-Ariga Y, 2007, J BIOCHEM, V141, P421, DOI 10.1093/jb/mvm046; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; KNOBLER E, 1989, HEPATOLOGY, V10, P995, DOI 10.1002/hep.1840100617; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; MCLAREN CE, 1987, AM J PHYSIOL, V252, pH857, DOI 10.1152/ajpheart.1987.252.4.H857; Migita CT, 2003, EUR J BIOCHEM, V270, P687, DOI 10.1046/j.1432-1033.2003.03421.x; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Okada K, 2009, FEBS LETT, V583, P313, DOI 10.1016/j.febslet.2008.12.015; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quinn KD, 2012, RAPID COMMUN MASS SP, V26, P1767, DOI 10.1002/rcm.6287; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sartorello R, 2010, CELL BIOL INT, V34, P859, DOI 10.1042/CBI20090427; Scholl PF, 2005, CURR TOP MICROBIOL, V295, P293; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; van Dooren GG, 2012, ANTIOXID REDOX SIGN, V17, P634, DOI 10.1089/ars.2012.4539; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Weinberg ED, 2009, DRUG METAB REV, V41, P644, DOI 10.1080/03602530903178905; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Zhang JM, 1999, MOL BIOCHEM PARASIT, V99, P129, DOI 10.1016/S0166-6851(99)00008-0; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	79	39	41	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414078	http://dx.doi.org/10.1074/jbc.M112.414078			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992734	Green Published, hybrid			2022-12-25	WOS:000310642200018
J	Delli Pizzi, S; Madonna, R; Caulo, M; Romani, GL; De Caterina, R; Tartaro, A				Delli Pizzi, Stefano; Madonna, Rosalinda; Caulo, Massimo; Romani, Gian Luca; De Caterina, Raffaele; Tartaro, Armando			MR Angiography, MR Imaging and Proton MR Spectroscopy In-Vivo Assessment of Skeletal Muscle Ischemia in Diabetic Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ARTERY LIGATION MODEL; HIND-LIMB ISCHEMIA; GENE-THERAPY; 3 T; GROWTH; MICE; QUANTIFICATION; ANGIOGENESIS; CONTRAST	To prospectively evaluate the feasibility of using magnetic resonance (MR) techniques for in-vivo assessing a rat diabetic model of limb ischemia. Unilateral hind limb ischemia was induced by ligation of the iliac-femoral artery in male streptozotocin-treated and non-diabetic control rats. Four weeks after ligation, rats underwent MR Angiography (MRA), T-1-weighted and Short Time Inversion Recovery (STIR) sequences and muscle Proton MR Spectroscopy (H-1-MRS) on both hind limbs. After MR examinations, immunoblotting and immunofluorescence analysis were performed. MRA showed a signal void due to flow discontinuation distal to the artery ligation. T-1-weighted and STIR images showed, respectively, the presence of tissue swelling (p = 0.018 for non-diabetic; p = 0.027 for diabetic rats) and signal hyperintensity in tissue affected by occlusion. Mean total creatine/water for the occluded limb was significantly lower than for the non-occluded limbs in both non-diabetic (5.46 x 10(-4) vs 1.14 x 10(-3), p = 0.028) and diabetic rats (1.37 x 10(-4) vs 1.10 x 10(-3); p = 0.018). MR Imaging and H-1-MRS changes were more pronounced in diabetic than in non-diabetic occluded limbs (p = 0.032). MR findings were confirmed by using histological findings. Combined MR techniques can be used to demonstrate the presence of structural and metabolic changes produced by iliac-femoral artery occlusion in rat diabetic model of limb ischemia.	[Delli Pizzi, Stefano; Caulo, Massimo; Romani, Gian Luca; Tartaro, Armando] Univ G dAnnunzio, Dept Neurosci & Imaging, Inst Adv Biomed Technol, Chieti, Italy; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Dept Neurosci & Imaging, Div Cardiol, Ctr Excellence Aging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Tartaro, A (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Inst Adv Biomed Technol, Chieti, Italy.	tartaro@unich.it	tartaro, armando at/K-2184-2016; Pizzi, Stefano Delli/J-3935-2016; De Caterina, Raffaele/K-3857-2016	tartaro, armando at/0000-0003-0095-2792; Pizzi, Stefano Delli/0000-0003-4075-0132; De Caterina, Raffaele/0000-0003-1637-574X; Madonna, Rosalinda/0000-0001-6455-2777	Italian Ministry of University and Scientific Research; Istituto Nazionale Ricerche Cardiovascolari (INRC)	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Istituto Nazionale Ricerche Cardiovascolari (INRC)	This work was supported by grants from the Italian Ministry of University and Scientific Research and from the Istituto Nazionale Ricerche Cardiovascolari (INRC, to RDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-32; ARENA N, 1982, Bollettino Societa Italiana Biologia Sperimentale, V58, P1485; Asperio RM, 2001, RADIOLOGY, V220, P413, DOI 10.1148/radiology.220.2.r01au03413; Bottomley PA, 1998, LANCET, V351, P714, DOI 10.1016/S0140-6736(97)06402-7; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; de Lussanet QG, 2006, NMR BIOMED, V19, P77, DOI 10.1002/nbm.1003; de Lussanet QG, 2007, NMR BIOMED, V20, P717, DOI 10.1002/nbm.1133; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Emanueli C, 2007, FRONT BIOSCI-LANDMRK, V12, P2003, DOI 10.2741/2205; Fissoune R, 2009, ACAD RADIOL, V16, P890, DOI 10.1016/j.acra.2008.12.007; Gianella A, 2010, CARDIOVASC RES, V85, P503, DOI 10.1093/cvr/cvp325; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; GREENBERG B, 1987, PLAST RECONSTR SURG, V79, P959, DOI 10.1097/00006534-198706000-00018; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; HERFKENS RJ, 1983, RADIOLOGY, V147, P761, DOI 10.1148/radiology.147.3.6844611; Hsieh TJ, 2009, J COMPUT ASSIST TOMO, V33, P150, DOI 10.1097/RCT.0b013e318168f735; Huysman F, 2009, ACTA CHIR BELG, V109, P587; Jaspers K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016159; Kang J, 2008, J VASC SURG, V48, P701, DOI 10.1016/j.jvs.2008.04.006; Kattapuram TM, 2005, SKELETAL RADIOL, V34, P203, DOI 10.1007/s00256-004-0881-8; Korosoglou G, 2007, RADIOLOGY, V245, P761, DOI 10.1148/radiol.2452062067; Lee CW, 2010, CLIN IMAG, V34, P47, DOI 10.1016/j.clinimag.2009.03.013; Li XD, 2012, INT J CARDI IN PRESS; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; Lundberg G, 2003, EUR SURG RES, V35, P430, DOI 10.1159/000072228; Madonna R, 2010, INT J IMMUNOPATH PH, V23, P755, DOI 10.1177/039463201002300309; Madonna R, 2012, CIRC J, V76, P1517, DOI 10.1253/circj.CJ-11-1215; McMahon CJ, 2010, AM J ROENTGENOL, V194, pW284, DOI 10.2214/AJR.10.4247; Mompeo B, 1998, J SUBMICR CYTOL PATH, V30, P475; MORIKAWA S, 1991, MAGN RESON IMAGING, V9, P269, DOI 10.1016/0730-725X(91)90411-E; Nicholson C D, 1996, Vasc Med, V1, P43; Odaka K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025487; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0; Sinha S, 2009, MAGN RESON IMAGING, V27, P94, DOI 10.1016/j.mri.2008.06.001; Stehouwer CDA, 1997, CARDIOVASC RES, V34, P55, DOI 10.1016/S0008-6363(96)00272-6; Stramare R, 2010, RADIOL MED, V115, P585, DOI 10.1007/s11547-010-0531-2; Stueckle CA, 2006, AM J ROENTGENOL, V187, P1322, DOI 10.2214/AJR.05.0819; 't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; TOOKE JE, 1995, DIABETES, V44, P721, DOI 10.2337/diabetes.44.7.721; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VANSLYKE MA, 1995, MAGN RESON IMAGING, V13, P325, DOI 10.1016/0730-725X(94)00102-9; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Westerweel PE, 2005, CARDIOVASC PATHOL, V14, P294, DOI 10.1016/j.carpath.2005.07.007; Yan JL, 2009, J VASC SURG, V50, P1412, DOI 10.1016/j.jvs.2009.08.007; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; Ye Q, 2011, NMR BIOMED, V24, P1295, DOI 10.1002/nbm.1691	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44752	10.1371/journal.pone.0044752	http://dx.doi.org/10.1371/journal.pone.0044752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028603	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800015
J	Kekkonen, J; Wikstrom, M; Brommer, JE				Kekkonen, Jaana; Wikstrom, Mikael; Brommer, Jon E.			Heterozygosity in an Isolated Population of a Large Mammal Founded by Four Individuals Is Predicted by an Individual-Based Genetic Model	PLOS ONE			English	Article							WHITE-TAILED DEER; DIVERSITY; BOVINE; SIZE; DNA; MICROSATELLITES; MARKERS; CONSEQUENCES; BOTTLENECKS	Background: Within-population genetic diversity is expected to be dramatically reduced if a population is founded by a low number of individuals. Three females and one male white-tailed deer Odocoileus virginianus, a North American species, were successfully introduced in Finland in 1934 and the population has since been growing rapidly, but remained in complete isolation from other populations. Methodology/Principal Findings: Based on 14 microsatellite loci, the expected heterozygosity H was 0.692 with a mean allelic richness (AR) of 5.36, which was significantly lower than what was found in Oklahoma, U. S. A. (H = 0.742; AR = 9.07), demonstrating that a bottleneck occurred. Observed H was in line with predictions from an individual-based model where the genealogy of the males and females in the population were tracked and the population's demography was included. Conclusion: Our findings provide a rare within-population empirical test of the founder effect and suggest that founding a population by a small number of individuals need not have a dramatic impact on heterozygosity in an iteroparous species.	[Kekkonen, Jaana; Brommer, Jon E.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Brommer, Jon E.] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Brommer, Jon E.] Abo Akad Univ, Ekenas, Finland	University of Helsinki; Novia University of Applied Sciences; Abo Akademi University	Brommer, JE (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	jon.brommer@helsinki.fi	Brommer, Jon E/C-3613-2008	Brommer, Jon E/0000-0002-2435-2612	Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica; Ella and Georg Ehrnrooth Foundation; Academy of Finland [1131390]	Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica; Ella and Georg Ehrnrooth Foundation; Academy of Finland(Academy of Finland)	Funding was provided by Oskar Oflund Stiftelse, Societas pro Fauna et Flora Fennica, The Ella and Georg Ehrnrooth Foundation and the Academy of Finland (1131390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1986, P57; Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Anderson JD, 2002, J WILDLIFE MANAGE, V66, P67, DOI 10.2307/3802872; BANCROFT DR, 1995, PHILOS T R SOC B, V347, P263, DOI 10.1098/rstb.1995.0026; BISHOP MD, 1994, GENETICS, V136, P619; BREZINSKY L, 1993, ANIM GENET, V24, P75, DOI 10.1111/j.1365-2052.1993.tb00936.x; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; Carrol S.P, 2008, CONSERVATION BIOL EV; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Cornuet JM, 1996, GENETICS, V144, P2001; DEWOODY JA, 1995, J HERED, V86, P317, DOI 10.1093/oxfordjournals.jhered.a111593; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Dunham Jason, 1999, Conservation Ecology, V3, pUnpaginated; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falconer D. S, 1996, INTRO QUANTITATIVE G; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2002, INTRO CONSERVATION G; Franklin I.R., 1980, CONSERVATION BIOL EV; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Halls LK, 1984, WHITE TAILED DEER; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hartl DL, 2006, PRINCIPLES POPULATIO; Hedrick P.W., 2000, GENETICS POPULATIONS; JOHNSON DL, 1977, GENETICS, V87, P581; Jones KC, 2000, CALIF FISH GAME, V86, P115; Kaeuffer R, 2007, P ROY SOC B-BIOL SCI, V274, P527, DOI 10.1098/rspb.2006.3743; Kekkonen J, 2011, BIOL CONSERV, V144, P2931, DOI 10.1016/j.biocon.2011.08.012; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Masters RE, 2012, ECOLOGY MANAGEMENT D; McCullough D.R., 1979, GEORGE RESERVE DEER; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; MOORE SS, 1992, ANIM GENET, V23, P463, DOI 10.1111/j.1365-2052.1992.tb02168.x; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; NELSON ME, 1993, J MAMMAL, V74, P316, DOI 10.2307/1382386; Nygren K.F.A., 1984, P561; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pemberton JM, 1996, PHILOS T R SOC B, V351, P745, DOI 10.1098/rstb.1996.0069; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RYMAN N, 1981, OIKOS, V36, P257, DOI 10.2307/3544622; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Topping C, 2003, ANN ZOOL FENN, V40, P255; VAIMAN D, 1992, ANIM GENET, V23, P537, DOI 10.1111/j.1365-2052.1992.tb00175.x	49	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43482	10.1371/journal.pone.0043482	http://dx.doi.org/10.1371/journal.pone.0043482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028456	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900002
J	Hereward, JP; Walter, GH				Hereward, James P.; Walter, Gimme H.			Molecular Interrogation of the Feeding Behaviour of Field Captured Individual Insects for Interpretation of Multiple Host Plant Use	PLOS ONE			English	Article							PHYTOPHAGOUS INSECTS; BIOLOGICAL-CONTROL; DNA; HEMIPTERA; PCR; PREDATORS; HERBIVORE; MIRIDAE; CHOICE	The way in which herbivorous insect individuals use multiple host species is difficult to quantify under field conditions, but critical to understanding the evolutionary processes underpinning insect-host plant relationships. In this study we developed a novel approach to understanding the host plant interactions of the green mirid, Creontiades dilutus, a highly motile heteropteran bug that has been associated with many plant species. We combine quantified sampling of the insect across its various host plant species within particular sites and a molecular comparison between the insects' gut contents and available host plants. This approach allows inferences to be made as to the plants fed upon by individual insects in the field. Quantified sampling shows that this "generalist" species is consistently more abundant on two species in the genus Cullen (Fabaceae), its primary host species, than on any other of its numerous listed hosts. The chloroplast intergenic sequences reveal that C. dilutus frequently feeds on plants additional to the one from which it was collected, even when individuals were sampled from the primary host species. These data may be reconciled by viewing multiple host use in this species as an adaptation to survive spatiotemporally ephemeral habitats. The methodological framework developed here provides a basis from which new insights into the feeding behaviour and host plant relationships of herbivorous insects can be derived, which will benefit not only ecological interpretation but also our understanding of the evolution of these relationships.	[Hereward, James P.; Walter, Gimme H.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Hereward, James P.] Australian Cotton Res Inst, Cotton Catchment Communities Cooperat Res Ctr, Narrabri, NSW, Australia	University of Queensland	Hereward, JP (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	j.hereward@uq.edu.au	Hereward, James P/K-8720-2012; Walter, Gimme/AAC-3635-2019	Hereward, James P/0000-0002-6468-6342; Walter, Gimme/0000-0003-1025-7101	Cotton Research and Development Corporation; Cotton Cathcment Communities Co-operative Research Centre, Australia; Cotton Catchment Communities CRC	Cotton Research and Development Corporation(Cotton R&D Corp); Cotton Cathcment Communities Co-operative Research Centre, Australia; Cotton Catchment Communities CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was funded through a Phd stipend awarded to JPH by the Cotton Research and Development Corporation and the Cotton Cathcment Communities Co-operative Research Centre, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JPH received funding from the Cotton Research and Development Corporation, and the Cotton Catchment Communities CRC. This PhD funding was for research on the ecology of a cotton pest insect, and has no bearing on the results and interpretation presented. This also does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borer M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-310; Chinajariyawong A, 1988, SAP SUCKING BUGS ATT; Colebatch G, 2001, INSECT BIOCHEM MOLEC, V31, P415, DOI 10.1016/S0965-1748(00)00136-3; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; DRUMMOND AJ, 2010, GENEIOUS V 5 0; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Fournier V, 2008, OECOLOGIA, V157, P629, DOI 10.1007/s00442-008-1095-x; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Khan MH, 1999, ASPECTS BIOL ECOLOGY; Malausa T, 2007, MOL ECOL, V16, P4210, DOI 10.1111/j.1365-294X.2007.03457.x; Malipatil MB, 1997, AUST J ENTOMOL, V36, P1, DOI 10.1111/j.1440-6055.1997.tb01422.x; Manners AG, 2011, BIOL CONTROL, V58, P262, DOI 10.1016/j.biocontrol.2011.05.013; Manners AG, 2009, ARTHROPOD-PLANT INTE, V3, P87, DOI 10.1007/s11829-009-9059-6; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; McColl SA, 2011, AUST J ENTOMOL, V50, P107, DOI 10.1111/j.1440-6055.2010.00800.x; Miles MM, 1996, IDENTIFICATION PEST; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Mulatu B, 2004, OIKOS, V107, P231, DOI 10.1111/j.0030-1299.2004.13157.x; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Northam WT, 2012, SCI TOTAL ENVIRON, V416, P225, DOI 10.1016/j.scitotenv.2011.11.083; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Threlfall C., 2005, AUSTR COTTONGROWER, V26, P55; Traugott M, 2012, B ENTOMOL RES, V102, P239, DOI 10.1017/S0007485311000551; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; WALTER GH, 1994, AUST J ECOL, V19, P458, DOI 10.1111/j.1442-9993.1994.tb00512.x; Walter GH, 2003, INSECT PEST MANAGEME; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x	40	30	32	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44435	10.1371/journal.pone.0044435	http://dx.doi.org/10.1371/journal.pone.0044435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028538	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400025
J	Oliver, JD; Kaye, SJ; Tuckwell, D; Johns, AE; Macdonald, DA; Livermore, J; Warn, PA; Birch, M; Bromley, MJ				Oliver, Jason D.; Kaye, Sarah J.; Tuckwell, Danny; Johns, Anna E.; Macdonald, Darel A.; Livermore, Joanne; Warn, Peter A.; Birch, Mike; Bromley, Michael J.			The Aspergillus fumigatus Dihydroxyacid Dehydratase Ilv3A/IlvC Is Required for Full Virulence	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; FUNGAL-INFECTIONS; IN-VIVO; NIDULANS; METABOLISM; INHIBITORS; SURVIVAL; SYNTHASE; MUTANTS	Dihydroxyacid dehydratase (DHAD) is a key enzyme in the branched-chain amino acid biosynthetic pathway that exists in a variety of organisms, including fungi, plants and bacteria, but not humans. In this study we identified four putative DHAD genes from the filamentous fungus Aspergillus fumigatus by homology to Saccharomyces cerevisiae ILV3. Two of these genes, AFUA_2G14210 and AFUA_1G03550, initially designated AfIlv3A and AfIlv3B for this study, clustered in the same group as S. cerevisiae ILV3 following phylogenetic analysis. To investigate the functions of these genes, AfIlv3A and AfIlv3B were knocked out in A. fumigatus. Deletion of AfIlv3B gave no apparent phenotype whereas the Delta ilv3A strain required supplementation with isoleucine and valine for growth. Thus, AfIlv3A is required for branched-chain amino acid synthesis in A. fumigatus. A recombinant AfIlv3A protein derived from AFUA_2G14210 was shown to have DHAD activity in an in vitro assay, confirming that AfIlv3A is a DHAD. In addition we show that mutants lacking AfIlv3A and ilv3B exhibit reduced levels of virulence in murine infection models, emphasising the importance of branched-chain amino acid biosynthesis in fungal infections, and hence the potential of targeting this pathway with antifungal agents. Here we propose that AfIlv3A/AFUA_2G2410 be named ilvC.	[Johns, Anna E.; Macdonald, Darel A.; Livermore, Joanne; Warn, Peter A.; Bromley, Michael J.] Univ Manchester, Sch Translat Med, Manchester, Lancs, England; [Oliver, Jason D.; Kaye, Sarah J.; Tuckwell, Danny; Birch, Mike] F2G Ltd, Manchester, Lancs, England	University of Manchester	Bromley, MJ (corresponding author), Univ Manchester, Sch Translat Med, Manchester, Lancs, England.	mike.bromley@manchester.ac.uk		Bromley, Michael/0000-0002-7611-0201	F2G Limited	F2G Limited	The authors have read the journal's policy and have the following conflicts: Jason D. Oliver and Mike Birch are current employees and Sarah J. Kaye, Danny Tuckwell, and Michael J. Bromley are former employees of F2G Limited. Michael Bromley currently has a PhD student funded in part by F2G Limited. Peter Warn acts as a consultant to F2G Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ARMSTRONG FB, 1977, BIOCHIM BIOPHYS ACTA, V498, P282, DOI 10.1016/0304-4165(77)90266-5; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1988, J BIOL CHEM, V263, P3558; FLINT DH, 1993, BIOORG CHEM, V21, P367, DOI 10.1006/bioo.1993.1031; Grandoni JA, 1998, J ANTIMICROB CHEMOTH, V42, P475, DOI 10.1093/jac/42.4.475; Hof H, 2008, MYCOSES, V51, P1, DOI 10.1111/j.1439-0507.2008.01522.x; KAKAR SN, 1964, GENETICS, V49, P213; KANAMORI M, 1963, J BIOL CHEM, V238, P998; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; KIRITANI K, 1966, J BIOL CHEM, V241, P2042; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; LIMBERG G, 1995, BIOORGAN MED CHEM, V3, P487, DOI 10.1016/0968-0896(95)00072-O; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MYERS JW, 1961, J BIOL CHEM, V236, P1414; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pitkanen HT, 2003, AMINO ACIDS, V24, P413, DOI 10.1007/s00726-002-0338-0; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RYAN ED, 1974, J BACTERIOL, V120, P631, DOI 10.1128/JB.120.2.631-637.1974; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tan S, 2006, AMINO ACIDS, V30, P195, DOI 10.1007/s00726-005-0254-1; VELASCO JA, 1993, GENE, V137, P179, DOI 10.1016/0378-1119(93)90004-M; XING RY, 1991, J BACTERIOL, V173, P2086, DOI 10.1128/jb.173.6.2086-2092.1991	35	23	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43559	10.1371/journal.pone.0043559	http://dx.doi.org/10.1371/journal.pone.0043559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028460	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900007
J	Umbach, AL; Zarkovic, J; Yu, JP; Ruckle, ME; McIntosh, L; Hock, JJ; Bingham, S; White, SJ; George, RM; Subbaiah, CC; Rhoads, DM				Umbach, Ann L.; Zarkovic, Jelena; Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee; Hock, Jeffery J.; Bingham, Scott; White, Samuel J.; George, Rajani M.; Subbaiah, Chalivendra C.; Rhoads, David M.			Comparison of Intact Arabidopsis thaliana Leaf Transcript Profiles during Treatment with Inhibitors of Mitochondrial Electron Transport and TCA Cycle	PLOS ONE			English	Article							ALTERNATIVE OXIDASE GENE; OXIDATIVE STRESS; COMPLEX-I; ABIOTIC STRESS; DIFFERENTIAL EXPRESSION; RESPIRATORY-CHAIN; OXYGEN; METABOLISM; NUCLEAR; DEFENSE	Plant mitochondria signal to the nucleus leading to altered transcription of nuclear genes by a process called mitochondrial retrograde regulation (MRR). MRR is implicated in metabolic homeostasis and responses to stress conditions. Mitochondrial reactive oxygen species (mtROS) are a MRR signaling component, but whether all MRR requires ROS is not established. Inhibition of the cytochrome respiratory pathway by antimycin A (AA) or the TCA cycle by monofluoroacetate (MFA), each of which initiates MRR, can increase ROS production in some plant cells. We found that for AA and MFA applied to leaves of soil-grown Arabidopsis thaliana plants, ROS production increased with AA, but not with MFA, allowing comparison of transcript profiles under different ROS conditions during MRR. Variation in transcript accumulation over time for eight nuclear encoded mitochondrial protein genes suggested operation of both common and distinct signaling pathways between the two treatments. Consequences of mitochondrial perturbations for the whole transcriptome were examined by microarray analyses. Expression of 1316 and 606 genes was altered by AA and MFA, respectively. A subset of genes was similarly affected by both treatments, including genes encoding photosynthesis-related proteins. MFA treatment resulted in more down-regulation. Functional gene category (MapMan) and cluster analyses showed that genes with expression levels affected by perturbation from AA or MFA inhibition were most similarly affected by biotic stresses such as pathogens. Overall, the data provide further evidence for the presence of mtROS-independent MRR signaling, and support the proposed involvement of MRR and mitochondrial function in plant responses to biotic stress.	[Rhoads, David M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Umbach, Ann L.] Duke Univ, Dept Biol, Durham, NC USA; [Zarkovic, Jelena; Hock, Jeffery J.; Bingham, Scott; White, Samuel J.; George, Rajani M.; Subbaiah, Chalivendra C.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Yu, Jianping; Ruckle, Michael E.; McIntosh, Lee] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of Arizona; Duke University; Arizona State University; Arizona State University-Tempe; Michigan State University; Michigan State University	Rhoads, DM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	drhoads@cals.arizona.edu	George, Rajani Mary/AAM-7256-2020	George, Rajani Mary/0000-0002-9153-5523; Yu, Jianping/0000-0003-0466-3197	National Science Foundation [IBN0110768, IOB0344497, IOS0822521]; United States Department of Energy [DEFG0291ER20021]; Division Of Integrative Organismal Systems [1005394] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (www.nsf.gov; IBN0110768 to J.Y. and L.M. and IOB0344497 and IOS0822521 to D.M.R.) and the United States Department of Energy (www.energy.gov; DEFG0291ER20021 to L.M.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amirsadeghi S, 2006, PLANT CELL PHYSIOL, V47, P1509, DOI 10.1093/pcp/pcl016; Bantseev V, 2006, ANN NY ACAD SCI, V1091, P17, DOI 10.1196/annals.1378.051; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Bechtold U, 2008, J EXP BOT, V59, P121, DOI 10.1093/jxb/erm289; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Camacho-Pereira J, 2009, PLANT PHYSIOL, V149, P1099, DOI 10.1104/pp.108.129247; Chandran D, 2009, PLANT PHYSIOL, V149, P1435, DOI 10.1104/pp.108.132985; Charlton WL, 2005, PLANT CELL REP, V23, P647, DOI 10.1007/s00299-004-0879-7; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Dinakar C, 2010, PHYSIOL PLANTARUM, V139, P13, DOI 10.1111/j.1399-3054.2010.01346.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Dojcinovic D, 2003, THESIS ARIZONA STATE; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Ederli L, 2006, PLANT PHYSIOL, V142, P595, DOI 10.1104/pp.106.085472; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Erbs G, 2003, MOL PLANT PATHOL, V4, P421, DOI [10.1046/j.1364-3703.2003.00179.x, 10.1046/J.1364-3703.2003.00179.X]; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gilliland A, 2003, PLANT PHYSIOL, V132, P1518, DOI 10.1104/pp.102.017640; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Gray GR, 2004, PLANT CELL REP, V23, P497, DOI 10.1007/s00299-004-0848-1; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Hausler RE, 2009, PLANT PHYSIOL, V149, P515, DOI 10.1104/pp.108.128124; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Ho LHM, 2008, PLANT PHYSIOL, V147, P1858, DOI 10.1104/pp.108.121384; Holzinger A, 2006, MICRON, V37, P190, DOI 10.1016/j.micron.2005.10.015; Jaspers P, 2010, PHYSIOL PLANTARUM, V138, P405, DOI 10.1111/j.1399-3054.2009.01321.x; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim YS, 1998, PLANT CELL PHYSIOL, V39, P565, DOI 10.1093/oxfordjournals.pcp.a029406; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; KUMAR AM, 1992, P NATL ACAD SCI USA, V89, P10842, DOI 10.1073/pnas.89.22.10842; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Lister R, 2004, PLANT PHYSIOL, V134, P777, DOI 10.1104/pp.103.033910; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsuo M, 2011, PLANT CELL PHYSIOL, V52, P333, DOI 10.1093/pcp/pcq192; Maxwell DP, 2002, PLANT J, V29, P269, DOI 10.1046/j.1365-313X.2002.01216.x; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McCourt P, 1998, METH MOL B, V82, P13; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Moschou PN, 2008, PLANT CELL, V20, P1708, DOI 10.1105/tpc.108.059733; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Newton K, 2004, AUST J PUBL ADMIN, V63, P121; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Norman C, 2004, PLANT PHYSIOL, V134, P1; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Papadakis AK, 2005, PLANTA, V220, P826, DOI 10.1007/s00425-004-1400-9; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Queval G, 2008, J EXP BOT, V59, P135, DOI 10.1093/jxb/erm193; Rasmusson AG, 2009, PHYSIOL PLANTARUM, V137, P371, DOI 10.1111/j.1399-3054.2009.01252.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Saisho D, 1997, PLANT MOL BIOL, V35, P585, DOI 10.1023/A:1005818507743; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Shedge V, 2010, PLANT PHYSIOL, V152, P1960, DOI 10.1104/pp.109.152827; Shimmura S, 1997, INVEST OPHTH VIS SCI, V38, P620; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subbaiah CC, 1998, PLANT PHYSIOL, V118, P759, DOI 10.1104/pp.118.3.759; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tcherkez G, 2009, PLANT PHYSIOL, V151, P620, DOI 10.1104/pp.109.142976; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turner JE, 2005, J BIOL CHEM, V280, P2780, DOI 10.1074/jbc.M407291200; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Vanlerberghe GC, 1996, PLANT PHYSIOL, V111, P589, DOI 10.1104/pp.111.2.589; VANLERBERGHE GC, 1994, PLANT PHYSIOL, V105, P867, DOI 10.1104/pp.105.3.867; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Vanlerberghe GC, 2002, PLANT PHYSIOL, V129, P1829, DOI 10.1104/pp.002691; Vanlerberghe GC, 2009, PHYSIOL PLANTARUM, V137, P392, DOI 10.1111/j.1399-3054.2009.01254.x; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090; Yu JP, 2001, PLANT PHYSIOL BIOCH, V39, P345, DOI 10.1016/S0981-9428(01)01254-2; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	104	28	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44339	10.1371/journal.pone.0044339	http://dx.doi.org/10.1371/journal.pone.0044339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028523	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900019
J	Dutra, CC; Koch, RL; Burkness, EC; Meissle, M; Romeis, J; Hutchison, WD; Fernandes, MG				Dutra, Carla C.; Koch, Robert L.; Burkness, Eric C.; Meissle, Michael; Romeis, Joerg; Hutchison, William D.; Fernandes, Marcos G.			Harmonia axyridis (Coleoptera: Coccinellidae) Exhibits Preference between Bt and Non-Bt Maize Fed Spodoptera frugiperda (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ASIAN LADY BEETLE; GENETICALLY-MODIFIED MAIZE; TRANSGENIC CORN; FALL ARMYWORM; RESISTANCE MANAGEMENT; NONTARGET ARTHROPODS; BIOLOGICAL-CONTROL; SWEET CORN; FED PREY; CRY1AB	A recent shift in managing insect resistance to genetically engineered (GE) maize consists of mixing non-GE seed with GE seed known as "refuge in a bag", which increases the likelihood of predators encountering both prey fed Bt and prey fed non-Bt maize. We therefore conducted laboratory choice-test feeding studies to determine if a predator, Harmonia axyridis, shows any preference between prey fed Bt and non-Bt maize leaves. The prey species was Spodoptera frugiperda, which were fed Bt maize (MON-810), expressing the single Cry1Ab protein, or non-Bt maize. The predators were third instar larvae and female adults of H. axyridis. Individual predators were offered Bt and non-Bt fed prey larvae that had fed for 24, 48 or 72 h. Ten and 15 larvae of each prey type were offered to third instar and adult predators, respectively. Observations of arenas were conducted at 1, 2, 3, 6, 15 and 24 h after the start of the experiment to determine the number and type of prey eaten by each individual predator. Prey larvae that fed on non-Bt leaves were significantly larger than larvae fed Bt leaves. Both predator stages had eaten nearly all the prey by the end of the experiment. However, in all combinations of predator stage and prey age, the number of each prey type consumed did not differ significantly. ELISA measurements confirmed the presence of Cry1Ab in leaf tissue (23-33 mu g/g dry weight) and S. frugiperda (2.1-2.2 mu g/g), while mean concentrations in H. axyridis were very low (0.01-0.2 mu g/g). These results confirm the predatory status of H. axyridis on S. frugiperda and that both H. axyridis adults and larvae show no preference between prey types. The lack of preference between Bt-fed and non-Bt-fed prey should act in favor of insect resistance management strategies using mixtures of GE and non-GE maize seed.	[Dutra, Carla C.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Agr, Dourados, Brazil; [Koch, Robert L.] Minnesota Dept Agr, Div Plant Protect, St Paul, MN USA; [Burkness, Eric C.; Hutchison, William D.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Meissle, Michael; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Fernandes, Marcos G.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Biol & Ambientais, Dourados, Brazil	Universidade Federal da Grande Dourados; University of Minnesota System; University of Minnesota Twin Cities; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Universidade Federal da Grande Dourados	Dutra, CC (corresponding author), Fundacao Univ Fed Grande Dourados, Fac Ciencias Agr, Dourados, Brazil.	hutch002@umn.edu	Romeis, Joerg/J-5360-2013; Meissle, Michael/C-3127-2009; Fernandes, Marcos/AAB-4726-2019	Romeis, Joerg/0000-0003-3652-8360; Meissle, Michael/0000-0002-5391-7715; Fernandes, Marcos/0000-0003-4377-5562; Hutchison, William D./0000-0001-9605-2996	Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil [BEX 4904-11-7]	Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil	Funding provided by Coordination for the Improvement of Higher Education Personnel (CAPES Foundation), Ministry of Education of Brazil for the doctoral grant (BEX 4904-11-7) to C.C. Dutra. The two maize hybrids for this trial were gifted by Monsanto Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth L., 2011, CORN GROWTH DEV; Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Burkness EC, 2011, J ECON ENTOMOL, V104, P1476, DOI 10.1603/EC11081; Figueiredo MDC, 2006, PESQUI AGROPECU BRAS, V41, P1693, DOI 10.1590/S0100-204X2006001200002; Cruz I, 1995, 21 EMBR CNPMS; Daly T, 2005, ENVIRON ENTOMOL, V34, P1292, DOI 10.1603/0046-225X(2005)034[1292:EOBTTC]2.0.CO;2; Almeida Lúcia Massutti de, 2002, Rev. Bras. Zool., V19, P941, DOI 10.1590/S0101-81752002000300031; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; dos Santos KB, 2009, BIOL CONTROL, V50, P157, DOI 10.1016/j.biocontrol.2009.03.014; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Evans EW, 2009, BIOL CONTROL, V51, P255, DOI 10.1016/j.biocontrol.2009.05.011; Fernandes O. D., 2003, Revista Brasileira de Milho e Sorgo, V2, P25; Fernandes OA, 2007, SCI AGR, V64, P249, DOI 10.1590/S0103-90162007000300006; Galvan TL, 2006, PEST MANAG SCI, V62, P797, DOI 10.1002/ps.1223; Galvan TL, 2005, BIOL CONTROL, V34, P108, DOI 10.1016/j.biocontrol.2005.04.005; Galvan TL, 2005, J ECON ENTOMOL, V98, P780, DOI 10.1603/0022-0493-98.3.780; Head G, 2001, ENTOMOL EXP APPL, V99, P37, DOI 10.1023/A:1018913429026; Heimpel GE, 2005, ENVIRON ENTOMOL, V34, P512, DOI 10.1603/0046-225X-34.3.512; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Koch RL, 2006, BIOCONTROL, V51, P741, DOI 10.1007/s10526-006-9016-6; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Koch RL, 2003, BIOL CONTROL, V28, P265, DOI 10.1016/S1049-9644(03)00102-6; Koch RL, 2011, CHECK LIST, V7, P476; Koch RL, 2006, NEOTROP ENTOMOL, V35, P421, DOI 10.1590/S1519-566X2006000400001; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Lopez-Edwards M, 1999, FLA ENTOMOL, V82, P254, DOI 10.2307/3496577; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Meier MS, 2001, BASIC APPL ECOL, V2, P35, DOI 10.1078/1439-1791-00034; Meissle M, 2005, TRANSGENIC RES, V14, P123, DOI 10.1007/s11248-004-6458-4; Mendes SM, 2011, PESQUI AGROPECU BRAS, V46, P239, DOI 10.1590/S0100-204X2011000300003; Musser FR, 2003, ENVIRON ENTOMOL, V32, P1131, DOI 10.1603/0046-225X-32.5.1131; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Onstad DW, 2011, J ECON ENTOMOL, V104, P343, DOI 10.1603/EC10388; Porcar M, 2010, B ENTOMOL RES, V100, P297, DOI 10.1017/S0007485309990290; Rauschen S, 2010, TRANSGENIC RES, V19, P727, DOI 10.1007/s11248-009-9351-3; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Sanders CJ, 2007, BIOL CONTROL, V40, P362, DOI 10.1016/j.biocontrol.2006.12.010; SAS Institute, 1996, SAS STAT SOFTW CHANG; Tian Jun-Ce, 2012, Transgenic Res, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; Vojtech E, 2005, TRANSGENIC RES, V14, P133, DOI 10.1007/s11248-005-2736-z; Wold SJ, 2001, J ENTOMOL SCI, V36, P177, DOI 10.18474/0749-8004-36.2.177; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118	49	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44867	10.1371/journal.pone.0044867	http://dx.doi.org/10.1371/journal.pone.0044867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024772	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100030
J	Takacs, AC; Swierzy, IJ; Luder, CGK				Takacs, Anna C.; Swierzy, Izabela J.; Lueder, Carsten G. K.			Interferon-gamma Restricts Toxoplasma gondii Development in Murine Skeletal Muscle Cells via Nitric Oxide Production and Immunity-Related GTPases	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BINDING PROTEIN IGTP; INFLAMMATORY MYOPATHIES; HOST-RESISTANCE; IN-VIVO; INTRACELLULAR PATHOGEN; ACTIVATED MACROPHAGES; PRIMED MACROPHAGES; TRYPANOSOMA-CRUZI; ACUTE INFECTION	The apicomplexan parasite Toxoplasma gondii is regularly transmitted to humans via the ingestion of contaminated meat products from chronically infected livestock. This route of transmission requires intracellular development and long-term survival of the parasite within muscle tissue. In this study, we determined the cell-autonomous immunity of mature primary embryonic or C2C12 skeletal muscle cells (SkMCs) to infection with T. gondii. Non-activated SkMCs and control fibroblasts sustained parasite replication; however, interferon (IFN)-gamma significantly inhibited parasite growth in SkMCs but not in fibroblasts. Intracellular parasite replication was diminished by IFN-gamma whereas host cell invasion was not affected. Tumor necrosis factor (TNF) did not further increase the IFN-gamma-triggered host defense of SkMCs against Toxoplasma. Remarkably, IFN-gamma alone or in combination with TNF decreased the high level of T. gondii bradyzoite formation being observed in non-activated SkMCs. Stimulation of SkMCs with IFN-gamma strongly triggered expression of inducible nitric oxide synthase (iNOS) transcripts, and induced significantly higher levels of nitric oxide (NO) in SkMCs than in fibroblasts. Consequently, pharmacological inhibition of iNOS partially abrogated the IFN-gamma-induced toxoplasmacidal activity of SkMCs. In addition, SkMCs strongly up-regulated immunity-regulated GTPases (IRGs) following stimulation with IFN-gamma. IRGs accumulated on Toxoplasma-containing vacuoles in SkMCs in a parasite strain-dependent manner. Subsequent vacuole disruption and signs of degenerating parasites were regularly recognized in IFN-gamma-treated SkMCs infected with type II parasites. Together, murine SkMCs exert potent toxoplasmacidal activity after stimulation with IFN-gamma and have to be considered active participants in the local immune response against Toxoplasma in skeletal muscle.	[Takacs, Anna C.; Swierzy, Izabela J.; Lueder, Carsten G. K.] Univ Gottingen, Univ Med Ctr, Inst Med Microbiol, Gottingen, Germany	University of Gottingen	Takacs, AC (corresponding author), Univ Gottingen, Univ Med Ctr, Inst Med Microbiol, Gottingen, Germany.	clueder@gwdg.de			Federal Ministry of Education and Research (BMBF) (TOXONET consortium) [01KI0766, 01KI1002B]; Open-Access-Publication Fund of the Georg-August-University; German Research Council (DFG)	Federal Ministry of Education and Research (BMBF) (TOXONET consortium); Open-Access-Publication Fund of the Georg-August-University; German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF; TOXONET consortium, grant numbers 01KI0766 and 01KI1002B to CGKL). Publication of the study was supported by the Open-Access-Publication Fund of the Georg-August-University and the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1990, J IMMUNOL, V144, P2725; Aline F, 2002, INFECT IMMUN, V70, P2368, DOI 10.1128/IAI.70.5.2368-2374.2002; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Cuturic M, 1997, NEUROMUSCULAR DISORD, V7, P390, DOI 10.1016/S0960-8966(97)00098-9; Dubey JP, 1996, VET PATHOL, V33, P290, DOI 10.1177/030098589603300305; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; Fentress SJ, 2011, BIOESSAYS, V33, P693, DOI 10.1002/bies.201100054; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; FERGUSON DJP, 1987, VIRCHOWS ARCH A, V411, P39, DOI 10.1007/BF00734512; Ferreira-da-Silva Mda F, 2009, INT J MED MICROBIOL, V299, P381; Fichera LE, 2004, INFECT IMMUN, V72, P359, DOI 10.1128/IAI.72.1.359-363.2004; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GHERARDI R, 1992, ANN NEUROL, V32, P535, DOI 10.1002/ana.410320409; GOEBELS N, 1992, J IMMUNOL, V149, P661; GROSS U, 1995, CLIN DIAGN LAB IMMUN, V2, P542, DOI 10.1128/CDLI.2.5.542-548.1995; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Lykens JE, 2010, J IMMUNOL, V184, P877, DOI 10.4049/jimmunol.0902346; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; MacKenzie CR, 1999, EUR J IMMUNOL, V29, P3254, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3254::AID-IMMU3254&gt;3.0.CO;2-0; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Melzer T, 2008, INFECT IMMUN, V76, P4883, DOI 10.1128/IAI.01288-07; Montoya JG, 1997, CLIN INFECT DIS, V24, P676, DOI 10.1093/clind/24.4.676; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plonquet A, 2003, MUSCLE NERVE, V27, P761, DOI 10.1002/mus.10376; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; SIMS TA, 1989, BRIT J EXP PATHOL, V70, P317; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Vutova P, 2007, CELL MICROBIOL, V9, P1556, DOI 10.1111/j.1462-5822.2007.00893.x; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	62	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45440	10.1371/journal.pone.0045440	http://dx.doi.org/10.1371/journal.pone.0045440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024821	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100079
J	Valim, CXR; Basso, LR; Almeida, FBD; Reis, TF; Damasio, ARL; Arruda, LK; Martinez, R; Roque-Barreira, MC; Oliver, C; Jamur, MC; Coelho, PSR				Valim, Clarissa X. R.; Basso, Luiz Roberto, Jr.; dos Reis Almeida, Fausto B.; Reis, Thaila Fernanda; Lima Damasio, Andre Ricardo; Arruda, Luisa Karla; Martinez, Roberto; Roque-Barreira, Maria Cristina; Oliver, Constance; Jamur, Maria Celia; Rodrigues Coelho, Paulo Sergio			Characterization of PbPga1, an Antigenic GPI-Protein in the Pathogenic Fungus Paracoccidioides brasiliensis	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-WALL PROTEINS; ASPERGILLUS-NIDULANS; CANDIDA-ALBICANS; PICHIA-PASTORIS; NEUROSPORA-CRASSA; ANCHORED PROTEINS; O-GLYCOSYLATION; FUSION PROTEINS; GENOME-WIDE	Paracoccidioides brasiliensis is the etiologic agent of paracoccidioidomycosis (PCM), one of the most prevalent mycosis in Latin America. P. brasiliensis cell wall components interact with host cells and influence the pathogenesis of PCM. Cell wall components, such as glycosylphosphatidylinositol (GPI)-proteins play a critical role in cell adhesion and host tissue invasion. Although the importance of GPI-proteins in the pathogenesis of other medically important fungi is recognized, little is known about their function in P. brasiliensis cells and PCM pathogenesis. We cloned the PbPga1 gene that codifies for a predicted GPI-anchored glycoprotein from the dimorphic pathogenic fungus P. brasiliensis. PbPga1 is conserved in Eurotiomycetes fungi and encodes for a protein with potential glycosylation sites in a serine/threonine-rich region, a signal peptide and a putative glycosylphosphatidylinositol attachment signal sequence. Specific chicken anti-rPbPga1 antibody localized PbPga1 on the yeast cell surface at the septum between the mother cell and the bud with stronger staining of the bud. The exposure of murine peritoneal macrophages to rPbPga1 induces TNF-alpha release and nitric oxide (NO) production by macrophages. Furthermore, the presence of O-glycosylation sites was demonstrated by beta-elimination under ammonium hydroxide treatment of rPbPga1. Finally, sera from PCM patients recognized rPbPga1 by Western blotting indicating the presence of specific antibodies against rPbPga1. In conclusion, our findings suggest that the PbPga1gene codifies for a cell surface glycoprotein, probably attached to a GPI-anchor, which may play a role in P. brasiliensis cell wall morphogenesis and infection. The induction of inflammatory mediators released by rPbPga1 and the reactivity of PCM patient sera toward rPbPga1 imply that the protein favors the innate mechanisms of defense and induces humoral immunity during P. brasiliensis infection.	[Valim, Clarissa X. R.; Basso, Luiz Roberto, Jr.; dos Reis Almeida, Fausto B.; Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Oliver, Constance; Jamur, Maria Celia; Rodrigues Coelho, Paulo Sergio] Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Biagentes Patogen, Sao Paulo, Brazil; [Lima Damasio, Andre Ricardo] Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Sao Paulo, Brazil; [Arruda, Luisa Karla; Martinez, Roberto] Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil		Valim, CXR (corresponding author), Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Biagentes Patogen, Sao Paulo, Brazil.	pacoelho@fmrp.usp.br	Almeida, Fausto/N-6540-2013; Damasio, André RL/H-1162-2016; dos Reis, Thaila F/N-6237-2014; Roque-Barreira, Maria-Cristina/A-4552-2008; Arruda, L. Karla/D-5845-2013; Basso, Luiz/Q-2859-2017	Almeida, Fausto/0000-0002-3782-3698; Damasio, André RL/0000-0001-9304-3998; dos Reis, Thaila F/0000-0002-7776-977X; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Arruda, L. Karla/0000-0002-7505-210X; Basso, Luiz/0000-0002-8541-4258	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); CXRV; FBRA; TFR; ARLD; LRB; FAPESP [03/01440-2, 08/55831-6]; PSRC	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CXRV; FBRA; TFR; ARLD; LRB; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PSRC	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) predoctoral fellowships awarded to CXRV, FBRA, TFR, ARLD, a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico postdoctoral fellowship awarded to LRB and FAPESP research grants (03/01440-2 and 08/55831-6) awarded to PSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; AREZZO F, 1987, ANAL BIOCHEM, V167, P387, DOI 10.1016/0003-2697(87)90181-3; Arruda C, 2002, CLIN IMMUNOL, V103, P185, DOI 10.1006/clim.2002.5207; Arruda C, 2007, MICROBES INFECT, V9, P308, DOI 10.1016/j.micinf.2006.12.005; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Breinig F, 2002, APPL MICROBIOL BIOT, V58, P637, DOI 10.1007/s00253-002-0939-2; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Brul S, 1997, ANTON LEEUW INT J G, V72, P229, DOI 10.1023/A:1000429208049; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cao W, 2009, J GEN APPL MICROBIOL, V55, P381, DOI 10.2323/jgam.55.381; Carvalho KC, 2008, CLIN VACCINE IMMUNOL, V15, P622, DOI 10.1128/CVI.00437-07; Castro ND, 2005, GENET MOL RES, V4, P326; Castro ND, 2009, FEMS YEAST RES, V9, P103, DOI 10.1111/j.1567-1364.2008.00463.x; Choi CJ, 2005, FUNGAL GENET BIOL, V42, P590, DOI 10.1016/j.fgb.2005.02.002; Colombo AL, 2011, MED MYCOL, V49, P785, DOI 10.3109/13693786.2011.577821; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P873, DOI 10.1016/j.fgb.2005.06.006; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Duman JG, 1998, BIOTECHNOL APPL BIOC, V28, P39; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Frieman MB, 2004, MICROBIOL-SGM, V150, P3105, DOI 10.1099/mic.0.27420-0; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Gonzalez A, 2003, MED MYCOL, V41, P391, DOI 10.1080/13693780310001610038; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Gustafsson A, 2011, GLYCOBIOLOGY, V21, P1071, DOI 10.1093/glycob/cwr046; Hartl L, 2011, FUNGAL GENET BIOL, V48, P185, DOI 10.1016/j.fgb.2010.06.011; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Jeong HY, 2004, MYCOLOGIA, V96, P52, DOI 10.2307/3761987; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Mamoni RL, 2006, CYTOKINE, V35, P207, DOI 10.1016/j.cyto.2006.08.005; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Rademaker GJ, 1998, ANAL BIOCHEM, V257, P149, DOI 10.1006/abio.1997.2548; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Romano CC, 2002, CYTOKINE, V18, P149, DOI 10.1006/cyto.2002.0884; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SCORER CA, 1993, GENE, V136, P111, DOI 10.1016/0378-1119(93)90454-B; Soares AMVC, 2001, IMMUNOLOGY, V102, P480, DOI 10.1046/j.1365-2567.2001.01179.x; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Van den Steen P, 1998, BBA-GEN SUBJECTS, V1425, P587, DOI 10.1016/S0304-4165(98)00113-5; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Xie XF, 2010, YEAST, V27, P479, DOI 10.1002/yea.1787; Yamazaki H, 2008, FUNGAL GENET BIOL, V45, P963, DOI 10.1016/j.fgb.2008.02.008	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44792	10.1371/journal.pone.0044792	http://dx.doi.org/10.1371/journal.pone.0044792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024763	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100021
J	Kurimura, Y; Nishitani, C; Ariki, S; Saito, A; Hasegawa, Y; Takahashi, M; Hashimoto, J; Takahashi, S; Tsukamoto, T; Kuroki, Y				Kurimura, Yuichiro; Nishitani, Chiaki; Ariki, Shigeru; Saito, Atsushi; Hasegawa, Yoshihiro; Takahashi, Motoko; Hashimoto, Jiro; Takahashi, Satoshi; Tsukamoto, Taiji; Kuroki, Yoshio			Surfactant Protein D Inhibits Adherence of Uropathogenic Escherichia coli to the Bladder Epithelial Cells and the Bacterium-induced Cytotoxicity A POSSIBLE FUNCTION IN URINARY TRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; PULMONARY COLLECTINS; D BINDS; INNATE IMMUNITY; MYCOBACTERIUM-AVIUM; UROPLAKIN-IA; HOST-DEFENSE; FIMH ADHESIN; LUNG; INFECTION	The adherence of uropathogenic Escherichia coli (UPEC) to the host urothelial surface is the first step for establishing UPEC infection. Uroplakin Ia (UPIa), a glycoprotein expressed on bladder urothelium, serves as a receptor for FimH, a lectin located at bacterial pili, and their interaction initiates UPEC infection. Surfactant protein D (SP-D) is known to be expressed on mucosal surfaces in various tissues besides the lung. However, the functions of SP-D in the non-pulmonary tissues are poorly understood. The purposes of this study were to investigate the possible function of SP-D expressed in the bladder urothelium and the mechanisms by which SP-D functions. SP-D was expressed in human bladder mucosa, and its mRNA was increased in the bladder of the UPEC infection model in mice. SP-D directly bound to UPEC and strongly agglutinated them in a Ca2+-dependent manner. Co-incubation of SP-D with UPEC decreased the bacterial adherence to 5637 cells, the human bladder cell line, and the UPEC-induced cytotoxicity. In addition, preincubation of SP-D with 5637 cells resulted in the decreased adherence of UPEC to the cells and in a reduced number of cells injured by UPEC. SP-D directly bound to UPIa and competed with FimH for UPIa binding. Consistent with the in vitro data, the exogenous administration of SP-D inhibited UPEC adherence to the bladder and dampened UPEC-induced inflammation in mice. These results support the conclusion that SP-D can protect the bladder urothelium against UPEC infection and suggest a possible function of SP-D in urinary tract.	[Nishitani, Chiaki] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kurimura, Yuichiro; Hashimoto, Jiro; Takahashi, Satoshi; Tsukamoto, Taiji] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608556, Japan; [Saito, Atsushi; Hasegawa, Yoshihiro] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Nishitani, C (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	nchiaki@sapmed.ac.jp	Saito, Atsushi/M-7382-2018; Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Saito, Atsushi/0000-0003-3430-884X; Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; Gohtaro Sugawara Research Fund for Urological Diseases; Grants-in-Aid for Scientific Research [24591173] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; Gohtaro Sugawara Research Fund for Urological Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; and by a grant from the Gohtaro Sugawara Research Fund for Urological Diseases.	Ariki S, 2011, J IMMUNOL, V187, P2586, DOI 10.4049/jimmunol.1100024; Chiba H, 2002, J BIOL CHEM, V277, P20379, DOI 10.1074/jbc.M201089200; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; JANN B, 1993, CARBOHYD RES, V248, P241, DOI 10.1016/0008-6215(93)84131-O; Kingstone R. E., 1992, CURRENT PROTOCOLS MO, P16141; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 1997, FEBS LETT, V414, P387, DOI 10.1016/S0014-5793(97)01022-3; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Liu J, 2010, TOHOKU J EXP MED, V221, P35, DOI 10.1620/tjem.221.35; Madan T, 2001, INFECT IMMUN, V69, P2728, DOI 10.1128/IAI.69.4.2728-2731.2001; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mason RJ, 1998, EUR RESPIR J, V12, P1147, DOI 10.1183/09031936.98.12051147; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Oberley RE, 2005, PROSTATE, V65, P241, DOI 10.1002/pros.20292; Oberley RE, 2007, MOL HUM REPROD, V13, P863, DOI 10.1093/molehr/gam074; Oberley RE, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-42; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Sahly H, 2002, J IMMUNOL, V169, P3267, DOI 10.4049/jimmunol.169.6.3267; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Schembri MA, 2000, FEMS MICROBIOL LETT, V188, P147, DOI 10.1111/j.1574-6968.2000.tb09186.x; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhou G, 2001, J CELL SCI, V114, P4095	41	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.380287	http://dx.doi.org/10.1074/jbc.M112.380287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012359	Green Published, hybrid			2022-12-25	WOS:000311233800028
J	Holloway, RW; Bogachev, O; Bharadwaj, AG; McCluskey, GD; Majdalawieh, AF; Zhang, L; Ro, HS				Holloway, Ryan W.; Bogachev, Oleg; Bharadwaj, Alamelu G.; McCluskey, Greg D.; Majdalawieh, Amin F.; Zhang, Lei; Ro, Hyo-Sung			Stromal Adipocyte Enhancer-binding Protein (AEBP1) Promotes Mammary Epithelial Cell Hyperplasia via Proinflammatory and Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SONIC-HEDGEHOG; EXPRESSION; PATHWAY; GROWTH; GENE; INFLAMMATION; ACTIVATION; AKT	Disruption of mammary stromal-epithelial communication leads to aberrant mammary gland development and induces mammary tumorigenesis. Macrophages have been implicated in carcinogenesis primarily by creating an inflammatory microenvironment, which promotes growth of the adjacent epithelial cells. Adipocyte enhancer-binding protein 1 (AEBP1), a novel proinflammatory mediator, promotes macrophage inflammatory responsiveness by inducing NF-kappa B activity, which has been implicated in tumor cell growth and survival by aberrant sonic hedgehog (Shh) expression. Here, we show that stromal macrophage AEBP1 overexpression results in precocious alveologenesis in the virgin AEBP1 transgenic (AEBP1(TG)) mice, and the onset of ductal hyperplasia was accelerated in AEBP1TG mice fed a high fat diet, which induces endogenous AEBP1 expression. Transplantation of AEBP1(TG) bone marrow cells into non-transgenic (AEBP1(NT)) mice resulted in alveolar hyperplasia with up-regulation of NF-kappa B activity and TNF alpha expression as displayed in the AEBP1(TG) mammary macrophages and epithelium. Shh expression was induced in AEBP1(TG) macrophages and RAW264.7 macrophages overexpressing AEBP1. The Shh target genes Gli1 and Bmi1 expression was induced in the AEBP1(TG) mammary epithelium and HC11 mammary epithelial cells co-cultured with AEBP1(TG) peritoneal macrophages. The conditioned AEBP1(TG) macrophage culture media promoted NF-kappa B activity and survival signal, Akt activation, in HC11 cells, whereas such effects were abolished by TNF alpha neutralizing antibody treatment. Furthermore, HC11 cells displayed enhanced proliferation in response to AEBP1(TG) macrophages and their conditioned media. Our findings highlight the role of AEBP1 in the signaling pathways regulating the cross-talk between mammary epithelium and stroma that could predispose the mammary tissue to tumorigenesis.	[Ro, Hyo-Sung] Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Halifax, NS B3H 1X5, Canada	Dalhousie University	Ro, HS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Sir Charles Tupper Med Bld, Halifax, NS B3H 1X5, Canada.	hsro@dal.ca	Majdalawieh, Amin/AAZ-9349-2020	Majdalawieh, Amin/0000-0002-0240-1057; Ro, Hyo-Sung/0000-0003-4411-0386; McCluskey, Gregory/0000-0002-6594-4665	Canadian Institute of Health Research Grant [MOP-57675]; Canadian Breast Cancer Research Alliance Grant [019454]; Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance Grant; Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship	This work was supported by Canadian Institute of Health Research Grant MOP-57675 and Canadian Breast Cancer Research Alliance Grant 019454 (to H.S.R.).; Supported by a Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship.	Altaba ARI, 1999, NAT CELL BIOL, V1, pE147, DOI 10.1038/14099; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bogachev O, 2011, MOL MED, V17, P1056, DOI 10.2119/molmed.2011.00141; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kim WK, 2009, MOL ENDOCRINOL, V23, P1532, DOI 10.1210/me.2008-0453; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Li Z, 2006, CARCINOGENESIS, V27, P1054, DOI 10.1093/carcin/bgi324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Majdalawieh A, 2006, P NATL ACAD SCI USA, V103, P2346, DOI 10.1073/pnas.0508139103; Majdalawieh A, 2007, MOL BIOL CELL, V18, P930, DOI 10.1091/mbc.E06-03-0217; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Majdalawieh A, 2009, INT J BIOCHEM CELL B, V41, P1518, DOI 10.1016/j.biocel.2009.01.003; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Neumark E, 2003, INT J CANCER, V106, P879, DOI 10.1002/ijc.11337; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Ro HS, 2001, GENE, V280, P123, DOI 10.1016/S0378-1119(01)00771-5; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamasaki A, 2010, CANCER IMMUNOL IMMUN, V59, P675, DOI 10.1007/s00262-009-0783-7; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zhang L, 2005, ALGORITHMICA, V43, P1, DOI 10.1007/s00453-005-1154-1; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]	49	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39171	39181		10.1074/jbc.M112.404293	http://dx.doi.org/10.1074/jbc.M112.404293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995915	hybrid, Green Published			2022-12-25	WOS:000310982800072
J	Hukkelhoven, E; Liu, YH; Yeh, N; Ciznadija, D; Blain, SW; Koff, A				Hukkelhoven, Ellen; Liu, Yuhui; Yeh, Nancy; Ciznadija, Daniel; Blain, Stacy W.; Koff, Andrew			Tyrosine Phosphorylation of the p21 Cyclin-dependent Kinase Inhibitor Facilitates the Development of Proneural Glioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITORS; P27(KIP1); P21(CIP1); CELLS; P21(WAF1/CIP1); TRANSCRIPTION; PROGENITORS; ACTIVATION; SUBCLASSES; COMPLEXES	Phosphorylation of Tyr-88/Tyr-89 in the 3(10) helix of p27 reduces its cyclin-dependent kinase (CDK) inhibitory activity. This modification does not affect the interaction of p27 with cyclin-CDK complexes but does interfere with van der Waals and hydrogen bond contacts between p27 and amino acids in the catalytic cleft of the CDK. Thus, it had been suggested that phosphorylation of this site could switch the tumor-suppressive CDK inhibitory activity to an oncogenic activity. Here, we examined this hypothesis in the RCAS-PDGF-HA/nestin-TvA proneural glioma mouse model, in which p21 facilitates accumulation of nuclear cyclin D1-CDK4 and promotes tumor development. In these tumor cells, approximately one-third of the p21 is phosphorylated at Tyr-76 in the 3(10) helix. Mutation of this residue to glutamate reduced inhibitory activity in vitro. Mutation of this residue to phenylalanine reduced the tumor promoting activity of p21 in the animal model, whereas glutamate or alanine substitution allowed tumor formation. Consequently, we conclude that tyrosine phosphorylation contributes to the conversion of CDK inhibitors from tumor-suppressive roles to oncogenic roles.	[Hukkelhoven, Ellen; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Gerstner Sch Biomed Sci, New York, NY 10021 USA; [Liu, Yuhui; Yeh, Nancy; Ciznadija, Daniel; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, RRL917C,POB 207,1275 York Ave, New York, NY 10065 USA.	a-koff@ski.mskcc.org		Koff, Andrew/0000-0003-3271-3067	National Institutes of Health from NCI [CA89563]; NCI; Golfers Against Cancer and Cycle for Survival; Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship; Geoffrey Beene graduate student fellowship; Grayer fellowship; NATIONAL CANCER INSTITUTE [R01CA089563, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Golfers Against Cancer and Cycle for Survival; Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship; Geoffrey Beene graduate student fellowship; Grayer fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89563 from NCI (to A. K.). This work was also supported by a cancer center core grant from NCI (to the Memorial Sloan-Kettering Cancer Center), Golfers Against Cancer and Cycle for Survival (to A. K.), a Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship (to D. C.), and a Geoffrey Beene graduate student fellowship and a Grayer fellowship (to E. H.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gartel AL, 2002, MOL CANCER THER, V1, P639; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hashimoto Y, 1998, J BIOL CHEM, V273, P16544, DOI 10.1074/jbc.273.26.16544; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jones JM, 1999, CELL GROWTH DIFFER, V10, P213; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kavurma MM, 2004, J CELL BIOCHEM, V93, P904, DOI 10.1002/jcb.20238; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Ou L, 2011, J BIOL CHEM, V286, P30142, DOI 10.1074/jbc.M111.244095; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Robinson S, 2001, NEUROSURGERY, V48, P864, DOI 10.1097/00006123-200104000-00035; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Salpietro Maria, 2005, Clin Neurosurg, V52, P104; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Soos T J, 1998, Results Probl Cell Differ, V22, P111; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; TUDOS E, 1990, INT J PEPT PROT RES, V36, P236; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vidal A, 2005, P NATL ACAD SCI USA, V102, P6890, DOI 10.1073/pnas.0405823102; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285	56	15	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38523	38530		10.1074/jbc.M112.366542	http://dx.doi.org/10.1074/jbc.M112.366542			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007395	Green Published, hybrid			2022-12-25	WOS:000310982800012
J	Obara, K; Yamamoto, H; Kihara, A				Obara, Keisuke; Yamamoto, Hayashi; Kihara, Akio			Membrane Protein Rim21 Plays a Central Role in Sensing Ambient pH in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; GENE-EXPRESSION; PLASMA-MEMBRANE; RIM101 PATHWAY; YEAST; COMPLEX; ACTIVATION; TOPOLOGY; SYSTEM; FUNGI	External alkalization activates the Rim101 pathway in Saccharomyces cerevisiae. In this pathway, three integral membrane proteins, Rim21, Dfg16, and Rim9, are considered to be the components of the pH sensor machinery. However, how these proteins are involved in pH sensing is totally unknown. In this work, we investigated the localization, physical interaction, and interrelationship of Rim21, Dfg16, and Rim9. These proteins were found to form a complex and to localize to the plasma membrane in a patchy and mutually dependent manner. Their cellular level was also mutually dependent. In particular, the Rim21 level was significantly decreased in dfg16 Delta and rim9 Delta cells. Upon external alkalization, the proteins were internalized and degraded. We also demonstrate that the transient degradation of Rim21 completely suppressed the Rim101 pathway but that the degradation of Dfg16 or Rim9 did not. This finding strongly suggests that Rim21 is the pH sensor protein and that Dfg16 and Rim9 play auxiliary functions through maintaining the level of Rim21 and assisting in its plasma membrane localization. Even without external alkalization, the Rim101 pathway was activated in a Rim21-dependent manner by either protonophore treatment or depletion of phosphatidylserine in the inner leaflet of the plasma membrane, both of which caused plasma membrane depolarization like the external alkalization. Therefore, plasma membrane depolarization seems to be one of the key signals for the pH sensor molecule Rim21.	[Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamamoto, Hayashi] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Hokkaido University; Tokyo Institute of Technology	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science (JSPS) [23770135, 23657120]; The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation	This work was supported by Grant-in-aid for Young Scientists (B) 23770135 (to K. O.) and Grant-in-aid for Challenging Exploratory Research 23657120 (to A. K.) from the Japan Society for the Promotion of Science (JSPS) and The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation (to K. O.).	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Ikeda M, 2008, MOL BIOL CELL, V19, P1922, DOI 10.1091/mbc.E07-08-0806; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li WS, 1997, GENETICS, V145, P63; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Treton B, 2000, MOL GEN GENET, V263, P505, DOI 10.1007/s004380051195; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Weiss P, 2009, BIOCHEM J, V424, P89, DOI 10.1042/BJ20090957; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamagata M, 2011, BIOCHEM BIOPH RES CO, V410, P786, DOI 10.1016/j.bbrc.2011.06.061	37	51	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38473	38481		10.1074/jbc.M112.394205	http://dx.doi.org/10.1074/jbc.M112.394205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019326	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000310982800007
J	Valton, J; Dupuy, A; Daboussi, F; Thomas, S; Marechal, A; Macmaster, R; Melliand, K; Juillerat, A; Duchateau, P				Valton, Julien; Dupuy, Aurelie; Daboussi, Fayza; Thomas, Severine; Marechal, Alan; Macmaster, Rachel; Melliand, Kevin; Juillerat, Alexandre; Duchateau, Philippe			Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; CANCER; RECOGNITION	Within the past 2 years, transcription activator-like effector (TALE) DNA binding domains have emerged as the new generation of engineerable platform for production of custom DNA binding domains. However, their recently described sensitivity to cytosine methylation represents a major bottleneck for genome engineering applications. Using a combination of biochemical, structural, and cellular approaches, we were able to identify the molecular basis of such sensitivity and propose a simple, drug-free, and universal method to overcome it.	[Valton, Julien; Dupuy, Aurelie; Daboussi, Fayza; Thomas, Severine; Marechal, Alan; Macmaster, Rachel; Melliand, Kevin; Juillerat, Alexandre; Duchateau, Philippe] Cellectis SA, F-75013 Paris, France		Valton, J (corresponding author), Cellectis SA, 8 Rue Croix Jarry, F-75013 Paris, France.	julien.valton@cellectis.com; philippe.duchateau@cellectis.com		Valton, Julien/0000-0003-0826-5401; Daboussi, Fayza/0000-0001-7689-7975				Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; BARDSLEY WG, 1987, J THEOR BIOL, V126, P183, DOI 10.1016/S0022-5193(87)80228-X; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Ohm JE, 2010, CANCER RES, V70, P7662, DOI 10.1158/0008-5472.CAN-10-1361; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Valton J, 2012, J BIOL CHEM, V287, P30139, DOI 10.1074/jbc.M112.379966; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	26	145	174	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38427	38432		10.1074/jbc.C112.408864	http://dx.doi.org/10.1074/jbc.C112.408864			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019344	Green Published, hybrid			2022-12-25	WOS:000310982800002
J	Kim, SJ; Lee, JH; Kim, BS; So, HS; Park, R; Myung, NY; Um, JY; Hong, SH				Kim, Su-Jin; Lee, Jeong-Han; Kim, Beom-Su; So, Hong-Seob; Park, Raekil; Myung, Noh-Yil; Um, Jae-Young; Hong, Seung-Heon			(-)-Epigallocatechin-3-Gallate Protects against NO-Induced Ototoxicity through the Regulation of Caspase-1, Caspase-3, and NF-kappa B Activation	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; NUCLEAR-FACTOR; CELL-DEATH; INDUCED APOPTOSIS; ACOUSTIC OVERSTIMULATION; GUINEA-PIGS; TRANSCRIPTION FACTOR; RECRUITMENT DOMAIN; TEA CATECHINS; HAIR-CELLS	Excessive nitric oxide (NO) production is toxic to the cochlea and induces hearing loss. However, the mechanism through which NO induces ototoxicity has not been completely understood. The aim of this study was to gain further insight into the mechanism mediating NO-induced toxicity in auditory HEI-OC1 cells and in ex vivo analysis. We also elucidated whether and how epigallocatechin-3-gallate (EGCG), the main component of green tea polyphenols, regulates NO-induced auditory cell damage. To investigate NO-mediated ototoxicity, S-nitroso-N-acetylpenicillamine (SNAP) was used as an NO donor. SNAP was cytotoxic, generating reactive oxygen species, releasing cytochrome c, and activating caspase-3 in auditory cells. NO-induced ototoxicity also mediated the nuclear factor (NF)-kappa B/caspase-1 pathway. Furthermore, SNAP destroyed the orderly arrangement of the 3 outer rows of hair cells in the basal, middle, and apical turns of the organ of Corti from the cochlea of Sprague-Dawley rats at postnatal day 2. However, EGCG counteracted this ototoxicity by suppressing the activation of caspase-3/NF-kappa B and preventing the destruction of hair cell arrays in the organ of Corti. These findings may lead to the development of a model for pharmacological mechanism of EGCG and potential therapies against ototoxicity.	[Um, Jae-Young] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Kim, Su-Jin] Daegu Hanny Univ, Dept Cosmeceut Sci, Kyungsan, Gyeoungbuk, South Korea; [Lee, Jeong-Han; So, Hong-Seob; Park, Raekil; Myung, Noh-Yil; Hong, Seung-Heon] Wonkwang Univ, Ctr Metab Funct Regulat, Iksan, Jeonbuk, South Korea; [Kim, Beom-Su] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan, Jeonbuk, South Korea	Kyung Hee University; Wonkwang University; Wonkwang University	Um, JY (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	jyum@khu.ac.kr; jooklim@wonkwang.ac.kr	Um, Jae-Young/G-8787-2013		National Research Foundation of Korea [NRF]; Korea government [MEST] [2011 0030717]; Ministry of Education, Science and Technology [2011-0010435]	National Research Foundation of Korea [NRF](National Research Foundation of Korea); Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea [NRF] grant funded by the Korea government [MEST] [No. 2011 0030717], and partly this research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology(2011-0010435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAUER JA, 1991, J PHARMACOL EXP THER, V256, P249; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chen YS, 2005, HEARING RES, V203, P94, DOI 10.1016/j.heares.2004.12.006; Christman JW, 2000, CHEST, V117, P1482, DOI 10.1378/chest.117.5.1482; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Chu SH, 2011, SCAND J GASTROENTERO, V46, P148, DOI 10.3109/00365521.2010.525255; D'Acquisto F, 2001, CELL DEATH DIFFER, V8, P144, DOI 10.1038/sj.cdd.4400784; Delivani P, 2006, CELL DEATH DIFFER, V13, P2007, DOI 10.1038/sj.cdd.4402049; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Fiscus RR, 2002, J CARDIAC SURG, V17, P336; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hanson JB, 2003, INT J PEDIATR OTORHI, V67, P585, DOI 10.1016/S0165-5876(03)00035-1; Heinrich UR, 2008, LARYNGOSCOPE, V118, P837, DOI 10.1097/MLG.0b013e31816381ae; Heinrich UR, 2008, LARYNGOSCOPE, V118, P1438, DOI 10.1097/MLG.0b013e3181739bd9; Heinrich UR, 2005, BRAIN RES, V1047, P85, DOI 10.1016/j.brainres.2005.04.023; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Jeong HJ, 2003, ENDOCRINOLOGY, V144, P4080, DOI 10.1210/en.2003-0115; Jeong HJ, 2009, BIOL PHARM BULL, V32, P1027, DOI 10.1248/bpb.32.1027; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719; Kaygusuz I, 2001, HEARING RES, V162, P43, DOI 10.1016/S0378-5955(01)00365-3; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328; Liu W, 1998, NEUROREPORT, V9, P2609, DOI 10.1097/00001756-199808030-00034; Masuda M, 2006, BRAIN RES, V1068, P237, DOI 10.1016/j.brainres.2005.11.020; Nagashima R, 2007, NEUROCHEM INT, V51, P209, DOI 10.1016/j.neuint.2007.04.023; Nie GJ, 2002, ARCH BIOCHEM BIOPHYS, V397, P84, DOI 10.1006/abbi.2001.2636; Oh HM, 2004, FREE RADICAL BIO MED, V37, P463, DOI 10.1016/j.freeradbiomed.2004.04.042; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Schmitt NC, 2009, J NEUROSCI, V29, P3843, DOI 10.1523/JNEUROSCI.5842-08.2009; Schoonbroodt S, 1997, BIOCHEM J, V321, P777, DOI 10.1042/bj3210777; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; SHAFFER JE, 1992, J PHARMACOL EXP THER, V260, P286; Shi XR, 2007, HEARING RES, V224, P1, DOI 10.1016/j.heares.2006.10.011; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Suzuki M, 2000, J AGR FOOD CHEM, V48, P5649, DOI 10.1021/jf000313d; Takumida M, 2002, CURR OPIN NEUROL, V15, P11, DOI 10.1097/00019052-200202000-00003; Wang X, 2005, J NEUROSCI, V25, P11645, DOI 10.1523/JNEUROSCI.4181-05.2005; Watanabe K, 2000, ANTI-CANCER DRUG, V11, P401, DOI 10.1097/00001813-200006000-00011; Watanabe KI, 2002, ANTICANCER RES, V22, P4081; Yamamoto H, 2009, J NEUROSCI RES, V87, P1832, DOI 10.1002/jnr.22018; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zheng JL, 1996, EUR J NEUROSCI, V8, P1897, DOI 10.1111/j.1460-9568.1996.tb01333.x	55	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e43967	10.1371/journal.pone.0043967	http://dx.doi.org/10.1371/journal.pone.0043967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028481	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900003
J	Li, ZJ; Zhu, YS; Childress, AR; Detre, JA; Wang, Z				Li, Zhengjun; Zhu, Yisheng; Childress, Anna Rose; Detre, John A.; Wang, Ze			Relations between BOLD fMRI-Derived Resting Brain Activity and Cerebral Blood Flow	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; OXYGEN-CONSUMPTION; DEFAULT-MODE; OXIDATIVE-METABOLISM; SIGNAL FLUCTUATIONS; NETWORKS; CORTEX; MRI; ACTIVATION; AMPLITUDE	Consistent resting brain activity patterns have been repeatedly demonstrated using measures derived from resting BOLD fMRI data. While those metrics are presumed to reflect underlying spontaneous brain activity (SBA), it is challenging to prove that association because resting BOLD fMRI metrics are purely model-free and scale-free variables. Cerebral blood flow (CBF) is typically closely coupled to brain metabolism and is used as a surrogate marker for quantifying regional brain function, including resting function. Assessing the correlations between resting BOLD fMRI measures and CBF correlation should provide a means of linking of those measures to the underlying SBA, and a means to quantify those scale-free measures. The purpose of this paper was to examine the CBF correlations of 3 widely used neuroimaging-based SBA measures, including seed-region based functional connectivity (FC), regional homogeneity (ReHo), and amplitude of low frequency fluctuation (ALFF). Test-retest data were acquired to check the stability of potential correlations across time. Reproducible posterior cingulate cortex (PCC) FC vs regional CBF correlations were found in much of the default mode network and visual cortex. Dorsal anterior cingulate cortex (ACC) FC vs CBF correlations were consistently found in bilateral prefrontal cortex. Both ReHo and ALFF were found to be reliably correlated with CBF in most of brain cortex. None of the assessed SBA measures was correlated with whole brain mean CBF. These findings suggest that resting BOLD fMRI-derived measures are coupled with regional CBF and are therefore linked to regional SBA.	[Childress, Anna Rose; Wang, Ze] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Zhengjun; Zhu, Yisheng] Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China; [Detre, John A.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Ze/A-1043-2007		National Institute of Health [5R21DC011074-02, 1R03DA023496-01A1, DA015149, RR02305, 4R33DA026114-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025906, R03DA023496, R33DA026114, R01DA015149] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute of Health: 5R21DC011074-02, 1R03DA023496-01A1, DA015149, RR02305, and 4R33DA026114-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswal BB, 1999, J COMPUT ASSIST TOMO, V23, P265, DOI 10.1097/00004728-199903000-00016; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Clarke Donald D., 1999, P637; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; HUDETZ AG, 1992, J CEREBR BLOOD F MET, V12, P491, DOI 10.1038/jcbfm.1992.67; Hyder F, 1998, J APPL PHYSIOL, V85, P554, DOI 10.1152/jappl.1998.85.2.554; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kastrup A, 2002, NEUROIMAGE, V15, P74, DOI 10.1006/nimg.2001.0916; Kawahara Ichiro, 2010, No Shinkei Geka, V38, P645; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Li Zhengjun, 2012, ANN M ORG HUM BRAIN; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marrett S, 1997, ADV EXP MED BIOL, V413, P205; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao H, 2007, ISMRM ANN M 2007 BER, P3234; Rengachary SS, 2005, PRINCIPLES NEUROSURG; Roy C S, 1890, J Physiol, V11, P85; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Troiani V, 2008, NEUROIMAGE, V40, P932, DOI 10.1016/j.neuroimage.2007.12.002; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang Z, 2008, NEUROSCI LETT, V438, P275, DOI 10.1016/j.neulet.2008.04.084; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wang Z, 2008, NEUROIMAGE, V39, P973, DOI 10.1016/j.neuroimage.2007.09.045; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	67	86	88	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44556	10.1371/journal.pone.0044556	http://dx.doi.org/10.1371/journal.pone.0044556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028560	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800012
J	Pompei, S; Loreto, V; Tria, F				Pompei, Simone; Loreto, Vittorio; Tria, Francesca			Phylogenetic Properties of RNA Viruses	PLOS ONE			English	Article							TREE SHAPE STATISTICS; HUMAN INFLUENZA-A; EVOLUTION; RECONSTRUCTION; DYNAMICS; IMBALANCE; PATHOGENS; SELECTION; HISTORY; FITNESS	A new word, phylodynamics, was coined to emphasize the interconnection between phylogenetic properties, as observed for instance in a phylogenetic tree, and the epidemic dynamics of viruses, where selection, mediated by the host immune response, and transmission play a crucial role. The challenges faced when investigating the evolution of RNA viruses call for a virtuous loop of data collection, data analysis and modeling. This already resulted both in the collection of massive sequences databases and in the formulation of hypotheses on the main mechanisms driving qualitative differences observed in the (reconstructed) evolutionary patterns of different RNA viruses. Qualitatively, it has been observed that selection driven by the host immune response induces an uneven survival ability among co-existing strains. As a consequence, the imbalance level of the phylogenetic tree is manifestly more pronounced if compared to the case when the interaction with the host immune system does not play a central role in the evolutive dynamics. While many imbalance metrics have been introduced, reliable methods to discriminate in a quantitative way different level of imbalance are still lacking. In our work, we reconstruct and analyze the phylogenetic trees of six RNA viruses, with a special emphasis on the human Influenza A virus, due to its relevance for vaccine preparation as well as for the theoretical challenges it poses due to its peculiar evolutionary dynamics. We focus in particular on topological properties. We point out the limitation featured by standard imbalance metrics, and we introduce a new methodology with which we assign the correct imbalance level of the phylogenetic trees, in agreement with the phylodynamics of the viruses. Our thorough quantitative analysis allows for a deeper understanding of the evolutionary dynamics of the considered RNA viruses, which is crucial in order to provide a valuable framework for a quantitative assessment of theoretical predictions.	[Pompei, Simone; Loreto, Vittorio; Tria, Francesca] ISI, Complex Syst Lagrange Lab, Turin, Italy; [Pompei, Simone] Univ Turin, Dept Phys, Turin, Italy; [Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	University of Turin; Sapienza University Rome	Pompei, S (corresponding author), ISI, Complex Syst Lagrange Lab, Turin, Italy.	simo.pompei@gmail.com			Q-Aracne Compagnia San Paolo Project	Q-Aracne Compagnia San Paolo Project	The authors acknowledge the Q-Aracne Compagnia San Paolo Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous D, 1995, PROBABILITY DISTRIBU; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Donoghue M, 1994, AM J BOT, V81, P183; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1989, ADV CHEM PHYS, V75, P615; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Ford DJ, 2007, THESIS STANFORD U; Furuse Y, 2010, VIROL J, V4, P7; FUSCO G, 1995, J THEOR BIOL, V175, P235, DOI 10.1006/jtbi.1995.0136; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Herrada A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-155; Herrada EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002757; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Jukes TH, 1969, EVOLUTION PROTEIN MO; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keller-Schmidt S, 2010, ARXIV10123298V1QBIOP; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Matsen FA, 2007, IEEE ACM T COMPUT BI, V4, P506, DOI 10.1109/TCBB.2007.1020; Matsen FA, 2006, SYST BIOL, V55, P652, DOI 10.1080/10635150600889617; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Pompei S, 2010, MATH MOD METH APPL S, V20, P1511, DOI 10.1142/S0218202510004672; Pompei S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020109; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Stich M, 2009, EUR PHYS J B, V70, P583, DOI 10.1140/epjb/e2009-00254-8; Stich M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-110; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; TRIA F, 2010, P BIOCOMP2010 2010 I; Tria F, 2010, MOL BIOL EVOL, V27, P2587, DOI 10.1093/molbev/msq154; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whelan S, 2003, BIOINFORMATICS, V19, P1556, DOI 10.1093/bioinformatics/btg188; Willis JC, 1922, NATURE, V109, P177, DOI 10.1038/109177a0; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	51	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44849	10.1371/journal.pone.0044849	http://dx.doi.org/10.1371/journal.pone.0044849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028645	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900013
J	Gerc, AJ; Song, LJ; Challis, GL; Stanley-Wall, NR; Coulthurst, SJ				Gerc, Amy J.; Song, Lijiang; Challis, Gregory L.; Stanley-Wall, Nicola R.; Coulthurst, Sarah J.			The Insect Pathogen Serratia marcescens Db10 Uses a Hybrid Non-Ribosomal Peptide Synthetase-Polyketide Synthase to Produce the Antibiotic Althiomycin	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PHOSPHOPANTETHEINYL TRANSFERASE; ADENYLATION DOMAINS; MYXOCOCCUS-XANTHUS; NATURAL-PRODUCTS; EXTENDER UNITS; GENE-CLUSTER; BIOSYNTHESIS; IDENTIFICATION; SUPERFAMILY	There is a continuing need to discover new bioactive natural products, such as antibiotics, in genetically-amenable microorganisms. We observed that the enteric insect pathogen, Serratia marcescens Db10, produced a diffusible compound that inhibited the growth of Bacillis subtilis and Staphyloccocus aureus. Mapping the genetic locus required for this activity revealed a putative natural product biosynthetic gene cluster, further defined to a six-gene operon named alb1-alb6. Bioinformatic analysis of the proteins encoded by alb1-6 predicted a hybrid non-ribosomal peptide synthetase-polyketide synthase (NRPS-PKS) assembly line (Alb4/5/6), tailoring enzymes (Alb2/3) and an export/resistance protein (Alb1), and suggested that the machinery assembled althiomycin or a related molecule. Althiomycin is a ribosome-inhibiting antibiotic whose biosynthetic machinery had been elusive for decades. Chromatographic and spectroscopic analyses confirmed that wild type S. marcescens produced althiomycin and that production was eliminated on disruption of the alb gene cluster. Construction of mutants with in-frame deletions of specific alb genes demonstrated that Alb2-Alb5 were essential for althiomycin production, whereas Alb6 was required for maximal production of the antibiotic. A phosphopantetheinyl transferase enzyme required for althiomycin biosynthesis was also identified. Expression of Alb1, a predicted major facilitator superfamily efflux pump, conferred althiomycin resistance on another, sensitive, strain of S. marcescens. This is the first report of althiomycin production outside of the Myxobacteria or Streptomyces and paves the way for future exploitation of the biosynthetic machinery, since S. marcescens represents a convenient and tractable producing organism.	[Song, Lijiang; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Gerc, Amy J.; Stanley-Wall, Nicola R.; Coulthurst, Sarah J.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland	University of Warwick; University of Dundee	Challis, GL (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	g.l.challis@warwick.ac.uk; r.stanleywall@dundee.ac.uk; s.j.coulthurst@dundee.ac.uk		Stanley-Wall, Nicola/0000-0002-5936-9721; Coulthurst, Sarah/0000-0002-0808-1875; Challis, Gregory/0000-0001-5976-3545	Royal Society of Edinburgh/Scottish Government Personal Research Fellowship; Wellcome Trust [093711/B/10/Z]	Royal Society of Edinburgh/Scottish Government Personal Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	SJC is supported by a Royal Society of Edinburgh/Scottish Government Personal Research Fellowship (www.royalsoced.org.uk/). AJG is funded by a PhD studentship supported by the Wellcome Trust [093711/B/10/Z] (www.wellcome.ac.uk/). The Bruker MaXis mass spectrometer used in this research was obtained with support from Advantage West Midlands (AWM) and the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAI R, 1992, BIOCHEM PHARMACOL, V43, P2637, DOI 10.1016/0006-2952(92)90153-A; BURNS DJW, 1973, EUR J BIOCHEM, V37, P570, DOI 10.1111/j.1432-1033.1973.tb03020.x; CARDELLINA JH, 1979, J AM CHEM SOC, V101, P240, DOI 10.1021/ja00495a051; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cortina NS, 2011, CHEMBIOCHEM, V12, P1411, DOI 10.1002/cbic.201100154; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; FLYG C, 1980, J GEN MICROBIOL, V120, P173; FUJIMOTO H, 1970, J ANTIBIOT, V23, P271, DOI 10.7164/antibiotics.23.271; Gwynn MN, 2010, ANN NY ACAD SCI, V1213, P5, DOI 10.1111/j.1749-6632.2010.05828.x; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hopwood DA, 2007, MOL MICROBIOL, V63, P937, DOI 10.1111/j.1365-2958.2006.05584.x; INAMI K, 1985, B CHEM SOC JPN, V58, P352, DOI 10.1246/bcsj.58.352; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kim J, 2009, J MICROBIOL BIOTECHN, V19, P51, DOI 10.4014/jmb.0711.775; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; KUNZE B, 1982, J ANTIBIOT, V35, P635, DOI 10.7164/antibiotics.35.635; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; PAIK SG, 1994, J AM CHEM SOC, V116, P8116, DOI 10.1021/ja00097a019; Pavlidou M, 2011, FEMS MICROBIOL LETT, V319, P26, DOI 10.1111/j.1574-6968.2011.02263.x; Petty NK, 2006, MICROBIOL-SGM, V152, P1701, DOI 10.1099/mic.0.28712-0; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; SAKAKIBARA H, 1974, J ANTIBIOT, V27, P897, DOI 10.7164/antibiotics.27.897; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; YAMAGUCHI H, 1957, J ANTIBIOT, V10, P195; Zarantonello P, 2002, BIOORG MED CHEM LETT, V12, P561, DOI 10.1016/S0960-894X(01)00802-2; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389	44	35	36	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44673	10.1371/journal.pone.0044673	http://dx.doi.org/10.1371/journal.pone.0044673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028578	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900034
J	Lo Schiavo, V; Robert, P; Limozin, L; Bongrand, P				Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre			Quantitative Modeling Assesses the Contribution of Bond Strengthening, Rebinding and Force Sharing to the Avidity of Biomolecule Interactions	PLOS ONE			English	Article							RECEPTOR-LIGAND BONDS; BETA(2) INTEGRIN; TARGET-CELLS; ICAM-1 BONDS; ADHESION; BINDING; SPECTROSCOPY; SELECTIN; PARALLEL; KINETICS	Cell adhesion is mediated by numerous membrane receptors. It is desirable to derive the outcome of a cell-surface encounter from the molecular properties of interacting receptors and ligands. However, conventional parameters such as affinity or kinetic constants are often insufficient to account for receptor efficiency. Avidity is a qualitative concept frequently used to describe biomolecule interactions: this includes incompletely defined properties such as the capacity to form multivalent attachments. The aim of this study is to produce a working description of monovalent attachments formed by a model system, then to measure and interpret the behavior of divalent attachments under force. We investigated attachments between antibody-coated microspheres and surfaces coated with sparse monomeric or dimeric ligands. When bonds were subjected to a pulling force, they exhibited both a force-dependent dissociation consistent with Bell's empirical formula and a force- and time-dependent strengthening well described by a single parameter. Divalent attachments were stronger and less dependent on forces than monovalent ones. The proportion of divalent attachments resisting a force of 30 piconewtons for at least 5 s was 3.7 fold higher than that of monovalent attachments. Quantitative modeling showed that this required rebinding, i.e. additional bond formation between surfaces linked by divalent receptors forming only one bond. Further, experimental data were compatible with but did not require stress sharing between bonds within divalent attachments. Thus many ligand-receptor interactions do not behave as single-step reactions in the millisecond to second timescale. Rather, they exhibit progressive stabilization. This explains the high efficiency of multimerized or clustered receptors even when bonds are only subjected to moderate forces. Our approach provides a quantitative way of relating binding avidity to measurable parameters including bond maturation, rebinding and force sharing, provided these parameters have been determined. Also, this provides a quantitative description of the phenomenon of bond strengthening.	[Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] Aix Marseille Univ, LAI, Marseille, France; [Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] INSERM, UMR 1067, LAI, F-13258 Marseille, France; [Lo Schiavo, Valentina; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] CNRS, UMR 7333, LAI, Marseille, France; [Robert, Philippe; Bongrand, Pierre] Hop Conception, APHM, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lo Schiavo, V (corresponding author), Aix Marseille Univ, LAI, Marseille, France.	pierre.bongrand@inserm.fr	Limozin, Laurent/P-7134-2016; Robert, Philippe/P-9597-2016; Bongrand, Pierre/C-4456-2013	Limozin, Laurent/0000-0001-9523-8086; Robert, Philippe/0000-0002-1343-994X; Bongrand, Pierre/0000-0001-6185-6572	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University	Funding is academic, from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS) and University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDRE P, 1990, J CELL SCI, V97, P335; Bartsch TF, 2009, CHEMPHYSCHEM, V10, P1541, DOI 10.1002/cphc.200900211; BEESON C, 1994, P NATL ACAD SCI USA, V91, P8842, DOI 10.1073/pnas.91.19.8842; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bongrand P, 1999, REP PROG PHYS, V62, P921, DOI 10.1088/0034-4885/62/6/202; Bongrand P., 1984, CELL SURFACE DYNAMIC, P459; BYSTRYN JC, 1973, J EXP MED, V137, P301, DOI 10.1084/jem.137.2.301; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DETMERS PA, 1987, J CELL BIOL, V105, P1137, DOI 10.1083/jcb.105.3.1137; Doi M., 1988, THEORY POLYM DYNAMIC; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Erdmann T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108102; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Fuhrmann A, 2009, BIOPHYS J, V96, P5030, DOI 10.1016/j.bpj.2009.03.022; Glynn E., 1977, IMMUNOCHEMISTRY ADV, P240; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Guo S, 2008, BIOPHYS J, V95, P3964, DOI 10.1529/biophysj.108.133900; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HOLOWKA DA, 1976, BIOCHEMISTRY-US, V15, P3379, DOI 10.1021/bi00660a033; HORNICK CL, 1972, IMMUNOCHEMISTRY, V9, P325, DOI 10.1016/0019-2791(72)90096-1; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Loritz HM, 2011, J PHYS CHEM B, V115, P2582, DOI 10.1021/jp108280q; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCCLOSKEY MA, 1986, J CELL BIOL, V102, P2185, DOI 10.1083/jcb.102.6.2185; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pereverzev YV, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.010903; PIERRES A, 1995, J BIOL CHEM, V270, P26586, DOI 10.1074/jbc.270.44.26586; Pierres A, 2001, BIOPHYS J, V81, P25, DOI 10.1016/S0006-3495(01)75677-9; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Pierres A, 2007, FEBS LETT, V581, P1841, DOI 10.1016/j.febslet.2007.03.077; Pierres A, 2008, CELL MOL BIOENG, V1, P247, DOI 10.1007/s12195-008-0031-9; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Ray C, 2010, LANGMUIR, V26, P11951, DOI 10.1021/la101269q; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Robert P, 2008, BIOPHYS J, V95, P3999, DOI 10.1529/biophysj.108.135947; Robert P, 2012, BIOPHYS J, V102, P248, DOI 10.1016/j.bpj.2011.11.4018; Robert P, 2011, BIOPHYS J, V100, P2642, DOI 10.1016/j.bpj.2011.04.011; Robert P, 2009, BIOPHYS J, V96, P4642, DOI 10.1016/j.bpj.2009.03.020; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Seifert U, 2002, EUROPHYS LETT, V58, P792, DOI 10.1209/epl/i2002-00101-8; Sengupta K, 2009, SMALL, V5, P449, DOI 10.1002/smll.200800836; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; Wierenga PA, 2006, J COLLOID INTERF SCI, V299, P850, DOI 10.1016/j.jcis.2006.03.016; WILLIAMS AF, 1991, NATURE, V352, P473, DOI 10.1038/352473a0; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	68	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44070	10.1371/journal.pone.0044070	http://dx.doi.org/10.1371/journal.pone.0044070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024747	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100005
J	Niculescu, MD; Lupu, DS; Craciunescu, CN				Niculescu, Mihai D.; Lupu, Daniel S.; Craciunescu, Corneliu N.			Perinatal manipulation of alpha-linolenic acid intake induces epigenetic changes in maternal and offspring livers	FASEB JOURNAL			English	Article						Fads2; flaxseed oil; polyunsaturated fatty acids; DNA methylation; postnatal development	FATTY-ACID; PRETERM INFANTS; DOCOSAHEXAENOIC ACID; DNA METHYLATION; KAPPA-B; GROWTH; N-3; SUPPLEMENTATION; EXPRESSION; LACTATION	Previous studies indicated that the intake of alpha-linolenic acid (ALA) can alter the concentration of both omega-6 and omega-3 fatty acids in both mother and offspring, with consequences on postnatal brain development. This study describes the association between maternal ALA availability during gestation and lactation, and alterations in the Fads2 DNA methylation in both maternal and offspring livers, at the end of lactation period. Both Fads2 promoter and intron 1 DNA methylation were increased in the groups receiving postnatal flaxseed oil containing 50% ALA (mothers or pups), while bivariate analysis indicated a significant association of the Fads2 epigenetic status in the liver between each mother and its offspring. In addition, Fads2 expression was negatively correlated with promoter methylation at the individual level in maternal livers (P<0.05). This study also indicated that the interplay between ALA availability during gestation and lactation can differentially alter the expression of desaturases and elongases involved in omega-6 and omega-3 metabolic pathways. In summary, when considering the perinatal dietary ALA requirements in mice, both gestation and lactation periods should be considered as having distinct roles in modulating the metabolism of omega-6 and omega-3 fatty acids in maternal mouse livers.-Niculescu, M. D., Lupu, D. S., Craciunescu, C. N. Perinatal manipulation of alpha-linolenic acid intake induces epigenetic changes in maternal and offspring livers. FASEB J. 27, 350-358 (2013). www.fasebj.org	[Niculescu, Mihai D.; Lupu, Daniel S.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC 28081 USA; [Niculescu, Mihai D.; Lupu, Daniel S.; Craciunescu, Corneliu N.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina; University of North Carolina Chapel Hill	Niculescu, MD (corresponding author), Univ N Carolina, Inst Nutr Res, 500 Laureate Way, Kannapolis, NC 28081 USA.	mihai_niculescu@unc.edu	LUPU, DANIEL/A-6004-2011; LUPU, DANIEL/K-1990-2014	LUPU, DANIEL/0000-0001-8174-5482	University of North Carolina Center for Excellence in Children's Nutrition; Mead Johnson Nutrition	University of North Carolina Center for Excellence in Children's Nutrition; Mead Johnson Nutrition	This work was partially funded by a grant to M. D. N. from the University of North Carolina Center for Excellence in Children's Nutrition, sponsored by Mead Johnson Nutrition.	Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; CARLSON SE, 1992, LIPIDS, V27, P901, DOI 10.1007/BF02535870; Carlson SE, 1996, AM J CLIN NUTR, V63, P687, DOI 10.1093/ajcn/63.5.687; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; Clandinin MT, 2005, J PEDIATR-US, V146, P461, DOI 10.1016/j.jpeds.2004.11.030; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Deckelbaum RJ, 2012, J NUTR, V142, p641S, DOI 10.3945/jn.111.149831; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Fewtrell MS, 2004, J PEDIATR-US, V144, P471, DOI 10.1016/j.jpeds.2004.01.034; Garrel C, 2012, INT J BIOCHEM CELL B, V44, P123, DOI 10.1016/j.biocel.2011.10.007; Gibson RA, 2011, NESTLE NUTR WORKS SE, V67, P197, DOI 10.1159/000325585; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Guillou H, 2004, J LIPID RES, V45, P32, DOI 10.1194/jlr.M300339-JLR200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Harauma A, 2010, LIPIDS, V45, P659, DOI 10.1007/s11745-010-3443-y; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Innis SM, 2002, J PEDIATR-US, V140, P547, DOI 10.1067/mpd.2002.123282; Jordan RG, 2010, J MIDWIFERY WOM HEAL, V55, P520, DOI 10.1016/j.jmwh.2010.02.018; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; LANDS WEM, 1990, LIPIDS, V25, P505, DOI 10.1007/BF02537156; Makrides M, 2011, MATERN CHILD NUTR, V7, P80, DOI 10.1111/j.1740-8709.2011.00304.x; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Millar AA, 1997, PLANT J, V12, P121, DOI 10.1046/j.1365-313X.1997.12010121.x; Muhlhausler BS, 2011, PROSTAG LEUKOTR ESS, V85, P83, DOI 10.1016/j.plefa.2011.04.027; Muhlhausler Beverly Sara, 2011, Frontiers in Genetics, V2, P48, DOI 10.3389/fgene.2011.00048; Niculescu MD, 2011, INT J DEV NEUROSCI, V29, P795, DOI 10.1016/j.ijdevneu.2011.09.006; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Ren J, 2007, J AGR FOOD CHEM, V55, P5073, DOI 10.1021/jf0702693; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200	39	59	63	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					350	358		10.1096/fj.12-210724	http://dx.doi.org/10.1096/fj.12-210724			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22997227				2022-12-25	WOS:000313103200033
J	Yang, T; Jian, W; Luo, Y; Fu, XQ; Noguchi, C; Bungert, J; Huang, SM; Qiu, Y				Yang, Tao; Jian, Wei; Luo, Yi; Fu, Xueqi; Noguchi, Constance; Bungert, Joerg; Huang, Suming; Qiu, Yi			Acetylation of Histone Deacetylase 1 Regulates NuRD Corepressor Complex Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; ERYTHROID-DIFFERENTIATION; CELL-DIFFERENTIATION; CHROMATIN OCCUPANCY; GENE-EXPRESSION; DEPENDENT REGULATION; DISTINCT FUNCTIONS; LEUKEMIC-CELLS	Histone deacetylases (HDACs) play important roles in regulating cell proliferation and differentiation. The HDAC1-containing NuRD complex is generally considered as a corepressor complex and is required for GATA-1-mediated repression. However, recent studies also show that the NuRD complex is involved in GATA-1-mediated gene activation. We tested whether the GATA-1-associated NuRD complex loses its deacetylase activity and commits the GATA-1 complex to become an activator during erythropoiesis. We found that GATA-1-associated deacetylase activity gradually decreased upon induction of erythroid differentiation. GATA-1-associated HDAC1 is increasingly acetylated after differentiation. It has been demonstrated earlier that acetylated HDAC1 has no deacetylase activity. Indeed, overexpression of an HDAC1 mutant, which mimics acetylated HDAC1, promotes GATA-1-mediated transcription and erythroid differentiation. Furthermore, during erythroid differentiation, acetylated HDAC1 recruitment is increased at GATA-1-activated genes, whereas it is significantly decreased at GATA-1-repressed genes. Interestingly, deacetylase activity is not required for Mi2 remodeling activity, suggesting that remodeling activity may be required for both activation and repression. Thus, our data suggest that NuRD can function as a coactivator or repressor and that acetylated HDAC1 converts the NuRD complex from a repressor to an activator during GATA-1-directed erythroid differentiation.	[Yang, Tao; Jian, Wei; Luo, Yi; Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Bungert, Joerg; Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Yang, Tao; Fu, Xueqi] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Noguchi, Constance] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Jilin University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Qiu, Y (corresponding author), 2033 Mowry Rd,Rm 356, Gainesville, FL 32610 USA.	qiuy@ufl.edu	cheng, yong/I-4270-2012; yang, tao/J-2418-2015	yang, tao/0000-0002-4182-9793; , Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, R01 HL091929, R01091929-01A1S1, R01 DK 83389, R01 DK 52356]; Florida Bankhead Coley Research Foundation; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL095674 (to Y. Q.); R01 HL091929, R01091929-01A1S1-the American Recovery and Reinvestment Act Administrative Supplement, and R01 HL 090589 (to S. H.); and R01 DK 83389 and R01 DK 52356 (to J. B.). This work was also supported by a grant from the Florida Bankhead Coley Research Foundation (to Y. Q.). Supported by the Intramural Research programs, NIDDK, National Institutes of Health.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2001, GENE DEV, V15, P827; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hamiche A, 2004, METHOD ENZYMOL, V377, P353; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kobayashi M, 2007, J BIOCHEM, V142, P1, DOI 10.1093/jb/mvm122; Kransdorf EP, 2006, BLOOD, V108, P2836, DOI 10.1182/blood-2006-04-016394; Kuendgen A, 2007, CANCER-AM CANCER SOC, V110, P943, DOI 10.1002/cncr.22891; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Mahajan MC, 2007, J CELL BIOCHEM, V102, P801, DOI 10.1002/jcb.21507; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Snow JW, 2009, J BIOL CHEM, V284, P29310, DOI 10.1074/jbc.M109.043497; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; TSIFTSOGLOU AS, 1985, ANTICANCER RES, V5, P81; Valverde-Garduno V, 2004, BLOOD, V104, P3106, DOI 10.1182/blood-2004-04-1333; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	71	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40279	40291		10.1074/jbc.M112.349704	http://dx.doi.org/10.1074/jbc.M112.349704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23014989	Green Published, hybrid			2022-12-25	WOS:000311448800020
J	East, MP; Bowzard, JB; Dacks, JB; Kahn, RA				East, Michael P.; Bowzard, J. Bradford; Dacks, Joel B.; Kahn, Richard A.			ELMO Domains, Evolutionary and Functional Characterization of a Novel GTPase-activating Protein (GAP) Domain for Arf Protein Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; LIPID DROPLETS; CELL-MIGRATION; C-ELEGANS; CRKII/DOCK180/RAC PATHWAY; MAXIMUM-LIKELIHOOD; BINDING PROTEINS; MAMMALIAN-CELLS; CANDIDATE GENE; MIXED MODELS	The human family of ELMO domain-containing proteins (ELMODs) consists of six members and is defined by the presence of the ELMO domain. Within this family are two subclassifications of proteins, based on primary sequence conservation, protein size, and domain architecture, deemed ELMOD and ELMO. In this study, we used homology searching and phylogenetics to identify ELMOD family homologs in genomes from across eukaryotic diversity. This demonstrated not only that the protein family is ancient but also that ELMOs are potentially restricted to the supergroup Opisthokonta (Metazoa and Fungi), whereas proteins with the ELMOD organization are found in diverse eukaryotes and thus were likely the form present in the last eukaryotic common ancestor. The segregation of the ELMO clade from the larger ELMOD group is consistent with their contrasting functions as unconventional Rac1 guanine nucleotide exchange factors and the Arf family GTPase-activating proteins, respectively. We used unbiased, phylogenetic sorting and sequence alignments to identify the most highly conserved residues within the ELMO domain to identify a putative GAP domain within the ELMODs. Three independent but complementary assays were used to provide an initial characterization of this domain. We identified a highly conserved arginine residue critical for both the biochemical and cellular GAP activity of ELMODs. We also provide initial evidence of the function of human ELMOD1 as an Arf family GAP at the Golgi. These findings provide the basis for the future study of the ELMOD family of proteins and a new avenue for the study of Arf family GTPases.	[East, Michael P.; Bowzard, J. Bradford; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dacks, Joel B.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	Emory University; University of Alberta	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; Dacks, Joel/AAE-3308-2021	Kahn, Richard/0000-0002-0259-0601; Dacks, Joel/0000-0003-4520-5694	National Institutes of Health [R01-GM090158]; NINDS [P30-NS055077]; American Heart Association [09PRE2140029]; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures Discovery grant; New Faculty award; Canada Research Chairs Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures Discovery grant; New Faculty award; Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM090158 (to R. A. K.) and Grant P30-NS055077 from NINDS (to the Viral Vector and Microscopy Cores of the Emory Neuroscience Core Facilities). This work was also supported by American Heart Association Grant 09PRE2140029 (to M. P. E.), Natural Sciences and Engineering Research Council of Canada, and an Alberta Innovates Technology Futures Discovery grant and New Faculty award (to J. B. D.).; Recipient of support from the Canada Research Chairs Program.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2010, MOL MEMBR BIOL, V27, P469, DOI 10.3109/09687688.2010.521201; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Graham DJ, 2011, CURR BIOL, V21, pR914, DOI 10.1016/j.cub.2011.10.003; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Hommel A, 2010, MOL CELL BIOL, V30, P1231, DOI 10.1128/MCB.01269-09; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1991, J BIOL CHEM, V266, P15595; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kalantari F, 2010, MOL MEMBR BIOL, V27, P462, DOI 10.3109/09687688.2010.538936; Katz LA, 2011, PROTIST, V162, P762, DOI 10.1016/j.protis.2011.05.002; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Sevajol M, 2012, BIOCHIMIE, V94, P823, DOI 10.1016/j.biochi.2011.11.014; Shimazaki A, 2006, KIDNEY INT, V70, P1769, DOI 10.1038/sj.ki.5001939; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Yang C, 2011, CELL SIGNAL, V23, P99, DOI 10.1016/j.cellsig.2010.08.008; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	74	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.417477	http://dx.doi.org/10.1074/jbc.M112.417477			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23014990	Green Published, hybrid			2022-12-25	WOS:000311233800025
J	Rol, N; Favre, L; Benyacoub, J; Corthesy, B				Rol, Nicolas; Favre, Laurent; Benyacoub, Jalil; Corthesy, Blaise			The Role of Secretory Immunoglobulin A in the Natural Sensing of Commensal Bacteria by Mouse Peyer's Patch Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; MUCOSAL HOMEOSTASIS; IGA RESPONSE; T-CELL; GUT; HOST; CD8-ALPHA(+); RECEPTOR; SUBSETS	The mammalian gastrointestinal (GI) tract harbors a diverse population of commensal species collectively known as the microbiota, which interact continuously with the host. From very early in life, secretory IgA (SIgA) is found in association with intestinal bacteria. It is considered that this helps to ensure self-limiting growth of the microbiota and hence participates in symbiosis. However, the importance of this association in contributing to the mechanisms ensuring natural host-microorganism communication is in need of further investigation. In the present work, we examined the possible role of SIgA in the transport of commensal bacteria across the GI epithelium. Using an intestinal loop mouse model and fluorescently labeled bacteria, we found that entry of commensal bacteria in Peyer's patches (PP) via the M cell pathway was mediated by their association with SIgA. Preassociation of bacteria with nonspecific SIgA increased their dynamics of entry and restored the reduced transport observed in germ-free mice known to have a marked reduction in intestinal SIgA production. Selective SIgA-mediated targeting of bacteria is restricted to the tolerogenic CD11c(+)CD11b(+)CD8(-) dendritic cell subset located in the subepithelial dome region of PPs, confirming that the host is not ignorant of its resident commensals. In conclusion, our work supports the concept that SIgA-mediated monitoring of commensal bacteria targeting dendritic cells in the subepithelial dome region of PPs represents a mechanism whereby the host mucosal immune system controls the continuous dialogue between the host and commensal bacteria.	[Rol, Nicolas; Corthesy, Blaise] CHU Vaudois, Res & Dev Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Favre, Laurent; Benyacoub, Jalil] Nestle Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne 26, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nestle SA	Corthesy, B (corresponding author), CHU Vaudois, Res & Dev Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Rol, Nicolas/0000-0002-1977-2743	Swiss Science Research Foundation [3100-138422]	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss Science Research Foundation Grant 3100-138422 (to B. C.).	Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; CEBRA JJ, 1994, ADV EXP MED BIOL, V355, P255; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chung Y, 2005, BLOOD, V106, P201, DOI 10.1182/blood-2004-11-4240; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Duc M, 2010, J BIOL CHEM, V285, P953, DOI 10.1074/jbc.M109.059220; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jiang HQ, 2004, VACCINE, V22, P805, DOI 10.1016/j.vaccine.2003.11.022; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Willing BP, 2010, GUT MICROBES, V1, P213, DOI 10.4161/gmic.1.4.12520	44	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405001	http://dx.doi.org/10.1074/jbc.M112.405001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027876	Green Published, hybrid			2022-12-25	WOS:000311233800074
J	Zandberg, WF; Kumarasamy, J; Pinto, BM; Vocadlo, DJ				Zandberg, Wesley F.; Kumarasamy, Jayakanthan; Pinto, B. Mario; Vocadlo, David J.			Metabolic Inhibition of Sialyl-Lewis X Biosynthesis by 5-Thiofucose Remodels the Cell Surface and Impairs Selectin-Mediated Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL-TRANSFERASES; INCREASED EXPRESSION; GDP-FUCOSE; ANTIGEN; OLIGOSACCHARIDES; METASTASIS; CARCINOMA; GLYCANS; ANALOGS; LIGAND	Sialyl-Lewis X (sLe(X)) is a tetrasaccharide that serves as a ligand for the set of cell adhesion proteins known as selectins. This interaction enables adhesion of leukocytes and cancer cells to endothelial cells within capillaries, resulting in their extravasation into tissues. The last step in sLe(X) biosynthesis is the alpha 1,3-fucosyltrasferase (FUT)-catalyzed transfer of an L-fucose residue to carbohydrate acceptors. Impairing FUT activity compromises leukocyte homing to sites of inflammation and renders cancer cells less malignant. Inhibition of FUTs is, consequently, of great interest, but efforts to generate glycosyltransferase inhibitors, including FUT inhibitors, has proven challenging. Here we describe a metabolic engineering strategy to inhibit the biosynthesis of sLe(X) in cancer cells using peracetylated 5-thio-L-fucose (5T-Fuc). We show that 5T-Fuc is taken up by cancer cells and then converted into a sugar nucleotide analog, GDP-5T-Fuc, that blocks FUT activity and limits sLe(X) presentation on HepG2 cells with an EC50 in the low micromolar range. GDP-5T-Fuc itself does not get transferred by either FUT3 or FUT7 at a measurable rate. We further demonstrate that treatment of cells with 5T-Fuc impaired their adhesive properties to immobilized adhesion molecules and human endothelial cells. 5T-Fuc, therefore, is a useful probe that can be used to modulate sLe(X) levels in cells to evaluate the consequences of inhibiting FUT-mediated sLe(X) formation. These data also reveal the utility of using sugar analogues that lead to formation of donor substrate analogues within cells as a general approach to blocking glycosyltransferases in cells.	[Zandberg, Wesley F.; Kumarasamy, Jayakanthan; Pinto, B. Mario; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Kumarasamy, Jayakanthan/0000-0002-7926-9752	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Akamatsu S, 1996, GLYCOCONJUGATE J, V13, P1021, DOI 10.1007/BF01053198; Barthel SR, 2008, GLYCOBIOLOGY, V18, P806, DOI 10.1093/glycob/cwn070; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Clarke JL, 1996, J BIOL CHEM, V271, P10317, DOI 10.1074/jbc.271.17.10317; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; DENNIS JW, 1986, CANCER RES, V46, P5131; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Foster MM, 2003, CANCER RES, V63, P2775; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grabenhorst E, 1998, J BIOL CHEM, V273, P30985, DOI 10.1074/jbc.273.47.30985; Gravel P., 2002, PROTEIN PROTOCOLS HD, P779; HASHIMOTO H, 1990, J CARBOHYD CHEM, V9, P683, DOI 10.1080/07328309008543863; Hiller KM, 2000, MOL CARCINOGEN, V27, P280, DOI 10.1002/(SICI)1098-2744(200004)27:4<280::AID-MC6>3.0.CO;2-L; HOFF SD, 1989, CANCER RES, V49, P6883; Johnson PC, 1995, BIOREMED SER, V3, P1; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Koji HT, 2003, ANAL SCI, V19, P85, DOI 10.2116/analsci.19.85; Kretzschmar G, 1998, TETRAHEDRON, V54, P3765, DOI 10.1016/S0040-4020(98)00105-7; Luhn K, 2001, BLOOD, V97, P330, DOI 10.1182/blood.V97.1.330; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; MEHTA S, 1995, J AM CHEM SOC, V117, P9783, DOI 10.1021/ja00144a001; MUROI K, 1992, BLOOD, V79, P713; NAKAGOE T, 1993, CANCER, V72, P2323, DOI 10.1002/1097-0142(19931015)72:8<2323::AID-CNCR2820720807>3.0.CO;2-C; NAKAMORI S, 1993, CANCER RES, V53, P3632; NARITA T, 1993, CANCER, V71, P3044, DOI 10.1002/1097-0142(19930515)71:10<3044::AID-CNCR2820711026>3.0.CO;2-R; Norris AJ, 2004, BIOORG MED CHEM LETT, V14, P571, DOI 10.1016/j.bmcl.2003.12.003; Numahata K, 2002, CANCER, V94, P673, DOI 10.1002/cncr.10268; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Rinnbauer M, 2003, GLYCOBIOLOGY, V13, P435, DOI 10.1093/glycob/cwg043; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; St Hill CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016281; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; Togayachi A, 1999, INT J CANCER, V83, P70, DOI 10.1002/(SICI)1097-0215(19990924)83:1<70::AID-IJC14>3.0.CO;2-K; Trinchera M, 2011, INT J BIOCHEM CELL B, V43, P130, DOI 10.1016/j.biocel.2010.10.004; Tsuruta O, 2003, J ORG CHEM, V68, P6400, DOI 10.1021/jo0300035; Tsuruta O, 1999, BIOORG MED CHEM LETT, V9, P1019, DOI 10.1016/S0960-894X(99)00124-9; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Weston BW, 1999, CANCER RES, V59, P2127; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688; Zandberg WF, 2012, CHEMBIOCHEM, V13, P392, DOI 10.1002/cbic.201100647; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	52	35	39	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.403568	http://dx.doi.org/10.1074/jbc.M112.403568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019334	Green Published, hybrid			2022-12-25	WOS:000311233800069
J	Cao, DS; Wang, CB; Tang, RH; Chen, HQ; Zhang, Z; Tatsuguchi, M; Wang, DZ				Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Chen, Huaqun; Zhang, Zheng; Tatsuguchi, Mariko; Wang, Da-Zhi			Acetylation of Myocardin Is Required for the Activation of Cardiac and Smooth Muscle Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR-B; CARDIOVASCULAR DEVELOPMENT; HISTONE ACETYLTRANSFERASES; DNA-BINDING; IN-VIVO; DIFFERENTIATION; EXPRESSION; MYOD; COACTIVATORS	Myocardin belongs to the SAF-A/B, Acinus, PIAS (SAP) domain family of transcription factors and is specifically expressed in cardiac and smooth muscle. Myocardin functions as a transcriptional coactivator of SRF and is sufficient and necessary for smooth muscle gene expression. We have previously found that myocardin induces the acetylation of nucleosomal histones surrounding SRF-binding sites in the control regions of cardiac and smooth muscle genes through recruiting chromatin-modifying enzyme p300, yet no studies have determined whether myocardin itself is similarly modified. In this study, we show that myocardin is a direct target for p300-mediated acetylation. p300 acetylates lysine residues at the N terminus of the myocardin protein. Interestingly, a direct interaction between p300 and myocardin, which is mediated by the C terminus of myocardin, is required for the acetylation event. Acetylation of myocardin by p300 enhances the association of myocardin and SRF as well as the formation of the myocardin-SRF-CArG box ternary complex. Conversely, acetylation of myocardin decreases the binding of histone deacetylase 5 (HDAC5) to myocardin. Acetylation of myocardin is required for myocardin to activate smooth muscle genes. Our study demonstrates that acetylation plays a key role in modulating myocardin function in controlling cardiac and smooth muscle gene expression.	[Chen, Huaqun; Zhang, Zheng; Tatsuguchi, Mariko; Wang, Da-Zhi] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA; [Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Tatsuguchi, Mariko; Wang, Da-Zhi] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Tatsuguchi, Mariko; Wang, Da-Zhi] Univ N Carolina, McAllister Heart Inst, Sch Med, Chapel Hill, NC 27599 USA; [Chen, Huaqun] Nanjing Normal Univ, Sch Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Zheng] Chongqing Med Univ, Dept Cell Biol & Genet, Chongqing 400016, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing Normal University; Chongqing Medical University	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, 320 Longwood Ave, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	zhang, zheng/AAG-9966-2020	Tang, Ruhang/0000-0003-4918-3525	National Institutes of Health from the NHLBI [HL085635, HL075251]; March of Dimes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075251, R01HL085635] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); March of Dimes Foundation(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085635 and HL075251 from the NHLBI. This work was also supported by the March of Dimes Foundation.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Feng BA, 2008, AM J PHYSIOL-ENDOC M, V294, pE1119, DOI 10.1152/ajpendo.00029.2008; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Hasselgren PO, 2007, J CELL PHYSIOL, V213, P679, DOI 10.1002/jcp.21190; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Olson Eric N, 2006, Novartis Found Symp, V274, P3; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, J BIOL CHEM, V276, P44502, DOI 10.1074/jbc.M106501200; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	47	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38495	38504		10.1074/jbc.M112.353649	http://dx.doi.org/10.1074/jbc.M112.353649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007391	hybrid, Green Published			2022-12-25	WOS:000310982800009
J	Hinrichs, MH; Jalal, A; Brenner, B; Mandelkow, E; Kumar, S; Scholz, T				Hinrichs, Maike H.; Jalal, Avesta; Brenner, Bernhard; Mandelkow, Eckhard; Kumar, Satish; Scholz, Tim			Tau Protein Diffuses along the Microtubule Lattice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; KINESIN-1 MOTOR; IN-VIVO; BINDING; TUBULIN; PROCESSIVITY; MOVEMENT; NEURONS; COMPLEX	Current models for the intracellular transport of Tau protein suggest motor protein-dependent co-transport with microtubule fragments and diffusion of Tau in the cytoplasm, whereas Tau is believed to be stationary while bound to microtubules and in equilibrium with free diffusion in the cytosol. Observations that members of the microtubule-dependent kinesin family show Brownian motion along microtubules led us to hypothesize that diffusion along microtubules could also be relevant in the case of Tau. We used single-molecule total internal reflection fluorescence microscopy to probe for diffusion of individual fluorescently labeled Tau molecules along microtubules. This allowed us to avoid the problem that microtubule-dependent diffusion could be masked by excess of labeled Tau in solution that might occur in in vivo overexpression experiments. We found that approximately half of the individually detected Tau molecules moved bidirectionally along microtubules over distances up to several micrometers. Diffusion parameters such as diffusion coefficient, interaction time, and scanned microtubule length did not change with Tau concentration. Tau binding and diffusion along the microtubule lattice, however, were sensitive to ionic strength and pH and drastically reduced upon enzymatic removal of the negatively charged C termini of tubulin. We propose one-dimensional Tau diffusion guided by the microtubule lattice as one possible additional mechanism for Tau distribution. By such one-dimensional microtubule lattice diffusion, Tau could be guided to both microtubule ends, i.e. the sites where Tau is needed during microtubule polymerization, independently of directed motor-dependent transport. This could be important in conditions where active transport along microtubules might be compromised.	[Hinrichs, Maike H.; Jalal, Avesta; Brenner, Bernhard; Scholz, Tim] Hannover Med Sch, Inst Mol & Cell Physiol, D-30625 Hannover, Germany; [Mandelkow, Eckhard; Kumar, Satish] German Ctr Neurodegenerat Dis, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Mandelkow, Eckhard; Kumar, Satish] CAESAR Res Ctr, D-53175 Bonn, Germany	Hannover Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Scholz, T (corresponding author), Hannover Med Sch, Inst Mol & Cell Physiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	scholz.tim@mh-hannover.de	Scholz, Tim/A-7798-2013; Kumar, Satish/AAF-3112-2019	Kumar, Satish/0000-0002-2993-3694; Scholz, Tim/0000-0002-2127-9843	Deutsche Forschungsgemeinschaft Research Unit [FOR629]	Deutsche Forschungsgemeinschaft Research Unit(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Research Unit FOR629 grants (to T. S. and E. M.).	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; BURTON RF, 1983, COMP BIOCHEM PHYS B, V76, P663, DOI 10.1016/0305-0491(83)90375-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Mercken M, 1995, J NEUROSCI, V15, P8259; Minoura I, 2010, BIOPHYS J, V98, P1589, DOI 10.1016/j.bpj.2009.12.4323; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; NAKATA T, 1993, BIOPHYS J, V65, P2504, DOI 10.1016/S0006-3495(93)81304-3; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rump A, 2011, J CELL SCI, V124, P2521, DOI 10.1242/jcs.084335; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Scholz T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/9/095707; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Steffen W, 1996, J STRUCT BIOL, V117, P227, DOI 10.1006/jsbi.1996.0087; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Zimmermann D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025473	54	91	91	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38559	38568		10.1074/jbc.M112.369785	http://dx.doi.org/10.1074/jbc.M112.369785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019339	hybrid, Green Published			2022-12-25	WOS:000310982800016
J	Huelsenbeck, SC; Schorr, A; Roos, WP; Huelsenbeck, J; Henninger, C; Kaina, B; Fritz, G				Huelsenbeck, Stefanie C.; Schorr, Anne; Roos, Wynand P.; Huelsenbeck, Johannes; Henninger, Christian; Kaina, Bernd; Fritz, Gerhard			Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; SMALL-MOLECULE INHIBITOR; HUMAN ENDOTHELIAL-CELLS; CLINICAL HEART-FAILURE; TERM-FOLLOW-UP; IONIZING-RADIATION; DOXORUBICIN CARDIOTOXICITY; H2AX PHOSPHORYLATION; RHO GTPASES	To investigate the potency of the topoisomerase II (topo II) poisons doxorubicin and etoposide to stimulate the DNA damage response (DDR), S139 phosphorylation of histone H2AX (gamma H2AX) was analyzed using rat cardiomyoblast cells (H9c2). Etoposide caused a dose-dependent increase in the gamma H2AX level as shown by Western blotting. By contrast, the doxorubicin response was bell-shaped with high doses failing to increase H2AX phosphorylation. Identical results were obtained by immunohistochemical analysis of gamma H2AX focus formation, comet assay-based DNA strand break analysis, and measuring the formation of the topo II-DNA cleavable complex. At low dose, doxorubicin activated ataxia telangiectasia mutated (ATM) but not ATM and Rad3-related (ATR). Both the lipid-lowering drug lovastatin and the Rac1-specific inhibitor NSC23766 attenuated doxorubicin- and etoposide-stimulated H2AX phosphorylation, induction of DNA strand breaks, and topo II-DNA complex formation. Lovastatin and NSC23766 acted in an additive manner. They did not attenuate doxorubicin- induced increase in p-ATM and p-Chk2 levels. DDR stimulated by topo II poisons was partially blocked by inhibition of type I p21-associated kinases. DDR evoked by the topoisomerase I poison topotecan remained unaffected by lovastatin. The data show that the mechanisms involved in DDR stimulated by topo II poisons are agent-specific with anthracyclines lacking DDR-stimulating activity at high doses. Pharmacological inhibition of Rac1 signaling counteracts doxorubicin- and etoposide-stimulated DDR by disabling the formation of the topo II-DNA cleavable complex. Based on the data we suggest that Rac1-regulated mechanisms are required for DNA damage induction and subsequent activation of the DDR following treatment with topo II but not topo I poisons.	[Schorr, Anne; Henninger, Christian; Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, D-40225 Dusseldorf, Germany; [Huelsenbeck, Stefanie C.; Roos, Wynand P.; Huelsenbeck, Johannes; Kaina, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Toxicol, D-55131 Mainz, Germany	Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz	Fritz, G (corresponding author), Univ Dusseldorf, Inst Toxicol, Moorenstr 5, D-40225 Dusseldorf, Germany.	fritz@uni-duesseldorf.de	Kaina, Bernd/AAE-4692-2020; Roos, Wynand/B-4846-2008	Roos, Wynand/0000-0002-0474-7414; Henninger, Christian/0000-0001-6050-1518	Deutsche Krebshilfe Grant [107361]	Deutsche Krebshilfe Grant(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 107361.	Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0; Corna G, 2004, J BIOL CHEM, V279, P13738, DOI 10.1074/jbc.M310106200; Coso OA, 1996, J BIOL CHEM, V271, P3963; Damrot J, 2006, BRIT J PHARMACOL, V149, P988, DOI 10.1038/sj.bjp.0706953; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Feleszko W, 2000, CLIN CANCER RES, V6, P2044; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Fogli S, 2004, FASEB J, V18, P664, DOI 10.1096/fj.03-0724rev; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Haydont V, 2007, INT J RADIAT ONCOL, V68, P1471, DOI 10.1016/j.ijrobp.2007.03.044; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huelsenbeck J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.65; Jefferies CA, 2000, J BIOL CHEM, V275, P3114, DOI 10.1074/jbc.275.5.3114; Jeggo P, 2006, RADIAT PROT DOSIM, V122, P124, DOI 10.1093/rpd/ncl495; Kalfalah FM, 2011, MOL NUTR FOOD RES, V55, pS127, DOI 10.1002/mnfr.201000509; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; MEYER P, 1993, TOXICOL LETT, V67, P325, DOI 10.1016/0378-4274(93)90065-6; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; Nubel T, 2006, CLIN CANCER RES, V12, P933, DOI 10.1158/1078-0432.CCR-05-1903; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pernice F, 2006, EUR J PHARMACOL, V532, P223, DOI 10.1016/j.ejphar.2006.01.003; Rashid M, 2009, CIRC J, V73, P361, DOI 10.1253/circj.CJ-08-0817; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seiter Karen, 2005, Expert Opin Drug Saf, V4, P219, DOI 10.1517/14740338.4.2.219; Simunek T, 2009, PHARMACOL REP, V61, P154; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; Woodcock SA, 2010, CURR BIOL, V20, P669, DOI 10.1016/j.cub.2010.02.033; Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	64	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38590	38599		10.1074/jbc.M112.377903	http://dx.doi.org/10.1074/jbc.M112.377903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012366	Green Published, hybrid			2022-12-25	WOS:000310982800019
J	Moubarac, JC; Cargo, M; Receveur, O; Daniel, M				Moubarac, Jean-Claude; Cargo, Margaret; Receveur, Olivier; Daniel, Mark			Describing the Situational Contexts of Sweetened Product Consumption in a Middle Eastern Canadian Community: Application of a Mixed Method Design	PLOS ONE			English	Article							FOOD-CHOICE; PHYSICAL-ACTIVITY; VENDING MACHINES; ENERGY-INTAKE; CHOCOLATE; OBESITY; NUTRITION; ATTITUDES; DIET; QUESTIONNAIRE	Little is known about the situational contexts in which individuals consume processed sources of dietary sugars. This study aimed to describe the situational contexts associated with the consumption of sweetened food and drink products in a Catholic Middle Eastern Canadian community. A two-stage exploratory sequential mixed-method design was employed with a rationale of triangulation. In stage 1 (n = 62), items and themes describing the situational contexts of sweetened food and drink product consumption were identified from semi-structured interviews and were used to develop the content for the Situational Context Instrument for Sweetened Product Consumption (SCISPC). Face validity, readability and cultural relevance of the instrument were assessed. In stage 2 (n = 192), a cross-sectional study was conducted and exploratory factor analysis was used to examine the structure of themes that emerged from the qualitative analysis as a means of furthering construct validation. The SCISPC reliability and predictive validity on the daily consumption of sweetened products were also assessed. In stage 1, six themes and 40-items describing the situational contexts of sweetened product consumption emerged from the qualitative analysis and were used to construct the first draft of the SCISPC. In stage 2, factor analysis enabled the clarification and/or expansion of the instrument's initial thematic structure. The revised SCISPC has seven factors and 31 items describing the situational contexts of sweetened product consumption. Initial validation of the instrument indicated it has excellent internal consistency and adequate test-retest reliability. Two factors of the SCISPC had predictive validity for the daily consumption of total sugar from sweetened products (Snacking and Energy demands) while the other factors (Socialization, Indulgence, Constraints, Visual Stimuli and Emotional needs) were rather associated to occasional consumption of these products.	[Moubarac, Jean-Claude] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Cargo, Margaret; Daniel, Mark] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Receveur, Olivier] Univ Sao Paulo, Dept Nutr, Sao Paulo, Brazil	Universite de Montreal; University of South Australia; Universidade de Sao Paulo	Moubarac, JC (corresponding author), Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Sao Paulo, Brazil.	jcmoubarac@gmail.com	Cargo, Margaret D/B-2141-2010; Moubarac, Jean-Claude/ABE-6439-2020; Daniel, Mark/A-1151-2009; Moubarac, Jean-Claude/J-8235-2014	Daniel, Mark/0000-0001-9112-134X				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Ahern K., 2016, INT J QUAL METHODS, V1, P70, DOI [10.1177/160940690200100305, DOI 10.1177/160940690200100305]; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2005, PRACTICAL ASSESMENT; Anschutz DJ, 2009, APPETITE, V53, P119, DOI 10.1016/j.appet.2009.03.016; ARNOW B, 1995, INT J EAT DISORDER, V18, P79, DOI 10.1002/1098-108X(199507)18:1<79::AID-EAT2260180109>3.0.CO;2-V; Ayala GX, 2008, OBESITY, V16, P1002, DOI 10.1038/oby.2008.34; Benton D, 1998, PERS INDIV DIFFER, V24, P513, DOI 10.1016/S0191-8869(97)00215-8; Blanchet C., 2009, CONSOMMATION ALIMENT; Cepeda-Benito A, 2000, BEHAV RES THER, V38, P1125, DOI 10.1016/S0005-7967(99)00141-2; Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330; Chaput JP, 2008, PSYCHOSOM MED, V70, P797, DOI 10.1097/PSY.0b013e31818426fa; Cholestech Corporation, 2004, TECHN FOC; Christensen L, 2001, APPETITE, V36, P137, DOI 10.1006/appe.2001.0390; Corsica Joyce A, 2008, Eat Behav, V9, P447, DOI 10.1016/j.eatbeh.2008.07.004; Creswell JW, 2011, DESIGNING CONDUCTING; Devine CM, 2007, OBESITY, V15, p57S, DOI 10.1038/oby.2007.388; Devine CM, 2003, SOC SCI MED, V56, P617, DOI 10.1016/S0277-9536(02)00058-8; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Farley TA, 2010, AM J PUBLIC HEALTH, V100, P306, DOI 10.2105/AJPH.2009.178681; French SA, 2005, J NUTR, V135, P910, DOI 10.1093/jn/135.4.910; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Garriguet Didier, 2007, Health Rep, V18, P17; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Guba E., 1989, 4 GENERATION EVALUAT; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hassan-Wassef H, 2004, East Mediterr Health J, V10, P898; Hattersley L, 2009, PUBLIC HEALTH NUTR, V12, P1816, DOI 10.1017/S136898000800462X; Health Canada, 2010, CAN NUTR FIL VERS 20; Hendel-Paterson M, 2004, J AM DIET ASSOC, V104, P1597, DOI 10.1016/j.jada.2004.07.003; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; HETHERINGTON MM, 1995, PHYSIOL BEHAV, V57, P27, DOI 10.1016/0031-9384(94)00199-F; Issa C, 2009, INT J FOOD SCI NUTR, V60, P285, DOI 10.1080/09637480903107700; Jabs J, 2006, APPETITE, V47, P196, DOI 10.1016/j.appet.2006.02.014; Jaeger SR, 2009, APPETITE, V52, P318, DOI 10.1016/j.appet.2008.11.004; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Killaspy H, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-35; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; Liu Richard, 2010, Open Med, V4, pe143; Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425; Lofland J, 2006, ANAL SOCIAL SETTINGS, V4th; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Macht M, 2007, J NERV MENT DIS, V195, P1024, DOI 10.1097/NMD.0b013e31815c0878; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; Marquis M, 2005, CAN J DIET PRACT RES, V66, P77, DOI 10.3148/66.2.2005.77; MCKENZIE TL, 1991, J APPL BEHAV ANAL, V24, P141, DOI 10.1901/jaba.1991.24-141; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moubarac J-C, 2010, ETUDE COMPORTEMENT C; Moubarac J-C, 2011, WORLD NUTR, V3, P62; Muller J, 2008, APPETITE, V50, P499, DOI 10.1016/j.appet.2007.10.008; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Onwuegbuzie AJ, 2010, J MIX METHOD RES, V4, P56, DOI 10.1177/1558689809355805; Ovaskainen ML, 2006, EUR J CLIN NUTR, V60, P494, DOI 10.1038/sj.ejcn.1602343; Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763; Poulain J-P, 2002, MANAGER AUJOURDHUI A; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; Sabate J, 2004, BRIT J NUTR, V92, P199, DOI 10.1079/BJN20041229; Sallis JF, 2009, AM J PREV MED, V36, pS72, DOI 10.1016/j.amepre.2008.10.006; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schachter AR, 1974, OBESE HUMAN RATS; Statistics Canada, 2007, AR COMM 2007; Statistics Canada, 2009, ENQ SANT COLL CAN CY; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Stroebele N, 2004, NUTRITION, V20, P821, DOI 10.1016/j.nut.2004.05.012; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Vallianatos H., 2008, Food, Culture & Society, V11, P355, DOI 10.2752/175174408X347900; VANSTRIEN T, 1986, INT J OBESITY, V10, P29; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17; WHO, 2003, DIET NUTR PREVENTION, V916; Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007; World Cancer Research Fund/American Institute for Cancer Research, 2009, POL ACT CANC PREV FO; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	88	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44738	10.1371/journal.pone.0044738	http://dx.doi.org/10.1371/journal.pone.0044738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23028597	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000309392800014
J	Rodt, T; Luepke, M; Boehm, C; Hueper, K; Halter, R; Glage, S; Hoy, L; Wacker, F; Borlak, J; von Falck, C				Rodt, Thomas; Luepke, Matthias; Boehm, Claudia; Hueper, Katja; Halter, Roman; Glage, Silke; Hoy, Ludwig; Wacker, Frank; Borlak, Juergen; von Falck, Christian			Combined Micro-PET/Micro-CT Imaging of Lung Tumours in SPC-raf and SPC-myc Transgenic Mice	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CANCER; PET; ADENOCARCINOMAS; QUANTIFICATION; IRRADIATION; PROGRESSION; BIOMARKERS; RODENTS; PHANTOM	Introduction SPC-raf and SPC-myc transgenic mice develop disseminated and circumscribed lung adenocarcinoma respectively, allowing for assessment of carcinogenesis and treatment strategies. The purpose of this study was to investigate the technical feasibility, the correlation of initial findings to histology and the administered radiation dose of combined micro-PET/micro-CT in these animal models. Material and Methods: 14 C57BL/6 mice (4 nontransgenic, 4 SPC-raf transgenic, 6 SPC-myc transgenic) were examined using micro-CT and F-18-Fluoro-deoxyglucose micro-PET in-vivo. Micro-PET data was corrected for random events and scatter prior to reconstruction with a 3D-FORE/2D-OSEM iterative algorithm. Rigid micro-PET/micro-CT registration was performed. Tumour-to-non-tumour ratios were calculated for different lung regions and focal lesions. Diffuse tumour growth was quantified using a semiautomated micro-CT segmentation routine reported earlier. Regional histologic tumour load was assessed using a 4-point rating scale. Gamma radiation dose was determined using thermoluminescence dosimeters. Results: Micro-CT allowed visualisation of diffuse and circumscribed tumours in SPC-raf and SPC-myc transgenic animals along with morphology, while micro-PET provided information on metabolism, but lacked morphologic detail. Mean tumour-to-non-tumour ratio was 2.47 for circumscribed lesions. No significant correlation could be shown between histological tumour load and tumour-to-nontumour ratio for diffuse tumours in SPC-raf transgenic animals. Calculation of the expected dose based on gamma dosimetry yielded approximately 140 mGy/micro-PET examination additional to approximately 200 mGy due to micro-CT. Conclusions: Combined micro-PET/micro-CT imaging allows for in-vivo assessment of lung tumours in SPC-raf and SPC-myc transgenic mice. The technique has potential for the evaluation of carcinogenesis and treatment strategies in circumscribed lung tumours.	[Rodt, Thomas; Hueper, Katja; Wacker, Frank; von Falck, Christian] Hannover Med Sch, Dept Diagnost & Intervent Radiol, D-3000 Hannover, Germany; [Luepke, Matthias; Boehm, Claudia] Univ Vet Med Hannover, Hannover, Germany; [Halter, Roman] Fraunhofer Inst Toxicol & Expt Med, Dept Pharmaceut Res & Med Biotechnol, Hannover, Germany; [Glage, Silke] Hannover Med Sch, Dept Lab Anim Sci, D-3000 Hannover, Germany; [Hoy, Ludwig] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Inst Pharmaco & Toxicogenom, D-3000 Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Fraunhofer Gesellschaft; Hannover Medical School; Hannover Medical School; Hannover Medical School	Rodt, T (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, D-3000 Hannover, Germany.	Rodt.Thomas@mh-hannover.de	von Falck, Christian/AAO-2108-2020; Hueper, Katja/J-9566-2016	Hueper, Katja/0000-0002-3195-4400	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The publication of this study is supported by the German Research Foundation project "Open Access Publication". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2003, MOL CANCER RES, V1, P445; Bartling SH, 2010, METHODS, V50, P42, DOI 10.1016/j.ymeth.2009.07.006; Chatterji B, 2007, PROTEOMICS, V7, P3980, DOI 10.1002/pmic.200700290; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Day RM, 2008, J RADIAT RES, V49, P361, DOI 10.1269/jrr.07121; Ehrhardt A, 2003, J CANCER RES CLIN, V129, P71, DOI 10.1007/s00432-002-0400-z; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; Fei BW, 2006, MED PHYS, V33, P753, DOI 10.1118/1.2163831; Ford NL, 2005, MED PHYS, V32, P2888, DOI 10.1118/1.2013007; Funk T, 2004, MED PHYS, V31, P2680, DOI 10.1118/1.1781553; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Guo WY, 2007, NUCL MED COMMUN, V28, P804, DOI 10.1097/MNM.0b013e3282d25a0d; Johnston SM, 2010, P SOC PHOTO OPT INST, V7622; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Kreissl MC, 2006, J NUCL MED, V47, P974; Kuntz J, 2010, PHYS MED BIOL, V55, P2069, DOI 10.1088/0031-9155/55/7/018; Lee YZ, 2011, ACAD RADIOL, V18, P588, DOI 10.1016/j.acra.2010.11.022; Memon AA, 2009, CANCER RES, V69, P873, DOI 10.1158/0008-5472.CAN-08-3118; MILLER GG, 1986, INT J RADIAT ONCOL, V12, P1971, DOI 10.1016/0360-3016(86)90134-3; Namati E, 2010, MED PHYS, V37, P4793, DOI 10.1118/1.3476454; Ramasamy K, 2011, CLIN CANCER RES, V17, P753, DOI 10.1158/1078-0432.CCR-10-2290; Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; Rodt T, 2009, FRONT BIOSCI-LANDMRK, V14, P1939, DOI 10.2741/3353; Rutters H, 2006, PROTEOMICS, V6, P3127, DOI 10.1002/pmic.200500188; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; Taschereau R, 2007, MED PHYS, V34, P1026, DOI 10.1118/1.2558115; von Falck C, 2009, FRONT BIOSCI-LANDMRK, V14, P2193, DOI 10.2741/3371; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Zeraatkar N, 2011, MED PHYS, V38, P1217, DOI 10.1118/1.3547721	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44427	10.1371/journal.pone.0044427	http://dx.doi.org/10.1371/journal.pone.0044427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028537	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800008
J	Kita, Y; Takamura, T; Misu, H; Ota, T; Kurita, S; Takeshita, Y; Uno, M; Matsuzawa-Nagata, N; Kato, K; Ando, H; Fujimura, A; Hayashi, K; Kimura, T; Ni, YH; Otoda, T; Miyamoto, K; Zen, Y; Nakanuma, Y; Kaneko, S				Kita, Yuki; Takamura, Toshinari; Misu, Hirofumi; Ota, Tsuguhito; Kurita, Seiichiro; Takeshita, Yumie; Uno, Masafumi; Matsuzawa-Nagata, Naoto; Kato, Ken-ichiro; Ando, Hitoshi; Fujimura, Akio; Hayashi, Koji; Kimura, Toru; Ni, Yinhua; Otoda, Toshiki; Miyamoto, Ken-ichi; Zen, Yoh; Nakanuma, Yasuni; Kaneko, Shuichi			Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; NECROSIS-FACTOR-ALPHA; PLACEBO-CONTROLLED TRIAL; TYPE-2 DIABETIC-PATIENTS; HEPATIC STELLATE CELLS; INSULIN-RESISTANCE; PROTEIN-KINASE; GENE-EXPRESSION; VITAMIN-E	Background: Optimal treatment for nonalcoholic steatohepatitis (NASH) has not yet been established, particularly for individuals without diabetes. We examined the effects of metformin, commonly used to treat patients with type 2 diabetes, on liver pathology in a non-diabetic NASH mouse model. Methodology/Principal Findings: Eight-week-old C57BL/6 mice were fed a methionine-and choline-deficient plus high fat (MCD+HF) diet with or without 0.1% metformin for 8 weeks. Co-administration of metformin significantly decreased fasting plasma glucose levels, but did not affect glucose tolerance or peripheral insulin sensitivity. Metformin ameliorated MCD+HF diet-induced hepatic steatosis, inflammation, and fibrosis. Furthermore, metformin significantly reversed hepatic steatosis and inflammation when administered after the development of experimental NASH. Conclusions/Significance: These histological changes were accompanied by reduced hepatic triglyceride content, suppressed hepatic stellate cell activation, and the downregulation of genes involved in fatty acid metabolism, inflammation, and fibrogenesis. Metformin prevented and reversed steatosis and inflammation of NASH in an experimental non-diabetic model without affecting peripheral insulin resistance.	[Kita, Yuki; Takamura, Toshinari; Misu, Hirofumi; Ota, Tsuguhito; Kurita, Seiichiro; Takeshita, Yumie; Uno, Masafumi; Kato, Ken-ichiro; Ni, Yinhua; Otoda, Toshiki; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9201192, Japan; [Matsuzawa-Nagata, Naoto; Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa 9201192, Japan; [Ando, Hitoshi; Fujimura, Akio] Jichi Med Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Shimotsuke, Tochigi, Japan; [Hayashi, Koji; Kimura, Toru] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Osaka, Japan; [Zen, Yoh; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University; Jichi Medical University; Dainippon Sumitomo Pharmaceutical Company; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9201192, Japan.		NAGATA, Naoto/D-9261-2012; ANDO, Hitoshi/O-8199-2016; Yinhua, Ni/H-3079-2015	NAGATA, Naoto/0000-0002-2389-2334; ANDO, Hitoshi/0000-0001-6179-9993; Yinhua, Ni/0000-0001-7738-5971	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23591301, B-23791022]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C-23591301 to TT), and a Grant-in-aid for Young Scientists (B-23791022 to HM) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; ANFOSSO F, 1993, J CLIN INVEST, V91, P2185, DOI 10.1172/JCI116445; Basu R, 2008, DIABETES, V57, P24, DOI 10.2337/db07-0827; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Caligiuri A, 2008, HEPATOLOGY, V47, P668, DOI 10.1002/hep.21995; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; CLARKE SD, 1993, J ANIM SCI, V71, P1957, DOI 10.2527/1993.7171957x; Ersoy C, 2008, DIABETES RES CLIN PR, V81, P56, DOI 10.1016/j.diabres.2008.02.006; Hamaguchi E, 2003, J PHARMACOL EXP THER, V307, P987, DOI 10.1124/jpet.103.054346; Hamaguchi E, 2010, DIABETES CARE, V33, P284, DOI 10.2337/dc09-0148; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Ota S, 2009, BIOCH BIOPHYS RES CO; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stojanovic VR, 2012, SCI WORLD J, DOI 10.1100/2012/845046; Takamura T, 2004, DIABETOLOGIA, V47, P638, DOI 10.1007/s00125-004-1366-y; Takamura T, 2008, OBESITY SILVER SPRIN; Takeshita Y, 2006, METABOLISM, V55, P1464, DOI 10.1016/j.metabol.2006.06.016; Takeshita Y, 2008, EUR J PHARMACOL, V579, P426, DOI 10.1016/j.ejphar.2007.11.016; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	114	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43056	10.1371/journal.pone.0043056	http://dx.doi.org/10.1371/journal.pone.0043056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028442	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900004
J	Grueber, CE; Wallis, GP; King, TM; Jamieson, IG				Grueber, Catherine E.; Wallis, Graham P.; King, Tania M.; Jamieson, Ian G.			Variation at Innate Immunity Toll-Like Receptor Genes in a Bottlenecked Population of a New Zealand Robin	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL-SELECTION; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; INFECTIOUS-DISEASE; NEW-GENERATION; 2 TLR2; MHC; EVOLUTION; POLYMORPHISMS	Toll-like receptors (TLRs) are an ancient family of genes encoding transmembrane proteins that bind pathogen-specific molecules and initiate both innate and adaptive aspects of the immune response. Our goal was to determine whether these genes show sufficient genetic diversity in a bottlenecked population to be a useful addition or alternative to the more commonly employed major histocompatibility complex (MHC) genotyping in a conservation genetics context. We amplified all known avian TLR genes in a severely bottlenecked population of New Zealand's Stewart Island robin (Petroica australis rakiura), for which reduced microsatellite diversity was previously observed. We genotyped 17-24 birds from a reintroduced island population (including the 12 founders) for nine genes, seven of which were polymorphic. We observed a total of 24 single-nucleotide polymorphisms overall, 15 of which were non-synonymous, representing up to five amino-acid variants at a locus. One locus (TLR1LB) showed evidence of past directional selection. Results also confirmed a passerine duplication of TLR7. The levels of TLR diversity that we observe are sufficient to justify their further use in addressing conservation genetic questions, even in bottlenecked populations.	[Grueber, Catherine E.; Wallis, Graham P.; King, Tania M.; Jamieson, Ian G.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Grueber, Catherine E.; King, Tania M.; Jamieson, Ian G.] Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	University of Otago; Massey University	Grueber, CE (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	catherine.grueber@otago.ac.nz	Jamieson, Ian G/E-1505-2011; King, Tania/C-2664-2018; Grueber, Catherine E./H-4707-2011; Wallis, Graham/E-5410-2011	Grueber, Catherine E./0000-0002-8179-1822; Wallis, Graham/0000-0002-6408-7868	Marsden Fund, University of Otago [UOO1009]; Landcare Research, University of Otago [C09X0503]; Allan Wilson Centre for Molecular Ecology and Evolution	Marsden Fund, University of Otago; Landcare Research, University of Otago; Allan Wilson Centre for Molecular Ecology and Evolution	This research received funding from the Marsden Fund (Contract no. UOO1009), Landcare Research (Contract no. C09X0503), University of Otago and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Alcaide M, 2009, CONSERV GENET, V10, P1349, DOI 10.1007/s10592-008-9653-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bergman IM, 2012, INT J IMMUNOGENET, V39, P68, DOI 10.1111/j.1744-313X.2011.01057.x; Boessenkool S, 2007, CONSERV GENET, V8, P705, DOI 10.1007/s10592-006-9219-5; Bollmer JL, 2010, J HERED, V101, P448, DOI 10.1093/jhered/esq018; Bonneaud C, 2012, MOL ECOL, V21, P2628, DOI 10.1111/j.1365-294X.2012.05551.x; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fleming C.A., 1950, T ROYAL SOC NZ, VZ78, P127; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Garrigan D, 2003, EVOLUTION, V57, P1707; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Harper G. A., 2009, Notornis, V56, P63; Hedrick P.W., 2000, GENETICS POPULATIONS; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-149; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Laws RJ, 2011, ANIM CONSERV, V14, P47, DOI 10.1111/j.1469-1795.2010.00388.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palermo S, 2009, ANIM GENET, V40, P289, DOI 10.1111/j.1365-2052.2008.01833.x; Pespeni MH, 2012, P ROY SOC B-BIOL SCI, V279, P1412, DOI 10.1098/rspb.2011.1823; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Ramasamy KT, 2011, J POULT SCI, V48, P168, DOI 10.2141/jpsa.011008; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rozen S., 1998, PRIMER3; Ruan WK, 2012, MOL BIOL REP, V39, P3419, DOI 10.1007/s11033-011-1113-7; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Smyth RP, 2010, GENE, V469, P45, DOI 10.1016/j.gene.2010.08.009; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stow AJ, 2004, MOL ECOL, V13, P443, DOI 10.1046/j.1365-294X.2003.02060.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Takaki A, 2012, IMMUNOGENETICS, V64, P15, DOI 10.1007/s00251-011-0556-2; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SS, 2007, J EVOLUTION BIOL, V20, P2035, DOI 10.1111/j.1420-9101.2007.01362.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend SM, 2012, CONSERV GENET RESOUR, V4, P633, DOI 10.1007/s12686-012-9610-0; Tschirren B, 2011, J EVOLUTION BIOL, V24, P1232, DOI 10.1111/j.1420-9101.2011.02254.x; Tschirren B, 2012, EVOLUTION, V66, P720, DOI 10.1111/j.1558-5646.2011.01473.x; Turner AK, 2012, MOL ECOL, V21, P1632, DOI 10.1111/j.1365-294X.2012.05501.x; Uematsu Satoshi, 2008, V183, P1; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Vinkler M, 2009, FOLIA ZOOL, V58, P15; Volmer C, 2011, J GEN VIROL, V92, P534, DOI 10.1099/vir.0.026443-0; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	72	59	60	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45011	10.1371/journal.pone.0045011	http://dx.doi.org/10.1371/journal.pone.0045011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024782	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100040
J	Garcia-Ayllon, MS; Millan, C; Serra-Basante, C; Bataller, R; Saez-Valero, J				Garcia-Ayllon, Maria-Salud; Millan, Cristina; Serra-Basante, Carol; Bataller, Ramon; Saez-Valero, Javier			Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; BUTYRYLCHOLINESTERASE; EXPRESSION; APOPTOSIS; CHOLINESTERASES; INDUCTION; VARIANTS; PROTEIN; PLASMA; ROLES	Background & Aims: There have been many studies on plasma butyrylcholinesterase in liver dysfunction. However, no data is available about acetylcholinesterase in human cirrhosis, although profound changes have been described in cirrhotic rat models. Methods: Human serum and liver acetylcholinesterase and its molecular forms were determined enzymatically, after butyrylcholinesterase immunodepletion. The distinct species of acetylcholinesterase, with a distinct C-terminus, were determined by western blotting, and the level of liver transcripts by real-time PCR. Liver acetylcholinesterase was also evaluated by immunocytochemistry. Results: In patients with liver cirrhosis, the activity of plasma acetylcholinesterase (rich in light species), appeared to be apparently unaffected. However, the levels of the soluble readthrough (R) acetylcholinesterase form, an acetylcholinesterase species usually associated with stress and pathology, was increased compared to controls. Human liver acetylcholinesterase activity levels were also unchanged, but protein levels of the acetylcholinesterase-R and other acetylcholinesterase subunit species were increased in the cirrhotic liver. This increase in acetylcholinesterase protein expression in the cirrhotic liver was confirmed by PCR analysis. Immunohistological examination confirmed that acetylcholinesterase immunoreactivity is increased in parenchymal cells of the cirrhotic liver. Conclusions: We demonstrate significant changes in acetylcholinesterase at the protein and mRNA levels in liver cirrhosis, with no difference in enzymatic activity. The altered expression of acetylcholinesterase protein may reflect changes in its pathophysiological role.	[Garcia-Ayllon, Maria-Salud; Serra-Basante, Carol; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Garcia-Ayllon, Maria-Salud; Serra-Basante, Carol; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Alacant, Spain; [Garcia-Ayllon, Maria-Salud] Hosp Gen Univ Elche, Unidad Invest, Elche, Spain; [Millan, Cristina; Bataller, Ramon] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain; [Bataller, Ramon] CIBERehd, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Garcia-Ayllon, MS (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain.	ms.garcia@umh.es; j.saez@umh.es	Sáez, Javier/K-5756-2014; GARCIA-AYLLON, MARIA-SALUD/M-4387-2019	Sáez, Javier/0000-0001-7480-320X; Bataller, Ramon/0000-0002-1119-7799; Garcia-Ayllon, Maria-Salud/0000-0001-5140-9752	Fundacion CIEN-Reina Sofia; Fondo de Investigaciones Sanitarias [PS09/00684, CP11/00312]; CIBERNED, Instituto de Salud Carlos III from Spain	Fundacion CIEN-Reina Sofia; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBERNED, Instituto de Salud Carlos III from Spain	This work was supported by grants from Fundacion CIEN-Reina Sofia, Fondo de Investigaciones Sanitarias (PS09/00684), and CIBERNED, Instituto de Salud Carlos III from Spain to JSV; and Fondo de Investigaciones Sanitarias (CP11/00312) to MSGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Birikh KR, 2003, P NATL ACAD SCI USA, V100, P283, DOI 10.1073/pnas.0135647100; Botella-Lopez A, 2008, INT J BIOCHEM CELL B, V40, P766, DOI 10.1016/j.biocel.2007.10.021; BURNETT W, 1960, GUT, V1, P294, DOI 10.1136/gut.1.4.294; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Cohen O, 2002, MOL PSYCHIATR, V7, P874, DOI 10.1038/sj.mp.4001103; Deutsch VR, 2002, EXP HEMATOL, V30, P1153, DOI 10.1016/S0301-472X(02)00900-1; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Dori A, 2005, CEREB CORTEX, V15, P419, DOI 10.1093/cercor/bhh145; EDWARDS JA, 1982, J NEUROCHEM, V38, P1393, DOI 10.1111/j.1471-4159.1982.tb07918.x; Garcia-Ayllon MS, 2007, J NEUROCHEM, V101, P1701, DOI 10.1111/j.1471-4159.2007.04461.x; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Garcia-Ayllon MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008701; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; GEORGE ST, 1981, EUR J BIOCHEM, V121, P177, DOI 10.1111/j.1432-1033.1981.tb06447.x; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Haertl R, 2011, J NEUROCHEM, V116, P1088, DOI 10.1111/j.1471-4159.2010.07164.x; Jennings LL, 2003, BIOCHEMISTRY-US, V42, P11083, DOI 10.1021/bi034756x; KARPEL R, 1994, EXP CELL RES, V210, P268, DOI 10.1006/excr.1994.1039; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li B, 2008, J PHARMACOL EXP THER, V324, P1146, DOI 10.1124/jpet.107.133330; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG BRAIN RES, V98, P139; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Perry C, 2007, LEUKEMIA, V21, P1472, DOI 10.1038/sj.leu.2404722; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saez-Valero J, 2002, NEUROSCI LETT, V325, P199, DOI 10.1016/S0304-3940(02)00282-3; SAEZVALERO J, 1993, J NEUROSCI RES, V35, P678, DOI 10.1002/jnr.490350610; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Small DH, 1996, NEUROCHEM INT, V28, P453, DOI 10.1016/0197-0186(95)00099-2; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; STIEGER S, 1987, J NEUROCHEM, V49, P460, DOI 10.1111/j.1471-4159.1987.tb02887.x; Weber U, 1999, CHEM-BIOL INTERACT, V119, P341, DOI 10.1016/S0009-2797(99)00045-9; Xie J, 2011, J MOL CELL BIOL, V3, P250, DOI 10.1093/jmcb/mjq047; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079	42	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44598	10.1371/journal.pone.0044598	http://dx.doi.org/10.1371/journal.pone.0044598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028565	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700025
J	Ivanov, SV; Panaccione, A; Brown, B; Guo, Y; Moskaluk, CA; Wick, MJ; Brown, JL; Ivanova, AV; Issaeva, N; El-Naggar, AK; Yarbrough, WG				Ivanov, S. V.; Panaccione, A.; Brown, B.; Guo, Y.; Moskaluk, C. A.; Wick, M. J.; Brown, J. L.; Ivanova, A. V.; Issaeva, N.; El-Naggar, A. K.; Yarbrough, W. G.			TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior	ONCOGENE			English	Article						TrkC; Bcl2; neurotrophin-3; migration; salivary adenoid cystic carcinoma; invasion	SALIVARY-GLAND TUMORS; TYROSINE KINASE RECEPTOR; ETV6-NTRK3 GENE FUSION; CELL-PROLIFERATION; NEUROTROPHIN RECEPTORS; NEUROBLASTOMA-CELLS; MYOEPITHELIAL CELLS; SOMATIC MUTATIONS; BREAST-CANCER; EXPRESSION	Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are limited to surgery and radiotherapy. Based on expression analysis performed on clinical specimens of salivary cancers, we identified in ACC expression of the neurotrophin-3 receptor TrkC/NTRK3, neural crest marker SOX10, and other neurologic genes. Here, we characterize TrkC as a novel ACC marker, which was highly expressed in 17 out of 18 ACC primary-tumor specimens, but not in mucoepidermoid salivary carcinomas or head and neck squamous cell carcinoma. Expression of the TrkC ligand NT-3 and Tyr-phosphorylation of TrkC detected in our study suggested the existence of an autocrine signaling loop in ACC with potential therapeutic significance. NT-3 stimulation of U2OS cells with ectopic TrkC expression triggered TrkC phosphorylation and resulted in Ras, Erk 1/2 and Akt activation, as well as VEGFR1 phosphorylation. Without NT-3, TrkC remained unphosphorylated, stimulated accumulation of phospho-p53 and had opposite effects on p-Akt and p-Erk 1/2. NT-3 promoted motility, migration, invasion, soft-agar colony growth and cytoskeleton restructuring in TrkC-expressing U2OS cells. Immunohistochemical analysis demonstrated that TrkC-positive ACC specimens also show high expression of Bcl2, a Trk target regulated via Erk 1/2, in agreement with activation of the TrkC pathway in real tumors. In normal salivary gland tissue, both TrkC and Bcl2 were expressed in myoepithelial cells, suggesting a principal role for this cell lineage in the ACC origin and progression. Sub-micromolar concentrations of a novel potent Trk inhibitor AZD7451 completely blocked TrkC activation and associated tumorigenic behaviors. Pre-clinical studies on ACC tumors engrafted in mice showed efficacy and low toxicity of AZD7451, validating our in vitro data and stimulating more research into its clinical application. In summary, we describe in ACC a previously unrecognized pro-survival neurotrophin signaling pathway and link it with cancer progression.	[Ivanov, S. V.; Panaccione, A.; Ivanova, A. V.; Issaeva, N.; Yarbrough, W. G.] Yale Univ, Sch Med, Dept Surg, Otolaryngol Sect, New Haven, CT 06510 USA; [Panaccione, A.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Brown, B.] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Brown, B.] Vanderbilt Univ, Sch Med, Barry Baker Lab Head & Neck Oncol, Nashville, TN 37212 USA; [Guo, Y.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Moskaluk, C. A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Wick, M. J.] South Texas Accelerated Res Therapeut, Sun Antonio, TX USA; [Brown, J. L.] AstraZeneca R&D Boston, Waltham, MA USA; [El-Naggar, A. K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Yarbrough, W. G.] Smilow Canc Hosp, H&N Dis Ctr, New Haven, CT USA; [Yarbrough, W. G.] Yale Canc Ctr, Mol Virol Program, New Haven, CT USA	Yale University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Virginia; AstraZeneca; University of Texas System; UTMD Anderson Cancer Center; Yale University	Ivanov, SV (corresponding author), Yale Phys Bldg,800 Howard Ave,4th Floor, New Haven, CT 06519 USA.	sergey.ivanov@yale.edu; wendell.yarbrough@yale.edu	Issaeva, Natalia/K-4577-2019	Issaeva, Natalia/0000-0001-5483-6610; Ivanov, Sergey/0000-0001-9770-7237	Adenoid Cystic Carcinoma Research Foundation; NIH from the National Institute of Dental and Craniofacial Research [5RC1DE020332-02]; Vanderbilt Ingram Cancer Center; Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences; Robert J Kleberg Jr and Helen C Kleberg Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020332] Funding Source: NIH RePORTER	Adenoid Cystic Carcinoma Research Foundation; NIH from the National Institute of Dental and Craniofacial Research; Vanderbilt Ingram Cancer Center; Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences; Robert J Kleberg Jr and Helen C Kleberg Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by funds from the Adenoid Cystic Carcinoma Research Foundation to SI and WGY and by the NIH Challenge Grant 5RC1DE020332-02 from the National Institute of Dental and Craniofacial Research to WGY. This work was also supported in part by the Vanderbilt Ingram Cancer Center, the Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, the Robert J Kleberg Jr and Helen C Kleberg Foundation, and by an endowment to the Barry Baker Laboratory for Head and Neck Oncology.	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Azevedo RS, 2008, HEAD NECK PATHOL, V2, P257, DOI 10.1007/s12105-008-0074-1; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Bouzas-Rodriguez J, 2010, J CLIN INVEST, V120, P850, DOI 10.1172/JCI41013; Buzanska L, 2010, TOXICOLOGY, V270, P35, DOI 10.1016/j.tox.2009.06.005; Chummun S, 2001, BRIT J PLAST SURG, V54, P476, DOI 10.1054/bjps.2001.3636; DARDICK I, 1985, HEAD NECK SURG, V7, P395, DOI 10.1002/hed.2890070509; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Edsjo A, 2001, CELL GROWTH DIFFER, V12, P39; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; FITZPATRICK PJ, 1986, INT J RADIAT ONCOL, V12, P1743, DOI 10.1016/0360-3016(86)90314-7; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Hardy G, 1998, SADJ, V53, P371; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; HUBNER G, 1971, CANCER-AM CANCER SOC, V27, P1255, DOI 10.1002/1097-0142(197105)27:5<1255::AID-CNCR2820270533>3.0.CO;2-1; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; JAO W, 1976, CANCER, V37, P1322, DOI 10.1002/1097-0142(197603)37:3<1322::AID-CNCR2820370313>3.0.CO;2-7; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kruttgen A, 2006, BRAIN PATHOL, V16, P304, DOI 10.1111/j.1750-3639.2006.00037.x; Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K; Kummoona R, 2008, J ORAL PATHOL MED, V37, P345, DOI 10.1111/j.1600-0714.2007.00624.x; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lavoie JF, 2005, J BIOL CHEM, V280, P29199, DOI 10.1074/jbc.M502364200; Marchetti D, 2007, J EXP CLIN CANC RES, V26, P5; Marchetti D, 2003, PATHOL ONCOL RES, V9, P147, DOI 10.1007/BF03033729; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mehlen P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pe47; Montano X, 1997, ONCOGENE, V15, P245, DOI 10.1038/sj.onc.1201215; Montano X, 2009, ONCOGENE, V28, P3787, DOI 10.1038/onc.2009.143; Moskaluk CA, 2011, LAB INVEST, V91, P1480, DOI 10.1038/labinvest.2011.105; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Postigo A, 2002, GENE DEV, V16, P633, DOI 10.1101/gad.217902; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rajan N, 2011, ONCOGENE, V30, P4243, DOI 10.1038/onc.2011.133; REGEZI JA, 1977, OTOLARYNG CLIN N AM, V10, P297; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Sakamoto Y, 2001, ONCOL REP, V8, P477; Sanchez-Mejias A, 2009, J MED GENET, V46, P862, DOI 10.1136/jmg.2009.067819; Sinnappah-Kang ND, 2005, INT J ONCOL, V27, P617; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; Tauszig-Delamasure S, 2011, EXPERT OPIN THER TAR, V15, P847, DOI 10.1517/14728222.2011.575361; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Wang T, 2008, J MED CHEM, V51, P4672, DOI 10.1021/jm800343j; Wang T, 2009, EXPERT OPIN THER PAT, V19, P305, DOI 10.1517/13543770902721261; Wood Laura D, 2006, Hum Mutat, V27, P1060, DOI 10.1002/humu.9452; Wu SM, 2010, STEM CELL RES, V4, P38, DOI 10.1016/j.scr.2009.09.002; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	65	51	53	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3698	3710		10.1038/onc.2012.377	http://dx.doi.org/10.1038/onc.2012.377			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	23027130				2022-12-25	WOS:000322904400005
J	Gustafsson, TN; Sahlin, M; Lu, J; Sjoberg, BM; Holmgren, A				Gustafsson, Tomas N.; Sahlin, Margareta; Lu, Jun; Sjoberg, Britt-Marie; Holmgren, Arne			Bacillus anthracis Thioredoxin Systems, Characterization and Role as Electron Donors for Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-B; HELICOBACTER-PYLORI; DIPHOSPHATE REDUCTASE; GENOME SEQUENCE; HYDROGEN DONOR; NRDH-REDOXIN; HIGH-LEVEL; IN-VIVO; SUBTILIS; PROTEIN	Bacillus anthracis is the causative agent of anthrax, which is associated with a high mortality rate. Like several medically important bacteria, B. anthracis lacks glutathione but encodes many genes annotated as thioredoxins, thioredoxin reductases, and glutaredoxin-like proteins. We have cloned, expressed, and characterized three potential thioredoxins, two potential thioredoxin reductases, and three glutaredoxin-like proteins. Of these, thioredoxin 1 (Trx1) and NrdH reduced insulin, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), and the manganese-containing type Ib ribonucleotide reductase (RNR) from B. anthracis in the presence of NADPH and thioredoxin reductase 1 (TR1), whereas thioredoxin 2 (Trx2) could only reduce DTNB. Potential TR2 was verified as an FAD-containing protein reducible by dithiothreitol but not by NAD(P)H. The recently discovered monothiol bacillithiol did not work as a reductant for RNR, either directly or via any of the redoxins. The catalytic efficiency of Trx1 was 3 and 20 times higher than that of Trx2 and NrdH, respectively, as substrates for TR1. Additionally, the catalytic efficiency of Trx1 as an electron donor for RNR was 7-fold higher than that of NrdH. In extracts of B. anthracis, Trx1 was responsible for almost all of the disulfide reductase activity, whereas Western blots showed that the level of Trx1 was 15 and 60 times higher than that of Trx2 and NrdH, respectively. Our findings demonstrate that the most important general disulfide reductase system in B. anthracis is TR1/Trx1 and that Trx1 is the physiologically relevant electron donor for RNR. This information may provide a basis for the development of novel antimicrobial therapies targeting this severe pathogen.	[Gustafsson, Tomas N.; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Sahlin, Margareta] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Stockholm University	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835; Sjoberg, Britt-Marie/0000-0001-5953-3360; Gustafsson, Tomas/0000-0002-4495-8267	Swedish Research Council [3529, 2978]; Swedish Cancer Society [961, 814]; K. A. Wallenberg Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported in part by Swedish Research Council Grants 3529 (to A. H.) and 2978 (to B. M. S.), Swedish Cancer Society Grants 961 (to A. H.) and 814 (to B. M. S.), and the K. A. Wallenberg Foundation (to A. H.).; Recipient of an M.D.-Ph.D. program fellowship from the Karolinska Institutet.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fieschi F, 1998, J BIOL CHEM, V273, P4329, DOI 10.1074/jbc.273.8.4329; FUCHS JA, 1972, NATURE-NEW BIOL, V238, P69, DOI 10.1038/newbio238069a0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Gustafsson TN, 2007, ACTA CRYSTALLOGR D, V63, P833, DOI 10.1107/S0907444907026303; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Huson D. H., 2012, SYSTEMATIC BIOL; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mohamed SF, 1998, BIOFACTORS, V7, P337, DOI 10.1002/biof.5520070405; Moller MC, 2008, J BACTERIOL, V190, P4660, DOI 10.1128/JB.00252-08; Mostertz J, 2008, PROTEOMICS, V8, P2676, DOI 10.1002/pmic.200701015; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; PRONGAY AJ, 1989, J BIOL CHEM, V264, P2656; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Scharf C, 1998, J BACTERIOL, V180, P1869, DOI 10.1128/JB.180.7.1869-1877.1998; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Windle HJ, 2000, J BIOL CHEM, V275, P5081, DOI 10.1074/jbc.275.7.5081; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	62	29	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413427	http://dx.doi.org/10.1074/jbc.M112.413427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012357	Green Published, hybrid			2022-12-25	WOS:000311233800038
J	Pietka, TA; Sulkin, MS; Kuda, O; Wang, W; Zhou, DQ; Yamada, KA; Yang, K; Su, X; Gross, RW; Nerbonne, JM; Efimov, IR; Abumrad, NA				Pietka, Terri A.; Sulkin, Matthew S.; Kuda, Ondrej; Wang, Wei; Zhou, Dequan; Yamada, Kathryn A.; Yang, Kui; Su, Xiong; Gross, Richard W.; Nerbonne, Jeanne M.; Efimov, Igor R.; Abumrad, Nada A.			CD36 Protein Influences Myocardial Ca2+ Homeostasis and Phospholipid Metabolism CONDUCTION ANOMALIES IN CD36-DEFICIENT MICE DURING FASTING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID TRANSPORT; SARCOPLASMIC-RETICULUM; PHOSPHOLAMBAN PHOSPHORYLATION; CONTRACTILE DYSFUNCTION; CARDIOVASCULAR-DISEASES; CALORIC RESTRICTION; SIGNALING PATHWAYS; LIPID-METABOLISM; SKELETAL-MUSCLE; RAT-HEART	Sarcolemmal CD36 facilitates myocardial fatty acid (FA) uptake, which is markedly reduced in CD36-deficient rodents and humans. CD36 also mediates signal transduction events involving a number of cellular pathways. In taste cells and macrophages, CD36 signaling was recently shown to regulate store-responsive Ca2+ flux and activation of Ca2+-dependent phospholipases A(2) that cycle polyunsaturated FA into phospholipids. It is unknown whether CD36 deficiency influences myocardial Ca2+ handling and phospholipid metabolism, which could compromise the heart, typically during stresses. Myocardial function was examined in fed or fasted (18-22 h) CD36(-/-) and WT mice. Echocardiography and telemetry identified conduction anomalies that were associated with the incidence of sudden death in fasted CD36(-/-) mice. No anomalies or death occurred in WT mice during fasting. Optical imaging of perfused hearts from fasted CD36(-/-) mice documented prolongation of Ca2+ transients. Consistent with this, knockdown of CD36 in cardiomyocytes delayed clearance of cytosolic Ca2+. Hearts of CD36(-/-) mice (fed or fasted) had 3-fold higher SERCA2a and 40% lower phospholamban levels. Phospholamban phosphorylation by protein kinase A (PKA) was enhanced after fasting reflecting increased PKA activity and cAMP levels in CD36(-/-) hearts. Abnormal Ca2+ homeostasis in the CD36(-/-) myocardium associated with increased lysophospholipid content and a higher proportion of 22: 6 FA in phospholipids suggests altered phospholipase A2 activity and changes in membrane dynamics. The data support the role of CD36 in coordinating Ca2+ homeostasis and lipid metabolism and the importance of this role during myocardial adaptation to fasting. Potential relevance of the findings to CD36-deficient humans would need to be determined.	[Su, Xiong; Abumrad, Nada A.] Washington Univ, Ctr Human Nutr, St Louis, MO 63110 USA; [Yamada, Kathryn A.; Gross, Richard W.; Nerbonne, Jeanne M.; Abumrad, Nada A.] Washington Univ, Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Div Bioorgan Chem, Dept Med, St Louis, MO 63110 USA; [Wang, Wei] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Sulkin, Matthew S.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Kuda, Ondrej] Acad Sci Czech Republ, Inst Physiol, Dept Adipose Tissue Biol, CR-14220 Prague, Czech Republic	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Abumrad, NA (corresponding author), Washington Univ, Ctr Human Nutr, Campus Box 8031, St Louis, MO 63110 USA.	NAbumrad@dom.wustl.edu	zhou, dequan/J-9937-2012; Efimov, Igor R/B-8040-2010; Efimov, Igor/R-5544-2017; Kuda, Ondrej/B-7990-2012; Efimov, Igor R./AAJ-3234-2021	zhou, dequan/0000-0002-2662-2882; Efimov, Igor R/0000-0002-1483-5039; Efimov, Igor/0000-0002-1483-5039; Kuda, Ondrej/0000-0001-7034-4536; 	National Institutes of Health [P01 HL057278, R01 DK33301, R01 HL034161, R01 HL085369, R21 HL108617, R01 HL114395, DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085369, R21HL108617, R01HL114395, R01HL034161, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL057278 (to R. W. G. and N. A. A.), R01 DK33301 (to N. A. A.), R01 HL034161 (to J. M. N.), R01 HL085369, R21 HL108617, and R01 HL114395 (to I. R. E.), and DK56341 (to Nutrition Obesity Research Center, Washington University).	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Angin Y., 2012, BIOCH J IN PRESS, pJ; Aoyama H, 2011, CARDIOVASC RES, V89, P79, DOI 10.1093/cvr/cvq252; Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; Chen J, 2012, AM J PHYSIOL-HEART C, V302, pH538, DOI 10.1152/ajpheart.00701.2011; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chossat N, 2001, CARDIOVASC RES, V49, P288, DOI 10.1016/S0008-6363(00)00234-0; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Farook VS, 2012, OBESITY, V20, P2083, DOI 10.1038/oby.2012.74; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fukuchi K, 1999, J NUCL MED, V40, P239; Garber AJ, 2004, MED CLIN N AM, V88, P837, DOI 10.1016/j.mcna.2004.04.001; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Glazer HP, 2009, CELL CYCLE, V8, P1738, DOI 10.4161/cc.8.11.8619; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Hall D, 2011, J HYPERTENS, V29, P690, DOI 10.1097/HJH.0b013e3283440115; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hui DY, 2012, CURR OPIN LIPIDOL, V23, P235, DOI 10.1097/MOL.0b013e328351b439; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Jeong MY, 2010, AM J PHYSIOL-HEART C, V298, pH1719, DOI 10.1152/ajpheart.00937.2009; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Lally JSV, 2012, ACTA PHYSIOL, V205, P71, DOI 10.1111/j.1748-1716.2012.02396.x; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu G, 2004, J PHYSIOL-LONDON, V555, P267, DOI 10.1113/jphysiol.2003.054064; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Negretti N, 2000, J PHYSIOL-LONDON, V523, P367, DOI 10.1111/j.1469-7793.2000.t01-1-00367.x; Noel SE, 2010, ATHEROSCLEROSIS, V211, P210, DOI 10.1016/j.atherosclerosis.2010.02.009; Norris SM, 2010, AM J PHYSIOL-CELL PH, V298, pC521, DOI 10.1152/ajpcell.00479.2009; Nozaki S, 1999, MOL CELL BIOCHEM, V192, P129, DOI 10.1023/A:1006816702425; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pinz I, 2011, J BIOL CHEM, V286, P10163, DOI 10.1074/jbc.M110.210757; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; Roberts W, 2010, BLOOD, V116, P4297, DOI 10.1182/blood-2010-01-265561; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; TAFFET GE, 1993, J MEMBRANE BIOL, V131, P35, DOI 10.1007/BF02258532; Taki J, 2007, EUR J NUCL MED MOL I, V34, pS34, DOI 10.1007/s00259-007-0439-9; Tanaka T, 2001, J LIPID RES, V42, P751; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603; Zhou D., 2012, FASEB J IN PRESS	73	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38901	38912		10.1074/jbc.M112.413609	http://dx.doi.org/10.1074/jbc.M112.413609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019328	Green Published, hybrid			2022-12-25	WOS:000310982800046
J	Ramachandran, L; Manu, KA; Shanmugam, MK; Li, F; Siveen, KS; Vali, S; Kapoor, S; Abbasi, T; Surana, R; Smoot, DT; Ashktorab, H; Tan, P; Ahn, KS; Yap, CW; Kumar, AP; Sethi, G				Ramachandran, Lalitha; Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Li, Feng; Siveen, Kodappully Sivaraman; Vali, Shireen; Kapoor, Shweta; Abbasi, Taher; Surana, Rohit; Smoot, Duane T.; Ashktorab, Hassan; Tan, Patrick; Ahn, Kwang Seok; Yap, Chun Wei; Kumar, Alan Prem; Sethi, Gautam			Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor gamma Activation Pathway in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; QUERCETIN; CELLS; CARCINOGENESIS; MECHANISMS; PREVENTION; DOCKING; BREAST; GROWTH	Gastric cancer (GC) is a lethal malignancy and the second most common cause of cancer-related deaths. Although treatment options such as chemotherapy, radiotherapy, and surgery have led to a decline in the mortality rate due to GC, chemoresistance remains as one of the major causes for poor prognosis and high recurrence rate. In this study, we investigated the potential effects of isorhamnetin (IH), a 3'-O-methylated metabolite of quercetin on the peroxisome proliferator-activated receptor gamma (PPAR-gamma) signaling cascade using proteomics technology platform, GC cell lines, and xenograft mice model. We observed that IH exerted a strong antiproliferative effect and increased cytotoxicity in combination with chemotherapeutic drugs. IH also inhibited the migratory/invasive properties of GC cells, which could be reversed in the presence of PPAR-gamma inhibitor. We found that IH increased PPAR-gamma activity and modulated the expression of PPAR-gamma regulated genes in GC cells. Also, the increase in PPAR-gamma activity was reversed in the presence of PPAR-gamma-specific inhibitor and a mutated PPAR-gamma dominant negative plasmid, supporting our hypothesis that IH can act as a ligand of PPAR-gamma. Using molecular docking analysis, we demonstrate that IH formed interactions with seven polar residues and six nonpolar residues within the ligand-binding pocket of PPAR-gamma that are reported to be critical for its activity and could competitively bind to PPAR-gamma. IH significantly increased the expression of PPAR-gamma in tumor tissues obtained from xenograft model of GC. Overall, our findings clearly indicate that antitumor effects of IH may be mediated through modulation of the PPAR-gamma activation pathway in GC.	[Surana, Rohit; Tan, Patrick; Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore; [Ramachandran, Lalitha; Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Li, Feng; Siveen, Kodappully Sivaraman; Surana, Rohit; Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Vali, Shireen; Kapoor, Shweta; Abbasi, Taher] Cellworks Res India Pvt Ltd, Bangalore, Karnataka, India; [Vali, Shireen; Kapoor, Shweta; Abbasi, Taher] Cellworks Grp Inc, Saratoga, CA 95070 USA; [Smoot, Duane T.; Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20060 USA; [Smoot, Duane T.; Ashktorab, Hassan] Howard Univ, Ctr Canc, Washington, DC 20060 USA; [Tan, Patrick] Genome Inst Singapore, Singapore 138672, Singapore; [Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Ahn, Kwang Seok] Kyung Hee Univ, Coll Oriental Med, Seoul 130701, South Korea; [Yap, Chun Wei] Natl Univ Singapore, Dept Pharm, Pharmaceut Data Explorat Lab, Singapore 117543, Singapore; [Kumar, Alan Prem] Curtin Univ Technol, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	National University of Singapore; National University of Singapore; Howard University; Howard University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Kyung Hee University; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton	Kumar, AP (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore.	csiapk@nus.edu.sg; phcgs@nus.edu.sg	Sethi, Gautam/F-2372-2011; Ashktorab, hassan/AAJ-2908-2020; Aryan, Manu/C-6609-2015; Yap, Chun Wei/B-2587-2010; Ahn, Kwang Seok/G-4249-2013; Kumar, Alan Prem/ABE-7492-2020	Sethi, Gautam/0000-0002-8677-8475; Yap, Chun Wei/0000-0002-2004-3492; Kumar, Alan Prem/0000-0002-3754-5712; Siveen, Kodappully Sivaraman/0000-0003-4669-1890; Kanjoormana Aryan, Manu/0000-0002-4437-6486	NUS Academic Research Fund [R-184-000-170-112]; National Medical Research Council of Singapore [R-184-000-211-213, R-713-000-124-213]; Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant [R-713-001-011-271]	NUS Academic Research Fund; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant	This work was supported by NUS Academic Research Fund Grant R-184-000-170-112 (to G. S.), National Medical Research Council of Singapore Grant R-184-000-211-213, National Medical Research Council of Singapore Grant R-713-000-124-213 (to A. P. K.), and Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant R-713-001-011-271 (to A. P. K.).	Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Boik John C., 2008, BMC Pharmacology, V8, P13, DOI 10.1186/1471-2210-8-13; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ford AC, 2011, BEST PRACT RES CL GA, V25, P581, DOI 10.1016/j.bpg.2011.09.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Jaramillo S, 2010, J AGR FOOD CHEM, V58, P10869, DOI 10.1021/jf102669p; Kannaiyan R, 2011, BRIT J PHARMACOL, V164, P1506, DOI 10.1111/j.1476-5381.2011.01449.x; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Lu J, 2005, CANCER RES, V65, P4769, DOI 10.1158/0008-5472.CAN-04-2293; Mannelli M, 2010, NEUROENDOCRINOLOGY, V92, P23, DOI 10.1159/000314312; Manu KA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-107; Nickkho-Amiry M, 2012, MOL CANCER RES, V10, P441, DOI 10.1158/1541-7786.MCR-11-0233; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Oyekan A, 2011, CLIN EXP HYPERTENS, V33, P287, DOI 10.3109/10641963.2010.531845; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Patel LR, 2011, FUTURE ONCOL, V7, P1285, DOI [10.2217/fon.11.112, 10.2217/FON.11.112]; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Reka AK, 2011, LUNG CANCER, V72, P154, DOI 10.1016/j.lungcan.2011.01.019; Roukos DH, 2005, NAT CLIN PRACT ONCOL, V2, P98, DOI 10.1038/ncponc0099; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Selgrad M, 2010, HELICOBACTER, V15, P40, DOI 10.1111/j.1523-5378.2010.00783.x; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Wan ZQ, 2011, MOL CELL BIOCHEM, V349, P1, DOI 10.1007/s11010-010-0637-9; Wang P, 2012, TOXICOL IN VITRO, V26, P221, DOI 10.1016/j.tiv.2011.11.015; Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514; Wang TT, 2006, CRIT REV ONCOL HEMAT, V58, P1, DOI 10.1016/j.critrevonc.2005.08.011; Wilding J. P., 2012, DIABETES OB IN PRESS; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yao LP, 2010, HYBRIDOMA, V29, P341, DOI 10.1089/hyb.2010.0013; Yeoh KG, 2007, J GASTROEN HEPATOL, V22, P970, DOI 10.1111/j.1440-1746.2007.04956.x; Yokoyama Y, 2011, J CANCER RES CLIN, V137, P1219, DOI 10.1007/s00432-011-0993-1	47	103	114	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388702	http://dx.doi.org/10.1074/jbc.M112.388702			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992727	Green Published, hybrid			2022-12-25	WOS:000310642200037
J	Takahashi, H; Sun, XY; Hamamoto, M; Yashiroda, Y; Yoshida, M				Takahashi, Hidekazu; Sun, Xiaoying; Hamamoto, Makiko; Yashiroda, Yoko; Yoshida, Minoru			The SAGA Histone Acetyltransferase Complex Regulates Leucine Uptake through the Agp3 Permease in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; UBIQUITIN LIGASE; GENE-EXPRESSION; CELL-GROWTH; ACETYLATION; STRESS; TOR2; DIFFERENTIATION	Metabolic responses of unicellular organisms are mostly acute, transient, and cell-autonomous. Regulation of nutrient uptake in yeast is one such rapid response. High quality nitrogen sources such as NH4+ inhibit uptake of poor nitrogen sources, such as amino acids. Both transcriptional and posttranscriptional mechanisms operate in nutrient uptake regulation; however, many components of this system remain uncharacterized in the fission yeast, Schizosaccharomyces pombe. Here, we demonstrate that the Spt-Ada-Gcn acetyltransferase (SAGA) complex modulates leucine uptake. Initially, we noticed that a branched-chain amino acid auxotroph exhibits a peculiar adaptive growth phenotype on solid minimal media containing certain nitrogen sources. In fact, the growth of many auxotrophic strains is inhibited by excess NH4Cl, possibly through nitrogen-mediated uptake inhibition of the corresponding nutrients. Surprisingly, DNA microarray analysis revealed that the transcriptional reprogramming during the adaptation of the branched-chain amino acid auxotroph was highly correlated with reprogramming observed in deletions of the SAGA histone acetyltransferase module genes. Deletion of gcn5(+) increased leucine uptake in the prototrophic background and rendered the leucine auxotroph resistant to NH4Cl. Deletion of tra1(+) caused the opposite phenotypes. The increase in leucine uptake in the gcn5 Delta mutant was dependent on an amino acid permease gene, SPCC965.11c(+). The closest budding yeast homolog of this permease is a relatively nonspecific amino acid permease AGP3, which functions in poor nutrient conditions. Our analysis identified the regulation of nutrient uptake as a physiological function for the SAGA complex, providing a potential link between cellular metabolism and chromatin regulation.	[Takahashi, Hidekazu; Sun, Xiaoying; Yashiroda, Yoko; Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Sun, Xiaoying; Hamamoto, Makiko] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa 2148571, Japan; [Yoshida, Minoru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST Res Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; Meiji University; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshidam@riken.jp	Yashiroda, Yoko/C-8769-2014; Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	CREST from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from CREST from the Japan Science and Technology Agency (to M. Y.) and by Grant-in-aid for Scientific Research on Innovative Areas 3307 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. T.)	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Aspuria PJ, 2008, MOL GENET GENOMICS, V279, P441, DOI 10.1007/s00438-008-0320-y; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calonge TM, 2010, GENETICS, V185, P81, DOI 10.1534/genetics.110.114769; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Collart M. A., 2001, CURRENT PROTOCOLS MO; Eden A, 1998, YEAST, V14, P189, DOI 10.1002/(SICI)1097-0061(19980130)14:2<189::AID-YEA210>3.0.CO;2-V; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helmlinger D, 2011, EMBO J, V30, P2843, DOI 10.1038/emboj.2011.181; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hunt C, 2001, YEAST, V18, P355, DOI 10.1002/1097-0061(20010315)18:4<355::AID-YEA676>3.0.CO;2-P; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Matsumoto S, 2002, GENETICS, V161, P1053; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakase Y, 2006, GENETICS, V173, P569, DOI 10.1534/genetics.106.056895; Nugent RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-59; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; Saleki R, 1997, MOL GEN GENET, V254, P520, DOI 10.1007/s004380050447; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Takahashi H, 2011, BIOCHEM BIOPH RES CO, V406, P42, DOI 10.1016/j.bbrc.2011.01.103; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170	40	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.411165	http://dx.doi.org/10.1074/jbc.M112.411165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992726	Green Published, hybrid			2022-12-25	WOS:000310642200049
J	Wagh, K; Bhatia, A; Alexe, G; Reddy, A; Ravikumar, V; Seiler, M; Boemo, M; Yao, M; Cronk, L; Naqvi, A; Ganesan, S; Levine, AJ; Bhanot, G				Wagh, Kshitij; Bhatia, Aatish; Alexe, Gabriela; Reddy, Anupama; Ravikumar, Vijay; Seiler, Michael; Boemo, Michael; Yao, Ming; Cronk, Lee; Naqvi, Asad; Ganesan, Shridar; Levine, Arnold J.; Bhanot, Gyan			Lactase Persistence and Lipid Pathway Selection in the Maasai	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECENT POSITIVE SELECTION; GENETIC-BASIS; DIACYLGLYCEROL ACYLTRANSFERASE; SERUM-CHOLESTEROL; HEPATIC STEATOSIS; KETOGENIC DIET; HEART-DISEASE; DGAT2; AFRICA	The Maasai are a pastoral people in Kenya and Tanzania, whose traditional diet of milk, blood and meat is rich in lactose, fat and cholesterol. In spite of this, they have low levels of blood cholesterol, and seldom suffer from gallstones or cardiac diseases. Field studies in the 1970s suggested that the Maasai have a genetic adaptation for cholesterol homeostasis. Analysis of HapMap 3 data using Fixation Index (Fst) and two metrics of haplotype diversity: the integrated Haplotype Score (iHS) and the Cross Population Extended Haplotype Homozygosity (XP-EHH), identified genomic regions and single nucleotide polymorphisms (SNPs) as strong candidates for recent selection for lactase persistence and cholesterol regulation in 143-156 founder individuals from the Maasai population in Kinyawa, Kenya (MKK). The non-synonmous SNP with the highest genome-wide Fst was the TC polymorphism at rs2241883 in Fatty Acid Binding Protein 1(FABP1), known to reduce low density lipoprotein and tri-glyceride levels in Europeans. The strongest signal identified by all three metrics was a 1.7 Mb region on Chr2q21. This region contains the genes LCT (Lactase) and MCM6 (Minichromosome Maintenance Complex Component) involved in lactase persistence, and the gene Rab3GAP1 (Rab3 GTPase-activating Protein Catalytic Subunit), which contains polymorphisms associated with total cholesterol levels in a genome-wide association study of >100,000 individuals of European ancestry. Sanger sequencing of DNA from six MKK samples showed that the GC-14010 polymorphism in the MCM6 gene, known to be associated with lactase persistence in Africans, is segregating in MKK at high frequency (similar to 58%). The Cytochrome P450 Family 3 Subfamily A (CYP3A) cluster of genes, involved in cholesterol metabolism, was identified by Fst and iHS as candidate loci under selection. Overall, our study identified several specific genomic regions under selection in the Maasai which contain polymorphisms in genes associated with lactase persistence and cholesterol regulation.	[Yao, Ming; Ganesan, Shridar; Levine, Arnold J.; Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Wagh, Kshitij; Bhatia, Aatish; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Alexe, Gabriela] Broad Inst, Cambridge, MA USA; [Alexe, Gabriela] Dana Farber Canc Inst, Boston, MA 02115 USA; [Reddy, Anupama; Seiler, Michael; Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ USA; [Ravikumar, Vijay; Boemo, Michael] Rutgers State Univ, Dept Math, Piscataway, NJ USA; [Cronk, Lee] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA; [Naqvi, Asad; Levine, Arnold J.; Bhanot, Gyan] Inst Adv Study, Princeton, NJ 08540 USA; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Institute for Advanced Study - USA; Rutgers State University New Brunswick	Levine, AJ (corresponding author), Canc Inst New Jersey, New Brunswick, NJ USA.	alevine@ias.edu; gyanbhanot@gmail.com	Wagh, Kshitij/ABB-5002-2020; Cronk, Lee/V-1918-2019					Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; ARHEM K, 1989, ANTHROPOS, V84, P1; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Best LG, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-77; BISS K, 1971, NEW ENGL J MED, V284, P694, DOI 10.1056/NEJM197104012841304; Brotons C, 1998, ATHEROSCLEROSIS, V139, P1, DOI 10.1016/S0021-9150(98)00056-2; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen XP, 2009, ENVIRON HEALTH PERSP, V117, P1541, DOI 10.1289/ehp.0800528; Coast E, 2001, MAASAI DEMOGRAPHY; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Cronk L., 2004, MUKOGODO MAASAI ETHN; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Dastani Z, 2010, EUR J HUM GENET, V18, P342, DOI 10.1038/ejhg.2009.157; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fisher E, 2007, MOL GENET METAB, V91, P278, DOI 10.1016/j.ymgme.2007.03.002; GIBNEY MJ, 1980, ATHEROSCLEROSIS, V35, P339, DOI 10.1016/0021-9150(80)90131-8; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; HO KJ, 1971, ARCH PATHOL, V91, P387; HO KJ, 1972, AM J CLIN NUTR, V25, P737; Hollis AC, 1910, J R ANTHROPOL INST G, V40, P473, DOI 10.2307/2843267; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jacobs A. H., 1965, TRADITIONAL POLITICA; Jacobs AH, 1973, CULTURAL SOURCE MAT, V3; Johns T, 1999, J ETHNOPHARMACOL, V66, P1, DOI 10.1016/S0378-8741(98)00179-2; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kang HC, 2004, EPILEPSIA, V45, P1116, DOI 10.1111/j.0013-9580.2004.10004.x; Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306; Kivisto KT, 2004, PHARMACOGENETICS, V14, P523, DOI 10.1097/01.fpc.0000114762.78957.a5; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; MANN GV, 1965, LANCET, V2, P1308; Mann GV, J ATHEROSCLEROSIS RE, V4, P289; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MATTSON FH, 1972, AM J CLIN NUTR, V25, P589; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; REYNOLDS J, 1983, GENETICS, V105, P767; Robitaille J, 2004, MOL GENET METAB, V82, P296, DOI 10.1016/j.ymgme.2004.06.002; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sankan SSO, 1973, MASAI; Shorvon S, 2004, TREATMENT EPILEPSY; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; Spencer P., 2003, TIME SPACE UNKNOWN M; Spencer Paul, 1988, MAASAI MATAPATO STUD; TAYLOR CB, 1971, AM J CLIN NUTR, V24, P1291; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; von Mitzlaff U, 1994, MAASAI WOMEN LIFE PA; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	71	35	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44751	10.1371/journal.pone.0044751	http://dx.doi.org/10.1371/journal.pone.0044751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028602	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900016
J	Verma, D; Ye, NN; Meng, FJ; Sachs, F; Rahimzadeh, J; Hua, SZ				Verma, Deepika; Ye, Nannan; Meng, Fanjie; Sachs, Frederick; Rahimzadeh, Jason; Hua, Susan Z.			Interplay between Cytoskeletal Stresses and Cell Adaptation under Chronic Flow	PLOS ONE			English	Article							MECHANOSENSITIVE ION CHANNELS; FLUID SHEAR-STRESS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; MECHANICAL-STRESS; FOCAL ADHESIONS; FORCE GENERATION; LIVING CELLS; RHO; MECHANOTRANSDUCTION	Using stress sensitive FRET sensors we have measured cytoskeletal stresses in a-actinin and the associated reorganization of the actin cytoskeleton in cells subjected to chronic shear stress. We show that long-term shear stress reduces the average actinin stress and this effect is reversible with removal of flow. The flow-induced changes in cytoskeletal stresses are found to be dynamic, involving a transient decrease in stress (phase-I), a short-term increase (3-6 min) (Phase-II), followed by a longer-term decrease that reaches a minimum in similar to 20 min (Phase-III), before saturating. These changes are accompanied by reorganization of the actin cytoskeleton from parallel F-actin bundles to peripheral bundles. Blocking mechanosensitive ion channels (MSCs) with Gd3+ and GsMTx4 (a specific inhibitor) eliminated the changes in cytoskeletal stress and the corresponding actin reorganization, indicating that Ca2+ permeable MSCs participate in the signaling cascades. This study shows that shear stress induced cell adaptation is mediated via MSCs.	[Meng, Fanjie; Sachs, Frederick; Hua, Susan Z.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Verma, Deepika; Ye, Nannan; Rahimzadeh, Jason; Hua, Susan Z.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hua, SZ (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	zhua@buffalo.edu			National Institutes of Health (NIH) [DK77302, HL054887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK077302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant DK77302 (S.Z.H.). F. M. was supported by NIH HL054887 (F. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Essig M, 2001, AM J PHYSIOL-RENAL, V281, pF751, DOI 10.1152/ajprenal.2001.281.4.F751; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Matthews BD, 2004, BIOCHEM BIOPH RES CO, V313, P758, DOI 10.1016/j.bbrc.2003.12.005; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Meng FJ, 2011, J CELL SCI, V124, P261, DOI 10.1242/jcs.071928; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Osborn EA, 2006, AM J PHYSIOL-CELL PH, V290, pC444, DOI 10.1152/ajpcell.00218.2005; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Resnick A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027058; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Ziembicki J, 2005, AM J PHYSIOL-RENAL, V289, pF826, DOI 10.1152/ajprenal.00412.2004	46	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44167	10.1371/journal.pone.0044167	http://dx.doi.org/10.1371/journal.pone.0044167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028495	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400021
J	Deutsch, D; Pietr, M; Knutsen, PM; Ahissar, E; Schneidman, E				Deutsch, Dudi; Pietr, Maciej; Knutsen, Per Magne; Ahissar, Ehud; Schneidman, Elad			Fast Feedback in Active Sensing: Touch-Induced Changes to Whisker-Object Interaction	PLOS ONE			English	Article							FUNCTIONAL PLASTICITY; RHYTHMIC WHISKING; RODENT WHISKING; FACIAL NUCLEUS; RAT; NEURONS; CORTEX; MOVEMENTS; LOCALIZATION; VIBRISSAE	Whisking mediated touch is an active sense whereby whisker movements are modulated by sensory input and behavioral context. Here we studied the effects of touching an object on whisking in head-fixed rats. Simultaneous movements of whiskers C1, C2, and D1 were tracked bilaterally and their movements compared. During free-air whisking, whisker protractions were typically characterized by a single acceleration-deceleration event, whisking amplitude and velocity were correlated, and whisk duration correlated with neither amplitude nor velocity. Upon contact with an object, a second acceleration-deceleration event occurred in about 25% of whisk cycles, involving both contacting (C2) and non-contacting (C1, D1) whiskers ipsilateral to the object. In these cases, the rostral whisker (C2) remained in contact with the object throughout the double-peak phase, which effectively prolonged the duration of C2 contact. These "touch-induced pumps'' (TIPs) were detected, on average, 17.9 ms after contact. On a slower time scale, starting at the cycle following first touch, contralateral amplitude increased while ipsilateral amplitude decreased. Our results demonstrate that sensory-induced motor modulations occur at various timescales, and directly affect object palpation.	[Deutsch, Dudi; Pietr, Maciej; Knutsen, Per Magne; Ahissar, Ehud; Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Knutsen, Per Magne] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Weizmann Institute of Science; University of California System; University of California San Diego	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il; elad.schneidman@weizmann.ac.il		schneidman, elad/0000-0001-8653-9848	European Union [ICT-215910]; Israeli Science Foundation [749/10]; United States-Israel Binational Science Foundation [2007121]; Minerva Foundation; Federal German Ministry for Education and Research; Peter and Patricia Gruber foundation; Human Frontier Science Program; Horowitz Center for Complexity Science	European Union(European Commission); Israeli Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Peter and Patricia Gruber foundation; Human Frontier Science Program(Human Frontier Science Program); Horowitz Center for Complexity Science	This work was supported by European Union grant BIOTACT (ICT-215910), the Israeli Science Foundation Grant No. 749/10, the United States-Israel Binational Science Foundation Grant No. 2007121, the Minerva Foundation funded by the Federal German Ministry for Education and Research, and the Peter and Patricia Gruber foundation. PMK was supported by a Long-Term Fellowship from the Human Frontier Science Program. EA holds the Helen Diller Family Professorial Chair of Neurobiology. ES was supported by the Horowitz Center for Complexity Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 1998, J NEUROSCI METH, V83, P89, DOI 10.1016/S0165-0270(98)00050-8; Bosman LWJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00053; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Cohen JD, 2008, J NEUROSCI, V28, P11205, DOI 10.1523/JNEUROSCI.2999-08.2008; Derdikman D, 2006, J NEUROSCI, V26, P9538, DOI 10.1523/JNEUROSCI.0918-06.2006; Deschenes M, 2011, CURR OPIN NEUROBIOL; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DORFL J, 1985, ACTA ANAT, V121, P248; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; ERZURUMLU RS, 1979, J COMP NEUROL, V188, P75, DOI 10.1002/cne.901880107; Galloway EM, 2008, PROG BRAIN RES, V169, P251, DOI 10.1016/S0079-6123(07)00015-5; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Landers M, 2002, SOMATOSENS MOT RES, V19, P358, DOI 10.1080/0899022021000037818; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Li YQ, 1997, J COMP NEUROL, V378, P283, DOI 10.1002/(SICI)1096-9861(19970210)378:2<283::AID-CNE10>3.0.CO;2-T; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Mitchinson B, 2011, PHILOS T R SOC B, V366, P3037, DOI 10.1098/rstb.2011.0156; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Munz M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00191; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeeva E, 2005, J NEUROSCI, V25, P9135, DOI 10.1523/JNEUROSCI.3073-05.2005; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; WINESKI LE, 1983, J ZOOL, V200, P261; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5; WISE SP, 1977, J COMP NEUROL, V175, P129, DOI 10.1002/cne.901750202; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; WOOLSTON DC, 1983, NEUROSCI LETT, V36, P43, DOI 10.1016/0304-3940(83)90483-4; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	61	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44272	10.1371/journal.pone.0044272	http://dx.doi.org/10.1371/journal.pone.0044272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028512	Green Published, gold			2022-12-25	WOS:000311313900016
J	Hoffmann, F; Kloas, W				Hoffmann, Frauke; Kloas, Werner			The Antiestrogens Tamoxifen and Fulvestrant Abolish Estrogenic Impacts of 17 alpha-ethinylestradiol on Male Calling Behavior of Xenopus laevis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING COMPOUNDS; AFFECTING REPRODUCTIVE-BIOLOGY; AFRICAN CLAWED FROGS; STICKLEBACK GASTEROSTEUS-ACULEATUS; MALE 3-SPINED STICKLEBACK; MESSENGER-RNA EXPRESSION; MALE SEX BEHAVIOR; BREAST-CANCER; ENVIRONMENTAL CHEMICALS; POMATOSCHISTUS-MINUTUS	Various synthetic chemicals released to the environment can interfere with the endocrine system of vertebrates. Many of these endocrine disrupting compounds (EDCs) exhibit estrogenic activity and can interfere with sexual development and reproductive physiology. More recently, also chemicals with different modes of action (MOAs), such as antiestrogenic, androgenic and antiandrogenic EDCs, have been shown to be present in the environment. However, to date EDC-research primarily focuses on exposure to EDCs with just one MOA, while studies examining the effects of simultaneous exposure to EDCs with different MOAs are rare, although they would reflect more real, natural exposure situations. In the present study the combined effects of estrogenic and antiestrogenic EDCs were assessed by analyzing the calling behavior of short-term exposed male Xenopus laevis. The estrogenic 17 alpha-ethinylestradiol (EE2), and the antiestrogenic EDCs tamoxifen (TAM) and fulvestrant (ICI) were used as model substances. As previously demonstrated, sole EE2 exposure (10-10 M) resulted in significant alterations of the male calling behavior, including altered temporal and spectral parameters of the advertisement calls. Sole TAM (10-7 M, 10-8 M, 10-10 M) or ICI (10-7 M) exposure, on the other hand, did not affect any of the measured parameters. If frogs were co-exposed to EE2 (10-10 M) and TAM (10-7 M) the effects of EE2 on some parameters were abolished, but co-exposure to EE2 and ICI (10-7 M) neutralized all estrogenic effects. Thus, although EDCs with antiestrogenic MOA might not exhibit any effects per se, they can alter the estrogenic effects of EE2. Our observations demonstrate that there is need to further investigate the combined effects of EDCs with various, not only opposing, MOAs as this would reflect realistic wildlife situations.	[Hoffmann, Frauke; Kloas, Werner] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Kloas, Werner] Humboldt Univ, Inst Biol, Dept Endocrinol, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hoffmann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany.	f.hoffmann@igb-berlin.de	Hoffmann, Frauke/F-9114-2017; Hoffmann, Frauke/H-5994-2015		German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany [AZ 20008/987]	German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany	The authors would like to acknowledge the financial support provided by the German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany (support code AZ 20008/987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREOLETTI GE, 1983, HORM BEHAV, V17, P103, DOI 10.1016/0018-506X(83)90020-X; Behrends T, 2010, GEN COMP ENDOCR, V168, P269, DOI 10.1016/j.ygcen.2010.01.017; Bell AM, 2004, HORM BEHAV, V45, P108, DOI 10.1016/j.yhbeh.2003.09.009; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Bentrem DJ, 2001, ENDOCRINOLOGY, V142, P838, DOI 10.1210/en.142.2.838; Brian JV, 2006, J FISH BIOL, V68, P1883, DOI 10.1111/j.0022-1112.2006.01053.x; Cevasco A, 2008, COMP BIOCHEM PHYS C, V147, P241, DOI 10.1016/j.cbpc.2007.10.001; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Clotfelter ED, 2004, ANIM BEHAV, V68, P665, DOI 10.1016/j.anbehav.2004.05.004; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Doloresco F, 2011, AM J HEALTH-SYST PH, V68, P921, DOI 10.2146/ajhp100712; Falconer IR, 2006, ENVIRON TOXICOL, V21, P181, DOI 10.1002/tox.20172; Hilton MJ, 2003, J CHROMATOGR A, V1015, P129, DOI 10.1016/S0021-9673(03)01213-5; Hoffmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032097; Hoffmann F, 2012, GEN COMP ENDOCR, V176, P385, DOI 10.1016/j.ygcen.2012.02.009; Hoffmann F, 2012, CHEMOSPHERE, V87, P1246, DOI 10.1016/j.chemosphere.2012.01.030; Hoffmann F, 2010, HORM BEHAV, V58, P653, DOI 10.1016/j.yhbeh.2010.06.008; Hutchinson TH, 2000, ENVIRON HEALTH PERSP, V108, P1007, DOI 10.2307/3434950; Inadera H, 2006, TOXICOL LETT, V164, P191, DOI 10.1016/j.toxlet.2006.03.006; Jackson IM, 1991, MED MANAGEMENT BREAS, P51; Kawahara T, 2000, ZOOL SCI, V17, P65, DOI 10.2108/zsj.17.65; KELLEY DB, 1976, HORM BEHAV, V7, P159, DOI 10.1016/0018-506X(76)90045-3; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Kloas W, 2002, INT REV CYTOL, V216, P1; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Massari A, 2010, GEN COMP ENDOCR, V168, P262, DOI 10.1016/j.ygcen.2010.04.012; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; NICHOLSON RI, 1995, ANN NY ACAD SCI, V761, P148, DOI 10.1111/j.1749-6632.1995.tb31376.x; Opitz R, 2006, TOXICOL SCI, V90, P337, DOI 10.1093/toxsci/kfj083; Opitz R, 2005, ENVIRON TOXICOL CHEM, V24, P653, DOI 10.1897/04-214R.1; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pottinger TG, 2003, PURE APPL CHEM, V75, P2321, DOI 10.1351/pac200375112321; Roberts PH, 2006, SCI TOTAL ENVIRON, V356, P143, DOI 10.1016/j.scitotenv.2005.04.031; Saaristo M, 2010, AQUAT TOXICOL, V97, P285, DOI 10.1016/j.aquatox.2009.12.015; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sun LW, 2009, AQUAT TOXICOL, V93, P83, DOI 10.1016/j.aquatox.2009.03.010; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; Urbatzka R, 2006, GEN COMP ENDOCR, V146, P119, DOI 10.1016/j.ygcen.2005.10.005; Urbatzka R, 2009, J MOL ENDOCRINOL, V43, P209, DOI 10.1677/JME-09-0058; Urbatzka R, 2007, COMP BIOCHEM PHYS C, V144, P310, DOI 10.1016/j.cbpc.2006.10.008; WAKELING AE, 1995, BIOCHEM PHARMACOL, V49, P1545, DOI 10.1016/0006-2952(94)00528-T; WAKELING AE, 1988, J STEROID BIOCHEM, V31, P645, DOI 10.1016/0022-4731(88)90014-3; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Wardley AM, 2002, INT J CLIN PRACT, V56, P305; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WETZEL DM, 1983, HORM BEHAV, V17, P388, DOI 10.1016/0018-506X(83)90048-X; Xu H, 2008, AQUAT TOXICOL, V88, P1, DOI 10.1016/j.aquatox.2008.01.020; YAGER D, 1982, AM ZOOL, V22, P887; Yang EJ, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P693; Zala SM, 2004, ANIM BEHAV, V68, P649, DOI 10.1016/j.anbehav.2004.01.005	62	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44715	10.1371/journal.pone.0044715	http://dx.doi.org/10.1371/journal.pone.0044715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028589	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900038
J	Li, Z; Chen, J; Li, L; Ran, JH; Li, XH; Liu, ZH; Liu, GJ; Gao, YC; Zhang, XL; Sun, HD				Li, Zhu; Chen, Juan; Li, Li; Ran, Jiang-Hua; Li, Xue-Hua; Liu, Zhi-Heng; Liu, Gui-Jie; Gao, Yan-Chao; Zhang, Xue-Li; Sun, Hiu-Dong			Human Hepatocyte Growth Factor (hHGF)-Modified Hepatic Oval Cells Improve Liver Transplant Survival	PLOS ONE			English	Article							2-ACETYLAMINOFLUORENE/PARTIAL HEPATECTOMY MODEL; STEM-CELLS; PROLIFERATION; REJECTION; RATS; COMPLICATIONS; REGENERATION; RECIPIENTS; INDUCTION; TOLERANCE	Despite progress in the field of immunosuppression, acute rejection is still a common postoperative complication following liver transplantation. This study aims to investigate the capacity of the human hepatocyte growth factor (hHGF) in modifying hepatic oval cells (HOCs) administered simultaneously with orthotopic liver transplantation as a means of improving graft survival. HOCs were activated and isolated using a modified 2-acetylaminofluorene/partial hepatectomy (2-AAF/PH) model in male Lewis rats. A HOC line stably expressing the HGF gene was established following stable transfection of the pBLAST2-hHGF plasmid. Our results demonstrated that hHGF-modified HOCs could efficiently differentiate into hepatocytes and bile duct epithelial cells in vitro. Administration of HOCs at the time of liver transplantation induced a wider distribution of SRY-positive donor cells in liver tissues. Administration of hHGF-HOC at the time of transplantation remarkably prolonged the median survival time and improved liver function for recipients compared to these parameters in the other treatment groups (P<0.05). Moreover, hHGF-HOC administration at the time of liver transplantation significantly suppressed elevation of interleukin-2 (IL-2), tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) levels while increasing the production of IL-10 and TGF-beta 1 (P<0.05). HOC or hHGF-HOC administration promoted cell proliferation, reduced cell apoptosis, and decreased liver allograft rejection rates. Furthermore, hHGF-modified HOCs more efficiently reduced acute allograft rejection (P<0.05 versus HOC transplantation only). Our results indicate that the combination of hHGF-modified HOCs with liver transplantation decreased host anti-graft immune responses resulting in a reduction of allograft rejection rates and prolonging graft survival in recipient rats. This suggests that HOC-based cell transplantation therapies can be developed as a means of treating severe liver injuries.	[Li, Zhu; Chen, Juan; Li, Xue-Hua; Liu, Zhi-Heng; Liu, Gui-Jie; Gao, Yan-Chao; Zhang, Xue-Li; Sun, Hiu-Dong] Liaocheng Peoples Hosp, Dept Hepatobiliary Surg, Liaocheng, Shandong, Peoples R China; [Li, Li; Ran, Jiang-Hua] First Peoples Hosp Kunming, Kunming, Yunnan, Peoples R China		Li, Z (corresponding author), Liaocheng Peoples Hosp, Dept Hepatobiliary Surg, Liaocheng, Shandong, Peoples R China.	lllllzhu@126.com						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azuma H, 2001, J AM SOC NEPHROL, V12, P1280, DOI 10.1681/ASN.V1261280; Chang John T, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE19, DOI 10.1097/01.mpg.0000313832.47207.0e; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Chung HW, 2007, TRANSPLANTATION, V83, P694, DOI 10.1097/01.tp.0000259386.59375.8a; Faris RA, 2001, ARTIF ORGANS, V25, P513, DOI 10.1046/j.1525-1594.2001.025007513.x; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Hasuike S, 2005, J GASTROEN HEPATOL, V20, P1753, DOI 10.1111/j.1440-1746.2005.03922.x; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kato H, 2007, HEPATO-GASTROENTEROL, V54, P821; Kaufman DB, 2004, AM J TRANSPLANT, V4, P38, DOI 10.1111/j.1600-6135.2004.00397.x; Knechtle SJ, 2009, SEMIN LIVER DIS, V29, P91, DOI 10.1055/s-0029-1192058; Locke Jayme E, 2009, Adv Surg, V43, P35; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mukherjee S, 2009, J TRANSPLANT, V2009, DOI 10.1155/2009/701464; Patel H, 2007, LEUKEMIA LYMPHOMA, V48, P885, DOI 10.1080/10428190701223275; Shiota G, 2000, FEBS LETT, V470, P325, DOI 10.1016/S0014-5793(00)01337-5; Smets F, 2008, PEDIATR TRANSPLANT, V12, P6, DOI 10.1111/j.1399-3046.2007.00788.x; Solez K, 2010, CURR OPIN ORGAN TRAN, V15, P49, DOI 10.1097/MOT.0b013e328334fedb; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Strom TB, 1996, CURR OPIN IMMUNOL, V8, P688, DOI 10.1016/S0952-7915(96)80087-2; Tamsel S, 2007, ABDOM IMAGING, V32, P339, DOI 10.1007/s00261-006-9041-z; Tosh D, 2005, J HEPATOL, V42, pS75, DOI 10.1016/j.jhep.2004.12.009; VanBuskirk AM, 1996, TRANSPLANTATION, V62, P229, DOI 10.1097/00007890-199607270-00014; Xie R., 2006, J JIANGSU U MED EDIT, V16, P392; Yamaura K, 2004, CIRCULATION, V110, P1650, DOI 10.1161/01.CIR.0000143052.45956.71; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; ZIMMERMANN FA, 1983, TRANSPLANT P, V15, P1272	31	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44805	10.1371/journal.pone.0044805	http://dx.doi.org/10.1371/journal.pone.0044805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028627	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900044
J	Randremanana, R; Randrianirina, F; Gousseff, M; Dubois, N; Razafindratsimandresy, R; Hariniana, ER; Garin, B; Randriamanantena, A; Rakotonirina, HC; Ramparany, L; Ramarokoto, CE; Rakotomanana, F; Ratsitorahina, M; Rajatonirina, S; Talarmin, A; Richard, V				Randremanana, Rindra; Randrianirina, Frederique; Gousseff, Marie; Dubois, Natasha; Razafindratsimandresy, Richter; Hariniana, Elisoa Ratsima; Garin, Benoit; Randriamanantena, Arthur; Rakotonirina, Hanitra Clara; Ramparany, Lovasoa; Ramarokoto, Charles Emile; Rakotomanana, Fanjasoa; Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Talarmin, Antoine; Richard, Vincent			Case-Control Study of the Etiology of Infant Diarrheal Disease in 14 Districts in Madagascar	PLOS ONE			English	Article							ROTAVIRUS INFECTION; ESCHERICHIA-COLI; GASTROENTERITIS; CHILDREN; AFRICA; CAMPYLOBACTER; COUNTRIES	Background: Acute diarrhea is a major cause of childhood morbidity and mortality worldwide. Its microbiological causes and clinico-epidemiological aspects were examined during the rainy seasons from 2008 to 2009 in 14 districts in Madagascar. Methods: Stool specimens of 2196 children with acute diarrhea and 496 healthy children were collected in a community setting. Intestinal parasites were diagnosed by microscopy and bacteria by culturing methods. Rota-, astro and adenoviruses were identified using commercially available ELISA kits and rotaviruses were confirmed using reverse transcriptase polymerase chain reaction (RT-PCR). Results: Intestinal microorganisms were isolated from 54.6% of diarrheal patients and 45.9% of healthy subjects (p =<0.01). The most common pathogens in diarrheic patients were intestinal parasites (36.5%). Campylobacter spp. and Rotavirus were detected in 9.7% and 6.7% of diarrheic patients. The detection rates of Entamoeba histolytica, Trichomonas intestinalis and Giardia lamblia were much greater in diarrheal patients than in non diarrheal subjects (odds ratios of 5.1, 3.2, 1.7 respectively). The abundance of other enteropathogens among the non diarrheal group may indicate prolonged excretion or limited pathogenicity. Conclusion: In developing countries, where the lack of laboratory capacities is great, cross sectional studies of enteropathogens and their spatial distribution, including diarrheal and non diarrheal subjects, are interesting tools in order to advise regional policies on treatment and diarrheic patient management.	[Randremanana, Rindra; Gousseff, Marie; Randriamanantena, Arthur; Ramarokoto, Charles Emile; Rakotomanana, Fanjasoa; Ratsitorahina, Maherisoa; Rajatonirina, Soatiana; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Randrianirina, Frederique; Hariniana, Elisoa Ratsima] Inst Pasteur Madagascar, Clin Biol Ctr, Antananarivo, Madagascar; [Dubois, Natasha; Garin, Benoit; Rakotonirina, Hanitra Clara] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Razafindratsimandresy, Richter; Ramparany, Lovasoa] Inst Pasteur Madagascar, Mol Biol Unit, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Richard, V (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	vrichard@pasteur.sn	Razafindratsimandresy, Richter/H-9881-2014	Ramarokoto, Charles Emile/0000-0001-7831-7057; Vincent, RICHARD/0000-0002-6961-1753; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075	TOTAL fondation; Institut Pasteur de Madagascar	TOTAL fondation; Institut Pasteur de Madagascar	Funding by TOTAL fondation and Institut Pasteur de Madagascar. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adiku TK, 2010, J INFECT DIS, V202, pS175, DOI 10.1086/653565; Areeshi M, 2008, ANN TROP MED PARASIT, V102, P309, DOI 10.1179/136485908X278793; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; CASSEL-BERAUD A M, 1990, Archives de l'Institut Pasteur de Madagascar, V57, P223; CASSELBERAUD AM, 1993, J DIARRHOEAL DIS RES, V11, P82; Esona MD, 2003, J TROP PEDIATRICS, V49, P160, DOI 10.1093/tropej/49.3.160; Gomez-Duarte OG, 2009, DIAGN MICR INFEC DIS, V63, P1, DOI 10.1016/j.diagmicrobio.2008.09.006; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rahouma A, 2011, AM J TROP MED HYG, V84, P886, DOI 10.4269/ajtmh.2011.11-0116; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; TAYLOR DN, 1992, CAMPLYLOBACTER JEJUNI, P20; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Waggie Z, 2010, J INFECT DIS, V202, pS23, DOI 10.1086/653554; Wolfaardt M, 1997, J MED VIROL, V51, P290, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;290::AID-JMV6&gt;3.0.CO;2-0	19	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44533	10.1371/journal.pone.0044533	http://dx.doi.org/10.1371/journal.pone.0044533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028555	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800012
J	He, Y; Xu, TT; Fossheim, LE; Zhang, XH				He, Yang; Xu, Tingting; Fossheim, Leif E.; Zhang, Xiao-Hua			FliC, a Flagellin Protein, Is Essential for the Growth and Virulence of Fish Pathogen Edwardsiella tarda	PLOS ONE			English	Article							III SECRETION; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; BIOFILM; POLYPHOSPHATE; REQUIREMENT; SALMONELLA; MOTILITIES; INSIGHTS; PROVIDES	Edwardsiella tarda is a flagellated Gram-negative bacterium which causes edwardsiellosis in fish. FliC, as a flagellar filament structural protein, is hypothesized to be involved in the pathogenesis of infection. In this study, a fliC in-frame deletion mutant of a virulent isolate of E. tarda was constructed through double crossover allelic exchange by means of the suicide vector pRE112, and its virulence-associated phenotypes and pathogenicity were tested. It was found that the deletion of fliC significantly decreased the diameter of flagella filaments. In addition, the mutant showed reduced pathogenicity to fish by increasing the LD50 value for 100-fold compared to the wild-type strain, as well as showed impaired bacterial growth, reduced motility, decreased biofilm formation and reduced levels of virulence-associated protein secretion involved in the type III secretion system (TTSS). The phenotypic characteristics of the fliC deletion mutant uncovered in this investigation suggest that fliC plays an essential role in normal flagellum function, bacterial growth, protein secretion by TTSS and bacterial virulence.	[He, Yang; Xu, Tingting; Fossheim, Leif E.; Zhang, Xiao-Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	He, Y (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	xhzhang@ouc.edu.cn			National High Technology Research Development Program of China (863 Programs) [2008AA092501]	National High Technology Research Development Program of China (863 Programs)(National High Technology Research and Development Program of China)	The work was supported by grants from the National High Technology Research Development Program of China (863 Programs, no. 2008AA092501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbass A, 2010, J FISH DIS, V33, P31, DOI 10.1111/j.1365-2761.2009.01086.x; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Austin B, 1989, METHODS MICROBIOLOGI; Dong Li, 2009, Marine Sciences (Beijing), V33, P57; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Lee DC, 2010, FISH PATHOL, V45, P17, DOI 10.3147/jsfp.45.17; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; Mashimo T, 2007, J BACTERIOL, V189, P5153, DOI 10.1128/JB.00061-07; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Seung HC, 2011, FISH SHELLFISH IMMUN, V31, P58; Simon R, 1983, BIOTECHNOLOGY, V1, P787; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tambalo DD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-219; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Verjan N, 2005, APPL ENVIRON MICROB, V71, P5654, DOI 10.1128/AEM.71.9.5654-5658.2005; Wakimoto N, 2004, AM J TROP MED HYG, V71, P687, DOI 10.4269/ajtmh.2004.71.687; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wardlaw A.C., 1985, PRACTICAL STAT EXPT; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Zhang XH, 2000, J FISH DIS, V23, P93, DOI 10.1046/j.1365-2761.2000.00214.x	32	48	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45070	10.1371/journal.pone.0045070	http://dx.doi.org/10.1371/journal.pone.0045070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024793	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100051
J	Kenchegowda, D; Harvey, SAK; Swamynathan, S; Lathrop, KL; Swamynathan, SK				Kenchegowda, Doreswamy; Harvey, Stephen A. K.; Swamynathan, Sudha; Lathrop, Kira L.; Swamynathan, Shivalingappa K.			Critical Role of Klf5 in Regulating Gene Expression during Post-Eyelid Opening Maturation of Mouse	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; METALLOPROTEINASE GELATINASE B; CONJUNCTIVAL GOBLET CELLS; KRUPPEL-LIKE FACTOR-4; PAS DOMAIN PROTEIN; TRANSCRIPTION FACTORS; OCULAR SURFACE; MOLECULAR-BASIS; STROMAL EDEMA; UP-REGULATION	Background: Klf5 plays an important role in maturation and maintenance of the mouse ocular surface. Here, we quantify WT and Klf5-conditional null (Klf5CN) corneal gene expression, identify Klf5-target genes and compare them with the previously identified Klf4-target genes to understand the molecular basis for non-redundant functions of Klf4 and Klf5 in the cornea. Methodology/Principal Findings: Postnatal day-11 (PN11) and PN56 WT and Klf5CN corneal transcriptomes were quantified by microarrays to compare gene expression in maturing WT corneas, identify Klf5-target genes, and compare corneal Klf4-and Klf5-target genes. Whole-mount corneal immunofluorescent staining was employed to examine CD45+ cell influx and neovascularization. Effect of Klf5 on expression of desmosomal components was studied by immunofluorescent staining and transient co-transfection assays. Expression of 714 and 753 genes was increased, and 299 and 210 genes decreased in PN11 and PN56 Klf5CN corneas, respectively, with 366 concordant increases and 72 concordant decreases. PN56 Klf5CN corneas shared 241 increases and 98 decreases with those previously described in Klf4CN corneas. Xenobiotic metabolism related pathways were enriched among genes decreased in Klf5CN corneas. Expression of angiogenesis and immune response-related genes was elevated, consistent with neovascularization and CD45+ cell influx in Klf5CN corneas. Expression of 1574 genes was increased and 1915 genes decreased in WT PN56 compared with PN11 corneas. Expression of ECM-associated genes decreased, while that of solute carrier family members increased in WT PN56 compared with PN11 corneas. Dsg1a, Dsg1b and Dsp were down-regulated in Klf5CN corneas and their corresponding promoter activities were stimulated by Klf5 in transient co-transfection assays. Conclusions/Significance: Differences between PN11 and PN56 corneal Klf5-target genes reveal dynamic changes in functions of Klf5 during corneal maturation. Klf5 contributes to corneal epithelial homeostasis by regulating the expression of desmosomal components. Klf4- and Klf5-target genes are largely distinct, consistent with their non-redundant roles in the mouse cornea.	[Kenchegowda, Doreswamy; Harvey, Stephen A. K.; Swamynathan, Sudha; Lathrop, Kira L.; Swamynathan, Shivalingappa K.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Swamynathan, Shivalingappa K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Swamynathan, Shivalingappa K.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kenchegowda, D (corresponding author), Univ Maryland, Dept Med, Baltimore, MD 21201 USA.	Swamynathansk@upmc.edu		Swamynathan, Shivalingappa/0000-0002-9158-1511	National Eye Institute (NEI) K22 Career Development Award [EY016875]; Department of Ophthalmology, Core Grant for Vision Research [5P30 EY08098-19]; Research to Prevent Blindness; Eye and Ear Foundation, Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, K22EY016875] Funding Source: NIH RePORTER	National Eye Institute (NEI) K22 Career Development Award; Department of Ophthalmology, Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation, Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (NEI) K22 Career Development Award EY016875 (SKS), startup funds from the Department of Ophthalmology, Core Grant for Vision Research (5P30 EY08098-19), Research to Prevent Blindness and the Eye and Ear Foundation, Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P1219, DOI 10.1167/iovs.04-1285; Bell SM, 2011, DEV BIOL, V358, P79, DOI 10.1016/j.ydbio.2011.07.020; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Boesch JS, 1999, ARCH BIOCHEM BIOPHYS, V361, P223, DOI 10.1006/abbi.1998.0989; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; BONANNO JA, 2003, EYE CONTACT LENS, V29, pS192; BONANNO JA, 2003, EYE CONTACT LENS S, V29, pS26; Bonanno Joseph A, 2003, Eye Contact Lens, V29, pS7; Chiambaretta F, 2006, INVEST OPHTH VIS SCI, V47, P582, DOI 10.1167/iovs.05-0551; Chiambaretta F, 2004, MOL VIS, V10, P901; Chiambaretta F, 2002, INVEST OPHTH VIS SCI, V43, P3422; Chu PH, 2008, INVEST OPHTH VIS SCI, V49, P5314, DOI 10.1167/iovs.08-2209; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Davis J, 2011, INVEST OPHTH VIS SCI, V52, P4158, DOI 10.1167/iovs.10-6726; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Dwivedi DJ, 2005, INVEST OPHTH VIS SCI, V46, P3623, DOI 10.1167/iovs.05-0028; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Farkas RH, 2004, INVEST OPHTH VIS SCI, V45, P1410, DOI 10.1167/iovs.03-0872; Fragiadaki M, 2011, MOL BIOL CELL, V22, P1836, DOI 10.1091/mbc.E10-08-0669; Francesconi CM, 2000, INVEST OPHTH VIS SCI, V41, P1054; Gage PJ, 2009, DEV DYNAM, V238, P2149, DOI 10.1002/dvdy.22033; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; GIPSON IK, 1992, ACTA OPHTHALMOL, V70, P13; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gupta D, 2011, INVEST OPHTHALMOL VI; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Harvey SAK, 2010, INVEST OPHTH VIS SCI, V51, P2917, DOI 10.1167/iovs.09-4498; Hausman RE, 2007, PROG RETIN EYE RES, V26, P162, DOI 10.1016/j.preteyeres.2006.11.001; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Hough RB, 2004, MOL CELL BIOL, V24, P1324, DOI 10.1128/MCB.24.3.1324-1340.2004; Kenchegowda D, 2011, DEV BIOL, V356, P5, DOI 10.1016/j.ydbio.2011.05.005; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Kloeckener-Gruissem B, 2008, AM J HUM GENET, V82, P772, DOI 10.1016/j.ajhg.2007.12.013; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Liao SY, 2003, J MED GENET, V40, P257, DOI 10.1136/jmg.40.4.257; Liesegang Thomas J., 2002, CLAO Journal, V28, P12; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; MANDELL RB, 1965, NATURE, V208, P292, DOI 10.1038/208292a0; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; Nakamura H, 2004, INVEST OPHTH VIS SCI, V45, P4327, DOI 10.1167/iovs.04-0353; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Norman B, 2004, INVEST OPHTH VIS SCI, V45, P429, DOI 10.1167/iovs.03-0449; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Sivak JM, 2000, DEV BIOL, V222, P41, DOI 10.1006/dbio.2000.9694; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Stasi K, 2007, INVEST OPHTH VIS SCI, V48, P727, DOI 10.1167/iovs.06-0497; Stucchi A, 2006, INFLAMM BOWEL DIS, V12, P581, DOI 10.1097/01.MIB.0000225338.14356.d5; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan Shivalingappa K., 2010, Human Genomics, V4, P263; Swamynathan S, 2011, INVEST OPHTH VIS SCI, V52, P1762, DOI 10.1167/iovs.10-6134; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Ueta M, 2005, INVEST OPHTH VIS SCI, V46, P579, DOI 10.1167/iovs.04-1055; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wolosin JM, 2004, INT J DEV BIOL, V48, P981, DOI 10.1387/ijdb.041876jw; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Young RD, 2009, INVEST OPHTH VIS SCI, V50, P4155, DOI 10.1167/iovs.09-3561; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	77	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44771	10.1371/journal.pone.0044771	http://dx.doi.org/10.1371/journal.pone.0044771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024760	Green Accepted, gold, Green Published			2022-12-25	WOS:000308860100018
J	Park, JH; Ryoo, S; Kim, SJ; Kim, GM; Chung, CS; Lee, KH; Bang, OY				Park, Jae-Hyun; Ryoo, Sookyung; Kim, Suk Jae; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Bang, Oh Young			Differential Risk Factors for Lacunar Stroke Depending on the MRI (White and Red) Subtypes of Microangiopathy	PLOS ONE			English	Article							SMALL VESSEL DISEASE; AMBULATORY BLOOD-PRESSURE; CEREBRAL MICROBLEEDS; PLASMA-FIBRINOGEN; BRAIN MICROBLEEDS; VISCOSITY; LESIONS; SILENT; AGE	Background: Leukoaraiosis and cerebral microbleeds (CMB), which represent cerebral microangiopathy, commonly coexist in patients with acute lacunar stroke. Since they may have different impacts on stroke prognosis and treatment, it is important to know the factors associated with leukoaraiosis-predominant vs. CMB-predominant microangiopathies. Methods: We prospectively recruited 226 patients with acute lacunar infarction and divided them into four groups according to the Fazekas' score and the presence of CMB: mild, red (predominant CMB), white (predominant leukoaraiosis) and severe microangiopathy groups. For comparison, we also evaluated 50 patients with intracerebral hemorrhage (ICH). We evaluated the clinical and laboratory findings of microangiopathy subtypes in patients with acute lacunar stroke and then compared them with those of primary ICH. Results: The risk factor profile was different among the groups. Patients with acute lacunar infarct but mild microangiopathy were younger, predominantly male, less hypertensive, and more frequently had smoking and heavy alcohol habits than other groups. The risk factor profile of red microangiopathy was similar to that of ICH but differed from that of white microangiopathy. The subjects in the white microangiopathy group were older and more frequently had diabetes than those in the red microangiopathy or ICH group. After adjustments for other factors, age [ odds ratio (OR) 1.13; 95% confidence interval (CI) 1.08-1.18; rho<0.001] and diabetes (OR 2.28; 95% CI 1.02-5.13; rho = 0.045) were independently associated with white microangiopathy, and age (OR 1.05; 95% CI 1.01-1.08; rho = 0.010) was independent predictor for red microangiopathy compared to mild microangiopathy. Conclusion: Patients with acute lacunar infarction have a different risk factor profile depending on microangiopathic findings. Our results indicate that diabetes may be an one of determinants of white (leukoaraiosis-predominant) microangiopathy, whereas smoking and alcohol habits in relatively young people may be a determinants of mild microangiopahic changes in patients with lacunar infarction.	[Park, Jae-Hyun; Ryoo, Sookyung; Kim, Suk Jae; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr			Korean Healthcare Technology R&D Project, Ministry of Health Welfare [A110208]	Korean Healthcare Technology R&D Project, Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (A110208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aono Y, 2007, ARTERIOSCL THROM VAS, V27, P963, DOI 10.1161/01.ATV.0000258947.17570.38; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Bang OY, 2007, CEREBROVASC DIS, V24, P520, DOI 10.1159/000110422; Bang OY, 2002, ARCH NEUROL-CHICAGO, V59, P259, DOI 10.1001/archneur.59.2.259; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Danesh J, 2000, EUR HEART J, V21, P515, DOI 10.1053/euhj.1999.1699; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Henskens LHG, 2008, HYPERTENSION, V51, P62, DOI 10.1161/HYPERTENSIONAHA.107.100610; Jackson C, 2005, BRAIN, V128, P2507, DOI 10.1093/brain/awh636; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Kidwell CS, 2009, NEUROLOGY, V73, P1614, DOI 10.1212/WNL.0b013e3181c17fa1; Kitamura A, 2006, STROKE, V37, P1374, DOI 10.1161/01.STR.0000221714.96986.5f; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SH, 2002, STROKE, V33, P2845, DOI 10.1161/01.STR.0000036092.23649.2E; Lominadze D, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02037.x; Lovelock CE, 2010, STROKE, V41, P1222, DOI 10.1161/STROKEAHA.109.572594; Nascetti S, 2001, EUR J EPIDEMIOL, V17, P953, DOI 10.1023/A:1016216808365; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Ryoo S, 2012, NEUROLOGY, V78, P888, DOI 10.1212/WNL.0b013e31824c4699; SCHNEIDER R, 1985, J NEUROL, V232, P357, DOI 10.1007/BF00313836; Shinohara Y, 2008, CEREBROVASC DIS, V26, P63, DOI 10.1159/000135654; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Tsuda Y, 1997, J NEUROL SCI, V147, P49, DOI 10.1016/S0022-510X(96)05309-9	31	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44865	10.1371/journal.pone.0044865	http://dx.doi.org/10.1371/journal.pone.0044865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024771	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100029
J	Qu, YY; Shi, SN; Zhou, H; Ma, Q; Li, XL; Zhang, XW; Zhou, JT				Qu, Yuanyuan; Shi, Shengnan; Zhou, Hao; Ma, Qiao; Li, Xinliang; Zhang, Xuwang; Zhou, Jiti			Characterization of a Novel Phenol Hydroxylase in Indoles Biotranformation from a Strain Arthrobacter sp W1	PLOS ONE			English	Article							BACTERIAL MULTICOMPONENT MONOOXYGENASES; PSEUDOMONAS-STUTZERI OX1; SOLVENT 2-PHASE SYSTEM; ESCHERICHIA-COLI; INDIGO FORMATION; SUBSTRATE-SPECIFICITY; CYTOCHROME-P450 2A6; OXIDATION; GENE; SITE	Background: Indigoids, as popular dyes, can be produced by microbial strains or enzymes catalysis. However, the new valuable products with their transformation mechanisms, especially inter-conversion among the intermediates and products have not been clearly identified yet. Therefore, it is necessary to investigate novel microbial catalytic processes for indigoids production systematically. Findings: A phenol hydroxylase gene cluster (4,606 bp) from Arthrobacter sp. W1 (PHw1) was obtained. This cluster contains six components in the order of KLMNOP, which exhibit relatively low sequence identities (37-72%) with known genes. It was suggested that indole and all the tested indole derivatives except for 3-methylindole were transformed to various substituted indigoid pigments, and the predominant color products derived from indoles were identified by spectrum analysis. One new purple product from indole, 2-(7-oxo-1H-indol-6(7H)-ylidene) indolin-3-one, should be proposed as the dimerization of isatin and 7-hydroxylindole at the C-2 and C-6 positions. Tunnel entrance and docking studies were used to predict the important amino acids for indoles biotransformation, which were further proved by site-directed mutagenesis. Conclusions/Significance: We showed that the phenol hydroxylase from genus Arthrobacter could transform indoles to indigoids with new chemical compounds being produced. Our work should show high insights into understanding the mechanism of indigoids bio-production.	[Qu, Yuanyuan; Zhou, Hao; Ma, Qiao; Li, Xinliang; Zhang, Xuwang; Zhou, Jiti] Dalian Univ Technol, Minist Educ, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China; [Shi, Shengnan] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China	Dalian University of Technology; Harbin Institute of Technology	Qu, YY (corresponding author), Dalian Univ Technol, Minist Educ, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Dalian, Peoples R China.	qyy@dlut.edu.cn	Ma, Qiao/L-1317-2015; zhou, hao/K-2701-2015; Zhang, Xuwang/L-7097-2019; ma, qiao/AAK-2605-2021	zhou, hao/0000-0002-3901-6582; Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [51078054, 14 21176040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 51078054; No. 14 21176040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafaro V, 2005, APPL ENVIRON MICROB, V71, P4736, DOI 10.1128/AEM.71.8.4736-4743.2005; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Choi HS, 2003, BIOCHEM BIOPH RES CO, V306, P930, DOI 10.1016/S0006-291X(03)01087-8; Doukyu N, 2003, APPL MICROBIOL BIOT, V60, P720, DOI 10.1007/s00253-002-1187-1; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Doukyu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1075, DOI 10.1271/bbb.62.1075; Drewlo S, 2001, APPL ENVIRON MICROB, V67, P1964, DOI 10.1128/AEM.67.4.1964-1969.2001; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Guengerich FP, 2004, J MED CHEM, V47, P3236, DOI 10.1021/jm030561b; HART S, 1992, J GEN MICROBIOL, V138, P211, DOI 10.1099/00221287-138-1-211; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Huxtable R J, 2001, Mol Interv, V1, P141; Kim D, 2005, J BIOL CHEM, V280, P40319, DOI 10.1074/jbc.M508171200; Kim JY, 2005, LETT APPL MICROBIOL, V41, P163, DOI 10.1111/j.1472-765X.2005.01734.x; Kim JY, 2003, LETT APPL MICROBIOL, V36, P343, DOI 10.1046/j.1472-765X.2003.01279.x; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; MERMOD N, 1986, BIO-TECHNOL, V4, P321, DOI 10.1038/nbt0486-321; Meyer A, 2002, J BIOL CHEM, V277, P34161, DOI 10.1074/jbc.M205621200; MURDOCK D, 1993, BIO-TECHNOL, V11, P381, DOI 10.1038/nbt0393-381; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; NORDLUND I, 1990, J BACTERIOL, V172, P6826, DOI 10.1128/jb.172.12.6826-6833.1990; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Powlowski J, 1997, J BIOL CHEM, V272, P945, DOI 10.1074/jbc.272.2.945; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Qu YY, 2011, APPL MICROBIOL BIOT, V89, P655, DOI 10.1007/s00253-010-2874-y; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Rosic NN, 2009, APPL MICROBIOL BIOT, V82, P203, DOI 10.1007/s00253-008-1812-8; Rui LY, 2005, APPL MICROBIOL BIOT, V66, P422, DOI 10.1007/s00253-004-1698-z; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Smith J.A., 2000, CURRENT PROTOCOLS MO; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang P, 2009, APPL BIOCHEM BIOTECH, V159, P623, DOI 10.1007/s12010-008-8494-7; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Zhang ZG, 2009, J BIOTECHNOL, V139, P12, DOI 10.1016/j.jbiotec.2008.09.010	44	19	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44313	10.1371/journal.pone.0044313	http://dx.doi.org/10.1371/journal.pone.0044313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028517	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700019
J	Xu, BL; Wang, J; Zhang, M; Wang, P; Wei, ZG; Sun, Y; Tao, QQ; Ren, LM; Hu, XX; Guo, Y; Fei, J; Zhang, L; Li, N; Zhao, YF				Xu, Beilei; Wang, Jing; Zhang, Min; Wang, Ping; Wei, Zhiguo; Sun, Yi; Tao, Qiqing; Ren, Liming; Hu, Xiaoxiang; Guo, Ying; Fei, Jing; Zhang, Lei; Li, Ning; Zhao, Yaofeng			Expressional Analysis of Immunoglobulin D in Cattle (Bos taurus), a Large Domesticated Ungulate	PLOS ONE			English	Article							B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; CLASS SWITCH RECOMBINATION; EXCEPTIONALLY LONG CDR3H; CONSTANT-REGION DOMAIN; ILEAL PEYERS-PATCHES; H GENE FAMILY; HUMAN IGD; T-CELL; REPERTOIRE DEVELOPMENT	For decades, it has remained unknown whether artiodactyls, such as cattle, pigs, and sheep, express immunoglobulin D (IgD), although the delta gene was identified in these species nearly 10 years ago. By developing a mouse anti-bovine IgD heavy chain monoclonal antibody (13C2), we show that secreted bovine IgD was present mainly as a monomer in serum and was heavily glycosylated by N-linked saccharides. Nonetheless, IgD was detectable in some but not all of the Holstein cattle examined. Membrane-bound IgD was detected in the spleen by western blotting. Flow cytometric analysis demonstrated that IgD-positive B cells constituted a much lower percentage of B cells in the bovine spleen (similar to 6.8% of total B cells), jejunal Peyer's patches (similar to 0.8%), and peripheral blood leukocytes (similar to 1.2%) than in humans and mice. Furthermore, IgD-positive B cells were almost undetectable in bovine bone marrow and ileal Peyer's patches. We also demonstrated that the bovine delta gene can be expressed via class switch recombination. Accordingly, bovine delta germline transcription, which involves an I delta exon and is highly homologous to I mu, was confirmed. However, we could not identify an I delta promoter, despite bovine E mu demonstrating both enhancer and promoter activity. This study has answered a long-standing question in cattle B cell biology and significantly contributes to our understanding of B cell development in this species.	[Xu, Beilei; Wang, Jing; Zhang, Min; Wang, Ping; Sun, Yi; Tao, Qiqing; Ren, Liming; Hu, Xiaoxiang; Guo, Ying; Fei, Jing; Zhang, Lei; Li, Ning; Zhao, Yaofeng] China Agr Univ, Coll Biol Sci, Natl Engn Lab Anim Breeding, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Xu, BL (corresponding author), China Agr Univ, Coll Biol Sci, Natl Engn Lab Anim Breeding, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yaofengzhao@cau.edu.cn		wang, jing/0000-0002-7120-0857	National Science Fund for Distinguished Young Scholars [30725029]; Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program) [2010CB945300]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Science Fund for Distinguished Young Scholars (30725029), the Taishan Scholar Foundation of Shandong Province, the National Basic Research Program of China (973 Program-2010CB945300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 1998, J EXP MED, V187, P1169, DOI 10.1084/jem.187.8.1169; Bernstein RM, 1996, P NATL ACAD SCI USA, V93, P3289, DOI 10.1073/pnas.93.8.3289; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Butler JE, 1996, INT IMMUNOL, V8, P1897, DOI 10.1093/intimm/8.12.1897; Butler JE, 2011, J IMMUNOL, V187, P5141, DOI 10.4049/jimmunol.1101871; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Du LK, 2008, J EXP MED, V205, P3031, DOI 10.1084/jem.20081915; Ekman A, 2012, DEV COMP IMMUNOL, V37, P39, DOI 10.1016/j.dci.2011.12.009; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; FINKELMAN FD, 1979, J IMMUNOL, V123, P1253; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kluin PM, 1995, EUR J IMMUNOL, V25, P3504, DOI 10.1002/eji.1830251244; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; MacHugh ND, 1997, IMMUNOLOGY, V92, P340, DOI 10.1046/j.1365-2567.1997.00350.x; MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1; MELLIS SJ, 1983, J BIOL CHEM, V258, P1557; MOORE KW, 1981, P NATL ACAD SCI-BIOL, V78, P1800, DOI 10.1073/pnas.78.3.1800; NAESSENS J, 1992, EUR J IMMUNOL, V22, P1713, DOI 10.1002/eji.1830220708; Naessens J, 1997, INT IMMUNOL, V9, P349, DOI 10.1093/intimm/9.3.349; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Overed-Sayer CL., 2009, CURR PROTOC IMMUNOL, V85, P291, DOI [10.1002/0471142735.im0209bs85, DOI 10.1002/0471142735.IM0209BS85]; Pessa-Morikawa T, 2004, DEV COMP IMMUNOL, V28, P77, DOI 10.1016/S0145-305X(03)00104-6; PUTNAM FW, 1981, P NATL ACAD SCI-BIOL, V78, P6168, DOI 10.1073/pnas.78.10.6168; Rogers AN, 2005, J IMMUNOL, V174, P3386, DOI 10.4049/jimmunol.174.6.3386; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 2002, SCAND J IMMUNOL, V55, P140, DOI 10.1046/j.1365-3083.2002.01028.x; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Shojaei F, 2003, MOL IMMUNOL, V40, P61, DOI 10.1016/S0161-5890(03)00098-1; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sinkora M, 2011, J IMMUNOL, V187, P5150, DOI 10.4049/jimmunol.1101879; Song HF, 2007, J IMMUNOL, V178, P926, DOI 10.4049/jimmunol.178.2.926; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; SU LK, 1990, MOL CELL BIOL, V10, P2619, DOI 10.1128/MCB.10.6.2619; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Swenson CD, 1998, EUR J IMMUNOL, V28, P2366, DOI 10.1002/(SICI)1521-4141(199808)28:08<2366::AID-IMMU2366>3.0.CO;2-D; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Weill JC, 1998, DEV COMP IMMUNOL, V22, P379, DOI 10.1016/S0145-305X(98)00014-7; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Yasuda M, 2006, VET RES, V37, P401, DOI 10.1051/vetres:2006008; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200; Zhao YF, 2003, J IMMUNOL, V171, P1312, DOI 10.4049/jimmunol.171.3.1312; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408	53	6	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44719	10.1371/journal.pone.0044719	http://dx.doi.org/10.1371/journal.pone.0044719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028592	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700032
J	Marin, M; Thallmair, V; Ott, T				Marin, Macarena; Thallmair, Veronika; Ott, Thomas			The Intrinsically Disordered N-terminal Region of AtREM1.3 Remorin Protein Mediates Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; NATIVELY UNFOLDED PROTEINS; VIRUS-X MOVEMENT; IMPORTIN-ALPHA; MEMBRANE RAFTS; BINDING-SITES; I-TASSER; ARABIDOPSIS; PREDICTION; DOMAIN	The longstanding structure-function paradigm, which states that a protein only serves a biological function in a structured state, had to be substantially revised with the description of intrinsic disorder in proteins. Intrinsically disordered regions that undergo a stimulus-dependent disorder-to-order transition are common to a large number of signaling proteins. However, little is known about the functionality of intrinsically disordered regions in plant proteins. Here we investigated intrinsic disorder in a plant-specific remorin protein that has been described as a signaling component in plant-microbe interactions. Using bioinformatic, biochemical, and biophysical approaches, we characterized the highly abundant remorin AtREM1.3, showing that its N-terminal region is intrinsically disordered. Although only the AtREM1.3 C-terminal domain is essential for stable homo-oligomerization, the N-terminal region facilitates this interaction. Furthermore, we confirmed the stable interaction between AtREM1.3 and four isoforms of the importin alpha protein family in a yeast two-hybrid system and by an in planta bimolecular fluorescent complementation assay. Phosphorylation of Ser-66 in the intrinsically disordered N-terminal region decreases the interaction strength with the importin alpha proteins. Hence, the N-terminal region may constitute a regulatory domain, stabilizing these interactions.	[Marin, Macarena; Thallmair, Veronika; Ott, Thomas] Univ Munich, Inst Genet, D-82152 Martinsried, Germany	University of Munich	Marin, M (corresponding author), Univ Munich, Inst Genet, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.	macarena.marin@bio.lmu.de; Thomas.Ott@biologie.uni-muenchen.de	Ott, Thomas/G-7056-2011; Marin, Macarena/H-8742-2013; Ott, Thomas/H-8192-2013	Marin, Macarena/0000-0002-6966-2446; Ott, Thomas/0000-0002-4494-9811	Collaborative Research Center (Sonder-forschungsbereich) [SFB924]; Emmy Noether Program [OT423/2-1]; Deutsche Forschungsgemeinschaft	Collaborative Research Center (Sonder-forschungsbereich)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Collaborative Research Center (Sonder-forschungsbereich) SFB924 and Emmy Noether Program Grant OT423/2-1 funded by the Deutsche Forschungsgemeinschaft.	Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FARMER EE, 1989, P NATL ACAD SCI USA, V86, P1539, DOI 10.1073/pnas.86.5.1539; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Merkle T, 2011, PLANT CELL REP, V30, P153, DOI 10.1007/s00299-010-0928-3; MILLER JH, 1974, EXPT MOL GENETICS, P352; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Perraki A, 2012, PLANT PHYSIOL, V160, P624, DOI 10.1104/pp.112.200519; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; R Core Team, 2012, R LANG ENV STAT COMP; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; REYMOND P, 1995, P NATL ACAD SCI USA, V92, P4145, DOI 10.1073/pnas.92.10.4145; Romero, 1997, GENOME INFORM SER WO, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sun XL, 2010, J BIOL CHEM, V285, P11557, DOI 10.1074/jbc.M109.027011; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030817; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; Yoon MK, 2006, PROTEINS, V65, P856, DOI 10.1002/prot.21089; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	44	44	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.414292	http://dx.doi.org/10.1074/jbc.M112.414292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027878	Green Published, hybrid			2022-12-25	WOS:000311233800065
J	Wang, C; Sun, BG; Zhou, YG; Grubb, A; Gan, L				Wang, Chao; Sun, Binggui; Zhou, Yungui; Grubb, Anders; Gan, Li			Cathepsin B Degrades Amyloid-beta in Mice Expressing Wild-type Human Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL CYSTEINE PROTEINASES; ALZHEIMERS-DISEASE; CYSTATIN-C; A-BETA; TRANSGENIC MICE; MOUSE MODEL; INACTIVATION; DEGRADATION; INHIBITORS; DEFICITS	Accumulation of amyloid-beta (A beta), believed to be a key trigger of Alzheimer disease (AD), could result from impaired clearance mechanisms. Previously, we showed that the cysteine protease cathepsin B (CatB) degrades A beta, most likely by C-terminal truncation, in mice expressing human amyloid precursor protein with familial AD-linked mutations (hAPP(FAD)). In addition, the A beta-degrading activity of CatB is inhibited by its endogenous inhibitor, cystatin C (CysC). Reducing CysC expression markedly lowers A beta levels by enhancing CatB-mediated A beta degradation in hAPP(FAD) mice. However, because a vast majority of AD patients do not carry familial mutations, we investigated how the CysC-CatB axis affects A beta levels in mice expressing wild-type hAPP (hAPP(WT)). Enhancing CatB activity by CysC deletion significantly lowered total A beta and A beta 42 levels in hAPP(WT) mice, whereas CatB deletion increased A beta levels. To determine whether neuron-derived CatB degrades A beta in vivo, we generated transgenic mice overexpressing CatB under the control of a neuron-specific enolase promoter. Enhancing neuronal CatB activity in hAPP(WT) mice significantly lowered A beta 42 levels. The processing of hAPP(WT) was unaffected by increasing or ablating CatB activity. Thus, the CysC-CatB axis affects degradation of A beta 42 derived from hAPP lacking familial mutations. These findings support the notion that enhancing CatB activity could lower A beta, especially A beta 42, in AD patients with or without familial mutations.	[Wang, Chao; Sun, Binggui; Zhou, Yungui; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Wang, Chao; Sun, Binggui; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Lund University; Skane University Hospital	Gan, L (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Wang, Chao/A-4626-2016; Sun, Binggui/J-9028-2016	Wang, Chao/0000-0003-0357-4096; Sun, Binggui/0000-0002-0386-6569; Grubb, Anders/0000-0002-0125-3662	National Institutes of Health [R01 AG030207-01A2]; National Center for Research Resources [CO6 RRO18928]; California Health Services; Swedish Research Council Grant [05196]; S. D. Bechtel, Jr. Foundation; NATIONAL INSTITUTE ON AGING [R01AG030207, R01AG036884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California Health Services; Swedish Research Council Grant(Swedish Research Council); S. D. Bechtel, Jr. Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG030207-01A2 (to L. G.) and Grant CO6 RRO18928 from the National Center for Research Resources (a facilities grant to the J. David Gladstone Institutes). This work was also supported by the California Health Services (to L. G.), Swedish Research Council Grant 05196 (to A. G.), the S. D. Bechtel, Jr. Foundation, and Alden W. and Helen T. Clausen.	Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; BANATI RB, 1993, GLIA, V7, P183, DOI 10.1002/glia.440070208; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cimerman N, 1999, J ENZYM INHIB, V14, P167, DOI 10.3109/14756369909036552; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; TAGAWA K, 1992, ANN NY ACAD SCI, V674, P129, DOI 10.1111/j.1749-6632.1992.tb27482.x; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V208, P353, DOI 10.1006/bbrc.1995.1345; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; TURK B, 1995, BIOL CHEM H-S, V376, P225, DOI 10.1515/bchm3.1995.376.4.225; Viswanathan K., 2012, ACS MED CHE IN PRESS; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341	32	71	73	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.371641	http://dx.doi.org/10.1074/jbc.M112.371641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024364	Green Published, hybrid			2022-12-25	WOS:000311233800051
J	Hibbert, RG; Sixma, TK				Hibbert, Richard G.; Sixma, Titia K.			Intrinsic Flexibility of Ubiquitin on Proliferating Cell Nuclear Antigen (PCNA) in Translesion Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; FANCONI-ANEMIA PATHWAY; MONOUBIQUITINATED PCNA; BINDING DOMAINS; E2; DIUBIQUITIN; COMPLEX; DAMAGE; SUMO	Ubiquitin conjugation provides a crucial signaling role in hundreds of cellular pathways; however, a structural understanding of ubiquitinated substrates is lacking. One important substrate is monoubiquitinated PCNA (PCNA-Ub), which signals for recruitment of damage-tolerant polymerases in the translesion synthesis (TLS) pathway of DNA damage avoidance. We use a novel and efficient enzymatic method to produce PCNA-Ub at high yield with a native isopeptide bond and study its Usp1/UAF1-dependent deconjugation. In solution we find that the ubiquitin moiety is flexible relative to the PCNA, with its hydrophobic patch mostly accessible for recruitment of TLS polymerases, which promotes the interaction with polymerase eta. The studies are a prototype for the nature of the ubiquitin modification.	[Hibbert, Richard G.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Hibbert, RG (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.hibbert@nki.nl; t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632	European Union RUBICON Network of Excellence; European Research Council advanced grant	European Union RUBICON Network of Excellence; European Research Council advanced grant(European Research Council (ERC))	This work was supported by the European Union RUBICON Network of Excellence and an European Research Council advanced grant (to T. K. S.).	Acharya N, 2010, P NATL ACAD SCI USA, V107, P10401, DOI 10.1073/pnas.1005492107; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Freudenthal BD, 2010, NAT STRUCT MOL BIOL, V17, P479, DOI 10.1038/nsmb.1776; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hibbert RG, 2009, DNA REPAIR, V8, P525, DOI 10.1016/j.dnarep.2009.01.014; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Konarev P., 2012, J APPL CRYSTALLOGR, V39, P277; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tsutakawa SE, 2011, P NATL ACAD SCI USA, V108, P17672, DOI 10.1073/pnas.1110480108; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang KL, 2011, GENE DEV, V25, P1847, DOI 10.1101/gad.17020911; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	36	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39216	39223		10.1074/jbc.M112.389890	http://dx.doi.org/10.1074/jbc.M112.389890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989887	Green Published, hybrid			2022-12-25	WOS:000310982800076
J	Gurriaran-Rodriguez, U; Santos-Zas, I; Al-Massadi, O; Mosteiro, CS; Beiroa, D; Nogueiras, R; Crujeiras, AB; Seoane, LM; Senaris, J; Garcia-Caballero, T; Gallego, R; Casanueva, FF; Pazos, Y; Camina, JP				Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Beiroa, Daniel; Nogueiras, Ruben; Crujeiras, Ana B.; Seoane, Luisa M.; Senaris, Jose; Garcia-Caballero, Tomas; Gallego, Rosalia; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.			The Obestatin/GPR39 System Is Up-regulated by Muscle Injury and Functions as an Autocrine Regenerative System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER CELLS; SKELETAL-MUSCLE; GROWTH-FACTOR; SATELLITE CELLS; GENE-EXPRESSION; STEM-CELLS; IN-VITRO; DIFFERENTIATION; RECEPTOR; ACTIVATION	The maintenance and repair of skeletal muscle are attributable to an elaborate interaction between extrinsic and intrinsic regulatory signals that regulate the myogenic process. In the present work, we showed that obestatin, a 23-amino acid peptide encoded by the ghrelin gene, and the GPR39 receptor are expressed in rat skeletal muscle and are up-regulated upon experimental injury. To define their roles in muscle regeneration, L6E9 cells were used to perform in vitro assays. For the in vivo assays, skeletal muscle tissue was obtained from male rats and maintained under continuous subcutaneous infusion of obestatin. In differentiating L6E9 cells, preproghrelin expression and correspondingly obestatin increased during myogenesis being sustained throughout terminal differentiation. Autocrine action was demonstrated by neutralization of the endogenous obestatin secreted by differentiating L6E9 cells using a specific anti-obestatin antibody. Knockdown experiments by preproghrelin siRNA confirmed the contribution of obestatin to the myogenic program. Furthermore, GPR39 siRNA reduced obestatin action and myogenic differentiation. Exogenous obestatin stimulation was also shown to regulate myoblast migration and proliferation. Furthermore, the addition of obestatin to the differentiation medium increased myogenic differentiation of L6E9 cells. The relevance of the actions of obestatin was confirmed in vivo by the up-regulation of Pax-7, MyoD, Myf5, Myf6, myogenin, and myosin heavy chain (MHC) in obestatin-infused rats when compared with saline-infused rats. These data elucidate a novel mechanism whereby the obestatin/GPR39 system is coordinately regulated as part of the myogenic program and operates as an autocrine signal regulating skeletal myogenesis.	[Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Crujeiras, Ana B.; Seoane, Luisa M.; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.] CHUS, Inst Invest Sanitaria Santiago IDIS, Area Endocrinol Mol & Celular, Serv Gallego Salud SERGAS, Santiago De Compostela 15706, Spain; [Senaris, Jose] CHUS, Serv Gallego Salud SERGAS, Serv Cirugia Ortoped & Traumatol, Santiago De Compostela 15706, Spain; [Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Beiroa, Daniel; Nogueiras, Ruben; Crujeiras, Ana B.; Seoane, Luisa M.; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.] Hosp Clin Univ Santiago de Compostela Choupana, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Santiago De Compostela 15706, Spain; [Beiroa, Daniel; Nogueiras, Ruben] Univ Santiago de Compostela, Dept Fisiol, Santiago De Compostela 15704, Spain; [Garcia-Caballero, Tomas; Gallego, Rosalia] Univ Santiago de Compostela, Dept Ciencias Morfol, Santiago De Compostela 15704, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela 15704, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Camina, JP (corresponding author), Hosp Clin Univ Santiago, SERGAS, Area Endocrinol Mol & Celular, IDIS,Lab Endocrinol Celular Lab 4, Choupana S-N, Santiago De Compostela 15706, Spain.	jesus.perez@usc.es	Nogueiras, Ruben/AAS-9427-2021; Beiroa, Daniel/AAB-8662-2020; seoane, luisa M/E-6570-2013; Garcia-Caballero, Tomas/H-7213-2015; Al-Massadi, Omar/C-1526-2017; Zas, Icia Santos/ABI-7849-2020; Crujeiras, Ana/ABA-8866-2021	Nogueiras, Ruben/0000-0002-9976-9930; Beiroa, Daniel/0000-0003-1862-1668; Al-Massadi, Omar/0000-0003-0645-6159; Zas, Icia Santos/0000-0002-0310-9074; Crujeiras, Ana/0000-0003-4392-0301; Gurriaran, Uxia/0000-0002-5375-0142; Garcia-Caballero, Tomas/0000-0002-7938-1437; Rosalia, Gallego/0000-0002-6015-4680	Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain) [PS09/02202]; Ministerio de Economia y Competitividad [SAF2010-20451]; Xunta de Galicia [INCITE09918374PR]; Fundacion Mutua Madrilena; Xunta de Galicia through an Isabel Barreto research-staff contract; ISCIII; SERGAS through a Miguel Servet research-staff stabilization contract	Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain); Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Xunta de Galicia through an Isabel Barreto research-staff contract; ISCIII(Instituto de Salud Carlos III); SERGAS through a Miguel Servet research-staff stabilization contract	This work was supported in part by grants from Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain; Grant PS09/02202), Ministerio de Economia y Competitividad (Grant SAF2010-20451), Xunta de Galicia (Grant INCITE09918374PR), and Fundacion Mutua Madrilena.; Supported by the Xunta de Galicia through an Isabel Barreto research-staff contract.; Supported by the ISCIII and SERGAS through a Miguel Servet research-staff stabilization contract.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Gurriaran-Rodriguez U, 2011, J ENDOCRINOL, V210, pR1, DOI 10.1530/JOE-11-0233; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Leloup L, 2007, INT J BIOCHEM CELL B, V39, P1177, DOI 10.1016/j.biocel.2007.03.003; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Machida S, 2004, P NUTR SOC, V63, P337, DOI 10.1079/PNS2004354; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Mousavi K, 2006, J NEUROSCI, V26, P5739, DOI 10.1523/JNEUROSCI.5398-05.2006; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Pazos Y, 2007, GROWTH FACTORS, V25, P373, DOI 10.1080/08977190801889313; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Toschi A, 2011, MOL ENDOCRINOL, V25, P1661, DOI 10.1210/me.2011-1049; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wu MZ, 2011, J CELL PHYSIOL, V226, P29, DOI 10.1002/jcp.22353; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhang JV, 2008, MOL ENDOCRINOL, V22, P1464, DOI 10.1210/me.2007-0569; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zizzari P, 2007, ENDOCRINOLOGY, V148, P1648, DOI 10.1210/en.2006-1231	58	27	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45					38379	38389		10.1074/jbc.M112.374926	http://dx.doi.org/10.1074/jbc.M112.374926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992743	Green Published, hybrid			2022-12-25	WOS:000310642200070
J	Jaffa, MA; Kobeissy, F; Al Hariri, M; Chalhoub, H; Eid, A; Ziyadeh, FN; Jaffa, AA				Jaffa, Miran A.; Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Eid, Assaad; Ziyadeh, Fuad N.; Jaffa, Ayad A.			Global Renal Gene Expression Profiling Analysis in B-2-Kinin Receptor Null Mice: Impact of Diabetes	PLOS ONE			English	Article							EARLY NATURAL-HISTORY; GROWTH-FACTOR-BETA; B2 RECEPTOR; KNOCKOUT MICE; KININ B1; NEPHROPATHY; KIDNEY; PATHOGENESIS; MODEL; COMPLICATIONS	Diabetic nephropathy (DN), the leading cause of end-stage renal failure, is clinically manifested by albuminuria and a progressive decline in glomerular filtration rate. The risk factors and mechanisms that contribute to the development and progression of DN are still incompletely defined. To address the involvement of bradykinin B-2-receptors (B2R) in DN, we used a genome wide approach to study the effects of diabetes on differential renal gene expression profile in wild type and B2R knockout (B2R-/-) mice. Diabetes was induced with streptozotocin and plasma glucose levels and albumin excretion rate (AER) were measured at predetermined times throughout the 23 week study period. Longitudinal analysis of AER indicated that diabetic B2R-/-D null mice had a significantly decreased AER levels compared to wild type B2R+/+ D mice (P = 0.0005). Results from the global microarray study comparing gene expression profiles among four groups of mice respectively: (B2R+/+C, B2R+/+D, B2R-/-C and B2R-/-D) highlighted the role of several altered pathological pathways in response to disruption of B2R and to the diabetic state that included: endothelial injury, oxidative stress, insulin and lipid metabolism and inflammatory process with a marked alteration in the pro-apoptotic genes. The findings of the present study provide a global genomics view of biomarkers that highlight the mechanisms and putative pathways involved in DN.	[Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Ziyadeh, Fuad N.; Jaffa, Ayad A.] Amer Univ Beirut, Dept Biochem, Beirut, Lebanon; [Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Ziyadeh, Fuad N.; Jaffa, Ayad A.] Amer Univ Beirut, Dept Mol Genet, Beirut, Lebanon; [Jaffa, Miran A.] Amer Univ Beirut, Fac Hlth Sci, Epidemiol & Populat Hlth Dept, Beirut, Lebanon; [Eid, Assaad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Jaffa, Ayad A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; Medical University of South Carolina	Jaffa, AA (corresponding author), Amer Univ Beirut, Dept Biochem, Beirut, Lebanon.	aj24@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944	National Institutes of Health [HL077192, HL087986]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087986, R01HL077192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants HL077192 and HL087986 (AAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarov D, 2006, BIOL CHEM, V387, P15, DOI 10.1515/BC.2006.004; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Bascands JL, 2009, BIOCHEM BIOPH RES CO, V386, P407, DOI 10.1016/j.bbrc.2009.06.063; Blazquez-Medela AM, 2010, CURR DIABETES REV, V6, P68, DOI 10.2174/157339910790909422; Brown WV, 2008, AM J CARDIOL, V102, p10L, DOI 10.1016/j.amjcard.2008.09.068; Busch M, 2010, EUR J CLIN INVEST, V40, P742, DOI 10.1111/j.1365-2362.2010.02317.x; Christopher J, 2002, INT IMMUNOPHARMACOL, V2, P1771, DOI 10.1016/S1567-5769(02)00188-1; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; HARVEY JN, 1990, DIABETES, V39, P299, DOI 10.2337/diabetes.39.3.299; HARVEY JN, 1992, DIABETOLOGIA, V35, P857, DOI 10.1007/BF00399932; Haseyama T, 2002, TOHOKU J EXP MED, V198, P233, DOI 10.1620/tjem.198.233; Hedeker D, 1999, J EDUC BEHAV STAT, V24, P70, DOI 10.3102/10769986024001070; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; JAFFA AA, 1995, DIABETES, V44, P156, DOI 10.2337/diabetes.44.2.156; Jozwiak Lucyna, 2004, Mol Diagn, V8, P157, DOI 10.2165/00066982-200408030-00003; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Maltais I, 2002, CAN J PHYSIOL PHARM, V80, P323, DOI 10.1139/Y02-036; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Monti J, 2001, HYPERTENSION, V38, pE1, DOI 10.1161/01.HYP.38.1.e1; Mukhtar A, 2007, SAUDI J KIDNEY DIS T, V18, P100; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Panzer U, 1999, NEPHROLOGIE, V20, P335; Rincon-Choles H, 2002, KIDNEY INT, V62, pS8, DOI 10.1046/j.1523-1755.62.s82.3.x; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; Sakharova OV, 2001, CURR OPIN NEPHROL HY, V10, P727, DOI 10.1097/00041552-200111000-00001; Schanstra JP, 2007, KIDNEY INT, V72, P442, DOI 10.1038/sj.ki.5002172; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Tan Y, 2005, AM J PHYSIOL-RENAL, V288, pF483, DOI 10.1152/ajprenal.00165.2004; Tan Y, 2007, AM J PHYSIOL-RENAL, V293, pF1026, DOI 10.1152/ajprenal.00203.2007; Tang SCW, 2011, LAB INVEST, V91, P1351, DOI 10.1038/labinvest.2011.81; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; Zuccollo A, 1996, CAN J PHYSIOL PHARM, V74, P586, DOI 10.1139/y96-047	41	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44714	10.1371/journal.pone.0044714	http://dx.doi.org/10.1371/journal.pone.0044714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028588	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900037
J	Petrizzo, A; Tornesello, ML; Napolitano, M; D'Alessio, G; Megna, AS; Dolcetti, R; De Re, V; Wang, E; Marincola, FM; Buonaguro, FM; Buonaguro, L				Petrizzo, Annacarmen; Tornesello, Maria Lina; Napolitano, Maria; D'Alessio, Giovanna; Megna, Angelo Salomone; Dolcetti, Riccardo; De Re, Valli; Wang, Ena; Marincola, Franco M.; Buonaguro, Franco M.; Buonaguro, Luigi			Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN DENDRITIC CELLS; NF-KAPPA-B; COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILE; YELLOW-FEVER VACCINE; MIXED CRYOGLOBULINEMIA; FOLLICULAR LYMPHOMA; IMMUNE-RESPONSES	Hepatitis C virus (HCV) has been identified as one of the major risk factors for type II mixed cryoglobulinemia (MC), during the clinical evolution of chronic hepatitis, which may lead to development of B cell non-Hodgkin's lymphoma (NHL). We have previously shown that the candidate idiotype vaccine, based on the IGKV3-20 light chain protein, is able to induce activation and maturation of circulating antigen presenting cells (APCs) in both HCV-positive and HCV-negative healthy control subjects, with production of Th2-type cytokines. Here, the effect of the recombinant IGKV3-20 protein on human peripheral blood mononuclear cells (PBMCs) from HCV-positive subjects, with known blood levels of cryoglobulins, is shown via gene expression profiling analysis combined to multiparameter flow cytometry and multiplex analyses of cytokines.	[Petrizzo, Annacarmen; Tornesello, Maria Lina; Buonaguro, Franco M.; Buonaguro, Luigi] Natl Canc Inst Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, Naples, Italy; [Napolitano, Maria] Natl Canc Inst Fond G Pascale, Clin Immunol Lab, Naples, Italy; [D'Alessio, Giovanna; Megna, Angelo Salomone] Rummo Hosp, Div Infect Dis, Benevento, Italy; [Dolcetti, Riccardo] Natl Canc Inst, Ctr Riferimento Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy; [Wang, Ena; Marincola, Franco M.] NIH, IDIS, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Franco M.] NIH, Trans NIH Ctr Human Immunol, Bethesda, MD 20892 USA	IRCCS Aviano (CRO); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Buonaguro, L (corresponding author), Natl Canc Inst Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, Naples, Italy.	l.buonaguro@istitutotumori.na.it	Dolcetti, Riccardo/O-3832-2015; DE RE, VALLI/AAA-1374-2019; Buonaguro, Luigi/AAV-5655-2020; Buonaguro, Franco M./T-6028-2019; De Re, Valli/K-4121-2016; Maria, Buonaguro Franco/AAF-4888-2019; Tornesello, Maria Lina/A-1964-2008; napolitano, maria/K-1615-2016	Dolcetti, Riccardo/0000-0003-1625-9853; DE RE, VALLI/0000-0001-6100-9373; Buonaguro, Franco M./0000-0002-7491-7220; De Re, Valli/0000-0001-6100-9373; Tornesello, Maria Lina/0000-0002-3523-3264; Buonaguro, Luigi/0000-0002-6380-7114; napolitano, maria/0000-0002-8996-3297; Petrizzo, Annacarmen/0000-0003-3228-6958	Italian Ministry of Research [ACC 4]; Associazione Italiana per la ricerca sul Cancro [10301]; Fondazione Federica per la Vita; University of Udine	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Federica per la Vita; University of Udine	The study was funded by Italian Ministry of Research through the project "Alleanza Contro il Cancro'' (Contract No. ACC 4). AP was a Ph.D. student at University of Udine "Biomedical Science and Biotechnology'' and the recipient of a fellowship granted through the project. The work was partly supported by a grant from the Associazione Italiana per la ricerca sul Cancro (contract 10301 to RD) and the Fondazione Federica per la Vita (to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOUCHE M, 1990, LEUKEMIA RES, V14, P699, DOI 10.1016/0145-2126(90)90097-S; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Arico E, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-45; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; Bende RJ, 2005, J EXP MED, V201, P1229, DOI 10.1084/jem.20050068; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Buonaguro L, 2009, J VIROL, V83, P304, DOI 10.1128/JVI.01606-08; Buonaguro L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-18; Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Chougnet C, 1999, J IMMUNOL, V163, P1666; Chung YM, 2001, BIOCHEM BIOPH RES CO, V284, P15, DOI 10.1006/bbrc.2001.4936; Cortesini NSF, 2004, TRANSPL IMMUNOL, V13, P73, DOI 10.1016/j.trim.2004.06.001; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; Dammacco F, 1997, CLIN REV ALLERG IMMU, V15, P97, DOI 10.1007/BF02828280; De Re V, 2007, GASTROENTEROLOGY, V132, P1205, DOI 10.1053/j.gastro.2007.02.009; De Re V, 2000, INT J CANCER, V87, P211, DOI 10.1002/1097-0215(20000715)87:2&lt;211::AID-IJC9&gt;3.0.CO;2-8; De Re V, 2000, BLOOD, V96, P3578; de Re V, 2009, ANN NY ACAD SCI, V1173, P152, DOI 10.1111/j.1749-6632.2009.04677.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fairfax BP, 2011, J IMMUNOL, V186, P3058, DOI 10.4049/jimmunol.1001791; Fan Z, 2007, CLIN VACCINE IMMUNOL, V14, P1127, DOI 10.1128/CVI.00141-07; FERRI C, 1994, J INTERN MED, V236, P31, DOI 10.1111/j.1365-2796.1994.tb01116.x; FERRI C, 1994, BRIT J HAEMATOL, V88, P392, DOI 10.1111/j.1365-2141.1994.tb05036.x; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hollander N, 2009, CRIT REV IMMUNOL, V29, P399, DOI 10.1615/CritRevImmunol.v29.i5.30; Huang XL, 2005, J VIROL, V79, P3052, DOI 10.1128/JVI.79.5.3052-3062.2005; Inoges S, 2006, J NATL CANCER I, V98, P1292, DOI 10.1093/jnci/djj358; Ito T, 2009, J BIOL CHEM, V284, P24289, DOI 10.1074/jbc.M109.007286; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Kostareli E, 2011, LEUKEMIA; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Martorelli D, 2011, CANC IMMUNOL IMMUNOT; Martyak LA, 2009, CLIN GASTROENTEROL H, V7, P900, DOI 10.1016/j.cgh.2009.03.035; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Moradpour D, 2005, EUR J GASTROEN HEPAT, V17, P477, DOI 10.1097/00042737-200505000-00002; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; OJCIUS DM, 1990, CANCER CELL-MON REV, V2, P138; Perotti M, 2008, AUTOIMMUN REV, V7, P468, DOI 10.1016/j.autrev.2008.03.008; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pilsbury LE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/536478; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Raglow Z, 2011, PHARMACOL THERAPEUT, V132, P30, DOI 10.1016/j.pharmthera.2011.05.005; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Smilevska T, 2008, BLOOD CELL MOL DIS, V41, P215, DOI 10.1016/j.bcmd.2008.06.002; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stavenhagen JB, 2008, ADV ENZYME REGUL, V48, P152, DOI 10.1016/j.advenzreg.2007.11.011; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tenca C, 2005, J IMMUNOL, V174, P6757, DOI 10.4049/jimmunol.174.11.6757; Uddin S, 1998, BRIT J HAEMATOL, V101, P446, DOI 10.1046/j.1365-2141.1998.00731.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502; Zignego AL, 2002, ANN INTERN MED, V137, P571, DOI 10.7326/0003-4819-137-7-200210010-00008; Zignego AL, 2007, WORLD J GASTROENTERO, V13, P2467, DOI 10.3748/wjg.v13.i17.2467; Zuckerman E, 1997, ANN INTERN MED, V127, P423, DOI 10.7326/0003-4819-127-6-199709150-00002	80	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44870	10.1371/journal.pone.0044870	http://dx.doi.org/10.1371/journal.pone.0044870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028651	gold, Green Published			2022-12-25	WOS:000311313900047
J	Shi, WQ; Wang, GA; Han, WX				Shi, Weiqi; Wang, Guoan; Han, Wenxuan			Altitudinal Variation in Leaf Nitrogen Concentration on the Eastern Slope of Mount Gongga on the Tibetan Plateau, China	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; STOICHIOMETRY; WORLDWIDE; POPULATIONS; GRADIENTS; PATTERNS; CARBON; PLANTS; SOIL	Mount Gongga spans 6500 m in elevation and has intact and continuous vertical vegetation belts, ranging from subtropical evergreen broad-leaved vegetation to an alpine frigid sparse grass and desert zone. Investigating the altitudinal trends in leaf nitrogen (N) on Mount Gongga can increase our understanding of the global biogeography of foliar N. In this study, 460 leaf samples from mosses, ferns, and seed plants were collected along an altitudinal gradient on the eastern slope of Mount Gongga, and the variation in leaf N concentration (mass basis) with elevation was analyzed. There are considerable differences in leaf N between mosses and ferns, mosses and seed plants, C-4 and C-3 plants, and evergreen and deciduous woody plants. The general altitudial pattern of leaf N in Mount Gongga plants was that leaf N kept increasing until an elevation of about 2200 m above sea level, with a corresponding mean annual temperature (MAT) of 8.5 degrees C, and then decreased with increasing elevation. However, the evergreen woody plants displayed a decline trend in leaf N across the altitude gradient. Our findings provide an insight into the altitudinal variation in leaf N.	[Wang, Guoan] China Agr Univ, Coll Resources & Environm Sci, Dept Environm Sci & Engn, Beijing 100094, Peoples R China; [Shi, Weiqi] Chinese Acad Trop Agr Sci, S Subtrop Crops Res Inst, Zhanjiang, Guangdong, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Dept Ecol & Ecol Engn, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; China Agricultural University	Wang, GA (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Dept Environm Sci & Engn, Beijing 100094, Peoples R China.	gawang@cau.edu.cn; hanwenxuan@cau.edu.cn	Han, Wenxuan/B-8791-2016	Han, Wenxuan/0000-0001-8678-7147	National Natural Science Foundation of China [40973006, 41173083]; Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences [SSCRI200912, 1251022011001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences	This research was supported by grants from the National Natural Science Foundation of China (No. 40973006, 41173083) and supported by the Fundamental Research Funds of the National Non profit Research Institute for South Subtropical Crops Research Institute, Chinese Academy of Tropical Agricultural Sciences (SSCRI200912, 1251022011001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman WD, 1999, ARCT ANTARCT ALP RES, V31, P191, DOI 10.2307/1552608; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Chen FB, 1993, RES ALPINE ECOLOGY E; Chen Y, 2011, EUR J NEUROL, V18, P1246, DOI 10.1111/j.1468-1331.2011.03367.x; FRIEND AD, 1989, FUNCT ECOL, V3, P117, DOI 10.2307/2389682; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2012, GLOBAL ECOL BIOGEOGR, V21, P376, DOI 10.1111/j.1466-8238.2011.00677.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Hou X., 1982, CHINESE VEGETABLE GE; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Li CY, 2007, TREE PHYSIOL, V27, P399, DOI 10.1093/treephys/27.3.399; Li CY, 2006, SILVA FENN, V40, P5, DOI 10.14214/sf.348; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhong XH, 1997, RES FOREST MOUNT GON	19	16	24	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44628	10.1371/journal.pone.0044628	http://dx.doi.org/10.1371/journal.pone.0044628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028570	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900031
J	Yang, Z; Zhang, QZ; Xu, K; Shan, JJ; Shen, JJ; Liu, LM; Xu, YM; Xia, F; Bie, P; Zhang, X; Cui, YH; Bian, XW; Qian, C				Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Xia, Feng; Bie, Ping; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng			Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model	PLOS ONE			English	Article							IMMUNOLOGICAL EFFECTOR-CELLS; GENE-THERAPY; HEPATOCELLULAR-CARCINOMA; IN-VIVO; CANCER; INTERLEUKIN-12; IMMUNOTHERAPY; EFFICACY; VIRUS; CHEMOTHERAPY	Both adoptive immunotherapy and gene therapy hold a great promise for treatment of malignancies. However, these strategies exhibit limited anti-tumor activity, when they are used alone. In this study, we explore whether combination of cytokine-induced killer (CIK) adoptive immunotherapy with oncolytic adenovirus-mediated transfer of human interleukin-12 (hIL-12) gene induce the enhanced antitumor potency. Our results showed that oncolytic adenovirus carrying hIL-12 (AdCN205-IL12) could produce high levels of hIL-12 in liver cancer cells, as compared with replication-defective adenovirus expressing hIL-12 (Ad-IL12). AdCN205-IL12 could specifically induce cytotoxocity to liver cancer cells. Combination of CIK cells with AdCN205-IL12 could induce higher antitumor activity to liver cancer cells in vitro than that induced by either CIK or AdCN205-IL12 alone, or combination of CIK and control vector AdCN205-GFP. Furthermore, treatment of the established liver tumors with the combined therapy of CIK cells and AdCN205-IL12 resulted in tumor regression and long-term survival. High level expression of hIL-12 in tumor tissues could increase traffic of CIK cells to tumor tissues and enhance their antitumor activities. Our study provides a novel strategy for the therapy of cancer by the combination of CIK adoptive immunotherapy with oncolytic adenovirus-mediated transfer of immune stimulatory molecule hIL-12.	[Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Xia, Feng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Qian, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China.	cqian3184@yahoo.com.cn	Zhang, Xia/B-8152-2008; Bian, Xiu-Wu/D-4736-2017	Zhang, Xia/0000-0002-9040-1486; Bian, Xiu-Wu/0000-0003-4383-0197; Zhi, Yang/0000-0002-3974-7297	National Basic Research Program of China (973 Program) [2010CB529406]; National Natural Sciences Foundation of China [81090423, 81020108026]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from National Basic Research Program of China (973 Program, No 2010CB529406) and National Natural Sciences Foundation of China (No. 81090423 and 81020108026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton E, 2007, GENE THER, V14, P1439, DOI 10.1038/sj.gt.3303001; Alves A, 2004, CANCER GENE THER, V11, P782, DOI 10.1038/sj.cgt.7700760; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Cui Q, 2008, HEPATOLOGY, V47, P105, DOI 10.1002/hep.21951; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dudley ME, 2007, SEMIN ONCOL, V34, P524, DOI 10.1053/j.seminoncol.2007.09.002; Finke S, 1998, GENE THER, V5, P31, DOI 10.1038/sj.gt.3300560; He XP, 2011, HUM GENE THER, V22, P283, DOI 10.1089/hum.2010.058; Helms MW, 2010, CANCER IMMUNOL IMMUN, V59, P1325, DOI 10.1007/s00262-010-0860-y; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Hu WX, 2007, CANCER BIOL THER, V6, P1773, DOI 10.4161/cbt.6.11.4855; Jiang JT, 2006, ANTICANCER RES, V26, P2237; Jin J, 2011, ONCOL REP, V25, P33, DOI 10.3892/or_00001038; Kaino M, 1997, J GASTROENTEROL, V32, P40, DOI 10.1007/BF01213295; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Leonard JP, 1997, BLOOD, V90, P2541; Li HT, 2007, CANCER RES, V67, P7850, DOI 10.1158/0008-5472.CAN-07-1087; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Liu Liang, 2012, CLIN CANC RES; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; LU PH, 1994, J IMMUNOL, V153, P1687; Luo JJ, 2008, CLIN CANCER RES, V14, P2450, DOI 10.1158/1078-0432.CCR-07-4596; Ma Y, 2012, CYTOTHERAPY; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; MULE JJ, 1984, SCIENCE, V225, P1487, DOI 10.1126/science.6332379; Niam M, 2011, EXP HEMATOL, V39, P897, DOI 10.1016/j.exphem.2011.06.005; Niu Q, 2011, INT IMMUNOPHARMACOL, V11, P449, DOI 10.1016/j.intimp.2010.12.014; Nussler AK, 1999, IN VITRO CELL DEV-AN, V35, P190, DOI 10.1007/s11626-999-0026-4; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Pievani A, 2011, BLOOD; Pievani A, 2011, BLOOD, V117, P510, DOI 10.1182/blood-2010-06-290858; Qian C, 2006, CELL RES, V16, P182, DOI 10.1038/sj.cr.7310025; Qian C, 2002, GASTROENTEROLOGY, V123, P639, DOI 10.1053/gast.2002.35132; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sacco S, 1997, BLOOD, V90, P4473; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Sangro B, 2010, CURR OPIN MOL THER, V12, P561; Schmidt-Wolf IGH, 1999, BRIT J CANCER, V81, P1009, DOI 10.1038/sj.bjc.6690800; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Varghese S, 2006, CANCER GENE THER, V13, P253, DOI 10.1038/sj.cgt.7700900; Wang B, 2012, HEPATO-GASTROENTEROL, V59, P515, DOI 10.5754/hge11534; Wong RJ, 2004, CLIN CANCER RES, V10, P4509, DOI 10.1158/1078-0432.CCR-04-0081; Yu L, 2007, ANTICANCER RES, V27, P2311; Zabala M, 2004, CANCER RES, V64, P2799, DOI 10.1158/0008-5472.CAN-03-3061; Zhang W, 2007, CANCER BIOL THER, V6, P1726, DOI 10.4161/cbt.6.11.4831; Zhou P, 2011, CANCER BIOL THER, V11, P450, DOI 10.4161/cbt.11.5.14669	47	34	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44802	10.1371/journal.pone.0044802	http://dx.doi.org/10.1371/journal.pone.0044802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028626	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900043
J	Karmperis, AC; Aravossis, K; Tatsiopoulos, IP; Sotirchos, A				Karmperis, Athanasios C.; Aravossis, Konstantinos; Tatsiopoulos, Ilias P.; Sotirchos, Anastasios			On the Fair Division of Multiple Stochastic Pies to Multiple Agents within the Nash Bargaining Solution	PLOS ONE			English	Article							PROFIT; RISK; COORDINATION; MANAGEMENT; COST; GAME; COOPERATION; ALLOCATION; CONTRACT	The fair division of a surplus is one of the most widely examined problems. This paper focuses on bargaining problems with fixed disagreement payoffs where risk-neutral agents have reached an agreement that is the Nash-bargaining solution (NBS). We consider a stochastic environment, in which the overall return consists of multiple pies with uncertain sizes and we examine how these pies can be allocated with fairness among agents. Specifically, fairness is based on the Aristotle's maxim: "equals should be treated equally and unequals unequally, in proportion to the relevant inequality". In this context, fairness is achieved when all the individual stochastic surplus shares which are allocated to agents are distributed in proportion to the NBS. We introduce a novel algorithm, which can be used to compute the ratio of each pie that should be allocated to each agent, in order to ensure fairness within a symmetric or asymmetric NBS.	[Karmperis, Athanasios C.; Aravossis, Konstantinos; Tatsiopoulos, Ilias P.; Sotirchos, Anastasios] Natl Tech Univ Athens, Sch Mech Engn, Sect Ind Management & Operat Res, Athens, Greece; [Karmperis, Athanasios C.] Minist Def, Army Corps Engn, Athens, Greece	National Technical University of Athens	Karmperis, AC (corresponding author), Natl Tech Univ Athens, Sch Mech Engn, Sect Ind Management & Operat Res, Athens, Greece.	athkarmp@mail.ntua.gr		Karmperis, Athanasios C./0000-0001-6696-3692				Aristotle, 1984, COMPLETE WORKS ARIST; Baek SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038529; Barbanel JB, 2004, MATH SOC SCI, V48, P251, DOI 10.1016/j.mathsocsci.2004.03.006; BINMORE K, 1989, Q J ECON, V104, P753, DOI 10.2307/2937866; Binmore K, 2001, P BRIT ACAD, P149; Bughin J, 1999, EUR ECON REV, V43, P549, DOI 10.1016/S0014-2921(98)00036-1; Carraro C, 2005, 3642 WORLD BANK, P20; CHUN YS, 1988, MATH SOC SCI, V15, P231, DOI 10.1016/0165-4896(88)90009-1; Csoka P, 2011, IMPOSSIBILITY FAIR R; Csoka P, 2009, GAME ECON BEHAV, V67, P266, DOI 10.1016/j.geb.2008.11.001; Ding HP, 2011, INT J PROD ECON, V133, P70, DOI 10.1016/j.ijpe.2010.06.015; Gillies D.B., 1959, CONTRIBUTIONS THEORY, V4, P47; Guardiola LA, 2007, DECIS SUPPORT SYST, V44, P17, DOI 10.1016/j.dss.2006.12.015; Harsanyi J.C., 1959, CONTRIBUTIONS THEORY, V40, P324; HARSANYI JC, 1963, INT ECON REV, V4, P194, DOI 10.2307/2525487; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Hennet JC, 2010, INT J PROD ECON, V127, P112, DOI 10.1016/j.ijpe.2010.04.047; Hoefer M, 2013, INT J GAME THEORY, V42, P29, DOI 10.1007/s00182-011-0312-8; KALAI E, 1985, ECONOMETRICA, V53, P307, DOI 10.2307/1911238; Kalai E., 1977, International Journal of Game Theory, V6, P129, DOI 10.1007/BF01774658; Karmperis A.C., 2012, INT J MATH MODELS ME, V6, P209; Karmperis AC, 2012, RECENT RES APPL MATH, P20; Karmperis AC, 2012, WASTE MANAGE, V32, P194, DOI 10.1016/j.wasman.2011.09.001; KEPAPTSOGLOU Konstantinos, 2010, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V10, P53, DOI 10.1016/S1570-6672(09)60063-5; Kunter M, 2012, EUR J OPER RES, V216, P477, DOI 10.1016/j.ejor.2011.07.001; Li SJ, 2009, INT J PROD ECON, V120, P88, DOI 10.1016/j.ijpe.2008.07.015; Linh CT, 2009, EUR J OPER RES, V198, P822, DOI 10.1016/j.ejor.2008.10.019; Lo Nigro G, 2011, INT J PROD ECON, V131, P234, DOI 10.1016/j.ijpe.2009.08.014; Madani K, 2011, ADV WATER RESOUR, V34, P174, DOI 10.1016/j.advwatres.2010.10.003; Mitropoulou CC, 2011, RELIAB ENG SYST SAFE, V96, P1311, DOI 10.1016/j.ress.2011.04.002; MOULIN H, 1987, INT J GAME THEORY, V16, P161, DOI 10.1007/BF01756289; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Neumann J., 1944, THEORY GAMES EC BEHA; Rausser GC, 2000, POLITICAL EC WATER P, P52; Renna P, 2011, ROBOT CIM-INT MANUF, V27, P405, DOI 10.1016/j.rcim.2010.08.009; Roth AE, 1979, LECT NOTES EC MATH S, V170, P19; Saleh Y, 2011, EUR J OPER RES, V215, P244, DOI 10.1016/j.ejor.2011.05.048; SCHMEIDL.D, 1969, SIAM J APPL MATH, V17, P1163, DOI 10.1137/0117107; Shapley LS, 2016, 17 VALUE N PERSON GA, V17, P307, DOI [10.1515/9781400881970-018, DOI 10.1515/9781400881970-018]; Shi CV, 2010, EUR J OPER RES, V206, P86, DOI 10.1016/j.ejor.2010.01.047; Supatgiat C., 2001, Computational Economics, V17, P93, DOI 10.1023/A:1011274413023; TIJS SH, 1986, MANAGE SCI, V32, P1015, DOI 10.1287/mnsc.32.8.1015; Tziralis G, 2009, MANAG DECIS ECON, V30, P393, DOI 10.1002/mde.1458; van den Brink R, 2011, J ENVIRON ECON MANAG, V63, P388; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; Wu DD, 2010, INT J PROD RES, V48, P4919, DOI 10.1080/00207540903051684; Young H. P., 1985, International Journal of Game Theory, V14, P65, DOI 10.1007/BF01769885	47	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44535	10.1371/journal.pone.0044535	http://dx.doi.org/10.1371/journal.pone.0044535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024752	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100010
J	Vijayakumar, A; Wu, YJ; Buffin, NJ; Li, XS; Sun, H; Gordon, RE; Yakar, S; LeRoith, D				Vijayakumar, Archana; Wu, YingJie; Buffin, Nicholas J.; Li, Xiaosong; Sun, Hui; Gordon, Ronald E.; Yakar, Shoshana; LeRoith, Derek			Skeletal Muscle Growth Hormone Receptor Signaling Regulates Basal, but Not Fasting-Induced, Lipid Oxidation	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL TRANSCRIPTION FACTOR; GENE-EXPRESSION; METABOLIC-CONTROL; PPAR-DELTA; PGC-1-ALPHA; EXERCISE; ACTIVATION; ALPHA; DIET	Background: Growth hormone (GH) stimulates whole-body lipid oxidation, but its regulation of muscle lipid oxidation is not clearly defined. Mice with a skeletal muscle-specific knockout of the GH receptor (mGHRKO model) are protected from high fat diet (HFD)-induced insulin resistance and display increased whole-body carbohydrate utilization. In this study we used the mGRHKO mice to investigate the role of muscle GHR signaling on lipid oxidation under regular chow (RC)- and HFD-fed conditions, and in response to fasting. Methodology/Principal Findings: Expression of lipid oxidation genes was analyzed by real-time PCR in the muscles of RC-and HFD-fed mice, and after 24 h fasting in the HFD-fed mice. Expression of lipid oxidation genes was lower in the muscles of the mGHRKO mice relative to the controls, irrespective of diet. However, in response to 24 h fasting, the HFD-fed mGHRKO mice displayed up-regulation of lipid oxidation genes similar to the fasted controls. When subjected to treadmill running challenge, the HFD-fed mGHRKO mice demonstrated increased whole-body lipid utilization. Additionally, under fasted conditions, the adipose tissue of the mGHRKO mice displayed increased lipolysis as compared to both the fed mGHRKO as well as the fasted control mice. Conclusions/Significance: Our data show that muscle GHR signaling regulates basal lipid oxidation, but not the induction of lipid oxidation in response to fasting. We further demonstrate that muscle GHR signaling is involved in muscle-adipose tissue cross-talk; however the mechanisms mediating this remain to be elucidated.	[Vijayakumar, Archana; Wu, YingJie; Buffin, Nicholas J.; Sun, Hui; Yakar, Shoshana; LeRoith, Derek] Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Wu, YingJie; Sun, Hui; Yakar, Shoshana] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, David B Kriser Dent Ctr, New York, NY USA; [Li, Xiaosong] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Li, Xiaosong] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Gordon, Ronald E.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA	Icahn School of Medicine at Mount Sinai; New York University; Yeshiva University; Yeshiva University; Icahn School of Medicine at Mount Sinai	Vijayakumar, A (corresponding author), Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA.	derek.leroith@mssm.edu			National Institutes of Health grant [DK-20541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	X.L. is supported by the National Institutes of Health grant DK-20541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gesing A, 2011, J GERONTOL A-BIOL, V66, P1062, DOI 10.1093/gerona/glr080; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Helge JW, 2007, J PHYSIOL-LONDON, V581, P1247, DOI 10.1113/jphysiol.2007.128348; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Johansen T, 2003, HORM METAB RES, V35, P243, DOI 10.1055/s-2003-39481; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686; MELMED S, 1984, J CLIN INVEST, V73, P1425, DOI 10.1172/JCI111347; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pasarica M, 2007, J CLIN ENDOCR METAB, V92, P4265, DOI 10.1210/jc.2007-0786; Peyreigne C, 2002, HORM RES, V58, P287, DOI 10.1159/000066448; RANDLE PJ, 1963, LANCET, V1, P785; Richelsen B, 2000, METABOLISM, V49, P906, DOI 10.1053/meta.2000.6738; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schwartzbauer G, 1998, MOL GENET METAB, V63, P243, DOI 10.1006/mgme.1998.2685; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; Sjogren K, 2007, AM J PHYSIOL-ENDOC M, V293, pE364, DOI 10.1152/ajpendo.00054.2007; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	44	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44777	10.1371/journal.pone.0044777	http://dx.doi.org/10.1371/journal.pone.0044777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024761	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100019
J	Zhu, L; Su, M; Lucast, L; Liu, LJ; Netzer, WJ; Gandy, SE; Cai, DM				Zhu, Li; Su, Meng; Lucast, Louise; Liu, Lijuan; Netzer, William J.; Gandy, Samuel E.; Cai, Dongming			Dynamin 1 Regulates Amyloid Generation through Modulation of BACE-1	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; PRECURSOR-PROTEIN; BETA-SECRETASE; CELL-SURFACE; IN-VIVO; ENDOCYTOSIS; PRESENILIN-1; INHIBITION; PATHWAYS; PHOSPHORYLATION	Background: Several lines of investigation support the notion that endocytosis is crucial for Alzheimer's disease (AD) pathogenesis. Substantial evidence have already been reported regarding the mechanisms underlying amyloid precursor protein (APP) traffic, but the regulation of beta-site APP-Cleaving Enzyme 1 (BACE-1) distribution among endosomes, TGN and plasma membrane remains unclear. Dynamin, an important adaptor protein that controls sorting of many molecules, has recently been associated with AD but its functions remain controversial. Here we studied possible roles for dynamin 1 (dyn1) in A beta biogenesis. Principal Findings: We found that genetic perturbation of dyn1 reduces both secreted and intracellular A beta levels in cell culture. There is a dramatic reduction in BACE-1 cleavage products of APP (sAPP beta and beta CTF). Moreover, dyn1 knockdown (KD) leads to BACE-1 redistribution from the Golgi-TGN/endosome to the cell surface. There is an increase in the amount of surface holoAPP upon dyn1 KD, with resultant elevation of alpha-secretase cleavage products sAPP alpha and alpha CTF. But no changes are seen in the amount of nicastrin (NCT) or PS1 N-terminal fragment (NTF) at cell surface with dyn1 KD. Furthermore, treatment with a selective dynamin inhibitor Dynasore leads to similar reduction in beta CTF and A beta levels, comparable to changes with BACE inhibitor treatment. But combined inhibition of BACE-1 and dyn1 does not lead to further reduction in A beta, suggesting that the A beta-lowering effects of dynamin inhibition are mainly mediated through regulation of BACE-1 internalization. A beta levels in dyn1(-/-) primary neurons, as well as in 3-month old dyn1 haploinsufficient animals with AD transgenic background are consistently reduced when compared to their wildtype counterparts. Conclusions: In summary, these data suggest a previously unknown mechanism by which dyn1 affects amyloid generation through regulation of BACE-1 subcellular localization and therefore its enzymatic activities.	[Zhu, Li; Su, Meng; Gandy, Samuel E.; Cai, Dongming] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Zhu, Li; Su, Meng; Gandy, Samuel E.; Cai, Dongming] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; [Zhu, Li; Gandy, Samuel E.; Cai, Dongming] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Lucast, Louise; Liu, Lijuan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Lucast, Louise; Liu, Lijuan] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA; [Netzer, William J.] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Su, Meng] John Hopkins Med Ctr, Dept Pathol, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yale University; Yale University; Rockefeller University; Johns Hopkins University; Johns Hopkins Medicine	Zhu, L (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	dongming.cai@mssm.edu		Cai, Dongming/0000-0002-0601-6826	Department of Veteran Affairs Career Development Award; Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund	Department of Veteran Affairs Career Development Award; Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund	The authors' studies are supported by Department of Veteran Affairs Career Development Award (to D.C.) and Mount Sinai School of Medicine Friedman Brain Institute Seeding Fund (to D.C.). The funders provide financial support to our studies. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidaralieva NJ, 2008, J HUM GENET, V53, P296, DOI 10.1007/s10038-008-0251-9; Bettens K, 2009, NEUROBIOL AGING, V30, P2000, DOI 10.1016/j.neurobiolaging.2008.02.003; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kamagata E, 2009, BIOCHEM BIOPH RES CO, V379, P691, DOI 10.1016/j.bbrc.2008.12.147; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kuwano R, 2006, HUM MOL GENET, V15, P2170, DOI 10.1093/hmg/ddl142; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Tamayev R, 2011, EMBO MOL MED; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yu CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-19	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45033	10.1371/journal.pone.0045033	http://dx.doi.org/10.1371/journal.pone.0045033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024787	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100045
J	Dottorini, T; Persampieri, T; Palladino, P; Baker, DA; Spaccapelo, R; Senin, N; Crisanti, A				Dottorini, Tania; Persampieri, Tania; Palladino, Pietro; Baker, Dean A.; Spaccapelo, Roberta; Senin, Nicola; Crisanti, Andrea			Regulation of Anopheles gambiae male accessory gland genes influences postmating response in female	FASEB JOURNAL			English	Article						reproductive biology; malaria; vector control; fertility; heat-shock factor	SEMINAL FLUID PROTEINS; MOLECULAR POPULATION-GENETICS; DROSOPHILA-MELANOGASTER; SEX-PEPTIDE; SPERM STORAGE; REPRODUCTIVE-BEHAVIOR; PROTEASE INHIBITOR; ECTOPIC EXPRESSION; IMMUNE-RESPONSE; MALARIA VECTOR	In Drosophila, the accessory gland proteins (Acps) secreted from the male accessory glands (MAGs) and transferred along with sperm into the female reproductive tract have been implicated in triggering postmating behavioral changes, including refractoriness to subsequent mating and propensity to egg laying. Recently, Acps have been found also in Anopheles, suggesting similar functions. Understanding the mechanisms underlying transcriptional regulation of Acps and their functional role in modulating Anopheles postmating behavior may lead to the identification of novel vector control strategies to reduce mosquito populations. We identified heat-shock factor (HSF) binding sites within the Acp promoters of male Anopheles gambiae and discovered three distinct Hsf isoforms; one being significantly up-regulated in the MAGs after mating. Through genome-wide transcription analysis of Hsf-silenced males, we observed significant down-regulation in 50% of the Acp genes if compared to control males treated with a construct directed against an unrelated bacterial sequence. Treated males retained normal life span and reproductive behavior compared to control males. However, mated wild-type females showed a similar to 46% reduction of egg deposition rate and a similar to 23% reduction of hatching rate (similar to 58% combined reduction of progeny). Our results highlight an unsuspected role of HSF in regulating Acp transcription in A. gambiae and provide evidence that Acp down-regulation in males leads a significant reduction of progeny, thus opening new avenues toward the development of novel vector control strategies.-Dottorini, T., Persampieri, T., Palladino, P., Baker, D. A., Spaccapelo, R., Senin, N., Crisanti, A. Regulation of Anopheles gambiae male accessory gland genes influences postmating response in female. FASEB J. 27, 86-97 (2013). www.fasebj.org	[Dottorini, Tania; Persampieri, Tania; Palladino, Pietro; Spaccapelo, Roberta; Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Senin, Nicola] Univ Perugia, Dept Ind Engn, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, SAF, London SW7 2AZ, England; [Baker, Dean A.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Perugia; University of Perugia; Imperial College London; University of Cambridge	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, SAF, S Kensington Campus, London SW7 2AZ, England.	acrs@imperial.ac.uk	senin, nicola/B-5292-2016	senin, nicola/0000-0002-9556-0363; Spaccapelo, Roberta/0000-0003-2100-6172; Dottorini, Tania/0000-0001-7733-906X; Crisanti, Andrea/0000-0002-2406-4426	European Union [PIEF-GA-2010-273268, IAPP-218164]; BBSRC [BB/E021794/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021794/1] Funding Source: researchfish	European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Alessandro Trusso for 3'-RACE analysis and sequencing of HSF1, HSF2, and HSF3 and for preparing the RNA samples for microarray analysis; as well as Elena Levashina, Manlio DiCristina, Nikolai Windbichler, and Tony Nolan for the insight and suggestions. The authors thank the anonymous reviewers for the constructive and insightful comments that helped to improve the manuscript. This work was supported by the European Union, (PIEF-GA-2010-273268), programs Vectrap and FIGHTMAL (IAPP-218164). The authors declare no conflicts of interest.	Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Begun DJ, 2005, MOL BIOL EVOL, V22, P2010, DOI 10.1093/molbev/msi201; Begun DJ, 2000, GENETICS, V156, P1879; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CLARK AG, 1995, GENETICS, V139, P189; Collins AM, 2006, INSECT MOL BIOL, V15, P541, DOI 10.1111/j.1365-2583.2006.00674.x; Dai ZM, 2012, NUCLEIC ACIDS RES, V40, P27, DOI 10.1093/nar/gkr689; Davies SJ, 2006, INSECT BIOCHEM MOLEC, V36, P846, DOI 10.1016/j.ibmb.2006.08.009; Domanitskaya EV, 2007, FEBS J, V274, P5659, DOI 10.1111/j.1742-4658.2007.06088.x; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Dottorini T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-34; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; HARSHMAN LG, 1994, EVOLUTION, V48, P758, DOI [10.2307/2410484, 10.1111/j.1558-5646.1994.tb01359.x]; Heifetz Y, 2005, P NATL ACAD SCI USA, V102, P743, DOI 10.1073/pnas.0407692102; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; HIHARA F, 1981, ZOOL MAG, V90, P303; Holloway AK, 2004, MOL BIOL EVOL, V21, P1625, DOI 10.1093/molbev/msh195; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; Kapelnikov A, 2008, P NATL ACAD SCI USA, V105, P13912, DOI 10.1073/pnas.0710997105; Kern AD, 2004, GENETICS, V167, P725, DOI 10.1534/genetics.103.020883; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Lung O, 2002, GENETICS, V160, P211; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Magnusson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021572; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Mueller JL, 2008, GENETICS, V178, P1605, DOI 10.1534/genetics.107.083766; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Neubaum DM, 1999, GENETICS, V153, P845; OSBOURN AE, 2009, OPERONS CELL MOL LIF, DOI DOI 10.1007/S00018-009-0114-3; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Ram KR, 2005, INSECT BIOCHEM MOLEC, V35, P1059, DOI 10.1016/j.ibmb.2005.05.001; Rexhepaj A, 2003, EUR J BIOCHEM, V270, P4306, DOI 10.1046/j.1432-1033.2003.03823.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Tram U, 1999, GENETICS, V153, P837; Voordouw MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-103; Wagstaff BJ, 2005, GENETICS, V171, P1083, DOI 10.1534/genetics.105.043372; Wagstaff BJ, 2005, MOL BIOL EVOL, V22, P818, DOI 10.1093/molbev/msi067; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Walters JR, 2010, MOL BIOL EVOL, V27, P2000, DOI 10.1093/molbev/msq092; Walters JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-592; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wong A, 2008, GENETICS, V180, P921, DOI 10.1534/genetics.108.092106; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	78	12	12	1	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					86	97		10.1096/fj.12-219444	http://dx.doi.org/10.1096/fj.12-219444			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22997226	Bronze			2022-12-25	WOS:000313103200010
J	Rosenhouse-Dantsker, A; Noskov, S; Han, HZ; Adney, SK; Tang, QY; Rodriguez-Menchaca, AA; Kowalsky, GB; Petrou, VI; Osborn, CV; Logothetis, DE; Levitan, I				Rosenhouse-Dantsker, Avia; Noskov, Sergei; Han, Huazhi; Adney, Scott K.; Tang, Qiong-Yao; Rodriguez-Menchaca, Aldo A.; Kowalsky, Gregory B.; Petrou, Vasileios I.; Osborn, Catherine V.; Logothetis, Diomedes E.; Levitan, Irena			Distant Cytosolic Residues Mediate a Two-way Molecular Switch That Controls the Modulation of Inwardly Rectifying Potassium (Kir) Channels by Cholesterol and Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED ANION CURRENT; MEMBRANE CHOLESTEROL; K+ CHANNELS; CRYSTAL-STRUCTURE; SENSITIVITY; ACTIVATION; HYPERCHOLESTEROLEMIA; PIP2; IDENTIFICATION; DYNAMICS	Inwardly rectifying potassium (Kir) channels play an important role in setting the resting membrane potential and modulating membrane excitability. An emerging feature of several Kir channels is that they are regulated by cholesterol. However, the mechanism by which cholesterol affects channel function is unclear. Here we show that mutations of two distant Kir2.1 cytosolic residues, Leu-222 and Asn-251, form a two-way molecular switch that controls channel modulation by cholesterol and affects critical hydrogen bonding. Notably, these two residues are linked by a residue chain that continues from Asn-251 to connect adjacent subunits. Furthermore, our data indicate that the same switch also regulates the sensitivity of the channels to phosphatidylinositol 4,5-bisphosphate, a phosphoinositide that is required for activation of Kir channels. Thus, although cholesterol and phosphatidylinositol 4,5-bisphosphate do not interact with the same region of Kir2.1, these different modulators induce a common gating pathway of the channel.	[Rosenhouse-Dantsker, Avia; Han, Huazhi; Kowalsky, Gregory B.; Osborn, Catherine V.; Levitan, Irena] Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA; [Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Noskov, Sergei] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Adney, Scott K.; Tang, Qiong-Yao; Rodriguez-Menchaca, Aldo A.; Petrou, Vasileios I.; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Calgary; University of Calgary; Virginia Commonwealth University	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA.	dantsker@uic.edu	Rodríguez-Menchaca, Aldo A./AAD-4603-2019; Petrou, Vasileios/U-5296-2017; Han, Huazhi/B-2261-2015; Noskov, Sergei/B-3654-2010	Rodríguez-Menchaca, Aldo A./0000-0001-7501-8836; Petrou, Vasileios/0000-0002-3194-9863; Noskov, Sergei/0000-0001-7769-335X; Adney, Scott/0000-0001-8743-5944	National Institutes of Health [HL-073965, HL-083298, HL-059949]; American Heart Association [11SDG5190025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, R01HL073965, R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-073965, HL-083298 (to I. L.), and HL-059949 (to D. E. L.). This work was also supported by American Heart Association Scientist Development Grant 11SDG5190025 (to A. R.-D.).	Ambudkar Indu S, 2004, Sci STKE, V2004, ppe32, DOI 10.1126/stke.2432004pe32; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann Donald W., 1995, P307; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTTER OF, 1960, NATURE, V188, P495, DOI 10.1038/188495a0; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mirshahi T, 2006, BIOPHYS J, V90, P2776, DOI 10.1529/biophysj.105.069302; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2004, J GEN PHYSIOL, V123, P77, DOI 10.1085/jgp.200308882; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sanguinetti M. C., 2010, CARDIAC ELECTROPHYSI, P105; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Singh DK, 2011, BBA-BIOMEMBRANES, V1808, P2527, DOI 10.1016/j.bbamem.2011.07.006; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Tai KH, 2009, BIOCHEMISTRY-US, V48, P8758, DOI 10.1021/bi9007808; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	59	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40266	40278		10.1074/jbc.M111.336339	http://dx.doi.org/10.1074/jbc.M111.336339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22995912	Green Published, hybrid			2022-12-25	WOS:000311448800019
J	Connolly, S; Kingsbury, T				Connolly, Sean; Kingsbury, Tami			Regulatory Subunit Myristoylation Antagonizes Calcineurin Phosphatase Activation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR; PROTEIN N-MYRISTOYLTRANSFERASE; MYRISTIC ACID AUXOTROPHY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET; BINDING; STRESS; NFAT	The Ca2+/calmodulin-stimulated protein phosphatase calcineurin is a critical component of Ca2+ signaling cascades in eukaryotic cells. Myristoylation of the regulatory subunit of calcineurin (CNB) is conserved from yeast to humans. Here, we show that CNB myristoylation antagonizes phosphatase activation in yeast. Disruption of CNB myristoylation by mutation of the myristoylated glycine triggered constitutive expression of a calcineurin-dependent reporter gene and enhanced calcineurin-dependent phenotypes. Basal phosphatase activity was also increased in nmt1-181 yeast with reduced N-myristoyltransferase activity. Our findings are the first demonstration of a functional role for CNB myristoylation and reveal the importance of Nmt1 in modulating cellular calcineurin activation.	[Connolly, Sean; Kingsbury, Tami] Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Marlene & Stewart Greenbaum Canc Ctr, Dept Physiol,Program Oncol,Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kingsbury, T (corresponding author), Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Marlene & Stewart Greenbaum Canc Ctr, Dept Physiol,Program Oncol,Sch Med, 20 S Penn St, Baltimore, MD 21201 USA.	tking001@umaryland.edu			National Institutes of Health from the NCI [R021 NS058464, 3P30CA134274]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058464] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R021 NS058464 (to T. K.) and Subaward 3P30CA134274 from the NCI.	AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; DURONIO RJ, 1991, J CELL BIOL, V113, P1313, DOI 10.1083/jcb.113.6.1313; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Feng B, 2001, BIOCHEMISTRY-US, V40, P8808, DOI 10.1021/bi0025161; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hayashi N, 2010, P JPN ACAD B-PHYS, V86, P494, DOI 10.2183/pjab.86.494; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jeromin A, 2004, J BIOL CHEM, V279, P27158, DOI 10.1074/jbc.M312172200; JOHNSON DR, 1993, J BIOL CHEM, V268, P483; Kennedy MT, 1996, J BIOL CHEM, V271, P26517, DOI 10.1074/jbc.271.43.26517; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lee SC, 2007, MOL MICROBIOL, V63, P1039, DOI 10.1111/j.1365-2958.2006.05575.x; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; Musson REA, 2011, CURR MED CHEM, V18, P301; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; POLITINO M, 1987, J BIOL CHEM, V262, P10109; Raju RVS, 2000, MOL CELL BIOCHEM, V204, P135, DOI 10.1023/A:1007012622030; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; ZHU DH, 1995, J BIOL CHEM, V270, P24831, DOI 10.1074/jbc.270.42.24831	51	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.366617	http://dx.doi.org/10.1074/jbc.M112.366617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027860	Green Published, hybrid			2022-12-25	WOS:000311233800008
J	Rao, MD; Liu, HC; Yang, M; Zhao, CC; He, ZG				Rao, Muding; Liu, Huicong; Yang, Min; Zhao, Chunchao; He, Zheng-Guo			A Copper-responsive Global Repressor Regulates Expression of Diverse Membrane-associated Transporters and Bacterial Drug Resistance in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID METABOLISM; ESCHERICHIA-COLI; GNTR FAMILY; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR; EFFLUX PUMP; MOLECULAR-MECHANISMS; NEGATIVE REGULATOR; TUBERCULOSIS; SMEGMATIS	Sequencing of entire bacterial genomes has led to the identification of many membrane-associated transporters, including several multidrug resistance transport proteins, in recent years. However, the regulators and signaling pathways involved in the expression of these genes remain largely unknown. In this study, we have identified Ms2173, a GntR/FadR family transcription factor, as a novel global regulator in Mycobacterium smegmatis. Ms2173 was found to specifically recognize a 15-bp palindromic motif and to broadly regulate expression of 292 genes, including 37 genes that encode membrane-associated transport proteins. Copper ions induced Ms2173 to form inactive proteins lacking DNA-binding activity. Ms2173 was shown to function as a repressor of its target genes. Interestingly, we found that the function of Ms2173 was linked to mycobacterial drug resistance. Compared with the substantially enhanced drug resistance in the Ms2173-deleted mutant strain, the strains overexpressing Ms2173 were more sensitive to anti-tuberculosis drugs than the wild-type strain. Additionally, copper ions could partially counteract the in vivo function of Ms2173. We have thus characterized the first mycobacterial GntR/Fad-like transcription factor that functions as a copper ion-responsive global repressor that we have renamed GfcR. These findings further enhance our understanding of membrane-associated transporter regulation and drug resistance in mycobacteria.	[Rao, Muding; Liu, Huicong; Yang, Min; Zhao, Chunchao; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014	Yang, Min/0000-0003-2924-5717; Rao, Muding/0000-0001-9399-2333	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31025002 and 30930003, by Fundamental Research Funds for the Central Universities Grant 2011PY140, by the Creative Research Groups of Hubei, and by the Hubei Chutian Scholar Program (to H. Z. G.).	Agranoff D, 2004, FRONT BIOSCI-LANDMRK, V9, P2996, DOI 10.2741/1454; Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies J., 1997, ANTIBIOTIC RESISTANC; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gaballa A, 2003, MICROBIOL-SGM, V149, P3413, DOI 10.1099/mic.0.26225-0; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Lee MH, 2003, J BACTERIOL, V185, P4315, DOI 10.1128/JB.185.15.4315-4325.2003; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Strausak D, 1997, J BIOL CHEM, V272, P8932; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Vindal V, 2007, TUBERCULOSIS, V87, P242, DOI 10.1016/j.tube.2006.11.002; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; World Health Organization, 2010, GLOB TUB CONTR WHO R; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zheng MY, 2009, ACTA CRYSTALLOGR D, V65, P356, DOI 10.1107/S0907444909004727	51	18	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.383604	http://dx.doi.org/10.1074/jbc.M112.383604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23014988	Green Published, hybrid			2022-12-25	WOS:000311233800041
J	Socodato, R; Santiago, FN; Portugal, CC; Domingues, AF; Santiago, AR; Relvas, JB; Ambrosio, AF; Paes-de-Carvalho, R				Socodato, Renato; Santiago, Felipe N.; Portugal, Camila C.; Domingues, Ana F.; Santiago, Ana R.; Relvas, Joao B.; Ambrosio, Antonio F.; Paes-de-Carvalho, Roberto			Calcium-permeable alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Trigger Neuronal Nitric-oxide Synthase Activation to Promote Nerve Cell Death in an Src Kinase-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; EMBRYO RETINA CELLS; CREB PHOSPHORYLATION; CYCLIC-GMP; IN-VITRO; EXPRESSION; GLUTAMATE; PROLIFERATION; SYNTHETASE; NMDA	In the retina information decoding is dependent on excitatory neurotransmission and is critically modulated by AMPA glutamate receptors. The Src-tyrosine kinase has been implicated in modulating neurotransmission in CNS. Thus, our main goal was to correlate AMPA-mediated excitatory neurotransmission with the modulation of Src activity in retinal neurons. Cultured retinal cells were used to access the effects of AMPA stimulation on nitric oxide (NO) production and Src phosphorylation. 4-Amino-5-methylamino-2',7'-difluorofluoresceindiacetatefluorescence mainly determined NO production, and immunocytochemistry and Western blotting evaluated Src activation. AMPA receptors activation rapidly up-regulated Src phosphorylation at tyrosine 416 (stimulatory site) and down-regulated phosphotyrosine 527 (inhibitory site) in retinal cells, an effect mainly mediated by calcium-permeable AMPA receptors. Interestingly, experiments confirmed that neuronal NOS was activated in response to calcium-permeable AMPA receptor stimulation. Moreover, data suggest NO pathway as a key regulatory signaling in AMPA-induced Src activation in neurons but not in glial cells. The NO donor SNAP (S-nitroso-N-acetyl-DL-penicillamine) and a soluble guanylyl cyclase agonist (YC-1) mimicked AMPA effect in Src Tyr-416 phosphorylation, reinforcing that Src activation is indeed modulated by the NO pathway. Gain and loss-of-function data demonstrated that ERK is a downstream target of AMPA-induced Src activation and NO signaling. Furthermore, AMPA stimulated NO production in organotypic retinal cultures and increased Src activity in the in vivo retina. Additionally, AMPA-induced apoptotic retinal cell death was regulated by both NOS and Src activity. Because Src activity is pivotal in several CNS regions, the data presented herein highlight that Src modulation is a critical step in excitatory retinal cell death.	[Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Programa Neurociencias, BR-24020971 Niteroi, RJ, Brazil; [Socodato, Renato; Portugal, Camila C.; Santiago, Ana R.; Ambrosio, Antonio F.] Univ Coimbra, Fac Med, Inst Biolmed Invest Luz & Imagem, Ctr Ophthalmol & Vis Sci, P-3004548 Coimbra, Portugal; [Domingues, Ana F.; Relvas, Joao B.] Inst Mol & Cellular Biol, P-4150180 Oporto, Portugal	Universidade Federal Fluminense; Universidade de Coimbra; Universidade do Porto	Paes-de-Carvalho, R (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Programa Neurociencias, Caixa Postal 100180, BR-24020971 Niteroi, RJ, Brazil.	robpaes@vm.uff.br	Portugal, Camila C/A-6267-2013; Paes-de-Carvalho, Roberto/F-8788-2018; Ambrósio, António F/I-3722-2012; Santiago, Ana Raquel/I-6566-2013; Relvas, Joao B/A-1142-2008; Socodato, Renato/A-7237-2013	Portugal, Camila C/0000-0002-1093-6545; Paes-de-Carvalho, Roberto/0000-0002-4081-7547; Ambrósio, António F/0000-0002-0477-1641; Santiago, Ana Raquel/0000-0002-7541-7041; Relvas, Joao B/0000-0001-7636-0924; Socodato, Renato/0000-0002-6882-5020; Domingues, Ana Filipa/0000-0003-3062-9144	CNPq; CAPES; FAPERJ; PRONEX/FAPERJ; CAPES/FCT fellowships [4349/10-9, 4349/10-5]; FCT, Portugal [PEst-C/SAU/UI3282/2011]; FEDER-COMPETE-POFC [PEst-C/SAU/UI3282/2011]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PRONEX/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES/FCT fellowships; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER-COMPETE-POFC	This work was supported by grants from CNPq, CAPES, FAPERJ, PRONEX/FAPERJ, CAPES/FCT fellowships (processes 4349/10-9 and 4349/10-5) and by PEst-C/SAU/UI3282/2011 (FCT, Portugal, and FEDER-COMPETE-POFC).	Allcorn S, 1996, EUR J NEUROSCI, V8, P2499, DOI 10.1111/j.1460-9568.1996.tb01544.x; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Catsicas M, 2001, J NEUROBIOL, V49, P200, DOI 10.1002/neu.1075; Cossenza M, 2000, J NEUROCHEM, V74, P1885, DOI 10.1046/j.1471-4159.2000.0741885.x; Cristovao AJ, 2002, INT J DEV NEUROSCI, V20, P1, DOI 10.1016/S0736-5748(02)00006-0; Socodato RED, 2009, J NEUROCHEM, V108, P417, DOI 10.1111/j.1471-4159.2008.05778.x; Diamond JS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00027; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Frade JG, 2009, HIPPOCAMPUS, V19, P603, DOI 10.1002/hipo.20536; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Leung EL, 2010, MOL CANCER RES, V8, P578, DOI 10.1158/1541-7786.MCR-09-0178; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Magalhaes CR, 2006, INT J DEV NEUROSCI, V24, P53, DOI 10.1016/j.ijdevneu.2005.10.004; Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x; Mishra OP, 2009, NEUROSCI LETT, V460, P61, DOI 10.1016/j.neulet.2009.05.041; MONCADA S, 1991, PHARMACOL REV, V43, P109; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pena-Altamira E, 2010, CURR PHARM DESIGN, V16, P440, DOI 10.2174/138161210790232211; Portugal CC, 2012, J BIOL CHEM, V287, P3860, DOI 10.1074/jbc.M111.260166; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; SCHLAEPFER DD, 1994, NATURE, V372, P786; Socodato R, 2011, J NEUROCHEM, V116, P227, DOI 10.1111/j.1471-4159.2010.07096.x; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; TSUBOKAWA H, 1995, J NEUROPHYSIOL, V74, P218, DOI 10.1152/jn.1995.74.1.218; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	38	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38680	38694		10.1074/jbc.M112.353961	http://dx.doi.org/10.1074/jbc.M112.353961			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992730	hybrid, Green Published			2022-12-25	WOS:000310982800027
J	Zhu-Mauldin, X; Marsh, SA; Zou, LY; Marchase, RB; Chatham, JC				Zhu-Mauldin, Xiaoyuan; Marsh, Susan A.; Zou, Luyun; Marchase, Richard B.; Chatham, John C.			Modification of STIM1 by O-linked N-Acetylglucosamine (O-GlcNAc) Attenuates Store-operated Calcium Entry in Neonatal Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CA2+ ENTRY; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; CHANNEL FUNCTION; CRAC CHANNEL; HEXOSAMINE BIOSYNTHESIS; PLASMA-MEMBRANE; ION SELECTIVITY; ORAI CHANNELS	Store-operated calcium entry (SOCE) is a major Ca2+ signaling pathway responsible for regulating numerous transcriptional events. In cardiomyocytes SOCE has been shown to play an important role in regulating hypertrophic signaling pathways, including nuclear translocation of NFAT. Acute activation of pathways leading to O-GlcNAc synthesis have been shown to impair SOCE-mediated transcription and in diabetes, where O-GlcNAc levels are chronically elevated, cardiac hypertrophic signaling is also impaired. Therefore the goal of this study was to determine whether changes in cardiomyocyte O-GlcNAc levels impaired the function of STIM1, a widely recognized mediator of SOCE. We demonstrated that acute activation of SOCE in neonatal cardiomyocytes resulted in STIM1 puncta formation, which was inhibited in a dose-dependent manner by increasing O-GlcNAc synthesis with glucosamine or inhibiting O-GlcNAcase with thiamet-G. Glucosamine and thiamet-G also inhibited SOCE and were associated with increased O-GlcNAc modification of STIM1. These results suggest that activation of cardiomyocyte O-GlcNAcylation attenuates SOCE via STIM1 O-GlcNAcylation and that this may represent a new mechanism by which increased O-GlcNAc levels regulate Ca2+-mediated events in cardiomyocytes. Further, since SOCE is a fundamental mechanism underlying Ca2+ signaling in most cells and tissues, it is possible that STIM1 represents a nexus linking protein O-GlcNAcylation with Ca2+-mediated transcription.	[Zou, Luyun; Chatham, John C.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Zhu-Mauldin, Xiaoyuan; Marchase, Richard B.; Chatham, John C.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Marsh, Susan A.] Washington State Univ, Program Nutr & Exercise Physiol, Coll Pharm, Spokane, WA 99210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington State University	Chatham, JC (corresponding author), Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, 1670 Univ Blvd,Volker Hall G038, Birmingham, AL 35294 USA.	jchatham@uab.edu	Marsh, Sue/J-3711-2014	Marsh, Sue/0000-0002-7530-0417	NHLBI, National Institutes of Health [HL104549, HL101192, HL110366]; Washington State University of Office Research; Alabama Drug Discovery Alliance through the UAB CCTS [RR025777]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110366, R15HL104549, R01HL101192] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington State University of Office Research; Alabama Drug Discovery Alliance through the UAB CCTS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part, by the NHLBI, National Institutes of Health Grants HL104549 (to S. A. M.), HL101192 and HL110366 (to J. C. C.); the Washington State University of Office Research (to S. A. M.), and the Alabama Drug Discovery Alliance through the UAB CCTS RR025777 (to J. C. C. and R. B. M.).	Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bannister RA, 2008, BIOPHYS J, V94, P2631, DOI 10.1529/biophysj.107.116467; Bannister RA, 2009, CHANNELS, V3, P268, DOI 10.4161/chan.3.4.9342; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Darbha S, 1996, CELL CALCIUM, V20, P361, DOI 10.1016/S0143-4160(96)90042-1; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Jardin I, 2011, BLOOD CELL MOL DIS, V46, P252, DOI 10.1016/j.bcmd.2010.12.008; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohba T, 2009, BIOCHEM BIOPH RES CO, V389, P172, DOI 10.1016/j.bbrc.2009.08.117; Pang Y, 2004, DIABETES, V53, P1074, DOI 10.2337/diabetes.53.4.1074; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Rivera AA, 1995, AM J PHYSIOL-CELL PH, V269, pC1482, DOI 10.1152/ajpcell.1995.269.6.C1482; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2011, CIRCULATION, V124, P766, DOI 10.1161/CIRCULATIONAHA.111.045179; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stiber JA, 2011, CELL CALCIUM, V49, P341, DOI 10.1016/j.ceca.2010.11.012; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Valverde CA, 2010, CARDIOVASC RES, V85, P671, DOI 10.1093/cvr/cvp371; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Walsh CM, 2010, BIOCHEM J, V430, P453, DOI 10.1042/BJ20100650; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	65	68	70	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39094	39106		10.1074/jbc.M112.383778	http://dx.doi.org/10.1074/jbc.M112.383778			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992728	hybrid, Green Published			2022-12-25	WOS:000310982800065
J	Brodland, GW; Veldhuis, JH				Brodland, G. Wayne; Veldhuis, Jim H.			The Mechanics of Metastasis: Insights from a Computational Model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TYPE-1 MATRIX-METALLOPROTEINASE; FINITE-ELEMENT MODEL; TUMOR-CELL; COMPUTER-SIMULATIONS; EMBRYONIC EPITHELIA; SURFACE TENSIONS; FORCE MICROSCOPY; CANCER-CELLS; IN-SILICO	Although it may seem obvious that mechanical forces are required to drive metastatic cell movements, understanding of the mechanical aspects of metastasis has lagged far behind genetic and biochemical knowledge. The goal of this study is to learn about the mechanics of metastasis using a cell-based finite element model that proved useful for advancing knowledge about the forces that drive embryonic cell and tissue movements. Metastasis, the predominant cause of cancer-related deaths, involves a series of mechanical events in which one or more cells dissociate from a primary tumour, migrate through normal tissue, traverse in and out of a multi-layer circulatory system vessel and resettle. The present work focuses on the dissemination steps, from dissociation to circulation. The model shows that certain surface tension relationships must be satisfied for cancerous cells to dissociate from a primary tumour and that these equations are analogous to those that govern dissociation of embryonic cells. For a dissociated cell to then migrate by invadopodium extension and contraction and exhibit the shapes seen in experiments, the invadopodium must generate a contraction equal to approximately twice that produced by the interfacial tension associated with surrounding cells. Intravasation through the wall of a vessel is governed by relationships akin to those in the previous two steps, while release from the vessel wall is governed by equations that involve surface and interfacial tensions. The model raises a number of potential research questions. It also identifies how specific mechanical properties and the sub-cellular structural components that give rise to them might be changed so as to thwart particular metastatic steps and thereby block the spread of cancer.	[Brodland, G. Wayne; Veldhuis, Jim H.] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Brodland, GW (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	brodland@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alaoui-Jamali MA, 2011, AM J TRANSL RES, V3, P434; Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Benko R, 2007, ANN BIOMED ENG, V35, P672, DOI 10.1007/s10439-006-9250-1; Bravo-Cordero JJ, 2011, CURR OPIN CELL BIOL; Brodland G. W., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P17, DOI 10.1080/10255840600554703; Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Brodland G. Wayne, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P121, DOI 10.1080/10255840601124704; Brodland G. Wayne, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P89; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Brodland GW, 2010, HFSP J, V4, P142, DOI 10.2976/1.3338713; Brodland GW, 2009, HFSP J, V3, P273, DOI 10.2976/1.3175812; Brodland GW, 2006, INT J DEV BIOL, V50, P151, DOI 10.1387/ijdb.052040gb; Brodland GW, 2006, INT J PLASTICITY, V22, P965, DOI 10.1016/j.ijplas.2005.05.002; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; Brodland GW, 2011, IEEE T BIOMED ENG; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calorini L, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-24; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CLAUSI DA, 1993, DEVELOPMENT, V118, P1013; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Davidson LA, 2008, CURR TOP DEV BIOL, V81, P113, DOI 10.1016/S0070-2153(07)81003-9; Eaton S, 2003, MECH DEVELOP, V120, P1257, DOI 10.1016/j.mod.2003.07.002; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Foty RA, 2004, INT J DEV BIOL, V48, P397, DOI 10.1387/ijdb.041810rf; Foty RA, 1996, DEVELOPMENT, V122, P1611; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Hutson MS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148105; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Jia DX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-94; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Katoh M, 2005, ONCOL REP, V14, P1583; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Krens SFG, 2011, CURR TOP DEV BIOL, V95, P189, DOI 10.1016/B978-0-12-385065-2.00006-2; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Logan D.L., 2011, 1 COURSE FINITE ELEM; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McGrath DM, 2011, MAGN RESON MED; Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Preziosi L., 2003, CANC MODELLING SIMUL; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Ramasubramanian A, 2006, ANN BIOMED ENG, V34, P1355, DOI 10.1007/s10439-006-9152-2; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Rejniak KA, 2012, MATH MED BIOL, V29, P1, DOI 10.1093/imammb/dqr029; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Said N, 2009, CANCER METAST REV, V28, P327, DOI 10.1007/s10555-009-9197-4; Samavati N, 2011, J PATHOL INFORM, V2, P10; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Sawyer CA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3077211; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Steinberg MS, 1997, J CELL PHYSIOL, V173, P135, DOI 10.1002/(SICI)1097-4652(199711)173:2<135::AID-JCP10>3.3.CO;2-Y; Strobl-Mazzulla P.H., 2012, SEMIN CANC BIOL; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Szabo A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016010; Tanner C, 2011, MED PHYS, V38, P682, DOI 10.1118/1.3525837; Viens D, 2007, J BIOMECH ENG-T ASME, V129, P651, DOI 10.1115/1.2768375; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	74	19	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44281	10.1371/journal.pone.0044281	http://dx.doi.org/10.1371/journal.pone.0044281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028513	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900007
J	Pozo, C; Guillen-Gosalbez, G; Sorribas, A; Jimenez, L				Pozo, Carlos; Guillen-Gosalbez, Gonzalo; Sorribas, Albert; Jimenez, Laureano			Identifying the Preferred Subset of Enzymatic Profiles in Nonlinear Kinetic Metabolic Models via Multiobjective Global Optimization and Pareto Filters	PLOS ONE			English	Article							BIOCHEMICAL SYSTEMS-ANALYSIS; NORMAL CONSTRAINT METHOD; MULTICRITERIA OPTIMIZATION; ETHANOL; REPRESENTATION; DEFINITION; OPTIMALITY; NETWORKS; STRATEGY; LAW	Optimization models in metabolic engineering and systems biology focus typically on optimizing a unique criterion, usually the synthesis rate of a metabolite of interest or the rate of growth. Connectivity and non-linear regulatory effects, however, make it necessary to consider multiple objectives in order to identify useful strategies that balance out different metabolic issues. This is a fundamental aspect, as optimization of maximum yield in a given condition may involve unrealistic values in other key processes. Due to the difficulties associated with detailed non-linear models, analysis using stoichiometric descriptions and linear optimization methods have become rather popular in systems biology. However, despite being useful, these approaches fail in capturing the intrinsic nonlinear nature of the underlying metabolic systems and the regulatory signals involved. Targeting more complex biological systems requires the application of global optimization methods to non-linear representations. In this work we address the multi-objective global optimization of metabolic networks that are described by a special class of models based on the power-law formalism: the generalized mass action (GMA) representation. Our goal is to develop global optimization methods capable of efficiently dealing with several biological criteria simultaneously. In order to overcome the numerical difficulties of dealing with multiple criteria in the optimization, we propose a heuristic approach based on the epsilon constraint method that reduces the computational burden of generating a set of Pareto optimal alternatives, each achieving a unique combination of objectives values. To facilitate the post-optimal analysis of these solutions and narrow down their number prior to being tested in the laboratory, we explore the use of Pareto filters that identify the preferred subset of enzymatic profiles. We demonstrate the usefulness of our approach by means of a case study that optimizes the ethanol production in the fermentation of Saccharomyces cerevisiae.	[Pozo, Carlos; Guillen-Gosalbez, Gonzalo; Jimenez, Laureano] URV, ETSEQ, Dept Engn Quim EQ, Tarragona, Spain; [Sorribas, Albert] Univ Lleida, Inst Recerca Biomed Lleida IRBLLEIDA, Dept Ciencies Med Basiques, Lleida, Spain	Universitat Rovira i Virgili; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Guillen-Gosalbez, G (corresponding author), URV, ETSEQ, Dept Engn Quim EQ, Tarragona, Spain.	gonzalo.guillen@urv.cat	Guillén-Gosálbez, Gonzalo/G-3531-2016; Fernández, Carlos Pozo/E-1051-2019; Sorribas, Albert/A-2181-2009; Pozo, Carlos/AAQ-3291-2020; Jimenez Esteller, Laureano/F-6782-2011	Guillén-Gosálbez, Gonzalo/0000-0001-6074-8473; Fernández, Carlos Pozo/0000-0002-5645-674X; Sorribas, Albert/0000-0002-7407-4075; Pozo, Carlos/0000-0002-5645-674X; Jimenez Esteller, Laureano/0000-0002-3186-7235	Spanish Ministry of Education and Science [DPI2008-04099, PHB2008-0090-PC, BFU2008-00196, CTQ2009-14420-C02]; Spanish Ministry of External Affairs [HS2007-0006, A/023551/09]; Spanish Ministry of Science and Innovation [ENE2011-28269-C03-03]; Generalitat de Catalunya (FI programs); Spanish Ministry of Education, Culture and Sport (FPU programs)	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of External Affairs(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya (FI programs)(Generalitat de Catalunya); Spanish Ministry of Education, Culture and Sport (FPU programs)	The authors wish to acknowledge support of this research work from the Spanish Ministry of Education and Science (projects DPI2008-04099, PHB2008-0090-PC, BFU2008-00196 and CTQ2009-14420-C02), the Spanish Ministry of External Affairs (projects HS2007-0006 and A/023551/09), the Spanish Ministry of Science and Innovation (ENE2011-28269-C03-03), the Generalitat de Catalunya (FI programs; http://www10.gencat.net/agaur_web/AppJava/a_beca.jsp?categoria=predoctorals&id_beca=16701) and the Spanish Ministry of Education, Culture and Sport (FPU programs; http://www.educacion.gob.es/educacion/universidades/convocatorias/titulados-doctores-profesores/fpu/convocatoria.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 2000, HPL200098 HEWL PACK; Alvarez-Vasquez F, 2000, BIOTECHNOL BIOENG, V70, P82, DOI 10.1002/1097-0290(20001005)70:1&lt;82::AID-BIT10&gt;3.0.CO;2-V; Bergamini ML, 2005, COMPUT CHEM ENG, V29, P1914, DOI 10.1016/j.compchemeng.2005.04.003; Biegler LT, 2004, COMPUT CHEM ENG, V28, P1169, DOI 10.1016/j.compchemeng.2003.11.003; Branke E, 2004, LECT NOTES COMPUT SC, V3242, P722, DOI 10.1007/978-3-540-30217-9_73; Branke J, 2001, ADV ENG SOFTW, V32, P499, DOI 10.1016/S0965-9978(00)00110-1; Branke J., 2004, KNOWLEDGE INCORPORAT, P461; Cheng FY, 1998, AIAA J, V36, P1105, DOI 10.2514/2.488; CLOQUELL V, 1999, THESIS U POLITCNICA; CLOQUELL V, 2001, 17 C NAC ING PROYECT; Das I, 1998, SIAM J OPTIMIZ, V8, P631, DOI 10.1137/S1052623496307510; Das I, 1999, STRUCT OPTIMIZATION, V18, P30, DOI 10.1007/BF01210689; Deb K, 2005, LECT NOTES COMPUT SC, V3410, P150; Deb K., 2005, KANGAL REP, P1; DEB K, 2003, NAT COMP SER, P263; EHRGOTT M, 1998, MULTICRITERIA OPTIMI; Farina M, 2004, IEEE T SYST MAN CY A, V34, P315, DOI 10.1109/TSMCA.2004.824873; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hatzimanikatis V, 1996, BIOTECHNOL BIOENG, V52, P485, DOI 10.1002/(SICI)1097-0290(19961120)52:4<485::AID-BIT4>3.0.CO;2-L; HEINRICH R, 2005, REGULATION CELLULAR; Kim IK, 2012, FEMS YEAST RES, V12, P228, DOI 10.1111/j.1567-1364.2011.00779.x; Li RD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S12; Liu PK, 2008, BIOINFORMATICS, V24, P1085, DOI 10.1093/bioinformatics/btn075; Marin-Sanguino A, 2003, MATH BIOSCI, V184, P187, DOI 10.1016/S0025-5564(03)00046-4; Marin-Sanguino A, 2009, MATH BIOSCI, V218, P50, DOI 10.1016/j.mbs.2008.12.010; Mattson CA, 2004, ENG OPTIMIZ, V36, P721, DOI 10.1080/0305215042000274942; Mattson CA, 2003, AIAA J, V41, P1190, DOI 10.2514/2.2063; Messac A, 2004, AIAA J, V42, P2101, DOI 10.2514/1.8977; Messac A, 2003, STRUCT MULTIDISCIP O, V25, P86, DOI 10.1007/s00158-002-0276-1; MONTUSIEWICZ J, 1990, ENG COST PROD ECON, V20, P191, DOI 10.1016/0167-188X(90)90102-N; Parachin NS, 2011, METAB ENG, V13, P508, DOI 10.1016/j.ymben.2011.05.005; Polisetty PK, 2008, BIOTECHNOL BIOENG, V99, P1154, DOI 10.1002/bit.21679; Pozo C, 2011, IND ENG CHEM RES, V50, P5225, DOI 10.1021/ie101368k; Pozo C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-137; Pozo C, 2010, COMPUT CHEM ENG, V34, P1719, DOI 10.1016/j.compchemeng.2010.03.001; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SCHUSTER S, 1991, J MATH BIOL, V29, P443, DOI 10.1007/BF00160471; Sendin JOH, 2010, IET SYST BIOL, V4, P236, DOI 10.1049/iet-syb.2009.0045; Sendin OH, 2006, MATH COMP MODEL DYN, V12, P469, DOI 10.1080/13873950600723442; Sorribas A, 2010, J BIOTECHNOL, V149, P141, DOI 10.1016/j.jbiotec.2010.01.026; Vera J, 2003, BIOTECHNOL BIOENG, V83, P335, DOI 10.1002/bit.10676; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2003, MATH BIOSCI, V182, P81, DOI 10.1016/S0025-5564(02)00162-1; VOIT EO, 1992, BIOTECHNOL BIOENG, V40, P572, DOI 10.1002/bit.260400504; Wu WH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-145	47	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43487	10.1371/journal.pone.0043487	http://dx.doi.org/10.1371/journal.pone.0043487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028457	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900003
J	During, L; Thorsen, M; Petersen, DSN; Koster, B; Jensen, TH; Holmberg, S				During, Louis; Thorsen, Michael; Petersen, Darima Sophia Njama; Koster, Brian; Jensen, Torben Heick; Holmberg, Steen			MRN1 Implicates Chromatin Remodeling Complexes and Architectural Factors in mRNA Maturation	PLOS ONE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; SWI/SNF-RELATED COMPLEXES; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PRP19P-ASSOCIATED COMPLEX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; GENE-EXPRESSION; U6 SNRNA; YEAST	A functional relationship between chromatin structure and mRNA processing events has been suggested, however, so far only a few involved factors have been characterized. Here we show that rsc nhp6 Delta Delta mutants, deficient for the function of the chromatin remodeling factor RSC and the chromatin architectural proteins Nhp6A/Nhp6B, accumulate intron-containing pre-mRNA at the restrictive temperature. In addition, we demonstrate that rsc8-ts16 nhp6 Delta Delta cells contain low levels of U6 snRNA and U4/U6 di-snRNA that is further exacerbated after two hours growth at the restrictive temperature. This change in U6 snRNA and U4/U6 di-snRNA levels in rsc8-ts16 nhp6 Delta Delta cells is indicative of splicing deficient conditions. We identify MRN1 (multi-copy suppressor of rsc nhp6 Delta Delta) as a growth suppressor of rsc nhp6 Delta Delta synthetic sickness. Mrn1 is an RNA binding protein that localizes both to the nucleus and cytoplasm. Genetic interactions are observed between 2 mu m-MRN1 and the splicing deficient mutants snt309 Delta, prp3, prp4, and prp22, and additional genetic analyses link MRN1, SNT309, NHP6A/B, SWI/SNF, and RSC supporting the notion of a role of chromatin structure in mRNA processing.	[During, Louis; Thorsen, Michael; Petersen, Darima Sophia Njama; Koster, Brian; Holmberg, Steen] Univ Copenhagen, Dept Biol, Copenhagen BioCtr, Copenhagen, Denmark; [Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University	Holmberg, S (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen BioCtr, Copenhagen, Denmark.	gensteen@bio.ku.dk	Holmberg, Steen/N-1128-2014; Jensen, Torben H/G-2954-2017	Holmberg, Steen/0000-0002-0262-3207; Jensen, Torben Heick/0000-0001-5127-1239	Faculty of Natural Sciences, University of Copenhagen; Danish National Research Foundation (Grundforskningsfonden); Danish Research Councils; Carlsberg Foundation; Manufacturer Vilhelm Pedersen and Wife Memorial Legacy	Faculty of Natural Sciences, University of Copenhagen; Danish National Research Foundation (Grundforskningsfonden)(Danmarks Grundforskningsfond); Danish Research Councils(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Manufacturer Vilhelm Pedersen and Wife Memorial Legacy	L.D. was supported by a Ph.D. stipend from the Faculty of Natural Sciences, University of Copenhagen, T.H.J. was supported by the Danish National Research Foundation (Grundforskningsfonden), and S.H. was supported by grants from the Danish Research Councils, The Carlsberg Foundation and Manufacturer Vilhelm Pedersen and Wife Memorial Legacy (this support was granted on recommendation from the Novo Nordisk Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Anthony JG, 1997, RNA, V3, P1143; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; COSTIGAN C, 1994, MOL CELL BIOL, V14, P2391, DOI 10.1128/MCB.14.4.2391; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Du J, 1998, GENETICS, V150, P987; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; HU J, 1994, NUCLEIC ACIDS RES, V22, P1724, DOI 10.1093/nar/22.9.1724; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kruppa M, 2001, MOL CELL, V7, P309, DOI 10.1016/S1097-2765(01)00179-4; Lopez S, 2001, MOL CELL BIOL, V21, P3096, DOI 10.1128/MCB.21.9.3096-3104.2001; Lygerou Z, 1999, MOL CELL BIOL, V19, P2008; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; Moore MJ, 2006, MOL CELL, V24, P903, DOI 10.1016/j.molcel.2006.12.006; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moreira JMA, 2000, EMBO J, V19, P6804, DOI 10.1093/emboj/19.24.6804; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Papoulas O, 2001, P NATL ACAD SCI USA, V98, P5728, DOI 10.1073/pnas.091533398; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; RYMOND BC, 1993, P NATL ACAD SCI USA, V90, P848, DOI 10.1073/pnas.90.3.848; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Wong MCVL, 2002, MOL CELL BIOL, V22, P4218, DOI 10.1128/MCB.22.12.4218-4229.2002; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938	65	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44373	10.1371/journal.pone.0044373	http://dx.doi.org/10.1371/journal.pone.0044373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028530	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900022
J	Hou, HS; Liao, CL; Sytwu, HK; Liao, NS; Huang, TY; Hsieh, TY; Chu, HC				Hou, Hsein-San; Liao, Ching-Len; Sytwu, Huey-Kang; Liao, Nan-Shih; Huang, Tien-Yu; Hsieh, Tsai-Yuan; Chu, Heng-Cheng			Deficiency of Interleukin-15 Enhances Susceptibility to Acetaminophen-Induced Liver Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; INDUCED HEPATOTOXICITY; IN-VIVO; ISCHEMIA-REPERFUSION; HEME OXYGENASE-1; REACTIVE OXYGEN; D-GALACTOSAMINE; PROTECTIVE ROLE; WILD-TYPE	Hepatocytes have a direct necrotic role in acetaminophen (APAP)-induced liver injury (AILI), prolonged secondary inflammatory response through innate immune cells and cytokines also significantly contributes to APAP hepatotoxicity. Interleukin 15 (IL-15), a multifunction cytokine, regulates the adaptive immune system and influences development and function of innate immune cells. To better understand the role of IL-15 in liver injury, we treated wild-type (WT) and IL-15-knockout (Il15(-/-)) mice with a hepatotoxic dose of APAP to induce AILI and evaluated animal survival, liver damage, APAP metabolism in livers and the inflammatory response. Production of pro-inflammatory cytokines/chemokines was greater in Il15(-/-) than WT mice. Subanalysis of hepatic infiltrated monocytes revealed greater neutrophil influx, along with greater hepatic induction of inducible nitric oxide synthase (iNOS), in Il15(-/-) than WT mice. In addition, the level of hepatic hemeoxygenase 1 (HO-1) was partially suppressed in Il15(-/-) mice, but not in WT mice. Interestingly, elimination of Kupffer cells and neutrophils did not alter the vulnerability to excess APAP in Il15(-/-) mice. However, injection of galactosamine, a hepatic transcription inhibitor, significantly reduced the increased APAP sensitivity in Il15(-/-) mice but had minor effect on WT mice. We demonstrated that deficiency of IL-15 increased mouse susceptibility to AILI. Moreover, Kupffer cell might affect APAP hepatotoxicity through IL-15.	[Hou, Hsein-San; Liao, Ching-Len; Sytwu, Huey-Kang; Liao, Nan-Shih; Chu, Heng-Cheng] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liao, Ching-Len; Sytwu, Huey-Kang] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Liao, Nan-Shih] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Tien-Yu; Hsieh, Tsai-Yuan; Chu, Heng-Cheng] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center; Tri-Service General Hospital	Chu, HC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	dr.chu0803@gmail.com	Liao, Nan-Shih/ABE-7580-2020	Liao, Nan-Shih/0000-0003-3707-4145	National Science Council [NSC94-2314-B-016-047]; Tri-Service General Hospital, National Defense Medical Center [TSGH-C97-44, TSGH-C98-48, TSGH-C99-61]; Department of Defense, Taiwan [P98-25, I-3]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, National Defense Medical Center; Department of Defense, Taiwan(United States Department of Defense)	This study was supported in part by the National Science Council (NSC94-2314-B-016-047), Tri-Service General Hospital, National Defense Medical Center (TSGH-C97-44, TSGH-C98-48 and TSGH-C99-61) and the Department of Defense, Taiwan (P98-25 and I-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Alleva DG, 1997, J IMMUNOL, V159, P2941; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Bouchard A, 2004, J LEUKOCYTE BIOL, V75, P893, DOI 10.1189/jlb.1103585; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; Connolly MK, 2011, HEPATOLOGY, V54, P959, DOI 10.1002/hep.24429; Conti F, 2003, TRANSPLANTATION, V76, P210, DOI 10.1097/01.TP.0000067530.95852.67; Cover C, 2006, TOXICOL APPL PHARM, V216, P98, DOI 10.1016/j.taap.2006.04.010; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; Gomez-Nicola D, 2010, EXP NEUROL, V222, P235, DOI 10.1016/j.expneurol.2009.12.034; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Harstad EB, 2002, TOXICOL APPL PHARM, V180, P178, DOI 10.1006/taap.2002.9385; Hinson JA, 2002, NITRIC OXIDE-BIOL CH, V6, P160, DOI 10.1006/niox.2001.0404; Hoetzel A, 2001, HEPATOLOGY, V33, P925, DOI 10.1053/jhep.2001.23431; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2002, FASEB J, V16, DOI 10.1096/fj.02-0046com; JAESCHKE H, 1990, J PHARMACOL EXP THER, V255, P935; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Knight TR, 2002, TOXICOL APPL PHARM, V181, P133, DOI 10.1006/taap.2002.9407; Kon K, 2004, HEPATOLOGY, V40, P1170, DOI 10.1002/hep.20437; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li BF, 2006, HEPATOLOGY, V43, P1211, DOI 10.1002/hep.21174; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MALEY F, 1968, BIOCHEM J, V107, P637, DOI 10.1042/bj1070637; Masson MJ, 2008, HEPATOLOGY, V48, P889, DOI 10.1002/hep.22400; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Meazza R, 1996, ONCOGENE, V12, P2187; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mirghomizadeh F, 2009, J BIOL CHEM, V284, P32635, DOI 10.1074/jbc.M109.015446; Misra I, 1998, PROTEIN EXPRES PURIF, V13, P268, DOI 10.1006/prep.1998.0897; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Nishimura H, 1998, J IMMUNOL, V160, P936; NUSSLER AK, 1995, HEPATOLOGY, V21, P1552, DOI 10.1016/0270-9139(95)90459-X; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Onu A, 1997, J IMMUNOL, V158, P255; Possamai LA, 2010, WORLD J GASTROENTERO, V16, P1811, DOI 10.3748/wjg.v16.i15.1811; Ruckert R, 2009, IMMUNOLOGY, V126, P63, DOI 10.1111/j.1365-2567.2008.02878.x; Sakamoto N, 2003, LIVER TRANSPLANT, V9, P940, DOI 10.1053/jlts.2003.50182; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Sumioka I, 2004, LIFE SCI, V74, P2551, DOI 10.1016/j.lfs.2003.10.011; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Yee SB, 2007, CHEM RES TOXICOL, V20, P734, DOI 10.1021/TX600349f; Yoshihara K, 2006, GUT, V55, P334, DOI 10.1136/gut.2005.076000	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44880	10.1371/journal.pone.0044880	http://dx.doi.org/10.1371/journal.pone.0044880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028657	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900048
J	Wang, LY; Li, ST; Dorf, ME				Wang, Lingyan; Li, Shitao; Dorf, Martin E.			NEMO Binds Ubiquitinated TANK-Binding Kinase 1 (TBK1) to Regulate Innate Immune Responses to RNA Viruses	PLOS ONE			English	Article							MEDIATED ANTIVIRAL RESPONSE; I INTERFERON-PRODUCTION; TUMOR-SUPPRESSOR CYLD; KAPPA-B; NEGATIVE REGULATOR; SIGNALING PATHWAY; PROTEIN; IRF3; ACTIVATION; LIGASE	RIG-I-like receptors (RLR) are intracellular sensors utilized by nearly all cell types for recognition of viral RNA, initiation of antiviral defense, and induction of type I interferons (IFN). TBK1 is a critical kinase implicated in RLR-dependent IFN transcription. Posttranslational modification of TBK1 by K63-linked ubiquitin is required for RLR driven signaling. However, the TBK1 ubiquitin acceptor sites and the function of ubiquitinated TBK1 in the signaling cascade are unknown. We now show that TBK1 is ubiquitinated on residues K69, K154, and K372 in response to infection with RNA virus. The K69 and K154 residues are critical for innate antiviral responses and IFN production. Ubiquitinated TBK1 recruits the downstream adaptor NEMO through ubiquitin binding domains. The assembly of the NEMO/TBK1 complex on the mitochondrial protein MAVS leads to activation of TBK1 kinase activity and phosphorylation of the transcription factor, interferon response factor 3. The combined results refine current views of RLR signaling, define the role of TBK1 polyubiquitination, and detail the mechanisms involved in signalosome assembly.	[Wang, Lingyan; Li, Shitao; Dorf, Martin E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Li, ST (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.	shitao_li@hms.harvard.edu; dorf@hms.harvard.edu		Li, Shitao/0000-0002-1398-8519	Public Health Service [AI089829, NS057162, AI099860]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089829, R21AI099860, R56AI089829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057162] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grants AI089829, NS057162 and AI099860. S.L. is a John and Virginia Kaneb fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Di YW, 2008, CELL SIGNAL, V20, P705, DOI 10.1016/j.cellsig.2007.12.007; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Ma X, 2012, P NATL ACAD SCI US; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	40	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43756	10.1371/journal.pone.0043756	http://dx.doi.org/10.1371/journal.pone.0043756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028469	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900009
J	Chen, PP; Douglas, SD; Meshki, J; Tuluc, F				Chen, Panpan; Douglas, Steven D.; Meshki, John; Tuluc, Florin			Neurokinin 1 Receptor Mediates Membrane Blebbing and Sheer Stress-Induced Microparticle Formation in HEK293 Cells	PLOS ONE			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VIVO; EXOSOMES; MICROVESICLES; CANCER; COMMUNICATION; INFORMATION; SECRETION; MECHANISM; DISEASES	Cell-derived microparticles participate in intercellular communication similar to the classical messenger systems of small and macro-molecules that bind to specialized membrane receptors. Microparticles have been implicated in the regulation of a variety of complex physiopathologic processes, such as thrombosis, the control of innate and adaptive immunity, and cancer. The neurokinin 1 receptor (NK1R) is a Gq-coupled receptor present on the membrane of a variety of tissues, including neurons in the central and peripheral nervous system, immune cells, endocrine and exocrine glands, and smooth muscle. The endogenous agonist of NK1R is the undecapeptide substance P (SP). We have previously described intracellular signaling mechanisms that regulate NK1R-mediated rapid cell shape changes in HEK293 cells and U373MG cells. In the present study, we show that the activation of NK1R in HEK293 cells, but not in U373MG cells, leads to formation of sheer-stress induced microparticles that stain positive with the membrane-selective fluorescent dye FM 2-10. SP-induced microparticle formation is independent of elevated intracellular calcium concentrations and activation of NK1R present on HEK293-derived microparticles triggers detectable calcium increase in SP-induced microparticles. The ROCK inhibitor Y27632 and the dynamin inhibitor dynasore inhibited membrane blebbing and microparticle formation in HEK293 cells, strongly suggesting that microparticle formation in this cell type is dependent on membrane blebbing.	[Chen, Panpan; Douglas, Steven D.; Meshki, John; Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Div Allergy Immunol, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Tuluc, Florin] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Tuluc, Florin] Childrens Hosp Philadelphia, Res Inst, Flow Cytometry Core Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chen, PP (corresponding author), Childrens Hosp Philadelphia, Res Inst, Div Allergy Immunol, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu		Douglas, Steven/0000-0002-3748-3603	National Institutes of Health [U01MH090325, R01-MH049981]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants U01MH090325 and R01-MH049981 (to SDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Gabriel DA, 2010, SEMIN THROMB HEMOST, V36, P824, DOI 10.1055/s-0030-1267036; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Key NS, 2010, THROMB RES, V125, pS80, DOI 10.1016/S0049-3848(10)70020-7; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meshki J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025332; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; Meziani F, 2008, PHARMACOL REP, V60, P75; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Nusbaum P, 2005, J BIOL CHEM, V280, P5843, DOI 10.1074/jbc.M413405200; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Vasina EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.94; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964	38	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45322	10.1371/journal.pone.0045322	http://dx.doi.org/10.1371/journal.pone.0045322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024816	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100074
J	Fang, CY; Huang, SY; Wu, CC; Hsu, HY; Chou, SP; Tsai, CH; Chang, Y; Takada, K; Chen, JY				Fang, Chih-Yeu; Huang, Sheng-Yen; Wu, Chung-Chun; Hsu, Hui-Yu; Chou, Sheng-Ping; Tsai, Ching-Hwa; Chang, Yao; Takada, Kenzo; Chen, Jen-Yang			The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							GENOME INSTABILITY; N-NITROSAMINES; HIGH-FREQUENCY; CLASS-I; EXPRESSION; GENE; EBV; ANTIBODY; ETIOLOGY; CANCER	Seroepidemiological studies imply a correlation between Epstein-Barr virus (EBV) reactivation and the development of nasopharyngeal carcinoma (NPC). N-nitroso compounds, phorbols, and butyrates are chemicals found in food and herb samples collected from NPC high-risk areas. These chemicals have been reported to be risk factors contributing to the development of NPC, however, the underlying mechanism is not fully understood. We have demonstrated previously that low dose N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 0.1 mu mg/ml) had a synergistic effect with 12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium butyrate (SB) in enhancing EBV reactivation and genome instability in NPC cells harboring EBV. Considering that residents in NPC high-risk areas may contact regularly with these chemical carcinogens, it is vital to elucidate the relation between chemicals and EBV and their contributions to the carcinogenesis of NPC. In this study, we constructed a cell culture model to show that genome instability, alterations of cancer hallmark gene expression, and tumorigenicity were increased after recurrent EBV reactivation in NPC cells following combined treatment of TPA/SB and MNNG. NPC cells latently infected with EBV, NA, and the corresponding EBV-negative cell, NPC-TW01, were periodically treated with MNNG, TPA/SB, or TPA/SB combined with MNNG. With chemically-induced recurrent reactivation of EBV, the degree of genome instability was significantly enhanced in NA cells treated with a combination of TPA/SB and MNNG than those treated individually. The Matrigel invasiveness, as well as the tumorigenicity in mouse, was also enhanced in NA cells after recurrent EBV reactivation. Expression profile analysis by microarray indicates that many carcinogenesis-related genes were altered after recurrent EBV reactivation, and several aberrations observed in cell lines correspond to alterations in NPC lesions. These results indicate that cooperation between chemical carcinogens can enhance the reactivation of EBV and, over recurrent reactivations, lead to alteration of cancer hallmark gene expression with resultant enhancement of tumorigenesis in NPC.	[Fang, Chih-Yeu; Wu, Chung-Chun; Chou, Sheng-Ping; Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town, Miaoli County, Taiwan; [Huang, Sheng-Yen] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Huang, Sheng-Yen] Natl Hlth Res Inst, Hsinchu, Taiwan; [Huang, Sheng-Yen; Hsu, Hui-Yu] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Tsai, Ching-Hwa; Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan; [Chang, Yao] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Health Research Institutes - Taiwan; National Tsing Hua University; National Taiwan University; National Health Research Institutes - Taiwan; Hokkaido University	Fang, CY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town, Miaoli County, Taiwan.	cjy@nhri.org.tw	Chen, Jen-Yang/D-2085-2010; Chang, Yao/B-2653-2010; Fang, Chih-Yeu/AAH-5170-2021	Fang, Chih-Yeu/0000-0002-8280-3012	National Health Research Institutes and National Science Council, Taiwan [NSC96-3112-B-400-010, NSC97-3112-B400-007, NSC98-3112-B-400-002, NSC99-3112-B-400-009, NSC101-2325-B-400-023]	National Health Research Institutes and National Science Council, Taiwan	This work was supported in part by National Health Research Institutes and National Science Council, Taiwan (NSC96-3112-B-400-010, NSC97-3112-B400-007, NSC98-3112-B-400-002, NSC99-3112-B-400-009, NSC101-2325-B-400-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BOUVIER G, 1991, IARC SCI PUBL, V105, P204; Chan ASC, 2000, CANCER RES, V60, P5365; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039217; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHEN JY, 1985, J MED VIROL, V16, P99, DOI 10.1002/jmv.1890160202; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Chilosi M, 1998, AM J PATHOL, V152, P209; COCHET C, 1993, VIROLOGY, V197, P358, DOI 10.1006/viro.1993.1597; Cordes C, 2011, INT J ONCOL, V39, P185, DOI 10.3892/ijo.2011.1006; Crawford D, 2004, COMMUN ACM, V47, P5, DOI 10.1145/986213.986220; de-The G., 1982, HERPESVIRUSES, P25; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Feng BJ, 2007, INT J CANCER, V121, P1550, DOI 10.1002/ijc.22813; Feng P, 2000, J GEN VIROL, V81, P2417, DOI 10.1099/0022-1317-81-10-2417; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haverkos HW, 2004, ONCOGENE, V23, P6492, DOI 10.1038/sj.onc.1207822; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HENLE W, 1977, INT J CANCER, V20, P663, DOI 10.1002/ijc.2910200504; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; HIRAYAMA T, 1981, PREV MED, V10, P614, DOI 10.1016/0091-7435(81)90051-7; Ho J H, 1972, Adv Cancer Res, V15, P57, DOI 10.1016/S0065-230X(08)60372-3; Hoffmann D, 1996, CRIT REV TOXICOL, V26, P199, DOI 10.3109/10408449609017931; Hsu WL, 2009, CANCER EPIDEM BIOMAR, V18, P1218, DOI 10.1158/1055-9965.EPI-08-1175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang SY, 2010, CHEM-BIOL INTERACT, V188, P623, DOI 10.1016/j.cbi.2010.09.020; Hui ABY, 1999, INT J CANCER, V82, P498, DOI 10.1002/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S; IARC, 1997, WORK GROUP EV CARC R, P248; ITO Y, 1980, CANCER RES, V40, P4329; Ivanova T, 2004, INT J CANCER, V108, P882, DOI 10.1002/ijc.11652; Kristensen M, 1991, Ann Acad Med Singap, V20, P597; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; LIN CT, 1990, LAB INVEST, V62, P713; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; LYNN T, 1973, JPN J EXP MED, V43, P121; MARTELRENOIR D, 1995, J GEN VIROL, V76, P1401, DOI 10.1099/0022-1317-76-6-1401; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; Mutirangura A, 1997, BRIT J CANCER, V76, P770, DOI 10.1038/bjc.1997.460; Myzak MC, 2006, CURR DRUG TARGETS, V7, P443, DOI 10.2174/138945006776359467; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; OCKEN PR, 1969, J LIPID RES, V10, P460; OCONNELL JF, 1986, CANCER LETT, V30, P269, DOI 10.1016/0304-3835(86)90051-0; OKANO M, 1988, Clinical Microbiology Reviews, V1, P300; Oraldi M, 2011, CHEM-BIOL INTERACT, V191, P171, DOI 10.1016/j.cbi.2011.01.011; Patel M, 2008, LUNG CANCER, V59, P340, DOI 10.1016/j.lungcan.2007.08.033; POIRIER S, 1987, INT J CANCER, V39, P293, DOI 10.1002/ijc.2910390305; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SbihLammali F, 1996, VIROLOGY, V222, P64, DOI 10.1006/viro.1996.0398; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Szaniawska B, 1996, CANCER LETT, V107, P205, DOI 10.1016/0304-3835(96)04369-8; Takano Y, 1999, J PATHOL, V189, P194; Wente MN, 2005, PANCREAS, V31, P119, DOI 10.1097/01.mpa.0000173459.81193.4d; Wong TS, 2002, CLIN CANCER RES, V8, P433; Wu CC, 2010, NUCLEIC ACIDS RES, V38, P1932, DOI 10.1093/nar/gkp1169; Ye L, 2011, CANCER LETT, V307, P6, DOI 10.1016/j.canlet.2011.03.007; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1985, ADV CANCER RES, V44, P121, DOI 10.1016/S0065-230X(08)60027-5; Zhao ZG, 2004, JPN J CLIN ONCOL, V34, P414, DOI 10.1093/jjco/hyh073; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; ZURHAUSEN H, 1978, NATURE, V272, P373	73	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44810	10.1371/journal.pone.0044810	http://dx.doi.org/10.1371/journal.pone.0044810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024765	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100023
J	Hansen, AN; Bendiksen, CD; Sylvest, L; Friis, T; Staerk, D; Jorgensen, FS; Olsen, CA; Houen, G				Hansen, Anders N.; Bendiksen, Christine D.; Sylvest, Lene; Friis, Tina; Staerk, Dan; Jorgensen, Flemming Steen; Olsen, Christian A.; Houen, Gunnar			Synthesis and Antiangiogenic Activity of N-Alkylated Levamisole Derivatives	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC IMPLICATIONS; ANGIOGENESIS INHIBITOR; TYROSINE KINASES; CANCER-PATIENTS; IN-VITRO; DISEASE; RESVERATROL; MECHANISMS; SIRT1	Inhibition of angiogenesis is a promising addition to current cancer treatment strategies. Neutralization of vascular endothelial growth factor by monoclonal antibodies is clinically effective but may cause side effects due to thrombosis. Low molecular weight angiogenesis inhibitors are currently less effective than antibody treatment and are also associated with serious side effects. The discovery of new chemotypes with efficient antiangiogenic activity is therefore of pertinent interest. (S)-Levamisole hydrochloride, an anthelminthic drug approved for human use and with a known clinical profile, was recently shown to be an inhibitor of angiogenesis in vitro and exhibited tumor growth inhibition in mice. Here we describe the synthesis and in vitro evaluation of a series of N-alkylated analogues of levamisole with the aim of characterizing structure-activity relationships with regard to inhibition of angiogenesis. N-Methyllevamisole and p-bromolevamisole proved more effective than the parent compound, (S)-levamisole hydrochloride, with respect to inhibition of angiogenesis and induction of undifferentiated cluster morphology in human umbilical vein endothelial cells grown in co-culture with normal human dermal fibroblasts. Interestingly, the cluster morphology caused by N-methyllevamisole was different than the clusters observed for levamisole, and a third "cord-like" morphology resembling that of the known drug suramin was observed for an aniline-containing derivative. New chemotypes exhibiting antiangiogenic effects in vitro are thus described, and further investigation of their underlying mechanism of action is warranted.	[Hansen, Anders N.; Staerk, Dan; Jorgensen, Flemming Steen; Olsen, Christian A.] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, Copenhagen, Denmark; [Bendiksen, Christine D.; Sylvest, Lene; Friis, Tina; Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Hansen, AN (corresponding author), Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, Copenhagen, Denmark.	cao@kemi.dtu.dk; gh@ssi.dk	Staerk, Dan/X-6110-2018	Staerk, Dan/0000-0003-0074-298X; Houen, Gunnar/0000-0002-5948-4156; Jorgensen, Flemming Steen/0000-0001-8040-2998; Olsen, Christian Adam/0000-0002-2953-8942	Danish Cancer Society; Familien Erichsen's Mindefond; Lundbeck Foundation; Lundbeck Foundation (Young Group Leader Fellowship); Danish Independent Research Council-Natural Sciences [10-080907]; Technical University of Denmark	Danish Cancer Society(Danish Cancer Society); Familien Erichsen's Mindefond; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation (Young Group Leader Fellowship); Danish Independent Research Council-Natural Sciences; Technical University of Denmark	This work was supported by a scholarship from the Danish Cancer Society (CDB), and by Familien Erichsen's Mindefond (GH). CAO thanks the Lundbeck Foundation for a Young Group Leader Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Birgitte Simonsen (Faculty of Pharmaceutical Sciences) is gratefully acknowledged for assistance with analytical HPLC and optical rotation measurements. Dorthe Tange Olsen, Anne Mortensen, Jon Allan Norring and Brian Hauschildt (Statens Serum Institut) are gratefully acknowledged for technical assistance with the alkaline phosphatase assay and the co-culture assay. C.A.O. thanks the Lundbeck Foundation (Young Group Leader Fellowship), the Danish Independent Research Council-Natural Sciences (Steno Grant No. 10-080907), and the Technical University of Denmark for financial support.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; AMERY WKP, 1992, INT J IMMUNOPHARMACO, V14, P481, DOI 10.1016/0192-0561(92)90179-O; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P603, DOI 10.1002/jhet.5570140413; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P607, DOI 10.1002/jhet.5570140414; BIGG DCH, 1977, J HETEROCYCLIC CHEM, V14, P989, DOI 10.1002/jhet.5570140608; Birman VB, 2006, ORG LETT, V8, P1351, DOI 10.1021/ol060065s; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Cabeza JA, 2006, ORGANOMETALLICS, V25, P1831, DOI 10.1021/om060042h; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang L, 2011, BIOORG MED CHEM LETT, V21, P2297, DOI 10.1016/j.bmcl.2011.02.089; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cruciani Gabriele, 2005, MOL INTERACTION FIEL; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DAMATO RJ, 1994, INVEST OPHTH VIS SCI, V35, P1996; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; DEBRABANDER M, 1992, ANTICANCER RES, V12, P177; DEBRABANDER M, 1992, INT J ONCOL, V1, P337; Eskens FALM, 2008, EUR J CANCER, V44, P2350, DOI 10.1016/j.ejca.2008.07.042; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friis T, 2003, APMIS, V111, P658, DOI 10.1034/j.1600-0463.2003.1110609.x; Friis Tina, 2005, Angiogenesis, V8, P25, DOI 10.1007/s10456-005-3588-0; Friis T, 2006, APMIS, V114, P211, DOI 10.1111/j.1600-0463.2006.apm_189.x; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Goncalves V, 2007, J MED CHEM, V50, P5135, DOI 10.1021/jm0706970; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Jones MK, 1999, NAT MED, V5, P1418; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Li LN, 2009, BIOORGAN MED CHEM, V17, P7290, DOI 10.1016/j.bmc.2009.08.048; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; MCGILL PE, 1976, LANCET, V1, P149; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; RAEYMAEK.AH, 1966, J MED CHEM, V9, P545, DOI 10.1021/jm00322a023; ROSENTHAL M, 1977, LANCET, V1, P904; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; SCHUERMANS Y, 1975, LANCET, V1, P111; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; STEVENSON HC, 1991, J CLIN ONCOL, V9, P2052, DOI 10.1200/JCO.1991.9.11.2052; Sylvest L, 2010, APMIS, V118, P49, DOI 10.1111/j.1600-0463.2009.02561.x; Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647; Taylor RN, 2009, REPROD SCI, V16, P140, DOI 10.1177/1933719108324893; THIENPON.D, 1966, NATURE, V209, P1024, DOI 10.1038/2091084a0; Timar J, 2008, ANTI-CANCER AGENT ME, V8, P462, DOI 10.2174/187152008784533035; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; VANBELLE H, 1976, CLIN CHEM, V22, P972; VANBELLE H, 1976, GEN PHARMACOL, V7, P53, DOI 10.1016/0306-3623(76)90033-1; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; ZANIBONI A, 1990, MED ONCOL TUMOR PHAR, V7, P287	62	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45405	10.1371/journal.pone.0045405	http://dx.doi.org/10.1371/journal.pone.0045405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024819	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100077
J	Zhou, SL; Shen, DD; Wang, YJ; Gong, LL; Tang, XY; Yu, B; Gu, XS; Ding, F				Zhou, Songlin; Shen, Dingding; Wang, Yongjun; Gong, Leilei; Tang, Xiaoyan; Yu, Bin; Gu, Xiaosong; Ding, Fei			microRNA-222 Targeting PTEN Promotes Neurite Outgrowth from Adult Dorsal Root Ganglion Neurons following Sciatic Nerve Transection	PLOS ONE			English	Article							INTRINSIC GROWTH-STATE; CONDITIONING LESION; AXONAL REGENERATION; IN-VITRO; PERIPHERAL REGENERATION; GENE-EXPRESSION; CELL-SURVIVAL; SENSORY AXONS; INHIBITION; MIR-222	Dorsal root ganglia (DRG) neurons spontaneously undergo neurite growth after nerve injury. MicroRNAs (miRNAs), as small, non-coding RNAs, negatively regulate gene expression in a variety of biological processes. The roles of miRNAs in the regulation of responses of DRG neurons to injury stimuli, however, are not fully understood. Here, microarray analysis was performed to profile the miRNAs in L4-L6 DRGs following rat sciatic nerve transection. The 26 known miRNAs were differentially expressed at 0, 1, 4, 7, 14 d post injury, and the potential targets of the miRNAs were involved in nerve regeneration, as analyzed by bioinformatics. Among the 26 miRNAs, microRNA-222 (miR-222) was our research focus because its increased expression promoted neurite outgrowth while it silencing by miR-222 inhibitor reduced neurite outgrowth. Knockdown experiments confirmed that phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a major inhibitor of nerve regeneration, was a direct target of miR-222 in DRG neurons. In addition, we found that miR-222 might regulate the phosphorylation of cAMP response element binding protein (CREB) through PTEN, and c-Jun activation might enhance the miR-222 expression. Collectively, our data suggest that miR-222 could regulate neurite outgrowth from DRG neurons by targeting PTEN.	[Zhou, Songlin; Shen, Dingding; Wang, Yongjun; Gong, Leilei; Yu, Bin; Gu, Xiaosong; Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Tang, Xiaoyan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Nantong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, SL (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn; shengdd@public.nt.js.cn			National Natural Science Foundation of China [81130080, 81171180, 30870811]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China (Grant No. 81130080, 81171180, and 30870811), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BISBY MA, 1983, J NEUROBIOL, V14, P467, DOI 10.1002/neu.480140607; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gao Y, 2003, J NEUROSCI, V23, P11770; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gu TT, 2011, CANCER RES, V71, P2821, DOI 10.1158/0008-5472.CAN-10-3399; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shim S, 2010, EXP NEUROL, V223, P38, DOI 10.1016/j.expneurol.2009.10.001; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun T, 2009, CELL CYCLE, V8, P2315, DOI 10.4161/cc.8.15.9221; Sun Y, 2007, MOL CANCER THER, V6, P2477, DOI 10.1158/1535-7163.MCT-07-0186; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Wu D, 2012, EXP NEUROL, V233, P555, DOI 10.1016/j.expneurol.2011.11.041; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	50	84	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44768	10.1371/journal.pone.0044768	http://dx.doi.org/10.1371/journal.pone.0044768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028614	Green Submitted, gold, Green Published			2022-12-25	WOS:000308788700037
J	Furutani, Y; Kawasaki, M; Matsuno, H; Mitsui, S; Mori, K; Yoshihara, Y				Furutani, Yutaka; Kawasaki, Miwa; Matsuno, Hitomi; Mitsui, Sachiko; Mori, Kensaku; Yoshihara, Yoshihiro			Vitronectin Induces Phosphorylation of Ezrin/Radixin/Moesin Actin-binding Proteins through Binding to Its Novel Neuronal Receptor Telencephalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; EXTRACELLULAR-MATRIX; HIPPOCAMPAL-NEURONS; ADHESION MOLECULE; SPINE MATURATION; INTEGRINS; BRAIN; LOCALIZATION; GLYCOPROTEIN; CYTOSKELETON	Vitronectin (VN) is an extracellular matrix protein abundantly present in blood and a wide variety of tissues and plays important roles in a number of biological phenomena mainly through its binding to alpha V integrins. However, its definite function in the brain remains largely unknown. Here we report the identification of telencephalin (TLCN/ICAM-5) as a novel VN receptor on neuronal dendrites. VN strongly binds to TLCN, a unique neuronal member of the ICAM family, which is specifically expressed on dendrites of spiny neurons in the mammalian telencephalon. VN-coated microbeads induce the formation of phagocytic cup-like plasma membrane protrusions on dendrites of cultured hippocampal neurons and trigger the activation of TLCN-dependent intracellular signaling cascade including the phosphorylation of ezrin/radixin/moesin actin-binding proteins and recruitment of F-actin and phosphatidylinositol 4,5-bisphosphate for morphological transformation of the dendritic protrusions. These results suggest that the extracellular matrix molecule VN and its neuronal receptor TLCN play a pivotal role in the phosphorylation of ezrin/radixin/moesin proteins and the formation of phagocytic cup-like structures on neuronal dendrites.	[Furutani, Yutaka; Kawasaki, Miwa; Matsuno, Hitomi; Mitsui, Sachiko; Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Furutani, Yutaka; Yoshihara, Yoshihiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka 5600082, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Yoshihara, Y (corresponding author), RIKEN Brain Sci Inst, Lab Neurobiol Synapse, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshihara@brain.riken.jp	Yoshihara, Yoshihiro/N-6481-2015; Furutani, Yutaka/C-3652-2017	Yoshihara, Yoshihiro/0000-0002-0319-7166; Furutani, Yutaka/0000-0002-2945-0166; Mori, Kensaku/0000-0001-7853-9370	Japan Society for the Promotion of Science KAKENHI [22700354, 24500392]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI [23123525]; MEXT KAKENHI [20022046]; Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 22700354 and 24500392, Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI Grant 23123525 (to Y.F.), MEXT KAKENHI Grant 20022046 (to Y.Y.), a Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant (to Y.Y.), and a grant from Takeda Science Foundation (to Y.Y.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benson DL, 1998, J NEUROSCI RES, V52, P43, DOI 10.1002/(SICI)1097-4547(19980401)52:1<43::AID-JNR5>3.3.CO;2-A; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; Mitsui S, 2005, J NEUROSCI, V25, P1122, DOI 10.1523/JNEUROSCI.3853-04.2005; Mitsui S, 2007, CEREB CORTEX, V17, P522, DOI 10.1093/cercor/bhj177; Mizuno T, 1997, J BIOL CHEM, V272, P1156, DOI 10.1074/jbc.272.2.1156; MORI K, 1987, P NATL ACAD SCI USA, V84, P3921, DOI 10.1073/pnas.84.11.3921; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Niquet J, 1996, GLIA, V16, P359, DOI 10.1002/(SICI)1098-1136(199604)16:4<359::AID-GLIA8>3.0.CO;2-V; Nyman-Huttunen H, 2006, J CELL SCI, V119, P3057, DOI 10.1242/jcs.03045; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; SEIFFERT D, 1995, DEV DYNAM, V203, P71, DOI 10.1002/aja.1002030108; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tian L, 1997, J IMMUNOL, V158, P928; Vasilyev DV, 2004, J PHYSIOL-LONDON, V560, P659, DOI 10.1113/jphysiol.2004.069104; Vasilyev DV, 2003, J PHYSIOL-LONDON, V547, P859, DOI 10.1113/jphysiol.2002.036889; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	30	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39041	39049		10.1074/jbc.M112.383851	http://dx.doi.org/10.1074/jbc.M112.383851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019340	hybrid, Green Published			2022-12-25	WOS:000310982800060
J	Haynes, LM; Bouchard, BA; Tracy, PB; Mann, KG				Haynes, Laura M.; Bouchard, Beth A.; Tracy, Paula B.; Mann, Kenneth G.			Prothrombin Activation by Platelet-associated Prothrombinase Proceeds through the Prethrombin-2 Pathway via a Concerted Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION FACTOR-V; FACTOR-XA; FUNCTIONAL-CHARACTERIZATION; CATALYZED ACTIVATION; ANTITHROMBIN-III; MEMBRANE-PROTEIN; GLYCOPROTEIN-VI; FLOW CONDITIONS; KINETIC-MODEL	The protease alpha-thrombin is a key enzyme of the coagulation process as it is at the cross-roads of both the pro- and anticoagulant pathways. The main source of alpha-thrombin in vivo is the activation of prothrombin by the prothrombinase complex assembled on either an activated cell membrane or cell fragment, the most relevant of which is the activated platelet surface. When prothrombinase is assembled on synthetic phospholipid vesicles, prothrombin activation proceeds with an initial cleavage at Arg-320 yielding the catalytically active, yet effectively anticoagulant intermediate meizothrombin, which is released from the enzyme complex similar to 30-40% of the time. Prothrombinase assembled on the surface of activated platelets has been shown to proceed through the inactive intermediate prethrombin-2 via an initial cleavage at Arg-271 followed by cleavage at Arg-320. The current work tests whether or not platelet-associated prothrombinase proceeds via a concerted mechanism through a study of prothrombinase assembly and function on collagen-adhered, thrombin-activated, washed human platelets in a flow chamber. Prothrombinase assembly was demonstrated through visualization of bound factor Xa by confocal microscopy using a fluorophore-labeled anti-factor Xa antibody, which demonstrated the presence of distinct platelet subpopulations capable of binding factor Xa. When prothrombin activation was monitored at a typical venous shear rate over preassembled platelet-associated prothrombinase neither potential intermediate, meizothrombin or prethrombin-2, was observed in the effluent. Collectively, these findings suggest that platelet-associated prothrombinase activates prothrombin via an efficient concerted mechanism in which neither intermediate is released.	[Haynes, Laura M.; Bouchard, Beth A.; Tracy, Paula B.; Mann, Kenneth G.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Mann, KG (corresponding author), Univ Vermont, Coll Med, Dept Biochem, 208 S Pk Dr, Colchester, VT 05446 USA.	Kenneth.Mann@uvm.edu		Bouchard, Beth/0000-0002-0399-566X	National Institutes of Health [P01HL46703]; Hemostatis and Thrombosis Training Grant from NHLBI, National Institutes of Health [5T32HL007594]; NHLBI, National Institutes of Health [K02HL091111]; University of Vermont College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, P01HL046703, K02HL091111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hemostatis and Thrombosis Training Grant from NHLBI, National Institutes of Health; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Vermont College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by P01HL46703 from the National Institutes of Health (Project 1 to K. G. M.) and (Project 3 to P. B. T.) Supported by a Hemostatis and Thrombosis Training Grant 5T32HL007594 from NHLBI, National Institutes of Health. Supported by K02HL091111 from NHLBI, National Institutes of Health and the University of Vermont College of Medicine.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; Batar P, 2001, J LAB CLIN MED, V138, P393, DOI 10.1067/mlc.2001.120049; BEUMER S, 1995, BLOOD, V86, P3452, DOI 10.1182/blood.V86.9.3452.bloodjournal8693452; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Billy D, 1997, BLOOD COAGUL FIBRIN, V8, P168, DOI 10.1097/00001721-199704000-00003; Boskovic DS, 2001, J BIOL CHEM, V276, P28686, DOI 10.1074/jbc.M101813200; Bouchard BA, 1997, J BIOL CHEM, V272, P9244; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Brooks EG, 2009, BLOOD, V114, P1276, DOI 10.1182/blood-2009-03-209981; BUTENAS S, 1992, BIOCHEMISTRY-US, V31, P5399, DOI 10.1021/bi00138a023; Butenas S, 1997, THROMB HAEMOSTASIS, V78, P1193; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; Fager A. M., 2009, J THROMB HAEMOST, V7, p198a; Fager AM, 2010, ARTERIOSCL THROM VAS, V30, P2400, DOI 10.1161/ATVBAHA.110.216531; FUSTER V, 1990, CIRCULATION, V82, P47; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Haynes LM, 2012, J BIOL CHEM, V287, P5225, DOI 10.1074/jbc.M111.302075; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Kim PY, 2012, BIOPHYS CHEM, V160, P75, DOI 10.1016/j.bpc.2011.09.004; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Lee CJ, 2011, J THROMB HAEMOST, V9, P2123, DOI 10.1111/j.1538-7836.2011.04463.x; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1990, BLOOD, V76, P1; MILETICH JP, 1977, P NATL ACAD SCI USA, V74, P4033, DOI 10.1073/pnas.74.9.4033; MONKOVIC DD, 1990, J BIOL CHEM, V265, P17132; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; NESHEIM ME, 1993, THROMB HAEMOSTASIS, V70, P80; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; RUGGERI ZM, 1982, P NATL ACAD SCI-BIOL, V79, P6038, DOI 10.1073/pnas.79.19.6038; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; TRACY PB, 1982, BLOOD, V60, P59; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1979, J BIOL CHEM, V254, P354; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035	56	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38647	38655		10.1074/jbc.M112.407791	http://dx.doi.org/10.1074/jbc.M112.407791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989889	Green Published, hybrid			2022-12-25	WOS:000310982800024
J	Kim, YH; Kwon, HJ; Kim, DS				Kim, Yeon Hyang; Kwon, Hyung-Joo; Kim, Doo-Sik			Matrix Metalloproteinase 9 (MMP-9)-dependent Processing of beta ig-h3 Protein Regulates Cell Migration, Invasion, and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BRONCHIAL EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; BETAIG-H3 GENE; IN-VITRO; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; DOWN-REGULATION; EXPRESSION; IDENTIFICATION	Cell migration is critically involved in inflammation, cancer, and development. In this study, transforming growth factor-beta-induced protein (beta ig-h3) was identified as a substrate of matrix metalloproteinase-9 (MMP-9) by site-directed mutagenesis. beta ig-h3 has two cleavage sites with the consensus sequence Pro-Xaa-Xaa-Hy-(Ser/Thr) (Hy is a hydrophobic amino acid) (PGSFT beginning at amino acid 135 and PPMGT beginning at amino acid 501). Using recombinant human beta ig-h3 and MMP-9, beta ig-h3 from beta ig-h3-transfected HEK293F cells, and MMP-9 from MMP-9-transfected HEK293F cells, human macrophages, and neutrophils, we found that MMP-9 proteolytically cleaves beta ig-h3. Cleavage leads to the loss of its adhesive property and its release from extracellular matrix proteins, collagen IV, and fibronectin. Spheroids formed by increased cell-cell interactions were observed in beta ig-h3-transfected HEK293F cells but not in vehicle-transfected HEK293F cells. In human glioma U87MG cells, MMP-9 constitutive overexpression resulted in endogenous beta ig-h3 cleavage. beta ig-h3 cleavage by MMP-9 led to increased cell invasion, and beta ig-h3 knockdown also resulted in increased cell invasion. The beta ig-h3 fragment cleaved by MMP-9 could bind to the surface of macrophages, and it may play a role as a peptide chemoattractant by inducing macrophage migration via focal adhesion kinase/Src-mediated signal activation. Thus, intact beta ig-h3 is responsible for cell migration inhibition, cell-cell contact, and cell-extracellular matrix interaction. Experimental evidence indicates that MMP-9-cleaved beta ig-h3 plays a role in MMP-9-mediated tumor cell and macrophage migration.	[Kim, Yeon Hyang; Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Kwon, Hyung-Joo] Hallym Univ, Coll Med, Dept Microbiol, Gangwon Do 200702, South Korea	Yonsei University; Hallym University	Kim, YH (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	yeonhkim@yonsei.ac.kr; dskim@yonsei.ac.kr			National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0081760]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Future-based Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 2009-0081760.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Becker J, 2006, CANCER RES, V66, P5314, DOI 10.1158/0008-5472.CAN-05-3049; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Calaf GM, 2008, INT J MOL MED, V21, P561; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim YH, 2010, NITRIC OXIDE-BIOL CH, V23, P112, DOI 10.1016/j.niox.2010.04.009; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Krekoski CA, 2002, J NEUROSCI, V22, P10408; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Nabokikh A, 2007, EXP CLIN ENDOCR DIAB, V115, P674, DOI 10.1055/s-2007-984477; Nagase H, 1997, BIOL CHEM, V378, P151; Nygardas PT, 2002, CLIN EXP IMMUNOL, V128, P245, DOI 10.1046/j.1365-2249.2002.01855.x; Oh JE, 2005, J BIOL CHEM, V280, P21629, DOI 10.1074/jbc.m412293200; Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2; OPDENAKKER G, 1991, FEBS LETT, V284, P73, DOI 10.1016/0014-5793(91)80765-U; Park MJ, 2002, CANCER RES, V62, P6318; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RIES C, 1995, BIOL CHEM H-S, V376, P345; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Shao GZ, 2006, CANCER RES, V66, P4566, DOI 10.1158/0008-5472.CAN-05-2130; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WEBER KT, 1995, HERZ, V20, P81; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zhao YL, 2004, RADIAT RES, V162, P655, DOI 10.1667/RR3270; Zhao YL, 2002, ONCOGENE, V21, P7471, DOI 10.1038/sj.onc.1205891	53	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38957	38969		10.1074/jbc.M112.357863	http://dx.doi.org/10.1074/jbc.M112.357863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019342	hybrid, Green Published			2022-12-25	WOS:000310982800052
J	Mori, K; Hamanaka, H; Oshima, Y; Araki, Y; Ishikawa, F; Nose, K; Shibanuma, M				Mori, Kazunori; Hamanaka, Hiroyuki; Oshima, Yukiko; Araki, Yuri; Ishikawa, Fumihiro; Nose, Kiyoshi; Shibanuma, Motoko			A HIC-5-and KLF4-dependent Mechanism Transactivates p21(Cip1) in Response to Anchorage Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; CYCLE PROGRESSION; FOCAL ADHESIONS; LIM PROTEIN; GENE; KINASE; EXPRESSION; MATRIX; ACTIVATION; WAF1/CIP1	Anchorage loss elicits a set of responses in cells, such as transcriptional changes, in order to prevent inappropriate cell growth in ectopic environments. However, the mechanisms underlying these responses are poorly understood. In this study, we investigated the transcriptional up-regulation of cyclin-dependent kinase inhibitor p21(Cip1) during anchorage loss, which is important for cell cycle arrest of nonadherent cells in the G1 phase. Up-regulation was mediated by an upstream element, designated as the detachment-responsive element (DRE), that contained Kruppel-like factor 4 (KLF4) and runt-related transcription factor 1 (RUNX1) recognition sites; both of these together were necessary for transactivation, as individually they were insufficient. RNAi experiments revealed that KLF4 and a multidomain adaptor protein, hydrogen peroxide-inducible clone 5 (HIC-5), were critically involved in DRE transactivation. The role of HIC-5 in this mechanism was to tether KLF4 to DNA sites in response to cellular detachment. In addition, further analysis suggested that oligomerization and subsequent nuclear matrix localization of HIC-5, which was accelerated spontaneously in cells during anchorage loss, was assumed to potentiate the scaffolding function of HIC-5 in the nucleus and consequently regulate p21(Cip1) transcription in a manner responding to anchorage loss. At the RUNX1 site, a LIM-only protein, CRP2, imposed negative regulation on transcription, which appeared to be removed by anchorage loss and contributed to increased transcriptional activity of DRE together with regulation at the KLF4 sites. In conclusion, this study revealed a novel transcriptional mechanism that regulated gene expression in a detachment-dependent manner, thereby contributing to anchorage-dependent cell growth.	[Shibanuma, Motoko] Showa Univ, Sch Pharm, Dept Mol Biol, Div Canc Cell Biol,Shinagawa Ku, Tokyo 1428555, Japan	Showa University	Shibanuma, M (corresponding author), Showa Univ, Sch Pharm, Dept Mol Biol, Div Canc Cell Biol,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	smotoko@pharm.showa-u.ac.jp		Mori, Kazunori/0000-0001-7121-9956	High-Technology Research Center from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22790327]; Private University High Technology Research Center from Project MEXT	High-Technology Research Center from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Private University High Technology Research Center from Project MEXT	This work was supported in part by Grant-in-aid for Young Scientists (B) 22790327, the High-Technology Research Center Project from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and a Private University High Technology Research Center Project matching fund subsidy from MEXT.	Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Egawa K, 1998, BIOL PHARM BULL, V21, P899; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Mori K, 2006, J BIOL CHEM, V281, P22048, DOI 10.1074/jbc.M513111200; Mori K, 2009, MOL BIOL CELL, V20, P218, DOI 10.1091/mbc.E08-04-0428; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; WEINBERG WC, 1994, CANCER RES, V54, P5584; Wu RC, 1997, J BIOL CHEM, V272, P29091, DOI 10.1074/jbc.272.46.29091; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810	33	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38854	38865		10.1074/jbc.M112.377721	http://dx.doi.org/10.1074/jbc.M112.377721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007394	Green Published, hybrid			2022-12-25	WOS:000310982800042
J	Sunamura, E; Konno, H; Imashimizu, M; Mochimaru, M; Hisabori, T				Sunamura, Ei-Ichiro; Konno, Hiroki; Imashimizu, Mari; Mochimaru, Mari; Hisabori, Toru			A Conformational Change of the gamma Subunit Indirectly Regulates the Activity of Cyanobacterial F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; COUPLING FACTOR-I; ESCHERICHIA-COLI F-1-ATPASE; EPSILON-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; NUCLEOTIDE-BINDING; ALPHA(3)BETA(3)GAMMA COMPLEX; PHOTOSYNTHETIC F-1-ATPASE; INVERSE REGULATION; CATALYTIC-ACTIVITY	The central shaft of the catalytic core of ATP synthase, the gamma subunit consists of a coiled-coil structure of N- and C-terminal alpha-helices, and a globular domain. The gamma subunit of cyanobacterial and chloroplast ATP synthase has a unique 30 - 40-amino acid insertion within the globular domain. We recently prepared the insertion-removed alpha(3)beta(3)gamma complex of cyanobacterial ATP synthase (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855865). Although the insertion is thought to be located in the periphery of the complex and far from catalytic sites, the mutant complex shows a remarkable increase in ATP hydrolysis activity due to a reduced tendency to lapse into ADP inhibition. We postulated that removal of the insertion affects the activity via a conformational change of two central alpha-helices in gamma. To examine this hypothesis, we prepared a mutant complex that can lock the relative position of two central alpha-helices to each other by way of a disulfide bond formation. The mutant obtained showed a significant change in ATP hydrolysis activity caused by this restriction. The highly active locked complex was insensitive to N-dimethyldodecylamine-N-oxide, suggesting that the complex is resistant to ADP inhibition. In addition, the lock affected is an element of inhibition. In contrast, the change in activity caused by removal of the gamma insertion was independent from the conformational restriction of the central axis component. These results imply that the global conformational change of the gamma subunit indirectly regulates complex activity by changing both ADP inhibition and is an element of inhibition.	[Sunamura, Ei-Ichiro; Konno, Hiroki; Imashimizu, Mari; Mochimaru, Mari; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Konno, Hiroki] Kanazawa Univ, BioAFM Frontier Res Ctr, Imaging Res Div, Kanazawa, Ishikawa 9201192, Japan; [Mochimaru, Mari] Komazawa Univ, Dept Nat Sci, Tokyo 1548525, Japan; [Hisabori, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan	Tokyo Institute of Technology; Kanazawa University; Japan Science & Technology Agency (JST)	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [22651048]	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST) and Grant-in-aid for Scientific Research 22651048 (to T. H.) from the Japan Society for the Promotion of Science.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DUNHAM KR, 1981, J BIOL CHEM, V256, P212; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Haruyama Takamitsu, 2010, Biophysics (Nagoya-shi), V6, P59, DOI 10.2142/biophysics.6.59; He F, 2007, BIOCHEMISTRY-US, V46, P2411, DOI 10.1021/bi062295k; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; Kagawa Y, 1996, J BIOENERG BIOMEMBR, V28, P421, DOI 10.1007/BF02113984; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MILLS JD, 1980, FEBS LETT, V112, P173, DOI 10.1016/0014-5793(80)80173-6; MINKOV IB, 1979, BIOCHEM BIOPH RES CO, V89, P1300, DOI 10.1016/0006-291X(79)92150-8; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Samra HS, 2008, J BIOENERG BIOMEMBR, V40, P69, DOI 10.1007/s10863-008-9131-4; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; VASILYEVA EA, 1982, BIOCHEM J, V202, P9, DOI 10.1042/bj2020009; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WERNER S, 1990, FEBS LETT, V261, P204, DOI 10.1016/0014-5793(90)80671-5; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; YOSHIDA M, 1983, J BIOL CHEM, V258, P4407; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	53	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38695	38704		10.1074/jbc.M112.395053	http://dx.doi.org/10.1074/jbc.M112.395053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012354	Green Published, hybrid			2022-12-25	WOS:000310982800028
J	Xiong, XW; Tao, RY; DePinho, RA; Dong, XC				Xiong, Xiwen; Tao, Rongya; DePinho, Ronald A.; Dong, X. Charlie			The Autophagy-related Gene 14 (Atg14) Is Regulated by Forkhead Box O Transcription Factors and Circadian Rhythms and Plays a Critical Role in Hepatic Autophagy and Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOLOGICAL HYPERTROPHY; OXIDATIVE STRESS; HEART; FOXO; DEGRADATION; ACTIVATION; CATABOLISM; PATHWAYS	Autophagy plays a critical role in cell survival from prolonged starvation and recycling of aggregated proteins and damaged organelles. One of the essential genes involved in the autophagic initiation is autophagy-related 14 (Atg14), also called Barkor for Beclin 1-associated autophagy-related key regulator. Although its crucial role in the autophagic process has been reported, the gene regulation of Atg14 and its metabolic functions remain unclear. In this work we have identified that the Atg14 gene is regulated by forkhead box O (FoxO) transcription factors and circadian rhythms in the mouse liver. Luciferase reporter analyses and chromatin immunoprecipitation assays have revealed well conserved cis-elements for FoxOs and Clock/Bmal1 in the proximal promoter of the Atg14 gene. To examine the functions of hepatic Atg14, we have performed the gene knockdown and overexpression in the mouse livers. Remarkably, knockdown of Atg14 leads to elevated levels of triglycerides in the liver and serum as well. Conversely, overexpression of Atg14 improves hypertriglyceridemia in both high fat diet-treated wild-type mice and FoxO1/3/4 liver-specific knock-out mice. In summary, our data suggest that Atg14 is a new target gene of FoxOs and the core clock machinery, and this gene plays an important role in hepatic lipid metabolism.	[Xiong, Xiwen; Tao, Rongya; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iupui.edu	tao, rongya/B-8042-2014; Xiong, Xiwen/GSN-0686-2022	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	National Institutes of Health [R00DK077505, R01DK091592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091592, R00DK077505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DK077505 and R01DK091592 (NIDDK; to X. C. D.).	Chaanine AH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.5; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2009, METHOD ENZYMOL, V453, P397, DOI 10.1016/S0076-6879(08)04020-2; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Komatsu M., 2012, PHARM RES IN PRESS; Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sadagurski M, 2011, J CLIN INVEST, V121, P4070, DOI 10.1172/JCI46305; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Schips TG, 2011, CARDIOVASC RES, V91, P587, DOI 10.1093/cvr/cvr144; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Singh R, 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/282041; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Skop V, 2012, PHYSIOL RES, V61, P287, DOI 10.33549/physiolres.932285; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wang XJ, 2011, CARDIOVASC RES, V91, P561, DOI 10.1093/cvr/cvr196; Weidberg H, 2009, DEV CELL, V16, P628, DOI 10.1016/j.devcel.2009.05.001; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang PG, 2011, AUTOPHAGY, V7, P159, DOI 10.4161/auto.7.2.14223; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	48	135	142	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39107	39114		10.1074/jbc.M112.412569	http://dx.doi.org/10.1074/jbc.M112.412569			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992773	Green Published, hybrid			2022-12-25	WOS:000310982800066
J	Stringer, AM; Singh, N; Yermakova, A; Petrone, BL; Amarasinghe, JJ; Reyes-Diaz, L; Mantis, NJ; Wade, JT				Stringer, Anne M.; Singh, Navjot; Yermakova, Anastasiya; Petrone, Brianna L.; Amarasinghe, Jayaleka J.; Reyes-Diaz, Lucia; Mantis, Nicholas J.; Wade, Joseph T.			FRUIT, a Scar-Free System for Targeted Chromosomal Mutagenesis, Epitope Tagging, and Promoter Replacement in Escherichia coli and Salmonella enterica	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; COMPLETE GENOME SEQUENCE; EFFICIENT; GENES; DELETIONS; SELECTION; OVERLAP; MARKER	Recombineering is a widely-used approach to delete genes, introduce insertions and point mutations, and introduce epitope tags into bacterial chromosomes. Many recombineering methods have been described, for a wide range of bacterial species. These methods are often limited by (i) low efficiency, and/or (ii) introduction of "scar'' DNA into the chromosome. Here, we describe a rapid, efficient, PCR-based recombineering method, FRUIT, that can be used to introduce scar-free point mutations, deletions, epitope tags, and promoters into the genomes of enteric bacteria. The efficiency of FRUIT is far higher than that of the most widely-used recombineering method for Escherichia coli. We have used FRUIT to introduce point mutations and epitope tags into the chromosomes of E. coli K-12, Enterotoxigenic E. coli, and Salmonella enterica. We have also used FRUIT to introduce constitutive and inducible promoters into the chromosome of E. coli K-12. Thus, FRUIT is a versatile, efficient recombineering approach that can be applied in multiple species of enteric bacteria.	[Stringer, Anne M.; Singh, Navjot; Petrone, Brianna L.; Amarasinghe, Jayaleka J.; Mantis, Nicholas J.; Wade, Joseph T.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Yermakova, Anastasiya; Mantis, Nicholas J.; Wade, Joseph T.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Reyes-Diaz, Lucia] SUNY Albany, UASRP CSTEP Program, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wade, JT (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	jwade@wadsworth.org		Mantis, Nicholas/0000-0002-5083-8640; Wade, Joseph/0000-0002-9779-3160	National Institutes of Health (NIH) [DP2OD007188, R03AI094245, R01HD061916]; NIH training grant [T32AI055429]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI094245, T32AI055429] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007188] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants DP2OD007188 (JTW), R03AI094245 (JTW), and R01HD061916 (NJM). JJA and AY were supported by NIH training grant T32AI055429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cho BK, 2006, BIOTECHNIQUES, V40, P67, DOI 10.2144/000112039; Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; MORALEJO P, 1993, J BACTERIOL, V175, P5585, DOI 10.1128/JB.175.17.5585-5594.1993; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Thomason L, 2005, CURRENT PROTOCOLS MO, P11611; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359	33	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44841	10.1371/journal.pone.0044841	http://dx.doi.org/10.1371/journal.pone.0044841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028641	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500009
J	Fujikane, R; Sanada, M; Sekiguchi, M; Hidaka, M				Fujikane, Ryosuke; Sanada, Masayuki; Sekiguchi, Mutsuo; Hidaka, Masumi			The Identification of a Novel Gene, MAPO2, That Is Involved in the Induction of Apoptosis Triggered by O-6-Methylguanine	PLOS ONE			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; COMPLEMENTARY-DNA; MISMATCH REPAIR; MUTL-ALPHA; MGMT; MICE; MUTAGENESIS; PROTEIN; CLONING; ROLES	O-6-Methylguanine, one of alkylated DNA bases, is especially mutagenic. Cells containing this lesion are eliminated by induction of apoptosis, associated with the function of mismatch repair (MMR) proteins. A retrovirus-mediated gene-trap mutagenesis was used to isolate new genes related to the induction of apoptosis, triggered by the treatment with an alkylating agent, N-methyl-N-nitrosourea (MNU). This report describes the identification of a novel gene, MAPO2 (O-6-methylguanine-induced apoptosis 2), which is originally annotated as C1orf201. The MAPO2 gene is conserved among a wide variety of multicellular organisms and encodes a protein containing characteristic PxPxxY repeats. To elucidate the function of the gene product in the apoptosis pathway, a human cell line derived from HeLa MR cells, in which the MAPO2 gene was stably knocked down by expressing specific miRNA, was constructed. The knockdown cells grew at the same rate as HeLa MR, thus indicating that MAPO2 played no role in the cellular growth. After exposure to MNU, HeLa MR cells and the knockdown cells underwent cell cycle arrest at G(2)/M phase, however, the production of the sub-G1 population in the knockdown cells was significantly suppressed in comparison to that in HeLa MR cells. Moreover, the activation of BAK and caspase-3, and depolarization of mitochondrial membrane, hallmarks for the induction of apoptosis, were also suppressed in the knockdown cells. These results suggest that the MAPO2 gene product might positively contribute to the induction of apoptosis triggered by O-6-methylguanine.	[Fujikane, Ryosuke; Sanada, Masayuki; Hidaka, Masumi] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Adv Sci Res Ctr, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Hidaka, M (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan.	hidaka@college.fdcnet.ac.jp		Fujikane, Ryosuke/0000-0002-6621-3848	Fukuoka Foundation for Sound Health; MEXT	Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Cancer Research Fund from Fukuoka Foundation for Sound Health (to RF), MEXT-Grants-in-Aid and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COSSARIZZA A, 1994, EXP CELL RES, V214, P323, DOI 10.1006/excr.1994.1264; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Komori K, 2009, ONCOGENE, V28, P1142, DOI 10.1038/onc.2008.462; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; Ochs K, 2000, CANCER RES, V60, P5815; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pepponi R, 2003, J PHARMACOL EXP THER, V304, P661, DOI 10.1124/jpet.102.043950; Sakumi K, 1997, CANCER RES, V57, P2415; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; Takagi Y, 2008, BIOCHEM PHARMACOL, V76, P303, DOI 10.1016/j.bcp.2008.05.008; Tsuzuki T, 1996, CARCINOGENESIS, V17, P1215, DOI 10.1093/carcin/17.6.1215; Wei MC, 2000, GENE DEV, V14, P2060; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	27	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44817	10.1371/journal.pone.0044817	http://dx.doi.org/10.1371/journal.pone.0044817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028632	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700017
J	Gritsun, TA; le Feber, J; Rutten, WLC				Gritsun, Taras A.; le Feber, Joost; Rutten, Wim L. C.			Growth Dynamics Explain the Development of Spatiotemporal Burst Activity of Young Cultured Neuronal Networks in Detail	PLOS ONE			English	Article							CORTICAL-NEURONS; RAT; SYNAPSES; CORTEX; ADHESION; MODELS; CELLS	A typical property of isolated cultured neuronal networks of dissociated rat cortical cells is synchronized spiking, called bursting, starting about one week after plating, when the dissociated cells have sufficiently sent out their neurites and formed enough synaptic connections. This paper is the third in a series of three on simulation models of cultured networks. Our two previous studies [26,27] have shown that random recurrent network activity models generate intra- and inter-bursting patterns similar to experimental data. The networks were noise or pacemaker-driven and had Izhikevich-neuronal elements with only short-term plastic (STP) synapses (so, no long-term potentiation, LTP, or depression, LTD, was included). However, elevated pre-phases (burst leaders) and after-phases of burst main shapes, that usually arise during the development of the network, were not yet simulated in sufficient detail. This lack of detail may be due to the fact that the random models completely missed network topology. and a growth model. Therefore, the present paper adds, for the first time, a growth model to the activity model, to give the network a time dependent topology and to explain burst shapes in more detail. Again, without LTP or LTD mechanisms. The integrated growth-activity model yielded realistic bursting patterns. The automatic adjustment of various mutually interdependent network parameters is one of the major advantages of our current approach. Spatio-temporal bursting activity was validated against experiment. Depending on network size, wave reverberation mechanisms were seen along the network boundaries, which may explain the generation of phases of elevated firing before and after the main phase of the burst shape. In summary, the results show that adding topology and growth explain burst shapes in great detail and suggest that young networks still lack/do not need LTP or LTD mechanisms.	[Gritsun, Taras A.; le Feber, Joost; Rutten, Wim L. C.] Univ Twente, Neural Engn Dept, Inst Biomed Engn MIRA, NL-7500 AE Enschede, Netherlands	University of Twente	Rutten, WLC (corresponding author), Univ Twente, Neural Engn Dept, Inst Biomed Engn MIRA, POB 217, NL-7500 AE Enschede, Netherlands.	w.l.c.rutten@utwente.nl			European Union Marie-Curie Neurovers-IT project [MRTN-CT-2005-019247]	European Union Marie-Curie Neurovers-IT project	The work presented in this paper was funded by the European Union Marie-Curie Neurovers-IT project (MRTN-CT-2005-019247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Graham BP, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S9; Gritsun T, 2011, BIOL CYBERN, V105, P197, DOI 10.1007/s00422-011-0457-3; Gritsun T, 2008, MEA M 2008, P26; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kitano K, 2007, J COMPUT NEUROSCI, V23, P237, DOI 10.1007/s10827-007-0030-1; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2009, BIOPHYS J, V96, P3443, DOI 10.1016/j.bpj.2009.01.013; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MEIER JH, 1992, IEEE T BIO-MED ENG, V39, P122, DOI 10.1109/10.121643; Muller TH, 1997, J NEUROPHYSIOL, V77, P3218, DOI 10.1152/jn.1997.77.6.3218; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; PARNAVELAS JG, 1980, BRAIN RES, V193, P373, DOI 10.1016/0006-8993(80)90171-7; Ramakers GJA, 2001, DEV BRAIN RES, V126, P163, DOI 10.1016/S0165-3806(00)00148-6; Robertson R, 2007, NEUROCOMPUTING, V70, P1619, DOI 10.1016/j.neucom.2006.10.053; Ruardij TG, 2000, IEEE T BIO-MED ENG, V47, P1593, DOI 10.1109/10.887940; Ruardij TG, 2003, MED BIOL ENG COMPUT, V41, P227, DOI 10.1007/BF02344894; Samsonovich AV, 2003, J NEUROSCI RES, V71, P173, DOI 10.1002/jnr.10475; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Segev R, 2000, NEURAL NETWORKS, V13, P185, DOI 10.1016/S0893-6080(99)00084-2; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Stegenga J, 2008, IEEE T BIOMED ENG; Stegenga J, 2009, IEEE T BIO-MED ENG, V56, P1220, DOI 10.1109/TBME.2008.2006856; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; van Pelt J, 2002, NETWORK-COMP NEURAL, V13, P261, DOI 10.1088/0954-898X/13/3/302; VANPELT J, 2003, BRAIN MIND, V4, P51, DOI DOI 10.1023/A:1024160131897; Voigt T, 2005, J NEUROSCI, V25, P4605, DOI 10.1523/JNEUROSCI.3803-04.2005; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Wiertz RWF, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056003; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; YAVIN E, 1973, J CELL BIOL, V57, P232, DOI 10.1083/jcb.57.1.232; Zubler F, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.025.2009	46	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43352	10.1371/journal.pone.0043352	http://dx.doi.org/10.1371/journal.pone.0043352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028450	Green Published, gold			2022-12-25	WOS:000309388400008
J	Zhou, Y; Ni, HP; Li, MH; Sanzari, JK; Diffenderfer, ES; Lin, LY; Kennedy, AR; Weissman, D				Zhou, Yu; Ni, Houping; Li, Minghong; Sanzari, Jenine K.; Diffenderfer, Eric S.; Lin, Liyong; Kennedy, Ann R.; Weissman, Drew			Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; CYTOKINE PRODUCTION; SOLUBLE CD14; BINDING PROTEIN; HIV-INFECTION; PLASMA-LEVELS; FLIGHT; SPACEFLIGHT; RESPONSES; MODEL	The environmental conditions that could lead to an increased risk for the development of an infection during prolonged space flight include: microgravity, stress, radiation, disturbance of circadian rhythms, and altered nutritional intake. A large body of literature exists on the impairment of the immune system by space flight. With the advent of missions outside the Earth's magnetic field, the increased risk of adverse effects due to exposure to radiation from a solar particle event (SPE) needs to be considered. Using models of reduced gravity and SPE radiation, we identify that either 2 Gy of radiation or hindlimb suspension alone leads to activation of the innate immune system and the two together are synergistic. The mechanism for the transient systemic immune activation is a reduced ability of the GI tract to contain bacterial products. The identification of mechanisms responsible for immune dysfunction during extended space missions will allow the development of specific countermeasures.	[Zhou, Yu; Ni, Houping; Li, Minghong; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Diffenderfer, Eric S.; Lin, Liyong; Kennedy, Ann R.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.	drew@mail.med.upenn.edu	Lin, Liyong/I-1195-2019	Lin, Liyong/0000-0002-0820-8063	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58]	National Space Biomedical Research Institute (NSBRI) through NASA	This research was funded by a grant from the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58, http://www.nsbri.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2009, ADV EXP MED BIOL, V667, P39, DOI 10.1007/978-1-4419-1603-7_4; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Blanc S, 2001, J EXP BIOL, V204, P4107; Bolke E, 2001, CLIN CHIM ACTA, V303, P49, DOI 10.1016/S0009-8981(00)00373-9; Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9; Budagov R S, 2000, Radiats Biol Radioecol, V40, P188; Bukh AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021275; Cano R, 2010, J MOL MED, V88, P487, DOI 10.1007/s00109-009-0582-9; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Holub M, 2006, FOLIA MICROBIOL, V51, P469, DOI 10.1007/BF02931593; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Huang Hong, 2007, J Inflamm (Lond), V4, P22; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Mallis MM, 2005, AVIAT SPACE ENVIR MD, V76, pB94; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morukov V B, 2010, Fiziol Cheloveka, V36, P19; Musacchia X J, 1985, Physiologist, V28, pS237; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; Ni H, 2011, RADIAT RES, V175, P485, DOI 10.1667/RR2373.1; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061; Palmer JL, 2011, J BURN CARE RES, V32, P317, DOI 10.1097/BCR.0b013e31820aafa9; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Pierson DL, 1996, FEMS IMMUNOL MED MIC, V16, P273, DOI 10.1111/j.1574-695X.1996.tb00146.x; PIERSON DL, 1995, J MED VET MYCOL, V33, P145; Ran XZ, 2007, J TRAUMA, V62, P193, DOI 10.1097/01.ta.0000215434.24726.72; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Schaffer M, 2002, J SURG RES, V107, P93, DOI 10.1006/jsre.2002.6494; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Shi CM, 2006, MED SCI MONITOR, V12, pRA1; Smart DF, 2003, ADV SPACE RES-SERIES, V32, P109, DOI 10.1016/S0273-1177(03)90377-2; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; Srinivasan A, 2007, J LEUKOCYTE BIOL, V81, P403, DOI 10.1189/jlb.0306194; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 2011, AVIAT SPACE ENVIR MD, V82, P627, DOI 10.3357/ASEM.2980.2011; TAYLOR GR, 1974, AEROSPACE MED, V45, P824; Uri JJ, 2005, ACTA ASTRONAUT, V56, P883, DOI 10.1016/j.actaastro.2005.01.014; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wilson JW, 1999, RADIAT MEAS, V30, P361, DOI 10.1016/S1350-4487(99)00063-3; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423	73	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44329	10.1371/journal.pone.0044329	http://dx.doi.org/10.1371/journal.pone.0044329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028522	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388400023
J	Martin, JE; Buffetaut, E; Naksri, W; Lauprasert, K; Claude, J				Martin, Jeremy E.; Buffetaut, Eric; Naksri, Wilailuck; Lauprasert, Komsorn; Claude, Julien			Gavialis from the Pleistocene of Thailand and Its Relevance for Drainage Connections from India to Java	PLOS ONE			English	Article							MAMMALIAN FAUNAS; EVOLUTION; MIOCENE; GHARIAL; AGES; ASIA	Background: The genus Gavialis comprises a single living but endangered species, G. gangeticus, as well as fossil species recorded in the Miocene to Pleistocene deposits of the Indian subcontinent. The genus is also represented in the Pleistocene deposits of Java by the species G. bengawanicus, which was recently recognized to be valid. Surprisingly, no detailed report of the genus exists between these two provinces and the recent evolutionary history of Gavialis is not understood. Methodology/Principal Findings: We report new material consisting of skull and mandibular remains of Gavialis from the Early Pleistocene of Khok Sung, Nakhon Ratchasima Province, northeastern Thailand. The Gavialis material described herein is attributed to Gavialis cf. bengawanicus and sheds new light on the occurrence of the genus in mainland SE Asia. Conclusions/Significance: Comparison of this new material with other species referred to the genus Gavialis led us to preliminary restrict the content of the genus to three species, namely G. gangeticus Gmelin, G. bengawanicus Dubois and G. lewisi Lull. The occurrence of G. cf. bengawanicus in Thailand allows us to propose a scenario for the dispersal of Gavialis from Indo-Pakistan to Indonesia, thus bridging a geographical gap between these two provinces. Dispersal by sea appears a less likely possibility than dispersal through fluvial drainages.	[Martin, Jeremy E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Martin, Jeremy E.; Naksri, Wilailuck; Lauprasert, Komsorn] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Maha Sarakham, Thailand; [Buffetaut, Eric] Ctr Natl Rech Sci, Ecole Normale Super, Geol Lab, Unite Mixte Rech 8538, Paris, France; [Lauprasert, Komsorn] Mahasarakham Univ, Fac Sci, Dept Biol, Maha Sarakham, Thailand; [Claude, Julien] Univ Montpellier 2, Inst Rech Dev, Ctr Natl Rech Sci, Inst Sci Evolut Montpellier, Montpellier, France	University of Bristol; Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Martin, JE (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	j.e.martin@bristol.ac.uk	Claude, julien/G-7411-2016; Martin, Jeremy/L-4542-2016; Lauprasert, Komsorn/W-4059-2019	Claude, julien/0000-0002-9267-1228; Martin, Jeremy/0000-0001-9159-645X; 	Mahasarakham University; Marie Curie Fellowship	Mahasarakham University; Marie Curie Fellowship(European Commission)	This work was supported by Mahasarakham University fiscal year 2010. JEM is funded by a Marie Curie Fellowship, FP7 framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood SW, 2002, SYST PARASITOL, V51, P1, DOI 10.1023/A:1012988516995; Bourret RL, 1941, TORTUES INDOCHINE; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Buckland W., 1828, T GEOLOGICAL SOC LON, V2, P377; Buffetaut E., 1982, Geobios Memoire Special (Lyon), P127; CAUTLEY PT, 1836, ASIATIC RES, V19, P32; Chaimanee Y, 2005, 252005 DMR; Claude J, 2011, ANN PALEONTOL, V3-4, P113; Clift W., 1828, T GEOLOGICAL SOC L 2, V2, P369; De Vis CW, 1905, ANN QUEENSLAND MUSEU, V6, P26; Delfino M, 2010, J VERTEBR PALEONTOL, V30, P427, DOI 10.1080/02724631003617910; Dubois E., 1908, TIJDSCHR KON NED A 2, V25, P1235; Ducrocq S, 1995, J SOUTHE ASIAN EARTH, V12, P65, DOI 10.1016/0743-9547(95)00021-6; DUCROCQ S, 1994, PALAEOGEOGR PALAEOCL, V108, P149, DOI 10.1016/0031-0182(94)90027-2; Falconer H., 1840, T GEOLOGICAL SOC LON, V2, P499; Gmelin J.F., 1789, CAROLI LINNE SYSTEMA, V1, P1033; Grote PJ, 2007, COUR FOR SEKENBG, V258, P171; Hanta R, 2008, J VERTEBR PALEONTOL, V28, P1182, DOI 10.1671/0272-4634-28.4.1182; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; Hutchison C.S., 1989, GEOLOGICAL EVOLUTION; Janensch W, 1911, GEOLOGISCHE PALAONTO, P61; Kotsakis T., 2005, RENDICONTI SOC PALEO, V2, P201; Lacassin R, 1998, GEOLOGY, V26, P703, DOI 10.1130/0091-7613(1998)026<0703:HRLASS>2.3.CO;2; Langston W., 1965, U CALIFORNIA PUBLICA, V52, P1; Leslie AJ, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P265; Lull RS, 1944, AM J SCI, V242, P417, DOI 10.2475/ajs.242.8.417; Lydekker R., 1886, PALAEONTOLOGIA INDIC, V3, P209; MARTIN BGH, 1977, J ZOOL, V182, P541; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MOLNAR R E, 1982, Memoirs of the Queensland Museum, V20, P675; Molnar Ralph E., 1993, P344; MOOK CHARLES C., 1932, AMER MUS NOVILATES [NEW YORK], V514, P1; NORELL M A, 1989, Postilla, P1; Oppel M., 1811, ORDNUNG FAMILIEN GAT; Pilgrim G. E., 1912, Mem Geol Surv India Pal Ind, V4; Piras P, 2010, EVOL DEV, V12, P568, DOI 10.1111/j.1525-142X.2010.00442.x; Rauhe M, 1999, FOSSIL VERTEBRATES OF ARABIA, P163; Setiyabudi E., 2009, J FOSSIL RES, V42, P1; Singh L.A.K., 1982, British Journal of Herpetology, V6, P259; Steel R., 1973, HDB PALAOHERPETOL 16; Stevenson C., 2010, CROCODILES STATUS SU, P139; Taplin L.E., 1985, P403; ter Haar C., 1934, TOELICHTING BIJ BLAD; TONG H., 2006, 2005 HEYUAN INT DIN, P183; Tougard C, 2006, QUATERNARY SCI REV, V25, P126, DOI 10.1016/j.quascirev.2005.04.010; Trutnau L., 2006, CROCODILIANS THEIR N; van der Maarel FH, 1932, WETEN MEDEDEELINGEN, V15; Velez-Juarbe J, 2007, P ROY SOC B-BIOL SCI, V274, P1245, DOI 10.1098/rspb.2006.0455; von Koenigswald GHR, 1935, KONINKLIJKE NEDERLAN, V38, P188; Wermuth H., 1953, Mitteilungen aus dem Zoologischen Museum in Berlin, V29, P375; WHITAKER R., 2007, IGUANA, V14, P25; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x	54	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44541	10.1371/journal.pone.0044541	http://dx.doi.org/10.1371/journal.pone.0044541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028557	Green Published, gold			2022-12-25	WOS:000311313900030
J	Mezil, L; Berruyer-Pouyet, C; Cabaud, O; Josselin, E; Combes, S; Brunel, JM; Viens, P; Collette, Y; Birnbaum, D; Lopez, M				Mezil, Lynda; Berruyer-Pouyet, Carole; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc			Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer	PLOS ONE			English	Article							STEM-CELLS; KINASE; RESISTANCE; ALPHA; GEMCITABINE; PATHWAYS; MEDIATE; TARGET; ENZYME; DRUGS	Background: Targeted therapies, associated with standard chemotherapies, have improved breast cancer care. However, primary and acquired resistances are frequently observed and the development of new concepts is needed. High-throughput approaches to identify new active and safe molecules with or without an "a priori'' are currently developed. Also, repositioning already-approved drugs in cancer therapy is of growing interest. The thiomorpholine hydroxamate compound TMI-1 has been previously designed to inhibit metalloproteinase activity for the treatment of rheumatoid arthritis. We present here the repositioning of TMI-1 drug in breast cancer. Methodology/Principal Findings: We tested the effect of TMI-1 on luminal, basal and ERBB2-overexpressing breast tumor cell lines and on MMTV-ERBB2/neu tumor evolution. We measured the effects on i) cell survival, ii) cell cycle, iii) extrinsic and intrinsic apoptotic pathways, iv) association with doxorubicin, docetaxel and lapatinib, v) cancer stem cells compartment. In contrast with conventional cytotoxic drugs, TMI-1 was highly selective for tumor cells and cancer stem cells at submicromolar range. All non-malignant cells tested were resistant even at high concentration. TMI-1 was active on triple negative (TN) and ERBB2-overexpressing breast tumor cell lines, and was also highly efficient on human and murine "primary'' ERBB2-overexpressing cells. Treatment of transgenic MMTV-ERBB2/neu mice with 100 mg/kg/day TMI-1 alone induced tumor apoptosis, inhibiting mammary gland tumor occurrence and development. No adverse effects were noticed during the treatment. This compound had a strong synergistic effect in association with docetaxel, doxorubicin and lapatinib. We showed that TMI-1 mediates its selective effects by caspase-dependent apoptosis. TMI-1 was efficient in 34/40 tumor cell lines of various origins (ED50: 0.6 mu M to 12.5 mu M). Conclusions/Significance: This is the first demonstration of the tumor selective cytotoxic action of a thiomorpholin hydroxamate compound. TMI-1 is a novel repositionable drug not only for the treatment of adverse prognosis breast cancers but also for other neoplasms.	[Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc] Aix Marseille Univ, CRCM, Marseille, France; [Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Birnbaum, Daniel; Lopez, Marc] CNRS, INSERM, Oncol Mol Lab, U1068,UMR7258, Marseille, France; [Combes, Sebastien; Brunel, Jean-Michel; Collette, Yves] CNRS, INSERM, Lab iSCB, U1068,UMR7258, Marseille, France; [Mezil, Lynda; Cabaud, Olivier; Josselin, Emmanuelle; Combes, Sebastien; Brunel, Jean-Michel; Viens, Patrice; Collette, Yves; Birnbaum, Daniel; Lopez, Marc] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Berruyer-Pouyet, Carole] Aix Marseille Univ, CIML, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lopez, M (corresponding author), Aix Marseille Univ, CRCM, Marseille, France.	marc.lopez@inserm.fr	Viens, Patrice/Q-8499-2018; COLLETTE, Yves/F-2270-2013	Viens, Patrice/0000-0003-1511-1048; COLLETTE, Yves/0000-0001-5359-7099; jean michel, brunel/0000-0002-9355-8980; BERRUYER, Carole/0000-0003-0244-8071	INSERM; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC); Institut National du Cancer; Algerian government	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Algerian government	This work was supported by INSERM, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (LNCC) (Label 2010-2012) (http://www.ligue-cancer.net/) and Institut National du Cancer (AO-translationnelle 2009) (http://www.e-cancer.fr/). LM is supported by the Algerian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cussac D, 2004, BLOOD, V103, P1464; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Howe LR, 2002, CANCER RES, V62, P5405; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Jordheim LP, 2006, CANCER CHEMOTH PHARM, V58, P547, DOI 10.1007/s00280-006-0195-8; Kenny PA, 2007, EXPERT OPIN THER TAR, V11, P1287, DOI 10.1517/14728222.11.10.1287; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Malicet Cedric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thabet MM, 2006, CURR OPIN INVEST DR, V7, P1014; Weir SJ, 2012, CANCER RES, V72, P1055, DOI 10.1158/0008-5472.CAN-11-3439; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Wong ST, 2009, PHARMACOTHERAPY, V29, P954, DOI 10.1592/phco.29.8.954; Zhang YH, 2004, INT IMMUNOPHARMACOL, V4, P1845, DOI 10.1016/j.intimp.2004.08.003; Zhang YH, 2004, J PHARMACOL EXP THER, V309, P348, DOI 10.1124/jpet.103.059675; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	41	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43409	10.1371/journal.pone.0043409	http://dx.doi.org/10.1371/journal.pone.0043409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028451	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900006
J	Tandon, M; Wang, LR; Xu, Q; Xie, XQ; Wipf, P; Wang, QJ				Tandon, Manuj; Wang, Lirong; Xu, Qi; Xie, Xiangqun; Wipf, Peter; Wang, Qiming Jane			A Targeted Library Screen Reveals a New Inhibitor Scaffold for Protein Kinase D	PLOS ONE			English	Article							CANCER CELL-GROWTH; PROSTATE-CANCER; IN-VIVO; SIGNALING PATHWAY; C-MU; POTENT; INVASION; RECEPTOR; IDENTIFICATION; PROLIFERATION	Protein kinase D (PKD) has emerged as a potential therapeutic target in multiple pathological conditions, including cancer and heart diseases. Potent and selective small molecule inhibitors of PKD are valuable for dissecting PKD-mediated cellular signaling pathways and for therapeutic application. In this study, we evaluated a targeted library of 235 small organic kinase inhibitors for PKD1 inhibitory activity at a single concentration. Twenty-eight PKD inhibitory chemotypes were identified and six exhibited excellent PKD1 selectivity. Five of the six lead structures share a common scaffold, with compound 139 being the most potent and selective for PKD vs PKC and CAMK. Compound 139 was an ATP-competitive PKD1 inhibitor with a low double-digit nanomolar potency and was also cell-active. Kinase profiling analysis identified this class of small molecules as pan-PKD inhibitors, confirmed their selectivity again PKC and CAMK, and demonstrated an overall favorable selectivity profile that could be further enhanced through structural modification. Furthermore, using a PKD homology model based on similar protein kinase structures, docking modes for compound 139 were explored and compared to literature examples of PKD inhibition. Modeling of these compounds at the ATP-binding site of PKD was used to rationalize its high potency and provide the foundation for future further optimization. Accordingly, using biochemical screening of a small number of privileged scaffolds and computational modeling, we have identified a new core structure for highly potent PKD inhibition with promising selectivity against closely related kinases. These lead structures represent an excellent starting point for the further optimization and the design of selective and therapeutically effective small molecule inhibitors of PKD.	[Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA; [Tandon, Manuj; Wang, Qiming Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Lirong; Xu, Qi; Xie, Xiangqun; Wipf, Peter] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wipf, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pwipf@pitt.edu; qjw1@pitt.edu	Wipf, Peter/AAG-1771-2021; Wang, Qiming Jane/B-6064-2012	Wipf, Peter/0000-0001-7693-5863; Wang, Qiming Jane/0000-0002-9502-4851	National Institutes of Health [R01CA129127-01, R01CA142580-01, P50-GM067082]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01CA129127-01, R01CA142580-01, and P50-GM067082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bossuyt J., 2008, CIRC RES; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen JZ, 2007, J CHEM INF MODEL, V47, P1626, DOI 10.1021/ci7000814; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Chen SQ, 2007, BIOORG MED CHEM LETT, V17, P2134, DOI 10.1016/j.bmcl.2007.01.081; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Ivison SM, 2007, J IMMUNOL, V178, P5735, DOI 10.4049/jimmunol.178.9.5735; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Meurice N, 2010, J MED CHEM, V53, P669, DOI 10.1021/jm901247a; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025134; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sundram V, 2011, MOL CANC RES; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Trejo A, 2003, J MED CHEM, V46, P4702, DOI 10.1021/jm0301787; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Xie XQ, 2003, PROTEINS, V53, P307, DOI 10.1002/prot.10511; Yamashita K, 2010, INT IMMUNOPHARMACOL, V10, P277, DOI 10.1016/j.intimp.2009.11.011; Yera ER, 2011, J MED CHEM, V54, P6771, DOI 10.1021/jm200666a; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu HH, 2008, PAIN, V137, P574, DOI 10.1016/j.pain.2007.10.025; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	47	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44653	10.1371/journal.pone.0044653	http://dx.doi.org/10.1371/journal.pone.0044653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028574	gold, Green Published, Green Accepted			2022-12-25	WOS:000311313900033
J	Boini, KM; Xia, M; Abais, JM; Xu, M; Li, CX; Li, PL				Boini, Krishna M.; Xia, Min; Abais, Justine M.; Xu, Ming; Li, Cai-xia; Li, Pin-Lan			Acid Sphingomyelinase Gene Knockout Ameliorates Hyperhomocysteinemic Glomerular Injury in Mice Lacking Cystathionine-beta-Synthase	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-DEATH; PODOCYTE INJURY; CYSTIC-FIBROSIS; RENAL FIBROSIS; CERAMIDE; HOMOCYSTEINE; INFLAMMATION; APOPTOSIS; RATS	Acid sphingomyelinase (ASM) has been implicated in the development of hyperhomocysteinemia (hHcys)-induced glomerular oxidative stress and injury. However, it remains unknown whether genetically engineering of ASM gene produces beneficial or detrimental action on hHcys-induced glomerular injury. The present study generated and characterized the mice lacking cystathionine beta-synthase (Cbs) and Asm mouse gene by cross breeding Cbs(+/-) and Asm(+/-) mice. Given that the homozygotes of Cbs(-/-/)Asm(-/-) mice could not survive for 3 weeks. Cbs(+/-/)Asm(+/+), Cbs(+/-/)Asm(+/-) and Cbs(+/-/)Asm(-/-) as well as their Cbs wild type littermates were used to study the role of Asm(-/-) under a background of Cbs(+/-) with hHcys. HPLC analysis revealed that plasma Hcys level was significantly elevated in Cbs heterozygous (Cbs(+/-)) mice with different copies of Asm gene compared to Cbs(+/+) mice with different Asm gene copies. Cbs(+/-/)Asm(+/+) mice had significantly increased renal Asm activity, ceramide production and O-2 center dot(-) level compared to Cbs(+/+/)Asm(+/+), while Cbs(+/-/)Asm(-/-) mice showed significantly reduced renal Asm activity, ceramide production and O-2 center dot(-) level due to increased plasma Hcys levels. Confocal microscopy demonstrated that colocalization of podocin with ceramide was much lower in Cbs(+/-/)Asm(-/-) mice compared to Cbs(+/-/)Asm(+/+) mice, which was accompanied by a reduced glomerular damage index, albuminuria and proteinuria in Cbs(+/-/)Asm(-/-) mice. Immunofluorescent analyses of the podocin, nephrin and desmin expression also illustrated less podocyte damages in the glomeruli from Cbs(+/-/)Asm(-/-) mice compared to Cbs(+/-/)Asm(+/+) mice. In in vitro studies of podocytes, hHcys-enhanced O-2 center dot(-) production, desmin expression, and ceramide production as well as decreases in VEGF level and podocin expression in podocytes were substantially attenuated by prior treatment with amitriptyline, an Asm inhibitor. In conclusion, Asm gene knockout or corresponding enzyme inhibition protects the podocytes and glomeruli from hHcys-induced oxidative stress and injury.	[Boini, Krishna M.; Xia, Min; Abais, Justine M.; Xu, Ming; Li, Cai-xia; Li, Pin-Lan] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Virginia Commonwealth University	Boini, KM (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012		National Institutes of Health [DK54927, HL091464, HL57244, HL075316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091464, R29HL057244, R01HL057244, R01HL075316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK54927, HL091464, HL57244 and HL075316 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar E, 2009, KIDNEY INT, V75, P596, DOI 10.1038/ki.2008.578; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Carnicer R, 2008, FRONT BIOSCI, V13, P5155, DOI 10.2741/3071; Chen YF, 2002, CIRCULATION, V106, P1275, DOI 10.1161/01.CIR.0000027586.64231.1B; Dhami R, 2010, CELL PHYSIOL BIOCHEM, V26, P749, DOI 10.1159/000322342; Dimanche-Boitrel MT, 2005, DRUG RESIST UPDATE, V8, P5, DOI 10.1016/j.drup.2005.02.003; Ernest S, 2005, PHYSIOL GENOMICS, V21, P404, DOI 10.1152/physiolgenomics.00199.2004; Fillet M, 2002, J CHROMATOGR A, V949, P225, DOI 10.1016/S0021-9673(01)01422-4; Floege J, 1995, J CLIN INVEST, V96, P2809, DOI 10.1172/JCI118351; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Ingram AJ, 2004, KIDNEY INT, V66, P733, DOI 10.1111/j.1523-1755.2004.00795.x; Kang DH, 2003, CURR OPIN NEPHROL HY, V12, P43, DOI 10.1097/00041552-200301000-00008; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Robert K, 2003, J BIOL CHEM, V278, P31504, DOI 10.1074/jbc.M213036200; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; van der Wouden Els A., 2004, Journal of Pharmacological and Toxicological Methods, V50, P13, DOI 10.1016/j.vascn.2004.03.004; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9; Zhang C, 2010, BBA-MOL CELL RES, V1803, P482, DOI 10.1016/j.bbamcr.2009.12.006; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45020	10.1371/journal.pone.0045020	http://dx.doi.org/10.1371/journal.pone.0045020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024785	Green Published, gold			2022-12-25	WOS:000308860100043
J	Haka, AS; Potteaux, S; Fraser, H; Randolph, GJ; Maxfield, FR				Haka, Abigail S.; Potteaux, Stephane; Fraser, Haley; Randolph, Gwendalyn J.; Maxfield, Frederick R.			Quantitative Analysis of Monocyte Subpopulations in Murine Atherosclerotic Plaques by Multiphoton Microscopy	PLOS ONE			English	Article							CELLS; MICE; GENERATION; EMIGRATION; DISEASE; LESIONS	The progressive accumulation of monocyte-derived cells in the atherosclerotic plaque is a hallmark of atherosclerosis. However, it is now appreciated that monocytes represent a heterogeneous circulating population of cells that differ in functionality. New approaches are needed to investigate the role of monocyte subpopulations in atherosclerosis since a detailed understanding of their differential mobilization, recruitment, survival and emigration during atherogenesis is of particular importance for development of successful therapeutic strategies. We present a novel methodology for the in vivo examination of monocyte subpopulations in mouse models of atherosclerosis. This approach combines cellular labeling by fluorescent beads with multiphoton microscopy to visualize and monitor monocyte subpopulations in living animals. First, we show that multiphoton microscopy is an accurate and timesaving technique to analyze monocyte subpopulation trafficking and localization in plaques in excised tissues. Next, we demonstrate that multiphoton microscopy can be used to monitor monocyte subpopulation trafficking in atherosclerotic plaques in living animals. This novel methodology should have broad applications and facilitate new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.	[Haka, Abigail S.; Fraser, Haley; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Potteaux, Stephane; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Potteaux, Stephane; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA	Cornell University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Haka, AS (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY USA.	frmaxfie@med.cornell.edu	Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866; Potteaux, Stephane/0000-0003-3068-8769	National Institutes of Health from National Institute of Allergy and Infectious Diseases [RO1 AI06741]; Experimental Therapeutics Institute at Mount Sinai School of Medicine; NIH NRSA post-doctoral training fellowship; Fondation pour 1 Recherche Medicale (France); European Society of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083] Funding Source: NIH RePORTER	National Institutes of Health from National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Institute at Mount Sinai School of Medicine; NIH NRSA post-doctoral training fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour 1 Recherche Medicale (France); European Society of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health RO1 AI06741 from National Institute of Allergy and Infectious Diseases and a grant from the Experimental Therapeutics Institute at Mount Sinai School of Medicine to G.J.R. A.S.H. was supported by an NIH NRSA post-doctoral training fellowship. S.P. was funded in part by Fondation pour 1 Recherche Medicale (France) and a 2007 Norman Alpert Visiting Scientist Award from the European Society of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Ding SF, 2010, AM J PHYSIOL-HEART C, V298, pH2121, DOI 10.1152/ajpheart.00308.2009; Dunn K. W., 2007, CURR PROTOC CYTOM, P19; Feig JE, 2007, PLOS ONE; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Ingersoll MA, 2012, IMMUNOBIOLOGY; Jacob MP, 2001, PATHOL BIOL, V49, P326, DOI 10.1016/S0369-8114(01)00151-1; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Ko ACT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3353960; KOSTNER GM, 1989, CIRCULATION, V80, P1313, DOI 10.1161/01.CIR.80.5.1313; Lilledahl MB, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772652; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rothstein EC, 2006, J MICROSC-OXFORD, V222, P58, DOI 10.1111/j.1365-2818.2006.01570.x; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yu WM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2800337; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zoumi A, 2004, BIOPHYS J, V87, P2778, DOI 10.1529/biophysj.104.042887	33	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44823	10.1371/journal.pone.0044823	http://dx.doi.org/10.1371/journal.pone.0044823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024767	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100025
J	Valdez, LD; Macri, PA; Braunstein, LA				Daniel Valdez, Lucas; Alejandro Macri, Pablo; Adriana Braunstein, Lidia			Temporal Percolation of the Susceptible Network in an Epidemic Spreading	PLOS ONE			English	Article							SIR DYNAMICS	In this work, we study the evolution of the susceptible individuals during the spread of an epidemic modeled by the susceptible-infected-recovered (SIR) process spreading on the top of complex networks. Using an edge-based compartmental approach and percolation tools, we find that a time-dependent quantity Phi(S)(t), namely, the probability that a given neighbor of a node is susceptible at time t, is the control parameter of a node void percolation process involving those nodes on the network not-reached by the disease. We show that there exists a critical time t(c) above which the giant susceptible component is destroyed. As a consequence, in order to preserve a macroscopic connected fraction of the network composed by healthy individuals which guarantee its functionality, any mitigation strategy should be implemented before this critical time t(c). Our theoretical results are confirmed by extensive simulations of the SIR process.	[Daniel Valdez, Lucas; Alejandro Macri, Pablo; Adriana Braunstein, Lidia] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Dept Fis, Inst Invest Fis Mar del Plata, Mar Del Plata, Buenos Aires, Argentina; [Adriana Braunstein, Lidia] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA	National University of Mar del Plata; Boston University	Valdez, LD (corresponding author), Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Dept Fis, Inst Invest Fis Mar del Plata, Mar Del Plata, Buenos Aires, Argentina.	ldvaldes@mdp.edu.ar						ANDERSON R M, 1991; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Braunstein LA, 2007, INT J BIFURCAT CHAOS, V17, P2215, DOI 10.1142/S0218127407018361; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Lagorio C, 2009, PHYSICA A, V388, P755, DOI 10.1016/j.physa.2008.10.045; LEATH PL, 1976, PHYS REV B, V14, P5046, DOI 10.1103/PhysRevB.14.5046; Lindquist J, 2011, J MATH BIOL, V62, P143, DOI 10.1007/s00285-010-0331-2; Miller JC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010101; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2011, J MATH BIOL, V62, P349, DOI 10.1007/s00285-010-0337-9; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Parshani R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.258701; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4	22	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44188	10.1371/journal.pone.0044188	http://dx.doi.org/10.1371/journal.pone.0044188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028498	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700016
J	Fujii, N; Sakaue, H; Sasaki, H; Fujii, N				Fujii, Norihiko; Sakaue, Hiroaki; Sasaki, Hiroshi; Fujii, Noriko			A Rapid, Comprehensive Liquid Chromatography-Mass Spectrometry (LC-MS)-based Survey of the Asp Isomers in Crystallins from Human Cataract Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ASPARTIC ACID; ALPHA-A-CRYSTALLIN; IMMUNOHISTOCHEMICAL LOCALIZATION; SIMULTANEOUS STEREOINVERSION; CONTAINING PROTEINS; BACKBONE CLEAVAGE; B-CRYSTALLIN; DEAMIDATION; AGE; RACEMIZATION	Cataracts are caused by clouding of the eye lens and may lead to partial or total loss of vision. The mechanism of cataract development, however, is not well understood. It is thought that abnormal aggregates of lens proteins form with age, causing loss of lens clarity and development of the cataract. Lens proteins are composed of soluble alpha-, beta-, and gamma-crystallins, and as long lived proteins, they undergo post-translational modifications including isomerization, deamidation, and oxidation, which induce insolubilization, aggregation, and loss of function that may lead to cataracts. Therefore, analysis of post-translational modifications of individual amino acid residues in proteins is important. However, detection of the optical isomers of amino acids formed in these proteins is difficult because optical resolution is only achieved using complex methodology. In this study, we describe a new method for the analysis of isomerization of individual Asp residues in proteins using LC-MS and the corresponding synthetic peptides containing the Asp isomers. This makes it possible to analyze isomers of Asp residues in proteins precisely and quickly. We demonstrate that Asp-58, -76, -84, and -151 of alpha A-crystallin and Asp-62 and -96 of alpha B-crystallin are highly converted to L beta-, D beta-, and D alpha-isomers. The amount of isomerization of Asp is greater in the insoluble fraction at all Asp sites in lens proteins, therefore indicating that isomerization of these Asp residues affects the higher order structure of the proteins and contributes to the increase in aggregation, insolubilization, and disruption of function of proteins in the lens, leading to the cataract.	[Fujii, Norihiko; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Sakaue, Hiroaki; Fujii, Noriko] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Sasaki, Hiroshi] Kanazawa Med Univ, Uchinada, Ishikawa 9200293, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Fujii, N (corresponding author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	nfujii@rri.kyoto-u.ac.jp	Sakaue, Hiroaki/AAT-7104-2021	Sakaue, Hiroaki/0000-0002-1977-0318	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AMICHE M, 1989, MOL PHARMACOL, V35, P774; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; COSTE J, 1990, TETRAHEDRON LETT, V31, P205, DOI 10.1016/S0040-4039(00)94371-5; Foulon CF, 2000, CANCER RES, V60, P4453; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; Fujii N, 2010, AMINO ACIDS, V39, P1393, DOI 10.1007/s00726-010-0597-0; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HELFMAN PM, 1976, NATURE, V262, P279; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P977, DOI 10.1136/bjo.2008.144212; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P974, DOI 10.1136/bjo.2007.135889; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P3923, DOI 10.1167/iovs.06-1284; KAMATANI Y, 1990, FEBS LETT, V276, P95, DOI 10.1016/0014-5793(90)80516-L; Kantorow M, 1998, INT J BIOL MACROMOL, V22, P307, DOI 10.1016/S0141-8130(98)00028-2; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Li XJ, 2010, ANAL CHEM, V82, P3606, DOI 10.1021/ac9028467; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Masuda W, 2002, ARCH ORAL BIOL, V47, P757, DOI 10.1016/S0003-9969(02)00064-X; Mori Y, 2011, J CHROMATOGR B, V879, P3303, DOI 10.1016/j.jchromb.2011.05.010; Ohtani S, 1998, GROWTH DEVELOP AGING, V62, P141; PERRY RE, 1987, EXP EYE RES, V44, P269, DOI 10.1016/S0014-4835(87)80011-8; Ritz-Timme S, 2003, INT J LEGAL MED, V117, P96, DOI 10.1007/s00414-002-0355-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Shimizu K, 2012, MOL VIS, V18, P1823; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Takemoto L, 1995, EXP EYE RES, V61, P743, DOI 10.1016/S0014-4835(05)80025-9; Takemoto L, 1996, EXP EYE RES, V63, P585, DOI 10.1006/exer.1996.0149; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Yamazaki Y, 2010, ANAL CHEM, V82, P6384, DOI 10.1021/ac100310x; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	46	65	67	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.399972	http://dx.doi.org/10.1074/jbc.M112.399972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007399	Green Published, hybrid			2022-12-25	WOS:000311233800066
J	Lee, KM; Park, Y; Bari, W; Yoon, MY; Go, J; Kim, SC; Lee, HI; Yoon, SS				Lee, Kang-Mu; Park, Yongjin; Bari, Wasimul; Yoon, Mi Young; Go, Junhyeok; Kim, Sang Cheol; Lee, Hyung-il; Yoon, Sang Sun			Activation of Cholera Toxin Production by Anaerobic Respiration of Trimethylamine N-oxide in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; ARGININE TRANSLOCATION SYSTEM; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EL-TOR; SHEWANELLA-ONEIDENSIS; SECRETORY PATHWAY; PROTEIN SECRETION; BIOFILM FORMATION; II SECRETION	Vibrio cholerae is a Gram-negative bacterium that causes cholera. Although the pathogenesis caused by this deadly pathogen takes place in the intestine, commonly thought to be anaerobic, anaerobiosis-induced virulence regulations are not fully elucidated. Anerobic growth of the V. cholerae strain, N16961, was promoted when trimethylamine N-oxide (TMAO) was used as an alternative electron acceptor. Strikingly, cholera toxin (CT) production was markedly induced during anaerobic TMAO respiration. N16961 mutants unable to metabolize TMAO were incapable of producing CT, suggesting a mechanistic link between anaerobic TMAO respiration and CT production. TMAO reductase is transported to the periplasm via the twin arginine transport (TAT) system. A similar defect in both anaerobic TMAO respiration and CT production was also observed in a N16961 TAT mutant. In contrast, the abilities to grow on TMAO and to produce CT were not affected in a mutant of the general secretion pathway. This suggests that V. cholerae may utilize the TAT system to secrete CT during TMAO respiration. During anaerobic growth with TMAO, N16961 cells exhibit green fluorescence when stained with 2',7'-dichlorofluorescein diacetate, a specific dye for reactive oxygen species (ROS). Furthermore, CT production was decreased in the presence of an ROS scavenger suggesting a positive role of ROS in regulating CT production. When TMAO was co-administered to infant mice infected with N16961, the mice exhibited more severe pathogenic symptoms. Together, our results reveal a novel anaerobic growth condition that stimulates V. cholerae to produce its major virulence factor.	[Lee, Kang-Mu; Park, Yongjin; Bari, Wasimul; Yoon, Mi Young; Go, Junhyeok; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul 120752, South Korea; [Kim, Sang Cheol] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Lee, Hyung-il] Univ Ulsan, Dept Chem, Ulsan 680749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea Project Med Sci 21, 250 Seongsanno, Seoul 120752, South Korea.	sangsun_yoon@yuhs.ac		LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation of Korea (NRF); Korean Government (MEST) [2009-0087951, 2011-0016210]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A110096]; Yonsei University College of Medicine Research [6-2011-0101]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; Yonsei University College of Medicine Research	This work was supported by grants from the National Research Foundation of Korea (NRF), funded by Korean Government (MEST) Grants 2009-0087951 and 2011-0016210. This work was also supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Grant A110096 and Yonsei University College of Medicine Research Grant 6-2011-0101.	Al-Sheboul S, 2011, ANAEROBE, V17, P501, DOI 10.1016/j.anaerobe.2011.06.008; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; Bordi C, 2004, J BACTERIOL, V186, P4502, DOI 10.1128/JB.186.14.4502-4509.2004; Braun M, 2005, J BACTERIOL, V187, P5996, DOI 10.1128/JB.187.17.5996-6004.2005; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Gon S, 2001, J BIOL CHEM, V276, P11545, DOI 10.1074/jbc.M008875200; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Iredell Jonathan R., 1994, Trends in Microbiology, V2, P187, DOI 10.1016/0966-842X(94)90109-I; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Klose KE, 2001, INT J MED MICROBIOL, V291, P81, DOI 10.1078/1438-4221-00104; KONISHI K, 1981, MICROBIOL IMMUNOL, V25, P1221, DOI 10.1111/j.1348-0421.1981.tb00132.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Marrero K, 2009, RES MICROBIOL, V160, P48, DOI 10.1016/j.resmic.2008.10.005; Martinez I, 2005, J AGR FOOD CHEM, V53, P6889, DOI 10.1021/jf0507902; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; NICHOLLS KM, 1976, J APPL BACTERIOL, V41, P265, DOI 10.1111/j.1365-2672.1976.tb00629.x; Nobechi K, 1925, J BACTERIOL, V10, P197, DOI 10.1128/JB.10.3.197-215.1925; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Sanchez J, 2004, J BACTERIOL, V186, P1355, DOI 10.1128/JB.186.5.1355-1361.2004; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2000, INT J MED MICROBIOL, V290, P345, DOI 10.1016/S1438-4221(00)80038-7; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	54	41	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.394932	http://dx.doi.org/10.1074/jbc.M112.394932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019319	Green Published, hybrid			2022-12-25	WOS:000311233800043
J	Liu, G; Tian, H; Huang, YQ; Hu, J; Ji, YX; Li, SQ; Feng, YQ; Guo, L; Zhu, YG				Liu, Gai; Tian, Han; Huang, Yun-Qing; Hu, Jun; Ji, Yan-Xiao; Li, Shao-Qing; Feng, Yu-Qi; Guo, Lin; Zhu, Ying-Guo			Alterations of Mitochondrial Protein Assembly and Jasmonic Acid Biosynthesis Pathway in Honglian (HL)-type Cytoplasmic Male Sterility Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE GAMETOPHYTE DEVELOPMENT; PROGRAMMED CELL-DEATH; PLANT-MITOCHONDRIA; RESPIRATORY-CHAIN; SEX DETERMINATION; OXIDATIVE STRESS; INNER MEMBRANE; T-CYTOPLASM; CMS LINE; MAIZE	It has been suggested that the mitochondrial chimeric gene orfH79 is the cause for abortion of microspores in Honglian cytoplasmic male sterile rice, yet little is known regarding its mechanism of action. In this study, we used a mass spectrometry-based quantitative proteomics strategy to compare the mitochondrial proteome between the sterile line Yuetai A and its fertile near-isogenic line Yuetai B. We discovered a reduced quantity of specific proteins in mitochondrial complexes in Yuetai A compared with Yuetai B, indicating a defect in mitochondrial complex assembly in the sterile line. Western blotting showed that ORFH79 protein and ATP1 protein, an F-1 sector component of complex V, are both associated with large protein complexes of similar size. Respiratory complex activity assays and transmission electron microscopy revealed functional and morphological defects in the mitochondria of Yuetai A when compared with Yuetai B. In addition, we identified one sex determination TASSELSEED2-like protein increased in Yuetai A, leading to the discovery of an aberrant variation of the jasmonic acid pathway during the development of microspores.	[Tian, Han; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Gai; Hu, Jun; Ji, Yan-Xiao; Li, Shao-Qing; Zhu, Ying-Guo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Tian, Han; Feng, Yu-Qi; Guo, Lin] Wuhan Univ, Key Lab Analyt Chem Biol & Med, Minist Educ, Dept Chem, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Guo, L (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guol@whu.edu.cn; zhuyg@public.wh.hb.cn	Feng, Yu-Qi/H-1479-2011	Feng, Yu-Qi/0000-0003-1107-5385	National Basic Research Program of China [2007CB109005, 2013CB911102]; National Natural Science Foundation of China [31071391, 91019013, 91017013, 31070327, 30921001]; National High-Tech Research and Development Project Grant [2009AA101101]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Project Grant(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported in part by the National Basic Research Program of China Grants 2007CB109005 and 2013CB911102, National Natural Science Foundation of China Grants 31071391, 91019013, 91017013, 31070327, and 30921001, the National High-Tech Research and Development Project Grant 2009AA101101, and the 111 Project of China Grant B06018.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Budar F., 2007, PLANT MITOCHONDRIA, P278; Chen ML, 2011, J CHROMATOGR B, V879, P938, DOI 10.1016/j.jchromb.2011.03.003; Chen X, 2011, J CHROMATOGR B, V879, P25, DOI 10.1016/j.jchromb.2010.11.004; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Duroc Y, 2009, PLANT MOL BIOL, V70, P123, DOI 10.1007/s11103-009-9461-6; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Heazlewood JL, 2003, PLANT PHYSIOL, V132, P230, DOI 10.1104/pp.102.018986; Huang S, 2009, PLANT PHYSIOL, V149, P719, DOI 10.1104/pp.108.131300; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; LEVINGS CS, 1992, PLANT MOL BIOL, V19, P135, DOI 10.1007/BF00015611; Li SQ, 2007, J INTEGR PLANT BIOL, V49, P791, DOI 10.1111/j.1744-7909.2007.00513.x; Li SQ, 2004, FUNCT PLANT BIOL, V31, P369, DOI 10.1071/FP03224; Li X. M., 2000, HEREDITY, V22, P201; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mihr C, 2001, J PLANT PHYSIOL, V158, P787, DOI 10.1078/0176-1617-00292; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Peng XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-125; RHOADS DM, 1995, J BIOENERG BIOMEMBR, V27, P437, DOI 10.1007/BF02110006; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; Schaller F, 2001, J EXP BOT, V52, P11, DOI 10.1093/jexbot/52.354.11; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; WISE RP, 1987, PLANT MOL BIOL, V9, P121, DOI 10.1007/BF00015644; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wu XQ, 2007, FEBS J, V274, P1172, DOI 10.1111/j.1742-4658.2007.05642.x; Yi P, 2002, CHINESE SCI BULL, V47, P744, DOI 10.1360/02tb9168; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	38	29	36	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382549	http://dx.doi.org/10.1074/jbc.M112.382549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027867	Green Published, hybrid			2022-12-25	WOS:000311233800072
J	Mikami, T; Koyama, S; Yabuta, Y; Kitagawa, H				Mikami, Tadahisa; Koyama, Shinji; Yabuta, Yumi; Kitagawa, Hiroshi			Chondroitin Sulfate Is a Crucial Determinant for Skeletal Muscle Development/Regeneration and Improvement of Muscular Dystrophies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; DIFFERENTIATION; MDX; 4-O-SULFOTRANSFERASE-1; PROTEOGLYCANS; REGENERATION; MECHANISMS; EXPRESSION; PATHWAYS; LINKAGE	Skeletal muscle formation and regeneration require myoblast fusion to form multinucleated myotubes or myofibers, yet their molecular regulation remains incompletely understood. We show here that the levels of extra- and/or pericellular chondroitin sulfate (CS) chains in differentiating C2C12 myoblast culture are dramatically diminished at the stage of extensive syncytial myotube formation. Forced down-regulation of CS, but not of hyaluronan, levels enhanced myogenic differentiation in vitro. This characteristic CS reduction seems to occur through a cellautonomous mechanism that involves HYAL1, a known catabolic enzyme for hyaluronan and CS. In vivo injection of a bacterial CS-degrading enzyme boosted myofiber regeneration in a mouse cardiotoxin-induced injury model and ameliorated dystrophic pathology in mdx muscles. Our data suggest that the control of CS abundance is a promising new therapeutic approach for the treatment of skeletal muscle injury and progressive muscular dystrophies.	[Mikami, Tadahisa; Koyama, Shinji; Yabuta, Yumi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Scientific Research on Innovative Areas [23110003]; Ministry of Education, Culture, Sports, Science and Technology, Japan;  [24590132]	Japan Private School Promotion Foundation; Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by the Scientific Promotion Fund from the Japan Private School Promotion Foundation, Grant-in-aid for Scientific Research (C) 24590132 (to T. M.), Scientific Research on Innovative Areas 23110003 (to H. K.), and Supported Program for the Strategic Research Foundation at Private Universities (2012-2016) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carrino DA, 1999, POULTRY SCI, V78, P769, DOI 10.1093/ps/78.5.769; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kim MH, 2011, HUM MOL GENET, V20, P1324, DOI 10.1093/hmg/ddr015; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; MCARDLE A, 1994, MUSCLE NERVE, V17, P1378, DOI 10.1002/mus.880171206; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Roffe S, 2010, EXP CELL RES, V316, P1061, DOI 10.1016/j.yexcr.2010.01.003; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784	44	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38531	38542		10.1074/jbc.M111.336925	http://dx.doi.org/10.1074/jbc.M111.336925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007393	Green Published, hybrid			2022-12-25	WOS:000310982800013
J	Morrison, K; Witte, K; Mayers, JR; Schuh, AL; Audhya, A				Morrison, Kylee; Witte, Kristen; Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon			Roles of Acidic Phospholipids and Nucleotides in Regulating Membrane Binding and Activity of a Calcium-independent Phospholipase A(2) Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; IPLA(2)BETA; APOPTOSIS; ENZYMES; MITOCHONDRIAL; TRAFFICKING; DEFICIENCY; SECRETION	Phospholipase A(2) activity plays key roles in generating lipid second messengers and regulates membrane topology through the generation of asymmetric lysophospholipids. In particular, the Group VIA phospholipase A(2) (GVIA-iPLA(2)) subfamily of enzymes functions independently of calcium within the cytoplasm of cells and has been implicated in numerous cellular processes, including proliferation, apoptosis, and membrane transport steps. However, mechanisms underlying the spatial and temporal regulation of these enzymes have remained mostly unexplored. Here, we examine the subset of Caenorhabditis elegans lipases that harbor a consensus motif common to members of the GVIA-iPLA(2) subfamily. Based on sequence homology, we identify IPLA-1 as the closest C. elegans homolog of human GVIA-iPLA(2) enzymes and use a combination of liposome interaction studies to demonstrate a role for acidic phospholipids in regulating GVIA-iPLA(2) function. Our studies indicate that IPLA-1 binds directly to multiple acidic phospholipids, including phosphatidylserine, phosphatidylglycerol, cardiolipin, phosphatidic acid, and phosphorylated derivatives of phosphatidylinositol. Moreover, the presence of these acidic lipids dramatically elevates the specific activity of IPLA-1 in vitro. We also found that the addition of ATP and ADP promote oligomerization of IPLA-1, which probably underlies the stimulatory effect of nucleotides on its activity. We propose that membrane composition and the presence of nucleotides play key roles in recruiting and modulating GVIA-iPLA(2) activity in cells.	[Morrison, Kylee; Witte, Kristen; Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin Madison, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Audhya, A (corresponding author), Univ Wisconsin Madison, Sch Med, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	audhya@wisc.edu			National Institutes of Health [1R01GM088151]; March of Dimes [5-FY09-525]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM088151 (to A. A.). This work was also supported by March of Dimes Basil O'Connor Award 5-FY09-525 (to A. A.).	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Carrilho I, 2008, EUR J PAEDIATR NEURO, V12, P491, DOI 10.1016/j.ejpn.2008.01.005; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P849; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Inoue T, 2004, P NATL ACAD SCI USA, V101, P13233, DOI 10.1073/pnas.0405507101; KEMPNER ES, 1988, ADV ENZYMOL RAMB, V61, P107; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Oestvang J, 2006, BBA-MOL CELL BIOL L, V1761, P1309, DOI 10.1016/j.bbalip.2006.06.003; PIETRO ES, 2009, PLOS BIOL, V0007; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Schmidt JA, 2010, TRAFFIC, V11, P1530, DOI 10.1111/j.1600-0854.2010.01115.x; Seeds MC, 1999, CLIN REV ALLERG IMMU, V17, P5, DOI 10.1007/BF02737594; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225	48	12	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38824	38834		10.1074/jbc.M112.391508	http://dx.doi.org/10.1074/jbc.M112.391508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007400	Green Published, hybrid			2022-12-25	WOS:000310982800039
J	Sun, C; Tian, L; Nie, J; Zhang, H; Han, X; Shi, YG				Sun, Chao; Tian, Liang; Nie, Jia; Zhang, Hai; Han, Xiao; Shi, Yuguang			Inactivation of MARK4, an AMP-activated Protein Kinase (AMPK)-related Kinase, Leads to Insulin Hypersensitivity and Resistance to Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; STIMULATED PHOSPHORYLATION; HEPATIC STEATOSIS; METABOLIC-RATE; KNOCKOUT MICE; CELL POLARITY; IN-VIVO; LKB1; FAMILY; DYSFUNCTION	MARK4, also known as Par-1d/MarkL1, is a member of the AMP-activated protein kinase (AMPK)-related family of kinases, which are implicated in the regulation of dynamic biological functions, including glucose and energy homeostasis. However, the physiological function of MARK4 in mammals remains elusive. Here, we investigated a role for MARK4 in regulating energy homeostasis by generating mice with targeted inactivation of the mark4 gene. We show that MARK4 deficiency in mice caused hyperphagia, hyperactivity, and hypermetabolism, leading to protection from diet-induced obesity and its related metabolic complications through up-regulation of brown fat activity. Consequently, MARK4 deficiency mitigated insulin resistance associated with diet-induced obesity by dramatically enhancing insulin-stimulated AKT phosphorylation in major metabolic tissues. Ablation of MARK4 also significantly improved glucose homeostasis by up-regulating the activity and expression of AMPK kinase in key metabolic tissues. Taken together, these data identify a key role of MARK4 in energy metabolism, implicating the kinase as a novel drug target for the treatment of obesity and type 2 diabetes.	[Sun, Chao; Tian, Liang] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Sun, Chao; Tian, Liang; Nie, Jia; Zhang, Hai; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Nie, Jia; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China	Northwest A&F University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nanjing Medical University	Shi, YG (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,H166, Hershey, PA 17033 USA.	yus11@psu.edu	nie, jia/AAE-8355-2019	nie, jia/0000-0001-9085-7224	National Institutes of Health [DK076685]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076685, R01DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S.). This work was also supported by a scholarship from the China Scholarship Council (to L. T.).	Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Chen MB, 2005, J CLIN ENDOCR METAB, V90, P3665, DOI 10.1210/jc.2004-1980; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Gosmanov AR, 2004, AM J PHYSIOL-ENDOC M, V287, pE8, DOI 10.1152/ajpendo.00485.2003; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2007, CELL METAB, V6, P339, DOI 10.1016/j.cmet.2007.10.001; Hojlund K, 2004, AM J PHYSIOL-ENDOC M, V286, pE239, DOI 10.1152/ajpendo.00326.2003; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jessen N, 2010, BBA-MOL BASIS DIS, V1802, P593, DOI 10.1016/j.bbadis.2010.04.008; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; Kobayashi T, 2004, HYPERTENSION, V44, P956, DOI 10.1161/01.HYP.0000147559.10261.a7; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lennerz JK, 2010, MOL CELL BIOL, V30, P5043, DOI 10.1128/MCB.01472-09; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; PARSA I, 1988, CANCER RES, V48, P2265; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; SEIDELL JC, 1992, INT J OBESITY, V16, P667; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	40	50	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388934	http://dx.doi.org/10.1074/jbc.M112.388934			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992738	hybrid, Green Published			2022-12-25	WOS:000310642200063
J	Bourdes, A; Rudder, S; East, AK; Poole, PS				Bourdes, Alexandre; Rudder, Steven; East, Alison K.; Poole, Philip S.			Mining the Sinorhizobium meliloti Transportome to Develop FRET Biosensors for Sugars, Dicarboxylates and Cyclic Polyols	PLOS ONE			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; LEGUMINOSARUM BV TRIFOLII; RIBOSE-BINDING-PROTEIN; RHIZOBIUM-LEGUMINOSARUM; ACID-BINDING; FLUORESCENT NANOSENSORS; RHODOBACTER-CAPSULATUS; HAEMOPHILUS-INFLUENZAE; MYOINOSITOL CATABOLISM; CRYSTAL-STRUCTURES	Background: Forster resonance energy transfer (FRET) biosensors are powerful tools to detect biologically important ligands in real time. Currently FRET bisosensors are available for twenty-two compounds distributed in eight classes of chemicals (two pentoses, two hexoses, two disaccharides, four amino acids, one nucleobase, two nucleotides, six ions and three phytoestrogens). To expand the number of available FRET biosensors we used the induction profile of the Sinorhizobium meliloti transportome to systematically screen for new FRET biosensors. Methodology/Principal Findings: Two new vectors were developed for cloning genes for solute-binding proteins (SBPs) between those encoding FRET partner fluorescent proteins. In addition to a vector with the widely used cyan and yellow fluorescent protein FRET partners, we developed a vector using orange (mOrange2) and red fluorescent protein (mKate2) FRET partners. From the sixty-nine SBPs tested, seven gave a detectable FRET signal change on binding substrate, resulting in biosensors for D-quinic acid, myo-inositol, L-rhamnose, L-fucose, beta-diglucosides (cellobiose and gentiobiose), D-galactose and C4-dicarboxylates (malate, succinate, oxaloacetate and fumarate). To our knowledge, we describe the first two FRET biosensor constructs based on SBPs from Tripartite ATP-independent periplasmic (TRAP) transport systems. Conclusions/Significance: FRET based on orange (mOrange2) and red fluorescent protein (mKate2) partners allows the use of longer wavelength light, enabling deeper penetration of samples at lower energy and increased resolution with reduced back-ground auto-fluorescence. The FRET biosensors described in this paper for four new classes of compounds; (i) cyclic polyols, (ii) L-deoxy sugars, (iii) beta-linked disaccharides and (iv) C4-dicarboxylates could be developed to study metabolism in vivo.	[Bourdes, Alexandre; Rudder, Steven; East, Alison K.; Poole, Philip S.] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Poole, PS (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England.	philip.poole@jic.ac.uk		Rudder, Steven/0000-0003-0050-9037	Biotechnology and Biological Science Research Council UK [BB/F004753/1]; BBSRC [BB/F004753/1, BBS/E/J/000C0642] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0642, BB/F004753/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Science Research Council UK grant no BB/F004753/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagaria A, 2011, PROTEINS, V79, P1352, DOI 10.1002/prot.22965; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermejo C, 2011, BIOCHEM J, V438, P1, DOI 10.1042/BJ20110428; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-20; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dumbrepatil AB, 2010, ANALYST, V135, P2879, DOI 10.1039/c0an00385a; East AK, 2008, ADV APPL MICROBIOL, V64, P137, DOI 10.1016/S0065-2164(08)00405-X; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Fehr M, 2005, BIOCHEM SOC T, V33, P287, DOI 10.1042/BST0330287; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Galbraith MP, 1998, MICROBIOL-SGM, V144, P2915, DOI 10.1099/00221287-144-10-2915; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Ha JS, 2007, APPL ENVIRON MICROB, V73, P7408, DOI 10.1128/AEM.01080-07; Horler RSP, 2009, J BIOL CHEM, V284, P31156, DOI 10.1074/jbc.M109.054296; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kaper T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-11; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; Morinaga T, 2010, MICROBIOL-SGM, V156, P1538, DOI 10.1099/mic.0.037499-0; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Okada S, 2009, PROTEIN SCI, V18, P2518, DOI 10.1002/pro.266; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Richardson JS, 2007, J BACTERIOL, V189, P8437, DOI 10.1128/JB.01032-07; Richardson JS, 2004, J BACTERIOL, V186, P8433, DOI 10.1128/JB.186.24.8433-8442.2004; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; SHAW JG, 1991, MOL MICROBIOL, V5, P3055, DOI 10.1111/j.1365-2958.1991.tb01865.x; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Wlodkowic D, 2011, METHOD CELL BIOL, V102, P105, DOI 10.1016/B978-0-12-374912-3.00005-5; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	55	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e43578	10.1371/journal.pone.0043578	http://dx.doi.org/10.1371/journal.pone.0043578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028462	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700003
J	D'Onghia, G; Maiorano, P; Carlucci, R; Capezzuto, F; Carluccio, A; Tursi, A; Sion, L				D'Onghia, Gianfranco; Maiorano, Porzia; Carlucci, Roberto; Capezzuto, Francesca; Carluccio, Angela; Tursi, Angelo; Sion, Letizia			Comparing Deep-Sea Fish Fauna between Coral and Non-Coral "Megahabitats" in the Santa Maria di Leuca Cold-Water Coral Province (Mediterranean Sea)	PLOS ONE			English	Article							NORTHERN IONIAN SEA; FEEDING-HABITS; HATTON BANK; ATLANTIC; REEFS; COMMUNITIES; BEHAVIOR; ASSOCIATIONS; ASSEMBLAGES; MEGAFAUNA	Two experimental longline surveys were carried out in the Santa Maria di Leuca (SML) cold-water coral province (Mediterranean Sea) during May-June and September-October 2010 to investigate the effect of corals on fish assemblages. Two types of "megahabitat" characterized by the virtual absence of fishing were explored. One was characterized by complex topography including mesohabitats with carbonate mounds and corals. The other type of megahabitat, although characterized by complex topographic features, lacks carbonate mounds and corals. The fishing vessel was equipped with a 3,000 m monofilament longline with 500 hooks and snoods of 2.5 m in length. A total of 9 hauls, using about 4,500 hooks, were carried out both in the coral megahabitat and in the non-coral megahabitat during each survey. The fish Leucoraja fullonica and Pteroplatytrygon violacea represent new records for the SML coral province. The coral by-catch was only obtained in the coral megahabitat in about 55% of the stations investigated in both surveys. The total catches and the abundance indices of several species were comparable between the two habitat typologies. The species contributing most to the dissimilarity between the two megahabitat fish assemblages were Pagellus bogaraveo, Galeus melastomus, Etmopterus spinax and Helicolenus dactylopterus for density and P. bogaraveo, Conger conger, Polyprion americanus and G. melastomus for biomass. P. bogaraveo was exclusively collected in the coral megahabitat, whereas C. conger, H. dactylopterus and P. americanus were found with greater abundance in the coral than in the non-coral megahabitat. Differences in the sizes between the two megahabitats were detected in E. spinax, G. melastomus, C. conger and H. dactylopterus. Although these differences most probably related to the presence-absence of corals, both megahabitats investigated play the role of attraction-refuge for deep-sea fish fauna, confirming the important role of the whole SML coral province as a refuge area from fishing.	[D'Onghia, Gianfranco; Maiorano, Porzia; Carlucci, Roberto; Capezzuto, Francesca; Carluccio, Angela; Tursi, Angelo; Sion, Letizia] Univ Bari Aldo Moro, Dept Biol, CoNISMa, Bari, Italy	CoNISMa; Universita degli Studi di Bari Aldo Moro	D'Onghia, G (corresponding author), Univ Bari Aldo Moro, Dept Biol, CoNISMa, Bari, Italy.	g.donghia@biologia.uniba.it	SION, LETIZIA/E-4205-2015; Carlucci, Roberto/C-5728-2009; Carlucci, Roberto/ABC-7196-2020	SION, LETIZIA/0000-0002-0308-1841; Carlucci, Roberto/0000-0002-9287-6936; D'Onghia, Gianfranco/0000-0003-0952-9472; CAPEZZUTO, Francesca/0000-0002-1498-0228; Tursi, Angelo Raffaele/0000-0002-7776-2738	EU 7FP CoralFISH project	EU 7FP CoralFISH project	This study was supported by the EU 7FP CoralFISH project (www.eu-fp7-coralfish.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Baker KD, 2012, DEEP-SEA RES PT I, V65, P171, DOI 10.1016/j.dsr.2012.03.012; Bianchi G., 1999, FAO SPECIES IDENTIFI; Bourcier M, 1973, TETHYS, V4, P811; Budillon G, 2010, DEEP-SEA RES PT II, V57, P441, DOI 10.1016/j.dsr2.2009.08.017; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Capezzuto F, 2012, DEEP-SEA RES PT I, V59, P1, DOI 10.1016/j.dsr.2011.10.006; Carbonara P., 2003, Biologia Marina Mediterranea, V10, P102; Carlier A, 2009, MAR ECOL PROG SER, V397, P125, DOI 10.3354/meps08361; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Consoli P, 2010, J APPL ICHTHYOL, V26, P583, DOI 10.1111/j.1439-0426.2010.01467.x; Corselli C, 2010, DEEP-SEA RES PT II, V57, P323, DOI 10.1016/j.dsr2.2009.08.018; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; D'Onghia G, 1998, ITAL J ZOOL, V65, P287, DOI 10.1080/11250009809386834; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2011, MAR ECOL PROG SER, V443, P95, DOI 10.3354/meps09432; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; DOnghia G, 1995, ANN I OCEANOGR PARIS, V71, P35; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Munoz PD, 2011, J MAR BIOL ASSOC UK, V91, P939, DOI 10.1017/S0025315410001773; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Foubert A, 2005, ERLANGEN EARTH C SER, P403, DOI 10.1007/3-540-27673-4_20; Freese JL, 2003, MAR FISH REV, V65, P38; Freiwald A, 2002, FACIES, V47, P179, DOI 10.1007/BF02667712; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; Indennidate A., 2010, BIOL MAR MEDITERR, V17, P340; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Le Guilloux E, 2009, DEEP-SEA RES PT II, V56, P2394, DOI 10.1016/j.dsr2.2009.04.014; Maiorano P, 2010, CHEM ECOL, V26, P219, DOI 10.1080/02757541003693987; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Matarrese A., 1996, Cybium, V20, P197; Matarrese A, 1998, ITAL J ZOOL, V65, P203, DOI 10.1080/11250009809386814; MESSING C G, 1990, Palaios, V5, P15, DOI 10.2307/3514994; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Morato T, 2001, B MAR SCI, V69, P1073; Morato T, 1999, LIFE MAR SCI A, V17A, P51, DOI 10.1111/j.1439-0426.2010.01467.x; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2000, THESIS U BERGEN; Nouar A, 2000, CAH BIOL MAR, V41, P313; Reed JK, 2006, B MAR SCI, V78, P343; Roberts JM, 2008, FACIES, V54, P297, DOI 10.1007/s10347-008-0140-x; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2003, 2 INT S DEEP SEA COR, P483; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Savini A, 2010, DEEP-SEA RES PT II, V57, P326, DOI 10.1016/j.dsr2.2009.08.014; Sion L., 2003, Biologia Marina Mediterranea, V10, P935; Soffker M, 2011, DEEP-SEA RES PT I, V58, P818, DOI 10.1016/j.dsr.2011.06.002; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Sulak KJ, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P65; Taviani M, 2005, ERLANGEN EARTH C SER, P137, DOI 10.1007/3-540-27673-4_7; Tissot BN, 2006, FISH B-NOAA, V104, P167; Tunesi L, 1997, ATT 12 C ASS IT OC L, V1, P61; Tursi A., 1993, Cybium, V17, P187; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Uiblein F, 2003, MAR ECOL PROG SER, V257, P223, DOI 10.3354/meps257223; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Xavier JC, 2010, J MAR BIOL ASSOC UK, V90, P493, DOI 10.1017/S0025315409990555; Yoklavich MM, 2000, FISH B-NOAA, V98, P625	68	53	54	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e445090	10.1371/journal.pone.0044509	http://dx.doi.org/10.1371/journal.pone.0044509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028551	Green Submitted, gold, Green Published			2022-12-25	WOS:000309554700013
J	Daghino, S; Murat, C; Sizzano, E; Girlanda, M; Perotto, S				Daghino, Stefania; Murat, Claude; Sizzano, Elisa; Girlanda, Mariangela; Perotto, Silvia			Fungal Diversity Is Not Determined by Mineral and Chemical Differences in Serpentine Substrates	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; GENETIC DIVERSITY; BACTERIAL COMMUNITIES; CENOCOCCUM-GEOPHILUM; SOILS; ECTOMYCORRHIZAL; IDENTIFICATION; ASBESTOS; REVEAL; PLANT	The physico-chemical properties of serpentine soils lead to strong selection of plant species. Whereas many studies have described the serpentine flora, little information is available on the fungal communities dwelling in these sites. Asbestos minerals, often associated with serpentine rocks, can be weathered by serpentine-isolated fungi, suggesting an adaptation to this substrate. In this study, we have investigated whether serpentine substrates characterized by the presence of rocks with distinct mineral composition could select for different fungal communities. Both fungal isolation and 454 pyrosequencing of amplicons obtained from serpentine samples following direct DNA extraction revealed some fungal taxa shared by the four ophiolitic substrates, but also highlighted several substrate-specific taxa. Bootstrap analysis of 454 OTU abundances indicated weak clustering of fungal assemblages from the different substrates, which did not match substrate classification based on exchangeable macronutrients and metals. Intra-substrate variability, as assessed by DGGE profiles, was similar across the four serpentine substrates, and comparable to inter-substrate variability. These findings indicate the absence of a correlation between the substrate ( mineral composition and available cations) and the diversity of the fungal community. Comparison of culture-based and culture-independent methods supports the higher taxonomic precision of the former, as complementation of the better performance of the latter.	[Daghino, Stefania; Sizzano, Elisa; Girlanda, Mariangela; Perotto, Silvia] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Daghino, Stefania; Perotto, Silvia] Univ Turin, Interdept Ctr G Scansetti Studies Asbestos & Othe, Turin, Italy; [Murat, Claude] Lorraine Univ Interact Arbres Microorganismes, Inst Natl Rech Agron, Unite Mixte Rech, Ctr Nancy, Champenoux, France	University of Turin; University of Turin; INRAE	Daghino, S (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	stefania.daghino@unito.it	Murat, Claude/AAA-5226-2020; Daghino, Stefania/AAO-7718-2021	Murat, Claude/0000-0003-0685-7307; PEROTTO, Silvia/0000-0003-0121-1806; DAGHINO, Stefania/0000-0001-5722-1558	Regione Piemonte; University of Torino; Fondazione San Paolo	Regione Piemonte(Regione Piemonte); University of Torino; Fondazione San Paolo(Compagnia di San Paolo)	Dr. Daghino was supported by a fellowship from Regione Piemonte. Local funding by the University of Torino and Fondazione San Paolo is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; [Anonymous], 2006, RENDICONTI SOC GEOL; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Branco S, 2010, MOL ECOL, V19, P5566, DOI 10.1111/j.1365-294X.2010.04913.x; Branco S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011757; Brooks R. R., 1987, SERPENTINE ITS VEGET; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burford Euan P., 2003, Mycologist, V17, P98, DOI 10.1017/S0269915X03003112; COMPAGNONI R, 1985, AM MINERAL, V70, P767; Daghino S, 2008, FEMS MICROBIOL LETT, V285, P242, DOI 10.1111/j.1574-6968.2008.01239.x; Daghino S, 2009, FEMS MICROBIOL ECOL, V69, P132, DOI 10.1111/j.1574-6941.2009.00695.x; DeGrood SH, 2005, SOIL BIOL BIOCHEM, V37, P1427, DOI 10.1016/j.soilbio.2004.12.013; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Escarre J, 2000, NEW PHYTOL, V145, P429, DOI 10.1046/j.1469-8137.2000.00599.x; Favero-Longo SE, 2006, PLANT BIOSYST, V140, P190, DOI 10.1080/11263500600756546; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Fornero E, 2009, SCI TOTAL ENVIRON, V407, P1010, DOI 10.1016/j.scitotenv.2008.10.021; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gladish S, 2010, CAN J FOREST RES, V40, P1671, DOI 10.1139/X10-092; Goncalves SC, 2007, MYCORRHIZA, V17, P677, DOI 10.1007/s00572-007-0145-2; Goncalves SC, 2009, MYCORRHIZA, V19, P221, DOI 10.1007/s00572-008-0211-4; Groppo C, 2005, J TOXICOL ENV HEAL A, V68, P1, DOI 10.1080/15287390590523867; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones J.B., 2001, LAB GUIDE CONDUCTING, DOI [DOI 10.1201/9781420025293, 10.1201/9781420025293]; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lazarus BE, 2011, PLANT SOIL, V342, P327, DOI 10.1007/s11104-010-0698-2; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mengoni A, 2004, MICROB ECOL, V48, P209, DOI 10.1007/s00248-003-0149-1; Moser AM, 2009, PLANT SOIL, V315, P185, DOI 10.1007/s11104-008-9743-9; Motta R, 2001, J VEG SCI, V12, P219, DOI 10.2307/3236606; Murat C, 2005, FEMS MICROBIOL LETT, V245, P307, DOI 10.1016/j.femsle.2005.03.019; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oline DK, 2006, APPL ENVIRON MICROB, V72, P6965, DOI 10.1128/AEM.00690-06; Podani J., 2001, SYNTAX 2000 COMPUTER; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rajakaruna N., 2008, GEN ECOLOGY ENCY ECO, V2nd, P1201; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Roccotiello E, 2010, FRESEN ENVIRON BULL, V19, P2420; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schipper LA, 2004, PLANT SOIL, V262, P151, DOI 10.1023/B:PLSO.0000037027.56794.08; Simonovicova A, 2004, INT BIODETER BIODEGR, V54, P7, DOI 10.1016/j.ibiod.2003.11.004; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Suihko ML, 2007, SYST APPL MICROBIOL, V30, P494, DOI 10.1016/j.syapm.2007.05.001; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; White T., 1990, PCR PROTOCOLS GUIDE, P315	65	20	21	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44233	10.1371/journal.pone.0044233	http://dx.doi.org/10.1371/journal.pone.0044233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028507	Green Published, gold			2022-12-25	WOS:000309388900008
J	Ben-Tzvi, O; Abelson, A; Gaines, SD; Bernardi, G; Beldade, R; Sheehy, MS; Paradis, GL; Kiflawi, M				Ben-Tzvi, Ofer; Abelson, Avigdor; Gaines, Steven D.; Bernardi, Giacomo; Beldade, Ricardo; Sheehy, Michael S.; Paradis, Georges L.; Kiflawi, Moshe			Evidence for Cohesive Dispersal in the Sea	PLOS ONE			English	Article							CORAL-REEF FISHES; GREAT-BARRIER-REEF; POPULATION CONNECTIVITY; ELEMENTAL SIGNATURES; MARINE POPULATIONS; SWIMMING ABILITIES; DEMERSAL FISHES; PELAGIC LARVAE; OTOLITHS; RECRUITMENT	As with many marine species, the vast majority of coral-reef fishes have a bipartite life cycle consisting of a dispersive larval stage and a benthic adult stage. While the potentially far-reaching demographic and ecological consequences of marine dispersal are widely appreciated, little is known of the structure of the larval pool and of the dispersive process itself. Utilizing Palindrome Sequence Analysis of otolith micro-chemistry (PaSA;) we show that larvae of Neopomacentrus miryae (Pomacentridae) appear to remain in cohesive cohorts throughout their entire pelagic larval duration (PLD; similar to 28 days). Genetically, we found cohort members to be maternally (mtDNA) unrelated. While physical forcing cannot be negated as contributing to initial cohort formation, the small scale of the observed spatial structure suggests that some behavioral modification may be involved from a very early age. This study contributes to our ongoing re-evaluation of the processes that structure marine populations and communities and the spatial scales at which they operate.	[Ben-Tzvi, Ofer; Kiflawi, Moshe] Interuniv Inst Marine Sci Eilat, Elat, Israel; [Ben-Tzvi, Ofer; Abelson, Avigdor] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Gaines, Steven D.; Sheehy, Michael S.; Paradis, Georges L.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Bernardi, Giacomo; Beldade, Ricardo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Paradis, Georges L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Kiflawi, Moshe] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Tel Aviv University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; University of California System; University of California Santa Barbara; Ben Gurion University	Ben-Tzvi, O (corresponding author), Interuniv Inst Marine Sci Eilat, Elat, Israel.	obentzvi@gmail.com	Beldade, Ricardo/B-3724-2012; Gaines, Steven/Y-3234-2019; KIFLAWI, MOSHE/AAH-7991-2021; Bernardi, Giacomo/F-6346-2011	Beldade, Ricardo/0000-0003-1911-0122; Bernardi, Giacomo/0000-0002-8249-4678; Kiflawi, Moshe/0000-0002-9705-6486	Israel Science Foundation [283/06]; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; US-Israel Bi-National Science Foundation (BSF); The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development; Middle Eastern Regional Cooperation (USAID-MERC); A. W. Mellon Foundation; Boxenbaum-Neta Foundation	Israel Science Foundation(Israel Science Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US-Israel Bi-National Science Foundation (BSF)(US-Israel Binational Science Foundation); The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development; Middle Eastern Regional Cooperation (USAID-MERC)(United States Agency for International Development (USAID)); A. W. Mellon Foundation; Boxenbaum-Neta Foundation	US-Israel Bi-National Science Foundation (BSF) URL: http://www.bsf. org.il/ BSFPublic/Default.aspx The Red Sea Marine Peace Park (RSMPP) program of the US agency for international development URL: http://ww w.mfa.gov.il/MFA/Archive/Communiques/1997/BINATIONAL%20RED%20SEA%20MARINE%20PEACE%20PARK%20-% 20Oct-97 Middle Eastern Regional Cooperation (USAID-MERC) URL:http://www.usaid.go v/our_work/merc/program_description.html. Boxenbaum-Neta Foundation URL (Hebrew): http://www.aev.co.il/default.asp?catid = %7B80DE5766-C4B6-4705-A1AA-CCBBA6CEC902%7D. Israel Science Foundation grant 283/06 URL: http://www.isf.org.il/. A. W. Mellon Foundation URL: http://www.mellon.org/.PISCO, the Partnership for Interdisciplinary Studies of Coastal Oceans, funded by the David and Lucille Packard and the Gordon and Betty Moore Foundations. URL: http://www.piscoweb.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Ben-Tzvi O, 2008, MAR ECOL PROG SER, V359, P229, DOI 10.3354/meps07343; Ben-Tzvi O, 2007, LIMNOL OCEANOGR-METH, V5, P97, DOI 10.4319/lom.2007.5.97; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1995, MAR ECOL PROG SER, V122, P115, DOI 10.3354/meps122115; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; GAINES SD, 1992, NATURE, V360, P579, DOI 10.1038/360579a0; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; JAN RQ, 1992, B I ZOOL ACAD SINICA, V31, P231; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; LEE WJ, 1995, J MOL EVOL, V41, P54; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Leis JM, 1997, MAR ECOL PROG SER, V159, P165, DOI 10.3354/meps159165; Leis JM, 2004, MAR FRESHW BEHAV PHY, V37, P65, DOI 10.1080/10236240410001705761; Leis JM, 1998, ENVIRON BIOL FISH, V53, P259, DOI 10.1023/A:1007424719764; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Patterson HM, 2004, MAR ECOL PROG SER, V270, P229, DOI 10.3354/meps270229; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thorrold Simon R., 2002, P243, DOI 10.1016/B978-012615185-5/50015-3; Thorrold SR, 2007, OCEANOGRAPHY, V20, P80, DOI 10.5670/oceanog.2007.31; Warner RR, 2005, LIMNOL OCEANOGR, V50, P1529, DOI 10.4319/lo.2005.50.5.1529	35	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e42672	10.1371/journal.pone.0042672	http://dx.doi.org/10.1371/journal.pone.0042672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028433	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900002
J	Zhao, DH; Jiang, H; Cai, Y; An, SQ				Zhao, Dehua; Jiang, Hao; Cai, Ying; An, Shuqing			Artificial Regulation of Water Level and Its Effect on Aquatic Macrophyte Distribution in Taihu Lake	PLOS ONE			English	Article							VEGETATION; SHALLOW; IMAGERY; FLUCTUATIONS; EXPANSION; WETLANDS; TREE; BAY	Management of water levels for flood control, water quality, and water safety purposes has become a priority for many lakes worldwide. However, the effects of water level management on the distribution and composition of aquatic vegetation has received little attention. Relevant studies have used either limited short-term or discrete long-term data and thus are either narrowly applicable or easily confounded by the effects of other environmental factors. We developed classification tree models using ground surveys combined with 52 remotely sensed images (15-30 m resolution) to map the distributions of two groups of aquatic vegetation in Taihu Lake, China from 1989-2010. Type 1 vegetation included emergent, floating, and floating-leaf plants, whereas Type 2 consisted of submerged vegetation. We sought to identify both inter-and intra-annual dynamics of water level and corresponding dynamics in the aquatic vegetation. Water levels in the ten-year period from 2000-2010 were 0.06-0.21 m lower from July to September (wet season) and 0.22-0.27 m higher from December to March (dry season) than in the 1989-1999 period. Average intra-annual variation (CVa) decreased from 10.21% in 1989-1999 to 5.41% in 2000-2010. The areas of both Type 1 and Type 2 vegetation increased substantially in 2000-2010 relative to 1989-1999. Neither annual average water level nor CVa influenced aquatic vegetation area, but water level from January to March had significant positive and negative correlations, respectively, with areas of Type 1 and Type 2 vegetation. Our findings revealed problems with the current management of water levels in Taihu Lake. To restore Taihu Lake to its original state of submerged vegetation dominance, water levels in the dry season should be lowered to better approximate natural conditions and reinstate the high variability (i.e., greater extremes) that was present historically.	[Zhao, Dehua; Jiang, Hao; Cai, Ying; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; State Key Development Program for Basic Research of China [2008CB418004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was financially supported by the National Natural Science Foundation of China (No. 31000226)(http://www.nsfc.gov.cn) and the State Key Development Program for Basic Research of China (2008CB418004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2009, LECT CHINAS ENV YALE; Bain MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003806; Baker C, 2006, WETLANDS, V26, P465, DOI 10.1672/0277-5212(2006)26[465:MWARAU]2.0.CO;2; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Coops H, 2004, LIMNOLOGICA, V34, P57, DOI 10.1016/S0075-9511(04)80022-7; Davranche A, 2010, REMOTE SENS ENVIRON, V114, P552, DOI 10.1016/j.rse.2009.10.009; de Colstoun ECB, 2003, REMOTE SENS ENVIRON, V85, P316, DOI 10.1016/S0034-4257(03)00010-5; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; [谷孝鸿 Gu Xiaohong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1541; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Havens KE, 2003, HYDROBIOLOGIA, V493, P173, DOI 10.1023/A:1025497621547; He Jun, 2008, Hupo Kexue, V20, P790; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jin Xiangcan, 2007, Hupo Kexue, V19, P151; Kloiber SM, 2002, WATER RES, V36, P4330, DOI 10.1016/S0043-1354(02)00146-X; Li EH, 2010, ECOL ENG, V36, P427, DOI 10.1016/j.ecoleng.2009.11.009; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; Liira J, 2010, AQUAT BOT, V93, P207, DOI 10.1016/j.aquabot.2010.08.001; [刘伟龙 LIU Weilong], 2007, [生态环境, Ecology and Environment], V16, P363; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; Lorenz AW, 2012, J APPL ECOL, V49, P202, DOI 10.1111/j.1365-2664.2011.02082.x; Lu Na, 2009, Huanjing Kexue, V30, P2898; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; Michelan TS, 2010, FRESHWATER BIOL, V55, P1315, DOI 10.1111/j.1365-2427.2009.02355.x; Midwood JD, 2010, WETLANDS, V30, P1141, DOI 10.1007/s13157-010-0105-z; O'Farrell I, 2011, AQUAT SCI, V73, P275, DOI 10.1007/s00027-010-0175-2; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Ot'ahel'ova H, 2011, LIMNOLOGICA, V41, P316, DOI 10.1016/j.limno.2011.01.005; Ozesmi Stacy L., 2002, Wetlands Ecology and Management, V10, P381, DOI 10.1023/A:1020908432489; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Paillisson JM, 2006, AQUAT BOT, V84, P259, DOI 10.1016/j.aquabot.2005.10.004; Pan G, 2011, ECOL ENG, V37, P302, DOI 10.1016/j.ecoleng.2010.11.019; Qin BQ, 2009, ECOL ENG, V35, P1569, DOI 10.1016/j.ecoleng.2009.04.003; Qin Boqiang, 2009, Hupo Kexue, V21, P445; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Squires MM, 2002, FRESHWATER BIOL, V47, P2123, DOI 10.1046/j.1365-2427.2002.00959.x; Szabo S, 2010, FRESHWATER BIOL, V55, P681, DOI 10.1111/j.1365-2427.2009.02308.x; Tuckett RE, 2010, FRESHWATER BIOL, V55, P1118, DOI 10.1111/j.1365-2427.2010.02386.x; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Van Geest GJ, 2005, HYDROBIOLOGIA, V539, P239, DOI 10.1007/s10750-004-4879-y; Van Geest GJ, 2005, J APPL ECOL, V42, P251, DOI 10.1111/j.1365-2664.2005.00995.x; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Wei AH, 2007, FISHERIES, V32, P167, DOI 10.1577/1548-8446(2007)32[167:UOIITM]2.0.CO;2; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; [杨英宝 Yang Yingbao], 2005, [湖泊科学, Scientia Limnologica Sinica], V17, P133; Zhang SY, 2010, ECOL ENG, V36, P1611, DOI 10.1016/j.ecoleng.2010.05.006; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Zhao DH, 2012, J ENVIRON MANAGE, V95, P98, DOI 10.1016/j.jenvman.2011.10.007; Zhao DH, 2011, ADV WATER RESOUR, V34, P165, DOI 10.1016/j.advwatres.2010.08.010; Zhu Guangwei, 2008, Hupo Kexue, V20, P21	60	31	34	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44836	10.1371/journal.pone.0044836	http://dx.doi.org/10.1371/journal.pone.0044836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028639	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900046
J	Fasanaro, P; Romani, S; Voellenkle, C; Maimone, B; Capogrossi, MC; Martelli, F				Fasanaro, Pasquale; Romani, Sveva; Voellenkle, Christine; Maimone, Biagina; Capogrossi, Maurizio C.; Martelli, Fabio			ROD1 Is a Seedless Target Gene of Hypoxia-Induced miR-210	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MICRORNA; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; RECOGNITION; REGULATOR; SURVIVAL; BINDING; SITES	Most metazoan microRNA (miRNA) target sites have perfect pairing to the "seed" sequence, a highly conserved region centering on miRNA nucleotides 2-7. Thus, complementarity to this region is a necessary requirement for target prediction algorithms. However, also non-canonical miRNA binding can confer target regulation. Here, we identified a seedless target of miR-210, a master miRNA of the hypoxic response. We analyzed 20 genes that were inversely correlated to miR-210 expression and did not display any complementarity with miR-210 seed sequence. We validated ROD1 (Regulator of Differentiation 1, also named PTBP3, Polypyrimidine Tract Binding protein 3) as a miR-210 seedless transcript enriched in miR-210-containing RNA-induced silencing complexes. ROD1 was not indirectly targeted by a miR-210-induced miRNA. Conversely, we identified a "centered" miR-210 binding site in ROD1 involving 10 consecutive bases in the central portion of miR-210. Reporter assays showed that miR-210 inhibited ROD1 by the direct binding to this sequence, demonstrating that ROD1 is a bona fide seedless target of miR-210. As expected, both ROD1 mRNA and protein were down-modulated upon hypoxia in a miR-210 dependent manner. ROD1 targeting by miR-210 was biologically significant: the rescue of ROD1 inhibition significantly increased hypoxia-induced cell death. These data highlight the importance of ROD1 regulation by miR-210 for cell homeostasis.	[Fasanaro, Pasquale; Maimone, Biagina; Capogrossi, Maurizio C.] Ist Dermopat Immacolata IRCCS, Rome, Italy; [Romani, Sveva] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Voellenkle, Christine; Martelli, Fabio] IRCCS Policlin San Donato, Milan, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Casa Sollievo Della Sofferenza; IRCCS Policlinico San Donato	Fasanaro, P (corresponding author), Ist Dermopat Immacolata IRCCS, Rome, Italy.	fabio.martelli@grupposandonato.it	Voellenkle, Christine/AAD-3092-2021; Martelli, Fabio/AAL-3788-2020; Voellenkle, Christine/J-8144-2016	Martelli, Fabio/0000-0002-8624-7738; Voellenkle, Christine/0000-0003-0824-060X	Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro [AIRC IG-11436]	Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was partly supported by Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro (AIRC IG-11436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Elefant N, 2011, BIOINFORMATICS, V27, P3093, DOI 10.1093/bioinformatics/btr534; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Sadvakassova G, 2009, J CELL PHYSIOL, V220, P672, DOI 10.1002/jcp.21817; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	31	30	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44651	10.1371/journal.pone.0044651	http://dx.doi.org/10.1371/journal.pone.0044651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024754	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100012
J	Shipman, M; Lubick, K; Fouchard, D; Guram, R; Grieco, P; Jutila, M; Dratz, EA				Shipman, Matt; Lubick, Kirk; Fouchard, David; Guram, Rajani; Grieco, Paul; Jutila, Mark; Dratz, Edward A.			Proteomic and Systems Biology Analysis of Monocytes Exposed to Securinine, a GABA(A) Receptor Antagonist and Immune Adjuvant	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ACID-BINDING PROTEINS; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; COXIELLA-BURNETII; L-PLASTIN; DENDRITIC CELLS; CHOLESTEROL-METABOLISM; THIOREDOXIN REDUCTASE; IDENTIFICATION DATA	Securinine, a GABA(A) receptor antagonist, has been reported to enhance monocyte cell killing of Coxiella burnetii without obvious adverse effects in vivo. We employed multiplex 2D gel electrophoresis using Zdyes, a new generation of covalently linked fluorescent differential protein detection dyes to analyze changes in the monocyte proteome in response to Securinine. Securinine antagonism of GABA(A) receptors triggers the activation of p38. We used the differential protein expression results to guide a search of the literature and network analysis software to construct a systems biology model of the effect of Securinine on monocytes. The model suggests that various metabolic modulators (fatty acid binding protein 5, inosine 5'-monophosphate dehydrogenase, and thioredoxin) are at least partially reshaping the metabolic landscape within the monocytes. The actin bundling protein L-plastin, and the Ca2+ binding protein S100A4 also appear to have important roles in the immune response stimulated by Securinine. Fatty acid binding protein 5 (FABP5) may be involved in effecting lipid raft composition, inflammation, and hormonal regulation of monocytes, and the model suggests that FABP5 may be a central regulator of metabolism in activated monocytes. The model also suggests that the heat shock proteins have a significant impact on the monocyte immune response. The model provides a framework to guide future investigations into the mechanisms of Securinine action and with elaboration may help guide development of new types of immune adjuvants.	[Shipman, Matt; Fouchard, David; Guram, Rajani; Grieco, Paul; Dratz, Edward A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Lubick, Kirk; Jutila, Mark] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Shipman, M (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	mshipman@chemistry.montana.edu			Department of Defense grant [W81XWH-07-2-0048]; National Institutes of Health (NIH) Cobre grant [1P20RR024237]; NIH grant [2R42RR021790A1]; Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237] Funding Source: NIH RePORTER	Department of Defense grant(United States Department of Defense); National Institutes of Health (NIH) Cobre grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Department of Defense grant #W81XWH-07-2-0048; National Institutes of Health (NIH) Cobre grant #1P20RR024237; NIH grant #2R42RR021790A1; and the Murdock Charitable Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arthur JC, 2007, J IMMUNOL, V179, P6291, DOI 10.4049/jimmunol.179.9.6291; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Ausiello CM, 2006, MICROBES INFECT, V8, P714, DOI 10.1016/j.micinf.2005.09.007; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Barry R, 2003, PROTEOMIC ANAL SULFO; Barry RC, 2006, ELECTROPHORESIS, V27, P2970, DOI 10.1002/elps.200500851; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Bishop SC, 2007, CURR CANCER DRUG TAR, V7, P369, DOI 10.2174/156800907780809778; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Boye K, 2008, INT J CANCER, V123, P1301, DOI 10.1002/ijc.23617; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chavez-Salinas S, 2008, VIRUS RES, V138, P111, DOI 10.1016/j.virusres.2008.08.012; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Cui JF, 2006, PROTEOMICS, V6, P5953, DOI 10.1002/pmic.200500460; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Daxecker H, 2002, CLIN CHIM ACTA, V318, P71, DOI 10.1016/S0009-8981(01)00801-4; DAYTON JS, 1994, J IMMUNOL, V152, P984; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dratz EA, 2009, USA patent 9/1/2009, Patent No. [#7,582,260, 7582260]; Dratz EA, 2008, Novel Optical Labeling Molecules for Proteomics and Other Biological Analyses, Patent No. [PCT application US2008/059963, 2008059963]; Dratz EA, 2010, Novel Zwitterionic Fluorescent Dyes for Labeling in Proteomic and Other Biological Analyses. Methods Claims, Patent No. [USA patent issued, Number 7,833,799, 7833799]; Dukhanina EA, 2008, B EXP BIOL MED+, V145, P78, DOI 10.1007/s10517-008-0003-z; El Mezayen R, 2007, IMMUNOL LETT, V111, P36, DOI 10.1016/j.imlet.2007.04.011; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fenyo D, 2007, J PROTEOME RES, V6, P1997, DOI 10.1021/pr070025y; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; GORG A, 1998, 2 DIMENSIONAL ELECTR; Han J, 2004, J PROTEOME RES, V3, P807, DOI 10.1021/pr049945w; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hofmeister-Mueller V, 2009, CANCER IMMUNOL IMMUN, V58, P1265, DOI 10.1007/s00262-008-0640-0; Howe D, 2006, CELL MICROBIOL, V8, P496, DOI 10.1111/j.1462-5822.2005.00641.x; Howe D, 2005, ANN NY ACAD SCI, V1063, P123, DOI 10.1196/annals.1355.020; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jonsson CA, 2002, CELL IMMUNOL, V216, P93, DOI 10.1016/S0008-8749(02)00502-6; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Liu FZ, 2004, BIOSCI BIOTECH BIOCH, V68, P894, DOI 10.1271/bbb.68.894; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Moosavi MA, 2005, INT J BIOCHEM CELL B, V37, P2366, DOI 10.1016/j.biocel.2005.04.020; Oshizawa T, 2003, J BIOCHEM, V134, P827, DOI 10.1093/jb/mvg208; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Pabst MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-13; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i; Pereira SR, 2005, PROTEOMICS, V5, P1186, DOI 10.1002/pmic.200400988; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rajagopal D, 2006, EUR J IMMUNOL, V36, P828, DOI 10.1002/eji.200535326; Rana S, 2010, FASEB J, V24, P2126, DOI 10.1096/fj.09-148999; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Saba JA, 2007, J PROTEOME RES, V6, P2211, DOI 10.1021/pr070031u; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Samoilis G, 2007, J PROTEOME RES, V6, P3032, DOI 10.1021/pr070077n; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shui H, 2009, MOL BIOL REPORTS; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tarabykina S, 2007, CURR CANCER DRUG TAR, V7, P217, DOI 10.2174/156800907780618329; Tseng M-Y, 2009, ORAL ONCOLOGY; Wabnitz GH, 2007, EUR J IMMUNOL, V37, P649, DOI 10.1002/eji.200636320; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wang Y, 2005, J IMMUNOL, V174, P3306, DOI 10.4049/jimmunol.174.6.3306; Williams CH, 2000, EUR J BIOCHEM, V267, P6101, DOI 10.1046/j.1432-1327.2000.01700.x; Woods DE, 2005, PEDIATR PULM, V39, P141, DOI 10.1002/ppul.20167; Yasumatsu R, 2006, AM J PHYSIOL-LUNG C, V291, pL619, DOI 10.1152/ajplung.00507.2005; Zeng WL, 2000, J CELL BIOCHEM, V78, P519, DOI 10.1002/1097-4644(20000915)78:4<519::AID-JCB1>3.0.CO;2-V; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	106	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41278	10.1371/journal.pone.0041278	http://dx.doi.org/10.1371/journal.pone.0041278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028424	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700002
J	Ramachandran, PL; Craig, TA; Atanasova, EA; Cui, GF; Owen, BA; Bergen, HR; Mer, G; Kumar, R				Ramachandran, Pradeep L.; Craig, Theodore A.; Atanasova, Elena A.; Cui, Gaofeng; Owen, Barbara A.; Bergen, H. Robert, III; Mer, Georges; Kumar, Rajiv			The Potassium Channel Interacting Protein 3 (DREAM/KChIP3) Heterodimerizes with and Regulates Calmodulin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; DNA-BINDING; DREAM; CALSENILIN; CALCINEURIN; CALSENILIN/DREAM/KCHIP3; MODULATION; FRAGMENT; SUBUNIT; MICE	Downstream regulatory element antagonistic modulator (DREAM/KChIP3), a neuronal EF-hand protein, modulates pain, potassium channel activity, and binds presenilin 1. Using affinity capture of neuronal proteins by immobilized DREAM/KChIP3 in the presence and absence of calcium (Ca2+) followed by mass spectroscopic identification of interacting proteins, we demonstrate that in the presence of Ca2+, DREAM/KChIP3 interacts with the EF-hand protein, calmodulin (CaM). The interaction of DREAM/KChIP3 with CaM does not occur in the absence of Ca2+. In the absence of Ca2+, DREAM/KChIP3 binds the EF-hand protein, calcineurin subunit-B. Ca2+-bound DREAM/KChIP3 binds CaM with a dissociation constant of similar to 3 mu M as assessed by changes in DREAM/KChIP3 intrinsic protein fluorescence in the presence of CaM. Two-dimensional H-1,N-15 heteronuclear single quantum coherence spectra reveal changes in chemical shifts and line broadening upon the addition of CaM to N-15 DREAM/KChIP3. The amino-terminal portion of DREAM/KChIP3 is required for its binding to CaM because a construct of DREAM/KChIP3 lacking the first 94 amino-terminal residues fails to bind CaM as assessed by fluorescence spectroscopy. The addition of Ca2+-bound DREAM/KChIP3 increases the activation of calcineurin (CN) by calcium CaM. A DREAM/KChIP3 mutant incapable of binding Ca2+ also stimulates calmodulin-dependent CN activity. The shortened form of DREAM/KChIP3 lacking the NH2-terminal amino acids fails to activate CN in the presence of calcium CaM. Our data demonstrate the interaction of DREAM/KChIP3 with the important EF-hand protein, CaM, and show that the interaction alters CN activity.	[Ramachandran, Pradeep L.; Craig, Theodore A.; Kumar, Rajiv] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Ramachandran, Pradeep L.; Craig, Theodore A.; Kumar, Rajiv] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Atanasova, Elena A.; Cui, Gaofeng; Owen, Barbara A.; Bergen, H. Robert, III; Mer, Georges; Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Owen, Barbara A.] Mayo Clin, Div Surg Res, Rochester, MN 55905 USA; [Bergen, H. Robert, III] Mayo Clin, Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kumar, R (corresponding author), Mayo Clin, Div Nephrol & Hypertens, MS 1-120,200 1st St SW, Rochester, MN 55905 USA.	rkumar@mayo.edu	Mer, Georges/AAT-4946-2021; Cui, Gaofeng/A-1107-2013	Mer, Georges/0000-0002-1900-1578; Cui, Gaofeng/0000-0001-5267-9033; Kumar, Rajiv/0000-0003-3497-3057	National Institutes of Health [AR-058003, AR-60869]; Marion and Ralph Falk Medical Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060869, R21AR058003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marion and Ralph Falk Medical Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-058003 and AR-60869. This work was also supported by a grant from the Marion and Ralph Falk Medical Trust.	Alexander JC, 2009, LEARN MEMORY, V16, P167, DOI 10.1101/lm.1261709; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Frost RJA, 2010, CELL METAB, V12, P205, DOI 10.1016/j.cmet.2010.08.007; Hammond PI, 2003, MOL BRAIN RES, V111, P104, DOI 10.1016/S0169-328X(02)00693-9; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Juranic N, 2007, PROTEIN SCI, V16, P1329, DOI 10.1110/ps.062689807; Kakihana K, 2012, BONE MARROW TRANSPL, V47, P593, DOI 10.1038/bmt.2011.120; Kretsinger RH, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2012.00041; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rivas M, 2011, SCI CHINA LIFE SCI, V54, P786, DOI 10.1007/s11427-011-4196-4; Rivas M, 2011, ANTIOXID REDOX SIGN, V14, P1237, DOI 10.1089/ars.2010.3385; Sato Y, 2007, ANESTH ANALG, V105, P1489, DOI 10.1213/01.ane.0000286173.60987.72; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.398495	http://dx.doi.org/10.1074/jbc.M112.398495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019329	Green Published, hybrid			2022-12-25	WOS:000311233800016
J	Zhu, L; Wang, LD; Luo, XL; Zhang, YX; Ding, QR; Jiang, XM; Wang, X; Pan, Y; Chen, Y				Zhu, Lu; Wang, Lingdi; Luo, Xiaolin; Zhang, Yongxian; Ding, Qiurong; Jiang, Xiaomeng; Wang, Xiao; Pan, Yi; Chen, Yan			Tollip, an Intracellular Trafficking Protein, Is a Novel Modulator of the Transforming Growth Factor-beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1 RECEPTOR; KAPPA-B; TGF; UBIQUITIN; INTERLEUKIN-1; SMAD7; ACTIVATION; COMPLEX; DOMAIN; LIPOPOLYSACCHARIDE	Upon activation, TGF-beta type I receptor (T beta RI) undergoes active ubiquitination via recruitment of E3 ligases to the receptor complex by Smad7. However, how ubiquitination of T beta RI is coupled to intracellular trafficking, and protein degradation remains unclear. We report here that Tollip, an adaptor protein that contains both ubiquitin-associated domains and endosome-targeting domain, plays an important role in modulating trafficking and degradation of T beta RI. Tollip was previously demonstrated to possess a functional role in modulating the signaling of interleukin-1 and Toll-like receptors. We identify here that Tollip interacts with Smad7, a major modulatory protein involved in the negative regulation of TGF-beta signaling. Overexpression of Tollip antagonizes TGF-beta-stimulated transcriptional response, Smad2 phosphorylation, and epithelial-mesenchymal transition. Tollip also interacts with ubiquitinated T beta RI, and such interaction requires ubiquitin-associated domains of Tollip. The interaction and intracellular colocalization of Tollip with T beta RI is enhanced by Smad7. Overexpression of Tollip accelerates protein degradation of activated T beta RI. In addition, Tollip alters subcellular compartmentalization and endosomal trafficking of activated T beta RI. Collectively, our studies reveal that Tollip cooperates with Smad7 to modulate intracellular trafficking and degradation of ubiquitinated T beta RI, whereby negatively regulates TGF-beta signaling pathway.	[Zhu, Lu; Wang, Lingdi; Luo, Xiaolin; Zhang, Yongxian; Ding, Qiurong; Jiang, Xiaomeng; Wang, Xiao; Pan, Yi; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014; Zhu, Lu/N-1073-2017	Luo, Xiaolin/0000-0003-3215-8112; Zhu, Lu/0000-0003-2716-4649	National Natural Science Foundation of China [30830037, 81021002, 81130077, 30971660]; Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; Chinese Academy of Sciences [KSCX2-EW-R-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by research grants from National Natural Science Foundation of China (30830037, 81021002, and 81130077 (to Y. C.) and 30971660 (to Y. P.)), Ministry of Science and Technology of China (2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.)), and Chinese Academy of Sciences (KSCX2-EW-R-08 (to Y. C.)).	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270	33	57	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.388009	http://dx.doi.org/10.1074/jbc.M112.388009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027871	Green Published, hybrid			2022-12-25	WOS:000311233800035
J	Farizano, JV; Pescaretti, MD; Lopez, FE; Hsu, FF; Delgado, MA				Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Hsu, Fong-Fu; Delgado, Monica A.			The PmrAB System-inducing Conditions Control Both Lipid A Remodeling and O-antigen Length Distribution, Influencing the Salmonella Typhimurium-Host Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; 2-COMPONENT REGULATORY SYSTEMS; POLYMYXIN-RESISTANT MUTANTS; ESCHERICHIA-COLI; CHAIN-LENGTH; SIGNAL-TRANSDUCTION; PHOSPHOETHANOLAMINE MODIFICATION; ANTIMICROBIAL PEPTIDES; BACTERIAL-RESISTANCE; RESPONSE REGULATOR	The Salmonella enterica serovar Typhimurium lipopolysaccharide consisting of covalently linked lipid A, non-repeating core oligosaccharide, and the O-antigen polysaccharide is the most exposed component of the cell envelope. Previous studies demonstrated that all of these regions act against the host immunity barrier. The aim of this study was to define the role and interaction of PmrAB-dependent gene products required for the lipopolysaccharide component synthesis or modification mainly during the Salmonella infection. The PmrAB two-component system activation promotes a remodeling of lipid A and the core region by addition of 4-aminoarabinose and/or phosphoethanolamine. These PmrA-dependent activities are produced by activation of ugd, pbgPE, pmrC, cpta, and pmrG transcription. In addition, under PmrA regulator activation, the expression of wzz(fepE) and wzz(st) genes is induced, and their products are required to determine the O-antigen chain length. Here we report for the first time that Wzz(st) protein is necessary to maintain the balance of 4-aminoarabinose and phosphoethanolamine lipid A modifications. Moreover, we demonstrate that the interaction of the PmrA-dependent pbgE(2) and pbgE(3) gene products is important for the formation of the short O-antigen region. Our results establish that PmrAB is the global regulatory system that controls lipopolysaccharide modification, leading to a coordinate regulation of 4-aminoarabinose incorporation and O-antigen chain length to respond against the host defense mechanisms.	[Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Delgado, Monica A.] Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, Inst Super Invest Biol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Delgado, Monica A.] Inst Quim Biol Dr Bernabe Bloj, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Washington University (WUSTL)	Delgado, MA (corresponding author), Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, Inst Super Invest Biol, Chacabuco 461, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.	monicad@fbqf.unt.edu.ar	Delgado, Monica Alejandra/H-2740-2019	Delgado, Monica Alejandra/0000-0002-4283-6979; Farizano, Juan Vicente/0000-0003-0180-4927; Hsu, Fong-Fu/0000-0001-5368-0183; Pescaretti, Maria de las Mercedes/0000-0002-9299-2080	National Institutes of Health [P41-RR00954, P60-DK20579, P30-DK56341]; Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET) [PIP 2518]; Universidad Nacional de Tucuman [CIUNT 26/D439]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Tucuman; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P41-RR00954, P60-DK20579, and P30-DK56341 (to the mass spectrometry facility of Washington University). This work was also supported by Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET) Grant PIP 2518 and Universidad Nacional de Tucuman Grant CIUNT 26/D439.	Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Bishop RE, 2004, J ENDOTOXIN RES, V10, P107, DOI 10.1179/096805104225004004; BRADE H, 1999, ENDOTOXIN HLTH DIS, P31; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Burns SM, 1998, INFECT IMMUN, V66, P4244; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; DASGUPTA T, 1994, INFECT IMMUN, V62, P809, DOI 10.1128/IAI.62.3.809-817.1994; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Joiner K A, 1985, Curr Top Microbiol Immunol, V121, P99; JOINER KA, 1982, J EXP MED, V155, P797, DOI 10.1084/jem.155.3.797; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kawasaki K, 2005, J ENDOTOXIN RES, V11, P57, DOI 10.1179/096805105225006696; Kawasaki K, 2004, J ENDOTOXIN RES, V10, P439, DOI 10.1179/096805104225006264; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Miller J.H., 1972, EXPT MOL GENETICS; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 2002, MOL CLONING LAB MANU; SANDERSON KE, 1995, MICROBIOL REV, V59, P241, DOI 10.1128/MMBR.59.2.241-303.1995; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	60	23	24	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38778	38789		10.1074/jbc.M112.397414	http://dx.doi.org/10.1074/jbc.M112.397414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019341	Green Published, hybrid			2022-12-25	WOS:000310982800035
J	Navaratnarajah, CK; Negi, S; Braun, W; Cattaneo, R				Navaratnarajah, Chanakha K.; Negi, Surendra; Braun, Werner; Cattaneo, Roberto			Membrane Fusion Triggering THREE MODULES WITH DIFFERENT STRUCTURE AND FUNCTION IN THE UPPER HALF OF THE MEASLES VIRUS ATTACHMENT PROTEIN STALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEASLES-VIRUS HEMAGGLUTININ; PARAMYXOVIRUS FUSION; ATTACHMENT PROTEIN; CELL-FUSION; FUNCTIONAL INTERACTION; 4-HELIX BUNDLE; F-PROTEIN; RECEPTOR; STALK; REGION	The measles virus (MV) fusion apparatus consists of a fusion protein and an attachment protein named hemagglutinin (H). After receptor-binding through its cuboidal head, the H-protein transmits the fusion-triggering signal through its stalk to the fusion protein. However, the structural basis of signal transmission is unclear because only structures of H-heads without their stalk have been solved. On the other hand, the entire ectodomain structure of the hemagglutinin-neuraminidase protein of another Paramyxovirus revealed a four-helix bundle stalk. To probe the structure of the 95-residue MV H-stalk we individually substituted head-proximal residues (positions 103-153) with cysteine, and biochemically and functionally characterized the resultant proteins. Our results indicate that most residues in the central segment (positions 103-117) can be cross-linked by engineered disulfide bonds, and thus may be engaged in a tetrameric structure. While covalent tetramerization disrupts fusion triggering function, disulfide bond reduction restores it in most positions except Asp-113. The next stalk segment (residues 123-138) also has high propensity to form covalent tetramers, but since these cross-links have little or no effect on function, it can conduct the fusion-triggering signal while remaining in a stabilized tetrameric configuration. This segment may act as a spacer, maintaining H-heads at an optimal height. Finally, the head-proximal segment (residues 139-154) has very limited propensity to trap tetramers, suggesting bifurcation into two flexible linkers clamped by inter-subunit covalent links formed by natural Cys-139 and Cys-154. We discuss the modular structure of the MV H-stalk in the context of membrane fusion triggering and cell entry by Paramyxoviruses.	[Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Grad Sch, Rochester, MN 55905 USA; [Negi, Surendra; Braun, Werner] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Negi, Surendra; Braun, Werner] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cattaneo, R (corresponding author), Mayo Clin, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	cattaneo.roberto@mayo.edu	Braun, Werner/A-6642-2012; Navaratnarajah, Chanakha/AAB-6171-2019	Navaratnarajah, Chanakha/0000-0002-4513-8412	National Institutes of Health Grant [R01 CA090636]; NATIONAL CANCER INSTITUTE [R01CA090636] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA090636 (to R. C.).	Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; ALKHATIB G, 1986, VIROLOGY, V150, P479, DOI 10.1016/0042-6822(86)90312-0; [Anonymous], 2011, NATURE, V473, P434; Apte-Sengupta S, 2012, J BIOL CHEM, V287, P33026, DOI 10.1074/jbc.M112.373308; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Lamb R.A., 2007, FIELDS VIROLOGY, VFifth, P1305; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Moss WJ, 2009, CURR TOP MICROBIOL, V330, P173; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Navaratnarajah CK, 2012, CURR OPIN VIROL, V2, P43, DOI 10.1016/j.coviro.2011.12.002; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; NORRBY E, 1971, VIROLOGY, V44, P599, DOI 10.1016/0042-6822(71)90374-6; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; Plemper RK, 2001, J BIOL CHEM, V276, P44239, DOI 10.1074/jbc.M105967200; Porotto M, 2012, J VIROL, V86, P5730, DOI 10.1128/JVI.06793-11; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; RICHARDSON CD, 1983, VIROLOGY, V131, P518, DOI 10.1016/0042-6822(83)90517-2; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zokarkar A, 2012, J VIROL, V86, P2600, DOI 10.1128/JVI.06546-11	44	41	44	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38543	38551		10.1074/jbc.M112.410563	http://dx.doi.org/10.1074/jbc.M112.410563			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007387	Green Published, hybrid			2022-12-25	WOS:000310982800014
J	Fernandez-Pevida, A; Rodriguez-Galan, O; Diaz-Quintana, A; Kressler, D; de la Cruz, J				Fernandez-Pevida, Antonio; Rodriguez-Galan, Olga; Diaz-Quintana, Antonio; Kressler, Dieter; de la Cruz, Jesus			Yeast Ribosomal Protein L40 Assembles Late into Precursor 60 S Ribosomes and Is Required for Their Cytoplasmic Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; ELONGATION-FACTOR 2; EUKARYOTIC 80S RIBOSOME; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; INITIATION-FACTOR; CRYSTAL-STRUCTURE; SUBUNIT BIOGENESIS; UBIQUITIN FUSION; ADAPTER PROTEIN	Most ribosomal proteins play important roles in ribosome biogenesis and function. Here, we have examined the contribution of the essential ribosomal protein L40 in these processes in the yeast Saccharomyces cerevisiae. Deletion of either the RPL40A or RPL40B gene and in vivo depletion of L40 impair 60 S ribosomal subunit biogenesis. Polysome profile analyses reveal the accumulation of half-mers and a moderate reduction in free 60 S ribosomal subunits. Pulse-chase, Northern blotting, and primer extension analyses in the L40-depleted strain clearly indicate that L40 is not strictly required for the precursor rRNA (pre-rRNA) processing reactions but contributes to optimal 27 SB pre-rRNA maturation. Moreover, depletion of L40 hinders the nucleo-cytoplasmic export of pre-60 S ribosomal particles. Importantly, all these defects most likely appear as the direct consequence of impaired Nmd3 and Rlp24 release from cytoplasmic pre-60 S ribosomal subunits and their inefficient recycling back into the nucle(ol)us. In agreement, we show that hemagglutinin epitope-tagged L40A assembles in the cytoplasm into almost mature pre-60 S ribosomal particles. Finally, we have identified that the hemagglutinin epitope-tagged L40A confers resistance to sordarin, a translation inhibitor that impairs the function of eukaryotic elongation factor 2, whereas the rpl40a and rpl40b null mutants are hypersensitive to this antibiotic. We conclude that L40 is assembled at a very late stage into pre-60 S ribosomal subunits and that its incorporation into 60 S ribosomal subunits is a prerequisite for subunit joining and may ensure proper functioning of the translocation process.	[de la Cruz, Jesus] Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain; [Diaz-Quintana, Antonio] Univ Seville, Consejo Super Invest Cient, Inst Bioquim Vegetal & Fotosintesis, E-41092 Seville, Spain; [Kressler, Dieter] Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Fribourg	de la Cruz, J (corresponding author), Univ Seville, Fac Biol, Dept Genet, Avda Reina Mercedes 6, E-41012 Seville, Spain.	jdlcd@us.es	Rodríguez-Galán, Olga/K-5580-2015; DE LA CRUZ, JESUS/A-7309-2013; Kressler, Dieter/C-2218-2012; IBIS, GENICA/O-1906-2015; Díaz-Quintana, Antonio/A-1946-2011	Rodríguez-Galán, Olga/0000-0002-3137-8554; DE LA CRUZ, JESUS/0000-0001-5870-659X; Díaz-Quintana, Antonio/0000-0001-8973-8009; Kressler, Dieter/0000-0003-4855-3563	Spanish Ministry of Science and Innovation; European Regional Development Grant [BFU2010-15690]; Andalusian Government Grant [CVI-271, P08-CVI-03508]; Swiss National Science Foundation [PP00P3_123341]; University of Seville	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Grant; Andalusian Government Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Seville	This work was supported in part by Spanish Ministry of Science and Innovation and European Regional Development Grant BFU2010-15690, Andalusian Government Grant CVI-271, P08-CVI-03508 (to J. d. l. C.), and Swiss National Science Foundation Grant PP00P3_123341 (to D. K.).; Recipient of a fellowship from the University of Seville.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Babiano R, 2012, MOL CELL BIOL, V32, P3228, DOI 10.1128/MCB.00539-12; Babiano R, 2010, NUCLEIC ACIDS RES, V38, P5177, DOI 10.1093/nar/gkq260; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; Belk JP, 1999, RNA, V5, P1055, DOI 10.1017/S1355838299990027; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Botet J, 2008, ANTIMICROB AGENTS CH, V52, P1623, DOI 10.1128/AAC.01603-07; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Briones C, 2000, NUCLEIC ACIDS RES, V28, P4497, DOI 10.1093/nar/28.22.4497; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Capa L, 1998, ANTIMICROB AGENTS CH, V42, P2694, DOI 10.1128/AAC.42.10.2694; CHAN YL, 1995, BIOCHEM BIOPH RES CO, V215, P682, DOI 10.1006/bbrc.1995.2518; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Dalley JA, 2008, MOL BIOL CELL, V19, P2876, DOI 10.1091/mbc.E07-10-1074; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Dresios J, 2003, J BIOL CHEM, V278, P3314, DOI 10.1074/jbc.M207533200; EICHLER DC, 1994, PROG NUCLEIC ACID RE, V49, P197; Eisinger DP, 1997, MOL CELL BIOL, V17, P5136, DOI 10.1128/MCB.17.9.5136; Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Fewell SW, 1999, MOL CELL BIOL, V19, P826; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gadal O, 2001, EMBO J, V20, P3695, DOI 10.1093/emboj/20.14.3695; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Gerbi SA, 2004, MOL BIOL INTELL UNIT, P170; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hackmann A, 2011, EMBO REP, V12, P1024, DOI 10.1038/embor.2011.155; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Ho JHN, 2000, RNA, V6, P1625, DOI 10.1017/S1355838200001291; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Garcia-Gomez JJ, 2011, MOL CELL BIOL, V31, P4156, DOI 10.1128/MCB.05436-11; Justice MC, 1999, J BIOL CHEM, V274, P4869, DOI 10.1074/jbc.274.8.4869; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kaiser C., 1994, METHODS YEAST GENETI; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kressler D, 1998, MOL CELL BIOL, V18, P1855, DOI 10.1128/MCB.18.4.1855; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; LASTICK SM, 1980, EUR J BIOCHEM, V113, P175; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; McIntosh KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023579; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P1826, DOI 10.1093/nar/gkn034; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; Oeffinger M, 2010, J CELL BIOL, V189, P1071, DOI 10.1083/jcb.201006033; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Petrov Alexey, 2004, RNA Biol, V1, P59; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rhodin MHJ, 2011, MOL GENET GENOMICS, V285, P505, DOI 10.1007/s00438-011-0623-2; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P7519, DOI 10.1093/nar/gkp806; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P3514, DOI 10.1093/nar/gkp209; Rosado IV, 2004, RNA, V10, P1073, DOI 10.1261/rna.7340404; Rosado IV, 2007, MOL CELL BIOL, V27, P1207, DOI 10.1128/MCB.01523-06; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos C, 2004, ANTIMICROB AGENTS CH, V48, P2930, DOI 10.1128/AAC.48.8.2930-2936.2004; SANTOS C, 1994, J BIOL CHEM, V269, P15689; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Venema J, 1998, METH MOL B, V77, P257; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verschoor A, 1998, NUCLEIC ACIDS RES, V26, P655, DOI 10.1093/nar/26.2.655; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wu B, 2008, PROTEIN SCI, V17, P589, DOI 10.1110/ps.073273008; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	148	36	36	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400564	http://dx.doi.org/10.1074/jbc.M112.400564			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22995916	Green Published, hybrid			2022-12-25	WOS:000310642200071
J	Gielis, J; Caratelli, D; Fougerolle, Y; Ricci, PE; Tavkelidze, I; Gerats, T				Gielis, Johan; Caratelli, Diego; Fougerolle, Yohan; Ricci, Paolo Emilio; Tavkelidze, Ilia; Gerats, Tom			Universal Natural Shapes: From Unifying Shape Description to Simple Methods for Shape Analysis and Boundary Value Problems	PLOS ONE			English	Article							SCATTERING; GROWTH	Gielis curves and surfaces can describe a wide range of natural shapes and they have been used in various studies in biology and physics as descriptive tool. This has stimulated the generalization of widely used computational methods. Here we show that proper normalization of the Levenberg-Marquardt algorithm allows for efficient and robust reconstruction of Gielis curves, including self-intersecting and asymmetric curves, without increasing the overall complexity of the algorithm. Then, we show how complex curves of k-type can be constructed and how solutions to the Dirichlet problem for the Laplace equation on these complex domains can be derived using a semi-Fourier method. In all three methods, descriptive and computational power and efficiency is obtained in a surprisingly simple way.	[Gielis, Johan] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium; [Gielis, Johan; Gerats, Tom] Radboud Univ Nijmegen, Sect Plant Genet, Inst Wetland & Water Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Caratelli, Diego] Delft Univ Technol, Int Res Ctr Telecommun & Radar, Delft, Netherlands; [Fougerolle, Yohan] Univ Bourgogne, CNRS, Lab Le2i, UMC 5158, Le Creusot, France; [Ricci, Paolo Emilio] Campus Biomed Univ, Rome, Italy; [Tavkelidze, Ilia] I Javakhishvili Tbilisi State Univ, I Vekua Inst Appl Math, Tbilisi, Georgia	University of Antwerp; Radboud University Nijmegen; Delft University of Technology; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University Campus Bio-Medico - Rome Italy; Ivane Javakhishvili Tbilisi State University	Gielis, J (corresponding author), Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium.	johan.gielis@ua.ac.be	Gielis, JOhan/AAK-2564-2020; Caratelli, Diego/J-3178-2013; Gielis, Johan/ABD-7862-2020; Gerats, Tom/A-3528-2012	Caratelli, Diego/0000-0003-2454-2632; Gielis, Johan/0000-0002-4536-3839; 				Antonelli P. L., 1993, FUNDAMENTAL THEORIES, V58; Arnold VI, 1998, COMMUNICATION   0307; Bera N, 2008, EUR PHYS J D, V46, P41, DOI 10.1140/epjd/e2007-00282-6; Biswas A, 2004, GRAPH MODELS, V66, P133, DOI 10.1016/j.gmod.2004.01.003; Bokhabrine Y., 2007, 2007 IEEE INT C IM P, V2, pII; Caratelli D, 2010, APPL MATH COMPUT, V216, P556, DOI 10.1016/j.amc.2010.01.077; Caratelli D., 2010, LECT NOTES TBILISI I; Caratelli D, 2010, COMPUT MATH APPL, V59, P176, DOI 10.1016/j.camwa.2009.07.060; Cervantes E, 2010, J PLANT PHYSIOL, V167, P408, DOI 10.1016/j.jplph.2009.09.013; Chen B. Y., 1984, SERIES PURE MATH, V1; Chern S. S., 2000, MATH FRONTIERS PERSP, P33; D'Arcy Thompson W, 1917, GROWTH FORM; Faisal TR, 2010, J BIONIC ENG, V7, pS11, DOI 10.1016/S1672-6529(09)60212-2; Fougerolle YD, 2006, IEEE IMAGE PROC, P2193, DOI 10.1109/ICIP.2006.312975; Fougerolle Y. D., 2009, P GRAPP 2009 INT C C; Fougerolle YD, 2005, IEEE T VIS COMPUT GR, V11, P529, DOI 10.1109/TVCG.2005.72; Gielis J, 2003, AM J BOT, V90, P333, DOI 10.3732/ajb.90.3.333; Gielis J, 2005, KRAGUJEVAC J MATH, V28, P55; Gielis J., 2003, INVENTING CIRCLE; Gielis J., 2004, P INT C COMP COMM CO, P265; Gielis J, 2010, HIST MECH MACH SCI, V11, P29, DOI 10.1007/978-90-481-9091-1_3; Goenner H.F.M, 2008, ARXIV08114529; Gross A. D., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P690, DOI 10.1109/CCV.1988.590052; Guitart R, 2009, GABRIEL LAME PEREGRI, V44, P119; Hadjidemetriou S, 2009, LECT NOTES COMPUT SC, V5762, P665, DOI 10.1007/978-3-642-04271-3_81; Haesen S, 2005, NATO SC S SS III C S, V197, P197; Huclova S, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/36/365405; Janner A, 2006, ACTA CRYSTALLOGR A, V62, P270, DOI 10.1107/S010876730601748X; JANNER A, 1992, ACTA CRYSTALLOGR A, V48, P884, DOI 10.1107/S0108767392005166; Janner A, 2001, CRYST ENG, V4, P119, DOI 10.1016/S1463-0184(01)00005-3; Koiso M., 2008, FORMA, V28, P1; Lame G., 1818, EXAMEN DIFFERENTES M; Lestrel PE, 2011, P 1 S BIOL IN PRESS; Loria G, 1902, SPEZIELLE ALGEBRAISC; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Natalini P, 2008, NUMER ALGORITHMS, V49, P299, DOI 10.1007/s11075-008-9201-z; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Richardson JS, 2008, RNA, V14, P465, DOI 10.1261/rna.657708; Ronse de Craene L, 2010, FLORA DIAGRAMS; Schrodinger E, 1940, WISEN NATUURKUNDIG T, P2; Simeoni M, 2009, SUP DIEL RES ANT ANT, P1, DOI [10.1109/APS.2009.5171981, DOI 10.1109/APS.2009.5171981]; Tassadit A, 2011, SUPERLATTICE MICROST, V49, P288, DOI 10.1016/j.spmi.2010.07.003; Thom R., 1972, STRUCTURAL STABILITY; Thompson A.C., 1996, ENCY MATH ITS APPL, V63; Verstraelen L., 1991, GEOMETRY TOPOLOGY SU, V3, P304; Verstraelen L, 2008, MURC SPAIN WORKSH DI; Vinogradov SS, 2009, ELECTROMAGNETICS, V29, P268, DOI 10.1080/02726340902718526; Voisin S, 2009, IEEE IMAGE PROC, P529, DOI 10.1109/ICIP.2009.5413905; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Yajima T, 2009, P ROY SOC A-MATH PHY, V465, P1763, DOI 10.1098/rspa.2008.0453	52	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e29324	10.1371/journal.pone.0029324	http://dx.doi.org/10.1371/journal.pone.0029324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028417	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500001
J	Kiddle, SJ; Thambisetty, M; Simmons, A; Riddoch-Contreras, J; Hye, A; Westman, E; Pike, I; Ward, M; Johnston, C; Lupton, MK; Lunnon, K; Soininen, H; Kloszewska, I; Tsolaki, M; Vellas, B; Mecocci, P; Lovestone, S; Newhouse, S; Dobson, R				Kiddle, Steven John; Thambisetty, Madhav; Simmons, Andrew; Riddoch-Contreras, Joanna; Hye, Abdul; Westman, Eric; Pike, Ian; Ward, Malcolm; Johnston, Caroline; Lupton, Michelle Katharine; Lunnon, Katie; Soininen, Hilkka; Kloszewska, Iwona; Tsolaki, Magda; Vellas, Bruno; Mecocci, Patrizia; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard		Alzheimers Dis Neuroimaging Initia	Plasma Based Markers of [C-11] PiB-PET Brain Amyloid Burden	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; CLUSTERIN CONCENTRATION; BIOMARKERS; MRI; CLASSIFICATION; PREDICTION; DEPOSITION; CORTISOL; LEVEL	Changes in brain amyloid burden have been shown to relate to Alzheimer's disease pathology, and are believed to precede the development of cognitive decline. There is thus a need for inexpensive and non-invasive screening methods that are able to accurately estimate brain amyloid burden as a marker of Alzheimer's disease. One potential method would involve using demographic information and measurements on plasma samples to establish biomarkers of brain amyloid burden; in this study data from the Alzheimer's Disease Neuroimaging Initiative was used to explore this possibility. Sixteen of the analytes on the Rules Based Medicine Human Discovery Multi-Analyte Profile 1.0 panel were found to associate with [C-11]-PiB PET measurements. Some of these markers of brain amyloid burden were also found to associate with other AD related phenotypes. Thirteen of these markers of brain amyloid burden - c-peptide, fibrinogen, alpha-1-antitrypsin, pancreatic polypeptide, complement C3, vitronectin, cortisol, AXL receptor kinase, interleukin-3, interleukin-13, matrix metalloproteinase-9 total, apolipoprotein E and immunoglobulin E - were used along with co-variates in multiple linear regression, and were shown by cross-validation to explain > 30% of the variance of brain amyloid burden. When a threshold was used to classify subjects as PiB positive, the regression model was found to predict actual PiB positive individuals with a sensitivity of 0.918 and a specificity of 0.545. The number of APOE epsilon 4 alleles and plasma apolipoprotein E level were found to contribute most to this model, and the relationship between these variables and brain amyloid burden was explored.	[Kiddle, Steven John; Simmons, Andrew; Westman, Eric; Johnston, Caroline; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard] S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Kiddle, Steven John; Simmons, Andrew; Riddoch-Contreras, Joanna; Hye, Abdul; Westman, Eric; Johnston, Caroline; Lupton, Michelle Katharine; Lunnon, Katie; Lovestone, Simon; Newhouse, Stephen; Dobson, Richard] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Thambisetty, Madhav] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Pike, Ian; Ward, Malcolm] Proteome Sci Plc, Surrey, England; [Soininen, Hilkka] Univ Eastern Finland, Sch Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Tsolaki, Magda] Aristotle Univ Thessaloniki, G Papanicolaou Hosp, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Vellas, Bruno] Toulouse Univ Hosp, Dept Geriatr Med, Grontople Toulouse, Toulouse, France; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy	South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Medical University Lodz; Aristotle University of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki; CHU de Toulouse; University of Perugia	Kiddle, SJ (corresponding author), S London & Maudsley Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England.	steven.kiddle@kcl.ac.uk; richard.j.dobson@kcl.ac.uk	Levey, Allan/F-2104-2011; Dobson, Richard j/C-9269-2011; Preda, Adrian/K-8889-2013; Westman, Eric/H-5771-2011; Mecocci, Patrizia/W-2116-2019; Lunnon, Katie/C-4638-2012; Simmons, Andrew/B-8848-2008; Hsiung, Robin/AAT-1661-2021; Newhouse, Stephen J/C-9330-2011; Kiddle, Steven/H-3463-2012	Levey, Allan/0000-0002-3153-502X; Dobson, Richard j/0000-0003-4224-9245; Preda, Adrian/0000-0003-3373-2438; Westman, Eric/0000-0002-3115-2977; Mecocci, Patrizia/0000-0003-0729-5246; Lunnon, Katie/0000-0001-7570-6065; Simmons, Andrew/0000-0003-2306-5811; Hsiung, Robin/0000-0002-8017-0856; Newhouse, Stephen J/0000-0002-1843-9842; Hye, Abdul/0000-0003-2237-4823; Pike, Ian/0000-0002-3071-0041; Tsolaki, Magda/0000-0002-2072-8010; Lupton, Michelle/0000-0002-7274-7299; Lovestone, Simon/0000-0003-0473-4565; Ward, Malcolm/0000-0003-2164-6938; Kiddle, Steven/0000-0003-4350-7437	ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; National Institutes of Health [P30 AG010129, K01 AG030514]; InnoMed (Innovative Medicines in Europe); European Union; National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London; Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; Alzheimers Research UK [ART-PG2010-4, ART-ESG2006-3, ART-PG2000-1] Funding Source: researchfish; Medical Research Council [G0400061] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish; MRC [G0400061] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG019610, U01AG024904, P30AG013846, ZIAAG000200, P30AG010129] Funding Source: NIH RePORTER	ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); InnoMed (Innovative Medicines in Europe); European Union(European Commission); National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London; Abbott(Abbott Laboratories); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Alzheimer's Disease Neuroimaging Initiative (ADNI) data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514. This study was supported by InnoMed (Innovative Medicines in Europe www.imi.europa.eu/) an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. This study was also supported by funds from the National Institutes for Health Research Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Intellectual property has been registered on the use of plasma proteins for use as biomarkers for AD by King's College London and Proteome Sciences, with SL and M. Thambisetty named as inventors. IP and MW were full-time employees of Proteome Sciences, London, United Kingdom, at the time of their contribution to the work described in this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Patent Title Methods and Compositions Relating to Alzheimer's Disease Subject Covers utility of around 30 proteins, specifically listing 16 in the Dependent claims for diagnosis of Alzheimer's disease Filing Proteome Sciences with King's Business United Kingdom Priority GB0421639.6 dated 29/09/2004 PCT Application PCT/GB2005/003756 dated 29/09/2005 Application in Europe, Japan, United States, Australia, and Canada, dated 15/03/2007 to 16/10/2007. In addition Alzheimer's Disease Neuroimaging Initiative recieved funding from: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bemelmans KJ, 2007, ACTA NEUROPSYCHIATR, V19, P231, DOI 10.1111/j.1601-5215.2006.00172.x; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Doecke JD, ARCH NEUROL; EVANS AE, 1993, HUM GENET, V92, P191; Ewers M, 2012, CEREB CORTEX, V22, P1993, DOI 10.1093/cercor/bhr271; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kim S, 2011, PPCOR PARTIAL SEMIPA; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Koivunen J, 2008, DEMENT GERIATR COGN, V26, P378, DOI 10.1159/000163927; Lee BK, 2008, AM J PSYCHIAT, V165, P1456, DOI 10.1176/appi.ajp.2008.07091532; Lindeman RH, 1980, INTRO BIVARIATE MULT, P120; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Lyketsos CG, 2004, ALZ DIS ASSOC DIS, V18, P171; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Mold M, 2012, J ALZHEIMERS DIS, V29, P875, DOI 10.3233/JAD-2012-120076; Nishiyama E, 1996, DEMENTIA, V7, P256, DOI 10.1159/000106889; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Soares HD, ARCH NEUROL; Stevenson M., EPIR R PACKAGE ANAL; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Thambisetty M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028527; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, J ALZHEIMERS DIS, V22, P1099, DOI 10.3233/JAD-2010-101350; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; WETTERLING T, 1994, CLIN INVESTIGATOR, V72, P196; Zambrano A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-82; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495	53	66	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44260	10.1371/journal.pone.0044260	http://dx.doi.org/10.1371/journal.pone.0044260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028511	Green Submitted, gold, Green Published			2022-12-25	WOS:000309554700010
J	Busceti, CL; Bucci, D; Molinaro, G; Di Pietro, P; Zangrandi, L; Gradini, R; Moratalla, R; Battaglia, G; Bruno, V; Nicoletti, F; Fornai, F				Busceti, Carla Letizia; Bucci, Domenico; Molinaro, Gemma; Di Pietro, Paola; Zangrandi, Luca; Gradini, Roberto; Moratalla, Rosario; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Fornai, Francesco			Lack or Inhibition of Dopaminergic Stimulation Induces a Development Increase of Striatal Tyrosine Hydroxylase-Positive Interneurons	PLOS ONE			English	Article							NIGROSTRIATAL DEGENERATION; POSTNATAL-DEVELOPMENT; PARKINSONS-DISEASE; GENE-TRANSCRIPTION; RAT STRIATUM; NEURONS; RECEPTORS; RELEASE; NUMBER; INNERVATION	We examined the role of endogenous dopamine (DA) in regulating the number of intrinsic tyrosine hydroxylase-positive (TH+) striatal neurons using mice at postnatal day (PND) 4 to 8, a period that corresponds to the developmental peak in the number of these neurons. We adopted the strategy of depleting endogenous DA by a 2-day treatment with alpha-methyl-p-tyrosine (alpha MpT, 150 mg/kg, i.p.). This treatment markedly increased the number of striatal TH+ neurons, assessed by stereological counting, and the increase was highly correlated to the extent of DA loss. Interestingly, TH+ neurons were found closer to the clusters of DA fibers after DA depletion, indicating that the concentration gradient of extracellular DA critically regulates the distribution of striatal TH+ neurons. A single i.p. injection of the D1 receptor antagonist, SCH23390 (0.1 mg/kg), the D2/D3 receptor antagonist, raclopride (0.1 mg/kg), or the D4 receptor antagonist, L-745,870 (5 mg/kg) in mice at PND4 also increased the number of TH+ neurons after 4 days. Treatment with the D1-like receptor agonist SKF38393 (10 mg/kg) or with the D2-like receptor agonist, quinpirole (1 mg/kg) did not change the number of TH+ neurons. At least the effects of SCH23390 were prevented by a combined treatment with SKF38393. Immunohistochemical analysis indicated that striatal TH+ neurons expressed D2 and D4 receptors, but not D1 receptors. Moreover, treatment with the alpha 4 beta 2 receptor antagonist dihydro-beta-erythroidine (DH beta E) (3.2 mg/kg) also increased the number of TH+ neurons. The evidence that DH beta E mimicked the action of SCH23390 in increasing the number of TH+ neurons supports the hypothesis that activation of D1 receptors controls the number of striatal TH+ neurons by enhancing the release of acetylcholine. These data demonstrate for the first time that endogenous DA negatively regulates the number of striatal TH+ neurons by direct and indirect mechanisms mediated by multiple DA receptor subtypes.	[Busceti, Carla Letizia; Bucci, Domenico; Molinaro, Gemma; Di Pietro, Paola; Zangrandi, Luca; Gradini, Roberto; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Fornai, Francesco] IRCCS Neuromed, Pozzilli, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Moratalla, Rosario] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, E-28002 Madrid, Spain; [Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Fornai, Francesco] Univ Pisa, Dept Human Morphol & Appl Biol, Pisa, Italy	IRCCS Neuromed; Sapienza University Rome; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Sapienza University Rome; University of Pisa	Fornai, F (corresponding author), IRCCS Neuromed, Pozzilli, Italy.	francesco.fornai@med.unipi.it	Bucci, Domenico/AAA-5475-2019; Nicoletti, Ferdinando/K-4410-2016; FORNAI, FRANCESCO/AAA-5312-2019; Busceti, Carla Letizia/F-9941-2011; Di Pietro, Paola/K-5137-2016; Molinaro, Gemma/G-8822-2011; Battaglia, Giuseppe/A-7709-2010; Nicoletti, Ferdinando/T-4898-2019; bruno, Valeria/F-3146-2012; Busceti, Carla Letizia/K-6485-2016; Bucci, Domenico/G-6747-2011; Moratalla, Rosario V/H-9280-2015; Nicoletti, Ferdinando/A-2446-2010	Bucci, Domenico/0000-0003-3239-2435; FORNAI, FRANCESCO/0000-0002-3883-5084; Di Pietro, Paola/0000-0003-1327-1961; Battaglia, Giuseppe/0000-0001-7571-3417; bruno, Valeria/0000-0003-4231-0739; Busceti, Carla Letizia/0000-0002-1417-1893; Moratalla, Rosario V/0000-0002-7623-8010; NICOLETTI, Ferdinando/0000-0003-3366-7269; Zangrandi, Luca/0000-0003-4374-6665; Nicoletti, Ferdinando/0000-0003-0917-443X				ANDERSEN SL, 1993, J NEUROCHEM, V61, P2247, DOI 10.1111/j.1471-4159.1993.tb07466.x; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Battaglia G, 2006, J NEUROSCI, V26, P7222, DOI 10.1523/JNEUROSCI.1595-06.2006; Bedard A, 2002, NEUROSCI LETT, V328, P213, DOI 10.1016/S0304-3940(02)00530-X; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; Betarbet R, 1997, J NEUROSCI, V17, P6761; BIRD ED, 1980, ACTA PSYCHIAT SCAND, V61, P63, DOI 10.1111/acps.1980.61.s280.63; Busceti CL, 2008, J NEURAL TRANSM, V115, P1375, DOI 10.1007/s00702-008-0112-x; CABOCHE J, 1991, DEV BRAIN RES, V58, P111, DOI 10.1016/0165-3806(91)90243-C; Cossette M, 1999, NEUROSCI RES, V34, P51, DOI 10.1016/S0168-0102(99)00029-2; Cossette M, 2004, EUR J NEUROSCI, V20, P2089, DOI 10.1111/j.1460-9568.2004.03661.x; CRAWLEY JN, 1984, NEUROCHEM INT, V6, P755, DOI 10.1016/0197-0186(84)90007-X; DAMSMA G, 1990, EUR J PHARMACOL, V186, P335, DOI 10.1016/0014-2999(90)90456-G; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; KILBOURNE EJ, 1991, DEV BRAIN RES, V58, P143, DOI 10.1016/0165-3806(91)90247-G; King MA, 2002, METHODS, V28, P293, DOI 10.1016/S1046-2023(02)00235-9; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Masuda M, 2011, EUR J NEUROSCI, V34, P1355, DOI 10.1111/j.1460-9568.2011.07873.x; Meredith GE, 1999, EUR J NEUROSCI, V11, P3585, DOI 10.1046/j.1460-9568.1999.00774.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Palfi S, 2002, J NEUROSCI, V22, P4942, DOI 10.1523/JNEUROSCI.22-12-04942.2002; Pisani A, 2000, J NEUROSCI, V20, part. no.; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; RESTANI P, 1990, PHARMACOL RES, V22, P343, DOI 10.1016/1043-6618(90)90732-S; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; SPOKES EGS, 1979, ADV NEUROL, V23, P481; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; TASHIRO Y, 1989, NEUROSCI LETT, V97, P6, DOI 10.1016/0304-3940(89)90130-4; TENNYSON VM, 1972, BRAIN RES, V46, P251, DOI 10.1016/0006-8993(72)90019-4; Tinti C, 1997, J BIOL CHEM, V272, P19158, DOI 10.1074/jbc.272.31.19158; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	40	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44025	10.1371/journal.pone.0044025	http://dx.doi.org/10.1371/journal.pone.0044025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028485	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900013
J	Liu, G; Mac Gabhann, F; Popel, AS				Liu, Gang; Mac Gabhann, Feilim; Popel, Aleksander S.			Effects of Fiber Type and Size on the Heterogeneity of Oxygen Distribution in Exercising Skeletal Muscle	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; EXTENSOR DIGITORUM LONGUS; INTERSTITIAL FLUID VOLUME; BLOOD-FLOW; MICROVASCULAR NETWORKS; COMPUTATIONAL MODEL; OXIDATIVE CAPACITY; VEGF GRADIENTS; SHEAR-STRESS; TRANSPORT	The process of oxygen delivery from capillary to muscle fiber is essential for a tissue with variable oxygen demand, such as skeletal muscle. Oxygen distribution in exercising skeletal muscle is regulated by convective oxygen transport in the blood vessels, oxygen diffusion and consumption in the tissue. Spatial heterogeneities in oxygen supply, such as microvascular architecture and hemodynamic variables, had been observed experimentally and their marked effects on oxygen exchange had been confirmed using mathematical models. In this study, we investigate the effects of heterogeneities in oxygen demand on tissue oxygenation distribution using a multiscale oxygen transport model. Muscles are composed of different ratios of the various fiber types. Each fiber type has characteristic values of several parameters, including fiber size, oxygen consumption, myoglobin concentration, and oxygen diffusivity. Using experimentally measured parameters for different fiber types and applying them to the rat extensor digitorum longus muscle, we evaluated the effects of heterogeneous fiber size and fiber type properties on the oxygen distribution profile. Our simulation results suggest a marked increase in spatial heterogeneity of oxygen due to fiber size distribution in a mixed muscle. Our simulations also suggest that the combined effects of fiber type properties, except size, do not contribute significantly to the tissue oxygen spatial heterogeneity. However, the incorporation of the difference in oxygen consumption rates of different fiber types alone causes higher oxygen heterogeneity compared to control cases with uniform fiber properties. In contrast, incorporating variation in other fiber type-specific properties, such as myoglobin concentration, causes little change in spatial tissue oxygenation profiles.	[Liu, Gang; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Syst Biol Lab, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Liu, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Syst Biol Lab, Baltimore, MD 21205 USA.	gangliu2001@gmail.com	Liu, Gang/A-1359-2014; Mac Gabhann, Feilim/A-3436-2010; Popel, Aleksander S/A-6724-2009; Liu, Gang/F-7414-2011	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235; Liu, Gang/0000-0002-8758-1797	National Institutes of Health (NIH) [R01 HL18292, HL101200, R00 HL093219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093219, R01HL018292, R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL18292 and HL101200 (ASP) and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SK, 1997, EXP PHYSIOL, V82, P231, DOI 10.1113/expphysiol.1997.sp004012; Altman PL., 1971, RESP CIRCULATION; AUKLAND K, 1981, PHYSIOL REV, V61, P556, DOI 10.1152/physrev.1981.61.3.556; Beard DA, 2003, AM J PHYSIOL-HEART C, V285, pH1826, DOI 10.1152/ajpheart.00380.2003; Blomstrand E, 1997, J PHYSIOL-LONDON, V501, P455, DOI 10.1111/j.1469-7793.1997.455bn.x; CHRISTOF.C, 1969, J APPL PHYSIOL, V26, P56, DOI 10.1152/jappl.1969.26.1.56; CLARK A, 1985, BIOPHYS J, V47, P171, DOI 10.1016/S0006-3495(85)83890-X; Deveci D, 2001, AM J PHYSIOL-HEART C, V281, pH241, DOI 10.1152/ajpheart.2001.281.1.H241; EGGINTON S, 1990, J ANAT, V168, P73; Egginton S, 2011, BIOCHEM SOC T, V39, P1633, DOI 10.1042/BST20110715; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Ellis CG, 2002, AM J PHYSIOL-HEART C, V282, pH156, DOI 10.1152/ajpheart.2002.282.1.H156; ELLSWORTH ML, 1988, MICROVASC RES, V35, P341, DOI 10.1016/0026-2862(88)90089-1; ELLSWORTH ML, 1984, AM J PHYSIOL, V246, pH161, DOI 10.1152/ajpheart.1984.246.2.H161; FEDERSPIEL WJ, 1986, MICROVASC RES, V32, P164, DOI 10.1016/0026-2862(86)90052-X; Flessner Michael F., 1997, American Journal of Physiology, V273, pH2783; Goldman D, 2004, AM J PHYSIOL-HEART C, V287, pH2535, DOI 10.1152/ajpheart.00889.2003; Goldman D, 2000, J THEOR BIOL, V206, P181, DOI 10.1006/jtbi.2000.2113; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Grinberg O, 2005, ADV EXP MED BIOL, V566, P127; GROEBE K, 1990, AM J PHYSIOL, V259, pH84, DOI 10.1152/ajpheart.1990.259.1.H84; HONIG CR, 1984, ADV EXP MED BIOL, V169, P23; Hoofd L, 2009, ADV EXP MED BIOL, V645, P55, DOI 10.1007/978-0-387-85998-9_9; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Ji JW, 2006, J THEOR BIOL, V241, P94, DOI 10.1016/j.jtbi.2005.11.019; JURGENS KD, 1994, P NATL ACAD SCI USA, V91, P3829, DOI 10.1073/pnas.91.9.3829; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; LARGE J, 1985, J PHYSIOL-LONDON, V362, P13, DOI 10.1113/jphysiol.1985.sp015659; Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; MAHLER M, 1985, J GEN PHYSIOL, V86, P105, DOI 10.1085/jgp.86.1.105; MAXWELL LC, 1980, J APPL PHYSIOL, V49, P627, DOI 10.1152/jappl.1980.49.4.627; McGuire BJ, 2001, J APPL PHYSIOL, V91, P2255, DOI 10.1152/jappl.2001.91.5.2255; MENG H, 1993, J APPL PHYSIOL, V74, P2194, DOI 10.1152/jappl.1993.74.5.2194; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Pittman R.N., 2011, REGULATION TISSUE OX; POPEL AS, 1979, AM J PHYSIOL, V237, pH681, DOI 10.1152/ajpheart.1979.237.6.H681; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Pries AR, 2009, CARDIOVASC RES, V81, P328, DOI 10.1093/cvr/cvn318; REED RK, 1981, ACTA PHYSIOL SCAND, V112, P141, DOI 10.1111/j.1748-1716.1981.tb06797.x; Roy TK, 1996, AM J PHYSIOL-HEART C, V271, pH721, DOI 10.1152/ajpheart.1996.271.2.H721; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Soukup T, 2002, ACTA HISTOCHEM, V104, P399, DOI 10.1078/0065-1281-00660; STELTZER H, 1994, ANAESTHESIA, V49, P229; Talmadge Robert J., 1993, Current Opinion in Rheumatology, V5, P695; Tyml K, 1999, J APPL PHYSIOL, V87, P1496, DOI 10.1152/jappl.1999.87.4.1496; Wagner PD, 2001, ADV EXP MED BIOL, V502, P21; Wang D, 1997, BIOPHYS J, V73, P2764, DOI 10.1016/S0006-3495(97)78305-X; Welter M, 2009, J THEOR BIOL, V259, P405, DOI 10.1016/j.jtbi.2009.04.005; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wust RCI, 2009, ADV EXP MED BIOL, V645, P75, DOI 10.1007/978-0-387-85998-9_12; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	60	35	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44375	10.1371/journal.pone.0044375	http://dx.doi.org/10.1371/journal.pone.0044375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028531	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900023
J	Wang, DY; Hadj-Henni, L; Thierry, S; Arne, P; Chermette, R; Botterel, F; Hadrich, I; Makni, F; Ayadi, A; Ranque, S; Huang, WY; Guillot, J				Wang, Dong Ying; Hadj-Henni, Leila; Thierry, Simon; Arne, Pascal; Chermette, Rene; Botterel, Francoise; Hadrich, Ines; Makni, Fattouma; Ayadi, Ali; Ranque, Stephane; Huang, Wei Yi; Guillot, Jacques			Simple and Highly Discriminatory VNTR-Based Multiplex PCR for Tracing Sources of Aspergillus flavus Isolates	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; INVASIVE ASPERGILLOSIS; FUNGAL KERATITIS; INFECTIONS; FUMIGATUS; DNA; STRAINS; BIRDS; UNIT	Aspergillus flavus is second only to A. fumigatus in causing invasive aspergillosis and it is the major agent responsible for fungal sinusitis, keratitis and endophthalmitis in many countries in the Middle East, Africa and Southeast Asia. Despite the growing challenge due to A. flavus, data on the molecular epidemiology of this fungus remain scarce. The objective of the present study was to develop a new typing method based on the detection of VNTR (Variable number tandem repeat) markers. Eight VNTR markers located on 6 different chromosomes (1, 2, 3, 5, 7 and 8) of A. flavus were selected, combined by pairs for multiplex amplifications and tested on 30 unrelated isolates and six reference strains. The Simpson index for individual markers ranged from 0.398 to 0.818. A combined loci index calculated with all the markers yielded an index of 0.998. The MLVA (Multiple Locus VNTR Analysis) technique proved to be specific and reproducible. In a second time, a total of 55 isolates from Chinese avian farms and from a Tunisian hospital have been evaluated. One major cluster of genotypes could be defined by using the graphing algorithm termed Minimum Spanning Tree. This cluster comprised most of the isolates collected in an avian farm in southern China. The MLVA technique should be considered as an excellent and cost-effective typing method that could be used in many laboratories without the need for sophisticated equipment.	[Arne, Pascal; Chermette, Rene; Guillot, Jacques] ENVA, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France; [Wang, Dong Ying; Huang, Wei Yi] Guangxi Univ, Coll Anim Sci & Technol, Dept Parasitol, Nanning 530004, Peoples R China; [Wang, Dong Ying; Hadj-Henni, Leila; Thierry, Simon] ANSES, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France; [Botterel, Francoise] UPE, Lab Sante Anim, UMR BIPAR, Creteil, France; [Hadrich, Ines; Makni, Fattouma; Ayadi, Ali] Fac Med Sfax, Lab Biol Mol Parasitaire & Fong, Sfax, Tunisia; [Ranque, Stephane] Aix Marseille Univ, UMR MD3, Marseille, France; [Ranque, Stephane] APHM, Lab Parasitol Mycol, Marseille, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Guangxi University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite de Sfax; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Guillot, J (corresponding author), ENVA, Lab Sante Anim, UMR BIPAR, Maisons Alfort, France.	jguillot@vet-alfort.fr	Guillot, Jacques/J-9428-2016; Ranque, Stéphane/K-2317-2015	Guillot, Jacques/0000-0003-3577-6979; Ranque, Stéphane/0000-0003-3293-5276; Arne, Pascal/0000-0001-9727-7716	French Ambassy in the People's Republic of China	French Ambassy in the People's Republic of China	DYW is a PhD student who received a grant from the French Ambassy in the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arne P, 2011, INT J MICROBIOL; Bagyalakshmi R, 2007, J MICROBIOL METH, V68, P1, DOI 10.1016/j.mimet.2006.05.021; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Beernaert LA, 2010, AVIAN PATHOL, V39, P325, DOI 10.1080/03079457.2010.506210; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grubisha LC, 2010, MOL ECOL, V19, P269, DOI 10.1111/j.1365-294X.2009.04467.x; Hadrich I, 2010, J CLIN MICROBIOL, V48, P2396, DOI 10.1128/JCM.01269-09; Hadrich I, 2011, MYCOPATHOLOGIA, V172, P83, DOI 10.1007/s11046-011-9406-x; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; James MJ, 2000, J CLIN MICROBIOL, V38, P3612, DOI 10.1128/JCM.38.10.3612-3618.2000; KHAIRALLAH SH, 1992, DOC OPHTHALMOL, V79, P269, DOI 10.1007/BF00158257; Krishnan S, 2009, MYCOSES, V52, P206, DOI 10.1111/j.1439-0507.2008.01642.x; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Midorikawa GEO, 2008, LETT APPL MICROBIOL, V47, P12, DOI 10.1111/j.1472-765X.2008.02377.x; Montiel D, 2003, MYCOL RES, V107, P1427, DOI 10.1017/S0953756203008797; MOODY SF, 1990, APPL ENVIRON MICROB, V56, P2441, DOI 10.1128/AEM.56.8.2441-2452.1990; Pasqualotto AC, 2009, MED MYCOL, V47, pS261, DOI 10.1080/13693780802247702; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Rudramurthy SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016086; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Taj-Aldeen SJ, 2003, EUR ARCH OTO-RHINO-L, V260, P331, DOI 10.1007/s00405-002-0547-x; Tell LA, 2005, MED MYCOL, V43, pS71, DOI 10.1080/13693780400020089; Thierry S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-315; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Wang YW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-278; Wong TY, 1997, INT OPHTHALMOL, V21, P127, DOI 10.1023/A:1026462631716	33	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44204	10.1371/journal.pone.0044204	http://dx.doi.org/10.1371/journal.pone.0044204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028503	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800009
J	Zhan, TZ; Poppelreuther, M; Ehehalt, R; Fullekrug, J				Zhan, Tianzuo; Poppelreuther, Margarete; Ehehalt, Robert; Fuellekrug, Joachim			Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 Increase the Cellular Fatty Acid Uptake of 3T3-L1 Adipocytes but Are Localized on Intracellular Membranes	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; TRANSPORT PROTEINS; EPITHELIAL-CELLS; LIPID-METABOLISM; ADIPOSE-TISSUE; INSULIN; BINDING; EXPRESSION; FAT/CD36; ENZYMES	Long chain acyl-CoA synthetases are essential enzymes of lipid metabolism, and have also been implicated in the cellular uptake of fatty acids. It is controversial if some or all of these enzymes have an additional function as fatty acid transporters at the plasma membrane. The most abundant acyl-CoA synthetases in adipocytes are FATP1, ACSVL4/FATP4 and ACSL1. Previous studies have suggested that they increase fatty acid uptake by direct transport across the plasma membrane. Here, we used a gain-of-function approach and established FATP1, ACSVL4/FATP4 and ACSL1 stably expressing 3T3-L1 adipocytes by retroviral transduction. All overexpressing cell lines showed increased acyl-CoA synthetase activity and fatty acid uptake. FATP1 and ACSVL4/FATP4 localized to the endoplasmic reticulum by confocal microscopy and subcellular fractionation whereas ACSL1 was found on mitochondria. Insulin increased fatty acid uptake but without changing the localization of FATP1 or ACSVL4/FATP4. We conclude that overexpressed acyl-CoA synthetases are able to facilitate fatty acid uptake in 3T3-L1 adipocytes. The intracellular localization of FATP1, ACSVL4/FATP4 and ACSL1 indicates that this is an indirect effect. We suggest that metabolic trapping is the mechanism behind the influence of acyl-CoA synthetases on cellular fatty acid uptake.	[Zhan, Tianzuo; Poppelreuther, Margarete; Ehehalt, Robert; Fuellekrug, Joachim] Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zhan, TZ (corresponding author), Heidelberg Univ, Mol Cell Biol Lab, Heidelberg, Germany.	Joachim.Fuellekrug@med.uni-heidelberg.de	Füllekrug, Joachim/A-6581-2008	Zhan, Tianzuo/0000-0002-9346-3180; Ehehalt, Robert/0000-0003-4252-5801	German research foundation DFG [FU 340/5-1, EH 196/5-1]	German research foundation DFG(German Research Foundation (DFG))	This work was supported by the German research foundation DFG (FU 340/5-1 to J.F. and EH 196/5-1 to R.E.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Digel M, 2011, AM J PHYSIOL-ENDOC M, V301, pE785, DOI 10.1152/ajpendo.00079.2011; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Frohnert BI, 2000, PROG LIPID RES, V39, P83, DOI 10.1016/S0163-7827(99)00018-1; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Gargiulo CE, 1999, J LIPID RES, V40, P881; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Joost HG, 2000, METH MOL B, V155, P77; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lawen A, 2005, INT J BIOCHEM CELL B, V37, P277, DOI 10.1016/j.biocel.2004.05.013; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu Q, 2010, FASEB J; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Ruan H, 2001, DIABETES, V50, P233, DOI 10.2337/diabetes.50.2.233; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sebastian D, 2009, J LIPID RES; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; van Oort MM, 2007, BIOCH BIOPHYS ACTA; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; WADA I, 1991, J BIOL CHEM, V266, P19599; Wang YL, 2004, OBES RES, V12, P1781, DOI 10.1038/oby.2004.221; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wiczer BM, 2009, J LIPID RES; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	64	52	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45087	10.1371/journal.pone.0045087	http://dx.doi.org/10.1371/journal.pone.0045087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024797	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100055
J	Fang, CC; Huang, JW; Shyu, RS; Yen, CJ; Shiao, CH; Chiang, CK; Hu, RH; Tsai, TJ				Fang, Cheng-Chung; Huang, Jenq-Wen; Shyu, Ren-Shi; Yen, Chung-Jen; Shiao, Cheng-Hsiang; Chiang, Chih-Kang; Hu, Rey-Heng; Tsai, Tun-Jun			Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline	PLOS ONE			English	Article							DIALYSIS PATIENTS; MORPHOLOGIC CHANGES; SCLEROSIS; MEMBRANE; PATHOGENESIS; GROWTH; PERMEABILITY; EXPRESSION; DIAGNOSIS; BIOLOGY	Excessive fibrin deposition in the peritoneum is thought to be involved in the development of encapsulating peritoneal sclerosis (EPS), an important cause of morbidity and mortality in peritoneal dialysis patients. We investigated fibrin-induced epithelial-to-mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs) as a possible mechanism of fibrin involvement in EPS. In vitro, fibrin overlay of PMCs altered their morphology; increased alpha-smooth muscle actin, fibronectin, fibroblast specific protein-1, and alpha(v)beta(3) integrin expression; and decreased cytokeratin 18 and E-cadherin expression. Fibrin overlay also increased focal adhesion kinase and Src kinase phosphorylation. Fibrin-induced changes were inhibited by treating the cells with alpha(v)beta(3) integrin antibody or pentoxifylline (PTX). In a rat model, intraperitoneal injection of Staphylococcus aureus and fibrinogen induced severe EPS features, which were attenuated by PTX treatment. PTX-treated rats also showed preserved peritoneal ultrafiltration function and lower concentrations of cytokines than the untreated rats. S. aureus- and fibrinogen-injected rats had higher percentage of cytokeratin-positive cells in the omentum fibrotic tissue than controls; this was also reduced by PTX treatment. Our results suggest that fibrin induces EMT of PMCs by engaging alpha(v)beta(3) integrin and activating associated kinases. Our EPS animal model showed that fibrin-induced EMT was involved in the pathogenesis of peritoneal fibrosis and was inhibited by PTX.	[Fang, Cheng-Chung] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Fang, Cheng-Chung; Huang, Jenq-Wen; Yen, Chung-Jen; Shiao, Cheng-Hsiang; Chiang, Chih-Kang; Hu, Rey-Heng; Tsai, Tun-Jun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Fang, Cheng-Chung; Huang, Jenq-Wen; Yen, Chung-Jen; Chiang, Chih-Kang; Tsai, Tun-Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Shyu, Ren-Shi] Min Sheng Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Shiao, Cheng-Hsiang] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Hu, Rey-Heng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Fang, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	tjtsai@ntuh.gov.tw		YEN, CHUNG-JEN/0000-0001-5372-3657; HUANG, JENQ-WEN/0000-0001-8011-2317; CHIANG, CHIH-KANG/0000-0001-9021-4616; FANG, CHENG-CHUNG/0000-0001-5386-6674; TSAI, TUN-JUN/0000-0002-1666-8940; HU, REY-HENG/0000-0001-6709-031X	National Science Council [NSC92-2314-B-002-192, NSC93-2314-B-002-148]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund; Department of Medical Research in National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund; Department of Medical Research in National Taiwan University Hospital	This study was supported by grants from the National Science Council NSC92-2314-B-002-192 and NSC93-2314-B-002-148, the Ta-Tung Kidney Foundation, the Mrs. Hsiu-Chin Lee Kidney Research Fund and by the Department of Medical Research in National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKharfy KM, 2000, SHOCK, V13, P346, DOI 10.1097/00024382-200005000-00002; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; De Vriese AS, 2001, PERITON DIALYSIS INT, V21, pS9; Del Paso G, 2005, INT J ARTIF ORGANS, V28, P135, DOI 10.1177/039139880502800209; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Dobbie JW, 1997, PERITON DIALYSIS INT, V17, P121; Fang CC, 2003, PERITON DIALYSIS INT, V23, P228; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Fang CC, 2006, AM J KIDNEY DIS, V48, P875, DOI 10.1053/j.ajkd.2006.07.026; Goedde M, 1997, PERITON DIALYSIS INT, V17, P162; Ha H, 2002, NEPHROLOGY, V7, P220, DOI 10.1046/j.1440-1797.2002.00122.x; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hendriks PMEM, 1997, PERITON DIALYSIS INT, V17, P136; Hoff CM, 2005, PERITON DIALYSIS INT, V25, pS57; Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Hung KY, 2003, NEPHROL DIAL TRANSPL, V18, P670, DOI 10.1093/ndt/gfg141; Io H, 2004, KIDNEY INT, V65, P1927, DOI 10.1111/j.1523-1755.2004.00599.x; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, INT J ARTIF ORGANS, V28, P150, DOI 10.1177/039139880502800211; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; KREDIET RT, 1989, AM J KIDNEY DIS, V13, P299, DOI 10.1016/S0272-6386(89)80036-8; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS19; Lambie ML, 2010, KIDNEY INT, V78, P611, DOI 10.1038/ki.2010.186; Mandl-Weber S, 2001, AM J KIDNEY DIS, V37, P815, DOI 10.1016/S0272-6386(01)80131-1; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Margetts PJ, 2002, J AM SOC NEPHROL, V13, P2787, DOI 10.1681/ASN.V13112787; Margetts PJ, 2002, AM J PATHOL, V160, P2285, DOI 10.1016/S0002-9440(10)61176-5; Ng YY, 2009, AM J NEPHROL, V29, P43, DOI 10.1159/000150600; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Polubinska A, 2000, KIDNEY INT, V57, P1182, DOI 10.1046/j.1523-1755.2000.00946.x; Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141; SAMLASKA CP, 1994, J AM ACAD DERMATOL, V30, P603, DOI 10.1016/S0190-9622(94)70069-9; WHAWELL SA, 1995, EUR J SURG, V161, P315; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809	42	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44765	10.1371/journal.pone.0044765	http://dx.doi.org/10.1371/journal.pone.0044765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028611	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700035
J	Salm, F; Cwiek, P; Ghosal, A; Buccarello, AL; Largey, F; Wotzkow, C; Holand, K; Styp-Rekowska, B; Djonov, V; Zlobec, I; Bodmer, N; Gross, N; Westermann, F; Schafer, SC; Arcaro, A				Salm, F.; Cwiek, P.; Ghosal, A.; Buccarello, A. Lucia; Largey, F.; Wotzkow, C.; Hoeland, K.; Styp-Rekowska, B.; Djonov, V.; Zlobec, I.; Bodmer, N.; Gross, N.; Westermann, F.; Schaefer, S. C.; Arcaro, A.			RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance	ONCOGENE			English	Article						neuroblastoma; RNAi screen; FGFR2; BCL2; chemoresistance; cisplatin	NF-KAPPA-B; DEPENDENT PATHWAY; EXPRESSION; APOPTOSIS; BCL-2; RESISTANCE; AMPLIFICATION; ENZASTAURIN; INHIBITOR; CISPLATIN	Chemotherapeutic drug resistance is one of the major causes for treatment failure in high-risk neuroblastoma (NB), the most common extra cranial solid tumor in children. Poor prognosis is typically associated with MYCN amplification. Here, we utilized a loss-of-function kinome-wide RNA interference screen to identify genes that cause cisplatin sensitization. We identified fibroblast growth factor receptor 2 (FGFR2) as an important determinant of cisplatin resistance. Pharmacological inhibition of FGFR2 confirmed the importance of this kinase in NB chemoresistance. Silencing of FGFR2 sensitized NB cells to cisplatin-induced apoptosis, which was regulated by the downregulation of the anti-apoptotic proteins BCL2 and BCLXL. Mechanistically, FGFR2 was shown to activate protein kinase C-delta to induce BCL2 expression. FGFR2, as well as the ligand fibroblast growth factor-2, were consistently expressed in primary NB and NB cell lines, indicating the presence of an autocrine loop. Expression analysis revealed that FGFR2 correlates with MYCN amplification and with advanced stage disease, demonstrating the clinical relevance of FGFR2 in NB. These findings suggest a novel role for FGFR2 in chemoresistance and provide a rational to combine pharmacological inhibitors against FGFR2 with chemotherapeutic agents for the treatment of NB.	[Salm, F.; Cwiek, P.; Wotzkow, C.; Hoeland, K.; Arcaro, A.] Univ Bern, Dept Clin Res, CH-3004 Bern, Switzerland; [Ghosal, A.; Buccarello, A. Lucia; Largey, F.; Bodmer, N.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Styp-Rekowska, B.; Djonov, V.] Univ Bern, Inst Anat, CH-3004 Bern, Switzerland; [Zlobec, I.; Schaefer, S. C.] Univ Bern, Inst Pathol, CH-3004 Bern, Switzerland; [Gross, N.] CHU Vaudois, Univ Lausanne Hosp, Dept Paediat, CH-1011 Lausanne, Switzerland; [Westermann, F.] German Canc Res Ctr, Dept Tumor Genet, Heidelberg, Dkfz, Germany	University of Bern; University Children's Hospital Zurich; University of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Helmholtz Association; German Cancer Research Center (DKFZ)	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Tiefenaustr 120C, CH-3004 Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	buccarello, lucia/AAO-1407-2020; Arcaro, Alexandre/G-1711-2010; Westermann, Frank/F-7509-2013	buccarello, lucia/0000-0002-3393-653X; Arcaro, Alexandre/0000-0001-9107-2947; Djonov, Valentin/0000-0002-5062-1169; Zlobec, Inti/0000-0001-6741-3000; Cwiek, Paulina/0000-0002-0964-6364	Gottfried und Julia Bangerter-Rhyner-Stiftung; Jubilaumsstiftung Swiss Life; European Union [259348]	Gottfried und Julia Bangerter-Rhyner-Stiftung; Jubilaumsstiftung Swiss Life; European Union(European Commission)	This work was supported by grants from the Gottfried und Julia Bangerter-Rhyner-Stiftung and Jubilaumsstiftung Swiss Life. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259348.	Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Byron SA, 2009, FUTURE ONCOL, V5, P27, DOI 10.2217/14796694.5.1.27; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cole C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12585; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Erovic BM, 2005, CLIN CANCER RES, V11, P8632, DOI 10.1158/1078-0432.CCR-05-1170; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Flahaut M, 2006, GENE CHROMOSOME CANC, V45, P495, DOI 10.1002/gcc.20312; Galanski M, 2006, RECENT PAT ANTI-CANC, V1, P285, DOI 10.2174/157489206777442287; Ghobrial IM, 2011, AM J HEMATOL, V86, P573, DOI 10.1002/ajh.22048; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goldsmith KC, 2010, CELL DEATH DIFFER, V17, P872, DOI 10.1038/cdd.2009.171; Goldsmith KC, 2005, CANCER LETT, V228, P133, DOI 10.1016/j.canlet.2005.01.048; Guo BC, 2004, CURR OPIN IMMUNOL, V16, P367, DOI 10.1016/j.coi.2004.03.012; Herbst RS, 2007, CLIN CANCER RES, V13, p4641S, DOI 10.1158/1078-0432.CCR-07-0538; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Ma S, 2007, CURR OPIN ONCOL, V19, P590, DOI 10.1097/CCO.0b013e3282f10a00; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Michaud WA, 2009, CLIN CANCER RES, V15, P1645, DOI 10.1158/1078-0432.CCR-08-2581; Muth D, CANC RES, V70, P3791; Nikolova Z, 1998, J CELL SCI, V111, P2741; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Sagulenko V, 2008, CARCINOGENESIS, V29, P1869, DOI 10.1093/carcin/bgn147; Sheridan C, 2010, ONCOGENE, V29, P6428, DOI 10.1038/onc.2010.380; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Terrile M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028356; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3944	3953		10.1038/onc.2012.416	http://dx.doi.org/10.1038/onc.2012.416			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	23027129				2022-12-25	WOS:000323748100003
J	Li, ST; Sun, BD; Nilsson, MI; Bird, A; Tarnopolsky, MA; Thurberg, BL; Bali, D; Koeberl, DD				Li, Songtao; Sun, Baodong; Nilsson, Mats I.; Bird, Andrew; Tarnopolsky, Mark A.; Thurberg, Beth L.; Bali, Deeksha; Koeberl, Dwight D.			Adjunctive beta 2-agonists reverse neuromuscular involvement in murine Pompe disease	FASEB JOURNAL			English	Article						mannose-6-phosphate receptor; gene therapy; adeno-associated virus; acid alpha-glucosidase; acid maltase; glycogen storage disease type II	ACID-ALPHA-GLUCOSIDASE; ENZYME REPLACEMENT THERAPY; BETA-ADRENOCEPTOR AGONISTS; BECKER MUSCULAR-DYSTROPHY; GLYCOGEN-STORAGE; SKELETAL-MUSCLE; MOUSE MODEL; IMMUNE-RESPONSE; PILOT TRIAL; IN-VITRO	Pompe disease has resisted enzyme replacement therapy with acid alpha-glucosidase (GAA), which has been attributed to inefficient cation-independent mannose-6-phosphate receptor (CI-MPR) mediated uptake. We evaluated beta 2-agonist drugs, which increased CI-MPR expression in GAA knockout (KO) mice. Clenbuterol along with a low-dose adeno-associated virus vector increased Rotarod latency by 75% at 4 wk, in comparison with vector alone (P < 2 x 10(-5)). Glycogen content was lower in skeletal muscles, including soleus (P < 0.01), extensor digitorum longus (EDL; P < 0.001), and tibialis anterior (P < 0.05) following combination therapy, in comparison with vector alone. Glycogen remained elevated in the muscles following clenbuterol alone, indicating an adjunctive effect with gene therapy. Elderly GAA-KO mice treated with combination therapy demonstrated 2-fold increased wire-hang latency, in comparison with vector or clenbuterol alone (P < 0.001). The glycogen content of skeletal muscle decreased following combination therapy in elderly mice (P < 0.05). Finally, CI-MPR-KO/GAA-KO mice did not respond to combination therapy, indicating that clenbuterol's effect depended on CI-MPR expression. In summary, adjunctive beta 2-agonist treatment increased CI-MPR expression and enhanced efficacy from gene therapy in Pompe disease, which has implications for other lysosomal storage disorders that involve primarily the brain.-Li, S., Sun, B., Nilsson, M. I., Bird, A., Tarnopolsky, M. A., Thurberg, B. L., Bali, D., Koeberl, D. D. Adjunctive beta 2-agonists reverse neuromuscular involvement in murine Pompe disease. FASEB J. 27, 34-44 (2013). www.fasebj.org	[Li, Songtao; Sun, Baodong; Bird, Andrew; Bali, Deeksha; Koeberl, Dwight D.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Nilsson, Mats I.; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON, Canada; [Nilsson, Mats I.; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Thurberg, Beth L.] Genzyme Corp, Dept Pathol, Framingham, MA 01701 USA	Duke University; McMaster University; McMaster University; Sanofi-Aventis; Genzyme Corporation	Koeberl, DD (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Box 103856, Durham, NC 27710 USA.	koebe001@mc.duke.edu	Nilsson, Mats/AAG-2068-2021	Nilsson, Mats/0000-0001-5656-5578	U.S. National Insitutes of Health (NIH) from the National Heart, Lung, and Blood Institute [R01 HL081122]; Genzyme Corp.; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081122] Funding Source: NIH RePORTER	U.S. National Insitutes of Health (NIH) from the National Heart, Lung, and Blood Institute; Genzyme Corp.(Sanofi-AventisGenzyme Corporation); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Insitutes of Health (NIH) grant R01 HL081122 from the National Heart, Lung, and Blood Institute. Partial research grant support for this work from Genzyme Corp. to Y. T. C., D. B., and A. M. W. under a sponsored research agreement is highly appreciated. B. S. was supported by a development grant from the Muscular Dystrophy Association. Ms. Jian Dai provided outstanding technical support for Western blot analysis. Dr. Sarah Young assisted with statistical analyses. GAA-KO mice were provided courtesy of Dr. Nina Raben (NIH, Bethesda, MD, USA). Muscle-specific CI-MPR-KO mice were provided courtesy of Dr. Randy Jirtle (Duke University, Durham, NC, USA). rhGAA was provided under agreement with Genzyme Corp. The AAV8 packaging plasmid was provided courtesy of Dr. James M. Wilson (University of Pennsylvania, Philadelphia, PA, USA). Conflicts of interest: D. B. and D. D. K. have received research/grant support from Genzyme Corp. in the past. B. T. is an employee of Genzyme Corp.	Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Angelini EPC, 2004, BASIC APPL MYOL, V14, P71; Awede BL, 2002, AM J PHYSIOL-ENDOC M, V282, pE31, DOI 10.1152/ajpendo.2002.282.1.E31; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Cresawn KO, 2005, HUM GENE THER, V16, P68, DOI 10.1089/hum.2005.16.68; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Fowler EG, 2004, NEUROLOGY, V62, P1006, DOI 10.1212/01.WNL.0000118530.71646.0F; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Grubb JH, 2010, REJUV RES, V13, P229, DOI 10.1089/rej.2009.0920; Hoshino D, 2012, AM J PHYSIOL-REG I, V302, pR373, DOI 10.1152/ajpregu.00183.2011; Iizuka Hiroyuki, 1998, Journal of Smooth Muscle Research, V34, P139; Jones HN, 2010, DYSPHAGIA, V25, P277, DOI 10.1007/s00455-009-9252-x; Kamalakkannan G, 2008, J HEART LUNG TRANSPL, V27, P457, DOI 10.1016/j.healun.2008.01.013; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kissel JT, 2001, NEUROLOGY, V57, P1434, DOI 10.1212/WNL.57.8.1434; Kobayashi H, 2010, MOL GENET METAB, V100, P14, DOI 10.1016/j.ymgme.2010.01.015; Koeberl DD, 2008, MOL THER, V16, P665, DOI 10.1038/mt.2008.15; Koeberl DD, 2012, MOL GENET METAB, V105, P221, DOI 10.1016/j.ymgme.2011.11.005; Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; MACLENNAN PA, 1989, BIOCHEM J, V264, P573, DOI 10.1042/bj2640573; Mah CS, 2010, MOL THER, V18, P502, DOI 10.1038/mt.2009.305; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Matsumoto T, 2006, ARCH ORAL BIOL, V51, P603, DOI 10.1016/j.archoralbio.2006.01.003; Matthes F, 2011, J BIOL CHEM, V286, P17487, DOI 10.1074/jbc.M110.189381; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mounier R, 2007, PFLUG ARCH EUR J PHY, V453, P497, DOI 10.1007/s00424-006-0122-1; NIALS AT, 1993, BRIT J PHARMACOL, V110, P1112, DOI 10.1111/j.1476-5381.1993.tb13929.x; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Ryall JG, 2008, PHARMACOL THERAPEUT, V120, P219, DOI 10.1016/j.pharmthera.2008.06.003; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Skura CL, 2008, NEUROLOGY, V70, P137, DOI 10.1212/01.WNL.0000287070.00149.a9; Soraru G, 2006, AMYOTROPH LATERAL SC, V7, P246, DOI 10.1080/14660820600600558; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; Sun B., 2010, J GENE MED, V25, P277; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Sun BD, 2009, J GENE MED, V11, P913, DOI 10.1002/jgm.1372; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; Taksir TV, 2007, J HISTOCHEM CYTOCHEM, V55, P991, DOI 10.1369/jhc.7A7239.2007; Torneke K, 1998, J VET PHARMACOL THER, V21, P388, DOI 10.1046/j.1365-2885.1998.00156.x; Uc EY, 2002, MOVEMENT DISORD, V17, P54, DOI 10.1002/mds.10002.abs; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Wang LL, 2007, HUM GENE THER, V18, P185, DOI 10.1089/hum.2007.001; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Wylie AA, 2003, AM J PATHOL, V162, P321, DOI 10.1016/S0002-9440(10)63823-0; Xu F, 2005, J GENE MED, V7, P171, DOI 10.1002/jgm.660; Yanovitch TL, 2010, J PEDIAT OPHTH STRAB, V47, P34, DOI 10.3928/01913913-20100106-08; Zhu Y, 2005, NEUROMUSCULAR DISORD, V15, P712; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; ZIMMER A, 1976, ARZNEIMITTEL-FORSCH, V26, P1446	56	38	38	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					34	44		10.1096/fj.12-207472	http://dx.doi.org/10.1096/fj.12-207472			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22993195	Green Published, Green Submitted			2022-12-25	WOS:000313103200005
J	Motiani, RK; Zhang, XX; Harmon, KE; Keller, RS; Matrougui, K; Bennett, JA; Trebak, M				Motiani, Rajender K.; Zhang, Xuexin; Harmon, Kelly E.; Keller, Rebecca S.; Matrougui, Khalid; Bennett, James A.; Trebak, Mohamed			Orai3 is an estrogen receptor alpha-regulated Ca2+ channel that promotes tumorigenesis	FASEB JOURNAL			English	Article						CRAC; SOCE; Orai1; breast cancer; Ca2+ signaling	CAPACITATIVE CALCIUM-ENTRY; BREAST-CANCER; MICE LACKING; I-CRAC; CELL; ACTIVATION; BORATE; STIM1; DEFICIENCY; APOPTOSIS	Store-operated Ca2+ entry (SOCE) encoded by Orai1 proteins is a ubiquitous Ca2+-selective conductance involved in cellular proliferation and migration. We recently described up-regulation of Orai3 channels that selectively mediate SOCE in estrogen receptor alpha-expressing (ER alpha(+)) breast cancer cells. However, the connection between ER alpha(+) and Orai3 and the role of Orai3 in tumorigenesis remain unknown. Here, we show that ER alpha knockdown decreases Orai3 mRNA (by similar to 63%) and protein (by similar to 44%) with no effect on Orai1. ER alpha knockdown decreases Orai3-mediated SOCE (by similar to 43%) and the corresponding Ca2+ release-activated Ca2+ (CRAC) current (by similar to 42%) in ER alpha(+) MCF7 cells. The abrogation of SOCE in MCF7 cells on ER alpha knockdown can be rescued by ectopic expression of Orai3. ER alpha activation increased Orai3 expression and SOCE in MCF7 cells. Epidermal growth factor (EGF) and thrombin stimulate Ca2+ influx into MCF7 cells through Orai3. Orai3 knockdown inhibited SOCE-dependent phosphorylation of extracellular signal-regulated kinase (ERK1/2; by similar to 44%) and focal adhesion kinase (FAK; by similar to 46%) as well as transcriptional activity of nuclear factor for activated T cells (NFAT; by similar to 49%). Significantly, Orai3 knockdown selectively decreased anchorage-independent growth (by similar to 58%) and Matrigel invasion (by similar to 44%) of ER alpha(+) MCF7 cells with no effect on ER alpha(-) MDA-MB231 cells. Moreover, Orai3 knockdown inhibited ER alpha(+) cell tumorigenesis in immunodeficient mice (similar to 66% reduction in tumor volume). These data establish Orai3 as an ER alpha-regulated channel and a potential selective therapeutic target for ER alpha(+) breast cancers.-Motiani, R. K., Zhang, X., Harmon, K. E., Keller, R. S., Matrougui, K., Bennett, J. A., Trebak, M. Orai3 is an estrogen receptor alpha-regulated Ca2+ channel that promotes tumorigenesis. FASEB J. 27, 63-75 (2013). www.fasebj.org	[Motiani, Rajender K.; Zhang, Xuexin; Harmon, Kelly E.; Keller, Rebecca S.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Bennett, James A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Matrougui, Khalid] Tulane Univ, Dept Physiol, Hypertens & Renal Ctr Excellence, New Orleans, LA 70118 USA	Albany Medical College; Albany Medical College; Tulane University	Trebak, M (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, Mail Code 8,47 New Scotland Ave, Albany, NY 12208 USA.	trebakm@mail.amc.edu	Trebak, Mohamed/E-7405-2014; Zhang, Xuexin/I-7600-2013; 张学新, XUEXIN ZHANG/AAD-7645-2019	张学新, XUEXIN ZHANG/0000-0001-8276-3885	U.S. National Institutes of Health (NIH) [HL-097111]; NIH [HL-095566]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL095566] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research in the authors' laboratory is supported by grant HL-097111 from the U.S. National Institutes of Health (NIH) to M. T., and in part by NIH grant HL-095566 to K.M.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Green D, 2010, CELL CYCLE, V9, P656, DOI 10.4161/cc.9.4.10729; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Herynk Matthew H., 2009, P1, DOI 10.1007/978-0-387-09463-2_1; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McNally B. A., 2012, J PHYSL, V590, P4171; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Santen R, 2009, ANN NY ACAD SCI, V1155, P132, DOI 10.1111/j.1749-6632.2008.03685.x; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Shuttleworth TJ, 2012, J PHYSIOL-LONDON, V590, P241, DOI 10.1113/jphysiol.2011.220574; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2011, J PHYSIOL-LONDON, V589, P5337, DOI 10.1113/jphysiol.2011.220517; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777	45	130	133	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					63	75		10.1096/fj.12-213801	http://dx.doi.org/10.1096/fj.12-213801			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22993197	Green Published			2022-12-25	WOS:000313103200008
J	Ong, KT; Mashek, MT; Bu, SY; Mashek, DG				Ong, Kuok Teong; Mashek, Mara T.; Bu, So Young; Mashek, Douglas G.			Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation	FASEB JOURNAL			English	Article						insulin sensitivity; steatosis; fatty acid and glucose metabolism	ADIPOSE TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE; FATTY LIVER; PPAR-ALPHA; TRIACYLGLYCEROL LIPASE; DIABETES-MELLITUS; TRANSGENIC MICE; STEATOSIS; GLUCOKINASE; SENSITIVITY	Adipose triglyceride lipase (ATGL) is the predominant triacylglycerol (TAG) hydrolase in mammals; however, the tissue-specific effects of ATGL outside of adipose tissue have not been well characterized. Hence, we tested the contribution of hepatic ATGL on mediating glucose tolerance and insulin action. Glucose or insulin tolerance tests and insulin signaling were performed in C57BL/6 mice administered control (nongene specific shRNA) or Atgl shRNA adenoviruses. Glucose and lipid metabolism assays were conducted in primary hepatocytes isolated from mice transduced with control or Atgl shRNA adenoviruses. Knocking down hepatic ATGL completely abrogated the increase in serum insulin following either 1 or 12 wk of feeding a high-fat (HF) diet despite higher hepatic TAG content. Glucose tolerance tests demonstrated that ATGL knockdown normalized glucose tolerance in HF-diet-fed mice. The observed improvements in glucose tolerance were present despite unaltered hepatic insulin signaling and increased liver TAG. Mice with suppressed hepatic ATGL had reduced hepatic glucose production in vivo, and hepatocytes isolated from Atgl shRNA-treated mice displayed a 26% decrease in glucose production and a 38% increase in glucose oxidation compared to control cells. Taken together, these data suggest that hepatic ATGL knockdown enhances glucose tolerance by increasing hepatic glucose utilization and uncouples impairments in insulin action from hepatic TAG accumulation.-Ong, K. T., Mashek, M. T., Bu, SY., Mashek, D. G. Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. FASEB J. 27, 313-321 (2013). www.fasebj.org	[Ong, Kuok Teong; Mashek, Mara T.; Bu, So Young; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Mashek, DG (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.	dmashek@umn.edu	Mashek, Douglas/ABD-6844-2021; Ong, Kuok Teong/H-8274-2015	Ong, Kuok Teong/0000-0001-8605-375X; Mashek, Douglas/0000-0001-7033-3386	U.S. National Institutes of Health (NIH) [DK090364]; Minnesota Obesity Center [NIH DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090364, P30DK050456] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Obesity Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Katie Ress and Ellen Fischer for their excellent technical support. This work was supported by a grant from the U.S. National Institutes of Health (NIH; DK090364) to D.G.M and the Minnesota Obesity Center (NIH DK050456). K.T.O researched and analyzed the data, and wrote and edited the manuscript. S.Y.B assisted in performing the research. M.T.M assisted in performing the research and editing the manuscript. D.G. M contributed to all aspect of this work and is the guarantor of this article. The authors declare no conflicts of interest.	Ahren B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Conti R, 2011, DIABETES, V60, P644, DOI 10.2337/db10-0346; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fan YB, 2011, J BIOL CHEM, V286, P40584, DOI 10.1074/jbc.M111.232918; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; LOPASCHUK GD, 1989, MOL CELL BIOCHEM, V88, P175; MARTIN C, 1991, METABOLISM, V40, P420, DOI 10.1016/0026-0495(91)90154-O; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; RANDLE PJ, 1963, LANCET, V1, P785; RATHEISER K, 1991, METABOLISM, V40, P1185, DOI 10.1016/0026-0495(91)90214-H; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Winzell MS, 2011, EUR J PHARMACOL, V663, P80, DOI 10.1016/j.ejphar.2011.05.009; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	39	40	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					313	321		10.1096/fj.12-213454	http://dx.doi.org/10.1096/fj.12-213454			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22993196	Green Published			2022-12-25	WOS:000313103200029
J	Dong, WY; Zhang, XY; Wang, HM; Dai, XQ; Sun, XM; Qiu, WW; Yang, FT				Dong, Wenyi; Zhang, Xinyu; Wang, Huimin; Dai, Xiaoqin; Sun, Xiaomin; Qiu, Weiwen; Yang, Fengting			Effect of Different Fertilizer Application on the Soil Fertility of Paddy Soils in Red Soil Region of Southern China	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; ORGANIC-MATTER; PHOSPHORUS FRACTIONS; YIELD DECLINES; CROP YIELD; RICE; CARBON; WHEAT; MANURE; DYNAMICS	Appropriate fertilizer application is an important management practice to improve soil fertility and quality in the red soil regions of China. In the present study, we examined the effects of five fertilization treatments [these were: no fertilizer (CK), rice straw return (SR), chemical fertilizer (NPK), organic manure (OM) and green manure (GM)] on soil pH, soil organic carbon (SOC), total nitrogen (TN), C/N ratio and available nutrients (AN, AP and AK) contents in the plowed layer (0-20 cm) of paddy soil from 1998 to 2009 in Jiangxi Province, southern China. Results showed that the soil pH was the lowest with an average of 5.33 units in CK and was significantly higher in NPK (5.89 units) and OM (5.63 units) treatments (P<0.05). The application of fertilizers have remarkably improved SOC and TN values compared with the CK, Specifically, the OM treatment resulted in the highest SOC and TN concentrations (72.5% and 51.2% higher than CK) and NPK treatment increased the SOC and TN contents by 22.0% and 17.8% compared with CK. The average amounts of C/N ratio ranged from 9.66 to 10.98 in different treatments, and reached the highest in OM treatment (P<0.05). During the experimental period, the average AN and AP contents were highest in OM treatment (about 1.6 and 29.6 times of that in the CK, respectively) and second highest in NPK treatment (about 1.2 and 20.3 times of that in the CK). Unlike AN and AP, the highest value of AK content was observed in NPK treatments with 38.10 mg.kg(-1). Thus, these indicated that organic manure should be recommended to improve soil fertility in this region and K fertilizer should be simultaneously applied considering the soil K contents. Considering the long-term fertilizer efficiency, our results also suggest that annual straw returning application could improve soil fertility in this trial region.	[Dong, Wenyi; Zhang, Xinyu; Wang, Huimin; Dai, Xiaoqin; Sun, Xiaomin; Yang, Fengting] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Qiu, Weiwen] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; New Zealand Institute for Plant & Food Research Ltd	Zhang, XY (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	zhangxy@igsnrr.ac.cn	wang, huimin/HDM-8421-2022; Zhang, Kevin/F-5215-2010	qiu, weiwen/0000-0003-4924-7365	Chinese Academy of Sciences [KZCX2-EW-310]; National Natural Science Foundation of China [41171153, 41001179]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-310) and National Natural Science Foundation of China (No. 41171153, 41001179). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D., 2015, SOIL AGR CHEM ANAL, V3; Bhamidimarri SMR, 1996, WATER SCI TECHNOL, V33, P89, DOI 10.1016/0273-1223(96)00265-X; Bhandari A. L., 1992, Journal of the Indian Society of Soil Science, V40, P742; Bi LD, 2009, AGR ECOSYST ENVIRON, V129, P534, DOI 10.1016/j.agee.2008.11.007; Blair N, 2006, SOIL TILL RES, V91, P30, DOI 10.1016/j.still.2005.11.002; Cao CY, 2011, ECOL ENG, V37, P1467, DOI 10.1016/j.ecoleng.2011.03.012; [陈安磊 Chen Anlei], 2010, [生态学报, Acta Ecologica Sinica], V30, P5059; [陈惟财 CHEN Wei-cai], 2009, [土壤通报, Journal of Soil Science], V40, P523; Chen XW, 2003, FOREST ECOL MANAG, V186, P197, DOI 10.1016/S0378-1127(03)00258-5; Darilek JL, 2009, AGR ECOSYST ENVIRON, V129, P286, DOI 10.1016/j.agee.2008.10.002; Daugelene N, 2008, EURASIAN SOIL SCI+, V41, P638, DOI 10.1134/S1064229308060094; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Gu YF, 2009, EUR J SOIL BIOL, V45, P239, DOI 10.1016/j.ejsobi.2009.02.005; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; Huang S, 2010, AGR ECOSYST ENVIRON, V138, P44, DOI 10.1016/j.agee.2010.03.015; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Imbeah M, 1998, BIORESOURCE TECHNOL, V63, P197, DOI 10.1016/S0960-8524(97)00165-X; Kapkiyai JJ, 1999, SOIL BIOL BIOCHEM, V31, P1773, DOI 10.1016/S0038-0717(99)00088-7; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Kumar A, 2001, J AGRON CROP SCI, V186, P47, DOI 10.1046/j.1439-037x.2001.00452.x; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Lee SB, 2009, SOIL TILL RES, V104, P227, DOI 10.1016/j.still.2009.02.007; Li BY, 2010, PEDOSPHERE, V20, P725, DOI 10.1016/S1002-0160(10)60063-X; Li CK, 1983, RED SOILS CHINA; Li J, 2006, ACTA ECOLOGICA SINIC, V26, P2449; Li ZhongPei, 2006, Agricultural Sciences in China, V5, P522, DOI 10.1016/S1671-2927(06)60087-4; Liu KH, 2010, PEDOSPHERE, V20, P399, DOI 10.1016/S1002-0160(10)60029-X; Liu M, 2011, AGR SCI CHINA, V10, P259, DOI 10.1016/S1671-2927(11)60003-5; Lukin L. Yu., 1994, Agrokhimiya, P38; Ma Li, 2009, Acta Pedologica Sinica, V46, P1050; Manna MC, 2007, SOIL TILL RES, V94, P397, DOI 10.1016/j.still.2006.08.013; MITCHELL CC, 1991, AGRON J, V83, P24, DOI 10.2134/agronj1991.00021962008300010010x; Motavalli PP, 2002, BIOL FERT SOILS, V36, P35, DOI 10.1007/s00374-002-0500-6; Nardi S, 2004, EUR J AGRON, V21, P357, DOI 10.1016/j.eja.2003.10.006; Nie J, 2007, PEDOSPHERE, V17, P295, DOI 10.1016/S1002-0160(07)60036-8; Qu J. F., 2009, CHINESE J TROPICAL A, V29, P75; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; SIKKA R, 1995, BIORESOURCE TECHNOL, V51, P199, DOI 10.1016/0960-8524(94)00119-L; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; Sun W, 2011, AGR FOREST METEOROL, V151, P1193, DOI 10.1016/j.agrformet.2011.04.009; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P4949, DOI 10.1016/j.biortech.2007.09.026; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Vogeler I, 2009, SOIL TILL RES, V103, P137, DOI 10.1016/j.still.2008.10.004; [王伯仁 Wang Boren], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P85; Wang YC, 2010, NUTR CYCL AGROECOSYS, V86, P105, DOI 10.1007/s10705-009-9276-5; Whitbread A, 2003, AGR ECOSYST ENVIRON, V100, P251, DOI 10.1016/S0167-8809(03)00189-0; [吴晓晨 Wu xiaochen], 2008, [生态环境, Ecology and Environment], V17, P2019; Wu ZH, 2003, ENVIRON POLLUT, V121, P469, DOI 10.1016/S0269-7491(02)00272-5; Yang JY, 2006, ENVIRON POLLUT, V143, P9, DOI 10.1016/j.envpol.2005.11.010; Yang ShengMao, 2006, Agricultural Sciences in China, V5, P57, DOI 10.1016/S1671-2927(06)60020-5; [袁颖红 YUAN Yinghong], 2008, [土壤, Soils], V40, P237; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhang MK, 2005, SOIL TILL RES, V80, P13, DOI 10.1016/j.still.2004.02.019; Zhang MK, 2004, GEODERMA, V118, P167, DOI 10.1016/S0016-7061(03)00191-5; Zhao J., 2011, ACTA ECOL SIN, V31, P212, DOI [10.1016/j.chnaes.2011.04.001, DOI 10.1016/J.CHNAES.2011.04.001]	57	126	141	12	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44504	10.1371/journal.pone.0044504	http://dx.doi.org/10.1371/journal.pone.0044504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028550	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900012
J	Oh, Y; Fleming, L; Statham, B; Hamblin, P; Barnett, P; Paton, DJ; Park, JH; Joo, YS; Parida, S				Oh, Yooni; Fleming, Lucy; Statham, Bob; Hamblin, Pip; Barnett, Paul; Paton, David J.; Park, Jong-Hyeon; Joo, Yi Seok; Parida, Satya			Interferon-gamma Induced by In Vitro Re-Stimulation of CD4+T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection	PLOS ONE			English	Article							DELTA-T-CELLS; MOUTH-DISEASE; IMMUNE-RESPONSES; VIRUS FMDV; HETEROTYPIC RECOGNITION; NONSTRUCTURAL PROTEINS; CELLULAR-RESPONSES; THERMAL-STABILITY; WHOLE-BLOOD; CD4	The immune defense against FMDV has been correlated to the antibody mediated component. However, there are occasions when some animals with high virus neutralising (VN) antibody are not protected following challenge and some with low neutralising antibody which do not succumb to disease. The importance of cell mediated immunity in clinical protection is less clear and so we investigated the source and production of interferon-gamma (IFN-gamma) in re-stimulated whole blood of FMDV immunized cattle and its correlation to vaccine induced protection and FMDV persistence. We were able to show a positive correlation between IFN-gamma response and vaccine induced protection as well as reduction of long term persistence of FMD virus. When combining this IFN-gamma response in re-stimulated blood with virus neutralizing antibody titer in serum on the day of challenge, a better correlation of vaccine-induced protection with IFN-gamma and VN antibody was predicted. Our investigations also showed that CD4+ T-cells are the major proliferating phenotype and IFN-gamma producing cells.	[Park, Jong-Hyeon; Joo, Yi Seok] Natl Vet Res & Quarantine Serv, Anyang, South Korea	Animal & Plant Quarantine Agency		satya.parida@iah.ac.uk	Parida, Satya/E-5463-2015	Parida, Satya/0000-0001-8253-9461	NVRQS, Korea [1355]; Defra, United Kingdom [SE1125]; European Commission [226556]; BBSRC/UK aid (CIDLID) [BB/H009175/1]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001192, BBS/E/I/00001416, BB/H009175/1] Funding Source: researchfish; BBSRC [BB/H009175/1, BBS/E/I/00001416] Funding Source: UKRI	NVRQS, Korea; Defra, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC/UK aid (CIDLID); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported financially by NVRQS, Korea (project 1355), Defra, United Kingdom (project SE1125), the European Commission (FMD_DISCONVAC project of the EU 7th Framework Programme, grant 226556) and BBSRC/UK aid (CIDLID grant BB/H009175/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EC, 1982, J COMP PATHOL, V92, P495, DOI 10.1016/0021-9975(82)90002-0; [Anonymous], 2006, EUROPEAN PHARMACOPOE, V63; [Anonymous], 2008, MANUAL STANDARDS DIA; Antas PRZ, 2004, BRAZ J MED BIOL RES, V37, P1119, DOI 10.1590/S0100-879X2004000800003; Bautista EM, 2003, VET IMMUNOL IMMUNOP, V92, P61, DOI 10.1016/S0165-2427(03)00004-7; BECKER Y, 1994, VIRUS GENES, V8, P199, DOI 10.1007/BF01703078; BENSAID A, 1991, VET IMMUNOL IMMUNOP, V27, P51, DOI 10.1016/0165-2427(91)90078-Q; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Blanco E, 2001, J VIROL, V75, P3164, DOI 10.1128/JVI.75.7.3164-3174.2001; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BORCA MV, 1986, IMMUNOLOGY, V59, P261; BROWN F, 1992, VACCINE, V10, P1022, DOI 10.1016/0264-410X(92)90111-V; Childerstone AJ, 1999, J GEN VIROL, V80, P663, DOI 10.1099/0022-1317-80-3-663; COLLEN T, 1990, J GEN VIROL, V71, P309, DOI 10.1099/0022-1317-71-2-309; Collen T, 1998, VIRUS RES, V56, P125, DOI 10.1016/S0168-1702(98)00035-5; Collen T., 1994, Cell-mediated immunity in ruminants., P173; Collen T, 1991, T CELL RESPONSES CAT; Cox SJ, 2010, VACCINE, V28, P2318, DOI 10.1016/j.vaccine.2009.12.065; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; DAVIS WC, 1991, VET IMMUNOL IMMUNOP, V27, P43, DOI 10.1016/0165-2427(91)90077-P; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Foster M, 1998, VET QUART, V20, pS28; Fowler V, 2012, ANTIVIR RES, V94, P25, DOI 10.1016/j.antiviral.2012.02.002; Gerner W, 2007, VET RES, V38, P565, DOI 10.1051/vetres:2007016; Goris N, 2007, VACCINE, V25, P3373, DOI 10.1016/j.vaccine.2006.12.049; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzman E, 2008, J GEN VIROL, V89, P667, DOI 10.1099/vir.0.83417-0; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hegde NR, 2009, VACCINE, V27, P2199, DOI 10.1016/j.vaccine.2009.01.032; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; HOLM S, 1979, SCAND J STAT, V6, P65; HOWARD CJ, 1989, EUR J IMMUNOL, V19, P757, DOI 10.1002/eji.1830190428; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACHUGH ND, 1991, VET IMMUNOL IMMUNOP, V27, P65, DOI 10.1016/0165-2427(91)90081-M; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; MCCULLOUGH KC, 1992, VET MICROBIOL, V30, P99, DOI 10.1016/0378-1135(92)90106-4; McCullough KC, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P173; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Oh Y, 2006, SESS RES GROUP STAND; Parida S, 2006, VACCINE, V24, P964, DOI 10.1016/j.vaccine.2005.08.108; Parida S, 2007, J VET DIAGN INVEST, V19, P539, DOI 10.1177/104063870701900513; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Reeve R, 2011, VACCINE, V29, P5467, DOI 10.1016/j.vaccine.2011.05.056; Reid E, 2011, J VIROL, V85, P4297, DOI 10.1128/JVI.02495-10; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; SAIZ JC, 1992, J GEN VIROL, V73, P2601, DOI 10.1099/0022-1317-73-10-2601; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Sammin DJ, 2007, VET REC, V160, P647, DOI 10.1136/vr.160.19.647; Sanz-Parra A, 1999, VIROLOGY, V259, P129, DOI 10.1006/viro.1999.9717; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; SOPP P, 1991, VET IMMUNOL IMMUNOP, V27, P163, DOI 10.1016/0165-2427(91)90095-T; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takamatsu HH, 2006, VET IMMUNOL IMMUNOP, V112, P49, DOI 10.1016/j.vetimm.2006.03.011; Takamatsu HH, 2002, VET IMMUNOL IMMUNOP, V87, P223, DOI 10.1016/S0165-2427(02)00083-1; Tassignon J, 2005, J IMMUNOL METHODS, V305, P188, DOI 10.1016/j.jim.2005.07.014; VANLIEROP MJC, 1995, J VIROL, V69, P4511, DOI 10.1128/JVI.69.7.4511-4514.1995; Vesosky B, 2004, INFECT IMMUN, V72, P4612, DOI 10.1128/IAI.72.8.4612-4618.2004; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Zhang ZD, 2002, ARCH VIROL, V147, P2157, DOI 10.1007/s00705-002-0867-6	65	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44365	10.1371/journal.pone.0044365	http://dx.doi.org/10.1371/journal.pone.0044365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028529	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900010
J	Plaza, SM; Scheffer, LK; Saunders, M				Plaza, Stephen M.; Scheffer, Louis K.; Saunders, Mathew			Minimizing Manual Image Segmentation Turn-Around Time for Neuronal Reconstruction by Embracing Uncertainty	PLOS ONE			English	Article								The ability to automatically segment an image into distinct regions is a critical aspect in many visual processing applications. Because inaccuracies often exist in automatic segmentation, manual segmentation is necessary in some application domains to correct mistakes, such as required in the reconstruction of neuronal processes from microscopic images. The goal of the automated segmentation tool is traditionally to produce the highest-quality segmentation, where quality is measured by the similarity to actual ground truth, so as to minimize the volume of manual correction necessary. Manual correction is generally orders-of-magnitude more time consuming than automated segmentation, often making handling large images intractable. Therefore, we propose a more relevant goal: minimizing the turn-around time of automated/manual segmentation while attaining a level of similarity with ground truth. It is not always necessary to inspect every aspect of an image to generate a useful segmentation. As such, we propose a strategy to guide manual segmentation to the most uncertain parts of segmentation. Our contributions include 1) a probabilistic measure that evaluates segmentation without ground truth and 2) a methodology that leverages these probabilistic measures to significantly reduce manual correction while maintaining segmentation quality.			Saunders, M (corresponding author), Janelia Farm Res Campus, Ashburn, VA USA.	plaza.stephen@gmail.com						Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain V, 2011, LEARNING AGGLOMERATE; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Unnikrishnan R, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P394; Unnikrishnan R, 2007, IEEE T PATTERN ANAL, V29, P929, DOI 10.1109/TPAMI.2007.1046	11	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44448	10.1371/journal.pone.0044448	http://dx.doi.org/10.1371/journal.pone.0044448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028540	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800009
J	Schmiegelow, C; Scheike, T; Oesterholt, M; Minja, D; Pehrson, C; Magistrado, P; Lemnge, M; Rasch, V; Lusingu, J; Theander, TG; Nielsen, BB				Schmiegelow, Christentze; Scheike, Thomas; Oesterholt, Mayke; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lemnge, Martha; Rasch, Vibeke; Lusingu, John; Theander, Thor G.; Nielsen, Birgitte Bruun			Development of a Fetal Weight Chart Using Serial Trans-Abdominal Ultrasound in an East African Population: A Longitudinal Observational Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; BIRTH-WEIGHT; GESTATIONAL-AGE; PERINATAL-MORTALITY; INFANTS BORN; PREGNANCY; STANDARDS; RESTRICTION; PERCENTILES; MATTER	Objective: To produce a fetal weight chart representative of a Tanzanian population, and compare it to weight charts from Sub-Saharan Africa and the developed world. Methods: A longitudinal observational study in Northeastern Tanzania. Pregnant women were followed throughout pregnancy with serial trans-abdominal ultrasound. All pregnancies with pathology were excluded and a chart representing the optimal growth potential was developed using fetal weights and birth weights. The weight chart was compared to a chart from Congo, a chart representing a white population, and a chart representing a white population but adapted to the study population. The prevalence of SGA was assessed using all four charts. Results: A total of 2193 weight measurements from 583 fetuses/newborns were included in the fetal weight chart. Our chart had lower percentiles than all the other charts. Most importantly, in the end of pregnancy, the 10th percentiles deviated substantially causing an overestimation of the true prevalence of SGA newborns if our chart had not been used. Conclusions: We developed a weight chart representative for a Tanzanian population and provide evidence for the necessity of developing regional specific weight charts for correct identification of SGA. Our weight chart is an important tool that can be used for clinical risk assessments of newborns and for evaluating the effect of intrauterine exposures on fetal and newborn weight.	[Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Scheike, Thomas] Univ Copenhagen, Inst Publ Hlth, Dept Biostat, Copenhagen, Denmark; [Oesterholt, Mayke] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Minja, Daniel; Magistrado, Pamela; Lemnge, Martha; Lusingu, John] Natl Inst Med Res, Tanga Med Res Ctr, Tanga, Tanzania; [Pehrson, Caroline] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, DK-5000 Odense, Denmark; [Nielsen, Birgitte Bruun] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Radboud University Nijmegen; National Institute of Medical Research; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University	Schmiegelow, C (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	christentzes@yahoo.dk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022; Rasch, Vibeke/G-9393-2019	Theander, Thor/0000-0002-3509-7514; Rasch, Vibeke/0000-0001-6557-0985; Lusingu, John P. A./0000-0002-9407-0602; Pehrson, Caroline/0000-0002-5736-4847; Scheike, Thomas/0000-0002-2148-4740; shmiegelow, christentze/0000-0002-9360-9741	European Union Framework 7 (STOPPAM, Tanzania) [200889]; Copenhagen University PhD school	European Union Framework 7 (STOPPAM, Tanzania); Copenhagen University PhD school	This study was funded by European Union Framework 7 (STOPPAM, Tanzania) (contract number 200889 and URL: http://cordis.europa.eu/fp7/capacities/research-sme_en.html) and by the Copenhagen University PhD school (URL: http://healthsciences.ku.dk/phd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYANGADE SO, 1986, INT J GYNECOL OBSTET, V24, P35, DOI 10.1016/0020-7292(86)90021-4; Bernstein I M, 1996, J Matern Fetal Med, V5, P124; Bernstein PS, 1997, CLIN OBSTET GYNECOL, V40, P723, DOI 10.1097/00003081-199712000-00006; BOERSMA ER, 1979, TROP GEOGR MED, V31, P7; BROMLEY B, 1993, ULTRASOUND OBST GYN, V3, P395, DOI 10.1046/j.1469-0705.1993.03060395.x; Castetbon K, 1999, J TROP PEDIATRICS, V45, P152, DOI 10.1093/tropej/45.3.152; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Cisse R, 2000, Sante, V10, P169; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; Fan J., 1996, LOCAL POLYNOMIAL MOD; Fry A G, 2002, J Matern Fetal Neonatal Med, V12, P247, DOI 10.1080/jmf.12.4.247.252; Gaillard R, 2011, EUR J EPIDEMIOL, V26, P919, DOI 10.1007/s10654-011-9629-7; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Graafmans WC, 2002, EPIDEMIOLOGY, V13, P569, DOI 10.1097/00001648-200209000-00013; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Hutcheon JA, 2008, BJOG-INT J OBSTET GY, V115, P1397, DOI 10.1111/j.1471-0528.2008.01870.x; Jacquemyn Y, 2000, EARLY HUM DEV, V57, P1, DOI 10.1016/S0378-3782(99)00049-3; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Landis SH, 2009, ULTRASOUND OBST GYN, V34, P379, DOI 10.1002/uog.6357; Mahajan S, 2008, BRIT J NUTR, V100, P408, DOI 10.1017/S000711450889438X; Merialdi M, 2005, ULTRASOUND OBST GYN, V26, P123, DOI 10.1002/uog.1954; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mirghani HM, 2005, J OBSTET GYNAECOL RE, V31, P409, DOI 10.1111/j.1447-0756.2005.00311.x; Mongelli M, 1996, ACTA OBSTET GYN SCAN, V75, P28, DOI 10.3109/00016349609033279; Nahum GG, 2003, AM J OBSTET GYNECOL, V188, P566, DOI 10.1067/mob.2003.155; Narchi H, 2010, J MATERN-FETAL NEO M, V23, P48, DOI 10.3109/14767050903067352; National Bureau of Statistics Tanga Regional Commissioners office, 2008, TANG REG SOC PROF; Odibo AO, 2011, J MATERN-FETAL NEO M, V24, P411, DOI 10.3109/14767058.2010.506566; Ott WJ, 2006, CLIN OBSTET GYNECOL, V49, P295, DOI 10.1097/00003081-200606000-00011; OTT WJ, 1993, AM J OBSTET GYNECOL, V168, P1710, DOI 10.1016/0002-9378(93)90681-8; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Raman S, 1996, INT J GYNECOL OBSTET, V54, P143, DOI 10.1016/0020-7292(96)02685-9; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Salpou Daniel, 2008, BMC Pregnancy Childbirth, V8, P48, DOI 10.1186/1471-2393-8-48; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273; Zhang J, 2011, AM J EPIDEMIOL, V173, P539, DOI 10.1093/aje/kwq411; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Zhang X, 2007, BJOG-INT J OBSTET GY, V114, P474, DOI 10.1111/j.1471-0528.2007.01273.x	46	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44773	10.1371/journal.pone.0044773	http://dx.doi.org/10.1371/journal.pone.0044773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028617	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800017
J	Bottacini, F; Milani, C; Turroni, F; Sanchez, B; Foroni, E; Duranti, S; Serafini, F; Viappiani, A; Strati, F; Ferrarini, A; Delledonne, M; Henrissat, B; Coutinho, P; Fitzgerald, GF; Margolles, A; van Sinderen, D; Ventura, M				Bottacini, Francesca; Milani, Christian; Turroni, Francesca; Sanchez, Borja; Foroni, Elena; Duranti, Sabrina; Serafini, Fausta; Viappiani, Alice; Strati, Francesco; Ferrarini, Alberto; Delledonne, Massimo; Henrissat, Bernard; Coutinho, Pedro; Fitzgerald, Gerald F.; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco			Bifidobacterium asteroides PRL2011 Genome Analysis Reveals Clues for Colonization of the Insect Gut	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; SP-NOV; TRANSCRIPTIONAL REGULATION; DNA MICROARRAYS; GENE-EXPRESSION; OXYGEN; SEQUENCE; ATPASE; RESPIRATION	Bifidobacteria are known as anaerobic/microaerophilic and fermentative microorganisms, which commonly inhabit the gastrointestinal tract of various animals and insects. Analysis of the 2,167,301 bp genome of Bifidobacterium asteroides PRL2011, a strain isolated from the hindgut of Apis mellifera var. ligustica, commonly known as the honey bee, revealed its predicted capability for respiratory metabolism. Conservation of the latter gene clusters in various B. asteroides strains enforces the notion that respiration is a common metabolic feature of this ancient bifidobacterial species, which has been lost in currently known mammal-derived Bifidobacterium species. In fact, phylogenomic based analyses suggested an ancient origin of B. asteroides and indicates it as an ancestor of the genus Bifidobacterium. Furthermore, the B. asteroides PRL2011 genome encodes various enzymes for coping with toxic products that arise as a result of oxygen-mediated respiration.	[Bottacini, Francesca; Turroni, Francesca; Fitzgerald, Gerald F.; van Sinderen, Douwe] Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland; [Bottacini, Francesca; Turroni, Francesca; Fitzgerald, Gerald F.; van Sinderen, Douwe] Natl Univ Ireland, Dept Microbiol, Biosci Inst, Cork, Ireland; [Milani, Christian; Foroni, Elena; Duranti, Sabrina; Serafini, Fausta; Viappiani, Alice; Strati, Francesco; Ventura, Marco] Univ Parma, Lab Probiogen, Dept Genet Biol Microorganisms Anthropol & Evolut, I-43100 Parma, Italy; [Sanchez, Borja; Margolles, Abelardo] CSIC, IPLA, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain; [Ferrarini, Alberto; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37100 Verona, Italy; [Henrissat, Bernard; Coutinho, Pedro] Univ Aix Marseille, Marseille, France	University College Cork; University College Cork; University of Parma; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Verona; UDICE-French Research Universities; Aix-Marseille Universite	van Sinderen, D (corresponding author), Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland.	d.vansinderen@ucc.ie; marco.ventura@unipr.it	Turroni, Francesca/K-9660-2016; Bottacini, Francesca/AAO-2431-2021; Delledonne, Massimo/O-8685-2017; Margolles, Abelardo/H-3871-2012; Milani, Christian/ABA-8160-2020; Duranti, Sabrina/AAI-7916-2020; Henrissat, Bernard/J-2475-2012; Van Sinderen, Douwe/A-6778-2015; Strati, Francesco/K-7789-2016; ventura, marco/M-8230-2015; Sanchez, Borja/B-7770-2009	Turroni, Francesca/0000-0001-5363-0231; Bottacini, Francesca/0000-0002-0142-2956; Margolles, Abelardo/0000-0003-2278-1816; Duranti, Sabrina/0000-0002-7724-5669; Henrissat, Bernard/0000-0002-3434-8588; Van Sinderen, Douwe/0000-0003-1823-7957; Strati, Francesco/0000-0001-7217-3355; Sanchez, Borja/0000-0003-1408-8018; Ferrarini, Alberto/0000-0002-8452-3380; Milani, Christian/0000-0002-5062-3164; Ventura, Marco/0000-0002-4875-4560; Delledonne, Massimo/0000-0002-7100-4581	Cariparma Bank Foundation; Federation European Microbiology society (FEMS); Irish Research Council for Science, Engineering & Technology (IRCSET); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [07/CE/B1368, 08/SRC/B1393]	Cariparma Bank Foundation; Federation European Microbiology society (FEMS); Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This work was financially supported by the Cariparma Bank Foundation to MV. This work was also financially supported by a Federation European Microbiology society (FEMS) Advanced Fellowship 2011 and an Irish Research Council for Science, Engineering & Technology (IRCSET) Embark postdoctoral fellowship to FT. DV is a member of The Alimentary Pharmabiotic Centre and the Alimentary Glycoscience Research Cluster, both funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (grant nos. 07/CE/B1368 and 08/SRC/B1393, respectively). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Bilban M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-19; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brokl M, 2010, J AGR FOOD CHEM, V58, P11561, DOI 10.1021/jf102646n; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI [DOI 10.1128/jb.172.11.6333-6338.1990, 10.1128/jb.172.11.6333-6338.1990]; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; Creevey CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002269; DEVRIES W, 1969, ARCH MIKROBIOL, V65, P275; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Kasimoglu E, 1996, J BACTERIOL, V178, P5563, DOI 10.1128/jb.178.19.5563-5567.1996; Kawasaki S, 2006, APPL ENVIRON MICROB, V72, P6854, DOI 10.1128/AEM.01216-06; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, ANAEROBE, V16, P165, DOI 10.1016/j.anaerobe.2009.07.007; Kim JF, 2009, J BACTERIOL, V191, P678, DOI 10.1128/JB.01515-08; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Lemme A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-58; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macfarlane S, 2011, ADV APPL MICROBIOL, V75, P111, DOI 10.1016/B978-0-12-387046-9.00005-0; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; MCGAVIN GC, 1994, NATURE, V370, P261; Meile L, 1997, SYST APPL MICROBIOL, V20, P57, DOI 10.1016/S0723-2020(97)80048-3; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Mozzetti V, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-60; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paoli M, 2001, PROG BIOPHYS MOL BIO, V76, P103, DOI 10.1016/S0079-6107(01)00007-4; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez B, 2006, ENVIRON MICROBIOL, V8, P1825, DOI 10.1111/j.1462-2920.2006.01067.x; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Scardovi V, 1969, Zentralbl Bakteriol Parasitenkd Infektionskr Hyg, V123, P64; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; SHIMAMURA S, 1992, J DAIRY SCI, V75, P3296, DOI 10.3168/jds.S0022-0302(92)78105-3; Simpson PJ, 2005, J APPL MICROBIOL, V99, P493, DOI 10.1111/j.1365-2672.2005.02648.x; Simpson PJ, 2004, INT J SYST EVOL MICR, V54, P401, DOI 10.1099/ijs.0.02667-0; Stevens TJ, 2008, PROTEINS, V70, P378, DOI 10.1002/prot.21521; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121; Ventura M, 2004, APPL ENVIRON MICROB, V70, P6197, DOI 10.1128/AEM.70.10.6197-6209.2004; Ventura M, 2001, FEMS MICROBIOL ECOL, V36, P113, DOI 10.1111/j.1574-6941.2001.tb00831.x; Ventura M, 2012, TRENDS MICR IN PRESS; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; Ventura M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000785; Volfovsky N., 2001, GENOME BIOL, V2, DOI [DOI 10.1186/GB-2001-2-8-RESEARCH0027, 10.1186/gb-2001-2-8-research0027]; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Yokota A, 2000, J BACTERIOL, V182, P5196, DOI 10.1128/JB.182.18.5196-5201.2000	80	100	112	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44229	10.1371/journal.pone.0044229	http://dx.doi.org/10.1371/journal.pone.0044229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028506	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900007
J	Berent, I; Vaknin-Nusbaum, V; Balaban, E; Galaburda, AM				Berent, Iris; Vaknin-Nusbaum, Vered; Balaban, Evan; Galaburda, Albert M.			Dyslexia Impairs Speech Recognition but Can Spare Phonological Competence	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; LANGUAGE IMPAIRMENT; PERCEPTION DEFICITS; NONSPEECH SOUNDS; BRAIN RESPONSES; CHILDREN; DISCRIMINATION; REPRESENTATIONS; IDENTIFICATION; DIFFICULTIES	Dyslexia is associated with numerous deficits to speech processing. Accordingly, a large literature asserts that dyslexics manifest a phonological deficit. Few studies, however, have assessed the phonological grammar of dyslexics, and none has distinguished a phonological deficit from a phonetic impairment. Here, we show that these two sources can be dissociated. Three experiments demonstrate that a group of adult dyslexics studied here is impaired in phonetic discrimination (e. g., ba vs. pa), and their deficit compromises even the basic ability to identify acoustic stimuli as human speech. Remarkably, the ability of these individuals to generalize grammatical phonological rules is intact. Like typical readers, these Hebrew-speaking dyslexics identified ill-formed AAB stems (e. g., titug) as less wordlike than well-formed ABB controls (e. g., gitut), and both groups automatically extended this rule to nonspeech stimuli, irrespective of reading ability. The contrast between the phonetic and phonological capacities of these individuals demonstrates that the algebraic engine that generates phonological patterns is distinct from the phonetic interface that implements them. While dyslexia compromises the phonetic system, certain core aspects of the phonological grammar can be spared.	[Berent, Iris] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Vaknin-Nusbaum, Vered] Akko & Univ Haifa, Western Galilee Coll, Haifa, Israel; [Balaban, Evan] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Galaburda, Albert M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cognit Neurol,Med Sch, Boston, MA 02215 USA	Northeastern University; McGill University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Berent, I (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	i.berent@neu.edu	Balaban, Evan/AAV-2353-2020; Vaknin-Nusbaum, Vered/AHD-9240-2022	Balaban, Evan/0000-0002-0391-3433; Vaknin-Nusbaum, Vered/0000-0003-3799-876X	National Institute on Deafness and Other Communication Disorders [R01DC003277]; Canadian Fund for Innovation [9908]; National Insitutes of Health [HD057853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003277] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Canadian Fund for Innovation; National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institute on Deafness and Other Communication Disorders grant R01DC003277 to IB, Canadian Fund for Innovation 9908 to EB and National Insitutes of Health grant HD057853 to AMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER WL, 1989, J SOC BIOL STRUCT, V12, P1, DOI 10.1016/0140-1750(89)90015-8; Adlard A, 1998, Q J EXP PSYCHOL-A, V51, P153, DOI 10.1080/713755750; [Anonymous], 1995, HDB PHONOLOGICAL THE; Azadpour M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001966; Bat-El O, 2006, LINGUIST INQ, V37, P179, DOI 10.1162/ling.2006.37.2.179; Beaujean AA, 2006, PERS INDIV DIFFER, V41, P353, DOI 10.1016/j.paid.2006.01.014; Berent I, 2002, COGNITION, V83, P113, DOI 10.1016/S0010-0277(01)00167-6; Berent I, 1997, COGNITION, V64, P39, DOI 10.1016/S0010-0277(97)00016-4; Berent I, 2001, COGNITIVE PSYCHOL, V42, P1, DOI 10.1006/cogp.2000.0742; Berent I, 2001, J MEM LANG, V44, P644, DOI 10.1006/jmla.2000.2760; Berent I, 2012, PHONOLOGICAL MIND; Berent I, 2008, P NATL ACAD SCI USA, V105, P5321, DOI 10.1073/pnas.0801469105; Berent I, 2007, COGNITION, V104, P254, DOI 10.1016/j.cognition.2006.06.002; Berent I, 2012, LINGUIST INQ, V43, P97, DOI 10.1162/LING_a_00075; Berent I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00182; Berent I, 2010, J EXP PSYCHOL GEN, V139, P418, DOI 10.1037/a0020094; Berent I, 2006, MENT LEX, V1, P201, DOI 10.1075/ml.1.2.03ber; Blomert L, 2004, J SPEECH LANG HEAR R, V47, P1030, DOI 10.1044/1092-4388(2004/077); BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; BRANDT J, 1980, BRAIN LANG, V9, P324, DOI 10.1016/0093-934X(80)90152-2; Brentari D, 2012, NATURAL LANGUAGE LIN, V30; Brentari Diane, 1998, PROSODIC MODEL SIGN; Breznitz Z, 2004, ELUL LEARNING DISABI; Buchwald AB, 2007, LANG COGNITIVE PROC, V22, P910, DOI 10.1080/01690960701273532; Chiappe P, 2001, J EXP CHILD PSYCHOL, V80, P58, DOI 10.1006/jecp.2000.2624; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Corina DP, 2001, NEUROREPORT, V12, P1195, DOI 10.1097/00001756-200105080-00029; de Lacy Paul, 2004, PHONOLOGY, V21, P145, DOI DOI 10.1017/S0952675704000193; Dehaene S., 2009, READING BRAIN SCI EV; Frey MC, 2004, PSYCHOL SCI, V15, P373, DOI 10.1111/j.0956-7976.2004.00687.x; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Gervain J, 2012, J COGNITIVE NEUROSCI, V24, P564, DOI 10.1162/jocn_a_00157; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; GODFREY JJ, 1981, J EXP CHILD PSYCHOL, V32, P401, DOI 10.1016/0022-0965(81)90105-3; Greenberg JH, 1950, WORD, V6, P162, DOI 10.1080/00437956.1950.11659378; Hayes Bruce, 1999, FUNCTIONALISM FORMAL, VI, P243, DOI DOI 10.1002/9780470756171.CH15; Hazan V, 2009, J SPEECH LANG HEAR R, V52, P1510, DOI 10.1044/1092-4388(2009/08-0220); Helenius P, 2002, J COGNITIVE NEUROSCI, V14, P603, DOI 10.1162/08989290260045846; Janse E, 2010, J PSYCHOLINGUIST RES, V39, P523, DOI 10.1007/s10936-010-9150-2; KEATING PA, 1984, LANGUAGE, V60, P286, DOI 10.2307/413642; Lalain M, 2003, BRAIN COGNITION, V53, P253, DOI 10.1016/S0278-2626(03)00121-0; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leppanen PHT, 2002, DEV NEUROPSYCHOL, V22, P407, DOI 10.1207/S15326942dn2201_4; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Maassen B, 2001, CLIN LINGUIST PHONET, V15, P319; Maionchi-Pino N, 2012, COMPREHENSIVE INT AP; Marcus G., 2001, ALGEBRAIC MIND INTEG; Marshall CR, 2010, COGN NEUROPSYCHOL, V27, P563, DOI 10.1080/02643294.2011.588693; Marshall CR, 2009, LANGUAGE, V85, P39, DOI 10.1353/lan.0.0081; McArthur G, 2009, DEVELOPMENTAL SCI, V12, P768, DOI 10.1111/j.1467-7687.2008.00804.x; MCCARTHY JJ, 1981, LINGUIST INQ, V12, P373; MCCARTHY JJ, 1986, LINGUIST INQ, V17, P207; MCCARTHY JJ, 1989, LINGUIST INQ, V20, P71; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); MESTER RA, 1989, LANGUAGE, V65, P258, DOI 10.2307/415333; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Olson R., 1990, READING ITS DEV COMP, P261; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Ouimet T, 2009, DYSLEXIA CHICHESTER, V16, P45; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Paul I, 2006, EUR J NEUROSCI, V24, P2945, DOI 10.1111/j.1460-9568.2006.05153.x; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; PINKER S, 1988, COGNITION, V28, P73, DOI 10.1016/0010-0277(88)90032-7; Poulsen M, 2011, APPL PSYCHOLINGUIST, V32, P245, DOI 10.1017/S0142716410000391; Prince Alan., 2004, OPTIMALITY THEORY CO; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Robertson EK, 2009, DEVELOPMENTAL SCI, V12, P753, DOI 10.1111/j.1467-7687.2009.00806.x; Rose S, 2004, LANGUAGE, V80, P475, DOI 10.1353/lan.2004.0144; Rosen S, 2001, J SPEECH LANG HEAR R, V44, P720, DOI 10.1044/1092-4388(2001/057); Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W, 2011, NAT LANG LINGUIST TH, V29, P503, DOI 10.1007/s11049-011-9128-2; Savill NJ, 2011, BRAIN RES, V1385, P192, DOI 10.1016/j.brainres.2011.02.012; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Shankweiler D., 2012, ENCY HUMAN BEHAV, V3, P249; Shany M, 2005, ALEPH TAPH ASSESSMEN; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Smolensky Paul, 2006, HARMONIC MIND NEURAL, P27; Soroli E, 2010, DYSLEXIA, V16, P318, DOI 10.1002/dys.415; SUZUKI K, 1998, TYPOLOGICAL INVESTIG; Szenkovits G, 2005, DYSLEXIA, V11, P253, DOI 10.1002/dys.308; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Theodore RM, 2010, J ACOUST SOC AM, V128, P2090, DOI 10.1121/1.3467771; Theodore RM, 2009, J ACOUST SOC AM, V125, P3974, DOI 10.1121/1.3106131; van Herten M, 2008, BRAIN RES, V1201, P100, DOI 10.1016/j.brainres.2008.01.060; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; WERKER JF, 1987, CAN J PSYCHOL, V41, P48, DOI 10.1037/h0084150; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wolmetz M, 2011, J COGNITIVE NEUROSCI, V23, P552, DOI 10.1162/jocn.2010.21495; YIP M, 1988, LINGUIST INQ, V19, P65; Zeguers MHT, 2011, DEVELOPMENTAL SCI, V14, P1340, DOI 10.1111/j.1467-7687.2011.01091.x; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x; Zsiga EC, 2000, J PHONETICS, V28, P69, DOI 10.1006/jpho.2000.0109	101	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44875	10.1371/journal.pone.0044875	http://dx.doi.org/10.1371/journal.pone.0044875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028654	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400046
J	Chuang, CM; Chang, CH; Wang, HE; Chen, KC; Peng, CC; Hsieh, CL; Peng, RY				Chuang, Chao-Ming; Chang, Chi-Huang; Wang, Hui-Er; Chen, Kuan-Chou; Peng, Chiung-Chi; Hsieh, Chiu-Lan; Peng, Robert Y.			Valproic Acid Downregulates RBP4 and Elicits Hypervitaminosis A-Teratogenesis-A Kinetic Analysis on Retinol/Retinoic Acid Homeostatic System	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; HISTONE-DEACETYLASE INHIBITORS; EXPRESSION; MECHANISM; ANTICONVULSANT; DEHYDROGENASE; METABOLITES; RECEPTORS; CARNITINE; OXIDATION	Background: Valproic acid (VPA) is an antiepileptic and anti-migraine prophylactic drug. VPA exhibits two severe side effects, namely acute liver toxicity and teratogenicity. These side effects are usually seen at the genetic and somatic levels. The cited action mechanisms involve inhibition of histone deacetylase, hypofolatenemia, hyperhomocysteinemia, and reactive oxidative stress. The proteomic information associated with VPA teratogenicity is still unavailable. We hypothesized that proteomic analysis might help us identify functional proteins that could be relevantly affected by VPA, and this phenomenon could be very sensitive in early embryonic stage, resulting in VPA teratogenicity. Methodology/Principal Findings: Proteomic analysis on the chicken embryos at Hamburger and Hamilton (HH) stage 28 showed that there were significant downregulations of ovotransferrins, carbonic anhydrase-2, retinol binding protein-4 (RBP4), NADH cytochrome b5 reductase 2 (CYB5R2), apolipoprotein A1, and protein SET, together with upregulation of 60S ribosomal protein L22. Among these, RBP4 was the most significantly downregulated (-32%). Kinetic analysis suggested that this situation could trigger hypervitaminosis A (+39.3%), a condition that has been well known to induce teratogenesis.. Conclusions/Significance: This is the first report showing that VPA dowregulates RBP4. Our finding not only has led to a possible mechanism of VPA teratogenesis, but also has initiated new preventive strategies for avoiding VPA teratogeneis.	[Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Sch Med, Coll Med, Taipei, Taiwan; [Chuang, Chao-Ming] Hungkuang Univ, Dept Nursing, Taichung, Shalu County, Taiwan; [Chang, Chi-Huang; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Shalu County, Taiwan; [Wang, Hui-Er] Hungkuang Univ, Dept Food & Appl Technol, Taichung, Shalu County, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Shuang Ho Hosp, Taipei, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Hsieh, Chiu-Lan] Changhua Univ Educ, Grad Inst Biotechnol, Changhua, Taiwan	Taipei Medical University; Hungkuang University; Hungkuang University; Hungkuang University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Changhua University of Education	Chen, KC (corresponding author), Taipei Med Univ, Dept Urol, Sch Med, Coll Med, Taipei, Taiwan.	kc.chen416@msa.hinet.net; misspeng@ms2.hinet.net; clhsieh@ncue.edu.tw			National Science Council [NSC 99-2313-B-018-002-MY3, 99-2320-B-038-011-MY3, 101-2320-B-039-040-]	National Science Council(Ministry of Science and Technology, Taiwan)	The authors are grateful for financial support from the National Science Council (NSC 99-2313-B-018-002-MY3, 99-2320-B-038-011-MY3 and 101-2320-B-039-040-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are also grateful for the Mass Spectrometric Analyses performed at the Proteomics Core Laboratory, Office of Research and Development of China Medical University, Taichung, Taiwan.	Bennett GD, 1997, EPILEPSIA, V38, P415, DOI 10.1111/j.1528-1157.1997.tb01730.x; Berni R, 1994, J BIOL CHEM, V69, P29613; Chen H, 2000, DRUG METAB DISPOS, V28, P315; COHLAN SQ, 1953, SCIENCE, V117, P535, DOI 10.1126/science.117.3046.535; DENCKER L, 1990, DEVELOPMENT, V110, P343; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Eikel D, 2006, CHEM RES TOXICOL, V19, P272, DOI 10.1021/tx0502241; Fernandez I, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-7; FEX G, 1979, EUR J BIOCHEM, V99, P353, DOI 10.1111/j.1432-1033.1979.tb13263.x; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Gropper SS, 2009, ADV NUTR HUMAN METAB, P373; Hsieh CL, 2012, TOXICOLOGY, V291, P32, DOI 10.1016/j.tox.2011.10.015; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Ishikura H, 1996, J ANAL TOXICOL, V20, P55, DOI 10.1093/jat/20.1.55; JACONI S, 1995, J LIPID RES, V36, P1247; JENKINSON PC, 1986, TERATOGEN CARCIN MUT, V6, P547, DOI 10.1002/tcm.1770060608; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; KAKKAD BP, 1988, J BIOL CHEM, V263, P12916; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Koch S, 1996, ACTA PAEDIATR, V85, P739, DOI 10.1111/j.1651-2227.1996.tb14137.x; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Kwon HJ, 2002, INT J CANCER, V97, P290, DOI 10.1002/ijc.1602; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; LOSCHER W, 1983, J PHARMACOL EXP THER, V226, P845; LUDER AS, 1990, J CLIN INVEST, V86, P1574, DOI 10.1172/JCI114877; Maden M, 1997, DEVELOPMENT, V124, P2799; MADEN M, 1991, DIFFERENTIATION, V47, P49, DOI 10.1111/j.1432-0436.1991.tb00220.x; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; MOONEY MP, 1981, NEUROBEH TOXICOL TER, V3, P1; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; OMTZIGT JGC, 1992, NEUROLOGY, V42, P119; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Peter H, 2006, BIOCH PATHOBIOCHEMIE, P123; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1993, DEVELOPMENT, V118, P267; Sha K, 2010, BIRTH DEFECTS RES B, V89, P124, DOI 10.1002/bdrb.20236; SUNDARESAN PR, 1977, J NUTR, V107, P70, DOI 10.1093/jn/107.1.70; Tabatabaei AR, 1999, CHEM RES TOXICOL, V12, P323, DOI 10.1021/tx9801864; Takebayashi K, 2011, BIOCHEM BIOPH RES CO, V408, P58, DOI 10.1016/j.bbrc.2011.03.116; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; VANDERLAAN JW, 1979, J NEUROCHEM, V32, P1769, DOI 10.1111/j.1471-4159.1979.tb02290.x; Whitsel AI, 2002, TERATOLOGY, V66, P153, DOI 10.1002/tera.10093; Wysocka-Kapcinska M, 2010, PROTEIN EXPRES PURIF, V71, P28, DOI 10.1016/j.pep.2010.01.015	54	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43692	10.1371/journal.pone.0043692	http://dx.doi.org/10.1371/journal.pone.0043692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028466	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400012
J	Schnatwinkel, C; Niswander, L				Schnatwinkel, Carsten; Niswander, Lee			Nubp1 Is Required for Lung Branching Morphogenesis and Distal Progenitor Cell Survival in Mice	PLOS ONE			English	Article							MOUSE EMBRYOS; PROTEIN; ORIENTATION; EXPRESSION; EPITHELIUM; DYNAMICS; POLARITY; ATPASES; BRAIN; TUBE	The lung is a complex system in biology and medicine alike. Whereas there is a good understanding of the anatomy and histology of the embryonic and adult lung, less is known about the molecular details and the cellular pathways that ultimately orchestrate lung formation and affect its health. From a forward genetic approach to identify novel genes involved in lung formation, we identified a mutated Nubp1 gene, which leads to syndactyly, eye cataract and lung hypoplasia. In the lung, Nubp1 is expressed in progenitor cells of the distal epithelium. Nubp1(m1Nisw) mutants show increased apoptosis accompanied by a loss of the distal progenitor markers Sftpc, Sox9 and Foxp2. In addition, Nubp1 mutation disrupts localization of the polarity protein Par3 and the mitosis relevant protein Numb. Using knock-down studies in lung epithelial cells, we also demonstrate a function of Nubp1 in regulating centrosome dynamics and microtubule organization. Together, Nubp1 represents an essential protein for lung progenitor survival by coordinating vital cellular processes including cell polarity and centrosomal dynamics.	[Niswander, Lee] Univ Colorado, Sch Med, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA; Childrens Hosp Colorado, Aurora, CO USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Niswander, L (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA.	Lee.Niswander@ucdenver.edu	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594	American Asthma Foundation award; National Institutes of Health (NIH) [R21HL089431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089431] Funding Source: NIH RePORTER	American Asthma Foundation award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by an American Asthma Foundation award and by National Institutes of Health (NIH) (R21HL089431). LN is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu AM, 1999, DEVELOPMENT, V126, P4827; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Okuno T, 2010, MOL BIOL REP, V37, P1165, DOI 10.1007/s11033-009-9477-7; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44871	10.1371/journal.pone.0044871	http://dx.doi.org/10.1371/journal.pone.0044871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028652	Green Published, Green Submitted, gold			2022-12-25	WOS:000309742800021
J	Arnold, M; Durairaj, V; Mundt, E; Schulze, K; Breunig, KD; Behrens, SE				Arnold, Marina; Durairaj, Vijay; Mundt, Egbert; Schulze, Katja; Breunig, Karin D.; Behrens, Sven-Erik			Protective Vaccination against Infectious Bursal Disease Virus with Whole Recombinant Kluyveromyces lactis Yeast Expressing the Viral VP2 Subunit	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; GLUCOSE REPRESSION; HETEROLOGOUS PROTEINS; ANTIGENIC PROPERTIES; VIRULENT CHALLENGE; STRUCTURAL PROTEIN; CONFERS PROTECTION; INDUCE PROTECTION; CAPSID PROTEIN	Here we report on vaccination approaches against infectious bursal disease (IBD) of poultry that were performed with complete yeast of the species Kluyveromyces lactis (K. lactis). Employing a genetic system that enables the rapid production of stably transfected recombinant K. lactis, we generated yeast strains that expressed defined quantities of the virus capsid forming protein VP2 of infectious bursal disease virus (IBDV). Both, subcutaneous as well as oral vaccination regiments with the heat-inactivated but otherwise untreated yeast induced IBDV-neutralizing antibodies in mice and chickens. A full protection against a subsequent IBDV infection was achieved by subcutaneous inoculation of only milligram amounts of yeast per chicken. Oral vaccination also generated protection: while mortality was observed in control animals after virus challenge, none of the vaccinees died and ca. one-tenth were protected as indicated by the absence of lesions in the bursa of Fabricius. Recombinant K. lactis was thus indicated as a potent tool for the induction of a protective immune response by different applications. Subcutaneously applied K. lactis that expresses the IBDV VP2 was shown to function as an efficacious anti-IBD subunit vaccine.	[Arnold, Marina; Behrens, Sven-Erik] Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biochem & Biotechnol, Halle, Germany; [Arnold, Marina; Schulze, Katja; Breunig, Karin D.] Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biol, Halle, Germany; [Durairaj, Vijay; Mundt, Egbert] Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Athens, GA USA; [Mundt, Egbert] IDT Biol GmbH, Dessau Rosslau, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University System of Georgia; University of Georgia; IDT Biologika	Arnold, M (corresponding author), Univ Halle Wittenberg, Fac Life Sci NFI, Inst Biochem & Biotechnol, Halle, Germany.	sven.behrens@biochemtech.uni-halle.de			ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA) [03FO1232]	ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA)(Federal Ministry of Education & Research (BMBF))	This study was supported by the ForMaT initiative of the Bundesministerium fur Bildung und Forschung (BMBF; project VAKZiNOVA, 03FO1232), Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiani A, 2010, FEMS YEAST RES, V10, P1060, DOI 10.1111/j.1567-1364.2010.00665.x; AZAD AA, 1991, VACCINE, V9, P715, DOI 10.1016/0264-410X(91)90286-F; Backhaus K, 2011, EUR J CELL BIOL, V90, P745, DOI 10.1016/j.ejcb.2011.04.005; BATHURST IC, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.20; BECHT H, 1988, J GEN VIROL, V69, P631, DOI 10.1099/0022-1317-69-3-631; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Blanquet S, 2004, J BIOTECHNOL, V110, P37, DOI 10.1016/j.jbiotec.2004.01.012; BOX P, 1989, WORLD POULTRY, V53, P17; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; Bublot M, 2007, J COMP PATHOL, V137, pS81, DOI 10.1016/j.jcpa.2007.04.017; Burns KE, 2003, AVIAN DIS, V47, P54, DOI 10.1637/0005-2086(2003)047[0054:EOTEOH]2.0.CO;2; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Cox E, 2006, VET RES, V37, P511, DOI 10.1051/vetres:2006014; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; DARTEIL R, 1995, VIROLOGY, V211, P481, DOI 10.1006/viro.1995.1430; Dey S, 2009, J VIROL METHODS, V157, P84, DOI 10.1016/j.jviromet.2008.11.020; Donnini C, 2004, APPL ENVIRON MICROB, V70, P2632, DOI 10.1128/AEM.70.5.2632-2638.2004; DROUAL R, 1990, AVIAN DIS, V34, P473, DOI 10.2307/1591439; ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189; FAHEY KJ, 1991, AVIAN DIS, V35, P365, DOI 10.2307/1591191; FAHEY KJ, 1989, J GEN VIROL, V70, P1473, DOI 10.1099/0022-1317-70-6-1473; Francois A, 2004, VACCINE, V22, P2351, DOI 10.1016/j.vaccine.2003.10.039; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P39, DOI 10.1006/mpat.2000.0364; Gellissen G, 1997, GENE, V190, P87, DOI 10.1016/S0378-1119(97)00020-6; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; HEINE HG, 1993, ARCH VIROL, V131, P277, DOI 10.1007/BF01378632; Hensel A, 1996, J BIOTECHNOL, V44, P171, DOI 10.1016/0168-1656(95)00150-6; HIRAI K, 1979, INFECT IMMUN, V25, P964, DOI 10.1128/IAI.25.3.964-970.1979; Hoshi S, 1999, COMP IMMUNOL MICROB, V22, P63, DOI 10.1016/S0147-9571(98)00017-4; Icard AH, 2008, AVIAN DIS, V52, P590, DOI 10.1637/8302-040408-Reg.1; JAGADISH MN, 1991, GENE, V108, P275, DOI 10.1016/0378-1119(91)90445-H; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; Krijger JJ, 2012, MICROB CELL IN PRESS; KUGER P, 1990, NUCLEIC ACIDS RES, V18, P745, DOI 10.1093/nar/18.4.745; Kumar K, 2000, TROP ANIM HEALTH PRO, V32, P357, DOI 10.1023/A:1005225501513; Lai SY, 2004, PROCESS BIOCHEM, V39, P571, DOI 10.1016/S0032-9592(03)00124-9; Li L, 2006, VACCINE, V24, P5919, DOI 10.1016/j.vaccine.2006.04.057; Lu YN, 2004, CANCER RES, V64, P5084, DOI 10.1158/0008-5472.CAN-04-1487; LUCIO B, 1979, AVIAN DIS, V23, P1037, DOI 10.2307/1589620; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; MULDER W, 1995, CURR GENET, V28, P267, DOI 10.1007/BF00309786; MULLER H, 1986, ARCH VIROL, V87, P191, DOI 10.1007/BF01315299; OKOYE JOA, 1983, TROP ANIM HEALTH PRO, V15, P221, DOI 10.1007/BF02242062; Perozo F, 2008, AVIAN DIS, V52, P315, DOI 10.1637/8122-100207-ResNote.1; Petkov DI, 2009, AVIAN DIS, V53, P347, DOI 10.1637/8456-082208-Reg.1; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; Pitcovski J, 1996, AVIAN DIS, V40, P753, DOI 10.2307/1592294; Prideaux CT, 1999, INFECT IMMUN, V67, P1962; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rautenschlein S, 2002, VET IMMUNOL IMMUNOP, V89, P159, DOI 10.1016/S0165-2427(02)00202-7; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Rong J, 2007, VACCINE, V25, P7900, DOI 10.1016/j.vaccine.2007.09.006; ROSALES AG, 1989, AVIAN DIS, V33, P729, DOI 10.2307/1591152; Rosenberger JK, 1986, 123 M AM VET MED ASS; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Schreuder MP, 1996, VACCINE, V14, P383, DOI 10.1016/0264-410X(95)00206-G; Schroder A, 2000, J GEN VIROL, V81, P533, DOI 10.1099/0022-1317-81-2-533; Shaw I, 2000, VACCINE, V18, P3230, DOI 10.1016/S0264-410X(00)00133-X; Sheppard M, 1998, ARCH VIROL, V143, P915, DOI 10.1007/s007050050342; Sherman F., 1986, METHODS YEAST GENETI; Shin SJ, 2005, FEMS IMMUNOL MED MIC, V43, P155, DOI 10.1016/j.femsim.2004.07.004; SNYDER DB, 1992, ARCH VIROL, V127, P89, DOI 10.1007/BF01309577; SNYDER DB, 1988, AVIAN DIS, V32, P527, DOI 10.2307/1590923; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; TSUKAMOTO K, 1995, AVIAN DIS, V39, P218, DOI 10.2307/1591863; Tsukamoto K, 2002, J VIROL, V76, P5637, DOI 10.1128/JVI.76.11.5637-5645.2002; Uccelletti D, 2004, J BIOTECHNOL, V109, P93, DOI 10.1016/j.jbiotec.2003.10.037; VAKHARIA VN, 1994, VACCINE, V12, P452, DOI 10.1016/0264-410X(94)90124-4; van Ooyen AJJ, 2006, FEMS YEAST RES, V6, P381, DOI 10.1111/j.1567-1364.2006.00049.x; Villegas P, 2008, AVIAN DIS, V52, P670, DOI 10.1637/8289-032008-ResNote.1; WOOD GW, 1983, RES VET SCI, V35, P114, DOI 10.1016/S0034-5288(18)32213-6; Wu H, 2004, AVIAN DIS, V48, P663, DOI 10.1637/7074; Wu JX, 2007, PLANT BIOTECHNOL J, V5, P570, DOI 10.1111/j.1467-7652.2007.00270.x; WYETH PJ, 1982, VET REC, V110, P359, DOI 10.1136/vr.110.15.359; Xu XG, 2011, AVIAN DIS, V55, P223, DOI 10.1637/9597-111210-Reg.1; ZENKE FT, 1993, MOL CELL BIOL, V13, P7566, DOI 10.1128/MCB.13.12.7566; Zhou XM, 2010, VACCINE, V28, P3990, DOI 10.1016/j.vaccine.2010.03.021	79	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e42870	10.1371/journal.pone.0042870	http://dx.doi.org/10.1371/journal.pone.0042870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024743	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100001
J	Park, SB; Seo, MS; Kim, HS; Kang, KS				Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun			Isolation and Characterization of Canine Amniotic Membrane-Derived Multipotent Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; MESENCHYMAL STROMAL CELLS; STEM/PROGENITOR CELLS; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; THERAPY; FLUID	Recent studies have shown that amniotic membrane tissue is a rich source of stem cells in humans. In clinical applications, the amniotic membrane tissue had therapeutic effects on wound healing and corneal surface reconstruction. Here, we successfully isolated and identified multipotent stem cells (MSCs) from canine amniotic membrane tissue. We cultured the canine amniotic membrane-derived multipotent stem cells (cAM-MSCs) in low glucose DMEM medium. cAM-MSCs have a fibroblast-like shape and adhere to tissue culture plastic. We characterized the immunophenotype of cAM-MSCs by flow cytometry and measured cell proliferation by the cumulative population doubling level (CPDL). We performed differentiation studies for the detection of trilineage multipotent ability, under the appropriate culture conditions. Taken together, our results show that cAM-MSCs could be a rich source of stem cells in dogs. Furthermore, cAM-MSCs may be useful as a cell therapy application for veterinary regenerative medicine.	[Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea; [Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Park, Sang-Bum; Seo, Min-Soo; Kim, Hyung-Sik; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, BK Program Vet Sci 21, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, SB (corresponding author), Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013		National Research Foundation of Korea (NRF) grant; Korean government (MEST) [2010-0020265]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST, 2010-0020265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Diaz-Prado S, 2010, TISSUE ENG C; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Gargett CE, 2006, AUST NZ J OBSTET GYN, V46, P250, DOI 10.1111/j.1479-828X.2006.00582.x; Jurga M, 2006, J NEUROSCI RES, V83, P627, DOI 10.1002/jnr.20766; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Masson NM, 2006, AM J PHYSIOL-GASTR L, V291, pG45, DOI 10.1152/ajpgi.00465.2005; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Mihu CM, 2009, ROM J MORPHOL EMBRYO, V50, P73; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Oh HJ, 2011, THERIOGENOLOGY, V75, P1221, DOI 10.1016/j.theriogenology.2010.11.035; Park SB, 2009, GROWTH FACTORS, V27, P425, DOI 10.3109/08977190903289875; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Ryu HH, 2009, J VET SCI, V10, P273, DOI 10.4142/jvs.2009.10.4.273; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Wang JF, 2004, HAEMATOLOGICA, V89, P837; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243	27	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44693	10.1371/journal.pone.0044693	http://dx.doi.org/10.1371/journal.pone.0044693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024756	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100014
J	de Oliveira, LAS; Imbiriba, LA; Russo, MM; Nogueira-Campos, AA; Rodrigues, ED; Pereira, MG; Volchan, E; Vargas, CD				Santos de Oliveira, Laura Alice; Imbiriba, Luis Aureliano; Russo, Maite Mello; Nogueira-Campos, Anaelli A.; Rodrigues, Erika de C.; Pereira, Mirtes G.; Volchan, Eliane; Vargas, Claudia Domingues			Preparing to Grasp Emotionally Laden Stimuli	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; TRANSCRANIAL MAGNETIC STIMULATION; MOVEMENT-RELATED POTENTIALS; POSTERIOR PARIETAL CORTEX; VOLUNTARY MOVEMENT; READINESS; EXCITABILITY; MODULATION; ACTIVATION; OBJECTS	Background: Contemporary theories of motor control propose that motor planning involves the prediction of the consequences of actions. These predictions include the associated costs as well as the rewarding nature of movements' outcomes. Within the estimation of these costs and rewards would lie the valence, that is, the pleasantness or unpleasantness of a given stimulus with which one is about to interact. The aim of this study was to test if motor preparation encompasses valence. Methodology/Principal Findings: The readiness potential, an electrophysiological marker of motor preparation, was recorded before the grasping of pleasant, neutral and unpleasant stimuli. Items used were balanced in weight and placed inside transparent cylinders to prompt a similar grip among trials. Compared with neutral stimuli, the grasping of pleasant stimuli was preceded by a readiness potential of lower amplitude, whereas that of unpleasant stimuli was associated with a readiness potential of higher amplitude. Conclusions/Significance: We show for the first time that the sensorimotor cortex activity preceding the grasping of a stimulus is affected by its valence. Smaller readiness potential amplitudes found for pleasant stimuli could imply in the recruitment of pre-set motor repertoires, whereas higher amplitudes found for unpleasant stimuli would emerge from a discrepancy between the required action and their aversiveness. Our results indicate that the prediction of action outcomes encompasses an estimate of the valence of a stimulus with which one is about to interact.	[Santos de Oliveira, Laura Alice; Russo, Maite Mello; Nogueira-Campos, Anaelli A.; Volchan, Eliane; Vargas, Claudia Domingues] Univ Fed Rio de Janeiro, Programa Neurobiol Inst Biofis Carlos Chgas Filho, Lab Neurobiol 2, Rio De Janeiro, Brazil; [Santos de Oliveira, Laura Alice; Rodrigues, Erika de C.] Ctr Univ Augusto Motta UNISUAM, Programa Posgraduacao Ciencias Reabilitacao, Rio De Janeiro, Brazil; [Imbiriba, Luis Aureliano] Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, Rio De Janeiro, Brazil; [Pereira, Mirtes G.] Univ Fed Fluminense, Inst Biomed, Niteroi, RJ, Brazil	Universidade Federal do Rio de Janeiro; Centro Universitario Augusto Motta (UNISUAM); Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense	de Oliveira, LAS (corresponding author), Univ Fed Rio de Janeiro, Programa Neurobiol Inst Biofis Carlos Chgas Filho, Lab Neurobiol 2, Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Volchan, Eliane/C-5792-2013; de Oliveira, Laura A S/T-2180-2017; de Carvalho Rodrigues, Erika/AAE-9445-2020; Pereira, Mirtes Garcia/J-6222-2016; Rodrigues, Erika/R-6007-2017; Vargas, Claudia D./A-1523-2016	de Oliveira, Laura A S/0000-0002-5554-457X; de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Pereira, Mirtes Garcia/0000-0003-4682-223X; Rodrigues, Erika/0000-0001-5464-2963; Vargas, Claudia D./0000-0001-6202-3580	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB); Rede Instituto Brasileiro de Neurociencia (IBN Net)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB); Rede Instituto Brasileiro de Neurociencia (IBN Net)	Funding was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Comite Frances de Avaliacao da Cooperacao Universitaria e Cientifica com o Brasil (CAPES/COFECUB) and Rede Instituto Brasileiro de Neurociencia (IBN Net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BAUER H, 1981, PSYCHOPHYSIOLOGY, V18, P466, DOI 10.1111/j.1469-8986.1981.tb02482.x; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Butler T, 2007, NEUROSCIENCE, V150, P1, DOI 10.1016/j.neuroscience.2007.09.048; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Coombes SA, 2012, CEREB CORTEX, V22, P616, DOI 10.1093/cercor/bhr141; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Darwin C., 1872, P374; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEECKE L, 1990, REV NEUROL, V146, P612; DEECKE L, 1987, CIBA F SYMP, V132, P231; Dirnberger G, 2011, INT J PSYCHOPHYSIOL, V81, P127, DOI 10.1016/j.ijpsycho.2011.04.008; Elliot JA, 2008, APPROACH AVOIDANCE M, P3; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Grecucci A, 2009, ARCH ITAL BIOL, V147, P37, DOI 10.4449/aib.v147i1/2.755; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Jahanshahi M, 2003, MOVEMENT DISORD, V18, P1470, DOI 10.1002/mds.10595; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KELLER I, 1990, ELECTROEN CLIN NEURO, V76, P351, DOI 10.1016/0013-4694(90)90036-J; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kristeva-Feige R, 1997, BRAIN RES PROTOC, V1, P13, DOI 10.1016/S1385-299X(97)80327-3; Lang P.J., 2008, A8 U FLOR; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Makris S, 2011, BRAIN COGNITION, V77, P257, DOI 10.1016/j.bandc.2011.08.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; McCallum WC, 1993, HUMAN SLOW POTENTIAL, P1; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morecraft RJ, 1997, NEUROREPORT, V8, P3933; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Sabatinelli D, 2004, NEUROREPORT, V15, P1109, DOI 10.1097/00001756-200405190-00005; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Stepniewska I, 2005, P NATL ACAD SCI USA, V102, P4878, DOI 10.1073/pnas.0501048102; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu-Wilson M, 2009, EXP BRAIN RES, V196, P475, DOI 10.1007/s00221-009-1879-1; Yazawa S, 2000, EXP BRAIN RES, V131, P165, DOI 10.1007/s002219900311	65	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45235	10.1371/journal.pone.0045235	http://dx.doi.org/10.1371/journal.pone.0045235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024811	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100069
J	Spangler, JB; Ficklin, SP; Luo, F; Freeling, M; Feltus, FA				Spangler, Jacob B.; Ficklin, Stephen P.; Luo, Feng; Freeling, Michael; Feltus, F. Alex			Conserved Non-Coding Regulatory Signatures in Arabidopsis Co-Expressed Gene Modules	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENOME DUPLICATIONS; NETWORKS; EXPRESSION; STORAGE; THALIANA; ELEMENTS; BIOLOGY; ORGANIZATION; INFORMATION	Complex traits and other polygenic processes require coordinated gene expression. Co-expression networks model mRNA co-expression: the product of gene regulatory networks. To identify regulatory mechanisms underlying coordinated gene expression in a tissue-enriched context, ten Arabidopsis thaliana co-expression networks were constructed after manually sorting 4,566 RNA profiling datasets into aerial, flower, leaf, root, rosette, seedling, seed, shoot, whole plant, and global (all samples combined) groups. Collectively, the ten networks contained 30% of the measurable genes of Arabidopsis and were circumscribed into 5,491 modules. Modules were scrutinized for cis regulatory mechanisms putatively encoded in conserved non-coding sequences (CNSs) previously identified as remnants of a whole genome duplication event. We determined the non-random association of 1,361 unique CNSs to 1,904 co-expression network gene modules. Furthermore, the CNS elements were placed in the context of known gene regulatory networks (GRNs) by connecting 250 CNS motifs with known GRN cis elements. Our results provide support for a regulatory role of some CNS elements and suggest the functional consequences of CNS activation of co-expression in specific gene sets dispersed throughout the genome.	[Spangler, Jacob B.; Feltus, F. Alex] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA; [Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Clemson University; Clemson University; University of California System; University of California Berkeley	Spangler, JB (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	ffeltus@clemson.edu	Ficklin, Stephen/L-4324-2019	Ficklin, Stephen/0000-0001-9138-6292; Feltus, Frank/0000-0002-2123-6114	National Science Foundation [MCB-0820345]; Division Of Computer and Network Systems [1228312] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0820821] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grant MCB-0820345 from the National Science Foundation to FAF (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 0820345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Dongen S, 2000, CLUSTER ALGORITHM GR; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Ficklin SP, 2010, PLANT PHYSL; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Freeling M, 2009, CURR OPIN PLANT BIOL, V12, P126, DOI 10.1016/j.pbi.2009.01.005; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Jeziorska DM, 2009, SEMIN CELL DEV BIOL, V20, P856, DOI 10.1016/j.semcdb.2009.07.007; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mejia-Guerra MK, 2012, BBA-GENE REGUL MECH, V1819, P454, DOI 10.1016/j.bbagrm.2012.02.016; Moreno-Risueno MA, 2010, CURR OPIN PLANT BIOL, V13, P126, DOI 10.1016/j.pbi.2009.11.005; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; PANG PP, 1988, PLANT MOL BIOL, V11, P805, DOI 10.1007/BF00019521; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Spangler JB, 2012, NEW PHYTOL, V193, P241, DOI 10.1111/j.1469-8137.2011.03916.x; Thomas BC, 2007, P NATL ACAD SCI USA, V104, P3348, DOI 10.1073/pnas.0611574104; Vogel C., 2010, MOL SYST BIOL, P6; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zheng XQ, 2011, J PLANT PHYSIOL, V168, P611, DOI 10.1016/j.jplph.2010.09.010	44	7	8	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45041	10.1371/journal.pone.0045041	http://dx.doi.org/10.1371/journal.pone.0045041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024789	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100047
J	Delwig, A; Logan, AM; Copenhagen, DR; Ahn, AH				Delwig, Anton; Logan, Anne M.; Copenhagen, David R.; Ahn, Andrew H.			Light Evokes Melanopsin-Dependent Vocalization and Neural Activation Associated with Aversive Experience in Neonatal Mice	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; RETINAL GANGLION-CELLS; PAIN PERCEPTION; PATHWAYS; OPSIN; STIMULATION; AMYGDALA; MOUSE; RAT; SENSITIZATION	Melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs) are the only functional photoreceptive cells in the eye of newborn mice. Through postnatal day 9, in the absence of functional rods and cones, these ipRGCs mediate a robust avoidance behavior to a light source, termed negative phototaxis. To determine whether this behavior is associated with an aversive experience in neonatal mice, we characterized light-induced vocalizations and patterns of neuronal activation in regions of the brain involved in the processing of aversive and painful stimuli. Light evoked distinct melanopsin-dependent ultrasonic vocalizations identical to those emitted under stressful conditions, such as isolation from the litter. In contrast, light did not evoke the broad-spectrum calls elicited by acute mechanical pain. Using markers of neuronal activation, we found that light induced the immediate-early gene product Fos in the posterior thalamus, a brain region associated with the enhancement of responses to mechanical stimulation of the dura by light, and thought to be the basis for migrainous photophobia. Additionally, light induced the phosphorylation of extracellular-related kinase (pERK) in neurons of the central amygdala, an intracellular signal associated with the processing of the aversive aspects of pain. However, light did not activate Fos expression in the spinal trigeminal nucleus caudalis, the primary receptive field for painful stimulation to the head. We conclude that these light-evoked vocalizations and the distinct pattern of brain activation in neonatal mice are consistent with a melanopsin-dependent neural pathway involved in processing light as an aversive but not acutely painful stimulus.	[Delwig, Anton; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Logan, Anne M.; Ahn, Andrew H.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ahn, Andrew H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Delwig, A (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	cope@phy.ucsf.edu; ahn@neurology.ufl.edu		Ahn, Andrew H/0000-0003-1780-9300	National Institutes of Health [NS066091, EY01869]; March of Dimes; Research to Prevent Blindness (Department of Ophthalmology); Knights Templar Eye Foundation; ARRA [NS047113]; National Eye Institute (Core grant) [EY 002162]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY001869, R37EY001869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047113, K02NS066091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Research to Prevent Blindness (Department of Ophthalmology)(Research to Prevent Blindness (RPB)); Knights Templar Eye Foundation; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (Core grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health NS066091 (AHA), EY01869 (DRC), March of Dimes (DRC) and Research to Prevent Blindness (Department of Ophthalmology and DRC), Knights Templar Eye Foundation (AD), a supplement funded by the ARRA NS047113 (AHA) and National Eye Institute (Core grant EY 002162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard JF, 1996, PROG BRAIN RES, V107, P243; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Crozier WJ, 1927, J GEN PHYSIOL, V10, P407, DOI 10.1085/jgp.10.3.407; de Prado BM, 2009, J PAIN, V10, P992, DOI 10.1016/j.jpain.2009.03.018; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dobolyi A, 2005, J COMP NEUROL, V489, P92, DOI 10.1002/cne.20618; Dolgonos S, 2011, INVEST OPHTH VIS SCI, V52, P7852, DOI 10.1167/iovs.11-7604; DRUMMOND PD, 1993, CEPHALALGIA, V13, P321, DOI 10.1046/j.1468-2982.1993.1305321.x; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; Hamilton R, 2005, EARLY HUM DEV, V81, P461, DOI 10.1016/j.earlhumdev.2004.10.019; Han JS, 2005, J NEUROSCI, V25, P10717, DOI 10.1523/JNEUROSCI.4112-05.2005; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hofer Myron A, 2002, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0814s17; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kowacs PA, 2001, CEPHALALGIA, V21, P184, DOI 10.1046/j.1468-2982.2001.00178.x; Lasky RE, 2009, PEDIATRICS, V123, P540, DOI 10.1542/peds.2007-3418; Lemasson M, 2005, BEHAV PROCESS, V68, P13, DOI 10.1016/j.beproc.2004.09.001; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Morag I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006982.pub2; Noseda R, 2010, NAT NEUROSCI; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Qiu J, 2006, NATURE, V444, P143, DOI 10.1038/444143a; Recober A, 2010, NEUROPHARMACOLOGY, V58, P156, DOI 10.1016/j.neuropharm.2009.07.009; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; ROUTTENBERG A, 1978, DEV PSYCHOBIOL, V11, P469, DOI 10.1002/dev.420110510; Shogan M G, 1993, Neonatal Netw, V12, P7; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; THORINGTON L, 1985, ANN NY ACAD SCI, V453, P28, DOI 10.1111/j.1749-6632.1985.tb11796.x; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; YASUI Y, 1991, J COMP NEUROL, V308, P293, DOI 10.1002/cne.903080212	40	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43787	10.1371/journal.pone.0043787	http://dx.doi.org/10.1371/journal.pone.0043787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028470	Green Submitted, Green Published, gold			2022-12-25	WOS:000308788700012
J	Mahe, S; Duhamel, M; Le Calvez, T; Guillot, L; Sarbu, L; Bretaudeau, A; Collin, O; Dufresne, A; Kiers, ET; Vandenkoornhuyse, P				Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier; Dufresne, Alexis; Kiers, E. Toby; Vandenkoornhuyse, Philippe			PHYMYCO-DB: A Curated Database for Analyses of Fungal Diversity and Evolution	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-IDENTIFICATION; PHYLOGENY; SEQUENCES; TREE; CLASSIFICATION; RELIABILITY; PROGRESS; ANIMALS; ORIGINS	Background: In environmental sequencing studies, fungi can be identified based on nucleic acid sequences, using either highly variable sequences as species barcodes or conserved sequences containing a high-quality phylogenetic signal. For the latter, identification relies on phylogenetic analyses and the adoption of the phylogenetic species concept. Such analysis requires that the reference sequences are well identified and deposited in public-access databases. However, many entries in the public sequence databases are problematic in terms of quality and reliability and these data require screening to ensure correct phylogenetic interpretation. Methods and Principal Findings: To facilitate phylogenetic inferences and phylogenetic assignment, we introduce a fungal sequence database. The database PHYMYCO-DB comprises fungal sequences from GenBank that have been filtered to satisfy stringent sequence quality criteria. For the first release, two widely used molecular taxonomic markers were chosen: the nuclear SSU rRNA and EF1-alpha gene sequences. Following the automatic extraction and filtration, a manual curation is performed to remove problematic sequences while preserving relevant sequences useful for phylogenetic studies. As a result of curation, similar to 20% of the automatically filtered sequences have been removed from the database. To demonstrate how PHYMYCO-DB can be employed, we test a set of environmental Chytridiomycota sequences obtained from deep sea samples. Conclusion: PHYMYCO-DB offers the tools necessary to: (i) extract high quality fungal sequences for each of the 5 fungal phyla, at all taxonomic levels, (ii) extract already performed alignments, to act as 'reference alignments', (iii) launch alignments of personal sequences along with stored data. A total of 9120 SSU rRNA and 672 EF1-alpha high-quality fungal sequences are now available. The PHYMYCO-DB is accessible through the URL http://phymycodb.genouest.org/.	[Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Dufresne, Alexis; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS, UMR ECOBIO 6553, Rennes, France; [Mahe, Stephane; Duhamel, Marie; Le Calvez, Thomas; Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier; Dufresne, Alexis; Vandenkoornhuyse, Philippe] Univ Europeenne Bretagne, Rennes, France; [Duhamel, Marie; Kiers, E. Toby] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Guillot, Laetitia; Sarbu, Ludmila; Bretaudeau, Anthony; Collin, Olivier] Univ Rennes 1, CNRS, UMR IRISA 6074, Rennes, France; [Le Calvez, Thomas] AQUASIM, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Universite de Bretagne Occidentale; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Mahe, S (corresponding author), Univ Rennes 1, CNRS, UMR ECOBIO 6553, Campus Beaulieu, Rennes, France.	philippe.vandenkoornhuyse@univ-rennes1.fr	Toby, Kiers/H-4819-2017	Toby, Kiers/0000-0002-0597-1653; Collin, Olivier/0000-0002-8959-8402; Guillot, Laetitia/0000-0002-9990-0126; Dufresne, Alexis/0000-0001-8231-9098	Total Corporate Foundation for biodiversity and the sea; French National Agency for Research [ANR-10-STRA-002]; French ministry of research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant	Total Corporate Foundation for biodiversity and the sea; French National Agency for Research(French National Research Agency (ANR)); French ministry of research(Ministry of Research, FranceEuropean Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the "Total Corporate Foundation for biodiversity and the sea'' and a grant from the French National Agency for Research within the Systerra call (ANR-10-STRA-002). MD has a Ph.D. grant from the French ministry of research. ETK is supported by an Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) "vidi'' and "meervoud'' grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; Avise J.C., 2004, MOL MARKERS NATURAL; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1999, AM NAT, V154, pS178, DOI 10.1086/303292; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bar-Hen A, 2008, MOL BIOL EVOL, V25, P869, DOI 10.1093/molbev/msn030; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bhattacharya D, 2002, J MOL EVOL, V55, P74, DOI 10.1007/s00239-001-2305-x; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Bridge PD, 2004, NEW PHYTOL, V161, P15; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Auria G, 2006, BIOINFORMATICS, V22, P527, DOI 10.1093/bioinformatics/btk033; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Hawksworth DL, 2009, NATURE, V458, P29, DOI 10.1038/458029c; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2004, NEW PHYTOL, V161, P13; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Holst-Jensen A, 2004, NEW PHYTOL, V161, P11, DOI 10.1111/j.1469-8137.2004.00961.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kaminuma E, 2011, NUCLEIC ACIDS RES, V39, pD22, DOI 10.1093/nar/gkq1041; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lim YW, 2008, ANTON LEEUW INT J G, V93, P99, DOI 10.1007/s10482-007-9184-0; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Moon CD, 2002, MYCOLOGIA, V94, P694, DOI 10.2307/3761720; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simmons DR, 2009, MYCOL RES, V113, P450, DOI 10.1016/j.mycres.2008.11.019; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Vandenkoornhuyse P, 1998, MYCOLOGIA, V90, P791, DOI 10.2307/3761320; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Xu Pengfei, 2007, Journal of Genetics and Genomics, V34, P180, DOI 10.1016/S1673-8527(07)60019-8	55	22	23	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43117	10.1371/journal.pone.0043117	http://dx.doi.org/10.1371/journal.pone.0043117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028445	Green Published, gold			2022-12-25	WOS:000308788700009
J	Hartman, Z; Zhao, H; Agazie, YM				Hartman, Z.; Zhao, H.; Agazie, Y. M.			HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling	ONCOGENE			English	Article						HER2; EGFR; autophosphorylation; signaling; tumorigenesis	EPIDERMAL-GROWTH-FACTOR; CLATHRIN-COATED PITS; ERBB-RELATED GENE; FACTOR RECEPTOR; DOWN-REGULATION; CRYSTAL-STRUCTURE; BREAST-CANCER; MOLECULAR-MECHANISM; KINASE DOMAIN; ACTIVATION	One of the causes of breast cancer is overexpression of the human epidermal growth factor receptor 2 (HER2). Enhanced receptor autophosphorylation and resistance to activation-induced downregulation have been suggested as mechanisms for HER2-induced sustained signaling and cell transformation. However, the molecular mechanisms underlying these possibilities remain incompletely understood. In the current report, we present evidence that show that HER2 overexpression does not lead to receptor hyper-autophosphorylation, but alters patterns in a manner that favors receptor stability and sustained signaling. Specifically, HER2 overexpression blocks epidermal growth factor receptor (EGFR) tyrosine phosphorylation on Y1045 and Y1068, the known docking sites of c-Cbl and Grb2, respectively, whereas promoting phosphorylation on Y1173, the known docking site of the Gab adaptor proteins and phospholipase C gamma. Under these conditions, HER2 itself is phosphorylated on Y1221/1222, with no known role, and on Y1248 that corresponds to Y1173 of EGFR. Interestingly, suppressed EGFR autophosphorylation on the Grb2 and c-Cbl-binding sites correlated with receptor stability and sustained signaling, suggesting that HER2 accomplishes these tasks by altering autophosphorylation patterns. In conformity with these findings, mutation of the Grb2-binding site on EGFR (Y1068F-EGFR) conferred resistance to ligand-induced degradation, which in turn induced sustained signaling, and increased cell proliferation and transformation. These findings suggest that the Grb2-binding site on EGFR is redundant for signaling, but critical for receptor regulation. On the other hand, mutation of the putative Grb2-binding site in HER2 (Y1139) did not affect stability, signaling or transformation, suggesting that Y1139 in HER2 may not serve as a Grb2-binding site. In agreement with the role of EGFR in HER2 signaling, inhibition of EGFR expression reduced HER2-induced anchorage-independent growth and tumorigenesis. These results imply that complementing HER2-targeted therapies with anti-EGFR drugs may be beneficial in HER2-positive breast cancer.	[Hartman, Z.; Zhao, H.; Agazie, Y. M.] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Agazie, Y. M.] W Virginia Univ, Sch Med, Marry Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Agazie, YM (corresponding author), W Virginia Univ, Sch Med, Dept Biochem, 1 Med Ctr Dr, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu			National Cancer Institute (NCI), a component of the National Institute of Health (NIH) [CA124940]; NATIONAL CANCER INSTITUTE [R01CA124940] Funding Source: NIH RePORTER	National Cancer Institute (NCI), a component of the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant number CA124940 from the National Cancer Institute (NCI), a component of the National Institute of Health (NIH) to YMA.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DIONNE CA, 1991, ANN NY ACAD SCI, V638, P161, DOI 10.1111/j.1749-6632.1991.tb49026.x; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Ekman S, 1999, ONCOGENE, V18, P2481, DOI 10.1038/sj.onc.1202606; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; FENG GS, 1994, ONCOGENE, V9, P1545; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; HELIN K, 1991, J BIOL CHEM, V266, P8363; Hendriks BS, 2003, BIOPHYS J, V85, P2732, DOI 10.1016/S0006-3495(03)74696-7; Huang GC, 1999, J CELL BIOCHEM, V74, P23; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Rana P, BREAST CANC AUCKL, V6, P67; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; Russo C, 2002, ANN NY ACAD SCI, V973, P323, DOI 10.1111/j.1749-6632.2002.tb04660.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHLESSINGER J, 1992, COLD SPRING HARB SYM, V57, P67, DOI 10.1101/SQB.1992.057.01.009; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; SORKIN A, 1993, ONCOGENE, V8, P3021; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yamanashi Y, J BIOCH, V151, P353; Yuan YL, 2008, J LARYNGOL OTOL, V122, P952, DOI 10.1017/S0022215107000606; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou XD, 2012, CELL SIGNAL, V24, P140, DOI 10.1016/j.cellsig.2011.08.015; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	55	41	42	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4169	4180		10.1038/onc.2012.418	http://dx.doi.org/10.1038/onc.2012.418			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23027125	Green Accepted			2022-12-25	WOS:000323748500012
J	Didovyk, A; Verdine, GL				Didovyk, Andriy; Verdine, Gregory L.			Structural Origins of DNA Target Selection and Nucleobase Extrusion by a DNA Cytosine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID STRUCTURES; HHAI METHYLTRANSFERASE; SOFTWARE; MECHANISM; VISUALIZATION; METHYLATION; SYSTEM; IDENTIFICATION; RECOGNITION; CATALYSIS	Epigenetic methylation of cytosine residues in DNA is an essential element of genome maintenance and function in organisms ranging from bacteria to humans. DNA 5-cytosine methyltransferase enzymes (DCMTases) catalyze cytosine methylation via reaction intermediates in which the DNA is drastically remodeled, with the target cytosine residue extruded from the DNA helix and plunged into the active site pocket of the enzyme. We have determined a crystal structure of M.HaeIII DCMTase in complex with its DNA substrate at a previously unobserved state, prior to extrusion of the target cytosine and frameshifting of the DNA recognition sequence. The structure reveals that M.HaeIII selects the target cytosine and destabilizes its base-pairing through a precise, focused, and coordinated assault on the duplex DNA, which isolates the target cytosine from its nearest neighbors and thereby facilitates its extrusion from DNA.	[Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Didovyk, Andriy; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu			National Institutes of Health Grant [GM044853]; National Center for Research Resources at the National Institutes of Health [RR-15301]; National Institutes of Health from the NCI [Y1-CO-1020]; National Institutes of Health from the NIGMS [Y1-GM-1104]; United States Department of Energy (U.S. DOE) [DE-AC02-06CH11357]; U.S. DOE, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy (U.S. DOE)(United States Department of Energy (DOE)); U.S. DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044853 (to G. L. V.). This work is based upon research conducted at the Advanced Photon Source on the NE-CAT and GM/CA-CAT beamlines. NE-CAT is supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. GM/CA-CAT was supported, in whole or in part, by National Institutes of Health Grants Y1-CO-1020 from the NCI and Y1-GM-1104 from the NIGMS. Use of the Advanced Photon Source was supported by the United States Department of Energy (U.S. DOE) under Contract DE-AC02-06CH11357 and by the U.S. DOE, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHEN L, 1993, J AM CHEM SOC, V115, P5318, DOI 10.1021/ja00065a063; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estabrook RA, 2009, J BIOL CHEM, V284, P22690, DOI 10.1074/jbc.M109.015966; Gerasimaite R, 2011, NUCLEIC ACIDS RES, V39, P3771, DOI 10.1093/nar/gkq1329; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papworth C, 1996, STRATEGIES, V9, P4; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radlinska M, 2005, PROTEINS, V58, P263, DOI 10.1002/prot.20297; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; WU JC, 1987, J BIOL CHEM, V262, P4778; Zangi R, 2010, J MOL BIOL, V400, P632, DOI 10.1016/j.jmb.2010.05.021; Zhang XD, 2006, P NATL ACAD SCI USA, V103, P6148, DOI 10.1073/pnas.0601587103	31	1	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40099	40105		10.1074/jbc.M112.413054	http://dx.doi.org/10.1074/jbc.M112.413054			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012373	Green Published, hybrid			2022-12-25	WOS:000311448800001
J	Bugaj, V; Sansom, SC; Wen, DH; Hatcher, LI; Stockand, JD; Mironova, E				Bugaj, Vladislav; Sansom, Steven C.; Wen, Donghai; Hatcher, Lori I.; Stockand, James D.; Mironova, Elena			Flow-sensitive K+-coupled ATP Secretion Modulates Activity of the Epithelial Na+ Channel in the Distal Nephron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT; CONNEXIN HEMICHANNELS; CONNECTING TUBULE; SODIUM-CHANNEL; ENAC ACTIVITY; RENAL NA+; HYPERTENSION; EXCRETION; MEMBRANE; CELLS	The epithelial Na+ channel (ENaC) in the aldosterone-sensitive distal nephron (ASDN) is under tonic inhibition by a local purinergic signaling system responding to changes in dietary sodium intake. Normal BKCa channel function is required for flow-sensitive ATP secretion in the ASDN. We tested here whether ATP secreted through connexin channels in a coupled manner with K+ efflux through BKCa channels is required for inhibitory purinergic regulation of ENaC in response to increases in sodium intake. Inhibition of connexin channels relieves purinergic inhibition of ENaC. Deletion of the BK-beta 4 regulatory subunit, which is required for normal BKCa channel function and flow-sensitive ATP secretion in the ASDN, suppresses increases in urinary ATP in response to increases in sodium intake. As a consequence, ENaC activity, particularly in the presence of high sodium intake, is inappropriately elevated in BK-beta 4 nul lmice. ENaC in BK-beta 4 null mice, however, responds normally to exogenous ATP, indicating that increases in activity do not result from end-organ resistance but rather from lowered urinary ATP. Consistent with this, disruption of purinergic regulation increases ENaC activity in wild type but not BK-beta 4 null mice. Consequently, sodium excretion is impaired in BK-beta 4 null mice. These results demonstrate that the ATP secreted in the ASDN in a BKCa channel-dependent manner is physiologically available for purinergic inhibition of ENaC in response to changes in sodium homeostasis. Impaired sodium excretion resulting form loss of normal purinergic regulation of ENaC in BK-beta 4 null mice likely contributes to their elevated blood pressure.	[Bugaj, Vladislav; Stockand, James D.; Mironova, Elena] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Sansom, Steven C.; Wen, Donghai; Hatcher, Lori I.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Texas System; University of Texas Health San Antonio; University of Nebraska System; University of Nebraska Medical Center	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01 DK059594, R01 DK71014]; American Heart Association Fellowship [10POST3200019]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594, R01DK071014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK059594 (to J. D. S.) and R01 DK71014 (to S. C. S.). This work was also supported by American Heart Association Fellowship 10POST3200019 (to V. B.).	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2011, AM J PHYSIOL-REG I, V301, pR510, DOI 10.1152/ajpregu.00148.2011; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Stockand JD, 2010, J AM SOC NEPHROL, V21, P1903, DOI 10.1681/ASN.2010040377; Taniguchi J, 1998, J MEMBRANE BIOL, V164, P35, DOI 10.1007/s002329900391; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415	27	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38552	38558		10.1074/jbc.M112.408476	http://dx.doi.org/10.1074/jbc.M112.408476			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23002235	Green Published, hybrid			2022-12-25	WOS:000310982800015
J	Cannino, G; El-Khoury, R; Pirinen, M; Hutz, B; Rustin, P; Jacobs, HT; Dufour, E				Cannino, Giuseppe; El-Khoury, Riyad; Pirinen, Marja; Hutz, Bettina; Rustin, Pierre; Jacobs, Howard T.; Dufour, Eric			Glucose Modulates Respiratory Complex I Activity in Response to Acute Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ELECTRON-TRANSPORT; OXIDATIVE-PHOSPHORYLATION; TCA CYCLE; NDI1 GENE; SUCCINATE; CHAIN; MECHANISMS; EXPRESSION; DISORDERS	Proper coordination between glycolysis and respiration is essential, yet the regulatory mechanisms involved in sensing respiratory chain defects and modifying mitochondrial functions accordingly are unclear. To investigate the nature of this regulation, we introduced respiratory bypass enzymes into cultured human (HEK293T) cells and studied mitochondrial responses to respiratory chain inhibition. In the absence of respiratory chain inhibitors, the expression of alternative respiratory enzymes did not detectably alter cell physiology or mitochondrial function. However, in permeabilized cells NDI1 (alternative NADH dehydrogenase) bypassed complex I inhibition, whereas alternative oxidase (AOX) bypassed complex III or IV inhibition. In contrast, in intact cells the effects of the AOX bypass were suppressed by growth on glucose, whereas those produced by NDI1 were unaffected. Moreover, NDI1 abolished the glucose suppression of AOX-driven respiration, implicating complex I as the target of this regulation. Rapid Complex I down-regulation was partly released upon prolonged respiratory inhibition, suggesting that it provides an "emergency shutdown" system to regulate metabolism in response to dysfunctions of the oxidative phosphorylation. This system was independent of HIF1, mitochondrial superoxide, or ATP synthase regulation. Our findings reveal a novel pathway for adaptation to mitochondrial dysfunction and could provide new opportunities for combatting diseases.	[Cannino, Giuseppe; Pirinen, Marja; Hutz, Bettina; Jacobs, Howard T.; Dufour, Eric] Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, Tampere 33014, Finland; [Cannino, Giuseppe; Pirinen, Marja; Hutz, Bettina; Jacobs, Howard T.; Dufour, Eric] Univ Tampere, Tampere Univ Hosp, Ctr Lab Med, Tampere 33014, Finland; [El-Khoury, Riyad; Rustin, Pierre] INSERM, U676, F-75019 Paris, France; [El-Khoury, Riyad; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, F-75019 Paris, France	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dufour, E (corresponding author), FI 33014 Univ Tampere, Inst Biomed Technol, Tampere 33100, Finland.	eric.dufour@uta.fi	Cannino, Giuseppe/AAS-7269-2021; Dufour, Eric/AAF-6210-2020; Jacobs, Howard T/G-2434-2011	Dufour, Eric/0000-0001-6690-5329; Jacobs, Howard/0000-0003-1895-6003	Leducq Foundation; ERC; Academy of Finland; Juselius Foundation; Tampere University Hospital Medical Research Fund; Pirkanmaa Hospital District	Leducq Foundation(Leducq Foundation); ERC(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Juselius Foundation; Tampere University Hospital Medical Research Fund; Pirkanmaa Hospital District	Supported by the Leducq Foundation.; Supported by ERC, Academy of Finland, Juselius Foundation, and the Tampere University Hospital Medical Research Fund.; Supported by the Academy of Finland and Pirkanmaa Hospital District.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Cannino G, 2009, MITOCHONDRION, V9, P471, DOI 10.1016/j.mito.2009.08.007; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lee YJ, 2011, J BIOL CHEM, V286, P20267, DOI 10.1074/jbc.M110.209379; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Matsukawa K, 2009, FEBS LETT, V583, P148, DOI 10.1016/j.febslet.2008.11.040; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pellinen R, 2004, INT J ONCOL, V25, P1753; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Spector David L., 1998; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tanaka-Esposito C, 2012, TRANSL RES, V160, P207, DOI 10.1016/j.trsl.2012.01.024; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; WARBURG O, 1967, H-S Z PHYSIOL CHEM, V348, P1686, DOI 10.1515/bchm2.1967.348.1.1686; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong A, 2002, BIOCHEM BIOPH RES CO, V298, P750, DOI 10.1016/S0006-291X(02)02546-9; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	42	30	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38729	38740		10.1074/jbc.M112.386060	http://dx.doi.org/10.1074/jbc.M112.386060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007390	Green Published, hybrid			2022-12-25	WOS:000310982800031
J	Brosseau, L; Drame, PM; Besnard, P; Toto, JC; Foumane, V; Le Mire, J; Mouchet, F; Remoue, F; Allan, R; Fortes, F; Carnevale, P; Manguin, S				Brosseau, Laura; Drame, Papa Makhtar; Besnard, Patrick; Toto, Jean-Claude; Foumane, Vincent; Le Mire, Jacques; Mouchet, Francois; Remoue, Franck; Allan, Richard; Fortes, Filomeno; Carnevale, Pierre; Manguin, Sylvie			Human Antibody Response to Anopheles Saliva for Comparing the Efficacy of Three Malaria Vector Control Methods in Balombo, Angola	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; IMMUNO-EPIDEMIOLOGIC TOOL; EVALUATING HUMAN EXPOSURE; FIELD-EVALUATION; GLAND PROTEINS; INDOOR USE; GAMBIAE; PEPTIDE; BITES; ZEROFLY(R)	Human antibody (Ab) response to Anopheles whole saliva, used as biomarker of Anopheles exposure, was investigated over a period of two years (2008-2009), in children between 2 to 9 years old, before and after the introduction of three different malaria vector control methods; deltamethrin treated long lasting impregnated nets (LLIN) and insecticide treated plastic sheeting (ITPS) - Zero Fly (R)) (ITPS-ZF), deltamethrin impregnated Durable (Wall) Lining (ITPS-DL - Zerovector (R)) alone, and indoor residual spraying (IRS) with lambdacyhalothrin alone. These different vector control methods resulted in considerable decreases in all three entomological (82.4%), parasitological (54.8%) and immunological criteria analyzed. The highest reductions in the number of Anopheles collected and number of positive blood smears, respectively 82.1% and 58.3%, were found in Capango and Canjala where LLIN and ITPS-ZF were implemented. The immunological data based on the level of anti-saliva IgG Ab in children of all villages dropped significantly from 2008 to 2009, except in Chissequele. These results indicated that these three vector control methods significantly reduced malaria infections amongst the children studied and IRS significantly reduced the human-Anopheles contact. The number of Anopheles, positive blood smears, and the levels of anti-saliva IgG Ab were most reduced when LLIN and ITPS-ZF were used in combination, compared to the use of one vector control method alone, either ITPS-DL or IRS. Therefore, as a combination of two vector control methods is significantly more effective than one control method only, this control strategy should be further developed at a more global scale.	[Brosseau, Laura; Manguin, Sylvie] Inst Rech Dev, UMR MD3, Montpellier, France; [Drame, Papa Makhtar; Mouchet, Francois; Remoue, Franck] Inst Rech Dev, UMR MIVEGEC, Montpellier, France; [Besnard, Patrick; Le Mire, Jacques] Med Serv Sonamet, Lobito, Angola; [Toto, Jean-Claude; Foumane, Vincent] Org Coordinat Lutte Endemioes Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Allan, Richard] Mentor Initiat, Crawley, England; [Fortes, Filomeno] Natl Malaria Control Programme, Luanda, Angola	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Manguin, S (corresponding author), Inst Rech Dev, UMR MD3, Montpellier, France.	sylvie.manguin@ird.fr	Manguin, Sylvie/GOE-5338-2022; Mouchet, Francois/I-2349-2012; Manguin, Sylvie/G-1787-2015	Manguin, Sylvie/0000-0002-5925-7164; Manguin, Sylvie/0000-0002-5925-7164; BROSSEAU, Laura/0000-0002-4911-2287; Fortes, Fabiane/0000-0001-6217-3474	Diabetes Australia Research Trust Southern Australia (DART S.A.); Fondation Infectiopole Sud	Diabetes Australia Research Trust Southern Australia (DART S.A.); Fondation Infectiopole Sud	This study received funding support from Diabetes Australia Research Trust Southern Australia (DART S.A.) and Drame PM was supported by a post-doctoral fellowship from "Fondation Infectiopole Sud". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIER JC, 1987, AM J TROP MED HYG, V36, P459, DOI 10.4269/ajtmh.1987.36.459; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Curtis CF, 1999, T ROY SOC TROP MED H, V93, P460, DOI 10.1016/S0035-9203(99)90337-1; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Djenontin A, 2010, AM J TROP MED HYG, V83, P266, DOI 10.4269/ajtmh.2010.10-0012; Djenontin A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-233; Drame PM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-72; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Graham K, 2002, MED VET ENTOMOL, V16, P404, DOI 10.1046/j.1365-2915.2002.00395.x; Mittal PK, 2011, J VECTOR DIS, V48, P138; Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; PENNEYS NS, 1988, J AM ACAD DERMATOL, V18, P87, DOI 10.1016/S0190-9622(88)70013-4; Poinsignon A, 2010, TROP MED INT HEALTH, V15, P1198, DOI 10.1111/j.1365-3156.2010.02611.x; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Sharma SK, 2009, INDIAN J MED RES, V130, P458; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; WHO, 2010, WORLD MALARIA REPORT 2010, P1	25	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44189	10.1371/journal.pone.0044189	http://dx.doi.org/10.1371/journal.pone.0044189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028499	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700008
J	Hammarlund, E; Amanna, IJ; Dubois, ME; Barron, A; Engelmann, F; Messaoudi, I; Slifka, MK				Hammarlund, Erika; Amanna, Ian J.; Dubois, Melissa E.; Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem; Slifka, Mark K.			A Flow Cytometry-Based Assay for Quantifying Non-Plaque Forming Strains of Yellow Fever Virus	PLOS ONE			English	Article							WEST-NILE-VIRUS; LIMITING DILUTION ANALYSIS; INFECTION; DENGUE; ACTIVATION; CELLS; NEUTRALIZATION; QUANTITATION; FREQUENCIES; VACCINES	Primary clinical isolates of yellow fever virus can be difficult to quantitate by standard in vitro methods because they may not form discernable plaques or induce a measurable cytopathic effect (CPE) on cell monolayers. In our hands, the Dakar strain of yellow fever virus (YFV-Dakar) could not be measured by plaque assay (PA), focus-forming assay (FFA), or by measurement of CPE. For these reasons, we developed a YFV-specific monoclonal antibody (3A8.B6) and used it to optimize a highly sensitive flow cytometry-based tissue culture limiting dilution assay (TC-LDA) to measure levels of infectious virus. The TC-LDA was performed by incubating serial dilutions of virus in replicate wells of C6/36 cells and stained intracellularly for virus with MAb 3A8.B6. Using this approach, we could reproducibly quantitate YFV-Dakar in tissue culture supernatants as well as from the serum of viremic rhesus macaques experimentally infected with YFV-Dakar. Moreover, the TC-LDA approach was >10-fold more sensitive than standard plaque assay for quantitating typical plaque-forming strains of YFV including YFV-17D and YFV-FNV (French neurotropic vaccine). Together, these results indicate that the TC-LDA technique is effective for quantitating both plaque-forming and non-plaque-forming strains of yellow fever virus, and this methodology may be readily adapted for the study and quantitation of other non-plaque-forming viruses.	[Hammarlund, Erika; Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem; Slifka, Mark K.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Amanna, Ian J.; Dubois, Melissa E.; Slifka, Mark K.] Najit Technol Inc, Beaverton, OR USA; [Barron, Alex; Engelmann, Flora; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Hammarlund, E (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	slifkam@ohsu.edu		Barron, Alexander/0000-0001-5962-553X; Amanna, Ian/0000-0001-7545-4013	National Institutes of Health [UO1 AI082196, U54 AI081680, R44 AI079898]; Oregon National Primate Research Center [8P51 OD011092-53]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI079898, U54AI081680, U01AI082196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants, UO1 AI082196 (to MKS), U54 AI081680 (to Jay A. Nelson, subproject to MKS), R44 AI079898 (to IJA and MKS) and Oregon National Primate Research Center grant, 8P51 OD011092-53 (to MKS and IM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0; ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022553; Liu JE, 2008, J VIROL METHODS, V154, P20, DOI 10.1016/j.jviromet.2008.09.019; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MILLER RG, 1977, IMMUNOL REV, V35, P38, DOI 10.1111/j.1600-065X.1977.tb00234.x; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; Monath TP CM, 2008, VACCINES; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960; TASWELL C, 1981, J IMMUNOL, V126, P1614; TASWELL C, 1979, THYMUS, V1, P119; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474	25	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e41707	10.1371/journal.pone.0041707	http://dx.doi.org/10.1371/journal.pone.0041707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028428	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388400004
J	Schaal, SM; Sen Garg, M; Ghosh, M; Lovera, L; Lopez, M; Patel, M; Louro, J; Patel, S; Tuesta, L; Chan, WM; Pearse, DD				Schaal, Sandra Marie; Sen Garg, Maneesh; Ghosh, Mousumi; Lovera, Lilie; Lopez, Michael; Patel, Monal; Louro, Jack; Patel, Samik; Tuesta, Luis; Chan, Wai-Man; Pearse, Damien Daniel			The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury	PLOS ONE			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; OLFACTORY ENSHEATHING GLIA; AMP-SPECIFIC PHOSPHODIESTERASE; IMPROVES FUNCTIONAL RECOVERY; INHIBITOR ROLIPRAM; SCHWANN-CELLS; DIFFERENTIAL EXPRESSION; AXONAL REGENERATION; CYTOKINE PRODUCTION; SIGNALING PATHWAY	The extent of damage following spinal cord injury (SCI) can be reduced by various neuroprotective regimens that include maintaining levels of cyclic adenosine monophosphate (cyclic AMP), via administration of the phosphodiesterase 4 (PDE4) inhibitor Rolipram. The current study sought to determine the optimal neuroprotective dose, route and therapeutic window for Rolipram following contusive SCI in rat as well as its prominent PDE target and putative mechanism of protection. Rolipram or vehicle control (10% ethanol) was given subcutaneously (s.c.) daily for 2 wk post-injury (PI) after which the preservation of oligodendrocytes, neurons and central myelinated axons was stereologically assessed. Doses of 0.1 mg/kg to 1.0 mg/kg (given at 1 h PI) increased neuronal survival; 0.5 mg to 1.0 mg/kg protected oligodendrocytes and 1.0 mg/kg produced optimal preservation of central myelinated axons. Ethanol also demonstrated significant neuronal and oligo-protection; though the preservation provided was significantly less than Rolipram. Subsequent use of this optimal Rolipram dose, 1.0 mg/kg, via different routes (i.v., s.c. or oral, 1 h PI), demonstrated that i.v. administration produced the most significant and consistent cyto- and axo-protection, although all routes were effective. Examination of the therapeutic window for i. v. Rolipram (1.0 mg/kg), when initiated between 1 and 48 h after SCI, revealed maximal neuroprotection at 2 h post-SCI, although the protective efficacy of Rolipram could still be observed when administration was delayed for up to 48 h PI. Importantly, use of the optimal Rolipram regimen significantly improved locomotor function after SCI as measured by the BBB score. Lastly we show SCI-induced changes in PDE4A, B and D expression and phosphorylation as well as cytokine expression and immune cell infiltration. We demonstrate that Rolipram abrogates SCI-induced PDE4B1 and PDE4A5 production, PDE4A5 phosphorylation, MCP-1 expression and immune cell infiltration, while preventing post-injury reductions in IL-10. This work supports the use of Rolipram as an acute neuroprotectant following SCI and defines an optimal administration protocol and target for its therapeutic application.	[Schaal, Sandra Marie; Sen Garg, Maneesh; Ghosh, Mousumi; Lovera, Lilie; Lopez, Michael; Patel, Monal; Louro, Jack; Patel, Samik; Tuesta, Luis; Chan, Wai-Man; Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Schaal, Sandra Marie; Pearse, Damien Daniel] Univ Miami, Neurosci Program, Miami, FL USA; [Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Pearse, Damien Daniel] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Pearse, DD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	DPearse@med.miami.edu	Pearse, Damien D/D-3176-2011	Pearse, Damien D/0000-0003-1783-221X	United States National Institutes of Health (NIH) NINDS [RO1NSO56281]; Carnival Cruise Lines; Hearst Foundation; Bryon Riesch Paralysis Foundation; Craig H. Neilsen Foundation; Daniel Heumann Foundation; Miami Project to Cure Paralysis; Buoniconti Fund; State of Florida; Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056281] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) NINDS; Carnival Cruise Lines; Hearst Foundation; Bryon Riesch Paralysis Foundation; Craig H. Neilsen Foundation; Daniel Heumann Foundation; Miami Project to Cure Paralysis; Buoniconti Fund; State of Florida; Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: United States National Institutes of Health (NIH) NINDS Grant Number RO1NSO56281 (D. D. P.), Carnival Cruise Lines (commercial, funding provided as a donation with no commercial interest), The Hearst Foundation, The Bryon Riesch Paralysis Foundation, The Craig H. Neilsen Foundation, The Daniel Heumann Foundation, The Miami Project to Cure Paralysis, The Buoniconti Fund, The State of Florida, and a Lois Pope LIFE Fellowship (S. M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Altura BM, 1996, NEUROSCI LETT, V220, P207, DOI 10.1016/S0304-3940(96)13268-7; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Aspiotis R, 2010, BIOORG MED CHEM LETT, V20, P5502, DOI 10.1016/j.bmcl.2010.07.076; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Barber R, 2004, AM J PHYSIOL-LUNG C, V287, pL332, DOI 10.1152/ajplung.00384.2003; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P674; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beard MB, 2002, CELL SIGNAL, V14, P453, DOI 10.1016/S0898-6568(01)00264-9; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Belmadani A, 2003, J NEUROVIROL, V9, P45, DOI 10.1080/13550280390173409; Belmadani A, 2004, NEUROREPORT, V15, P2093, DOI 10.1097/00001756-200409150-00019; Berrocal YA, 2007, NEUROSCI LETT, V413, P58, DOI 10.1016/j.neulet.2006.11.030; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bhat RV, 1996, GLIA, V17, P169; Bielekova B, 2009, MULT SCLER J, V15, P1206, DOI 10.1177/1352458509345903; Block F, 2004, BRAIN RES, V998, P29, DOI 10.1016/j.brainres.2003.10.058; Block F, 2001, NEUROSCI LETT, V298, P103, DOI 10.1016/S0304-3940(00)01729-8; Block F, 2001, NEUROREPORT, V12, P1507, DOI 10.1097/00001756-200105250-00041; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Burnouf C, 2002, CURR PHARM DESIGN, V8, P1255, DOI 10.2174/1381612023394665; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; D'Sa C, 2002, J NEUROCHEM, V81, P745, DOI 10.1046/j.1471-4159.2002.00878.x; Dai HN, 2009, J NEUROTRAUM, V26, P1719, DOI [10.1089/neu.2008.0592, 10.1089/neu.2008-0592]; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; Davis KM, 2001, J BIOMED SCI, V8, P7, DOI 10.1159/000054008; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034; Duplantier AJ, 1996, J MED CHEM, V39, P120, DOI 10.1021/jm9505066; Farooqui SM, 2000, BRAIN RES, V867, P52, DOI 10.1016/S0006-8993(00)02224-1; Faroqui SM, 2001, BIOL REPROD, V64, P1583, DOI 10.1095/biolreprod64.6.1583; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francischi JN, 2000, EUR J PHARMACOL, V399, P243, DOI 10.1016/S0014-2999(00)00330-7; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; GENAIN CP, 1995, P NATL ACAD SCI USA, V92, P3601, DOI 10.1073/pnas.92.8.3601; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Guizar-Sahagun G, 2009, SPINAL CORD, V47, P156, DOI 10.1038/sc.2008.85; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HARRIS AL, 1989, J PHARMACOL EXP THER, V251, P199; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; HEASLIP RJ, 1995, EUR J PHARMACOL, V286, P281, DOI 10.1016/0014-2999(95)00457-2; HORROBIN DF, 1977, PROSTAG OTH LIPID M, V14, P667, DOI 10.1016/0090-6980(77)90194-0; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Huston E, 2000, J BIOL CHEM, V275, P28063; Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kajana S, 2008, EXP NEUROL, V210, P671, DOI 10.1016/j.expneurol.2007.12.021; Kajana S, 2009, J SPINAL CORD MED, V32, P175, DOI 10.1080/10790268.2009.11760769; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kontogeorgakos VA, 2009, ARCH ORTHOP TRAUM SU, V129, P189, DOI 10.1007/s00402-008-0594-x; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Laliberte F, 2002, FEBS LETT, V512, P205, DOI 10.1016/S0014-5793(02)02259-7; Larson JL, 1996, PHARMACOL TOXICOL, V78, P44, DOI 10.1111/j.1600-0773.1996.tb00178.x; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Leskovar A, 2000, J EXP BIOL, V203, P1783; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; MacKenzie SJ, 1998, P NATL ACAD SCI USA, V95, P3549, DOI 10.1073/pnas.95.7.3549; Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pearse DD, 2004, J NEUROTRAUM, V21, P1223, DOI 10.1089/0897715041953876; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pearse DD, 2001, NEUROSCIENCE, V107, P143, DOI 10.1016/S0306-4522(01)00320-7; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; PRASAD KN, 1971, NATURE-NEW BIOL, V233, P141, DOI 10.1038/newbio233141a0; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; Saldou N, 1998, CELL SIGNAL, V10, P427, DOI 10.1016/S0898-6568(97)00169-1; Schaal SM, 2007, CELL TRANSPLANT, V16, P207, DOI 10.3727/000000007783464768; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Sipski ML, 2006, NAT CLIN PRACT NEURO, V2, P402, DOI 10.1038/ncpneuro0221; Sivaswamy S, 2010, EUR J NEUROSCI, V32, P1800, DOI 10.1111/j.1460-9568.2010.07451.x; Sommer N, 1997, J NEUROIMMUNOL, V79, P54, DOI 10.1016/S0165-5728(97)00111-2; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; SUTHERLAND E W, 1960, Acta Endocrinol Suppl (Copenh), V34(Suppl 50), P171; Takami T, 2002, J NEUROSCI, V22, P6670; Tator C H, 1999, Neurosurg Focus, V6, pe8; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thrivikraman KV, 2002, BRAIN RES PROTOC, V10, P84, DOI 10.1016/S1385-299X(02)00185-X; TORPHY TJ, 1991, THORAX, V46, P512, DOI 10.1136/thx.46.7.512; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; VERGHESE MW, 1995, MOL PHARMACOL, V47, P1164; WACHTEL H, 1983, J PHARM PHARMACOL, V35, P440, DOI 10.1111/j.2042-7158.1983.tb04318.x; Walsh KA, 2010, ORTHOPEDICS, V33, P249, DOI 10.3928/01477447-20100225-15; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; WEST NR, 1989, J NEUROPATH EXP NEUR, V48, P94, DOI 10.1097/00005072-198901000-00008; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; Ye Y, 1997, J NEUROCHEM, V69, P2397; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang HT, 2006, PSYCHOPHARMACOLOGY, V186, P209, DOI 10.1007/s00213-006-0369-4	130	46	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43634	10.1371/journal.pone.0043634	http://dx.doi.org/10.1371/journal.pone.0043634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028463	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400011
J	Liu, HT; Kuo, HC				Liu, Hsin-Tzu; Kuo, Hann-Chorng			Increased Urine and Serum Nerve Growth Factor Levels in Interstitial Cystitis Suggest Chronic Inflammation Is Involved in the Pathogenesis of Disease	PLOS ONE			English	Article							LUMBOSACRAL SPINAL-CORD; NEUROTROPHIC FACTOR; BLADDER DYSFUNCTION; INJURED RATS; STRESS; IMMUNONEUTRALIZATION; PATHOPHYSIOLOGY; CELL	Objective: Interstitial cystitis/bladder pain syndrome (IC/BPS) is considered a bladder disorder due to localized chronic inflammation. This study investigated the nerve growth factor (NGF) levels in serum and urine in patients with IC/BPS. Materials and Methods: Thirty patients with IC/BPS and 28 normal subjects without lower urinary tract symptoms were recruited from an outpatient clinic. IC/BPS was diagnosed by frequency, bladder pain, and the presence of glomerulations during cystoscopic hydrodistention. Serum and urine were collected before any treatment was given. Serum NGF and urinary NGF/Cr levels were compared between IC/BPS and the controls. Results: Urinary NGF levels were significantly higher in patients with IC/PBS (26.3 +/- 11.2 pg/ml) than in controls (1.40 +/- 0.63 pg) (p = 0.014). After normalization, the urinary NGF/Cr levels were significantly greater in IC/BPS (0.69 +/- 0.38 pg/mg) than controls (0.20 +/- 0.01, p = 0.011). Relative to the levels in control subjects (1.90 +/- 0.38 pg/mL), the mean serum NGF levels were higher in patients IC/BPS patients (3.48 +/- 0.55 pg/mL) (p = 0.015). No significant correlation was found between the serum and urinary NGF levels in IC/BPS patients. However, the clinical characteristics and medical co-morbidities did not show significant difference between IC/BPS patients with a higher and lower serum NGF level. Conclusions: Increased urinary NGF levels in IC/BPS patients suggest that chronic inflammation is involved in this bladder disorder. Increased circulating serum NGF levels were noted in over half of patients with IC/BPS, however, the urinary and serum NGF were not inter-correlated and elevated serum NGF did not relate with clinical features.	[Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualin, Taiwan; [Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualin, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University	Liu, HT (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualin, Taiwan.	htl1@ms43.hinet.net; hck@tzuchi.com.tw						Alleva E, 2001, PHYSIOL BEHAV, V73, P313, DOI 10.1016/S0031-9384(01)00498-X; Antunes-Lopes T, 2011, ADV UROL, V2011, DOI 10.1155/2011/382431; Bonini S, 1999, INT ARCH ALLERGY IMM, V118, P159, DOI 10.1159/000024055; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Chuang YC, 2001, J UROLOGY, V165, P975, DOI 10.1016/S0022-5347(05)66587-1; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Joachim RA, 2008, CLIN EXP ALLERGY, V38, P283, DOI 10.1111/j.1365-2222.2007.02899.x; Jockers-Scherubl MC, 2007, PROG NEURO-PSYCHOPH, V31, P200, DOI 10.1016/j.pnpbp.2006.09.006; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Liu HT, 2009, NEUROUROL URODYNAM, V28, P78, DOI 10.1002/nau.20599; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Orita S, 2010, J ORTHOP RES, V28, P1614, DOI 10.1002/jor.21170; Peters EMJ, 2011, J INVEST DERMATOL, V131, P735, DOI 10.1038/jid.2010.317; Rothrock NE, 2001, UROLOGY, V57, P422, DOI 10.1016/S0090-4295(00)00988-2; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Seki S, 2004, J UROLOGY, V171, P478, DOI 10.1097/01.ju.0000088340.26588.74; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	27	44	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44687	10.1371/journal.pone.0044687	http://dx.doi.org/10.1371/journal.pone.0044687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028581	gold, Green Published, Green Submitted			2022-12-25	WOS:000309742800015
J	Sugiura, D; Denda-Nagai, K; Takashima, M; Murakami, R; Nagai, S; Takeda, K; Irimura, T				Sugiura, Daisuke; Denda-Nagai, Kaori; Takashima, Mitsuyo; Murakami, Ryuichi; Nagai, Shigenori; Takeda, Kazuyoshi; Irimura, Tatsuro			Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHIC EPITHELIAL MUCIN; IMMORTALIZED B-CELLS; COMPLEMENTARY-DNA; DENDRITIC CELLS; WILD-TYPE; CANCER; CARCINOMA; ANTIGEN; VACCINATION	MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy with MUC1. Although MUC1.Tg mice have previously been shown to be immunologically tolerant to MUC1, the involvement of regulatory T (Treg) cells in this phenotype remains unclear. Here, we showed that numbers of Treg cells in MUC1-expressing tumors were greater in MUC1.Tg mice than in control C57BL/6 (B6) mice, and that the growth of tumor cells expressing MUC1, but not that of control cells, in MUC1.Tg mice was faster than in B6 mice. The MUC1.Tg mice appeared to develop MUC1-specific peripheral tolerance, as transferred MUC1-specific T cells were unable to function in MUC1.Tg mice but were functional in control B6 mice. The suppressive function of CD4(+)CD25(high) cells from MUC1.Tg mice was more potent than that of cells from control B6 mice when Treg cell activity against MUC1-specific T cells was compared in vitro. Therefore, the enhanced growth of MUC1-expressing tumor cells in MUC1.Tg mice is likely due to the presence of MUC1-specific Treg cells.	[Sugiura, Daisuke; Denda-Nagai, Kaori; Takashima, Mitsuyo; Murakami, Ryuichi; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan; [Nagai, Shigenori] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	University of Tokyo; Keio University; Juntendo University	Denda-Nagai, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan.	denda@mol.f.u-tokyo.ac.jp; irimura@mol.f.u-tokyo.ac.jp		Sugiura, Daisuke/0000-0002-3865-3889; Murakami, Ryuichi/0000-0001-8257-585X; Nagai, Shigenori/0000-0002-5018-5942; Denda-Nagai, Kaori/0000-0001-8325-3289	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [24659029, 23300355] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Daisuke Sugiura was a Research Fellow of the Japan Society for the Promotion of Science, and this work was supported grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addey C, 2011, J IMMUNOL, V186, P4557, DOI 10.4049/jimmunol.1003797; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Bos R, 2005, CANCER RES, V65, P6443, DOI 10.1158/0008-5472.CAN-05-0666; Bos R, 2008, CANCER RES, V68, P8446, DOI 10.1158/0008-5472.CAN-08-1864; Budiu RA, 2009, DIS MODEL MECH, V2, P593, DOI 10.1242/dmm.002535; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Denda-Nagai K, 2000, GLYCOCONJUGATE J, V17, P649, DOI 10.1023/A:1011039013134; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; HAHN S, 1995, IMMUNOL REV, V146, P57, DOI 10.1111/j.1600-065X.1995.tb00684.x; Hamanaka Y, 2003, INT J CANCER, V103, P97, DOI 10.1002/ijc.10801; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JEROME KR, 1993, J IMMUNOL, V151, P1654; JEROME KR, 1992, CANCER RES, V52, P5985; Kamata M, 2002, CLIN EXP METASTAS, V19, P689, DOI 10.1023/A:1021332932531; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Merlo A, 2010, J IMMUNOL, V184, P5895, DOI 10.4049/jimmunol.0902850; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Rowse GJ, 1998, CANCER RES, V58, P315; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Sugiura D, 2010, CANCER SCI, V101, P1965, DOI 10.1111/j.1349-7006.2010.01634.x; Sugiura D, 2008, CANCER SCI, V99, P2477, DOI 10.1111/j.1349-7006.2008.00967.x; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Turner MS, 2007, J IMMUNOL, V178, P2787, DOI 10.4049/jimmunol.178.5.2787; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vlad AM, 2004, ADV IMMUNOL, V82, P249, DOI 10.1016/S0065-2776(04)82006-6; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44770	10.1371/journal.pone.0044770	http://dx.doi.org/10.1371/journal.pone.0044770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028615	Green Submitted, Green Published, gold			2022-12-25	WOS:000309742800018
J	Zhu, WB; Wu, CC; Deng, WY; Pei, RJ; Wang, Y; Cao, L; Qin, B; Lu, MJ; Chen, XW				Zhu, Wenbo; Wu, Chunchen; Deng, Wanyu; Pei, Rongjun; Wang, Yun; Cao, Liang; Qin, Bo; Lu, Mengji; Chen, Xinwen			Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo	PLOS ONE			English	Article							HEPATITIS-C VIRUS; AMINO-ACID SUBSTITUTIONS; T-CELL FUNCTION; B-VIRUS; DENDRITIC CELLS; STRUCTURAL PROTEINS; VIRAL INTERFERENCE; HUH-7 CELLS; BALB/C MICE; MOUSE MODEL	The hepatitis C virus (HCV) core protein is a multifunctional protein that can interfere with the induction of an immune response. It has been reported that the HCV core protein inhibits HBV replication in vitro. In this study, we test the effect of the HCV core gene on the priming of the immune response to hepatitis B surface antigen (HBsAg) and on the replication of HBV in vivo. Our results showed that the full-length HCV core gene inhibits the induction of an immune response to the heterogeneous antigen, HBsAg, at the site of inoculation when HCV core (pC191) and HBsAg (pHBsAg) expression plasmids are co-administered as DNA vaccines into BALB/c mice. The observed interference effect of the HCV core occurs in the priming stage and is limited to the DNA form of the HBsAg antigen, but not to the protein form. The HCV core reduces the protective effect of the HBsAg when the HBsAg and the HCV core are co-administered as vaccines in an HBV hydrodynamic mouse model because the HCV core induces immune tolerance to the heterogeneous HBsAg DNA antigen. These results suggest that HCV core may play an important role in viral persistence by the attenuation of host immune responses to different antigens. We further tested whether the HCV core interfered with the priming of the immune response in hepatocytes via the hydrodynamic co-injection of an HBV replication-competent plasmid and an HCV core plasmid. The HCV core inhibited HBV replication and antigen expression in both BALB/c (H-2d) and C57BL/6 (H-2b) mice, the mouse models of acute and chronic hepatitis B virus infections. Thus, the HCV core inhibits the induction of a specific immune response to an HBsAg DNA vaccine. However, HCV C also interferes with HBV gene expression and replication in vivo, as observed in patients with coinfection.	[Zhu, Wenbo; Wu, Chunchen; Deng, Wanyu; Pei, Rongjun; Wang, Yun; Cao, Liang; Qin, Bo; Lu, Mengji; Chen, Xinwen] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Duisburg Essen	Zhu, WB (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	chenxw@wh.iov.cn	Cao, Liang/E-4055-2017; Lu, Mengji/ABF-9410-2020	Cao, Liang/0000-0001-5974-9815; 	National Basic Research Priorities Program of China [2007CB512901, 2011CB106303]; Deutsche Forschungsgemeinschaft [GRK 1045/2, TRR60]	National Basic Research Priorities Program of China(National Basic Research Program of China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the National Basic Research Priorities Program of China (2007CB512901 and 2011CB106303) (http://www.973.gov.cn/AreaAppl.aspx) and the grants of Deutsche Forschungsgemeinschaft (GRK 1045/2 and TRR60) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI A, 1995, J HEPATOL, V22, P38; Alberti A, 2005, ALIMENT PHARM THER, V22, P74, DOI 10.1111/j.1365-2036.2005.02602.x; Alekseeva Ekaterina, 2009, Genet Vaccines Ther, V7, P7, DOI 10.1186/1479-0556-7-7; Ando Y, 1997, CLIN DIAGN LAB IMMUN, V4, P104, DOI 10.1128/CDLI.4.1.104-106.1997; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; BRADLEY DW, 1983, J MED VIROL, V11, P207, DOI 10.1002/jmv.1890110304; Chen SY, 2003, J BIOL CHEM, V278, P591, DOI 10.1074/jbc.M204241200; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Duenas-Carrera S, 2000, VACCINE, V19, P992, DOI 10.1016/S0264-410X(00)00209-7; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Eyre NS, 2009, J HEPATOL, V51, P446, DOI 10.1016/j.jhep.2009.04.025; Gordon EJ, 2000, J INFECT DIS, V181, P42, DOI 10.1086/315162; Hahn CS, 2000, VIROLOGY, V276, P127, DOI 10.1006/viro.2000.0541; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Hu GJ, 1999, VACCINE, V17, P3160, DOI 10.1016/S0264-410X(99)00130-9; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Inchauspe G, 1997, VACCINE, V15, P853, DOI 10.1016/S0264-410X(96)00275-7; Isaguliants MG, 2004, VACCINE, V22, P1656, DOI 10.1016/j.vaccine.2003.09.047; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Jardi R, 2001, HEPATOLOGY, V34, P404, DOI 10.1053/jhep.2001.26511; Kim HS, 2002, ARCH PHARM RES, V25, P364, DOI 10.1007/BF02976640; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; LAGGING LM, 1995, J VIROL, V69, P5859, DOI 10.1128/JVI.69.9.5859-5863.1995; Lee CH, 2001, VIROLOGY, V279, P271, DOI 10.1006/viro.2000.0694; Lei Yan-Chang, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P738; Liao G, 2008, HEPATOLOGY, V47, P25, DOI 10.1002/hep.21992; LIAW YF, 1994, GASTROENTEROLOGY, V106, P1048, DOI 10.1016/0016-5085(94)90766-8; LIAW YF, 1991, INFECTION, V19, P250, DOI 10.1007/BF01644957; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Mann EA, 2006, VIRUS RES, V121, P51, DOI 10.1016/j.virusres.2006.04.001; MIMMS LT, 1993, BRIT MED J, V307, P1095, DOI 10.1136/bmj.307.6912.1095; Ohkawa K, 2004, J BIOL CHEM, V279, P11719, DOI 10.1074/jbc.M308560200; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Sarobe P, 2003, J VIROL, V77, P10862, DOI 10.1128/JVI.77.20.10862-10871.2003; Sarobe P, 2002, J VIROL, V76, P5062, DOI 10.1128/JVI.76.10.5062-5070.2002; Satoi J, 2001, J VIROL, V75, P12121, DOI 10.1128/JVI.75.24.12121-12127.2001; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; Szabo G, 2008, J HEPATOL, V48, P8, DOI 10.1016/j.jhep.2007.10.005; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Wu CC, 2010, J GEN VIROL, V91, P483, DOI 10.1099/vir.0.012740-0; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yao ZQ, 2005, J VIROL, V79, P15417, DOI 10.1128/JVI.79.24.15417-15429.2005; Zhu WB, 2010, CLIN VACCINE IMMUNOL, V17, P1139, DOI 10.1128/CVI.00490-09; Zimmermann M, 2008, J HEPATOL, V48, P51, DOI 10.1016/j.jhep.2007.08.008	53	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45146	10.1371/journal.pone.0045146	http://dx.doi.org/10.1371/journal.pone.0045146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024803	Green Submitted, gold, Green Published			2022-12-25	WOS:000308860100061
J	Blatti, JL; Beld, J; Behnke, CA; Mendez, M; Mayfield, SP; Burkart, MD				Blatti, Jillian L.; Beld, Joris; Behnke, Craig A.; Mendez, Michael; Mayfield, Stephen P.; Burkart, Michael D.			Manipulating Fatty Acid Biosynthesis in Microalgae for Biofuel through Protein-Protein Interactions	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; AUTOMATED DOCKING; ACP THIOESTERASE; CHLAMYDOMONAS; EXPRESSION; CHAIN; TRIACYLGLYCEROLS; IDENTIFICATION; PURIFICATION; SPECIFICITY	Microalgae are a promising feedstock for renewable fuels, and algal metabolic engineering can lead to crop improvement, thus accelerating the development of commercially viable biodiesel production from algae biomass. We demonstrate that protein-protein interactions between the fatty acid acyl carrier protein (ACP) and thioesterase (TE) govern fatty acid hydrolysis within the algal chloroplast. Using green microalga Chlamydomonas reinhardtii (Cr) as a model, a structural simulation of docking CrACP to CrTE identifies a protein-protein recognition surface between the two domains. A virtual screen reveals plant TEs with similar in silico binding to CrACP. Employing an activity-based crosslinking probe designed to selectively trap transient protein-protein interactions between the TE and ACP, we demonstrate in vitro that CrTE must functionally interact with CrACP to release fatty acids, while TEs of vascular plants show no mechanistic crosslinking to CrACP. This is recapitulated in vivo, where overproduction of the endogenous CrTE increased levels of short-chain fatty acids and engineering plant TEs into the C. reinhardtii chloroplast did not alter the fatty acid profile. These findings highlight the critical role of protein-protein interactions in manipulating fatty acid biosynthesis for algae biofuel engineering as illuminated by activity-based probes.	[Blatti, Jillian L.; Beld, Joris; Burkart, Michael D.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Behnke, Craig A.; Mendez, Michael] Sapphire Energy Inc, San Diego, CA USA; [Mayfield, Stephen P.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Blatti, JL (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	mburkart@ucsd.edu		Behnke, Craig/0000-0001-6949-7957	United States Department of Energy (DOE) [DE-EE0003373]; United States National Science Foundation (NSF) [0742551]; Rubicon Postdoctoral Fellowship; California Energy Commission CILMSF [500-10-039.]	United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States National Science Foundation (NSF)(National Science Foundation (NSF)); Rubicon Postdoctoral Fellowship; California Energy Commission CILMSF	Funding was provided by the United States Department of Energy (DOE) DE-EE0003373; United States National Science Foundation (NSF) 0742551; Rubicon Postdoctoral Fellowship; and California Energy Commission CILMSF 500-10-039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL V1 4; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dani KGS, 2011, PLANT BIOLOGY, V13, P453, DOI 10.1111/j.1438-8677.2010.00410.x; DAVIES HM, 1993, PHYTOCHEMISTRY, V33, P1353, DOI 10.1016/0031-9422(93)85089-A; DORMANN P, 1995, ARCH BIOCHEM BIOPHYS, V316, P612, DOI 10.1006/abbi.1995.1081; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Facciotti MT, 1998, FETT-LIPID, V100, P167; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gong Y, 2011, J BASIC MICROB, V51, P1; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kan YA, 2010, J PHYCOL, V46, P1356, DOI 10.1111/j.1529-8817.2010.00904.x; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Mayer KM, 2005, J BIOL CHEM, V280, P3621, DOI 10.1074/jbc.M411351200; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Meier JL, 2008, MOL BIOSYST, V4, P663, DOI 10.1039/b801397g; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Mendez M., 2010, PRODUCTION FATTY ACI; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Murugan E, 2010, PROTEIN EXPRES PURIF, V71, P132, DOI 10.1016/j.pep.2010.01.007; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryall K, 2003, GENE, V313, P139, DOI 10.1016/S0378-1119(03)00671-1; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Walker TL, 2005, J PHYCOL, V41, P1077, DOI 10.1111/j.1529-8817.2005.00133.x; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Weissman KJ, 2006, CHEM BIOL, V13, P625, DOI 10.1016/j.chembiol.2006.04.010; Worthington AS, 2008, CHEMBIOCHEM, V9, P2096, DOI 10.1002/cbic.200800198; Worthington AS, 2006, ACS CHEM BIOL, V1, P687, DOI 10.1021/cb6003965; Worthington AS, 2010, ORG BIOMOL CHEM, V8, P1769, DOI 10.1039/b925966j; Worthington AS, 2006, ORG BIOMOL CHEM, V4, P44, DOI 10.1039/b512735a; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	57	82	101	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42949	10.1371/journal.pone.0042949	http://dx.doi.org/10.1371/journal.pone.0042949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028438	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700006
J	Chan, LJ; Rosengren, KJ; Layfield, SL; Bathgate, RAD; Separovic, F; Samuel, CS; Hossain, MA; Wade, JD				Chan, Linda J.; Rosengren, K. Johan; Layfield, Sharon L.; Bathgate, Ross A. D.; Separovic, Frances; Samuel, Chrishan S.; Hossain, Mohammed A.; Wade, John D.			Identification of Key Residues Essential for the Structural Fold and Receptor Selectivity within the A-chain of Human Gene-2 (H2) Relaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PEPTIDE RECEPTORS; SOLID-PHASE SYNTHESIS; BINDING SITE; IN-VIVO; INSULIN-RECEPTOR; ACTIVATION; HORMONE; LIGAND; COLLAGEN; LGR7	Human gene-2 (H2) relaxin is currently in Phase III clinical trials for the treatment of acute heart failure. It is a 53-amino acid insulin-like peptide comprising two chains and three disulfide bonds. It interacts with two of the relaxin family peptide (RXFP) receptors. Although its cognate receptor is RXFP1, it is also able to cross-react with RXFP2, the native receptor for a related peptide, insulin-like peptide 3. In order to understand the basis of this cross-reactivity, it is important to elucidate both binding and activation mechanisms of this peptide. The primary binding mechanism of this hormone has been extensively studied and well defined. H2 relaxin binds to the leucine-rich repeats of RXFP1 and RXFP2 using B-chain-specific residues. However, little is known about the secondary interaction that involves the A-chain of H2 relaxin and transmembrane exoloops of the receptors. We demonstrate here through extensive mutation of the A-chain that the secondary interaction between H2 relaxin and RXFP1 is not driven by any single amino acid, although residues Tyr-3, Leu-20, and Phe-23 appear to contribute. Interestingly, these same three residues are important drivers of the affinity and activity of H2 relaxin for RXFP2 with additional minor contributions from Lys-9, His-12, Lys-17, Arg-18, and Arg-22. Our results provide new insights into the mechanism of secondary activation interaction of RXFP1 and RXFP2 by H2 relaxin, leading to a potent and RXFP1-selective analog, H2:A(4-24)(F23A), which was tested in vitro and in vivo and found to significantly inhibit collagen deposition similar to native H2 relaxin.	[Chan, Linda J.; Layfield, Sharon L.; Bathgate, Ross A. D.; Samuel, Chrishan S.; Hossain, Mohammed A.; Wade, John D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Chan, Linda J.; Separovic, Frances; Hossain, Mohammed A.; Wade, John D.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3145, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland; Monash University	Samuel, CS (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	chrishan.samuel@florey.edu.au; akhter.hossain@florey.edu.au; john.wade@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Separovic, Frances/D-9698-2011; Rosengren, K. Johan/P-4450-2016	Bathgate, Ross/0000-0001-6301-861X; Separovic, Frances/0000-0002-6484-2763; Rosengren, K. Johan/0000-0002-5007-8434; Hossain, Mohammed/0000-0002-9961-0006; Wade, John/0000-0002-1352-6568	National Health and Medical Research Council (NHMRC) (Australia) [508995, 1023078]; Victorian Government; Reid Trust; Florey Foundation	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Reid Trust; Florey Foundation	This research was funded by National Health and Medical Research Council (NHMRC) (Australia) Project Grants 508995 and 1023078 (to J. D. W., M. A. H., and R. A. D. B.). Studies at the Florey Neuroscience Institutes were supported by the Victorian Government's Operational Infrastructure Support Program.; Recipient of Reid Trust and Florey Foundation Fellowships.	Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bathgate Ross A D, 2012, Front Endocrinol (Lausanne), V3, P11, DOI 10.3389/fendo.2012.00011; Brooks WW, 2009, COMPARATIVE MED, V59, P339; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14586, DOI 10.1074/jbc.M414443200; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hossain MA, 2012, PEPTIDES, V35, P102, DOI 10.1016/j.peptides.2012.02.021; Hossain MA, 2011, J BIOL CHEM, V286, P37555, DOI 10.1074/jbc.M111.282194; Hossain MA, 2010, CURR PROTEIN PEPT SC, V11, P719; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kong RCK, 2010, MOL CELL ENDOCRINOL, V320, P1, DOI 10.1016/j.mce.2010.02.003; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Park JI, 2008, J BIOL CHEM, V283, P32099, DOI 10.1074/jbc.M806817200; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel Chrishan S., 2009, V466, P223, DOI 10.1007/978-1-59745-352-3_16; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2008, BIOCONJUGATE CHEM, V19, P1456, DOI 10.1021/bc800127p; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1983, BIOPOLYMERS, V22, P131, DOI 10.1002/bip.360220121; Zhang S, 2008, INT J PEPT RES THER, V14, P301, DOI 10.1007/s10989-008-9148-x	49	18	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41152	41164		10.1074/jbc.M112.409284	http://dx.doi.org/10.1074/jbc.M112.409284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23024363	Green Published, hybrid			2022-12-25	WOS:000311887600031
J	Kim, SK; Jung, I; Lee, H; Kang, K; Kim, M; Jeong, K; Kwon, CS; Han, YM; Kim, YS; Kim, D; Lee, D				Kim, Seung-Kyoon; Jung, Inkyung; Lee, Hosuk; Kang, Keunsoo; Kim, Mirang; Jeong, Kwiwan; Kwon, Chang Seob; Han, Yong-Mahn; Kim, Yong Sung; Kim, Dongsup; Lee, Daeyoup			Human Histone H3K79 Methyltransferase DOT1L Methyltransferase Binds Actively Transcribing RNA Polymerase II to Regulate Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ELONGATION; H3 METHYLATION; H2B MONOUBIQUITINATION; TERMINAL DOMAIN; UBIQUITINATION; YEAST; RECRUITMENT; NUCLEOSOME; KINASE; SET2	Histone-modifying enzymes play a pivotal role in gene expression and repression. In human, DOT1L (Dot1-like) is the only known histone H3 lysine 79 methyltransferase. hDOT1L is associated with transcriptional activation, but the general mechanism connecting hDOT1L to active transcription remains largely unknown. Here, we report that hDOT1L interacts with the phosphorylated C-terminal domain of actively transcribing RNA polymerase II (RNAPII) through a region conserved uniquely in multicellular DOT1 proteins. Genome-wide profiling analyses indicate that the occupancy of hDOT1L largely overlaps with that of RNAPII at actively transcribed genes, especially surrounding transcriptional start sites, in embryonic carcinoma NCCIT cells. We also find that C-terminal domain binding or H3K79 methylations by hDOT1L is important for the expression of target genes such as NANOG and OCT4 and a marker for pluripotency in NCCIT cells. Our results indicate that a functional interaction between hDOT1L and RNAPII targets hDOT1L and subsequent H3K79 methylations to actively transcribed genes.	[Kim, Seung-Kyoon; Lee, Hosuk; Kang, Keunsoo; Jeong, Kwiwan; Han, Yong-Mahn; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jung, Inkyung; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kwon, Chang Seob] Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, Pusan 614822, South Korea; [Kim, Mirang; Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	daeyoup@kaist.ac.kr	Han, Yong-Mahn/C-1652-2011; Jung, Inkyung/CAJ-5773-2022; Kim, Dongsup/C-1612-2011; Lee, Daeyoup/C-1653-2011; Lee, Hosuk/AAE-9102-2022	Lee, Daeyoup/0000-0003-2006-1823; Kim, Seung-Kyoon/0000-0001-9776-4047; Jung, Inkyung/0000-0002-5885-2754	Epigenomic Research Program for Human Stem Cells Grant [2007-2004134]; Stem Cell Research Program Grant [2012M 3A9B 4027953]; Ministry of Education, Science & Technology (South Korea); KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea)	Epigenomic Research Program for Human Stem Cells Grant; Stem Cell Research Program Grant; Ministry of Education, Science & Technology (South Korea); KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea)	This work was supported by Epigenomic Research Program for Human Stem Cells Grant 2007-2004134, Stem Cell Research Program Grant 2012M 3A9B 4027953, and grants from the Ministry of Education, Science & Technology (South Korea) and the KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea).	Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; DAMJANOV I, 1993, EUR UROL, V23, P2; DAMJANOV I, 1993, LAB INVEST, V68, P220; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Hiromi N., 2009, COMP FUNCT GENOM, V2009, P8; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Jung I, 2012, GENOME RES, V22, P1026, DOI 10.1101/gr.120634.111; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Suganuma T, 2002, P NATL ACAD SCI USA, V99, P13073, DOI 10.1073/pnas.192586699; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; TESHIMA T, 1988, INT J RADIAT ONCOL, V14, P281, DOI 10.1016/0360-3016(88)90433-6; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	59	52	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.384057	http://dx.doi.org/10.1074/jbc.M112.384057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012353	hybrid, Green Published			2022-12-25	WOS:000311233800039
J	Sassa, A; Beard, WA; Prasad, R; Wilson, SH				Sassa, Akira; Beard, William A.; Prasad, Rajendra; Wilson, Samuel H.			DNA Sequence Context Effects on the Glycosylase Activity of Human 8-Oxoguanine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; THYMINE GLYCOL RESIDUE; DUAL-REACTION MODE; POLYMERASE-BETA; SACCHAROMYCES-CEREVISIAE; MUTATIONAL HOTSPOT; TANDEM MUTATIONS; AP-ENDONUCLEASE; BOVINE TESTIS; HUMAN-CELLS	Human 8-oxoguanine DNA glycosylase (OGG1) is a key enzyme involved in removing 7,8-dihydro-8-oxoguanine (8-oxoG), a highly mutagenic DNA lesion generated by oxidative stress. The removal of 8-oxoG by OGG1 is affected by the local DNA sequence, and this feature most likely contributes to observed mutational hot spots in genomic DNA. To elucidate the influence of local DNA sequence on 8-oxoG excision activity of OGG1, we conducted steady-state, pre-steady-state, and single turnover kinetic evaluation of OGG1 in alternate DNA sequence contexts. The sequence context effect was studied for a mutational hot spot at a CpG dinucleotide. Altering either the global DNA sequence or the 5'-flanking unmodified base pair failed to influence the excision of 8-oxoG. Methylation of the cytosine 5' to 8-oxoG also did not affect 8-oxoG excision. In contrast, a 5'-neighboring mismatch strongly decreased the rate of 8-oxoG base removal. Substituting the 5'-C in the CpG dinucleotide with T, A, or tetrahydrofuran (i.e. T:G, A:G, and tetrahydrofuran: G mispairs) resulted in a 10-, 13-, and 4-fold decrease in the rate constant for 8-oxoG excision, respectively. A greater loss in activity was observed when T:C or A:C was positioned 5' of 8-oxoG (59- and 108-fold, respectively). These results indicate that neighboring structural abnormalities 5' to 8-oxoG deter its repair thereby enhancing its mutagenic potential.	[Sassa, Akira; Beard, William A.; Prasad, Rajendra; Wilson, Samuel H.] NIEHS, NIH, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beard, WA (corresponding author), 111 TW Alexander Dr,POB 12233,MD F3-01, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Sassa, Akira/0000-0003-2454-0223	National Institutes of Health Research Project in the Intramural Research Program, NIEHS [Z01-ES050158]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health Research Project in the Intramural Research Program, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Project Grant Z01-ES050158 in the Intramural Research Program, NIEHS.	Acosta-Silva C, 2010, J PHYS CHEM B, V114, P10217, DOI 10.1021/jp103850h; Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Brown KL, 2008, J AM CHEM SOC, V130, P11701, DOI 10.1021/ja8016544; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cao HC, 2007, NUCLEIC ACIDS RES, V35, P4833, DOI 10.1093/nar/gkm497; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Hatahet Z, 1998, P NATL ACAD SCI USA, V95, P8556, DOI 10.1073/pnas.95.15.8556; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hussain SP, 2000, P NATL ACAD SCI USA, V97, P12770, DOI 10.1073/pnas.220416097; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jiang Y, 2009, CHEM RES TOXICOL, V22, P574, DOI 10.1021/tx8003449; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; KAO JY, 1993, J BIOL CHEM, V268, P17787; Kirpota OO, 2011, NUCLEIC ACIDS RES, V39, P4836, DOI 10.1093/nar/gkq1333; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kung HC, 1997, J BIOL CHEM, V272, P9227; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Larson ED, 2003, DNA REPAIR, V2, P1199, DOI 10.1016/S1568-7864(03)00140-X; Lee DH, 2002, NUCLEIC ACIDS RES, V30, P3566, DOI 10.1093/nar/gkf478; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; McKibbin PL, 2012, J AM CHEM SOC, V134, P1653, DOI 10.1021/ja208510m; Miller JH, 2005, RADIAT RES, V164, P582, DOI 10.1667/RR3381.1; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; Morland I, 2005, DNA REPAIR, V4, P381, DOI 10.1016/j.dnarep.2004.11.002; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; Oliva MR, 1997, MOL CARCINOGEN, V18, P232, DOI 10.1002/(SICI)1098-2744(199704)18:4<232::AID-MC7>3.0.CO;2-F; PATEL DJ, 1984, FED PROC, V43, P2663; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sakumi K, 2003, CANCER RES, V63, P902; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Scott AD, 1999, YEAST, V15, P205, DOI 10.1002/(SICI)1097-0061(199902)15:3<205::AID-YEA361>3.0.CO;2-1; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Sunaga N, 2001, CARCINOGENESIS, V22, P1355, DOI 10.1093/carcin/22.9.1355; Sung RJ, 2012, J BIOL CHEM, V287, P18044, DOI 10.1074/jbc.M111.313635; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yamane A, 2003, CARCINOGENESIS, V24, P1031, DOI 10.1093/carcin/bgg056; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	69	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36702	36710		10.1074/jbc.M112.397786	http://dx.doi.org/10.1074/jbc.M112.397786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989888	Green Published, hybrid			2022-12-25	WOS:000310588500008
J	Guney, E; Oliva, B				Guney, Emre; Oliva, Baldo			Exploiting Protein-Protein Interaction Networks for Genome-Wide Disease-Gene Prioritization	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TOPOLOGICAL FEATURES; CANDIDATE GENES; COMPLEX TRAITS; ASSOCIATION; DISORDERS; IDENTIFICATION; INFLAMMATION; PREDICTION; PHENOTYPE	Complex genetic disorders often involve products of multiple genes acting cooperatively. Hence, the pathophenotype is the outcome of the perturbations in the underlying pathways, where gene products cooperate through various mechanisms such as protein-protein interactions. Pinpointing the decisive elements of such disease pathways is still challenging. Over the last years, computational approaches exploiting interaction network topology have been successfully applied to prioritize individual genes involved in diseases. Although linkage intervals provide a list of disease-gene candidates, recent genome-wide studies demonstrate that genes not associated with any known linkage interval may also contribute to the disease phenotype. Network based prioritization methods help highlighting such associations. Still, there is a need for robust methods that capture the interplay among disease-associated genes mediated by the topology of the network. Here, we propose a genome-wide network-based prioritization framework named GUILD. This framework implements four network-based disease-gene prioritization algorithms. We analyze the performance of these algorithms in dozens of disease phenotypes. The algorithms in GUILD are compared to state-of-the-art network topology based algorithms for prioritization of genes. As a proof of principle, we investigate top-ranking genes in Alzheimer's disease (AD), diabetes and AIDS using disease-gene associations from various sources. We show that GUILD is able to significantly highlight disease-gene associations that are not used a priori. Our findings suggest that GUILD helps to identify genes implicated in the pathology of human disorders independent of the loci associated with the disorders.	[Guney, Emre; Oliva, Baldo] Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Barcelona, Catalonia, Spain	Pompeu Fabra University	Oliva, B (corresponding author), Univ Pompeu Fabra, Struct Bioinformat Grp GRIB, Barcelona Res Pk Biomed PRBB, Barcelona, Catalonia, Spain.	baldo.oliva@upf.edu	Oliva, Baldomero/A-2690-2009; Gasull, Martina/J-4076-2019; Guney, Emre/B-2568-2017	Oliva, Baldomero/0000-0003-0702-0250; Guney, Emre/0000-0002-3466-6535	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons); Spanish Ministry of Science and Innovation (MICINN); FEDER (Fonds Europeen de Developpement Regional) [BIO2008-0205, BIO2011-22568, PSE-0100000-2007, PSE-0100000-2009]; EU [EUI2009-04018]	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER (Fonds Europeen de Developpement Regional)(European Commission); EU(European Commission)	Departament d'Educacio i Universitats de la Generalitat de Catalunya i del Fons Social Europeu (Department of Education and Universities of the Generalitat of Catalonia and the European Social Fons). Spanish Ministry of Science and Innovation (MICINN), FEDER (Fonds Europeen de Developpement Regional) BIO2008-0205, BIO2011-22568, PSE-0100000-2007, and PSE-0100000-2009; and by EU grant EraSysbio+ (SHIPREC) Euroinvestigacion (EUI2009-04018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Broeckel U, 2004, J PHYSIOL-LONDON, V554, P40, DOI 10.1113/jphysiol.2003.051128; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Garcia-Garcia J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-56; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hofmann-Apitius M, 2008, PHILOS T R SOC A, V366, P3091, DOI 10.1098/rsta.2008.0099; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kitsios GD, 2009, ANN HUM GENET, V73, P514, DOI 10.1111/j.1469-1809.2009.00533.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2011, GENOME RES; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001	55	72	74	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e43557	10.1371/journal.pone.0043557	http://dx.doi.org/10.1371/journal.pone.0043557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028459	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800002
J	Wang, Y; Lin, B				Wang, Yan; Lin, Bo			In Silico Investigations of the Anti-Catabolic Effects of Pamidronate and Denosumab on Multiple Myeloma-Induced Bone Disease	PLOS ONE			English	Article							BREAST-CANCER; BISPHOSPHONATE PAMIDRONATE; POSTMENOPAUSAL WOMEN; MONOCLONAL-ANTIBODY; ZOLEDRONIC ACID; DOUBLE-BLIND; RESORPTION; EFFICACY; CELLS; MODEL	It is unclear whether the new anti-catabolic agent denosumab represents a viable alternative to the widely used anti-catabolic agent pamidronate in the treatment of Multiple Myeloma (MM)-induced bone disease. This lack of clarity primarily stems from the lack of sufficient clinical investigations, which are costly and time consuming. However, in silico investigations require less time and expense, suggesting that they may be a useful complement to traditional clinical investigations. In this paper, we aim to (i) develop integrated computational models that are suitable for investigating the effects of pamidronate and denosumab on MM-induced bone disease and (ii) evaluate the responses to pamidronate and denosumab treatments using these integrated models. To achieve these goals, pharmacokinetic models of pamidronate and denosumab are first developed and then calibrated and validated using different clinical datasets. Next, the integrated computational models are developed by incorporating the simulated transient concentrations of pamidronate and denosumab and simulations of their actions on the MM-bone compartment into the previously proposed MM-bone model. These integrated models are further calibrated and validated by different clinical datasets so that they are suitable to be applied to investigate the responses to the pamidronate and denosumab treatments. Finally, these responses are evaluated by quantifying the bone volume, bone turnover, and MM-cell density. This evaluation identifies four denosumab regimes that potentially produce an overall improved bone-related response compared with the recommended pamidronate regime. This in silico investigation supports the idea that denosumab represents an appropriate alternative to pamidronate in the treatment of MM-induced bone disease.	[Wang, Yan] Univ Melbourne, Sch Engn, Dept Infrastructure Engn, Melbourne, Vic, Australia; [Lin, Bo] Henan Univ, Sch Med, Kaifeng, Peoples R China	University of Melbourne; Henan University	Wang, Y (corresponding author), Univ Melbourne, Sch Engn, Dept Infrastructure Engn, Melbourne, Vic, Australia.	wangyan00@tsinghua.org.cn						Abrahamsen B, 2005, CURR OPIN MOL THER, V7, P604; Aghaloo TL, 2010, J ORAL MAXIL SURG, V68, P959, DOI 10.1016/j.joms.2009.10.010; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; BELCH AR, 1991, J CLIN ONCOL, V9, P1397, DOI 10.1200/JCO.1991.9.8.1397; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933; Cheng A, 2005, AUST DENT J, V50, pS4, DOI 10.1111/j.1834-7819.2005.tb00384.x; Cremers S, 2002, EUR J CLIN PHARMACOL, V57, P883, DOI 10.1007/s00228-001-0411-8; Cremers SCLM, 2005, J BONE MINER RES, V20, P1543, DOI 10.1359/JBMR.050522; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Diamond T, 1997, BRIT J HAEMATOL, V97, P641, DOI 10.1046/j.1365-2141.1997.1042920.x; Elad S, 2006, CLIN LAB HAEMATOL, V28, P393, DOI 10.1111/j.1365-2257.2006.00841.x; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Gordon S, 2002, BRIT J HAEMATOL, V119, P475, DOI 10.1046/j.1365-2141.2002.03824.x; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; International myeloma working group, 2007, MAYO CLIN P, V86; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Kitano M, 2005, J BONE MINER METAB, V23, P48, DOI 10.1007/s00774-004-0540-0; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kunzmann V, 2000, BLOOD, V96, P384; KYLE RA, 1975, NEW ENGL J MED, V293, P1334, DOI 10.1056/NEJM197512252932602; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lipton A, 2007, J CLIN ONCOL, V25, P4431, DOI 10.1200/JCO.2007.11.8604; Marathe A, 2008, J PHARMACOL EXP THER, V326, P555, DOI 10.1124/jpet.108.137703; Mundy GR, 1993, PHYSL PHARM BONE; Nau KC, 2008, AM FAM PHYSICIAN, V78, P853; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Rosen LS, 2001, CANCER J, V7, P377; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Silbermann R, 2010, CURR CLIN ONCOL, P1, DOI 10.1007/978-1-60761-554-5_1; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Srivastava AK, 2001, CALCIFIED TISSUE INT, V69, P327, DOI 10.1007/s00223-001-1034-x; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Terpos E, 2000, EUR J HAEMATOL, V65, P331, DOI 10.1034/j.1600-0609.2000.065005331.x; Terpos E, 2007, LEUKEMIA, V21, P1875, DOI 10.1038/sj.leu.2404843; Toutain PL, 2002, AAPS PHARMSCI, V4; Vanderkerken K, 2003, CANCER RES, V63, P287; Vij R, 2009, AM J HEMATOL, V84, P650, DOI 10.1002/ajh.21509; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027494; Woitge HW, 1999, J BONE MINER RES, V14, P792, DOI 10.1359/jbmr.1999.14.5.792; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yeh HS, 2006, EUR J CANCER, V42, P1554, DOI 10.1016/j.ejca.2005.11.035	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44868	10.1371/journal.pone.0044868	http://dx.doi.org/10.1371/journal.pone.0044868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028650	Green Published, gold			2022-12-25	WOS:000309392800020
J	Lhomme, P; Ayasse, M; Valterova, I; Lecocq, T; Rasmont, P				Lhomme, Patrick; Ayasse, Manfred; Valterova, Irena; Lecocq, Thomas; Rasmont, Pierre			Born in an Alien Nest : How Do Social Parasite Male Offspring Escape from Host Aggression?	PLOS ONE			English	Article							CHEMICAL RECOGNITION SYSTEM; DUFOURS GLAND SECRETION; SLAVE-MAKING ANT; POLISTES-ATRIMANDIBULARIS; INTERSPECIFIC RECOGNITION; POLYERGUS-BREVICEPS; POSTPHARYNGEAL GLAND; SPECIES HYMENOPTERA; OVARIAN DEVELOPMENT; PSITHYRUS-VESTALIS	Social parasites exploit the colony resources of social insects. Some of them exploit the host colony as a food resource or as a shelter whereas other species also exploit the brood care behavior of their social host. Some of these species have even lost the worker caste and rely completely on the host's worker force to rear their offspring. To avoid host defenses and bypass their recognition code, these social parasites have developed several sophisticated chemical infiltration strategies. These infiltration strategies have been highly studied in several hymenopterans. Once a social parasite has successfully entered a host nest and integrated its social system, its emerging offspring still face the same challenge of avoiding host recognition. However, the strategy used by the offspring to survive within the host nest without being killed is still poorly documented. In cuckoo bumblebees, the parasite males completely lack the morphological and chemical adaptations to social parasitism that the females possess. Moreover, young parasite males exhibit an early production of species-specific cephalic secretions, used as sexual pheromones. Host workers might thus be able to recognize them. Here we used a bumblebee host-social parasite system to test the hypothesis that social parasite male offspring exhibit a chemical defense strategy to escape from host aggression during their intranidal life. Using behavioral assays, we showed that extracts from the heads of young cuckoo bumblebee males contain a repellent odor that prevents parasite males from being attacked by host workers. We also show that social parasitism reduces host worker aggressiveness and helps parasite offspring acceptance.	[Lhomme, Patrick; Lecocq, Thomas; Rasmont, Pierre] Univ Mons, Zool Lab, B-7000 Mons, Belgium; [Ayasse, Manfred] Univ Ulm, Inst Expt Ecol, Dept Chem Ecol, Ulm, Germany; [Valterova, Irena] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Mons; Ulm University; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Lhomme, P (corresponding author), Univ Mons, Zool Lab, B-7000 Mons, Belgium.	patrick.lhomme@umons.ac.be; irena@uochb.cas.cz	Lhomme, Patrick/AFN-5332-2022; Lhomme, Patrick/M-6395-2014	Lhomme, Patrick/0000-0001-6735-9104; Lhomme, Patrick/0000-0001-6735-9104; Valterova, Irena/0000-0001-5723-6143; Lecocq, Thomas/0000-0002-4947-0332	Fonds pour la Recherche dans l'Industrie et l'Agriculture; Fonds National pour la Recherche Scientifique; Academy of Sciences of the Czech Republic [Z40550506]	Fonds pour la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Fonds National pour la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Fonds pour la Recherche dans l'Industrie et l'Agriculture, the Fonds National pour la Recherche Scientifique and the Academy of Sciences of the Czech Republic (research project Z40550506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN L, 1979, ZOON, V7, P1; Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino Toshiharu, 2000, Entomological Science, V3, P1; AYASSE M, 1995, APIDOLOGIE, V26, P163, DOI 10.1051/apido:19950301; Bagneres AG, 1996, SCIENCE, V272, P889, DOI 10.1126/science.272.5263.889; Bauer S, 2009, BEHAV ECOL SOCIOBIOL, V64, P45, DOI 10.1007/s00265-009-0817-3; Beekman M, 2008, ANNU REV ENTOMOL, V53, P19, DOI 10.1146/annurev.ento.53.103106.093515; BENTON T, 2006, BUMBLEBEES; Bergman P, 1997, THESIS GOTEBORG U; BERGSTROM G, 1981, Entomologica Scandinavica Supplement, P173; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; CARLIN NF, 1986, BEHAV ECOL SOCIOBIOL, V19, P123, DOI 10.1007/BF00299947; CARLIN NF, 1988, INSECT SOC, V35, P191, DOI 10.1007/BF02223932; Cervo R, 2008, BEHAV ECOL SOCIOBIOL, V62, P1319, DOI 10.1007/s00265-008-0560-1; CERVO R, 1994, ETHOL ECOL EVOL, P61; Cervo R, 2006, ANN ZOOL FENN, V43, P531; Chapman NC, 2009, BEHAV ECOL, V20, P817, DOI 10.1093/beheco/arp065; Chernenko A, 2011, ETHOLOGY, V117, P1081, DOI 10.1111/j.1439-0310.2011.01972.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Coppee A, 2011, CHEMOECOLOGY, V21, P75, DOI 10.1007/s00049-011-0070-x; D'Ettorre P, 2002, P ROY SOC B-BIOL SCI, V269, P1911, DOI 10.1098/rspb.2002.2110; D'Ettorre P, 2000, CHEMOECOLOGY, V10, P135, DOI 10.1007/PL00001815; D'Ettorre P., 1998, INS SOC LIFE, V2, P71; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; De Meulemeester T, 2011, INSECT SOC, V58, P227, DOI 10.1007/s00040-011-0146-1; DESCOINS C, 1984, NOVA ACTA REG SOC, V3, P149; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Dronnet S, 2005, APIDOLOGIE, V36, P59, DOI 10.1051/apido:2004070; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; Errard C, 2003, INSECT SOC, V50, P268, DOI 10.1007/s00040-003-0677-1; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; ERRARD C, 1994, J INSECT BEHAV, V7, P83, DOI 10.1007/BF01989829; FISHER RM, 1992, CAN ENTOMOL, V124, P69, DOI 10.4039/Ent12469-1; FISHER RM, 1987, ANIM BEHAV, V35, P1026, DOI 10.1016/S0003-3472(87)80159-8; Grangier J, 2007, BEHAV PROCESS, V74, P93, DOI 10.1016/j.beproc.2006.10.009; Hartel S, 2006, APIDOLOGIE, V37, P462, DOI 10.1051/apido:2006012; HEFETZ A, 1984, EXPERIENTIA, V40, P539, DOI 10.1007/BF01982317; HEFETZ A, 1992, NATURWISSENSCHAFTEN, V79, P417, DOI 10.1007/BF01138575; Hernandez JV, 2006, ANIM BEHAV, V71, P945, DOI 10.1016/j.anbehav.2005.09.004; Hovorka O, 1998, J CHEM ECOL, V24, P183, DOI 10.1023/A:1022353315874; HOWARD RW, 1982, J CHEM ECOL, V8, P1227, DOI 10.1007/BF00990755; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson CA, 2005, BEHAV ECOL SOCIOBIOL, V57, P245, DOI 10.1007/s00265-004-0851-0; Johnson CA, 2001, J CHEM ECOL, V27, P1787, DOI 10.1023/A:1010456608626; Katzav-Gozansky T, 2004, NATURWISSENSCHAFTEN, V91, P186, DOI 10.1007/s00114-004-0513-0; Katzav-Gozansky T, 2008, J INSECT PHYSIOL, V54, P378, DOI 10.1016/j.jinsphys.2007.10.008; Kreuter K, 2012, BEHAV ECOL SOCIOBIOL, V66, P475, DOI 10.1007/s00265-011-1294-z; KULLENBERG B, 1973, ZOON Supplement, P23; Lahav S, 1998, BEHAV ECOL SOCIOBIOL, V43, P203, DOI 10.1007/s002650050482; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lecocq T, 2011, SYST ENTOMOL, V36, P453, DOI 10.1111/j.1365-3113.2011.00576.x; Lenoir A, 2001, INSECT SOC, V48, P101, DOI 10.1007/PL00001751; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Liu ZB, 2000, J ETHOL, V18, P69, DOI 10.1007/s101640070002; Liu Zhibin, 2003, Entomological Science, V6, P125, DOI 10.1046/j.1343-8786.2003.00014.x; Lorenzi MC, 2007, BIOL J LINN SOC, V91, P505, DOI 10.1111/j.1095-8312.2007.00815.x; LORENZI MC, 1992, B ZOOL, V59, P267, DOI 10.1080/11250009209386681; Lorenzi MC, 2003, INSECT SOC, V50, P82, DOI 10.1007/s000400300013; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; Lorenzi MC, 1999, J INSECT BEHAV, V12, P147, DOI 10.1023/A:1020906631121; Martin SJ, 2008, J INSECT PHYSIOL, V54, P700, DOI 10.1016/j.jinsphys.2008.01.010; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Martin SJ, 2010, J CHEM ECOL, V36, P855, DOI 10.1007/s10886-010-9805-3; Mori A, 2000, INSECT SOC, V47, P7, DOI 10.1007/s000400050002; Nash D. R., 2008, SOCIOBIOLOGY COMMUNI, P55, DOI DOI 10.1093/ACPROF:OSO/9780199216840.003.0004; OBIN MS, 1989, ANIM BEHAV, V38, P430, DOI 10.1016/S0003-3472(89)80036-3; ONDRICEKFALLSCHEER RL, 1992, SOCIOBIOLOGY, V20, P245; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Ruano F, 2005, J INSECT PHYSIOL, V51, P1158, DOI 10.1016/j.jinsphys.2005.06.005; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Sramkova A, 2009, CHEMOECOLOGY, V19, P55, DOI 10.1007/s00049-009-0009-7; Stearns S.C., 1992, pi; STUART RJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P229, DOI 10.1007/BF00292504; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; TENGO J, 1977, SCIENCE, V196, P1117, DOI 10.1126/science.196.4294.1117; Tengo J, 1976, J CHEM ECOL, V2, P57, DOI 10.1007/BF00988024; TOPOFF H, 1988, ETHOLOGY, V78, P209; Tsuneoka Y, 2009, APPL ENTOMOL ZOOL, V44, P133, DOI 10.1303/aez.2009.133; Turillazzi S, 2000, NATURWISSENSCHAFTEN, V87, P172, DOI 10.1007/s001140050697; Urbanova K, 2004, BIOCHEM SYST ECOL, V32, P1025, DOI 10.1016/j.bse.2004.02.010; Valterova I, 1996, COLLECT CZECH CHEM C, V61, P1501, DOI 10.1135/cccc19961501; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847; Vergara CH, 2003, APIDOLOGIE, V34, P563, DOI 10.1051/apido:2003056; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; Visicchio R, 2000, ETHOL ECOL EVOL, V12, P67, DOI 10.1080/03949370.2000.9728323; Wilson E.O., 1971, INSECT SOC; Wisenden BD, 1999, REV FISH BIOL FISHER, V9, P45, DOI 10.1023/A:1008865801329; Zimma BO, 2003, J COMP PHYSIOL A, V189, P769, DOI 10.1007/s00359-003-0451-x	92	24	24	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e43053	10.1371/journal.pone.0043053	http://dx.doi.org/10.1371/journal.pone.0043053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028441	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900001
J	Cheng, JF; Joyce, A; Yates, K; Aouizerat, B; Sanyal, AJ				Cheng, Jianfeng; Joyce, Andrew; Yates, Katherine; Aouizerat, Bradley; Sanyal, Arun J.			Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)	PLOS ONE			English	Article							SAMPLING VARIABILITY; ANTIOXIDANT ENZYMES; GLUTATHIONE; SENSITIZES	Vitamin E was recently shown to improve hepatic histology in a randomized controlled trial of pioglitazone or vitamin E for nonalcoholic steatohepatitis (PIVENS). The current study utilized samples collected in the PIVENS trial to identify: (1) baseline metabolomic profiles that could identify who would respond to vitamin E treatment and (2) end of treatment metabolomic profiles reflective of histologic improvement. A comprehensive analysis of metabolomics profiles (n = 547) quantified by mass spectrometry was performed in vitamin E responders (n = 16), vitamin E non-responders (n = 15), and placebo responders (n = 15). At baseline, phenyl-propionic acid (Odds ratio: 29.4, p < 0.01), indole-propionic acid levels (Odds ratio: 16.2, p < 0.01) were directly associated with a subsequent histologic response to vitamin E treatment whereas gamma-carboxyethylhydroxychroman (CEHC) levels were inversely related to histologic response. Adjusting for baseline values by analysis of covariance, the end of treatment levels of gamma-glutamyl leucine (Fold change: 0.82, p < 0.02) and gamma-glutamyl valine (Fold change: 0.8, p < 0.03) were significantly lower in vitamin E responders compared to non-responders. The levels of gamma-glutamyl transpeptidase were not significantly different across the two groups. Subjects receiving placebo who demonstrated a histologic improvement also demonstrated lower levels of gamma-glutamylated amino acids (leucine, valine and isoleucine) compared to vitamin E non-responders. These data provide exploratory proof that there are measurable differences in the metabolic profile of subjects who are likely (vs unlikely) to respond to vitamin E treatment for NASH and in those experiencing histologic improvement (vs no improvement) on treatment and support further studies to validate these biomarkers.	[Cheng, Jianfeng; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA; [Joyce, Andrew] Venebio Grp LLC, Richmond, VA USA; [Yates, Katherine] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Aouizerat, Bradley] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA	Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Sanyal, AJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA.	asanyal@mcvh-vcu.edu			ARRA (American Recovery and Reinvestment Act) from the National Institutes of Health [3UO1 DK 061731-08S1]; NASH [R01 - NIDDK - 1R01DK08140];  [2T32 DK 007150-35]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061731, U01DK061730, T32DK007150] Funding Source: NIH RePORTER	ARRA (American Recovery and Reinvestment Act) from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASH; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an ARRA (American Recovery and Reinvestment Act) supplement to a contract (3UO1 DK 061731-08S1) from the National Institutes of Health, NASH R01 - NIDDK - 1R01DK08140 and a training grant (2T32 DK 007150-35) awarded to Dr. Arun Sanyal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Arun J, 2010, NEW ENGL J MED, V362, P18; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Attwood G, 2006, J APPL MICROBIOL, V100, P1261, DOI 10.1111/j.1365-2672.2006.02896.x; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Colell A, 1998, GASTROENTEROLOGY, V115, P1541, DOI 10.1016/S0016-5085(98)70034-4; [Committee DDIC USDoHaH], 2004, ACT PLAN LIV DIS; Djavaheri-Mergny M, 2002, MOL CELL BIOCHEM, V232, P103, DOI 10.1023/A:1014834315936; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Garcia-Ruiz C, 2006, J GASTROEN HEPATOL, V21, pS3, DOI 10.1111/j.1440-1746.2006.04570.x; Hardeland R, 1999, ADV EXP MED BIOL, V467, P389; Li N, 1998, J CELL PHYSIOL, V177, P148, DOI 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Miele Luca, 2006, Recenti Prog Med, V97, P1; Mitsuyoshi Hironori, 2006, Nihon Rinsho, V64, P1077; Nobili V, 2005, CLIN CHIM ACTA, V355, P105, DOI 10.1016/j.cccn.2004.12.022; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sachdeva R, 2005, CHEM RES TOXICOL, V18, P1018, DOI 10.1021/tx0496441; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2004, CLIN GASTROENTEROL H, V2, P1107, DOI 10.1016/S1542-3565(04)00457-4; Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17	26	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44106	10.1371/journal.pone.0044106	http://dx.doi.org/10.1371/journal.pone.0044106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028489	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400018
J	Du, DL; Lee, CF; Li, XQ				Du, Donglei; Lee, Connie F.; Li, Xiu-Qing			Systematic Differences in Signal Emitting and Receiving Revealed by PageRank Analysis of a Human Protein Interactome	PLOS ONE			English	Article							SUBCELLULAR REDISTRIBUTION; INTERACTION NETWORKS; TRANSDUCTION; PHOSPHATASES; ALIGNMENT; PATHWAYS; 2-HYBRID; PROMOTES; RANKING; CANCER	Most protein PageRank studies do not use signal flow direction information in protein interactions because this information was not readily available in large protein databases until recently. Therefore, four questions have yet to be answered: A) What is the general difference between signal emitting and receiving in a protein interactome? B) Which proteins are among the top ranked in directional ranking? C) Are high ranked proteins more evolutionarily conserved than low ranked ones? D) Do proteins with similar ranking tend to have similar subcellular locations? In this study, we address these questions using the forward, reverse, and non-directional PageRank approaches to rank an information-directional network of human proteins and study their evolutionary conservation. The forward ranking gives credit to information receivers, reverse ranking to information emitters, and non-directional ranking mainly to the number of interactions. The protein lists generated by the forward and non-directional rankings are highly correlated, but those by the reverse and non-directional rankings are not. The results suggest that the signal emitting/receiving system is characterized by key-emittings and relatively even receivings in the human protein interactome. Signaling pathway proteins are frequent in top ranked ones. Eight proteins are both informational top emitters and top receivers. Top ranked proteins, except a few species-related novel-function ones, are evolutionarily well conserved. Protein-subunit ranking position reflects subunit function. These results demonstrate the usefulness of different PageRank approaches in characterizing protein networks and provide insights to protein interaction in the cell.	[Li, Xiu-Qing] Agr & Agri Food Canada, Mol Genet Lab, Potato Res Ctr, Fredericton, NB, Canada; [Du, Donglei; Lee, Connie F.] Univ New Brunswick, Fac Business Adm, Quantiat Study Grp, Fredericton, NB, Canada; [Lee, Connie F.] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY USA	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); University of New Brunswick; Columbia University	Li, XQ (corresponding author), Agr & Agri Food Canada, Mol Genet Lab, Potato Res Ctr, Fredericton, NB, Canada.	Xiu-Qing.Li@agr.gc.ca		Du, Donglei/0000-0003-0111-8572; Li, Xiu-Qing/0000-0002-7308-0596				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball P, 2006, NATURE, V439, P770, DOI 10.1038/439770a; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen Z., 2011, J COMPUT INFO SYS, V7, P3149; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Gough NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002601; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Krallinger M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S3; Kuang R, 2005, BIOINFORMATICS, V21, P3711, DOI 10.1093/bioinformatics/bti608; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Li F, 2002, FEBS LETT, V524, P49, DOI 10.1016/S0014-5793(02)02994-0; Li XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018615; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Liu W, 2009, MOL CELL PROTEOMICS, V8, P2063, DOI 10.1074/mcp.M800354-MCP200; Liu ZG, 2007, BIOCHEM BIOPH RES CO, V353, P47, DOI 10.1016/j.bbrc.2006.11.133; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelka P, 2007, J CELL PHYSIOL, V212, P13, DOI 10.1002/jcp.20983; Polden J, 2011, PROTEOMICS, V11, P3582, DOI 10.1002/pmic.201000182; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sebolt-Leopold JS, 2008, CLIN CANCER RES, V14, P3651, DOI 10.1158/1078-0432.CCR-08-0333; Shapiro MJ, 2005, J BIOL CHEM, V280, P38242, DOI 10.1074/jbc.M507441200; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Stenmark H, 2001, GENOME BIOL, V2; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44872	10.1371/journal.pone.0044872	http://dx.doi.org/10.1371/journal.pone.0044872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028653	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400045
J	Rougerie, R; Naumann, S; Nassig, WA				Rougerie, Rodolphe; Naumann, Stefan; Naessig, Wolfgang A.			Morphology and Molecules Reveal Unexpected Cryptic Diversity in the Enigmatic Genus Sinobirma Bryk, 1944 (Lepidoptera: Saturniidae)	PLOS ONE			English	Article								The wild silkmoth genus Sinobirma Bryk, 1944 is a poorly known monotypic taxon from the eastern end of the Himalaya Range. It was convincingly proposed to be closely related to some members of an exclusively Afro-tropical group of Saturniidae, but its biogeographical and evolutionary history remains enigmatic. After examining recently collected material from Tibet, northern India, and northeastern Myanmar, we realized that this unique species, S. malaisei Bryk, 1944 only known so far from a few specimens and from a very restricted area near the border between north-eastern Myanmar and the Yunnan province of China, may in fact belong to a group of closely related cryptic species. In this work, we combined morphological comparative study, DNA barcoding, and the sequences of a nuclear marker (D2 expansion segment of the 28S rRNA gene) to unequivocally delimit three distinct species in the genus Sinobirma, of which two are described as new to science: S. myanmarensis sp. n. and S. bouyeri sp. n. An informative DNA barcode sequence was obtained from the female holotype of S. malaisei-collected in 1934-ensuring the proper assignation of this name to the newly collected and studied specimens. Our findings represent another example of the potential of coupling traditional taxonomy and DNA barcoding for revealing and solving difficult cases of cryptic diversity. This approach is now being generalized to the world fauna of Saturniidae, with the participation of most of the taxonomists studying these moths.	[Rougerie, Rodolphe] Univ Rouen, Lab Ecol, Mont St Aignan, France; [Naessig, Wolfgang A.] Forschungsinst Senckenberg, Frankfurt, Germany	Universite de Rouen Normandie; Senckenberg Gesellschaft fur Naturforschung (SGN)	Rougerie, R (corresponding author), Univ Rouen, Lab Ecol, Mont St Aignan, France.	rrougeri@gmail.com	Rougerie, Rodolphe/D-2930-2009	Rougerie, Rodolphe/0000-0003-0937-2815	Upper-Normandy region through the University of Rouen, France; government of Canada through Genome Canada; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)	Upper-Normandy region through the University of Rouen, France(Region Normandie); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	RR was supported by a postdoctoral fellowship by the Upper-Normandy region through the University of Rouen, France. Laboratory analyses on sequences generated between 2007 and 2010 were funded by the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life project, by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouyer Thierry, 2004, Nachrichten des Entomologischen Vereins Apollo, V25, P27; Bryk Felix, 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; Decaens T, 2008, ZOOTAXA, P34, DOI 10.11646/zootaxa.1944.1.2; Fletcher DS, 1982, THE GENERIC NAMES OF, V4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2009, SPIXIANA, V32, P161; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Nassig WA, 1994, NACHR ENT VER APOLLO, V15, P369; Nassig Wolfgang A., 2010, Journal of Research on the Lepidoptera, V43, P37; Naumann S, 2004, MEMOIR, V1, P235; Naumann Stefan, 2010, Nachrichten des Entomologischen Vereins Apollo, V31, P31; Naumann Stefan, 2008, Nachrichten des Entomologischen Vereins Apollo, V29, P149; Oberprieler R.G., 1997, Metamorphosis Occasional Supplement, V3, P142; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rougerie R, 2003, NOTA LEPID, V25, P227; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaglia T, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1923.1.2; Vinciguerra Roberto, 2005, Beitraege zur Kenntnis der Wilden Seidenspinner, V3, P46; ZHU H.-F, 1996, FAUNA SINICA INSECTA, V5	23	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43920	10.1371/journal.pone.0043920	http://dx.doi.org/10.1371/journal.pone.0043920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028478	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400014
J	Shiogai, Y; Dhamala, M; Oshima, K; Hasler, M				Shiogai, Yuri; Dhamala, Mukesh; Oshima, Kumiko; Hasler, Martin			Cortico-Cardio-Respiratory Network Interactions during Anesthesia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; LINEAR-DEPENDENCE; TIME-SERIES; OSCILLATIONS; AWARENESS; FEEDBACK; CORTEX; STATES; SLEEP	General anesthetics are used during medical and surgical procedures to reversibly induce a state of total unconsciousness in patients. Here, we investigate, from a dynamic network perspective, how the cortical and cardiovascular systems behave during anesthesia by applying nonparametric spectral techniques to cortical electroencephalography, electrocardiogram and respiratory signals recorded from anesthetized rats under two drugs, ketamine-xylazine (KX) and pentobarbital (PB). We find that the patterns of low-frequency cortico-cardio-respiratory network interactions may undergo significant changes in network activity strengths and in number of network links at different depths of anesthesia dependent upon anesthetics used.	[Dhamala, Mukesh] Georgia State Univ, Dept Phys & Astron, Neurosci Inst, Ctr Behav Neurosci, Atlanta, GA 30303 USA; [Shiogai, Yuri; Oshima, Kumiko; Hasler, Martin] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland	University System of Georgia; Georgia State University; Ecole Polytechnique Federale de Lausanne	Dhamala, M (corresponding author), Georgia State Univ, Dept Phys & Astron, Neurosci Inst, Ctr Behav Neurosci, Atlanta, GA 30303 USA.	mdhamala@gsu.edu	Dhamala, Mukesh/AAX-3207-2021		FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia); National Foundation Career Award [BCS 0955037]; Division Of Behavioral and Cognitive Sci [0955037] Funding Source: National Science Foundation	FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia); National Foundation Career Award; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia) to ICLANOS team. The author MD would also like to acknowledge National Foundation Career Award (BCS 0955037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Eckhorn R, 2001, VIS COGN, V8, P519, DOI 10.1080/13506280143000098; FELDMAN JL, 1988, ANNU REV PHYSIOL, V50, P593; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Foster BL, 2008, COGN NEURODYNAMICS, V2, P283, DOI 10.1007/s11571-008-9063-z; Galletly DC, 1998, BRIT J ANAESTH, V80, P164, DOI 10.1093/bja/80.2.164; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hales S, 1733, STATICAL ESSAYS HEAE; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Musizza B, 2007, J PHYSIOL-LONDON, V580, P315, DOI 10.1113/jphysiol.2006.126748; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Orser BA, 2008, NEW ENGL J MED, V358, P1189, DOI 10.1056/NEJMe0800998; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Raeder J, 2003, ADV EXP MED BIOL, V523, P269; Rosenblum MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041909; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Stefanovska A, 2000, PHYS REV LETT, V85, P4831, DOI 10.1103/PhysRevLett.85.4831; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Wixson K, 1987, LAB ANIM SCI, V37, P736	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44634	10.1371/journal.pone.0044634	http://dx.doi.org/10.1371/journal.pone.0044634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028572	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400030
J	Vasilyan, D; Bohme, M				Vasilyan, Davit; Boehme, Madelaine			Pronounced Peramorphosis in Lissamphibians-Aviturus exsecratus (Urodela, Cryptobranchidae) from the Paleocene-Eocene Thermal Maximum of Mongolia	PLOS ONE			English	Article							EVOLUTION	Background: The oldest and largest member of giant salamanders (Cryptobranchidae) Aviturus exsecratus appears in the latest Paleocene (near the Paleocene-Eocene Thermal Maximum) of Mongolia. Based on femoral and vertebral morphology and metrics, a terrestrial adaptation has been supposed for this species. Methodology/Principal Findings: A detailed morphological reinvestigation of published as well as unpublished material reveals that this salamander shows a vomerine dentition that is posteriorly shifted and arranged in a zigzag pattern, a strongly developed olfactory region within the cranial cavity, and the highest bone ossification and relatively longest femur among all fossil and recent cryptobranchids. Conclusions/Significance: The presence of these characteristics indicates a peramorphic developmental pattern for Aviturus exsecratus. Our results from Av. exsecratus indicate for the first time pronounced peramorphosis within a crown-group lissamphibian. Av. exsecratus represents a new developmental trajectory within both fossil and recent lissamphibian clades characterized by extended ontogeny and large body size, resembling the pattern known from late Paleozoic eryopines. Moreover, Av. exsecratus is not only a cryptobranchid with distinctive peramorphic characters, but also the first giant salamander with partially terrestrial (amphibious) lifestyle. The morphology of the vomers and dentaries suggests the ability of both underwater and terrestrial feeding.	[Vasilyan, Davit; Boehme, Madelaine] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine] Senckenberg Ctr Human Evolut & Palaeoecol HEP, Tubingen, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Vasilyan, D (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.	davit.vasilyan@ifg.uni-tuebingen.de	Vasilyan, Davit/H-9603-2019	Vasilyan, Davit/0000-0001-8712-0678	Deutsche Forschungsgemeinschaft [BO1550/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was financed by Deutsche Forschungsgemeinschaft, grant nr. BO1550/14-1 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Badamgarev D, 1985, PALEONTOLOGY STRATIG; Bohme M, 2012, PALAEOGEOGR PALAEOCL, V342, P64, DOI 10.1016/j.palaeo.2012.04.032; Chkhikvadze V.M., 1982, VERTEBR HUNGARICA, V21, P63; CUNDALL D, 1987, EXPERIENTIA, V43, P1229, DOI 10.1007/BF01945537; Duellman WE, 1994, BIOL AMPHIBIA; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Estes R., 1981, GYMNOPHIONA CAUDATA; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Gubin Yu.M., 1991, Paleontologicheskii Zhurnal, V1991, P96; LUTERBACHER H.-P., 2004, GEOLOGIC TIME SCALE, P384, DOI DOI 10.1017/CBO9780511536045.021; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Osawa G., 1902, MITT MED FAC U TOKIO, V5, P1; Pawley K, 2006, J PALEONTOL, V80, P561, DOI 10.1666/0022-3360(2006)80[561:TASOEM]2.0.CO;2; Rose CS, 1996, J ZOOL, V239, P253, DOI 10.1111/j.1469-7998.1996.tb05451.x; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Secord R, 2006, AM J SCI, V306, P211, DOI 10.2475/ajs.306.4.211; Sever D. M., 2003, REPROD BIOL PHYLOGEN; Shishkin MA, 1975, FOSSIL FAUNA FLORA M, P230; Ting Suyin, 2003, Geological Society of America Special Paper, V369, P521; Tolstikova NV, 1976, PALEONTOLOGY BIOSTRA, P145; Vasilyan D, 2012, J VERTEBRAT IN PRESS; Westphal F., 1958, PALAEONTOGR ABT A, V110, P20; Witzmann Florian, 2009, Palaeodiversity, P233; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zug G. R., 2001, HERPETOLOGY, P57	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e40665	10.1371/journal.pone.0040665	http://dx.doi.org/10.1371/journal.pone.0040665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028420	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400001
J	Oehme, AK; Rashed, AN; Hefele, B; Wong, ICK; Rascher, W; Neubert, A				Oehme, Ann-Kathrin; Rashed, Asia N.; Hefele, Barbara; Wong, Ian C. K.; Rascher, Wolfgang; Neubert, Antje			Adverse Drug Reactions in Hospitalised Children in Germany Are Decreasing: Results of a Nine Year Cohort-Based Comparison	PLOS ONE			English	Article							CYSTIC-FIBROSIS; RISK-FACTORS; INTENSIFIED SURVEILLANCE; PEDIATRIC-PATIENTS; PAYMENT SYSTEM; METAANALYSIS; QUALITY; CARE; IMPLEMENTATION; MULTICENTER	Background: In recent years, efforts have been made to improve paediatric drug therapy. The aim of this research was to investigate any changes regarding the frequency and nature of adverse drug reactions (ADRs) in hospitalized children in one paediatric general medical ward over a 9-year period. Methodology: Two prospective observational cohort studies were conducted at a large University hospital in Germany in 1999 and 2008, respectively. Children aged 0-18 years admitted to the study ward during the study periods were included. ADRs were identified using intensive chart review. Uni- and multivariable regression has been used for data analysis. Results: A total of 520 patients (574 admissions) were included [1999: n = 144 (167); 2008: n = 376 (407)]. Patients received a total of 2053 drugs [median 3, interquartile range (IQR) 2-5]. 19% of patients did not receive any medication. Median length of stay was 4 days (IQR 3-7; range 1-190 days) with a significantly longer length of stay in 1999. The overall ADR incidence was 13.1% (95% CI, 9.8-16.3) varying significantly between the two study cohorts [1999: 21.9%, 95% CI, 14.7-29.0; 2008: 9.2%, 95% CI, 5.9-12.5 (p < 0.001)]. Antibacterials and corticosteroids for systemic use caused most of the ADRs in both cohorts (1999; 2008). Exposure to systemic antibacterials decreased from 62.9% to 43.5% whereas exposure to analgesics and anti-inflammatory drugs increased from 17.4% to 45.2%, respectively. The use of high risk drugs decreased from 75% to 62.2%. In 1999, 45.7% and in 2008 96.2% of ADRs were identified by treating clinicians (p < 0.001). Conclusions: Between 1999 and 2008, the incidence of ADRs decreased significantly. Improved treatment strategies and an increased awareness of ADRs by physicians are most likely to be the cause for this positive development. Nevertheless further research on ADRs particularly in primary care and the establishment of prospective pharmacovigilance systems are still needed.	[Rashed, Asia N.; Wong, Ian C. K.; Neubert, Antje] UCL Sch Pharm, Ctr Paediat Pharm Res, London, England; [Oehme, Ann-Kathrin; Rascher, Wolfgang] Univ Erlangen Nurnberg, Dept Paediat & Adolescents Med, D-91054 Erlangen, Germany; [Hefele, Barbara] Univ Erlangen Nurnberg, Dept Children & Adolescents Med, D-91054 Erlangen, Germany; [Neubert, Antje] Univ Erlangen Nurnberg, Dept Paediat & Adolescents Med, Paediat Clin Study Ctr, D-91054 Erlangen, Germany	University of London; University College London; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Neubert, A (corresponding author), UCL Sch Pharm, Ctr Paediat Pharm Res, London, England.	antje.neubert@uk-erlangen.de		Rashed, Asia/0000-0003-1313-0915; Wong, Ian Chi Kei/0000-0001-8242-0014	ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg	ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg	This study was financially supported by the ELAN funds of the Medical Faculty of the Friedrich Alexander University, Erlangen-Nuremberg (www.http://www.elan.med.uni-erlangen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2010, BRIT J CLIN PHARMACO, V70, P481, DOI 10.1111/j.1365-2125.2010.03682.x; Buckley MS, 2007, PEDIATR CRIT CARE ME, V8, P145, DOI 10.1097/01.PCC.0000257038.39434.04; Carrasco-Garrido P, 2009, BRIT J CLIN PHARMACO, V68, P455, DOI 10.1111/j.1365-2125.2009.03449.x; Ceci Adriana, 2009, Paediatr Drugs, V11, P18; Choonara, 2002, PAEDIAT PERINATOL DR, V5, P12, DOI [10.1185/146300902322125109, DOI 10.1185/146300902322125109]; Clavenna A, 2009, ARCH DIS CHILD, V94, P724, DOI 10.1136/adc.2008.154377; Dormann H, 2000, DRUG SAFETY, V22, P161, DOI 10.2165/00002018-200022020-00007; Gonzalez-Martin G, 1998, INT J CLIN PHARM TH, V36, P530; Haffner S, 2005, DRUG SAFETY, V28, P453, DOI 10.2165/00002018-200528050-00008; Hay AD, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13270; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Knopf H, 2010, BRIT J CLIN PHARMACO, V70, P409, DOI 10.1111/j.1365-2125.2010.03713.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Martinez-Mir I, 1999, BRIT J CLIN PHARMACO, V47, P681, DOI 10.1046/j.1365-2125.1999.00943.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Neubert A, 2006, EUR J CLIN PHARMACOL, V62, P959, DOI 10.1007/s00228-006-0197-9; Neubert A, 2010, PHARMACOL RES, V62, P243, DOI 10.1016/j.phrs.2010.04.006; Perrott DA, 2004, ARCH PEDIAT ADOL MED, V158, P521, DOI 10.1001/archpedi.158.6.521; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rashed AN, 2012, DRUG SAFETY, V35, P481, DOI 10.2165/11597920-000000000-00000; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Reinhold T, 2009, GESUNDHEITSWESEN, V71, P306, DOI 10.1055/s-0028-1119399; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; Schonhofer P, 2003, LANCET, V361, P968, DOI 10.1016/S0140-6736(03)12751-1; Schumock G T, 1992, Hosp Pharm, V27, P538; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Stern M, 2008, EUR RESPIR J, V31, P29, DOI 10.1183/09031936.00056507; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Thuermann PA, 2002, DRUG SAFETY, V25, P713, DOI 10.2165/00002018-200225100-00004; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016; van der Hooft CS, 2008, PHARMACOEPIDEM DR S, V17, P365, DOI 10.1002/pds.1565; van Westreenen Mireille, 2010, Paediatr Drugs, V12, P343, DOI 10.2165/11316240-000000000-00000; Weiss J, 2002, PEDIATRICS, V110, P254, DOI 10.1542/peds.110.2.254; WHO, 2005, WHO ADV REACT TERM T; WHO, 2011, INT CLASS DIS VERS 1; WHO, 1972, 498 WHO, VWHO Meeting; Wiedemann B, 2001, EUR RESPIR J, V17, P1187, DOI 10.1183/09031936.01.00053901; Wilke MH, 2001, UNFALLCHIRURG, V104, P372, DOI 10.1007/s001130050745; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44349	10.1371/journal.pone.0044349	http://dx.doi.org/10.1371/journal.pone.0044349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028526	Green Published, gold			2022-12-25	WOS:000311313900021
J	Li, XH; Feng, YY; Deng, HX; Zhang, WZ; Kuang, D; Deng, QF; Dai, XY; Lin, DF; Huang, SL; Xin, LL; He, YF; Huang, K; He, MA; Guo, H; Zhang, XM; Wu, TC				Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Zhang, Wangzhen; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun			The Dose-Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers?	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; EXPOSURE; RISK; POPULATION; MORTALITY; DISEASE; EVENTS; BRAIN; PAHS	Background: Air pollution has been associated with an increased risk of cardiopulmonary mortality and decreased heart rate variability (HRV). However, it is unclear whether coke oven emissions (COEs) and polycyclic aromatic hydrocarbons (PAHs) are associated with HRV. Objectives: Our goal in the present study was to investigate the association of exposure to COEs and the urinary metabolite profiles of PAHs with HRV of coke oven workers. Methods: We measured benzene soluble matter, carbon monoxide, sulfur dioxide, particulate matters, and PAHs at different workplaces of a coke oven plant. We determined 10 urinary PAH metabolites and HRV indices of 1333 workers using gas chromatography-mass spectrometry and a 3-channel digital Holter monitor, respectively. Results: Our results showed that there was a significant COEs-related dose-dependent decrease in HRV, and an inverse relationship between the quartiles of urinary 2-hydroxynaphthalene and five HRV indices (p(trend)<0.01 for all). After adjustment for potential confounders, elevation per interquartile range (IQR) (1.81 mu g/mmol creatinine) of urinary 2-hydroxynaphthalene was associated with a 5.46% (95% CI, 2.50-8.32) decrease in standard deviation of NN intervals (SDNN). As workers worked more years, SDNN gradually declined in the same quartiles of 2-hydroxynaphthalene levels (p(trend) = 1.40x10(-4)), especially in workers with the highest levels of 2-hydroxynaphthalene. Conclusions: Occupational exposure to COEs is associated with a dose-response decrease in HRV. In particular, increased exposure to 2-hydroxynaphthalene is associated with significantly decreased HRV. Increase of working years and exposure levels has resulted in a gradual decline of HRV.	[Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Li, Xiaohai; Feng, Yingying; Deng, Huaxin; Kuang, Dan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Xin, Lili; He, Yunfeng; Huang, Kun; He, Meian; Guo, Huan; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhang, Wangzhen] Wuhan Iron & Steel Grp Corp, Inst Ind Hlth, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China Baowu Steel Group	Li, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/F-3206-2018; Xin, lili/HHS-3172-2022; Lin, Dafeng/J-1015-2014; Zhang, Xiaomin/GVT-8927-2022		National Key Basic Research and Development Program (973 project) [2011CB503806]; Natural National Scientific Foundation of China [30972453]	National Key Basic Research and Development Program (973 project)(National Basic Research Program of China); Natural National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Key Basic Research and Development Program (973 project) (2011CB503806) and Natural National Scientific Foundation of China (30972453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 1995, TOX PROF POL AR HYDR; Agency for Toxic Substances and Disease Registry, 2005, TOX PROF NAPHTH 1 ME; Baccarelli A, 2008, CIRCULATION, V117, P1802, DOI 10.1161/CIRCULATIONAHA.107.726067; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; Camm AJ, 1996, CIRCULATION, V93, P1043; Campo L, 2008, J CHROMATOGR B, V875, P531, DOI 10.1016/j.jchromb.2008.10.017; Cavallari JM, 2007, ENVIRON HEALTH PERSP, V115, P1046, DOI 10.1289/ehp.10019; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Gesto M, 2006, COMP BIOCHEM PHYS C, V144, P173, DOI 10.1016/j.cbpc.2006.08.002; GONZALEZ FJ, 1994, DRUG METAB REV, V26, P165, DOI 10.3109/03602539409029789; Grova N, 2011, CHEM RES TOXICOL, V24, P1653, DOI 10.1021/tx2003596; Huikuri HV, 2001, AUTON NEUROSCI-BASIC, V90, P95, DOI 10.1016/S1566-0702(01)00273-9; Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Lee MS, 2011, OCCUP ENVIRON MED, V68, P474, DOI 10.1136/oem.2010.055681; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; [National Institute of Occupational Safety and Health NIOSH Manual of Analytical Methods], 1998, NIOSH MAN AN METH; National Toxicology Program, 2011, Rep Carcinog, V12, P120; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Roggi C, 1997, SCI TOTAL ENVIRON, V199, P247, DOI 10.1016/S0048-9697(97)05458-2; Routledge HC, 2006, HEART, V92, P220, DOI 10.1136/hrt.2004.051672; Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; van Boven AJ, 1998, AM HEART J, V135, P571, DOI 10.1016/S0002-8703(98)70269-8; Weichenthal S, 2011, ENVIRON HEALTH PERSP, V119, P1373, DOI 10.1289/ehp.1003321; Wellenius GA, 2011, INHAL TOXICOL, V23, P84, DOI 10.3109/08958378.2010.554461; Wheeler A, 2006, ENVIRON HEALTH PERSP, V114, P560, DOI 10.1289/ehp.8337; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang XB, 2007, ENVIRON HEALTH PERSP, V115, P1573, DOI 10.1289/ehp.10104; Zanobetti A, 2010, ENVIRON HEALTH PERSP, V118, P324, DOI 10.1289/ehp.0901003	38	46	51	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44562	10.1371/journal.pone.0044562	http://dx.doi.org/10.1371/journal.pone.0044562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024753	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100011
J	White, HE; Dent, CL; Hall, VJ; Crolla, JA; Chitty, LS				White, Helen E.; Dent, Carolyn L.; Hall, Victoria J.; Crolla, John A.; Chitty, Lyn S.			Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis	PLOS ONE			English	Article							MATERNAL PLASMA; DNA; BLOOD; SERUM	Background: Analysis of cell free fetal (cff) DNA in maternal plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fetal rhesus D status and some single gene disorders. True positive results rely on detection of the fetal target being analysed. No amplification of the target may be interpreted either as a true negative result or a false negative result due to the absence or very low levels of cffDNA. The hypermethylated RASSF1A promoter has been reported as a universal fetal marker to confirm the presence of cffDNA. Using methylation-sensitive restriction enzymes hypomethylated maternal sequences are digested leaving hypermethylated fetal sequences detectable. Complete digestion of maternal sequences is required to eliminate false positive results. Methods: cfDNA was extracted from maternal plasma (n = 90) and digested with methylation-sensitive and insensitive restriction enzymes. Analysis of RASSF1A, SRY and DYS14 was performed by real-time PCR. Results: Hypermethylated RASSF1A was amplified for 79 samples (88%) indicating the presence of cffDNA. SRY real time PCR results and fetal sex at delivery were 100% accurate. Eleven samples (12%) had no detectable hypermethylated RASSF1A and 10 of these (91%) had gestational ages less than 7 weeks 2 days. Six of these samples were male at delivery, five had inconclusive results for SRY analysis and one sample had no amplifiable SRY. Conclusion: Use of this assay for the detection of hypermethylated RASSF1A as a universal fetal marker has the potential to improve the diagnostic reliability of NIPD for fetal sex determination and single gene disorders.	[White, Helen E.; Dent, Carolyn L.; Hall, Victoria J.] Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England; [White, Helen E.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Crolla, John A.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Chitty, Lyn S.] UCL, London Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, Fetal Med Unit, London, England	Salisbury District Hospital; University of Southampton; Salisbury District Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	White, HE (corresponding author), Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England.	hew@soton.ac.uk		chitty, lyn/0000-0002-4857-7138	National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project) [RP-PG-0707-10107]; NIHR Biomedical Research Centre at University College London Hospitals; Great Ormond Street Hospital Children's Charity; National Institute for Health Research [RP-PG-0707-10107] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1253] Funding Source: researchfish	National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project); NIHR Biomedical Research Centre at University College London Hospitals; Great Ormond Street Hospital Children's Charity; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This article presents independent research commissioned by the National Institutes for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID'' project, RP-PG-0707-10107). LSC receives some funding from the NIHR Biomedical Research Centre at University College London Hospitals and the Great Ormond Street Hospital Children's Charity. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Forest MG, 1998, TRENDS ENDOCRIN MET, V9, P284, DOI 10.1016/S1043-2760(98)00067-8; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Page-Christiaens GCML, 2006, ANN NY ACAD SCI, V1075, P123, DOI 10.1196/annals.1368.016; Pertl B, 2000, HUM GENET, V106, P45, DOI 10.1007/s004390051008; Raymond FL, 2010, PRENATAL DIAG, V30, P674, DOI 10.1002/pd.2575; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	21	38	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45073	10.1371/journal.pone.0045073	http://dx.doi.org/10.1371/journal.pone.0045073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024794	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308860100052
J	Wu, XG; Yung, LM; Cheng, WH; Yu, PB; Babitt, JL; Lin, HY; Xia, Y				Wu, Xinggang; Yung, Lai-Ming; Cheng, Wai-Hang; Yu, Paul B.; Babitt, Jodie L.; Lin, Herbert Y.; Xia, Yin			Hepcidin Regulation by BMP Signaling in Macrophages Is Lipopolysaccharide Dependent	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-6; MESSENGER-RNA EXPRESSION; IRON-METABOLISM; INHIBITION; INTERLEUKIN-6; TRANSCRIPTION; INFLAMMATION; OVERLOAD; PROMOTER; ELEMENTS	Hepcidin is an antimicrobial peptide, which also negatively regulates iron in circulation by controlling iron absorption from dietary sources and iron release from macrophages. Hepcidin is synthesized mainly in the liver, where hepcidin is regulated by iron loading, inflammation and hypoxia. Recently, we have demonstrated that bone morphogenetic protein (BMP)hemojuvelin (HJV)-SMAD signaling is central for hepcidin regulation in hepatocytes. Hepcidin is also expressed by macrophages. Studies have shown that hepcidin expression by macrophages increases following bacterial infection, and that hepcidin decreases iron release from macrophages in an autocrine and/or paracrine manner. Although previous studies have shown that lipopolysaccharide (LPS) can induce hepcidin expression in macrophages, whether hepcidin is also regulated by BMPs in macrophages is still unknown. Therefore, we examined the effects of BMP signaling on hepcidin expression in RAW 264.7 and J774 macrophage cell lines, and in primary peritoneal macrophages. We found that BMP4 or BMP6 alone did not have any effect on hepcidin expression in macrophages although they stimulated Smad1/5/8 phosphorylation and Id1 expression. In the presence of LPS, however, BMP4 and BMP6 were able to stimulate hepcidin expression in macrophages, and this stimulation was abolished by the NF-kappa B inhibitor Ro1069920. These results suggest that hepcidin expression is regulated differently in macrophages than in hepatocytes, and that BMPs regulate hepcidin expression in macrophages in a LPS-NF-kappa B dependent manner.	[Wu, Xinggang; Cheng, Wai-Hang; Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yung, Lai-Ming; Yu, Paul B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Babitt, Jodie L.; Lin, Herbert Y.] Harvard Univ, Massachusetts Gen Hosp, Program Anemia Signaling Res,Program Membrane Bio, Div Nephrol,Ctr Syst Biol,Dept Med,Med Sch, Boston, MA USA	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Jinan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wu, XG (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	Xia.Yin@cuhk.edu.hk	Yu, Paul B./J-7540-2019; Xia, Yin/M-5440-2018	Yu, Paul B./0000-0003-2145-4944; Xia, Yin/0000-0003-0315-7532; Cheng, Wai Hang/0000-0002-3408-9184	Chinese University of Hong Kong; Hong Kong Research Grant Council (RGC) [2140759]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837] Funding Source: NIH RePORTER	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YX is supported in part by the startup funding offered by the Chinese University of Hong Kong and Hong Kong Research Grant Council (RGC) 2140759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bleuming S, 2006, J PATHOL, V209, P190, DOI 10.1002/path.1976; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; Lee GT, 2010, J BIOL CHEM, V285, P39401, DOI 10.1074/jbc.M110.103705; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P47, DOI 10.1016/j.bcmd.2005.04.006; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pinto JP, 2010, IMMUNOLOGY, V130, P217, DOI 10.1111/j.1365-2567.2009.03226.x; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu SJ, 2012, INNATE IMMUN-LONDON, V18, P318, DOI 10.1177/1753425911405087; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	38	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44622	10.1371/journal.pone.0044622	http://dx.doi.org/10.1371/journal.pone.0044622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028567	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700026
J	Eliasen, R; Daly, NL; Wulff, BS; Andresen, TL; Conde-Frieboes, KW; Craik, DJ				Eliasen, Rasmus; Daly, Norelle L.; Wulff, Birgitte S.; Andresen, Thomas L.; Conde-Frieboes, Kilian W.; Craik, David J.			Design, Synthesis, Structural and Functional Characterization of Novel Melanocortin Agonists Based on the Cyclotide Kalata B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ALPHA-MELANOTROPIN; PLANT CYCLOTIDES; KNOTTED PROTEINS; RECEPTOR MC4-R; HIGHLY POTENT; PEPTIDES; IDENTIFICATION; EXPRESSION; SCAFFOLD	Obesity is an increasingly important global health problem that lacks current treatment options. The melanocortin receptor 4 (MC4R) is a target for obesity therapies because its activation triggers appetite suppression and increases energy expenditure. Cyclotides have been suggested as scaffolds for the insertion and stabilization of pharmaceutically active peptides. In this study, we explored the development of appetite-reducing peptides by synthesizing MC4R agonists based on the insertion of the His-Phe-Arg-Trp sequence into the cyclotide kalata B1. The ability of the analogues to fold similarly to kalata B1 but display MC4R activity were investigated. Four peptides were synthesized using t-butoxycarbonyl peptide chemistry with a C-terminal thioester to facilitate backbone cyclization. The structures of the peptides were found to be similar to kalata B1, evaluated by H alpha NMR chemical shifts. KB1(GHFRWG;23-28) had a K-i of 29 nM at the MC4R and was 107 or 314 times more selective over this receptor than MC1R or MC5R, respectively, and had no detectable binding to MC3R. The peptide had higher affinity for the MC4R than the endogenous agonist, alpha-melanocyte stimulation hormone, but it was less potent at the MC4R, with an EC50 of 580 nM for activation of the MC4R. In conclusion, we synthesized melanocortin analogues of kalata B1 that preserve the structural scaffold and display receptor binding and functional activity. KB1(GHFRWG;23-28) is potent and selective for the MC4R. This compound validates the use of cyclotides as scaffolds and has the potential to be a new lead for the treatment of obesity.	[Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Eliasen, Rasmus; Wulff, Birgitte S.; Conde-Frieboes, Kilian W.] Novo Nordisk AS, DK-2760 Malov, Denmark; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Queensland Trop Hlth Alliance, Cairns, Qld 4870, Australia; [Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld 4870, Australia; [Eliasen, Rasmus; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	University of Queensland; Novo Nordisk; James Cook University; James Cook University; Technical University of Denmark	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Andresen, Thomas L/B-5324-2012; Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Eliasen, Rasmus/H-7707-2012	Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Eliasen, Rasmus/0000-0003-3137-8324; Andresen, Thomas Lars/0000-0002-1048-127X; Conde-Frieboes, Kilian/0000-0001-5303-4448	Australian Research Council [DP0984390]; National Health and Medical Research Council [APP1026501]; Danish Agency for Science Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Danish Agency for Science Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program	This work was supported by Australian Research Council Grant DP0984390 and the National Health and Medical Research Council Grant APP1026501 (to University of Queensland) and by the Industrial Ph.D. Program by the Danish Agency for Science Technology and Innovation and the Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program (to Novo Nordisk).	Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; CASTRUCCI AMD, 1984, COMP BIOCHEM PHYS B, V78, P519, DOI 10.1016/0305-0491(84)90090-7; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; CHHAJLANI V, 1993, BIOCHEM BIOPH RES CO, V195, P866, DOI 10.1006/bbrc.1993.2125; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Claeson P, 1998, J NAT PROD, V61, P77, DOI 10.1021/np970342r; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conde-Frieboes K, 2012, J MED CHEM, V55, P1969, DOI 10.1021/jm201489a; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emmerson PJ, 2007, CURR TOP MED CHEM, V7, P1121; FATHI Z, 1995, NEUROCHEM RES, V20, P107, DOI 10.1007/BF00995160; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FUJINARI EM, 1992, J CHROMATOGR, V592, P209, DOI 10.1016/0021-9673(92)85087-A; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P174; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Haskell-Luevano C, 2001, J MED CHEM, V44, P2247, DOI 10.1021/jm010061n; He SW, 2010, BIOORG MED CHEM LETT, V20, P6524, DOI 10.1016/j.bmcl.2010.09.049; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HRUBY VJ, 1987, J MED CHEM, V30, P2126, DOI 10.1021/jm00394a033; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lindholm P, 2002, MOL CANCER THER, V1, P365; Millard EL, 2009, J BIOL CHEM, V284, P4944, DOI 10.1074/jbc.M804950200; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Schoepke T., 1993, SCI PHARM, V61, P145; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wannamethee SG, 1998, J HUM HYPERTENS, V12, P735, DOI 10.1038/sj.jhh.1000714; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Wilczynski A, 2004, J MED CHEM, V47, P2194, DOI 10.1021/jm0303608; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wolf HK, 1997, J HUM HYPERTENS, V11, P733, DOI 10.1038/sj.jhh.1000531; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wright SM, 2011, NAT REV ENDOCRINOL, V7, P69, DOI 10.1038/nrendo.2010.231	62	78	78	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40493	40501		10.1074/jbc.M112.395442	http://dx.doi.org/10.1074/jbc.M112.395442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012369	hybrid, Green Published			2022-12-25	WOS:000311448800040
J	Glaser, S; van Dooren, GG; Agrawal, S; Brooks, CF; McFadden, GI; Striepen, B; Higgins, MK				Glaser, Stephanie; van Dooren, Giel G.; Agrawal, Swati; Brooks, Carrie F.; McFadden, Geoffrey I.; Striepen, Boris; Higgins, Matthew K.			Tic22 Is an Essential Chaperone Required for Protein Import into the Apicoplast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; CRYSTAL-STRUCTURE; INTERMEMBRANE SPACE; CHLOROPLASTS; IDENTIFICATION; MACHINERIES; COMPONENTS; SUBSTRATE	Most plastids proteins are post-translationally imported into organelles through multisubunit translocons. The TIC and TOC complexes perform this role in the two membranes of the plant chloroplast and in the inner two membranes of the apicoplasts of the apicomplexan parasites, Toxoplasma gondii and Plasmodium falciparum. Tic22 is a ubiquitous intermembrane translocon component that interacts with translocating proteins. Here, we demonstrate that T. gondii Tic22 is an apicoplast-localized protein, essential for parasite survival and protein import into the apicoplast stroma. The structure of Tic22 from P. falciparum reveals a fold conserved from cyanobacteria to plants, which displays a non-polar groove on each side of the molecule. We show that these grooves allow Tic22 to act as a chaperone. General chaperones are common components of protein translocation systems where they maintain cargo proteins in an unfolded conformation during transit. Such a chaperone had not been identified in the intermembrane space of plastids and we propose that Tic22 fulfills this role.	[van Dooren, Giel G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Glaser, Stephanie] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Agrawal, Swati; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Australian National University; University of Cambridge; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Melbourne; University of Oxford	van Dooren, GG (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	giel.vandooren@anu.edu.au; striepen@uga.edu; matthew.higgins@bioch.ox.ac.uk	van Dooren, Giel G/A-8896-2012; McFadden, Geoffrey McFadden I/F-7667-2014	van Dooren, Giel G/0000-0003-2455-9821; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Striepen, Boris/0000-0002-7426-432X; Agrawal, Swati/0000-0001-6295-6954; Higgins, Matthew/0000-0002-2870-1955	Australian Research Council Discovery grant; National Health and Medical Research Council Program Grant; Medical Research Council grant; National Institutes of Health [AI 64671]; Medical Research Council; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671] Funding Source: NIH RePORTER; MRC [G0901062] Funding Source: UKRI; Medical Research Council [G0901062] Funding Source: researchfish	Australian Research Council Discovery grant(Australian Research Council); National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an Australian Research Council Discovery grant (to G. v. D.), a National Health and Medical Research Council Program Grant (to G. I. M.), a Medical Research Council grant (to M. K. H.), and a grant from the National Institutes of Health (AI 64671) (to B. S.).; Supported by a Medical Research Council Studentship.; Supported by a predoctoral fellowship from the American Heart Association. Present address: Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48105.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Bullmann L, 2010, J BIOL CHEM, V285, P6848, DOI 10.1074/jbc.M109.074807; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; del Valle LJ, 2002, BBA-PROTEINS PROTEOM, V1601, P100, DOI 10.1016/S1570-9639(02)00429-6; Glaser S, 2012, ACTA CRYSTALLOGR F, V68, P351, DOI 10.1107/S1744309112004952; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Panse VG, 2000, J BIOL CHEM, V275, P18698, DOI 10.1074/jbc.275.25.18698; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Scott SV, 1996, J CELL BIOL, V132, P63, DOI 10.1083/jcb.132.1.63; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Tripp J, 2012, J BIOL CHEM, V287, P24164, DOI 10.1074/jbc.M112.341644; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Vojta L, 2007, FEBS J, V274, P5043, DOI 10.1111/j.1742-4658.2007.06023.x; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040	34	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405100	http://dx.doi.org/10.1074/jbc.M112.405100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027875	hybrid, Green Published			2022-12-25	WOS:000311233800022
J	Wu, Y; Feng, ZJ; Gao, SB; Matkar, S; Xu, B; Duan, HB; Lin, X; Li, SH; Hua, XX; Jin, GH				Wu, Yuan; Feng, Zi-Jie; Gao, Shu-Bin; Matkar, Smita; Xu, Bin; Duan, Hong-Bin; Lin, Xiao; Li, Shan-Hua; Hua, Xianxin; Jin, Guang-Hui			Interplay between Menin and K-Ras in Regulating Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HISTONE METHYLATION; HUMAN CANCER; GENE; GROWTH; EXPRESSION; PROTEIN; IDENTIFICATION; SUPPRESSION; MUTATIONS	MEN1, which encodes the nuclear protein menin, acts as a tumor suppressor in lung cancer and is often inactivated in human primary lung adenocarcinoma. Here, we show that the inactivation of MEN1 is associated with increased DNA methylation at the MEN1 promoter by K-Ras. On one hand, the activated K-Ras up-regulates the expression of DNA methyltransferases and enhances the binding of DNA methyltransferase 1 to the MEN1 promoter, leading to increased DNA methylation at the MEN1 gene in lung cancer cells; on the other hand, menin reduces the level of active Ras-GTP at least partly by preventing GRB2 and SOS1 from binding to Ras, without affecting the expression of GRB2 and SOS1. In human lung adenocarcinoma samples, we further demonstrate that reduced menin expression is associated with the enhanced expression of Ras (p < 0.05). Finally, excision of the Men1 gene markedly accelerates the K-Ras(G12D)-induced tumor formation in the Men1(f/f); K-Ras(G12D/+); Cre ER mouse model. Together, these findings uncover a previously unknown link between activated K-Ras and menin, an important interplay governing tumor activation and suppression in the development of lung cancer.	[Wu, Yuan; Feng, Zi-Jie; Gao, Shu-Bin; Xu, Bin; Lin, Xiao; Li, Shan-Hua; Hua, Xianxin; Jin, Guang-Hui] Xiamen Univ, Dept Basic Med Sci, Coll Med, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China; [Duan, Hong-Bin] Xiamen Univ, Dept Thorac Surg, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China; [Wu, Yuan] Hubei Canc Hosp, Dept Radiotherapy, Wuhan 430079, Hubei, Peoples R China; [Matkar, Smita; Hua, Xianxin] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Xiamen University; Xiamen University; University of Pennsylvania; Pennsylvania Medicine	Hua, XX (corresponding author), Xiamen Univ, Dept Basic Med Sci, Coll Med, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China.	huax@mail.med.upenn.edu; ghjin@xmu.edu.cn		Feng, Zijie/0000-0002-5633-3686	Natural Science Foundation of China [81071926, 81272719, 81101763, 81101924]; Natural Science Foundation of Fujian Province [2011J06016]; Natural Science Foundation of Xiamen [3502Z20104001]; Fundamental Research Grant for the central universities, Xiamen University [2010121106]; National Institutes of Health [R01 DK085121]; Lung Cancer Research Foundation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085121] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Natural Science Foundation of Xiamen; Fundamental Research Grant for the central universities, Xiamen University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Cancer Research Foundation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Natural Science Foundation of China Grants 81071926 and 81272719 (to G. H. J.), 81101763 (to S. B. G.), and 81101924 (to S. L.); Natural Science Foundation of Fujian Province Grant 2011J06016 (to G. H. J.); Natural Science Foundation of Xiamen Grant 3502Z20104001 (to G. H. J.); Fundamental Research Grant 2010121106 for the central universities, Xiamen University (to G. H. J.). This work was also supported by National Institutes of Health Grant R01 DK085121 (to X. H.) and a Lung Cancer Research Foundation Grant (to X. H.).	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BOS JL, 1989, CANCER RES, V49, P4682; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Gao SB, 2008, ANN ENDOCRINOL-PARIS, V69, P426, DOI 10.1016/j.ando.2008.06.001; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin SH, 2003, CANCER RES, V63, P4204; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Kwon O, 2010, CARCINOGENESIS, V31, P1194, DOI 10.1093/carcin/bgq071; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; RODENHUIS S, 1992, CANCER RES, V52, pS2665; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Xu B, 2011, J BIOL CHEM, V286, P13937, DOI 10.1074/jbc.M110.197830; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	45	30	34	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382416	http://dx.doi.org/10.1074/jbc.M112.382416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027861	Green Published, hybrid			2022-12-25	WOS:000311233800067
J	Bosch, D; Saiardi, A				Bosch, Daniel; Saiardi, Adolfo			Arginine Transcriptional Response Does Not Require Inositol Phosphate Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE KINASE-ACTIVITY; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; STRESS TOLERANCE; GENE-EXPRESSION; HUMAN HOMOLOG; IN-VITRO; MULTIKINASE; YEAST; METABOLISM	Inositol phosphates are key signaling molecules affecting a large variety of cellular processes. Inositol-polyphosphate multikinase (IPMK) is a central component of the inositol phosphate biosynthetic routes, playing essential roles during development. IPMK phosphorylates inositol 1,4,5-trisphosphate to inositol tetrakisphosphate and subsequently to inositol pentakisphosphate and has also been described to function as a lipid kinase. Recently, a catalytically inactive mammalian IPMK was reported to be involved in nutrient signaling by way of mammalian target of rapamycin and AMP-activated protein kinase. In yeast, the IPMK homologue, Arg82, is the sole inositol-trisphosphate kinase. Arg82 has been extensively studied as part of the transcriptional complex regulating nitrogen sensing, in particular arginine metabolism. Whether this role requires Arg82 catalytic activity has long been a matter of contention. In this study, we developed a novel method for the real time study of promoter strength in vivo and used it to demonstrate that catalytically inactive Arg82 fully restored the arginine-dependent transcriptional response. We also showed that expression in yeast of catalytically active, but structurally very different, mammalian or plant IPMK homologue failed to restore arginine regulation. Our work indicates that inositol phosphates do not regulate arginine-dependent gene expression.	[Saiardi, Adolfo] UCL, MRC LMCB, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, MRC LMCB, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk			Medical Research Council, Cell Biology Unit; MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: researchfish	Medical Research Council, Cell Biology Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council funding of the Cell Biology Unit.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Bang S, 2012, P NATL ACAD SCI USA, V109, P616, DOI 10.1073/pnas.1119751109; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BERCY J, 1987, GENE, V55, P277, DOI 10.1016/0378-1119(87)90287-3; Blind RD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003111; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Caddick SEK, 2007, BIOCHEM J, V403, P381, DOI 10.1042/BJ20061772; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chang SC, 2002, J BIOL CHEM, V277, P43836, DOI 10.1074/jbc.M206134200; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DUBOIS E, 1991, MOL CELL BIOL, V11, P2162, DOI 10.1128/MCB.11.4.2162; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; DURR M, 1979, ARCH MICROBIOL, V121, P169, DOI 10.1007/BF00689982; El Alami M, 2003, MOL MICROBIOL, V49, P457, DOI 10.1046/j.1365-2958.2003.03562.x; El Bakkoury M, 2000, MOL MICROBIOL, V35, P15, DOI 10.1046/j.1365-2958.2000.01665.x; Frederick JP, 2005, P NATL ACAD SCI USA, V102, P8454, DOI 10.1073/pnas.0503706102; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hsieh CH, 2006, NUCL MED BIOL, V33, P653, DOI 10.1016/j.nucmedbio.2006.04.001; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JONSSON JJ, 1991, ANAL BIOCHEM, V199, P232, DOI 10.1016/0003-2697(91)90095-B; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Meyer R, 2012, BIOL CHEM, V393, P149, DOI 10.1515/hsz-2011-0209; MICHELL RH, 1981, PHILOS T R SOC B, V296, P123, DOI 10.1098/rstb.1981.0177; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Resnick A. C., 2009, WILEY ENCY CHEM BIOL, V2, P349, DOI [10.1002/9780470048672.wecb252, DOI 10.1002/9780470048672.WECB252]; Resnick AC, 2005, P NATL ACAD SCI USA, V102, P12783, DOI 10.1073/pnas.0506184102; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Smith JJ, 2008, EUKARYOT CELL, V7, P471, DOI 10.1128/EC.00409-07; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Suzuki M, 2007, GENE, V405, P55, DOI 10.1016/j.gene.2007.09.006; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Xia HJ, 2003, PLANT CELL, V15, P449, DOI 10.1105/tpc.006676; Yaghoubi SS, 2006, NAT PROTOC, V1, P2137, DOI 10.1038/nprot.2006.334; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Zhu JQ, 2009, PHYSIOL PLANTARUM, V136, P407, DOI 10.1111/j.1399-3054.2009.01235.x	58	22	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.384255	http://dx.doi.org/10.1074/jbc.M112.384255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992733	Green Published, hybrid			2022-12-25	WOS:000310642200067
J	Broderick, S; Wang, XX; Simms, N; Page-McCaw, A				Broderick, Sarah; Wang, Xiaoxi; Simms, Nicholas; Page-McCaw, Andrea			Drosophila Ninjurin A Induces Nonapoptotic Cell Death	PLOS ONE			English	Article							IMMUNE-RESPONSE; ADHESION MOLECULE; TRANSMEMBRANE PROTEIN; BACTERIAL-INFECTION; INNATE IMMUNITY; HOST-DEFENSE; ACTIVATION; GENE; MELANOGASTER; EXPRESSION	Ninjurins are conserved transmembrane proteins that are upregulated across species in response to injury and stress. Their biological functions are not understood, in part because there have been few in vivo studies of their function. We analyzed the expression and function of one of three Drosophila Ninjurins, NijA. We found that NijA protein is redistributed to the cell surface in larval immune tissues after septic injury and is upregulated by the Toll pathway. We generated a null mutant of NijA, which displayed no detectable phenotype. In ectopic expression studies, NijA induced cell death, as evidenced by cell loss and acridine orange staining. These dying cells did not display hallmarks of apoptotic cells including TUNEL staining and inhibition by p35, indicating that NijA induced nonapoptotic cell death. In cell culture, NijA also induced cell death, which appeared to be cell autonomous. These in vivo studies identify a new role for the Ninjurin family in inducing nonapoptotic cell death.	[Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37203 USA; [Broderick, Sarah; Wang, Xiaoxi; Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Dept Cell & Dev Biol, Nashville, TN USA; [Broderick, Sarah; Wang, Xiaoxi; Page-McCaw, Andrea] Vanderbilt Univ Sch Med, Program Dev Biol, Nashville, TN USA; [Simms, Nicholas] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Rensselaer Polytechnic Institute	Page-McCaw, A (corresponding author), Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37203 USA.	andrea.page-mccaw@vanderbilt.edu	Wang, Xiaoxi/C-7178-2015	Wang, Xiaoxi/0000-0002-2232-8504	Basil O'Connor Starter Scholar Research Award [5-FY07-99]; National Institutes of Health [R01 GM073883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073883] Funding Source: NIH RePORTER	Basil O'Connor Starter Scholar Research Award(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Basil O'Connor Starter Scholar Research Award no. 5-FY07-99 and by National Institutes of Health R01 GM073883, both to APM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; ANDERSON KV, 1979, DEV BIOL, V70, P217, DOI 10.1016/0012-1606(79)90018-6; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bass BP, 2009, CELL DEATH DIFFER, V16, P1362, DOI 10.1038/cdd.2009.79; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Glasheen BM, 2009, P NATL ACAD SCI USA, V106, P2659, DOI 10.1073/pnas.0804171106; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Kanda H, 2011, P NATL ACAD SCI USA, V108, P18977, DOI 10.1073/pnas.1103242108; Kim JW, 2001, MOL CELLS, V11, P151; Koike M, 2008, J DERMATOL, V35, P6, DOI 10.1111/j.1346-8138.2007.00403.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; MCGUIRE SE, 2004, SCI STKE, pPL6; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Primrose DA, 2007, J CELL SCI, V120, P1189, DOI 10.1242/jcs.03417; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Salmen S, 2007, CLIN EXP IMMUNOL, V150, P539, DOI 10.1111/j.1365-2249.2007.03524.x; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Taylor K, 2007, FLY, V1, P197, DOI 10.4161/fly.5082; Toyama T, 2004, J HEPATOL, V41, P637, DOI 10.1016/j.jhep.2004.06.027; WERTMAN KF, 1992, GENETICS, V132, P337; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wright CW, 2005, VIROLOGY, V335, P61, DOI 10.1016/j.virol.2005.02.007; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang S, 2006, GENE DEV, V20, P1899, DOI 10.1101/gad.1426906	57	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44567	10.1371/journal.pone.0044567	http://dx.doi.org/10.1371/journal.pone.0044567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028562	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900013
J	Chen, ZL; Gerhold-Ay, A; Gebhard, S; Boehm, D; Solbach, C; Lebrecht, A; Battista, M; Sicking, I; Cotarelo, C; Cadenas, C; Marchan, R; Stewart, JD; Gehrmann, M; Koelbl, H; Hengstler, JG; Schmidt, M				Chen, Zonglin; Gerhold-Ay, Aslihan; Gebhard, Susanne; Boehm, Daniel; Solbach, Christine; Lebrecht, Antje; Battista, Marco; Sicking, Isabel; Cotarelo, Christina; Cadenas, Cristina; Marchan, Rosemarie; Stewart, Joanna D.; Gehrmann, Mathias; Koelbl, Heinz; Hengstler, Jan G.; Schmidt, Marcus			Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer	PLOS ONE			English	Article							B-CELLS; PROGNOSTIC-SIGNIFICANCE; INVASIVE-CARCINOMA; ST-GALLEN; LYMPHOCYTES; RECURRENCE; EXPRESSION; INFLAMMATION; PATTERNS; IMMUNITY	Background: Biomarkers of the immune system are currently not used as prognostic factors in breast cancer. We analyzed the association of the B cell/plasma cell marker immunoglobulin kappa C (IGKC) and survival of untreated node-negative breast cancer patients. Material and Methods: IGKC expression was evaluated by immunostaining in a cohort of 335 node-negative breast cancer patients with a median follow-up of 152 months. The prognostic significance of IGKC for disease-free survival (DFS) and breast cancer-specific overall survival (OS) was evaluated with Kaplan-Meier survival analysis as well as univariate and multivariate Cox analysis adjusted for age at diagnosis, pT stage, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, Ki-67 and human epidermal growth factor receptor 2 (HER-2) status. Results: 160 patients (47.7%) showed strong expression of IGKC. Univariate analysis showed that IGKC was significantly associated with DFS (P = 0.017, hazard ratio [HR] = 0.570, 95% confidence interval [CI] = 0.360-0.903) and OS (P = 0.011, HR = 0.438, 95% CI = 0.233-0.822) in the entire cohort. The significance of IGKC was especially strong in ER negative and in luminal B carcinomas. In multivariate analysis IGKC retained its significance independent of established clinical factors for DFS (P = 0.004, HR = 0.504, 95% CI = 0.315-0.804) as well as for OS (P = 0.002, HR = 0.371, 95% CI = 0.196-0.705). Conclusion: Expression of IGKC has an independent protective impact on DFS and OS in node-negative breast cancer.	[Chen, Zonglin; Gebhard, Susanne; Boehm, Daniel; Solbach, Christine; Lebrecht, Antje; Battista, Marco; Sicking, Isabel; Koelbl, Heinz; Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany; [Gerhold-Ay, Aslihan] Johannes Gutenberg Univ Mainz, Dept Med Biometry Epidemiol & Informat, Mainz, Germany; [Cotarelo, Christina] Johannes Gutenberg Univ Mainz, Dept Pathol, D-6500 Mainz, Germany; [Cadenas, Cristina; Marchan, Rosemarie; Stewart, Joanna D.; Hengstler, Jan G.] Dortmund Univ Technol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Gehrmann, Mathias] Bayer GmbH, Leverkusen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Bayer AG	Schmidt, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany.	marcus.schmidt@unimedizin-mainz.de	Hengstler, Jan G./O-1415-2013; Lebrecht, Antje/F-6456-2014; Schmidt, Marcus/H-3383-2013; Stewart, Joanna Dawn/H-1614-2012	Lebrecht, Antje/0000-0002-8442-6505; Schmidt, Marcus/0000-0003-1365-2414; Stewart, Joanna Dawn/0000-0002-2608-1967; Hengstler, Jan/0000-0002-1427-5246; Marchan, Rosemarie/0000-0003-4414-1633	Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile); China Scholarship Council, Peking, China [2009616032]	Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile); China Scholarship Council, Peking, China(China Scholarship Council)	This work was supported by the Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile) and China Scholarship Council (financial support to ZC) (No. 2009616032; Peking, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Kim S, 2008, J IMMUNOTHER, V31, P446, DOI 10.1097/CJI.0b013e31816d1d6a; Lee AHS, 2006, HISTOPATHOLOGY, V48, P692, DOI 10.1111/j.1365-2559.2006.02410.x; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Oh E, 2012, BREAST CANCER RES TR, V132, P499, DOI 10.1007/s10549-011-1626-8; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Rosenblatt J, 2007, CANCER RES, V67, P5058, DOI 10.1158/0008-5472.CAN-06-3903; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; van 't Veer LJ, 2002, NATURE, V415, P530, DOI [DOI 10.1038/415530A, 10.1038/415530a]; Wang Y, 2007, BREAST CANCER RES TR, V104, P129, DOI 10.1007/s10549-006-9409-3; WEIKEL W, 1991, BREAST CANCER RES TR, V18, P149, DOI 10.1007/BF01990030	28	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44741	10.1371/journal.pone.0044741	http://dx.doi.org/10.1371/journal.pone.0044741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028600	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309973900015
J	Rignell-Hydbom, A; Lindh, CH; Dillner, J; Jonsson, BAG; Rylander, L				Rignell-Hydbom, Anna; Lindh, Christian H.; Dillner, Joakim; Jonsson, Bo A. G.; Rylander, Lars			A Nested Case-Control Study of Intrauterine Exposure to Persistent Organochlorine Pollutants and the Risk of Hypospadias	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; TESTICULAR DYSGENESIS SYNDROME; POLYCHLORINATED-BIPHENYLS; SEXUAL-DIFFERENTIATION; BREAST-MILK; MALE-RAT; CRYPTORCHIDISM; PESTICIDES; PHTHALATE; FISH	Background: Environmental exposures to endocrine disrupting chemicals have been suggested as a risk factor for male genital abnormalities such as hypospadias. The aim of this case-control study was to investigate the association between fetal exposure to persistent organochlorine pollutants (POP) and the risk for hypospadias. Methodology/Principal Findings: The Southern Sweden Maternity Cohort (SSMC) contains serum samples collected in early pregnancy among women in Southern Sweden. Linkages with the Medical Birth Register, the Malformation Register and the In-patient Register resulted in 390 SSMC mothers who had given birth to a boy with hypospadias in year 1986-2002 (mean 1995). For 237 of these (cases) sufficient amounts of serum for the chemical analyses were available. For each case, a control boy from the SSMC was randomly selected, matched for maternal age, birth year, parity and maternal smoking. PCB-153, p,p'-DDE and hexachlorbenzene (HCB) were used as biomarkers for POP exposure. The exposures were categorized into quartiles based on the distributions among the controls. There were no statistically significant trends between the a priori categorisation of the exposure variables and the risk for hypospadias. However, when the upper HCB quartile (>26 ng/ml) was compared to the other quartiles an odds ratio of 1.65 (95% CI 1.02 to 2.69) was obtained. p,p'-DDE levels above median (>1.0 ng/ml) compared to levels below 0.1 ng/ml gave an OR of 1.69 (95% CI 0.97 to 2.93). Conclusions: The present study suggests that fetal exposure to HCB and p,p'-DDE may be a risk factor for hypospadias.	[Rignell-Hydbom, Anna; Lindh, Christian H.; Jonsson, Bo A. G.; Rylander, Lars] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Lund University; Karolinska Institutet	Rignell-Hydbom, A (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Jonsson, Bo/0000-0002-8767-0589; Lindh, Christian/0000-0001-7435-9890	Swedish Research Council [2008-32038-63634-60]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Swedish Research Council (2008-32038-63634-60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aoki Y, 2001, ENVIRON RES, V86, P2, DOI 10.1006/enrs.2001.4244; Araneta MRG, 2003, BIRTH DEFECTS RES A, V67, P246, DOI 10.1002/bdra.10033; Bergonzi R, 2009, CHEMOSPHERE, V76, P747, DOI 10.1016/j.chemosphere.2009.05.026; Bhatia R, 2005, ENVIRON HEALTH PERSP, V113, P220, DOI 10.1289/ehp.7382; Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Costa Lucio G., 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P367, DOI 10.2478/v10004-007-0025-3; Damgaard IN, 2006, ENVIRON HEALTH PERSP, V114, P1133, DOI 10.1289/ehp.8741; FEIN GG, 1984, J PEDIATR-US, V105, P315, DOI 10.1016/S0022-3476(84)80139-0; Fernandez MF, 2007, ENVIRON HEALTH PERSP, V115, P8, DOI 10.1289/ehp.9351; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Giordano F, 2010, BIRTH DEFECTS RES A, V88, P241, DOI 10.1002/bdra.20657; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Krysiak-Baltyn K, 2010, INT J ANDROL, V33, P270, DOI 10.1111/j.1365-2605.2009.00996.x; Longnecker MP, 2002, AM J EPIDEMIOL, V155, P313, DOI 10.1093/aje/155.4.313; Manson JM, 2003, BIRTH DEFECTS RES A, V67, P825, DOI 10.1002/bdra.10084; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; Pierik FH, 2002, HUM REPROD, V17, P1112, DOI 10.1093/humrep/17.4.1112; Pierik PH, 2004, ENV HLTH PERSPECT, V112, P1570; Porta M, 2012, ENVIRON INT, V44, P106, DOI 10.1016/j.envint.2012.02.005; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Virtanen HE, 2012, INT J ANDROL, V35, P283, DOI 10.1111/j.1365-2605.2011.01233.x; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; Wetterauer B, 2012, ENVIRON SCI POLLUT R, V19, P403, DOI 10.1007/s11356-011-0570-9	34	27	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44767	10.1371/journal.pone.0044767	http://dx.doi.org/10.1371/journal.pone.0044767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028613	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500008
J	Shill, J; Mavoa, H; Crammond, B; Loff, B; Peeters, A; Lawrence, M; Allender, S; Sacks, G; Swinburn, BA				Shill, Jane; Mavoa, Helen; Crammond, Brad; Loff, Bebe; Peeters, Anna; Lawrence, Mark; Allender, Steven; Sacks, Gary; Swinburn, Boyd A.			Regulation to Create Environments Conducive to Physical Activity: Understanding the Barriers and Facilitators at the Australian State Government Level	PLOS ONE			English	Article								Introduction: Policy and regulatory interventions aimed at creating environments more conducive to physical activity (PA) are an important component of strategies to improve population levels of PA. However, many potentially effective policies are not being broadly implemented. This study sought to identify potential policy/regulatory interventions targeting PA environments, and barriers/facilitators to their implementation at the Australian state/territory government level. Methods: In-depth interviews were conducted with senior representatives from state/territory governments, statutory authorities and non-government organisations (n = 40) to examine participants': 1) suggestions for regulatory interventions to create environments more conducive to PA; 2) support for preselected regulatory interventions derived from a literature review. Thematic and constant comparative analyses were conducted. Results: Policy interventions most commonly suggested by participants fell into two areas: 1) urban planning and provision of infrastructure to promote active travel; 2) discouraging the use of private motorised vehicles. Of the eleven preselected interventions presented to participants, interventions relating to walkability/cycling and PA facilities received greatest support. Interventions involving subsidisation (of public transport, PA-equipment) and the provision of more public transport infrastructure received least support. These were perceived as not economically viable or unlikely to increase PA levels. Dominant barriers were: the powerful 'road lobby', weaknesses in the planning system and the cost of potential interventions. Facilitators were: the provision of evidence, collaboration across sectors, and synergies with climate change/environment agendas. Conclusion: This study points to how difficult it will be to achieve policy change when there is a powerful 'road lobby' and government investment prioritises road infrastructure over PA-promoting infrastructure. It highlights the pivotal role of the planning and transport sectors in implementing PA-promoting policy, however suggests the need for clearer guidelines and responsibilities for state and local government levels in these areas. Health outcomes need to be given more direct consideration and greater priority within non-health sectors.	[Shill, Jane; Mavoa, Helen; Lawrence, Mark; Allender, Steven; Sacks, Gary; Swinburn, Boyd A.] Deakin Univ, World Hlth Org Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Allender, Steven] Univ Oxford, Dept Publ Hlth, Oxford, England; [Crammond, Brad; Loff, Bebe; Peeters, Anna] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Deakin University; World Health Organization; University of Oxford; Monash University	Mavoa, H (corresponding author), Deakin Univ, World Hlth Org Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia.	helen.mavoa@deakin.edu.au	Sacks, Gary/I-5731-2014; Peeters, Anna/M-8284-2019; PEETERS, ANNA/B-3663-2013; Allender, Steven/G-9881-2011	Sacks, Gary/0000-0001-9736-1539; Peeters, Anna/0000-0003-4340-9132; PEETERS, ANNA/0000-0003-4340-9132; Lawrence, Mark/0000-0001-6899-3983; Allender, Steven/0000-0002-4842-3294	National Health and Medical Research Council Strategic Award [410507]	National Health and Medical Research Council Strategic Award	This study was funded by a National Health and Medical Research Council Strategic Award grant (ID 410507) http://www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2011, HEALTH PROMOT INT, DOI [10.1093/heapro/dar1018, DOI 10.1093/HEAPRO/DAR1018]; Allender Steven, 2009, Aust New Zealand Health Policy, V6, P20, DOI 10.1186/1743-8462-6-20; ANAO and Department of the Prime Minister and Cabinet, 2006, IMPL PROGR POL IN MA, P13; Australian Bureau of Statistics, 2004, 4835 0 55 001 PHYS A; Australian Local Government Association, 2011, ED BUDG 2011 12 AN F; Bauman A.E., 2007, ENV CORRELATES PHYS; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Buse K., 2005, MAKING HLTH POLICY; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; De Leeuw E., 1993, HEALTH PROMOT INT, V8, P49, DOI [DOI 10.1093/HEAPRO/8.1.49, 10.1093/heapro/8.1.49]; *DEP INFR, 2002, MELB 2030 PLANN SUST; Department of Infrastructure and Transport, 2011, NAT BUILD PROGR; Department of Innovation Industry Science and Research, 2011, 114 DEP INN IND SCI; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Government of South Australia, 2010, S AUSTR APPR HLTH AL; Grant JL, 2010, CAN J PUBLIC HEALTH, V101, P237, DOI 10.1007/BF03404381; Haines A, 2009, LANCET, V374, P2035, DOI 10.1016/S0140-6736(09)61667-6; Hillsdon M., 2005, EFFECTIVENESS PUBLIC; Kickbusch I, 2010, IMPLEMENTING HLTH AL; Landry R, 2001, RES POLICY, V30, P333, DOI 10.1016/S0048-7333(00)00081-0; Lawrence M, 2007, PUBLIC HLTH NUTR PRI, P450; Lawrence M, 2010, PREVENTING CHILDHOOD; Lewis J. M., 2005, HLTH POLICY POLITICS; Litman T., 2011, EVALUATING NONMOTORI; Milio N, 1987, Health Promot, V2, P263, DOI 10.1093/heapro/2.3.263; Millstone E, 2007, OBES REV, V8, P29, DOI 10.1111/j.1467-789X.2007.00356.x; Morabia Alfredo, 2009, Prev Med, V49, P275, DOI 10.1016/j.ypmed.2009.09.016; National Preventative Health Taskforce, 2010, TAK PREV ACT RESP AU; National Prevention Council, 2011, NAT PREV STRAT; Parliament of Australia, 2010, MULT SYST GOV AUSTR; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Port Phillip City Council, 2011, PORT PHILL PLANN SCH; Russell J, 2008, J HEALTH SERV RES PO, V13, P40, DOI 10.1258/jhsrp.2007.006029; Sabatier P. A., 1993, POLICY CHANGE LEARNI; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Shill J, 2012, OBES REV, V13, P162, DOI 10.1111/j.1467-789X.2011.00937.x; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; VCEC, 2006, MAK RIGHT CHOIC OPT; Victorian Government, 2008, VICT TRANSP PLAN; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; WHO, PREV INS PHYS ACT; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yancey AK, 2009, PREV MED, V49, P277, DOI 10.1016/j.ypmed.2009.08.012	45	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e42831	10.1371/journal.pone.0042831	http://dx.doi.org/10.1371/journal.pone.0042831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23028434	Green Published, gold			2022-12-25	WOS:000309517500003
J	Chi, X; Zhi, L; Gelderman, MP; Vostal, JG				Chi, Xuan; Zhi, Li; Gelderman, Monique P.; Vostal, Jaroslav G.			Host Platelets and, in Part, Neutrophils Mediate Lung Accumulation of Transfused UVB-Irradiated Human Platelets in a Mouse Model of Acute Lung Injury	PLOS ONE			English	Article							ULTRAVIOLET-A LIGHT; RED-BLOOD-CELLS; PHOTOCHEMICAL INACTIVATION; PATHOGEN INACTIVATION; AMOTOSALEN HCL; IN-VITRO; MICE; RECEPTORS; ANTIBODIES; AGGREGATION	We previously reported that ultraviolet light B (UVB)-treated human platelets (hPLTs) can cause acute lung injury (ALI) in a two-event SCID mouse model in which the predisposing event was Lipopolysaccharide (LPS) injection and the second event was infusion of UVB-treated hPLTs. To delineate contributions of host mouse platelets (mPLTs) and neutrophils in the pathogenesis of ALI in this mouse model, we depleted mPLTs or neutrophils and measured hPLT accumulation in the lung. We also assessed lung injury by protein content in bronchoalveolar lavage fluid (BALF). LPS injection followed by infusion of UVB-treated hPLTs resulted in sequestration of both mPLTs and hPLTs in the lungs of SCID mice, although the numbers of neutrophils in the lung were not significantly different from the control group. Depletion of mouse neutrophils caused only a mild reduction in UVB-hPLTs accumulation in the lungs and a mild reduction in protein content in BALF. In comparison, depletion of mPLTs almost completely abolished hPLTs accumulation in the lung and significantly reduced protein content in BALF. UVB-treated hPLTs bound to host mPLTs, but did not bind to neutrophils in the lung. Aspirin treatment of hPLTs in vitro abolished hPLT accumulation in the lung and protected mice from lung injury. Our data indicate that host mPLTs accumulated in the lungs in response to an inflammatory challenge and subsequently mediated the attachment of transfused UVB-hPLTs. Neutrophils also recruited a small percentage of platelets to the lung. These findings may help develop therapeutic strategies for ALI which could potentially result from transfusion of UV illuminated platelets.	[Chi, Xuan; Zhi, Li; Gelderman, Monique P.; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	Jaroslav.Vostal@fda.hhs.gov			Food and Drug Administration (FDA)	Food and Drug Administration (FDA)	This work was supported by the Food and Drug Administration's (FDA) Critical Path Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; DUARTE APT, 1986, THROMB RES, V43, P33, DOI 10.1016/0049-3848(86)90042-3; Faust N, 2000, BLOOD, V96, P719; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Heal JM, 2004, BLOOD REV, V18, P149, DOI 10.1016/S0268-960X(03)00057-2; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Piper JT, 2007, TRANSFUSION, V47, P1540, DOI 10.1111/j.1537-2995.2007.01295.x; ROSENBLUM WI, 1982, THROMB RES, V28, P713, DOI 10.1016/0049-3848(82)90096-2; Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Salles II, 2009, BLOOD, V114, P5044, DOI 10.1182/blood-2009-02-205989; SCHNEIDER RC, 1980, AM REV RESPIR DIS, V122, P445; Sealey AL, 2002, J IMMUNOL METHODS, V260, P303, DOI 10.1016/S0022-1759(01)00524-5; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x; Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; Ware J, 2004, THROMB HAEMOSTASIS, V92, P478, DOI 10.1160/TH04-05-0308; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44829	10.1371/journal.pone.0044829	http://dx.doi.org/10.1371/journal.pone.0044829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028636	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400042
J	Dharmaratne, N; Glendining, KA; Young, TR; Tran, H; Sawatari, A; Leamey, CA				Dharmaratne, Nuwan; Glendining, Kelly A.; Young, Timothy R.; Tran, Heidi; Sawatari, Atomu; Leamey, Catherine A.			Ten-m3 Is Required for the Development of Topography in the Ipsilateral Retinocollicular Pathway	PLOS ONE			English	Article							UNCROSSED RETINAL PROJECTIONS; LATERAL GENICULATE-NUCLEUS; EPHRIN-AS; INTRACELLULAR DOMAIN; BRANCH EXTENSION; EXPRESSION; EYE; RETINOGENICULATE; PROTEINS; RECEPTOR	The alignment of ipsilaterally and contralaterally projecting retinal axons that view the same part of visual space is fundamental to binocular vision. While much progress has been made regarding the mechanisms which regulate contralateral topography, very little is known of the mechanisms which regulate the mapping of ipsilateral axons such that they align with their contralateral counterparts. Results: Using the advantageous model provided by the mouse retinocollicular pathway, we have performed anterograde tracing experiments which demonstrate that ipsilateral retinal axons begin to form terminal zones (TZs) in the superior colliculus (SC), within the first few postnatal days. These appear mature by postnatal day 11. Importantly, TZs formed by ipsilaterally-projecting retinal axons are spatially offset from those of contralaterally-projecting axons arising from the same retinotopic location from the outset. This pattern is consistent with that required for adult visuotopy. We further demonstrate that a member of the Ten-m/Odz/Teneurin family of homophilic transmembrane glycoproteins, Ten-m3, is an essential regulator of ipsilateral retinocollicular topography. Ten-m3 mRNA is expressed in a high-medial to low-lateral gradient in the developing SC. This corresponds topographically with its high-ventral to low-dorsal retinal gradient. In Ten-m3 knockout mice, contralateral ventrotemporal axons appropriately target rostromedial SC, whereas ipsilateral axons exhibit dramatic targeting errors along both the mediolateral and rostrocaudal axes of the SC, with a caudal shift of the primary TZ, as well as the formation of secondary, caudolaterally displaced TZs. In addition to these dramatic ipsilateral-specific mapping errors, both contralateral and ipsilateral retinocollicular TZs exhibit more subtle changes in morphology. Conclusions: We conclude that important aspects of adult visuotopy are established via the differential sensitivity of ipsilateral and contralateral axons to intrinsic guidance cues. Further, we show that Ten-m3 plays a critical role in this process and is particularly important for the mapping of the ipsilateral retinocollicular pathway.	[Leamey, Catherine A.] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Leamey, CA (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia.	cathy@physiol.usyd.edu.au		Young, Timothy Raymond/0000-0002-6568-4592; Leamey, Catherine/0000-0002-3390-4933	National Health and Medical Research Council (NHMRC) [632685]; University of Sydney	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	This work was funded by National Health and Medical Research Council (NHMRC) project grant 632685 and University of Sydney research and development grants to CAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; LAVAIL JH, 1978, J COMP NEUROL, V182, P399, DOI 10.1002/cne.901820304; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Leamey CA, 2009, CURR OPIN NEUROBIOL, V19, P181, DOI 10.1016/j.conb.2009.05.006; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Merlin S, 2012, CEREB CORTEX; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plas DT, 2008, J NEUROSCI, V28, P7057, DOI 10.1523/JNEUROSCI.3598-06.2008; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; REESE BE, 1986, J COMP NEUROL, V250, P8, DOI 10.1002/cne.902500103; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Upton AL, 2002, NEUROSCIENCE, V111, P597, DOI 10.1016/S0306-4522(01)00602-9; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Winters JJ, 2011, J NEUROSCI, V31, P17736, DOI 10.1523/JNEUROSCI.1482-11.2011; Wu HH, 2000, DEV BRAIN RES, V120, P105, DOI 10.1016/S0165-3806(99)00145-5; Wu HH, 2000, J COMP NEUROL, V426, P651, DOI 10.1002/1096-9861(20001030)426:4<651::AID-CNE11>3.0.CO;2-X; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	55	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43083	10.1371/journal.pone.0043083	http://dx.doi.org/10.1371/journal.pone.0043083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028443	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400005
J	Hong, HS; Ahmad, F; Eberhard, J; Bhatnagar, N; Bollmann, BA; Keudel, P; Ballmaier, M; Zielinska-Skowronek, M; Schmidt, RE; Meyer-Olson, D				Hong, Henoch S.; Ahmad, Fareed; Eberhard, JohannaM.; Bhatnagar, Nupur; Bollmann, Benjamin A.; Keudel, Phillip; Ballmaier, Matthias; Zielinska-Skowronek, Margot; Schmidt, Reinhold E.; Meyer-Olson, Dirk			Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTION; SUBSET; CYTOTOXICITY; EXPANSION; IMMUNITY; TARGETS; INNATE	NK cells are pivotal sentinels of the innate immune system and distinct subpopulations in peripheral blood have been described. A number of studies addressed HIV-induced alterations of NK cell phenotype and functionality mainly focusing on CD56(dim)CD16(+) and CD56(-)CD16(+) NK cells. However, the impact of HIV-infection on CD56(bright) NK cells is less well understood. Here we report a rise of CD56(bright) NK cells in HIV-infected individuals, which lack CCR7-expression and strongly correlate with HIV viral load. CCR7(-)CD56(bright) NK cells were characterized by increased cytolytic potential, higher activation states and a more differentiated phenotype. These cells thus acquired a number of features of CD56(dim)CD16(+) NK cells. Furthermore, CD56 bright NK cells from HIV patients exhibited higher degranulation levels compared to uninfected individuals. Thus, chronic HIV-infection is associated with a phenotypic and functional shift of CD56(bright) NK cells, which provides a novel aspect of HIV-associated pathogenesis within the NK cell compartment.	[Hong, Henoch S.; Ahmad, Fareed; Eberhard, JohannaM.; Bhatnagar, Nupur; Bollmann, Benjamin A.; Keudel, Phillip; Zielinska-Skowronek, Margot; Schmidt, Reinhold E.; Meyer-Olson, Dirk] Hannover Med Sch, Klin Immunol & Rheumatol, D-30623 Hannover, Germany; [Hong, Henoch S.] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA	Hannover Medical School; Harvard University	Meyer-Olson, D (corresponding author), Hannover Med Sch, Klin Immunol & Rheumatol, D-30623 Hannover, Germany.	meyer.dirk@mh-hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995; Eberhard, Johanna Maria/0000-0002-8367-3870; Hong, Henoch/0000-0002-3367-1738	Bundesministerium fur Bildung und Forschung; Stiftung Zukunfts- und Innovationsfonds Niedersachsen; European AIDS Treatment Network (NEAT); Helmholtz-Zentrum fur Infektionsforschung [IG-SCID-TwinPro02]; MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School; Deutsche Forschungsgemeinschaft [HO 4527/1-1]; Bundesministerium fur Bildung und Forschung [IND 06/20]; NEAT	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Stiftung Zukunfts- und Innovationsfonds Niedersachsen; European AIDS Treatment Network (NEAT); Helmholtz-Zentrum fur Infektionsforschung; MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NEAT	D.M.O. is supported by grants from the Bundesministerium fur Bildung und Forschung, Stiftung Zukunfts- und Innovationsfonds Niedersachsen, the European AIDS Treatment Network (NEAT) and the Helmholtz-Zentrum fur Infektionsforschung (IG-SCID-TwinPro02). H.S.H. is supported by a fellowship from the MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School and by a post-doctoral fellowship from the Deutsche Forschungsgemeinschaft (HO 4527/1-1). R.E.S. is supported by grant IND 06/20 from Bundesministerium fur Bildung und Forschung and NEAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eller MA, 2009, JAIDS-J ACQ IMM DEF, V51, P380, DOI 10.1097/QAI.0b013e3181aa256e; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Hong HS, 2010, AIDS, V24, P1823, DOI 10.1097/QAD.0b013e32833b556f; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Hong HS, 2009, IMMUNOL LETT, V125, P100, DOI 10.1016/j.imlet.2009.06.008; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kottilil S, 2007, JAIDS-J ACQ IMM DEF, V46, P151, DOI 10.1097/QAI.0b013e3180dc9909; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Mirandola P, 2004, BLOOD, V104, P2418, DOI 10.1182/blood-2004-04-1294; NAGLER A, 1989, J IMMUNOL, V143, P3183; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	32	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44820	10.1371/journal.pone.0044820	http://dx.doi.org/10.1371/journal.pone.0044820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028633	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400040
J	Philipp, EER; Wessels, W; Gruber, H; Strahl, J; Wagner, AE; Ernst, IMA; Rimbach, G; Kraemer, L; Schreiber, S; Abele, D; Rosenstiel, P				Philipp, Eva E. R.; Wessels, Wiebke; Gruber, Heike; Strahl, Julia; Wagner, Anika E.; Ernst, Insa M. A.; Rimbach, Gerald; Kraemer, Lars; Schreiber, Stefan; Abele, Doris; Rosenstiel, Philip			Gene Expression and Physiological Changes of Different Populations of the Long-Lived Bivalve Arctica islandica under Low Oxygen Conditions	PLOS ONE			English	Article							HYPOXIA TOLERANCE; PROLONGED ANOXIA; BALTIC SEA; KIEL BAY; LIFE; TEMPERATURE; DEPRESSION; ADAPTATION; STRESS; PHOSPHOFRUCTOKINASE	The bivalve Arctica islandica is extremely long lived (>400 years) and can tolerate long periods of hypoxia and anoxia. European populations differ in maximum life spans (MLSP) from 40 years in the Baltic to >400 years around Iceland. Characteristic behavior of A. islandica involves phases of metabolic rate depression (MRD) during which the animals burry into the sediment for several days. During these phases the shell water oxygen concentrations reaches hypoxic to anoxic levels, which possibly support the long life span of some populations. We investigated gene regulation in A. islandica from a long-lived (MLSP 150 years) German Bight population and the short-lived Baltic Sea population, experimentally exposed to different oxygen levels. A new A. islandica transcriptome enabled the identification of genes important during hypoxia/anoxia events and, more generally, gene mining for putative stress response and (anti-) aging genes. Expression changes of a) antioxidant defense: Catalase, Glutathione peroxidase, manganese and copper-zinc Superoxide dismutase; b) oxygen sensing and general stress response: Hypoxia inducible factor alpha, Prolyl hydroxylase and Heat-shock protein 70; and c) anaerobic capacity: Malate dehydrogenase and Octopine dehydrogenase, related transcripts were investigated. Exposed to low oxygen, German Bight individuals suppressed transcription of all investigated genes, whereas Baltic Sea bivalves enhanced gene transcription under anoxic incubation (0 kPa) and, further, decreased these transcription levels again during 6 h of re-oxygenation. Hypoxic and anoxic exposure and subsequent re-oxygenation in Baltic Sea animals did not lead to increased protein oxidation or induction of apoptosis, emphasizing considerable hypoxia/re-oxygenation tolerance in this species. The data suggest that the energy saving effect of MRD may not be an attribute of Baltic Sea A. islandica chronically exposed to high environmental variability (oxygenation, temperature, salinity). Contrary, higher physiological flexibility and stress hardening may predispose these animals to perform a pronounced stress response at the expense of life span.	[Philipp, Eva E. R.; Wessels, Wiebke; Gruber, Heike; Kraemer, Lars; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Strahl, Julia; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Wagner, Anika E.; Ernst, Insa M. A.; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Foodsci, Kiel, Germany	University of Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Kiel	Philipp, EER (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	e.philipp@ikmb.uni-kiel.de; p.rosenstiel@mucosa.de	Rimbach, Gerald/A-7178-2011; Wagner, Anika/AAE-3579-2019; Rosenstiel, Philip/A-5137-2009; Kraemer, Lars/B-9289-2017	Rimbach, Gerald/0000-0001-7888-4684; Wagner, Anika/0000-0003-3047-7128; Rosenstiel, Philip/0000-0002-9692-8828; Kraemer, Lars/0000-0002-0586-8357; Abele, Doris/0000-0002-5766-5017	Medical Faculty Kiel; DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces"; German Research Foundation (DFG) priority programme "Host-parasite co-evolution", Genomics Analysis platform [1399]	Medical Faculty Kiel; DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces"; German Research Foundation (DFG) priority programme "Host-parasite co-evolution", Genomics Analysis platform(German Research Foundation (DFG))	This research was supported by the Medical Faculty Kiel, the DFG clusters of Excellence "The Future Ocean" and "Inflammation at Interfaces", and the German Research Foundation (DFG) priority programme 1399 "Host-parasite co-evolution", Genomics Analysis platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2002, NATURE, V420, P27, DOI 10.1038/420027a; Abele D, 2011, TEMPERATURE ADAPTATI, P67; Abele D, 2008, FREE RADICAL RES, V42, P474, DOI 10.1080/10715760802108849; Abele D, 2007, FRONT BIOSCI-LANDMRK, V12, P933, DOI 10.2741/2115; Abele D, 2010, CAN J FISH AQUAT SCI, V67, P977, DOI 10.1139/F10-035; Altieri AH, 2006, MAR ECOL PROG SER, V325, P295, DOI 10.3354/meps325295; [Anonymous], 2008, AQUACULTURE, DOI DOI 10.1016/j.aquaculture.2008.03.041; Basova L, 2012, AQUAT BIOL, V14, P141, DOI 10.3354/ab00387; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Buttemer WA, 2010, FUNCTIONAL ECOLOGY, V9999; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; FELBECK H, 1980, COMP BIOCHEM PHYS B, V66, P205, DOI 10.1016/0305-0491(80)90054-1; Gorr TA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P733, DOI 10.1086/648581; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Greenway SC, 1999, J EXP MAR BIOL ECOL, V242, P259, DOI 10.1016/S0022-0981(99)00103-3; Greenway SC, 2000, J COMP PHYSIOL B, V170, P285, DOI 10.1007/s003600000098; Hermes-Lima M, 1998, COMP BIOCHEM PHYS B, V120, P437, DOI 10.1016/S0305-0491(98)10053-6; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hicks DW, 2005, J MOLLUS STUD, V71, P401, DOI 10.1093/mollus/eyi042; Hiebenthal C, 2012, AQUAT BIOL, V14, P289, DOI 10.3354/ab00405; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ivanina AV, 2010, AQUAT TOXICOL, V99, P330, DOI 10.1016/j.aquatox.2010.05.013; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Larade K, 2002, CELL MOL RESPONSES S; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Mangel M, 2008, FUNCT ECOL, V22, P422, DOI 10.1111/j.1365-2435.2008.01410.x; Morley SA, 2007, OECOLOGIA, V153, P29, DOI 10.1007/s00442-007-0720-4; OESCHGER R, 1990, MAR ECOL PROG SER, V59, P133, DOI 10.3354/meps059133; Philipp EER, 2012, BIOINFORMATICS; Philipp EER, 2010, GERONTOLOGY, V56, P55, DOI 10.1159/000221004; Piontkivska H, 2010, COMP BIOCH PHYSL D; PORTNER HO, 1984, MAR BIOL, V79, P237, DOI 10.1007/BF00393255; Ramnanan CJ, 2009, MOL CELL BIOCHEM, V323, P9, DOI 10.1007/s11010-008-9959-2; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; REGNOUF F, 1970, COMP BIOCHEM PHYSIOL, V32, P411, DOI 10.1016/0010-406X(70)90458-5; Rimoldi S, 2012, MOL BIOL REP, V39, P4009, DOI 10.1007/s11033-011-1181-8; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumohr H, 2001, DIFFERENT FACES ANOX, P273; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sonanez-Organis JG, 2009, COMP BIOCHEM PHYS C, V150, P395, DOI 10.1016/j.cbpc.2009.06.005; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008; Strahl J, 2011, J EXP BIOL, V214, P4223, DOI 10.1242/jeb.055178; Strahl J, 2011, COMP BIOCHEM PHYS A, V158, P513, DOI 10.1016/j.cbpa.2010.12.015; Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6; TAYLOR AC, 1976, J MAR BIOL ASSOC UK, V56, P95, DOI 10.1017/S0025315400020464; THEEDE H, 1969, MAR BIOL, V2, P325, DOI 10.1007/BF00355712; Tschischka K, 2000, J EXP BIOL, V203, P3355; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; Wanamaker AD, 2008, RADIOCARBON, V50, P399, DOI 10.1017/S0033822200053510; WEIGELT M, 1986, MEERESFORSCHUNG, V31, P124; WEIGELT M, 1990, MEERESFORSCHUNG, V33, P1; WITBAARD R, 1994, NETH J SEA RES, V33, P91, DOI 10.1016/0077-7579(94)90054-X; ZAMMIT VA, 1976, BIOCHEM J, V160, P447, DOI 10.1042/bj1600447; Ziuganov V V, 2004, Adv Gerontol, V14, P21	65	38	38	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44621	10.1371/journal.pone.0044621	http://dx.doi.org/10.1371/journal.pone.0044621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028566	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400029
J	Varlet, M; Marin, L; Issartel, J; Schmidt, RC; Bardy, BG				Varlet, Manuel; Marin, Ludovic; Issartel, Johann; Schmidt, R. C.; Bardy, Benoit G.			Continuity of Visual and Auditory Rhythms Influences Sensorimotor Coordination	PLOS ONE			English	Article							MOTOR TRACKING; SYNCHRONIZATION; MOVEMENT; DYNAMICS; INFORMATION; TRANSITIONS; SEQUENCES; RESPONSES; VELOCITY; FEEDBACK	People often coordinate their movement with visual and auditory environmental rhythms. Previous research showed better performances when coordinating with auditory compared to visual stimuli, and with bimodal compared to unimodal stimuli. However, these results have been demonstrated with discrete rhythms and it is possible that such effects depend on the continuity of the stimulus rhythms (i.e., whether they are discrete or continuous). The aim of the current study was to investigate the influence of the continuity of visual and auditory rhythms on sensorimotor coordination. We examined the dynamics of synchronized oscillations of a wrist pendulum with auditory and visual rhythms at different frequencies, which were either unimodal or bimodal and discrete or continuous. Specifically, the stimuli used were a light flash, a fading light, a short tone and a frequency-modulated tone. The results demonstrate that the continuity of the stimulus rhythms strongly influences visual and auditory motor coordination. Participants' movement led continuous stimuli and followed discrete stimuli. Asymmetries between the half-cycles of the movement in term of duration and nonlinearity of the trajectory occurred with slower discrete rhythms. Furthermore, the results show that the differences of performance between visual and auditory modalities depend on the continuity of the stimulus rhythms as indicated by movements closer to the instructed coordination for the auditory modality when coordinating with discrete stimuli. The results also indicate that visual and auditory rhythms are integrated together in order to better coordinate irrespective of their continuity, as indicated by less variable coordination closer to the instructed pattern. Generally, the findings have important implications for understanding how we coordinate our movements with visual and auditory environmental rhythms in everyday life.	[Varlet, Manuel; Marin, Ludovic; Bardy, Benoit G.] Univ Montpellier I, EuroMov, Montpellier, France; [Issartel, Johann] Dublin City Univ, Dublin 9, Ireland; [Schmidt, R. C.] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA	Universite de Montpellier; Dublin City University; College of the Holy Cross	Varlet, M (corresponding author), Univ Montpellier I, EuroMov, Montpellier, France.	manuel.varlet@gmail.com	Bardy, Benoît/AAU-3078-2021	Bardy, Benoit/0000-0001-9272-1734; Varlet, Manuel/0000-0001-5772-2061; Marin, Ludovic/0000-0002-9040-8012	SKILLS, an Integrated Project (FP6-IST) of the Commission of the European Community [035005]; Agence Nationale de la Recherche [ANR-09-BLAN-0405-01]	SKILLS, an Integrated Project (FP6-IST) of the Commission of the European Community; Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by SKILLS, an Integrated Project (FP6-IST contract #035005) of the Commission of the European Community and by an Agence Nationale de la Recherche grant (Project SCAD # ANR-09-BLAN-0405-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Balasubramaniam R, 2004, EXP BRAIN RES, V159, P129, DOI 10.1007/s00221-004-2066-z; Bald L, 1942, J APPL PSYCHOL, V26, P382, DOI 10.1037/h0059216; Batschelet E, 1981, CIRCULAR STAT BIOL; BEEK PJ, 1988, HUM MOVEMENT SCI, V7, P301, DOI 10.1016/0167-9457(88)90015-2; Buekers MJ, 2000, NEUROSCI LETT, V290, P181, DOI 10.1016/S0304-3940(00)01350-1; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; BYBLOW WD, 1995, J MOTOR BEHAV, V27, P123, DOI 10.1080/00222895.1995.9941705; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; de Rugy A, 2008, EXP BRAIN RES, V184, P269, DOI 10.1007/s00221-007-1180-0; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso JAS, 2001, P ROY SOC B-BIOL SCI, V268, P1207; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P150, DOI 10.1037/0096-1523.11.2.150; Lagarde J, 2006, EXP BRAIN RES, V173, P673, DOI 10.1007/s00221-006-0410-1; McAnally KI, 2002, ACTA PSYCHOL, V109, P331, DOI 10.1016/S0001-6918(01)00065-8; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; MYERS AK, 1981, PERCEPT PSYCHOPHYS, V30, P33, DOI 10.3758/BF03206134; Peper CLE, 1998, BIOL CYBERN, V79, P291, DOI 10.1007/s004220050479; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2003, J MOTOR BEHAV, V35, P355, DOI 10.1080/00222890309603156; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Roerdink M, 2005, HUM MOVEMENT SCI, V24, P379, DOI 10.1016/j.humov.2005.06.007; Roerdink M, 2008, EXP BRAIN RES, V184, P143, DOI 10.1007/s00221-007-1085-y; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Torre K, 2008, ACTA PSYCHOL, V129, P284, DOI 10.1016/j.actpsy.2008.08.003; Torre K, 2010, MOTOR CONTROL, V14, P323, DOI 10.1123/mcj.14.3.323; Torre K, 2009, EXP BRAIN RES, V199, P157, DOI 10.1007/s00221-009-1991-2; Varlet M, HUM MOV SCI IN PRESS; WARREN DH, 1981, PERCEPT PSYCHOPHYS, V30, P557, DOI 10.3758/BF03202010; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G; Wing AM, 2010, EXP BRAIN RES, V200, P277, DOI 10.1007/s00221-009-2134-5; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	48	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44082	10.1371/journal.pone.0044082	http://dx.doi.org/10.1371/journal.pone.0044082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028488	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400017
J	Yamauchi, M; Yamaguchi, R; Nakata, A; Kohno, T; Nagasaki, M; Shimamura, T; Imoto, S; Saito, A; Ueno, K; Hatanaka, Y; Yoshida, R; Higuchi, T; Nomura, M; Beer, DG; Yokota, J; Miyano, S; Gotoh, N				Yamauchi, Mai; Yamaguchi, Rui; Nakata, Asuka; Kohno, Takashi; Nagasaki, Masao; Shimamura, Teppei; Imoto, Seiya; Saito, Ayumu; Ueno, Kazuko; Hatanaka, Yousuke; Yoshida, Ryo; Higuchi, Tomoyuki; Nomura, Masaharu; Beer, David G.; Yokota, Jun; Miyano, Satoru; Gotoh, Noriko			Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma	PLOS ONE			English	Article							SIGNATURES; INHIBITORS	Purpose: To identify stage I lung adenocarcinoma patients with a poor prognosis who will benefit from adjuvant therapy. Patients and Methods: Whole gene expression profiles were obtained at 19 time points over a 48-hour time course from human primary lung epithelial cells that were stimulated with epidermal growth factor (EGF) in the presence or absence of a clinically used EGF receptor tyrosine kinase (RTK)-specific inhibitor, gefitinib. The data were subjected to a mathematical simulation using the State Space Model (SSM). "Gefitinib-sensitive" genes, the expressional dynamics of which were altered by addition of gefitinib, were identified. A risk scoring model was constructed to classify high- or low-risk patients based on expression signatures of 139 gefitinib-sensitive genes in lung cancer using a training data set of 253 lung adenocarcinomas of North American cohort. The predictive ability of the risk scoring model was examined in independent cohorts of surgical specimens of lung cancer. Results: The risk scoring model enabled the identification of high-risk stage IA and IB cases in another North American cohort for overall survival (OS) with a hazard ratio (HR) of 7.16 (P = 0.029) and 3.26 (P = 0.0072), respectively. It also enabled the identification of high-risk stage I cases without bronchioalveolar carcinoma (BAC) histology in a Japanese cohort for OS and recurrence-free survival (RFS) with HRs of 8.79 (P = 0.001) and 3.72 (P = 0.0049), respectively. Conclusion: The set of 139 gefitinib-sensitive genes includes many genes known to be involved in biological aspects of cancer phenotypes, but not known to be involved in EGF signaling. The present result strongly re-emphasizes that EGF signaling status in cancer cells underlies an aggressive phenotype of cancer cells, which is useful for the selection of early-stage lung adenocarcinoma patients with a poor prognosis.	[Yamauchi, Mai; Nakata, Asuka; Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo, Japan; [Yamaguchi, Rui; Nagasaki, Masao; Shimamura, Teppei; Imoto, Seiya; Saito, Ayumu; Ueno, Kazuko; Hatanaka, Yousuke; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Yoshida, Ryo; Higuchi, Tomoyuki] Inst Stat Math, Tachikawa, Tokyo, Japan; [Nomura, Masaharu] Tokyo Med Univ, Dept Thorac Surg, Shinjuku Ku, Tokyo, Japan; [Beer, David G.] Univ Michigan, Dept Surg, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Chuo Ku, Tokyo 104, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Tokyo Medical University; University of Michigan System; University of Michigan; National Cancer Center - Japan	Gotoh, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo, Japan.	ngotoh@ims.u-tokyo.ac.jp	GOTOH, Noriko/D-8430-2015	Miyano, Satoru/0000-0002-1753-6616; Nagasaki, Masao/0000-0002-4292-8785; Gotoh, Noriko/0000-0003-3733-260X; Shimamura, Teppei/0000-0003-2994-872X	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan [22130009]; Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan; National Cancer Center Research and Development Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan; National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by a grant for the 3rd-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/) to JY, TK, and NG, by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan (http://www.mext.go.jp/english/) to NG (22130009), by Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT of Japan (http://www.mext.go.jp/english/) to SM, and by the National Cancer Center Research and Development Fund to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Liang Yulan, 2006, Functional & Integrative Genomics, V6, P1, DOI 10.1007/s10142-005-0006-z; Okayama H, 2012, CANCER RES IN PRESS; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yamaguchi R, 2008, GENOME INFORM SER, V21, P101; Yamauchi M, 2009, BIOMARK MED, V3, P139, DOI 10.2217/BMM.09.9; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	23	104	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e43923	10.1371/journal.pone.0043923	http://dx.doi.org/10.1371/journal.pone.0043923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028479	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400015
J	De Ingeniis, J; Ratnikov, B; Richardson, AD; Scott, DA; Aza-Blanc, P; De, SK; Kazanov, M; Pellecchia, M; Ronai, Z; Osterman, AL; Smith, JW				De Ingeniis, Jessica; Ratnikov, Boris; Richardson, Adam D.; Scott, David A.; Aza-Blanc, Pedro; De, Surya K.; Kazanov, Marat; Pellecchia, Maurizio; Ronai, Ze'ev; Osterman, Andrei L.; Smith, Jeffrey W.			Functional Specialization in Proline Biosynthesis of Melanoma	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BREAST-CANCER; OXIDASE; APOPTOSIS; METABOLISM; PYRROLINE-5-CARBOXYLATE; OVEREXPRESSION; STIMULATION; EXPRESSION; GENERATION	Proline metabolism is linked to hyperprolinemia, schizophrenia, cutis laxa, and cancer. In the latter case, tumor cells tend to rely on proline biosynthesis rather than salvage. Proline is synthesized from either glutamate or ornithine; both are converted to pyrroline-5-carboxylate (P5C), and then to proline via pyrroline-5-carboxylate reductases (PYCRs). Here, the role of three isozymic versions of PYCR was addressed in human melanoma cells by tracking the fate of C-13-labeled precursors. Based on these studies we conclude that PYCR1 and PYCR2, which are localized in the mitochondria, are primarily involved in conversion of glutamate to proline. PYCRL, localized in the cytosol, is exclusively linked to the conversion of ornithine to proline. This analysis provides the first clarification of the role of PYCRs to proline biosynthesis.	[De Ingeniis, Jessica; Ratnikov, Boris; Richardson, Adam D.; Scott, David A.; Aza-Blanc, Pedro; De, Surya K.; Kazanov, Marat; Pellecchia, Maurizio; Ronai, Ze'ev; Osterman, Andrei L.; Smith, Jeffrey W.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	De Ingeniis, J (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	jsmith@sanfordburnham.org	Richardson, Adam D/N-7845-2014; Pellecchia, Maurizio/Y-7072-2018; Kazanov, Marat D/D-6381-2013	Richardson, Adam D/0000-0003-3646-2584; Kazanov, Marat D/0000-0002-2314-5507; RONAI, ZEEV/0000-0002-3859-0400; De, SURYA/0000-0001-5014-0798; Scott, David/0000-0002-8668-2449	National Institutes of Health [PO1CA128814]; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1CA128814 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOER P, 1991, BIOCHEM MED METAB B, V46, P28, DOI 10.1016/0885-4505(91)90047-O; Bunk B, 2006, BIOINFORMATICS, V22, P2962, DOI 10.1093/bioinformatics/btl526; Donald SP, 2001, CANCER RES, V61, P1810; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Kretz R, 2011, J INHERIT METAB DIS, V34, P731, DOI 10.1007/s10545-011-9319-3; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Meng ZH, 2006, J MOL BIOL, V359, P1364, DOI 10.1016/j.jmb.2006.04.053; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Satyamoorthy K, 2003, CANCER RES, V63, P756; Scott DA, 2011, J BIOL CHEM; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X	32	87	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45190	10.1371/journal.pone.0045190	http://dx.doi.org/10.1371/journal.pone.0045190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024808	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100066
J	Fuentes, EN; Ruiz, P; Valdes, JA; Molina, A				Fuentes, Eduardo N.; Ruiz, Pamela; Antonio Valdes, Juan; Molina, Alfredo			Catabolic Signaling Pathways, Atrogenes, and Ubiquitinated Proteins Are Regulated by the Nutritional Status in the Muscle of the Fine Flounder	PLOS ONE			English	Article							GROWTH-FACTOR-I; SKELETAL-MUSCLE; GENE-EXPRESSION; LIGASE ATROGIN1/MAFBX; PROTEASOME PATHWAY; ATROPHY; PROTEOLYSIS; ATROGIN-1; INSULIN; TARGET	A description of the intracellular mechanisms that modulate skeletal muscle atrophy in early vertebrates is still lacking. In this context, we used the fine flounder, a unique and intriguing fish model, which exhibits remarkably slow growth due to low production of muscle-derived IGF-I, a key growth factor that has been widely acknowledged to prevent and revert muscle atrophy. Key components of the atrophy system were examined in this species using a detailed time-course of sampling points, including two contrasting nutritional periods. Under basal conditions high amounts of the atrogenes MuRF-1 and Atrogin-1 were observed. During fasting, the activation of the P38/MAPK and Akt/FoxO signaling pathways decreased; whereas, the activation of the I kappa B alpha/NF kappa B pathway increased. These changes in signal transduction activation were concomitant with a strong increase in MuRF-1, Atrogin-1, and protein ubiquitination. During short-term refeeding, the P38/MAPK and Akt/FoxO signaling pathways were strongly activated, whereas the activation of the I kappa B alpha/NF kappa B pathway decreased significantly. The expression of both atrogenes, as well as the ubiquitination of proteins, dropped significantly during the first hour of refeeding, indicating a strong anti-atrophic condition during the onset of refeeding. During long-term refeeding, Akt remained activated at higher than basal levels until the end of refeeding, and Atrogin-1 expression remained significantly lower during this period. This study shows that the components of the atrophy system in skeletal muscle appeared early in the evolution of vertebrates and some mechanisms have been conserved, whereas others have not. These results represent an important achievement for the area of fish muscle physiology, showing an integrative view of the atrophy system in a non-mammalian species and contributing to novel insights on the molecular basis of muscle growth regulation in earlier vertebrates.	[Fuentes, Eduardo N.; Ruiz, Pamela; Antonio Valdes, Juan; Molina, Alfredo] Univ Andres Bello, Fac Biol, Dept Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile	Universidad Andres Bello	Fuentes, EN (corresponding author), Univ Andres Bello, Fac Biol, Dept Ciencias Biol, Lab Biotecnol Mol, Santiago, Chile.	amolina@unab.cl	Molina, Alfredo/K-5531-2015; Fuentes, Eduardo/G-1290-2014	Fuentes, Eduardo/0000-0001-7400-8548; Ruiz, Pamela/0000-0003-0093-4439	Universidad Andres Research Bello Fund [DI-14-11/I]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1090416]	Universidad Andres Research Bello Fund; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1090416 (to AM) and Universidad Andres Research Bello Fund DI-14-11/I (to ENF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaix D, 2001, CURR OPIN CLIN NUTR, V4, P45, DOI 10.1097/00075197-200101000-00009; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, BIOCHEM BIOPH RES CO, V396, P265, DOI 10.1016/j.bbrc.2010.04.076; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cleveland BM, 2010, AM J PHYSIOL-REG I, V298, pR341, DOI 10.1152/ajpregu.00516.2009; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Fuentes EN, 2012, ENDOCRINOLOGY, V153, P283, DOI 10.1210/en.2011-1313; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; JOHNSTON IA, 1982, COMP BIOCHEM PHYS B, V73, P105, DOI 10.1016/0305-0491(82)90204-8; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lin YC, 2011, FISH PHYSIOL BIOCHEM, V37, P977, DOI 10.1007/s10695-011-9502-3; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Safian D, 2012, J ENDOCRINOL, V214, P95, DOI 10.1530/JOE-12-0057; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2010, J PROTEOMICS, V73, P778, DOI 10.1016/j.jprot.2009.10.014; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; STICKLAND NC, 1983, J ANAT, V137, P323; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tacchi L, 2010, COMP BIOCHEM PHYS B, V157, P364, DOI 10.1016/j.cbpb.2010.08.004; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	34	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44256	10.1371/journal.pone.0044256	http://dx.doi.org/10.1371/journal.pone.0044256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024748	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100006
J	Payne, CJ; Jessop, TS; Guay, PJ; Johnstone, M; Feore, M; Mulder, RA				Payne, Catherine J.; Jessop, Tim S.; Guay, Patrick-Jean; Johnstone, Michele; Feore, Megan; Mulder, Raoul A.			Population, Behavioural and Physiological Responses of an Urban Population of Black Swans to an Intense Annual Noise Event	PLOS ONE			English	Article							HUMAN DISTURBANCE; STRESS-RESPONSE; LIFE-HISTORY; ENERGY-EXPENDITURE; FLIGHT DISTANCE; PENGUINS; EXPOSURE; ECOLOGY; BIRDS; WILD	Wild animals in urban environments are exposed to a broad range of human activities that have the potential to disturb their life history and behaviour. Wildlife responses to disturbance can range from emigration to modified behaviour, or elevated stress, but these responses are rarely evaluated in concert. We simultaneously examined population, behavioural and hormonal responses of an urban population of black swans Cygnus atratus before, during and after an annual disturbance event involving large crowds and intense noise, the Australian Formula One Grand Prix. Black swan population numbers were lowest one week before the event and rose gradually over the course of the study, peaking after the event, suggesting that the disturbance does not trigger mass emigration. We also found no difference in the proportion of time spent on key behaviours such as locomotion, foraging, resting or self-maintenance over the course of the study. However, basal and capture stress-induced corticosterone levels showed significant variation, consistent with a modest physiological response. Basal plasma corticosterone levels were highest before the event and decreased over the course of the study. Capture-induced stress levels peaked during the Grand Prix and then also declined over the remainder of the study. Our results suggest that even intensely noisy and apparently disruptive events may have relatively low measurable short-term impact on population numbers, behaviour or physiology in urban populations with apparently high tolerance to anthropogenic disturbance. Nevertheless, the potential long-term impact of such disturbance on reproductive success, individual fitness and population health will need to be carefully evaluated.	[Payne, Catherine J.; Jessop, Tim S.; Johnstone, Michele; Feore, Megan; Mulder, Raoul A.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Guay, Patrick-Jean] Victoria Univ, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia	University of Melbourne; Victoria University	Payne, CJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	r.mulder@unimelb.edu.au	Jessop, Tim/Q-2473-2019; Jessop, Tim/I-6647-2012	Jessop, Tim S./0000-0002-7712-4373	Department of Zoology of the University of Melbourne; Victoria University fellowship	Department of Zoology of the University of Melbourne; Victoria University fellowship	Funding was provided by the Department of Zoology of the University of Melbourne and a Victoria University fellowship to P.J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen R, 1996, BIOL CONSERV, V77, P169, DOI 10.1016/0006-3207(96)00004-3; Barja I, 2007, J STEROID BIOCHEM, V104, P136, DOI 10.1016/j.jsbmb.2007.03.008; BATTEN L A, 1977, Biological Conservation, V11, P49, DOI 10.1016/0006-3207(77)90027-1; Bechet A, 2004, J APPL ECOL, V41, P689, DOI 10.1111/j.0021-8901.2004.00928.x; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Conomy JT, 1998, J WILDLIFE MANAGE, V62, P1135, DOI 10.2307/3802568; Crino OL, 2011, GEN COMP ENDOCR, V173, P323, DOI 10.1016/j.ygcen.2011.06.001; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Donaldson Michael R., 2007, Urban Ecosystems, V10, P139, DOI 10.1007/s11252-006-0015-2; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2000, BIRD STUDY, V47, P13, DOI 10.1080/00063650009461156; Finney SK, 2005, BIOL CONSERV, V121, P53, DOI 10.1016/j.biocon.2004.04.009; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; Frid A, 2002, CONSERV ECOL, V6; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guay PJ, 2009, EMU, V109, P248, DOI 10.1071/MU09020; HENSON P, 1991, WILDLIFE SOC B, V19, P248; Hill D, 1997, J APPL ECOL, V34, P275, DOI 10.2307/2404876; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Kitchen Kim, 2010, Australian Field Ornithology, V27, P1; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lowry H, 2011, ETHOLOGY, V117, P490, DOI 10.1111/j.1439-0310.2011.01902.x; Manor R, 2005, J WILDLIFE MANAGE, V69, P1683, DOI 10.2193/0022-541X(2005)69[1683:EOHDOU]2.0.CO;2; Martin JGA, 2008, BEHAV PROCESS, V77, P66, DOI 10.1016/j.beproc.2007.06.004; McClung MR, 2004, BIOL CONSERV, V119, P279, DOI 10.1016/j.biocon.2003.11.012; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Monaghan P, 2011, P ROYAL SOC B; MONIE L, 2011, THESIS VICTORIA U ST; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; Nisbet ICT, 2000, WATERBIRDS, V23, P312; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; Paton DC, 2000, DISTURBANCE DISTANCE; Regel J, 1997, POLAR BIOL, V18, P246, DOI 10.1007/s003000050185; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Riddington R, 1996, BIRD STUDY, V43, P269, DOI 10.1080/00063659609461019; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; URQUHART J, 1984, ANNU REV PHARMACOL, V24, P199; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x; Webb NV, 2005, CONDOR, V107, P178, DOI 10.1650/7607; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; WINGFIELD JC, 1995, AM ZOOL, V35, P285; Wright AJ, 2007, INT J COMP PSYCHOL, V20	57	18	18	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45014	10.1371/journal.pone.0045014	http://dx.doi.org/10.1371/journal.pone.0045014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AD	23024783	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308860100041
J	van Sighem, A; Vidondo, B; Glass, TR; Bucher, HC; Vernazza, P; Gebhardt, M; de Wolf, F; Derendinger, S; Jeannin, A; Bezemer, D; Fraser, C; Low, N				van Sighem, Ard; Vidondo, Beatriz; Glass, Tracy R.; Bucher, Heiner C.; Vernazza, Pietro; Gebhardt, Martin; de Wolf, Frank; Derendinger, Steven; Jeannin, Andre; Bezemer, Daniela; Fraser, Christophe; Low, Nicola		Swiss HIV Cohort Study	Resurgence of HIV Infection among Men Who Have Sex with Men in Switzerland: Mathematical Modelling Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRANSMISSION; EPIDEMIC; PREVENTION; HIV/AIDS; BEHAVIOR	Background: New HIV infections in men who have sex with men (MSM) have increased in Switzerland since 2000 despite combination antiretroviral therapy (cART). The objectives of this mathematical modelling study were: to describe the dynamics of the HIV epidemic in MSM in Switzerland using national data; to explore the effects of hypothetical prevention scenarios; and to conduct a multivariate sensitivity analysis. Methodology/Principal Findings: The model describes HIV transmission, progression and the effects of cART using differential equations. The model was fitted to Swiss HIV and AIDS surveillance data and twelve unknown parameters were estimated. Predicted numbers of diagnosed HIV infections and AIDS cases fitted the observed data well. By the end of 2010, an estimated 13.5% (95% CI 12.5, 14.6%) of all HIV-infected MSM were undiagnosed and accounted for 81.8% (95% CI 81.1, 82.4%) of new HIV infections. The transmission rate was at its lowest from 1995-1999, with a nadir of 46 incident HIV infections in 1999, but increased from 2000. The estimated number of new infections continued to increase to more than 250 in 2010, although the reproduction number was still below the epidemic threshold. Prevention scenarios included temporary reductions in risk behaviour, annual test and treat, and reduction in risk behaviour to levels observed earlier in the epidemic. These led to predicted reductions in new infections from 2 to 26% by 2020. Parameters related to disease progression and relative infectiousness at different HIV stages had the greatest influence on estimates of the net transmission rate. Conclusions/Significance: The model outputs suggest that the increase in HIV transmission amongst MSM in Switzerland is the result of continuing risky sexual behaviour, particularly by those unaware of their infection status. Long term reductions in the incidence of HIV infection in MSM in Switzerland will require increased and sustained uptake of effective interventions.	[van Sighem, Ard; de Wolf, Frank; Bezemer, Daniela] Stichting HIV Monitoring, Amsterdam, Netherlands; [Vidondo, Beatriz; Gebhardt, Martin; Derendinger, Steven] Swiss Fed Off Publ Hlth, Div Communicable Dis, Bern, Switzerland; [Vidondo, Beatriz; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Glass, Tracy R.; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Vernazza, Pietro] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Jeannin, Andre] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London, England	University of Bern; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Kantonsspital St. Gallen; Imperial College London; University of Lausanne; Imperial College London	van Sighem, A (corresponding author), Stichting HIV Monitoring, Amsterdam, Netherlands.	low@ispm.unibe.ch	Fraser, Christophe/A-8109-2008; Pantaleo, Giuseppe/K-6163-2016; Glass, Tracy R/D-5046-2017; Low, Nicola/H-4718-2019	Fraser, Christophe/0000-0003-2399-9657; Glass, Tracy R/0000-0001-7075-9803; Low, Nicola/0000-0003-4817-8986; Vidondo, Beatriz/0000-0001-9693-2301	Swiss School of Public Health; Swiss Federal Office of Public Health; Dutch Ministry of Health; UK Medical Research Council; Royal Society; MRC [G0600719, G0800596] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B, G0800596] Funding Source: researchfish	Swiss School of Public Health; Swiss Federal Office of Public Health; Dutch Ministry of Health; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received support from the Swiss School of Public Health plus (www.ssphplus.ch) and the Swiss Federal Office of Public Health (http://www.bag.admin.ch/aktuell/); Stichting HIV Monitoring (HIV Monitoring Foundation) is financed by the Dutch Ministry of Health (www.rijksoverheid.nl); Christophe Fraser receives funding from the UK Medical Research Council (www.mrc.ac.uk) and the Royal Society (www.royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Balthasar H, 2007, INT J PUBLIC HEALTH, V52, P27, DOI 10.1007/s00038-006-5086-6; Balthasar H, 2010, JAIDS-J ACQ IMM DEF, V54, P542, DOI 10.1097/QAI.0b013e3181e19a6b; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Cairns G, 2011, HIV PREVALENCE IS CA; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Daneel S, 2008, SWISS MED WKLY, V138, P453, DOI 2008/31/smw-12007; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Glass TR, 2004, AIDS, V18, P1707, DOI 10.1097/01.aids.0000131396.21963.81; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Heijman T, 2011, AIDS S4, DOI [10.1097/QAD.0b013e32834f9d7c, DOI 10.1097/QAD.0B013E32834F9D7C]; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Imhof C, 2010, BAG B, V40, P863; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lambert PC, 2007, BIOSTATISTICS, V8, P576, DOI 10.1093/biostatistics/kxl030; Lociciro S, 2010, COMPORTEMENTS FACE V; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mayer KH, 2011, CLIN INFECT DIS, V52, P1371, DOI 10.1093/cid/cir206; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; Staub R, 2009, MED REV, V10, P12; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Swiss Federal Office for Public Health, 2011, BAG B, V12, P253; Swiss Federal Office of Public Health, 2011, HIV AIDS SCHWEIZ 201; Van de Ven P, 2000, AIDS, V14, P2951, DOI 10.1097/00002030-200012220-00023; van Sighem A, 2011, MONITORING REPORT 20; Ward H, 2007, CLIN INFECT DIS, V44, P26, DOI 10.1086/509922; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649	36	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44819	10.1371/journal.pone.0044819	http://dx.doi.org/10.1371/journal.pone.0044819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024766	Green Published, gold, Green Accepted			2022-12-25	WOS:000308860100024
J	Ducreux, S; Gregory, P; Schwaller, B				Ducreux, Sylvie; Gregory, Patrick; Schwaller, Beat			Inverse Regulation of the Cytosolic Ca2+ Buffer Parvalbumin and Mitochondrial Volume in Muscle Cells via SIRT1/PGC-1 alpha Axis	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SKELETAL-MUSCLE; CALBINDIN D-28K; GENE-EXPRESSION; TWITCH MUSCLE; FIBER-TYPE; PGC-1-ALPHA; SIRT1; DEFICIENCY; KINASE	Skeletal muscles show a high plasticity to cope with various physiological demands. Different muscle types can be distinguished by the force, endurance, contraction/relaxation kinetics (fast-twitch vs. slow-twitch muscles), oxidative/glycolytic capacity, and also with respect to Ca2+-signaling components. Changes in Ca2+ signaling and associated Ca2+-dependent processes are thought to underlie the high adaptive capacity of muscle fibers. Here we investigated the consequences and the involved mechanisms caused by the ectopic expression of the Ca2+-binding protein parvalbumin (PV) in C2C12 myotubes in vitro, and conversely, the effects caused by its absence in in fast-twitch muscles of parvalbumin null-mutant (PV-/-) mice in vivo. The absence of PV in fast-twitch muscle tibialis anterior (TA) resulted in an increase in the peroxisome proliferator-activated receptor c coactivator 1 alpha (PGC-1 alpha) and of its positive regulator, the deacetylase sirtuin 1 (SIRT1). TA muscles from PV-/- mice also have an increased mitochondrial volume. Mild ionophore treatment of control (PV-devoid) C2C12 myotubes causing a moderate elevation in [Ca2+](c) resulted in an increase in mitochondrial volume, together with elevated PGC-1 alpha and SIRT1 expression levels, whilst it increased PV expression levels in myotubes stably transfected with PV. In PV-expressing myotubes the mitochondrial volume, PGC-1 alpha and SIRT1 were significantly lower than in control C2C12 myotubes already at basal conditions and application of ionophore had no effect on either one. SIRT1 activation causes a down-regulation of PV in transfected myotubes, whilst SIRT1 inhibition has the opposite effect. We conclude that PV expression and mitochondrial volume in muscle cells are inversely regulated via a SIRT1/PGC-1 alpha signaling axis.	[Ducreux, Sylvie; Gregory, Patrick; Schwaller, Beat] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Ducreux, S (corresponding author), Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland.	Beat.Schwaller@unifr.ch	DUCREUX, SYLVIE/D-6257-2013	DUCREUX, SYLVIE/0000-0003-3207-9537; Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 113518]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (grants #130680 and #113518 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Allen DL, 2002, J BIOL CHEM, V277, P45323, DOI 10.1074/jbc.M208302200; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arif SH, 2009, BIOESSAYS, V31, P410, DOI 10.1002/bies.200800170; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Chen G, 2006, NEUROSCIENCE, V142, P97, DOI 10.1016/j.neuroscience.2006.06.008; Chen GP, 2001, AM J PHYSIOL-CELL PH, V281, pC114, DOI 10.1152/ajpcell.2001.281.1.C114; Chen M, 2010, BIOCHEM BIOPH RES CO, V396, P894, DOI 10.1016/j.bbrc.2010.05.018; Chin ER, 2004, P NUTR SOC, V63, P279, DOI 10.1079/PNS2004335; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; D'Orlando C, 2002, BRAIN RES, V945, P181, DOI 10.1016/S0006-8993(02)02753-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; Day SM, 2008, PHYSIOL GENOMICS, V33, P312, DOI 10.1152/physiolgenomics.00302.2007; Farre-Castany MA, 2007, BEHAV BRAIN RES, V178, P250, DOI 10.1016/j.bbr.2007.01.002; Freyssenet D, 1999, J BIOL CHEM, V274, P9305, DOI 10.1074/jbc.274.14.9305; Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Kubis HP, 1997, P NATL ACAD SCI USA, V94, P4205, DOI 10.1073/pnas.94.8.4205; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Matsuoka Y, 2008, CELL TISSUE RES, V332, P123, DOI 10.1007/s00441-008-0582-z; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Racay P, 2006, FEBS J, V273, P96, DOI 10.1111/j.1742-4658.2005.05046.x; Rasouri S, 2007, M S-MED SCI, V23, P840, DOI 10.1051/medsci/20072310840; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Saarikettu J, 2004, J BIOL CHEM, V279, P41004, DOI 10.1074/jbc.M408120200; Schmidt U, 2005, CARDIOVASC RES, V66, P318, DOI 10.1016/j.cardiores.2004.06.028; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Schwaller B, BIOCH BIOPHYSICA ACT; Schwaller B., 2010, COLD SPRING HARB PER, V2; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; SRETER FA, 1987, AM J PHYSIOL, V253, pC296, DOI 10.1152/ajpcell.1987.253.2.C296; Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamaguchi T, 2010, AM J PHYSIOL-CELL PH, V298, pC140, DOI 10.1152/ajpcell.00050.2009; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44837	10.1371/journal.pone.0044837	http://dx.doi.org/10.1371/journal.pone.0044837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028640	gold, Green Published, Green Submitted			2022-12-25	WOS:000308788700044
J	Roberts, SK; McAinsh, M; Widdicks, L				Roberts, Stephen K.; McAinsh, Martin; Widdicks, Lisa			Cch1p Mediates Ca2+ Influx to Protect Saccharomyces cerevisiae against Eugenol Toxicity	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; CANDIDA-ALBICANS; CALCIUM; YEAST; AMIODARONE; CHANNEL; STRESS; FLUCONAZOLE; HOMOLOG; RELEASE	Eugenol has antifungal activity and is recognised as having therapeutic potential. However, little is known of the cellular basis of its antifungal activity and a better understanding of eugenol tolerance should lead to better exploitation of eugenol in antifungal therapies. The model yeast, Saccharomyces cerevisiae, expressing apoaequorin was used to show that eugenol induces cytosolic Ca2+ elevations. We investigated the eugenol Ca2+ signature in further detail and show that exponentially growing cells exhibit Ca2+ elevation resulting exclusively from the influx of Ca2+ across the plasma membrane whereas in stationary growth phase cells Ca2+ influx from intracellular and extracellular sources contribute to the eugenol-induced Ca2+ elevation. Ca2+ channel deletion yeast mutants were used to identify the pathways mediating Ca2+ influx; intracellular Ca2+ release was mediated by the vacuolar Ca2+ channel, Yvc1p, whereas the Ca2+ influx across the plasma membrane could be resolved into Cch1p-dependent and Cch1p-independent pathways. We show that the growth of yeast devoid the plasma membrane Ca2+ channel, Cch1p, was hypersensitive to eugenol and that this correlated with reduced Ca2+ elevations. Taken together, these results indicate that a cch1p-mediated Ca2+ influx is part of an intracellular signal which protects against eugenol toxicity. This study provides fresh insight into the mechanisms employed by fungi to tolerate eugenol toxicity which should lead to better exploitation of eugenol in antifungal therapies.	[Roberts, Stephen K.; Widdicks, Lisa] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; Lancaster University	Roberts, SK (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	s.k.roberts@lancaster.ac.uk		roberts, stephen/0000-0003-1740-5330; McAinsh, Martin Robert/0000-0003-4294-6470	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Loukin SH, 2007, FASEB J, V21, P1813, DOI 10.1096/fj.06-7898com; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Maresova L, 2009, J BIOL CHEM, V284, P2795, DOI 10.1074/jbc.M806693200; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Pinontoan R, 2002, BIOSCI BIOTECH BIOCH, V66, P1069, DOI 10.1271/bbb.66.1069; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008	31	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43989	10.1371/journal.pone.0043989	http://dx.doi.org/10.1371/journal.pone.0043989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028482	gold, Green Published, Green Accepted			2022-12-25	WOS:000308788700013
J	De Menna, M; D'Amato, V; Ferraro, A; Fusco, A; Di Lauro, R; Garbi, C; De Vita, G				De Menna, M.; D'Amato, V.; Ferraro, A.; Fusco, A.; Di Lauro, R.; Garbi, C.; De Vita, G.			Wnt4 inhibits cell motility induced by oncogenic Ras	ONCOGENE			English	Article						cancer; cell motility; miR-24; Ras; Wnt4	UP-REGULATION; EXPRESSION; MIGRATION; DIFFERENTIATION; ACTIVATION; PATHWAY; BETA	Aberrant motility and invasive ability are relevant hallmarks of malignant tumor cells. Pathways regulating the movement of cancer cells from the site of primary tumor toward adjacent and/or distant tissues are not entirely defined. By using a model of malignant transformation induced by Ras, we identified Wnt4 as an early target of Ras oncogenic signaling. Here we show that Wnt4 is repressed by Ras and that forced Wnt4 expression inhibits Ras-induced cell motility. Accordingly, we found that Wnt4 is downregulated in human anaplastic thyroid carcinomas, the most malignant and metastatic thyroid cancer histotype. Wnt4 interferes with Ras-induced actin cytoskeleton reorganization through non-canonical pathways, by altering the balance between the activation of different Rho-family small guanosine triphosphatases (GTPases). Finally, we demonstrate that Wnt4 is post-transcriptionally repressed by miR-24, a Ras-induced micro RNA (miRNA) targeting the 3'-untranslated region (UTR) of Wnt4. Taken together our data highlight a novel Ras-regulated miRNA-dependent circuitry regulating the motile phenotype of cancer cells.	[De Menna, M.; D'Amato, V.; Ferraro, A.; Fusco, A.; Di Lauro, R.; Garbi, C.; De Vita, G.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-580131 Naples, Italy; [Fusco, A.] CNR, Ist Endocrinol Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	De Vita, G (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-580131 Naples, Italy.	gdevita@unina.it	Ferraro, Angelo/H-3193-2019; De Vita, Gabriella/H-4422-2011; Di Lauro, Roberto/A-2746-2012; Ferraro, Angelo/A-4172-2014	Ferraro, Angelo/0000-0002-2044-7569; De Vita, Gabriella/0000-0002-7302-1174; Di Lauro, Roberto/0000-0001-9493-3036; Ferraro, Angelo/0000-0002-2044-7569; Fusco, Alfredo/0000-0003-3332-5197; De Menna, Marta/0000-0002-6306-3485	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC).	Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baratta MG, 2009, MOL ENDOCRINOL, V23, P838, DOI 10.1210/me.2008-0353; Benhaj K, 2006, ONCOL REP, V15, P701; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Bui TD, 1997, BRIT J CANCER, V75, P1131, DOI 10.1038/bjc.1997.195; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hingorani SR, 2003, CURR OPIN GENET DEV, V13, P6, DOI 10.1016/S0959-437X(02)00017-5; HUGUET EL, 1994, CANCER RES, V54, P2615; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Quinlan MP, 1999, ONCOGENE, V18, P6434, DOI 10.1038/sj.onc.1203026; Roger PP, 2010, MOL CELL ENDOCRINOL, V321, P3, DOI 10.1016/j.mce.2009.11.015; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Tanigawa S, 2011, DEV BIOL, V352, P58, DOI 10.1016/j.ydbio.2011.01.012; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vainio SJ, 2003, J NEPHROL, V16, P279; Vincent JP, 2011, EMBO J, V30, P3665, DOI 10.1038/emboj.2011.311; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xie L, 2011, CLIN BIOCHEM, V44, P216, DOI 10.1016/j.clinbiochem.2010.11.002	38	16	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4110	4119		10.1038/onc.2012.419	http://dx.doi.org/10.1038/onc.2012.419			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23027131				2022-12-25	WOS:000323748500006
J	Meldrum, KK; Zhang, HJ; Hile, KL; Moldower, LL; Dong, ZZ; Meldrum, DR				Meldrum, Kirstan K.; Zhang, Hongji; Hile, Karen L.; Moldower, Lyle L.; Dong, Zizheng; Meldrum, Daniel R.			Profibrotic Effect of Interleukin-18 in HK-2 Cells Is Dependent on Stimulation of the Toll-like Receptor 4 (TLR4) Promoter and Increased TLR4 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; UNILATERAL URETERAL OBSTRUCTION; TUBULOINTERSTITIAL FIBROSIS; GENE-EXPRESSION; RENAL FIBROSIS; TISSUE FIBROSIS; IL-18; TRANSDIFFERENTIATION; FIBROBLASTS	IL-18 is an important mediator of obstruction-induced renal fibrosis and tubular epithelial cell injury independent of TGF-beta 1 activity. We sought to determine whether the profibrotic effect of IL-18 is mediated through Toll-like receptor 4 (TLR4). Male C57BL6 wild type and mice transgenic for human IL-18-binding protein were subjected to left unilateral ureteral obstruction versus sham operation. The kidneys were harvested 1 week postoperatively and analyzed for IL-18 production and TLR4 expression. In a separate arm, renal tubular epithelial cells (HK-2) were directly stimulated with IL-18 in the presence or absence of a TLR4 agonist, TLR4 antagonist, or TLR4 siRNA knockdown. Cell lysates were analyzed for TLR4, alpha-smooth muscle actin, and E-cadherin expression. TLR4 promotor activity, as well as AP-1 activation and the effect of AP-1 knockdown on TLR4 expression, was evaluated in HK-2 cells in response to IL-18 stimulation. The results demonstrate that IL-18 induces TLR4 expression during unilateral ureteral obstruction and induces TLR4 expression in HK-2 cells via AP-1 activation. Inhibition of TLR4 or knockdown of TLR4 gene expression in turn prevents IL-18-induced profibrotic changes in HK-2 cells. These results suggest that IL-18 induces profibrotic changes in tubular epithelial cells via increased TLR4 expression/signaling.	[Meldrum, Kirstan K.] Univ Florida, Dept Urol, Gainesville, FL 32610 USA; [Moldower, Lyle L.; Meldrum, Daniel R.] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Meldrum, Kirstan K.; Zhang, Hongji; Hile, Karen L.] Indiana Univ, Dept Urol, Indianapolis, IN 46202 USA; [Dong, Zizheng] Indiana Univ, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Meldrum, KK (corresponding author), Univ Florida, Div Pediat Neurol, 1600 SW Archer Rd,M203F, Gainesville, FL 32610 USA.	Kirstan.Meldrum@urology.ufl.edu			National Institutes of Health [R01 DK 081695]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 081695.	ALVAREZ RJ, 1992, KIDNEY INT, V41, P14, DOI 10.1038/ki.1992.3; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Faust J, 2002, ARTHRITIS RHEUM-US, V46, P3083, DOI 10.1002/art.10563; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Healy E, 1998, CURR OPIN NEPHROL HY, V7, P525, DOI 10.1097/00041552-199809000-00007; HUMES HD, 1992, EXP CELL RES, V201, P8, DOI 10.1016/0014-4827(92)90342-6; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Klahr S, 2001, Heart Dis, V3, P205, DOI 10.1097/00132580-200105000-00013; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Meldrum KK, 2002, AM J PHYSIOL-HEART C, V282, pH540, DOI 10.1152/ajpheart.00072.2001; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Miyajima A, 2001, J UROLOGY, V165, P1714, DOI 10.1016/S0022-5347(05)66400-2; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Rastaldi MP, 2006, J NEPHROL, V19, P407; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 1996, EXP NEPHROL, V4, P267; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; VanderBrink BA, 2011, J UROLOGY, V186, P1502, DOI 10.1016/j.juro.2011.05.046; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40391	40399		10.1074/jbc.M112.402420	http://dx.doi.org/10.1074/jbc.M112.402420			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027874	hybrid, Green Published			2022-12-25	WOS:000311448800030
J	Burstel, I; Siebert, E; Winter, G; Hummel, P; Zebger, I; Friedrich, B; Lenz, O				Buerstel, Ingmar; Siebert, Elisabeth; Winter, Gordon; Hummel, Philipp; Zebger, Ingo; Friedrich, Baerbel; Lenz, Oliver			A Universal Scaffold for Synthesis of the Fe(CN)(2)(CO) Moiety of [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION PROTEINS HYPC; ALCALIGENES-EUTROPHUS; ACTIVE-SITE; ESCHERICHIA-COLI; CATALYTIC CYCLE; CYANIDE; CN; FE; IDENTIFICATION; BIOSYNTHESIS	Hydrogen-cycling [NiFe] hydrogenases harbor a dinuclear catalytic center composed of nickel and iron ions, which are coordinated by four cysteine residues. Three unusual diatomic ligands in the form of two cyanides (CN-) and one carbon monoxide (CO) are bound to the iron and apparently account for the complexity of the cofactor assembly process, which involves the function of at least six auxiliary proteins, designated HypA, -B, -C, -D, -E, and -F. It has been demonstrated previously that the HypC, -D, -E, and -F proteins participate in cyanide synthesis and transfer. Here, we show by infrared spectroscopic analysis that the purified HypCD complexes from Ralstonia eutropha and Escherichia coli carry in addition to both cyanides the CO ligand. We present experimental evidence that in vivo the attachment of the CN- ligands is a prerequisite for subsequent CO binding. With the aid of genetic engineering and subsequent mutant analysis, the functional role of conserved cysteine residues in HypD from R. eutropha was investigated. Our results demonstrate that the HypCD complex serves as a scaffold for the assembly of the Fe(CN)(2)(CO) entity of [NiFe] hydrogenase.	[Siebert, Elisabeth; Hummel, Philipp; Zebger, Ingo] Tech Univ Berlin, Max Volmer Lab, D-10623 Berlin, Germany; [Buerstel, Ingmar; Winter, Gordon; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany	Technical University of Berlin; Humboldt University of Berlin	Zebger, I (corresponding author), Tech Univ Berlin, Max Volmer Lab, Str 17 Juni 135, D-10623 Berlin, Germany.	ingo.zebger@tu-berlin.de; oliver.lenz@cms.hu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019; Winter, Gordon/R-6185-2017	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Winter, Gordon/0000-0001-8855-8057	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis."	Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Burstel I, 2011, J BIOL CHEM, V286, P44937, DOI 10.1074/jbc.M111.309351; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dernedde J, 1996, EUR J BIOCHEM, V235, P351, DOI 10.1111/j.1432-1033.1996.00351.x; DERNEDDE J, 1993, ARCH MICROBIOL, V159, P545, DOI 10.1007/BF00249034; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; Gordon JC, 2010, ORGANOMETALLICS, V29, P4682, DOI 10.1021/om100436c; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Magalon A, 2001, FEBS LETT, V499, P73, DOI 10.1016/S0014-5793(01)02525-X; Moreland AC, 2000, INORG CHEM, V39, P3029, DOI 10.1021/ic9912629; Nakamoto K., 2008, INFRARED RAMAN SPECT, P403; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; PRIEFERT H, 1991, J BACTERIOL, V173, P4056, DOI 10.1128/jb.173.13.4056-4071.1991; Rauchfuss TB, 2001, J AM CHEM SOC, V123, P6933, DOI 10.1021/ja015948n; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Schwarze A, 2010, APPL ENVIRON MICROB, V76, P2641, DOI 10.1128/AEM.02700-09; SRIVASTAVA S, 1982, ARCH MICROBIOL, V131, P203, DOI 10.1007/BF00405879; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Thiemermann S, 1996, J BACTERIOL, V178, P2368, DOI 10.1128/jb.178.8.2368-2374.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Wolf I, 1998, ARCH MICROBIOL, V170, P451, DOI 10.1007/s002030050666	38	41	41	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38845	38853		10.1074/jbc.M112.376947	http://dx.doi.org/10.1074/jbc.M112.376947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019332	Green Published, hybrid			2022-12-25	WOS:000310982800041
J	Renner, LD; Weibel, DB				Renner, Lars D.; Weibel, Douglas B.			MinD and MinE Interact with Anionic Phospholipids and Regulate Division Plane Formation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; CELL-DIVISION; MEMBRANE INTERACTION; IN-VITRO; TOPOLOGICAL REGULATION; SUPPORTED MEMBRANES; PROTEIN-PATTERNS; POLE OSCILLATION; RAPID POLE; LOCALIZATION	The Min proteins (MinC, MinD, and MinE) form a pole-to-pole oscillator that controls the spatial assembly of the division machinery in Escherichia coli cells. Previous studies identified that interactions of MinD with phospholipids positioned the Min machinery at the membrane. We extend these studies by measuring the affinity, kinetics, and ATPase activity of E. coli MinD, MinE, and MinDE binding to supported lipid bilayers containing varying compositions of anionic phospholipids. Using quartz crystal microbalance measurements, we found that the binding affinity (K-d) for the interaction of recombinant E. coli MinD and MinE with lipid bilayers increased with increasing concentration of the anionic phospholipids phosphatidylglycerol and cardiolipin. The K-d for MinD (1.8 mu M) in the presence of ATP was smaller than for MinE (12.1 mu M) binding to membranes consisting of 95:5 phosphatidylcholine/cardiolipin. The simultaneous binding of MinD and MinE to membranes revealed that increasing the concentration of anionic phospholipid stimulates the initial rate of adsorption (k(on)). The ATPase activity of MinD decreased in the presence of anionic phospholipids. These results indicate that anionic lipids, which are concentrated at the poles, increase the retention of MinD and MinE and explain its dwell time at this region of bacterial cells. These studies provide insight into interactions between MinD and MinE and between these proteins and membranes that are relevant to understanding the process of bacterial cell division, in which the interaction of proteins and membranes is essential.	[Renner, Lars D.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	weibel@biochem.wisc.edu	Renner, Lars D/D-6291-2012; Renner, Lars David/AAQ-2732-2021	Renner, Lars D/0000-0003-0178-1788; 	Alfred P. Sloan Foundation; Kinship Foundation; Deutsche Forschungsgemeinschaft; National Science Foundation [DMR-0520527]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Kinship Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	This work was supported by an Alfred P. Sloan Foundation fellowship (to D.B.W.), the Kinship Foundation Searle Scholarship (to D.B.W.), a Deutsche Forschungsgemeinschaft fellowship (to L.D.R.), and National Science Foundation Grant DMR-0520527.	Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cytrynbaum EN, 2007, BIOPHYS J, V93, P1134, DOI 10.1529/biophysj.106.097162; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2004, PHYS BIOL, V1, P229, DOI 10.1088/1478-3967/1/4/005; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; Israelachvili J, 2005, Q REV BIOPHYS, V38, P331, DOI 10.1017/S0033583506004203; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Johnson JM, 2002, BIOPHYS J, V83, P3371, DOI 10.1016/S0006-3495(02)75337-X; Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Li G, 2012, MOL MICROBIOL, V84, P276, DOI 10.1111/j.1365-2958.2012.08021.x; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mazor S, 2008, BBA-BIOMEMBRANES, V1778, P2505, DOI 10.1016/j.bbamem.2008.08.004; Mazor S, 2008, BBA-BIOMEMBRANES, V1778, P2496, DOI 10.1016/j.bbamem.2008.08.003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Ramirez-Arcos S, 2002, MOL MICROBIOL, V46, P493, DOI 10.1046/j.1365-2958.2002.03168.x; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schweizer J, 2012, P NATL ACAD SCI USA, V109, P15283, DOI 10.1073/pnas.1206953109; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Szeto TH, 2001, J BACTERIOL, V183, P6684, DOI 10.1128/JB.183.22.6684-6687.2001; Varma A, 2008, J BACTERIOL, V190, P2106, DOI 10.1128/JB.00720-07; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x	49	60	63	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38835	38844		10.1074/jbc.M112.407817	http://dx.doi.org/10.1074/jbc.M112.407817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012351	hybrid, Green Published			2022-12-25	WOS:000310982800040
J	Wun, KS; Ross, F; Patel, O; Besra, GS; Porcelli, SA; Richardson, SK; Keshipeddy, S; Howell, AR; Godfrey, DI; Rossjohn, J				Wun, Kwok S.; Ross, Fiona; Patel, Onisha; Besra, Gurdyal S.; Porcelli, Steven A.; Richardson, Stewart K.; Keshipeddy, Santosh; Howell, Amy R.; Godfrey, Dale I.; Rossjohn, Jamie			Human and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT NKT CELLS; STRUCTURAL BASIS; CUTTING EDGE; RECOGNITION; GLYCOLIPIDS; CD1D; SELECTION; LYMPHOCYTES; KINETICS; AGONISTS	Human and mouse type I natural killer T (NKT) cells respond to a variety of CD1d-restricted glycolipid antigens (Ags), with their NKT cell antigen receptors ( NKT TCRs) exhibiting reciprocal cross-species reactivity that is underpinned by a conserved NKT TCR-CD1d-Ag docking mode. Within this common docking footprint, the NKT TCR recognizes, to varying degrees of affinity, a range of Ags. Presently, it is unclear whether the human NKTTCRs will mirror the generalities underpinning the fine specificity of the mouse NKT TCR-CD1d-Ag interaction. Here, we assessed human NKT TCR recognition against altered glycolipid ligands of alpha-galactosylceramide (alpha-GalCer) and have determined the structures of a human NKT TCR in complex with CD1d-4',4 ''-deoxy-alpha-GalCer and CD1d-alpha-GalCer with a shorter, di-unsaturated acyl chain (C20:2). Altered glycolipid ligands with acyl chain modifications did not affect the affinity of the human NKT TCR-CD1d-Ag interaction. Surprisingly, human NKT TCR recognition is more tolerant to modifications at the 4'-OH position in comparison with the 3'-OH position of alpha-GalCer, which contrasts the fine specificity of the mouse NKT TCR-CD1d-Ag recognition (4'-OH > 3'-OH). The fine specificity differences between human and mouse NKT TCRs was attributable to differing interactions between the respective complementarity-determining region 1 alpha loops and the Ag. Accordingly, germline encoded fine-specificity differences underpin human and mouse type I NKT TCR interactions, which is an important consideration for therapeutic development and NKT cell physiology.	[Ross, Fiona; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Wun, Kwok S.; Patel, Onisha; Rossjohn, Jamie] Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Richardson, Stewart K.; Keshipeddy, Santosh; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Melbourne; Monash University; University of Birmingham; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Howell, Amy/0000-0003-1958-6411; keshipeddy, santosh/0000-0002-9375-2230; Besra, Gurdyal/0000-0002-5605-0395; Patel, Onisha/0000-0001-6701-7139; Wun, Kwok/0000-0002-1908-4596; Godfrey, Dale/0000-0002-3009-5472	National Health and Medical Research Council of Australia (NHMRC); ARC; Cancer Council of Victoria; NIH [GM 087136]; ARC Future Fellowship; NHMRC Australia Fellowship; NHMRC Senior Principal Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1048717] Funding Source: National Science Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Future Fellowship(Australian Research Council); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the National Health and Medical Research Council of Australia (NHMRC), the ARC, the Cancer Council of Victoria and an NIH RO1 Grant GM 087136.; Supported by an ARC Future Fellowship.; Supported by an NHMRC Senior Principal Research Fellowship. To whom correspondence may be addressed. Tel.: 613-8344-5689; Fax:613-93471540; E-mail: godfrey@unimelb.edu.au.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. Tel: 613-99029236; Fax: 613-99025000; E-mail: jamie.rossjohn@monash.edu.	Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg NA, 2007, ADV EXP MED BIOL, V598, P20; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Cerundolo V, 2010, CURR OPIN IMMUNOL, V22, P417, DOI 10.1016/j.coi.2010.04.003; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kerzerho J, 2012, J IMMUNOL, V188, P2254, DOI 10.4049/jimmunol.1103049; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Patel O, 2011, P NATL ACAD SCI USA, V108, P19007, DOI 10.1073/pnas.1109066108; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Raju R, 2009, BIOORG MED CHEM LETT, V19, P4122, DOI 10.1016/j.bmcl.2009.06.005; Rhost S, 2012, SCAND J IMMUNOL, V76, P246, DOI 10.1111/j.1365-3083.2012.02750.x; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39139	39148		10.1074/jbc.M112.412320	http://dx.doi.org/10.1074/jbc.M112.412320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995911	Green Published, hybrid			2022-12-25	WOS:000310982800069
J	Huan, ML; Zhang, B; Teng, ZH; Cui, H; Wang, JP; Liu, XY; Xia, H; Zhou, SY; Mei, QB				Huan, Menglei; Zhang, Bangle; Teng, Zenghui; Cui, Han; Wang, Jieping; Liu, Xinyou; Xia, Hui; Zhou, Siyuan; Mei, Qibing			In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin	PLOS ONE			English	Article							CELL LUNG-CANCER; MICELLES; PACLITAXEL; COPOLYMER; THERAPY; RELEASE; TARGET; GROWTH; MODEL	Background: Conventional chemotherapy agent such as doxorubicin (DOX) is of limited clinical use because of its inherently low selectivity, which can lead to systemic toxicity in normal healthy tissue. Methods: A pH stimuli-sensitive conjugate based on polyethylene glycol (PEG) with covalently attachment doxorubicin via hydrazone bond (PEG-hyd-DOX) was prepared for tumor targeting delivery system. While PEG-DOX conjugates via amid bond (PEG-ami-DOX) was synthesized as control. Results: The synthetic conjugates were confirmed by proton nuclear magnetic resonance (NMR) spectroscopy, the release profile of DOX from PEG-hyd-DOX was acid-liable for the hydrazone linkage between DOX and PEG, led to different intracellular uptake route; intracellular accumulation of PEG-hyd-DOX was higher than PEG-ami-DOX due to its pH-triggered profile, and thereby more cytotoxicity against MCF-7, MDA-MB-231 (breast cancer models) and HepG2 (hepatocellular carcinoma model) cell lines. Following the in vitro results, we xenografted MDA-MB-231 cell onto SCID mice, PEG-hyd-DOX showed stronger antitumor efficacy than free DOX and was tumor-targeting. Conclusions: Results from these in vivo experiments were consistent with our in vitro results; suggested this pH-triggered PEG-hyd-DOX conjugate could target DOX to tumor tissues and release free drugs by acidic tumor environment, which would be potent in antitumor drug delivery.	[Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, State Adm Tradit Chinese Med, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, Xian 710032, Peoples R China; [Huan, Menglei; Zhang, Bangle; Teng, Zenghui; Cui, Han; Zhou, Siyuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Wang, Jieping; Liu, Xinyou] Fourth Mil Med Univ, Tangdu Hosp, Dept Pharm, Xian 710032, Peoples R China; [Xia, Hui] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Thorac Cardio Surg, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital	Mei, QB (corresponding author), Fourth Mil Med Univ, Sch Pharm, State Adm Tradit Chinese Med, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, Xian 710032, Peoples R China.	meiqibing@hotmail.com		Zhang, Bang-Le/0000-0001-9008-5391	Natural Science Foundation of Shaanxi Province [2010JM4043]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the Natural Science Foundation of Shaanxi Province (2010JM4043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E, 2007, J CONTROL RELEASE, V122, P365, DOI 10.1016/j.jconrel.2007.04.014; Chen CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1586, DOI 10.1271/bbb.80096; Chen W, 2010, J CONTROL RELEASE, V142, P40, DOI 10.1016/j.jconrel.2009.09.023; Cheng C, 2008, BIOCONJUGATE CHEM, V19, P1194, DOI 10.1021/bc8000062; Cuong N.V., 2011, CANCERS, V3, P61, DOI DOI 10.3390/CANCERS3010061; Denmeade SR, 1998, CANCER RES, V58, P2537; Fox ME, 2009, MOL PHARMACEUT, V6, P1562, DOI 10.1021/mp9001206; Gettinger S, 2008, SEMIN RESP CRIT CARE, V29, P291, DOI 10.1055/s-2008-1076749; Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008; Huan ML, 2009, BIOORG MED CHEM LETT, V19, P2579, DOI 10.1016/j.bmcl.2009.03.016; Kakinoki A, 2008, BIOL PHARM BULL, V31, P103, DOI 10.1248/bpb.31.103; Kim TH, 2010, BIOMATERIALS, V31, P7386, DOI 10.1016/j.biomaterials.2010.06.004; Ko J, 2007, J CONTROL RELEASE, V123, P109, DOI 10.1016/j.jconrel.2007.07.012; Kotsakis A, 2010, EXPERT OPIN PHARMACO, V11, P2363, DOI 10.1517/14656566.2010.498581; Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Lee ALZ, 2009, BIOMATERIALS, V30, P919, DOI 10.1016/j.biomaterials.2008.10.062; Leroux JC, 2001, J CONTROL RELEASE, V72, P71, DOI 10.1016/S0168-3659(01)00263-2; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Lin JP, 2009, BIOMATERIALS, V30, P108, DOI 10.1016/j.biomaterials.2008.09.010; Murakami T, 2008, NANOMEDICINE-UK, V3, P453, DOI 10.2217/17435889.3.4.453; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Ryu BY, 2008, J BIOMAT SCI-POLYM E, V19, P311, DOI 10.1163/156856208783720994; Sethuraman VA, 2006, BIOMACROMOLECULES, V7, P64, DOI 10.1021/bm0503571; Xiong XB, 2010, BIOMATERIALS, V31, P757, DOI 10.1016/j.biomaterials.2009.09.080; Zhu SJ, 2010, BIOMATERIALS, V31, P1360, DOI 10.1016/j.biomaterials.2009.10.044	26	24	25	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44116	10.1371/journal.pone.0044116	http://dx.doi.org/10.1371/journal.pone.0044116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028490	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700005
J	Chen, MJ; Xu, B; Ji, WL; Qiao, SL; Hu, N; Hu, YH; Wu, W; Qiu, LL; Zhang, RY; Wang, YB; Wang, SL; Zhou, ZM; Xia, YK; Wang, XR				Chen, Minjian; Xu, Bin; Ji, Wenliang; Qiao, Shanlei; Hu, Nan; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Zhang, Ruyang; Wang, Yubang; Wang, Shoulin; Zhou, Zuomin; Xia, Yankai; Wang, Xinru			Bisphenol A Alters n-6 Fatty Acid Composition and Decreases Antioxidant Enzyme Levels in Rat Testes: A LC-QTOF-Based Metabolomics Study	PLOS ONE			English	Article							MICROSOMAL LIPID-PEROXIDATION; TANDEM MASS-SPECTROMETRY; SPERM DNA-DAMAGE; OXIDATIVE STRESS; ENVIRONMENTAL CONTAMINANTS; IN-VIVO; EXPOSURE; STEROIDOGENESIS; INFERTILITY; URINARY	Background: Male reproductive toxicity induced by exposure to bisphenol A (BPA) has been widely reported. The testes have proven to be a major target organ of BPA toxicity, so studying testicular metabolite variation holds promise for the discovery of mechanisms linked to the toxic effects of BPA on reproduction. Methodology/Principal Findings: Male Sprague-Dawley rats were orally administered doses of BPA at the levels of 0, 50 mg/kg/d for 8 weeks. We used an unbiased liquid chromatography-quadrupole time-of-flight (LC-QTOF)-based metabolomics approach to discover, identify, and analyze the variation of testicular metabolites. Two n-6 fatty acids, linoleic acid (LA) and arachidonic acid (AA) were identified as potential testicular biomarkers. Decreased levels of LA and increased levels of AA as well as AA/LA ratio were observed in the testes of the exposed group. According to these suggestions, testicular antioxidant enzyme levels were detected. Testicular superoxide dismutase (SOD) declined significantly in the exposed group compared with that in the non-exposed group, and the glutathione peroxidase (GSH-Px) as well as catalase (CAT) also showed a decreasing trend in BPA treated group. Conclusions/Significance: BPA caused testicular n-6 fatty acid composition variation and decreased antioxidant enzyme levels. This study emphasizes that metabolomics brings the promise of biomarkers identification for the discovery of mechanisms underlying reproductive toxicity.	[Chen, Minjian; Xu, Bin; Qiao, Shanlei; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Wang, Shoulin; Zhou, Zuomin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Chen, Minjian; Xu, Bin; Qiao, Shanlei; Hu, Yanhui; Wu, Wei; Qiu, Lianglin; Wang, Shoulin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Ji, Wenliang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Hu, Nan] Bruker Daltonics Inc, Shanghai Off, Shanghai, Peoples R China; [Zhang, Ruyang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Wang, Yubang] Nanjing Med Univ, Sch Publ Hlth, Safety Assessment & Res Ctr Drug Pesticide & Vet, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Nanjing Medical University; Nanjing Medical University	Chen, MJ (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Peoples R China.	yankaixia@njmu.edu.cn; xrwang@njmu.edu.cn	Wang, Xin/AAN-8435-2021; Wu, Wei/C-4409-2012	Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284	National 973 Program [2009CB941703]; Key Project of National Natural Science Foundation of China [30930079]; National Natural Science Foundation of China [81072328]; The Key Project of MOE [211063]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National 973 Program(National Basic Research Program of China); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Key Project of MOE; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants from the National 973 Program, 2009CB941703; Key Project of National Natural Science Foundation of China No. 30930079; National Natural Science Foundation of China, No. 81072328; The Key Project of MOE, No. 211063; and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9; Aitken RJ, 2006, J CLIN ENDOCR METAB, V91, P4154, DOI 10.1210/jc.2006-1309; Aly HAA, 2009, FOOD CHEM TOXICOL, V47, P1733, DOI 10.1016/j.fct.2009.03.019; Appasamy M, 2007, REPROD BIOMED ONLINE, V14, P159, DOI 10.1016/S1472-6483(10)60783-3; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BRUNA E, 1989, LIPIDS, V24, P970, DOI 10.1007/BF02544543; Burczynski JM, 2001, FREE RADICAL BIO MED, V30, P1029, DOI 10.1016/S0891-5849(01)00497-X; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041; Dandekar S P, 2002, J Postgrad Med, V48, P186; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; de Catalfo GEH, 2005, CELL BIOCHEM FUNCT, V23, P175, DOI [10.1027/cbf.1135, 10.1002/cbf.1135]; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Hales DB, 2005, ANN NY ACAD SCI, V1061, P120, DOI 10.1196/annals.1336.014; Izumi Y, 2011, SYST BIOL REPROD MED, V57, P228, DOI 10.3109/19396368.2011.574248; JORDAN RA, 1982, BIOCHEM PHARMACOL, V31, P1393, DOI 10.1016/0006-2952(82)90034-X; LAWTON LJ, 1991, BIOL TRACE ELEM RES, V28, P83, DOI 10.1007/BF02863075; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li YJ, 2009, TOXICOL SCI, V108, P427, DOI 10.1093/toxsci/kfp024; LOKESH BR, 1981, J LIPID RES, V22, P905; Mathur PP, 2011, ASIAN J ANDROL, V13, P585, DOI 10.1038/aja.2011.40; McBurney RN, 2009, TOXICOL PATHOL, V37, P52, DOI 10.1177/0192623308329287; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Naughton CK, 2001, HUM REPROD UPDATE, V7, P473, DOI 10.1093/humupd/7.5.473; Oresic M, 2008, TRENDS BIOTECHNOL, V26, P647, DOI 10.1016/j.tibtech.2008.09.001; Parman T, 2011, TOXICOL SCI, V124, P487, DOI 10.1093/toxsci/kfr238; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Sikka SC, 2001, CURR MED CHEM, V8, P851, DOI 10.2174/0929867013373039; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; United States Environmental Protection Agency, 2010, BISPH A ACT PLAN CAS; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Volkel W, 2005, DRUG METAB DISPOS, V33, P1748, DOI 10.1124/dmd.105.005454; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4	40	23	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44754	10.1371/journal.pone.0044754	http://dx.doi.org/10.1371/journal.pone.0044754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024759	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100017
J	Mori, MA; Sales, VM; Motta, FL; Fonseca, RG; Alenina, N; Guadagnini, D; Schadock, I; Silva, ED; Torres, HAM; dos Santos, EL; Castro, CH; D'Almeida, V; Andreotti, S; Campana, AB; Sertie, RAL; Saad, MJA; Lima, FB; Bader, M; Pesquero, JB				Mori, Marcelo A.; Sales, Vicencia Micheline; Motta, Fabiana Louise; Fonseca, Raphael Gomes; Alenina, Natalia; Guadagnini, Dioze; Schadock, Ines; Silva, Elton Dias; Torres, Hugo A. M.; dos Santos, Edson Lucas; Castro, Charlles Heldan; D'Almeida, Vania; Andreotti, Sandra; Campana, Amanda Baron; Sertie, Rogerio A. L.; Saad, Mario J. A.; Lima, Fabio Bessa; Bader, Michael; Pesquero, Joao Bosco			Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity	PLOS ONE			English	Article							SYSTEMIC INSULIN-RESISTANCE; ADIPOSE-TISSUE; GLUT4 TRANSLOCATION; B-2 RECEPTOR; BRADYKININ; MUSCLE; ADIPONECTIN; METABOLISM; INHIBITION; EXPRESSION	Background: Kinins participate in the pathophysiology of obesity and type 2 diabetes by mechanisms which are not fully understood. Kinin B-1 receptor knockout mice (B-1(-/-)) are leaner and exhibit improved insulin sensitivity. Methodology/Principal Findings: Here we show that kinin B-1 receptors in adipocytes play a role in controlling whole body insulin action and glucose homeostasis. Adipocytes isolated from mouse white adipose tissue (WAT) constitutively express kinin B-1 receptors. In these cells, treatment with the B-1 receptor agonist des-Arg(9)-bradykinin improved insulin signaling, GLUT4 translocation, and glucose uptake. Adipocytes from B-1(-/-) mice showed reduced GLUT4 expression and impaired glucose uptake at both basal and insulin-stimulated states. To investigate the consequences of these phenomena to whole body metabolism, we generated mice where the expression of the kinin B-1 receptor was limited to cells of the adipose tissue (aP2-B-1/B-1(-/-)). Similarly to B-1(-/-) mice, aP2-B-1/B-1(-/-) mice were leaner than wild type controls. However, exclusive expression of the kinin B1 receptor in adipose tissue completely rescued the improved systemic insulin sensitivity phenotype of B-1(-/-) mice. Adipose tissue gene expression analysis also revealed that genes involved in insulin signaling were significantly affected by the presence of the kinin B-1 receptor in adipose tissue. In agreement, GLUT4 expression and glucose uptake were increased in fat tissue of aP2-B-1/B-1(-/-) when compared to B-1(-/-) mice. When subjected to high fat diet, aP2-B-1/B-1(-/-) mice gained more weight than B-1(-/-) littermates, becoming as obese as the wild types. Conclusions/Significance: Thus, kinin B-1 receptor participates in the modulation of insulin action in adipocytes, contributing to systemic insulin sensitivity and predisposition to obesity.	[Mori, Marcelo A.; Sales, Vicencia Micheline; Motta, Fabiana Louise; Fonseca, Raphael Gomes; Silva, Elton Dias; Torres, Hugo A. M.; dos Santos, Edson Lucas; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Alenina, Natalia; Schadock, Ines; Saad, Mario J. A.; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Guadagnini, Dioze] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Castro, Charlles Heldan] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [D'Almeida, Vania] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Andreotti, Sandra; Campana, Amanda Baron; Sertie, Rogerio A. L.; Lima, Fabio Bessa] Univ Sao Paulo, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Mori, MA (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.	jbpesquero@unifesp.br	D'Almeida, Vania/AAB-7115-2020; Lima, Fabio Bessa/H-2677-2014; Lima, Fabio/L-5634-2019; Castro, Charlles HM/C-1594-2012; Sertié, Rogerio/H-2701-2014; dos Santos, Edson Lucas/AAU-5857-2020; Santos, Edson/C-6820-2014; D'Almeida, Vânia/AAV-3955-2020; Bader, Michael/K-2124-2013; Saad, Mario/ABD-8262-2020; Mori, Marcelo A/R-2881-2018	Lima, Fabio Bessa/0000-0003-0573-9544; Castro, Charlles HM/0000-0001-9144-996X; dos Santos, Edson Lucas/0000-0002-6557-7914; Santos, Edson/0000-0002-6557-7914; D'Almeida, Vânia/0000-0003-0947-5312; Mori, Marcelo A/0000-0001-7112-5263; Motta, Fabiana/0000-0003-2230-995X; Schadock, Ines/0000-0002-6717-6276; Bader, Michael/0000-0003-4780-4164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Deutsche Forschungsgemeinschaft [BA1374/16-1]; German Ministry of Education and Science [BRA09/014]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Science	This work was supported by grants of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), Deutsche Forschungsgemeinschaft (BA1374/16-1) and the German Ministry of Education and Science (BRA09/014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x; Cassis LA, 2008, CURR HYPERTENS REP, V10, P93, DOI 10.1007/s11906-008-0019-9; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Dias JP, 2012, DIABETES OBES METAB, V14, P244, DOI 10.1111/j.1463-1326.2011.01521.x; DIETZE G, 1977, KLIN WOCHENSCHR, V55, P357, DOI 10.1007/BF01488118; Dietze GJ, 1996, DIABETES, V45, pS110, DOI 10.2337/diab.45.1.S110; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2001, HYPERTENSION, V38, P1355, DOI 10.1161/hy1201.096574; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LIMA FB, 1994, DIABETES, V43, P53, DOI 10.2337/diabetes.43.1.53; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Merino VF, 2009, J MOL MED, V87, P953, DOI 10.1007/s00109-009-0501-0; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Prada PO, 2007, DIABETOLOGIA, V50, P1949, DOI 10.1007/s00125-007-0723-z; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zuccollo A, 1999, IMMUNOPHARMACOLOGY, V45, P69, DOI 10.1016/S0162-3109(99)00149-6	37	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44782	10.1371/journal.pone.0044782	http://dx.doi.org/10.1371/journal.pone.0044782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024762	Green Published, Green Accepted, gold			2022-12-25	WOS:000308860100020
J	Palazzo, C; Ravaud, JF; Trinquart, L; Dalichampt, M; Ravaud, P; Poiraudeau, S				Palazzo, Clemence; Ravaud, Jean-Francois; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe; Poiraudeau, Serge			Respective Contribution of Chronic Conditions to Disability in France: Results from the National Disability-Health Survey	PLOS ONE			English	Article							ATTRIBUTABLE FRACTIONS; SELF-REPORT; PEOPLE; RISK; AGREEMENT; DISEASE; IMPACT	Background: Representative national data on disability are becoming increasingly important in helping policymakers decide on public health strategies. We assessed the respective contribution of chronic health conditions to disability for three age groups (18-40, 40-65, and >65 years old) using data from the 2008-2009 Disability-Health Survey in France. Methods: Data on 12 chronic conditions and on disability for 24,682 adults living in households were extracted from the Disability-Health Survey results. A weighting factor was applied to obtain representative estimates for the French population. Disability was defined as at least one restriction in activities of daily living (ADL), severe disability as the inability to perform at least one ADL alone, and self-reported disability as a general feeling of being disabled. To account for comorbidities, we assessed the contribution of each chronic disorder to disability by using the average attributable fraction (AAF). Findings: We estimated that 38.8 million people in France (81.7% [95% CI 80.9; 82.6]) had a chronic condition: 14.3% (14.0; 14.6) considered themselves disabled, 4.6% (4.4;4.9) were restricted in ADL and 1.7% (1.5;1.8) were severely disabled. Musculoskeletal and sensorial impairments contributed the most to self-reported disability (AAF 15.4% and 12.3%). Neurological and musculoskeletal diseases had the largest impact on disability (AAF 17.4% and 16.4%, respectively). Neurological disorders contributed the most to severe disability (AAF 31.0%). Psychiatric diseases contributed the most to disability categories for patients 18-40 years old (AAFs 23.8%-40.3%). Cardiovascular conditions were also among the top four contributors to disability categories (AAFs 8.5%-11.1%). Conclusions: Neurological, musculoskeletal, and cardiovascular chronic disorders mainly contribute to disability in France. Psychiatric impairments have a heavy burden for people 18-40 years old. These findings should help policymakers define priorities for health-service delivery in France and perhaps other developed countries.	[Palazzo, Clemence; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe] INSERM, U738, Paris, France; [Palazzo, Clemence; Trinquart, Ludovic; Dalichampt, Marie; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] Univ Paris 05, PRES, Paris, France; [Palazzo, Clemence; Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, F-75674 Paris, France; [Ravaud, Jean-Francois; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, Paris, France; [Ravaud, Jean-Francois] INSERM, U988, Villejuif, France; [Ravaud, Jean-Francois] CNRS, UMR 8211, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Palazzo, C (corresponding author), INSERM, U738, Paris, France.	clemence.palazzo@cch.aphp.fr	RAVAUD, Jean-François/F-7190-2013; POIRAUDEAU, SERGE/P-5301-2016; ravaud, philippe/C-1694-2009; Trinquart, Ludovic/H-4961-2019	RAVAUD, Jean-François/0000-0003-3959-4195; Trinquart, Ludovic/0000-0002-3028-4900; Poiraudeau, Serge/0000-0002-1988-9124; Ravaud, Philippe/0000-0001-8264-9206	French National Institute of Statistics and Economic Studies (INSEE); French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry [PA 11/R 10100LL]; Pfizer France	French National Institute of Statistics and Economic Studies (INSEE); French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry; Pfizer France(Pfizer)	This work was supported by the French National Institute of Statistics and Economic Studies (INSEE) and the French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry (contract PA 11/R 10100LL). The French National Institute of Statistics and Economic Studies (INSEE) and the French Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received a grant from Pfizer France, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijanseppa S, 2005, J EPIDEMIOL COMMUN H, V59, P413, DOI 10.1136/jech.2004.026302; Allonier C, 2007, B INFORM EC SANTE, P123; [Anonymous], 2011, LANCET, V377, P1977, DOI 10.1016/S0140-6736(11)60844-1; [Anonymous], 2007, TRENDS SEVERE DISABI; Australian Institute of Health and Welfare, 2004, DIS ITS REL HLTH CON; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; FLEISS JL, 1979, AM J EPIDEMIOL, V110, P103, DOI 10.1093/oxfordjournals.aje.a112794; Goillot C, 2003, ENQUETES HANDICAPS I; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gregory PC, 2011, J GERONTOL A; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Moe JO, 2011, EUR J AGEING, V8, P49, DOI 10.1007/s10433-011-0179-3; Nerich V, 2006, INFLAMM BOWEL DIS, V12, P218, DOI 10.1097/01.MIB.0000206540.38834.8c; Noel Delphine, 2012, Rev Prat, V62, P38; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Participation and Activity Limitation Survey 2006, 2006, PART ACT LIM SURV 20; Peng XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012129; Perruccio AV, 2007, J EPIDEMIOL COMMUN H, V61, P1056, DOI 10.1136/jech.2006.047308; Ravaud JF, 2002, POPULATION, V57, P541, DOI 10.2307/1535058; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; SAS Institute, 2008, INTR SURV SAMPL AN P; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; WHO, 2007, INT CLASS DIS ICD; WHO, 2001, WHO INT CLASS FUNCT; World Health Organisation, 2004, WHO REG EST 2004; Wray LA, 2001, GERONTOLOGIST, V41, P499, DOI 10.1093/geront/41.4.499	31	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44994	10.1371/journal.pone.0044994	http://dx.doi.org/10.1371/journal.pone.0044994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AD	23024781	gold, Green Submitted, Green Published			2022-12-25	WOS:000308860100039
J	Willcock, S; Phillips, OL; Platts, PJ; Balmford, A; Burgess, ND; Lovett, JC; Ahrends, A; Bayliss, J; Doggart, N; Doody, K; Fanning, E; Green, J; Hall, J; Howell, KL; Marchant, R; Marshall, AR; Mbilinyi, B; Munishi, PKT; Owen, N; Swetnam, RD; Topp-Jorgensen, EJ; Lewis, SL				Willcock, Simon; Phillips, Oliver L.; Platts, Philip J.; Balmford, Andrew; Burgess, Neil D.; Lovett, Jon C.; Ahrends, Antje; Bayliss, Julian; Doggart, Nike; Doody, Kathryn; Fanning, Eibleis; Green, Jonathan; Hall, Jaclyn; Howell, Kim L.; Marchant, Rob; Marshall, Andrew R.; Mbilinyi, Boniface; Munishi, Pantaleon K. T.; Owen, Nisha; Swetnam, Ruth D.; Topp-Jorgensen, Elmer J.; Lewis, Simon L.			Towards Regional, Error-Bounded Landscape Carbon Storage Estimates for Data-Deficient Areas of the World	PLOS ONE			English	Article							EASTERN ARC MOUNTAINS; LAND-USE CHANGE; MIOMBO WOODLANDS; BIOMASS DYNAMICS; FOREST STRUCTURE; NUTRIENT STOCKS; EMISSIONS; SOIL; DEFORESTATION; PLANTATIONS	Monitoring landscape carbon storage is critical for supporting and validating climate change mitigation policies. These may be aimed at reducing deforestation and degradation, or increasing terrestrial carbon storage at local, regional and global levels. However, due to data-deficiencies, default global carbon storage values for given land cover types such as 'lowland tropical forest' are often used, termed 'Tier 1 type' analyses by the Intergovernmental Panel on Climate Change (IPCC). Such estimates may be erroneous when used at regional scales. Furthermore uncertainty assessments are rarely provided leading to estimates of land cover change carbon fluxes of unknown precision which may undermine efforts to properly evaluate land cover policies aimed at altering land cover dynamics. Here, we present a repeatable method to estimate carbon storage values and associated 95% confidence intervals (CI) for all five IPCC carbon pools (aboveground live carbon, litter, coarse woody debris, belowground live carbon and soil carbon) for data-deficient regions, using a combination of existing inventory data and systematic literature searches, weighted to ensure the final values are regionally specific. The method meets the IPCC 'Tier 2' reporting standard. We use this method to estimate carbon storage over an area of 33.9 million hectares of eastern Tanzania, reporting values for 30 land cover types. We estimate that this area stored 6.33 (5.92-6.74) Pg C in the year 2000. Carbon storage estimates for the same study area extracted from five published Africa-wide or global studies show a mean carbon storage value of similar to 50% of that reported using our regional values, with four of the five studies reporting lower carbon storage values. This suggests that carbon storage may have been underestimated for this region of Africa. Our study demonstrates the importance of obtaining regionally appropriate carbon storage estimates, and shows how such values can be produced for a relatively low investment.	[Willcock, Simon; Phillips, Oliver L.; Owen, Nisha; Lewis, Simon L.] Univ Leeds, Leeds, W Yorkshire, England; [Platts, Philip J.; Balmford, Andrew; Bayliss, Julian; Green, Jonathan; Swetnam, Ruth D.] Univ Cambridge, Cambridge, England; [Platts, Philip J.; Marchant, Rob; Marshall, Andrew R.] Univ York, York YO10 5DD, N Yorkshire, England; [Burgess, Neil D.] WWF US, Washington, DC USA; [Burgess, Neil D.; Topp-Jorgensen, Elmer J.] Univ Copenhagen, Copenhagen, Denmark; [Lovett, Jon C.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Ahrends, Antje] Royal Bot Gardens, Edinburgh, Midlothian, Scotland; [Doggart, Nike] Tanzanian Forest Conservat Grp, Dar Es Salaam, Tanzania; [Doody, Kathryn] Frankfurt Zool Soc, Frankfurt, Germany; [Fanning, Eibleis; Owen, Nisha] Soc Environm Explorat, London, England; [Hall, Jaclyn] Univ Louvain, Louvain, Belgium; [Howell, Kim L.] Univ Dar Es Salaam, Dar Es Salaam, Tanzania; [Marshall, Andrew R.] Flamingo Land Ltd, Malton, England; [Mbilinyi, Boniface; Munishi, Pantaleon K. T.] Sokoine Univ Agr, Morogoro, Tanzania; [Lewis, Simon L.] UCL, London, England	University of Leeds; University of Cambridge; University of York - UK; World Wildlife Fund; University of Copenhagen; University of Twente; Royal Botanic Gardens, Kew; University of Dar es Salaam; Sokoine University of Agriculture; University of London; University College London	Willcock, S (corresponding author), Univ Leeds, Leeds, W Yorkshire, England.	gysw@leeds.ac.uk	Green, Jonathan M H/D-7081-2017; Lewis, Simon/I-9025-2012; Swetnam, Ruth D/I-2848-2017; Phillips, Oliver/A-1523-2011; Topp-Jørgensen, Elmer/N-6198-2019; Platts, Philip J./C-2002-2009; Topp-Jørgensen, Elmer/I-7488-2013	Swetnam, Ruth D/0000-0002-5199-9622; Phillips, Oliver/0000-0002-8993-6168; Topp-Jørgensen, Elmer/0000-0002-5050-9273; Platts, Philip J./0000-0002-0153-0121; Green, Jonathan/0000-0002-5003-0203; Hall, Jaclyn/0000-0002-5289-5585; Balmford, Andrew/0000-0002-0144-3589; Marchant, Robert/0000-0001-5013-4056; Willcock, Simon/0000-0001-9534-9114; Lewis, Simon/0000-0002-8066-6851; Bayliss, Julian/0000-0002-1480-294X	Leverhulme Trust; Royal Society University Research Fellowship; Stokenchurch Charity; Udzungwa Forest Project; WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund	Leverhulme Trust(Leverhulme Trust); Royal Society University Research Fellowship(Royal Society of London); Stokenchurch Charity; Udzungwa Forest Project; WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund	This study is part of the Valuing the Arc research programme (http://valuingthearc.org/) funded by the Leverhulme Trust (http://www.leverhulme.ac.uk/). Simon L. Lewis was funded by a Royal Society University Research Fellowship; Simon Willcock additionally by the Stokenchurch Charity; Andrew R. Marshall received additional funding from the Udzungwa Forest Project and WWF Tanzania Programme Office, through the Critical Ecosystem Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Batjes N. H., 2004, SOTER BASED SOIL PAR; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Cadavid LF, 1998, FIELD CROP RES, V57, P45, DOI 10.1016/S0378-4290(97)00114-7; Chamshama SAO, 1980, THINNING PINUS PATUL; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; de Boer WF, 2000, AQUAT BOT, V66, P225, DOI 10.1016/S0304-3770(99)00072-8; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DESHMUKH I, 1986, J APPL ECOL, V23, P115, DOI 10.2307/2403085; Doherty RM, 2010, GLOBAL CHANGE BIOL, V16, P617, DOI 10.1111/j.1365-2486.2009.01997.x; Economic Research Bureau, 2006, STUD EST MECH PAYM W; Eggleston S., 2006, 2006 IPCC GUIDELINES, V5; Ek TM, 1994, THESIS AGR U NORWAY; FORCONSULT, 2005, FOR COND ASS E ARC M; Garcia-Oliva F, 2004, CLIMATIC CHANGE, V65, P347, DOI 10.1023/B:CLIM.0000038211.84327.d9; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; *GLC, 2003, GLOB LAND COV 2000 D; Glenday J, 2008, ENVIRON MONIT ASSESS, V142, P85, DOI 10.1007/s10661-007-9910-0; Glenday J, 2006, FOREST ECOL MANAG, V235, P72, DOI 10.1016/j.foreco.2006.08.014; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hartemink AE, 2004, AGROFOREST SYST, V63, P33, DOI 10.1023/B:AGFO.0000049431.12758.01; Hartemink AE, 1997, LAND DEGRAD DEV, V8, P305, DOI 10.1002/(SICI)1099-145X(199712)8:4<305::AID-LDR261>3.0.CO;2-0; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; [HTSL Forest Resources Management Project], 1997, NAT REC LEV LAND US; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; IPCC, 2006, GUID NAT GREENH GAS; ISRIC, 2010, SOTER WISE BASED SOI; Jones MB, 1997, J TROP ECOL, V13, P347, DOI 10.1017/S0266467400010555; Kairo JG, 2008, FOREST ECOL MANAG, V255, P2670, DOI 10.1016/j.foreco.2008.01.031; Kamau DM, 2008, PLANT SOIL, V307, P29, DOI 10.1007/s11104-008-9576-6; Kaonga ML, 2005, THESIS U CAMBRIDGE; Kraenzel M, 2002, FOREST ECOL MANAG, V5863, P1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2001, ADV SOIL SCI ASSESSM; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lioubimtseva E, 1998, GLOBAL PLANET CHANGE, V17, P95, DOI 10.1016/S0921-8181(98)00015-0; LOVETT J C, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P287; Manlay RJ, 2002, AGR ECOSYST ENVIRON, V88, P215, DOI 10.1016/S0167-8809(01)00218-3; Marshall N. T, 1998, SEARCHING CURE CONSE, P112; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Michelsen A, 2004, SOIL BIOL BIOCHEM, V36, P1707, DOI 10.1016/j.soilbio.2004.04.028; Mills A. J., 2005, South African Journal of Plant and Soil, V22, P183; Mitchard ETA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/049001; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mshandete AM, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol10-issue4-fulltext-7; Munishi PKT, 2004, J TROP FOR SCI, V16, P78; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; [NBS National Bureau of Statistics Ministry of Planning Economy and Empowerment], 2006, TANZ CENS 2002 AN RE, VX, P193; Nunifu TK, 1997, THESIS LAKEHEAD U TH; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Penman J., 2003, Definitions and methodological options to inventory emissions from direct human-induced degradation of forests and devegetation of other vegetation types; Pfliegner K, 2005, ARC J, V19, P11; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Platts PJ, 2011, ENVIRON CONSERV, V38, P312, DOI 10.1017/S0376892911000191; Platts PJ, ECOGRAPHY IN PRESS; Prentice Iain Colin, 2001, CARBON CYCLE ATMOSPH; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Rossi J, 2009, CATENA, V77, P19, DOI 10.1016/j.catena.2008.12.003; Ruesch A. S., 2008, NEW IPCC TIERL GLOBA; RUTHERFORD MC, 1993, ECOL MODEL, V67, P129, DOI 10.1016/0304-3800(93)90002-A; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saunders M. J., 2007, Wetlands Ecology and Management, V15, P489, DOI 10.1007/s11273-007-9051-9; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Scholes RJ, 1993, AFRICAN SAVANNAS SYN; SCHROEDER P, 1994, AGROFOREST SYST, V27, P89, DOI 10.1007/BF00704837; SCHROTH G, 1995, AGROFOREST SYST, V31, P181, DOI 10.1007/BF00711725; Shirima DD, 2011, AFR J ECOL, V49, P332, DOI 10.1111/j.1365-2028.2011.01269.x; Sierra CA, 2007, FOREST ECOL MANAG, V243, P299, DOI 10.1016/j.foreco.2007.03.026; Slim FJ, 1996, MAR FRESHWATER RES, V47, P999, DOI 10.1071/MF9960999; Smidansky ED, 2003, PLANTA, V216, P656, DOI 10.1007/s00425-002-0897-z; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEINKE TD, 1995, HYDROBIOLOGIA, V295, P159, DOI 10.1007/BF00029123; STOORVOGEL JJ, 1993, FERT RES, V35, P227, DOI 10.1007/BF00750641; STROMGAARD P, 1985, FOREST ECOL MANAG, V12, P163, DOI 10.1016/0378-1127(85)90089-1; Swetnam RD, 2011, J ENVIRON MANAGE, V92, P563, DOI 10.1016/j.jenvman.2010.09.007; Topp-Jorgensen E, 2005, BIODIVERS CONSERV, V14, P2653, DOI 10.1007/s10531-005-8399-5; Tothill JC, 1985, 2 INT SAV S CSIRO BR; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Unruh J. D., 1993, Climate Research, V3, P39, DOI 10.3354/cr003039; Vagen TG, 2005, LAND DEGRAD DEV, V16, P53, DOI 10.1002/ldr.644; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Wagner F., 2003, IPCC GOOD PRACTICE G; Wauters JB, 2008, FOREST ECOL MANAG, V255, P2347, DOI 10.1016/j.foreco.2007.12.038; WOOMER PL, 1993, WATER AIR SOIL POLL, V70, P403, DOI 10.1007/BF01105011; Zahabu E, 2006, HANDEI VILLAGE FORES; Zahabu E, 2006, KITULANGALO FOREST A; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	97	21	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44795	10.1371/journal.pone.0044795	http://dx.doi.org/10.1371/journal.pone.0044795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024764	Green Published, Green Accepted, gold			2022-12-25	WOS:000308860100022
J	Brune, M; Scheele, D; Heinisch, C; Tas, C; Wischniewski, J; Gunturkun, O				Bruene, Martin; Scheele, Dirk; Heinisch, Christine; Tas, Cumhur; Wischniewski, Julia; Guentuerkuen, Onur			Empathy Moderates the Effect of Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex on Costly Punishment	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; DECISION-MAKING; ULTIMATUM GAME; NEURAL BASIS; PSYCHOPATHY; COOPERATION; EVOLUTION; CHOICE; BASES	Humans incur considerable costs to punish unfairness directed towards themselves or others. Recent studies using repetitive transcranial magnetic stimulation (rTMS) suggest that the right dorsolateral prefrontal cortex (DLPFC) is causally involved in such strategic decisions. Presently, two partly divergent hypotheses are discussed, suggesting either that the right DLPFC is necessary to control selfish motives by implementing culturally transmitted social norms, or is involved in suppressing emotion-driven prepotent responses to perceived unfairness. Accordingly, we studied the role of the DLPFC in costly (i.e. third party) punishment by applying rTMS to the left and right DLPFC before playing a Dictator Game with the option to punish observed unfair behavior (DG-P). In addition, sham stimulation took place. Individual differences in empathy were assessed with the German version of the Interpersonal Reactivity Index. Costly punishment increased (non-significantly) upon disruption of the right - but not the left - DLPFC as compared to sham stimulation. However, empathy emerged as a highly significant moderator variable of the effect of rTMS over the right, but not left, DLPFC, suggesting that the right DLPFC is involved in controlling prepotent emotional responses to observed unfairness, depending on individual differences in empathy.	[Bruene, Martin; Heinisch, Christine; Tas, Cumhur; Wischniewski, Julia] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany; [Scheele, Dirk] Univ Bonn, Dept Psychol, Bonn, Germany; [Guentuerkuen, Onur] Ruhr Univ Bochum, Dept Biopsychol, Fac Psychol, Bochum, Germany	Ruhr University Bochum; University of Bonn; Ruhr University Bochum	Brune, M (corresponding author), Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Univ Str 150, Bochum, Germany.	martin.bruene@rub.de	Scheele, Dirk/K-1194-2015; Brüne, Martin/AAX-3202-2020	Scheele, Dirk/0000-0002-7613-0376; Brüne, Martin/0000-0002-2507-0561; Gunturkun, Onur/0000-0003-4173-5233	Friedrich Ebert Stiftung	Friedrich Ebert Stiftung	Julia Wischniewski was supported by the Friedrich Ebert Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, NEUROPSYCHOBIOLOGY, V57, P44, DOI 10.1159/000129666; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Brandstatter H, 2001, EUR J PERSONALITY, V15, pS53, DOI 10.1002/per.424; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glenn AL, 2009, MOL PSYCHIATR, V14, P909, DOI 10.1038/mp.2009.76; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hobbes Thomas, 2008, LEVIATHAN-J MELVILLE; Judd CM, 2001, PSYCHOL METHODS, V6, P115, DOI 10.1037/1082-989X.6.2.115; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Lundqvist D., 1998, KAROLINSKA DIRECTED; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Paulus C., 2009, SAARBRUCKER PERSONLI; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheele D, 2012, BIOL PSYCHIAT; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Smith A, 1776, THEORY MORAL SENTIME; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wischniewski J, J PERSONAL IN PRESS	38	26	28	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44747	10.1371/journal.pone.0044747	http://dx.doi.org/10.1371/journal.pone.0044747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028601	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700033
J	Nguyen, HB; Babcock, JT; Wells, CD; Quilliam, LA				Nguyen, H. B.; Babcock, J. T.; Wells, C. D.; Quilliam, L. A.			LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap	ONCOGENE			English	Article						LKB1; Yap; Hippo; polarity; growth	HIPPO SIGNALING PATHWAY; LUNG-CANCER; ORGAN SIZE; ACTIVATION; PROTEIN; TRANSCRIPTION; APOPTOSIS; POLARITY; ACTS; GENE	The liver kinase B1 (LKB1) tumor suppressor inhibits cell growth through its regulation of cellular metabolism and apical-basal polarity. The best understood mechanism whereby LKB1 limits cell growth is through activation of the AMP-activated-protein-kinase/mammalian-target-of-rapamycin (AMPK/mTOR) pathway to control metabolism. As LKB1 is also required for polarized epithelial cells to resist hyperplasia, it is anticipated to function through additional mechanisms. Recently, Yes-associated protein (Yap) has emerged as a transcriptional co-activator that modulates tissue homeostasis in response to cell-cell contact. Thus this study examined a possible connection between Yap and LKB1. Restoration of LKB1 expression in HeLa cells, which lack this tumor suppressor, or short-hairpin RNA knockdown of LKB1 in NTERT immortalized keratinocytes, demonstrated that LKB1 promotes Yap phosphorylation, nuclear exclusion and proteasomal degradation. The ability of phosphorylation-defective Yap mutants to rescue LKB1 phenotypes, such as reduced cell proliferation and cell size, suggest that Yap inhibition contributes to LKB1 tumor suppressor function(s). However, failure of Lats1/2 knockdown to suppress LKB1-mediated Yap regulation suggested that LKB1 signals to Yap via a non-canonical pathway. Additionally, LKB1 inhibited Yap independently of either AMPK or mTOR activation. These findings reveal a novel mechanism whereby LKB1 may restrict cancer cell growth via the inhibition of Yap.	[Nguyen, H. B.; Babcock, J. T.; Wells, C. D.; Quilliam, L. A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Quilliam, LA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, MS 4075,635 Barnhill Dr, Indianapolis, IN 46202 USA.	lquillia@iupui.edu			US Department of Defense [W81XWH1110355]; LAM Foundation; IUPUI; NATIONAL CANCER INSTITUTE [R01CA151765] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); LAM Foundation; IUPUI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dan Spandau for NTERT cells, Jacob Adler and Bill Ranahan for experimental advice. This work was supported by US Department of Defense award W81XWH1110355, the LAM Foundation and a research support funds grant from IUPUI to LAQ.	Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bao YJ, 2011, J BIOCHEM, V150, P199, DOI 10.1093/jb/mvr063; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gill RK, 2011, ONCOGENE, V30, P3784, DOI 10.1038/onc.2011.98; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; HAUSER CA, 1995, METHOD ENZYMOL, V255, P412; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Huang H, 1999, DEVELOPMENT, V126, P5365; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; van Veelen W, 2011, ONCOGENE, V30, P2289, DOI 10.1038/onc.2010.630; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	45	60	67	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 29	2013	32	35					4100	4109		10.1038/onc.2012.431	http://dx.doi.org/10.1038/onc.2012.431			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23027127	Green Accepted			2022-12-25	WOS:000323748500005
J	Darshi, M; Trinh, KN; Murphy, AN; Taylor, SS				Darshi, Manjula; Trinh, Kristina N.; Murphy, Anne N.; Taylor, Susan S.			Targeting and Import Mechanism of Coiled-coil Helix Coiled-coil Helix Domain-containing Protein 3 (ChChd3) into the Mitochondrial Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISTAE MORPHOLOGY; N-MYRISTOYLATION; MEMBRANE; MITOFILIN; MIA40; BIOGENESIS; COMPLEX; KINASE; SAM50; IDENTIFICATION	Coiled-coil helix coiled-coil helix domain-containing protein 3 (ChChd3) is a mitochondrial inner membrane (IM) protein facing toward the intermembrane space (IMS). In the IMS, ChChd3 complexes with multiple proteins at the crista junctions and contact sites and plays a key role in maintaining crista integrity. ChChd3 is myristoylated at the N terminus and has a CHCH domain with twin CX9C motifs at its C terminus. The CHCH domain proteins are traditionally imported and trapped in the IMS by using a disulfide relay system mediated by Mia40 and Erv1. In this study, we systematically analyzed the role of the myristoylation and the CHCH domain in the import and mitochondrial localization of ChChd3. Based on our results, we predict that myristoylation promotes binding of ChChd3 to the outer membrane and that the CHCH domain translocates the protein across the outer membrane. By analysis of the CHCH domain cysteine mutants, we further show that they have distinct roles in binding to Mia40 in the IMS and proper folding of the protein. The transient disulfide-bonded intermediate with Mia40 is formed preferentially between the second cysteine in helix 1, Cys(193), and the active site cysteine in Mia40, Cys(55). Although each of the four cysteines is essential for folding of the protein and binding to mitofilin and Sam50, they are not involved in import. Together our results indicate that both the myristoylation and the CHCH domain are essential for the import and mitochondrial localization of ChChd3. Once imported, ChChd3 binds to Mia40 for further folding and assembly into macromolecular complexes.	[Darshi, Manjula; Taylor, Susan S.] UCSD, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Trinh, Kristina N.; Taylor, Susan S.] UCSD, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Murphy, Anne N.; Taylor, Susan S.] UCSD, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), UCSD, Howard Hughes Med Inst, Leichtag 415, La Jolla, CA 92093 USA.	staylor@ucsd.edu	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK54441 (to S. S. T.).	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; LaPorte SL, 2005, P NATL ACAD SCI USA, V102, P1889, DOI 10.1073/pnas.0408890102; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; [No title captured]	32	52	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.387696	http://dx.doi.org/10.1074/jbc.M112.387696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019327	hybrid, Green Published			2022-12-25	WOS:000311233800020
J	Fu, CY; Su, YF; Lee, MH; Chang, GD; Tsai, HJ				Fu, Chuan-Yang; Su, Ying-Fang; Lee, Ming-Hsuan; Chang, Geen-Dong; Tsai, Huai-Jen			Zebrafish Dkk3a Protein Regulates the Activity of myf5 Promoter through Interaction with Membrane Receptor Integrin alpha 6b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICKKOPF GENES; TYROSINE KINASE; SKELETAL-MUSCLE; MAP KINASE; REIC/DKK-3; CELLS; ACTIVATION; EXPRESSION; ADHESION; CANCER	Myogenic regulatory factor Myf5 plays important roles in muscle development. In zebrafish myf5, a microRNA (miR), termed miR-3906 or miR-In300, was reported to silence dick-kopf-3-related gene (dkk3r or dkk3a), resulting in repression of myf5 promoter activity. However, the membrane receptor that interacts with ligand Dkk3a to control myf5 expression through signal transduction remains unknown. To address this question, we applied immunoprecipitation and LC-MS/MS to screen putative membrane receptors of Dkk3a, and Integrin alpha 6b (Itg alpha 6b) was finally identified. To further confirm this, we used cell surface binding assays, which showed that Dkk3a and Itg alpha 6b were co-expressed at the cell membrane of HEK-293T cells. Cross-linking immunoprecipitation data also showed high affinity of Itg alpha 6b for Dkk3a. We further proved that the beta-propeller repeat domains of Itg alpha 6b are key segments bound by Dkk3a. Moreover, when dkk3a and itg alpha 6b mRNAs were co-injected into embryos, luciferase activity was up-regulated 4-fold greater than that of control embryos. In contrast, the luciferase activities of dkk3a knockdown embryos co-injected with itg alpha 6b mRNA and itg alpha 6b knockdown embryos co-injected with dkk3a mRNA were decreased in a manner similar to that in control embryos, respectively. Knockdown of itg alpha 6b resulted in abnormal somite shape, fewer somitic cells, weaker or absent myf5 expression, and reduced the protein level of phosphorylated p38a in somites. These defective phenotypes of trunk muscular development were similar to those of dkk3a knockdown embryos. We demonstrated that the secreted ligand Dkk3a binds to the membrane receptor Itg alpha 6b, which increases the protein level of phosphorylated p38a and activates myf5 promoter activity of zebrafish embryos during myogenesis.	[Fu, Chuan-Yang; Su, Ying-Fang; Lee, Ming-Hsuan; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 106, Taiwan; [Chang, Geen-Dong] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan	National Taiwan University; National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sect 4,Roosevelt Rd, Taipei 106, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Republic of China [100-2313-B-002-043-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grant 100-2313-B-002-043-MY3. We are grateful to the staffs of TC5 Bio-Image Tools, Technology Commons, College of Life Science, NTU for help with the CLSM.	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen YH, 2002, DIFFERENTIATION, V70, P447, DOI 10.1046/j.1432-0436.2002.700807.x; Chiang YH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/780108; Chong SW, 2009, J FISH BIOL, V74, P1693, DOI 10.1111/j.1095-8649.2009.02174.x; CHUN JS, 1993, MOL BIOL CELL, V4, P271; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Hsu RJ, 2011, J BIOL CHEM, V286, P6855, DOI 10.1074/jbc.M110.161638; Hsu RJ, 2010, NUCLEIC ACIDS RES, V38, P4384, DOI 10.1093/nar/gkq148; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Kurose K, 2004, J UROLOGY, V171, P1314, DOI 10.1097/01.ju.0000101047.64379.d4; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nozaki I, 2001, INT J ONCOL, V19, P117; Ochiai K, 2011, BIOCHEM BIOPH RES CO, V412, P391, DOI 10.1016/j.bbrc.2011.07.109; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Tajbakhsh S, 2005, EXP CELL RES, V306, P364, DOI 10.1016/j.yexcr.2005.03.033; Tsuji T, 2001, BIOCHEM BIOPH RES CO, V289, P257, DOI 10.1006/bbrc.2001.5972; Untergasser G, 2011, GENE EXPR PATTERNS, V11, P491, DOI 10.1016/j.gep.2011.08.005; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wilschut KJ, 2011, STEM CELL RES, V7, P112, DOI 10.1016/j.scr.2011.05.001; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	48	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.395012	http://dx.doi.org/10.1074/jbc.M112.395012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024366	Green Published, hybrid			2022-12-25	WOS:000311233800070
J	Merceron, R; Foucault, M; Haser, R; Mattes, R; Watzlawick, H; Gouet, P				Merceron, Romain; Foucault, Marine; Haser, Richard; Mattes, Ralf; Watzlawick, Hildegard; Gouet, Patrice			The Molecular Mechanism of Thermostable alpha-Galactosidases AgaA and AgaB Explained by X-ray Crystallography and Mutational Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS NCIM-5146; 1.9 ANGSTROM STRUCTURE; CRYSTAL-STRUCTURE; COLD ADAPTATION; N-ACETYLGALACTOSAMINIDASE; PSYCHROPHILIC ENZYMES; SUBSTRATE-SPECIFICITY; GLYCOSYL HYDROLASES; CATALYTIC MECHANISM; GLYCOSIDASES	The alpha-galactosidase AgaA from the thermophilic microorganism Geobacillus stearothermophilus has great industrial potential because it is fully active at 338 K against raffinose and can increase the yield of manufactured sucrose. AgaB has lower affinity for its natural substrates but is a powerful tool for the enzymatic synthesis of disaccharides by transglycosylation. These two enzymes have 97% identity and belong to the glycoside hydrolase (GH) family GH36 for which few structures are available. To understand the structural basis underlying the differences between these two enzymes, we determined the crystal structures of AgaA and AgaB by molecular replacement at 3.2- and 1.8 angstrom-resolution, respectively. We also solved a 2.8-angstrom structure of the AgaA(A355E) mutant, which has enzymatic properties similar to those of AgaB. We observe that residue 355 is located 20 angstrom away from the active site and that the A355E substitution causes structural rearrangements resulting in a significant displacement of the invariant Trp(336) at catalytic subsite - 1. Hence, the active cleft of AgaA is narrowed in comparison with AgaB, and AgaA is more efficient than AgaB against its natural substrates. The structure of AgaA(A355E) complexed with 1-deoxygalactonojirimycin reveals an induced fit movement; there is a rupture of the electrostatic interaction between Glu(355) and Asn(335) and a return of Trp(336) to an optimal position for ligand stacking. The structures of two catalytic mutants of AgaA(A355E) complexed with raffinose and stachyose show that the binding interactions are stronger at subsite -1 to enable the binding of various alpha-galactosides.	[Mattes, Ralf; Watzlawick, Hildegard] Univ Stuttgart, Inst Ind Genet, D-70569 Stuttgart, Germany; [Merceron, Romain; Foucault, Marine; Haser, Richard; Gouet, Patrice] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France	University of Stuttgart; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Watzlawick, H (corresponding author), Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany.	hildegard.watzlawick@iig.uni-stuttgart.de; p.gouet@ibcp.fr		gouet, patrice/0000-0001-9485-6157	European Community's Seventh Framework Program [283570]	European Community's Seventh Framework Program	This work was supported by the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement 283570 (BioStruct-X).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aittaleb M, 1997, PROTEIN ENG, V10, P475, DOI 10.1093/protein/10.5.475; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Bruel L, 2011, J BIOL CHEM, V286, P40814, DOI 10.1074/jbc.M111.286039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DORN E, 1978, BIOCHEM J, V174, P85, DOI 10.1042/bj1740085; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Fernandez-Leiro R, 2010, J BIOL CHEM, V285, P28020, DOI 10.1074/jbc.M110.144584; Foucault M, 2006, ACTA CRYSTALLOGR F, V62, P100, DOI [10.1107/S1744309105042582, 10.1107/S1744309105042562]; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Fridjonsson O, 1999, FEMS MICROBIOL LETT, V176, P147, DOI 10.1016/S0378-1097(99)00231-1; Fridjonsson O, 2002, J BACTERIOL, V184, P3385, DOI 10.1128/JB.184.12.3385-3391.2002; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Fujimoto Z, 2009, BIOSCI BIOTECH BIOCH, V73, P2360, DOI 10.1271/bbb.90604; GANTER C, 1988, J BIOTECHNOL, V8, P301, DOI 10.1016/0168-1656(88)90022-3; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Gote MM, 2007, ENZYME MICROB TECH, V40, P1312, DOI 10.1016/j.enzmictec.2006.10.004; Gote MM, 2006, PROCESS BIOCHEM, V41, P1311, DOI 10.1016/j.procbio.2006.01.003; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeBlanc Jean Guy, 2004, Genet Mol Res, V3, P432; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Spangenberg P, 2000, CARBOHYD RES, V329, P65, DOI 10.1016/S0008-6215(00)00170-1; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	31	33	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.394114	http://dx.doi.org/10.1074/jbc.M112.394114			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012371	hybrid, Green Published			2022-12-25	WOS:000311233800034
J	Tian, J; Lee, SO; Liang, L; Luo, J; Huang, CK; Li, L; Niu, YJ; Chang, C				Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Niu, Yuanjie; Chang, Chawnshang			Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2 '-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; TUMOR-INITIATING CELLS; GENE-EXPRESSION; SELF-RENEWAL; MICE LACKING; PHASE-II; DIFFERENTIATION; IDENTIFICATION; LINES; POPULATION	Androgen receptor (AR) expression surveys found that normal prostate/prostate cancer (PCa) stem/progenitor cells, but not embryonic or mesenchymal stem cells, expressed little AR with high methylation in the AR promoter. Mechanism dissection revealed that the differential methylation pattern in the AR promoter could be due to differential expression of methyl-transferases and binding of methylation binding protein to the AR promoter region. The low expression of AR in normal prostate/PCa stem/progenitor cells was reversed after adding 5-aza-2'-deoxycytidine, a demethylating agent, which could then lead to decreased stemness and drive cells into a more differentiated status, suggesting that the methylation in the AR promoter of prostate stem/progenitor cells is critical not only in maintaining the stemness but also critical in protection of cells from differentiation. Furthermore, induced AR expression, via alteration of its methylation pattern, led to suppression of the self-renewal/proliferation of prostate stem/progenitor cells and PCa tumorigenesis in both in vitro assays and in vivo orthotopic xenografted mouse studies. Taken together, these data prove the unique methylation pattern of AR promoter in normal prostate/PCa stem/progenitor cells and the influence of AR on their renewal/proliferation and differentiation. Targeting PCa stem/progenitor cells with alteration of methylated AR promoter status might provide a new potential therapeutic approach to battle PCa because the PCa stem/progenitor cells have high tumorigenicity.	[Tian, Jing; Niu, Yuanjie] Tianjin Med Univ, Chawnshang Chang Sex Hormone Res Ctr, Tianjin Inst Urol, Tianjin 300211, Peoples R China; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Liang, Liang; Li, Lei] Xi An Jiao Tong Univ, Sex Hormone Res Ctr, Dept Urol, Affiliated Hosp 1, Xian 710061, Peoples R China; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	Tianjin Medical University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Xi'an Jiaotong University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Niu, YJ (corresponding author), Tianjin Med Univ, Chawnshang Chang Sex Hormone Res Ctr, Tianjin Inst Urol, Tianjin 300211, Peoples R China.	niuyuanjie@gmail.com; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [CA127300]; George Whipple Professorship Endowment; National Natural Science Foundation for Young Scholars of China [81202024, 518304]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; NATIONAL CANCER INSTITUTE [R01CA127300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taiwan Department of Health Clinical Trial and Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127300. This work was also supported by the George Whipple Professorship Endowment, the National Natural Science Foundation for Young Scholars of China (Grant 81202024 and 973 Grant 518304), and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University, Taichung, Taiwan).	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Ariff IM, 2012, J NEUROSCI RES, V90, P529, DOI 10.1002/jnr.22804; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chang CY, 2006, FERTIL STERIL, V85, P1195, DOI 10.1016/j.fertnstert.2005.11.031; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; Crawford PA, 1997, MOL CELL BIOL, V17, P3997, DOI 10.1128/MCB.17.7.3997; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; CUNHA GR, 1992, J ANDROL, V13, P465; Deonarain MP, 2009, MABS-AUSTIN, V1, P12, DOI 10.4161/mabs.1.1.7347; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Jiang M, 2010, CELL DEATH DIFFER, V17, P469, DOI 10.1038/cdd.2009.148; Juffroy O, 2009, DIFFERENTIATION, V78, P223, DOI 10.1016/j.diff.2009.07.005; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Kinoshita H, 2000, CANCER RES, V60, P3623; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kontic M, 2012, CLIN LUNG CANCER, V13, P297, DOI 10.1016/j.cllc.2011.11.003; Lee S. O., 2012, J MOL CELL IN PRESS; Li HW, 2011, J SURG ONCOL, V103, P558, DOI 10.1002/jso.21806; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Ramos KS, 2011, BIRTH DEFECTS RES A, V91, P693, DOI 10.1002/bdra.20786; Rasheed ZA, 2011, STEM CELLS, V29, P883, DOI 10.1002/stem.648; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Sonpavde G, 2007, CLIN GENITOURIN CANC, V5, P457, DOI 10.3816/CGC.2007.n.036; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Thibault A, 1998, TUMORI, V84, P87, DOI 10.1177/030089169808400120; TILLEY WD, 1990, CANCER RES, V50, P5382; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Trowbridge JJ, 2012, NAT GENET, V44, P13, DOI 10.1038/ng.1043; Van Leenders GJLH, 2001, BJU INT, V88, P35, DOI 10.1046/j.1464-410X.2001.00117.x; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Yu SQ, 2011, PROSTATE, V71, P517, DOI 10.1002/pros.21264; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135	62	49	52	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.395574	http://dx.doi.org/10.1074/jbc.M112.395574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012352	Green Published, hybrid			2022-12-25	WOS:000311233800063
J	Xu, RY; Ori, A; Rudd, TR; Uniewicz, KA; Ahmed, YA; Guimond, SE; Skidmore, MA; Siligardi, G; Yates, EA; Fernig, DG				Xu, Ruoyan; Ori, Alessandro; Rudd, Timothy R.; Uniewicz, Katarzyna A.; Ahmed, Yassir A.; Guimond, Scott E.; Skidmore, Mark A.; Siligardi, Giuliano; Yates, Edwin A.; Fernig, David G.			Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions IMPLICATIONS FOR BINDING SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; DIFFERENTIAL SCANNING FLUOROMETRY; CIRCULAR-DICHROISM SPECTROSCOPY; CRYSTAL-STRUCTURE; SULFATE PROTEOGLYCANS; RECEPTOR SPECIFICITY; FACTOR FGF; NMR; OLIGOSACCHARIDES; AFFINITY	The functions of a large number (>435) of extracellular regulatory proteins are controlled by their interactions with heparan sulfate (HS). In the case of fibroblast growth factors (FGFs), HS binding determines their transport between cells and is required for the assembly of high affinity signaling complexes with their cognate FGF receptor. However, the specificity of the interaction of FGFs with HS is still debated. Here, we use a panel of FGFs (FGF-1, FGF-2, FGF-7, FGF-9, FGF-18, and FGF-21) spanning five FGF subfamilies to probe their specificities for HS at different levels as follows: binding parameters, identification of heparin-binding sites (HBSs) in the FGFs, changes in their secondary structure caused by heparin binding and structures in the sugar required for binding. For interaction with heparin, the FGFs exhibit K-D values varying between 38 nM (FGF-18) and 620 nM(FGF-9) and association rate constants spanning over 20-fold (FGF-1, 2,900,000 M-1 s(-1) and FGF-9, 130,000 M-1 s(-1)). The canonical HBS in FGF-1, FGF-2, FGF-7, FGF-9, and FGF-18 differs in its size, and these FGFs have a different complement of secondary HBS, ranging from none (FGF-9) to two (FGF-1). Differential scanning fluorimetry identified clear preferences in these FGFs for distinct structural features in the polysaccharide. These data suggest that the differences in heparin-binding sites in both the protein and the sugar are greatest between subfamilies and may be more restricted within a FGF subfamily in accord with the known conservation of function within FGF subfamilies.	[Skidmore, Mark A.; Yates, Edwin A.; Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Dept Chem & Struct Biol, Liverpool L69 7ZB, Merseyside, England; [Ori, Alessandro] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Rudd, Timothy R.] Ist Chim & Biochim, I-20133 Milan, Italy; [Uniewicz, Katarzyna A.] PromoCell GmbH, D-69126 Heidelberg, Germany; [Skidmore, Mark A.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Siligardi, Giuliano] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England	University of Liverpool; European Molecular Biology Laboratory (EMBL); Keele University; Diamond Light Source	Yates, EA (corresponding author), Univ Liverpool, Dept Struct & Chem Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	eayates@liverpool.ac.uk; dgfernig@liverpool.ac.uk	Ori, Alessandro/B-7067-2011; Yates, Edwin A/I-4808-2013; Rudd, Tim/M-6129-2019; Ori, Alessandro/M-8586-2019; Siligardi, Giuliano/AAO-7024-2020; Fernig, David G/A-3590-2008	Ori, Alessandro/0000-0002-3046-0871; Rudd, Tim/0000-0003-4434-0333; Ori, Alessandro/0000-0002-3046-0871; Fernig, David G/0000-0003-4875-4293; Yates, Edwin/0000-0001-9365-5433; Guimond, Scott/0000-0002-5903-418X	Cancer and Polio Research Fund; North West Cancer Research Fund; Biotechnology and Biological Sciences Research Council; Alexander von Humboldt Foundation; Marie Curie Actions	Cancer and Polio Research Fund; North West Cancer Research Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Marie Curie Actions(European Commission)	This work was supported in part by the Cancer and Polio Research Fund, the North West Cancer Research Fund, and Biotechnology and Biological Sciences Research Council.; Supported by postdoctoral fellowships from the Alexander von Humboldt Foundation and Marie Curie Actions.	BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KE YQ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P307, DOI 10.1016/0167-4781(92)90029-Y; Kinsella L, 1998, GLYCOCONJUGATE J, V15, P419, DOI 10.1023/A:1006986104865; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lozano RM, 2000, BIOCHEMISTRY-US, V39, P4982, DOI 10.1021/bi992544n; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Powell AK, 2010, NAT PROTOC, V5, P821, DOI 10.1038/nprot.2010.17; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; Rudd TR, 2008, CARBOHYD RES, V343, P2184, DOI 10.1016/j.carres.2007.12.019; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Rudd TR, 2010, ORG BIOMOL CHEM, V8, P5390, DOI 10.1039/c0ob00246a; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Thompson Sophie M, 2011, BMC Dev Biol, V11, P38, DOI 10.1186/1471-213X-11-38; Uniewicz KA, 2010, ANAL CHEM, V82, P3796, DOI 10.1021/ac100188x; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yates EA, 1996, CARBOHYD RES, V294, P15; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	57	56	58	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.398826	http://dx.doi.org/10.1074/jbc.M112.398826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019343	hybrid, Green Published			2022-12-25	WOS:000311233800073
J	Grzegorzewicz, AE; Kordulakova, J; Jones, V; Born, SEM; Belardinelli, JM; Vaquie, A; Gundi, VAKB; Madacki, J; Slama, N; Laval, F; Vaubourgeix, J; Crew, RM; Gicquel, B; Daffe, M; Morbidoni, HR; Brennan, PJ; Quemard, A; McNeil, MR; Jackson, M				Grzegorzewicz, Anna E.; Kordulakova, Jana; Jones, Victoria; Born, Sarah E. M.; Belardinelli, Juan M.; Vaquie, Adrien; Gundi, Vijay A. K. B.; Madacki, Jan; Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Crew, Rebecca M.; Gicquel, Brigitte; Daffe, Mamadou; Morbidoni, Hector R.; Brennan, Patrick J.; Quemard, Annaik; McNeil, Michael R.; Jackson, Mary			A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG; CYCLOPROPANATION; DERIVATIVES; SYSTEM	Isoxyl (ISO) and thiacetazone (TAC), two prodrugs once used in the clinical treatment of tuberculosis, have long been thought to abolish Mycobacterium tuberculosis (M. tuberculosis) growth through the inhibition of mycolic acid biosynthesis, but their respective targets in this pathway have remained elusive. Here we show that treating M. tuberculosis with ISO or TAC results in both cases in the accumulation of 3-hydroxy C-18, C-20, and C-22 fatty acids, suggestive of an inhibition of the dehydratase step of the fatty-acid synthase type II elongation cycle. Consistently, overexpression of the essential hadABC genes encoding the (3R)-hydroxyacyl-acyl carrier protein dehydratases resulted in more than a 16- and 80-fold increase in the resistance of M. tuberculosis to ISO and TAC, respectively. A missense mutation in the hadA gene of spontaneous ISO- and TAC-resistant mutants was sufficient to confer upon M. tuberculosis high level resistance to both drugs. Other mutations found in hypersusceptible or resistant M. tuberculosis and Mycobacterium kansasii isolates mapped to hadC. Mutations affecting the non-essential mycolic acid methyltransferases MmaA4 and MmaA2 were also found in M. tuberculosis spontaneous ISO- and TAC-resistant mutants. That MmaA4, at least, participates in the activation of the two prodrugs as proposed earlier is not supported by our biochemical evidence. Instead and in light of the known interactions of both MmaA4 and MmaA2 with HadAB and HadBC, we propose that mutations affecting these enzymes may impact the binding of ISO and TAC to the dehydratases.	[Grzegorzewicz, Anna E.; Jones, Victoria; Born, Sarah E. M.; Vaquie, Adrien; Gundi, Vijay A. K. B.; Crew, Rebecca M.; Brennan, Patrick J.; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Kordulakova, Jana; Madacki, Jan] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Belardinelli, Juan M.; Morbidoni, Hector R.] Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, Santa Fe, NM, Argentina; [Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Daffe, Mamadou; Quemard, Annaik] CNRS, IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Daffe, Mamadou; Quemard, Annaik] Univ Toulouse Paul Sabatier, F-31077 Toulouse, France; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, F-75015 Paris, France	Colorado State University; Comenius University Bratislava; National University of Rosario; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	M.Mcneil@colostate.edu; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Belardinelli, Juan Manuel/N-7335-2019; LAUZERAL-VIZCAINO, Françoise/W-8898-2019; Gundi, Vijay A.K.B./B-6121-2013; Kordulakova, Jana/I-3887-2014; Jackson, Mary/D-5345-2017	Belardinelli, Juan Manuel/0000-0003-1336-9141; LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Vaubourgeix, Julien/0000-0003-4872-0464; Quemard, Annaik/0000-0002-5545-3424; Madacki, Jan/0000-0001-6534-4240; Born, Sarah/0000-0001-5964-3121	National Institutes of Health from the NIAID [AI085992, AI063054]; Heiser Program for Research in Leprosy and Tuberculosis; Slovak Research and Development Agency [APVV-0441-10]; National University of Rosario; Proyectos de Investigacion Cientifica y Tecnologica from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina [38198]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054, RC1AI085992] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Heiser Program for Research in Leprosy and Tuberculosis; Slovak Research and Development Agency(Slovak Research and Development Agency); National University of Rosario; Proyectos de Investigacion Cientifica y Tecnologica from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI085992 and AI063054 from the NIAID. This work was also supported by the Heiser Program for Research in Leprosy and Tuberculosis (a fellowship to J. K.), Slovak Research and Development Agency Contract APVV-0441-10, and grants from the National University of Rosario and Proyectos de Investigacion Cientifica y Tecnologica Grant 38198 from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli J.M., 2012, MOL MICROBI IN PRESS; Brown JR, 2011, BIOORGAN MED CHEM, V19, P5585, DOI 10.1016/j.bmc.2011.07.034; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Kordulakova J, 2007, ANTIMICROB AGENTS CH, V51, P3824, DOI 10.1128/AAC.00433-07; LAMBELIN G, 1970, ANTIBIOT CHEMOTHER, V16, P84; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; Nishida CR, 2011, CHEM-BIOL INTERACT, V192, P21, DOI 10.1016/j.cbi.2010.09.015; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Titscher R, 1966, Prax Pneumol, V20, P202; URBANCIK B, 1970, ANTIBIOT CHEMOTHER, V16, P117; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; WINDER FG, 1971, J GEN MICROBIOL, V66, P379, DOI 10.1099/00221287-66-3-379	25	66	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38434	38441		10.1074/jbc.M112.400994	http://dx.doi.org/10.1074/jbc.M112.400994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23002234	Green Published, hybrid			2022-12-25	WOS:000310982800003
J	Kudo, Y; Iizuka, S; Yoshida, M; Tsunematsu, T; Kondo, T; Subarnbhesaj, A; Deraz, EM; Siriwardena, SBSM; Tahara, H; Ishimaru, N; Ogawa, I; Takata, T				Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Tsunematsu, Takaaki; Kondo, Tomoyuki; Subarnbhesaj, Ajiravudh; Deraz, Elsayed M.; Siriwardena, Samadarani B. S. M.; Tahara, Hidetoshi; Ishimaru, Naozumi; Ogawa, Ikuko; Takata, Takashi			Matrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; COLLAGENASE-3 EXPRESSION; CANCER; HEAD; METASTASIS; MYOFIBROBLASTS; FIBROBLASTS; TRANSITION; INHIBITORS; MIGRATION	Matrix metalloproteinases (MMPs) are extracellular zinc-dependent endopeptidases involved in the degradation and remodeling of extracellular matrix in physiological and pathological processes. MMPs also have a role in cell proliferation, migration, differentiation, angiogenesis, and apoptosis. We previously identified cancer invasion-related factors by comparing the gene expression profiles between parent and the highly invasive clone of cancer cells. Matrix metalloproteinase-13 (MMP-13) was identified as a common up-regulated gene by cancer invasion-related factors. Although MMP-13 slightly promoted tumor invasion, we found that MMP-13 was involved in tumor angiogenesis. Conditioned medium from MMP-13-overexpressing cells promoted capillary formation of immortalized human umbilical vein endothelial cells. Furthermore, treatment with recombinant MMP-13 protein enhanced capillary tube formation both in vitro and in vivo. MMP-13-promoted capillary tube formation was mediated by activation of focal adhesion kinase and ERK. Interestingly, MMP-13-promoted the secretion of VEGF-A from fibroblasts and endothelial cells. By immunohistochemical analysis, we found a possible correlation between MMP-13 expression and the number of blood vessels in human cancer cases. In summary, these findings suggest that MMP-13 may directly and indirectly promote tumor angiogenesis.	[Kudo, Yasusei; Kondo, Tomoyuki; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan; [Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Tsunematsu, Takaaki; Subarnbhesaj, Ajiravudh; Deraz, Elsayed M.; Siriwardena, Samadarani B. S. M.; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan	Tokushima University; Hiroshima University; Hiroshima University; Hiroshima University	Kudo, Y (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	yasusei@tokushima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science, and Culture of Japan; research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science; Kurozumi Memorial Foundation grant; Grants-in-Aid for Scientific Research [23300363] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science; Kurozumi Memorial Foundation grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, and Culture of Japan (to Y. K. and T. Ta.), a research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science (to S. I. and T. Ts.), and a Kurozumi Memorial Foundation grant (to Y. K.).	Anno K, 2007, BIOCHEM BIOPH RES CO, V353, P926, DOI 10.1016/j.bbrc.2006.12.112; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Baek Y.Y, 2011, EUR J PHARMACOL, V674, P629; Bauer KS, 2000, J PHARMACOL EXP THER, V292, P31; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Corte MD, 2005, INT J BIOL MARKER, V20, P242, DOI 10.1177/172460080502000407; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Culhaci N, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-42; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; del Casar Lizcano J M, 2003, Gastroenterol Hepatol, V26, P1; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOLKMAN J, 2000, CANC MED, P132; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Howell GMS, 2005, HEAD NECK-J SCI SPEC, V27, P710, DOI 10.1002/hed.20222; ILLC D, 1995, NATURE, V377, P539; Johansson N, 1999, AM J PATHOL, V154, P469, DOI 10.1016/S0002-9440(10)65293-5; Johansson N, 1997, AM J PATHOL, V151, P499; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Krecicki T, 2003, EUR ARCH OTO-RHINO-L, V260, P494, DOI 10.1007/s00405-003-0610-2; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Luukkaa M, 2006, HEAD NECK-J SCI SPEC, V28, P225, DOI 10.1002/hed.20322; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nielsen BS, 2001, CANCER RES, V61, P7091; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Pendas AM, 2000, CLIN CHIM ACTA, V291, P137, DOI 10.1016/S0009-8981(99)00225-9; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Roeb E, 2004, INT J COLORECTAL DIS, V19, P518, DOI 10.1007/s00384-004-0592-6; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; SCHOR SL, 1985, J CELL SCI, V73, P221; Tardif G, 2004, MOD RHEUMATOL, V14, P1489; Uitto VJ, 1998, AM J PATHOL, V152, P1489; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	48	81	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38716	38728		10.1074/jbc.M112.373159	http://dx.doi.org/10.1074/jbc.M112.373159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992737	hybrid, Green Published			2022-12-25	WOS:000310982800030
J	McKoy, AF; Chen, J; Schupbach, T; Hecht, MH				McKoy, Angela Fortner; Chen, Jermont; Schupbach, Trudi; Hecht, Michael H.			A Novel Inhibitor of Amyloid beta (A beta) Peptide Aggregation FROM HIGH THROUGHPUT SCREENING TO EFFICACY IN AN ANIMAL MODEL OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINKGO-BILOBA; DROSOPHILA MODEL; PROTEIN; OLIGOMERS; TOXICITY; ASSAY	Compelling evidence indicates that aggregation of the amyloid beta (A beta) peptide is a major underlying molecular culprit in Alzheimer disease. Specifically, soluble oligomers of the 42-residue peptide (A beta 42) lead to a series of events that cause cellular dysfunction and neuronal death. Therefore, inhibiting A beta 42 aggregation may be an effective strategy for the prevention and/or treatment of disease. We describe the implementation of a high throughput screen for inhibitors of A beta 42 aggregation on a collection of 65,000 small molecules. Among several novel inhibitors isolated by the screen, compound D737 was most effective in inhibiting A beta 42 aggregation and reducing A beta 42-induced toxicity in cell culture. The protective activity of D737 was most significant in reducing the toxicity of high molecular weight oligomers of A beta 42. The ability of D737 to prevent A beta 42 aggregation protects against cellular dysfunction and reduces the production/accumulation of reactive oxygen species. Most importantly, treatment with D737 increases the life span and locomotive ability of flies in a Drosophila melanogaster model of Alzheimer disease.	[McKoy, Angela Fortner; Chen, Jermont; Hecht, Michael H.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Schupbach, Trudi] Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Hecht, MH (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hecht@princeton.edu		Hecht, Michael/0000-0002-5538-9813	National Institutes of Health [5R21AG028462]; NCI Initiative for Chemical Genetics, National Institutes of Health [N01-CO-12400]; Alzheimer Association [IIRG-08-89944]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R21AG028462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Initiative for Chemical Genetics, National Institutes of Health; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21AG028462 (to M. H. H.) and the NCI Initiative for Chemical Genetics, National Institutes of Health, under Contract N01-CO-12400 and has been performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. This work was also supported by Award IIRG-08-89944 from the Alzheimer Association (to M. H. H.) and by the Howard Hughes Medical Institute (to T. S.).	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clippingdale AB, 2001, J PEPT SCI, V7, P227; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2006, NY TIMES BK REV, P1; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shaykhalishahi H, 2009, EUR J PHARMACOL, V622, P1, DOI 10.1016/j.ejphar.2009.07.017; Shi C, 2009, CHEM-BIOL INTERACT, V181, P115, DOI 10.1016/j.cbi.2009.05.010; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yao ZX, 2001, BRAIN RES, V889, P181, DOI 10.1016/S0006-8993(00)03131-0; Yazdanparast R, 2009, TOXICOL IN VITRO, V23, P1277, DOI 10.1016/j.tiv.2009.07.024	37	91	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38992	39000		10.1074/jbc.M112.348037	http://dx.doi.org/10.1074/jbc.M112.348037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992731	Green Published, hybrid			2022-12-25	WOS:000310982800055
J	Yang, FK; Yao, YX; Jiang, YP; Lu, L; Ma, YP; Dai, W				Yang, Feikun; Yao, Yixin; Jiang, Yongping; Lu, Luo; Ma, Yupo; Dai, Wei			Sumoylation Is Important for Stability, Subcellular Localization, and Transcriptional Activity of SALL4, an Essential Stem Cell Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; PROTEASE 2; SOX2; ONCOGENE; GENE; PHOSPHORYLATION; PLURIPOTENCY; MUTATIONS; REGULATOR; ROLES	SALL4 is a transcription factor that plays a key role in the maintenance and self-renewal of embryonic stem cells and hematopoietic stem cells. Given that little is known about regulation of SALL4, we studied biochemical modifications of SALL4B, a major splicing variant of SALL4, and elucidated their biological function. SALL4B was primarily modified by ubiquitination when it was expressed in both Sf9 and HEK293T cells. A significant fraction of SALL4B was further modified by sumoylation when it was expressed in HEK293T cells. Constitutive SUMO-modification of SALL4B was also detected in Tera-1, a cell line of the teratocarcinoma origin. SALL4B sumoylation was independent of ubiquitination and lysine residues 156, 316, 374, and 401 were essential for sumoylation. Chromatin fraction contained more SUMO-deficient SALL4B. Despite a shorter half-life than the wild-type counterpart, SUMO-deficient SALL4B interacted with OCT4 more efficiently than the wild-type SALL4B. RNAi-mediated silencing of SALL4 expression caused significant down-regulation of both OCT4 and SOX2, which was rescued by ectopic expression of SALL4B but not by SUMO-deficient mutant. Significantly, compared with the wild-type SALL4B, SUMO-deficient mutant exhibited compromised trans-activation or trans-repression activities in reporter gene assays. Combined, our studies reveal sumoylation as a novel form of post-translational modification for regulating the stability, subcellular localization, and transcriptional activity of SALL4.	[Yang, Feikun; Yao, Yixin; Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Jiang, Yongping; Ma, Yupo; Dai, Wei] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215021, Peoples R China; [Jiang, Yongping; Ma, Yupo; Dai, Wei] Peking Union Med Coll, Suzhou 215021, Peoples R China; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Mol Med, Torrance, CA 90501 USA; [Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	New York University; NYU Langone Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dai, W (corresponding author), NYU, Langone Med Ctr, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; Yao, Yixin/0000-0003-1891-7186	US Public Service Awards [CA090658, ES019929]; NIEHS Center Grant [ES000260]; key State project of China on iPS and stem cell research [2011ZX09102-010-04]; NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020591, P30ES000260, R03ES019929] Funding Source: NIH RePORTER	US Public Service Awards; NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); key State project of China on iPS and stem cell research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by US Public Service Awards (to W. D.) (CA090658 and ES019929), NIEHS Center Grant ES000260, and a key State project of China on iPS and stem cell research (2011ZX09102-010-04).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Miertus J, 2006, HUM GENET, V119, P154, DOI 10.1007/s00439-005-0124-7; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Paradisi I, 2007, AM J MED GENET A, V143A, P326, DOI 10.1002/ajmg.a.31603; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Shuai X, 2009, CANCER GENET CYTOGEN, V194, P119, DOI 10.1016/j.cancergencyto.2009.06.006; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang BB, 2010, INT J CARDIOL, V145, P224, DOI 10.1016/j.ijcard.2009.05.067; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang FK, 2012, J BIOL CHEM, V287, P4875, DOI 10.1074/jbc.M111.318261; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yang WH, 2009, MOL CELL BIOL, V29, P613, DOI 10.1128/MCB.00295-08; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	41	25	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38600	38608		10.1074/jbc.M112.391441	http://dx.doi.org/10.1074/jbc.M112.391441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012367	hybrid, Green Published			2022-12-25	WOS:000310982800020
J	Sasahara, K; Cody, ML; Cohen, D; Taylor, CE				Sasahara, Kazutoshi; Cody, Martin L.; Cohen, David; Taylor, Charles E.			Structural Design Principles of Complex Bird Songs: A Network-Based Approach	PLOS ONE			English	Article							REPERTOIRE SIZE; SMALL-WORLD; EVOLUTION; SYNTAX; RULES	Bird songs are acoustic communication signals primarily used in male-male aggression and in male-female attraction. These are often monotonous patterns composed of a few phrases, yet some birds have extremely complex songs with a large phrase repertoire, organized in non-random fashion with discernible patterns. Since structure is typically associated with function, the structures of complex bird songs provide important clues to the evolution of animal communication systems. Here we propose an efficient network-based approach to explore structural design principles of complex bird songs, in which the song networks-transition relationships among different phrases and the related structural measures-are employed. We demonstrate how this approach works with an example using California Thrasher songs, which are sequences of highly varied phrases delivered in succession over several minutes. These songs display two distinct features: a large phrase repertoire with a 'small-world' architecture, in which subsets of phrases are highly grouped and linked with a short average path length; and a balanced transition diversity amongst phrases, in which deterministic and non-deterministic transition patterns are moderately mixed. We explore the robustness of this approach with variations in sample size and the amount of noise. Our approach enables a more quantitative study of global and local structural properties of complex bird songs than has been possible to date.	[Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Cody, Martin L.; Taylor, Charles E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Cohen, David] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Cohen, David] Carnegie Mellon Univ, Dept Elect & Comp Engn, Moffett Field, CA USA	Nagoya University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Carnegie Mellon University	Sasahara, K (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	sasahara@is.nagoya-u.ac.jp		Sasahara, Kazutoshi/0000-0003-2572-0648; Cody, Martin/0000-0003-2028-8390	National Science Foundation [1125423]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [24700291]	National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by National Science Foundation Award No. 1125423. KS was supported by the Japan Society for the Promotion of Science Fellowship and a Grant-in Aid (No. 24700291) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MC, 1986, AM NAT, V128, P491, DOI 10.1086/284582; Bollobas B., 2001, RANDOM GRAPHS; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; CHATFIELD C, 1970, J THEOR BIOL, V29, P427, DOI 10.1016/0022-5193(70)90107-4; Cody ML, 1998, BIRDS N AM ONLINE; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Garamszegi LZ, 2005, BEHAV ECOL SOCIOBIOL, V57, P305, DOI 10.1007/s00265-004-0866-6; HIEBERT SM, 1989, ANIM BEHAV, V37, P266, DOI 10.1016/0003-3472(89)90115-2; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Kakishita Y, 2009, DATA MIN KNOWL DISC, V18, P446, DOI 10.1007/s10618-008-0122-1; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; Kroodsma Donald, 2005, SINGING LIFE BIRDS; LEMON RE, 1993, ETHOLOGY, V93, P198; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; Marler P, 2004, NATURES MUSIC SCI BI, P39; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Sasahara K, 2007, ARTIF LIFE, V13, P259, DOI 10.1162/artl.2007.13.3.259; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; Todt D, 1998, BIOL CYBERN, V79, P487, DOI 10.1007/s004220050498; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Zann RA., 1996, ZEBRA FINCH SYNTHESI	34	50	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44436	10.1371/journal.pone.0044436	http://dx.doi.org/10.1371/journal.pone.0044436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028539	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700012
J	van Zoggel, H; Carpentier, G; Dos Santos, C; Hamma-Kourbali, Y; Courty, J; Amiche, M; Delbe, J				van Zoggel, Hanneke; Carpentier, Gilles; Dos Santos, Celia; Hamma-Kourbali, Yamina; Courty, Jose; Amiche, Mohamed; Delbe, Jean			Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2	PLOS ONE			English	Article							AFFIN REGULATORY PEPTIDE; CARCINOMA-CELL LINES; PHOSPHOLIPID-MEMBRANES; FROG-SKIN; BOVINE LACTOFERRICIN; CYTOLYTIC ACTIVITY; CATIONIC PEPTIDES; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; CANCER-CELLS	Recently, we have found that the skin secretions of the Amazonian tree frog Phyllomedusa bicolor contains molecules with antitumor and angiostatic activities and identified one of them as the antimicrobial peptide dermaseptin (Drs) B2. In the present study we further explored the in vitro and in vivo antitumor activity of this molecule and investigated its mechanism of action. We showed that Drs B2 inhibits the proliferation and colony formation of various human tumor cell types, and the proliferation and capillary formation of endothelial cells in vitro. Furthermore, Drs B2 inhibited tumor growth of the human prostate adenocarcinoma cell line PC3 in a xenograft model in vivo. Research on the mechanism of action of Drs B2 on tumor PC3 cells demonstrated a rapid increasing amount of cytosolic lactate dehydrogenase, no activation of caspase-3, and no changes in mitochondrial membrane potential. Confocal microscopy analysis revealed that Drs B2 can interact with the tumor cell surface, aggregate and penetrate the cells. These data together indicate that Drs B2 does not act by apoptosis but possibly by necrosis. In conclusion, Drs B2 could be considered as an interesting and promising pharmacological and therapeutic leader molecule for the treatment of cancer.	[van Zoggel, Hanneke; Carpentier, Gilles; Dos Santos, Celia; Hamma-Kourbali, Yamina; Courty, Jose; Amiche, Mohamed; Delbe, Jean] Univ Paris Est Creteil, Lab Rech Croissance Cellulaire Reparat & Regenera, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Delbe, J (corresponding author), Univ Paris Est Creteil, Lab Rech Croissance Cellulaire Reparat & Regenera, Creteil, France.	delbe@univ-paris12.fr	Hamma-Kourbali, Yamina/R-3692-2018; Courty, Jose/Q-3702-2018; Delbe, Jean/R-3680-2018; AMICHE, Mohamed/R-3684-2018	Hamma-Kourbali, Yamina/0000-0002-2754-8928; Dos Santos, Celia/0000-0002-0431-1004; Carpentier, Gilles/0000-0002-3730-7263	French Agence Nationale de la Recherche [ANR-06-RIB 016-02]; French Association pour la Recherche sur le Cancer; ANR [ANR-06-RIB 016-02]; French Institut national du cancer from the Centre National de la Recherche Scientifique [INCA-PL06-093]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR(French National Research Agency (ANR)); French Institut national du cancer from the Centre National de la Recherche Scientifique	Hanneke van Zoggel was funded by a grant from the French Agence Nationale de la Recherche (ANR-06-RIB 016-02) and by the French Association pour la Recherche sur le Cancer. This work was partly supported by a grant from ANR (ANR-06-RIB 016-02) and a grant from the French Institut national du cancer (INCA-PL06-093) from the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour A, 2008, BIOCHIMIE, V90, P1791, DOI 10.1016/j.biochi.2008.04.010; AMICHE M, 1994, J BIOL CHEM, V269, P17847; AMICHE M, 1993, BIOCHEM BIOPH RES CO, V191, P983, DOI 10.1006/bbrc.1993.1314; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; BAKER MA, 1993, CANCER RES, V53, P3052; Banki K, 1999, J IMMUNOL, V162, P1466; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier G, 2010, IMAGE J; Carpentier G, 2009, IMAGE J; Charpentier S, 1998, J BIOL CHEM, V273, P14690, DOI 10.1074/jbc.273.24.14690; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Conlon JM, 2007, TOXICON, V50, P498, DOI 10.1016/j.toxicon.2007.04.017; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DALY JW, 1992, P NATL ACAD SCI USA, V89, P10960, DOI 10.1073/pnas.89.22.10960; DAUCHEL MC, 1989, J CELL BIOCHEM, V39, P411, DOI 10.1002/jcb.240390407; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Eliassen LT, 2002, ANTICANCER RES, V22, P2703; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Gatti L, 2005, METH MOLEC MED, V111, P127; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GOSPODAROWICZ D, 1983, J CELL BIOL, V97, P1677, DOI 10.1083/jcb.97.6.1677; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffa A., 2010, GIT IMAGING MICROSCO, V1, P43; HABERMANN E, 1965, BIOCHEM Z, V343, P192; Hamma-Kourbali Y, 2008, J CELL PHYSIOL, V214, P250, DOI 10.1002/jcp.21191; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huet E, 2011, AM J PATHOL, V179, P1278, DOI 10.1016/j.ajpath.2011.05.036; Jenssen H, 2005, J PEPT RES, V66, P48, DOI 10.1111/j.1747-0285.2006.00332.x; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; La Rocca P, 1999, BIOPHYS CHEM, V76, P145, DOI 10.1016/S0301-4622(98)00232-4; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Liao PC, 2005, LIFE SCI, V76, P1623, DOI 10.1016/j.lfs.2004.09.021; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Littmann E, 1997, IEEE T NEURAL NETWOR, V8, P175, DOI 10.1109/72.554203; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Mai JC, 2001, CANCER RES, V61, P7709; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; MOR A, 1994, BIOCHEMISTRY-US, V33, P6642, DOI 10.1021/bi00187a034; MOR A, 1994, J BIOL CHEM, V269, P1934; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Nicolas P, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P295, DOI 10.1016/B978-012369442-3/50048-9; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Nishimura M, 2004, J DERMATOL SCI, V36, P87, DOI 10.1016/j.jdermsci.2004.07.001; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Papo N, 2003, BIOCHEMISTRY-US, V42, P9346, DOI 10.1021/bi027212o; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Rasband W.S., 1997, IMAGE J; Ridler T, 1978, IEEE T SYSTEMS MAN C; Savoia D, 2008, BIOORGAN MED CHEM, V16, P8205, DOI 10.1016/j.bmc.2008.07.032; Shin SY, 2000, BIOCHEM BIOPH RES CO, V275, P904, DOI 10.1006/bbrc.2000.3269; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Vacherot F, 1999, PROSTATE, V38, P126, DOI 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C; van Zoggel H, 2012, AMINO ACIDS, V42, P385, DOI 10.1007/s00726-010-0815-9; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Walter J, 2001, IMAGE J; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375; Yoo YC, 1997, JPN J CANCER RES, V88, P184, DOI 10.1111/j.1349-7006.1997.tb00364.x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	76	46	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44351	10.1371/journal.pone.0044351	http://dx.doi.org/10.1371/journal.pone.0044351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028527	Green Published, gold			2022-12-25	WOS:000309388900009
J	Gorostiza, A; Acunha-Alonzo, V; Regalado-Liu, L; Tirado, S; Granados, J; Samano, D; Rangel-Villalobos, H; Gonzalez-Martin, A				Gorostiza, Amaya; Acunha-Alonzo, Victor; Regalado-Liu, Lucia; Tirado, Sergio; Granados, Julio; Samano, David; Rangel-Villalobos, Hector; Gonzalez-Martin, Antonio			Reconstructing the History of Mesoamerican Populations through the Study of the Mitochondrial DNA Control Region	PLOS ONE			English	Article							GENETIC-STRUCTURE; MTDNA; PATTERNS; DIVERSITY; ANCESTRY; SOFTWARE; BARRIERS; MESTIZOS; AMERICA; ORIGIN	The study of genetic information can reveal a reconstruction of human population's history. We sequenced the entire mtDNA control region (positions 16.024 to 576 following Cambridge Reference Sequence, CRS) of 605 individuals from seven Mesoamerican indigenous groups and one Aridoamerican from the Greater Southwest previously defined, all of them in present Mexico. Samples were collected directly from the indigenous populations, the application of an individual survey made it possible to remove related or with other origins samples. Diversity indices and demographic estimates were calculated. Also AMOVAs were calculated according to different criteria. An MDS plot, based on FST distances, was also built. We carried out the construction of individual networks for the four Amerindian haplogroups detected. Finally, barrier software was applied to detect genetic boundaries among populations. The results suggest: a common origin of the indigenous groups; a small degree of European admixture; and inter-ethnic gene flow. The process of Mesoamerica's human settlement took place quickly influenced by the region's orography, which development of genetic and cultural differences facilitated. We find the existence of genetic structure is related to the region's geography, rather than to cultural parameters, such as language. The human population gradually became fragmented, though they remained relatively isolated, and differentiated due to small population sizes and different survival strategies. Genetic differences were detected between Aridoamerica and Mesoamerica, which can be subdivided into "East", "Center", "West" and "Southeast". The fragmentation process occurred mainly during the Mesoamerican Pre-Classic period, with the Otomi being one of the oldest groups. With an increased number of populations studied adding previously published data, there is no change in the conclusions, although significant genetic heterogeneity can be detected in Pima and Huichol groups. This result may be explained because populations historically assigned as belonging to the same group were, in fact, different indigenous populations.	[Gorostiza, Amaya; Regalado-Liu, Lucia; Tirado, Sergio; Gonzalez-Martin, Antonio] Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain; [Gorostiza, Amaya] GENOM SAU Grp Zeltia, Lab Identificac Genet, Madrid, Spain; [Acunha-Alonzo, Victor] Escuela Nacl Antropol & Hist, Genet Mol Lab, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Immunogenet, Dept Trasplantes, Mexico City, DF, Mexico; [Samano, David] Univ Autonoma Estado Mexico, Acad Cultura Cient Humanist, Mexico City, DF, Mexico; [Rangel-Villalobos, Hector] Univ Guadalajara, Ctr Univ Cienaga, Inst Invest Genet Mol, Ocotlan, Mexico	Complutense University of Madrid; PharmaMar; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma del Estado de Mexico; Universidad de Guadalajara	Gonzalez-Martin, A (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain.	antonio@bio.ucm.es	Acuna Alonzo, Victor/E-2312-2013; Gonzalez-Martin, Antonio/A-5489-2015; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Acuna Alonzo, Victor/0000-0003-2205-7625; Gonzalez-Martin, Antonio/0000-0003-0276-0778; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782	Mexican government (CONACyT) [129693]; Ministerio de Ciencia e Innovacion, Spain [HAR 2010-21963]	Mexican government (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Mexican government (CONACyT No129693 grant) to H. R.-V. and HAR 2010-21963 from Ministerio de Ciencia e Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbujani G, 2006, HUM HERED, V61, P15, DOI 10.1159/000091832; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Bolnick DA, 2003, AM J PHYS ANTHROPOL, V122, P336, DOI 10.1002/ajpa.10284; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CAMPBELL L, 1986, LANGUAGE, V62, P530, DOI 10.2307/415477; Campbell Lyle, 1997, AM INDIAN LANGUAGES; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Crawford MH, 2010, HUM BIOL, V82, P695, DOI 10.3378/027.082.0511; Duverger C, 2007, PRIMER MESTIZAJE CLA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hedrick BC, 1974, MESOAMERICAN SW A RE; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hernandez Montes M, 2004, TEPEHUAS PUEBLOS IND; Hope M, 2006, PIMAS; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kemp BM, 2005, BIOMOLECULAR ARCHAEO, P22; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kroeber AL, 1939, U CALIFORNIA PUBLICA; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Moctezuma Zamarron JL, 2007, MAYOS; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Nikolai G, 2006, MAYAS CIVILIZACION M; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Pailes RA, 1995, WORLDWIDE ARCHAEOLOG; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramachandran S, 2011, AM J PHYS ANTHROPOL, V146, P515, DOI 10.1002/ajpa.21533; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Salazar-Flores J, 2010, AM J HUM BIOL, V22, P401, DOI 10.1002/ajhb.21013; Sanders William T., 1968, MESOAMERICA EVOLUTIO; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Tajima F, 1996, GENETICS, V143, P1457; Tajima F, 1993, MECH MOL EVOLUTION I; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TORRONI A, 1993, AM J HUM GENET, V53, P563; Townsend RF, 1992, AZTECS; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	55	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44666	10.1371/journal.pone.0044666	http://dx.doi.org/10.1371/journal.pone.0044666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028577	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400032
J	Morillo, E; Sanchez-Trujillo, MA; Moyano, JR; Villaverde, J; Gomez-Pantoja, ME; Perez-Martinez, JI				Morillo, Esmeralda; Antonia Sanchez-Trujillo, Maria; Ramon Moyano, Jose; Villaverde, Jaime; Eulalia Gomez-Pantoja, Maria; Ignacio Perez-Martinez, Jose			Enhanced Solubilisation of Six PAHs by Three Synthetic Cyclodextrins for Remediation Applications: Molecular Modelling of the Inclusion Complexes	PLOS ONE			English	Article							HYDROXYPROPYL-BETA-CYCLODEXTRIN; FORMATION-CONSTANTS; CONTAMINATED SOILS; AROMATIC-HYDROCARBONS; HERBICIDE NORFLURAZON; GAMMA-CYCLODEXTRIN; ORGANIC-COMPOUNDS; MM2 CALCULATIONS; CHEMISTRY; THERMODYNAMICS	Solubilisation of six polycyclic aromatic hydrocarbons (PAHs) (acenaphthene, anthracene, fluoranthene, fluorene, phenanthrene and pyrene) by three synthetic cyclodextrins (CDs) (2-hydroxypropyl-beta-CD, hydroxypropyl-gamma-CD and ramdomly methylated-beta-CD) was investigated in order to select the CD which presents the greatest increase in solubility and better complexation parameters for its use in contaminated scenarios. The presence of the three cyclodextrins greatly enhanced the apparent water solubility of all the PAHs through the formation of inclusion complexes of 1: 1 stoichiometry. Anthracene, fluoranthene, fluorene and phenanthrene clearly presented a higher solubility when beta-CD derivatives were used, and especially the complexes with the ramdomly methylated-beta-CD were favoured. On the contrary, pyrene presented its best solubility results when using 2-hydroxypropyl-gamma-CD, but for acenaphthene the use of any of the three CDs gave the same results. Complementary to experimental phase-solubility studies, a more in-depth estimation of the inclusion process for the different complexes was carried out using molecular modelling in order to find a correlation between the degree of solubilisation and the fit of PAH molecules within the cavity of the different CDs and to know the predominant driving forces of the complexation.	[Morillo, Esmeralda; Antonia Sanchez-Trujillo, Maria; Villaverde, Jaime; Eulalia Gomez-Pantoja, Maria] Sci Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol Seville, Agrochem & Soil Conservaton Dept, Seville, Spain; [Ramon Moyano, Jose; Ignacio Perez-Martinez, Jose] Univ Seville, Fac Pharm, Dept Pharm & Pharmaceut Technol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Sevilla	Morillo, E (corresponding author), Sci Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol Seville, Agrochem & Soil Conservaton Dept, Seville, Spain.	morillo@irnase.csic.es	Villaverde, Jaime/J-3835-2015; Pérez-Martínez, José Ignacio/AAT-6984-2020; Villaverde, Jaime/AAG-1424-2021; Morillo, Esmeralda/E-2180-2017; Moyano Mendez, Jose Ramon/L-8949-2018	Villaverde, Jaime/0000-0002-8694-7929; Villaverde, Jaime/0000-0002-8694-7929; Morillo, Esmeralda/0000-0002-4485-2315; Perez Martinez, Jose Ignacio/0000-0001-5955-716X; Moyano Mendez, Jose Ramon/0000-0003-0200-3806; Gomez-Pantoja Cabezas, Maria Eulalia/0000-0001-5802-2083	Spanish Ministry of Science and Innovation [CTM2006-04626, CTM2009-07335]; Fondo Europeo de Desarrollo Regional, FEDER; CSIC [JAEPre 0800763]; Fondo Social Europeo (FSE)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional, FEDER(European CommissionSpanish Government); CSIC; Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission)	Support from projects CTM2006-04626 and CTM2009-07335, Spanish Ministry of Science and Innovation (co-funded by Fondo Europeo de Desarrollo Regional, FEDER), are greatly appreciated. M. A. Sanchez-Trujillo acknowledges a research contract from CSIC (JAEPre 0800763) cofinanced by Fondo Social Europeo (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan IJ, 2007, ENVIRON SCI TECHNOL, V41, P5498, DOI 10.1021/es0704939; [Anonymous], 2009, HYPERCH 8 0 8 WIND; Aree T, 1999, CARBOHYD RES, V315, P199, DOI 10.1016/S0008-6215(99)00033-6; Badr T, 2004, J HAZARD MATER, V112, P215, DOI 10.1016/j.jhazmat.2004.04.017; Balogh K, 2007, J INCL PHENOM MACRO, V57, P457, DOI 10.1007/s10847-006-9234-7; Barbiric DJ, 2000, J MOL STRUC-THEOCHEM, V532, P171, DOI 10.1016/S0166-1280(00)00516-9; Bardi L, 2007, J INCL PHENOM MACRO, V57, P439, DOI 10.1007/s10847-006-9231-x; BLYSHAK LA, 1989, ANAL CHEM, V61, P955, DOI 10.1021/ac00184a008; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Castagne D, 2010, J PHARM PHARM SCI, V13, P362, DOI 10.18433/J3BS34; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; DELAPENA AM, 1991, J PHYS CHEM-US, V95, P3330; Do Thi T, 2010, J PHARM SCI-US, V99, P3863, DOI 10.1002/jps.22227; Dodziuk H., 2006, CYCLODEXTRINS THEIR, P333; FATHALLAH M, 1994, J ORG CHEM, V59, P1288, DOI 10.1021/jo00085a015; Fenyvesi E, 1996, J INCLUS PHENOM MOL, V25, P229, DOI 10.1007/BF01041575; Fifere A, 2011, CELL CHEM TECHNOL, V45, P149; Gruiz K, 2010, CONSTRUCTION FOR A SUSTAINABLE ENVIRONMENT, P207; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Immel S, 1996, STARCH-STARKE, V48, P225, DOI 10.1002/star.19960480606; JAIME C, 1990, J ORG CHEM, V55, P4772, DOI 10.1021/jo00302a058; Ko SO, 1999, ENVIRON SCI TECHNOL, V33, P2765, DOI 10.1021/es9813360; Leila N, 2011, J MOL LIQ, V160, P8, DOI 10.1016/j.molliq.2011.02.016; Lipkowitz KB, 1998, CHEM REV, V98, P1829, DOI 10.1021/cr9700179; Liu L, 2002, J INCL PHENOM MACRO, V42, P1, DOI 10.1023/A:1014520830813; Liu L, 2004, J INCL PHENOM MACRO, V50, P95, DOI 10.1007/s10847-003-8847-3; Loftsson T, 2004, J PHARM SCI-US, V93, P1091, DOI 10.1002/jps.20047; Loftsson T, 2007, INT J PHARMACEUT, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044; Molnar M, 2002, J INCL PHENOM MACRO, V44, P447, DOI 10.1023/A:1023032305920; Morillo E, 2007, J ENVIRON MONITOR, V9, P1001, DOI 10.1039/b705955h; Morillo E, 2008, WATER AIR SOIL POLL, V187, P41, DOI 10.1007/s11270-007-9495-9; Morillo E, 2006, CYCLODEXTRINS THEIR, P459; Ockenden WA, 2003, ENVIRON POLLUT, V121, P75, DOI 10.1016/S0269-7491(02)00204-X; OHASHI M, 1990, J AM CHEM SOC, V112, P5824, DOI 10.1021/ja00171a023; Pinzaru I. A., 2011, Journal of Agroalimentary Processes and Technologies, V17, P123; Ravelet C, 2002, J LIQ CHROMATOGR R T, V25, P421, DOI 10.1081/JLC-120003363; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; SANEMASA I, 1989, B CHEM SOC JPN, V62, P3098, DOI 10.1246/bcsj.62.3098; Stroud JL, 2009, ENVIRON POLLUT, V157, P2678, DOI 10.1016/j.envpol.2009.05.009; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Uekama K, 2006, CYCLODEXTRINS THEIR, P381, DOI DOI 10.1002/3527608982.CH14; UNECE, 1998, PROT PERS ORG POLL 1; Villaverde J, 2005, J AGR FOOD CHEM, V53, P5366, DOI 10.1021/jf0502449; Villaverde J, 2006, J AGR FOOD CHEM, V54, P4766, DOI 10.1021/jf060548a; Wan JZ, 2009, J HAZARD MATER, V166, P221, DOI 10.1016/j.jhazmat.2008.11.021; WANG XJ, 1993, ENVIRON SCI TECHNOL, V27, P2821, DOI 10.1021/es00049a023; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Ying GG, 2006, ENVIRON INT, V32, P417, DOI 10.1016/j.envint.2005.07.004; Yong CW, 2008, PHARM RES, V25, P1092, DOI 10.1007/s11095-007-9506-y; Zhou HW, 2009, J COMPUT AID MOL DES, V23, P153, DOI 10.1007/s10822-008-9247-y	51	44	44	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44137	10.1371/journal.pone.0044137	http://dx.doi.org/10.1371/journal.pone.0044137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028493	Green Published, gold			2022-12-25	WOS:000309388400020
J	Yang, Q; Makarkin, VN; Winterton, SL; Khramov, AV; Ren, D				Yang, Qiang; Makarkin, Vladimir N.; Winterton, Shaun L.; Khramov, Alexander V.; Ren, Dong			A Remarkable New Family of Jurassic Insects (Neuroptera) with Primitive Wing Venation and Its Phylogenetic Position in Neuropterida	PLOS ONE			English	Article							OVERLYING DAOHUGOU BED; GIANT LACEWINGS NEUROPTERA; CRETACEOUS CRATO-FORMATION; INNER-MONGOLIA; NORTHEASTERN CHINA; CLADISTIC-ANALYSIS; EARLY EOCENE; AGE; IGNIMBRITE; AETHEOGRAMMATIDAE	Background: Lacewings (insect order Neuroptera), known in the fossil record since the Early Permian, were most diverse in the Mesozoic. A dramatic variety of forms ranged in that time from large butterfly-like Kalligrammatidae to minute two-winged Dipteromantispidae. Principal Findings: We describe the intriguing new neuropteran family Parakseneuridae fam. nov. with three new genera and 15 new species from the Middle Jurassic of Daohugou (Inner Mongolia, China) and the Early/Middle Jurassic of Sai-Sagul (Kyrgyzstan): Parakseneura undula gen. et sp. nov., P. albomacula gen. et sp. nov., P. curvivenis gen. et sp. nov., P. nigromacula gen. et sp. nov., P. nigrolinea gen. et sp. nov., P. albadelta gen. et sp. nov., P. cavomaculata gen. et sp. nov., P. inflata gen. et sp. nov., P. metallica gen. et sp. nov., P. emarginata gen. et sp. nov., P. directa gen. et sp. nov., Pseudorapisma jurassicum gen. et sp. nov., P. angustipenne gen. et sp. nov., P. maculatum gen. et sp. nov. (Daohugou); Shuraboneura ovata gen. et sp. nov. (Sai-Sagul). The family comprises large neuropterans with most primitive wing venation in the order indicated by the presence of ScA and AA1+2, and the dichotomous branching of MP, CuA, CuP, AA3+4, AP1+2. The phylogenetic position of Parakseneuridae was investigated using a phylogenetic analysis of morphological scoring for 33 families of extinct and extant Neuropterida combined with DNA sequence data for representatives of all extant families. Parakseneuridae were recovered in a clade with Osmylopsychopidae, Prohemerobiidae, and Ithonidae. Conclusions/Significance: The presence of the presumed AA1+2 in wings of Parakseneuridae is a unique plesiomorphic condition hitherto unknown in Neuropterida, the clade comprising Neuroptera, Megaloptera, Raphidioptera. The relative uncertainty of phylogenetic position of Parakseneuridae and the majority of other families of Neuroptera reflects deficient paleontological data, especially from critical important periods for the order, earliest Triassic and latest Triassic/earliest Jurassic.	[Yang, Qiang; Makarkin, Vladimir N.; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Makarkin, Vladimir N.] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok 690022, Russia; [Winterton, Shaun L.] Calif Dept Food & Agr, Calif State Collect Arthropods, Sacramento, CA 95814 USA; [Khramov, Alexander V.] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia	Capital Normal University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences; California Department of Food & Agriculture; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences	Makarkin, VN (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	vnmakarkin@mail.ru; rendong@mail.cnu.edu.cn	Winterton, Shaun L/C-3804-2009	Khramov, Alexander/0000-0002-6888-5162	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31071964, 31172143]; China Geological Survey [1212011120116]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Geological Survey(China Geological Survey)	This research is supported by the National Basic Research Program of China (973 Program) (2012CB821906), the National Natural Science Foundation of China (No. 31071964, 31172143) and China Geological Survey (1212011120116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PHILLIP A., 1958, PSYCHE, V65, P115, DOI 10.1155/1958/26768; Archibald SB, 2006, J SYST PALAEONTOL, V4, P119, DOI 10.1017/S1477201906001817; ASPOCK H, 1991, MONOGRAPHISCHE DARST, V1; Aspock U, 2002, ZOOL SCR, V31, P51, DOI 10.1046/j.0300-3256.2001.00087.x; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock Ulrike, 1992, P63; Bethoux O., 2010, ALAVESIA, V3, P87; Bethoux Olivier, 2005, Illiesia, V1, P52; Beutel RG, 2010, ZOOL J LINN SOC-LOND, V158, P533, DOI 10.1111/j.1096-3642.2009.00560.x; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Comstock JH, 1918, WINGS INSECTS; Contreras-Ramos A, 2011, ZOOTAXA, P1; Engel Michael S., 2005, Transactions of the Kansas Academy of Science, V108, P59, DOI 10.1660/0022-8443(2005)108[0059:ARKLFT]2.0.CO;2; Engel MS, 2011, J KANSAS ENTOMOL SOC, V84, P315, DOI 10.2317/JKES110623.1; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Grimaldi David, 2005, pi; Handlirsch A, 1906, HDB PALAEONTOLOGEN Z; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; He HY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022787; Jepson JE, 2007, PALAEOGEOGR PALAEOCL, V248, P109, DOI 10.1016/j.palaeo.2006.11.015; Jepson JE, 2009, CRETACEOUS RES, V30, P1325, DOI 10.1016/j.cretres.2009.07.012; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; [季强 Ji Qiang], 2002, [地质论评, Geological Review], V48, P221; Ji Qiang, 2005, Geological Review (Beijing), V51, P609; Khramov AV, 2010, PALEONTOL J+, V44, P188, DOI 10.1134/S0031030110020103; Krivokhatsky VA, 1998, THESIS RUSS ACAD SCI; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; Kukalova-Peck J., 1991, P141; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Kuzichkina YM, 1958, C UN STRAT CHARTS CE, P112; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Lambkin Kevin J., 1992, Memoirs of the Queensland Museum, V32, P183; [柳永清 Liu Yanxue], 2004, [地质通报, Geological Bulletin of China], V23, P1180; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Liu YQ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022466; MacLeod E.G., 1964, THESIS HARVARD U CAM; Makarkin V.N., 1990, NOVOSTI FAUNISTIKI S, P63; Makarkin Vladimir N., 1993, Tropical Zoology, V6, P217; Makarkin VN, 2007, CRETACEOUS RES, V28, P743, DOI 10.1016/j.cretres.2006.11.003; Makarkin VN, 2012, CRETACEOUS RES, V35, P57, DOI 10.1016/j.cretres.2011.11.013; Makarkin VN, 2011, ZOOKEYS, P199, DOI 10.3897/zookeys.130.1418; Makarkin VN, 2010, ACTA GEOL SIN-ENGL, V84, P655, DOI 10.1111/j.1755-6724.2010.00238.x; Makarkin VN, 2010, ANN SOC ENTOMOL FR, V46, P254, DOI 10.1080/00379271.2010.10697666; Makarkin VN, 2009, ANN ENTOMOL SOC AM, V102, P964, DOI 10.1603/008.102.0606; Makarkin VN, 2005, CRETACEOUS RES, V26, P801, DOI 10.1016/j.cretres.2005.05.009; Makarkin VN, 2005, ZOOTAXA, P15; Makarkin VN, 2003, CAN ENTOMOL, V135, P637; Makarkin VN, 2003, ANN ENTOMOL SOC AM, V96, P171, DOI 10.1603/0013-8746(2003)096[0171:FAOTGP]2.0.CO;2; Makarkin VN, 2012, FOSSIL RECO IN PRESS; Makarkin VN, 2012, ACTA PALAEO IN PRESS; Martynov AV, 1937, T PALEONT I AKAD NAU, V7; Martynova O.M, 1949, T PALEONTOLOGICHESKO, V20, P150; Martynova OM, 1952, T PALEONTOL I AN SSS, V40, P197; Menon F, 2008, PALAEONTOLOGY, V51, P149, DOI 10.1111/j.1475-4983.2007.00740.x; Mi J.R., 1996, EARLY MIDDLE JURASSI; Nel A, 2005, ANN SOC ENTOMOL FR, V41, P29, DOI 10.1080/00379271.2005.10697440; Nel Andre, 2003, Geodiversitas, V25, P109; Novokshonov V.G., 1996, PALEONTOL J, V30, P38; OSWALD JD, 1993, J NEW YORK ENTOMOL S, V101, P143; Panfilov D.V., 1968, P166; Peng YY, 2010, ZOOTAXA, P59; Peng YY, 2011, ZOOKEYS, P217, DOI 10.3897/zookeys.130.1576; Ponomarenko A. G., 1992, T JOINT SOVIET MONGO, V41, P101; Ponomarenko A.G., 2002, HIST INSECTS, P176; PONOMARENKO AG, 1992, PALEONTOL J, V26, P56; Ren D, 2003, J NEW YORK ENTOMOL S, V111, P1, DOI 10.1664/0028-7199(2003)111[0001:NOFNFT]2.0.CO;2; Ren D, 2002, J KANSAS ENTOMOL SOC, V75, P188; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2008, J KANSAS ENTOMOL SOC, V81, P161, DOI 10.2317/JKES-0804.15.1; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ren Dong, 2002, Entomologia Sinica, V9, P53; Ren D, 2010, ZOOTAXA, P50; Ren D, 2009, CRETACEOUS RES, V30, P1217, DOI 10.1016/j.cretres.2009.06.004; Schluter T., 1986, P103; Selden PA, 2008, J ARACHNOL, V36, P306, DOI 10.1636/CA07-106.1; Shen Yan-bin, 2003, Journal of Stratigraphy, V27, P311; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sukacheva ID, 2004, PALEONTOL J+, V38, P182; Swofford DL, 1999, PAUP PHYL AN US PARS; Sziraki G., 1996, Folia Entomologica Hungarica, V57, P277; Tan Jing-Jing, 2002, Acta Zootaxonomica Sinica, V27, P428; Tillyard R. J., 1919, Proceedings of the Linnean Society of New South Wales, V44; Tjeder B., 1992, ENTOMOLOGICA SCAND S, V41, P3; Vilesov, 1995, PALEONTOL J, V29, P115; Vshivkova TS, 2010, P 10 INT S NEUR PIR, P278; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Wang YJ, 2011, 11 INT S NEUR PONT D, P24; Wang YJ, 2010, THESIS CHINESE AGR U; Wang YJ, 2010, P NATL ACAD SCI USA, V107, P16212, DOI 10.1073/pnas.1006460107; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Winterton Shaun L., 2003, Entomologische Abhandlungen (Dresden), V61, P158; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Winterton SL, 2011, 11 INT S NEUR PONT D, P20; Withycombe C. L., 1925, Transactions of the Entomological Society of London, V1924, P303; Wu Q.C., 2002, FOSSIL TREASURES LIA; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Yang Q, 2012, PALAEONTOLO IN PRESS; Yang Q, 2011, ZOOTAXA, P60; Yang W, 2004, S PETR GEOD CHIN HAI, P326; Zhang JF, 2006, CAN J EARTH SCI, V43, P9, DOI 10.1139/E05-092; Zhang JF, 2003, ORIENT INSECTS, V37, P301, DOI 10.1080/00305316.2003.10417351; Zhang Jun-feng, 2002, Journal of Stratigraphy, V26, P173; Zhang W.-t., 1987, Acta Palaeontologica Sinica, V26, P111; Zherikhin V. V., 1978, DEV CHANGES CRETACEO; Zimmerman E. C., 1957, INSECTS HAWAII, V6, P19; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	112	82	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44762	10.1371/journal.pone.0044762	http://dx.doi.org/10.1371/journal.pone.0044762			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028608	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900040
J	Aragao, F; Vera, J; Pinto, IV				Aragao, Filipa; Vera, Jose; Pinto, Ines Vaz			Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; CELL COUNT; HIV; PREDICTORS; PROTEASE; REGIMEN; EMTRICITABINE; INDIVIDUALS; LAMIVUDINE	Introduction: Current Portuguese HIV treatment guidelines recommend initiating antiretroviral therapy with a regimen composed of two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor (2NRTI+NNRTI) or two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor (2NRTI+PI/r). Given the lower daily cost of NNRTI as the third agent when compared to the average daily costs of PI/r, it is relevant to estimate the long term impact of each treatment option in the Portuguese context. Methods: We developed a microsimulation discrete events model for cost-effectiveness analysis of HIV treatment, simulating individual paths from ART initiation to death. Four driving forces determine the course of events: CD4+ cell count, viral load, resistance and adherence. Distributions of time to event are conditional to individuals' characteristics and past history. Time to event was modeled using parametric survival analysis using Stata 11 (R). Disease progression was structured according to therapy lines and the model was parameterized with cohort Portuguese observational data. All resources were valued at 2009 prices. The National Health Service's perspective was assumed considering a lifetime horizon and a 5% annual discount rate. Results: In this analysis, initiating therapy with two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor reduces the average number of switches by 17%, saves 19.573(sic) per individual and increases life expectancy by 1.7 months showing to be a dominant strategy in 57% of the simulations when compared to two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor. Conclusion: This study suggests that, when clinically valid, initiating therapy with two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor is a cost-saving strategy and equally effective when compared to two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor as the first regimen.	[Aragao, Filipa] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Aragao, Filipa] Associacao SER, Cascais, Portugal; [Vera, Jose; Pinto, Ines Vaz] HPP Hosp Cascais, Alcabideche, Cascais, Portugal	Universidade Nova de Lisboa	Aragao, F (corresponding author), Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal.	filipaaragao@gmail.com	Pinto, Inês/GVT-4690-2022	Vaz-Pinto, Ines/0000-0002-6281-8591; Aragao, Filipa/0000-0003-3446-6725; Vaz, Ines Regio/0000-0003-2410-7307	Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao" [XXI/BD/19954/99]; Gilead Sciences; Fundacao para a Ciencia e Tecnologia; ViiV Healthcare; Boheringer Ingelheim; MSD; Gilead Sciencies; BMS; Abbott; Janssen	Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao"; Gilead Sciences(Gilead Sciences); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ViiV Healthcare; Boheringer Ingelheim; MSD; Gilead Sciencies(Gilead Sciences); BMS(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was financially supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao"- Formar e Qualificar - Medida 1.1., grant Praxis XXI/BD/19954/99 as part of FA's PhD grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' have read the journal's policy and have the following conflicts: FA has received consultancy fees and travel grants from Gilead Sciences, paid scientific work from Escola Nacional de Saude Publica and Janssen-Cilag. FA has received grants from Fundacao para a Ciencia e Tecnologia. FA is a volunteer at the non-governmental organization Associacao SER+ and earns no financial or other benefits as a result of such affiliation. JV has received consultancy fees, travel grants and honoraria for speaking or participation at meetings from ViiV Healthcare, Boheringer Ingelheim, MSD, Gilead Sciencies, BMS, Abbott and Janssen. IVP has received travel grants and honoraria for speaking or participation at meetings from ViiV Healthcare, Boheringer Ingelheim, MSD, Gilead Sciencies, BMS, Abbott and Janssen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Administracao Central do Sistema de Saude IP, 2009, CAT APR PUBL SAUD; Aragao F, 2010, ARQUIVOS MED, V24, P209; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Barth-Jones DC, 2000, PROCEEDINGS OF THE 2000 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1985, DOI 10.1109/WSC.2000.899196; Barton P, 2004, HEALTH TECHNOL ASSES, V8, P1; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck EJ, 2010, PLOS ONE, V6; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Centro de Vigilancia Epidemiologica de Doencas Transmissiveis, 2011, SIT INF HIV SID PORT; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Coordenacao Nacional para a Infeccao VIH/sida, 2009, REC PORT TRAT INF VI; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; EMEA-European Medicines Agency, 2009, REP PREZ SCI DISC; European AIDS Clinical Society, 2009, GUID CLIN MAN TREATM; [European Centre for Disease Prevention and Control WHO Regional Office for Europe], 2011, HIV AIDS SURV EUR 20; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Geretti AM, 2008, ANTIVIR THER, V13, P927; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; INFARMED Autoridade Nacional do Medicamento e Produtos de Saude I. P., 2011, CONS MED MEIO HOSP D; INFARMED Autoridade Nacional do Medicamento e Produtos de Saude I.P, 2010, AN MERC MED AMB SERV; Instituto Nacional de Estatistica, 2009, TAB COMPL MORT PORT; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kagay CR, 2002, PHARMACOECONOMICS, V20, P215; Krentz HB, 2003, CAN MED ASSOC J, V169, P106; Kuhne FC, 2010, HIV CLIN TRIALS, V11, P80, DOI 10.1310/hct1102-80; Kuhne FC, 2007, IHEA 2007 6 WORLD C; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Liddy J, 2007, TIME VIRAL SUPPRESSI; Llibre-Codina JM, 2007, ENFERM INFEC MICR CL, V25, P98, DOI 10.1157/13098570; Lozano F, 2011, DOCUMENTO CONSENSO G; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; McDowell Allen, 2004, DO YOU FIT MODEL DEP; Panel on Antiretroviral Guidelines for Adults and Adolescent, 2011, PAN ANT GUID AD AD G; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Phillips AN, 2008, J INT AIDS SOC S1, pO17; Reis A, 2007, ADESAO TERAPEUTICA I; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Silva EA, 1999, ORIENTACOES METODOLO; Simpson KN, 2009, PHARMACOECONOMICS, V27, P159, DOI 10.2165/00019053-200927020-00006; Simpson KN, 2004, HIV CLIN TRIALS, V5, P294, DOI 10.1310/WT81-MEM4-5C4L-CHPK; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; United Nations Economic Commission for Europe, 2010, UNECE STAT DAT EC ST; United Nations Programme on HIV/AIDS, 2009, AIDS EP UPD; Vieira IT, 2003, J OPER RES SOC, V54, P713, DOI 10.1057/palgrave.jors.2601566; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; WHO Regional Office for Europe, 2011, EUR HLTH ALL DAT; Ying H, 2007, IEEE T SYST MAN CY B, V37, P966, DOI 10.1109/TSMCB.2007.895360; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44774	10.1371/journal.pone.0044774	http://dx.doi.org/10.1371/journal.pone.0044774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028618	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800019
J	Turck, N; Robin, X; Walter, N; Fouda, C; Hainard, A; Sztajzel, R; Wagner, G; Hochstrasser, DF; Montaner, J; Burkhard, PR; Sanchez, JC				Turck, Natacha; Robin, Xavier; Walter, Nadia; Fouda, Catherine; Hainard, Alexandre; Sztajzel, Roman; Wagner, Ghislaine; Hochstrasser, Denis F.; Montaner, Joan; Burkhard, Pierre R.; Sanchez, Jean-Charles			Blood Glutathione S-Transferase-pi as a Time Indicator of Stroke Onset	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ATTENUATED INVERSION-RECOVERY; POSTMORTEM CEREBROSPINAL-FLUID; RAT CEREBRAL-CORTEX; HEMORRHAGIC TRANSFORMATION; THROMBOLYTIC THERAPY; EARLY-DIAGNOSIS; SYMPTOM ONSET; GST-PI; SERUM	Background: Ability to accurately determine time of stroke onset remains challenging. We hypothesized that an early biomarker characterized by a rapid increase in blood after stroke onset may help defining better the time window during which an acute stroke patient may be candidate for intravenous thrombolysis or other intravascular procedures. Methods: The blood level of 29 proteins was measured by immunoassays on a prospective cohort of stroke patients (N = 103) and controls (N = 132). Mann-Whitney U tests, ROC curves and diagnostic odds ratios were applied to evaluate their clinical performances. Results: Among the 29 molecules tested, GST-pi concentration was the most significantly elevated marker in the blood of stroke patients (p<0.001). More importantly, GST-pi displayed the best area under the curve (AUC, 0.79) and the best diagnostic odds ratios (10.0) for discriminating early (N = 22, <3 h of stroke onset) vs. late stroke patients (N = 81, >3 h after onset). According to goal-oriented distinct cut-offs (sensitivity(Se)-oriented: 17.7 or specificity(Sp)-oriented: 65.2 ug/L), the GST-pi test obtained 91%Se/50%Sp and 50%Se/91%Sp, respectively. Moreover, GST-pi showed also the highest AUC (0.83) and performances for detecting patients treated with tPA (N = 12) compared to ineligible patients (N = 103). Conclusions: This study demonstrates that GST-pi can accurately predict the time of stroke onset in over 50% of early stroke patients. The GST-pi test could therefore complement current guidelines for tPA administration and potentially increase the number of patients accessing thrombolysis.	[Turck, Natacha; Robin, Xavier; Walter, Nadia; Fouda, Catherine; Hainard, Alexandre; Hochstrasser, Denis F.; Sanchez, Jean-Charles] Fac Med, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland; [Robin, Xavier] Ctr Med Univ Geneva, Swiss Inst Bioinformat, Geneva, Switzerland; [Sztajzel, Roman; Wagner, Ghislaine; Burkhard, Pierre R.] Univ Geneva, Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Montaner, Joan] Autonomous Univ Barcelona UAB, Vall dHebron Hosp, VHIR, Neurovasc Res Lab, Catalonia, Spain; [Montaner, Joan] Autonomous Univ Barcelona UAB, Vall dHebron Hosp, Stroke Unit, Catalonia, Spain; [Sztajzel, Roman; Wagner, Ghislaine; Burkhard, Pierre R.] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Geneva	Turck, N (corresponding author), Fac Med, Dept Human Prot Sci, Biomed Prote Res Grp, Geneva, Switzerland.	natacha.turck@unige.ch	Robin, Xavier/A-1680-2009; Montaner, Joan/D-3063-2015	Robin, Xavier/0000-0002-6813-3200; Montaner, Joan/0000-0003-4845-2279	Proteome Sciences plc; Fondo de Investigaciones Sanitarias [FIS PI08/361, PI11/0176]	Proteome Sciences plc; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	Neurovascular Research Laboratory takes part in the Spanish stroke research network (RENEVAS, RD06/0026/0010) and the European Stroke Network (EUSTROKE 7FP Health F2-08-202213). This Swiss study was funded by Proteome Sciences plc. UNIGE has granted to Proteome Sciences the exclusive (worldwide) license to a patent protecting GSTP and NDKA as brain damage markers. The Spanish project was funded in part by a grant from the Fondo de Investigaciones Sanitarias (FIS PI08/361 and PI11/0176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Allard L, 2007, BIOMARK INSIGHTS, V2, P155; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; Bauer B, 2008, J CEREBR BLOOD F MET, V28, P1222, DOI 10.1038/jcbfm.2008.16; Brouns R, CLIN CHEM, V56, P451; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410; Fink JN, 2002, STROKE, V33, P988, DOI 10.1161/01.STR.0000014585.17714.67; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grotta JC, 2001, ARCH NEUROL-CHICAGO, V58, P2009, DOI 10.1001/archneur.58.12.2009; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Martinez-Lara E, 2003, NEUROBIOL AGING, V24, P501, DOI 10.1016/S0197-4580(02)00139-2; Mendioroz M, 2011, J NEUROL, V258, P486, DOI 10.1007/s00415-010-5785-z; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Nadeau JO, 2005, CAN J NEUROL SCI, V32, P433, DOI 10.1017/S0317167100004418; Perkins CJ, 2001, STROKE, V32, P2774, DOI 10.1161/hs1201.099634; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schumacher HC, 2007, ANN EMERG MED, V50, P99, DOI 10.1016/j.annemergmed.2007.01.021; SHEN HX, 1995, BIOCHEM PHARMACOL, V50, P1233, DOI 10.1016/0006-2952(95)00263-Y; Sienkiewicz-Jarosz H, 2009, NEUROL NEUROCHIR POL, V43, P126; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	39	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43830	10.1371/journal.pone.0043830	http://dx.doi.org/10.1371/journal.pone.0043830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028472	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800007
J	Gilbert, JR; Shapiro, LR; Barnes, GR				Gilbert, Jessica R.; Shapiro, Laura R.; Barnes, Gareth R.			Peak-Clustering Method for MEG Group Analysis to Minimise Artefacts Due to Smoothness	PLOS ONE			English	Article							CATEGORY-SPECIFICITY; PERMUTATION METHODS; BEAMFORMER IMAGES; RANDOM-FIELD; OBJECTS; CORTEX; BRAIN	Magnetoencephalography (MEG), a non-invasive technique for characterizing brain electrical activity, is gaining popularity as a tool for assessing group-level differences between experimental conditions. One method for assessing task-condition effects involves beamforming, where a weighted sum of field measurements is used to tune activity on a voxel-by-voxel basis. However, this method has been shown to produce inhomogeneous smoothness differences as a function of signal-tonoise across a volumetric image, which can then produce false positives at the group level. Here we describe a novel method for group-level analysis with MEG beamformer images that utilizes the peak locations within each participant's volumetric image to assess group-level effects. We compared our peak-clustering algorithm with SnPM using simulated data. We found that our method was immune to artefactual group effects that can arise as a result of inhomogeneous smoothness differences across a volumetric image. We also used our peak-clustering algorithm on experimental data and found that regions were identified that corresponded with task-related regions identified in the literature. These findings suggest that our technique is a robust method for group-level analysis with MEG beamformer images.	[Gilbert, Jessica R.; Shapiro, Laura R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Barnes, Gareth R.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	Aston University; University of London; University College London	Gilbert, JR (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	gilberjr@aston.ac.uk; l.r.shapiro@aston.ac.uk	Barnes, Gareth/ABB-7650-2020; Gilbert, Jessica/I-7074-2019	Barnes, Gareth/0000-0002-5396-7712; Gilbert, Jessica/0000-0002-4194-6172; Shapiro, Laura/0000-0002-3276-457X	Wellcome Trust [091593] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Gerlach C, 2006, NEUROPSYCHOLOGIA, V44, P1247, DOI 10.1016/j.neuropsychologia.2005.09.010; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; Mattout Jeremie, 2007, Comput Intell Neurosci, P67613, DOI 10.1155/2007/67613; Moss HE, 2005, CEREB CORTEX, V15, P616, DOI 10.1093/cercor/bhh163; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Price CJ, 2003, COGN NEUROPSYCHOL, V20, P561, DOI 10.1080/02643290244000284; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Woolrich M, 2011, NEUROIMAGE, V57, P1466, DOI 10.1016/j.neuroimage.2011.04.041; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45084	10.1371/journal.pone.0045084	http://dx.doi.org/10.1371/journal.pone.0045084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024795	Green Published, gold, Green Accepted			2022-12-25	WOS:000308860100053
J	Kumar, V; Lo, PHY; Sawai, H; Kato, N; Takahashi, A; Deng, ZZ; Urabe, Y; Mbarek, H; Tokunaga, K; Tanaka, Y; Sugiyama, M; Mizokami, M; Muroyama, R; Tateishi, R; Omata, M; Koike, K; Tanikawa, C; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Kumar, Vinod; Lo, Paulisally Hau Yi; Sawai, Hiromi; Kato, Naoya; Takahashi, Atsushi; Deng, Zhenzhong; Urabe, Yuji; Mbarek, Hamdi; Tokunaga, Katsushi; Tanaka, Yasuhito; Sugiyama, Masaya; Mizokami, Masashi; Muroyama, Ryosuke; Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko; Tanikawa, Chizu; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; T-CELLS; SUSCEPTIBILITY LOCUS; JAPANESE POPULATION; NKG2D LIGANDS; EXPRESSION; GENE; ALLELE	MHC class I polypeptide-related chain A (MICA) molecule is induced in response to viral infection and various types of stress. We recently reported that a single nucleotide polymorphism (SNP) rs2596542 located in the MICA promoter region was significantly associated with the risk for hepatitis C virus (HCV)-induced hepatocellular carcinoma (HCC) and also with serum levels of soluble MICA (sMICA). In this study, we focused on the possible involvement of MICA in liver carcinogenesis related to hepatitis B virus (HBV) infection and examined correlation between the MICA polymorphism and the serum sMICA levels in HBV-induced HCC patients. The genetic association analysis revealed a nominal association with an SNP rs2596542; a G allele was considered to increase the risk of HBV-induced HCC (P = 0.029 with odds ratio of 1.19). We also found a significant elevation of sMICA in HBV-induced HCC cases. Moreover, a G allele of SNP rs2596542 was significantly associated with increased sMICA levels (P = 0.009). Interestingly, HCC patients with the high serum level of sMICA (>5 pg/ml) exhibited poorer prognosis than those with the low serum level of sMICA (<= 5 pg/ml) (P = 0.008). Thus, our results highlight the importance of MICA genetic variations and the significance of sMICA as a predictive biomarker for HBV-induced HCC.	[Kumar, Vinod; Lo, Paulisally Hau Yi; Deng, Zhenzhong; Urabe, Yuji; Mbarek, Hamdi; Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Sawai, Hiromi; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Kato, Naoya; Muroyama, Ryosuke] Univ Tokyo, Inst Med Sci, Unit Dis Control Genome Med, Tokyo, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Tateishi, Ryosuke; Omata, Masao; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nagoya City University; National Center for Global Health & Medicine - Japan; University of Tokyo	Kumar, V (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Kumar, Vinod/ABC-4866-2020; Kubo, Michiaki/N-7947-2015; Tateishi, Ryosuke/G-7758-2014; Matsuda, Koichi/D-4597-2011	Kumar, Vinod/0000-0002-2775-6049; Tateishi, Ryosuke/0000-0003-3021-2517; Mbarek, Hamdi/0000-0002-1108-0371; Matsuda, Koichi/0000-0001-7292-2686; Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [23710316] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kumar V, 2011, J HUM GENET, V56, P436, DOI 10.1038/jhg.2011.35; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Lu M, 2009, IMMUNOLOGY, V128, pe230, DOI 10.1111/j.1365-2567.2008.02953.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Tamaki S, 2008, HUM IMMUNOL, V69, P88, DOI 10.1016/j.humimm.2008.01.010; Tamaki S, 2007, J ORAL PATHOL MED, V36, P351, DOI 10.1111/j.1600-0714.2007.00539.x; Tamaki S, 2009, CLIN IMMUNOL, V130, P331, DOI 10.1016/j.clim.2008.09.004; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Urabe Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002541; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	36	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44743	10.1371/journal.pone.0044743	http://dx.doi.org/10.1371/journal.pone.0044743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024757	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100015
J	Tsang, LM; Achituv, Y; Chu, KH; Chan, BKK				Tsang, Ling Ming; Achituv, Yair; Chu, Ka Hou; Chan, Benny Kwok Kan			Zoogeography of Intertidal Communities in the West Indian Ocean as Determined by Ocean Circulation Systems: Patterns from the Tetraclita Barnacles	PLOS ONE			English	Article							GENETIC-STRUCTURE; COMPARATIVE PHYLOGEOGRAPHY; CHTHAMALUS-MALAYENSIS; POPULATION-STRUCTURE; LARVAL DEVELOPMENT; SOUTH-AFRICA; RED-SEA; CIRRIPEDIA; DISPERSAL; CRUSTACEA	The Indian Ocean is the least known ocean in the world with the biogeography of marine species in the West Indian Ocean (WIO) understudied. The hydrography of WIO is characterized by four distinct oceanographic systems and there were few glacial refugia formations in the WIO during the Pleistocene. We used the widely distributed intertidal barnacle Tetraclita to test the hypothesis that the distribution and connectivity of intertidal animals in the WIO are determined by the major oceanographic regime but less influenced by historical events such as Pleistocene glaciations. Tetraclita were studied from 32 locations in the WIO. The diversity and distribution of Tetraclita species in the Indian Ocean were examined based on morphological examination and sequence divergence of two mitochondrial genes (12S rDNA and COI) and one nuclear gene (histone 3, H3). Divergence in DNA sequences revealed the presence of seven evolutionarily significant units (ESUs) of Tetraclita in WIO, with most of them recognized as valid species. The distribution of these ESUs is closely tied to the major oceanographic circulation systems. T. rufotincta is distributed in the Monsoonal Gyre. T. ehsani is present in the Gulf of Oman and NW India. Tetraclita sp. nov. is associated with the Hydrochemical Front at 10 degrees S latitude. T. reni is confined to southern Madagascan and Mauritian waters, influenced by the West Wind Drift. The endemic T. achituvi is restricted to the Red Sea. Tetraclita serrata consists of two ESUs (based on mtDNA analysis) along the east to west coast of South Africa. The two ESUs could not be distinguished from morphological analysis and nuclear H3 sequences. Our results support that intertidal species in the West Indian Ocean are associated with each of the major oceanographic circulation systems which determine gene flow. Geographical distribution is, however, less influenced by the geological history of the region.	[Tsang, Ling Ming; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Simon FS Li Marine Sci Lab, Shatin, Hong Kong, Peoples R China; [Achituv, Yair] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Chan, Benny Kwok Kan] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Chinese University of Hong Kong; Bar Ilan University; Academia Sinica - Taiwan	Tsang, LM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Simon FS Li Marine Sci Lab, Shatin, Hong Kong, Peoples R China.	chankk@gate.sinica.edu.tw	Tsang, Ling Ming/Q-7628-2018; Chu, Ka Hou/B-8010-2011	Tsang, Ling Ming/0000-0002-5029-5690; Chu, Ka Hou/0000-0001-8107-5415; Chan, Benny/0000-0001-9479-024X	Career Development Award in Academia Sinica, Taiwan [AS-98-CDA-L15]; The Research Committee; The Chinese University of Hong Kong; Research Grants Council; Hong Kong Special Administrative Region [CUHK463509]; Israel Science Foundation (ISF) [574/10]	Career Development Award in Academia Sinica, Taiwan; The Research Committee; The Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grants Council(Hong Kong Research Grants Council); Hong Kong Special Administrative Region; Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by grants from the Career Development Award in Academia Sinica, Taiwan (AS-98-CDA-L15) to BKKC, The Research Committee, The Chinese University of Hong Kong, and Research Grants Council, Hong Kong Special Administrative Region, (Project no. CUHK463509) to KHC and Israel Science Foundation (ISF) grant 574/10 to YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHITUV Y, 1978, J EXP MAR BIOL ECOL, V31, P315, DOI 10.1016/0022-0981(78)90066-7; ACHITUV Y, 1987, J EXP MAR BIOL ECOL, V108, P181, DOI 10.1016/S0022-0981(87)80022-9; ACHITUV Y, 1972, Journal of Experimental Marine Biology and Ecology, V8, P73, DOI 10.1016/0022-0981(72)90057-3; Acker J.G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Antony Fernando S., 2006, MONOGRAPH INDIAN BAR; Appelbaum L, 2002, MOL ECOL, V11, P1731, DOI 10.1046/j.1365-294X.2002.01560.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber PH, 2006, EVOLUTION, V60, P1825; Barnard MA, 1924, ANN S AFR MUS, V20, P89; BARNES M, 1981, J EXP MAR BIOL ECOL, V54, P149, DOI 10.1016/0022-0981(81)90141-6; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Burrows MT, 1999, J MAR BIOL ASSOC UK, V79, P93, DOI 10.1017/S0025315498000101; Bustamante RH, 1996, J BIOGEOGR, V23, P339, DOI 10.1046/j.1365-2699.1996.00026.x; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chan BKK, 2008, MAR ECOL PROG SER, V362, P201, DOI 10.3354/meps07446; Chan BKK, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2019.1.4; Chan BKK, 2003, J CRUSTACEAN BIOL, V23, P522, DOI 10.1651/C-2350; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Daniel A, 1974, P S MAR INTERTIDAL B, V38, P179; Darwin C., 1854, MONOGRAPH SUBCLASS C; De Grave S, 2001, J BIOGEOGR, V28, P1239, DOI 10.1046/j.1365-2699.2001.00633.x; Dietrich G., 1973, BIOL INDIAN OCEAN, P1; DiMarco SF, 2002, DEEP-SEA RES PT II, V49, P1481, DOI 10.1016/S0967-0645(01)00159-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BS, 2004, MAR ECOL PROG SER, V270, P163, DOI 10.3354/meps270163; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FISHELSON L, 1971, MAR BIOL, V10, P113, DOI 10.1007/BF00354828; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froukh T, 2007, MOL ECOL, V16, P1359, DOI 10.1111/j.1365-294X.2007.03236.x; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; He LJ, 2011, MAR ECOL-EVOL PERSP, V32, P52, DOI 10.1111/j.1439-0485.2010.00406.x; JAYARAMAN R., 1957, PROC INDIAN ACAD SCI SECT B, V45, P151; Johnson D. H., 1973, BIOL INDIAN OCEAN; Keith SA, 2011, DIVERS DISTRIB, V17, P275, DOI 10.1111/j.1472-4642.2010.00734.x; Kemp JM, 1998, J BIOGEOGR, V25, P919, DOI 10.1046/j.1365-2699.1998.00249.x; Kensley B, 1981, SMITHSONIAN CONTRIBU, V338, P1, DOI DOI 10.5479/SI.00810282.338; LAWSON TJ, 1977, MAR BIOL, V43, P71, DOI 10.1007/BF00392573; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P1907, DOI 10.1016/S0278-4343(00)00053-4; Lutjeharms JRE, 2006, AGULHAS CURRENT; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; Newman W.A., 1976, Memoirs of the San Diego Society of Natural History, VNo. 9, P1; Nylander J, 2004, MR MODELTEST V2 PROG; OMAR GI, 1995, SCIENCE, V270, P1341, DOI 10.1126/science.270.5240.1341; Pannacciulli FG, 1997, MAR BIOL, V128, P73, DOI 10.1007/s002270050070; Pilsbry HA, 1916, US NATL MUSEUM B, V93, P241; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; REN X, 1989, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V11, P431; ROBERTS CM, 1992, J BIOGEOGR, V19, P239, DOI 10.2307/2845449; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross Arnold, 1999, Pakistan Journal of Marine Sciences, V8, P41; Samyn Y, 2005, J BIOGEOGR, V32, P1523, DOI 10.1111/j.1365-2699.2005.01295.x; Schils T, 2003, J BIOGEOGR, V30, P1339, DOI 10.1046/j.1365-2699.2003.00933.x; Shahdadi A, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.136.1772; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shemesh E, 2009, ZOOL SCR, V38, P365, DOI 10.1111/j.1463-6409.2008.00384.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; Sirocko F, 2003, NATURE, V423, P813, DOI 10.1038/423813a; Southward AJ, 2003, J MAR BIOL ASSOC UK, V83, P797, DOI 10.1017/S0025315403007835h; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Tsang LM, 2011, CRUTACEAN ISSUE 19 P; Utinomi H., 1969, Videnskabelige Meddelelser Dansk naturh Foren, V132, P79; Utinomi H., 1968, VIDENSK MEDDEL NATUR, V131, P161; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Wagh A. B., 1969, Current Science, V38, P344; Wagh AB, 1971, J BOMBAY NATURAL HIS, V71, P322; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; WYRTKI K, 1971, P531; Wyrtki K, 1973, BIOL INDIAN OCEAN, P1; Yan Y, 2004, J CRUSTACEAN BIOL, V24, P519, DOI 10.1651/C-2491; Yan Y, 2001, J MAR BIOL ASSOC UK, V81, P623, DOI 10.1017/S0025315401004283; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	89	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45120	10.1371/journal.pone.0045120	http://dx.doi.org/10.1371/journal.pone.0045120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024801	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100059
J	Wick, WD; Yang, OO				Wick, W. David; Yang, Otto O.			Biologically-Directed Modeling Reflects Cytolytic Clearance of SIV-Infected Cells In Vivo in Macaques	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; COMBINATION ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY VIRUS CHALLENGE; RHESUS MACAQUES; NONCYTOLYTIC MECHANISMS; IMMUNE-RESPONSES; TYPE-1 INFECTION; HIV REPLICATION; ESCAPE VARIANTS; PRIMARY VIREMIA	The disappointing outcomes of cellular immune-based vaccines against HIV-1 despite strong evidence for the protective role of CD8(+) T lymphocytes (CTLs) has prompted revisiting the mechanisms of cellular immunity. Prior data from experiments examining the kinetics of Simian Immunodeficiency Virus (SIV) clearance in infected macaques with or without in vivo CD8 depletion were interpreted as refuting the concept that CTLs suppress SIV/HIV by direct killing of infected cells. Here we briefly review the biological evidence for CTL cytolytic activity in viral infections, and utilize biologically-directed modeling to assess the possibility of a killing mechanism for the antiviral effect of CTLs, taking into account the generation, proliferation, and survival of activated CD4(+) and CD8(+) T lymphocytes, as well as the life cycle of the virus. Our analyses of the published macaque data using these models support a killing mechanism, when one considers T lymphocyte and HIV-1 lifecycles, and factors such as the eclipse period before release of virions by infected cells, an exponential pattern of virion production by infected cells, and a variable lifespan for acutely infected cells. We conclude that for SIV/HIV pathogenesis, CTLs deserve their reputation as being cytolytic.	[Wick, W. David] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med,Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wick, WD (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	wdavid.wick@gmail.com			National Institutes of Health [AI054280, AI051970, AI043203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054280, R01AI043203, R01AI051970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge support from grants AI054280 (WDW), AI051970 (OOY), and AI043203 (OOY) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buseyne F, 1996, VIROLOGY, V225, P248, DOI 10.1006/viro.1996.0597; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Koibuchi T, 2005, J VIROL, V79, P8171, DOI 10.1128/JVI.79.13.8171-8181.2005; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; McMichael AJ, 2000, PHILOS T R SOC B, V355, P363, DOI 10.1098/rstb.2000.0575; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sopper S, 2003, BLOOD, V101, P1213, DOI 10.1182/blood-2002-06-1644; SRIVASTAVA KK, 1991, J VIROL, V65, P3900, DOI 10.1128/JVI.65.7.3900-3902.1991; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1989, IMMUNOLOGY, V66, P628; Wick D, 2002, J THEOR BIOL, V219, P19, DOI 10.1006/yjtbi.3103; Wick D, 1999, MATH BIOSCI, V158, P127, DOI 10.1016/S0025-5564(99)00003-6; Wick WD, 2006, PLOS COMPUT BIOL, V2, P564, DOI 10.1371/journal.pcbi.0020064; Wick WD, 2005, DETERMINISTIC AND STOCHASTIC MODELS OF AIDS EPIDEMICS AND HIV INFECTIONS WITH INTERVENTION, P189, DOI 10.1142/9789812569264_0009; Wick WD, 2009, J VIROL, V83, P2349, DOI 10.1128/JVI.00821-08; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44778	10.1371/journal.pone.0044778	http://dx.doi.org/10.1371/journal.pone.0044778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028619	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700039
J	Zhang, YP; Li, J; Tardif, T; Burmeister, M; Villafuerte, SM; McBride-Chang, C; Li, H; Shi, BJ; Liang, WL; Zhang, ZX; Shu, H				Zhang, Yuping; Li, Jun; Tardif, Twila; Burmeister, Margit; Villafuerte, Sandra M.; McBride-Chang, Catherine; Li, Hong; Shi, Bingjie; Liang, Weilan; Zhang, Zhixiang; Shu, Hua			Association of the DYX1C1 Dyslexia Susceptibility Gene with Orthography in the Chinese Population	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; CANDIDATE GENE; SUPPORT; ADOLESCENTS; CHILDREN; VARIANT; SKILLS; EKN1; TWIN	Several independent studies have supported the association of DYX1C1 with dyslexia, but its role in general reading development remains unclear. Here, we investigated the contribution of this gene to reading, with a focus on orthographic skills, in a sample of 284 unrelated Chinese children aged 5 to 11 years who were participating in the Chinese Longitudinal Study of Reading Development. We tested this association using a quantitative approach for Chinese character reading, Chinese character dictation, orthographic judgment, and visual skills. Significant or marginally significant associations were observed at the marker rs11629841 with children's orthographic judgments at ages 7 and 8 years (all P values<0.020). Significant associations with Chinese character dictation (all P values<0.013) were also observed for this single-nucleotide polymorphism (SNP) at ages 9, 10, and 11 years. Further analyses revealed that the association with orthographic skills was specific to the processing of specific components of characters (P values<0.046). No association was found at either SNP of rs3743205 or rs57809907. Our findings suggest that DYX1C1 influences reading development in the general Chinese population and supports a universal effect of this gene.	[Zhang, Yuping; Li, Jun; Shi, Bingjie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tardif, Twila] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Burmeister, Margit; Villafuerte, Sandra M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [McBride-Chang, Catherine] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Li, Hong] Beijing Normal Univ, Dept Psychol, Beijing 100875, Peoples R China; [Liang, Weilan; Zhang, Zhixiang] Peking Univ, Hosp 1, Beijing 100871, Peoples R China	Beijing Normal University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese University of Hong Kong; Beijing Normal University; Peking University	Zhang, YP (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434; Tardif, Twila Z/0000-0001-8739-9090	Natural Science Foundation of China [30870758]; Fundamental Research Funds for the Central University; U.S. Natural Sciences Foundation [BCS-0350272]; Research Grants Council of the Hong Kong Special Administrative Region [448907]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; U.S. Natural Sciences Foundation; Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This research was supported by a grant from the Natural Science Foundation of China (30870758), by the Fundamental Research Funds for the Central University, and by BCS-0350272 from the U.S. Natural Sciences Foundation. Funding was also provided by the Research Grants Council of the Hong Kong Special Administrative Region (project reference #448907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates TC, 2010, MOL PSYCHIATR, V15, P1190, DOI 10.1038/mp.2009.120; Bellini G, 2005, J MOL NEUROSCI, V27, P311, DOI 10.1385/JMN:27:3:311; Brkanac Z, 2007, AM J MED GENET B, V144B, P556, DOI 10.1002/ajmg.b.30471; Chow BWY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016640; Cope NA, 2005, MOL PSYCHIATR, V10, P237, DOI 10.1038/sj.mp.4001596; Dahdouh F, 2009, PSYCHIAT GENET, V19, P59, DOI 10.1097/YPG.0b013e32832080e1; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Gardner MF, 1996, TESTS VISUAL PERCEPT; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Han ZX, 2007, COGN NEUROPSYCHOL, V24, P431, DOI 10.1080/02643290701381853; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Hultquist AM, 1997, ANN DYSLEXIA, V47, P89, DOI 10.1007/s11881-997-0022-x; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Lei L, 2011, J CHILD PSYCHOL PSYC, V52, P212, DOI 10.1111/j.1469-7610.2010.02311.x; LI H, 2006, PSYCHOL DEV ED, V18, P35; Li H, 2012, J RES READ, V35, P287, DOI 10.1111/j.1467-9817.2010.01460.x; Lim CKP, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-16; Lin D, 2010, PSYCHOL SCI, V21, P1117, DOI 10.1177/0956797610375447; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Marino C, 2005, EUR J HUM GENET, V13, P491, DOI 10.1038/sj.ejhg.5201356; McBride-Chang C, 2002, CHILD DEV, V73, P1392, DOI 10.1111/1467-8624.00479; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Meng HY, 2005, HUM GENET, V118, P87, DOI 10.1007/s00439-005-0017-9; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Ouellette G, 2008, CHILD DEV, V79, P899, DOI 10.1111/j.1467-8624.2008.01166.x; Pak A.K.H., 2005, READ WRIT, V18, P437, DOI [10.1007/s11145-005-6575-3, DOI 10.1007/S11145-005-6575-3]; Paracchini S, 2011, GENES BRAIN BEHAV, V10, P158, DOI 10.1111/j.1601-183X.2010.00651.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raven JC., 1996, STANDARD PROGR MATRI; Saviour Pushpa, 2008, Indian J Hum Genet, V14, P99, DOI 10.4103/0971-6866.45002; Scerri TS, 2004, J MED GENET, V41, P853, DOI 10.1136/jmg.2004.018341; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H, 1999, READING CHINESE SCRIPT, P1; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tardif T., 2008, CHINESE COMMUNICATIV; Wigg KG, 2004, MOL PSYCHIATR, V9, P1111, DOI 10.1038/sj.mp.4001543; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; Yang JF, 2009, J MEM LANG, V61, P238, DOI 10.1016/j.jml.2009.05.001	47	53	55	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e42969	10.1371/journal.pone.0042969	http://dx.doi.org/10.1371/journal.pone.0042969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028439	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700007
J	Green, NM; Moody, KS; Debatis, M; Marshak-Rothstein, A				Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann			Activation of Autoreactive B Cells by Endogenous TLR7 and TLR3 RNA Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTOR-3; SMALL NUCLEAR RNAS; INNATE IMMUNITY; SUBCELLULAR-LOCALIZATION; BINDING-SITES; MURINE MODEL; I INTERFERON; MOUSE MODEL; IFN	The key step in the activation of autoreactive B cells is the internalization of nucleic acid containing ligands and delivery of these ligands to the Toll-like Receptor (TLR) containing endolysosomal compartment. Ribonucleoproteins represent a large fraction of autoantigens in systemic autoimmune diseases. Here we demonstrate that many uridine-rich mammalian RNA sequences associated with common autoantigens effectively activate autoreactive B cells. Priming with type I IFN increased the magnitude of activation, and the range of which RNAs were stimulatory. A subset of RNAs that contain a high degree of self-complementarity also activated B cells through TLR3. For the RNA sequences that activated predominantly through TLR7, the activation is proportional to uridine-content, and more precisely defined by the frequency of specific uridine-containing motifs. These results identify parameters that define specific mammalian RNAs as ligands for TLRs.	[Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA 01605 USA; [Green, Nathaniel M.; Moody, Krishna-Sulayman; Marshak-Rothstein, Ann] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University	Marshak-Rothstein, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, 364 Plantat St, Worcester, MA 01605 USA.	ann.rothstein@umassmed.edu			National Institutes of Health [AR05-256, AR035230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035230, P01AR050256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR05-256 and AR035230.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Avalos AM, 2010, EUR J IMMUNOL, V40, P2692, DOI 10.1002/eji.200940184; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; EILAT D, 1991, J IMMUNOL, V147, P361; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; FENN BJ, 1990, ANAL BIOCHEM, V190, P78, DOI 10.1016/0003-2697(90)90136-W; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Forsbach A, 2007, OLIGONUCLEOTIDES, V17, P405, DOI 10.1089/oli.2007.0098; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gesteland RF., 1993, RNA WORLD NATURE MOD; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Jurk M, 2011, NUCLEIC ACID THER, V21, P201, DOI 10.1089/nat.2011.0298; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Levine SM, 2007, ARTHRITIS RHEUM, V56, P2729, DOI 10.1002/art.22790; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; Loh C, 2011, EUR J IMMUNOL, V41, P527, DOI 10.1002/eji.201040983; Marshall-Clarke S, 2006, EUR J IMMUNOL, V36, P95, DOI 10.1002/eji.200535331; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nandula SR, 2011, ORAL DIS, V17, P801, DOI 10.1111/j.1601-0825.2011.01839.x; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Patole PS, 2007, J AUTOIMMUN, V29, P52, DOI 10.1016/j.jaut.2007.04.004; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Soejima M, 2011, ARTHRITIS RHEUM-US, V63, P479, DOI 10.1002/art.30113; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tluk S, 2009, INT IMMUNOL, V21, P607, DOI 10.1093/intimm/dxp030; Tournadre A, 2012, ARTHRITIS RHEUM-US, V64, P533, DOI 10.1002/art.33350; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Villarreal GM, 1997, LUPUS, V6, P425, DOI 10.1177/096120339700600503; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.383000	http://dx.doi.org/10.1074/jbc.M112.383000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019335	Green Published, hybrid			2022-12-25	WOS:000311233800047
J	Forouzan, D; Ammelburg, M; Hobel, CF; Stroh, LJ; Sessler, N; Martin, J; Lupas, AN				Forouzan, Dara; Ammelburg, Moritz; Hobel, Cedric F.; Stroeh, Luisa J.; Sessler, Nicole; Martin, Joerg; Lupas, Andrei N.			The Archaeal Proteasome Is Regulated by a Network of AAA ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOARCHAEON HALOFERAX-VOLCANII; 20S PROTEASOME; THERMOPLASMA-ACIDOPHILUM; MYCOBACTERIUM-TUBERCULOSIS; PROTEINS; PATHWAY; GATE; PARTICLE; TRANSLOCATION; DEGRADATION	The proteasome is the central machinery for targeted protein degradation in archaea, Actinobacteria, and eukaryotes. In its basic form, it consists of a regulatory ATPase complex and a proteolytic core particle. The interaction between the two is governed by an HbYX motif (where Hb is a hydrophobic residue, Y is tyrosine, and X is any amino acid) at the C terminus of the ATPase subunits, which stimulates gate opening of the proteasomal alpha-subunits. In archaea, the proteasome-interacting motif is not only found in canonical proteasome-activating nucleotidases of the PAN/ARC/Rpt group, which are absent in major archaeal lineages, but also in proteins of the CDC48/p97/VAT and AMA groups, suggesting a regulatory network of proteasomal ATPases. Indeed, Thermoplasma acidophilum, which lacks PAN, encodes one CDC48 protein that interacts with the 20S proteasome and activates the degradation of model substrates. In contrast, Methanosarcina mazei contains seven AAA proteins, five of which, both PAN proteins, two out of three CDC48 proteins, and the AMA protein, function as proteasomal gatekeepers. The prevalent presence of multiple, distinct proteasomal ATPases in archaea thus results in a network of regulatory ATPases that may widen the substrate spectrum of proteasomal protein degradation.	[Forouzan, Dara; Ammelburg, Moritz; Hobel, Cedric F.; Martin, Joerg; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Stroeh, Luisa J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Sessler, Nicole] Univ Tubingen, Proteome Ctr, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Lupas, AN (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	andrei.lupas@tuebingen.mpg.de	Ammelburg, Moritz/F-1401-2011	Ammelburg, Moritz/0000-0001-8282-6487	institutional funds of the Max Planck Society	institutional funds of the Max Planck Society	This work was supported by institutional funds of the Max Planck Society.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Djuranovic S, 2006, J STRUCT BIOL, V156, P130, DOI 10.1016/j.jsb.2006.03.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Madding LS, 2007, J BACTERIOL, V189, P583, DOI 10.1128/JB.01382-06; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Medalia N, 2006, J STRUCT BIOL, V156, P84, DOI 10.1016/j.jsb.2006.03.015; Neuwald AF, 1999, GENOME RES, V9, P27; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pamnani V, 1997, FEBS LETT, V404, P263, DOI 10.1016/S0014-5793(97)00138-5; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Ruepp A, 1998, FEBS LETT, V425, P87, DOI 10.1016/S0014-5793(98)00205-1; Ruepp A, 2001, J STRUCT BIOL, V135, P126, DOI 10.1006/jsbi.2001.4402; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Serek-Heuberger J, 2009, BIOCHEM SOC T, V37, P118, DOI 10.1042/BST0370118; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Summer H, 2006, J STRUCT BIOL, V156, P120, DOI 10.1016/j.jsb.2006.01.010; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	54	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39254	39262		10.1074/jbc.M112.386458	http://dx.doi.org/10.1074/jbc.M112.386458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992741	hybrid, Green Published			2022-12-25	WOS:000310982800080
J	Lee, SJ; Zhu, B; Akabayov, B; Richardson, CC				Lee, Seung-Joo; Zhu, Bin; Akabayov, Barak; Richardson, Charles C.			Zinc-binding Domain of the Bacteriophage T7 DNA Primase Modulates Binding to the DNA Template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA PRIMER SYNTHESIS; GENE 4 PROTEIN; HELICASE; RECOGNITION; SEQUENCE; RESIDUES; INITIATION; EVOLUTION; EXTENSION; INSIGHTS	The zinc-binding domain (ZBD) of prokaryotic DNA primases has been postulated to be crucial for recognition of specific sequences in the single-stranded DNA template. To determine the molecular basis for this role in recognition, we carried out homolog-scanning mutagenesis of the zinc-binding domain of DNA primase of bacteriophage T7 using a bacterial homolog from Geobacillus stearothermophilus. The ability of T7 DNA primase to catalyze template-directed oligoribonucleotide synthesis is eliminated by substitution of any five-amino acid residue-long segment within the ZBD. The most significant defect occurs upon substitution of a region (Pro-16 to Cys-20) spanning two cysteines that coordinate the zinc ion. The role of this region in primase function was further investigated by generating a protein library composed of multiple amino acid substitutions for Pro-16, Asp-18, and Asn-19 followed by genetic screening for functional proteins. Examination of proteins selected from the screening reveals no change in sequence-specific recognition. However, the more positively charged residues in the region facilitate DNA binding, leading to more efficient oligoribonucleotide synthesis on short templates. The results suggest that the zinc-binding mode alone is not responsible for sequence recognition, but rather its interaction with the RNA polymerase domain is critical for DNA binding and for sequence recognition. Consequently, any alteration in the ZBD that disturbs its conformation leads to loss of DNA-dependent oligoribonucleotide synthesis.	[Lee, Seung-Joo; Zhu, Bin; Akabayov, Barak; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742	National Institutes of Health [GM 54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54397 (to C.C.R.).	Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; HINE AV, 1994, P NATL ACAD SCI USA, V91, P12327, DOI 10.1073/pnas.91.25.12327; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Koepsell SA, 2006, J BACTERIOL, V188, P4673, DOI 10.1128/JB.00316-06; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson MA, 2008, NUCLEIC ACIDS RES, V36, P5260, DOI 10.1093/nar/gkn461; Larson MA, 2010, NUCLEIC ACIDS RES, V38, P7167, DOI 10.1093/nar/gkq588; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; Rosenberg AH, 1996, J BIOL CHEM, V271, P26819, DOI 10.1074/jbc.271.43.26819; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Thirlway J, 2006, J BACTERIOL, V188, P1534, DOI 10.1128/JB.188.4.1534-1539.2006; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	35	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39030	39040		10.1074/jbc.M112.414151	http://dx.doi.org/10.1074/jbc.M112.414151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23024359	Green Published, hybrid			2022-12-25	WOS:000310982800059
J	Chanda, D; Kim, YH; Kim, DK; Lee, MW; Lee, SY; Park, TS; Koo, SH; Lee, CH; Choi, HS				Chanda, Dipanjan; Kim, Yong-Hoon; Kim, Don-Kyu; Lee, Min-Woo; Lee, Su-Yeon; Park, Tae-Sik; Koo, Seung-Hoi; Lee, Chul-Ho; Choi, Hueng-Sik			Activation of Cannabinoid Receptor Type 1 (Cb1r) Disrupts Hepatic Insulin Receptor Signaling via Cyclic AMP-response Element-binding Protein H (Crebh)-mediated Induction of Lipin1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; BOUND TRANSCRIPTION FACTOR; FATTY LIVER; RESISTANCE; DIACYLGLYCEROL; METABOLISM; CREBH; ENDOCANNABINOIDS; GLUCONEOGENESIS; EXPRESSION	Activation of hepatic cannabinoid 1 receptor (Cb1r) signaling has been implicated in the development of phenotypes associated with fatty liver, hypertriglyceridemia, and insulin resistance. In the current study, we have elucidated the critical role of endoplasmic reticulum-bound transcription factor cyclic AMP-response element-binding protein H (Crebh) in mediating activated Cb1r signaling in inducing phosphatidic acid phosphatase Lipin1 gene expression and subsequently deregulating hepatic insulin receptor signaling. Cb1r agonist (2-arachidonoylglycerol (2-AG)) treatment induced Lipin1 gene expression in a Crebh-dependent manner via recruiting CREBH to the endogenous Lipin1 gene promoter. Adenoviral overexpression of Crebh or 2-AG treatment in mice induced Lipin1 gene expression to increase the hepatic diacylglycerol (DAG) level and phosphorylation of protein kinase C epsilon (PKC epsilon). This in turn inhibited hepatic insulin receptor signaling. Knockdown of Crebh or Cb1r antagonism attenuated 2-AG-mediated induction of Lipin1 gene expression and decreased DAG production in mouse liver and subsequently restored insulin receptor signaling. Similarly, knockdown of Lipin1 attenuated the 2-AG-induced increase in the DAG level and PKC epsilon phosphorylation. Finally, shRNA-mediated knockdown of Crebh partially but significantly blunted Lipin1 expression and the DAG level in db/db mice. These results demonstrate a novel mechanism by which Cb1r signaling induces Lipin1 gene expression and increases DAG production by activating Crebh, thereby deregulating insulin receptor signaling pathway and lipid homeostasis.	[Kim, Yong-Hoon; Lee, Chul-Ho] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon 305806, South Korea; [Chanda, Dipanjan; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat,Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Lee, Su-Yeon; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam 461701, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Gachon University	Lee, CH (corresponding author), Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon 305806, South Korea.	chullee@kribb.re.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Chanda, Dipanjan/AAU-3996-2021	Koo, Seung-Hoi/0000-0001-8769-2879; Chanda, Dipanjan/0000-0003-0685-187X	Korea Research Foundation; Ministry of Education, Science and Technology [2010-0019512]; National Creative Research Initiatives; Korean Ministry of Education, Science and Technology [20110018305]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea	Korea Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Creative Research Initiatives; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea	This work was supported by the Future-based Technology Development Program (BIO Fields) through the Korea Research Foundation funded by the Ministry of Education, Science and Technology (Grant 2010-0019512) (to H.-S. C), a National Creative Research Initiatives grant funded by the Korean Ministry of Education, Science and Technology (Grant 20110018305) (to H.-S. C), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea (to C.-H. L.).	Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; HEYDRICK SJ, 1991, DIABETES, V40, P1707, DOI 10.2337/diabetes.40.12.1707; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kaiser JP, 2009, ARCH BIOCHEM BIOPHYS, V482, P104, DOI 10.1016/j.abb.2008.11.004; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	29	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377978	http://dx.doi.org/10.1074/jbc.M112.377978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989885	Green Published, hybrid			2022-12-25	WOS:000310642200038
J	Li, JG; Chen, CG; Huang, P; Wang, YJ; Liu-Chen, LY				Li, Jian-Guo; Chen, Chongguang; Huang, Peng; Wang, Yujun; Liu-Chen, Lee-Yuan			14-3-3 zeta Protein Regulates Anterograde Transport of the Human kappa-Opioid Receptor (hKOPR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-DEPENDENT INTERACTION; ENDOPLASMIC-RETICULUM LOCALIZATION; CELL-SURFACE EXPRESSION; MEMBRANE-PROTEINS; U50,488H-INDUCED INTERNALIZATION; GABA(B) RECEPTORS; DOWN-REGULATION; K+ CHANNELS; TRAFFICKING; INTERACTS	By proteomic analysis, we found that 14-3-3 zeta was one of the proteins co-immunoprecipitated with human kappa-opioid receptor (hKOPR) from extracts of solubilized Neuro2A cells stably expressing FLAG-hKOPR (N2A-FLAG-hKOPR cells). 14-3-3 proteins are a family of conserved regulatory molecules in eukaryotic cells, where they participate in signal transduction, metabolism, and membrane protein transport. 14-3-3 zeta co-localized with the hKOPR in N2A cells. The hKOPR C-tail interacted with 14-3-3 zeta in rat brain extracts and bound directly to purified 14-3-3 zeta as demonstrated by pulldown techniques. 14-3-3 zeta siRNA decreased expression of the hKOPR in N2A-FLAG-hKOPR cells and cultured primary cortical neurons of E19 rats by similar to 25% as determined by immunoblotting, ligand binding, and flow cytometry. The effect of 14-3-3 zeta siRNA was reversed by overexpression of 14-3-3 zeta. Expression of the 14-3-3 scavenger protein pGpLI-R18 also decreased hKOPR expression. 14-3-3 zeta siRNA did not change expressions of the hDOPR and rMOPR in N2A cells. Pulse-chase study showed that 14-3-3 zeta siRNA decreased the amount of mature hKOPR but did not change the rate of maturation or stability of hKOPR protein. Mutations of R354A/S358A in the putative 14-3-3 interaction motif (354)RQSTS(358) in the hKOPR C-tail reduced interaction of the hKOPR with 14-3-3 zeta and abolished the effect of 14-3-3 zeta knockdown on hKOPR expression. Mutation of the endoplasmic reticulum retention motif (RVR)-R-359 adjacent to the 14-3-3 interaction motif in the hKOPR C-tail decreased interaction of coatomer protein I (COPI) with the hKOPR and abolished 14-3-3 zeta-mediated regulation of hKOPR expression. 14-3-3 zeta knockdown increased association of COPI with the hKOPR. These results suggest that 14-3-3 zeta promotes expression of the hKOPR by inhibiting COPI and RVR motif-mediated endoplasmic reticulum localization machinery.	[Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Ctr Subst Abuse Res, 3500 N Broad St,MERB 851, Philadelphia, PA 19140 USA.	lliuche@temple.edu			National Institutes of Health [R01 DA17302, P30 DA13429]; National Institutes of Heath [P30CA016520, ES013508]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA17302 and P30 DA13429 (to L.-Y. L.-C.).; The mass spectrometry analysis was provided by Proteomics Core Facility, The University of Pennsylvania (fee for service) was supported by National Institutes of Heath Grants P30CA016520 (to Abramson Cancer Center) and ES013508 (to the Center of Excellence in Environmental Toxicology). We thank Kelly DiMattio for editing the manuscript.	Arulpragasam A, 2012, BIOCHEM J, V441, P995, DOI 10.1042/BJ20111277; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, FRONT BIOSCI-LANDMRK, V14, P634, DOI 10.2741/3269; Cohen BD, 2004, MOL CELL ENDOCRINOL, V220, P1, DOI 10.1016/j.mce.2004.04.012; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Li JG, 2008, MOL PHARMACOL, V73, P1319, DOI 10.1124/mol.107.042846; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nakao K, 2009, DRUG TODAY, V45, P323, DOI [10.1358/dot.2009.45.5.1377595, 10.1358/dot.2009.45.5.1362067]; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Pagano A, 2001, J NEUROSCI, V21, P1189; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Tazawa H, 2003, BBA-GEN SUBJECTS, V1620, P32, DOI 10.1016/S0304-4165(02)00503-2; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yan WL, 2006, BIOCHEM PHARMACOL, V71, P624, DOI 10.1016/j.bcp.2005.11.027; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	48	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.359679	http://dx.doi.org/10.1074/jbc.M112.359679			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989890	Green Published, hybrid			2022-12-25	WOS:000310642200017
J	Sernova, NV; Gelfand, MS				Sernova, Natalia V.; Gelfand, Mikhail S.			Comparative Genomics of CytR, an Unusual Member of the LacI Family of Transcription Factors	PLOS ONE			English	Article							CAMP RECEPTOR PROTEIN; DIFFERENT OPERATORS SUGGESTS; COLI CYTIDINE REPRESSOR; CRP ACTIVATOR PROTEIN; ESCHERICHIA-COLI; DEOP2 PROMOTER; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; BINDING-SITES	CytR is a transcription regulator from the LacI family, present in some gamma-proteobacteria including Escherichia coli and known not only for its cellular role, control of transport and utilization of nucleosides, but for a number of unusual structural properties. The present study addressed three related problems: structure of CytR-binding sites and motifs, their evolutionary conservation, and identification of new members of the CytR regulon. While the majority of CytR-binding sites are imperfect inverted repeats situated between binding sites for another transcription factor, CRP, other architectures were observed, in particular, direct repeats. While the similarity between sites for different genes in one genome is rather low, and hence the consensus motif is weak, there is high conservation of orthologous sites in different genomes (mainly in the Enterobacteriales) arguing for the presence of specific CytR-DNA contacts. On larger evolutionary distances candidate CytR sites may migrate but the approximate distance between flanking CRP sites tends to be conserved, which demonstrates that the overall structure of the CRP-CytR-DNA complex is gene-specific. The analysis yielded candidate CytR-binding sites for orthologs of known regulon members in less studied genomes of the Enterobacteriales and Vibrionales and identified a new candidate member of the CytR regulon, encoding a transporter named NupT (YcdZ).	[Sernova, Natalia V.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 117234, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Gelfand, MS (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.	gelfand@iitp.ru	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846	Ministry of Education and Science of Russia [07.514.11.4007]; Russian Foundation of Basic Research [10-04-00431]; Russian Academy of Sciences via the Program in Molecular and Cellular Biology	Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences via the Program in Molecular and Cellular Biology(Russian Academy of Sciences)	This study was partially supported by the Ministry of Education and Science of Russia via contract 07.514.11.4007, the Russian Foundation of Basic Research via grant 10-04-00431, and the Russian Academy of Sciences via the Program in Molecular and Cellular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, BIOCHEMISTRY-US, V20, P4774, DOI 10.1021/bi00519a038; ANDERSON WB, 1971, J BIOL CHEM, V246, P5929; Barbier CS, 1997, J BIOL CHEM, V272, P16962, DOI 10.1074/jbc.272.27.16962; BARBIER CS, 1993, J BACTERIOL, V175, P4625, DOI 10.1128/JB.175.15.4625-4630.1993; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brikun I, 1996, J BACTERIOL, V178, P1614, DOI 10.1128/jb.178.6.1614-1622.1996; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; GERLACH P, 1991, J BACTERIOL, V173, P5419, DOI 10.1128/jb.173.17.5419-5430.1991; GERLACH P, 1990, MOL MICROBIOL, V4, P479, DOI 10.1111/j.1365-2958.1990.tb00614.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMMERJESPERSEN K, 1975, MOL GEN GENET, V137, P327, DOI 10.1007/BF00703258; Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002; HOLST B, 1992, EMBO J, V11, P3635, DOI 10.1002/j.1460-2075.1992.tb05448.x; Holt AK, 2010, BIOCHEMISTRY-US, V49, P432, DOI 10.1021/bi901583n; Jorgensen CI, 1998, MOL MICROBIOL, V27, P41, DOI 10.1046/j.1365-2958.1998.00655.x; Kallipolitis BH, 1997, CELL, V89, P1101, DOI 10.1016/S0092-8674(00)80297-4; Kallipolitis BH, 2004, J MOL BIOL, V342, P1, DOI 10.1016/j.jmb.2004.05.067; Kallipolitis BH, 1998, MOL MICROBIOL, V29, P1091, DOI 10.1046/j.1365-2958.1998.00999.x; Lai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035018; Meibom KL, 2000, J BIOL CHEM, V275, P11951, DOI 10.1074/jbc.275.16.11951; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; MOLLEGAARD NE, 1993, J BIOL CHEM, V268, P17471; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; NORREGAARDMADSEN M, 1994, MOL MICROBIOL, V14, P989, DOI 10.1111/j.1365-2958.1994.tb01333.x; Patching SG, 2005, ORG BIOMOL CHEM, V3, P462, DOI 10.1039/b414739a; PEDERSEN H, 1991, J BIOL CHEM, V266, P17804; PEDERSEN H, 1995, MOL MICROBIOL, V17, P843, DOI 10.1111/j.1365-2958.1995.mmi_17050843.x; Pedersen H, 1997, EMBO J, V16, P2108, DOI 10.1093/emboj/16.8.2108; Perini LT, 1996, J BIOL CHEM, V271, P33242, DOI 10.1074/jbc.271.52.33242; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; RASMUSSEN PB, 1993, NUCLEIC ACIDS RES, V21, P879, DOI 10.1093/nar/21.4.879; Rasmussen PB, 1996, P NATL ACAD SCI USA, V93, P10151, DOI 10.1073/pnas.93.19.10151; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SEEGER C, 1995, J BACTERIOL, V177, P5506, DOI 10.1128/jb.177.19.5506-5516.1995; SINGER JT, 1985, J BACTERIOL, V163, P1095, DOI 10.1128/JB.163.3.1095-1100.1985; SOGAARDANDERSEN L, 1993, CELL, V75, P557, DOI 10.1016/0092-8674(93)90389-8; SOGAARDANDERSEN L, 1991, P NATL ACAD SCI USA, V88, P4921, DOI 10.1073/pnas.88.11.4921; SOGAARDANDERSEN L, 1991, MOL MICROBIOL, V5, P969, DOI 10.1111/j.1365-2958.1991.tb00772.x; SOGAARDANDERSEN L, 1990, MOL MICROBIOL, V4, P1595, DOI 10.1111/j.1365-2958.1990.tb02071.x; SOGAARDANDERSEN L, 1990, J BACTERIOL, V172, P5706, DOI 10.1128/jb.172.10.5706-5713.1990; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomsen LE, 1999, J MOL BIOL, V288, P165, DOI 10.1006/jmbi.1999.2668; Tretyachenko-Ladokhina V, 2002, J MOL BIOL, V316, P531, DOI 10.1006/jmbi.2001.5302; Tretyachenko-Ladokhina V, 2006, J MOL BIOL, V362, P271, DOI 10.1016/j.jmb.2006.06.085; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; VALENTINHANSEN P, 1986, NUCLEIC ACIDS RES, V14, P2215, DOI 10.1093/nar/14.5.2215; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; ZHANG YB, 1992, J BACTERIOL, V174, P5758, DOI 10.1128/JB.174.17.5758-5759.1992; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; Zolotukhina M, 2003, RES MICROBIOL, V154, P510, DOI 10.1016/S0923-2508(03)00125-6	55	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44194	10.1371/journal.pone.0044194	http://dx.doi.org/10.1371/journal.pone.0044194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028500	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700009
J	Osi, A; Prondvai, E; Butler, R; Weishampel, DB				Osi, Attila; Prondvai, Edina; Butler, Richard; Weishampel, David B.			Phylogeny, Histology and Inferred Body Size Evolution in a New Rhabdodontid Dinosaur from the Late Cretaceous of Hungary	PLOS ONE			English	Article							ORNITHOPOD DINOSAURIA; BONE MICROSTRUCTURE; ORNITHISCHIA; OSTEOLOGY; REMAINS; ISLAND; RULE	Background: Rhabdodontid ornithopod dinosaurs are characteristic elements of Late Cretaceous European vertebrate faunas and were previously collected from lower Campanian to Maastrichtian continental deposits. Phylogenetic analyses have placed rhabdodontids among basal ornithopods as the sister taxon to the clade consisting of Tenontosaurus, Dryosaurus, Camptosaurus, and Iguanodon. Recent studies considered Zalmoxes, the best known representative of the clade, to be significantly smaller than closely related ornithopods such as Tenontosaurus, Camptosaurus, or Rhabdodon, and concluded that it was probably an island dwarf that inhabited the Maastrichtian Hat, eg Island. Methodology/Principal Findings: Rhabdodontid remains from the Santonian of western Hungary provide evidence for a new, small-bodied form, which we assign to Mochlodon vorosi n. sp. The new species is most similar to the early Campanian M. suessi from Austria, and the close affinities of the two species is further supported by the results of a global phylogenetic analysis of ornithischian dinosaurs. Bone histological studies of representatives of all rhabdodontids indicate a similar adult body length of 1.6-1.8 m in the Hungarian and Austrian species, 2.4-2.5 m in the subadults of both Zalmoxes robustus and Z. shqiperorum and a much larger, 5-6 m adult body length in Rhabdodon. Phylogenetic mapping of femoral lengths onto the results of the phylogenetic analysis suggests a femoral length of around 340 mm as the ancestral state for Rhabdodontidae, close to the adult femoral lengths known for Zalmoxes (320-333 mm). Conclusions/Significance: Our analysis of body size evolution does not support the hypothesis of autapomorhic nanism for Zalmoxes. However, Rhabdodon is reconstructed as having undergone autapomorphic giantism and the reconstructed small femoral length (245 mm) of Mochlodon is consistent with a reduction in size relative to the ancestral rhabdodontid condition. Our results imply a pre-Santonian divergence between western and eastern rhabdodontid lineages within the western Tethyan archipelago.	[Osi, Attila; Prondvai, Edina] Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary; [Butler, Richard] Univ Munich, GeoBio Ctr, Munich, Germany; [Weishampel, David B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	Eotvos Lorand University; Hungarian Academy of Sciences; University of Munich; Johns Hopkins University	Osi, A (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary.	hungaros@gmail.com	Butler, Richard J./A-5239-2011; Ősi, Attila/K-2414-2018; Prondvai, Edina/I-3178-2019	Butler, Richard J./0000-0003-2136-7541; Ősi, Attila/0000-0003-2967-997X; Prondvai, Edina/0000-0002-1284-8311	MTA-ELTE Lendulet Dinosaur Research Group [95102]; Hungarian Scientific Research Fund [OTKA T-38045, PD 73021, NF 84193]; National Geographic Society [7228-02, 7508-03]; Bolyai Fellowship; Hungarian Natural History Museum; Eotvos Lorand University; Jurassic Foundation; Hantken Foundation; Hungarian Oil and Gas Company (MOL); Alexander von Humboldt Postdoctoral Research Fellowship; German Research Foundation Emmy Noether Programme [BU 2587/3-1]	MTA-ELTE Lendulet Dinosaur Research Group; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Geographic Society(National Geographic Society); Bolyai Fellowship(Hungarian Academy of Sciences); Hungarian Natural History Museum; Eotvos Lorand University; Jurassic Foundation; Hantken Foundation; Hungarian Oil and Gas Company (MOL); Alexander von Humboldt Postdoctoral Research Fellowship(Alexander von Humboldt Foundation); German Research Foundation Emmy Noether Programme(German Research Foundation (DFG))	Field and laboratory work was supported by the MTA-ELTE Lendulet Dinosaur Research Group (Grant no. 95102), Hungarian Scientific Research Fund (OTKA T-38045, PD 73021, NF 84193), National Geographic Society (Grant No. 7228-02, 7508-03), Bolyai Fellowship (O. A.), Hungarian Natural History Museum, Eotvos Lorand University, Jurassic Foundation, Hantken Foundation, and the Hungarian Oil and Gas Company (MOL). RJB was supported during the completion of this research by an Alexander von Humboldt Postdoctoral Research Fellowship and the German Research Foundation Emmy Noether Programme (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Brinkmann W, 1988, DOCUMENTA NATURAE, V45, P1; BUFFETAUT E, 1991, CR ACAD SCI II, V312, P943; Buffetaut E., 1996, NEUES JB GEOLOGIE PA, V1, P1; Buffetaut Eric, 1993, Modern Geology, V18, P161; Bunzel E., 1871, ABHANDLUNGEN KAISERL, V5, P1; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Carrano Matthew T., 2006, P225; CASE TJ, 1993, OECOLOGIA, V94, P102, DOI 10.1007/BF00317309; Cerda IA, 2012, J VERTEBR PALEONTOL, V32, P355, DOI 10.1080/02724634.2012.646804; Chanthasit P., 2010, THESIS U CLAUDE BERN; Codrea V, 2010, PALAEOGEOGR PALAEOCL, V293, P391, DOI 10.1016/j.palaeo.2009.10.027; Company J., 2004, THESIS U VALENCIA VA; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; DiCroce Tony, 2001, P183; Fejfar O, 2005, ACTA PALAEONTOL POL, V50, P295; GALTON P M, 1980, Palaeontology (Oxford), V23, P411; Galton P.M., 1983, Geologica et Palaeontologica, V17, P207; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Garcia G, 1999, CR ACAD SCI II A, V328, P415, DOI 10.1016/S1251-8050(99)80108-6; Godefroit P, 2009, GEODIVERSITAS, V31, P525, DOI 10.5252/g2009n3a3; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Gould GC, 2004, B AM MUS NAT HIST, P219; Han F-L, 2012, J VERT PALE IN PRESS; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Jianu C.-M., 1994, SARGETIA, V16, P29; Knauer J, 1992, ANN REPORT HUNGARIAN, V1990, P463; Lapparent A. F.de., 1947, Memoires de la Societe Geologique de France Paleontologie, V56, P1; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Matheron P, 1869, MEMOIRES ACAD IMPERI, V1868, P345; Matheron P, 1892, C R ASS FRANC AVANC, V20, P382; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Neraudeau D, 2003, C R PALEVOL, V2, P221, DOI 10.1016/S1631-0683(03)00032-0; NEWTON ET, 1892, GEOLOGICAL MAGAZINE, V9, P49; Nopcsa F., 1902, Denkschriften der Akademie Wien, Vlxxii, P149; Nopcsa F., 1904, Denkschriften der Akademie Wien, Vlxxiv, P229; Nopcsa F., 1923, Quarterly Journal of the Geological Society of London, V79, P100; Nopcsa F., 1914, VERHANDLUNGEN ZOOLOG, V54, P12; Nopcsa F., 1925, PALAEONT HUNG, V1, P273; Nopcsa F., 1915, MITTEILUNGEN JAHRBUC, V23, P3; Novas FE, 2004, AMEGHINIANA, V41, P75; Osi A, 2004, GEOBIOS-LYON, V37, P749, DOI 10.1016/j.geobios.2003.06.005; Osi A, 2009, CRETACEOUS SEDIMENTS, P51; Osi A, 2012, BERNISSART IN PRESS; Palombo MR, 2011, TERRA DELGLI ELEFANT, P479; Pereda Suberbiola Xabier, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P257; Pincemaille M, 1997, ORNITHOPODE CRETACE; Pincemaille-Quillevere M, 2006, B SOC GEOL FR, V177, P97, DOI 10.2113/gssgfbull.177.2.97; Pincemaille-Quillevere Marie, 2002, Oryctos, V4, P39; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Ruiz-Omenaca Jose Ignacio, 2007, P3; Sachs S, 2006, GEOBIOS-LYON, V39, P415, DOI 10.1016/j.geobios.2005.01.003; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Scheetz R.D., 1999, THESIS MONTANA STATE; Seeley H.G., 1881, Q J GEOLOGICAL SOC, V37, P620, DOI [DOI 10.1144/GSL.JGS.1881.037.01-04.49, 10.1144/GSL.JGS.1881.037.01-04.49]; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Steel R, 1969, HDB PALAOHERPETOLOGI, V15, P1; Stein K., 2009, METHODS FOSSIL PREPA, P69; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tuba Gy, 2006, FOLDTANI KOZLONY, V136, P1; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Weishampel DB, 2011, TRANSYLVANIAN DINOSAURS, P1; Wells N.A., 1989, Paleontological Society Special Publication, P120; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978	79	58	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44318	10.1371/journal.pone.0044318	http://dx.doi.org/10.1371/journal.pone.0044318			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028518	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000309392800005
J	van Wijk, B; Gunst, QD; Moorman, AFM; van den Hoff, MJB				van Wijk, Bram; Gunst, Quinn D.; Moorman, Antoon F. M.; van den Hoff, Maurice J. B.			Cardiac Regeneration from Activated Epicardium	PLOS ONE			English	Article							ZEBRAFISH HEART REGENERATION; BONE MORPHOGENETIC PROTEIN; FOLLISTATIN-LIKE 1; MYOCARDIAL-INFARCTION; MATRICELLULAR PROTEINS; CORONARY VASCULATURE; MOUSE EPICARDIUM; PROGENITOR CELLS; PRECURSOR POOL; STEM-CELLS	In contrast to lower vertebrates, the mammalian heart has a very limited regenerative capacity. Cardiomyocytes, lost after ischemia, are replaced by fibroblasts. Although the human heart is able to form new cardiomyocytes throughout its lifespan, the efficiency of this phenomenon is not enough to substitute sufficient myocardial mass after an infarction. In contrast, zebrafish hearts regenerate through epicardial activation and initiation of myocardial proliferation. With this study we obtain insights into the activation and cellular contribution of the mammalian epicardium in response to ischemia. In a mouse myocardial infarction model we analyzed the spatio-temporal changes in expression of embryonic epicardial, EMT, and stem cell markers and the contribution of cells of the Wt1-lineage to the infarcted area. Though the integrity of the epicardial layer overlaying the infarct is lost immediately after the induction of the ischemia, it was found to be regenerated at three days post infarction. In this regenerated epicardium, the embryonic gene program is transiently re-expressed as well as proliferation. Concomitant with this activation, Wt1-lineage positive subepicardial mesenchyme is formed until two weeks post-infarction. These mesenchymal cells replace the cardiomyocytes lost due to the ischemia and contribute to the fibroblast population, myofibroblasts and coronary endothelium in the infarct, and later also to the cardiomyocyte population. We show that in mice, as in lower vertebrates, an endogenous, epicardium-dependent regenerative response to injury is induced. Although this regenerative response leads to the formation of new cardiomyocytes, their number is insufficient in mice but sufficient in lower vertebrates to replace lost cardiomyocytes. These molecular and cellular analyses provide basic knowledge essential for investigations on the regeneration of the mammalian heart aiming at epicardium-derived cells.	[van Wijk, Bram; Gunst, Quinn D.; Moorman, Antoon F. M.; van den Hoff, Maurice J. B.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van den Hoff, MJB (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.vandenhoff@amc.uva.nl		van den Hoff, Maurice/0000-0002-3837-8055	Netherlands Heart Foundation [1996M002]; European Community [LSHM-CT-2005-018630]	Netherlands Heart Foundation(Netherlands Heart Foundation); European Community(European Commission)	The presented work was supported by Netherlands Heart Foundation grant 1996M002 and the European Community's Sixth Framework Program contract ("HeartRepair") grant LSHM-CT-2005-018630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Barnett P, 2011, MED BIOL ENG COMPUT, V49, P723, DOI 10.1007/s11517-011-0776-5; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bornstein P, 2000, MATRIX BIOL, V19, P555, DOI 10.1016/S0945-053X(00)00103-7; Buermans HPJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015504; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Di Nardo P, 2010, J CELL PHYSIOL, V224, P590, DOI 10.1002/jcp.22165; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuhn EN, 2010, J CELL PHYSIOL, V225, P321, DOI 10.1002/jcp.22281; Lavine KJ, 2007, TRENDS CARDIOVAS MED, V17, P77, DOI 10.1016/j.tcm.2007.01.002; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Manner J, 1999, ANAT RECORD, V255, P212; Markwald RR, 2010, ANN NY ACAD SCI, V1188, P177, DOI 10.1111/j.1749-6632.2009.05098.x; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Munoz-Chapuli R, 2002, TEX HEART I J, V29, P243; Munoz-Chapuli R, 2002, REV ESP CARDIOL, V55, P1070, DOI 10.1016/S0300-8932(02)76758-4; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scheinowitz M, 1997, INT J CARDIOL, V59, P1, DOI 10.1016/S0167-5273(96)02902-6; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Song YH, 2011, CELL CYCLE, V10, P2281, DOI 10.4161/cc.10.14.16513; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Van Amerongen MJ, 2008, J PATHOL, V214, P377, DOI 10.1002/path.2281; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; van Wijk B, 2010, TRENDS CARDIOVAS MED, V20, P1, DOI 10.1016/j.tcm.2010.02.011; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	63	132	136	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44692	10.1371/journal.pone.0044692	http://dx.doi.org/10.1371/journal.pone.0044692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028582	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900011
J	Zha, MW; Zhong, C; Ou, Y; Han, L; Wang, JC; Ding, JP				Zha, Manwu; Zhong, Chen; Ou, Ying; Han, Li; Wang, Jianchuan; Ding, Jianping			Crystal Structures of Human CaMKI alpha Reveal Insights into the Regulation Mechanism of CaMKI	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; CALMODULIN; COMPLEX; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; POTENTIATION; BINDING; CYCLIN	Human calcium/calmodulin-dependent protein kinase I (CaMKI) plays pivotal roles in the nervous system. The activity of human CaMKI is regulated by a regulatory region including an autoinhibitory segment and a CaM-binding segment. We report here four structures of three CaMKI alpha truncates in apo form and in complexes with ATP. In an apo, autoinhibited structure, the activation segment adopts a unique helical conformation which together with the autoinhibitory segment constrains helices alpha C and alpha D in inactive conformations, sequesters Thr177 from being phosphorylated, and occludes the substrate-binding site. In an ATP-bound, inactive structure, the activation segment is largely disordered and the CaM-binding segment protrudes out ready for CaM binding. In an ATP-bound, active structure, the regulatory region is dissociated from the catalytic core and the catalytic site assumes an active conformation. Detailed structural analyses reveal the interplay of the regulatory region, the activation segment, and the nucleotide-binding site in the regulation of CaMKI.	[Zha, Manwu; Zhong, Chen; Ou, Ying; Han, Li; Wang, Jianchuan; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ding, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	jpding@sibs.ac.cn		ding, jian ping/0000-0001-7029-7346	National Natural Science Foundation of China [30800171]; Ministry of Science and Technology of China [2011CB966301, 2011CB911102]; Science and Technology Commission of Shanghai Municipality [10JC1416500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (30800171), the Ministry of Science and Technology of China (2011CB966301 and 2011CB911102), and the Science and Technology Commission of Shanghai Municipality (10JC1416500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44828	10.1371/journal.pone.0044828	http://dx.doi.org/10.1371/journal.pone.0044828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028635	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388900012
J	Coppe, A; Bortoluzzi, S; Murari, G; Marino, IAM; Zane, L; Papetti, C				Coppe, Alessandro; Bortoluzzi, Stefania; Murari, Giulia; Marino, Ilaria Anna Maria; Zane, Lorenzo; Papetti, Chiara			Sequencing and Characterization of Striped Venus Transcriptome Expand Resources for Clam Fishery Genetics	PLOS ONE			English	Article							CHAMELEA-GALLINA; ADRIATIC SEA; SSR-MARKERS; ANNOTATION; ASSEMBLER; SOFTWARE; GENOMICS; MOLLUSK	Background: The striped venus Chamelea gallina clam fishery is among the oldest and the largest in the Mediterranean Sea, particularly in the inshore waters of northern Adriatic Sea. The high fishing pressure has lead to a strong stock abundance decline, enhanced by several irregular mortality events. The nearly complete lack of molecular characterization limits the available genetic resources for C. gallina. We achieved the first transcriptome of this species with the aim of identifying an informative set of expressed genes, potential markers to assess genetic structure of natural populations and molecular resources for pathogenic contamination detection. Methodology/Principal Findings: The 454-pyrosequencing of a normalized cDNA library of a pool C. gallina adult individuals yielded 298,494 raw reads. Different steps of reads assembly and filtering produced 36,422 contigs of high quality, one half of which (18,196) were annotated by similarity. A total of 111 microsatellites and 20,377 putative SNPs were identified. A panel of 13 polymorphic transcript-linked microsatellites was developed and their variability assessed in 12 individuals. Remarkably, a scan to search for contamination sequences of infectious origin indicated the presence of several Vibrionales species reported to be among the most frequent clam pathogen's species. Results reported in this study were included in a dedicated database available at http://compgen.bio.unipd.it/chameleabase. Conclusions/Significance: This study represents the first attempt to sequence and de novo annotate the transcriptome of the clam C. gallina. The availability of this transcriptome opens new perspectives in the study of biochemical and physiological role of gene products and their responses to large and small-scale environmental stress in C. gallina, with high throughput experiments such as custom microarray or targeted re-sequencing. Molecular markers, such as the already optimized EST-linked microsatellites and the discovered SNPs will be useful to estimate effects of demographic processes and to detect minute levels of population structuring.	[Coppe, Alessandro; Bortoluzzi, Stefania; Murari, Giulia; Marino, Ilaria Anna Maria; Zane, Lorenzo; Papetti, Chiara] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Zane, L (corresponding author), Univ Padua, Dept Biol, Via G Colombo, Padua, Italy.	lorenzo.zane@unipd.it	Zane, Lorenzo/G-6249-2010; Bortoluzzi, Stefania/G-8211-2011	Zane, Lorenzo/0000-0002-6963-2132; Bortoluzzi, Stefania/0000-0001-8240-3070; Papetti, Chiara/0000-0002-4567-459X	Veneto Region (Italy) [4069]; University of Padova [GRIC11Z79P, GRIC110B82, CPDA110183]	Veneto Region (Italy); University of Padova	This work was part of the project CLODIA funded by the Veneto Region (Italy) Law 15/2007 (DGR n. 4069) to Mariella Rasotto and LZ. AC, CP and IAMM are post-doctorate fellows supported by University of Padova salary grants GRIC11Z79P, GRIC110B82 and by University of Padova research grant CPDA110183, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; BACKELJAU T, 1994, J MAR BIOL ASSOC UK, V74, P211, DOI 10.1017/S0025315400035773; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Colakoglu FA, 2011, BIOL TRACE ELEM RES, V143, P983, DOI 10.1007/s12011-010-8943-3; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dame R.F., 2011, ECOLOGY MARINE BIVAL; EGGLETON JD, 2007, STRUCTURE DYNAMICS N, P91; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Froglia C., 1989, MARINE INVERTEBRATE; Garrison, 2010, FREEBAYES; Giangaspero A, 2005, PREV VET MED, V69, P203, DOI 10.1016/j.prevetmed.2005.02.006; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huvet A, 2012, MAR BIOTECHNOL, V14, P402, DOI 10.1007/s10126-011-9421-4; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moran VA, 2012, NUCL ACIDS RES; Moreira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035009; Morello EB, 2005, FISH RES, V76, P430, DOI 10.1016/j.fishres.2005.07.002; Roldan EM, 2011, J FOOD SAFETY, V31, P257, DOI 10.1111/j.1745-4565.2010.00294.x; Moschino V, 2006, COMP BIOCHEM PHYS A, V145, P433, DOI 10.1016/j.cbpa.2006.07.021; Munoz P, 2006, FISH SHELLFISH IMMUN, V20, P12, DOI 10.1016/j.fsi.2005.02.002; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romanelli M, 2009, ACTA ADRIAT, V50, P171; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Torresi M, 2011, VET ITAL, V47, P371; Traversa D, 2004, APPL ENVIRON MICROB, V70, P4367, DOI 10.1128/AEM.70.7.4367-4370.2004; Trevisan R, 2012, AQUAT TOXICOL, V108, P85, DOI 10.1016/j.aquatox.2011.09.023; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang HX, 2011, GENES GENET SYST, V86, P197, DOI 10.1266/ggs.86.197; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	52	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44185	10.1371/journal.pone.0044185	http://dx.doi.org/10.1371/journal.pone.0044185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028497	gold, Green Submitted, Green Published			2022-12-25	WOS:000311313900014
J	Martinez-Malaxetxebarria, I; Muts, R; van Dijk, L; Parker, CT; Miller, WG; Huynh, S; Gaastra, W; van Putten, JPM; Fernandez-Astorga, A; Wosten, MSM				Martinez-Malaxetxebarria, Irati; Muts, Rudy; van Dijk, Linda; Parker, Craig T.; Miller, William G.; Huynh, Steven; Gaastra, Wim; van Putten, Jos P. M.; Fernandez-Astorga, Aurora; Wosten, Marcm. S. M.			Regulation of Energy Metabolism by the Extracytoplasmic Function (ECF) sigma Factors of Arcobacter butzleri	PLOS ONE			English	Article							2-COMPONENT SYSTEM; ESCHERICHIA-COLI; NONHUMAN PRIMATE; STRESS-RESPONSE; CAMPYLOBACTER; SUSCEPTIBILITY; PREVALENCE; TRANSPORT; ABORTIONS; BACTERIA	The extracytoplasmic function (ECF) sigma factors are fundamental for bacterial adaptation to distinct environments and for survival under different stress conditions. The emerging pathogen Arcobacter butzleri possesses seven putative pairs of sigma/anti-sigma factors belonging to the ECF family. Here, we report the identification of the genes regulated by five out of the seven A. butzleri ECF sigma factors. Three of the ECF sigma factors play an apparent role in transport, energy generation and the maintenance of redox balance. Several genes like the nap, sox and tct genes are regulated by more than one ECF sigma factor, indicating that the A. butzleri ECF sigma factors form a network of overlapping regulons. In contrast to other eubacteria, these A. butzleri ECF regulons appear to primarily regulate responses to changing environments in order to meet metabolic needs instead of an obvious role in stress adaptation.	[Martinez-Malaxetxebarria, Irati; Muts, Rudy; van Dijk, Linda; Gaastra, Wim; van Putten, Jos P. M.; Wosten, Marcm. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Martinez-Malaxetxebarria, Irati; Fernandez-Astorga, Aurora] Univ Basque Country UPV EHU, Fac Pharm, Dept Immunol Microbiol & Parasitol, Vitoria, Spain; [Parker, Craig T.; Miller, William G.; Huynh, Steven] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	Utrecht University; University of Basque Country; United States Department of Agriculture (USDA)	Wosten, MSM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	M.Wosten@uu.nl	Malax-etxebarria, Irati Martinez/AAB-4230-2019; FERNANDEZ ASTORGA, AURORA/L-6415-2014	Malax-etxebarria, Irati Martinez/0000-0002-6576-6707; van Putten, Jos/0000-0002-4126-8172; Parker, Craig/0000-0002-7719-8882; FERNANDEZ ASTORGA, AURORA/0000-0003-0509-3093; Wosten, Marc/0000-0002-7464-7232	Basque Government [IT-528-10, BF106.85, EC-2009-1-4]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant [917.66.330]; US Department of Agriculture Current Research Information System (USDA-CRIS) project [5325-42000-047-00D]; European Molecular Biology Organization (EMBO) Short Term Fellowship [ASTF29-2010]	Basque Government(Basque Government); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant; US Department of Agriculture Current Research Information System (USDA-CRIS) project; European Molecular Biology Organization (EMBO) Short Term Fellowship	This work was supported in part by the Basque Government (IT-528-10) through a Predoctoral Fellowship of the Basque Government for the Training of Researches (BF106.85); by a parallel incentive within the Predoctoral Fellowship of the Basque Government for short stays in different Research Centers (EC-2009-1-4); and by a European Molecular Biology Organization (EMBO) Short Term Fellowship (ASTF29-2010) to IMM. This work was also supported by a fellowship of Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant 917.66.330 to MMSMW and by funds from US Department of Agriculture Current Research Information System (USDA-CRIS) project 5325-42000-047-00D. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; ANDERSON KF, 1993, INFECT IMMUN, V61, P2220, DOI 10.1128/IAI.61.5.2220-2223.1993; Atabay HI, 2001, LETT APPL MICROBIOL, V33, P430, DOI 10.1046/j.1472-765X.2001.01025.x; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Higgins R, 1999, LAB ANIM, V33, P87, DOI 10.1258/002367799780578499; Ho HTK, 2008, FEMS IMMUNOL MED MIC, V53, P85, DOI 10.1111/j.1574-695X.2008.00405.x; Houf K, 2004, MICROB DRUG RESIST, V10, P243, DOI 10.1089/mdr.2004.10.243; ICMSF, 2002, AN MICR TEST FOOD SA, P175; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; LERNER J, 1994, EUR J CLIN MICROBIOL, V13, P660, DOI 10.1007/BF01973994; Levican A, 2012, SYST APPL MICROBIOL, V35, P133, DOI 10.1016/j.syapm.2012.01.002; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Luo Y, 2010, J BACTERIOL, V192, P5736, DOI 10.1128/JB.00826-10; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Musmanno RA, 1997, MICROBIOLOGICA, V20, P63; NEILL SD, 1979, RES VET SCI, V27, P180, DOI 10.1016/S0034-5288(18)32825-X; On SLW, 2002, VET MICROBIOL, V85, P159, DOI 10.1016/S0378-1135(01)00503-X; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rice EW, 1999, LETT APPL MICROBIOL, V28, P31, DOI 10.1046/j.1365-2672.1999.00483.x; Samie A, 2007, J INFECTION, V54, P558, DOI 10.1016/j.jinf.2006.10.047; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Wosten MM, 1997, INITIATION TRANSCRIP, P120; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44796	10.1371/journal.pone.0044796	http://dx.doi.org/10.1371/journal.pone.0044796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028624	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900042
J	Steffener, J; Habeck, CG; Stern, Y				Steffener, Jason; Habeck, Christian G.; Stern, Yaakov			Age-Related Changes in Task Related Functional Network Connectivity	PLOS ONE			English	Article							EVENT-RELATED FMRI; INDEPENDENT COMPONENT ANALYSIS; VERBAL WORKING-MEMORY; DEFAULT MODE; TIME-SERIES; HUMAN BRAIN; BLOOD-FLOW; MRI DATA; ACTIVATION; MAINTENANCE	Aging has a multi-faceted impact on brain structure, brain function and cognitive task performance, but the interaction of these different age-related changes is largely unexplored. We hypothesize that age-related structural changes alter the functional connectivity within the brain, resulting in altered task performance during cognitive challenges. In this neuroimaging study, we used independent components analysis to identify spatial patterns of coordinated functional activity involved in the performance of a verbal delayed item recognition task from 75 healthy young and 37 healthy old adults. Strength of functional connectivity between spatial components was assessed for age group differences and related to speeded task performance. We then assessed whether age-related differences in global brain volume were associated with age-related differences in functional network connectivity. Both age groups used a series of spatial components during the verbal working memory task and the strength and distribution of functional network connectivity between these components differed across the age groups. Poorer task performance, i.e. slower speed with increasing memory load, in the old adults was associated with decreases in functional network connectivity between components comprised of the supplementary motor area and the middle cingulate and between the precuneus and the middle/superior frontal cortex. Advancing age also led to decreased brain volume; however, there was no evidence to support the hypothesis that age-related alterations in functional network connectivity were the result of global brain volume changes. These results suggest that age-related differences in the coordination of neural activity between brain regions partially underlie differences in cognitive performance.	[Steffener, Jason] Columbia Univ Coll Phys & Surg, Dept Neurol, Cognit Neurosci Div, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Steffener, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, Cognit Neurosci Div, New York, NY 10032 USA.	js2746@columbia.edu		Stern, Yaakov/0000-0001-7542-3241	National Institute of Aging grant [5R01AG026158-5, 1K01AG035061]; NATIONAL INSTITUTE ON AGING [R01AG026158, K01AG035061] Funding Source: NIH RePORTER	National Institute of Aging grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Aging grant 5R01AG026158-5 (to Y.S.) and National Institute of Aging grant 1K01AG035061 (to J.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, NEURO IMAGE IN PRESS; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blumen HM, 2011, BEHAV BRAIN RES, V224, P397, DOI 10.1016/j.bbr.2011.06.004; Bonchev Danail, 2005, P191; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chang C, 2010, FILM COMMENT, V46, P81; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grady CL, 1998, NEUROIMAGE, V8, P409, DOI 10.1006/nimg.1998.0376; Grinband J, 2008, NEUROIMAGE, V43, P509, DOI 10.1016/j.neuroimage.2008.07.065; Habeck C, 2005, NEURAL COMPUT, V17, P1602, DOI 10.1162/0899766053723023; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Honey GD, 2000, NEUROIMAGE, V12, P495, DOI 10.1006/nimg.2000.0624; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Metzak P, 2011, HUM BRAIN MAPP, V32, P856, DOI 10.1002/hbm.21072; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Steffener J, 2011, BIOCH BIOPH IN PRESS; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; Steffener J, 2009, BRAIN IMAGING BEHAV, V3, P142, DOI 10.1007/s11682-008-9056-x; Stern Y, 2011, BRAIN RES IN PRESS; Stern Y, 1987, MODIFIED MINIMENTAL; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tucker AM, 2011, BEHAV BRAIN RES, V218, P73, DOI 10.1016/j.bbr.2010.11.012; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Yu Q, 2011, FRONTIERS SYSTEMS NE, V5; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zarahn E, 2005, CEREB CORTEX, V15, P303, DOI 10.1093/cercor/bhh132; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	73	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44421	10.1371/journal.pone.0044421	http://dx.doi.org/10.1371/journal.pone.0044421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028536	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900025
J	Gong, XC; Liu, ZS; Guo, P; Chi, CQ; Chen, J; Wang, XB; Tang, YQ; Wu, XL; Liu, CZ				Gong, Xiao-Cui; Liu, Ze-Shen; Guo, Peng; Chi, Chang-Qiao; Chen, Jian; Wang, Xing-Biao; Tang, Yue-Qin; Wu, Xiao-Lei; Liu, Chun-Zhong			Bacteria in Crude Oil Survived Autoclaving and Stimulated Differentially by Exogenous Bacteria	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIESEL FUEL; PETROLEUM; MICROORGANISMS; STRESS; BIODEGRADATION; BIOSTIMULATION; HYDROCARBONS; DEGRADATION; SIMILARITY	Autoclaving of crude oil is often used to evaluate the hydrocarbon-degrading abilities of bacteria. This may be potentially useful for bioaugmentation and microbial enhanced oil recovery (MEOR). However, it is not entirely clear if "endogenous" bacteria (e.g., spores) in/on crude oil survive the autoclaving process, or influence subsequent evaluation of the hydrocarbon-degradation abilities of the "exogenous" bacterial strains. To test this, we inoculated autoclaved crude oil medium with six exogenous bacterial strains (three Dietzia strains, two Acinetobacter strains, and one Pseudomonas strain). The survival of the spore-forming Bacillus and Paenibacillus and the non-spore-forming mesophilic Pseudomonas, Dietzia, Alcaligenes, and Microbacterium was detected using a 16S rRNA gene clone library and terminal restriction fragment length polymorphism (T-RFLP) analysis. However, neither bacteria nor bacterial activity was detected in three controls consisting of non-inoculated autoclaved crude oil medium. These results suggest that detection of endogenous bacteria was stimulated by the six inoculated strains. In addition, inoculation with Acinetobacter spp. stimulated detection of Bacillus, while inoculation with Dietzia spp. and Pseudomonas sp. stimulated the detection of more Pseudomonas. In contrast, similar exogenous bacteria stimulated similar endogenous bacteria at the genus level. Based on these results, special emphasis should be applied to evaluate the influence of bacteria capable of surviving autoclaving on the hydrocarbon-degrading abilities of exogenous bacteria, in particular, with regard to bioaugmentation and MEOR. Bioaugmentation and MEOR technologies could then be developed to more accurately direct the growth of specific endogenous bacteria that may then improve the efficiency of treatment or recovery of crude oil.	[Gong, Xiao-Cui; Liu, Ze-Shen; Guo, Peng; Chi, Chang-Qiao; Chen, Jian; Wang, Xing-Biao; Tang, Yue-Qin; Wu, Xiao-Lei; Liu, Chun-Zhong] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China	Peking University	Wu, XL (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Wu, Xiao-Lei/G-6882-2011	Wu, Xiao-Lei/0000-0002-9897-6903	National Natural Science Foundation of China [31070107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, with the grant numbers of 31070107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1969, APPL MICROBIOL, V17, P745, DOI 10.1128/AEM.17.5.745-749.1969; ALHADHRAMI MN, 1995, MAR POLLUT BULL, V30, P403, DOI 10.1016/0025-326X(94)00235-2; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; BENEDICT RG, 1958, APPL MICROBIOL, V6, P401, DOI 10.1128/AEM.6.6.401-407.1958; Berry BJ, 2010, APPL ENVIRON MICROB, V76, P2377, DOI 10.1128/AEM.02147-09; Bonch-Osmolovskaya EA, 2003, APPL ENVIRON MICROB, V69, P6143, DOI 10.1128/AEM.69.10.6143-6151.2003; Chaillan F, 2004, RES MICROBIOL, V155, P587, DOI 10.1016/j.resmic.2004.04.006; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Colores GM, 2000, APPL ENVIRON MICROB, V66, P2959, DOI 10.1128/AEM.66.7.2959-2964.2000; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; Eguchi M, 1996, APPL ENVIRON MICROB, V62, P1287, DOI 10.1128/AEM.62.4.1287-1294.1996; GILBERT GL, 1964, APPL MICROBIOL, V12, P496, DOI 10.1128/AEM.12.6.496-503.1964; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Iwabuchi N, 2000, APPL ENVIRON MICROB, V68, P2337; Kanaly RA, 2002, APPL ENVIRON MICROB, V68, P5826, DOI 10.1128/AEM.68.12.5826-5833.2002; KILLHAM K, 1984, APPL ENVIRON MICROB, V47, P301, DOI 10.1128/AEM.47.2.301-306.1984; Lazar I, 2007, PETROL SCI TECHNOL, V25, P1353, DOI 10.1080/10916460701287714; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Li H, 2010, MICROB ECOL, V60, P771, DOI 10.1007/s00248-010-9733-3; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEASURES JC, 1975, NATURE, V257, P398, DOI 10.1038/257398a0; Meredith W, 2000, ORG GEOCHEM, V31, P1059, DOI 10.1016/S0146-6380(00)00136-4; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; Olivier SA, 2011, APPL ENVIRON MICROB, V77, P2317, DOI 10.1128/AEM.01957-10; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; RUTALA WA, 1982, APPL ENVIRON MICROB, V43, P1311, DOI 10.1128/AEM.43.6.1311-1316.1982; Sagripanti JL, 1999, APPL ENVIRON MICROB, V65, P4255; SCHLEY DG, 1960, APPL MICROBIOL, V8, P15, DOI 10.1128/AEM.8.1.15-19.1960; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seklemova E, 2001, BIODEGRADATION, V12, P311, DOI 10.1023/A:1014356223118; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9; Thomassin-Lacroix EJM, 2002, APPL MICROBIOL BIOT, V59, P551, DOI 10.1007/s00253-002-1038-0; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; van Hamme JD, 2001, APPL ENVIRON MICROB, V67, P4974; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wu XL, 2001, ENVIRON MICROBIOL, V3, P355, DOI 10.1046/j.1462-2920.2001.00199.x; Yamane K, 2011, FEMS MICROBIOL ECOL, V76, P220, DOI 10.1111/j.1574-6941.2011.01044.x; Yamane K, 2008, BIOSCI BIOTECH BIOCH, V72, P2831, DOI 10.1271/bbb.80227; Yoshida N, 2005, J BIOSCI BIOENG, V99, P143, DOI 10.1263/jbb.99.143; Yu SL, 2011, J ENVIRON SCI, V23, P1; Yu SL, 2010, J BIOSCI BIOENG, V110, P500, DOI 10.1016/j.jbiosc.2010.05.005; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	47	22	27	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e40842	10.1371/journal.pone.0040842	http://dx.doi.org/10.1371/journal.pone.0040842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028421	Green Published, Green Submitted, gold			2022-12-25	WOS:000309742800001
J	Suzuki, K; Adachi, Y; Numata, T; Nakada, S; Yanagita, M; Nakagata, N; Evans, SM; Graf, D; Economides, A; Haraguchi, R; Moon, AM; Yamada, G				Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yanagita, Motoko; Nakagata, Naomi; Evans, Sylvia M.; Graf, Daniel; Economides, Aris; Haraguchi, Ryuma; Moon, Anne M.; Yamada, Gen			Reduced BMP Signaling Results in Hindlimb Fusion with Lethal Pelvic/Urogenital Organ Aplasia: A New Mouse Model of Sirenomelia	PLOS ONE			English	Article							EXTERNAL GENITALIA; LIMB DEVELOPMENT; MUTANT MICE; ECTODERMAL RIDGE; CRE-RECOMBINASE; EXPRESSION; MESODERM; BUD; MECHANISMS; OUTGROWTH	Sirenomelia, also known as mermaid syndrome, is a developmental malformation of the caudal body characterized by leg fusion and associated anomalies of pelvic/urogenital organs including bladder, kidney, rectum and external genitalia. Most affected infants are stillborn, and the few born alive rarely survive beyond the neonatal period. Despite the many clinical studies of sirenomelia in humans, little is known about the pathogenic developmental mechanisms that cause the complex array of phenotypes observed. Here, we provide new evidences that reduced BMP (Bone Morphogenetic Protein) signaling disrupts caudal body formation in mice and phenocopies sirenomelia. Bmp4 is strongly expressed in the developing caudal body structures including the peri-cloacal region and hindlimb field. In order to address the function of Bmp4 in caudal body formation, we utilized a conditional Bmp4 mouse allele (Bmp4(flox/flox)) and the Isl1 (Islet1)-Cre mouse line. Isl1-Cre is expressed in the peri-cloacal region and the developing hindimb field. Isl1Cre; Bmp4(flox/flox) conditional mutant mice displayed sirenomelia phenotypes including hindlimb fusion and pelvic/urogenital organ dysgenesis. Genetic lineage analyses indicate that Isl1-expressing cells contribute to both the aPCM (anterior Peri-Cloacal Mesenchyme) and the hindlimb bud. We show Bmp4 is essential for the aPCM formation independently with Shh signaling. Furthermore, we show Bmp4 is a major BMP ligand for caudal body formation as shown by compound genetic analyses of Bmp4 and Bmp7. Taken together, this study reveals coordinated development of caudal body structures including pelvic/urogenital organs and hindlimb orchestrated by BMP signaling in Isl1-expressing cells. Our study offers new insights into the pathogenesis of sirenomelia.	[Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yamada, Gen] WMU, Inst Adv Med, Dept Dev Genet, Wakayama, Japan; [Suzuki, Kentaro; Adachi, Yasuha; Numata, Tomokazu; Nakada, Shoko; Yamada, Gen] Kumamoto Univ, IMEG, Dept Organ Format, Kumamoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan; [Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Graf, Daniel] Univ Zurich, Fac Med, Inst Oral Biol, Zurich, Switzerland; [Economides, Aris] Regeneron Pharmaceut, Genome Engn Technol, Tarrytown, NY USA; [Haraguchi, Ryuma] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Matsuyama, Ehime 790, Japan; [Moon, Anne M.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Kumamoto University; Kyoto University; Kumamoto University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Geneva; University of Zurich; Regeneron; Ehime University	Yamada, G (corresponding author), WMU, Inst Adv Med, Dept Dev Genet, Wakayama, Japan.	genyama77@yahoo.co.jp	Evans, Sylvia/G-1980-2015; Graf, Daniel/H-1214-2011; Yanagita, Motoko/AAJ-7731-2021	Graf, Daniel/0000-0003-1163-8117; Economides, Aris/0000-0002-6508-8942; Yanagita, Motoko/0000-0002-0339-9008; Nakagata, Naomi/0000-0002-5737-9993; moon, anne/0000-0002-9090-1093	Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences [22132006]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institutes of Health Grant [R01-ES016597-01A1];  [24590235]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Scientific Research on Innovative Areas Molecular Mechanisms for Establishment of Sex Differences (22132006); the global Center-of-Excellence (COE) Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grant-in-Aid for Young Scientists (B); Grant-in-Aid for Scientific Research (C) (24590235) and National Institutes of Health Grant R01-ES016597-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barbara PD, 2002, DEVELOPMENT, V129, P551; BARR M, 1988, TERATOLOGY, V38, P487, DOI 10.1002/tera.1420380513; Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Browne Marybeth, 2004, J Perinatol, V24, P329, DOI 10.1038/sj.jp.7211085; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V41, P245; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Garrido-Allepuz C, 2011, DIS MODEL MECH, V4, P289, DOI 10.1242/dmm.007732; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019370; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2012, PLOS ONE IN PRESS; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; KALLEN B, 1974, TERATOLOGY, V9, P99, DOI 10.1002/tera.1420090113; KALLEN B, 1992, J MED GENET, V29, P30, DOI 10.1136/jmg.29.1.30; Kawakami Y, 2011, DEVELOPMENT, V138, P4465, DOI 10.1242/dev.065359; Kimmel SG, 2000, J PEDIATR SURG, V35, P227, DOI 10.1016/S0022-3468(00)90014-9; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; MILDENBERGER H, 1988, J PEDIATR SURG, V23, P166, DOI 10.1016/S0022-3468(88)80150-7; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Omori A, 2011, CONGENIT ANOM, V51, P102, DOI 10.1111/j.1741-4520.2011.00318.x; Opitz JM, 2002, AM J MED GENET, V115, P269, DOI 10.1002/ajmg.10983; ORAHILLY R, 1989, TERATOLOGY, V40, P409, DOI 10.1002/tera.1420400502; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STEVENSON RE, 1986, PEDIATRICS, V78, P451; Stocker J T, 1987, Perspect Pediatr Pathol, V10, P7; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Taori KB., 2002, INDIAN J RADIOL IMAG, V12, P399; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Warburton David, 2004, Paediatr Respir Rev, V5 Suppl A, pS283, DOI 10.1016/S1526-0542(04)90052-8; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 2007, DEV BIOL, V306, P883, DOI 10.1016/j.ydbio.2007.03.517; Zakin L, 2005, DEVELOPMENT, V132, P2489, DOI 10.1242/dev.01822; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	62	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e43453	10.1371/journal.pone.0043453	http://dx.doi.org/10.1371/journal.pone.0043453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028455	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000309742800005
J	Fine-Coulson, K; Reaves, BJ; Karls, RK; Quinn, FD				Fine-Coulson, Kari; Reaves, Barbara J.; Karls, Russell K.; Quinn, Frederick D.			The Role of Lipid Raft Aggregation in the Infection of Type II Pneumocytes by Mycobacterium tuberculosis	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; IN-VITRO; MEMBRANE; CHOLESTEROL; CAVEOLAE; INVASION; ENTRY; ENDOCYTOSIS; ASSOCIATION; EXPRESSION	Dynamic, cholesterol-dense regions of the plasma membrane, known as lipid rafts (LR), have been observed to develop during and may be directly involved in infection of host cells by various pathogens. This study focuses on LR aggregation induced in alveolar epithelial cells during infection with Mycobacterium tuberculosis (Mtb) bacilli. We report dose- and time-dependent increases in LR aggregation after infection with three different strains at multiplicities of infection of 1, 10 and 100 from 2-24 hr post infection (hpi). Specific strain-dependent variations were noted among H37Rv, HN878 and CDC1551 with H37Rv producing the most significant increase from 15 aggregates per cell (APC) to 27 APC at MOI 100 during the 24 hour infection period. Treatment of epithelial cells with Culture Filtrate Protein, Total Lipids and gamma-irradiated whole cells from each strain failed to induce the level of LR aggregation observed during infection with any of the live strains. However, filtered supernatants from infected epithelial cells did produce comparable LR aggregation, suggesting a secreted mycobacterial product produced during infection of host cells is responsible for LR aggregation. Disruption of lipid raft formation prior to infection indicates that Mtb bacilli utilize LR aggregates for internalization and survival in epithelial cells. Treatment of host cells with the LR-disruption agent Filipin III produced a nearly 22% reduction in viable bacteria for strains H37Rv and HN878, and a 7% reduction for strain CDC1551 after 6 hpi. This study provides evidence for significant mycobacterial-induced changes in the plasma membrane of alveolar epithelial cells and that Mtb strains vary in their ability to facilitate aggregation and utilization of LR.	[Fine-Coulson, Kari; Reaves, Barbara J.; Karls, Russell K.; Quinn, Frederick D.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Fine-Coulson, K (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	fquinn@uga.edu		Karls, Russell/0000-0002-6474-6106	American Lung Association; University of Georgia Faculty of Infectious Diseases	American Lung Association; University of Georgia Faculty of Infectious Diseases	This work was supported in part by research grants from the American Lung Association (R.K.) and the University of Georgia Faculty of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Auriac A, 2010, HAEMATOL-HEMATOL J, V95, P1269, DOI 10.3324/haematol.2009.019992; Barczak AK, 2005, J INFECT DIS, V192, P600, DOI 10.1086/432006; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; Dobos KM, 2000, INFECT IMMUN, V68, P6300, DOI 10.1128/IAI.68.11.6300-6310.2000; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Fine KL, 2012, CELL MICROBIOL, DOI [10.1111/j.1462-5822.2012.01804, DOI 10.1111/J.1462-5822.2012.01804]; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hauck FR, 2009, AM FAM PHYSICIAN, V79, P879; Hayakawa E, 2007, BIOPHYS J, V93, P4018, DOI 10.1529/biophysj.107.104075; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manca C, 1999, J IMMUNOL, V162, P6740; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Munoz S, 2009, SCAND J IMMUNOL, V70, P256, DOI 10.1111/j.1365-3083.2009.02295.x; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; Radeva G, 2005, FEBS J, V272, P4924, DOI 10.1111/j.1742-4658.2005.04905.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shin DM, 2008, CELL MICROBIOL, V10, P1893, DOI 10.1111/j.1462-5822.2008.01179.x; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Togayachi A, 2010, P NATL ACAD SCI USA, V107, P11900, DOI 10.1073/pnas.0914298107; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Welin A, 2008, INFECT IMMUN, V76, P2882, DOI 10.1128/IAI.01549-07; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Xu ZX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008532; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146	76	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45028	10.1371/journal.pone.0045028	http://dx.doi.org/10.1371/journal.pone.0045028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024786	Green Submitted, Green Published, gold			2022-12-25	WOS:000308860100044
J	Gautam, A; Dixit, S; Embers, M; Gautam, R; Philipp, MT; Singh, SR; Morici, L; Dennis, VA				Gautam, Aarti; Dixit, Saurabh; Embers, Monica; Gautam, Rajeev; Philipp, Mario T.; Singh, Shree R.; Morici, Lisa; Dennis, Vida A.			Different Patterns of Expression and of IL-10 Modulation of Inflammatory Mediators from Macrophages of Lyme Disease-Resistant and -Susceptible Mice	PLOS ONE			English	Article							BORRELIA-BURGDORFERI LIPOPROTEINS; COLLAGEN-INDUCED ARTHRITIS; HUMAN MONOCYTIC CELLS; IFN-GAMMA; INTERLEUKIN-10 PRODUCTION; TREPONEMA-PALLIDUM; MESSENGER-RNA; HOST-DEFENSE; PROINFLAMMATORY CYTOKINES; BACTERIAL LIPOPROTEINS	C57BL/6J (C57) mice develop mild arthritis (Lyme disease-resistant) whereas C3H/HeN (C3H) mice develop severe arthritis (Lyme disease-susceptible) after infection with the spirochete Borrelia burgdorferi. We hypothesized that susceptibility and resistance to Lyme disease, as modeled in mice, is associated with early induction and regulation of inflammatory mediators by innate immune cells after their exposure to live B. burgdorferi spirochetes. Here, we employed multiplex ELISA and qRT-PCR to investigate quantitative differences in the levels of cytokines and chemokines produced by bone marrow-derived macrophages from C57 and C3H mice after these cells were exposed ex vivo to live spirochetes or spirochetal lipoprotein. Upon stimulation, the production of both cytokines and chemokines was up-regulated in macrophages from both mouse strains. Interestingly, however, our results uncovered two distinct patterns of spirochete- and lipoprotein-inducible inflammatory mediators displayed by mouse macrophages, such that the magnitude of the chemokine up-regulation was larger in C57 cells than it was in C3H cells, for most chemokines. Conversely, cytokine up-regulation was more intense in C3H cells. Gene transcript analyses showed that the displayed patterns of inflammatory mediators were associated with a TLR2/TLR1 transcript imbalance: C3H macrophages expressed higher TLR2 transcript levels as compared to those expressed by C57 macrophages. Exogenous IL-10 dampened production of inflammatory mediators, especially those elicited by lipoprotein stimulation. Neutralization of endogenously produced IL-10 increased production of inflammatory mediators, notably by macrophages of C57 mice, which also displayed more IL-10 than C3H macrophages. The distinct patterns of proinflammatory mediator production, along with TLR2/TLR1 expression, and regulation in macrophages from Lyme disease-resistant and -susceptible mice suggests itself as a blueprint to further investigate differential pathogenesis of Lyme disease.	[Gautam, Aarti; Dixit, Saurabh; Embers, Monica; Philipp, Mario T.; Dennis, Vida A.] Tulane Univ, Hlth Sci Ctr, Div Bacteriol & Parasitol, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gautam, Rajeev] Tulane Univ, Hlth Sci Ctr, Div Microbiol, Tulane Natl Primate Res Ctr, Covington, LA USA; [Dixit, Saurabh; Singh, Shree R.; Dennis, Vida A.] Alabama State Univ, Ctr Nanobiotechnol Res, Montgomery, AL 36101 USA; [Morici, Lisa] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Gautam, A (corresponding author), USA, Integrat Syst Biol Program, Ctr Environm Hlth Res, Ft Detrick, MD USA.	vdennis@alasu.edu	; dixit, saurabh/E-3296-2013	Singh, Shree R./0000-0002-3571-2222; dixit, saurabh/0000-0002-9140-9543; Embers, Monica/0000-0003-4051-7592	National Institute of Allergy and Infectious Diseases [R21AI073356]; National Center for Research Resources, National Institutes of Health [RR00164]; National Science Foundation-Centers of Research Excellence in Science and Technology [HRD- 0734232]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073356] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation-Centers of Research Excellence in Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project described was supported by Grant Number R21AI073356 from the National Institute of Allergy and Infectious Diseases; Grant Number RR00164 from the National Center for Research Resources, National Institutes of Health and Grant Number HRD- 0734232 from National Science Foundation-Centers of Research Excellence in Science and Technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anguita J, 1996, J CLIN INVEST, V97, P1028, DOI 10.1172/JCI118494; Anguita J, 1998, J INFECT DIS, V178, P1512, DOI 10.1086/314448; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Bockenstedt LK, 2001, INFECT IMMUN, V69, P5264, DOI 10.1128/IAI.69.9.5264-5269.2001; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brown CR, 2008, INFECT IMMUN, V76, P5500, DOI 10.1128/IAI.00808-08; Brown CR, 1999, INFECT IMMUN, V67, P3329, DOI 10.1128/IAI.67.7.3329-3333.1999; Brown CR, 2004, INFECT IMMUN, V72, P4956, DOI 10.1128/IAI.72.9.4956-4965.2004; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Burns MJ, 1998, INFECT IMMUN, V66, P4875, DOI 10.1128/IAI.66.10.4875-4883.1998; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; Dennis VA, 2006, INFECT IMMUN, V74, P5780, DOI 10.1128/IAI.00678-06; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; Diterich I, 2001, INFECT IMMUN, V69, P687, DOI 10.1128/IAI.69.2.687-694.2001; Ganapamo F, 2003, EUR J IMMUNOL, V33, P1934, DOI 10.1002/eji.200323655; Ganapamo F, 2000, INFECT IMMUN, V68, P7162, DOI 10.1128/IAI.68.12.7162-7165.2000; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; Glickstein L, 2001, INFECT IMMUN, V69, P3737, DOI 10.1128/IAI.69.6.3737-3743.2001; Harjacek M, 2000, J RHEUMATOL, V27, P497; Haupl T, 1997, FEMS IMMUNOL MED MIC, V19, P15; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Johansson ACM, 2001, J IMMUNOL, V167, P3505, DOI 10.4049/jimmunol.167.6.3505; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; KASAMA T, 1994, J IMMUNOL, V152, P3559; KeaneMyers A, 1996, J IMMUNOL, V156, P2488; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lisinski TJ, 2002, J LEUKOCYTE BIOL, V72, P503; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Londono D, 2011, J IMMUNOL, V186, P7176, DOI 10.4049/jimmunol.1100060; Ma Y, 1998, INFECT IMMUN, V66, P161, DOI 10.1128/IAI.66.1.161-168.1998; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller JC, 2008, EXP MOL PATHOL, V85, P20, DOI 10.1016/j.yexmp.2008.03.004; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2001, J INFECT DIS, V183, P1631, DOI 10.1086/320703; Mullegger RR, 2000, J INVEST DERMATOL, V115, P1115, DOI 10.1046/j.1523-1747.2000.00198.x; Murthy PK, 2000, INFECT IMMUN, V68, P6663, DOI 10.1128/IAI.68.12.6663-6669.2000; NORGARD MV, 1995, INFECT IMMUN, V63, P1507, DOI 10.1128/IAI.63.4.1507-1515.1995; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Olson CM, 2009, J IMMUNOL, V182, P3728, DOI 10.4049/jimmunol.0804111; Oosting M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025998; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Sabino GJ, 2011, AM J PATHOL, V179, P1917, DOI 10.1016/j.ajpath.2011.06.029; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Shin JJ, 2007, ARTHRITIS RHEUM-US, V56, P1325, DOI 10.1002/art.22441; Shin JHJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3128; Singh SK, 2005, CLIN EXP RHEUMATOL, V23, P311; Sjowall J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018220; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2012, ARTHRITIS RHEUM-US, V64, P1497, DOI 10.1002/art.34383; Strle K, 2009, J INFECT DIS, V200, P1936, DOI 10.1086/648091; Wang GQ, 2008, J IMMUNOL, V180, P8306, DOI 10.4049/jimmunol.180.12.8306; Wang XH, 2008, FEMS IMMUNOL MED MIC, V52, P124, DOI 10.1111/j.1574-695X.2007.00356.x; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Yakimchuk K, 2011, EUR J IMMUNOL, V41, P694, DOI 10.1002/eji.201040808	85	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e43860	10.1371/journal.pone.0043860	http://dx.doi.org/10.1371/journal.pone.0043860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024745	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100003
J	Ohkawa, N; Saitoh, Y; Tokunaga, E; Nihonmatsu, I; Ozawa, F; Murayama, A; Shibata, F; Kitamura, T; Inokuchi, K				Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Nihonmatsu, Itsuko; Ozawa, Fumiko; Murayama, Akiko; Shibata, Fumi; Kitamura, Toshio; Inokuchi, Kaoru			Spine Formation Pattern of Adult-Born Neurons Is Differentially Modulated by the Induction Timing and Location of Hippocampal Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; DENDRITIC SPINES; DENTATE GYRUS; SPATIAL MEMORY; FUNCTIONAL-INTEGRATION; NEUROGENESIS; BRAIN; ACTIN	In the adult hippocampus dentate gyrus (DG), newly born neurons are functionally integrated into existing circuits and play important roles in hippocampus-dependent memory. However, it remains unclear how neural plasticity regulates the integration pattern of new neurons into preexisting circuits. Because dendritic spines are major postsynaptic sites for excitatory inputs, spines of new neurons were visualized by retrovirus-mediated labeling to evaluate integration. Long-term potentiation (LTP) was induced at 12, 16, or 21 days postinfection (dpi), at which time new neurons have no, few, or many spines, respectively. The spine expression patterns were investigated at one or two weeks after LTP induction. Induction at 12 dpi increased later spinogenesis, although the new neurons at 12 dpi didn't respond to the stimulus for LTP induction. Induction at 21 dpi transiently mediated spine enlargement. Surprisingly, LTP induction at 16 dpi reduced the spine density of new neurons. All LTP-mediated changes specifically appeared within the LTP-induced layer. Therefore, neural plasticity differentially regulates the integration of new neurons into the activated circuit, dependent on their developmental stage. Consequently, new neurons at different developmental stages may play distinct roles in processing the acquired information by modulating the connectivity of activated circuits via their integration.	[Ohkawa, Noriaki; Saitoh, Yoshito; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Sugitani, Toyama, Japan; [Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Ozawa, Fumiko; Murayama, Akiko; Inokuchi, Kaoru] CREST, JST, Kawaguchi, Saitama, Japan; [Ohkawa, Noriaki; Saitoh, Yoshito; Tokunaga, Eri; Nihonmatsu, Itsuko; Ozawa, Fumiko; Murayama, Akiko; Inokuchi, Kaoru] MITILS, Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo, Japan; [Shibata, Fumi; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo, Japan	University of Toyama; Japan Science & Technology Agency (JST); Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Tokyo	Ohkawa, N (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Sugitani, Toyama, Japan.	inokuchi@med.u-toyama.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Kitamura, Toshio/AAA-2071-2021	Inokuchi, Kaoru/0000-0002-5393-3133; Ohkawa, Noriaki/0000-0002-6754-9933	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; Mitsubishi Foundation; Uehara Memorial Foundation; Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research [24650164] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) to KI, a Grant-in-Aid for Scientific Research to KI, a Grant-in-Aid for Young Scientists B to NO from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government, the Mitsubishi Foundation, the Uehara Memorial Foundation to KI, and the Sasakawa Scientific Research Grant from the Japan Science Society to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WC, 1994, P NATL ACAD SCI USA, V91, P10049, DOI 10.1073/pnas.91.21.10049; Abraham WC, 2002, J NEUROSCI, V22, P9626; Ambrogini P, 2010, HIPPOCAMPUS, V20, P799, DOI 10.1002/hipo.20679; Biou V, 2008, EUR J NEUROSCI, V27, P2847, DOI 10.1111/j.1460-9568.2008.06269.x; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Johnson OL, 2006, BRAIN RES, V1113, P1, DOI 10.1016/j.brainres.2006.06.116; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-13; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Li GN, 2010, CURR OPIN NEUROBIOL, V20, P126, DOI 10.1016/j.conb.2009.12.008; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Medvedev NI, 2010, NEUROSCIENCE, V165, P1170, DOI 10.1016/j.neuroscience.2009.11.047; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Popov VI, 2004, NEUROSCIENCE, V128, P251, DOI 10.1016/j.neuroscience.2004.06.029; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Tamamaki N, 1999, J COMP NEUROL, V411, P257; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	61	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45270	10.1371/journal.pone.0045270	http://dx.doi.org/10.1371/journal.pone.0045270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024813	gold, Green Published			2022-12-25	WOS:000308860100071
J	Dunne, JV; van Eeden, SF; Keen, KJ				Dunne, James V.; van Eeden, Stephan F.; Keen, Kevin J.			L-selectin and Skin Damage in Systemic Sclerosis	PLOS ONE			English	Article							SOLUBLE L-SELECTIN; ADHESION MOLECULES; PERIPHERAL-BLOOD; THICKNESS SCORE; SERUM LEVELS; T-CELLS; EXPRESSION; DISEASE; INFLAMMATION; LYMPHOCYTES	Background: L-selectin ligands are induced on the endothelium of inflammatory sites. L-selectin expression on neutrophils and monocytes may mediate the primary adhesion of these cells at sites of inflammation by mediating the leukocyte-leukocyte interactions that facilitate their recruitment. L-selectin retains functional activity in its soluble form. Levels of soluble L-selectin have been reported as both elevated and lowered in patients with systemic sclerosis (SSc). This preliminary study seeks to discern amongst these disparate results and to discover whether there is an association between L-selectin concentrations in plasma and skin damage in SSc patients. Methodology and Principal Findings: Nineteen cases with limited systemic sclerosis (lSSc) and 11 cases with diffuse systemic sclerosis (dSSc) were compared on a pairwise basis to age- and sex-matched controls. Criteria of the American College of Rheumatology were used to diagnose SSc. Skin involvement was assessed using the modified Rodnan skin score (mRSS). We find no association between mRSS and plasma L-selectin concentration in lSSc cases (p = 0.9944) but a statistically significant negative correlation in dSSc cases (R-2 = 73.11 per cent, p = 0.0008). The interpretation of the slope for dSSc cases is that for each increase of 100 ng/ml in soluble L-selectin concentration, the mRSS drops 4.22 (95 per cent CI: 2.29, 6.16). There was also a highly statistically significant negative correlation between sL-selectin and disease activity (p = 0.0007) and severity (p = 0.0007) in dSSc cases but not in lSSc cases (p = 0.2596, p = 0.7575, respectively). Conclusions and Significance: No effective treatments exist for skin damage in SSc patients. Nor is there a laboratory alternative to the modified Rodnan skin score as is the case for other organs within the body. Modulation of circulating L-selectin is a promising target for reducing skin damage in dSSc patients. Plasma levels of soluble L-selectin could serve as an outcome measure for dSSc patients in clinical trials.	[Dunne, James V.; van Eeden, Stephan F.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Dunne, James V.] British Columbia Scleroderma Clin, Vancouver, BC, Canada; [van Eeden, Stephan F.] James Hogg Heart & Lung Inst, Vancouver, BC, Canada; [Keen, Kevin J.] Univ No British Columbia, Dept Math & Stat, Prince George, BC V2L 5P2, Canada	University of British Columbia; University of Northern British Columbia	Dunne, JV (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	James.Dunne@VCH.ca	Dunne, James/ABF-6157-2021; Keen, Kevin J/D-5628-2013	Keen, Kevin J/0000-0001-5695-0505	Scleroderma Association of British Columbia; Heart and Stroke Foundation of Canada; Actelion Pharmaceuticals; Merck Canada Inc.	Scleroderma Association of British Columbia; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Actelion Pharmaceuticals; Merck Canada Inc.	This work was supported by research grants from the Scleroderma Association of British Columbia and the Heart and Stroke Foundation of Canada. Actelion Pharmaceuticals provides a grant-in-aid to the British Columbia Scleroderma Clinic. KJK received financial support from Merck Canada Inc. for an honorarium and travel. SvE is a Senior Scholar of the Michael Smith Foundation for Health Research, a Career Investigator of the American Lung Association and the Canadian Institutes of Health Research(CIHR/GSK) Professor in Chronic obstructive pulmonary disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Ates A, 2004, SCAND J IMMUNOL, V59, P315, DOI 10.1111/j.0300-9475.2004.01389.x; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Blann AD, 1996, BRIT J HAEMATOL, V95, P192, DOI 10.1046/j.1365-2141.1996.7562378.x; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Daoussis D, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/214013; Distler JHW, 2011, CLIN EXP RHEUMATOL, V29, pS40; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; Dunne JV, 2013, RHEUMATOL INT, V33, P475, DOI 10.1007/s00296-012-2378-4; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Gazitt Y, 2001, STEM CELLS, V19, P134, DOI 10.1634/stemcells.19-2-134; Haught WH, 1996, AM HEART J, V132, P1; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Hothorn T, 2008, J STAT SOFTW, V28, P1; Inaoki M, 2001, J DERMATOL SCI, V25, P78, DOI 10.1016/S0923-1811(00)00108-0; Jordan S, 2012, RHEUMATOLOGY, V51, P25, DOI 10.1093/rheumatology/ker490; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Keen KJ, 2012, RHEUMATOLOGY CURRE S; LEROY EC, 1988, J RHEUMATOL, V15, P202; Matsushita T, 2006, J RHEUMATOL, V33, P275; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitsuo A, 2006, RHEUMATOLOGY, V45, P1477, DOI 10.1093/rheumatology/kel119; Mommsen P, 2011, PATHOL RES PRACT, V207, P142, DOI 10.1016/j.prp.2010.12.003; Phumethum V, 2011, J RHEUMATOL, V38, P289, DOI 10.3899/jrheum.100361; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P28, DOI 10.1007/s100670050047; Shimada Y, 2001, CLIN EXP IMMUNOL, V124, P474, DOI 10.1046/j.1365-2249.2001.01514.x; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Tang MLK, 1998, J IMMUNOL, V160, P5113; Valentini G, 2003, CLIN EXP RHEUMATOL, V21, pS39; Vela-Ojeda J, 2010, STEM CELLS DEV, V19, P333, DOI 10.1089/scd.2009.0216; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Zhou LX, 2007, J INVEST DERMATOL, V127, P281, DOI 10.1038/sj.jid.5700517	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44814	10.1371/journal.pone.0044814	http://dx.doi.org/10.1371/journal.pone.0044814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028631	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700042
J	Perrone, G; Gaeta, LM; Zagami, M; Nasorri, F; Coppola, R; Borzomati, D; Bartolozzi, F; Altomare, V; Trodella, L; Tonini, G; Santini, D; Cavani, A; Muda, AO				Perrone, Giuseppe; Gaeta, Laura Maria; Zagami, Mariagiovanna; Nasorri, Francesca; Coppola, Roberto; Borzomati, Domenico; Bartolozzi, Francesco; Altomare, Vittorio; Trodella, Lucio; Tonini, Giuseppe; Santini, Daniele; Cavani, Andrea; Muda, Andrea Onetti			In Situ Identification of CD44+/CD242-Cancer Cells in Primary Human Breast Carcinomas	PLOS ONE			English	Article							CANCER-INITIATING CELLS; METASTASIS; CD44(+)/CD24(-); EXPRESSION; TUMORS; CD24; CHEMOTHERAPY; SURVIVE; MARKER; CD44	Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to their enhanced capacity for cancer development and their self-renewal potential. The identification of human tumourigenic breast cancer cells in surgical samples has recently received increased attention due to the implications for prognosis and treatment, although limitations exist in the interpretation of these studies. To better identify the CD44+/CD24- cells in routine surgical specimens, 56 primary breast carcinoma cases were analysed by immunofluorescence and confocal microscopy, and the results were compared using flow cytometry analysis to correlate the amount and distribution of the CD44+/CD24- population with clinicopathological features. Using these methods, we showed that the breast carcinoma cells displayed four distinct sub-populations based on the expression pattern of CD44 and CD24. The CD44+/CD24- cells were found in 91% of breast tumours and constituted an average of 6.12% (range, 0.11%-21.23%) of the tumour. A strong correlation was found between the percentage of CD44+/CD24- cells in primary tumours and distant metastasis development (p = 0.0001); in addition, there was an inverse significant association with ER and PGR status (p = 0.002 and p = 0.001, respectively). No relationship was evident with tumour size (T) and regional lymph node (N) status, differentiation grade, proliferative index or HER2 status. In a multivariate analysis, the percentage of CD44+/CD24- cancer cells was an independent factor related to metastasis development (p = 0.004). Our results indicate that confocal analysis of fluorescence-labelled breast cancer samples obtained at surgery is a reliable method to identify the CD44+/CD24- tumourigenic cell population, allowing for the stratification of breast cancer patients into two groups with substantially different relapse rates on the basis of CD44+/CD24- cell percentage.	[Perrone, Giuseppe; Gaeta, Laura Maria; Zagami, Mariagiovanna; Muda, Andrea Onetti] Campus Biomed Univ Rome, Dept Pathol, Rome, Italy; [Nasorri, Francesca; Cavani, Andrea] IDI IRCCS, Expt Immunol Lab, Rome, Italy; [Coppola, Roberto; Borzomati, Domenico] Campus Biomed Univ Rome, Dept Surg, Rome, Italy; [Bartolozzi, Francesco] Campus Biomed Univ Rome, Dept Epidemiol, Rome, Italy; [Altomare, Vittorio] Campus Biomed Univ Rome, Senol Unit, Rome, Italy; [Trodella, Lucio] Campus Biomed Univ Rome, Radiotherapy Unit, Rome, Italy; [Tonini, Giuseppe; Santini, Daniele] Campus Biomed Univ Rome, Oncol Unit, Rome, Italy; [Zagami, Mariagiovanna] Osped S Maria Misericordia, Dept Pathol, Udine, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Hospital Santa Maria della Misericordia	Perrone, G (corresponding author), Campus Biomed Univ Rome, Dept Pathol, Rome, Italy.	a.onetti@unicampus.it	perrone, giuseppe/ABF-5105-2020; Onetti Muda, Andrea/G-5384-2012; Coppola, Roberto/M-9998-2016; Muda, Andrea Onetti/AAA-5105-2020; Perrone, Giuseppe/E-7062-2011	Onetti Muda, Andrea/0000-0002-0274-6178; Coppola, Roberto/0000-0001-5798-0714; Perrone, Giuseppe/0000-0002-9538-5729; Altomare, Vittorio/0000-0002-9839-4129; Santini, Daniele/0000-0002-9118-3337; borzomati, domenico/0000-0001-8110-4917; Tonini, Giuseppe/0000-0003-4442-8677	Campus Bio-Medico University of Rome; "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy	Campus Bio-Medico University of Rome; "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy	This work was supported by grants from Campus Bio-Medico University of Rome (grant "Progetto d'Ateneo 2008'') and from "Consorzio Interuniversitario Trapianti d'organo'', Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Ahmed MA, 2011, BREAST CANC IN PRESS; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gaviraghi M, 2011, BIOSCIENCE REP, V31, P45, DOI 10.1042/BSR20100018; Hebbard L, 2000, J CELL SCI, V113, P2619; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hyun CL, 2008, J CLIN PATHOL, V61, P317, DOI 10.1136/jcp.2007.050336; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; ROBINS P, 1995, HUM PATHOL, V28, P873; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Snyder EL, 2009, LAB INVEST, V89, P857, DOI 10.1038/labinvest.2009.54; Sobin L, 2009, TNM CLASSIFICATION M; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang YM, 2008, CANCER INVEST, V26, P725, DOI 10.1080/07357900801941845	29	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e43110	10.1371/journal.pone.0043110	http://dx.doi.org/10.1371/journal.pone.0043110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028444	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700008
J	Tarry-Adkins, JL; Martin-Gronert, MS; Fernandez-Twinn, DS; Hargreaves, I; Alfaradhi, MZ; Land, JM; Aiken, CE; Ozanne, SE				Tarry-Adkins, Jane L.; Martin-Gronert, Malgorzata S.; Fernandez-Twinn, Denise S.; Hargreaves, Iain; Alfaradhi, Maria Z.; Land, John M.; Aiken, Catherine E.; Ozanne, Susan E.			Poor maternal nutrition followed by accelerated postnatal growth leads to alterations in DNA damage and repair, oxidative and nitrosative stress, and oxidative defense capacity in rat heart	FASEB JOURNAL			English	Article						developmental programming; aging; cardiovascular disease	MANGANESE-SUPEROXIDE-DISMUTASE; CATCH-UP GROWTH; NOX2 EXPRESSION; FETAL; PEROXYNITRITE; PROTEIN; CARDIOMYOCYTES; INACTIVATION; TELOMERES; DISEASE	Low birth weight and accelerated postnatal growth lead to increased risk of cardiovascular disease. We reported previously that rats exposed to a low-protein diet in utero and postnatal catch-up growth (recuperated) develop metabolic dysfunction and have reduced life span. Here we explored the hypothesis that cardiac oxidative and nitrosative stress leading to DNA damage and accelerated cellular aging could contribute to these phenotypes. Recuperated animals had a low birth weight (P<0.001) but caught up in weight to controls during lactation. At weaning, recuperated cardiac tissue had increased (P<0.05) protein nitrotyrosination and DNA single-stranded breaks. This condition was preceded by increased expression of DNA damage repair molecules 8-oxoguanine-DNA-glycosylase-1, nei-endonuclease-VIII-like, X-ray-repair-complementing-defective-repair-1, and Nthl endonuclease III-like-1 on d 3. These differences were maintained on d 22 and became more pronounced in the case of 8-oxoguanine-DNA-glycosylase-1 and nei-endonuclease-VIII-like. This was accompanied by increases in xanthine oxidase (P<0.001) and NADPH oxidase (P<0.05), major sources of reactive oxygen species (ROS). The detrimental effects of increased ROS in recuperated offspring may be exaggerated at 22 d by reductions (P<0.001) in the antioxidant enzymes peroxiredoxin-3 and CuZn-superoxide-dismutase. We conclude that poor fetal nutrition followed by accelerated postnatal growth results in increased cardiac nitrosative and oxidative-stress and DNA damage, which could contribute to age-associated disease risk.-Tarry-Adkins, J. L., Martin-Gronert, M. S., Fernandez-Twinn, D. S., Hargreaves, I., Alfaradhi, M. Z., Land, J. M., Aiken, C. E., Ozanne, S. E. Poor maternal nutrition followed by accelerated postnatal growth leads to alterations in DNA damage and repair, oxidative and nitrosative stress and oxidative defense capacity in rat heart. FASEB J. 27, 379-390 (2013). www.fasebj.org	[Tarry-Adkins, Jane L.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Cambridge CB2 OQQ, England; [Hargreaves, Iain; Land, John M.] UCL, Natl Hosp, Neurometabol Unit, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.	janeadkins@googlemail.com	Fernandez-Twinn, Denise/B-3881-2011; Hargreaves, Iain/AAJ-6757-2020	Fernandez-Twinn, Denise/0000-0003-2610-277X; Tarry-Adkins, Jane/0000-0001-9569-6132; Ozanne, Susan/0000-0001-8753-5144	UK Department of Health's National Institute for Health Research Biomedical Research Centres; British Heart Foundation; Biotechnology and Biological Sciences Research Council [BB/F015364/1] Funding Source: researchfish; British Heart Foundation [PG/09/037/27387, FS/09/029/27902] Funding Source: researchfish; Medical Research Council [G0600717, MC_UU_12012/4, G0600717B] Funding Source: researchfish; BBSRC [BB/F015364/1] Funding Source: UKRI; MRC [MC_UU_12012/4, G0600717, MC_PC_12012] Funding Source: UKRI	UK Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Wayman and D. Hawkes for their technical expertise. Part of this work was undertaken at University College London Hospital, University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. This work was supported by The British Heart Foundation. S.E.O. is a British Heart Foundation Senior Fellow and a member of the UK Medical Research Council Centre for Obesity and Related Metabolic Diseases.	Ago T, 2010, AGING-US, V2, P1012, DOI 10.18632/aging.100261; Alvarez B, 2004, FREE RADICAL BIO MED, V37, P813, DOI 10.1016/j.freeradbiomed.2004.06.006; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cas AD, 2013, NUTR METAB CARDIOVAS, V23, P272, DOI 10.1016/j.numecd.2011.04.005; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Csiszar Anna, 2005, Current Vascular Pharmacology, V3, P285, DOI 10.2174/1570161054368616; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Godfrey KM, 2011, SEMIN REPROD MED, V29, P257, DOI 10.1055/s-0031-1275518; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; KING TE, 1967, METHOD ENZYMOL, V10, P446; Krijnen PAJ, 2003, J CLIN PATHOL, V56, P194, DOI 10.1136/jcp.56.3.194; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Leeson CPM, 2001, CIRCULATION, V103, P1264; Lehrer-Graiwer JE, 2000, NEUROSCI LETT, V288, P107, DOI 10.1016/S0304-3940(00)01205-2; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Li LQ, 2009, J BIOCHEM, V145, P425, DOI 10.1093/jb/mvp011; Lim KJ, 2006, PEDIATR RES, V60, P83, DOI 10.1203/01.pdr.0000220361.08181.c3; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Meischl C, 2006, APOPTOSIS, V11, P913, DOI 10.1007/s10495-006-6304-7; Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ragan CI, 1988, MITOCHONDRIA PRACTIC, P79; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; Sasaki T, 2010, GERIATR GERONTOL INT, V10, pS10, DOI 10.1111/j.1447-0594.2010.00601.x; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Shelley P, 2007, MECH AGEING DEV, V128, P681, DOI 10.1016/j.mad.2007.10.002; Shepherd JA, 1969, METHOD ENZYMOL, V13, P11; Sindhu RK, 2005, LIFE SCI, V76, P945, DOI 10.1016/j.lfs.2004.10.014; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; Skilton MR, 2006, CLIN SCI, V111, P281, DOI 10.1042/CS20060036; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Son E, 2005, BIOCHEM PHARMACOL, V70, P590, DOI 10.1016/j.bcp.2005.05.027; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006; Wharton DC., 1967, METHOD ENZYMOL, P245; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085	56	65	67	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					379	390		10.1096/fj.12-218685	http://dx.doi.org/10.1096/fj.12-218685			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23024373				2022-12-25	WOS:000313103200036
J	Streb, S; Eicke, S; Zeeman, SC				Streb, Sebastian; Eicke, Simona; Zeeman, Samuel C.			The Simultaneous Abolition of Three Starch Hydrolases Blocks Transient Starch Breakdown in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER DIKINASE; DEBRANCHING ENZYMES; TRANSITORY STARCH; CIRCADIAN CONTROL; ALPHA-AMYLASE; BETA-AMYLASES; R1 PROTEIN; DEGRADATION; METABOLISM; ISOAMYLASE	In this study, we investigated which enzymes are involved in debranching amylopectin during transient starch degradation. Previous studies identified two debranching enzymes, isoamylase 3 (ISA3) and limit dextrinase (LDA), involved in this process. However, plants lacking both enzymes still degrade substantial amounts of starch. Thus, other enzymes/mechanisms must contribute to starch breakdown. We show that the chloroplastic alpha-amylase 3 (AMY3) also participates in starch degradation and provide evidence that all three enzymes can act directly at the starch granule surface. The isa3 mutant has a starch excess phenotype, reflecting impaired starch breakdown. In contrast, removal of AMY3, LDA, or both enzymes together has no impact on starch degradation. However, removal of AMY3 or LDA in addition to ISA3 enhances the starch excess phenotype. In plants lacking all three enzymes, starch breakdown is effectively blocked, and starch accumulates to the highest levels observed so far. This provides indirect evidence that the hetero-multimeric debranching enzyme ISA1-ISA2 is not involved in starch breakdown. However, we illustrate that ISA1-ISA2 can hydrolyze small soluble branched glucans that accumulate when ISA3 and LDA are missing, albeit at a slow rate. Starch accumulation in the mutants correlates inversely with plant growth.	[Streb, Sebastian; Eicke, Simona; Zeeman, Samuel C.] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Streb, S (corresponding author), ETH, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	sstreb@ethz.ch		Zeeman, Samuel/0000-0002-2791-0915; Streb, Sebastian/0000-0002-9095-6596	Swiss National Science Foundation [31002AB_131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grant 31002AB_131074 (to S.Z.) and by ETH Zurich.	Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GIDLEY MJ, 1987, CARBOHYD RES, V161, P291, DOI 10.1016/S0008-6215(00)90086-7; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Machovic M, 2006, FEBS LETT, V580, P6349, DOI 10.1016/j.febslet.2006.10.041; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Rasse DP, 2006, NEW PHYTOL, V172, P500, DOI 10.1111/j.1469-8137.2006.01848.x; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Yazdanbakhsh N, 2011, PLANT CELL ENVIRON, V34, P877, DOI 10.1111/j.1365-3040.2011.02286.x; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Yun MS, 2011, PLANT CELL PHYSIOL, V52, P1068, DOI 10.1093/pcp/pcr058; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	40	43	45	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41745	41756		10.1074/jbc.M112.395244	http://dx.doi.org/10.1074/jbc.M112.395244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23019330	Green Published, hybrid			2022-12-25	WOS:000312103000017
J	Karalewitz, APA; Fu, ZJ; Baldwin, MR; Kim, JJP; Barbieri, JT				Karalewitz, Andrew P. -A.; Fu, Zhuji; Baldwin, Michael R.; Kim, Jung-Ja P.; Barbieri, Joseph T.			Botulinum Neurotoxin Serotype C Associates with Dual Ganglioside Receptors to Facilitate Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; CLOSTRIDIAL-NEUROTOXINS; BINDING-SITES; PROTEIN-RECEPTOR; HEAVY-CHAIN; RECOGNITION; TETANUS; TOXIN; NEURONS; DOMAIN	Botulinum neurotoxins (BoNTs) cleave SNARE proteins in motor neurons that inhibits synaptic vesicle (SV) exocytosis, resulting in flaccid paralysis. There are seven BoNT serotypes (A-G). In current models, BoNTs initially bind gangliosides on resting neurons and upon SV exocytosis associate with the luminal domains of SV-associated proteins as a second receptor. The entry of BoNT/C is less clear. Characterizing the heavy chain receptor binding domain (HCR), BoNT/C was shown to utilize gangliosides as dual host receptors. Crystallographic and biochemical studies showed that the two ganglioside binding sites, termed GBP2 and Sia-1, were independent and utilized unique mechanisms to bind complex gangliosides. The GBP2 binding site recognized gangliosides that contained a sia5 sialic acid, whereas the Sia-1 binding site recognized gangliosides that contained a sia7 sialic acid and sugars within the backbone of the ganglioside. Utilizing gangliosides that uniquely recognized the GBP2 and Sia-1 binding sites, HCR/C entry into Neuro-2A cells required both functional ganglioside binding sites. HCR/C entered cells differently than the HCR of tetanus toxin, which also utilizes dual gangliosides as host receptors. A point-mutated HCR/C that lacked GBP2 binding potential retained the ability to bind and enter Neuro-2A cells. This showed that ganglioside binding at the Sia-1 site was accessible on the plasma membrane, suggesting that SV exocytosis may not be required to expose BoNT/C receptors. These studies highlight the utility of BoNT HCRs as probes to study the role of gangliosides in neurotransmission.	[Karalewitz, Andrew P. -A.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Baldwin, Michael R.] Univ Missouri, Dept Microbiol & Mol Genet, Columbia, MO 65212 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Missouri System; University of Missouri Columbia	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health from the NIAID; Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program; National Institutes of Health Grant [1-R00-NS-061763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grants from the NIAID and the Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program (to J. J. K. and J. T. B).; Supported by National Institutes of Health Grant 1-R00-NS-061763.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Benson MA, 2011, J BIOL CHEM, V286, P34015, DOI 10.1074/jbc.M111.272054; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kroken AR, 2011, J BIOL CHEM, V286, P26828, DOI 10.1074/jbc.M111.254086; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MORIISHI K, 1989, INFECT IMMUN, V57, P2886, DOI 10.1128/IAI.57.9.2886-2891.1989; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Nuemket N, 2011, BIOCHEM BIOPH RES CO, V411, P433, DOI 10.1016/j.bbrc.2011.06.173; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Sato MH, 1997, BIOTECHNIQUES, V23, P254, DOI 10.2144/97232bm17; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shapiro RE, 1997, J BIOL CHEM, V272, P30380, DOI 10.1074/jbc.272.48.30380; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Strotmeier J, 2011, MOL MICROBIOL, V81, P143, DOI 10.1111/j.1365-2958.2011.07682.x; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Varki A., 2009, ESSENTIALS GLYCOBIOL; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yeh FL, 2011, BIOCHEMISTRY-US, V50, P10419, DOI 10.1021/bi201490t; Yowler BC, 2004, GLYCOCONJUGATE J, V21, P287, DOI 10.1023/B:GLYC.0000046271.64647.fd	53	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40806	40816		10.1074/jbc.M112.404244	http://dx.doi.org/10.1074/jbc.M112.404244			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027864	hybrid, Green Published			2022-12-25	WOS:000311448800068
J	Mayer, F; Leone, V; Langer, JD; Faraldo-Gomez, JD; Muller, V				Mayer, Florian; Leone, Vanessa; Langer, Julian D.; Faraldo-Gomez, Jose D.; Mueller, Volker			A c Subunit with Four Transmembrane Helices and One Ion (Na+)-binding Site in an Archaeal ATP Synthase IMPLICATIONS FOR c RING FUNCTION AND STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING METHYLTRANSFERASE; PROTEIN SECONDARY STRUCTURE; ROTOR RING; V-TYPE; F-TYPE; METHANOPYRUS-KANDLERI; METHANOGENIC ARCHAEA; MOLECULAR-DYNAMICS; REACTIVE PROTEIN; A-TYPE	The ion-driven membrane rotors of ATP synthases consist of multiple copies of subunit c, forming a closed ring. Subunit c typically comprises two transmembrane helices, and the c ring features an ion-binding site in between each pair of adjacent subunits. Here, we use experimental and computational methods to study the structure and specificity of an archaeal c subunit more akin to those of V-type ATPases, namely that from Pyrococcus furiosus. The c subunit was purified by chloroform/methanol extraction and determined to be 15.8 kDa with four predicted transmembrane helices. However, labeling with DCCD as well as Na+-DCCD competition experiments revealed only one binding site for DCCD and Na+, indicating that the mature c subunit of this A(1)A(O) ATP synthase is indeed of the V-type. A structural model generated computationally revealed one Na+-binding site within each of the c subunits, mediated by a conserved glutamate side chain alongside other coordinating groups. An intriguing second glutamate located in-between adjacent c subunits was ruled out as a functional Na+-binding site. Molecular dynamics simulations indicate that the c ring of P. furiosus is highly Na+-specific under in vivo conditions, comparable with the Na+-dependent V1VO ATPase from Enterococcus hirae. Interestingly, the same holds true for the c ring from the methanogenic archaeon Methanobrevibacter ruminantium, whose c subunits also feature a V-type architecture but carry two Na+-binding sites instead. These findings are discussed in light of their physiological relevance and with respect to the mode of ion coupling in A(1)A(O) ATP synthases.	[Leone, Vanessa; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-60438 Frankfurt, Germany; [Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Faraldo-Gomez, Jose D.] Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Max Planck Society	Faraldo-Gomez, JD (corresponding author), Max Planck Inst Biophys, Theoret Mol Biophys Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	jose.faraldo@biophys.mpg.de; vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021; Faraldo-Gomez, Jose/H-7127-2016; Leone, Vanessa/AGZ-1133-2022	Mueller, Volker/0000-0001-7955-5508; Leone, Vanessa/0000-0001-7017-4020; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [SFB807, EXC115]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SFB807 (to V. M.) and EXC115 (to J. D. F.-G.) from the Deutsche Forschungsgemeinschaft.	ALTENDORF K, 1977, FEBS LETT, V73, P271, DOI 10.1016/0014-5793(77)80997-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Furutani Y, 2011, J AM CHEM SOC, V133, P2860, DOI 10.1021/ja1116414; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; JETTEN MSM, 1991, FEMS MICROBIOL LETT, V84, P313, DOI 10.1111/j.1574-6968.1991.tb04616.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLUGE C, 1993, J BIOL CHEM, V268, P14557; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Leone V, 2010, BIOPHYS J, V99, pL53, DOI 10.1016/j.bpj.2010.07.046; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lolkema JS, 2003, FEBS LETT, V543, P47, DOI 10.1016/S0014-5793(03)00398-3; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Ruppert C, 1999, J BIOL CHEM, V274, P25281, DOI 10.1074/jbc.274.36.25281; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1111/j.1574-6968.2001.tb10496.x; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200	61	21	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.411223	http://dx.doi.org/10.1074/jbc.M112.411223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007388	hybrid, Green Published			2022-12-25	WOS:000311233800005
J	Ghislat, G; Patron, M; Rizzuto, R; Knecht, E				Ghislat, Ghita; Patron, Maria; Rizzuto, Rosario; Knecht, Erwin			Withdrawal of Essential Amino Acids Increases Autophagy by a Pathway Involving Ca2+/Calmodulin-dependent Kinase Kinase-beta (CaMKK-beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN FIBROBLASTS; MAMMALIAN-CELLS; MTOR; PHOSPHORYLATION; CALCIUM; APOPTOSIS; ULK1; AMPK; MACROAUTOPHAGY	Autophagy is the main lysosomal catabolic process that becomes activated under stress conditions, such as amino acid starvation and cytosolic Ca2+ upload. However, the molecular details on how both conditions control autophagy are still not fully understood. Here we link essential amino acid starvation and Ca2+ in a signaling pathway to activate autophagy. We show that withdrawal of essential amino acids leads to an increase in cytosolic Ca2+, arising from both extracellular medium and intracellular stores, which induces the activation of adenosine monophosphate-activated protein kinase (AMPK) via Ca2+/calmodulin-dependent kinase kinase-beta (CaMKK-beta). Furthermore, we show that autophagy induced by amino acid starvation requires AMPK, as this induction is attenuated in its absence. Subsequently, AMPK activates UNC-51-like kinase (ULK1), a mammalian autophagy-initiating kinase, through phosphorylation at Ser-555 in a process that requires CaMKK-beta. Finally, the mammalian target of rapamycin complex C1 (mTORC1), a negative regulator of autophagy downstream of AMPK, is inhibited by amino acid starvation in a Ca2+-sensitive manner, and CaMKK-beta appears to be important for mTORC1 inactivation, especially in the absence of extracellular Ca2+. All these results highlight that amino acid starvation regulates autophagy in part through an increase in cellular Ca2+ that activates a CaMKK-beta-AMPK pathway and inhibits mTORC1, which results in ULK1 stimulation.	[Ghislat, Ghita; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Biol Celular, Valencia 46012, Spain; [Ghislat, Ghita; Knecht, Erwin] CIBERER, Valencia 46012, Spain; [Patron, Maria; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Padua	Knecht, E (corresponding author), Ctr Invest Principe Felipe, Lab Biol Celular, C Eduardo Primo Yufera 3, Valencia 46012, Spain.	knecht@cipf.es	Knecht, Erwin/K-2432-2014; Ghislat, Ghita/ABA-4769-2020; Knecht, Erwin/A-9366-2014	Knecht, Erwin/0000-0002-7208-3832; Rizzuto, Rosario/0000-0001-7044-5097	Ministerio de Educacion y Ciencia Grant [BFU2011-22630]; Fundacio Marato TV3 Grant [100130]	Ministerio de Educacion y Ciencia Grant(Spanish Government); Fundacio Marato TV3 Grant	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2011-22630 and Fundacio Marato TV3 Grant 100130).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Esteban I, 2007, FEBS LETT, V581, P3415, DOI 10.1016/j.febslet.2007.06.043; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Niemann A, 2000, J HISTOCHEM CYTOCHEM, V48, P251, DOI 10.1177/002215540004800210; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; PerezTerzic CM, 1995, BIOCHEM J, V312, P955, DOI 10.1042/bj3120955; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865	43	87	94	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38625	38636		10.1074/jbc.M112.365767	http://dx.doi.org/10.1074/jbc.M112.365767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027865	Green Published, hybrid			2022-12-25	WOS:000310982800022
J	Makise, M; Mackay, DR; Elgort, S; Shankaran, SS; Adam, SA; Ullman, KS				Makise, Masaki; Mackay, Douglas R.; Elgort, Suzanne; Shankaran, Sunita S.; Adam, Stephen A.; Ullman, Katharine S.			The Nup153-Nup50 Protein Interface and Its Role in Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-ASSOCIATED PROTEIN; NUCLEOPORIN NUP153; TF1 RETROTRANSPOSON; FISSION YEAST; LIVING CELLS; COMPLEX; TRANSPORT; ENVELOPE; BINDING; EXPORT	Interactions between Nup50 and soluble transport factors underlie the efficiency of certain nucleocytoplasmic transport pathways. The platform on which these interactions take place is important to building a complete understanding of nucleocytoplasmic trafficking. Nup153 is the nucleoporin that provides this scaffold for Nup50. Here, we have delineated requirements for the interaction between Nup153 and Nup50, revealing a dual interface. An interaction between Nup50 and a region in the unique N-terminal region of Nup153 is critical for the nuclear pore localization of Nup50. A second site of interaction is at the distal tail of Nup153 and is dependent on importin alpha. Both of these interactions involve the N-terminal domain of Nup50. The configuration of the Nup153-Nup50 partnership suggests that the Nup153 scaffold provides not just a means of pore targeting for Nup50 but also serves to provide a local environment that facilitates bringing Nup50 and importin alpha together, as well as other soluble factors involved in transport. Consistent with this, disruption of the Nup153-Nup50 interface decreases efficiency of nuclear import.	[Ullman, Katharine S.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Makise, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan; [Adam, Stephen A.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Sojo University; Northwestern University; Feinberg School of Medicine	Ullman, KS (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	katharine.ullman@hci.utah.edu		Ullman, Katharine/0000-0003-3693-2830; Adam, Stephen/0000-0003-3444-7655	National Institutes of Health Grant [R01 GM61275, P30 CA042014]; Grants-in-Aid for Scientific Research [24890288] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061275] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM61275 (to K. S. U.). Shared resources used in this work are supported in part by National Institutes of Health Grant P30 CA042014 awarded to the Huntsman Cancer Institute.	Al-Haboubi T, 2011, NUCLEUS-PHILA, V2, P500, DOI 10.4161/nucl.2.5.17913; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Chow KH, 2012, NUCLEUS-PHILA, V3, P349, DOI 10.4161/nucl.20822; Dimaano C, 2001, J BIOL CHEM, V276, P45349, DOI 10.1074/jbc.M102592200; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Fan F, 1997, GENOMICS, V40, P444, DOI 10.1006/geno.1996.4557; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Moore MS, 2003, TRENDS CELL BIOL, V13, P61, DOI 10.1016/S0962-8924(02)00044-2; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Moroianu J, 1997, P NATL ACAD SCI USA, V94, P9699, DOI 10.1073/pnas.94.18.9699; Muller D, 2000, EMBO J, V19, P2168, DOI 10.1093/emboj/19.10.2168; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Ogawa Y, 2012, TRAFFIC, V13, P934, DOI 10.1111/j.1600-0854.2012.01367.x; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Sistla S, 2007, MOL BIOL CELL, V18, P3692, DOI 10.1091/mbc.E06-12-1062; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Varadarajan P, 2005, MOL BIOL CELL, V16, P1823, DOI 10.1091/mbc.E04-07-0583; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Zhou LX, 2010, FEBS LETT, V584, P3013, DOI 10.1016/j.febslet.2010.05.038	37	40	40	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38515	38522		10.1074/jbc.M112.378893	http://dx.doi.org/10.1074/jbc.M112.378893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007389	Green Published, hybrid			2022-12-25	WOS:000310982800011
J	Oishi, A; Makita, N; Sato, J; Iiri, T				Oishi, Atsuro; Makita, Noriko; Sato, Junichiro; Iiri, Taroh			Regulation of RhoA Signaling by the cAMP-dependent Phosphorylation of RhoGDI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; LIGHT-CHAIN PHOSPHATASE; PROTEIN-KINASE; SMALL GTPASE; ADP-RIBOSYLTRANSFERASE; DISSOCIATION INHIBITOR; CELL BIOLOGY; GENE-PRODUCT; CYCLIC-AMP; IN-VIVO	RhoA plays a pivotal role in regulating cell shape and movement. Protein kinase A (PKA) inhibits RhoA signaling and thereby induces a characteristic morphological change, cell rounding. This has been considered to result from cAMP-induced phosphorylation of RhoA at Ser-188, which induces a stable RhoA-GTP-RhoGDI alpha complex and sequesters RhoA to the cytosol. However, few groups have shown RhoA phosphorylation in intact cells. Here we show that phosphorylation of RhoGDI alpha but not RhoA plays an essential role in the PKA-induced inhibition of RhoA signaling and in the morphological changes using cardiac fibroblasts. The knockdown of RhoGDI alpha by siRNA blocks cAMP-induced cell rounding, which is recovered by RhoGDI alpha-WT expression but not when a RhoGDI alpha-S174A mutant is expressed. PKA phosphorylates RhoGDI alpha at Ser-174 and the phosphorylation of RhoGDI alpha is likely to induce the formation of a active RhoA-RhoGDI alpha complex. Our present results thus reveal a principal molecular mechanism underlying G(g)/cAMP-induced cross-talk with G(q)/G(13)/RhoA signaling.	[Oishi, Atsuro; Makita, Noriko; Sato, Junichiro; Iiri, Taroh] Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan	University of Tokyo	Makita, N (corresponding author), Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan.	norimaki-tky@umin.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022	OISHI, Atsuro/0000-0003-1788-5485	Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22591008] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LANG P, 1993, BIOCHEM BIOPH RES CO, V196, P1522, DOI 10.1006/bbrc.1993.2424; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MIURA Y, 1993, J BIOL CHEM, V268, P510; Miyoshi J, 2009, AFCS NATURE MOL PAGE, DOI [10.1038/mp.a0002062.01, DOI 10.1038/MP.A0002062.01]; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; NEMOTO Y, 1992, J BIOL CHEM, V267, P20916; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shichi D, 2010, J BIOL CHEM, V285, P33680, DOI 10.1074/jbc.M110.122390; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	53	33	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38705	38715		10.1074/jbc.M112.401547	http://dx.doi.org/10.1074/jbc.M112.401547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012358	hybrid, Green Published			2022-12-25	WOS:000310982800029
J	Singh, AP; Arora, S; Bhardwaj, A; Srivastava, SK; Kadakia, MP; Wang, B; Grizzle, WE; Owen, LB; Singh, S				Singh, Ajay P.; Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Kadakia, Madhavi P.; Wang, Bin; Grizzle, William E.; Owen, Laurie B.; Singh, Seema			CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor kappa B IMPLICATIONS FOR BIDIRECTIONAL TUMOR-STROMAL INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; IN-VITRO; PROLIFERATION; SURVIVAL; PATHWAY; BIOLOGY; GROWTH; PROGRESSION; RESISTANCE; INITIATION	Recent evidence suggests a major role of tumor-stromal interactions in pancreatic cancer pathobiology. The chemokine CXCL12 (stromal cell-derived factor 1 (SDF-1)), abundantly produced by stromal cells, promotes progression, metastasis, and chemoresistance of pancreatic cancer cells. On the other hand, pancreatic tumor cell-derived sonic hedgehog (SHH) acts predominantly on stromal cells to induce desmoplasia and, thus, has a paracrine effect on tumorigenesis and therapeutic outcome. In this study, we examined the association between these two proteins of pathological significance in pancreatic cancer. Our data demonstrate that CXCL12 leads to a dose- and time-dependent up-regulation of SHH in pancreatic cancer cells. CXCL12-induced SHH up-regulation is specifically mediated through the receptor CXCR4 and is dependent on the activation of downstream Akt and ERK signaling pathways. Both Akt and ERK cooperatively promote nuclear accumulation of NF-kappa B by inducing the phosphorylation and destabilization of its inhibitory protein, I kappa B-alpha. Using dominant negative I kappa B-alpha, a SHH promoter (deletion mutant) reporter, and chromatin immunoprecipitation assays, we demonstrate that CXCL12 exposure enhances direct binding of NF-kappa B to the SHH promoter and that suppression of NF-kappa B activation abrogates CXCL12-induced SHH expression. Finally, our data demonstrate a strong correlative expression of CXCR4 and SHH in human pancreatic cancer tissues, whereas their expression is not observed in the normal pancreas. Altogether, our data reveal a novel mechanism underlying aberrant SHH expression in pancreatic cancer and identify a molecular link facilitating bidirectional tumor-stromal interactions.	[Singh, Ajay P.; Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Owen, Laurie B.; Singh, Seema] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA; [Singh, Ajay P.] Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA; [Wang, Bin] Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA; [Kadakia, Madhavi P.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of South Alabama; University of South Alabama; University of South Alabama; University System of Ohio; Wright State University Dayton; University of Alabama System; University of Alabama Birmingham	Singh, AP (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@usouthal.edu; seemasingh@usouthal.edu	Singh, Ajay/AAF-4414-2020	Wang, Bin/0000-0002-3689-6932; Singh, Ajay/0000-0003-3492-6330	National Cancer Institute (NCI) [CA137513, CA167137, CA101955]; University of South Alabama Mitchell Cancer Institute (USAMCI); NATIONAL CANCER INSTITUTE [P50CA101955, P20CA101955, R03CA137513, R21CA167137] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of South Alabama Mitchell Cancer Institute (USAMCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grants CA137513, CA167137 (to A. P. S.), and NCI P50 SPORE CA101955 (to W. E. G.), and by internal funding support from University of South Alabama Mitchell Cancer Institute (USAMCI).	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Ding YZ, 2010, PANCREAS, V39, P283, DOI 10.1097/MPA.0b013e3181c15619; do Carmo A, 2010, CANCER BIOL THER, V9, P56, DOI 10.4161/cbt.9.1.10342; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Erkan M., 2010, Experimental Oncology, V32, P128; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kelleher FC, 2011, CARCINOGENESIS, V32, P445, DOI 10.1093/carcin/bgq280; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Raffel C, 1997, CANCER RES, V57, P842; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	49	92	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39115	39124		10.1074/jbc.M112.409581	http://dx.doi.org/10.1074/jbc.M112.409581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995914	hybrid, Green Published			2022-12-25	WOS:000310982800067
J	Sinha, A; Rae, R; Iatsenko, I; Sommer, RJ				Sinha, Amit; Rae, Robbie; Iatsenko, Igor; Sommer, Ralf J.			System Wide Analysis of the Evolution of Innate Immunity in the Nematode Model Species Caenorhabditis elegans and Pristionchus pacificus	PLOS ONE			English	Article							PATHOGEN SERRATIA-MARCESCENS; GENE-EXPRESSION; C. ELEGANS; MICROARRAY DATA; LIFE-SPAN; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTOR; VIRULENCE FACTORS; INFECTION; DIVERSITY	The evolution of genetic mechanisms used to combat bacterial infections is critical for the survival of animals and plants, yet how these genes evolved to produce a robust defense system is poorly understood. Studies of the nematode Caenorhabditis elegans have uncovered a plethora of genetic regulators and effectors responsible for surviving pathogens. However, comparative studies utilizing other free-living nematodes and therefore providing an insight into the evolution of innate immunity have been lacking. Here, we take a systems biology approach and use whole genome microarrays to profile the transcriptional response of C. elegans and the necromenic nematode Pristionchus pacificus after exposure to the four different pathogens Serratia marcescens, Xenorhabdus nematophila, Staphylococcus aureus and Bacillus thuringiensis DB27. C. elegans is susceptible to all four pathogens whilst P. pacificus is only susceptible to S. marcescens and X. nematophila. We show an unexpected level of specificity in host responses to distinct pathogens within and across species, revealing an enormous complexity of effectors of innate immunity. Functional domains enriched in the transcriptomes on different pathogens are similar within a nematode species but different across them, suggesting differences in pathogen sensing and response networks. We find translation inhibition to be a potentially conserved response to gram-negative pathogens in both the nematodes. Further computational analysis indicates that both nematodes when fed on pathogens up-regulate genes known to be involved in other stress responses like heat shock, oxidative and osmotic stress, and genes regulated by DAF-16/FOXO and TGF-beta pathways. This study presents a platform for comparative systems analysis of two nematode model species, and a catalog of genes involved in the evolution of nematode immunity and identifies both pathogen specific and pan-pathogen responses. We discuss the potential effects of ecology on evolution of downstream effectors and upstream regulators on evolution of nematode innate immunity.	[Sinha, Amit; Rae, Robbie; Iatsenko, Igor; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Iatsenko, Igor/AAI-6699-2021; Sinha, Amit/B-6312-2013; Sinha, Amit/H-5116-2019	Iatsenko, Igor/0000-0002-9249-8998; Sinha, Amit/0000-0003-1849-710X; Sinha, Amit/0000-0003-1849-710X	Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was funded by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Eddy Sean R, 2009, Genome Inform, V23, P205; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Ewbank Jonathan J, 2006, WormBook, P1; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forst Steven, 2002, P57, DOI 10.1079/9780851995670.0057; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim KW, 2010, P NATL ACAD SCI USA, V107, P17445, DOI 10.1073/pnas.1012611107; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pires da Silva Andre, 2005, WormBook, P1; Pires-DaSilva A, 2004, GENE DEV, V18, P1198, DOI 10.1101/gad.293504; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002864; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roberts AF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-61; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Rudel D, 2005, DEV BIOL, V277, P200, DOI 10.1016/j.ydbio.2004.09.021; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulenburg H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-114; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sinha A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-254; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Thompson JN, 1994, COEVOLUTIONARY PROCE; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	93	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44255	10.1371/journal.pone.0044255	http://dx.doi.org/10.1371/journal.pone.0044255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028509	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900006
J	Rabinowitz, PM; Galusha, D; Vegso, S; Michalove, J; Rinne, S; Scotch, M; Kane, M				Rabinowitz, Peter M.; Galusha, Deron; Vegso, Sally; Michalove, Jennifer; Rinne, Seppo; Scotch, Matthew; Kane, Michael			Comparison of Human and Animal Surveillance Data for H5N1 Influenza A in Egypt 2006-2011	PLOS ONE			English	Article							AVIAN INFLUENZA; VIRUS; TEMPERATURE	Background: The majority of emerging infectious diseases are zoonotic (transmissible between animals and humans) in origin, and therefore integrated surveillance of disease events in humans and animals has been recommended to support effective global response to disease emergence. While in the past decade there has been extensive global surveillance for highly pathogenic avian influenza (HPAI) infection in both animals and humans, there have been few attempts to compare these data streams and evaluate the utility of such integration. Methodology: We compared reports of bird outbreaks of HPAI H5N1 in Egypt for 2006-2011 compiled by the World Organisation for Animal Health (OIE) and the UN Food and Agriculture Organization (FAO) EMPRESi reporting system with confirmed human H5N1 cases reported to the World Health Organization (WHO) for Egypt during the same time period. Principal Findings: Both human cases and bird outbreaks showed a cyclic pattern for the country as a whole, and there was a statistically significant temporal correlation between the data streams. At the governorate level, the first outbreak in birds in a season usually but not always preceded the first human case, and the time lag between events varied widely, suggesting regional differences in zoonotic risk and/or surveillance effectiveness. In a multivariate risk model, lower temperature, lower urbanization, higher poultry density, and the recent occurrence of a bird outbreak were associated with increased risk of a human case of HPAI in the same governorate, although the positive predictive value of a bird outbreak was low. Conclusions: Integrating data streams of surveillance for human and animal cases of zoonotic disease holds promise for better prediction of disease risk and identification of environmental and regional factors that can affect risk. Such efforts can also point out gaps in human and animal surveillance systems and generate hypotheses regarding disease transmission.	[Rabinowitz, Peter M.; Galusha, Deron; Vegso, Sally] Yale Univ, Yale Occupat & Environm Med Program, New Haven, CT 06520 USA; [Michalove, Jennifer] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Kane, Michael] Yale Univ, Yale Ctr Analyt Sci, New Haven, CT USA; [Scotch, Matthew] Arizona State Univ, Dept Biomed Informat, Phoenix, AZ USA; [Rinne, Seppo] Yale Univ, Dept Internal Med, New Haven, CT USA	Yale University; Yale University; Yale University; Arizona State University; Arizona State University-Downtown Phoenix; Yale University	Rabinowitz, PM (corresponding author), Yale Univ, Yale Occupat & Environm Med Program, New Haven, CT 06520 USA.	peter.rabinowitz@yale.edu		Radin, Jennifer/0000-0003-3843-0842; Rinne, Seppo/0000-0002-8662-1224; Trufan, Sally/0000-0003-3342-0629; Scotch, Matthew/0000-0001-5100-9724				Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; [Anonymous], 2009, SUSTAINING GLOBAL SU; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Food and Agriculture Organization (FAO), FAO AFR; Food and Agriculture Organization (FAO) FAO GeoNetwork, 2005, GLOB POULTR DENS; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Handoussa Heba, EGYPT HUMAN DEV REPO; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Paek MR, 2010, POULTRY SCI, V89, P1647, DOI 10.3382/ps.2010-00800; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Rabinowitz PM, 2008, ECOHEALTH, V5, P224, DOI 10.1007/s10393-008-0170-4; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; WHO, AV INFL; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	19	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e43851	10.1371/journal.pone.0043851	http://dx.doi.org/10.1371/journal.pone.0043851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028474	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500004
J	Culasso, ACA; Elizalde, M; Campos, RH; Barbini, L				Culasso, Andres C. A.; Elizalde, Mercedes; Campos, Rodolfo H.; Barbini, Luciana			Molecular Survey of Hepatitis C Virus in the Touristic City of Mar Del Plata, Argentina	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTION; INFERENCE; GENOTYPES	The global epidemiology of Hepatitis C Virus (HCV) may be roughly described by two groups of genotypes: the worldwide distributed ones (subtypes 1a, 1b, 2a and 3a, among others) and the endemic ones (subtypes 4a, 5a, 6a, among others). Epidemiological and population dynamic studies of the worldwide distributed genotypes have shown that subtypes 1a and 3a are common among intravenous drug users (IDUs) and that they are also in expansion in some countries. The molecular survey of HCV provides some clues about the epidemiological status of the infections in a local scale and the phylogenetic and demographic reconstruction analyses complement this study by inferring whether the infections of certain subtypes are in a steady state or expanding. Here, a molecular survey of the HCV variants that circulate in the touristic city of Mar del Plata (Buenos Aires, Argentina) was performed in samples obtained from 42 patients. The subtypes detected were 1a (32 patients), 3a (8 patients) and 1b (2 patients). The demographic history of subtype 1a inferred using the sequence data showed an exponential growth in the 1990's. The period of viral expansion was delayed compared with that observed for the same genotype in other countries where the transmission was associated with IDUs. Also, the phylogeographic analysis of HCV-1a showed a statistically significant association between the location of the samples and the phylogeny, which may be the result of the local transmission of HCV in the city. The molecular analysis helped in the description of the complex epidemiological context of a touristic city, and pointed out that some sanitary measures should be taken in order to reduce the transmission of HCV (and maybe of HIV) among IDUs.	[Culasso, Andres C. A.; Elizalde, Mercedes; Campos, Rodolfo H.; Barbini, Luciana] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar		Elizalde, Maria Mercedes/0000-0002-0533-4283	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-01169]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2006-00285]; Universidad de Buenos Aires [UBACyT 2008-B601]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was carried out thanks to the financial support of the grants: PIP 112-200801-01169 (Consejo Nacional de Investigaciones Cientificas y Tecnicas), PICT 2006-00285 (Agencia Nacional de Promocion Cientifica y Tecnologica) and UBACyT 2008-B601 (Universidad de Buenos Aires). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quarleri Jorge F., 2007, Acta Gastroenterologica Latinoamericana, V37, P76; Re VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019471; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44757	10.1371/journal.pone.0044757	http://dx.doi.org/10.1371/journal.pone.0044757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028605	gold, Green Published			2022-12-25	WOS:000309554700015
J	Noris, B; Nadel, J; Barker, M; Hadjikhani, N; Billard, A				Noris, Basilio; Nadel, Jacqueline; Barker, Mandy; Hadjikhani, Nouchine; Billard, Aude			Investigating Gaze of Children with ASD in Naturalistic Settings	PLOS ONE			English	Article							IMPAIRED RECOGNITION; SOCIAL CONTINGENCY; BIOLOGICAL MOTION; YOUNG-CHILDREN; EYE CONTACT; AUTISM; ATTENTION; SPECTRUM; STIMULI; INFORMATION	Background: Visual behavior is known to be atypical in Autism Spectrum Disorders (ASD). Monitor-based eye-tracking studies have measured several of these atypicalities in individuals with Autism. While atypical behaviors are known to be accentuated during natural interactions, few studies have been made on gaze behavior in natural interactions. In this study we focused on i) whether the findings done in laboratory settings are also visible in a naturalistic interaction; ii) whether new atypical elements appear when studying visual behavior across the whole field of view. Methodology/Principal Findings: Ten children with ASD and ten typically developing children participated in a dyadic interaction with an experimenter administering items from the Early Social Communication Scale (ESCS). The children wore a novel head-mounted eye-tracker, measuring gaze direction and presence of faces across the child's field of view. The analysis of gaze episodes to faces revealed that children with ASD looked significantly less and for shorter lapses of time at the experimenter. The analysis of gaze patterns across the child's field of view revealed that children with ASD looked downwards and made more extensive use of their lateral field of view when exploring the environment. Conclusions/Significance: The data gathered in naturalistic settings confirm findings previously obtained only in monitor-based studies. Moreover, the study allowed to observe a generalized strategy of lateral gaze in children with ASD when they were looking at the objects in their environment.	[Noris, Basilio; Billard, Aude] Ecole Polytech Fed Lausanne, Learning Algorithms & Syst Lab, Lausanne, Switzerland; [Nadel, Jacqueline] Hop La Pitie Salpetriere, Emot Ctr, Paris, France; [Barker, Mandy] Univ Lausanne, Univ Hosp Canton Vaud, Dept Child & Adolescent Psychiat, Lausanne, Switzerland; [Hadjikhani, Nouchine] Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland; [Hadjikhani, Nouchine] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, HST, Boston, MA 02114 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Massachusetts General Hospital	Noris, B (corresponding author), Ecole Polytech Fed Lausanne, Learning Algorithms & Syst Lab, Lausanne, Switzerland.	basilio.noris@epfl.ch	Hadjikhani, Nouchine/C-2018-2008	Hadjikhani, Nouchine/0000-0003-4075-3106	National Centre for Competence in Research of the Swiss National Science Foundation	National Centre for Competence in Research of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This work was funded by the IM2 program of the National Centre for Competence in Research of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; Billard A, 2007, ASSIST TECHNOL, V19, P37, DOI 10.1080/10400435.2007.10131864; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Bogdashina, 2003, SENSORY PERCEPTUAL I; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Elison JT, 2008, IMFAR LOND; Fletcher-Watson S, 2008, J AUTISM DEV DISORD, V38, P1785, DOI 10.1007/s10803-008-0548-8; Gaily E, 2009, EPILEPSIA, V50, P206, DOI 10.1111/j.1528-1167.2008.01961.x; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Grandin Temple, 1995, THINKING PICTURES EX; Grynszpan O, 2009, P IEEE C VI IN PRESS; HENDRICKSON A, 1992, BEHAV BRAIN RES, V49, P21, DOI 10.1016/S0166-4328(05)80191-3; HUTT C, 1966, BEHAV SCI, V11, P346, DOI 10.1002/bs.3830110504; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jones F, 2008, ARCH GEN PSYCHIAT, V65; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Merin N, 2007, J AUTISM DEV DISORD, V37, P108, DOI 10.1007/s10803-006-0342-4; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2007, DEV PSYCHOPATHOL, V19, P23, DOI 10.1017/S0954579407070022; Mundy P, 1997, J AUTISM DEV DISORD, V27, P653, DOI 10.1023/A:1025802832021; Mundy P., 2003, MANUAL ABRIDGED EARL; Nadel J., 1999, IMITATION INFANCY; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Noris B., 2010, J COMPUTER VISION IM, V2010; Noris B, 2007, ADV INTEL SOFT COMPU, V45, P663; Pedersen J, 1997, EUR CHILD ADOLES PSY, V6, P96; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; RICHER JM, 1976, ACTA PSYCHIAT SCAND, V53, P193, DOI 10.1111/j.1600-0447.1976.tb00074.x; RITVO ER, 1986, J AM ACAD CHILD PSY, V25, P137, DOI 10.1016/S0002-7138(09)60611-7; Robins B., 2005, Universal Access in the Information Society, V4, P105, DOI 10.1007/s10209-005-0116-3; Roos EM, 2008, AUTISM, V12, P275, DOI 10.1177/1362361307089521; Scassellati B, 2007, SPRINGER TRAC ADV RO, V28, P552; Seibert J. M., 1982, INFANT MENT HEALTH J, V3, P244, DOI [10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:4<244::AID-IMHJ2280030406>3.0.CO;2-R]; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shic F., 2007, DEV LEARN 2007 ICDL, P70; Shic F, 2008, P EYE TRACK RES APPL; Sigman M, 2004, MENT RETARD DEV D R, V10, P221, DOI 10.1002/mrdd.20046; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Soussignan R, 2006, INFANCY, V10, P123, DOI 10.1207/s15327078in1002_2; Sparrow S., 2016, VINELAND ADAPTIVE BE; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Swettenham J, 1998, J CHILD PSYCHOL PSYC, V39, P747, DOI 10.1111/1469-7610.00373; Trepagnier C, 2002, CYBERPSYCHOL BEHAV, V5, P213, DOI 10.1089/109493102760147204; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437; Young GS, 2009, DEV SCI; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	60	69	70	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44144	10.1371/journal.pone.0044144	http://dx.doi.org/10.1371/journal.pone.0044144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23028494	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700007
J	Srinivasan, S; Simms, JA; Nielsen, CK; Lieske, SP; Bito-Onon, JJ; Yi, H; Hopf, FW; Bonci, A; Bartlett, SE				Srinivasan, Subhashini; Simms, Jeffrey A.; Nielsen, Carsten K.; Lieske, Steven P.; Bito-Onon, Jade J.; Yi, Henry; Hopf, Frederic Woodward; Bonci, Antonello; Bartlett, Selena E.			The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration	PLOS ONE			English	Article							LONG-EVANS RATS; ALCOHOL DEPENDENCE; INDUCED REINSTATEMENT; OREXIN-A; MESOLIMBIC DOPAMINE; NALTREXONE RESPONSE; REWARD-SEEKING; FOOD-INTAKE; NEURONS; INVOLVEMENT	Recent studies have implicated the hypocretin/orexinergic system in reward-seeking behavior. Almorexant, a dual orexin/hypocretin R-1 and R-2 receptor antagonist, has proven effective in preclinical studies in promoting sleep in animal models and was in Phase III clinical trials for sleep disorders. The present study combines behavioral assays with in vitro biochemical and electrophysiological techniques to elucidate the role of almorexant in ethanol and sucrose intake. Using an operant self-administration paradigm, we demonstrate that systemic administration of almorexant decreased operant self-administration of both 20% ethanol and 5% sucrose. We further demonstrate that intra-ventral tegmental area (VTA) infusions, but not intra-substantia nigra infusions, of almorexant reduced ethanol self-administration. Extracellular recordings performed in VTA neurons revealed that orexin-A increased firing and this enhancement of firing was blocked by almorexant. The results demonstrate that orexin/hypocretin receptors in distinct brain regions regulate ethanol and sucrose mediated behaviors.	[Srinivasan, Subhashini; Simms, Jeffrey A.; Nielsen, Carsten K.; Lieske, Steven P.; Bito-Onon, Jade J.; Yi, Henry; Hopf, Frederic Woodward; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Bartlett, Selena E.] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, Emeryville, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Lieske, Steven P.] San Francisco VA Med Ctr, Dept Mental Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Queensland University of Technology (QUT); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bartlett, SE (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	selena.bartlett@qut.edu.au	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958; Srinivasan, Subhashini/0000-0003-0117-7839	Department of Defense, TATRC grant [W81XWH-10-1-0247]; state funding for medical research through UCSF	Department of Defense, TATRC grant; state funding for medical research through UCSF	The research was carried out with the help of Department of Defense, TATRC grant W81XWH-10-1-0247 (www.tatrc.org) awarded to S. E. B. and A. B. and the state funding for medical research through UCSF to S. E. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2008, ARCH GEN PSYCHIAT, V65, P135, DOI 10.1001/archpsyc.65.2.135; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Balcita-Pedicino JJ, 2007, J COMP NEUROL, V503, P668, DOI 10.1002/cne.21420; Barson JR, 2011, PHYSIOL BEHAV, V104, P128, DOI 10.1016/j.physbeh.2011.04.054; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2008, EUR J NEUROSCI, V28, P1545, DOI 10.1111/j.1460-9568.2008.06397.x; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Georgescu D, 2003, J NEUROSCI, V23, P3106; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; James MH, 2011, INT J NEUROPSYCHOPH, V14, P684, DOI 10.1017/S1461145711000423; Jupp B, 2011, BRAIN RES, V1391, P54, DOI 10.1016/j.brainres.2011.03.045; Kilduff TS, 2001, J COMP NEUROL, V435, P1, DOI 10.1002/cne.1189; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Korotkova TM, 2003, J NEUROSCI, V23, P7; Korotkova TM, 2002, REGUL PEPTIDES, V104, P83, DOI 10.1016/S0167-0115(01)00323-8; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Madhavan A, 2010, J NEUROSCI, V30, P14029, DOI 10.1523/JNEUROSCI.3366-10.2010; Malherbe P, 2009, MOL PHARMACOL, V76, P618, DOI 10.1124/mol.109.055152; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Moorman DE, 2010, J NEUROSCI, V30, P15585, DOI 10.1523/JNEUROSCI.2871-10.2010; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Neubauer DN, 2010, CURR OPIN INVEST DR, V11, P101; Novick A, 2008, LIFE SCI, V83, P74, DOI 10.1016/j.lfs.2008.05.006; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Rodgers RJ, 2001, EUR J NEUROSCI, V13, P1444, DOI 10.1046/j.0953-816x.2001.01518.x; Rodgers RJ, 2000, REGUL PEPTIDES, V96, P71, DOI 10.1016/S0167-0115(00)00203-2; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson H H, 1993, Alcohol Alcohol Suppl, V2, P469; SAMSON HH, 1992, ANN N Y ACAD SCI, V654, P242; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Shoblock JR, 2011, PSYCHOPHARMACOLOGY, V215, P191, DOI 10.1007/s00213-010-2127-x; Simms JA, 2012, NEUROPSYCHOPHARMACOL, V37, P906, DOI 10.1038/npp.2011.268; Simms JA, 2010, NEUROPSYCHOPHARMACOL, V35, P1453, DOI 10.1038/npp.2010.15; Steiner MA, 2011, NEUROPSYCHOPHARMACOL, V36, P848, DOI 10.1038/npp.2010.224; Stuber GD, 2010, CURR TOP BEHAV NEURO, V3, P3, DOI 10.1007/7854_2009_23; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Vittoz NM, 2006, NEUROPSYCHOPHARMACOL, V31, P384, DOI 10.1038/sj.npp.1300807; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wanat MJ, 2009, BIOL PSYCHIAT, V65, P646, DOI 10.1016/j.biopsych.2008.10.042; Yamada H, 2000, BIOCHEM BIOPH RES CO, V267, P527, DOI 10.1006/bbrc.1999.1998; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	60	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44726	10.1371/journal.pone.0044726	http://dx.doi.org/10.1371/journal.pone.0044726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028593	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800013
J	Fu, JJ; Bazazi, AR; Altice, FL; Mohamed, MN; Kamarulzaman, A				Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Mohamed, Mahmood N.; Kamarulzaman, Adeeba			Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation Centers	PLOS ONE			English	Article							CHI MINH CITY; HIV PREVENTION; HUMAN-RIGHTS; INJECT DRUGS; USERS; PEOPLE; CARE; CHALLENGES; PROVINCE; VIETNAM	Background: Throughout Asia, people who use drugs are confined in facilities referred to as compulsory drug detention and rehabilitation centers. The limited transparency and accessibility of these centers has posed a significant challenge to evaluating detainees and detention conditions directly. Despite HIV being highly prevalent in this type of confined setting, direct evaluation of detainees with HIV and their access to medical care has yet to be reported in the literature. Methods: We evaluated the health status of 100 adult male detainees with HIV and their access to medical care in the two largest Malaysian compulsory drug detention and rehabilitation centers holding HIV-infected individuals. Results: Approximately 80% of all detainees with HIV were surveyed in each detention center. Most participants reported multiple untreated medical conditions. None reported being able to access antiretroviral therapy during detention and only 9% reported receiving any HIV-related clinical assessment or care. Nearly a quarter screened positive for symptoms indicative of active tuberculosis, yet none reported having been evaluated for tuberculosis. Although 95% of participants met criteria for opioid dependence prior to detention, none reported being able to access opioid substitution therapy during detention, with 86% reporting current cravings for opioids and 87% anticipating relapsing to drug use after release. Fourteen percent of participants reported suicidal ideation over the previous two weeks. Conclusion: We identified a lack of access to antiretroviral therapy in two of the six compulsory drug detention and rehabilitation centers in Malaysia designated to hold HIV-infected individuals and found significant, unmet health needs among detainees with HIV. Individuals confined under such conditions are placed at considerably high risk for morbidity and mortality. Our findings underscore the urgent need for evidence-based drug policies that respect the rights of people who use drugs and seek to improve, rather than undermine, their health.	[Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Kamarulzaman, Adeeba] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA; [Bazazi, Alexander R.; Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Fu, Jeannia J.; Bazazi, Alexander R.; Altice, Frederick L.; Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Mohamed, Mahmood N.] Univ Utara Malaysia, Sintok, Kedah, Malaysia	Yale University; Yale University; Universiti Malaya; Universiti Utara Malaysia	Altice, FL (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA.	frederick.altice@yale.edu	KAMARULZAMAN, ADEEBA/B-5216-2010	Bazazi, Alexander/0000-0002-4284-5082	University of Malaysia Research University grant; NIH [MSTP TG T32GM07205]; Ministry of Higher Education, Malaysia: High Impact Research [E-000001-20001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072, R01DA025943] Funding Source: NIH RePORTER	University of Malaysia Research University grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Higher Education, Malaysia: High Impact Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the study was provided by the University of Malaysia Research University grant 2007. ARB is supported by NIH MSTP TG T32GM07205. This work was supported in part by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon JJ, 2011, JAIDS-J ACQ IMM DEF, V57, pE29, DOI 10.1097/QAI.0b013e318215de81; Black DW, 2004, J AM ACAD PSYCHIATRY, V32, P158; Bohn M, 1991, PROBL DRUG DEP 1991; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Choi P, 2010, INT J STD AIDS, V21, P416, DOI 10.1258/ijsa.2009.009180; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Fozi K, 2006, Med J Malaysia, V61, P519; Hariz NH, 2010, NEW STRAITS TIMES; Hien NT, 2000, AIDS CARE, V12, P483, DOI 10.1080/09540120050123882; Human Rights Watch, 2010, SKIN CABL ILL ARR AR; Human Rights Watch, 2010, DARKN KNOWS NO LIM I; Human Rights Watch, 2008, UNBR CYCL DRUG DEP T; Isa A R, 1993, Med J Malaysia, V48, P124; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Kamarulzaman A, 2009, JAIDS-J ACQ IMM DEF, V52, pS17, DOI 10.1097/QAI.0b013e3181bbc9af; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Ministry of Health of Malaysia (MOH), 2008, SUMM HIV AIDS CAS RE; Pearshouse Richard, 2009, HIV AIDS Policy Law Rev, V14, P11; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; Saucier Roxanne, 2010, INT J PRISONER HLTH, V6, P81, DOI DOI 10.1080/17449200802692086; SU J, 2004, CHINESE J DURG DEPEN, V13, P221; Thomson N., 2010, DETENTION TREATMENT; Tran SD, 1998, J ACQ IMMUN DEF SYND, V17, P283, DOI 10.1097/00042560-199803010-00015; United Nations Office on Drugs and Crime (UNODC) Economic and Social Commission for Asia and the Pacific (ESCAP) Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP REG CONS COMP CT; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; Wolfe D, 2010, JAIDS-J ACQ IMM DEF, V55, pS56, DOI 10.1097/QAI.0b013e3181f9c0de; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2009, ASS COMP TREATM PEOP; Zhu WX, 2009, DRUG ALCOHOL REV, V28, P641, DOI 10.1111/j.1465-3362.2009.00068.x	31	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44249	10.1371/journal.pone.0044249	http://dx.doi.org/10.1371/journal.pone.0044249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028508	Green Accepted, Green Published, gold			2022-12-25	WOS:000311313900015
J	Jahn, T; Zuther, M; Friedrichs, B; Heuser, C; Guhlke, S; Abken, H; Hombach, AA				Jahn, Tobias; Zuther, Martin; Friedrichs, Bjoern; Heuser, Claudia; Guhlke, Stefan; Abken, Hinrich; Hombach, Andreas A.			An IL12-IL2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation of NK and T cells for an Anti-Tumor Attack	PLOS ONE			English	Article							REED-STERNBERG CELLS; ANTI-CD16/CD30 BISPECIFIC ANTIBODY; TUMOR-CELLS; IMMUNE-SYSTEM; DISEASE; EXPRESSION; CYTOKINES; LYSIS; FRAGMENTS; SUBSETS	Successful immunotherapy of Hodgkin's disease is so far hampered by the striking unresponsiveness of lymphoma infiltrating immune cells. To mobilize both adoptive and innate immune cells for an anti-tumor attack we fused the pro-inflammatory cytokines IL2 and IL12 to an anti-CD30 scFv antibody in a dual cytokine fusion protein to accumulate both cytokines at the malignant CD30(+) Hodgkin/Reed-Sternberg cells in the lymphoma lesion. The tumor-targeted IL12-IL2 fusion protein was superior in activating resting T cells to amplify and secrete pro-inflammatory cytokines compared to targeted IL2 or IL12 alone. NK cells were also activated by the dual cytokine protein to secrete IFN-gamma and to lyse target cells. The tumor-targeted IL12-IL2, when applied by i.v. injection to immune-competent mice with established antigen-positive tumors, accumulated at the tumor site and induced tumor regression. Data demonstrate that simultaneous targeting of two cytokines in a spatial and temporal simultaneous fashion to pre-defined tissues is feasible by a dual-cytokine antibody fusion protein. In the case of IL12 and IL2, this produced superior anti-tumor efficacy implying the strategy to muster a broader immune cell response in the combat against cancer.	[Hombach, Andreas A.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Hombach, AA (corresponding author), Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany.	andreas.hombach@uk-koeln.de		Hombach, Andreas/0000-0001-9328-8442	"Deutsche Krebshilfe'', Bonn; Medical Faculty University of Cologne	"Deutsche Krebshilfe'', Bonn(Deutsche Krebshilfe); Medical Faculty University of Cologne	The study was funded through the "Deutsche Krebshilfe'', Bonn, and the "Koln Fortune'' program of the Medical Faculty University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlen H, 2000, ANN HEMATOL, V79, P110, DOI 10.1007/s002770050564; Cozen W, 2008, BLOOD, V111, P3377, DOI 10.1182/blood-2007-08-106872; ENGERT A, 1990, CANCER RES, V50, P2929; Evens AM, 2008, NAT CLIN PRACT ONCOL, V5, P543, DOI 10.1038/ncponc1186; Hartmann F, 1997, BLOOD, V89, P2042, DOI 10.1182/blood.V89.6.2042; Hartmann F, 2001, CLIN CANCER RES, V7, P1873; Heuser C, 2004, INT J CANCER, V110, P386, DOI 10.1002/ijc.20098; Heuser C, 2003, INT J CANCER, V106, P545, DOI 10.1002/ijc.11279; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; HOMBACH A, 1993, INT J CANCER, V55, P830, DOI 10.1002/ijc.2910550523; Hombach A, 2005, INT J CANCER, V115, P241, DOI 10.1002/ijc.20829; Hombach A, 1998, SCAND J IMMUNOL, V48, P497; Hombach A, 1998, J IMMUNOL METHODS, V218, P53, DOI 10.1016/S0022-1759(98)00115-X; JOST LM, 1992, J IMMUNOL METHODS, V147, P153, DOI 10.1016/S0022-1759(12)80003-2; KAPP U, 1994, ANN ONCOL, V5, pS121, DOI 10.1093/annonc/5.suppl_1.S121; Kemp RA, 2001, J IMMUNOL, V167, P6497, DOI 10.4049/jimmunol.167.11.6497; Kennedy-Nasser AA, 2011, PEDIATR HEMAT ONCOL, V28, P176, DOI 10.3109/08880018.2011.557261; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; Maggio E, 2002, ANN ONCOL, V13, P52, DOI 10.1093/annonc/13.S1.52; NEWCOM SR, 1992, BLOOD, V79, P191; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; POHL C, 1993, INT J CANCER, V54, P418, DOI 10.1002/ijc.2910540312; Poppema S, 2000, SEMIN CANCER BIOL, V10, P345, DOI 10.1006/scbi.2000.0327; Qin ZH, 2003, CANCER RES, V63, P4095; Ranft K, 2009, CANCER LETT, V282, P187, DOI 10.1016/j.canlet.2009.03.011; RENNER C, 1995, EUR J IMMUNOL, V25, P2027, DOI 10.1002/eji.1830250734; ROBBINS PF, 1991, CANCER RES, V51, P3657; Rooney CM, 2002, ANN HEMATOL, V81, pS39; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schliemann C, 2009, BLOOD, V113, P2275, DOI 10.1182/blood-2008-05-160747; Schreck S, 2009, HEMATOL ONCOL, V27, P31, DOI 10.1002/hon.878; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; SLIVNICK DJ, 1990, SEMIN ONCOL, V17, P673; Stein Harald, 2009, Curr Hematol Malig Rep, V4, P125, DOI 10.1007/s11899-009-0018-1; Toennies HM, 2004, J LEUKOCYTE BIOL, V75, P350, DOI 10.1189/jlb.0803401; van den Berg A, 1999, AM J PATHOL, V154, P1685, DOI 10.1016/S0002-9440(10)65424-7; Wang BL, 2001, ONCOGENE, V20, P6930, DOI 10.1038/sj.onc.1204871; Wu CY, 1997, J IMMUNOL, V159, P1658	40	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44482	10.1371/journal.pone.0044482	http://dx.doi.org/10.1371/journal.pone.0044482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028547	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900028
J	Patel, NR; Bole, M; Chen, C; Hardin, CC; Kho, AT; Mih, J; Deng, LH; Butler, J; Tschumperlin, D; Fredberg, JJ; Krishnan, R; Koziel, H				Patel, Naimish R.; Bole, Medhavi; Chen, Cheng; Hardin, Charles C.; Kho, Alvin T.; Mih, Justin; Deng, Linhong; Butler, James; Tschumperlin, Daniel; Fredberg, Jeffrey J.; Krishnan, Ramaswamy; Koziel, Henry			Cell Elasticity Determines Macrophage Function	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LUNG-MECHANICS; ACTIVATION; FILOPODIA; STIFFNESS; TUBERCULOSIS; PERSPECTIVE; PNEUMONIA; SUBSTRATE; ADHESIVE	Macrophages serve to maintain organ homeostasis in response to challenges from injury, inflammation, malignancy, particulate exposure, or infection. Until now, receptor ligation has been understood as being the central mechanism that regulates macrophage function. Using macrophages of different origins and species, we report that macrophage elasticity is a major determinant of innate macrophage function. Macrophage elasticity is modulated not only by classical biologic activators such as LPS and IFN-gamma, but to an equal extent by substrate rigidity and substrate stretch. Macrophage elasticity is dependent upon actin polymerization and small rhoGTPase activation, but functional effects of elasticity are not predicted by examination of gene expression profiles alone. Taken together, these data demonstrate an unanticipated role for cell elasticity as a common pathway by which mechanical and biologic factors determine macrophage function.	[Patel, Naimish R.; Bole, Medhavi; Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Pulm Crit Care & Sleep Med,Dept Med, Boston, MA 02215 USA; [Chen, Cheng; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Chen, Cheng; Hardin, Charles C.; Mih, Justin; Butler, James; Tschumperlin, Daniel; Fredberg, Jeffrey J.; Krishnan, Ramaswamy] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Kho, Alvin T.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Kho, Alvin T.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Chongqing University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Boston Children's Hospital	Patel, NR (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Pulm Crit Care & Sleep Med,Dept Med, Boston, MA 02215 USA.	npatel@bidmc.harvard.edu	Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Fredberg, Jeffrey/M-9877-2019	Deng, Linhong/0000-0003-1970-8239; Chen, Cheng/0000-0002-7323-1104	National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102373, K25HL091124, K25HL111212] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERZURUM SC, 1992, J IMMUNOL, V149, P154; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; FERTSCH D, 1984, J IMMUNOL, V132, P2436; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Gang Z, 2009, MICROSC RES TECHNIQ, V72, P672, DOI 10.1002/jemt.20716; Gaspari R, 2009, J ULTRAS MED, V28, P855, DOI 10.7863/jum.2009.28.7.855; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; INGENITO EP, 1994, J APPL PHYSIOL, V77, P2689, DOI 10.1152/jappl.1994.77.6.2689; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kang I, 2010, AM J RESP CELL MOL, V43, P591, DOI 10.1165/rcmb.2006-0381OC; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; MINK SN, 1981, J APPL PHYSIOL, V50, P283, DOI 10.1152/jappl.1981.50.2.283; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Pena OM, 2011, J IMMUNOL; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Pittet LA, 2011, AM J RESP CELL MOL B; Rook GAW, 2007, CURR MOL MED, V7, P327; Seo YS, 2010, SCAND J GASTROENTERO, V45, P449, DOI 10.3109/00365520903536515; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; WHEELER AP, 1990, J APPL PHYSIOL, V68, P2542, DOI 10.1152/jappl.1990.68.6.2542; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	44	173	174	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e41024	10.1371/journal.pone.0041024	http://dx.doi.org/10.1371/journal.pone.0041024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028423	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900001
J	Peixoto-Santos, JE; Galvis-Alonso, OY; Velasco, TR; Kandratavicius, L; Assirati, JA; Carlotti, CG; Scandiuzzi, RC; Serafini, LN; Leite, JP				Peixoto-Santos, Jose Eduardo; Galvis-Alonso, Orfa Yineth; Velasco, Tonicarlo Rodrigues; Kandratavicius, Ludmyla; Assirati, Joao Alberto; Carlotti, Carlos Gilberto; Scandiuzzi, Renata Caldo; Serafini, Luciano Neder; Leite, Joao Pereira			Increased Metallothionein I/II Expression in Patients with Temporal Lobe Epilepsy	PLOS ONE			English	Article							ACID-INDUCED SEIZURES; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SCLEROSIS; BRAIN-INJURY; EXTRACELLULAR METALLOTHIONEINS; SYNAPTIC REORGANIZATION; OXIDATIVE STRESS; MOSSY FIBERS; ZINC; NEURONS	In the central nervous system, zinc is released along with glutamate during neurotransmission and, in excess, can promote neuronal death. Experimental studies have shown that metallothioneins I/II (MT-I/II), which chelate free zinc, can affect seizures and reduce neuronal death after status epilepticus. Our aim was to evaluate the expression of MT-I/II in the hippocampus of patients with temporal lobe epilepsy (TLE). Hippocampi from patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE) and patients with TLE associated with tumor or dysplasia (TLE-TD) were evaluated for expression of MT-I/II, for the vesicular zinc levels, and for neuronal, astroglial, and microglial populations. Compared to control cases, MTLE group displayed widespread increase in MT-I/II expression, astrogliosis, microgliosis and reduced neuronal population. In TLE-TD, the same changes were observed, except that were mainly confined to fascia dentata. Increased vesicular zinc was observed only in the inner molecular layer of MTLE patients, when compared to control cases. Correlation and linear regression analyses indicated an association between increased MT-I/II and increased astrogliosis in TLE. MT-I/II levels did not correlate with any clinical variables, but MTLE patients with secondary generalized seizures (SGS) had less MT-I/II than MTLE patients without SGS. In conclusion, MT-I/II expression was increased in hippocampi from TLE patients and our data suggest that it is associated with astrogliosis and may be associated with different seizure spread patterns.	[Peixoto-Santos, Jose Eduardo; Velasco, Tonicarlo Rodrigues; Kandratavicius, Ludmyla; Scandiuzzi, Renata Caldo; Leite, Joao Pereira] Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Assirati, Joao Alberto; Carlotti, Carlos Gilberto] Univ Sao Paulo, Dept Neurosurg, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Serafini, Luciano Neder] Univ Sao Paulo, Dept Pathol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Galvis-Alonso, Orfa Yineth] Sao Jose do Rio Preto Med Sch, Dept Mol Biol, Sao Jose Do Rio Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Leite, JP (corresponding author), Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil.	jpleite@fmrp.usp.br	Galvis-Alonso, Orfa Yineth/AAZ-7872-2021; Galvis-Alonso, Orfa Yineth/AAZ-4868-2021; Kandratavicius, Ludmyla/H-2494-2013; Velasco, Tonicarlo R/Q-2170-2016; Carlotti, Carlos G/C-1608-2012; Leite, Joao/B-9070-2012; Peixoto-Santos, Jose Eduardo/L-5123-2013	Galvis-Alonso, Orfa Yineth/0000-0002-1173-5200; Kandratavicius, Ludmyla/0000-0003-4387-5977; Velasco, Tonicarlo R/0000-0001-7756-8882; Carlotti, Carlos G/0000-0002-7055-0564; Leite, Joao/0000-0003-0558-3519; Peixoto-Santos, Jose Eduardo/0000-0001-7461-1902	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56447-7, 2009/53447-7, 2008/52657-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, research grants 2005/56447-7 and 2009/53447-7 to JPL and master's grant 2008/52657-5 to JEPS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Berg AT, 2009, NEUROL CLIN, V27, P1003, DOI 10.1016/j.ncl.2009.06.001; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Brown CE, 2004, J COMP NEUROL, V479, P156, DOI 10.1002/cne.20308; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dominguez MI, 2006, EPILEPSIA, V47, P887, DOI 10.1111/j.1528-1167.2006.00501.x; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; EBADI M, 1995, NEUROCHEM INT, V27, P1, DOI 10.1016/0197-0186(94)00164-P; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Erickson JC, 1997, J NEUROSCI, V17, P1271; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Gomi F, 2005, BRAIN RES, V1033, P113, DOI 10.1016/j.brainres.2004.11.028; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; Hidalgo Juan, 2004, Environ Health Prev Med, V9, P87, DOI 10.1007/BF02898066; Kandratavicius L, 2012, PSYCHIAT RES, V195, P144, DOI 10.1016/j.psychres.2011.06.005; KILLE P, 1994, BBA-PROTEIN STRUCT M, V1205, P151, DOI 10.1016/0167-4838(94)90228-3; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; KIM JH, 1990, ACTA NEUROPATHOL, V80, P41, DOI 10.1007/BF00294220; Kobayashi E, 2002, ARCH NEUROL-CHICAGO, V59, P1891, DOI 10.1001/archneur.59.12.1891; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Leite JP, 2000, NEUROLOGY, V55, P1485, DOI 10.1212/WNL.55.10.1485; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marijic VF, 2006, COMP BIOCHEM PHYS C, V143, P382, DOI 10.1016/j.cbpc.2005.05.019; MATHERN GW, 1994, DEV BRAIN RES, V78, P70, DOI 10.1016/0165-3806(94)90011-6; MATHERN GW, 1995, J NEUROSURG, V82, P228, DOI 10.3171/jns.1995.82.2.0228; Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015; MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Montpied P, 1998, NEUROREPORT, V9, P79, DOI 10.1097/00001756-199801050-00016; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; NISHIMURA N, 1992, J HISTOCHEM CYTOCHEM, V40, P309, DOI 10.1177/40.2.1552172; O'Dwyer R, 2007, EPILEPSIA, V48, P524, DOI 10.1111/j.1528-1167.2006.00967.x; Palumaa P, 2005, BBA-PROTEINS PROTEOM, V1747, P205, DOI 10.1016/j.bbapap.2004.11.007; Pazdernik TL, 2001, J APPL TOXICOL, V21, pS87, DOI 10.1002/jat.818; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Pitkanen A, 2002, EPILEPSY RES, V50, P141, DOI 10.1016/S0920-1211(02)00076-1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Prayson RA, 2007, ANN DIAGN PATHOL, V11, P22, DOI 10.1016/j.anndiagpath.2006.03.004; Proper EA, 2001, ACTA NEUROPATHOL, V101, P405; RASSENDREN FA, 1990, NEURON, V4, P733, DOI 10.1016/0896-6273(90)90199-P; Salanova V, 1999, PEDIATR NEUROL, V20, P179, DOI 10.1016/S0887-8994(98)00128-3; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sonn K, 2010, J NEUROSCI RES, V88, P1074, DOI 10.1002/jnr.22281; Surges R, 2008, J NEUROL NEUROSUR PS, V79, P924, DOI 10.1136/jnnp.2007.129387; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; SUZUKI K, 1992, ACTA HISTOCHEM CYTOC, V25, P617, DOI 10.1267/ahc.25.617; Suzuki Keiji, 1994, Biological Signals, V3, P188; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szabo CA, 2006, AM J NEURORADIOL, V27, P2155; Takeda A, 2006, BIOMETALS, V19, P565, DOI 10.1007/s10534-005-6145-9; Treiber C, 2005, SCI AGING KNOWLEDGE, V2005, pe27; WAALKES MP, 1984, TOXICOL APPL PHARM, V74, P314, DOI 10.1016/0041-008X(84)90284-9; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; Zatta P, 2008, J CHEM NEUROANAT, V36, P1, DOI 10.1016/j.jchemneu.2008.02.008	78	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44709	10.1371/journal.pone.0044709	http://dx.doi.org/10.1371/journal.pone.0044709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028585	gold, Green Published, Green Submitted			2022-12-25	WOS:000311313900036
J	Byrne, DP; Dart, C; Rigden, DJ				Byrne, Dominic P.; Dart, Caroline; Rigden, Daniel J.			Evaluating Caveolin Interactions: Do Proteins Interact with the Caveolin Scaffolding Domain through a Widespread Aromatic Residue-Rich Motif?	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COUPLED RECEPTOR KINASES; INSULIN-RECEPTOR; FUNCTIONAL INTERACTION; TYROSINE KINASE; LIPID RAFTS; WEB SERVER; SUBCELLULAR-LOCALIZATION; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE	Caveolins are coat proteins of caveolae, small flask-shaped pits of the plasma membranes of most cells. Aside from roles in caveolae formation, caveolins recruit, retain and regulate many caveolae-associated signalling molecules. Caveolin-protein interactions are commonly considered to occur between a similar to 20 amino acid region within caveolin, the caveolin scaffolding domain (CSD), and an aromatic-rich caveolin binding motif (CBM) on the binding partner (phi X phi XXXX phi, phi XXXX phi XX phi or phi X phi XXXX phi XX phi, where phi is an aromatic and X an unspecified amino acid). The CBM resembles a typical linear motif - a short, simple sequence independently evolved many times in different proteins for a specific function. Here we exploit recent improvements in bioinformatics tools and in our understanding of linear motifs to critically examine the role of CBMs in caveolin interactions. We find that sequences conforming to the CBM occur in 30% of human proteins, but find no evidence for their statistical enrichment in the caveolin interactome. Furthermore, sequence- and structure-based considerations suggest that CBMs do not have characteristics commonly associated with true interaction motifs. Analysis of the relative solvent accessible area of putative CBMs shows that the majority of their aromatic residues are buried within the protein and are thus unlikely to interact directly with caveolin, but may instead be important for protein structural stability. Together, these findings suggest that the canonical CBM may not be a common characteristic of caveolin-target interactions and that interfaces between caveolin and targets may be more structurally diverse than presently appreciated.	[Byrne, Dominic P.; Dart, Caroline; Rigden, Daniel J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Rigden, DJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	drigden@liv.ac.uk		Dart, Caroline/0000-0002-3509-8349; Rigden, Daniel/0000-0002-7565-8937	British Heart Foundation New Horizons Award [NH/11/2/28923]; British Heart Foundation [NH/11/2/28923] Funding Source: researchfish	British Heart Foundation New Horizons Award; British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation New Horizons Award [grant number: NH/11/2/28923]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Brainard AM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-131; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Burgermeister E, 2011, MOL CELL BIOL, V31, P3497, DOI 10.1128/MCB.01421-10; Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Caselli A, 2007, BIOCHEMISTRY-US, V46, P6383, DOI 10.1021/bi0620858; Cha SH, 2004, IUBMB LIFE, V56, P621, DOI 10.1080/15216540400020353; Chambaut-Guerin AM, 2005, BIOL CELL, V97, P339, DOI 10.1042/BC200400062; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chun J, 2005, BIOCHEM BIOPH RES CO, V326, P136, DOI 10.1016/j.bbrc.2004.10.208; Chun J, 2005, CELL SIGNAL, V17, P751, DOI 10.1016/j.cellsig.2004.10.016; Coleman DE, 1999, J BIOL CHEM, V274, P16669, DOI 10.1074/jbc.274.24.16669; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Davey NE, 2010, NUCLEIC ACIDS RES, V38, pW534, DOI 10.1093/nar/gkq440; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Davies LM, 2010, J PHYSIOL-LONDON, V588, P3254, DOI 10.1113/jphysiol.2010.194779; de Marco MD, 2001, J BIOL CHEM, V276, P23009; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Escriche M, 2003, EXP CELL RES, V285, P72, DOI 10.1016/S0014-4827(02)00090-3; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galvagni F, 2007, BIOCHEMISTRY-US, V46, P3998, DOI 10.1021/bi061400n; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; IMAMURA T, 1994, J BIOL CHEM, V269, P31019; Imamura T, 1998, J BIOL CHEM, V273, P11183, DOI 10.1074/jbc.273.18.11183; IWANISHI M, 1993, DIABETOLOGIA, V36, P414, DOI 10.1007/BF00402277; Jablonski EM, 2006, BIOL CELL, V98, P33, DOI 10.1042/BC20040131; Jodoin J, 2003, J NEUROCHEM, V87, P1010, DOI 10.1046/j.1471-4159.2003.02081.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kwak JO, 2005, IUBMB LIFE, V57, P109, DOI 10.1080/15216540500104750; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lee WK, 2008, EXP MOL MED, V40, P505, DOI 10.3858/emm.2008.40.5.505; Levin AM, 2006, PROTEIN SCI, V15, P478, DOI 10.1110/ps.051911706; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lin DB, 2003, INVEST OPHTH VIS SCI, V44, P5259, DOI 10.1167/iovs.03-0296; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Martinez-Marmol R, 2008, J CELL PHYSIOL, V217, P667, DOI 10.1002/jcp.21538; Mayer G, 2004, CELL TISSUE RES, V316, P55, DOI 10.1007/s00441-004-0866-x; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Moh MC, 2009, BIOCHEM BIOPH RES CO, V378, P755, DOI 10.1016/j.bbrc.2008.11.119; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Panetta D, 2004, BIOCHEM BIOPH RES CO, V316, P240, DOI 10.1016/j.bbrc.2004.02.037; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato Y, 2004, J BIOL CHEM, V279, P8827, DOI 10.1074/jbc.M310327200; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Schilling K, 2006, MOL BIOL CELL, V17, P3870, DOI 10.1091/mbc.E05-08-0709; Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Spisni E, 2001, EXP CELL RES, V266, P31, DOI 10.1006/excr.2001.5198; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Taira J, 2011, BIOCHEMISTRY-US, V50, P6824, DOI 10.1021/bi200601t; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Vargas L, 2002, J BIOL CHEM, V277, P9351, DOI 10.1074/jbc.M108537200; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Weatheritt RJ, 2012, BIOINFORMATICS, V28, P976, DOI 10.1093/bioinformatics/bts072; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yamaguchi T, 2003, EUR J BIOCHEM, V270, P1816, DOI 10.1046/j.1432-1033.2003.03544.x; Yamaguchi Y, 2011, J CELL MOL MED, V15, P957, DOI 10.1111/j.1582-4934.2010.01063.x; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yue LL, 2011, J LIPID RES, V52, P489, DOI 10.1194/jlr.M011809; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100	134	80	81	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44879	10.1371/journal.pone.0044879	http://dx.doi.org/10.1371/journal.pone.0044879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028656	gold, Green Submitted, Green Published			2022-12-25	WOS:000309742800022
J	Buck, NE; Dashnow, H; Pitt, JJ; Wood, LR; Peters, HL				Buck, Nicole E.; Dashnow, Harriet; Pitt, James J.; Wood, Leonie R.; Peters, Heidi L.			Development of Transgenic Mice Containing an Introduced Stop Codon on the Human Methylmalonyl-CoA Mutase Locus	PLOS ONE			English	Article							NONSENSE MUTATION; MOUSE MODEL; IDENTIFICATION; ACIDEMIA; ACIDURIA; GENE	The mutation R403stop was found in an individual with mut(0) methylmalonic aciduria (MMA) which resulted from a single base change of C -> T in exon 6 of the methylmalonyl-CoA mutase gene (producing a TGA stop codon). In order to accurately model the human MMA disorder we introduced this mutation onto the human methylmalonyl-CoA mutase locus of a bacterial artificial chromosome. A mouse model was developed using this construct. The transgene was found to be intact in the mouse model, with 7 copies integrated at a single site in chromosome 3. The phenotype of the hemizygous mouse was unchanged until crossed against a methylmalonyl-CoA mutase knockout mouse. Pups with no endogenous mouse methylmalonyl-CoA mutase and one copy of the transgene became ill and died within 24 hours. This severe phenotype could be partially rescued by the addition of a transgene carrying two copies of the normal human methylmalonyl-CoA mutase locus. The "humanized'' mice were smaller than control litter mates and had high levels of methylmalonic acid in their blood and tissues. This new transgenic MMA stop codon model mimics (at both the phenotypic and genotypic levels) the key features of the human MMA disorder. It will allow the trialing of pharmacological and, cell and gene therapies for the treatment of MMA and other human metabolic disorders caused by stop codon mutations.	[Buck, Nicole E.; Dashnow, Harriet; Pitt, James J.; Wood, Leonie R.; Peters, Heidi L.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Pitt, James J.] Murdoch Childrens Res Inst, VCGS Pathol, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute	Buck, NE (corresponding author), Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	heidi.peters@mcri.edu.au	Dashnow, Harriet/AAG-8213-2019; peters, heidi/GWD-0358-2022	Dashnow, Harriet/0000-0001-8433-6270; Peters, Heidi/0000-0001-7189-5874	Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award	Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Murdoch Childrens Research Institute and the Victorian Government's Operational Infrastructure Support Program. HP was the recipient of a National Health and Medical Research Council clinical Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2005, HUM MUTAT, V25, P167, DOI 10.1002/humu.20128; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Chase TH, 2010, BLOOD, V115, P1267, DOI 10.1182/blood-2009-05-219808; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Lempp TJ, 2007, MOL GENET METAB, V90, P284, DOI 10.1016/j.ymgme.2006.10.002; LINDBLAD B, 1968, ACTA PAEDIATR SCAND, V57, P417, DOI 10.1111/j.1651-2227.1968.tb07314.x; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Osborn O, 2010, CELL MOL NEUROBIOL, V30, P23, DOI 10.1007/s10571-009-9427-x; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Peters Heidi L, 2002, Hum Mutat, V20, P406, DOI 10.1002/humu.9074; Rashed MS, 1997, CLIN CHEM, V43, P1129; Sangkuhl K, 2004, HUM MOL GENET, V13, P893, DOI 10.1093/hmg/ddh105; Worgan LC, 2006, HUM MUTAT, V27, P31, DOI 10.1002/humu.20258; Yang CM, 2007, P NATL ACAD SCI USA, V104, P15394, DOI 10.1073/pnas.0610878104	16	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44974	10.1371/journal.pone.0044974	http://dx.doi.org/10.1371/journal.pone.0044974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024777	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100035
J	Duan, JL; Cai, WM				Duan, Jianli; Cai, Weiming			OsLEA3-2, an Abiotic Stress Induced Gene of Rice Plays a Key Role in Salt and Drought Tolerance	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; LEA PROTEINS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; WATER-STRESS; SACCHAROMYCES-CEREVISIAE; SEQUENCE-ANALYSIS; FREEZING TOLERANCE; PLANT DESICCATION; EXPRESSION	Late embryogenesis abundant (LEA) proteins are involved in tolerance to drought, cold and high salinity in many different organisms. In this report, a LEA protein producing full-length gene OsLEA3-2 was identified in rice (Oryza sativa) using the Rapid Amplification of cDNA Ends (RACE) method. OsLEA3-2 was found to be only expressed in the embryo and can be induced by abiotic stresses. The coding protein localizes to the nucleus and overexpression of OsLEA3-2 in yeast improved growth performance compared with control under salt- and osmotic-stress conditions. OsLEA3-2 was also inserted into pHB vector and overexpressed in Arabidopsis and rice. The transgenic Arabidopsis seedlings showed better growth on MS media supplemented with 150 mM mannitol or 100 mM NaCl as compared with wild type plants. The transgenic rice also showed significantly stronger growth performance than control under salinity or osmotic stress conditions and were able to recover after 20 days of drought stress. In vitro analysis showed that OsLEA3-2 was able to protect LDH from aggregation on freezing and inactivation on desiccation. These results indicated that OsLEA3-2 plays an important role in tolerance to abiotic stresses.	[Duan, Jianli; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Duan, Jianli] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, JL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	wmcai@sibs.ac.cn	Duan, Jianli/GOP-3297-2022	Duan, Jianli/0000-0001-7347-4774	National Basic Research Program of China [2011CB710902]; National Scientific Program [2012AA101103-03]; National Natural Science Foundation of China [90917009, 31070237]; Knowledge Innovation Program of the Chinese Academy of Sciences [KJCX2-YW-L08]; China Manned Space Flight Technology Project; National Transgenic Program [2009ZX08004-008B]	National Basic Research Program of China(National Basic Research Program of China); National Scientific Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); China Manned Space Flight Technology Project; National Transgenic Program	This work was supported by the National Basic Research Program of China (grant 2011CB710902), the National Scientific Program (grant 2012AA101103-03), the National Natural Science Foundation of China (grant 90917009, 31070237), the Knowledge Innovation Program of the Chinese Academy of Sciences (grant KJCX2-YW-L08), the China Manned Space Flight Technology Project and the National Transgenic Program (grant 2009ZX08004-008B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YQ, 2012, MOL BIOL REP, V39, P2883, DOI 10.1007/s11033-011-1048-z; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; BARTELS D, 1988, PLANTA, V175, P485, DOI 10.1007/BF00393069; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURRY J, 1991, PLANT MOL BIOL, V16, P1073, DOI 10.1007/BF00016078; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; GODOY JA, 1990, PLANT MOL BIOL, V15, P695, DOI 10.1007/BF00016120; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hellwege EM, 1996, PLANTA, V198, P423, DOI 10.1007/BF00620059; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HONG BM, 1988, PLANT MOL BIOL, V11, P495, DOI 10.1007/BF00039030; Honjoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1656, DOI 10.1271/bbb.64.1656; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Lal S, 2008, TRANSGENIC RES, V17, P651, DOI 10.1007/s11248-007-9145-4; Liu Y, 2010, CURR MICROBIOL, V60, P373, DOI 10.1007/s00284-009-9552-2; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Moons A, 1997, GENE, V191, P197, DOI 10.1016/S0378-1119(97)00059-0; ROBERTS JK, 1993, PLANT CELL, V5, P769, DOI 10.1105/tpc.5.7.769; Sanchez-Ballesta MT, 2004, J AGR FOOD CHEM, V52, P1950, DOI 10.1021/jf035216+; TAKAHASHI R, 1994, PLANT MOL BIOL, V26, P339, DOI 10.1007/BF00039544; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Wang Bing-Feng, 2008, Journal of Forestry Research (Harbin), V19, P58, DOI 10.1007/s11676-008-0010-y; WHITE CN, 1995, PLANT PHYSIOL, V108, P1337, DOI 10.1104/pp.108.3.1337; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Zhang L, 2000, J BIOCHEM, V127, P611, DOI 10.1093/oxfordjournals.jbchem.a022648	35	121	143	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45117	10.1371/journal.pone.0045117	http://dx.doi.org/10.1371/journal.pone.0045117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024799	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100057
J	Sakaguchi, A; Joyce, E; Aoki, T; Schedl, P; Steward, R				Sakaguchi, Ayako; Joyce, Eric; Aoki, Tsutomu; Schedl, Paul; Steward, Ruth			The Histone H4 Lysine 20 Monomethyl Mark, Set by PR-Set7 and Stabilized by L(3)mbt, Is Necessary for Proper Interphase Chromatin Organization	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; DROSOPHILA-MELANOGASTER; CHROMOSOME STRUCTURE; RNA INTERFERENCE; CELL-LINES; METHYLATION; EXPRESSION; GENES; COMPLEX; TRIMETHYLATION	Drosophila PR-Set7 or SET8 is a histone methyltransferase that specifically monomethylates histone H4 lysine 20 (H4K20). L(3)MBT has been identified as a reader of methylated H4K20. It contains several conserved domains including three MBT repeats binding mono- and dimethylated H4K20 peptides. We find that the depletion of PR-Set7 blocks de novo H4K20me1 resulting in the immediate activation of the DNA damage checkpoint, an increase in the size of interphase nuclei, and drastic reduction of cell viability. L(3)mbt on the other hand stabilizes the monomethyl mark, as L(3)mbt-depleted S2 cells show a reduction of more than 60% of bulk monomethylated H4K20 (H4K20me1) while viability is barely affected. Ploidy and basic chromatin structure show only small changes in PR-Set7-depleted cells, but higher order interphase chromatin organization is significantly affected presumably resulting in the activation of the DNA damage checkpoint. In the absence of any other known functions of PR-Set7, the setting of the de novo monomethyl mark appears essential for cell viability in the presence or absence of the DNA damage checkpoint, but once newly assembled chromatin is established the monomethyl mark, protected by L(3)mbt, is dispensable.	[Sakaguchi, Ayako; Steward, Ruth] Rutgers State Univ, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Steward, Ruth] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Aoki, Tsutomu; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Joyce, Eric] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Princeton University; Harvard University; Harvard Medical School	Sakaguchi, A (corresponding author), Rutgers State Univ, Waksman Inst, Canc Inst New Jersey, Piscataway, NJ 08854 USA.	steward@waksman.rutgers.edu			National Institutes of Health [PHSHD 18055]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the National Institutes of Health (PHSHD 18055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Brustel J, 2011, TRENDS CELL BIOL; CARTWRIGHT IL, 1984, EMBO J, V3, P3101, DOI 10.1002/j.1460-2075.1984.tb02265.x; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dej KJ, 1999, DEVELOPMENT, V126, P293; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Karachentsev D, 2007, DEV BIOL, V304, P46, DOI 10.1016/j.ydbio.2006.12.019; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; LOUIS C, 1980, CELL, V22, P387, DOI 10.1016/0092-8674(80)90349-9; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Rice JC, 2001, NATURE, V414, P258, DOI 10.1038/35104721; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Sakaguchi A, 2008, GENETICS, V179, P317, DOI 10.1534/genetics.108.087650; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Silahtaroglu AN, 2003, MOL CELL PROBE, V17, P165, DOI 10.1016/S0890-8508(03)00048-3; Song YH, 2005, MOL CELLS, V19, P167; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; UDVARDY A, 1984, J MOL BIOL, V172, P385, DOI 10.1016/S0022-2836(84)80013-3; Williams BR, 2007, GENETICS, V177, P31, DOI 10.1534/genetics.107.076356; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yohn CB, 2003, GENETICS, V165, P1889; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45321	10.1371/journal.pone.0045321	http://dx.doi.org/10.1371/journal.pone.0045321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024815	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100073
J	Song, H; Meng, Q; Liu, XQ				Song, Huiling; Meng, Qing; Liu, Xiang-Qin			Protein Trans-Splicing of an Atypical Split Intein Showing Structural Flexibility and Cross-Reactivity	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; CRYSTAL-STRUCTURE; HIGHLY EFFICIENT; MINI-INTEIN; DNAE GENE; IN-VITRO; LIGATION; SEMISYNTHESIS; CYCLIZATION; MODULATION	Inteins catalyze a protein splicing reaction to excise the intein from a precursor protein and join the flanking sequences (exteins) with a peptide bond. In a split intein, the intein fragments (I-N and I-C) can reassemble non-covalently to catalyze a trans-splicing reaction that joins the exteins from separate polypeptides. An atypical split intein having a very small I-N and a large I-C is particularly useful for joining synthetic peptides with recombinant proteins, which can be a generally useful method of introducing site-specific chemical labeling or modifications into proteins. However, a large I-C derived from an Ssp DnaX intein was found recently to undergo spontaneous C-cleavage, which raised questions regarding its structure-function and ability to trans-splice. Here, we show that this I-C could undergo trans-splicing in the presence of I-N, and the trans-splicing activity completely suppressed the C-cleavage activity. We also found that this I-C could trans-splice with small I-N sequences derived from two other inteins, showing a cross-reactivity of this atypical split intein. Furthermore, we found that this I-C could trans-splice even when the I-N sequence was embedded in a nearly complete intein sequence, suggesting that the small I-N could project out of the central pocket of the intein to become accessible to the I-C. Overall, these findings uncovered a new atypical split intein that can be valuable for peptide-protein trans-splicing, and they also revealed an interesting structural flexibility and cross-reactivity at the active site of this intein.	[Song, Huiling; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Song, Huiling; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Donghua University; Dalhousie University	Song, H (corresponding author), Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China.	mengqing@dhu.edu.cn; paul.liu@dal.ca			National Sciences and Engineering Research Council of Canada; Chinese National High Technology Research and Development Program 863 [2006AA03Z451]; Chinese National Natural Science Foundation of China [30800186, 31070698]; Shanghai key projects of basic research [10JC1400300]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Chinese National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research	This work was supported by a grant to XQL from the National Sciences and Engineering Research Council of Canada and by research grants to QM from the Chinese National High Technology Research and Development Program 863 (NO 2006AA03Z451), the Chinese National Natural Science Foundation of China (NO 30800186 and 31070698), and the Shanghai key projects of basic research (NO 10JC1400300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368; Gorbalenya AE, 1998, NUCLEIC ACIDS RES, V26, P1741, DOI 10.1093/nar/26.7.1741; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kalia J, 2006, CHEMBIOCHEM, V7, P1375, DOI 10.1002/cbic.200600150; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Liu XQ, 1997, FEBS LETT, V408, P311, DOI 10.1016/S0014-5793(97)00393-1; Liu XQ, 1997, P NATL ACAD SCI USA, V94, P7851, DOI 10.1073/pnas.94.15.7851; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Paulus H, 2001, BIOORG CHEM, V29, P119, DOI 10.1006/bioo.2001.1203; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Qi XM, 2011, FEBS LETT, V585, P2513, DOI 10.1016/j.febslet.2011.06.035; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tan LP, 2005, PROTEIN PEPTIDE LETT, V12, P769, DOI 10.2174/0929866054864193; Toshio Yamazaki TO, 1998, J AM CHEM SOC, V120, P2; Volkmann G, 2009, PROTEIN SCI, V18, P2393, DOI 10.1002/pro.249; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Wu W, 2002, NUCLEIC ACIDS RES, V30, P4864, DOI 10.1093/nar/gkf621; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	34	6	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45355	10.1371/journal.pone.0045355	http://dx.doi.org/10.1371/journal.pone.0045355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024818	gold, Green Published, Green Submitted			2022-12-25	WOS:000308860100076
J	Zhang, HW; Abiraj, K; Thorek, DLJ; Waser, B; Smith-Jones, PM; Honer, M; Reubi, JC; Maecke, HR				Zhang, Hanwen; Abiraj, Keelara; Thorek, Daniel L. J.; Waser, Beatrice; Smith-Jones, Peter M.; Honer, Michael; Reubi, Jean Claude; Maecke, Helmut R.			Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN CANCER XENOGRAFTS; IN-VIVO EVALUATION; PROSTATE-CANCER; PEPTIDE RECEPTORS; HIGH-AFFINITY; MOUSE MODEL; EXPRESSION; ANTAGONIST; ANALOG	Bombesin receptors are under intense investigation as molecular targets since they are overexpressed in several prevalent solid tumors. We rationally designed and synthesized a series of modified bombesin (BN) peptide analogs to study the influence of charge and spacers at the N-terminus, as well as amino acid substitutions, on both receptor binding affinity and pharmacokinetics. This enabled development of a novel Cu-64/67-labeled BN peptide for PET imaging and targeted radiotherapy of BN receptor-positive tumors. Our results show that N-terminally positively charged peptide ligands had significantly higher affinity to human gastrin releasing peptide receptor (GRPr) than negatively charged or uncharged ligands (IC50: 3.2 +/- 0.5 vs 26.3 +/- 3.5 vs 41.5 +/- 2.5 nM). The replacement of Nle(14) by Met, and deletion of D-Tyr(6), further resulted in 8-fold higher affinity. Contrary to significant changes to human GRPr binding, modifications at the N-terminal and at the 6th, 11th, and 14th position of BN induced only slight influences on affinity to mouse GRPr. [Cu-II]-CPTA-[beta Ala(11)] BN(7-14) ([Cu-II]-BZH7) showed the highest internalization rate into PC-3 cells with relatively slow efflux because of its subnanomolar affinity to GRPr. Interestingly, [Cu-64/67]-BZH7 also displayed similar affinities to the other 2 human BN receptor subtypes. In vivo studies showed that [Cu-64/67]-BZH7 had a high accumulation in PC-3 xenografts and allowed for clear-cut visualization of the tumor in PET imaging. In addition, a CPTA-glycine derivative, forming a hippurane-type spacer, enhanced kidney clearance of the radiotracer. These data indicate that the species variation of BN receptor plays an important role in screening radiolabeled BN. As well, the positive charge from the metallated complex at the N-terminal significantly increases affinity to human GRPr. Application of these observations enabled the novel ligand [Cu-64/67]-BZH7 to clearly visualize PC-3 tumors in vivo. This study provides a strong starting point for optimizing radiopeptides for targeting carcinomas that express any of the BN receptor subtypes.	[Zhang, Hanwen; Maecke, Helmut R.] Univ Basel Hosp, Dept Radiol, Div Radiol Chem, CH-4031 Basel, Switzerland; [Zhang, Hanwen; Thorek, Daniel L. J.; Smith-Jones, Peter M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Abiraj, Keelara; Honer, Michael] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev pRED, Translat Res Sci, CH-4002 Basel, Switzerland; [Waser, Beatrice; Reubi, Jean Claude] Univ Bern, Inst Pathol, Div Cell Biol & Expt Canc Res, Bern, Switzerland; [Maecke, Helmut R.] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany	University of Basel; Memorial Sloan Kettering Cancer Center; Roche Holding; University of Bern; University of Freiburg	Zhang, HW (corresponding author), Univ Basel Hosp, Dept Radiol, Div Radiol Chem, CH-4031 Basel, Switzerland.	zhangh1@mskcc.org		Zhang, Hanwen/0000-0001-7710-5116	Swiss National Science Foundation [3100A0-100390]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank the Swiss National Science Foundation (Grant No. 3100A0-100390), for financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elgaliel WR, 2008, BIOCONJUGATE CHEM, V19, P2040, DOI 10.1021/bc800290c; Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; ANDERSON CJ, 1995, J NUCL MED, V36, P2315; Baum RP, 2007, EUR J NUCL MED MOL I, V34, pS193; Cescato R, 2008, J NUCL MED, V49, P318, DOI 10.2967/jnumed.107.045054; Chen XY, 2004, J NUCL MED, V45, P1390; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; de Jong M, 2010, J NUCL MED, V51, P501, DOI 10.2967/jnumed.109.065706; De Silva RA, 2011, J NUCL MED, V52, P986, DOI 10.2967/jnumed.110.085613; de Wiele CV, 2008, J NUCL MED, V49, P260, DOI 10.2967/jnumed.107.047167; Dimitrakopoulou-Strauss A, 2007, J NUCL MED, V48, P1245, DOI 10.2967/jnumed.106.038091; Fani M, 2008, CONTRAST MEDIA MOL I, V3, P53, DOI 10.1002/cmmi.232; Fani M, 2011, J NUCL MED, V52, P1110, DOI 10.2967/jnumed.111.087999; Garrison JC, 2008, BIOCONJUGATE CHEM, V19, P1803, DOI 10.1021/bc8001375; Garrison JC, 2007, J NUCL MED, V48, P1327, DOI 10.2967/jnumed.107.039487; HALMOS G, 1995, CANCER RES, V55, P280; Hoffman TJ, 2009, NUCL MED BIOL, V36, P579, DOI 10.1016/j.nucmedbio.2009.03.007; Lantry LE, 2006, J NUCL MED, V47, P1144; Lears KA, 2011, J NUCL MED, V52, P470, DOI 10.2967/jnumed.110.082826; Lin JT, 1995, EUR J PHARMACOL, V294, P55, DOI 10.1016/0014-2999(95)00510-2; Maina T, 2005, J NUCL MED, V46; Mansi R, 2011, EUR J NUCL MED MOL I, V38, P97, DOI 10.1007/s00259-010-1596-9; Mansi R, 2009, CLIN CANCER RES, V15, P5240, DOI 10.1158/1078-0432.CCR-08-3145; Mantey SA, 1997, J BIOL CHEM, V272, P26062, DOI 10.1074/jbc.272.41.26062; Markwalder R, 1999, CANCER RES, V59, P1152; Nimmagadda S, 2010, CANCER RES, V70, P3935, DOI 10.1158/0008-5472.CAN-09-4396; Nock B, 2003, EUR J NUCL MED MOL I, V30, P247, DOI 10.1007/s00259-002-1040-x; Nock BA, 2005, J MED CHEM, V48, P100, DOI 10.1021/jm049437y; Pradhan TK, 1998, EUR J PHARMACOL, V343, P275, DOI 10.1016/S0014-2999(97)01527-6; Prasanphanich AF, 2007, P NATL ACAD SCI USA, V104, P12462, DOI 10.1073/pnas.0705347104; Preston SR, 1996, CRIT REV ONCOL HEMAT, V23, P225, DOI 10.1016/1040-8428(96)00204-1; Reubi JC, 2004, EUR J NUCL MED MOL I, V31, P803, DOI 10.1007/s00259-004-1476-2; Reubi JC, 2002, CLIN CANCER RES, V8, P1139; Rogers BE, 2003, BIOCONJUGATE CHEM, V14, P756, DOI 10.1021/bc034018l; Schroeder RPJ, 2009, METHODS, V48, P200, DOI 10.1016/j.ymeth.2009.04.002; Schuhmacher J, 2005, J NUCL MED, V46, P691; SCHWARZBACH R, 1995, APPL RADIAT ISOTOPES, V46, P329, DOI 10.1016/0969-8043(95)00010-B; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; Shokeen M, 2009, ACCOUNTS CHEM RES, V42, P832, DOI 10.1021/ar800255q; SMITHJONES PM, 1991, BIOCONJUGATE CHEM, V2, P415, DOI 10.1021/bc00012a006; STUDER M, 1990, HELV CHIM ACTA, V73, P149, DOI 10.1002/hlca.19900730116; Sun BD, 2000, PROSTATE, V42, P295; Van de Wiele C, 2000, EUR J NUCL MED, V27, P1694, DOI 10.1007/s002590000355; Zhang HW, 2007, EUR J NUCL MED MOL I, V34, P1198, DOI 10.1007/s00259-006-0347-4; Zhang HW, 2004, CANCER RES, V64, P6707, DOI 10.1158/0008-5472.CAN-03-3845; Zhang XZ, 2006, J NUCL MED, V47, P492	46	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44046	10.1371/journal.pone.0044046	http://dx.doi.org/10.1371/journal.pone.0044046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024746	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100004
J	Linderman, JA; Chambers, MC; Gupta, AS; Schneider, DS				Linderman, Jessica A.; Chambers, Moria C.; Gupta, Avni S.; Schneider, David S.			Infection-Related Declines in Chill Coma Recovery and Negative Geotaxis in Drosophila melanogaster	PLOS ONE			English	Article							CARBON-DIOXIDE ANESTHESIA; TEMPERATURE STRESS; OXIDATIVE STRESS; IMMUNE-RESPONSE; COLD; RESISTANCE; EXPRESSION; LONGEVITY; GENES; AGE	Studies of infection in Drosophila melanogaster provide insight into both mechanisms of host resistance and tolerance of pathogens. However, research into the pathways involved in these processes has been limited by the relatively few metrics that can be used to measure sickness and health throughout the course of infection. Here we report measurements of infection-related declines in flies' performance on two different behavioral assays. D. melanogaster are slower to recover from a chill-induced coma during infection with either Listeria monocytogenes or Streptococcus pneumoniae. L. monocytogenes infection also impacts flies' performance during a negative geotaxis assay, revealing a decline in their rate of climbing as part of their innate escape response after startle. In addition to providing new measures for assessing health, these assays also suggest pathological consequences of and metabolic shifts that may occur over the course of an infection.	[Linderman, Jessica A.; Chambers, Moria C.; Gupta, Avni S.; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Linderman, JA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Chambers, Moria/0000-0002-2577-549X	Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094944] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Ellison Medical Foundation (http://www.ellisonfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKING R, 1990, DEV GENET, V11, P141, DOI 10.1002/dvg.1020110204; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Boyer L, 2012, ADV EXP MED BIOL, V710, P29, DOI 10.1007/978-1-4419-5638-5_4; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; de Carvalho JF, 2009, ISR MED ASSOC J, V11, P629; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; DRIVER CJI, 1980, EXP GERONTOL, V15, P167, DOI 10.1016/0531-5565(80)90061-3; French SS, 2011, INTEGR COMP BIOL, V51, P505, DOI 10.1093/icb/icr019; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Goto SG, 2010, BIOCHEM BIOPH RES CO, V391, P1251, DOI 10.1016/j.bbrc.2009.12.053; Hamilos G, 2012, INT J MICROBIOLOGY, V2012, P1; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Hosamani R, 2009, NEUROTOXICOLOGY, V30, P977, DOI 10.1016/j.neuro.2009.08.012; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Le Bourg E, 2010, BIOGERONTOLOGY; Le Bourg E, 2007, BIOGERONTOLOGY, V8, P431, DOI 10.1007/s10522-007-9086-6; Le Bourg E, 2010, BIOGERONTOLOGY, V11, P245, DOI 10.1007/s10522-009-9250-2; Le Bourg E, 2009, BIOGERONTOLOGY, V10, P613, DOI 10.1007/s10522-008-9206-y; LEBOURG E, 1984, GERONTOLOGY, V30, P79, DOI 10.1159/000212612; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Linder JE, 2009, FLY, V3, P143, DOI 10.4161/fly.8051; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Mansueto P, 2012, CLIN DEV IMMUNOL, P1; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Nilson TL, 2006, J INSECT PHYSIOL, V52, P1027, DOI 10.1016/j.jinsphys.2006.07.001; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; PERRON JM, 1972, J INSECT PHYSIOL, V18, P1869, DOI 10.1016/0022-1910(72)90157-6; Protzer U, 2012, LIVING LIVER HEPATIC, P1; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; SCHWAN WR, 1994, P NATL ACAD SCI USA, V91, P6428, DOI 10.1073/pnas.91.14.6428; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Udaka H, 2010, J INSECT PHYSIOL, V56, P1889, DOI 10.1016/j.jinsphys.2010.08.008; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xu J, 2012, INSECT MOL BIOL, V21, P269, DOI 10.1111/j.1365-2583.2012.01133.x; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535	48	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e41907	10.1371/journal.pone.0041907	http://dx.doi.org/10.1371/journal.pone.0041907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028430	gold, Green Published			2022-12-25	WOS:000308788700004
J	Megremis, S; Demetriou, P; Makrinioti, H; Manoussaki, AE; Papadopoulos, NG				Megremis, Spyridon; Demetriou, Philippos; Makrinioti, Heidi; Manoussaki, Alkistis E.; Papadopoulos, Nikolaos G.			The Genomic Signature of Human Rhinoviruses A, B and C	PLOS ONE			English	Article							SINGLE-STRANDED RNA; CPG; DINUCLEOTIDE; EVOLUTION; FREQUENCIES; SEQUENCE; VIRUSES; IDENTIFICATION; ACTIVATION; CLEAVAGE	Human rhinoviruses are single stranded positive sense RNA viruses that are presented in more than 50% of acute upper respiratory tract infections. Despite extensive studies on the genetic diversity of the virus, little is known about the forces driving it. In order to explain this diversity, many research groups have focused on protein sequence requirements for viable, functional and transmissible virus but have missed out an important aspect of viral evolution such as the genomic ontology of the virus. This study presents for the first time the genomic signature of 111 fully sequenced HRV strains from all three groups HRV-A, HRV-B and HRV-C. We observed an HRV genome tendency to eliminate CpG and UpA dinucleotides, coupling with over-representation of UpG and CpA. We propose a specific mechanism which describes how rapid changes in the HRV genomic sequence can take place under the strict control of conservation of the polypeptide backbone. Moreover, the distribution of the observed under- and over-represented dinucleotides along the HRV genome is presented. Distance matrice tables based on CpG and UpA odds ratios were constructed and viewed as heatmaps and distance trees. None of the suppressions can be attributed to codon usage or in RNA secondary structure requirements. Since viral recognition is dependent on RNA motifs rich in CpG and UpA, it is possible that the overall described genome evolution mechanism acts in order to protect the virus from host recognition.	[Megremis, Spyridon; Demetriou, Philippos; Makrinioti, Heidi; Manoussaki, Alkistis E.; Papadopoulos, Nikolaos G.] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece	National & Kapodistrian University of Athens	Megremis, S (corresponding author), Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece.	spyridonmegremis@gmail.com	Papadopoulos, Nikolaos/ABE-1774-2021; N.G., Papadopoulos/L-8670-2013	Papadopoulos, Nikolaos/0000-0002-4448-3468; N.G., Papadopoulos/0000-0002-4448-3468; Megremis, Spyridon/0000-0002-4082-5387; Papadopoulos, Nikolaos/0000-0002-2508-3872	European Commission's Seventh Framework programme [260895]	European Commission's Seventh Framework programme(European Commission)	This work was supported by the European Commission's Seventh Framework programme under grant agreement No 260895 (PREDICTA) KMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; DAMBE, SOFTW PACK DAT AN MO; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Domingo E, 1995, MOL EVOLUTION VIRUSE, P181; Domingo Esteban, 1994, P161; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Friedel M, 2009, BIOINFORMATICS, V25, P2603, DOI 10.1093/bioinformatics/btp436; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; GROMEIER M, 1999, ORIGIN EVOLUTION VIR, P287; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Kandimalla ER, 2003, BIOCHEM SOC T, V31, P654, DOI 10.1042/bst0310654; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Lai MMC, 1995, MOL BASIS VIRUS EVOL, P119; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289	36	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44557	10.1371/journal.pone.0044557	http://dx.doi.org/10.1371/journal.pone.0044557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028561	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700024
J	Desmond, CR; Atwal, RS; Xia, JR; Truant, R				Desmond, Carly R.; Atwal, Randy Singh; Xia, Jianrun; Truant, Ray			Identification of a Karyopherin beta 1/beta 2 Proline-Tyrosine Nuclear Localization Signal in Huntingtin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA EXPORT; IMPORTIN-ALPHA; DISEASE; TRANSPORT; FRAGMENTS; PROTEOLYSIS; TOXICITY; MULTIPLE; BRAINS	Among the known pathways of protein nuclear import, the karyopherin beta 2/transportin pathway is only the second to have a defined nuclear localization signal (NLS) consensus. Huntingtin, a 350-kDa protein, has defined roles in the nucleus, as well as a CRM1/exportin-dependent nuclear export signal; however, the NLS and exact pathway of import have remained elusive. Here, using a live cell assay and affinity chromatography, we show that huntingtin has a karyopherin beta 2-dependent prolinetyrosine (PY)-NLS in the amino terminus of the protein. This NLS comprises three consensus components: a basic charged sequence, a downstream conserved arginine, and a PY sequence. Unlike the classic PY-NLS, which has an unstructured intervening sequence between the consensus components, we show that a beta sheet structured region separating the consensus elements is critical for huntingtin NLS function. The huntingtin PY-NLS is also capable of import through the importin/karyopherin beta 1 pathway but was not functional in all cell types tested. We propose that this huntingtin PY-NLS may comprise a new class of multiple import factor-dependent NLSs with an internal structural component that may regulate NLS activity.	[Desmond, Carly R.; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Atwal, Randy Singh] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA	McMaster University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Truant, R (corresponding author), HSC 4N54,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	truantr@mcmaster.ca			Huntington Society of Canada; CHDI Inc.; Krembil Foundation; Canadian Institutes of Health Research Operating Grant [MOP-119391]	Huntington Society of Canada; CHDI Inc.; Krembil Foundation; Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by the Huntington Society of Canada, CHDI Inc., the Krembil Foundation, and the Canadian Institutes of Health Research Operating Grant MOP-119391 (to R.T.).	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Nikolaev I, 2003, EUKARYOT CELL, V2, P209, DOI 10.1128/EC.2.2.209-221.2003; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sato M, 2011, J COMP NEUROL, V519, P1770, DOI 10.1002/cne.22600; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Truant R, 1999, MOL CELL BIOL, V19, P1210; Truant R, 2007, PROG NEUROBIOL, V83, P211, DOI 10.1016/j.pneurobio.2006.11.004; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Voss TC, 2005, BIOTECHNIQUES, V38, P413, DOI 10.2144/05383RV01; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	35	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412379	http://dx.doi.org/10.1074/jbc.M112.412379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012356	hybrid, Green Published			2022-12-25	WOS:000311233800032
J	Zhao, HL; Chen, XL; Xie, BB; Zhou, MY; Gao, X; Zhang, XY; Zhou, BC; Weiss, AS; Zhang, YZ				Zhao, Hui-Lin; Chen, Xiu-Lan; Xie, Bin-Bin; Zhou, Ming-Yang; Gao, Xiang; Zhang, Xi-Ying; Zhou, Bai-Cheng; Weiss, Anthony S.; Zhang, Yu-Zhong			Elastolytic Mechanism of a Novel M23 Metalloprotease Pseudoalterin from Deep-sea Pseudoalteromonas sp CF6-2 CLEAVING NOT ONLY GLYCYL BONDS IN THE HYDROPHOBIC REGIONS BUT ALSO PEPTIDE BONDS IN THE HYDROPHILIC REGIONS INVOLVED IN CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LYTIC PROTEASE; PSEUDOMONAS-AERUGINOSA; ELASTIC FIBER; BACTERIOLYTIC ACTIVITY; EXTRACELLULAR-MATRIX; HUMAN TROPOELASTIN; ESCHERICHIA-COLI; ORGANIC NITROGEN; DESEASIN MCP-01; SORANGIUM SP	Elastin is a common insoluble protein that is abundant in marine vertebrates, and for this reason its degradation is important for the recycling of marine nitrogen. It is still unclear how marine elastin is degraded because of the limited study of marine elastases. Here, a novel protease belonging to the M23A subfamily, secreted by Pseudoalteromonas sp. CF6-2 from deep-sea sediment, was purified and characterized, and its elastolytic mechanism was studied. This protease, named pseudoalterin, has low identities ( < 40%) to the known M23 proteases. Pseudo-alterin has a narrow specificity but high activity toward elastin. Analysis of the cleavage sites of pseudoalterin on elastin showed that pseudoalterin cleaves the glycyl bonds in hydrophobic regions and the peptide bonds Ala-Ala, Ala-Lys, and Lys-Ala involved in cross-linking. Two peptic derivatives of desmosine, desmosine-Ala-Ala and desmosine-Ala-Ala-Ala, were detected in the elastin hydrolysate, indicating that pseudoalterin can dissociate cross-linked elastin. These results reveal a new elastolytic mechanism of the M23 protease pseudoalterin, which is different from the reported mechanism where the M23 proteases only cleave glycyl bonds in elastin. Genome analysis suggests that M23 proteases may be popular in deep-sea sediments, implying their important role in elastin degradation. An elastin degradation model of pseudoalterin was proposed, based on these results and scanning electron microscopic analysis of the degradation by pseudoalterin of bovine elastin and cross-linked recombinant tropoelastin. Our results shed light on the mechanism of elastin degradation in deep-sea sediment.	[Zhao, Hui-Lin; Chen, Xiu-Lan; Xie, Bin-Bin; Zhou, Ming-Yang; Gao, Xiang; Zhang, Xi-Ying; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Shandong University; University of Sydney	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; 	National Natural Science Foundation of China [31025001, 31000034, 91228210, 31170055, 81271896, 41276149]; Hi-Tech Research and Development Program of China [2011AA090703, 2012AA092103]; COMRA Program [DY125-15-T-05, DY125-13-E-01]; Special Fund of China for Marine-scientific Research in the Public Interest Grant [201005032-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); COMRA Program; Special Fund of China for Marine-scientific Research in the Public Interest Grant	The work was supported by National Natural Science Foundation of China Grants 31025001, 31000034, 91228210, 31170055, 81271896, and 41276149, Hi-Tech Research and Development Program of China Grants 2011AA090703 and 2012AA092103, COMRA Program Grants DY125-15-T-05 and DY125-13-E-01, and Special Fund of China for Marine-scientific Research in the Public Interest Grant 201005032-6.	Ahmed K, 2003, J BIOSCI BIOENG, V95, P27, DOI 10.1263/jbb.95.27; Albarbarawi O, 2010, ANAL CHEM, V82, P3745, DOI 10.1021/ac100152f; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRESSAN GM, 1983, J ULTRA MOL STRUCT R, V82, P335, DOI 10.1016/S0022-5320(83)80021-5; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Chen Z, 2009, EXP DERMATOL, V18, P378, DOI 10.1111/j.1600-0625.2008.00799.x; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573; DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; FEDER J, 1968, BIOCHEM BIOPH RES CO, V32, P326, DOI 10.1016/0006-291X(68)90389-6; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E., 2004, HDB PROTEOLYTIC ENZY, P998; KESSLER E, 2004, HDB PROTEOLYTIC ENZY, P401; Kessler E., 2004, HDB PROTEOLYTIC ENZY, P1001; KEWLEY MA, 1977, J ANAT, V123, P129; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332, DOI 10.1093/oxfordjournals.jbchem.a022116; LOEWY AG, 1993, J BIOL CHEM, V268, P9071; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018; Miyamoto K, 2002, BIOSCI BIOTECH BIOCH, V66, P416, DOI 10.1271/bbb.66.416; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Nilsen T, 2003, APPL ENVIRON MICROB, V69, P2975, DOI 10.1128/AEM.69.5.2975-2984.2003; OZA NB, 1973, INT J PEPT PROT RES, V5, P365; Park P. W., 2004, HDB PROTEOLYTIC ENZY, P1004; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Salvesen G, 1989, PROTEOLYTIC ENZYMES, P83; SCHINDLER CA, 1965, BIOCHIM BIOPHYS ACTA, V97, P242, DOI 10.1016/0304-4165(65)90088-7; Simmonds RS, 1995, MICROB ECOL HEALTH D, V8, P281, DOI 10.3109/08910609509140107; Tu Y, 2010, MATRIX BIOL, V29, P152, DOI 10.1016/j.matbio.2009.10.003; Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; USHIKI T, 1991, ARCH HISTOL CYTOL, V54, P427, DOI 10.1679/aohc.54.427; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; WHITAKER DR, 1965, CAN J BIOCHEM CELL B, V43, P1961, DOI 10.1139/o65-219; WHITAKER DR, 1965, CAN J BIOCHEM CELL B, V43, P1935, DOI 10.1139/o65-217; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN, P43; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; ZYSKIND JW, 1965, SCIENCE, V147, P1458, DOI 10.1126/science.147.3664.1458	54	26	28	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405076	http://dx.doi.org/10.1074/jbc.M112.405076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012370	Green Published, hybrid			2022-12-25	WOS:000311233800040
J	Cassone, M; Gagne, AL; Spruce, LA; Seeholzer, SH; Sebert, ME				Cassone, Marco; Gagne, Alyssa L.; Spruce, Lynn A.; Seeholzer, Steven H.; Sebert, Michael E.			The HtrA Protease from Streptococcus pneumoniae Digests Both Denatured Proteins and the Competence-stimulating Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-TRANSFORMATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; E-CADHERIN; DEGP; CHAPERONE; STRESS; SPECIFICITY; PHEROMONE; VIRULENCE	The HtrA protease of Streptococcus pneumoniae functions both in a general stress response role and as an error sensor that specifically represses genetic competence when the overall level of biosynthetic errors in cellular proteins is low. However, the mechanism through which HtrA inhibits development of competence has been unknown. We found that HtrA digested the pneumococcal competence-stimulating peptide (CSP) and constituted the primary extracytoplasmic CSP-degrading activity in cultures of S. pneumoniae. Mass spectrometry demonstrated that cleavage predominantly followed residue Phe-8 of the CSP-1 isoform of the peptide within its central hydrophobic patch, and in competition assays, both CSP-1 and CSP-2 interacted with HtrA with similar efficiencies. More generally, analysis of beta-casein digestion and of digestion within HtrA itself revealed a preference for substrates with non-polar residues at the P1 site. Consistent with a specificity for exposed hydrophobic residues, competition from native BSA only weakly inhibited digestion of CSP, but denaturation converted BSA into a strong competitive inhibitor of such proteolysis. Together these findings support a model in which digestion of CSP by HtrA is reduced in the presence of other unfolded proteins that serve as alternative targets for degradation. Such competition may provide a mechanism by which HtrA functions in a quality control capacity to monitor the frequency of biosynthetic errors that result in protein misfolding.	[Cassone, Marco; Gagne, Alyssa L.; Sebert, Michael E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Spruce, Lynn A.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Sebert, Michael E.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sebert, ME (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 3615 Civ Ctr Blvd,Abramson Res Bldg,Rm 1202C, Philadelphia, PA 19104 USA.	sebert@email.chop.edu			National Institutes of Health [R01 AI075194]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI075194 (to M. E. S.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Fan K, 2011, J STRUCT BIOL, V176, P16, DOI 10.1016/j.jsb.2011.06.009; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Huesgen PF, 2011, BIOCHEM J, V435, P733, DOI 10.1042/BJ20102131; Huston WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024547; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Livney YD, 2004, J DAIRY SCI, V87, P3638, DOI 10.3168/jds.S0022-0302(04)73502-X; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; PORTER RD, 1976, J VIROL, V19, P659, DOI 10.1128/JVI.19.2.659-667.1976; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Sebert ME, 2005, J BACTERIOL, V187, P3969, DOI 10.1128/JB.187.12.3969-3979.2005; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108	47	64	64	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38449	38459		10.1074/jbc.M112.391482	http://dx.doi.org/10.1074/jbc.M112.391482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012372	Green Published, hybrid			2022-12-25	WOS:000310982800005
J	Della-Maria, J; Hegde, ML; McNeill, DR; Matsumoto, Y; Tsai, MS; Ellenberger, T; Wilson, DM; Mitra, S; Tomkinson, AE				Della-Maria, Julie; Hegde, Muralidhar L.; McNeill, Daniel R.; Matsumoto, Yoshihiro; Tsai, Miaw-Sheue; Ellenberger, Tom; Wilson, David M., III; Mitra, Sankar; Tomkinson, Alan E.			The Interaction between Polynucleotide Kinase Phosphatase and the DNA Repair Protein XRCC1 Is Critical for Repair of DNA Alkylation Damage and Stable Association at DNA Damage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; N-TERMINAL DOMAIN; LIGASE III-ALPHA; POLYMERASE-BETA; AP ENDONUCLEASE; HUMAN-CELLS; POLY(ADP-RIBOSE) POLYMERASE; BRCT DOMAIN; IN-VITRO	XRCC1 plays a key role in the repair of DNA base damage and single-strand breaks. Although it has no known enzymatic activity, XRCC1 interacts with multiple DNA repair proteins and is a subunit of distinct DNA repair protein complexes. Here we used the yeast two-hybrid genetic assay to identify mutant versions of XRCC1 that are selectively defective in interacting with a single protein partner. One XRCC1 mutant, A482T, that was defective in binding to polynucleotide kinase phosphatase (PNKP) not only retained the ability to interact with partner proteins that bind to different regions of XRCC1 but also with aprataxin and aprataxin-like factor whose binding sites overlap with that of PNKP. Disruption of the interaction between PNKP and XRCC1 did not impact their initial recruitment to localized DNA damage sites but dramatically reduced their retention there. Furthermore, the interaction between PNKP and the DNA ligase III alpha-XRCC1 complex significantly increased the efficiency of reconstituted repair reactions and was required for complementation of the DNA damage sensitivity to DNA alkylation agents of xrcc1 mutant cells. Together our results reveal novel roles for the interaction between PNKP and XRCC1 in the retention of XRCC1 at DNA damage sites and in DNA alkylation damage repair.	[Della-Maria, Julie] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Della-Maria, Julie] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Hegde, Muralidhar L.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [McNeill, Daniel R.; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Ernest Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Ellenberger, Tom] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO 63110 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL)	Tomkinson, AE (corresponding author), 1 Univ New Mexico, Canc Res Facil, 915 Camino Salud, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Wilson, David M/AAK-5409-2021; Classen, Scott/AAY-8176-2020	Wilson, David M/0000-0002-8945-0395; Hegde, Muralidhar/0000-0001-7333-8123; Matsumoto, Yoshihiro/0000-0001-6580-7188	National Institutes of Health [R01 ES 012512, R01 CA81063, R01 GM052504, P01 CA 92584]; Intramural Research Program of the NIA, National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES 012512 (to A. E. T.), R01 CA81063 (to S. M.), R01 GM052504 (to T. E.), and P01 CA 92584 (to A. E. T., S. M., and T. E.) and by the Intramural Research Program of the NIA, National Institutes of Health.	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Cuneo MJ, 2010, P NATL ACAD SCI USA, V107, P6805, DOI 10.1073/pnas.0914077107; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Gryk MR, 2002, STRUCTURE, V10, P1709, DOI 10.1016/S0969-2126(02)00908-5; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Hanssen-Bauer A, 2011, ENVIRON MOL MUTAGEN, V52, P623, DOI 10.1002/em.20663; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2012, J BIOL CHEM, V287, P34202, DOI 10.1074/jbc.M112.384032; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Muniandy PA, 2009, J BIOL CHEM, V284, P27908, DOI 10.1074/jbc.M109.029025; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2005, BIOCHEMISTRY-US, V44, P10613, DOI 10.1021/bi050085m; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; THOMPSON LH, 1982, P NATL ACAD SCI-BIOL, V79, P534, DOI 10.1073/pnas.79.2.534; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; ZDZIENICKA MZ, 1992, MUTAGENESIS, V7, P265, DOI 10.1093/mutage/7.4.265	49	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39233	39244		10.1074/jbc.M112.369975	http://dx.doi.org/10.1074/jbc.M112.369975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992732	Green Published, hybrid			2022-12-25	WOS:000310982800078
J	Halff, EF; Diebolder, CA; Versteeg, M; Schouten, A; Brondijk, THC; Huizinga, EG				Halff, Els F.; Diebolder, Christoph A.; Versteeg, Marian; Schouten, Arie; Brondijk, T. Harma C.; Huizinga, Eric G.			Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP BINDING; 3-DIMENSIONAL STRUCTURE; NUCLEOTIDE-BINDING; MAMMALIAN-CELLS; FAMILY MEMBER; APOPTOSOME; ACTIVATION; CASPASE-1; SECRETION; PURIFICATION	The NOD-like receptors NAIP5 and NLRC4 play an essential role in the innate immune response to the bacterial tail protein flagellin. Upon flagellin detection, NAIP5 and NLRC4 form a hetero-oligomeric inflammasome that induces caspase-1-dependent cell death. So far, both the mechanism of formation of the NAIP5-NLRC4 inflammasome and its structure are poorly understood. In this study we combine inflammasome reconstitution in HEK293 cells, purification of inflammasome components, and negative stain electron microscopy to address these issues. We find that a Salmonella typhimurium flagellin fragment comprising the D0 domain and the neighboring spoke region is able to co-precipitate NAIP5 and induce formation of the NAIP5-NLRC4 inflammasome. Comparison with smaller fragments indicates that flagellin recognition is mediated by its C-terminal residues as well as the spoke region. Were constitute the inflammasome from purified flagellin, NAIP5, and NLRC4, thus proving that no other cellular components are required for its formation. Electron micrographs of the purified inflammasome provide unprecedented insight into its architecture, revealing disk-like complexes consisting of 11 or 12 protomers in which NAIP5 and NLRC4 appear to occupy equivalent positions. On the basis of our data, we propose a model for inflammasome formation wherein direct interaction of flagellin with a single NAIP5 induces the recruitment and progressive incorporation of NLRC4, resulting in the formation of a hetero-oligomeric inflammasome.	[Halff, Els F.; Diebolder, Christoph A.; Versteeg, Marian; Schouten, Arie; Brondijk, T. Harma C.; Huizinga, Eric G.] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Diebolder, Christoph A.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Huizinga, EG (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	e.g.huizinga@uu.nl	Brondijk, Harma/AAD-6485-2019; Halff, Els F/M-9110-2015	Brondijk, Harma/0000-0002-0234-673X; Halff, Els F/0000-0001-5814-0899; Diebolder, Christoph/0000-0001-7694-7362	Dutch Top Institute Pharma Project [D1-101]	Dutch Top Institute Pharma Project	This work was supported by the Dutch Top Institute Pharma Project D1-101.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Chaudhary D, 1998, J BIOL CHEM, V273, P17708, DOI 10.1074/jbc.273.28.17708; Chinnaiyan AM, 1997, NATURE, V388, P728, DOI 10.1038/41913; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	48	108	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38460	38472		10.1074/jbc.M112.393512	http://dx.doi.org/10.1074/jbc.M112.393512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012363	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000310982800006
J	Ramesh, B; Sendra, VG; Cirino, PC; Varadarajan, N				Ramesh, Balakrishnan; Sendra, Victor G.; Cirino, Patrick C.; Varadarajan, Navin			Single-cell Characterization of Autotransporter-mediated Escherichia coli Surface Display of Disulfide Bond-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL AUTOTRANSPORTERS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; CHAIN FV; SECRETION; DOMAIN; AUTODISPLAY; EXPRESSION; TOLERANCE; DISCOVERY	Autotransporters (ATs) are a family of bacterial proteins containing a C-terminal beta-barrel-forming domain that facilitates the translocation of N-terminal passenger domain whose functions range from adhesion to proteolysis. Genetic replacement of the native passenger domain with heterologous proteins is an attractive strategy not only for applications such as biocatalysis, live-cell vaccines, and protein engineering but also for gaining mechanistic insights toward understanding AT translocation. The ability of ATs to efficiently display functional recombinant proteins containing multiple disulfides has remained largely controversial. By employing high-throughput single-cell flow cytometry, we have systematically investigated the ability of the Escherichia coli AT Antigen 43 (Ag43) to display two different recombinant reporter proteins, a single-chain antibody (M18 scFv) that contains two disulfides and chymotrypsin that contains four disulfides, by varying the signal peptide and deleting the different domains of the native protein. Our results indicate that only the C-terminal beta-barrel and the threaded alpha-helix are essential for efficient surface display of functional recombinant proteins containing multiple disulfides. These results imply that there are no inherent constraints for functional translocation and display of disulfide bond-containing proteins mediated by the AT system and should open new avenues for protein display and engineering.	[Ramesh, Balakrishnan; Sendra, Victor G.; Cirino, Patrick C.; Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Varadarajan, Navin] Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Varadarajan, N (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	nvaradar@central.uh.edu	Cirino, Patrick/AAM-1203-2021	Varadarajan, Navin/0000-0001-7524-8228	Welch Foundation [E-1774]; University of Houston Startup funds; NATIONAL CANCER INSTITUTE [R01CA174385] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); University of Houston Startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Welch Foundation (Grant E-1774) and University of Houston Startup funds.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL, P10; Becker S, 2007, CHEMBIOCHEM, V8, P943, DOI 10.1002/cbic.200700020; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Jose J, 2005, BIOCHEM BIOPH RES CO, V333, P1218, DOI 10.1016/j.bbrc.2005.06.028; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leysath CE, 2009, J MOL BIOL, V387, P680, DOI 10.1016/j.jmb.2009.02.003; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Leyton DL, 2010, FEMS MICROBIOL LETT, V311, P133, DOI 10.1111/j.1574-6968.2010.02081.x; Li CK, 2008, BIOTECHNOL BIOENG, V99, P485, DOI 10.1002/bit.21548; Luirink J, 2003, PROTEIN SECRETION PATHWAYS IN BACTERIA, P1; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Nhan NT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-22; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Pyo HM, 2009, VACCINE, V27, P2030, DOI 10.1016/j.vaccine.2009.01.130; Rutherford N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-22; Rutherford N, 2006, J BACTERIOL, V188, P4111, DOI 10.1128/JB.01949-05; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schultheiss E, 2008, APPL ENVIRON MICROB, V74, P4782, DOI 10.1128/AEM.01575-07; Shibasaki S, 2001, APPL MICROBIOL BIOT, V57, P528; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Valls M, 2000, NAT BIOTECHNOL, V18, P661, DOI 10.1038/76516; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Varadarajan N, 2009, NAT PROTOC, V4, P893, DOI 10.1038/nprot.2009.60; VASQUEZ JR, 1989, J CELL BIOCHEM, V39, P265, DOI 10.1002/jcb.240390306; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; VOORHOUT WF, 1986, J MICROSC-OXFORD, V141, P303, DOI 10.1111/j.1365-2818.1986.tb02724.x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Zeng LY, 2011, JOVE-J VIS EXP, DOI 10.3791/3363	53	17	19	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38580	38589		10.1074/jbc.M112.388199	http://dx.doi.org/10.1074/jbc.M112.388199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019324	Green Published, hybrid			2022-12-25	WOS:000310982800018
J	Sengupta, S; Tu, SW; Wedin, K; Earnest, S; Stippec, S; Luby-Phelps, K; Cobb, MH				Sengupta, Samarpita; Tu, Szu-Wei; Wedin, Kyle; Earnest, Svetlana; Stippec, Steve; Luby-Phelps, Katherine; Cobb, Melanie H.			Interactions with WNK (With No Lysine) Family Members Regulate Oxidative Stress Response 1 and Ion Co-transporter Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; KINASE-DEFECTIVE ISOFORM; NA+-CL-COTRANSPORTER; GENOME-WIDE ANALYSIS; ALANINE-RICH KINASE; PROTEIN-KINASE; MEDIATED ENDOCYTOSIS; ACTIVATES SGK1; BLOOD-PRESSURE; OSR1	Two of the four WNK (with no lysine (K)) protein kinases are associated with a heritable form of ion imbalance culminating in hypertension. WNK1 affects ion transport in part through activation of the closely related Ste20 family protein kinases oxidative stress-responsive 1 (OSR1) and STE20/SPS1-related proline-, alanine-rich kinase (SPAK). Once activated by WNK1, OSR1 and SPAK phosphorylate and stimulate the sodium, potassium, two chloride co-transporters, NKCC1 and NKCC2, and also affect other related ion co-transporters. We find that WNK1 and OSR1 co-localize on cytoplasmic puncta in HeLa and other cell types. We show that the C-terminal region of WNK1 including a coiled coil is sufficient to localize the fragment in a manner similar to the full-length protein, but some other fragments lacking this region are mislocalized. Photo-bleaching experiments indicate that both hypertonic and hypotonic conditions reduce the mobility of GFP-WNK1 in cells. The four WNK family members can phosphorylate the activation loop of OSR1 to increase its activity with similar kinetic constants. C-terminal fragments of WNK1 that contain three RFXV interaction motifs can bind OSR1, block activation of OSR1 by sorbitol, and prevent the OSR1-induced enhancement of ion co-transporter activity in cells, further supporting the conclusion that association with WNK1 is required for OSR1 activation and function at least in some contexts. C-terminal WNK1 fragments can be phosphorylated by OSR1, suggesting that OSR1 catalyzes feedback phosphorylation of WNK1.	[Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sengupta, Samarpita; Tu, Szu-Wei; Wedin, Kyle; Earnest, Svetlana; Stippec, Steve; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Live Cell Imaging Facil, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luby-Phelps, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Kate.Phelps@UTSouthwestern.edu; Melanie.Cobb@UTSouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409; Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [GM53032]; National Cancer Institute Cancer Center Support Grant [1P30 CA142543-01]; Robert A. Welch Foundation [I1243]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53032 (to M. H. C.). This work was also supported by National Cancer Institute Cancer Center Support Grant 1P30 CA142543-01 and Robert A. Welch Foundation Grant I1243 (to M. H. C.).	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bergaya S, 2012, CURR OPIN NEPHROL HY, V21, P39, DOI 10.1097/MNH.0b013e32834d2fde; Cha SK, 2010, J BIOL CHEM, V285, P6604, DOI 10.1074/jbc.M109.056044; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Grimm PR, 2012, FASEB J, V26; Hannemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017992; Hannemann A, 2009, J BIOL CHEM, V284, P35348, DOI 10.1074/jbc.M109.060004; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Heroes E., 2012, FEBS J IN PRESS; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Nakamichi N, 2002, BIOSCI BIOTECH BIOCH, V66, P2429, DOI 10.1271/bbb.66.2429; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; RUIZPEREZ VL, 1995, CURR GENET, V28, P309, DOI 10.1007/BF00326428; San-Cristobal P, 2008, AM J PHYSIOL-RENAL, V295, pF1199, DOI 10.1152/ajprenal.90396.2008; Subramanya AR, 2006, KIDNEY INT, V70, P630, DOI 10.1038/sj.ki.5001634; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vidal-Petiot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037751; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	64	14	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.398750	http://dx.doi.org/10.1074/jbc.M112.398750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989884	Green Published, hybrid			2022-12-25	WOS:000310642200023
J	Banni, S; Carta, G; Murru, E; Cordeddu, L; Giordano, E; Marrosu, F; Puligheddu, M; Floris, G; Asuni, GP; Cappai, AL; Deriu, S; Follesa, P				Banni, Sebastiano; Carta, Gianfranca; Murru, Elisabetta; Cordeddu, Lina; Giordano, Elena; Marrosu, Francesco; Puligheddu, Monica; Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo			Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CEREBELLAR TREMOR; ENERGY-BALANCE; FOOD-INTAKE; ACTIVATION; EXPRESSION; OBESITY; SYSTEM; METABOLISM; THERAPY	Among the manifold effects of vagus nerve stimulation (VNS) delivered as an add-on treatment to patients with drug-resistant epilepsy, a moderate loss of body weight has been observed in some individuals. We have now investigated this effect in rats. Exposure of rats to VNS for 4 weeks reduced feed conversion efficiency as well as body weight gain (by similar to 25%) and the amount of mesenteric adipose tissue (by similar to 45%) in comparison with those in sham-operated control animals. A pair-fed experiment showed that both lower dietary intake and increase energy expenditure independently contributed to the reduction of body weight and mesenteric adipose tissue. Moreover, VNS increased the level of non-esterified fatty acids in plasma and mesenteric adipose tissue by similar to 50 and 80%, respectively, without affecting that in the liver. In addition, VNS reduced the amounts of endocannabinoids and increased N-palmitoylethanolamide, an endogenous ligand of the transcription factor PPAR alpha (peroxisome proliferator-activated receptor alpha) in mesenteric adipose tissue but not in the hypothalamus. These effects were accompanied by increased expression of the gene for brain-derived neurotrophic factor (BDNF) in the hypothalamus and up-regulation of the abundance of PPAR alpha in the liver. Our results suggest that the reduction in body fat induced by VNS in rats may result from the action of both central and peripheral mediators. The reduced feed conversion efficiency associated with VNS may be mediated by hypothalamic BDNF, down-regulation of endocannabinoid tone in mesenteric adipose tissue and a PPAR alpha-dependent increase in fatty acid oxidation in the liver, which in concerted action may account for the anorexic effect and increased energy expenditure.	[Banni, Sebastiano; Carta, Gianfranca; Murru, Elisabetta; Cordeddu, Lina; Giordano, Elena] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Marrosu, Francesco; Puligheddu, Monica] Univ Cagliari, Dept Publ Hlth & Clin & Mol Med, Cagliari, Italy; [Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari	Banni, S (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	banni@unica.it	Murru, Elisabetta/AAW-4909-2021; Carta, Gianfranca/AAB-8947-2022; Follesa, Paolo/K-5416-2015; Banni, Sebastiano/F-1906-2018; Puligheddu, Monica/AGD-8274-2022; Puligheddu, Monica/AAB-8503-2019	Carta, Gianfranca/0000-0002-3527-4197; Banni, Sebastiano/0000-0003-4805-1387; Follesa, Paolo/0000-0003-4857-476X; Floris, Gabriele/0000-0002-5818-774X; Murru, Maria Elisabetta/0000-0002-7394-5780	Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence [CE00042735]	Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence	This study was supported in part by the Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence, D.M. January 2001, grant protocol CE00042735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakr A, 2008, J CLIN NEUROSCI, V15, P127, DOI 10.1016/j.jocn.2007.07.083; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Banni S, 1996, J NUTR BIOCHEM, V7, P150, DOI 10.1016/0955-2863(95)00193-X; Banni S, 2001, J LIPID RES, V42, P1056; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Biggio F, 2009, INT J NEUROPSYCHOPH, P1; Bugajski AJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; CHIANG S. P., 1955, LARYNGOSCOPE, V65, P927; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di Marzo V, 2008, NAT CLIN PRACT CARD, V5, P610, DOI 10.1038/ncpcardio1319; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; FOLCH J, 1957, J BIOL CHEM, V226, P497; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kirkham T C, 2006, CNS Neurol Disord Drug Targets, V5, P272; Koren MS, 2006, EPILEPSY BEHAV, V8, P246, DOI 10.1016/j.yebeh.2005.10.001; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Marrosu F, 2007, MULT SCLER, V13, P1200, DOI 10.1177/1352458507078399; Marrosu F, 2005, NEUROLOGY, V65, P490, DOI 10.1212/01.wnl.0000172343.45110.79; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Morimoto C, 1997, J LIPID RES, V38, P132; Ono M, 1997, BIOCHEM BIOPH RES CO, V238, P633, DOI 10.1006/bbrc.1997.7220; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; RAMSAY RE, 1994, EPILEPSIA, V35, P627, DOI 10.1111/j.1528-1157.1994.tb02483.x; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; de Oliveira LCS, 2007, AUTON NEUROSCI-BASIC, V136, P63, DOI 10.1016/j.autneu.2007.04.004; Sobocki J, 2006, SURGERY, V139, P209, DOI 10.1016/j.surg.2005.06.025; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; VANDERTUIG JG, 1982, LIFE SCI, V30, P913, DOI 10.1016/0024-3205(82)90619-1; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR992, DOI 10.1152/ajpregu.00516.2006; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; YOSHIDA T, 1984, AM J PHYSIOL, V246, pR558, DOI 10.1152/ajpregu.1984.246.4.R558	46	35	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44813	10.1371/journal.pone.0044813	http://dx.doi.org/10.1371/journal.pone.0044813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028630	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900018
J	Han, FC; Yu, HP; Li, P; Zhang, JP; Tian, C; Li, HB; Zheng, QY				Han, Fengchan; Yu, Heping; Li, Ping; Zhang, Jiangping; Tian, Cong; Li, Hongbo; Zheng, Qing Yin			Mutation in Phex Gene Predisposes BALB/c-PhexHyp-Duk/Y Mice to Otitis Media	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBROBLAST GROWTH FACTOR-23; MIDDLE-EAR; MOUSE MODEL; EFFUSION; PROLIFERATION; CYTOKINES; ETIOLOGY	Genetic susceptibility underlying otitis media (OM) remains to be understood. We show in this study that mutation in Phex gene predisposes the BALB/c-Phex(Hyp-Duk)/Y (abbreviated Hyp-Duk/Y) mice to OM, which occurs at post-natal day 21 (P21) with an average penetrance of 73%. The OM was identified by effusion in the middle ear cavity and/or thickening of middle ear mucosae, and was characterised by increase in goblet cells, deformity of epithelial cilia and higher expression of proliferating cell nuclear antigen (PCNA) in cells of the middle ear mucosae. Moreover, the transcription levels of Tlr2, Tlr4, Nfkb1, Ccl4, Il1b and Tnf alpha in the ears of the Hyp-Duk/Y mice at P35 were significantly upregulated, compared to those of the controls. Higher expression levels of TLR2, TLR4, NF-kappa B and TNF-alpha in the middle ears were demonstrated by immunohistochemistry (IHC). However, the OM in the mice was not prevented by azithromycin administration from gestational day 18 to P35. Further study showed that, in contrast to the low mRNA levels of Phex gene in the ears of the Hyp-Duk/Y mice, the mRNA level of Fgf23 was significantly elevated at P9, P14, P21 and P35. Meanwhile, mRNA levels of EP2 (PGE2 receptor), which expressed in the middle ear epithelia as demonstrated by IHC, were already increased at P14 even before the occurrence of OM, indicating that PGE2, an inflammatory mediator, is involved in the OM development in the mutants. Taking together, Phex mutation primarily up-regulates gene expression levels in FGF23 mediated pathways in the middle ears, resulting in cell proliferation and defence impairment at the mucosae and subsequently bacterial infection. The Hyp-Duk/Y mouse is a new genetic mouse model of OM.	[Han, Fengchan; Li, Ping; Li, Hongbo; Zheng, Qing Yin] Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong, Peoples R China; [Han, Fengchan; Yu, Heping; Zhang, Jiangping; Tian, Cong; Zheng, Qing Yin] Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Zheng, Qing Yin] Jackson Lab, Bar Harbor, ME 04609 USA	Binzhou Medical University; Case Western Reserve University; Jackson Laboratory	Zheng, QY (corresponding author), Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong, Peoples R China.	qing.Zheng@case.edu	Tian, Cong/D-4921-2011; Tian, Cong/E-6300-2012	Tian, Cong/0000-0002-5645-6600	National Institutes of Health [R21DC005846, R01DC007392]; Foundation of Taishan Scholar [tshw20110575, ZR2012HZ004]; Binzhou Medical University [BY2012KYQD01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007392, R21DC005846, R01DC009246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Taishan Scholar; Binzhou Medical University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health grants (R21DC005846 and R01DC007392), Foundation of Taishan Scholar (tshw20110575 and ZR2012HZ004) and Research Initiation Grant of Binzhou Medical University (BY2012KYQD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; BUNSE T, 1987, ARCH OTO-RHINO-LARYN, V244, P123, DOI 10.1007/BF00458562; BUNSE T, 1987, ARCH OTO-RHINO-LARYN, V243, P387, DOI 10.1007/BF00464648; Darrow David H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P416, DOI 10.1097/00020840-200312000-00002; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Enomoto F, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P959; Erben RG, 2005, J BONE MINER RES, V20, P1149, DOI 10.1359/JBMR.050212; Fukumoto S, 2002, CURR OPIN NEPHROL HY, V11, P385, DOI 10.1097/00041552-200207000-00003; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; HERMAN P, 1994, AM J OTOLARYNG, V15, P258, DOI 10.1016/0196-0709(94)90092-2; Igaki JM, 1923, ENDOCR J, V58, P647; Imanishi Yasuo, 2002, Clin Calcium, V12, P634; JUNG TTK, 1988, LARYNGOSCOPE, V98, P980; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; LIM DJ, 1971, LARYNGOSCOPE, V81, P1772, DOI 10.1288/00005537-197111000-00003; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Martin A, 1923, FASEB J, V25, P2551; Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024; Megerian CA, 2008, HEARING RES, V237, P90, DOI 10.1016/j.heares.2008.01.002; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Samuel EA, 2008, CYTOKINE, V41, P38, DOI 10.1016/j.cyto.2007.10.009; Schachern PA, 2009, ARCH OTOLARYNGOL, V135, P657, DOI 10.1001/archoto.2009.72; Shalhoub V, CALCIF TISSUE INT, V89, P140; Skovbjerg S, CLIN MICROBIOL INFEC, V16, P1382; Smirnova MG, 2004, MEDIAT INFLAMM, V13, P75, DOI 10.1080/09629350410001688477; Syal A, 2006, AM J PHYSIOL-RENAL, V290, pF450, DOI 10.1152/ajprenal.00234.2005; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; TOS M, 1975, LARYNGOSCOPE, V85, P377, DOI 10.1288/00005537-197502000-00015; Tournis S. T., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P150; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e43010	10.1371/journal.pone.0043010	http://dx.doi.org/10.1371/journal.pone.0043010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028440	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900002
J	Rao, MV; Yuan, AD; Campbell, J; Kumar, A; Nixon, RA				Rao, Mala V.; Yuan, Aidong; Campbell, Jabbar; Kumar, Asok; Nixon, Ralph A.			The C-Terminal Domains of NF-H and NF-M Subunits Maintain Axonal Neurofilament Content by Blocking Turnover of the Stationary Neurofilament Network	PLOS ONE			English	Article							NEURONAL INTERMEDIATE-FILAMENTS; AMYOTROPHIC-LATERAL-SCLEROSIS; MOLECULAR-MASS SUBUNIT; GANGLION-CELL NEURONS; IN-VIVO; TRANSPORT RATE; RADIAL GROWTH; HEAVY SUBUNIT; SCIATIC-NERVE; TAIL DOMAIN	Newly synthesized neurofilaments or protofilaments are incorporated into a highly stable stationary cytoskeleton network as they are transported along axons. Although the heavily phosphorylated carboxyl-terminal tail domains of the heavy and medium neurofilament (NF) subunits have been proposed to contribute to this process and particularly to stability of this structure, their function is still obscure. Here we show in NF-H/M tail deletion [NF-(H/M)(tail Delta)] mice that the deletion of both of these domains selectively lowers NF levels 3-6 fold along optic axons without altering either rates of subunit synthesis or the rate of slow axonal transport of NF. Pulse labeling studies carried out over 90 days revealed a significantly faster rate of disappearance of NF from the stationary NF network of optic axons in NF-(H/M)(tail Delta) mice. Faster NF disappearance was accompanied by elevated levels of NF-L proteolytic fragments in NF-(H/M)(tail Delta) axons. We conclude that NF-H and NF-M C-terminal domains do not normally regulate NF transport rates as previously proposed, but instead increase the proteolytic resistance of NF, thereby stabilizing the stationary neurofilament cytoskeleton along axons.	[Rao, Mala V.; Yuan, Aidong; Campbell, Jabbar; Kumar, Asok; Nixon, Ralph A.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Rao, Mala V.; Yuan, Aidong; Nixon, Ralph A.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, Langone Med Ctr, New York, NY 10016 USA; [Kumar, Asok] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Rao, MV (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.	rao@nki.rfmh.org		Rao, Mala/0000-0001-7985-2414	NIH/NIH [AG005604]; NATIONAL INSTITUTE ON AGING [R01AG005604, R37AG005604] Funding Source: NIH RePORTER	NIH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIH AG005604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; ARCHER DR, 1994, J NEUROCHEM, V62, P1119; Chen JG, 2000, J CELL SCI, V113, P3861; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Ehlers MD, 1998, J NEUROSCI, V18, P720; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; GARNER JA, 1988, BRAIN RES, V458, P309, DOI 10.1016/0006-8993(88)90473-8; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; GOTOW T, 1994, J CELL SCI, V107, P1949; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HSIEH ST, 1994, J NEUROSCI, V14, P6392; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Jung C, 2000, CELL MOTIL CYTOSKEL, V47, P120, DOI 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6; Jung C, 2000, BRAIN RES, V856, P12, DOI 10.1016/S0006-8993(99)02314-8; Kim OJ, 2002, J NEUROSCI, V22, P5920; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; NAKAGAWA T, 1995, J CELL BIOL, V129, P411, DOI 10.1083/jcb.129.2.411; NIXON RA, 1980, BRAIN RES, V200, P69, DOI 10.1016/0006-8993(80)91095-1; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; Nixon RA, 1998, BIOESSAYS, V20, P798, DOI 10.1002/(SICI)1521-1878(199810)20:10<798::AID-BIES5>3.0.CO;2-7; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Rao MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017087; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; Sanchez I, 1996, J NEUROSCI, V16, P5095; SIHAG RK, 1991, J BIOL CHEM, V266, P18861; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Veeranna, 2010, NEUROBIOL A IN PRESS; Yabe JT, 2001, J NEUROSCI, V21, P2195; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	55	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44320	10.1371/journal.pone.0044320	http://dx.doi.org/10.1371/journal.pone.0044320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028520	Green Published, gold			2022-12-25	WOS:000309392800006
J	Khamis, FM; Masiga, DK; Mohamed, SA; Salifu, D; de Meyer, M; Ekesi, S				Khamis, Fathiya M.; Masiga, Daniel K.; Mohamed, Samira A.; Salifu, Daisy; de Meyer, Marc; Ekesi, Sunday			Taxonomic Identity of the Invasive Fruit Fly Pest, Bactrocera invadens: Concordance in Morphometry and DNA Barcoding	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; FLIES DIPTERA; PHYLOGENETIC-RELATIONSHIPS; DORSALIS COMPLEX; DISCRIMINATION; DACINAE; IDENTIFICATION; HISTORY; REGION	In 2003, a new fruit fly pest species was recorded for the first time in Kenya and has subsequently been found in 28 countries across tropical Africa. The insect was described as Bactrocera invadens, due to its rapid invasion of the African continent. In this study, the morphometry and DNA Barcoding of different populations of B. invadens distributed across the species range of tropical Africa and a sample from the pest's putative aboriginal home of Sri Lanka was investigated. Morphometry using wing veins and tibia length was used to separate B. invadens populations from other closely related Bactrocera species. The Principal component analysis yielded 15 components which correspond to the 15 morphometric measurements. The first two principal axes contributed to 90.7% of the total variance and showed partial separation of these populations. Canonical discriminant analysis indicated that only the first five canonical variates were statistically significant. The first two canonical variates contributed a total of 80.9% of the total variance clustering B. invadens with other members of the B. dorsalis complex while distinctly separating B. correcta, B. cucurbitae, B. oleae and B. zonata. The largest Mahalanobis squared distance (D-2 = 122.9) was found to be between B. cucurbitae and B. zonata, while the lowest was observed between B. invadens populations against B. kandiensis (8.1) and against B. dorsalis s.s (11.4). Evolutionary history inferred by the Neighbor-Joining method clustered the Bactrocera species populations into four clusters. First cluster consisted of the B. dorsalis complex (B. invadens, B. kandiensis and B. dorsalis s.s.), branching from the same node while the second group was paraphyletic clades of B. correcta and B. zonata. The last two are monophyletic clades, consisting of B. cucurbitae and B. oleae, respectively. Principal component analysis using the genetic distances confirmed the clustering inferred by the NJ tree.	[Khamis, Fathiya M.; Mohamed, Samira A.; Salifu, Daisy; Ekesi, Sunday] Int Ctr Insect Physiol & Ecol Icipe, African Fruit Fly Programme, Nairobi, Kenya; [Khamis, Fathiya M.] Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol Icipe, Mol Biol & Biotechnol Dept, Nairobi, Kenya; [de Meyer, Marc] Royal Museum Cent Africa, Tervuren, Belgium	International Centre of Insect Physiology & Ecology (ICIPE); Kenyatta University; International Centre of Insect Physiology & Ecology (ICIPE); Royal Museum for Central Africa	Khamis, FM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, African Fruit Fly Programme, Nairobi, Kenya.	fkhamis@icipe.org	Ekesi, Sunday/P-8944-2019	Masiga, Daniel/0000-0001-7513-0887	International Atomic Energy Agency (IAEA) Vienna, Austria [16072]; German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [81132021]	International Atomic Energy Agency (IAEA) Vienna, Austria(International Atomic Energy Agency); German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The authors are grateful to the International Atomic Energy Agency (IAEA) Vienna, Austria (Contract number 16072), and the German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) (Contract number 81132021) for grant support for this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda FXN, 2008, FRUITS, V63, P19, DOI 10.1051/fruits:2007041; Adsavakulchai A., 1999, Biotropia, V13, P37; Armstrong Karen F., 2000, P703; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 1997, B ENTOMOL RES, V87, P111, DOI 10.1017/S0007485300027243; Barr NB, 2006, B ENTOMOL RES, V96, P505, DOI 10.1079/BER2006452; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Bartlett MS, 1951, B J PSYCHOL-STAT SEC, V4, P1, DOI 10.1111/j.2044-8317.1951.tb00299.x; BAXTER MJ, 1995, J R STAT SOC C-APPL, V44, P513, DOI 10.2307/2986142; Billah M. K., 2005, International Journal of Tropical Insect Science, V25, P168, DOI 10.1079/IJT200573; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; De Meyer M, 2005, INSECT SYST EVOL, V36, P459, DOI 10.1163/187631205794761012; De Meyer M, 2000, ZOOL J LINN SOC-LOND, V128, P439, DOI 10.1111/j.1096-3642.2000.tb01523.x; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2005, AFR ENTOMOL, V13, P149; Drew RAI, 2008, BIOL J LINN SOC, V93, P217, DOI 10.1111/j.1095-8312.2007.00952.x; Drew RAI, 2006, J ECON ENTOMOL, V99, P1651, DOI 10.1603/0022-0493-99.5.1651; Ekesi S, 2006, B ENTOMOL RES, V96, P379, DOI 10.1079/BER2006442; Ekesi S, 2007, FIELD GUIDE MANAGEME; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; French C, 2005, INSECT PEST CONTROL, P19; Goergen G, 2011, ENVIRON ENTOMOL, V40, P844, DOI 10.1603/EN11017; Hajibabaei M, 2007, SCI DIRECT, V10, P1; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lawson AE, 2003, DORSALIS INTERACTIVE; Lux Slawomir A., 2003, Insect Science and its Application, V23, P355; MCNAMEE S, 1993, SYST ENTOMOL, V18, P231, DOI 10.1111/j.1365-3113.1993.tb00663.x; McPheron BA, 1996, FRUIT FLY PESTS WORL; McPheron Bruce A., 2000, P483; Morrow J, 2000, EVOLUTION, V54, P899, DOI 10.1111/j.0014-3820.2000.tb00090.x; Muraji M, 2002, APPL ENTOMOL ZOOL, V37, P437, DOI 10.1303/aez.2002.437; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Mwatawala Maulid W., 2006, Fruits, V61, P321, DOI 10.1051/fruits:2006031; Mwatawala MW, 2009, B ENTOMOL RES, P1; Nakahara Shigehito, 2001, Research Bulletin of the Plant Protection Service Japan, V37, P69; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perero JG, 1984, AN 2 C INT BIOM FAC, P421; R Core Team, 2021, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reyment RA, 1984, MULTIVARIATE MORPHOM; Rwomushana I, 2008, ANN ENTOMOL SOC AM, V101, P331, DOI 10.1603/0013-8746(2008)101[331:HPAHPP]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schutze MK, 2012, B ENTOMOL RES, V102, P103, DOI 10.1017/S0007485311000423; Selivon D, 1996, THESIS U SAO PAULO B, P137; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Sonvico A, 1996, J ECON ENTOMOL, V89, P1208, DOI 10.1093/jee/89.5.1208; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KH, 2011, CHEMOECOLOGY, V21, P25, DOI 10.1007/s00049-010-0063-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Vayssieres Jean-Francois, 2005, Fruits, V60, P371, DOI 10.1051/fruits:2005042; Vayssieres JF, 2009, CROP PROT, V28, P477, DOI 10.1016/j.cropro.2009.01.010; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; WILLIG MR, 1986, SYST ZOOL, V35, P195, DOI 10.2307/2413430; Zar JH, 1999, BIOSTATISTICAL ANAL	62	41	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44862	10.1371/journal.pone.0044862	http://dx.doi.org/10.1371/journal.pone.0044862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028649	Green Published, gold, Green Submitted			2022-12-25	WOS:000309742800020
J	Arulselvan, P; Wen, CC; Lan, CW; Chen, YH; Wei, WC; Yang, NS				Arulselvan, Palanisamy; Wen, Chih-Chun; Lan, Chun-Wen; Chen, Yung-Hsiang; Wei, Wen-Chi; Yang, Ning-Sun			Dietary Administration of Scallion Extract Effectively Inhibits Colorectal Tumor Growth: Cellular and Molecular Mechanisms in Mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; COLON-CANCER CHEMOPREVENTION; CRYPT FOCI FORMATION; NITRIC-OXIDE; WELSH ONION; ADHESION MOLECULES; DOWN-REGULATION; KAPPA-B; ANGIOGENESIS; EXPRESSION	Colorectal cancer is a common malignancy and a leading cause of cancer death worldwide. Diet is known to play an important role in the etiology of colon cancer and dietary chemoprevention is receiving increasing attention for prevention and/or alternative treatment of colon cancers. Allium fistulosum L., commonly known as scallion, is popularly used as a spice or vegetable worldwide, and as a traditional medicine in Asian cultures for treating a variety of diseases. In this study we evaluated the possible beneficial effects of dietary scallion on chemoprevention of colon cancer using a mouse model of colon carcinoma (CT-26 cells subcutaneously inoculated into BALB/c mice). Tumor lysates were subjected to western blotting for analysis of key inflammatory markers, ELISA for analysis of cytokines, and immunohistochemistry for analysis of inflammatory markers. Metabolite profiles of scallion extracts were analyzed by LC-MS/MS. Scallion extracts, particularly hot-water extract, orally fed to mice at 50 mg (dry weight)/kg body weight resulted in significant suppression of tumor growth and enhanced the survival rate of test mice. At the molecular level, scallion extracts inhibited the key inflammatory markers COX-2 and iNOS, and suppressed the expression of various cellular markers known to be involved in tumor apoptosis (apoptosis index), proliferation (cyclin D1 and c-Myc), angiogenesis (VEGF and HIF-1 alpha), and tumor invasion (MMP-9 and ICAM-1) when compared with vehicle control-treated mice. Our findings may warrant further investigation of the use of common scallion as a chemopreventive dietary agent to lower the risk of colon cancer.	[Arulselvan, Palanisamy; Wen, Chih-Chun; Lan, Chun-Wen; Chen, Yung-Hsiang; Wei, Wen-Chi; Yang, Ning-Sun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Taiwan Int Grad Program, Taipei, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lan, Chun-Wen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Wei, Wen-Chi] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Yang, Ning-Sun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Sun Yat Sen University; National Taiwan University	Arulselvan, P (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	nsyang@gate.sinica.edu.tw	Arulselvan, Palanisamy/M-6388-2014	Arulselvan, Palanisamy/0000-0002-1835-9738	National Science Council grant [NSC-99-2321-B-400-006]; Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship	National Science Council grant; Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship	This study was financially supported by a National Science Council grant (NSC-99-2321-B-400-006) and by Academia Sinica, Taiwan in the form of a Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anto RJ, 1996, MUTAT RES-GENET TOX, V370, P127, DOI 10.1016/0165-1218(96)00074-2; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Chen JH, 1999, J CARDIOVASC PHARM, V33, P515, DOI 10.1097/00005344-199904000-00001; Chen JH, 2000, J NUTR, V130, P34; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Chiu SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-513; Choi YL, 2004, J HISTOCHEM CYTOCHEM, V52, P591, DOI 10.1177/002215540405200504; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Dymicka-Piekarska V, 2009, THROMB RES, V124, P80, DOI 10.1016/j.thromres.2008.11.021; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hagos GK, 2007, MOL CANCER THER, V6, P2230, DOI 10.1158/1535-7163.MCT-07-0069; Hardy G, 2003, CURR OPIN CLIN NUTR, V6, P661, DOI 10.1097/00075197-200311000-00010; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hsu CH, 2007, ADV EXP MED BIOL, V595, P471; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Huerta S, 2008, EXPERT REV MOL DIAGN, V8, P277, DOI 10.1586/14737159.8.3.277; Kohno H, 2006, INT J CANCER, V118, P2936, DOI 10.1002/ijc.21719; La Vecchia C, 2004, PUBLIC HEALTH NUTR, V7, P965, DOI 10.1079/PHN2004562; Lee SJ, 2007, TOXICOL APPL PHARM, V225, P198, DOI 10.1016/j.taap.2007.07.010; Lee SI, 2008, J GASTROEN HEPATOL, V23, P138, DOI 10.1111/j.1440-1746.2007.05181.x; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Lopez-Lazaro M, 2006, CANCER EPIDEM BIOMAR, V15, P2332, DOI 10.1158/1055-9965.EPI-06-0369; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mousa AS, 2005, NUTR CANCER, V53, P104, DOI 10.1207/s15327914nc5301_12; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SANO H, 1995, CANCER RES, V55, P3785; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Singh RP, 2003, CURR CANCER DRUG TAR, V3, P205, DOI 10.2174/1568009033481985; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Singh V, 2006, NUTR CANCER, V55, P178, DOI 10.1207/s15327914nc5502_9; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451; Takahashi M, 2000, CARCINOGENESIS, V21, P1319, DOI 10.1093/carcin/21.7.1319; Tsai TH, 2005, J FOOD SCI, V70, pC93, DOI 10.1111/j.1365-2621.2005.tb09028.x; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Wang BS, 2005, FOOD CHEM, V91, P147, DOI 10.1016/j.foodchem.2004.06.009; Wang SX, 2006, INT J CANCER, V118, P932, DOI 10.1002/ijc.21289; Warren CA, 2009, J NUTR, V139, P101, DOI 10.3945/jn.108.096271; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yamamoto Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1311, DOI 10.1271/bbb.69.1311	52	20	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44658	10.1371/journal.pone.0044658	http://dx.doi.org/10.1371/journal.pone.0044658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024755	Green Published, gold, Green Submitted			2022-12-25	WOS:000308860100013
J	Li, JX; Mao, GK; Xia, GL				Li, Junxia; Mao, Guankun; Xia, Guoliang			FSH Modulates PKAI and GPR3 Activities in Mouse Oocyte of COC in a Gap Junctional Communication (GJC)-Dependent Manner to Initiate Meiotic Resumption	PLOS ONE			English	Article							PROTEIN-KINASE-A; FOLLICLE-STIMULATING-HORMONE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; MEDIATED GENE-EXPRESSION; CUMULUS CELL COMPLEX; ADENOSINE-MONOPHOSPHATE; MAMMALIAN OOCYTES; BINDING PROTEIN; GRANULOSA-CELLS; RODENT OOCYTES	Many studies have shown that cyclic adenosine-5'-monophosphate (cAMP)-dependent protein kinase A (PKA) and G-protein-coupled receptor 3 (GPR3) are crucial for controlling meiotic arrest in oocytes. However, it is unclear how gonadotropins modulate these factors to regulate oocyte maturation, especially by gap junctional communication (GJC). Using an in vitro meiosis-arrested mouse cumulus-oocyte complex (COC) culture model, we showed that there is a close relationship between follicle-stimulating hormone (FSH) and the PKA type I (PKAI) and GPR3. The effect of FSH on oocyte maturation was biphasic, initially inhibitory and then stimulatory. During FSH-induced maturation, rapid cAMP surges were observed in both cumulus cells and oocyte. Most GJC between cumulus cells and oocyte ceased immediately after FSH stimulation and recommenced after the cAMP surge. FSH-induced maturation was blocked by PKAI activator 8-AHA-cAMP. Levels of PKAI regulatory subunits and GPR3 decreased and increased, respectively, after FSH stimulation. In the presence of the GJC inhibitor carbenoxolone (CBX), FSH failed to induce the meiotic resumption and the changes in PKAI, GPR3 and cAMP surge in oocyte were no longer detected. Furthermore, GPR3 was upregulated by high cAMP levels, but not by PKAI activation. When applied after FSH stimulation, the specific phosphodiesterase 3A (PDE3A) inhibitor cilostamide immediately blocked meiotic induction, regardless of when it was administered. PKAI activation inhibited mitogen-activated protein kinase (MAPK) phosphorylation in the oocytes of COCs, which participated in the initiation of FSH-induced meiotic maturation in vitro. Just before FSH-induced meiotic maturation, cAMP, PKAI, and GPR3 returned to basal levels, and PDE3A activity and MAPK phosphorylation increased markedly. These experiments show that FSH induces a transient increase in cAMP levels and regulates GJC to control PKAI and GPR3 activities, thereby creating an inhibitory phase. After PDE3A and MAPK activities increase, meiosis resumes.	[Li, Junxia; Mao, Guankun; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Li, JX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	glxiachina@sohu.com		Xia, Guoliang/0000-0003-3674-0142	National Basic Research Program of China [2012CB944401, 2012CB944701]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2012CB944401 and No. 2012CB944701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; Brown RL, 2002, BIOL REPROD, V67, P981, DOI 10.1095/biolreprod.101.003046; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Constantinescu A, 2004, J BIOL CHEM, V279, P43321, DOI 10.1074/jbc.M406994200; Constantinescu A, 2002, J BIOL CHEM, V277, P18810, DOI 10.1074/jbc.M112107200; DEKEL N, 1988, MOL CELL ENDOCRINOL, V56, P115, DOI 10.1016/0303-7207(88)90015-9; Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; DOWNS SM, 1989, GAMETE RES, V23, P323, DOI 10.1002/mrd.1120230309; DOWNS SM, 1995, DEV BIOL, V167, P502, DOI 10.1006/dbio.1995.1044; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; Downs SM, 2002, DEV BIOL, V245, P200, DOI 10.1006/dbio.2002.0613; DOWNS SM, 1984, ENDOCRINOLOGY, V114, P418, DOI 10.1210/endo-114-2-418; Downs SM, 2008, MOL REPROD DEV, V75, P105, DOI 10.1002/mrd.20781; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Eppig JJ, 1997, BIOL REPROD, V56, P976, DOI 10.1095/biolreprod56.4.976; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; KNUTSEN HK, 1992, BIOCHEM BIOPH RES CO, V184, P454, DOI 10.1016/0006-291X(92)91215-C; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Ning G, 2008, MOL ENDOCRINOL, V22, P1682, DOI 10.1210/me.2007-0480; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; SHERIZLY I, 1988, HUM REPROD, V3, P761, DOI 10.1093/oxfordjournals.humrep.a136780; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Vozzi C, 2001, REPRODUCTION, V122, P619, DOI 10.1530/reprod/122.4.619; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Webb RJ, 2002, DEV BIOL, V246, P441, DOI 10.1006/dbio.2002.0630; Zhang B, 2011, MOL BIOL REP; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799	52	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e37835	10.1371/journal.pone.0037835	http://dx.doi.org/10.1371/journal.pone.0037835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028418	gold, Green Submitted, Green Published			2022-12-25	WOS:000308788700001
J	Marshall, BDL; Paczkowski, MM; Seemann, L; Tempalski, B; Pouget, ER; Galea, S; Friedman, SR				Marshall, Brandon D. L.; Paczkowski, Magdalena M.; Seemann, Lars; Tempalski, Barbara; Pouget, Enrique R.; Galea, Sandro; Friedman, Samuel R.			A Complex Systems Approach to Evaluate HIV Prevention in Metropolitan Areas: Preliminary Implications for Combination Intervention Strategies	PLOS ONE			English	Article							INJECTION-DRUG-USERS; ACTIVE ANTIRETROVIRAL THERAPY; NEW-YORK-CITY; HUMAN-IMMUNODEFICIENCY-VIRUS; SUBSTANCE-ABUSE TREATMENT; AGENT-BASED MODELS; OUT-OF-TREATMENT; CONCURRENT SEXUAL PARTNERSHIPS; UNITED-STATES; RISK BEHAVIORS	Background: HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public health problem. Continuing propagation in endemic settings and emerging regional outbreaks have indicated the need for comprehensive and coordinated HIV prevention. We describe the development of a conceptual framework and calibration of an agent-based model (ABM) to examine how combinations of interventions may reduce and potentially eliminate HIV transmission among drug-using populations. Methodology/Principal Findings: A multidisciplinary team of researchers from epidemiology, sociology, geography, and mathematics developed a conceptual framework based on prior ethnographic and epidemiologic research. An ABM was constructed and calibrated through an iterative design and verification process. In the model, "agents" represent IDU, NIDU, and non-drug users who interact with each other and within risk networks, engaging in sexual and, for IDUs, injection-related risk behavior over time. Agents also interact with simulated HIV prevention interventions (e. g., syringe exchange programs, substance abuse treatment, HIV testing) and initiate antiretroviral treatment (ART) in a stochastic manner. The model was constructed to represent the New York metropolitan statistical area (MSA) population, and calibrated by comparing output trajectories for various outcomes (e. g., IDU/NIDU prevalence, HIV prevalence and incidence) against previously validated MSA-level data. The model closely approximated HIV trajectories in IDU and NIDU observed in New York City between 1992 and 2002, including a linear decrease in HIV prevalence among IDUs. Exploratory results are consistent with empirical studies demonstrating that the effectiveness of a combination of interventions, including syringe exchange expansion and ART provision, dramatically reduced HIV prevalence among IDUs during this time period. Conclusions/Significance: Complex systems models of adaptive HIV transmission dynamics can be used to identify potential collective benefits of hypothetical combination prevention interventions. Future work will seek to inform novel strategies that may lead to more effective and equitable HIV prevention strategies for drug-using populations.	[Marshall, Brandon D. L.; Paczkowski, Magdalena M.; Galea, Sandro] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Marshall, Brandon D. L.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Seemann, Lars] Univ Houston, Dept Phys, Houston, TX USA; [Tempalski, Barbara; Pouget, Enrique R.; Friedman, Samuel R.] Natl Dev & Res Inst Inc, New York, NY USA; [Tempalski, Barbara; Pouget, Enrique R.; Friedman, Samuel R.] Inst AIDS Res, New York, NY USA	Columbia University; Brown University; University of Houston System; University of Houston; National Development & Research Institutes, Inc	Marshall, BDL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	brandon_marshall@brown.edu	Pouget, Enrique Rodriguez/AAJ-5786-2020; Marshall, Brandon/B-4895-2010; Galea, Sandro/GLR-6066-2022	Pouget, Enrique Rodriguez/0000-0002-5907-1909; Marshall, Brandon/0000-0002-0134-7052; Friedman, Sam/0000-0003-2083-1226; Galea, Sandro/0000-0002-7534-0945; Tempalski, Barbara/0000-0002-6128-2510	National Institutes of Health [R01-DA013336]; Canadian Institutes of Health Research; National Science Foundation [0840889]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project is funded by the National Institutes of Health (R01-DA013336, http://www.nih.gov/) as part of the Community Vulnerability and Responses to Drug-User Related HIV/AIDS (CVAR) study. Brandon Marshall is supported by a Postdoctoral Fellowship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). Lars Seemann is supported by the National Science Foundation (Award Number 0840889, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon J, 2006, AIDS BEHAV, V10, P707, DOI 10.1007/s10461-006-9082-x; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Anderson JE, 2000, AM J PUBLIC HEALTH, V90, P1089, DOI 10.2105/AJPH.90.7.1089; [Anonymous], 2007, PREV HIV INF INJ DRU; Aral SO, 2010, SEX TRANSM INFECT, V86, P1, DOI 10.1136/sti.2010.047373; Arasteh K, 2008, DRUG ALCOHOL DEPEN, V95, P54, DOI 10.1016/j.drugalcdep.2007.12.008; Arroyo J, 2010, COMPUT MATH ORGAN TH, V16, P416, DOI 10.1007/s10588-010-9078-y; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bagni R, 2002, JASSS-J ARTIF SOC S, V5; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bell AV, 2006, AM J PUBLIC HEALTH, V96, P1066, DOI 10.2105/AJPH.2004.061077; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Booth RE, 1996, DRUG ALCOHOL DEPEN, V42, P11, DOI 10.1016/0376-8716(96)01257-4; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Brown LS, 1996, J NATL MED ASSOC, V88, P37; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P916; Cioffi-Revilla C, 2002, P NATL ACAD SCI USA, V99, P7314, DOI 10.1073/pnas.082081499; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen J, 2011, SCIENCE, V334, P1338, DOI 10.1126/science.334.6061.1338; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; DeGruttola V, 2010, CLIN INFECT DIS, V50, pS102, DOI 10.1086/651480; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P1112; Des Jarlais DC, 2007, SEX TRANSM DIS, V34, P923, DOI 10.1097/OLQ.0b013e3180ca9647; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Des Jarlais DC, 2011, SUBST USE MISUSE, V46, P131, DOI 10.3109/10826084.2011.521456; Des Jarlais DC, 2010, SEX TRANSM DIS, V37, P637, DOI 10.1097/OLQ.0b013e3181e1a64a; Des Jarlais DC, 2010, DRUG ALCOHOL DEPEN, V109, P154, DOI 10.1016/j.drugalcdep.2009.12.028; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Foster J, 2005, CAMB J ECON, V29, P873, DOI 10.1093/cje/bei083; Friedman S. R., 2010, SOCIAL NETWORKS DRUG; Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7; Friedman SR, 2009, INT J DRUG POLICY, V20, P283, DOI 10.1016/j.drugpo.2008.10.006; FRIEDMAN SR, 1994, AIDS, V8, P357, DOI 10.1097/00002030-199403000-00010; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Fuller CM, 2002, DRUG ALCOHOL DEPEN, V66, P189, DOI 10.1016/S0376-8716(01)00200-9; Galea S, 2006, J ADDICT DIS, V25, P79, DOI 10.1300/J069v25n03_10; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005; Gibson DR, 2001, AIDS, V15, P1329, DOI 10.1097/00002030-200107270-00002; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorman DM, 2006, AM J PUBLIC HEALTH, V96, P2055, DOI 10.2105/AJPH.2005.063289; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Halkitis PN, 2007, ADDICTION, V102, P76, DOI 10.1111/j.1360-0443.2007.01769.x; Halperin DT, 2009, LANCET, V373, P544, DOI 10.1016/S0140-6736(09)60200-2; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Heidari S, 2011, J INT AIDS SOC, V14, DOI [10.1186/1758-2652-14-11, 10.1186/1758-2652-14-S2-S1]; Heimer R, 1998, J SUBST ABUSE TREAT, V15, P183, DOI 10.1016/S0740-5472(97)00220-1; Heimer R, 2007, AM J PUBLIC HEALTH, V97, P110, DOI 10.2105/AJPH.2005.078105; Howard DL, 2006, JAIDS-J ACQ IMM DEF, V42, P325, DOI 10.1097/01.qai.0000214819.88163.22; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; Jarlais DCD, 2008, PSYCHOSOM MED, V70, P606, DOI 10.1097/PSY.0b013e3181772157; Jenness SM, 2010, AIDS PATIENT CARE ST, V24, P175, DOI 10.1089/apc.2009.0227; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Joint United Nations Programme on HIV/AIDS, 2009, JOINT ACT RES UNAIDS; Jones GT, 2007, AM J PUBLIC HEALTH, V97, P780, DOI 10.2105/AJPH.2006.109058; Jose B, 1996, RACIAL ETHNIC VARIAT; Kapadia F, 2005, ADDICTION, V100, P990, DOI 10.1111/j.1360-0443.2005.01098.x; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; KARIM QA, 2010, LOGIC CIRCUITS CARBO, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Khan MR, 2009, JAIDS-J ACQ IMM DEF, V51, P470, DOI 10.1097/QAI.0b013e3181a2810a; Knight KR, 2007, JAIDS-J ACQ IMM DEF, V46, pS80, DOI 10.1097/QAI.0b013e3181576828; Kottiri BJ, 2002, J ACQ IMMUN DEF SYND, V30, P95, DOI 10.1097/00042560-200205010-00013; Kral AH, 1997, J ACQ IMMUN DEF SYND, V16, P211, DOI 10.1097/00042560-199711010-00011; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Kuo I, 2011, DRUG ALCOHOL DEPEN, V117, P139, DOI 10.1016/j.drugalcdep.2011.01.006; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; LEIGH BC, 1993, AM J PUBLIC HEALTH, V83, P1400, DOI 10.2105/AJPH.83.10.1400; LEMP GF, 1995, AM J PUBLIC HEALTH, V85, P1549, DOI 10.2105/AJPH.85.11.1549; Lieb S, 2004, J URBAN HEALTH, V81, P401, DOI 10.1093/jurban/jth126; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Lloyd JJ, 2008, AM J ADDICTION, V17, P414, DOI 10.1080/10550490802268165; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MacQueen Kathleen M, 2011, J Int AIDS Soc, V14 Suppl 2, pS3, DOI 10.1186/1758-2652-14-S2-S3; Maglio PP, 2011, AM J PREV MED, V40, P392, DOI 10.1016/j.amepre.2010.11.010; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marshall BDL, 2009, SEX TRANSM INFECT, V85, P121, DOI 10.1136/sti.2008.032524; Marshall BDL, 2007, JAIDS-J ACQ IMM DEF, V46, P248, DOI 10.1097/QAI.0b013e31814a5533; Maslow CB, 2002, AM J PUBLIC HEALTH, V92, P382, DOI 10.2105/AJPH.92.3.382; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Miller M, 2002, AIDS CARE, V14, P801, DOI 10.1080/0954012021000031877; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Molitor F, 1998, WESTERN J MED, V168, P93; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore D, 2009, ADDICTION, V104, P1991, DOI 10.1111/j.1360-0443.2009.02709.x; Morris John D, 2007, AIDS Res Ther, V4, P12, DOI 10.1186/1742-6405-4-12; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; MOSS AR, 1989, AIDS, V3, P55, DOI 10.1097/00002030-198902000-00001; Nagoski E, 2012, ARCH SEX BEHAV, V41, P849, DOI 10.1007/s10508-011-9867-5; New York State Department of Health, 1994, HIV INF NEW YORK STA; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Ompad DC, 2011, SUBST USE MISUSE, V46, P274, DOI 10.3109/10826084.2011.523284; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Potterat JJ, 2002, SEX TRANSM INFECT, V78, pI159, DOI 10.1136/sti.78.suppl_1.i159; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2003, J URBAN HEALTH, V80, P302, DOI 10.1093/jurban/jtg033; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; SELL RL, 1995, ARCH SEX BEHAV, V24, P235, DOI 10.1007/BF01541598; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Sherman SG, 2001, DRUG ALCOHOL DEPEN, V64, P97, DOI 10.1016/S0376-8716(00)00236-2; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Strathdee SA, 1999, J URBAN HEALTH, V76, P448, DOI 10.1007/BF02351502; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Substance Abuse and Mental Health Services Administration, 2010, NAT PREV EST TOP 20; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; vanHaastrecht HJA, 1996, AM J EPIDEMIOL, V143, P380; VANICHSENI S, 1993, AIDS, V7, P887, DOI 10.1097/00002030-199306000-00020; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; WATKINS KE, 1992, AM J DRUG ALCOHOL AB, V18, P389, DOI 10.3109/00952999209051037; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Windrum P, 2007, JASSS-J ARTIF SOC S, V10; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; Wood E, 2003, CAN MED ASSOC J, V169, P656; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Yang Y, 2011, AM J PREV MED, V40, P353, DOI 10.1016/j.amepre.2010.11.017; Young RM, 2000, J DRUG ISSUES, V30, P499, DOI 10.1177/002204260003000302; Zaccarelli M, 2002, AIDS PATIENT CARE ST, V16, P67, DOI 10.1089/10872910252806117; ZACCARELLI M, 1994, AIDS, V8, P345, DOI 10.1097/00002030-199403000-00008; Zanette D, 2008, J BIOL PHYS, V34, P135, DOI 10.1007/s10867-008-9060-9; Zule WA, 2000, AM J DRUG ALCOHOL AB, V26, P247, DOI 10.1081/ADA-100100603	179	32	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44833	10.1371/journal.pone.0044833	http://dx.doi.org/10.1371/journal.pone.0044833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028637	Green Published, Green Submitted, gold			2022-12-25	WOS:000308788700043
J	Guo, ZL; Liu, S; Hu, SM; Li, T; Huang, YS; Liu, GX; Zhang, H; Lin, SJ				Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao; Huang, Yousong; Liu, Guangxing; Zhang, Huan; Lin, Senjie			Prevalent Ciliate Symbiosis on Copepods: High Genetic Diversity and Wide Distribution Detected Using Small Subunit Ribosomal RNA Gene	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; PFIESTERIA-PISCICIDA; PROTOZOAN EPIBIONTS; PLANKTONIC COPEPODS; EUPHAUSIACEA; PERITRICHIA; ZOOPLANKTON; CRUSTACEANS; CILIOPHORA; PHYLOGENY	Toward understanding the genetic diversity and distribution of copepod-associated symbiotic ciliates and the evolutionary relationships with their hosts in the marine environment, we developed a small subunit ribosomal RNA gene (18S rDNA)based molecular method and investigated the genetic diversity and genotype distribution of the symbiotic ciliates on copepods. Of the 10 copepod species representing six families collected from six locations of Pacific and Atlantic Oceans, 9 were found to harbor ciliate symbionts. Phylogenetic analysis of the 391 ciliate 18S rDNA sequences obtained revealed seven groups (ribogroups), six (containing 99% of all the sequences) belonging to subclass Apostomatida, the other clustered with peritrich ciliate Vorticella gracilis. Among the Apostomatida groups, Group III were essentially identical to Vampyrophrya pelagica, and the other five groups represented the undocumented ciliates that were close to Vampyrophrya/Gymnodinioides/Hyalophysa. Group VI ciliates were found in all copepod species but one (Calanus sinicus), and were most abundant among all ciliate sequences obtained, indicating that they are the dominant symbiotic ciliates universally associated with copepods. In contrast, some ciliate sequences were found only in some of the copepods examined, suggesting the host selectivity and geographic differentiation of ciliates, which requires further verification by more extensive sampling. Our results reveal the wide occurrence and high genetic diversity of symbiotic ciliates on marine copepods and highlight the need to systematically investigate the host- and geography-based genetic differentiation and ecological roles of these ciliates globally.	[Guo, Zhiling; Liu, Sheng; Hu, Simin; Li, Tao] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Guo, Zhiling; Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Lin, Senjie] Xiamen Univ, Marine Biodivers & Global Change Lab, Xiamen, Fujian, Peoples R China; [Huang, Yousong; Liu, Guangxing; Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; University of Connecticut; Xiamen University; Ocean University of China	Guo, ZL (corresponding author), Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015; Guo, chentao/G-7320-2016	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Lei, Xu/0000-0003-2271-1287; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X	Key Topics in Innovation Engineering [KZCX2-YW-JS206]; National Science Foundation of China-Overseas Collaboration Fund [41129001, 40828006]; National Science Foundation of China [41076085, 41006067, 41076096, U1033003]; National Science Foundation grant [EF-0629624]	Key Topics in Innovation Engineering; National Science Foundation of China-Overseas Collaboration Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation grant(National Science Foundation (NSF))	The study was supported by Key Topics in Innovation Engineering (No. KZCX2-YW-JS206) (http://www.cas.cn/), National Science Foundation of China-Overseas Collaboration Fund (41129001, 40828006) (http://www.nsfc.gov.cn/), the National Science Foundation of China (41076085, 41006067, 41076096, U1033003) (http://www.nsfc.gov.cn/), and National Science Foundation grant EF-0629624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, CALANOIDAVOL, V7, P20; BASSON L, 1991, SYST PARASITOL, V18, P147, DOI 10.1007/BF00017668; Bozkurt A, 2009, CRUSTACEANA, V82, P515, DOI 10.1163/156854009X407687; BRADBURY PC, 1973, J PROTOZOOL, V20, P210, DOI 10.1111/j.1550-7408.1973.tb00865.x; Bradbury Phyllis C., 1994, P139; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Chatton E., 1935, Archives de Zoologie Experimentale et Generale Paris, V77, P1; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Clamp John C., 2008, Denisia, V23, P395; Doherty M, 2010, APPL ENVIRON MICROB, V76, P3924, DOI 10.1128/AEM.01604-09; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P643, DOI 10.1163/156854000504705; Fernandez-Leborans G, 2000, CRUSTACEANA, V73, P1205, DOI 10.1163/156854000505209; Fernandez-Leborans G, 2006, J NAT HIST, V40, P1983, DOI 10.1080/00222930601010861; Gerber R. P, 2000, IDENTIFICATION MAN 1; Gerber RP, 2000, IDENTIFICATION MAN 2; Gomez-Gutierrez J, 2010, DIS AQUAT ORGAN, V88, P249, DOI 10.3354/dao02155; GRIMES BH, 1992, J PROTOZOOL, V39, P65, DOI 10.1111/j.1550-7408.1992.tb01285.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENEBRY MS, 1979, T AM MICROSC SOC, V98, P495, DOI 10.2307/3225899; HOCKIN DC, 1984, CRUSTACEANA, V46, P319, DOI 10.1163/156854084X00261; Ismar SMH, 2008, MAR BIOL, V154, P335, DOI 10.1007/s00227-008-0928-9; Jayasree L, 2001, J NAT HIST, V35, P157, DOI 10.1080/00222930150215297; Landers SC, 2010, EUR J PROTISTOL, V46, P171, DOI 10.1016/j.ejop.2010.03.001; Lin SJ, 2006, J PLANKTON RES, V28, P667, DOI 10.1093/plankt/fbi150; LINDLEY JA, 1978, MAR BIOL, V46, P131, DOI 10.1007/BF00391528; Liu Sheng, 2010, Acta Ecologica Sinica, V30, P22; Lynn D.H., 2008, CIL PROT CHAR CLASS; Lynn DH, 2005, J EUKARYOT MICROBIOL, V52, p7S; Morado J. Frank, 1995, Reviews in Fisheries Science, V3, P275; NAGASAWA S, 1988, HYDROBIOLOGIA, V167, P255, DOI 10.1007/BF00026312; Ohtsuka S, 2004, MAR ECOL PROG SER, V282, P129, DOI 10.3354/meps282129; Ohtsuka Susumu, 2011, V15, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Qiu DJ, 2010, APPL ENVIRON MICROB, V76, P5639, DOI 10.1128/AEM.03009-09; Regali-Seleghim MH, 2004, J PLANKTON RES, V26, P501, DOI 10.1093/plankt/fbh055; Silva-Briano M, 2011, J LIMNOL, V70, P329, DOI 10.4081/jlimnol.2011.329; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner JT, 2004, ZOOL STUD, V43, P255; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; VALBONESI A, 1988, B ZOOL, V55, P179; Visse Marko, 2007, Proceedings of the Estonian Academy of Sciences Biology Ecology, V56, P173; Wahl M, 1997, HYDROBIOLOGIA, V355, P49, DOI 10.1023/A:1003054802699; Walkusz W, 2007, OCEANOLOGIA, V49, P369; WEISSMAN P, 1993, LIMNOL OCEANOGR, V38, P613, DOI 10.4319/lo.1993.38.3.0613; XU ZK, 1991, HYDROBIOLOGIA, V209, P183, DOI 10.1007/BF00015341; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	50	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e44847	10.1371/journal.pone.0044847	http://dx.doi.org/10.1371/journal.pone.0044847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	22242146	Green Submitted, gold, Green Published			2022-12-25	WOS:000308860100026
J	Luo, C; Qiu, C; Guo, ZW; Fang, JJ; Li, QF; Lei, X; Xia, Y; Lai, YX; Gong, QY; Zhou, D; Yao, DZ				Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Fang, Jiajia; Li, Qifu; Lei, Xu; Xia, Yang; Lai, Yongxiu; Gong, Qiyong; Zhou, Dong; Yao, Dezhong			Disrupted Functional Brain Connectivity in Partial Epilepsy: A Resting-State fMRI Study	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INDEPENDENT COMPONENT ANALYSIS; ALZHEIMERS-DISEASE; DEFAULT NETWORK; SPONTANEOUS FLUCTUATIONS; CINGULATE CORTEX; BOLD SIGNAL; MRI; SCHIZOPHRENIA; ATTENTION	Examining the spontaneous activity to understand the neural mechanism of brain disorder is a focus in recent resting-state fMRI. In the current study, to investigate the alteration of brain functional connectivity in partial epilepsy in a systematical way, two levels of analyses (functional connectivity analysis within resting state networks (RSNs) and functional network connectivity (FNC) analysis) were carried out on resting-state fMRI data acquired from the 30 participants including 14 healthy controls(HC) and 16 partial epilepsy patients. According to the etiology, all patients are subdivided into temporal lobe epilepsy group (TLE, included 7 patients) and mixed partial epilepsy group (MPE, 9 patients). Using group independent component analysis, eight RSNs were identified, and selected to evaluate functional connectivity and FNC between groups. Compared with the controls, decreased functional connectivity within all RSNs was found in both TLE and MPE. However, dissociating patterns were observed within the 8 RSNs between two patient groups, i.e, compared with TLE, we found decreased functional connectivity in 5 RSNs increased functional connectivity in 1 RSN, and no difference in the other 2 RSNs in MPE. Furthermore, the hierarchical disconnections of FNC was found in two patient groups, in which the intra-system connections were preserved for all three subsystems while the lost connections were confined to intersystem connections in patients with partial epilepsy. These findings may suggest that decreased resting state functional connectivity and disconnection of FNC are two remarkable characteristics of partial epilepsy. The selective impairment of FNC implicated that it is unsuitable to understand the partial epilepsy only from global or local perspective. We presumed that studying epilepsy in the multi-perspective based on RSNs may be a valuable means to assess the functional changes corresponding to specific RSN and may contribute to the understanding of the neuro-pathophysiological mechanism of epilepsy.	[Luo, Cheng; Qiu, Chuan; Guo, Zhiwei; Lei, Xu; Xia, Yang; Lai, Yongxiu; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Fang, Jiajia; Li, Qifu; Zhou, Dong] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Li, Qifu] Hainan Med Coll, Affiliated Hosp, Dept Neurol, Haikou, Peoples R China; [Lei, Xu] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Gong, Qiyong] Sichuan Univ, W China Hosp, Dept Radiol, HMRRC, Chengdu 610064, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; Hainan Medical University; Southwest University - China; Sichuan University	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	zhoudong66@yahoo.de; dyao@uestc.edu.cn	Lin, Senjie/A-7466-2011; zhang, yaqun/J-8478-2014; Guo, Zhiling/AAJ-6843-2020; Gong, Qiyong/W-3052-2019; Luo, Cheng/A-4647-2015; Guo, chentao/G-7320-2016	Guo, Zhiling/0000-0001-9549-2164; Gong, Qiyong/0000-0002-5912-4871; Luo, Cheng/0000-0003-0524-5886; Lei, Xu/0000-0003-2271-1287; Yao, Dezhong/0000-0002-8042-879X; Li, Qifu/0000-0003-3904-410X	973 project [2011CB707803]; National Nature Science Foundation of China [30870655, 81071222, 60736029, 81160166, 81100974]; 863 Project [2009AA02Z301]; PCSIRT project; project of Hainan Provincial Department of Health [Qiongwei 2009-52]	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); PCSIRT project(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); project of Hainan Provincial Department of Health	This project was funded by grants from the 973 project 2011CB707803, the National Nature Science Foundation of China #30870655, #81071222, #60736029, #81160166, #81100974, the 863 Project #2009AA02Z301, the PCSIRT project, the project of Hainan Provincial Department of Health (Qiongwei 2009-52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benbadis SR, 2001, NEUROL CLIN, V19, P251, DOI 10.1016/S0733-8619(05)70018-9; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Calhoun VD, 2004, BIOL PSYCHIAT, V55, P842, DOI 10.1016/j.biopsych.2004.01.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Frings L, 2009, J NEUROL, V256, P2021, DOI 10.1007/s00415-009-5233-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Laufs H, 2007, CURR OPIN NEUROL, V20, P417, DOI 10.1097/WCO.0b013e3282202b92; Lei X, 2011, HUM BRAIN MAPP, V32, P1141, DOI 10.1002/hbm.21098; Lei X, 2010, NEUROIMAGE, V52, P1123, DOI 10.1016/j.neuroimage.2010.01.024; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Masterton RAJ, 2010, NEUROIMAGE, V51, P252, DOI 10.1016/j.neuroimage.2010.01.109; Medvedev A. V., 2001, Australasian Physical and Engineering Sciences in Medicine, V24, P37, DOI 10.1007/BF03178284; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Pavlou E, 2011, CHILD NERV SYST, V27, P373, DOI 10.1007/s00381-010-1321-9; Qiao PF, 2011, BRAIN DEV IN PRESS; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wieser HG, 2004, EPILEPSIA, V45, P32; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	71	105	106	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2012	7	1							e28196	10.1371/journal.pone.0028196	http://dx.doi.org/10.1371/journal.pone.0028196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	058VE	22242146	Green Published, Green Submitted, gold			2022-12-25	WOS:000312662100002
J	Palavesam, A; Guerrero, FD; Heekin, AM; Wang, J; Dowd, SE; Sun, Y; Foil, LD; de Leon, AAP				Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; Dowd, Scot E.; Sun, Yan; Foil, Lane D.; de Leon, Adalberto A. Perez			Pyrosequencing-Based Analysis of the Microbiome Associated with the Horn Fly, Haematobia irritans	PLOS ONE			English	Article							BACTERIAL DIVERSITY; STAPHYLOCOCCUS-SAPROPHYTICUS; WOLBACHIA INFECTION; BITING FLIES; L DIPTERA; DNA; EXPRESSION; MUSCIDAE; TRACT; PARATRANSGENESIS	The horn fly, Haematobia irritans, is one of the most economically important pests of cattle. Insecticides have been a major element of horn fly management programs. Growing concerns with insecticide resistance, insecticide residues on farm products, and non-availability of new generation insecticides, are serious issues for the livestock industry. Alternative horn fly control methods offer the promise to decrease the use of insecticides and reduce the amount of insecticide residues on livestock products and give an impetus to the organic livestock farming segment. The horn fly, an obligatory blood feeder, requires the help of microflora to supply additional nutrients and metabolize the blood meal. Recent advancements in DNA sequencing methodologies enable researchers to examine the microflora diversity independent of culture methods. We used the bacterial 16S tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) method to carry out the classification analysis of bacterial flora in adult female and male horn flies and horn fly eggs. The bTEFAP method identified 16S rDNA sequences in our samples which allowed the identification of various prokaryotic taxa associated with the life stage examined. This is the first comprehensive report of bacterial flora associated with the horn fly using a culture-independent method. Several rumen, environmental, symbiotic and pathogenic bacteria associated with the horn fly were identified and quantified. This is the first report of the presence of Wolbachia in horn flies of USA origin and is the first report of the presence of Rikenella in an obligatory blood feeding insect.	[Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; de Leon, Adalberto A. Perez] ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA; [Palavesam, Azhahianambi] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Sun, Yan] Res & Testing Lab, Lubbock, TX USA; [Foil, Lane D.] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Palavesam, Azhahianambi] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Louisiana State University System; Louisiana State University; Tamil Nadu Veterinary & Animal Sciences University	Palavesam, A (corresponding author), ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA.	nambibio@gmail.com	Palavesam, Azhahianambi/H-3307-2019; Dowd, Scot E/M-5386-2017; Palavesam, Azhahianambi/K-7606-2015; Garcia-Vallve, Santiago/A-4226-2008; Pujadas, Gerard/B-1457-2010; Arola, Lluis/C-6074-2011; Muguerza, Begona/C-6704-2015	Palavesam, Azhahianambi/0000-0002-7108-6767; Dowd, Scot E/0000-0002-6296-1427; Palavesam, Azhahianambi/0000-0002-7108-6767; Quinones, Mar/0000-0003-0180-2147; Garcia-Vallve, Santiago/0000-0002-0348-7497; Pujadas, Gerard/0000-0003-2598-8089; Arola, Lluis/0000-0003-2767-1974; Muguerza, Begona/0000-0001-7384-8588	U.S. Department of Agriculture APHIS-IS [34-WT-10-5000-1992-IA]; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund [58-6205-0-038]; Agricultural Research Service	U.S. Department of Agriculture APHIS-IS; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank the U.S. Department of Agriculture APHIS-IS for support provided to this study through the cooperative agreement 34-WT-10-5000-1992-IA with the University of Maryland and U.S. Department of Agriculture-APHIS Cooperative Agreement Fund 58-6205-0-038 with the Agricultural Research Service. This article reports the results of research only. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation of endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2008, VET MICROBIOL, V127, P203, DOI 10.1016/j.vetmic.2007.08.006; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ai H, 2008, CARBOHYD POLYM, V72, P419, DOI 10.1016/j.carbpol.2007.09.010; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bomar L, 2011, MBIO, V2, DOI 10.1128/mBio.00012-11; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRUCE W. G., 1938, JOUR KANSAS ENT SOC, V11, P88; BYFORD RL, 1992, J ANIM SCI, V70, P597, DOI 10.2527/1992.702597x; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANO RJ, 1994, APPL ENVIRON MICROB, V60, P2164, DOI 10.1128/AEM.60.6.2164-2167.1994; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cupp EW, 1998, J MED ENTOMOL, V35, P591, DOI 10.1093/jmedent/35.4.591; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dugas JE, 2001, ARCH MICROBIOL, V175, P259, DOI 10.1007/s002030000243; Durvasula RV, 1999, MED VET ENTOMOL, V13, P115, DOI 10.1046/j.1365-2915.1999.00175.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Floate KD, 2006, BIOCONTROL SCI TECHN, V16, P767, DOI 10.1080/09583150600699606; FOIL LD, 1994, REV SCI TECH OIE, V13, P1125, DOI 10.20506/rst.13.4.821; FRANKEL H, 1978, BRIT J HIST SCI, V11, P130, DOI 10.1017/S0007087400016551; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; GARGALLO D, 1987, APPL ENVIRON MICROB, V53, P1983, DOI 10.1128/AEM.53.8.1983-1986.1987; GARGALLOVIOLA D, 1989, J CLIN MICROBIOL, V27, P860, DOI 10.1128/JCM.27.5.860-868.1989; Gilbert DG, 1989, IUBIO ARCH MOL GEN B; Gillespie BE, 1999, J DAIRY SCI, V82, P1581, DOI 10.3168/jds.S0022-0302(99)75386-5; Glaser RW, 1923, AM J HYG, V3, P469, DOI 10.1093/oxfordjournals.aje.a118948; Grisi L., 2002, A Hora Veterinaria, V21, P8; Hammer O., 1941, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V105, P141; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HEDMAN P, 1990, J INFECTION, V21, P11, DOI 10.1016/0163-4453(90)90554-L; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hornok S, 2008, VET PARASITOL, V154, P354, DOI 10.1016/j.vetpar.2008.03.019; HOVELIUS B, 1984, REV INFECT DIS, V6, P328; Jaklic D, 2008, J MED MICROBIOL, V57, P617, DOI 10.1099/jmm.0.47515-0; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; JUKES T H, 1969, P21; Kunz S. E., 1991, CRC HDB PEST MANAGEM, P68; Leite RC, 1998, MEM I OSWALDO CRUZ, V93, P761, DOI 10.1590/S0074-02761998000600012; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; LYSYK TJ, 1991, CAN ENTOMOL, V123, P1199, DOI 10.4039/Ent1231199-6; Maillard R, 2007, EMERG INFECT DIS, V13, P1383, DOI 10.3201/eid1309.070236; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Owens WE, 1998, AM J VET RES, V59, P1122; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perotti MA, 2001, J MED ENTOMOL, V38, P180, DOI 10.1603/0022-2585-38.2.180; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Rodriguez SD, 2009, INFECT GENET EVOL, V9, P1092, DOI 10.1016/j.meegid.2009.09.007; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; STEINHAUS EA, 1960, BACTERIOL REV, V24, P365, DOI 10.1128/MMBR.24.4.365-373.1960; STIRRAT JH, 1955, J PARASITOL, V41, P398, DOI 10.2307/3274240; Torres L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-105; Velasco R., 2001, INF AGROPECU BIOLECH, V14, P4; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Watrelot-Virieux D, 2006, J VET MED B, V53, P150, DOI 10.1111/j.1439-0450.2006.00923.x; Weiss BL, 2006, APPL ENVIRON MICROB, V72, P7013, DOI 10.1128/AEM.01507-06; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Yanti S. D., 2009, Asian Journal of Food and Agro-Industry, V2, pS241; Zhang B, 2009, VET PARASITOL, V162, P350, DOI 10.1016/j.vetpar.2009.03.012; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	80	98	101	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44390	10.1371/journal.pone.0044390	http://dx.doi.org/10.1371/journal.pone.0044390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23185345	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700011
J	Li, CY; Zhang, XT; Cao, RL; Yu, BH; Liang, HS; Zhou, M; Li, DY; Wang, YH; Liu, EZ				Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Yu, Bohai; Liang, Hongsheng; Zhou, Min; Li, Dayong; Wang, Yuehua; Liu, Enzhong			Allografts of the Acellular Sciatic Nerve and Brain-Derived Neurotrophic Factor Repair Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							SUPERIOR COLLICULUS; CHEMICAL-EXTRACTION; REGENERATION; GRAFTS; CELLS; MOTOR; TRANSECTION; IMPROVEMENT; SCAFFOLDS; MEMBRANE	Objective: We aimed to investigate whether an innovative growth factor-laden scaffold composed of acellular sciatic nerve (ASN) and brain-derived neurotrophic factor (BDNF) could promote axonal regeneration and functional recovery after spinal cord injury (SCI). Methods: Following complete transection at the thoracic level (T9), we immediately transplanted the grafts between the stumps of the severed spinal cords. We evaluated the functional recovery of the hindlimbs of the operated rats using the BBB locomotor rating scale system every week. Eight weeks after surgery, axonal regeneration was examined using the fluorogold (FG) retrograde tracing method. Electrophysiological analysis was carried out to evaluate the improvement in the neuronal circuits. Immunohistochemistry was employed to identify local injuries and recovery. Results: The results of the Basso-Beattie-Bresnahan (BBB) scale indicated that there was no significant difference between the individual groups. The FG retrograde tracing and electrophysiological analyses indicated that the transplantation of ASN-BDNF provided a permissive environment to support neuron regeneration. Conclusion: The ASN-BDNF transplantation provided a promising therapeutic approach to promote axonal regeneration and recovery after SCI, and can be used as part of a combinatory treatment strategy for SCI management.	[Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Liang, Hongsheng; Wang, Yuehua; Liu, Enzhong] Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China; [Yu, Bohai] Harbin Med Univ, Dept Microbiol, Immun & Infect Pathogen Biol Key Lab, Harbin, Heilongjiang Pr, Peoples R China; [Zhou, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Dayong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, CY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China.	enzhongliu@163.com			HeiLongJiang Province Sanitation Department Scientific Research Topic [2010-027]; Science Foundation of the China Postdoctor [2011M500687]	HeiLongJiang Province Sanitation Department Scientific Research Topic; Science Foundation of the China Postdoctor	This work was supported by HeiLongJiang Province Sanitation Department Scientific Research Topic (2010-027), and the Science Foundation of the China Postdoctor (2011M500687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CARTER DA, 1989, J NEUROSCI, V9, P4042; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Cote MP, 2011, NEUROTHERAPEUTICS, V8, P294, DOI 10.1007/s13311-011-0024-6; Cote MP, 2010, EXP NEUROL, V225, P173, DOI 10.1016/j.expneurol.2010.06.011; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Lee YS, 2010, EXP NEUROL, V224, P429, DOI 10.1016/j.expneurol.2010.05.003; Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197; Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5; Nordblom J, 2009, RESTOR NEUROL NEUROS, V27, P285, DOI 10.3233/RNN-2009-0478; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Sieck GC, 2009, RESP PHYSIOL NEUROBI, V169, P218, DOI 10.1016/j.resp.2009.08.008; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029; Zhong HB, 2007, J RECONSTR MICROSURG, V23, P479, DOI 10.1055/s-2007-992340	23	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42813	10.1371/journal.pone.0042813	http://dx.doi.org/10.1371/journal.pone.0042813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	23028587	gold, Green Published, Green Submitted			2022-12-25	WOS:000308213600008
J	Strode, C; de Melo-Santos, M; Magalhaes, T; Araujo, A; Ayres, C				Strode, Clare; de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia			Expression Profile of Genes during Resistance Reversal in a Temephos Selected Strain of the Dengue Vector, Aedes aegypti	PLOS ONE			English	Article							INSECTICIDE-RESISTANCE; ANOPHELES-GAMBIAE; DETOXIFICATION GENES; CULEX-QUINQUEFASCIATUS; LARVAL TOLERANCE; FIELD-EVALUATION; MALARIA VECTORS; MOSQUITO; CULICIDAE; DIPTERA	Background: The mosquito Aedes aegypti is one of the most important disease vectors because it transmits two major arboviruses, dengue and yellow fever, which cause significant global morbidity and mortality. Chemical insecticides form the cornerstone of vector control. The organophosphate temephos a larvicide recommended by WHO for controlling Ae. aegypti, however, resistance to this compound has been reported in many countries, including Brazil. Methodology/Principal Findings: The aim of this study was to identify genes implicated in metabolic resistance in an Ae. aegypti temephos resistant strain, named RecR, through microarray analysis. We utilized a custom 'Ae. aegypti detox chip' and validated microarray data through RT-PCR comparing susceptible and resistant individuals. In addition, we analyzed gene expression in 4th instar larvae from a reversed susceptible strain (RecRev), exposed and unexposed to temephos. The results obtained revealed a set of 13 and 6 genes significantly over expressed in resistant adult mosquitoes and larvae, respectively. One of these genes, the cytochrome P450 CYP6N12, was up-regulated in both stages. RT-PCR confirmed the microarray results and, additionally, showed no difference in gene expression between temephos exposed and unexposed RecRev mosquitoes. This suggested that the differences in the transcript profiles among the strains are heritable due to a selection process and are not caused by immediate insecticide exposure. Reversal of temephos resistance was demonstrated and, importantly, there was a positive correlation between a decrease in the resistance ratio and an accompanying decrease in the expression levels of previously over expressed genes. Some of the genes identified here have also been implicated in metabolic resistance in other mosquito species and insecticide resistant populations of Ae. aegypti. Conclusions/Significance: The identification of gene expression signatures associated to insecticide resistance and their suppression could greatly aid the development of improved strategies of vector control.	[Strode, Clare] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [de Melo-Santos, Maria; Magalhaes, Tereza; Araujo, Ana; Ayres, Contancia] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, Dept Entomol, Recife, PE, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Strode, C (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	c.strode@liv.ac.uk	Magalhaes, Tereza/V-6632-2019; Ball, Becky/E-6573-2011; Magalhaes, Catarina/A-6836-2016	Strode, Clare/0000-0003-2833-8073; Cary, Stephen/0000-0002-2876-2387; Ball, Becky/0000-0001-8592-1316; Magalhaes, Catarina/0000-0001-9576-2398; Ruprecht, Ulrike/0000-0002-0898-7677	National Council for Scientific and Technological Development 384 (CNPq Pronex grant) [550116/2010-9]; Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE) [APQ 1361-4.00/08]	National Council for Scientific and Technological Development 384 (CNPq Pronex grant); Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE)	This work was funded by National Council for Scientific and Technological Development 384 (CNPq Pronex grant 550116/2010-9) and Fundacao de Amparo a Ciencia e Tecnologia do 385 Estado de Pernambuco (FACEPE, Grant ID: APQ 1361-4.00/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Boyer S, 2006, ENVIRON TOXICOL CHEM, V25, P470, DOI 10.1897/05-267R2.1; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Lan Q., 1992, Insect Molecular Biology, V1, P71, DOI 10.1111/j.1365-2583.1993.tb00107.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu N, 1996, BIOCHEM GENET, V34, P133, DOI 10.1007/BF02396246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020; Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Peixoto CA, 2008, PARASITOL RES, V103, P717, DOI 10.1007/s00436-008-1020-6; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Raghavendra K, 2011, ACTA TROP, V118, P50, DOI 10.1016/j.actatropica.2011.02.001; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Raghavendra K, 2010, INDIAN J MED RES, V132, P260; Raghavendra K, 2010, PARASITOL RES, V107, P1291, DOI 10.1007/s00436-010-2001-0; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Saude Md, 2006, QUANTIFICATION METHO, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang JF, 1998, J MED ENTOMOL, V35, P716, DOI 10.1093/jmedent/35.5.716; WHO, 2021, DENGUE DENGUE HAEMOR; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	43	57	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2012	7	8							e39439	10.1371/journal.pone.0039439	http://dx.doi.org/10.1371/journal.pone.0039439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	984SU	23028563	Green Published, Green Accepted, gold			2022-12-25	WOS:000307212800002
J	Wang, W; Ao, L; Rayburn, ER; Xu, HX; Zhang, XR; Zhang, X; Nag, SA; Wu, XM; Wang, MH; Wang, H; Van Meir, EG; Zhang, R				Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Wang, Ming-Hai; Wang, Hui; Van Meir, Erwin G.; Zhang, Ruiwen			KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PRIVILEGED STRUCTURES; HIF-1 INHIBITORS; TUMOR HYPOXIA; HIF-1-ALPHA; PATHWAY; BIOLOGY; IDENTIFICATION; ANGIOGENESIS; CHECKPOINTS	The purpose of the present study was to determine the in vitro and in vivo anti-cancer activity and pharmacological properties of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1. In the present study, we investigated the in vitro activity of KCN1 on cell proliferation and cell cycle distribution of pancreatic cancer cells, using the MTT and BrdUrd assays, and flow cytometry. The in vivo anti-cancer effects of KCN1 were evaluated in two distinct xenograft models of pancreatic cancer. We also developed an HPLC method for the quantitation of the compound, and examined its stability in mouse plasma, plasma protein binding, and degradation by mouse S9 microsomal enzymes. Furthermore, we examined the pharmacokinetics of KCN1 following intravenous or intraperitoneal injection in mice. Results showed that, in a dose-dependent manner, KCN1 inhibited cell growth and induced cell cycle arrest in human pancreatic cancer cells in vitro, and showed in vivo anticancer efficacy in mice bearing Panc-1 or Mia Paca-2 tumor xenografts. The HPLC method provided linear detection of KCN1 in all of the matrices in the range from 0.1 to 100 mu M, and had a lower limit of detection of 0.085 mu M in mouse plasma. KCN1 was very stable in mouse plasma, extensively plasma bound, and metabolized by S9 microsomal enzymes. The pharmacokinetic studies indicated that KCN1 could be detected in all of the tissues examined, most for at least 24 h. In conclusion, our preclinical data indicate that KCN1 is a potential therapeutic agent for pancreatic cancer, providing a basis for its future development.	[Wang, Wei; Ao, Lin; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Div Clin Pharmacol, Birmingham, AL USA; [Wu, Xuming] Nantong Univ, Nantong Canc Hosp, Nantong, Peoples R China; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Alabama System; University of Alabama Birmingham; Nantong University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Emory University; Emory University; Emory University	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	evanmei@emory.edu; ruiwen.zhang@ttuhsc.edu	Nag, subhasree/T-1505-2019; Xu, Hongxia/AAN-8608-2021	Nag, subhasree/0000-0001-6933-4349; xu, hongxia/0000-0001-5215-734X; Van Meir, Erwin G./0000-0003-2444-7707	National Institutes of Health grant [R01 CA116804, R01 CA91980]; National Institutes of Health [R01 CA112029, R01 CA121211]; EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA091980, R01CA116804, R01CA121211] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project Key New Drug Creation and Manufacturing Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant R01 CA116804 (to EGVM). RZ was also supported by National Institutes of Health grants R01 CA112029 and R01 CA121211. EGVM was also supported by EmTechBio, the University Research Committee of Emory University, the Brain Tumor Foundation for Children, and the V Foundation for Cancer Research. HW was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), National Science and Technology Major Project Key New Drug Creation and Manufacturing Program 2009ZX09102-114, 2009ZX09301-011). MW was supported by National Institutes of Health grant R01 CA91980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, J DRUG TARGET, V5, P303, DOI 10.3109/10611869808995883; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Belozerov VE, 2006, CURR OPIN INVEST DR, V7, P1067; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mooring SR, 2011, J MED CHEM, V54, P8471, DOI 10.1021/jm201018g; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mun J, 2012, J MED CHEM, V55, P6738, DOI 10.1021/jm300752n; Mun JY, 2012, BIOORGAN MED CHEM, V20, P4590, DOI 10.1016/j.bmc.2012.04.064; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9939, DOI 10.1021/ja002033k; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9954, DOI 10.1021/ja002034c; Nojima Hiroshi, 2004, Methods Mol Biol, V280, P3; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pancreatic Cancer. National Cancer Institute, PANCR CANC; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Shi Q, 2012, ACS MED CHEM LETT, V3, P620, DOI 10.1021/ml300042k; Tan C, 2005, CANCER RES, V65, P605; Tan C, 2011, BIOORG MED CHEM LETT, V21, P5528, DOI 10.1016/j.bmcl.2011.06.099; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Tsaioun K, 2009, ATLA-ALTERN LAB ANIM, V37, P47, DOI 10.1177/026119290903701S10; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang JL, 2009, CURR PHARM DESIGN, V15, P2195, DOI 10.2174/138161209788682514; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; Weinmann M, 2004, ONKOLOGIE, V27, P83, DOI 10.1159/000075611; Wilson GD, 2007, FRONT BIOSCI-LANDMRK, V12, P3502, DOI 10.2741/2330; Yin S, 2012, CLIN CANC R IN PRESS; Zhang XR, 2012, MAR DRUGS, V10, P1138, DOI 10.3390/md10051138	46	50	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44883	10.1371/journal.pone.0044883	http://dx.doi.org/10.1371/journal.pone.0044883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028659	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700049
J	Yang, WH; He, KL; Zhang, J; Guo, SY				Yang, Wenhui; He, Kanglai; Zhang, Jie; Guo, Shuyuan			pH-Controlled Bacillus thuringiensis Cry1Ac Protoxin Loading and Release from Polyelectrolyte Microcapsules	PLOS ONE			English	Article							CALCIUM-CARBONATE PARTICLES; LOW-MOLECULAR-WEIGHT; DELTA-ENDOTOXIN; SPODOPTERA-EXIGUA; INSECTICIDAL ACTIVITY; MULTILAYER FILMS; DOMAIN III; TOXICITY; ENCAPSULATION; FORMULATIONS	Crystal proteins synthesized by Bacillus thuringiensis (Bt) have been used as biopesticides because of their toxicity to the insect larval hosts. To protect the proteins from environmental stress to extend their activity, we have developed a new microcapsule formulation. Poly (acrylic acid) (PAH) and poly (styrene sulfonate) (PSS) were fabricated through layer-by-layer self-assembly based on a CaCO3 core. Cry1Ac protoxins were loaded into microcapsules through layer-by-layer self-assembly at low pH, and the encapsulated product was stored in water at 4 degrees C. Scanning electron microscopy (SEM) was used to observe the morphology of the capsules. To confirm the successful encapsulation, the loading results were observed with a confocal laser scattering microscope (CLSM), using fluorescein-labeled Cry1Ac protoxin (FITC-Cry1Ac). The protoxins were released from the capsule under the alkaline condition corresponding to the midgut of certain insects, a condition which seldom exists elsewhere in the environment. The following bioassay experiment demonstrated that the microcapsules with Cry1Ac protoxins displayed approximately equivalent insecticidal activity to the Asian corn borer compared with free Cry1Ac protoxins, and empty capsules proved to have no effect on insects. Further result also indicated that the formulation could keep stable under the condition of heat and desiccation. These results suggest that this formulation provides a promising methodology that protects protoxins from the environment and releases them specifically in the target insects' midgut, which has shown potential as biopesticide in the field.	[Yang, Wenhui; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai; Zhang, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, WH (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn	Yang, Wan/K-7592-2013	Yang, Wan/0000-0002-7555-9728	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Natural Science Foundation of China [31171911]; National High Technology Research and Development Program of China (863 Program) [2011AA10A203]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the grants from the Major State Basic Research Development Program of China (973 Program; No. 2009CB118902), the Natural Science Foundation of China (No. 31171911), and the National High Technology Research and Development Program of China (863 Program; No. 2011AA10A203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov A, 2003, MACROMOL RAPID COMM, V24, P274, DOI 10.1002/marc.200390041; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Cote JC, 2001, PHYTOPROTECTION, V82, P73, DOI 10.7202/706218ar; de Maagd RA, 2000, APPL ENVIRON MICROB, V66, P1559, DOI 10.1128/AEM.66.4.1559-1563.2000; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; DIDYMUS JM, 1993, J CHEM SOC FARADAY T, V89, P2891, DOI 10.1039/ft9938902891; Donath E, 2002, CHEM-EUR J, V8, P5481, DOI 10.1002/1521-3765(20021202)8:23<5481::AID-CHEM5481>3.0.CO;2-8; Gao CY, 2002, ANGEW CHEM INT EDIT, V41, P3789, DOI 10.1002/1521-3773(20021018)41:20<3789::AID-ANIE3789>3.0.CO;2-D; Garcia-Gutierrez K, 2011, BIOPROC BIOSYST ENG, V34, P701, DOI 10.1007/s00449-011-0519-x; Huang DF, 2007, J INVERTEBR PATHOL, V95, P175, DOI 10.1016/j.jip.2007.02.016; IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850, DOI 10.1093/jee/64.4.850; IGNOFFO CM, 1992, FLA ENTOMOL, V75, P516, DOI 10.2307/3496133; Jada A, 2003, COLLOID SURFACE A, V219, P7, DOI 10.1016/S0927-7757(03)00010-4; Jada A, 2000, J MATER SCI LETT, V19, P2077, DOI 10.1023/A:1026737701570; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Lamprecht A, 2000, EUR J PHARM BIOPHARM, V49, P1, DOI 10.1016/S0939-6411(99)00063-6; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Myasnik M, 2001, CURR MICROBIOL, V43, P140, DOI 10.1007/s002840010276; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Rajamohan F, 1996, P NATL ACAD SCI USA, V93, P14338, DOI 10.1073/pnas.93.25.14338; Regev A, 1996, APPL ENVIRON MICROB, V62, P3581, DOI 10.1128/AEM.62.10.3581-3586.1996; Sopena F, 2009, CIENC INVESTIG AGRAR, V36, P27; Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U; Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P219, DOI 10.1603/0022-0493-93.2.219; Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.3.CO;2-P; Tong WJ, 2006, J PHYS CHEM B, V110, P12905, DOI 10.1021/jp055258w; Tong WJ, 2005, J PHYS CHEM B, V109, P13159, DOI 10.1021/jp0511092; Wei W, 2008, ADV MATER, V20, P2292, DOI 10.1002/adma.200702663; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004	35	152	155	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2012	7	9							e45233	10.1371/journal.pone.0045233	http://dx.doi.org/10.1371/journal.pone.0045233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AD	23024810	Green Published, Green Submitted, gold			2022-12-25	WOS:000308860100068
J	Singh, A; Baranwal, V; Shankar, A; Kanwar, P; Ranjan, R; Yadav, S; Pandey, A; Kapoor, S; Pandey, GK				Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.			Rice Phospholipase A Superfamily: Organization, Phylogenetic and Expression Analysis during Abiotic Stresses and Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; PATATIN-RELATED PHOSPHOLIPASES; LIPID ACYL HYDROLASE; GENE FAMILY; SHOOT GRAVITROPISM; PHOSPHATIDIC-ACID; DROUGHT STRESS; GUARD-CELL; REPRODUCTIVE DEVELOPMENT; SIGNAL-TRANSDUCTION	Background: Phospholipase A (PLA) is an important group of enzymes responsible for phospholipid hydrolysis in lipid signaling. PLAs have been implicated in abiotic stress signaling and developmental events in various plants species. Genome-wide analysis of PLA superfamily has been carried out in dicot plant Arabidopsis. A comprehensive genome-wide analysis of PLAs has not been presented yet in crop plant rice. Methodology/Principal Findings: A comprehensive bioinformatics analysis identified a total of 31 PLA encoding genes in the rice genome, which are divided into three classes; phospholipase A(1) (PLA(1)), patatin like phospholipases (pPLA) and low molecular weight secretory phospholipase A(2) (sPLA(2)) based on their sequences and phylogeny. A subset of 10 rice PLAs exhibited chromosomal duplication, emphasizing the role of duplication in the expansion of this gene family in rice. Microarray expression profiling revealed a number of PLA members expressing differentially and significantly under abiotic stresses and reproductive development. Comparative expression analysis with Arabidopsis PLAs revealed a high degree of functional conservation between the orthologs in two plant species, which also indicated the vital role of PLAs in stress signaling and plant development across different plant species. Moreover, sub-cellular localization of a few candidates suggests their differential localization and functional role in the lipid signaling. Conclusion/Significance: The comprehensive analysis and expression profiling would provide a critical platform for the functional characterization of the candidate PLA genes in crop plants.	[Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Dept Plant Mol Biol, New Delhi, India		Singh, A (corresponding author), Dept Plant Mol Biol, Univ Delhi S Campus, New Delhi, India.	gkpandey@south.du.ac.in	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	This work was supported by the Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Clewley J P, 1997, Methods Mol Biol, V70, P119; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Matos AR, 2008, PHYSIOL PLANTARUM, V134, P110, DOI 10.1111/j.1399-3054.2008.01123.x; Matos AR, 2009, PLANT PHYSIOL BIOCH, V47, P491, DOI 10.1016/j.plaphy.2009.02.011; Matos AR, 2001, FEBS LETT, V491, P188, DOI 10.1016/S0014-5793(01)02194-9; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; MAY C, 1998, BBA-LIPID LIPID MET, V1393, P267; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Paul RU, 1998, PLANT J, V16, P601, DOI 10.1046/j.1365-313x.1998.00333.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2010, TRENDS PLANT SCI, V15, P693, DOI 10.1016/j.tplants.2010.09.005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30947	10.1371/journal.pone.0030947	http://dx.doi.org/10.1371/journal.pone.0030947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	23028594	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600094
J	Singh, A; Dey, AB; Mohan, A; Sharma, PK; Mitra, DK				Singh, Amar; Dey, Aparajita Ballave; Mohan, Anant; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar			Foxp(3+) Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-gamma Producing T Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PD-1 EXPRESSION; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; TH1 RESPONSES; INFECTION; SUPPRESSION; EXPANSION; LIGANDS	CD(4+)CD(25+)Foxp(3+) Regulatory T cells (Treg) and programmed death-1 (PD-1) molecules have emerged as pivotal players in immune suppression of chronic diseases. However, their impact on the disease severity, therapeutic response and restoration of immune response in human tuberculosis remains unclear. Here, we describe the possible role of Treg cells, their M. tuberculosis driven expansion and contribution of PD-1 pathway to the suppressive function of Treg cells among pulmonary tuberculosis (PTB) patients. Multicolor flow cytometry, cell culture, cells sorting and ELISA were employed to execute the study. Our results showed significant increase in frequency of antigen-reactive Treg cells, which gradually declined during successful therapy and paralleled with decline of M. tuberculosis-specific IL-10 along with elevation of IFN-gamma production, and raising the IFN-gamma/IL-4 ratio. Interestingly, persistence of Treg cells tightly correlated with MDR tuberculosis. Also, we show that blocking PD-1/PD-L1 pathway abrogates Treg-mediated suppression, suggesting that the PD-1/PD-L1 pathway is required for Treg-mediated suppression of the antigen-specific T cells. Treg cells possibly play a role in dampening the effector immune response and abrogating PD-1 pathway on Treg cells significantly rescued protective T cell response, suggesting its importance in immune restoration among tuberculosis patients.	[Singh, Amar; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Dey, Aparajita Ballave; Mohan, Anant] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mitra, DK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by the Department of Biotechnology and the Indian Council of Medical Research, Government of India, New Delhi, India. For this study the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Antas PRZ, 2007, AM J RESP CRIT CARE, V176, P214, DOI 10.1164/ajrccm.176.2.214; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sharma S, 2009, AM J RESP CRIT CARE, V179; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	49	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44728	10.1371/journal.pone.0044728	http://dx.doi.org/10.1371/journal.pone.0044728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028594	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400035
